PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yu, WD; Ramakrishnan, R; Wang, Y; Chiang, K; Sung, TL; Rice, AP				Yu, Wendong; Ramakrishnan, Rajesh; Wang, Yan; Chiang, Karen; Sung, Tzu-Ling; Rice, Andrew P.			Cyclin T1-Dependent Genes in Activated CD4(+) T and Macrophage Cell Lines Appear Enriched in HIV-1 Co-Factors	PLOS ONE			English	Article								HIV-1 is dependent upon cellular co-factors to mediate its replication cycle in CD4(+) T cells and macrophages, the two major cell types infected by the virus in vivo. One critical co-factor is Cyclin T1, a subunit of a general RNA polymerase II elongation factor known as P-TEFb. Cyclin T1 is targeted directly by the viral Tat protein to activate proviral transcription. Cyclin T1 is up-regulated when resting CD4(+) T cells are activated and during macrophage differentiation or activation, conditions that are also necessary for high levels of HIV-1 replication. Because Cyclin T1 is a subunit of a transcription factor, the up-regulation of Cyclin T1 in these cells results in the induction of cellular genes, some of which might be HIV-1 co-factors. Using shRNA depletions of Cyclin T1 and transcriptional profiling, we identified 54 cellular mRNAs that appear to be Cyclin T1-dependent for their induction in activated CD4(+) T Jurkat T cells and during differentiation and activation of MM6 cells, a human monocytic cell line. The promoters for these Cyclin T1-dependent genes (CTDGs) are over-represented in two transcription factor binding sites, SREBP1 and ARP1. Notably, 10 of these CTDGs have been reported to be involved in HIV-1 replication, a significant over-representation of such genes when compared to randomly generated lists of 54 genes ( p value<0.00021). The results of siRNA depletion and dominant-negative protein experiments with two CTDGs identified here, CDK11 and Casein kinase 1 gamma 1, suggest that these genes are involved either directly or indirectly in HIV-1 replication. It is likely that the 54 CTDGs identified here include novel HIV-1 co-factors. The presence of CTDGs in the protein space that was available for HIV-1 to sample during its evolution and acquisition of Tat function may provide an explanation for why CTDGs are enriched in viral co-factors.	[Yu, Wendong; Ramakrishnan, Rajesh; Wang, Yan; Chiang, Karen; Sung, Tzu-Ling; Rice, Andrew P.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Yu, WD (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.	arice@bcm.tmc.edu		Rice, Andrew/0000-0002-1237-4769; Yu, Wendong/0000-0001-8958-6762	NIH [AI35381, AI45374]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI035381, R01AI035381, R21AI045374, R01AI045374] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the NIH (AI35381 and AI45374).	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354; Barboric M, 2005, PLOS BIOL, V3, P200, DOI 10.1371/journal.pbio.0030076; Barboric M, 2005, J VIROL, V79, P11135, DOI 10.1128/JVI.79.17.11135-11141.2005; Bengoechea-Alonso MT, 2007, CURR OPIN CELL BIOL, V19, P215, DOI 10.1016/j.ceb.2007.02.004; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; Bevec D, 1996, SCIENCE, V271, P1858, DOI 10.1126/science.271.5257.1858; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; De Martino MU, 2004, MOL ENDOCRINOL, V18, P820, DOI 10.1210/me.2003-0341; Dufner A, 2006, P NATL ACAD SCI USA, V103, P988, DOI 10.1073/pnas.0510380103; Freedland Eric S, 2004, Nutr Metab (Lond), V1, P12, DOI 10.1186/1743-7075-1-12; Garber ME, 1999, CURR OPIN IMMUNOL, V11, P460, DOI 10.1016/S0952-7915(99)80077-6; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Hauber I, 2005, J CLIN INVEST, V115, P76, DOI 10.1172/JCI200521949; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Herrmann CH, 1998, J VIROL, V72, P9881, DOI 10.1128/JVI.72.12.9881-9888.1998; HERRMANN CH, 1995, J VIROL, V69, P1612, DOI 10.1128/JVI.69.3.1612-1620.1995; Hoque M, 2003, MOL CELL BIOL, V23, P1688, DOI 10.1128/MCB.23.5.1688-1702.2003; HUANG Y, 1993, TOUGHENED PLASTICS, V1, P1; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Lam LT, 2001, GENOME BIOL, V2; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Liou LY, 2006, J LEUKOCYTE BIOL, V79, P388, DOI 10.1189/jlb.0805429; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Liou LY, 2004, J VIROL, V78, P8114, DOI 10.1128/JVI.78.15.8114-8119.2004; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Ma XT, 2004, ACTA BIOCH BIOPH SIN, V36, P250, DOI 10.1093/abbs/36.4.250; Meanwell NA, 2007, CURR OPIN INVEST DR, V8, P669; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Moriuchi M, 1998, J CLIN INVEST, V102, P1540, DOI 10.1172/JCI4151; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Park Joo-In, 2003, Keio Journal of Medicine, V52, P174; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Piguet V, 1998, EMBO J, V17, P2472, DOI 10.1093/emboj/17.9.2472; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rice AP, 2003, CURR HIV RES, V1, P395, DOI 10.2174/1570162033485159; RICE AP, 2007, FUTURE HIV THER, V1, P369; RICH EA, 1992, J CLIN INVEST, V89, P176, DOI 10.1172/JCI115559; RITTNER K, 1995, J MOL BIOL, V248, P562, DOI 10.1006/jmbi.1995.0243; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; SOUTHGATE CD, 1991, GENE DEV, V5, P2496, DOI 10.1101/gad.5.12b.2496; SPINA CA, 1995, J VIROL, V69, P2977, DOI 10.1128/JVI.69.5.2977-2988.1995; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Sung TL, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-66; Wang Y, 2006, VIROLOGY, V352, P485, DOI 10.1016/j.virol.2006.05.013; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Yang XZ, 1996, J VIROL, V70, P4576, DOI 10.1128/JVI.70.7.4576-4584.1996; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yu WD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-32; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	65	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3146	10.1371/journal.pone.0003146	http://dx.doi.org/10.1371/journal.pone.0003146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773076	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420100004
J	Uttl, B; Graf, P; Siegenthaler, AL				Uttl, Bob; Graf, Peter; Siegenthaler, Amy L.			The Influence of Object Relative Size on Priming and Explicit Memory	PLOS ONE			English	Article							IMPLICIT MEMORY; 3-DIMENSIONAL OBJECTS; WORD IDENTIFICATION; FRAGMENT COMPLETION; RECOGNITION; ASSOCIATIONS; ORIENTATION; SPECIFICITY; INVARIANCE; SHAPE	We investigated the effects of object relative size on priming and explicit memory for color photos of common objects. Participants were presented with color photos of pairs of objects displayed in either appropriate or inappropriate relative sizes. Implicit memory was assessed by speed of object size ratings whereas explicit memory was assessed by an old/new recognition test. Study-to-test changes in relative size reduced both priming and explicit memory and had large effects for objects displayed in large vs. small size at test. Our findings of substantial size-specific influences on priming with common objects under some but not other conditions are consistent with instance views of object perception and priming but inconsistent with structural description views.	[Uttl, Bob] Red Deer Coll, Red Deer, AB, Canada; [Graf, Peter] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada; [Siegenthaler, Amy L.] Lifemark Hlth Ctr, Calgary, AB, Canada	University of British Columbia	Uttl, B (corresponding author), Red Deer Coll, Red Deer, AB, Canada.	uttlbob@gmail.com						BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; CAVE CB, 1992, J EXP PSYCHOL LEARN, V18, P509, DOI 10.1037/0278-7393.18.3.509; CHURCH BA, 1994, J EXP PSYCHOL LEARN, V20, P521, DOI 10.1037/0278-7393.20.3.521; CRAIK FIM, 1974, Q J EXP PSYCHOL, V26, P274, DOI 10.1080/14640747408400413; CRAIK FIM, 2003, RETHINKING IMPLICIT, P327; FEUSTEL TC, 1983, J EXP PSYCHOL GEN, V112, P309, DOI 10.1037/0096-3445.112.3.309; FISER J, 1995, PERCEPTION, V24, P741, DOI 10.1068/p240741; Furmanski CS, 2000, VISION RES, V40, P473, DOI 10.1016/S0042-6989(99)00134-0; GRAF P, 1987, J EXP PSYCHOL LEARN, V13, P45, DOI 10.1037/0278-7393.13.1.45; GRAF P, 1990, J EXP PSYCHOL LEARN, V16, P978, DOI 10.1037/0278-7393.16.6.978; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; GRAF P, 1989, J EXP PSYCHOL LEARN, V15, P930, DOI 10.1037/0278-7393.15.5.930; JACOBY LL, 1981, J EXP PSYCHOL GEN, V110, P306, DOI 10.1037/0096-3445.110.3.306; JACOBY LL, 1987, J EXP PSYCHOL LEARN, V13, P456, DOI 10.1037/0278-7393.13.3.456; JOLICOEUR P, 1987, MEM COGNITION, V15, P531, DOI 10.3758/BF03198388; KOLERS PA, 1973, MEM COGNITION, V1, P347, DOI 10.3758/BF03198119; KOLERS PA, 1985, J EXP PSYCHOL HUMAN, V11, P726, DOI 10.1037/0096-1523.11.6.726; KOLERS PA, 1976, J EXP PSYCHOL-HUM L, V2, P554, DOI 10.1037/0278-7393.2.5.554; Loftus GR, 2005, PSYCHON B REV, V12, P43, DOI 10.3758/BF03196348; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; Marr D., 1982, VISION; Masson MEJ, 2003, CAN J EXP PSYCHOL, V57, P203, DOI 10.1037/h0087426; MASSON MEJ, 1986, J EXP PSYCHOL LEARN, V12, P479, DOI 10.1037/0278-7393.12.4.479; Osterberg G., 1935, ACTA OPHTHALMOL    S, V13, P1; Poldrack RA, 1996, PSYCHON B REV, V3, P434, DOI 10.3758/BF03214547; ROEDIGER HL, 1987, MEM COGNITION, V15, P379, DOI 10.3758/BF03197728; RUDNICKY AI, 1984, J EXP PSYCHOL HUMAN, V10, P231, DOI 10.1037/0096-1523.10.2.231; Rueckl J.G., 2003, RETHINKING IMPLICIT, P67; Ryan CS, 2003, PSYCHOL REC, V53, P467; Schacter D. L., 1994, MEMORY SYSTEMS 1994; SCHACTER DL, 1986, J EXP PSYCHOL LEARN, V12, P432, DOI 10.1037/0278-7393.12.3.432; SCHACTER DL, 1989, J EXP PSYCHOL LEARN, V15, P3, DOI 10.1037/0278-7393.15.1.3; SCHACTER DL, 1992, J EXP PSYCHOL LEARN, V18, P915, DOI 10.1037/0278-7393.18.5.915; Seamon JG, 1997, MEM COGNITION, V25, P367, DOI 10.3758/BF03211292; SNODGRASS JG, 1990, J EXP PSYCHOL GEN, V119, P276, DOI 10.1037/0096-3445.119.3.276; Srinivas K, 1996, MEM COGNITION, V24, P441, DOI 10.3758/BF03200933; Stankiewicz BJ, 2002, VIS COGN, V9, P719, DOI 10.1080/13506280143000232; STEELE LJ, 1998, CRIMINAL LAW B, V34, P348; TARR MJ, 1989, COGNITIVE PSYCHOL, V21, P233, DOI 10.1016/0010-0285(89)90009-1; TARR MJ, PSYCHONOMIC B REV, V2, P55; THIBOS LN, 1987, J OPT SOC AM A, V4, P1524, DOI 10.1364/JOSAA.4.001524; Thoma V, 2007, VIS COGN, V15, P179, DOI 10.1080/13506280500155627; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; TULVING E, 1993, EUR J COGN PSYCHOL, V5, P353, DOI 10.1080/09541449308520125; Uttl B, 1996, CAN J EXP PSYCHOL, V50, P87, DOI 10.1037/1196-1961.50.1.87; UTTL B, 2003, RETHINKING IMPLICIT, P302; Uttl B, 2007, SCAND J PSYCHOL, V48, P281, DOI 10.1111/j.1467-9450.2007.00571.x; Uttl B, 2006, SCAND J PSYCHOL, V47, P313, DOI 10.1111/j.1467-9450.2006.00532.x; WHITTLESEA BWA, 2003, RETHINKING IMPLICIT, P239, DOI DOI 10.1093/ACPROF:OSO/9780192632326.003.0011; ZIMMER HD, 1995, PSYCHOL RES-PSYCH FO, V57, P260, DOI 10.1007/BF00431287	55	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3109	10.1371/journal.pone.0003109	http://dx.doi.org/10.1371/journal.pone.0003109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422GW	18769670	gold, Green Published, Green Submitted			2022-12-27	WOS:000264416600005
J	Azuma, M; Kabe, Y; Kuramori, C; Kondo, M; Yamaguchi, Y; Handa, H				Azuma, Motoki; Kabe, Yasuaki; Kuramori, Chikanori; Kondo, Masao; Yamaguchi, Yuki; Handa, Hiroshi			Adenine Nucleotide Translocator Transports Haem Precursors into Mitochondria	PLOS ONE			English	Article							ADP/ATP CARRIER; IDENTIFICATION; PORPHYRINS; RESIDUES; SYNTHASE; MMFF94S; BAX	Haem is a prosthetic group for haem proteins, which play an essential role in oxygen transport, respiration, signal transduction, and detoxification. In haem biosynthesis, the haem precursor protoporphyrin IX (PP IX) must be accumulated into the mitochondrial matrix across the inner membrane, but its mechanism is largely unclear. Here we show that adenine nucleotide translocator (ANT), the inner membrane transporter, contributes to haem biosynthesis by facilitating mitochondrial accumulation of its precursors. We identified that haem and PP IX specifically bind to ANT. Mitochondrial uptake of PP IX was inhibited by ADP, a known substrate of ANT. Conversely, ADP uptake into mitochondria was competitively inhibited by haem and its precursors, suggesting that haem-related porphyrins are accumulated into mitochondria via ANT. Furthermore, disruption of the ANT genes in yeast resulted in a reduction of haem biosynthesis by blocking the translocation of haem precursors into the matrix. Our results represent a new model that ANT plays a crucial role in haem biosynthesis by facilitating accumulation of its precursors into the mitochondrial matrix.	[Azuma, Motoki; Kuramori, Chikanori; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa, Japan; [Kabe, Yasuaki] Keio Univ, Sch Med, Dept Integrat Med Biol, Tokyo 108, Japan; [Kondo, Masao] Toyoko Gakuen Womens Coll, Dept Early Childhood Care & Ed, Tokyo, Japan; [Handa, Hiroshi] Tokyo Inst Technol, Integrated Rese Inst, Solutions Res Org, Yokohama, Kanagawa, Japan	Tokyo Institute of Technology; Keio University; Tokyo Institute of Technology	Azuma, M (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X	New Energy and Industrial Technology Development Organization (NEDO); Japan Science and Technology Agency (JST)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported by a Grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Industrial Technology Development Organization (NEDO) and by Special Coordination Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST).	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Ascoli F, 1981, Methods Enzymol, V76, P72; Belzacq AS, 2003, CANCER RES, V63, P541; DAUM G, 1982, J BIOL CHEM, V257, P3028; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO;2-T; Hase Y, 2008, BIOCHEM BIOPH RES CO, V366, P66, DOI 10.1016/j.bbrc.2007.11.107; Heidkamper D, 1996, BIOCHEMISTRY-US, V35, P16144, DOI 10.1021/bi960668j; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Kabe Y, 2006, J BIOL CHEM, V281, P31729, DOI 10.1074/jbc.M604729200; Koch M, 2004, EMBO J, V23, P1720, DOI 10.1038/sj.emboj.7600189; KONDO M, 1987, LC FAMILY JASCO REPO, V22, P5; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Machida K, 2002, J BIOL CHEM, V277, P31243, DOI 10.1074/jbc.M204564200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Muller V, 1997, BIOCHEMISTRY-US, V36, P16008, DOI 10.1021/bi971867l; Ohtsu Y, 2005, ANAL BIOCHEM, V338, P245, DOI 10.1016/j.ab.2004.10.006; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Palmieri L, 2001, J BIOL CHEM, V276, P1916, DOI 10.1074/jbc.M004332200; PAUL MF, 1994, J BIOL CHEM, V269, P26158; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; PROULX KL, 1993, PROTEIN SCI, V2, P1092, DOI 10.1002/pro.5560020703; Robinson AJ, 2006, P NATL ACAD SCI USA, V103, P2617, DOI 10.1073/pnas.0509994103; SASSA S, 1977, J BIOL CHEM, V252, P2428; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; VERMA A, 1987, P NATL ACAD SCI USA, V84, P2256, DOI 10.1073/pnas.84.8.2256; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	27	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3070	10.1371/journal.pone.0003070	http://dx.doi.org/10.1371/journal.pone.0003070			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728780	Green Submitted, gold, Green Published			2022-12-27	WOS:000264796400010
J	Taylor, SL; Pollard, KS				Taylor, Sandra L.; Pollard, Katherine S.			Evaluation of Two Methods to Estimate and Monitor Bird Populations	PLOS ONE			English	Article							DETECTION PROBABILITY; ABUNDANCE; RECAPTURE; DENSITY; REMOVAL; CAPTURE	Background: Effective management depends upon accurately estimating trends in abundance of bird populations over time, and in some cases estimating abundance. Two population estimation methods, double observer (DO) and double sampling (DS), have been advocated for avian population studies and the relative merits and short-comings of these methods remain an area of debate. Methodology/Principal Findings: We used simulations to evaluate the performances of these two population estimation methods under a range of realistic scenarios. For three hypothetical populations with different levels of clustering, we generated DO and DS population size estimates for a range of detection probabilities and survey proportions. Population estimates for both methods were centered on the true population size for all levels of population clustering and survey proportions when detection probabilities were greater than 20%. The DO method underestimated the population at detection probabilities less than 30% whereas the DS method remained essentially unbiased. The coverage probability of 95% confidence intervals for population estimates was slightly less than the nominal level for the DS method but was substantially below the nominal level for the DO method at high detection probabilities. Differences in observer detection probabilities did not affect the accuracy and precision of population estimates of the DO method. Population estimates for the DS method remained unbiased as the proportion of units intensively surveyed changed, but the variance of the estimates decreased with increasing proportion intensively surveyed. Conclusions/Significance: The DO and DS methods can be applied in many different settings and our evaluations provide important information on the performance of these two methods that can assist researchers in selecting the method most appropriate for their particular needs.	[Taylor, Sandra L.; Pollard, Katherine S.] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA	University of California System; University of California Davis	Taylor, SL (corresponding author), Univ Calif Davis, Dept Stat, Davis, CA 95616 USA.	sltaylor@ucdavis.edu		Taylor, Sandra/0000-0001-7811-812X				Anderson DR, 2003, WILDLIFE SOC B, V31, P288; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; [Anonymous], 1982, ESTIMATION ANIMAL AB; Barbraud C, 2004, J FIELD ORNITHOL, V75, P172, DOI 10.1648/0273-8570-75.2.172; Bart J, 2004, WILDLIFE SOC B, V32, P1242, DOI 10.2193/0091-7648(2004)032[1242:DEIWS]2.0.CO;2; Bart J, 2002, AUK, V119, P36, DOI 10.1642/0004-8038(2002)119[0036:DSTEDA]2.0.CO;2; BART J, 1998, SAMPLING STAT METHOD; Brown S, 2007, CONDOR, V109, P1, DOI 10.1650/0010-5422(2007)109[1:SAADOT]2.0.CO;2; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cochran W.G., 1953, SAMPLING TECHNIQUES, Vsecond; Conway CJ, 2003, J WILDLIFE MANAGE, V67, P501, DOI 10.2307/3802708; COOK RD, 1979, BIOMETRICS, V35, P735, DOI 10.2307/2530104; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; EARNST SL, 2005, BIRD CONSERVATION IM, P781; Moore JE, 2004, AUK, V121, P865, DOI 10.1642/0004-8038(2004)121[0865:FCORAM]2.0.CO;2; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Norvell RE, 2003, AUK, V120, P1013, DOI 10.1642/0004-8038(2003)120[1013:ASCORA]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pollock KH, 2000, J AM STAT ASSOC, V95, P293; POLLOCK KH, 1991, J AM STAT ASSOC, V86, P225, DOI 10.2307/2289733; *R DEV COR TEAM, 2006, LANG ENV STAT COMP V; Thompson S.K., 2012, SAMPLING, V2nd; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2	23	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3047	10.1371/journal.pone.0003047	http://dx.doi.org/10.1371/journal.pone.0003047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728775	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796400005
J	Willis, ND; Cox, TR; Rahman-Casans, SF; Smits, K; Przyborski, SA; van den Brandt, P; van Engeland, M; Weijenberg, M; Wilson, RG; de Bruine, A; Hutchison, CJ				Willis, Naomi D.; Cox, Thomas R.; Rahman-Casans, Syed F.; Smits, Kim; Przyborski, Stefan A.; van den Brandt, Piet; van Engeland, Manon; Weijenberg, Matty; Wilson, Robert G.; de Bruine, Adriaan; Hutchison, Christopher J.			Lamin A/C Is a Risk Biomarker in Colorectal Cancer	PLOS ONE			English	Article								Background: A-type lamins are type V intermediate filament proteins encoded by the gene LMNA. Mutations in LMNA give rise to diverse degenerative diseases related to premature ageing. A-type lamins also influence the activity of the Retinoblastoma protein (pRb) and oncogenes such a beta-catenin. Consequently, it has been speculated that expression of A-type lamins may also influence tumour progression. Methodology/Principal Findings: An archive of colorectal cancer (CRC) and normal colon tissue was screened for expression of A-type lamins. We used the Cox proportional hazard ratio (HR) method to investigate patient survival. Using CRC cell lines we investigated the effects of lamin A expression on other genes by RT-PCR; on cell growth by FACS analysis; and on invasiveness by cell migration assays and siRNA knockdown of targeted genes. We found that lamin A is expressed in colonic stem cells and that patients with A-type lamin-expressing tumours have significantly worse prognosis than patients with A-type lamin negative tumours (HR = 1.85, p = 0.005). To understand this finding, we established a model system based upon expression of GFP-lamin A in CRC cells. We found that expression of GFP-lamin A in these cells did not affect cell proliferation but did promote greatly increased cell motility and invasiveness. The reason for this increased invasiveness was that expression of lamin A promoted up-regulation of the actin bundling protein T-plastin, leading to down regulation of the cell adhesion molecule E-cadherin. Conclusions: Expression of A-type lamins increases the risk of death from CRC because its presence gives rise to increased invasiveness and potentially a more stem cell-like phenotype. This report directly links A-type lamin expression to tumour progression and raises the profile of LMNA from one implicated in multiple but rare genetic conditions to a gene involved in one of the commonest diseases in the Western World.	[Willis, Naomi D.; Cox, Thomas R.; Przyborski, Stefan A.; Hutchison, Christopher J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Rahman-Casans, Syed F.; Wilson, Robert G.] James Cook Univ Hosp, Middlesbrough, Cleveland, England; [Smits, Kim; van den Brandt, Piet; Weijenberg, Matty] Univ Maastricht, Dept Epidemiol, Maastricht, Netherlands; [van Engeland, Manon; de Bruine, Adriaan] Univ Maastricht, Dept Pathol, Maastricht, Netherlands	Durham University; James Cook University Hospital; Maastricht University; Maastricht University	Willis, ND (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	c.j.hutchison@durham.ac.uk	van Engeland, Manon/A-7479-2009	van Engeland, Manon/0000-0002-7952-6843; Cox, Thomas/0000-0001-9294-1745; van den Brandt, Piet/0000-0001-8781-8099	National Health Service Research and Development Funds; Association for International Cancer Research; European Union Framework Program 6	National Health Service Research and Development Funds; Association for International Cancer Research; European Union Framework Program 6(European Commission)	National Health Service Research and Development Funds, Association for International Cancer Research, European Union Framework Program 6	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; BROERS JLV, 1993, AM J PATHOL, V143, P211; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cai WB, 1997, INT J RADIAT BIOL, V71, P573, DOI 10.1080/095530097143905; CANCE WG, 1992, J EXP CLIN CANC RES, V11, P233; COX DR, 1972, J R STAT SOC B, V34, P187; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dechat T, 2000, J CELL SCI, V113, P3473; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Dyer JA, 1997, CHROMOSOME RES, V5, P383, DOI 10.1023/A:1018496309156; Foran E, 2006, INT J CANCER, V118, P2098, DOI 10.1002/ijc.21593; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; HOZAK P, 1995, J CELL SCI, V108, P635; Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Kill IR, 1995, FEBS LETT, V377, P26, DOI 10.1016/0014-5793(95)01302-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lee KK, 2001, J CELL SCI, V114, P4567; LIN CS, 1993, J BIOL CHEM, V268, P2781; Lin F, 2005, HUM MOL GENET, V14, P437, DOI 10.1093/hmg/ddi040; LIN F, 1993, J BIOL CHEM, V268, P16321; MADSEN P, 1986, J CELL BIOL, V103, P2083, DOI 10.1083/jcb.103.6.2083; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Markiewicz E, 2006, EMBO J, V25, P3275, DOI 10.1038/sj.emboj.7601230; Moss SF, 1999, GUT, V45, P723, DOI 10.1136/gut.45.5.723; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; QIU JM, 1994, EPITHELIAL CELL BIOL, V3, P137; ROBER RA, 1989, DEVELOPMENT, V105, P365; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; STADELMANN B, 1990, LEUKEMIA RES, V14, P815, DOI 10.1016/0145-2126(90)90076-L; Tilli CMLJ, 2003, BRIT J DERMATOL, V148, P102, DOI 10.1046/j.1365-2133.2003.05026.x; Van Berlo JH, 2005, HUM MOL GENET, V14, P2839, DOI 10.1093/hmg/ddi316; VANDENBRANDT PA, 1990, INT J EPIDEMIOL, V19, P553; VANDENBRANDT PA, 1990, J CLIN EPIDEMIOL, V43, P285, DOI 10.1016/0895-4356(90)90009-E; Vaughan OA, 2001, J CELL SCI, V114, P2577; Venables RS, 2001, BRIT J CANCER, V84, P512, DOI 10.1054/bjoc.2000.1632; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Zhen YY, 2002, J CELL SCI, V115, P3207	50	165	170	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2988	10.1371/journal.pone.0002988	http://dx.doi.org/10.1371/journal.pone.0002988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714339	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264420900014
J	Coesel, S; Obornik, M; Varela, J; Falciatore, A; Bowler, C				Coesel, Sacha; Obornik, Miroslav; Varela, Joao; Falciatore, Angela; Bowler, Chris			Evolutionary Origins and Functions of the Carotenoid Biosynthetic Pathway in Marine Diatoms	PLOS ONE			English	Article							VIOLAXANTHIN DE-EPOXIDASE; XANTHOPHYLL-CYCLE; DIADINOXANTHIN CYCLE; GENE-EXPRESSION; LIGHT; PH; ARABIDOPSIS; ALGAE; PHOTOSYNTHESIS; IDENTIFICATION	Carotenoids are produced by all photosynthetic organisms, where they play essential roles in light harvesting and photoprotection. The carotenoid biosynthetic pathway of diatoms is largely unstudied, but is of particular interest because these organisms have a very different evolutionary history with respect to the Plantae and are thought to be derived from an ancient secondary endosymbiosis between heterotrophic and autotrophic eukaryotes. Furthermore, diatoms have an additional xanthophyll-based cycle for dissipating excess light energy with respect to green algae and higher plants. To explore the origins and functions of the carotenoid pathway in diatoms we searched for genes encoding pathway components in the recently completed genome sequences of two marine diatoms. Consistent with the supplemental xanthophyll cycle in diatoms, we found more copies of the genes encoding violaxanthin de-epoxidase (VDE) and zeaxanthin epoxidase (ZEP) enzymes compared with other photosynthetic eukaryotes. However, the similarity of these enzymes with those of higher plants indicates that they had very probably diversified before the secondary endosymbiosis had occurred, implying that VDE and ZEP represent early eukaryotic innovations in the Plantae. Consequently, the diatom chromist lineage likely obtained all paralogues of ZEP and VDE genes during the process of secondary endosymbiosis by gene transfer from the nucleus of the algal endosymbiont to the host nucleus. Furthermore, the presence of a ZEP gene in Tetrahymena thermophila provides the first evidence for a secondary plastid gene encoded in a heterotrophic ciliate, providing support for the chromalveolate hypothesis. Protein domain structures and expression analyses in the pennate diatom Phaeodactylum tricornutum indicate diverse roles for the different ZEP and VDE isoforms and demonstrate that they are differentially regulated by light. These studies therefore reveal the ancient origins of several components of the carotenoid biosynthesis pathway in photosynthetic eukaryotes and provide information about how they have diversified and acquired new functions in the diatoms.	[Coesel, Sacha; Falciatore, Angela; Bowler, Chris] Stazione Zool Anton Dohrn, Cell Signalling Lab, Naples, Italy; [Obornik, Miroslav] Univ S Bohemia, Acad Sci Czech Republic, Fac Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Varela, Joao] Univ Algarve, Ctr Marine Sci, Faro, Portugal; [Bowler, Chris] Ecole Normale Superieure, Dept Biol, CNRS UMR8186, Paris, France	Stazione Zoologica Anton Dohrn di Napoli; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Universidade do Algarve; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Coesel, S (corresponding author), Stazione Zool Anton Dohrn, Cell Signalling Lab, Naples, Italy.	cbowler@biologie.ens.fr	Obornik, Miroslav/G-9350-2014; Varela, João/M-4223-2013; Falciatore, Angela/Q-6161-2018; Coesel, Sacha/AAX-5588-2021; Bowler, Chris/AAC-6256-2019	Varela, João/0000-0003-3101-693X; Coesel, Sacha/0000-0001-9422-8388; Bowler, Chris/0000-0003-3835-6187; Falciatore, Angela/0000-0003-3318-9578	EU-funded FP6 Diatomics project [LSHG-CT-2004-512035]; EU-FP6 Marine Genomics Network of Excellence [GOCE-CT-2004-505403]; CNRS; Agence Nationale de la Recherche (France); Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/BD/4839/2001]; Academy of Sciences of the Czech Republic [IAA500220502]; HFSP-CDA [0014/2006]; US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396];  [ATIP "Blanche"]	EU-funded FP6 Diatomics project; EU-FP6 Marine Genomics Network of Excellence(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); HFSP-CDA; US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); 	Funding for this work was obtained from the EU-funded FP6 Diatomics project (LSHG-CT-2004-512035), the EU-FP6 Marine Genomics Network of Excellence (GOCE-CT-2004-505403), an ATIP "Blanche" grant from CNRS, and the Agence Nationale de la Recherche (France) to CB, the Fundacao para a Ciencia e a Tecnologia (Portugal) to SC (SFRH/BD/4839/2001), the Grant Agency of the Academy of Sciences of the Czech Republic to MO (IAA500220502), and the HFSP-CDA (0014/2006) to AF. Diatom genome sequencing at the Joint Genome Institute (Walnut Creek, CA, USA) was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. P. tricornutum ESTs were generated at Genoscope (Evry, Paris).	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Allen AE, 2006, CURR OPIN PLANT BIOL, V9, P264, DOI 10.1016/j.pbi.2006.03.013; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Bohne F, 2002, BBA-GENE STRUCT EXPR, V1579, P26, DOI 10.1016/S0167-4781(02)00500-6; Bouvier F, 1996, J BIOL CHEM, V271, P28861, DOI 10.1074/jbc.271.46.28861; Bugos RC, 1996, P NATL ACAD SCI USA, V93, P6320, DOI 10.1073/pnas.93.13.6320; Bugos RC, 1998, J BIOL CHEM, V273, P15321, DOI 10.1074/jbc.273.25.15321; CAVALIERSMITH T, 1981, BIOSYSTEMS, V14, P461, DOI 10.1016/0303-2647(81)90050-2; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falciatore A, 2005, CURR TOP DEV BIOL, V68, P317, DOI 10.1016/S0070-2153(05)68011-8; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; FALKOWSKI PG, 1991, J PHYCOL, V27, P8, DOI 10.1111/j.0022-3646.1991.00008.x; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flower DR, 1996, BIOCHEM J, V318, P1; Ganfornina MD, 2000, MOL BIOL EVOL, V17, P114, DOI 10.1093/oxfordjournals.molbev.a026224; Goss R, 2003, PLANTA, V217, P801, DOI 10.1007/s00425-003-1044-1; Goss R, 2006, J PLANT PHYSIOL, V163, P1008, DOI 10.1016/j.jplph.2005.09.008; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; Grouneva I, 2006, PHYSIOL PLANTARUM, V126, P205, DOI 10.1111/j.1399-3054.2006.00613.x; Guillard R.R.L., 1975, CULTURE PHYTOPLANKTO; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; HAGER A, 1994, PLANTA, V192, P581, DOI 10.1007/BF00203597; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hieber AD, 2000, BBA-PROTEIN STRUCT M, V1482, P84, DOI 10.1016/S0167-4838(00)00141-2; Hieber AD, 2002, PLANTA, V214, P476, DOI 10.1007/s00425-001-0704-2; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Im CS, 2006, PLANT J, V48, P1, DOI 10.1111/j.1365-313X.2006.02852.x; Jakob T, 2001, J PLANT PHYSIOL, V158, P383, DOI 10.1078/0176-1617-00288; Joshua S, 2005, PLANT PHYSIOL, V138, P1577, DOI 10.1104/pp.105.061168; Kleine T, 2007, PLANT PHYSIOL, V144, P1391, DOI 10.1104/pp.107.098293; Kooistra, 2007, ORIGIN EVOLUTION DIA; Kooistra WHCF, 2003, PROG MOLEC, V33, P59; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lavaud J, 2003, BIOCHEMISTRY-US, V42, P5802, DOI 10.1021/bi027112i; Lavaud J, 2002, FEBS LETT, V523, P163, DOI 10.1016/S0014-5793(02)02979-4; Lavaud J, 2002, PLANT PHYSIOL, V129, P1398, DOI 10.1104/pp.002014; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Li SL, 2006, MOL BIOL EVOL, V23, P663, DOI 10.1093/molbev/msj075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Maheswari U, 2005, NUCLEIC ACIDS RES, V33, pD344, DOI 10.1093/nar/gki121; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Marin E, 1996, EMBO J, V15, P2331, DOI 10.1002/j.1460-2075.1996.tb00589.x; Marquardt J, 2004, EUR J PHYCOL, V39, P285, DOI 10.1080/09670260410001712572; Mewes H, 2002, PLANT PHYSIOL, V130, P1527, DOI 10.1104/pp.006775; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Montsant A, 2007, J PHYCOL, V43, P585, DOI 10.1111/j.1529-8817.2007.00342.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nakamura Y, 2003, DNA RES, V10, P181, DOI 10.1093/dnares/10.4.181; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2005, J EXP BOT, V56, P375, DOI 10.1093/jxb/eri056; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Patron NJ, 2004, EUKARYOT CELL, V3, P1169, DOI 10.1128/EC.3.5.1169-1175.2004; Paul MJ, 2003, J EXP BOT, V54, P539, DOI 10.1093/jxb/erg052; PFUNDEL EE, 1994, PLANT PHYSIOL, V106, P1647, DOI 10.1104/pp.106.4.1647; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Salier JP, 2000, BBA-PROTEIN STRUCT M, V1482, P25, DOI 10.1016/S0167-4838(00)00144-8; Schubert N, 2006, J PHYCOL, V42, P1208, DOI 10.1111/j.1529-8817.2006.00274.x; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; STRANSKY H, 1970, ARCH MIKROBIOL, V73, P315, DOI 10.1007/BF00412298; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wagner H, 2006, NEW PHYTOL, V169, P95, DOI 10.1111/j.1469-8137.2005.01550.x; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; YAMAMOTO HY, 1972, PLANT PHYSIOL, V49, P224, DOI 10.1104/pp.49.2.224; Yoon HS, 2004, MOL BIOL EVOL, V21, P809, DOI 10.1093/molbev/msh075	73	104	108	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2896	10.1371/journal.pone.0002896	http://dx.doi.org/10.1371/journal.pone.0002896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682837	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600052
J	Gambhir, M; Michael, E				Gambhir, Manoj; Michael, Edwin			Complex Ecological Dynamics and Eradicability of the Vector Borne Macroparasitic Disease, Lymphatic Filariasis	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI MICROFILARIAE; FACTORS AFFECTING TRANSMISSION; AGE-STRUCTURED MODEL; ANOPHELINE MOSQUITOS; MATHEMATICAL-MODELS; DENSITY-DEPENDENCE; SOUTH-INDIA; LIFE-SPAN; INFECTION; PONDICHERRY	Background: The current global efforts to control the morbidity and mortality caused by infectious diseases affecting developing countries - such as HIV/AIDS, polio, tuberculosis, malaria and the Neglected Tropical Diseases ( NTDs)-have led to an increasing focus on the biological controllability or eradicability of disease transmission by management action. Here, we use an age-structured dynamical model of lymphatic filariasis transmission to show how a quantitative understanding of the dynamic processes underlying infection persistence and extinction is key to evaluating the eradicability of this macroparasitic disease. Methodology/Principal Findings: We investigated the persistence and extinction dynamics of lymphatic filariasis by undertaking a numerical equilibrium analysis of a deterministic model of parasite transmission, based on varying values of the initial L3 larval density in the system. The results highlighted the likely occurrence of complex dynamics in parasite transmission with three major outcomes for the eradicability of filariasis. First, both vector biting and worm breakpoint thresholds are shown to be complex dynamic entities with values dependent on the nature and magnitude of vector-and host specific density-dependent processes and the degree of host infection aggregation prevailing in endemic communities. Second, these thresholds as well as the potential size of the attractor domains and hence system resilience are strongly dependent on peculiarities of infection dynamics in different vector species. Finally, the existence of multiple stable states indicates the presence of hysteresis nonlinearity in the filariasis system dynamics in which infection thresholds for infection invasion are lower but occur at higher biting rates than do the corresponding thresholds for parasite elimination. Conclusions/Significance: The variable dynamic nature of thresholds and parasite system resilience reflecting both initial conditions and vector species-infection specificities, and the existence of hysteresis loop phenomenon, suggests that eradication of filariasis may require taking a more flexible and locally relevant approach to designing elimination programmes compared to the current command and control approach advocated by the global programme.	[Gambhir, Manoj; Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England	Imperial College London	Gambhir, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Dept Infect Dis Epidemiol, London, England.	m.gambhir@imperial.ac.uk	Michael, Edwin/D-3388-2014	Gambhir, Manoj/0000-0002-4831-6261	NIH [RO1 AI069387-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069387] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work of MG and EM was financially supported by NIH grant no. RO1 AI069387-01A1.	Allison H., 2006, SCI POLICY NATURAL R; Avise J, 2004, MOL MARKERS NATURAL; Berec L, 2007, TRENDS ECOL EVOL, V22, P185, DOI 10.1016/j.tree.2006.12.002; BRYAN JH, 1988, T ROY SOC TROP MED H, V82, P138, DOI 10.1016/0035-9203(88)90288-X; Burgman M., 2005, RISKS DECISIONS CONS; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; CHAN MS, 1995, EPIDEMIOL INFECT, V115, P325, DOI 10.1017/S0950268800058453; DAS PK, 1992, EPIDEMIOL INFECT, V108, P483, DOI 10.1017/S0950268800049992; Duerr HP, 2005, TRENDS PARASITOL, V21, P88, DOI 10.1016/j.pt.2004.11.011; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Freeland J., 2005, MOL ECOLOGY CHICHEST; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; GRENFELL BT, 1992, PARASITOLOGY, V104, pS81, DOI 10.1017/S0031182000075260; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Gyorkos TW, 2003, ACTA TROP, V86, P275, DOI 10.1016/S0001-706X(03)00048-2; HAIRSTON NG, 1968, B WORLD HEALTH ORGAN, V38, P935; HO BC, 1967, T ROY SOC TROP MED H, V61, P663, DOI 10.1016/0035-9203(67)90130-7; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holling C.S., 1978, ADAPTIVE ENV ASSESSM; Holling CS, 1996, CONSERV BIOL, V10, P328, DOI 10.1046/j.1523-1739.1996.10020328.x; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; King CL, 2001, PARASITE IMMUNOL, V23, P363, DOI 10.1046/j.1365-3024.2001.00395.x; Lammie PJ, 2006, TRENDS PARASITOL, V22, P313, DOI 10.1016/j.pt.2006.05.009; Lande R., 2003, OXFORD SERIES ECOLOG; LUDWIG D, 1978, J ANIM ECOL, V47, P315, DOI 10.2307/3939; Ludwig D., 1997, CONSERV ECOL, V1, P1; MAIZELS RM, 1993, NATURE, V365, P797, DOI 10.1038/365797a0; MAY R, 1973, STABILITY COMPLEXICI; MAY RM, 1977, MATH BIOSCI, V35, P301, DOI 10.1016/0025-5564(77)90030-X; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2007, ADV PARASIT, V65, P191, DOI 10.1016/S0065-308X(07)65003-9; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; OTTESEN EA, 1995, PARASITOL TODAY, V11, P129, DOI 10.1016/0169-4758(95)80128-6; Pichon G, 2002, ANN TROP MED PARASIT, V96, pS143, DOI 10.1179/000349802125002509; Rajagopalan P.K., 1980, Proceedings of the Indian National Science Academy Part B Biological Sciences, V46, P745; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Snow LC, 2006, MED VET ENTOMOL, V20, P261, DOI 10.1111/j.1365-2915.2006.00629.x; Snow LC, 2002, MED VET ENTOMOL, V16, P409, DOI 10.1046/j.1365-2915.2002.00396.x; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; SUBRAMANIAN S, 1994, AM J TROP MED HYG, V51, P244, DOI 10.4269/ajtmh.1994.51.244; SUBRAMANIAN S, 1989, EPIDEMIOL INFECT, V103, P693, DOI 10.1017/S0950268800031095; Subramanian S, 1998, PARASITOLOGY, V116, P243, DOI 10.1017/S0031182097002254; Turner SJ, 2001, GUIDEBOOK FOR INTEGRATED ECOLOGICAL ASSESSMENTS, P29; Utzinger J, 2006, PLOS MED, V3, P585, DOI 10.1371/journal.pmed.0030112; VANAMAIL P, 1990, INDIAN J MED RES-A, V91, P293; Vanamail P, 1996, T ROY SOC TROP MED H, V90, P119, DOI 10.1016/S0035-9203(96)90106-6; Walker B, 2004, ECOL SOC, V9; Walters C., 1986, ADAPTIVE MANAGEMENT; WANG YH, 1980, J ANIM ECOL, V49, P435, DOI 10.2307/4256	55	56	56	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2874	10.1371/journal.pone.0002874	http://dx.doi.org/10.1371/journal.pone.0002874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716676	Green Published, Green Submitted			2022-12-27	WOS:000264366600030
J	Han, YX; Wang, XJ; Dang, Y; Zheng, YH				Han, Yanxing; Wang, Xiaojun; Dang, Ying; Zheng, Yong-Hui			Demonstration of a Novel HIV-1 Restriction Phenotype from a Human T Cell Line	PLOS ONE			English	Article								Background: Although retroviruses may invade host cells, a productive infection can be established only after the virus counteracts inhibition from different types of host restriction factors. Fv1, APOBEC3G/F, TRIM5 alpha, ZAP, and CD317 inhibit the replication of different retroviruses by interfering with viral uncoating, reverse transcription, nuclear import, RNA stability, and release. In humans, although APOBEC3G/3F and CD317 block HIV-1 replication, their antiviral activities are neutralized by viral proteins Vif and Vpu. So far, no human gene has been found to effectively block wild type HIV-1 replication under natural condition. Thus, identification of such a gene product would be of great medical importance for the development of HIV therapies. Method and Findings: In this study, we discovered a new type of host restriction against the wild type HIV-1 from a CD4/CXCR4 double-positive human T cell line. We identified a CEM-derived cell line (CEM.NKR) that is highly resistant to productive HIV-1 infection. Viral production was reduced by at least 1000-fold when compared to the other permissive human T cell lines such as H9, A3.01, and CEM-T4. Importantly, this resistance was evident at extremely high multiplicity of infection. Further analyses demonstrated that HIV-1 could finish the first round of replication in CEM.NKR cells, but the released virions were poorly infectious. These virions could enter the target cells, but failed to initiate reverse transcription. Notably, this restriction phenotype was also present in CEM.NKR and 293T heterokaryons. Conclusions: These results clearly indicate that CEM.NKR cells express a HIV inhibitory gene(s). Further characterization of this novel gene product(s) will reveal a new antiretroviral mechanism that directly inactivates wild type HIV-1.	[Han, Yanxing; Wang, Xiaojun; Dang, Ying; Zheng, Yong-Hui] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Michigan State University	Zheng, YH (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	zhengyo@msu.ed	Han, Yanxing/GRO-5138-2022	Wang, Xiaojun/0000-0003-4521-4099	National Institutes of Health [AI063944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI080225, R56AI063944, R01AI063944] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant AI063944 from the National Institutes of Health to Y.-H.Z.	Besnier C, 2002, P NATL ACAD SCI USA, V99, P11920, DOI 10.1073/pnas.172384599; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bour S, 2000, Adv Pharmacol, V48, P75; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Dang Y, 2008, J BIOL CHEM, V283, P13124, DOI 10.1074/jbc.M708728200; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Dettenhofer M, 2001, J BIOL CHEM, V276, P5985, DOI 10.1074/jbc.M008933200; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; HOWELL DN, 1985, J IMMUNOL, V134, P971; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; JOLICOEUR P, 1980, J VIROL, V33, P183, DOI 10.1128/JVI.33.1.183-195.1980; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Kozak CA, 1996, VIROLOGY, V225, P300, DOI 10.1006/viro.1996.0604; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; LILLY F, 1967, SCIENCE, V155, P461, DOI 10.1126/science.155.3761.461; Madani N, 1998, J VIROL, V72, P10251, DOI 10.1128/JVI.72.12.10251-10255.1998; Malyguine AM, 1998, IMMUNOL LETT, V61, P67, DOI 10.1016/S0165-2478(97)00164-8; Munk C, 2002, P NATL ACAD SCI USA, V99, P13843, DOI 10.1073/pnas.212400099; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; NEUMANN JR, 1987, BIOTECHNIQUES, V5, P444; OhAinle M, 2006, J VIROL, V80, P3853, DOI 10.1128/JVI.80.8.3853-3862.2006; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; ROWE WP, 1973, J EXP MED, V137, P850, DOI 10.1084/jem.137.3.850; SCOTT JE, 1995, J IMMUNOL, V155, P143; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Spenlehauer C, 2001, VIROLOGY, V280, P292, DOI 10.1006/viro.2000.0780; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; YANG WK, 1980, P NATL ACAD SCI-BIOL, V77, P2994, DOI 10.1073/pnas.77.5.2994; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	48	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2796	10.1371/journal.pone.0002796	http://dx.doi.org/10.1371/journal.pone.0002796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665212	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300015
J	Hansson, B; Hasselquist, D; Tarka, M; Zehtindjiev, P; Bensch, S				Hansson, Bengt; Hasselquist, Dennis; Tarka, Maja; Zehtindjiev, Pavel; Bensch, Staffan			Postglacial Colonisation Patterns and the Role of Isolation and Expansion in Driving Diversification in a Passerine Bird	PLOS ONE			English	Article								Pleistocene glacial cycles play a major role in diversification and speciation, although the relative importance of isolation and expansion in driving diversification remains debated. We analysed mitochondrial DNA sequence data from 15 great reed warbler (Acrocephalus arundinaceus) populations distributed over the vast Eurasian breeding range of the species, and revealed unexpected postglacial expansion patterns from two glacial refugia. There were 58 different haplotypes forming two major clades, A and B. Clade A dominated in Western Europe with declining frequencies towards Eastern Europe and the Middle East, but showed a surprising increase in frequency in Western and Central Asia. Clade B dominated in the Middle East, with declining frequencies towards north in Central and Eastern Europe and was absent from Western Europe and Central Asia. A parsimonious explanation for these patterns is independent postglacial expansions from two isolated refugia, and mismatch distribution analyses confirmed this suggestion. Gene flow analyses showed that clade A colonised both Europe and Asia from a refugium in Europe, and that clade B expanded much later and colonised parts of Europe from a refugium in the Middle East. Great reed warblers in the eastern parts of the range have slightly paler plumage than western birds (sometimes treated as separate subspecies; A. a. zarudnyi and A. a. arundinaceus, respectively) and our results suggest that the plumage diversification took place during the easterly expansion of clade A. This supports the postglacial expansion hypothesis proposing that postglacial expansions drive diversification in comparatively short time periods. However, there is no indication of any (strong) reproductive isolation between clades and our data show that the refugia populations became separated during the last glaciation. This is in line with the Pleistocene speciation hypothesis invoking that much longer periods of time in isolation are needed for speciation to occur.	[Hansson, Bengt; Hasselquist, Dennis; Tarka, Maja; Bensch, Staffan] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Zehtindjiev, Pavel] Bulgarian Acad Sci, Inst Zool, Sofia, Bulgaria	Lund University; Bulgarian Academy of Sciences	Hansson, B (corresponding author), Lund Univ, Dept Anim Ecol, Ecol Bldg, S-22362 Lund, Sweden.	bengt.hansson@zooekol.lu.se	Hansson, Bengt/L-8874-2013; Tarka, Maja/L-8065-2013; Hasselquist, Dennis/M-5223-2014; Zehtidiev, Pavel/K-3236-2012	Hansson, Bengt/0000-0001-6694-8169; Tarka, Maja/0000-0001-9651-1101; Hasselquist, Dennis/0000-0002-0056-6616; Zehtidiev, Pavel/0000-0002-9786-3974	Swedish Research Council; Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society; Crafoordska Stiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); National Swedish Environment Protection Board; Carl Tryggers stiftelse; Royal Swedish Academy of Science; Hierta-Retzius Foundations; Lunds Djurskyddsfond; Magn Bergvalls Stiftelse; National Geographic Society(National Geographic Society); Crafoordska Stiftelsen	The work was supported by grants from the Swedish Research Council (VR), the Swedish council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), the National Swedish Environment Protection Board, the Carl Tryggers stiftelse, the Royal Swedish Academy of Science (the K. and A. Wallenbergs, the J.A. Ahlstrand, and the Hierta-Retzius Foundations), the Lunds Djurskyddsfond, the Magn Bergvalls Stiftelse, the National Geographic Society and the Crafoordska Stiftelsen.	[Anonymous], 1992, HDB BIRDS EUROPE MID; Baker Allan J., 1997, P51, DOI 10.1016/B978-012498315-1/50005-4; Ben-Shlomo R, 2007, MAMM GENOME, V18, P164, DOI 10.1007/s00335-007-9001-0; BENSCH S, 1991, J ANIM ECOL, V60, P857, DOI 10.2307/5418; Bensch S, 1998, EVOLUTION, V52, P877, DOI 10.1111/j.1558-5646.1998.tb03712.x; Bensch S, 1999, BIOL J LINN SOC, V66, P171, DOI 10.1006/bijl.1998.0261; Bensch S, 1999, EVOLUTION, V53, P1925, DOI 10.1111/j.1558-5646.1999.tb04573.x; Coyne J.A., 2004, SPECIATION; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; De Roo A., 1969, Gerfaut, V59, P260; del Hoyo J., 2006, HDB BIRDS WORLD; GarciaRamos G, 1997, EVOLUTION, V51, P21, DOI 10.2307/2410956; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Hansson B, 2004, EVOLUTION, V58, P870; Hansson B, 2002, OECOLOGIA, V130, P536, DOI 10.1007/s00442-001-0831-2; Hansson B, 2001, P ROY SOC B-BIOL SCI, V268, P1287, DOI 10.1098/rspb.2001.1640; Hansson B, 2004, EVOLUTION, V58, P2546, DOI 10.1111/j.0014-3820.2004.tb00883.x; Hansson B, 2003, MOL ECOL, V12, P631, DOI 10.1046/j.1365-294X.2003.01772.x; Hansson B, 2000, ECOLOGY, V81, P319, DOI 10.2307/177429; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hansson B, 2002, J AVIAN BIOL, V33, P311, DOI 10.1034/j.1600-048X.2002.330314.x; Hasselquist D, 1998, ECOLOGY, V79, P2376, DOI 10.2307/176829; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; HUDSON RR, 1992, GENETICS, V132, P583; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; ILES MM, 1998, AM J HUM GENET, V63, pA42; Johnson NK, 2004, EVOLUTION, V58, P1122; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Mila B, 2007, P R SOC B, V274, P2653, DOI 10.1098/rspb.2007.0852; Mila B, 2007, MOL ECOL, V16, P159, DOI 10.1111/j.1365-294X.2006.03119.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; NYLANDER JAA, 2004, MRMODELTEST2; Odeen A, 2003, MOL ECOL, V12, P2113, DOI 10.1046/j.1365-294X.2003.01883.x; OTTVALL R, 2002, AVIAN SCI, V4, P237; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saetre GP, 1997, NATURE, V387, P589; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SEUTIN G, 1995, EVOLUTION, V49, P962, DOI 10.1111/j.1558-5646.1995.tb02331.x; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SPENCER HG, 1986, AM NAT, V128, P241, DOI 10.1086/284557; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wenink PW, 1996, EVOLUTION, V50, P318, DOI 10.1111/j.1558-5646.1996.tb04495.x; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; [No title captured]	59	46	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2794	10.1371/journal.pone.0002794	http://dx.doi.org/10.1371/journal.pone.0002794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665223	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300013
J	Ospina-Alvarez, N; Piferrer, F				Ospina-Alvarez, Natalia; Piferrer, Francesc			Temperature-Dependent Sex Determination in Fish Revisited: Prevalence, a Single Sex Ratio Response Pattern, and Possible Effects of Climate Change	PLOS ONE			English	Article								Background: In gonochoristic vertebrates, sex determination mechanisms can be classified as genotypic (GSD) or temperature-dependent (TSD). Some cases of TSD in fish have been questioned, but the prevalent view is that TSD is very common in this group of animals, with three different response patterns to temperature. Methodology/Principal Findings: We analyzed field and laboratory data for the 59 fish species where TSD has been explicitly or implicitly claimed so far. For each species, we compiled data on the presence or absence of sex chromosomes and determined if the sex ratio response was obtained within temperatures that the species experiences in the wild. If so, we studied whether this response was statistically significant. We found evidence that many cases of observed sex ratio shifts in response to temperature reveal thermal alterations of an otherwise predominately GSD mechanism rather than the presence of TSD. We also show that in those fish species that actually have TSD, sex ratio response to increasing temperatures invariably results in highly male-biased sex ratios, and that even small changes of just 1-2 degrees C can significantly alter the sex ratio from 1:1 (males:females) up to 3:1 in both freshwater and marine species. Conclusions/Significance: We demonstrate that TSD in fish is far less widespread than currently believed, suggesting that TSD is clearly the exception in fish sex determination. Further, species with TSD exhibit only one general sex ratio response pattern to temperature. However, the viability of some fish populations with TSD can be compromised through alterations in their sex ratios as a response to temperature fluctuations of the magnitude predicted by climate change.	[Ospina-Alvarez, Natalia; Piferrer, Francesc] CSIC, Inst Invest Marinas, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Ospina-Alvarez, N (corresponding author), CSIC, Inst Invest Marinas, Vigo, Spain.	piferrer@icm.csic.es	Piferrer, Francesc/A-5634-2012; Ospina-Alvarez, Natalia/B-8067-2010	Piferrer, Francesc/0000-0003-0903-4736; Ospina-Alvarez, Natalia/0000-0001-8916-9934	Spanish Ministry of Education and Science; Government of Catalonia	Spanish Ministry of Education and Science(Spanish Government); Government of Catalonia(Generalitat de Catalunya)	Work supported by a Spanish Ministry of Education and Science grant ("Sexratio") to F.P. N.O.A. was supported by a scholarship from the aquaculture network (XRAq) from the Government of Catalonia.	Aida S, 1998, FISHERIES SCI, V64, P989, DOI 10.2331/fishsci.64.989; Azuma T, 2004, AQUACULTURE, V234, P461, DOI 10.1016/j.aquaculture.2003.11.023; Baroiller JF, 1999, CELL MOL LIFE SCI, V55, P910, DOI 10.1007/s000180050344; Baroiller JF, 2001, COMP BIOCHEM PHYS C, V130, P399, DOI 10.1016/S1532-0456(01)00267-8; BEAMISH FW, 1993, CAN J FISH AQUAT SCI, V50, P1299, DOI 10.1139/f93-147; Bezault E, 2007, AQUACULTURE, V272, pS3, DOI 10.1016/j.aquaculture.2007.07.227; Biro PA, 2007, P NATL ACAD SCI USA, V104, P9715, DOI 10.1073/pnas.0701638104; Bull J.J., 1983, EVOLUTION SEX DETERM; Cnaani A, 2008, SEX DEV, V2, P43, DOI 10.1159/000117718; Conover David O., 2004, P11; CONOVER DO, 1987, NATURE, V326, P496, DOI 10.1038/326496a0; CONOVER DO, 1987, COPEIA, P732, DOI 10.2307/1445667; CONOVER DO, 1981, SCIENCE, V213, P577, DOI 10.1126/science.213.4507.577; CONOVER DO, 1992, EVOLUTION, V46, P1722, DOI 10.1111/j.1558-5646.1992.tb01164.x; CORNEJO AM, 2003, BIOL ACUAT, V20, P19; Craig JK, 1996, CAN J FISH AQUAT SCI, V53, P141, DOI 10.1139/cjfas-53-1-141; CREWS D, 1994, J ENDOCRINOL, V142, P1, DOI 10.1677/joe.0.1420001; DAVIS KB, 1990, GEN COMP ENDOCR, V78, P218, DOI 10.1016/0016-6480(90)90008-A; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; FROESE R, 2008, FISHBASE; Fujioka Y, 2001, J FISH BIOL, V59, P851, DOI 10.1006/jfbi.2001.1700; HARRINGTON RW, 1967, BIOL BULL-US, V132, P174, DOI 10.2307/1539887; Harvey SC, 2003, CYTOGENET GENOME RES, V101, P314, DOI 10.1159/000074355; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; HOSTACHE G, 1995, CAN J ZOOL, V73, P1239, DOI 10.1139/z95-148; IPCC, 2007, CLIM CHANG 2007 PHYS; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Janzen Fredric J., 2004, P121; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; Kamel SJ, 2006, ECOL APPL, V16, P923, DOI 10.1890/1051-0761(2006)016[0923:DROSRD]2.0.CO;2; KRAAK SBM, 1993, NETH J ZOOL, V43, P260; Krueger WH, 1999, ENVIRON BIOL FISH, V55, P381, DOI 10.1023/A:1007575600789; Luckenbach JA, 2003, AQUACULTURE, V216, P315, DOI 10.1016/S0044-8486(02)00407-6; MAIR GC, 1991, THEOR APPL GENET, V82, P153, DOI 10.1007/BF00226206; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; NANDA I, 1993, J EXP ZOOL, V265, P301, DOI 10.1002/jez.1402650311; Nanda I, 2002, P NATL ACAD SCI USA, V99, P11778, DOI 10.1073/pnas.182314699; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Nomura T, 1998, FISHERIES SCI, V64, P753, DOI 10.2331/fishsci.64.753; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; PANDIAN TJ, 1990, J EXP ZOOL, V255, P88, DOI 10.1002/jez.1402550112; PARKER K, 1980, FISH B-NOAA, V78, P541; Patino R, 1996, J EXP ZOOL, V276, P209, DOI 10.1002/(SICI)1097-010X(19961015)276:3&lt;209::AID-JEZ5&gt;3.0.CO;2-R; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Piferrer F, 2005, GEN COMP ENDOCR, V142, P102, DOI 10.1016/j.ygcen.2005.02.011; PIFERRER F, 1994, J EXP ZOOL, V270, P255, DOI 10.1002/jez.1402700304; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Romer U, 1996, J FISH BIOL, V48, P714, DOI 10.1111/j.1095-8649.1996.tb01467.x; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Strussmann C.A., 1999, ENCY REPROD; SULLIVAN JA, 1986, EVOLUTION, V40, P152, DOI 10.1111/j.1558-5646.1986.tb05726.x; TABATA K, 1995, FISHERIES SCI, V61, P199, DOI 10.2331/fishsci.61.199; TABATA K, 1991, NIPPON SUISAN GAKK, V57, P845; Uchida D, 2004, COMP BIOCHEM PHYS A, V137, P11, DOI 10.1016/S1095-6433(03)00178-8; UEDA T, 1984, B JPN SOC SCI FISH, V50, P1495; Valenzuela N, 2003, AM NAT, V161, P676, DOI 10.1086/368292; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Yamamoto E, 1999, AQUACULTURE, V173, P235, DOI 10.1016/S0044-8486(98)00448-7; YAMAMOTO TO, 1968, J EXP ZOOL, V168, P215, DOI 10.1002/jez.1401680209; Zar JH., 1999, BIOSTAT ANAL	60	358	379	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2837	10.1371/journal.pone.0002837	http://dx.doi.org/10.1371/journal.pone.0002837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665231	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300056
J	Ostrom, M; Loffler, KA; Edfalk, S; Selander, L; Dahl, U; Ricordi, C; Jeon, J; Correa-Medina, M; Diez, J; Edlund, H				Ostrom, Maria; Loffler, Kelly A.; Edfalk, Sara; Selander, Lars; Dahl, Ulf; Ricordi, Camillo; Jeon, Jongmin; Correa-Medina, Mayrin; Diez, Juan; Edlund, Helena			Retinoic Acid Promotes the Generation of Pancreatic Endocrine Progenitor Cells and Their Further Differentiation into beta-Cells	PLOS ONE			English	Article							EMBRYONIC PANCREAS; MOTOR-NEURONS; INSULIN GENE; NEUROGENIN3; EXPRESSION; EMBRYOGENESIS; REQUIREMENT; ACTIVATION; MECHANISMS; MESODERM	The identification of secreted factors that can selectively stimulate the generation of insulin producing beta-cells from stem and/or progenitor cells represent a significant step in the development of stem cell-based beta-cell replacement therapy. By elucidating the molecular mechanisms that regulate the generation of beta-cells during normal pancreatic development such putative factors may be identified. In the mouse, beta-cells increase markedly in numbers from embryonic day (e) 14.5 and onwards, but the extra-cellular signal(s) that promotes the selective generation of beta-cells at these stages remains to be identified. Here we show that the retinoic acid (RA) synthesizing enzyme Raldh1 is expressed in developing mouse and human pancreas at stages when beta-cells are generated. We also provide evidence that RA induces the generation of Ngn3(+) endocrine progenitor cells and stimulates their further differentiation into beta-cells by activating a program of cell differentiation that recapitulates the normal temporal program of beta-cell differentiation.	[Ostrom, Maria; Loffler, Kelly A.; Edfalk, Sara; Selander, Lars; Dahl, Ulf] Umea Univ, Umea Ctr Mol Med, Umea, Sweden; [Ricordi, Camillo; Jeon, Jongmin; Correa-Medina, Mayrin; Diez, Juan; Edlund, Helena] Univ Miami, Leonard M Miller Sch Med, Diabetes Res Inst, Miami, FL USA	Umea University; University of Miami	Ostrom, M (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	helena.edlund@ucmm.umu.se	RICORDI, CAMILLO/AAA-4740-2019	Edlund, Helena/0000-0002-3553-7348; Loffler, Kelly/0000-0003-3302-5995; Ricordi, Camillo/0000-0001-8092-7153	Swedish Research Council; Juvenile Diabetes Research Foundation; Diabetes Research Institute Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Diabetes Research Institute Foundation	This work was supported by grants from the Swedish Research Council, Juvenile Diabetes Research Foundation, and the Diabetes Research Institute Foundation.	Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Apelqvist A, 1997, CURR BIOL, V7, P801, DOI 10.1016/S0960-9822(06)00340-X; Bramblett DE, 2002, GENOMICS, V79, P402, DOI 10.1006/geno.2002.6708; BRISCOE J, 2007, PHIL T R SOC B  0205; Chambers D, 2007, DEVELOPMENT, V134, P1369, DOI 10.1242/dev.02815; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; DAMM K, 1993, P NATL ACAD SCI USA, V90, P2989, DOI 10.1073/pnas.90.7.2989; Diez del Corral R, 2003, NEURON, V40, P65; Dumonteil E, 1996, DIABETES METAB, V22, P164; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Edlund H, 1999, CURR OPIN CELL BIOL, V11, P663, DOI 10.1016/S0955-0674(99)00033-2; Esni F, 2001, DEV BIOL, V238, P202, DOI 10.1006/dbio.2001.0405; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Li ZX, 2004, DEV BIOL, V269, P252, DOI 10.1016/j.ydbio.2004.01.043; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Miralles F, 1999, P NATL ACAD SCI USA, V96, P6267, DOI 10.1073/pnas.96.11.6267; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Pictet R., 1972, HDB PHYSL, P25; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Selander L, 2002, MECH DEVELOP, V113, P189, DOI 10.1016/S0925-4773(02)00023-0; Shen CN, 2007, DIFFERENTIATION, V75, P62, DOI 10.1111/j.1432-0436.2006.00116.x; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2004, DEV GENES EVOL, V214, P432, DOI 10.1007/s00427-004-0420-6; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Sun H, 2007, J CELL BIOL, V177, P647, DOI 10.1083/jcb.200609007; Tulachan SS, 2003, DIABETES, V52, P76, DOI 10.2337/diabetes.52.1.76; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Yamada K, 2005, FRONT BIOSCI-LANDMRK, V10, P3151, DOI 10.2741/1772	41	96	130	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2841	10.1371/journal.pone.0002841	http://dx.doi.org/10.1371/journal.pone.0002841			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665267	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300060
J	Gortazar, C; Torres, MJ; Vicente, J; Acevedo, P; Reglero, M; de la Fuente, J; Negro, JJ; Aznar-Martin, J				Gortazar, Christian; Torres, Maria Jose; Vicente, Joaquin; Acevedo, Pelayo; Reglero, Manuel; de la Fuente, Jose; Negro, Juan Jose; Aznar-Martin, Javier			Bovine Tuberculosis in Donana Biosphere Reserve: The Role of Wild Ungulates as Disease Reservoirs in the Last Iberian Lynx Strongholds	PLOS ONE			English	Article							MANDIBULAR LYMPH-NODES; DEER CERVUS-ELAPHUS; BOAR SUS-SCROFA; MYCOBACTERIUM-BOVIS; RED DEER; OROPHARYNGEAL TONSILS; HOME-RANGE; DAMA-DAMA; 4 AREAS; EPIDEMIOLOGY	Donana National Park (DNP) in southern Spain is a UNESCO Biosphere Reserve where commercial hunting and wildlife artificial feeding do not take place and traditional cattle husbandry still exists. Herein, we hypothesized that Mycobacterium bovis infection prevalence in wild ungulates will depend on host ecology and that variation in prevalence will reflect variation in the interaction between hosts and environmental risk factors. Cattle bTB reactor rates increased in DNP despite compulsory testing and culling of infected animals. In this study, 124 European wild boar, 95 red deer, and 97 fallow deer were sampled from April 2006 to April 2007 and analyzed for M. bovis infection. Modelling and GIS were used to identify risk factors and intra and inter-species relationships. Infection with M. bovis was confirmed in 65 (52.4%) wild boar, 26 (27.4%) red deer and 18 (18.5%) fallow deer. In the absence of cattle, wild boar M. bovis prevalence reached 92.3% in the northern third of DNP. Wild boar showed more than twice prevalence than that in deer (p<0.001). Modelling revealed that M. bovis prevalence decreased from North to South in wild boar (p<0.001) and red deer (p<0.01), whereas no spatial pattern was evidenced for fallow deer. Infection risk in wild boar was dependent on wild boar M. bovis prevalence in the buffer area containing interacting individuals (p<0.01). The prevalence recorded in this study is among the highest reported in wildlife. Remarkably, this high prevalence occurs in the absence of wildlife artificial feeding, suggesting that a feeding ban alone would have a limited effect on wildlife M. bovis prevalence. In DNP, M. bovis transmission may occur predominantly at the intra-species level due to ecological, behavioural and epidemiological factors. The results of this study allow inferring conclusions on epidemiological bTB risk factors in Mediterranean habitats that are not managed for hunting purposes. Our results support the need to consider wildlife species for the control of bTB in cattle and strongly suggest that bTB may affect animal welfare and conservation.	[Gortazar, Christian; Vicente, Joaquin; Acevedo, Pelayo; Reglero, Manuel; de la Fuente, Jose] UCLM, JCCM, CSIC, IREC Natl Wildlife Res Inst, Ciudad Real, Spain; [Torres, Maria Jose] Univ Seville, Dept Microbiol, Seville, Spain; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK USA; [Negro, Juan Jose] CSIC, Estacion Biol Donana, Dept Evolutionary Ecol, Seville, Spain; [Aznar-Martin, Javier] HH UU Virgen Rocio, Serv Microbiol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Sevilla; Oklahoma State University System; Oklahoma State University - Stillwater; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Gortazar, C (corresponding author), UCLM, JCCM, CSIC, IREC Natl Wildlife Res Inst, Ciudad Real, Spain.	christian.gortazar@uclm.es	de la Fuente, José/AAU-1197-2020; Torres, Maria/GVU-3391-2022; Acevedo, Pelayo/L-6737-2013; Negro, Juan Jose/I-2653-2015; IBIS, TUBERCULOSIS/O-9334-2015; Gortazar, Christian/E-7918-2012; Vicente, Joaquín/K-7822-2013	de la Fuente, José/0000-0001-7383-9649; Acevedo, Pelayo/0000-0002-3509-7696; Negro, Juan Jose/0000-0002-8697-5647; Gortazar, Christian/0000-0003-0012-4006; Vicente, Joaquín/0000-0001-8416-3672; Aznar Martin, Javier/0000-0001-7285-9728	Consejeria de Medio Ambiente, Junta de Andalucia; CICYT [AGL2005-07401]; INIA; Principado de Asturias; Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA); Grupo Santander - Fundacion Marcelino Botin	Consejeria de Medio Ambiente, Junta de Andalucia(Junta de Andalucia); CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); INIA(Instituto de Investigacion Agropecuaria (INIA)); Principado de Asturias(Principality of Asturias); Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA); Grupo Santander - Fundacion Marcelino Botin	The study was funded by Consejeria de Medio Ambiente, Junta de Andalucia. This is a contribution to CICYT - MEC research grant AGL2005-07401. Studies on diseases shared between domestics and wildlife are also supported by grants and contracts from INIA, Principado de Asturias, Castilla - La Mancha, Ministerio de Medio Ambiente y Medio Rural y Marino (OAPN and SDGSA), and Grupo Santander - Fundacion Marcelino Botin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2007, EPIDEMIOL INFECT, V135, P519, DOI 10.1017/S0950268806007059; Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; BELTRAN JF, 1985, P 17 C INT UN GAM BI, P961; BRAZA F, 1986, ACTA THERIOL, V31, P467, DOI 10.4098/AT.arch.86-42; CALDERON J, VACA MOSTRE IN PRESS; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Carranza J, 1999, BEHAV ECOL, V10, P525, DOI 10.1093/beheco/10.5.525; CHEESEMAN CL, 1981, J APPL ECOL, V18, P795, DOI 10.2307/2402370; Clifton-Hadley RS, 2005, CATTLE PRACT, V13, P369; Davini S, 2004, ACTA THERIOL, V49, P393, DOI 10.1007/BF03192537; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; de Mera IGF, 2008, DEV COMP IMMUNOL, V32, P85, DOI 10.1016/j.dci.2007.05.001; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; GARCIA MAG, 1999, INFORM PRELIMI UNPUB; Gil-Sanchez JM, 2006, ACTA THERIOL, V51, P85, DOI 10.1007/BF03192659; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2005, VET RES, V36, P43, DOI 10.1051/vetres:2004051; Gortazar C, 2003, VET REC, V152, P779, DOI 10.1136/vr.152.25.779; Gortazar C, 2007, EUR J WILDLIFE RES, V53, P241, DOI 10.1007/s10344-007-0098-y; Griffin JFT, 2004, TUBERCULOSIS, V84, P293, DOI 10.1016/j.tube.2003.11.001; Jolles AE, 2005, ECOLOGY, V86, P2358, DOI 10.1890/05-0038; Lugton IW, 1998, NEW ZEAL VET J, V46, P147, DOI 10.1080/00480169.1998.36079; Machackova M, 2003, VET MED-CZECH, V48, P51, DOI 10.17221/5750-VETMED; Martin S. W, 1987, VET EPIDEMIOLOGY, P48; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; MIGNONE W, 1996, RICER BIOL SELV S, V24, P619; Miller R, 2003, J WILDLIFE DIS, V39, P84, DOI 10.7589/0090-3558-39.1.84; MILLS MGL, 1995, WILDLIFE RES, V22, P75, DOI 10.1071/WR9950075; MUNRO R, 1986, MANAGEMENT DISEASES, P157; Naranjo V, 2006, FEMS IMMUNOL MED MIC, V46, P298, DOI 10.1111/j.1574-695X.2005.00035.x; Naranjo Victoria, 2007, Animal Health Research Reviews, V8, P81, DOI 10.1017/S1466252307001260; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Naranjo V, 2007, PROTEOMICS, V7, P220, DOI 10.1002/pmic.200600527; Naranjo V, 2006, VET MICROBIOL, V116, P224, DOI 10.1016/j.vetmic.2006.03.013; Nishi JS, 2002, ANN NY ACAD SCI, V969, P236, DOI 10.1111/j.1749-6632.2002.tb04385.x; Nugent G, 2002, J WILDLIFE DIS, V38, P665, DOI 10.7589/0090-3558-38.4.665; O'Brien DJ, 2006, VET MICROBIOL, V112, P313, DOI 10.1016/j.vetmic.2005.11.014; Olea-Popelka FJ, 2003, PREV VET MED, V59, P103, DOI 10.1016/S0167-5877(03)00055-2; Palomares F, 2005, BIOL CONSERV, V122, P53, DOI 10.1016/j.biocon.2004.06.020; Parra A, 2006, RES VET SCI, V80, P140, DOI 10.1016/j.rvsc.2005.05.010; Perez J, 2001, VET REC, V148, P414, DOI 10.1136/vr.148.13.414; Pfeiffer DU, 1995, NEW ZEAL VET J, V43, P272, DOI 10.1080/00480169./1995.35906; RHYAN JC, 1995, VET PATHOL, V32, P215, DOI 10.1177/030098589503200301; Rodwell TC, 2001, J MAMMAL, V82, P231, DOI 10.1644/1545-1542(2001)082&lt;0231:EOPEOB&gt;2.0.CO;2; Romero B, 2008, VET MICROBIOL, V132, P87, DOI 10.1016/j.vetmic.2008.04.032; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Saenz De Buruaga M, 1991, RECONOCIMIENTO SEXO; Serraino A, 1999, J CLIN MICROBIOL, V37, P2766, DOI 10.1128/JCM.37.9.2766-2771.1999; Vicente J, 2006, VET RES, V37, P107, DOI 10.1051/vetres:2005044; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; VIZCAINO LL, 1990, 32 INT S ERKR ZOO WI; Wobeser G, 2002, REV SCI TECH OIE, V21, P159, DOI 10.20506/rst.21.1.1326; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99	57	122	124	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2776	10.1371/journal.pone.0002776	http://dx.doi.org/10.1371/journal.pone.0002776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648665	Green Published, gold			2022-12-27	WOS:000264302900046
J	Benoist, JM; Pincede, I; Ballantyne, K; Plaghki, L; Le Bars, D				Benoist, Jean-Michel; Pincede, Ivanne; Ballantyne, Kay; Plaghki, Leon; Le Bars, Daniel			Peripheral and Central Determinants of a Nociceptive Reaction: An Approach to Psychophysics in the Rat	PLOS ONE			English	Article								Background: The quantitative end-point for many behavioral tests of nociception is the reaction time, i.e. the time lapse between the beginning of the application of a stimulus, e.g. heat, and the evoked response. Since it is technically impossible to heat the skin instantaneously by conventional means, the question of the significance of the reaction time to radiant heat remains open. We developed a theoretical framework, a related experimental paradigm and a model to analyze in psychophysical terms the "tail-flick" responses of rats to random variations of noxious radiant heat. Methodology/Principal Findings: A CO2 laser was used to avoid the drawbacks associated with standard methods of thermal stimulation. Heating of the skin was recorded with an infrared camera and was stopped by the reaction of the animal. For the first time, we define and determine two key descriptors of the behavioral response, namely the behavioral threshold (T beta) and the behavioral latency (L beta). By employing more than one site of stimulation, the paradigm allows determination of the conduction velocity of the peripheral fibers that trigger the response (V) and an estimation of the latency (Ld) of the central decision-making process. Ld (similar to 130 ms) is unaffected by ambient or skin temperature changes that affect the behavioral threshold (similar to 42.2-44.9 degrees C in the 20-30 degrees C range), behavioral latency (<500 ms), and the conduction velocity of the peripheral fibers that trigger the response (similar to 0.35-0.76 m/s in the 20-30 degrees C range). We propose a simple model that is verified experimentally and that computes the variations in the so-called "tail-flick latency" (TFL) caused by changes in either the power of the radiant heat source, the initial temperature of the skin, or the site of stimulation along the tail. Conclusions/Significance: This approach enables the behavioral determinations of latent psychophysical (T beta, L beta, Ld) and neurophysiological (V) variables that have been previously inaccessible with conventional methods. Such an approach satisfies the repeated requests for improving nociceptive tests and offers a potentially heuristic progress for studying nociceptive behavior on more firm physiological and psychophysical grounds. The validity of using a reaction time of a behavioral response to an increasing heat stimulus as a "pain index" is challenged. This is illustrated by the predicted temperature-dependent variations of the behavioral TFL elicited by spontaneous variations of the temperature of the tail for thermoregulation.	[Benoist, Jean-Michel] Univ Paris 06, Neurophysiol Lab, Paris, France; [Pincede, Ivanne; Le Bars, Daniel] INSERM, U713, Paris, France; [Benoist, Jean-Michel; Pincede, Ivanne; Le Bars, Daniel] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Ballantyne, Kay] Univ Dundee, Sch Dent, Dundee, Scotland; [Plaghki, Leon] Catholic Univ Louvain, Unite READ, B-1200 Brussels, Belgium	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Dundee; Universite Catholique Louvain	Benoist, JM (corresponding author), Univ Paris 06, Neurophysiol Lab, Paris, France.	lebars@chups.jussieu.fr			"I'Institut National de la Sante et de la Recherche Medicale" (INSERM); "Institut UPSA de la douleur"	"I'Institut National de la Sante et de la Recherche Medicale" (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Institut UPSA de la douleur"	This work was supported by "I'Institut National de la Sante et de la Recherche Medicale" (INSERM) and a grant from the "Institut UPSA de la douleur".	Berge OG, 2002, PAIN BRAIN, P77; BROMM B, 1984, HUM NEUROBIOL, V3, P33; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; BUETTNER K, 1951, J APPL PHYSIOL, V3, P691, DOI 10.1152/jappl.1951.3.12.691; CALVINO B, 1984, PAIN, V20, P261, DOI 10.1016/0304-3959(84)90015-0; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; CARROLL MN, 1959, ARCH INT PHARMACOD T, V123, P48; CARSTENS E, 1993, J NEUROPHYSIOL, V70, P630, DOI 10.1152/jn.1993.70.2.630; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; COVINO BG, 1980, PAIN, V9, P111; DANNEMAN PJ, 1994, PAIN, V58, P39, DOI 10.1016/0304-3959(94)90183-X; DEJESUS PV, 1973, NEUROLOGY, V23, P1182, DOI 10.1212/WNL.23.11.1182; Falmagne J.-C., 1985, ELEMENTS PSYCHOPHYSI; FLEISCHER E, 1983, BRAIN RES, V267, P81, DOI 10.1016/0006-8993(83)91041-7; FRANZ DN, 1968, J PHYSIOL-LONDON, V199, P319, DOI 10.1113/jphysiol.1968.sp008656; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; GRANAT FR, 1973, ARCH INT PHARMACOD T, V205, P52; GROSSMAN ML, 1982, J COMP NEUROL, V206, P9, DOI 10.1002/cne.902060103; HAIMICOHEN R, 1983, J NEUROSCI METH, V8, P127, DOI 10.1016/0165-0270(83)90113-9; HAMANN SR, 1992, BRAIN RES BULL, V29, P507, DOI 10.1016/0361-9230(92)90090-K; HANDWERKER HO, 1993, PHYSIOL REV, V73, P639, DOI 10.1152/physrev.1993.73.3.639; HANDWERKER HO, 1987, EXP BRAIN RES, V65, P493; HARDY JD, 1956, J APPL PHYSIOL, V9, P257, DOI 10.1152/jappl.1956.9.2.257; HOLE K, 1990, PAIN, V43, P391, DOI 10.1016/0304-3959(90)90039-G; KAWAKITA K, 1987, PHYSIOL BEHAV, V39, P235, DOI 10.1016/0031-9384(87)90015-1; LAMOTTE RH, 1983, FED PROC, V42, P2548; LAMOTTE RH, 1982, J NEUROSCI, V2, P765; LANGFORD LA, 1981, J COMP NEUROL, V203, P745, DOI 10.1002/cne.902030411; Le Bars D, 2001, PHARMACOL REV, V53, P597; LEVINE JD, 1980, BRAIN RES, V201, P129, DOI 10.1016/0006-8993(80)90780-5; Luce RD, 1986, RESPONSE TIMES THEIR; MARTINEZGOMEZ M, 1994, PHYSIOL BEHAV, V55, P651, DOI 10.1016/0031-9384(94)90040-X; McCarthy PW, 1995, BRAIN RES, V704, P79, DOI 10.1016/0006-8993(95)01107-2; MEYER RA, 1976, IEEE T BIO-MED ENG, V23, P54, DOI 10.1109/TBME.1976.324616; MITCHELL D, 1977, PROC R SOC SER B-BIO, V197, P169, DOI 10.1098/rspb.1977.0064; NECKER R, 1978, PAIN, V4, P231, DOI 10.1016/0304-3959(77)90135-X; NESS TJ, 1986, BRAIN RES, V386, P41, DOI 10.1016/0006-8993(86)90139-3; NESS TJ, 1987, BRAIN RES, V426, P169, DOI 10.1016/0006-8993(87)90437-9; PAINTAL AS, 1967, J PHYSIOL-LONDON, V193, P523, DOI 10.1113/jphysiol.1967.sp008376; PAINTAL AS, 1973, NEW DEVELOPMENTS ELE, V2, P19; Plaghki Leon, 2005, Curr Opin Investig Drugs, V6, P58; REN MF, 1979, CHINESE MED J-PEKING, V92, P576; Rothery P, 1993, MODELS BIOL MATH STA; STOLL AM, 1959, J APPL PHYSIOL, V14, P373, DOI 10.1152/jappl.1959.14.3.373; STOLWIJK JA, 1965, J APPL PHYSIOL, V20, P1006, DOI 10.1152/jappl.1965.20.5.1006; TANDRUP T, 1995, J COMP NEUROL, V357, P341, DOI 10.1002/cne.903570302; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P753, DOI 10.1113/jphysiol.1995.sp020766; TILLMAN DB, 1995, J PHYSIOL-LONDON, V485, P767, DOI 10.1113/jphysiol.1995.sp020767; TREEDE RD, 1995, J PHYSIOL-LONDON, V483, P747, DOI 10.1113/jphysiol.1995.sp020619; TSURUOKA M, 1988, PHYSIOL BEHAV, V43, P79, DOI 10.1016/0031-9384(88)90101-1; WADDELL PJ, 1989, NEUROSCIENCE, V30, P577, DOI 10.1016/0306-4522(89)90152-8; WAIBL H, 1973, ADV ANAT EMBRYOL CEL, V47, P1; Wang YZ, 2005, WORLD J GASTROENTERO, V11, P46, DOI 10.3748/wjg.v11.i1.46; YARNITSKY D, 1990, PAIN, V40, P85, DOI 10.1016/0304-3959(90)91055-N; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819; YOUNG AA, 1982, CAN J PHYSIOL PHARM, V60, P392, DOI 10.1139/y82-057; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	58	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3125	10.1371/journal.pone.0003125	http://dx.doi.org/10.1371/journal.pone.0003125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YG	18769624	Green Submitted, Green Published, gold			2022-12-27	WOS:000207566300001
J	Goncalves, MAFV; Holkers, M; van Nierop, GP; Wieringa, R; Pau, MG; de Vries, AAF				Goncalves, Manuel A. F. V.; Holkers, Maarten; van Nierop, Gijsbert P.; Wieringa, Roeland; Pau, Maria G.; de Vries, Antoine A. F.			Targeted Chromosomal Insertion of Large DNA into the Human Genome by a Fiber-Modified High-Capacity Adenovirus-Based Vector System	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; RECOMBINANT ADENOASSOCIATED VIRUS; GENE-EXPRESSION; VIRAL GENES; CELL-LINE; TRANSDUCTION; GENERATION; SEQUENCE; PROTEIN; HUMAN-CHROMOSOME-19	A prominent goal in gene therapy research concerns the development of gene transfer vehicles that can integrate exogenous DNA at specific chromosomal loci to prevent insertional oncogenesis and provide for long-term transgene expression. Adenovirus (Ad) vectors arguably represent the most efficient delivery systems of episomal DNA into eukaryotic cell nuclei. The most advanced recombinant Ads lack all adenoviral genes. This renders these so-called high-capacity (hc) Ad vectors less cytotoxic/immunogenic than those only deleted in early regions and creates space for the insertion of large/multiple transgenes. The versatility of hcAd vectors is been increased by capsid modifications to alter their tropism and by the incorporation into their genomes of sequences promoting chromosomal insertion of exogenous DNA. Adeno-associated virus (AAV) can insert its genome into a specific human locus designated AAVS1. Trans- and cis-acting elements needed for this reaction are the AAV Rep78/68 proteins and Rep78/68-binding sequences, respectively. Here, we describe the generation, characterization and testing of fiber-modified dual hcAd/AAV hybrid vectors (dHVs) containing both these elements. Due to the inhibitory effects of Rep78/68 on Ad-dependent DNA replication, we deployed a recombinase-inducible gene switch to repress Rep68 synthesis during vector rescue and propagation. Flow cytometric analyses revealed that rep68-positive dHVs can be produced similarly well as rep68-negative control vectors. Western blot experiments and immunofluorescence microscopy analyses demonstrated transfer of recombinase-dependent rep68 genes into target cells. Studies in HeLa cells and in the dystrophin-deficient myoblasts from a Duchenne muscular dystrophy (DMD) patient showed that induction of Rep68 synthesis in cells transduced with fiber-modified and rep68-positive dHVs leads to increased stable transduction levels and AAVS1-targeted integration of vector DNA. These results warrant further investigation especially considering the paucity of vector systems allowing permanent phenotypic correction of patient-own cell types with large DNA (e.g. recombinant full-length DMD genes).	[Goncalves, Manuel A. F. V.; Holkers, Maarten; van Nierop, Gijsbert P.; Wieringa, Roeland; Pau, Maria G.; de Vries, Antoine A. F.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Virus & Stem Cell Biol Lab, Leiden, Netherlands; [Pau, Maria G.] Crucell Holland BV, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johnson & Johnson	Goncalves, MAFV (corresponding author), Leiden Univ, Med Ctr, Dept Mol Cell Biol, Virus & Stem Cell Biol Lab, Leiden, Netherlands.	m.goncalves@lumc.nl	de Vries, Antoine/ABG-5787-2021; van Nierop, Gijsbert/J-1994-2018; Goncalves, Manuel AFV/V-2248-2019	Goncalves, Manuel AFV/0000-0002-8111-1073	Prinses Beatrix Fonds [MAR04-0222]; Association Francaise contre les Myopathies [12259-SR-GROUPE E]	Prinses Beatrix Fonds; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by research grants from the Prinses Beatrix Fonds against neuromuscular diseases (PBF; MAR04-0222) and the Association Francaise contre les Myopathies (AFM; 12259-SR-GROUPE E).	Balamotis MA, 2004, VIROLOGY, V324, P229, DOI 10.1016/j.virol.2004.03.030; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Carlson CA, 2002, METHOD ENZYMOL, V346, P277; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; Cudre-Mauroux C, 2003, HUM GENE THER, V14, P1525, DOI 10.1089/104303403322495034; Fischer A, 2005, PLOS MED, V2, P22, DOI 10.1371/journal.pmed.0020010; GIRAUD C, 1995, J VIROL, V69, P6917, DOI 10.1128/JVI.69.11.6917-6924.1995; Glauser DL, 2006, CURR GENE THER, V6, P315, DOI 10.2174/156652306777592090; Goncalves MAFV, 2006, REV MED VIROL, V16, P167, DOI 10.1002/rmv.494; Goncalves MAFV, 2005, J VIROL, V79, P3146, DOI 10.1128/JVI.79.5.3146-3162.2005; Goncalves MAFV, 2004, VIROLOGY, V321, P287, DOI 10.1016/j.virol.2004.01.007; Goncalves MAFV, 2001, VIROLOGY, V288, P236, DOI 10.1006/viro.2001.1073; Goncalves MAFV, 2002, J VIROL, V76, P10734, DOI 10.1128/JVI.76.21.10734-10744.2002; Goncalves MAFV, 2006, MOL THER, V13, P976, DOI 10.1016/j.ymthe.2005.11.018; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Hamilton H, 2004, J VIROL, V78, P7874, DOI 10.1128/JVI.78.15.7874-7882.2004; Holkers M, 2006, BIOTECHNIQUES, V41, P711, DOI 10.2144/000112307; Huser D, 2003, J GEN VIROL, V84, P133, DOI 10.1099/vir.0.18726-0; Huser D, 2002, J VIROL, V76, P7554, DOI 10.1128/JVI.76.15.7554-7559.2002; Jager L, 2007, CURR GENE THER, V7, P272; Knaan-Shanzer S, 2005, STEM CELLS, V23, P1598, DOI 10.1634/stemcells.2005-0016; Knaan-Shanzer SS, 2001, HUM GENE THER, V12, P1989, DOI 10.1089/104303401753204562; Kochanek S, 2001, CURR OPIN MOL THER, V3, P454; Kreppel F, 2004, J VIROL, V78, P9, DOI 10.1128/JVI.78.1.9-22.2004; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mitani K., 2002, Current Gene Therapy, V2, P135, DOI 10.2174/1566523024605591; Palmer DJ, 2005, HUM GENE THER, V16, P1, DOI 10.1089/hum.2005.16.1; Parks RJ, 1997, J VIROL, V71, P3293, DOI 10.1128/JVI.71.4.3293-3298.1997; Philpott NJ, 2002, P NATL ACAD SCI USA, V99, P12381, DOI 10.1073/pnas.182430299; Recchia A, 2004, MOL THER, V10, P660, DOI 10.1016/j.ymthe.2004.07.003; Recchia A, 1999, P NATL ACAD SCI USA, V96, P2615, DOI 10.1073/pnas.96.6.2615; Rinaudo D, 2000, J VIROL, V74, P281, DOI 10.1128/JVI.74.1.281-294.2000; Sambrook J., 2001, MOL CLONING LAB MANU; Saudan P, 2000, EMBO J, V19, P4351, DOI 10.1093/emboj/19.16.4351; Schmidt M, 2000, J VIROL, V74, P9441, DOI 10.1128/JVI.74.20.9441-9450.2000; Shayakhmetov DM, 2000, J VIROL, V74, P2567, DOI 10.1128/JVI.74.6.2567-2583.2000; Skuk D, 2003, J MUSCLE RES CELL M, V24, P285; Smith RH, 2008, GENE THER; Stecher H, 2001, MOL THER, V4, P36, DOI 10.1006/mthe.2000.0410; Steinwaerder DS, 1999, J VIROL, V73, P9303, DOI 10.1128/JVI.73.11.9303-9313.1999; Taboit-Dameron F, 1999, TRANSGENIC RES, V8, P223, DOI 10.1023/A:1008919925303; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Wang HJ, 2006, J VIROL, V80, P11699, DOI 10.1128/JVI.00779-06; Weitzman MD, 1996, J VIROL, V70, P1845, DOI 10.1128/JVI.70.3.1845-1854.1996; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Zhang HG, 2001, GENE THER, V8, P704, DOI 10.1038/sj.gt.3301454; Zhou CH, 1999, VIROLOGY, V261, P280, DOI 10.1006/viro.1999.9882	49	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3084	10.1371/journal.pone.0003084	http://dx.doi.org/10.1371/journal.pone.0003084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769728	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796800001
J	Azmy, YY; Gupta, A; Pugh, F				Azmy, Yousry Y.; Gupta, Anshuman; Pugh, Franklin			Computational Modelling of Genome-Side Transcription Assembly Networks Using a Fluidics Analogy	PLOS ONE			English	Article								Understanding how a myriad of transcription regulators work to modulate mRNA output at thousands of genes remains a fundamental challenge in molecular biology. Here we develop a computational tool to aid in assessing the plausibility of gene regulatory models derived from genome-wide expression profiling of cells mutant for transcription regulators. mRNA output is modelled as fluid flow in a pipe lattice, with assembly of the transcription machinery represented by the effect of valves. Transcriptional regulators are represented as external pressure heads that determine flow rate. Modelling mutations in regulatory proteins is achieved by adjusting valves' on/off settings. The topology of the lattice is designed by the experimentalist to resemble the expected interconnection between the modelled agents and their influence on mRNA expression. Users can compare multiple lattice configurations so as to find the one that minimizes the error with experimental data. This computational model provides a means to test the plausibility of transcription regulation models derived from large genomic data sets.	[Azmy, Yousry Y.] Penn State Univ, Dept Mech & Nuclear Engn, University Pk, PA 16802 USA; [Gupta, Anshuman] Penn State Univ, Dept Acad Serv & Emerg Technol, University Pk, PA 16802 USA; [Pugh, Franklin] Penn State Univ, Dept Biochem & Mol Biol, Ctr Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Azmy, YY (corresponding author), N Carolina State Univ, Dept Nucl Engn, Raleigh, NC 27695 USA.	bfp2@psu.edu			National Science Foundation [BES-0425662]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation BES-0425662	BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; BROOK A, 2005, GAMS USERS GUIDE; Cang Y, 2002, P NATL ACAD SCI USA, V99, P12727, DOI 10.1073/pnas.202236699; Chicca JJ, 1998, MOL CELL BIOL, V18, P1701, DOI 10.1128/MCB.18.3.1701; Crampin EJ, 2004, PROG BIOPHYS MOL BIO, V86, P77, DOI 10.1016/j.pbiomolbio.2004.04.002; Darst RP, 2003, J BIOL CHEM, V278, P13216, DOI 10.1074/jbc.M211445200; Dasgupta A, 2005, EMBO J, V24, P1717, DOI 10.1038/sj.emboj.7600646; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; DRUD A, 1985, MATH PROGRAMMING, V31; DRUD A, 1992, ORSA J COMPUTING, V6, P207, DOI DOI 10.1287/IJ0C.6.2.207; Goppelt A, 1996, NUCLEIC ACIDS RES, V24, P4450, DOI 10.1093/nar/24.22.4450; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Gumbs OH, 2003, EMBO J, V22, P3131, DOI 10.1093/emboj/cdg304; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Klamt S, 2003, BIOINFORMATICS, V19, P261, DOI 10.1093/bioinformatics/19.2.261; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Muldrow TA, 1999, MOL CELL BIOL, V19, P2835; Novak Kerry, 2006, BMC Med Educ, V6, P37, DOI 10.1186/1472-6920-6-37; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335	26	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3095	10.1371/journal.pone.0003095	http://dx.doi.org/10.1371/journal.pone.0003095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769485	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796600012
J	Perdigoto, CNLR; Gervais, L; Overstreet, E; Fischer, J; Guichet, A; Schweisguth, F				Perdigoto, Carolina N. L. R.; Gervais, Louis; Overstreet, Erin; Fischer, Janice; Guichet, Antoine; Schweisguth, Francois			Overexpression of Partner of Numb Induces Asymmetric Distribution of the PI4P 5-Kinase Skittles in Mitotic Sensory Organ Precursor Cells in Drosophila	PLOS ONE			English	Article								Unequal segregation of cell fate determinants at mitosis is a conserved mechanism whereby cell fate diversity can be generated during development. In Drosophila, each sensory organ precursor cell (SOP) divides asymmetrically to produce an anterior pIIb and a posterior pIIa cell. The Par6-aPKC complex localizes at the posterior pole of dividing SOPs and directs the actin-dependent localization of the cell fate determinants Numb, Partner of Numb (Pon) and Neuralized at the opposite pole. The plasma membrane lipid phosphatidylinositol (4,5)-bisphosphate (PIP2) regulates the plasma membrane localization and activity of various proteins, including several actin regulators, thereby modulating actin-based processes. Here, we have examined the distribution of PIP2 and of the PIP2-producing kinase Skittles (Sktl) in mitotic SOPs. Our analysis indicates that both Sktl and PIP2 reporters are uniformly distributed in mitotic SOPs. In the course of this study, we have observed that overexpression of full-length Pon or its localization domain (LD) fused to the Red Fluorescent Protein (RFP::Pon(LD)) results in asymmetric distribution of Sktl and PIP2 reporters in dividing SOPs. Our observation that Pon overexpression alters polar protein distribution is relevant because RFP::Pon(LD) is often used as a polarity marker in dividing progenitors.	[Perdigoto, Carolina N. L. R.; Schweisguth, Francois] Ecole Normale Superieure, CNRS, UMR8542, Paris, France; [Gervais, Louis; Guichet, Antoine] Inst Jacques Monod, CNRS, UMR, Paris, France; [Overstreet, Erin; Fischer, Janice] Univ Texas, Dept Mol, Cell & Dev Biol, Austin, TX USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Austin	Perdigoto, CNLR (corresponding author), Inst Pasteur, CNRS, URA2578, Paris, France.	fschweis@pasteur.fr	Gervais, Louis/AAG-3543-2021	Gervais, Louis/0000-0002-7284-7900	CNRS; ENS; FCT	CNRS(Centre National de la Recherche Scientifique (CNRS)); ENS; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the CNRS, ENS and FCT (C.P.).	Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cheng MK, 2004, GENETICS, V167, P1213, DOI 10.1534/genetics.103.018721; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Dho SE, 1999, J BIOL CHEM, V274, P33097, DOI 10.1074/jbc.274.46.33097; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gho M, 1999, DEVELOPMENT, V126, P3573; Halet G, 2005, BIOL CELL, V97, P501; Hassan BA, 1998, GENETICS, V150, P1527; Knoblich JA, 1997, P NATL ACAD SCI USA, V94, P13005, DOI 10.1073/pnas.94.24.13005; Langevin J, 2005, CURR BIOL, V15, P955, DOI 10.1016/j.cub.2005.04.054; Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4; Lu BW, 1998, CELL, V95, P225, DOI 10.1016/S0092-8674(00)81753-5; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; OVERSTREET E, 2005, ROLE EPSINS DROSOPHI; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Skwarek LC, 2007, DEV CELL, V13, P783, DOI 10.1016/j.devcel.2007.10.020; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Wu H, 2007, MOL CELL, V28, P886, DOI 10.1016/j.molcel.2007.10.028; Yaich L, 1998, J BIOL CHEM, V273, P10381, DOI 10.1074/jbc.273.17.10381; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3072	10.1371/journal.pone.0003072	http://dx.doi.org/10.1371/journal.pone.0003072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728778	Green Submitted, gold, Green Published			2022-12-27	WOS:000264796400012
J	Bharadwaj, A; Leelavathi, S; Mazumdar-Leighton, S; Ghosh, A; Ramakumar, S; Reddy, VS				Bharadwaj, Amit; Leelavathi, Sadhu; Mazumdar-Leighton, Sudeshna; Ghosh, Amit; Ramakumar, Suryanarayanarao; Reddy, Vanga S.			The Critical Role of Partially Exposed N-Terminal Valine Residue in Stabilizing GH10 Xylanase from Bacillus sp.NG-27 under Poly-Extreme Conditions	PLOS ONE			English	Article							ALKALI-THERMOSTABLE XYLANASE; HYDROPHOBIC INTERACTIONS; SEQUENCE-ANALYSIS; STRUCTURAL BASIS; X-RAY; PROTEIN; CLONING; ENDOXYLANASE; EXPRESSION; RESISTANCE	Background: Understanding the mechanisms that govern protein stability under poly-extreme conditions continues to be a major challenge. Xylanase (BSX) from Bacillus sp. NG-27, which has a TIM-barrel structure, shows optimum activity at high temperature and alkaline pH, and is resistant to denaturation by SDS and degradation by proteinase K. A comparative circular dichroism analysis was performed on native BSX and a recombinant BSX (R-BSX) with just one additional methionine resulting from the start codon. The results of this analysis revealed the role of the partially exposed N-terminus in the unfolding of BSX in response to an increase in temperature. Methodology: We investigated the poly-extremophilicity of BSX to deduce the structural features responsible for its stability under one set of conditions, in order to gain information about its stability in other extreme conditions. To systematically address the role of the partially exposed N-terminus in BSX stability, a series of mutants was generated in which the first hydrophobic residue, valine (Val1), was either deleted or substituted with various amino acids. Each mutant was subsequently analyzed for its thermal, SDS and proteinase K stability in comparison to native BSX. Conclusions: A single conversion of Val1 to glycine (Gly) changed R-BSX from being thermo- and alkali-stable and proteinase K and SDS resistant, to being thermolabile and proteinase K-, alkali- and SDS- sensitive. This result provided insight into the structure-function relationships of BSX under poly-extreme conditions. Molecular, biochemical and structural data revealed that the poly-extremophilicity of BSX is governed by a partially exposed N-terminus through hydrophobic interactions. Such hitherto unidentified N-terminal hydrophobic interactions may play a similar role in other proteins, especially those with TIM-barrel structures. The results of the present study are therefore of major significance for protein folding and protein engineering.	[Bharadwaj, Amit; Leelavathi, Sadhu; Reddy, Vanga S.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Bharadwaj, Amit; Mazumdar-Leighton, Sudeshna] Univ Delhi, Dept Bot, Delhi 110007, India; [Ghosh, Amit] Indian Inst Advanced Res, Gandhi Sagar, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore, Karnataka, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Bioinformat Ctr, Bangalore, Karnataka, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bharadwaj, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	vsreddy@icgeb.res.in	Ghosh, Amit/AAB-3140-2019		International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi and the Department of Biotechnology (DBT), Government of India.	ALBERTI E, 2003, ANNU REP NMR SPECTRO, V50, P121; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; FERSHT AR, 1993, CURR OPIN STRUC BIOL, V3, P75, DOI 10.1016/0959-440X(93)90205-Y; Frigerio F, 1996, PROTEIN ENG, V9, P439, DOI 10.1093/protein/9.5.439; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; GOLDENBERG DP, 1982, J BIOL CHEM, V257, P7864; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta N, 2000, APPL ENVIRON MICROB, V66, P2631, DOI 10.1128/AEM.66.6.2631-2635.2000; Ihsanawati, 2005, PROTEINS, V61, P999, DOI 10.1002/prot.20700; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee B, 1997, CURR OPIN BIOTECH, V8, P423, DOI 10.1016/S0958-1669(97)80063-8; Leelavathi S, 2003, MOL BREEDING, V11, P59, DOI 10.1023/A:1022168321380; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Manikandan K, 2005, ACTA CRYSTALLOGR F, V61, P747, DOI 10.1107/S1744309105020518; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Markert Y, 2001, PROTEIN ENG, V14, P791, DOI 10.1093/protein/14.10.791; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Nakasako M, 1999, J MOL BIOL, V289, P547, DOI 10.1006/jmbi.1999.2795; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Perl D, 2000, NAT STRUCT BIOL, V7, P380; RUSSELL RJM, 1995, CURR OPIN BIOTECH, V6, P370, DOI 10.1016/0958-1669(95)80064-6; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; VANDENBURG B, 1994, EUR J BIOCHEM, V220, P981; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002	28	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3063	10.1371/journal.pone.0003063	http://dx.doi.org/10.1371/journal.pone.0003063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725971	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796300009
J	DiGiulio, DB; Romero, R; Amogan, HP; Kusanovic, JP; Bik, EM; Gotsch, F; Kim, CJ; Erez, O; Edwin, S; Relman, DA				DiGiulio, Daniel B.; Romero, Roberto; Amogan, Harold P.; Kusanovic, Juan Pedro; Bik, Elisabeth M.; Gotsch, Francesca; Kim, Chong Jai; Erez, Offer; Edwin, Sam; Relman, David A.			Microbial Prevalence, Diversity and Abundance in Amniotic Fluid During Preterm Labor: A Molecular and Culture-Based Investigation	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; UREAPLASMA-UREALYTICUM; LEPTOTRICHIA-AMNIONII; SNEATHIA-SANGUINEGENS; BACTERIAL VAGINOSIS; SP NOV.; INFECTION; WOMEN; IDENTIFICATION; ASSOCIATION	Background: Preterm delivery causes substantial neonatal mortality and morbidity. Unrecognized intra-amniotic infections caused by cultivation-resistant microbes may play a role. Molecular methods can detect, characterize and quantify microbes independently of traditional culture techniques. However, molecular studies that define the diversity and abundance of microbes invading the amniotic cavity, and evaluate their clinical significance within a causal framework, are lacking. Methods and Findings: In parallel with culture, we used broad-range end-point and real-time PCR assays to amplify, identify and quantify ribosomal DNA (rDNA) of bacteria, fungi and archaea from amniotic fluid of 166 women in preterm labor with intact membranes. We sequenced up to 24 rRNA clones per positive specimen and assigned taxonomic designations to approximately the species level. Microbial prevalence, diversity and abundance were correlated with host inflammation and with gestational and neonatal outcomes. Study subjects who delivered at term served as controls. The combined use of molecular and culture methods revealed a greater prevalence (15% of subjects) and diversity (18 taxa) of microbes in amniotic fluid than did culture alone (9.6% of subjects; 11 taxa). The taxa detected only by PCR included a related group of fastidious bacteria, comprised of Sneathia sanguinegens, Leptotrichia amnionii and an unassigned, uncultivated, and previously-uncharacterized bacterium; one or more members of this group were detected in 25% of positive specimens. A positive PCR was associated with histologic chorioamnionitis (adjusted odds ratio [ OR] 20; 95% CI, 2.4 to 172), and funisitis (adjusted OR 18; 95% CI, 3.1 to 99). The positive predictive value of PCR for preterm delivery was 100 percent. A temporal association between a positive PCR and delivery was supported by a shortened amniocentesis-to-delivery interval (adjusted hazard ratio 4.6; 95% CI, 2.2 to 9.5). A dose-response association was demonstrated between bacterial rDNA abundance and gestational age at delivery (r(2) = 0.42; P, 0.002). Conclusions: The amniotic cavity of women in preterm labor harbors DNA from a greater diversity of microbes than previously suspected, including as-yet uncultivated, previously-uncharacterized taxa. The strength, temporality and gradient with which these microbial sequence types are associated with preterm delivery support a causal relationship.	[DiGiulio, Daniel B.; Relman, David A.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [DiGiulio, Daniel B.; Amogan, Harold P.; Bik, Elisabeth M.; Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Romero, Roberto; Kusanovic, Juan Pedro; Gotsch, Francesca; Kim, Chong Jai; Erez, Offer; Edwin, Sam] NIH, NICHD, Perinatol Res Branch, Bethesda, MD USA; [Romero, Roberto] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Kusanovic, Juan Pedro; Erez, Offer] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48202 USA; [Bik, Elisabeth M.; Relman, David A.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48202 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Stanford University; Wayne State University	DiGiulio, DB (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	relman@stanford.edu	Kusanovic, Juan Pedro/R-8616-2019; Erez, Offer/F-1466-2012; Bik, Elisabeth M/A-1204-2007; Kusanovic, Juan Pedro/AAM-5782-2020; Romero, Roberto/A-5268-2019	Erez, Offer/0000-0002-2213-8129; Bik, Elisabeth M/0000-0001-5477-0324; Kusanovic, Juan Pedro/0000-0003-0640-2070; Relman, David A./0000-0001-8331-1354; Romero, Roberto/0000-0002-4448-5121	Intramural Research Program of the National Institute of Child Health and Human Development; NIH [T32 AI052073-01, DP1OD000964]; DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI052073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DHHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the Intramural Research Program of the National Institute of Child Health and Human Development, NIH, DHHS, and by NIH grant T32 AI052073-01 (Epidemiology of Emerging Infections and Bioterrorism). DAR is supported by an NIH Directors Pioneer Award (NIH DP1OD000964). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS148, DOI 10.1093/clinids/17.Supplement_1.S148; Bucher HU, 2003, SWISS MED WKLY, V133, P93; Collins MD, 2001, SYST APPL MICROBIOL, V24, P358, DOI 10.1078/0723-2020-00047; *COMM UND PREM BIR, 2006, PRET BIRTH CAUS CONS; De Martino SJ, 2004, J CLIN MICROBIOL, V42, P5940, DOI 10.1128/JCM.42.12.5940-5943.2004; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Gardella C, 2004, AM J PERINAT, V21, P319, DOI 10.1055/s-2004-831884; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1998, PRENAT NEONAT MED, V3, P43; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064; Green NS, 2005, AM J OBSTET GYNECOL, V193, P626, DOI 10.1016/j.ajog.2005.02.106; Gundi VAKB, 2004, EMERG INFECT DIS, V10, P2056, DOI 10.3201/eid1011.031019; HANFF PA, 1995, CLIN INFECT DIS, V20, pS237, DOI 10.1093/clinids/20.Supplement_2.S237; Hebb JK, 2004, J INFECT DIS, V190, P2109, DOI 10.1086/425929; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hillier SL, 2005, NEW ENGL J MED, V353, P1886, DOI 10.1056/NEJMp058191; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Hitti J, 1997, CLIN INFECT DIS, V24, P1228, DOI 10.1086/513669; Hugenholtz P, 2002, GENOME BIOL, V3; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Jalava J, 1996, BRIT J OBSTET GYNAEC, V103, P664, DOI 10.1111/j.1471-0528.1996.tb09835.x; Katsoulis J, 2005, ORAL MICROBIOL IMMUN, V20, P128, DOI 10.1111/j.1399-302X.2004.00200.x; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leitich H, 2003, AM J OBSTET GYNECOL, V189, P139, DOI 10.1067/mob.2003.339; Leon R, 2007, J PERIODONTOL, V78, P1249, DOI 10.1902/jop.2007.060368; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; Markenson GR, 1997, AM J OBSTET GYNECOL, V177, P1471, DOI 10.1016/S0002-9378(97)70093-0; Miralles R, 2005, PEDIATR RES, V57, P570, DOI 10.1203/01.PDR.0000155944.48195.97; Oyarzun E, 1998, AM J OBSTET GYNECOL, V179, P1115, DOI 10.1016/S0002-9378(98)70115-2; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; Rivers TM, 1937, J BACTERIOL, V33, P1; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Shukla SK, 2002, J CLIN MICROBIOL, V40, P3346, DOI 10.1128/JCM.40.9.3346-3349.2002; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Thilesen CM, 2007, J CLIN MICROBIOL, V45, P2344, DOI 10.1128/JCM.00167-07; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WATTS DH, 1992, OBSTET GYNECOL, V79, P351; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Yi JY, 2005, MOL CELL PROBE, V19, P255, DOI 10.1016/j.mcp.2005.04.002; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4; Yoon BH, 2003, AM J OBSTET GYNECOL, V189, P919, DOI 10.1067/S0002-9378(03)00839-1; Yoon BH, 2000, AM J OBSTET GYNECOL, V183, P1130, DOI 10.1067/mob.2000.109036	53	515	543	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3056	10.1371/journal.pone.0003056	http://dx.doi.org/10.1371/journal.pone.0003056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725970	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796300003
J	Burgold, T; Spreafico, F; De Santa, F; Totaro, MG; Prosperini, E; Natoli, G; Testa, G				Burgold, Thomas; Spreafico, Fabio; De Santa, Francesca; Totaro, Maria Grazia; Prosperini, Elena; Natoli, Gioacchino; Testa, Giuseppe			The Histone H3 Lysine 27-Specific Demethylase Jmjd3 Is Required for Neural Commitment	PLOS ONE			English	Article								Patterns of methylation at lysine 4 and 27 of histone H3 have been associated with states of gene activation and repression that are developmentally regulated and are thought to underlie the establishment of lineage specific gene expression programs. Recent studies have provided fundamental insight into the problem of lineage specification by comparing global changes in chromatin and transcription between ES and neural stem (NS) cells, points respectively of departure and arrival for neural commitment. With these maps of the differentiated state in place, a central task is now to unravel the chromatin dynamics that enables these differentiation transitions. In particular, the observation that lineage-specific genes repressed in ES cells by Polycomb-mediated H3-K27 trimethylation (H3-K27me3) are demethylated and derepressed in differentiated cells posited the existence of a specific H3-K27 demethylase. In order to gain insight into the epigenetic transitions that enable lineage specification, we investigated the early stages of neural commitment using as model system the monolayer differentiation of mouse ES cells into neural stem (NS) cells. Starting from a comprehensive profiling of JmjC-domain genes, we report here that Jmjd3, recently identified as a H3-K27me3 specific demethylase, controls the expression of key regulators and markers of neurogenesis and is required for commitment to the neural lineage. Our results demonstrate the relevance of an enzymatic activity that antagonizes Polycomb regulation and highlight different modalities through which the dynamics of H3-K27me3 is related to transcriptional output. By showing that the H3-K27 demethylase Jmjd3 is required for commitment to the neural lineage and that it resolves the bivalent domain at the Nestin promoter, our work confirms the functional relevance of bivalent domain resolution that had been posited on the basis of the genome-wide correlation between their controlled resolution and differentiation. In addition, our data indicate that the regulation of H3-K27me3 is highly gene- and context-specific, suggesting that the interplay of methyltransferases and demethylases enables the fine-tuning more than the on/off alternation of methylation states.	[Burgold, Thomas; Spreafico, Fabio; De Santa, Francesca; Totaro, Maria Grazia; Prosperini, Elena; Natoli, Gioacchino; Testa, Giuseppe] European Inst Oncol, Milan, Italy	IRCCS European Institute of Oncology (IEO)	Burgold, T (corresponding author), European Inst Oncol, Milan, Italy.	giuseppe.testa@ifom-ieo-campus.it	DE SANTA, FRANCESCA/AAX-5810-2020; PROSPERINI, ELENA/AAB-1952-2021; Testa, Giuseppe/J-4572-2012; Natoli, gioacchino/J-2100-2018; De Santa, Francesca/A-2954-2014; Natoli, gioacchino/ABB-8679-2020	DE SANTA, FRANCESCA/0000-0002-0034-5450; De Santa, Francesca/0000-0002-0034-5450; Natoli, Gioacchino/0000-0003-0711-2411; Testa, Giuseppe/0000-0002-9104-0918	Marie-Curie Excellence; Italian Association for Cancer Research (AIRC)	Marie-Curie Excellence(European Commission); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro)	Research in G.N. lab was supported by the EC (Marie-Curie Excellence Grant TRANS-TAR), by a donation from Manetti and Roberts and Fondazione Umberto Veronesi and by the Italian Association for Cancer Research (AIRC). Research in G.T. lab was supported by a grant from the Italian Association for Cancer Research (AIRC).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; BYVOET P, 1972, ARCH BIOCHEM BIOPHYS, V148, P558, DOI 10.1016/0003-9861(72)90174-9; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nagy A., 2002, MANIPULATING MOUSE E; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Saccani S, 2002, GENE DEV, V16, P2219, DOI 10.1101/gad.232502; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	27	159	168	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3034	10.1371/journal.pone.0003034	http://dx.doi.org/10.1371/journal.pone.0003034			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716661	Green Published, gold, Green Submitted			2022-12-27	WOS:000264426800011
J	Marengo, EB; de Moraes, LV; Faria, M; Fernandes, BL; Carvalho, LV; Tambourgi, DV; Rizzo, LV; Portaro, FCV; Camargo, ACM; Sant'Anna, OA				Marengo, Eliana B.; de Moraes, Luciana V.; Faria, Marcella; Fernandes, Beatriz L.; Carvalho, Luciana V.; Tambourgi, Denise V.; Rizzo, Luiz V.; Portaro, Fernanda C. V.; Camargo, Antonio Carlos M.; Sant'Anna, Osvaldo A.			Administration of M. leprae Hsp65 Interferes with the Murine Lupus Progression	PLOS ONE			English	Article								The heat shock protein [Hsp] family guides several steps during protein synthesis, are abundant in prokaryotic and eukaryotic cells, and are highly conserved during evolution. The Hsp60 family is involved in assembly and transport of proteins, and is expressed at very high levels during autoimmunity or autoinflammatory phenomena. Here, the pathophysiological role of the wild type [WT] and the point mutated K(409)A recombinant Hsp65 of M. leprae in an animal model of Systemic Lupus Erythematosus [SLE] was evaluated in vivo using the genetically homogeneous [NZBxNZW]F-1 mice. Anti-DNA and anti-Hsp65 antibodies responsiveness was individually measured during the animal's life span, and the mean survival time [MST] was determined. The treatment with WT abbreviates the MST in 46%, when compared to non-treated mice [p<0.001]. An increase in the IgG2a/IgG1 anti-DNA antibodies ratio was also observed in animals injected with the WT Hsp65. Incubation of BALB/c macrophages with F1 serum from WT treated mice resulted in acute cell necrosis; treatment of these cells with serum from K(409)A treated mice did not cause any toxic effect. Moreover, the involvement of WT correlates with age and is dose-dependent. Our data suggest that Hsp65 may be a central molecule intervening in the progression of the SLE, and that the point mutated K(409)A recombinant immunogenic molecule, that counteracts the deleterious effect of WT, may act mitigating and delaying the development of SLE in treated mice. This study gives new insights into the general biological role of Hsp and the significant impact of environmental factors during the pathogenesis of this autoimmune process.	[Marengo, Eliana B.; Carvalho, Luciana V.; Tambourgi, Denise V.; Portaro, Fernanda C. V.; Sant'Anna, Osvaldo A.] Inst Butantan, Immunochem Lab, Sao Paulo, Brazil; [de Moraes, Luciana V.; Rizzo, Luiz V.] Univ Sao Paulo, Inst Ciencias Biomed, Clin Immunol Lab, Sao Paulo, Brazil; [Faria, Marcella; Fernandes, Beatriz L.; Camargo, Antonio Carlos M.] Ctr Appl Toxinol, CAT CEPID, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo	Marengo, EB (corresponding author), Inst Butantan, Immunochem Lab, Sao Paulo, Brazil.	gbrazil@usp.br	Portaro, F/B-8397-2012; Tambourgi, Denise/H-7114-2016; de Moraes, Luciana/M-1619-2013; Rizzo, Luiz Vicente/B-4458-2009; Portaro, Fernanda/I-6644-2015	Tambourgi, Denise/0000-0003-1896-9074; de Moraes, Luciana/0000-0001-6605-5547; 	FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo] [fellowships]; CNPq-Brazil	FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo](Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds of FAPESP [Fundacao de Amparo a Pesquisa do Estado de Sao Paulo] through the CAT/CEPID program. E. B. Marengo, L. V. Moraes and L. V. Carvalho are recipient of FAPESP fellowships. D. V. Tambourgi, L. V. Rizzo, A. C. M. Camargo and O.A. Sant'Anna are researchers of CNPq-Brazil.	Bengtsson AA, 2004, CLIN EXP IMMUNOL, V135, P535, DOI 10.1111/j.1365-2249.2003.02386.x; Biozzi G, 1979, Curr Top Microbiol Immunol, V85, P31; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNET FM, 1965, AUSTRALAS ANN MED, V14, P185; COHEN IR, 1991, ANNU REV IMMUNOL, V9, P567, DOI 10.1146/annurev.iy.09.040191.003031; Cohen IR, 2007, J AUTOIMMUN, V29, P246, DOI 10.1016/j.jaut.2007.07.016; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; George J, 1999, CIRCULATION, V99, P2227, DOI 10.1161/01.CIR.99.17.2227; GILES AR, 1987, THROMB HAEMOSTASIS, V58, P1078; Habich C, 2004, FEBS LETT, V568, P65, DOI 10.1016/j.febslet.2004.05.010; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Harats D, 2002, J AM COLL CARDIOL, V40, P1333, DOI 10.1016/S0735-1097(02)02135-6; HELYER BJ, 1963, BRIT J HAEMATOL, V9, P119, DOI 10.1111/j.1365-2141.1963.tb05450.x; HOJNIK M, 1994, LUPUS, V3, P515, DOI 10.1177/096120339400300615; IBANEZ OM, 1992, EUR J IMMUNOL, V22, P2555, DOI 10.1002/eji.1830221014; Ishikawa S, 1998, J IMMUNOL, V161, P1267; JONES DB, 1990, LANCET, V336, P583, DOI 10.1016/0140-6736(90)93390-B; Kaplan MJ, 2004, CLIN IMMUNOL, V112, P210, DOI 10.1016/j.clim.2004.04.007; Kaplan MJ, 2002, J IMMUNOL, V169, P6020, DOI 10.4049/jimmunol.169.10.6020; Kim EY, 2008, CLIN IMMUNOL, V127, P98, DOI 10.1016/j.clim.2008.01.003; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; MOUTON D, 1988, LIVEST PROD SCI, V20, P277, DOI 10.1016/0301-6226(88)90023-1; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Pisetsky DS, 1998, CLIN DIAGN LAB IMMUN, V5, P1; Pockley AG, 1999, CELL STRESS CHAPERON, V4, P29, DOI 10.1054/csac.1998.0121; Pockley AG, 1998, IMMUNOL INVEST, V27, P367, DOI 10.3109/08820139809022710; Poletaev A, 2003, AUTOIMMUN REV, V2, P264, DOI 10.1016/S1568-9972(03)00033-8; Portaro FCV, 2002, BIOCHEMISTRY-US, V41, P7400, DOI 10.1021/bi011999l; Prigogine I, 2003, ANN NY ACAD SCI, V988, P128, DOI 10.1111/j.1749-6632.2003.tb06091.x; PRIGOGINE I, 1978, SCIENCE, V201, P777, DOI 10.1126/science.201.4358.777; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; PUTTERMAN C, 1994, AUTOIMMUNE DIS MODEL, P217; Rea IM, 2001, EXP GERONTOL, V36, P341, DOI 10.1016/S0531-5565(00)00215-1; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Schett G, 1997, ATHEROSCLEROSIS, V128, P27, DOI 10.1016/S0021-9150(96)05975-8; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; SIQUEIRA M, 1976, EUR J IMMUNOL, V6, P241, DOI 10.1002/eji.1830060403; Stephanou A, 1998, SEMIN ARTHRITIS RHEU, V28, P155, DOI 10.1016/S0049-0172(98)80032-2; STRUHAR D, 1988, LUNG, V166, P107, DOI 10.1007/BF02714034; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; THOLE J, 1990, MOL BIOL MYCOBACTERI; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; VAARALA O, 1993, LANCET, V341, P923, DOI 10.1016/0140-6736(93)91213-6; Wermeling F, 2007, J EXP MED, V204, P2259, DOI 10.1084/jem.20070600; Westermeier R, 2002, PROTEOMICS PRACTICE; Wick G, 2001, TRENDS IMMUNOL, V22, P665, DOI 10.1016/S1471-4906(01)02089-0; WINFIELD JB, 1989, ARTHRITIS RHEUM, V32, P1497, DOI 10.1002/anr.1780321202; Xu QB, 2000, CIRCULATION, V102, P14, DOI 10.1161/01.CIR.102.1.14; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; XU QB, 1992, ARTERIOSCLER THROMB, V12, P789, DOI 10.1161/01.ATV.12.7.789; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	58	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3025	10.1371/journal.pone.0003025	http://dx.doi.org/10.1371/journal.pone.0003025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716655	gold, Green Submitted, Green Published			2022-12-27	WOS:000264426800004
J	Overgaard, M; Fehl, K; Mouridsen, K; Bergholt, B; Cleeremans, A				Overgaard, Morten; Fehl, Katrin; Mouridsen, Kim; Bergholt, Bo; Cleeremans, Axel			Seeing without Seeing? Degraded Conscious Vision in a Blindsight Patient	PLOS ONE			English	Article							SIGHT	Blindsight patients, whose primary visual cortex is lesioned, exhibit preserved ability to discriminate visual stimuli presented in their "blind'' field, yet report no visual awareness hereof. Blindsight is generally studied in experimental investigations of single patients, as very few patients have been given this "diagnosis''. In our single case study of patient GR, we ask whether blindsight is best described as unconscious vision, or rather as conscious, yet severely degraded vision. In experiment 1 and 2, we successfully replicate the typical findings of previous studies on blindsight. The third experiment, however, suggests that GR's ability to discriminate amongst visual stimuli does not reflect unconscious vision, but rather degraded, yet conscious vision. As our finding results from using a method for obtaining subjective reports that has not previously used in blindsight studies (but validated in studies of healthy subjects and other patients with brain injury), our results call for a reconsideration of blindsight, and, arguably also of many previous studies of unconscious perception in healthy subjects.	[Overgaard, Morten; Fehl, Katrin] Aarhus Univ Hosp, CNRU, Hammel Neurorehabil & Res Ctr, Hammel, Denmark; [Fehl, Katrin] Univ Marburg, Dept Psychol, D-35032 Marburg, Germany; [Mouridsen, Kim] Aarhus Univ Hosp, Ctr Funct Integrat Neurosci, Aarhus, Denmark; [Bergholt, Bo] Aarhus Univ Hosp, Dept Neurosurg, Aarhus, Denmark; [Cleeremans, Axel] Free Univ Brussels, Cognitive Sci Res Unit, Brussels, Belgium	Aarhus University; Philipps University Marburg; Aarhus University; Aarhus University; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Overgaard, M (corresponding author), Aarhus Univ Hosp, CNRU, Hammel Neurorehabil & Res Ctr, Hammel, Denmark.	neumov@sc.aaa.dk	Overgaard, Morten/B-3830-2010	Overgaard, Morten/0000-0002-2136-3455	The MindBridge project; European Commission [043457]	The MindBridge project; European Commission(European CommissionEuropean Commission Joint Research Centre)	Morten Overgaard was supported by The MindBridge project, co-funded by the European Commission under the Sixth Framework Programme, Contract No. 043457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Overgaard M, 2006, CONSCIOUS COGN, V15, P700, DOI 10.1016/j.concog.2006.04.002; Persaud N, 2007, NAT NEUROSCI, V10, P257, DOI 10.1038/nn1840; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Sergent C, 2004, PSYCHOL SCI, V15, P720, DOI 10.1111/j.0956-7976.2004.00748.x; Stoerig P, 2001, CONSCIOUS COGN, V10, P574, DOI 10.1006/ccog.2001.0526; Trevethan CT, 2007, COGNITION, V103, P491, DOI 10.1016/j.cognition.2006.04.011; Weiskrantz L, 2002, NAT NEUROSCI, V5, P101, DOI 10.1038/nn793; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Zeki S, 1998, BRAIN, V121, P25, DOI 10.1093/brain/121.1.25	11	97	97	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3028	10.1371/journal.pone.0003028	http://dx.doi.org/10.1371/journal.pone.0003028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KO	18716654	Green Published, Green Submitted, gold			2022-12-27	WOS:000264426800006
J	Guo, JJ; Zeng, QN; Emami, M; Ellis, BE; Chen, JG				Guo, Jianjun; Zeng, Qingning; Emami, Mohammad; Ellis, Brian E.; Chen, Jin-Gui			The GCR2 Gene Family Is Not Required for ABA Control of Seed Germination and Early Seedling Development in Arabidopsis	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; PLASMA-MEMBRANE RECEPTOR; COUPLED RECEPTOR; CELL-DIVISION; PERCEPTION; BIOSYNTHESIS; SUBUNIT; TIR1	Background: The plant hormone abscisic acid (ABA) regulates diverse processes of plant growth and development. It has recently been proposed that GCR2 functions as a G-protein-coupled receptor (GPCR) for ABA. However, the structural relationships and functionality of GCR2 have been challenged by several independent studies. A central question in this controversy is whether gcr2 mutants are insensitive to ABA, because gcr2 mutants were shown to display reduced sensitivity to ABA under one experimental condition (e. g. 22 degrees C, continuous white light with 150 mu mol m(-2) s(-1)) but were shown to display wild-type sensitivity under another slightly different condition (e. g. 23 degrees C, 14/10 hr photoperiod with 120 mu mol m(-2) s(-1)). It has been hypothesized that gcr2 appears only weakly insensitive to ABA because two other GCR2-like genes in Arabidopsis, GCL1 and GCL2, compensate for the loss of function of GCR2. Principal Findings: In order to test this hypothesis, we isolated a putative loss-of-function allele of GCL2, and then generated all possible combinations of mutations in each member of the GCR2 gene family. We found that all double mutants, including gcr2 gcl1, gcr2 gcl2, gcl1 gcl2, as well as the gcr2 gcl1 gcl2 triple mutant displayed wild-type sensitivity to ABA in seed germination and early seedling development assays, demonstrating that the GCR2 gene family is not required for ABA responses in these processes. Conclusion: These results provide compelling genetic evidence that GCR2 is unlikely to act as a receptor for ABA in the context of either seed germination or early seedling development.	Univ British Columbia, Dept Bot, Vancouver, BC, Canada; Univ British Columbia, Michael Smith Lab, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Guo, JJ (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jingui@interchange.ubc.ca	Chen, Jin-Gui/AFV-6337-2022; guo, jianjun/G-6852-2013; Chen, Jin-Gui/A-4773-2011; Zeng, Qingning/M-2245-2013	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; 	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work is supported by grants from the Natural Sciences and Engineering Research Council of Canada and the Canada Foundation for Innovation.	Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen JG, 2008, PLANT SIGNAL BEHAV, V3, P307, DOI 10.4161/psb.3.5.5292; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Finkelstein Ruth R, 2002, Arabidopsis Book, V1, pe0058, DOI 10.1199/tab.0058; Gao YJ, 2007, PLANT J, V52, P1001, DOI 10.1111/j.1365-313X.2007.03291.x; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Illingworth CJR, 2008, BIOPHYS CHEM, V133, P28, DOI 10.1016/j.bpc.2007.11.004; Johnston CA, 2007, SCIENCE, V318, DOI 10.1126/science.1143230; Jones AM, 2004, EMBO REP, V5, P572, DOI 10.1038/sj.embor.7400174; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Liu XG, 2007, SCIENCE, V318, DOI 10.1126/science.1143320; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Perfus-Barbeoch L, 2004, CURR OPIN PLANT BIOL, V7, P719, DOI 10.1016/j.pbi.2004.09.013; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Verslues PE, 2007, CURR OPIN PLANT BIOL, V10, P447, DOI 10.1016/j.pbi.2007.08.004; Wang XF, 2008, ANN BOT-LONDON, V101, P311, DOI 10.1093/aob/mcm284; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	26	52	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2982	10.1371/journal.pone.0002982	http://dx.doi.org/10.1371/journal.pone.0002982			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714360	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900009
J	Rasheed, S; Yan, JS; Lau, A; Chan, AS				Rasheed, Suraiya; Yan, Jasper S.; Lau, Alex; Chan, Arvan S.			HIV Replication Enhances Production of Free Fatty Acids, Low Density Lipoproteins and Many Key Proteins Involved in Lipid Metabolism: A Proteomics Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECEPTOR-RELATED PROTEIN; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN SERUM-ALBUMIN; APOLIPOPROTEIN-B METABOLISM; HEAT-SHOCK PROTEINS; LDL RECEPTOR; INSULIN-RESISTANCE; BINDING-PROTEIN; INFECTED PATIENTS	Background: HIV-infected patients develop multiple metabolic abnormalities including insulin resistance, lipodystrophy and dyslipidemia. Although progression of these disorders has been associated with the use of various protease inhibitors and other antiretroviral drugs, HIV-infected individuals who have not received these treatments also develop lipid abnormalities albeit to a lesser extent. How HIV alters lipid metabolism in an infected cell and what molecular changes are affected through protein interaction pathways are not well-understood. Results: Since many genetic, epigenetic, dietary and other factors influence lipid metabolism in vivo, we have chosen to study genome-wide changes in the proteomes of a human T-cell line before and after HIV infection in order to circumvent computational problems associated with multiple variables. Four separate experiments were conducted including one that compared 14 different time points over a period of > 3 months. By subtractive analyses of protein profiles overtime, several hundred differentially expressed proteins were identified in HIV-infected cells by mass spectrometry and each protein was scrutinized for its biological functions by using various bioinformatics programs. Herein, we report 18 HIV-modulated proteins and their interaction pathways that enhance fatty acid synthesis, increase low density lipoproteins (triglycerides), dysregulate lipid transport, oxidize lipids, and alter cellular lipid metabolism. Conclusions: We conclude that HIV replication alone (i.e. without any influence of antiviral drugs, or other human genetic factors), can induce novel cellular enzymes and proteins that are significantly associated with biologically relevant processes involved in lipid synthesis, transport and metabolism (p = < 0.0002-0.01). Translational and clinical studies on the newly discovered proteins may now shed light on how some of these proteins may be useful for early diagnosis of individuals who might be at high risk for developing lipid-related disorders. The target proteins could then be used for future studies in the development of inhibitors for preventing lipid-metabolic anomalies. This is the first direct evidence that HIV-modulates production of proteins that are significantly involved in disrupting the normal lipid-metabolic pathways.	[Rasheed, Suraiya; Yan, Jasper S.; Lau, Alex; Chan, Arvan S.] Univ So Calif, Keck Sch Med, Lab Viral Oncol AIDS & Prote Res, Los Angeles, CA 90033 USA	University of Southern California	Rasheed, S (corresponding author), Univ So Calif, Keck Sch Med, Lab Viral Oncol AIDS & Prote Res, Los Angeles, CA 90033 USA.	srasheed@usc.edu			The Rasheed Research and Endowment Funds at the University of Southern California (USC)	The Rasheed Research and Endowment Funds at the University of Southern California (USC)	The Rasheed Research and Endowment Funds at the University of Southern California (USC) sponsored this research. The funders (USC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjan R, 2005, THROMB HAEMOSTASIS, V94, P1048, DOI 10.1160/TH05-06-0384; Anderson DR, 2007, CARDIOVASC RES, V73, P597, DOI 10.1016/j.cardiores.2006.11.029; Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Arnedo M, 2007, PHARMACOGENET GENOM, V17, P755, DOI 10.1097/FPC.0b013e32814db8b7; Barbaro G, 2002, J CARDIOVASC RISK, V9, P295, DOI 10.1097/00043798-200210000-00011; Barbaro G, 2007, CURR PHARM DESIGN, V13, P2208, DOI 10.2174/138161207781039661; BEACH DC, 1982, BIOCHIM BIOPHYS ACTA, V711, P452, DOI 10.1016/0005-2760(82)90059-5; Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001; Behrens GMN, 2000, DRUG SAFETY, V23, P57, DOI 10.2165/00002018-200023010-00004; Ben-Romano R, 2004, DIABETOLOGIA, V47, P1107, DOI 10.1007/s00125-004-1408-5; Bonnet E, 2007, CLIN CHEM LAB MED, V45, P815, DOI 10.1515/CCLM.2007.140; Bozza PT, 1997, J EXP MED, V186, P909, DOI 10.1084/jem.186.6.909; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; Burch WL, 2000, J BIOL CHEM, V275, P16267, DOI 10.1074/jbc.M000446200; Camino-Lopez S, 2007, CARDIOVASC RES, V73, P208, DOI 10.1016/j.cardiores.2006.10.017; Carpentier A, 2005, ATHEROSCLEROSIS, V178, P165, DOI 10.1016/j.atherosclerosis.2004.07.035; Carr A, 2002, JAMA-J AM MED ASSOC, V288, P207, DOI 10.1001/jama.288.2.207; Carr A, 2000, CLIN INFECT DIS, V30, pS135, DOI 10.1086/313854; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carter V M, 2001, HIV Med, V2, P174, DOI 10.1046/j.1468-1293.2001.00073.x; Chakraborty A, 2008, P NATL ACAD SCI USA, V105, P1134, DOI 10.1073/pnas.0711168105; CHAMBON M, 1989, J STEROID BIOCHEM, V33, P915, DOI 10.1016/0022-4731(89)90240-9; Chan EY, 2007, J VIROL, V81, P7571, DOI 10.1128/JVI.00288-07; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CharnockJones DS, 1996, INT J BIOCHEM CELL B, V28, P81, DOI 10.1016/1357-2725(95)00120-4; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; CHULKOVA TM, 1993, FEBS LETT, V336, P327, DOI 10.1016/0014-5793(93)80830-N; Coll B, 2006, CYTOKINE, V34, P51, DOI 10.1016/j.cyto.2006.03.013; CONSTANS J, 1994, EUR J CLIN INVEST, V24, P416, DOI 10.1111/j.1365-2362.1994.tb02185.x; CURRIER J, 2008, J ACQUIR IMMUNE DEFI; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Dadaian M, 1999, J LIPID RES, V40, P940; Das S, 2006, DIABETOLOGIA, V49, P538, DOI 10.1007/s00125-005-0085-3; DE FS, 2008, CLIN CHEM; Desruisseaux MS, 2007, INFECT IMMUN, V75, P1066, DOI 10.1128/IAI.01455-06; Domingo P, 2003, JAIDS-J ACQ IMM DEF, V33, P114, DOI 10.1097/00126334-200305010-00017; DUCHARME NA, 2008, ENDOCRINOLOGY; Engstrom G, 2007, EUR J CARDIOV PREV R, V14, P392, DOI 10.1097/01.hjr.0000244582.30421.b2; FEINGOLD KR, 1993, J CLIN ENDOCR METAB, V76, P1423, DOI 10.1210/jc.76.6.1423; Feng ZH, 2006, MUTAT RES-FUND MOL M, V601, P125, DOI 10.1016/j.mrfmmm.2006.06.003; Fisher SD, 2006, ATHEROSCLEROSIS, V185, P1, DOI 10.1016/j.atherosclerosis.2005.09.025; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Fujiwara SI, 2008, BIOPHYS J, V94, P95, DOI 10.1529/biophysj.107.111377; Gao TY, 2002, J BIOL CHEM, V277, P31585, DOI 10.1074/jbc.M204335200; Giralt M, 2006, ANTIVIR THER, V11, P729; GOMEZ E, 1998, AIDS COALIT N Y, V34, P34; Grinspoon Steven K, 2005, Am J Med, V118 Suppl 2, p23S; GRUNFELD C, 1992, J CLIN ENDOCR METAB, V74, P1045, DOI 10.1210/jc.74.5.1045; Ha JS, 2006, BBA-MOL CELL BIOL L, V1761, P717, DOI 10.1016/j.bbalip.2006.05.016; Hashiguchi N, 2001, J TRAUMA, V51, P1104, DOI 10.1097/00005373-200112000-00015; Hazan U, 2002, FASEB J, V16, P1254, DOI 10.1096/fj.01-0947fje; Hertzel AV, 2002, J LIPID RES, V43, P2105, DOI 10.1194/jlr.M200227-JLR200; Hodgetts A, 2007, FUTURE MICROBIOL, V2, P35, DOI 10.2217/17460913.2.1.35; Huang H, 2005, BIOCHEMISTRY-US, V44, P10282, DOI 10.1021/bi0477891; Hurlimann D, 2005, HERZ, V30, P472, DOI 10.1007/s00059-005-2740-3; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; Kim SS, 2007, J PROTEOME RES, V6, P180, DOI 10.1021/pr060323f; Knowlton AA, 1998, J MOL CELL CARDIOL, V30, P811, DOI 10.1006/jmcc.1998.0646; Krishnaswamy G, 2000, Cardiol Rev, V8, P260, DOI 10.1097/00045415-200008050-00005; Lainka E, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e56; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lamia KA, 2004, MOL CELL BIOL, V24, P5080, DOI 10.1128/MCB.24.11.5080-5087.2004; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lee L, 2007, J INVEST DERMATOL, V127, P16, DOI 10.1038/sj.jid.5700511; Leonard EG, 2005, INFECT DIS CLIN N AM, V19, P713, DOI 10.1016/j.idc.2005.05.006; LEROY A, 1995, CURR OPIN LIPIDOL, V6, P281, DOI 10.1097/00041433-199510000-00007; Lewis P, 2007, CIRCULATION, V115, P2178, DOI 10.1161/CIRCULATIONAHA.106.664250; Liao ZH, 2001, AIDS RES HUM RETROV, V17, P1009, DOI 10.1089/088922201300343690; Llorente-Cortes V, 2007, J LIPID RES, V48, P2133, DOI 10.1194/jlr.M700039-JLR200; Llorente-Cortes V, 2005, ARTERIOSCL THROM VAS, V25, P497, DOI 10.1161/01.ATV.0000154280.62072.fd; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; LORENZ MW, ATHEROSCLEROSIS; MacDougall ED, 2006, AM J PATHOL, V168, P2064, DOI 10.2353/ajpath.2006.051009; Maggi P, 2006, AIDS REV, V8, P204; Mallon PWG, 2007, AIDS REV, V9, P3; Mallon PWG, 2006, PLOS MED, V3, P291, DOI 10.1371/journal.pmed.0030085; Mandrup S, 1998, J BIOL CHEM, V273, P23897, DOI 10.1074/jbc.273.37.23897; Maurin T, 2005, EXP CELL RES, V304, P544, DOI 10.1016/j.yexcr.2004.12.003; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mizrak SC, 2006, MOL REPROD DEV, V73, P1361, DOI 10.1002/mrd.20548; Molina L, 2007, PROTEOMICS, V7, P3116, DOI 10.1002/pmic.200700306; Moon YS, 2002, J LIPID RES, V43, P691; Mujawar Z, 2006, PLOS BIOL, V4, P1970, DOI 10.1371/journal.pbio.0040365; Murray I, 2000, ENDOCRINOLOGY, V141, P1041, DOI 10.1210/en.141.3.1041; Ng TWK, 2005, DIABETES, V54, P795, DOI 10.2337/diabetes.54.3.795; Olofsson SO, 2005, J INTERN MED, V258, P395, DOI 10.1111/j.1365-2796.2005.01556.x; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; ONSOVILLAVERDE C, 2003, AIDS, V17, P1173; Packard CJ, 2000, J LIPID RES, V41, P305; Panin L. E., 2003, Voprosy Virusologii, V48, P24; Park JJ, 2004, P NATL ACAD SCI USA, V101, P1022, DOI 10.1073/pnas.0307847100; Park SS, 2007, NUCLEOS NUCLEOT NUCL, V26, P453, DOI 10.1080/15257770701426203; Park TS, 2007, CURR OPIN LIPIDOL, V18, P277, DOI 10.1097/MOL.0b013e32814a57db; Parkes HA, 2006, AM J PHYSIOL-ENDOC M, V291, pE737, DOI 10.1152/ajpendo.00112.2006; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rasheed S, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-14; RASHEED S, 1986, VIROLOGY, V154, P395, DOI 10.1016/0042-6822(86)90465-4; Raulin J, 2002, PROG LIPID RES, V41, P27, DOI 10.1016/S0163-7827(01)00019-4; Rehberg EF, 1996, J BIOL CHEM, V271, P29945, DOI 10.1074/jbc.271.47.29945; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; ROHLFS EM, 1993, J CELL PHYSIOL, V157, P469, DOI 10.1002/jcp.1041570306; ROTHBLAT GH, 1992, J LIPID RES, V33, P1091; Santo SMSE, 2005, J LIPID RES, V46, P1097, DOI 10.1194/jlr.C500007-JLR200; Shahmanesh M, 2005, J CLIN ENDOCR METAB, V90, P755, DOI 10.1210/jc.2004-1273; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Shih SC, 1999, J BIOL CHEM, V274, P15407, DOI 10.1074/jbc.274.22.15407; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; SRINIVAS RV, 1990, VIROLOGY, V176, P48, DOI 10.1016/0042-6822(90)90229-K; Stephensen CB, 2007, AM J CLIN NUTR, V85, P173, DOI 10.1093/ajcn/85.1.173; STOIBER H, 1995, IMMUNOBIOLOGY, V193, P98, DOI 10.1016/S0171-2985(11)80158-0; Stoiber H, 2001, IMMUNOL REV, V180, P168, DOI 10.1034/j.1600-065X.2001.1800115.x; Susal C, 1996, BLOOD, V87, P2329, DOI 10.1182/blood.V87.6.2329.bloodjournal8762329; Tanwani LK, 2003, SOUTH MED J, V96, P180, DOI 10.1097/01.SMJ.0000051731.69719.2E; Tong FM, 2006, ARCH BIOCHEM BIOPHYS, V447, P46, DOI 10.1016/j.abb.2006.01.005; Umpleby AM, 2005, ANTIVIR THER, V10, P663; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Vigouroux C, 1999, DIABETES METAB, V25, P225; Wakasaki H, 1997, P NATL ACAD SCI USA, V94, P9320, DOI 10.1073/pnas.94.17.9320; Wang X, 2007, CURR OPIN CARDIOL, V22, P368, DOI 10.1097/HCO.0b013e3281ec5113; Way KJ, 2001, DIABETIC MED, V18, P945, DOI 10.1046/j.0742-3071.2001.00638.x; Wetsel RA, 1999, J BIOL CHEM, V274, P19429, DOI 10.1074/jbc.274.27.19429; WRIGHT D, 2008, CLIN TRIALS, V9, P103; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu WP, 2001, J BIOL CHEM, V276, P36454, DOI 10.1074/jbc.M105093200; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yu WG, 2000, BLOOD, V95, P1078, DOI 10.1182/blood.V95.3.1078.003k16_1078_1085; Zhao LJ, 2006, BIOFACTORS, V27, P93, DOI 10.1002/biof.5520270109	139	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3003	10.1371/journal.pone.0003003	http://dx.doi.org/10.1371/journal.pone.0003003			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714345	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900028
J	Staiger, H; Machicao, F; Kantartzis, K; Schafer, SA; Kirchhoff, K; Guthoff, M; Silbernagel, G; Stefan, N; Fritsche, A; Haering, HU				Staiger, Harald; Machicao, Fausto; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich			Novel Meta-Analysis-Derived Type 2 Diabetes Risk Loci Do Not Determine Prediabetic Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RELEASE; SUSCEPTIBILITY LOCI; COMMON VARIANTS; HHEX; POLYMORPHISMS; GENES; REPLICATION; RESISTANCE; REGION	Background: Genome-wide association (GWA) studies identified a series of novel type 2 diabetes risk loci. Most of them were subsequently demonstrated to affect insulin secretion of pancreatic beta-cells. Very recently, a meta-analysis of GWA data revealed nine additional risk loci with still undefined roles in the pathogenesis of type 2 diabetes. Using our thoroughly phenotyped cohort of subjects at an increased risk for type 2 diabetes, we assessed the association of the nine latest genetic variants with the predominant prediabetes traits, i.e., obesity, impaired insulin secretion, and insulin resistance. Methodology/Principal Findings: One thousand five hundred and seventy-eight metabolically characterized non-diabetic German subjects were genotyped for the reported candidate single nucleotide polymorphisms (SNPs) JAZF1 rs864745, CDC123/CAMK1D rs12779790, TSPAN8/LGR5 rs7961581, THADA rs7578597, ADAMTS9 rs4607103, NOTCH2 rs10923931, DCD rs1153188, VEGFA rs9472138, and BCL11A rs10490072. Insulin sensitivity was derived from fasting glucose and insulin concentrations, oral glucose tolerance test (OGTT), and hyperinsulinemic-euglycemic clamp. Insulin secretion was estimated from OGTT data. After appropriate adjustment for confounding variables and Bonferroni correction for multiple comparisons (corrected alpha-level: p = 0.0014), none of the SNPs was reliably associated with adiposity, insulin sensitivity, or insulin secretion (all p >= 0.0117, dominant inheritance model). The risk alleles of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 tended to associate with more than one measure of insulin sensitivity and insulin secretion, respectively, but did not reach formal statistical significance. The study was sufficiently powered (1-beta=0.8) to detect effect sizes of 0.19 <= d <= 0.25 (alpha = 0.0014) and 0.13 <= d <= 0.16 (alpha = 0.05). Conclusions/Significance: In contrast to the first series of GWA-derived type 2 diabetes candidate SNPs, we could not detect reliable associations of the novel risk loci with prediabetic phenotypes. Possible weak effects of ADAMTS9 SNP rs4607103 and VEGFA SNP rs9472138 on insulin sensitivity and insulin secretion, respectively, await further confirmation by larger studies.	[Staiger, Harald; Machicao, Fausto; Kantartzis, Konstantinos; Schaefer, Silke A.; Kirchhoff, Kerstin; Guthoff, Martina; Silbernagel, Guenther; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Staiger, H (corresponding author), Univ Tubingen Hosp, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Guthoff, Martina/D-3960-2018; Staiger, Harald/N-5871-2014; Kantartzis, Konstantinos/AAC-3999-2019	Guthoff, Martina/0000-0002-4294-980X; Stefan, Norbert/0000-0002-2186-9595; Silbernagel, Guenther/0000-0001-9323-329X; Kantartzis, Konstantinos/0000-0002-0584-1138; Staiger, Harald/0000-0002-9507-5333	German Research Foundation [KFO 114/2]	German Research Foundation(German Research Foundation (DFG))	The study was supported by a grant from the German Research Foundation (KFO 114/2). The funding organisation is a non-profit organisation and was not involved in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Boesgaard TW, 2008, DIABETOLOGIA, V51, P816, DOI 10.1007/s00125-008-0955-6; Duesing K, 2008, DIABETOLOGIA, V51, P821, DOI 10.1007/s00125-008-0973-4; Freeman H, 2006, HUM MOL GENET, V15, pR202, DOI 10.1093/hmg/ddl191; Furukawa Y, 2008, J CLIN ENDOCR METAB, V93, P310, DOI 10.1210/jc.2007-1029; GRARUP N, 2008, DIABETES; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Hertel JK, 2008, DIABETOLOGIA, V51, P971, DOI 10.1007/s00125-008-0982-3; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Kirchhoff K, 2008, DIABETOLOGIA, V51, P597, DOI 10.1007/s00125-008-0926-y; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schulze MB, 2007, DIABETOLOGIA, V50, P2405, DOI 10.1007/s00125-007-0766-1; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Staiger H, 2008, DIABETES, V57, P514, DOI 10.2337/db07-1254; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; STANCAKOVA A, 2008, J CLIN ENDOCRINOL ME; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; van Vliet-Ostaptchouk JV, 2008, EUR J HUM GENET, V16, P652, DOI 10.1038/sj.ejhg.5202008; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	25	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3019	10.1371/journal.pone.0003019	http://dx.doi.org/10.1371/journal.pone.0003019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714373	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900042
J	Fanshawe, TR; Lynch, AG; Ellis, IO; Green, AR; Hanka, R				Fanshawe, Thomas R.; Lynch, Andrew G.; Ellis, Ian O.; Green, Andrew R.; Hanka, Rudolf			Assessing Agreement between Multiple Raters with Missing Rating Information, Applied to Breast Cancer Tumour Grading	PLOS ONE			English	Article							PATHOLOGICAL PROGNOSTIC-FACTORS; LOW KAPPA; INDEX; MODEL	Background: We consider the problem of assessing inter-rater agreement when there are missing data and a large number of raters. Previous studies have shown only 'moderate' agreement between pathologists in grading breast cancer tumour specimens. We analyse a large but incomplete data-set consisting of 24177 grades, on a discrete 1-3 scale, provided by 732 pathologists for 52 samples. Methodology/Principal Findings: We review existing methods for analysing inter-rater agreement for multiple raters and demonstrate two further methods. Firstly, we examine a simple non-chance-corrected agreement score based on the observed proportion of agreements with the consensus for each sample, which makes no allowance for missing data. Secondly, treating grades as lying on a continuous scale representing tumour severity, we use a Bayesian latent trait method to model cumulative probabilities of assigning grade values as functions of the severity and clarity of the tumour and of rater-specific parameters representing boundaries between grades 1-2 and 2-3. We simulate from the fitted model to estimate, for each rater, the probability of agreement with the majority. Both methods suggest that there are differences between raters in terms of rating behaviour, most often caused by consistent over- or under-estimation of the grade boundaries, and also considerable variability in the distribution of grades assigned to many individual samples. The Bayesian model addresses the tendency of the agreement score to be biased upwards for raters who, by chance, see a relatively 'easy' set of samples. Conclusions/Significance: Latent trait models can be adapted to provide novel information about the nature of inter-rater agreement when the number of raters is large and there are missing data. In this large study there is substantial variability between pathologists and uncertainty in the identity of the 'true' grade of many of the breast cancer tumours, a fact often ignored in clinical studies.	[Fanshawe, Thomas R.] Univ Lancaster, Dept Med, Lancaster, England; [Lynch, Andrew G.] Univ Cambridge, Cambridge Res Inst, Li Ka Shing Ctr, Dept Oncol, Cambridge, England; [Ellis, Ian O.] Univ Nottingham, Nottingham, England; [Green, Andrew R.] Univ Nottingham, Sch Mol Med Sci, Div Pathol, Nottingham, England; [Hanka, Rudolf] Univ Cambridge, Wolfson Coll, Cambridge, England	Lancaster University; CRUK Cambridge Institute; University of Cambridge; University of Nottingham; University of Nottingham; University of Cambridge	Fanshawe, TR (corresponding author), Univ Lancaster, Dept Med, Lancaster, England.	t.fanshawe@lancaster.ac.uk	Green, Andrew/AAF-1991-2020	Green, Andrew/0000-0002-0488-5913; Lynch, Andy/0000-0002-7876-7338; Ellis, Ian/0000-0001-5292-8474	University of Cambridge, Cancer Research UK [C14303/A8646]; Hutchison Whampoa Limited; NHS Breast Screening Program	University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Hutchison Whampoa Limited; NHS Breast Screening Program	AGL would like to acknowledge the funding support of The University of Cambridge, Cancer Research UK (CUK grant number C14303/A8646) and Hutchison Whampoa Limited. The data files were provided by the the National External Quality Assurance (EQA) Scheme for Breast Screening Histopathology, funded by the NHS Breast Screening Program.	AGRESTI A, 1993, BIOMETRICS, V49, P131, DOI 10.2307/2532608; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Altaye M, 2001, BIOMETRICS, V57, P584, DOI 10.1111/j.0006-341X.2001.00584.x; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P46; Ellis I. O., 1995, P635; Ellis IO, 2006, J CLIN PATHOL, V59, P138, DOI 10.1136/jcp.2004.025551; ELLIS IO, 1992, HISTOPATHOLOGY, V20, P479; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Formann A K, 1996, Stat Methods Med Res, V5, P179, DOI 10.1177/096228029600500205; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; GUGGENMOOSHOLZMANN I, 1993, STAT MED, V12, P2191, DOI 10.1002/sim.4780122305; HARTMANN WH, 1984, CANCER, V53, P681, DOI 10.1002/1097-0142(19840201)53:3+<681::AID-CNCR2820531315>3.0.CO;2-3; JAMES IR, 1983, BIOMETRICS, V39, P651, DOI 10.2307/2531092; LANDIS JR, 1977, BIOMETRICS, V33, P671, DOI 10.2307/2529465; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; LANDIS JR, 1977, BIOMETRICS, V33, P174; LANGEHEINE R, 1988, LATENT TRAIT LATENT; MARTIN A, 2004, BRIT J MATH STAT PSY, V57, P1; Meyer JS, 2005, MODERN PATHOL, V18, P1067, DOI 10.1038/modpathol.3800388; Nelson JC, 2000, STAT METHODS MED RES, V9, P475, DOI 10.1191/096228000701555262; Pepe M. S., 2003, STAT EVALUATION MED; R Development Core Team, 2005, R LANG ENV STAT COMP; ROBBINS P, 1995, HUM PATHOL, V26, P873, DOI 10.1016/0046-8177(95)90010-1; Rogel A, 1998, STAT MED, V17, P489, DOI 10.1002/(SICI)1097-0258(19980228)17:4<489::AID-SIM751>3.0.CO;2-9; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; UEBERSAX JS, 1990, STAT MED, V9, P559, DOI 10.1002/sim.4780090509; UEBERSAX JS, 1993, BIOMETRICS, V49, P823, DOI 10.2307/2532202; UEBERSAX JS, 1993, J AM STAT ASSOC, V88, P421, DOI 10.2307/2290320; Yang I, 1997, BIOMETRICS, V53, P948, DOI 10.2307/2533555; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082; [No title captured]; [No title captured]; [No title captured]; [No title captured]	40	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2925	10.1371/journal.pone.0002925	http://dx.doi.org/10.1371/journal.pone.0002925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698346	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000264412600011
J	Wan, HQ; Sorrell, EM; Song, HC; Hossain, MJ; Ramirez-Nieto, G; Monne, I; Stevens, J; Cattoli, G; Capua, I; Chen, LM; Donis, RO; Busch, J; Paulson, JC; Brockwell, C; Webby, R; Blanco, J; Al-Natour, MQ; Perez, DR				Wan, Hongquan; Sorrell, Erin M.; Song, Haichen; Hossain, Md Jaber; Ramirez-Nieto, Gloria; Monne, Isabella; Stevens, James; Cattoli, Giovanni; Capua, Ilaria; Chen, Li-Mei; Donis, Ruben O.; Busch, Julia; Paulson, James C.; Brockwell, Christy; Webby, Richard; Blanco, Jorge; Al-Natour, Mohammad Q.; Perez, Daniel R.			Replication and Transmission of H9N2 Influenza Viruses in Ferrets: Evaluation of Pandemic Potential	PLOS ONE			English	Article							TO-HUMAN TRANSMISSION; AVIAN INFLUENZA; A VIRUSES; RECEPTOR SPECIFICITY; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; HUMAN INFECTION; HEMAGGLUTININ; POULTRY; EVOLUTION	H9N2 avian influenza A viruses are endemic in poultry of many Eurasian countries and have caused repeated human infections in Asia since 1998. To evaluate the potential threat of H9N2 viruses to humans, we investigated the replication and transmission efficiency of H9N2 viruses in the ferret model. Five wild-type (WT) H9N2 viruses, isolated from different avian species from 1988 through 2003, were tested in vivo and found to replicate in ferrets. However these viruses achieved mild peak viral titers in nasal washes when compared to those observed with a human H3N2 virus. Two of these H9N2 viruses transmitted to direct contact ferrets, however no aerosol transmission was detected in the virus displaying the most efficient direct contact transmission. A leucine (Leu) residue at amino acid position 226 in the hemagglutinin ( HA) receptor-binding site (RBS), responsible for human virus-like receptor specificity, was found to be important for the transmission of the H9N2 viruses in ferrets. In addition, an H9N2 avian-human reassortant virus, which contains the surface glycoprotein genes from an H9N2 virus and the six internal genes of a human H3N2 virus, showed enhanced replication and efficient transmission to direct contacts. Although no aerosol transmission was observed, the virus replicated in multiple respiratory tissues and induced clinical signs similar to those observed with the parental human H3N2 virus. Our results suggest that the establishment and prevalence of H9N2 viruses in poultry pose a significant threat for humans.	[Wan, Hongquan; Sorrell, Erin M.; Song, Haichen; Hossain, Md Jaber; Ramirez-Nieto, Gloria; Perez, Daniel R.] Univ Maryland, Dept Vet Med, Virginia Maryland Regional Coll Vet Med, College Pk, MD USA; [Monne, Isabella; Cattoli, Giovanni; Capua, Ilaria] Viale Univ, Ist Zooprofilattico Sperimentale Venezie, Natl Reference Lab Avian Influenza & Newcastle Dis, FAO, OIE, Padua, Italy; [Stevens, James; Chen, Li-Mei; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Mol Virol & Vaccines Branch, Atlanta, GA USA; [Busch, Julia; Paulson, James C.] Scripps Rese Inst, Dept Chem Physiol, La Jolla, CA USA; [Busch, Julia; Paulson, James C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA USA; [Brockwell, Christy; Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN USA; [Blanco, Jorge] Virion Syst Inc, Rockville, MD USA; [Al-Natour, Mohammad Q.] Jordan Univ Sci & Technol, Fac Vet Med, Dept Pathol & Anim Hlth, Irbid, Jordan	University System of Maryland; University of Maryland College Park; Food & Agriculture Organization of the United Nations (FAO); IZS delle Venezie; Centers for Disease Control & Prevention - USA; Scripps Research Institute; St Jude Children's Research Hospital; Jordan University of Science & Technology	Wan, HQ (corresponding author), Univ Maryland, Dept Vet Med, Virginia Maryland Regional Coll Vet Med, College Pk, MD USA.	dperez1@umd.edu	Monne, Isabella/K-7652-2016; Webby, Richard J/N-5657-2018; Perez, Daniel R./D-5044-2016; Ramirez-Nieto, Gloria C/N-2600-2018; Paulson, James/AAG-3565-2019; Blanco, Jorge/AAW-3752-2020; Stevens, James/GQH-1081-2022	Monne, Isabella/0000-0002-6564-4689; Perez, Daniel R./0000-0002-6569-5689; Ramirez-Nieto, Gloria C/0000-0002-8313-1609; Wan, Hongquan/0000-0002-6374-0343	CDC-HHS [1U01CI000355]; NIAID-NIH [R01AI052155]; CSREES-USDA [2005-05523]; NIGMS [GM062116]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	CDC-HHS; NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CSREES-USDA(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was made possible through funding by the CDC-HHS grant (1U01CI000355), NIAID-NIH, grant (R01AI052155) and CSREES-USDA grant (2005-05523). The authors thank the Scripps Research Institute and the Consortium for Functional Glycomics, funded by NIGMS grant GM062116, for the use of the glycan microarray technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Belser JA, 2007, J VIROL, V81, P11139, DOI 10.1128/JVI.01235-07; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Humberd J, 2006, J VIROL, V80, P2151, DOI 10.1128/JVI.80.5.2151-2161.2006; Joseph T, 2007, J VIROL, V81, P10558, DOI 10.1128/JVI.00970-07; Kaverin NV, 2004, J VIROL, V78, P240, DOI 10.1128/JVI.78.1.240-249.2004; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; LEIGH MW, 1995, VACCINE, V13, P1468, DOI 10.1016/0264-410X(95)00004-K; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2007, AVIAN DIS, V51, P390, DOI 10.1637/7550-033106R1.1; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Shi WF, 2008, ARCH VIROL, V153, P211, DOI 10.1007/s00705-007-1083-1; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; STEVENS J, 2008, J MOL BIOL IN PRESS; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yen HL, 2007, J VIROL, V81, P6890, DOI 10.1128/JVI.00170-07	51	221	248	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2923	10.1371/journal.pone.0002923	http://dx.doi.org/10.1371/journal.pone.0002923			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698430	Green Published, gold			2022-12-27	WOS:000264412600009
J	Bittar, F; Richet, H; Dubus, JC; Reynaud-Gaubert, M; Stremler, N; Sarles, J; Raoult, D; Rolain, JM				Bittar, Fadi; Richet, Herve; Dubus, Jean-Christophe; Reynaud-Gaubert, Martine; Stremler, Nathalie; Sarles, Jacques; Raoult, Didier; Rolain, Jean-Marc			Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis Patients	PLOS ONE			English	Article								Background: There is strong evidence that culture-based methods detect only a small proportion of bacteria present in the respiratory tracts of cystic fibrosis (CF) patients. Methodology/Principal Findings: Standard microbiological culture and phenotypic identification of bacteria in sputa from CF patients have been compared to molecular methods by the use of 16S rDNA amplification, cloning and sequencing. Twenty-five sputa from CF patients were cultured that yield 33 isolates (13 species) known to be pathogens during CF. For molecular cloning, 760 clones were sequenced (7.2 +/- 3.9 species/sputum), and 53 different bacterial species were identified including 16 species of anaerobes (30%). Discrepancies between culture and molecular data were numerous and demonstrate that accurate identification remains challenging. New or emerging bacteria not or rarely reported in CF patients were detected including Dolosigranulum pigrum, Dialister pneumosintes, and Inquilinus limosus. Conclusions/Significance: Our results demonstrate the complex microbial community in sputa from CF patients, especially anaerobic bacteria that are probably an underestimated cause of CF lung pathology. Metagenomic analysis is urgently needed to better understand those complex communities in CF pulmonary infections.	[Bittar, Fadi; Richet, Herve; Raoult, Didier; Rolain, Jean-Marc] Univ Aix Marseille 2, Fac Med & Pharm, CNRS IRD, URMITE,UMR 6236, Marseille, France; [Dubus, Jean-Christophe; Stremler, Nathalie; Sarles, Jacques] Hop La Timone, Ctr Ressources Competences Mucoviscidose Enfants, Dept Maladies Respiratoires, Marseille, France; [Reynaud-Gaubert, Martine] Hop St Marguerite, Ctr Ressources Competences Mucoviscidose Adultes, Dept Maladies Respiratoires, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bittar, F (corresponding author), Univ Aix Marseille 2, Fac Med & Pharm, CNRS IRD, URMITE,UMR 6236, Marseille, France.	jean-marc.rolain@univmed.fr	RAOULT, Didier/A-8434-2008; Dubus, Jean-Christophe/P-8242-2016; Reynaud-Gaubert, Martine LM/P-6958-2016; Bittar, Fadi/F-2037-2018; Rolain, Jean-Marc/Y-3788-2019	RAOULT, Didier/0000-0002-0633-5974; Bittar, Fadi/0000-0003-4052-344X; Rolain, Jean-Marc/0000-0002-2402-4467	French Association Vaincre La Mucoviscidose (VLM); Programme Hospitalier de Recherche Clinique 2006	French Association Vaincre La Mucoviscidose (VLM); Programme Hospitalier de Recherche Clinique 2006	The research for this article was supported in part by the French Association Vaincre La Mucoviscidose (VLM) and by Programme Hospitalier de Recherche Clinique 2006.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bahrani-Mougeot FK, 2007, J CLIN MICROBIOL, V45, P1588, DOI 10.1128/JCM.01963-06; Bittar F, 2008, EMERG INFECT DIS, V14, P993, DOI 10.3201/eid1406.071355; Chaparro C, 2001, AM J RESP CRIT CARE, V163, P43, DOI 10.1164/ajrccm.163.1.9811076; Chiron R, 2005, J CLIN MICROBIOL, V43, P3938, DOI 10.1128/JCM.43.8.3938-3943.2005; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; Cooke RFD, 2007, BRIT J BIOMED SCI, V64, P127, DOI 10.1080/09674845.2007.11732772; Duan KM, 2003, MOL MICROBIOL, V50, P1477, DOI 10.1046/j.1365-2958.2003.03803.x; Fenollar F, 2006, J CLIN MICROBIOL, V44, P1018, DOI 10.1128/JCM.44.3.1018-1028.2006; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hassett DJ, 2002, ADV DRUG DELIVER REV, V54, P1425, DOI 10.1016/S0169-409X(02)00152-7; Hill D, 2005, J CLIN MICROBIOL, V43, P5085, DOI 10.1128/JCM.43.10.5085-5090.2005; Hoedemaekers A, 2006, J CLIN MICROBIOL, V44, P3461, DOI 10.1128/JCM.01050-06; Hoffmann N, 2007, ANTIMICROB AGENTS CH, V51, P3677, DOI 10.1128/AAC.01011-06; Hutter G, 2003, MICROBIOL-SGM, V149, P67, DOI 10.1099/mic.0.25791-0; JEWES LA, 1990, J MED MICROBIOL, V31, P271, DOI 10.1099/00222615-31-4-271; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; LaClaire L, 2000, ANTIMICROB AGENTS CH, V44, P2001, DOI 10.1128/AAC.44.7.2001-2003.2000; Lecuyer H, 2007, J CLIN MICROBIOL, V45, P3474, DOI 10.1128/JCM.01373-07; McMenamin JD, 2000, CHEST, V117, P1661, DOI 10.1378/chest.117.6.1661; MORIO F, 2007, ANTIMICROB AGENTS CH; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Pitulle C, 1999, J CLIN MICROBIOL, V37, P3851, DOI 10.1128/JCM.37.12.3851-3855.1999; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rolph HJ, 2001, J CLIN MICROBIOL, V39, P3282, DOI 10.1128/JCM.39.9.3282-3289.2001; Saiman L, 2004, CLIN MICROBIOL REV, V17, P57, DOI 10.1128/CMR.17.1.57-71.2004; Saito D, 2006, J MED MICROBIOL, V55, P101, DOI 10.1099/jmm.0.46212-0; Sakamoto M, 2006, ORAL MICROBIOL IMMUN, V21, P112, DOI 10.1111/j.1399-302X.2006.00270.x; Schmoldt S, 2006, J MED MICROBIOL, V55, P1425, DOI 10.1099/jmm.0.46466-0; SHAKIL S, 2007, J BIOMED SCI; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van Belkum A, 2000, FEMS IMMUNOL MED MIC, V27, P51, DOI 10.1111/j.1574-695X.2000.tb01411.x; Vaudaux P, 2006, CLIN INFECT DIS, V43, P968, DOI 10.1086/507643; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wellinghausen N, 2005, J CLIN MICROBIOL, V43, P4070, DOI 10.1128/JCM.43.8.4070-4075.2005; Wellinghausen N, 2005, EMERG INFECT DIS, V11, P457, DOI 10.3201/eid1103.041078; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2	42	169	171	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2908	10.1371/journal.pone.0002908	http://dx.doi.org/10.1371/journal.pone.0002908			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682840	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600064
J	Glaberman, S; Du Pasquier, L; Caccone, A				Glaberman, Scott; Du Pasquier, Louis; Caccone, Adalgisa			Characterization of a Nonclassical Class I MHC Gene in a Reptile, the Galapagos Marine Iguana (Amblyrhynchus cristatus)	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; HLA-G MOLECULES; T-CELL; EVOLUTION; POLYADENYLATION; CLONING; EXPRESSION; DIVERSITY; APOPTOSIS; PATTERNS	Squamates are a diverse order of vertebrates, representing more than 7,000 species. Yet, descriptions of full-length major histocompatibility complex (MHC) genes in this group are nearly absent from the literature, while the number of MHC studies continues to rise in other vertebrate taxa. The lack of basic information about MHC organization in squamates inhibits investigation into the relationship between MHC polymorphism and disease, and leaves a large taxonomic gap in our understanding of amniote MHC evolution. Here, we use both cDNA and genomic sequence data to characterize a class I MHC gene (Amcr-UA) from the Galapagos marine iguana, a member of the squamate subfamily Iguaninae. Amcr-UA appears to be functional since it is expressed in the blood and contains many of the conserved peptide-binding residues that are found in classical class I genes of other vertebrates. In addition, comparison of Amcr-UA to homologous sequences from other iguanine species shows that the antigen-binding portion of this gene is under purifying selection, rather than balancing selection, and therefore may have a conserved function. A striking feature of Amcr-UA is that both the cDNA and genomic sequences lack the transmembrane and cytoplasmic domains that are necessary to anchor the class I receptor molecule into the cell membrane, suggesting that the product of this gene is secreted and consequently not involved in classical class I antigen-presentation. The truncated and conserved character of Amcr-UA lead us to define it as a nonclassical gene that is related to the few available squamate class I sequences. However, phylogenetic analysis placed Amcr-UA in a basal position relative to other published classical MHC genes from squamates, suggesting that this gene diverged near the beginning of squamate diversification.	[Glaberman, Scott; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Du Pasquier, Louis] Univ Basel, Inst Zool & Evolutionary Biol, Basel, Switzerland	Yale University; University of Basel	Glaberman, S (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	scott.glaberman@gmail.com	Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Glaberman, Scott/0000-0003-0594-4732	Yale Institute for Biospheric Studies (YIBS)	Yale Institute for Biospheric Studies (YIBS)	Funding for this project was provided by the Yale Institute for Biospheric Studies (YIBS). Work was also supported by pilot study funds from the YIBS Center for Field Ecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary G, 2005, GENE, V353, P31, DOI 10.1016/j.gene.2005.03.045; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Belov K, 2006, PLOS BIOL, V4, P317, DOI 10.1371/journal.pbio.0040046; BJORKMAN PJ, 1990, ANNU REV BIOCHEM, V59, P253, DOI 10.1146/annurev.bi.59.070190.001345; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flajnik M, 2004, TISSUE ANTIGENS, V64, P328; Fournel S, 2000, J IMMUNOL, V164, P6100, DOI 10.4049/jimmunol.164.12.6100; Glaberman S, 2008, IMMUNOGENETICS, V60, P371, DOI 10.1007/s00251-008-0298-y; GRIMHOLT U, 1993, IMMUNOGENETICS, V37, P469, DOI 10.1007/BF00222473; Hansen TH, 2007, NAT IMMUNOL, V8, P563, DOI 10.1038/ni1475; Hess CM, 2002, BIOSCIENCE, V52, P423, DOI 10.1641/0006-3568(2002)052[0423:TEOTMH]2.0.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; HUGHES AL, 1989, MOL BIOL EVOL, V6, P559; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaufman J, 1994, Semin Immunol, V6, P411, DOI 10.1006/smim.1994.1050; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; KOLLER BH, 1985, J IMMUNOL, V134, P2727; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; MELLOR AL, 1984, CELL, V36, P139, DOI 10.1016/0092-8674(84)90082-5; Miller HC, 2006, MOL BIOL EVOL, V23, P949, DOI 10.1093/molbev/msj099; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nylander J.A.A, 2004, MRMODELTEST V2; Pauws E, 2001, NUCLEIC ACIDS RES, V29, P1690, DOI 10.1093/nar/29.8.1690; Plant MH, 1999, BIOCHEM J, V344, P677, DOI 10.1042/0264-6021:3440677; Ploegh H, 1998, CURR OPIN IMMUNOL, V10, P57, DOI 10.1016/S0952-7915(98)80032-0; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; POTTS WK, 1990, TRENDS ECOL EVOL, V5, P181, DOI 10.1016/0169-5347(90)90207-T; RADA C, 1990, P NATL ACAD SCI USA, V87, P2167, DOI 10.1073/pnas.87.6.2167; Radtkey RR, 1996, P ROY SOC B-BIOL SCI, V263, P1023, DOI 10.1098/rspb.1996.0151; Rassmann K, 1997, MOL PHYLOGENET EVOL, V7, P158, DOI 10.1006/mpev.1996.0386; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Rebmann V, 1999, TISSUE ANTIGENS, V53, P14, DOI 10.1034/j.1399-0039.1999.530102.x; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Sambrook J., 2001, MOL CLONING LAB MANU; Shum BP, 1999, IMMUNOGENETICS, V49, P479, DOI 10.1007/s002510050524; STIERNBERG J, 1987, J IMMUNOL, V138, P3877; Stroynowski I, 1996, RES IMMUNOL, V147, P290, DOI 10.1016/0923-2494(96)89642-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Timon M, 1998, IMMUNOGENETICS, V47, P170; Vidal N, 2005, CR BIOL, V328, P1000, DOI 10.1016/j.crvi.2005.10.001; Vitt LJ, 2003, AM NAT, V162, P44, DOI 10.1086/375172; Wiens JJ, 2000, SYST BIOL, V49, P143, DOI 10.1080/10635150050207447; Zappacosta F, 2000, J IMMUNOL, V164, P1906, DOI 10.4049/jimmunol.164.4.1906	52	23	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2859	10.1371/journal.pone.0002859	http://dx.doi.org/10.1371/journal.pone.0002859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682845	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600015
J	Rube, CE; Palm, J; Erren, M; Fleckenstein, J; Konig, J; Remberger, K; Rube, C				Ruebe, Claudia E.; Palm, Jan; Erren, Michael; Fleckenstein, Jochen; Koenig, Jochem; Remberger, Klaus; Ruebe, Christian			Cytokine Plasma Levels: Reliable Predictors for Radiation Pneumonitis?	PLOS ONE			English	Article								Background: Radiotherapy (RT) is the primary treatment modality for inoperable, locally advanced non-small-cell lung cancer (NSCLC), but even with highly conformal treatment planning, radiation pneumonitis (RP) remains the most serious, dose-limiting complication. Previous clinical reports proposed that cytokine plasma levels measured during RT allow to estimate the individual risk of patients to develop RP. The identification of such cytokine risk profiles would facilitate tailoring radiotherapy to maximize treatment efficacy and to minimize radiation toxicity. However, cytokines are produced not only in normal lung tissue after irradiation, but are also over-expressed in tumour cells of NSCLC specimens. This tumour-derived cytokine production may influence circulating plasma levels in NSCLC patients. The aim of the present study was to investigate the prognostic value of TNF-alpha, IL-1 beta, IL-6 and TGF-beta 1 plasma levels to predict radiation pneumonitis and to evaluate the impact of tumour-derived cytokine production on circulating plasma levels in patients irradiated for NSCLC. Methodology/Principal Findings: In 52 NSCLC patients (stage I-III) cytokine plasma levels were investigated by ELISA before and weekly during RT, during follow-up (1/3/6/9 months after RT), and at the onset of RP. Tumour biopsies were immunohistochemically stained for IL-6 and TGF-beta 1, and immunoreactivity was quantified (grade 1-4). RP was evaluated according to LENT-SOMA scale. Tumour response was assessed according to RECIST criteria by chest-CT during follow-up. In our clinical study 21 out of 52 patients developed RP (grade I/II/III/IV: 11/3/6/1 patients). Unexpectedly, cytokine plasma levels measured before and during RT did not correlate with RP incidence. In most patients IL-6 and TGF-beta 1 plasma levels were already elevated before RT and correlated significantly with the IL-6 and TGF-beta 1 production in corresponding tumour biopsies. Moreover, IL-6 and TGF-beta 1 plasma levels measured during follow-up were significantly associated with the individual tumour responses of these patients. Conclusions/Significance: The results of this study did not confirm that cytokine plasma levels, neither their absolute nor any relative values, may identify patients at risk for RP. In contrast, the clear correlations of IL-6 and TGF-beta 1 plasma levels with the cytokine production in corresponding tumour biopsies and with the individual tumour responses suggest that the tumour is the major source of circulating cytokines in patients receiving RT for advanced NSCLC.	[Ruebe, Claudia E.; Palm, Jan; Fleckenstein, Jochen; Ruebe, Christian] Univ Saarland, Dept Radiotherapy & Radiooncol, D-6650 Homburg, Germany; [Erren, Michael] Univ Munster, Inst Clin Chem & Lab Med, Munster, Germany; [Koenig, Jochem] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Remberger, Klaus] Saarland Univ, Dept Pathol, Homburg, Germany	Saarland University; University of Munster; Johannes Gutenberg University of Mainz; Universitatsklinikum des Saarlandes	Rube, CE (corresponding author), Univ Saarland, Dept Radiotherapy & Radiooncol, D-6650 Homburg, Germany.	claudia.ruebe@uniklinik-saarland.de	König, Jochem/T-3500-2019	König, Jochem/0000-0003-4683-0360; Palm, Jan/0000-0003-1122-1557	Saarland University [HOMFOR A/2003/19]	Saarland University	This study was supported by grant HOMFOR A/2003/19 from Saarland University.	Albain KS, 2002, J CLIN ONCOL, V20, P3454, DOI 10.1200/JCO.2002.03.055; Anscher MS, 1998, INT J RADIAT ONCOL, V41, P1029, DOI 10.1016/S0360-3016(98)00154-0; Anscher MS, 1997, INT J RADIAT ONCOL, V37, P253, DOI 10.1016/S0360-3016(96)00529-9; Anscher MS, 2003, INT J RADIAT ONCOL, V56, P988, DOI 10.1016/S0360-3016(03)00184-6; Anscher MS, 2001, J CLIN ONCOL, V19, P3758, DOI 10.1200/JCO.2001.19.17.3758; Anumanthan G, 2005, BRIT J CANCER, V93, P1157, DOI 10.1038/sj.bjc.6602831; Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Asakura S, 1999, HUM PATHOL, V30, P195, DOI 10.1016/S0046-8177(99)90275-7; Asselin-Paturel C, 1998, INT J CANCER, V77, P7, DOI 10.1002/(SICI)1097-0215(19980703)77:1<7::AID-IJC2>3.0.CO;2-Y; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Bennett WP, 1998, CLIN CANCER RES, V4, P1499; Bhowmick NA, 2001, J BIOL CHEM, V276, P46707, DOI 10.1074/jbc.M106176200; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; CALIGIURI MAL, 2007, CYTOKINES GENESIS TR, P482; Chang KT, 2005, AM J PHYSIOL-LUNG C, V289, pL438, DOI 10.1152/ajplung.00033.2005; Chen YY, 2005, INT J RADIAT ONCOL, V62, P260, DOI 10.1016/j.ijrobp.2005.01.041; Chen YY, 2001, INT J RADIAT ONCOL, V49, P641, DOI 10.1016/S0360-3016(00)01445-0; Conze D, 2001, CANCER RES, V61, P8851; De Jaeger K, 2004, INT J RADIAT ONCOL, V58, P1378, DOI 10.1016/j.ijrobp.2003.09.078; Dranoff G, 2004, NAT REV CANCER, V4, P11, DOI 10.1038/nrc1252; Erasmus JJ, 2003, J CLIN ONCOL, V21, P2574, DOI 10.1200/JCO.2003.01.144; Fu XL, 2001, INT J RADIAT ONCOL, V50, P899, DOI 10.1016/S0360-3016(01)01524-3; Goumans MJ, 2003, TRENDS CARDIOVAS MED, V13, P301, DOI 10.1016/S1050-1738(03)00142-7; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Haura EB, 2006, CLIN LUNG CANCER, V7, P273, DOI 10.3816/CLC.2006.n.006; Hehlgans S, 2007, BBA-REV CANCER, V1775, P163, DOI 10.1016/j.bbcan.2006.09.001; Inoue A, 2001, INT J RADIAT ONCOL, V49, P649, DOI 10.1016/S0360-3016(00)00783-5; Ito M, 2006, J IMMUNOL, V176, P5637, DOI 10.4049/jimmunol.176.9.5637; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Kaminska J, 2006, ONCOLOGY-BASEL, V70, P115, DOI 10.1159/000093002; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kayacan O, 2006, AM J CLIN ONCOL-CANC, V29, P328, DOI 10.1097/01.coc.0000221300.72657.e0; Kong FM, 1996, LUNG CANCER-J IASLC, V16, P47, DOI 10.1016/S0169-5002(96)00611-3; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Lee CB, 2006, CLIN LUNG CANCER, V8, P195, DOI 10.3816/CLC.2006.n.047; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nestle U, 2000, INT J RADIAT ONCOL, V48, P95, DOI 10.1016/S0360-3016(00)00607-6; Novakova-Jiresova A, 2004, RADIOTHER ONCOL, V71, P183, DOI 10.1016/j.radonc.2004.01.019; Pantsulaia I, 2004, CALCIFIED TISSUE INT, V74, P47, DOI 10.1007/s00223-003-0046-0; Rube CE, 2005, INT J RADIAT ONCOL, V61, P1482, DOI 10.1016/j.ijrobp.2004.12.072; Rube CE, 2004, STRAHLENTHER ONKOL, V180, P541, DOI 10.1007/s00066-004-1279-1; Rube CE, 2004, RADIOTHER ONCOL, V72, P231, DOI 10.1016/j.radonc.2004.05.004; Rube CE, 2003, INT J RADIAT ONCOL, V56, P1414, DOI 10.1016/S0360-3016(03)00418-8; Rube CE, 2000, INT J RADIAT ONCOL, V47, P1033, DOI 10.1016/S0360-3016(00)00482-X; Rube CE, 2002, RADIOTHER ONCOL, V64, P177, DOI 10.1016/S0167-8140(02)00077-4; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Schallenkamp JM, 2007, INT J RADIAT ONCOL, V67, P410, DOI 10.1016/j.ijrobp.2006.09.030; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Shariat SF, 2001, J CLIN ONCOL, V19, P2856, DOI 10.1200/JCO.2001.19.11.2856; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Song LX, 2003, ONCOGENE, V22, P4150, DOI 10.1038/sj.onc.1206479; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Therasse P, 2006, EUR J CANCER, V42, P1031, DOI 10.1016/j.ejca.2006.01.026; Thomas M, 2008, LANCET ONCOL, V9, P636, DOI 10.1016/S1470-2045(08)70156-6; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; To Y, 2002, AM J RESP CELL MOL, V27, P220, DOI 10.1165/ajrcmb.27.2.4804; TORREAMIONE G, 1990, P NATL ACAD SCI USA, V87, P1486, DOI 10.1073/pnas.87.4.1486; Trott KR, 2004, INT J RADIAT ONCOL, V58, P463, DOI 10.1016/j.ijrobp.2003.09.045; Tsoutsou PG, 2006, INT J RADIAT ONCOL, V66, P1281, DOI 10.1016/j.ijrobp.2006.08.058; Vokes EE, 2002, J CLIN ONCOL, V20, P4191, DOI 10.1200/JCO.2002.03.054; Vujaskovic Z, 2000, INT J RADIAT BIOL, V76, P511, DOI 10.1080/095530000138510; Wang JY, 2002, INT J RADIAT ONCOL, V54, P735, DOI 10.1016/S0360-3016(02)02994-2; Yamaji H, 2004, CANCER IMMUNOL IMMUN, V53, P786, DOI 10.1007/s00262-004-0533-9; Yang K, 2007, INT J RADIAT BIOL, V83, P665, DOI 10.1080/09553000701558977; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; INT J RAD ONCOL BIOL, V31, P1049	69	61	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2898	10.1371/journal.pone.0002898	http://dx.doi.org/10.1371/journal.pone.0002898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682839	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600054
J	Sharot, T; Davidson, ML; Carson, MM; Phelps, EA				Sharot, Tali; Davidson, Matthew L.; Carson, Meredith M.; Phelps, Elizabeth A.			Eye Movements Predict Recollective Experience	PLOS ONE			English	Article							MEMORY; EMOTION; EVENTS	Previously encountered stimuli can bring to mind a vivid memory of the episodic context in which the stimulus was first experienced ("remembered'' stimuli), or can simply seem familiar ("known'' stimuli). Past studies suggest that more attentional resources are required to encode stimuli that are subsequently remembered than known. However, it is unclear if the attentional resources are distributed differently during encoding and recognition of remembered and known stimuli. Here, we record eye movements while participants encode photos, and later while indicating whether the photos are remembered, known or new. Eye fixations were more clustered during both encoding and recognition of remembered photos relative to known photos. Thus, recognition of photos that bring to mind a vivid memory for the episodic context in which they were experienced is associated with less distributed overt attention during encoding and recognition. The results suggest that remembering is related to encoding of a few distinct details of a photo rather than the photo as a whole. In turn, during recognition remembering may be trigged by enhanced memory for the salient details of the photos.	[Sharot, Tali] UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England; [Davidson, Matthew L.] Columbia Univ, Dept Psychol, New York, NY USA; [Carson, Meredith M.] Drexel Univ, Dept Psychol, Philadelphia, PA USA; [Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY USA	University of London; University College London; Columbia University; Drexel University; New York University	Sharot, T (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London, England.	liz.phelps@nyu.edu		Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [MH62104]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institutes of Health, MH62104 to EAP.	ALTHOFF RR, 1999, J EXPT PSYCHOL LEARN, V25, P1; CHRISTIANSON SA, 1991, J EXP PSYCHOL LEARN, V17, P693, DOI 10.1037/0278-7393.17.4.693; CHRISTIANSON SA, 1991, COGNITION EMOTION, V5, P81, DOI 10.1080/02699939108411027; Curran T, 2004, NEUROPSYCHOLOGIA, V42, P1088, DOI 10.1016/j.neuropsychologia.2003.12.011; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Gardiner JM, 2006, MEM COGNITION, V34, P227, DOI 10.3758/BF03193401; Hannula DE, 2007, J COGNITIVE NEUROSCI, V19, P1690, DOI 10.1162/jocn.2007.19.10.1690; Lang J.P., 1999, A4 U FLOR CTR RES PS; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Ochsner KN, 2000, J EXP PSYCHOL GEN, V129, P242, DOI 10.1037//0096-3445.129.2.242; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RAJARAM S, 1993, MEM COGNITION, V21, P89, DOI 10.3758/BF03211168; Ryan JD, 2000, PSYCHOL SCI, V11, P454, DOI 10.1111/1467-9280.00288; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wessel I, 2000, MEMORY, V8, P97; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; YONELINAS AP, 1994, CAN J EXP PSYCHOL, V48, P516, DOI 10.1037/1196-1961.48.4.516	19	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2884	10.1371/journal.pone.0002884	http://dx.doi.org/10.1371/journal.pone.0002884			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682731	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600040
J	Cao, H; Yang, CS; Rana, TM				Cao, Hong; Yang, Chao-Shun; Rana, Tariq M.			Evolutionary Emergence of microRNAs in Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; ES CELLS; DIFFERENTIATION; LINES; PLURIPOTENCY; EXPRESSION; NANOG; MORPHOGENESIS; ENHANCER; OCT-3/4	Human embryonic stem (hES) cells have unique abilities to divide indefinitely without differentiating and potential to differentiate into more than 200 cell types. These properties make hES cells an ideal model system for understanding early human development and for regenerative medicine. Molecular mechanisms including cellular signaling and transcriptional regulation play important roles in hES cell differentiation. However, very little information is available on posttranscriptional regulation of hES cell pluripotency, self-renewal, and early decisions about cell fate. microRNAs ( miRNAs), 22-nt long noncoding small RNAs found in plants and animals, regulate gene expression by targeting mRNAs for cleavage or translation repression. In hES cells we found that 276 miRNAs were expressed; of these, a set of 30 miRNAs had significantly changed expression during differentiation. Using a representative example, miR-302b, we show that miRNAs in human ES cells assemble into a bona fide RISC that contains Ago2 and can specifically cleave perfectly matched target RNA. Our results demonstrate that human ES cell differentiation is accompanied by changes in the expression of a unique set of miRNAs, providing a glimpse of a new molecular circuitry that may regulate early development in humans. Chromosomes 19 and X contained 98 and 40 miRNA genes, respectively, indicating that majority of miRNA genes in hES cells were expressed from these two chromosomes. Strikingly, distribution analysis of miRNA gene loci across six species including dog, rat, mouse, rhesus, chimpanzee, and human showed that miRNA genes encoded in chromosome 19 were drastically increased in chimpanzees and humans while miRNA gene loci on other chrosmomes were decreased as compared with dog, rat, and mouse. Comparative genomic studies showed 99% conservation of chromosome 19 miRNA genes between chimpanzees and humans. Together, these findings reveal the evolutionary emergence, similar to 5 million years ago, of miRNAs involved in regulating early human development. One could imagine that this burst of miRNA gene clusters at specific chromosomes was part of an evolutionary event during species divergence.	[Cao, Hong; Yang, Chao-Shun; Rana, Tariq M.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Cao, H (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	tariq.rana@umassmed.edu		Yang, Chao-Shun/0000-0002-1532-3377				Abeyta MJ, 2004, HUM MOL GENET, V13, P601, DOI 10.1093/hmg/ddh068; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Carpenter MK, 2004, DEV DYNAM, V229, P243, DOI 10.1002/dvdy.10431; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	27	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2820	10.1371/journal.pone.0002820	http://dx.doi.org/10.1371/journal.pone.0002820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665260	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300039
J	Milano, A; Pendergrass, SA; Sargent, JL; George, LK; McCalmont, TH; Connolly, MK; Whitfield, ML				Milano, Ausra; Pendergrass, Sarah A.; Sargent, Jennifer L.; George, Lacy K.; McCalmont, Timothy H.; Connolly, M. Kari; Whitfield, Michael L.			Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin	PLOS ONE			English	Article							HUMAN UROTENSIN-II; SYSTEMIC-SCLEROSIS; CLONING; CLASSIFICATION; RECEPTOR; PATTERNS; DISEASE; PROTEIN; IDENTIFICATION; ANTIGEN	Background: Scleroderma is a clinically heterogeneous disease with a complex phenotype. The disease is characterized by vascular dysfunction, tissue fibrosis, internal organ dysfunction, and immune dysfunction resulting in autoantibody production. Methodology and Findings: We analyzed the genome-wide patterns of gene expression with DNA microarrays in skin biopsies from distinct scleroderma subsets including 17 patients with systemic sclerosis (SSc) with diffuse scleroderma (dSSc), 7 patients with SSc with limited scleroderma (ISSc), 3 patients with morphea, and 6 healthy controls. 61 skin biopsies were analyzed in a total of 75 microarray hybridizations. Analysis by hierarchical clustering demonstrates nearly identical patterns of gene expression in 17 out of 22 of the forearm and back skin pairs of SSc patients. Using this property of the gene expression, we selected a set of 'intrinsic' genes and analyzed the inherent data-driven groupings. Distinct patterns of gene expression separate patients with dSSc from those with lSSc and both are easily distinguished from normal controls. Our data show three distinct patient groups among the patients with dSSc and two groups among patients with lSSc. Each group can be distinguished by unique gene expression signatures indicative of proliferating cells, immune infiltrates and a fibrotic program. The intrinsic groups are statistically significant (p < 0.001) and each has been mapped to clinical covariates of modified Rodnan skin score, interstitial lung disease, gastrointestinal involvement, digital ulcers, Raynaud's phenomenon and disease duration. We report a 177-gene signature that is associated with severity of skin disease in dSSc. Conclusions and Significance: Genome-wide gene expression profiling of skin biopsies demonstrates that the heterogeneity in scleroderma can be measured quantitatively with DNA microarrays. The diversity in gene expression demonstrates multiple distinct gene expression programs in the skin of patients with scleroderma.	[Milano, Ausra; Pendergrass, Sarah A.; Sargent, Jennifer L.; George, Lacy K.; Whitfield, Michael L.] Dartmouth Med Sch, Dept Genet, Hanover, NH USA; [Whitfield, Michael L.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Hanover, NH USA; [Connolly, M. Kari] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA; [Connolly, M. Kari] Univ Calif San Francisco, Dept Med Rheumatol, San Francisco, CA USA; [McCalmont, Timothy H.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Milano, A (corresponding author), Dartmouth Med Sch, Dept Genet, Hanover, NH USA.	michael.whitfield@dartmouth.edu	Whitfield, Michael/AAC-5010-2020	Pendergrass, Rion/0000-0002-0565-6522	Scleroderma Research Foundation; HHMI Biomedical Research Support Award [76200-560801]; Arthritis Foundation [Hulda Irene Duggan Arthritis Investigator Award]; National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS), NIH [AR007576]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007576] Funding Source: NIH RePORTER	Scleroderma Research Foundation; HHMI Biomedical Research Support Award; Arthritis Foundation; National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research grants from the Scleroderma Research Foundation to MKC and MLW. Additional support for MLW came from HHMI Biomedical Research Support Award #76200-560801 to Dartmouth College. SAP and LKG received support from a Hulda Irene Duggan Arthritis Investigator Award from the Arthritis Foundation to MLW. AM and SAP also received support from NIH Autoimmunity and Connective Tissue Biology Training Grant (AR007576) from the National Institute of Arthritis, Musculoskeletal and Skin diseases (NIAMS). The sponsors had no role in the design of the experiments, in the analysis of data or in the preparation and review of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; Arm JP, 1997, J IMMUNOL, V159, P2342; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAKER E, 1994, IMMUNOGENETICS, V40, P235, DOI 10.1007/BF00167085; BARNETT AJ, 1988, J RHEUMATOL, V15, P276; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Clements PJ, 2000, ARTHRITIS RHEUM-US, V43, P2445, DOI 10.1002/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q; CLEMENTS PJ, 1990, ARTHRITIS RHEUM, V33, P1256, DOI 10.1002/art.1780330828; *COMM SFSCOTARADAT, 1980, PRELIMINARY CRITERIA, V23, P581; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; CROFFORD LJ, 1994, J CLIN INVEST, V93, P1095, DOI 10.1172/JCI117060; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Douglas SA, 2000, BRIT J PHARMACOL, V131, P1262, DOI 10.1038/sj.bjp.0703690; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FLEISCHMAJER R, 1977, ARTHRITIS RHEUM, V20, P975, DOI 10.1002/art.1780200410; FLEISCHMAJER R, 1977, J INVEST DERMATOL, V69, P379, DOI 10.1111/1523-1747.ep12510308; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gardner H, 2006, ARTHRITIS RHEUM-US, V54, P1961, DOI 10.1002/art.21894; GORE Y, 2007, J BIOL CHEM; Grieco P, 2005, J MED CHEM, V48, P7290, DOI 10.1021/jm058043j; HALES DA, 1990, J CLUST SCI, V1, P127, DOI DOI 10.1007/BF00703589; HEID CA, 1996, REAL TIME QUANTITATI, V6, P986; Jensen PE, 1999, IMMUNOL REV, V172, P229, DOI 10.1111/j.1600-065X.1999.tb01368.x; Jensen PE, 1999, IMMUNOL RES, V20, P195, DOI 10.1007/BF02790403; KAZANDJIAN S, 1982, ACTA DERM-VENEREOL, V62, P425; Kojima F, 2003, ARTHRITIS RHEUM, V48, P2819, DOI 10.1002/art.11261; KORETZKY GA, 1990, NATURE, V346, P66, DOI 10.1038/346066a0; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Kraling BM, 1996, PATHOBIOLOGY, V64, P99, DOI 10.1159/000164015; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; LEDBETTER JA, 1981, J EXP MED, V153, P310, DOI 10.1084/jem.153.2.310; LEROY EC, 1988, J RHEUMATOL, V15, P202; LIU Y, 2007, J AM STAT ASS UNPUB; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolin AA, 2005, BIOINFORMATICS, V21, P3308, DOI 10.1093/bioinformatics/bti500; MASI AT, 1988, J RHEUMATOL, V15, P894; Mayes MD, 1998, SEMIN CUTAN MED SURG, V17, P22, DOI 10.1016/S1085-5629(98)80058-8; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; MEDSGER TA, 2001, ARTHRITIS ALLIED CON; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Perera A, 2007, ARTHRITIS RHEUM, V56, P2740, DOI 10.1002/art.22747; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; PRZETAK MM, 1995, FEBS LETT, V364, P268, DOI 10.1016/0014-5793(95)00407-Z; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rajkumar VS, 2005, ARTHRITIS RES THER, V7, pR1113, DOI 10.1186/ar1790; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sakkas LI, 2002, J IMMUNOL, V168, P3649, DOI 10.4049/jimmunol.168.7.3649; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sayers TJ, 1996, J LEUKOCYTE BIOL, V59, P763, DOI 10.1002/jlb.59.5.763; Scussel-Lonzetti L, 2002, MEDICINE, V81, P154, DOI 10.1097/00005792-200203000-00005; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2007, NAT BIOTECHNOL, V25, P675, DOI 10.1038/nbt1306; Seibold James R., 1997, Current Opinion in Rheumatology, V9, P571, DOI 10.1097/00002281-199711000-00014; SEWELL WA, 1986, P NATL ACAD SCI USA, V83, P8718, DOI 10.1073/pnas.83.22.8718; SEWELL WA, 1989, TRANSPLANT P, V21, P41; Shand L, 2007, ARTHRITIS RHEUM-US, V56, P2422, DOI 10.1002/art.22721; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; SMYTH MJ, 1995, IMMUNOGENETICS, V42, P101, DOI 10.1007/BF00178584; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Steen VD, 2000, ARTHRITIS RHEUM-US, V43, P2437, DOI 10.1002/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U; Steen VD, 2001, ARTHRITIS RHEUM, V44, P2828, DOI 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U; STUART JM, 2003, GENE COEXPRESSION NE, V392, P249; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; TROWBRIDGE IS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P46, DOI 10.1016/0167-4889(91)90043-W; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagtmann N, 1997, CURR BIOL, V7, P615, DOI 10.1016/S0960-9822(06)00263-6; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2003, P NATL ACAD SCI USA, V100, P12319, DOI 10.1073/pnas.1635114100; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; YUROVSKY VV, 1994, J IMMUNOL, V153, P881	86	281	282	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2696	10.1371/journal.pone.0002696	http://dx.doi.org/10.1371/journal.pone.0002696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648520	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200039
J	Datta, S; Sarvetnick, NE				Datta, Shrimati; Sarvetnick, Nora E.			IL-21 Limits Peripheral Lymphocyte Numbers through T Cell Homeostatic Mechanisms	PLOS ONE			English	Article								Background: IL-21, a member of the common gamma-chain utilizing family of cytokines, participates in immune and inflammatory processes. In addition, the cytokine has been linked to autoimmunity in humans and rodents. Methodology/Principal Findings: To investigate the mechanism whereby IL-21 affects the immune system, we investigated its role in T cell homeostasis and autoimmunity in both non-autoimmune C57BL/6 and autoimmune NOD mice. Our data indicate that IL-21R knockout C57BL/6 and NOD mice show increased size of their lymphocyte population and decreased homeostatic proliferation. In addition, our experimental results demonstrate that IL-21 inhibits T cell survival. These data suggest that IL-21 acts to limit the size of the T cell pool. Furthermore, our data suggest IL-21 may contribute to the development of autoimmunity. Conclusions/Significance: Taken together, our results suggest that IL-21 plays a global role in regulating T cell homeostasis, promoting the continuous adaptation of the T cell lymphoid space.	[Datta, Shrimati; Sarvetnick, Nora E.] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Datta, S (corresponding author), Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	noras@scripps.edu			NIH [A1064325]; The Larry L. Hillblom Foundation [postdoctoral fellowship]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Larry L. Hillblom Foundation	The work was supported by NIH grant A1064325 (to NS). SD was supported by a postdoctoral fellowship from The Larry L. Hillblom Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell K, 2005, NAT CELL BIOL, V7, P392, DOI 10.1038/ncb1242; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Alves NL, 2005, J IMMUNOL, V175, P755, DOI 10.4049/jimmunol.175.2.755; Asao H, 2001, J IMMUNOL, V167, P1, DOI 10.4049/jimmunol.167.1.1; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Barker BR, 2007, J IMMUNOL, V179, P3596, DOI 10.4049/jimmunol.179.6.3596; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Bour-Jordan H, 2007, J CLIN INVEST, V117, P3642, DOI 10.1172/JCI34236; Brown IE, 2006, J IMMUNOL, V177, P4521, DOI 10.4049/jimmunol.177.7.4521; Cantor J, 2005, J IMMUNOL, V175, P7738, DOI 10.4049/jimmunol.175.11.7738; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Davis ID, 2007, CLIN CANCER RES, V13, P6926, DOI 10.1158/1078-0432.CCR-07-1238; Falcone M, 1998, J IMMUNOL, V161, P1163; Ge Q, 2002, P NATL ACAD SCI USA, V99, P2989, DOI 10.1073/pnas.052714099; Georgescu L, 1997, J CLIN INVEST, V100, P2622, DOI 10.1172/JCI119806; GIORDANO C, 1995, DIABETOLOGIA, V38, P953, DOI 10.1007/BF00400585; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Goronzy JJ, 2001, TRENDS IMMUNOL, V22, P251, DOI 10.1016/S1471-4906(00)01841-X; Gurlo T, 1999, J IMMUNOL, V163, P5770; Habib T, 2002, BIOCHEMISTRY-US, V41, P8725, DOI 10.1021/bi0202023; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657; Kasaian MT, 2002, IMMUNITY, V16, P559, DOI 10.1016/S1074-7613(02)00295-9; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Krupica T, 2006, CLIN IMMUNOL, V120, P121, DOI 10.1016/j.clim.2006.04.569; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Li J, 2006, SCAND J IMMUNOL, V64, P515, DOI 10.1111/j.1365-3083.2006.01795.x; Li WQ, 2004, J BIOL CHEM, V279, P29160, DOI 10.1074/jbc.M401656200; Li YQ, 2005, J IMMUNOL, V175, P2261, DOI 10.4049/jimmunol.175.4.2261; Liu SJ, 2007, INT IMMUNOL, V19, P1213, DOI 10.1093/intimm/dxm093; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mehta DS, 2003, J IMMUNOL, V170, P4111, DOI 10.4049/jimmunol.170.8.4111; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Ostiguy V, 2007, J LEUKOCYTE BIOL, V82, P645, DOI 10.1189/jlb.0806494; Ozaki K, 2002, SCIENCE, V298, P1630, DOI 10.1126/science.1077002; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Peluso I, 2007, J IMMUNOL, V178, P732, DOI 10.4049/jimmunol.178.2.732; Qin JZ, 2001, BLOOD, V98, P2778, DOI 10.1182/blood.V98.9.2778; Rietz C, 2003, SCAND J IMMUNOL, V57, P342, DOI 10.1046/j.1365-3083.2003.01244.x; SARVETNICK N, 1990, NATURE, V346, P844, DOI 10.1038/346844a0; Schulze-Koops H, 2004, ARTHRITIS RES THER, V6, P178, DOI 10.1186/ar1208; Serreze DV, 2000, DIABETES, V49, P2007, DOI 10.2337/diabetes.49.12.2007; Smyth MJ, 2008, CANCER RES, V68, P3019, DOI 10.1158/0008-5472.CAN-07-6019; Stephanou A, 2000, CELL DEATH DIFFER, V7, P329, DOI 10.1038/sj.cdd.4400656; Strengeil M, 2002, J IMMUNOL, V169, P3600, DOI 10.4049/jimmunol.169.7.3600; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI12173; Vivien L, 2001, INT IMMUNOL, V13, P763, DOI 10.1093/intimm/13.6.763; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Vollmer TL, 2005, J IMMUNOL, V174, P2696, DOI 10.4049/jimmunol.174.5.2696; Wurster AL, 2002, J EXP MED, V196, P969, DOI 10.1084/jem.20020620; Yadav D, 2004, J IMMUNOL, V173, P3631, DOI 10.4049/jimmunol.173.6.3631; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	63	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3118	10.1371/journal.pone.0003118	http://dx.doi.org/10.1371/journal.pone.0003118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773086	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420100001
J	Di Natale, C; Martinelli, E; Paolesse, R; D'Amico, A; Filippini, D; Lundstrom, I				Di Natale, Corrado; Martinelli, Eugenio; Paolesse, Roberto; D'Amico, Arnaldo; Filippini, Daniel; Lundstrom, Ingemar			An Experimental Biomimetic Platform for Artificial Olfaction	PLOS ONE			English	Article								Artificial olfactory systems have been studied for the last two decades mainly from the point of view of the features of olfactory neuron receptor fields. Other fundamental olfaction properties have only been episodically considered in artificial systems. As a result, current artificial olfactory systems are mostly intended as instruments and are of poor benefit for biologists who may need tools to model and test olfactory models. Herewith, we show how a simple experimental approach can be used to account for several phenomena observed in olfaction. An artificial epithelium is formed as a disordered distributed layer of broadly selective color indicators dispersed in a transparent polymer layer. The whole epithelium is probed with colored light, imaged with a digital camera and the olfactory response upon exposure to an odor is the change of the multispectral image. The pixels are treated as olfactory receptor neurons, whose optical properties are used to build a convergence classifier into a number of mathematically defined artificial glomeruli. A non-homogenous exposure of the test structure to the odours gives rise to a time and spatial dependence of the response of the different glomeruli strikingly similar to patterns observed in the olfactory bulb. The model seems to mimick both the formation of glomeruli, the zonal nature of olfactory epithelium, and the spatio-temporal signal patterns at the glomeruli level. This platform is able to provide a readily available test vehicle for chemists developing optical indicators for chemical sensing purposes and for biologists to test models of olfactory system organization.	[Di Natale, Corrado; Martinelli, Eugenio; D'Amico, Arnaldo] Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy; [Paolesse, Roberto] Univ Roma Tor Vergata, Dept Chem Sci & Technol, Rome, Italy; [Filippini, Daniel; Lundstrom, Ingemar] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	University of Rome Tor Vergata; University of Rome Tor Vergata; Linkoping University	Di Natale, C (corresponding author), Univ Roma Tor Vergata, Dept Elect Engn, Rome, Italy.	dinatale@uniroma2.it	Di Natale, Corrado/M-8701-2014; Paolesse, Roberto/AAI-3182-2020; Martinelli, Eugenio/AAA-9105-2019; Paolesse, Roberto/B-8966-2013	Di Natale, Corrado/0000-0002-0543-4348; Martinelli, Eugenio/0000-0002-6673-2066; Paolesse, Roberto/0000-0002-2380-1404				Acebes A, 2001, J NEUROSCI, V21, P6264, DOI 10.1523/JNEUROSCI.21-16-06264.2001; Anslyn EV, 2007, J ORG CHEM, V72, P687, DOI 10.1021/jo0617971; Di Natale C, 2005, IEEE SENS J, V5, P1165, DOI 10.1109/JSEN.2005.858932; Dickinson TA, 1999, ANAL CHEM, V71, P2192, DOI 10.1021/ac981457i; Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0; Filippini D, 2003, CHEM COMMUN, P240, DOI 10.1039/b210677a; Filippini D, 2006, ANGEW CHEM INT EDIT, V45, P3800, DOI 10.1002/anie.200600050; Friedrich RW, 2004, J NEUROPHYSIOL, V91, P2658, DOI 10.1152/jn.01143.2003; Galizia CG, 2001, J INSECT PHYSIOL, V47, P115, DOI 10.1016/S0022-1910(00)00106-2; Galizia CG, 2000, CURR OPIN NEUROBIOL, V10, P504, DOI 10.1016/S0959-4388(00)00109-4; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Kent PF, 2003, BRAIN RES, V981, P1, DOI 10.1016/S0006-8993(03)02512-5; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0; Rakow NA, 2000, NATURE, V406, P710, DOI 10.1038/35021028; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott JW, 1997, J NEUROPHYSIOL, V77, P1950, DOI 10.1152/jn.1997.77.4.1950; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Vosshall LB, 2001, CHEM SENSES, V26, P207, DOI 10.1093/chemse/26.2.207	24	45	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3139	10.1371/journal.pone.0003139	http://dx.doi.org/10.1371/journal.pone.0003139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769554	gold, Green Published, Green Submitted			2022-12-27	WOS:000264419100007
J	Wang, FL; Grigorieva, EV; Li, JF; Senchenko, VN; Pavlova, TV; Anedchenko, EA; Kudryavtseva, AV; Tsimanis, A; Angeloni, D; Lerman, MI; Kashuba, VI; Klein, G; Zabarovsky, ER				Wang, Fuli; Grigorieva, Elvira V.; Li, Jingfeng; Senchenko, Vera N.; Pavlova, Tatiana V.; Anedchenko, Ekaterina A.; Kudryavtseva, Anna V.; Tsimanis, Alexander; Angeloni, Debora; Lerman, Michael I.; Kashuba, Vladimir I.; Klein, George; Zabarovsky, Eugene R.			HYAL1 and HYAL2 Inhibit Tumour Growth In Vivo but Not In Vitro	PLOS ONE			English	Article							HUMAN-CHROMOSOME 3P21.3; HUMAN EPITHELIAL MALIGNANCIES; JAAGSIEKTE SHEEP RETROVIRUS; HOMOZYGOUS DELETION REGION; REAL-TIME PCR; SUPPRESSOR GENE; CELL FUSION; LUNG; INACTIVATION; HYALURONAN	Background: We identified two 3p21.3 regions (LUCA and AP20) as most frequently affected in lung, breast and other carcinomas and reported their fine physical and gene maps. It is becoming increasingly clear that each of these two regions contains several TSGs. Until now TSGs which were isolated from AP20 and LUCA regions (e. g. G21/NPRL2, RASSF1A, RASSF1C, SEMA3B, SEMA3F, RBSP3) were shown to inhibit tumour cell growth both in vitro and in vivo. Methodology/Principal Findings: The effect of expression HYAL1 and HYAL2 was studied by colony formation inhibition, growth curve and cell proliferation tests in vitro and tumour growth assay in vivo. Very modest growth inhibition was detected in vitro in U2020 lung and KRC/Y renal carcinoma cell lines. In the in vivo experiment stably transfected KRC/Y cells expressing HYAL1 or HYAL2 were inoculated into SCID mice (10 and 12 mice respectively). Tumours grew in eight mice inoculated with HYAL1. Ectopic HYAL1 was deleted in all of them. HYAL2 was inoculated into 12 mice and only four tumours were obtained. In 3 of them the gene was deleted. In one tumour it was present but not expressed. As expected for tumour suppressor genes HYAL1 and HYAL2 were down-expressed in 15 fresh lung squamous cell carcinomas (100%) and clear cell RCC tumours (60-67%). Conclusions/Significance: The results suggest that the expression of either gene has led to inhibition of tumour growth in vivo without noticeable effect on growth in vitro. HYAL1 and HYAL2 thus differ in this aspect from other tumour suppressors like P53 or RASSF1A that inhibit growth both in vitro and in vivo. Targeting the microenvironment of cancer cells is one of the most promising venues of cancer therapeutics. As major hyaluronidases in human cells, HYAL1 and HYAL2 may control intercellular interactions and microenvironment of tumour cells providing excellent targets for cancer treatment.	[Wang, Fuli; Grigorieva, Elvira V.; Li, Jingfeng; Pavlova, Tatiana V.; Kashuba, Vladimir I.; Klein, George; Zabarovsky, Eugene R.] Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; [Grigorieva, Elvira V.] SD RAMS, Inst Mol Biol & Biophys, Novosibirsk, Russia; [Senchenko, Vera N.; Pavlova, Tatiana V.; Anedchenko, Ekaterina A.; Kudryavtseva, Anna V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Tsimanis, Alexander] Bioactivity Ltd, Rehovot, Israel; [Angeloni, Debora; Lerman, Michael I.] NCI, Ctr Canc Res, Lab Immunobiol, Canc Causing Genes Sect, Frederick, MD USA; [Angeloni, Debora] CNR, Inst Clin Physiol, Scuola Superiore SantAnna, Pisa, Italy; [Kashuba, Vladimir I.] Ukrainian Acad Scie, Inst Mol Biol & Genet, Kiev, Ukraine	Karolinska Institutet; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Scuola Superiore Sant'Anna; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Wang, FL (corresponding author), Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden.	eugzab@ki.se	Zabarovsky, Eugene R/A-6645-2010; Kudryavtseva, Anna V/C-9032-2014; Senchenko, Vera N/C-8992-2014; Grigorieva, Elvira/A-4937-2010; Kashuba, Vladimir/AAO-7742-2020; Kashuba, Vladimir I/N-3732-2017	Kudryavtseva, Anna V/0000-0002-3722-8207; Senchenko, Vera N/0000-0002-3119-515X; Grigorieva, Elvira/0000-0003-2457-9179; Kashuba, Vladimir I/0000-0001-9416-8282; Angeloni, Debora/0000-0002-3850-5392; Pavlova, Tatiana/0000-0002-2857-5696	Swedish Cancer Society; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Institute; Royal Swedish Academy of Sciences; INTAS; Karolinska Institute; Russian Federal Agency of Science and Innovations [02.512.11.21.01, 02.512.11.2241]; Russian Foundation for Basic Research [008-04-01577]; Concern Foundation in Los Angeles [fellowship]; Cancer Research Institute in New York; Intramural Research Program of the Center for Cancer Research, National Cancer Institute	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Swedish Institute; Royal Swedish Academy of Sciences; INTAS(INTASEuropean Commission); Karolinska Institute(Karolinska Institutet); Russian Federal Agency of Science and Innovations(Federal Agency for Science & Innovations (FASI)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Concern Foundation in Los Angeles; Cancer Research Institute in New York; Intramural Research Program of the Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research grants from the Swedish Cancer Society, the Swedish Research Council, the Swedish Foundation for International Cooperation in Research and Higher Education (STINT), the Swedish Institute, the Royal Swedish Academy of Sciences, INTAS and Karolinska Institute. VNS, EAA and AVK received grants from the Russian Federal Agency of Science and Innovations (State Contract no 02.512.11.21.01 and 02.512.11.2241) and the Russian Foundation for Basic Research (Project no. 008-04-01577). EVG was recipient of fellowship from the Concern Foundation in Los Angeles and the Cancer Research Institute in New York. TVP was supported by fellowship from The Swedish Institute. MIL and DA were supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimov A, 2000, ONCOGENE, V19, P1392, DOI 10.1038/sj.onc.1203449; Braga E, 2002, INT J CANCER, V100, P534, DOI 10.1002/ijc.10511; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Danilkovitch-Miagkova A, 2003, P NATL ACAD SCI USA, V100, P4580, DOI 10.1073/pnas.0837136100; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; GLANTZ SA, 1994, PRIMER BIOSTATISTICS, P1; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARRIS H, 1969, NATURE, V223, P363, DOI 10.1038/223363a0; Heppell-Parton AC, 1999, CANCER GENET CYTOGEN, V108, P110, DOI 10.1016/S0165-4608(98)00130-7; Imreh S, 2003, GENE CHROMOSOME CANC, V38, P307, DOI 10.1002/gcc.10271; Ji L, 2002, CANCER RES, V62, P2715; Kashuba VI, 2004, P NATL ACAD SCI USA, V101, P4906, DOI 10.1073/pnas.0401238101; Klein G, 2007, ADV CANCER RES, V98, P1, DOI 10.1016/S0065-230X(06)98001-4; Kosaki R, 1999, CANCER RES, V59, P1141; Lerman MI, 2000, CANCER RES, V60, P6116; Li F, 2004, CANCER RES, V64, P6438, DOI 10.1158/0008-5472.CAN-03-3869; Li JF, 2004, ONCOGENE, V23, P5941, DOI 10.1038/sj.onc.1207789; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Li JF, 1999, FEBS LETT, V451, P289, DOI 10.1016/S0014-5793(99)00598-0; Liu NF, 2001, CANCER RES, V61, P5207; Protopopov A, 2003, CANCER RES, V63, P404; Protopopov AI, 2002, J GENE MED, V4, P397, DOI 10.1002/jgm.283; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Senchenko V, 2003, ONCOGENE, V22, P2984, DOI 10.1038/sj.onc.1206429; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; WEINER F, 1971, J CELL SCI, V8, P681; ZABAROVSKY ER, 1990, NUCLEIC ACIDS RES, V18, P6319, DOI 10.1093/nar/18.21.6319; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835; ZHANG LR, 1995, CANCER RES, V55, P428	32	37	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3031	10.1371/journal.pone.0003031	http://dx.doi.org/10.1371/journal.pone.0003031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725949	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428800002
J	Baumgart, JP; Vitko, I; Bidaud, I; Kondratskyi, A; Lory, P; Perez-Reyes, E				Baumgart, Joel P.; Vitko, Iuliia; Bidaud, Isabelle; Kondratskyi, Artem; Lory, Philippe; Perez-Reyes, Edward			I-II Loop Structural Determinants in the Gating and Surface Expression of Low Voltage-Activated Calcium Channels	PLOS ONE			English	Article								The intracellular loops that interlink the four transmembrane domains of Ca2+- and Na+-channels (Ca-v, Na-v) have critical roles in numerous forms of channel regulation. In particular, the intracellular loop that joins repeats I and II (I-II loop) in high voltage-activated (HVA) Ca2+ channels possesses the binding site for Ca-v beta subunits and plays significant roles in channel function, including trafficking the alpha(1) subunits of HVA channels to the plasma membrane and channel gating. Although there is considerable divergence in the primary sequence of the I-II loop of Ca(v)1/Ca(v)2 HVA channels and Ca(v)3 LVA/T-type channels, evidence for a regulatory role of the I-II loop in T-channel function has recently emerged for Ca(v)3.2 channels. In order to provide a comprehensive view of the role this intracellular region may play in the gating and surface expression in Ca(v)3 channels, we have performed a structure-function analysis of the I-II loop in Ca(v)3.1 and Ca(v)3.3 channels using selective deletion mutants. Here we show the first 60 amino acids of the loop (post IS6) are involved in Ca(v)3.1 and Ca(v)3.3 channel gating and kinetics, which establishes a conserved property of this locus for all Ca(v)3 channels. In contrast to findings in Ca(v)3.2, deletion of the central region of the I-II loop in Ca(v)3.1 and Ca(v)3.3 yielded a modest increase (+30%) and a reduction (-30%) in current density and surface expression, respectively. These experiments enrich our understanding of the structural determinants involved in Ca(v)3 function by highlighting the unique role played by the intracellular I-II loop in Ca(v)3.2 channel trafficking, and illustrating the prominent role of the gating brake in setting the slow and distinctive slow activation kinetics of Ca(v)3.3.	[Baumgart, Joel P.; Vitko, Iuliia; Perez-Reyes, Edward] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Baumgart, Joel P.; Perez-Reyes, Edward] Univ Virginia, Neurosci Grad Program, Charlottesville, VA 22903 USA; [Bidaud, Isabelle; Lory, Philippe] Inst Genom Fonct, CNRS, UMR 5203, Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] INSERM, U661, Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] Univ Montpellier 1, F-34006 Montpellier, France; [Bidaud, Isabelle; Lory, Philippe] Univ Montpellier 2, F-34095 Montpellier, France; [Kondratskyi, Artem] Bogomoletz Inst Physiol, Dept Gen Physiol, Kiev, Ukraine	University of Virginia; University of Virginia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology	Baumgart, JP (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	eperez@virginia.edu	Baumgart, Joel/K-3139-2014	Baumgart, Joel/0000-0002-1109-2567; BIDAUD, Isabelle/0000-0002-1812-1447; LORY, philippe/0000-0002-1638-7604; Kondratskyi, Artem/0000-0003-3290-0524	National Institute of Health; Agence Nationale pour la Recherche [06-NEURO-035-01]; Fondation pour la Recherche sur le Cerveau; Epilepsy Foundation [Predoctoral Fellowship]; Sigma Xi [Grant-in-Aid]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur le Cerveau; Epilepsy Foundation; Sigma Xi	This work was supported by a National Institute of Health Grant (to EPR), Agence Nationale pour la Recherche 06-NEURO-035-01 (to PL), Fondation pour la Recherche sur le Cerveau (to PL), an Epilepsy Foundation Predoctoral Fellowship (to JPB) and a Sigma Xi Grant-in-Aid of Research (to JPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler HL, 2005, NEURON, V46, P891, DOI 10.1016/j.neuron.2005.05.011; Arias JM, 2005, FEBS LETT, V579, P3907, DOI 10.1016/j.febslet.2005.06.008; Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chen YC, 2003, ANN NEUROL, V54, P239, DOI 10.1002/ana.10607; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457; Hamid J, 2006, NEUROSCIENCE, V143, P717, DOI 10.1016/j.neuroscience.2006.08.023; HAMID J, 2006, NEUROSCIENCE; HUGUENARD JR, 1992, J NEUROSCI, V12, P3804, DOI 10.1523/jneurosci.12-10-03804.1992; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x; Lacinova L, 2002, FEBS LETT, V531, P235, DOI 10.1016/S0014-5793(02)03509-3; Lam AD, 2005, PFLUG ARCH EUR J PHY, V451, P349, DOI 10.1007/s00424-005-1407-5; Lambert RC, 1997, J NEUROSCI, V17, P6621; Lee JH, 1999, J NEUROSCI, V19, P1912; Leuranguer V, 1998, NEUROPHARMACOLOGY, V37, P701, DOI 10.1016/S0028-3908(98)00060-4; Marksteiner R, 2001, J PHYSIOL-LONDON, V537, P27, DOI 10.1111/j.1469-7793.2001.0027k.x; Monteil A, 2000, J BIOL CHEM, V275, P16530, DOI 10.1074/jbc.C000090200; Murbartian J, 2004, J NEUROPHYSIOL, V92, P3399, DOI 10.1152/jn.00498.2004; Nelson MT, 2007, J NEUROSCI, V27, P12577, DOI 10.1523/JNEUROSCI.2206-07.2007; Nelson MT, 2007, J NEUROSCI, V27, P8250, DOI 10.1523/JNEUROSCI.1800-07.2007; Park JY, 2004, J BIOL CHEM, V279, P21707, DOI 10.1074/jbc.M400684200; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Staes M, 2001, J PHYSIOL-LONDON, V530, P35, DOI 10.1111/j.1469-7793.2001.0035m.x; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; Su H, 2002, J NEUROSCI, V22, P3645; Talavera K, 2003, J GEN PHYSIOL, V121, P529, DOI 10.1085/jgp.200308794; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Tao J, 2008, MOL PHARMACOL, V73, P1596, DOI 10.1124/mol.107.043612; TRABOULSIE A, 2006, J PHYSL; Vitko I, 2005, J NEUROSCI, V25, P4844, DOI 10.1523/JNEUROSCI.0847-05.2005; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wolfe JT, 2003, NATURE, V424, P209, DOI 10.1038/nature01772	39	41	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2976	10.1371/journal.pone.0002976	http://dx.doi.org/10.1371/journal.pone.0002976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714336	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900003
J	Bruederle, CE; Hnasko, RM; Kraemer, T; Garcia, RA; Haas, MJ; Marmer, WN; Carter, JM				Bruederle, Cathrin E.; Hnasko, Robert M.; Kraemer, Thomas; Garcia, Rafael A.; Haas, Michael J.; Marmer, William N.; Carter, John Mark			Prion Infected Meat-and-Bone Meal Is Still Infectious after Biodiesel Production	PLOS ONE			English	Article							SPONGIFORM ENCEPHALOPATHY; DISEASE; SAFETY	The epidemic of bovine spongiform encephalopathy (BSE) has led to a world-wide drop in the market for beef by-products, such as Meat-and-Bone Meal (MBM), a fat-containing but mainly proteinaceaous product traditionally used as an animal feed supplement. While normal rendering is insufficient, the production of biodiesel from MBM has been suggested to destroy infectivity from transmissible spongiform encephalopathies (TSEs). In addition to producing fuel, this method simultaneously generates a nutritious solid residue. In our study we produced biodiesel from MBM under defined conditions using a modified form of alkaline methanolysis. We evaluated the presence of prion in the three resulting phases of the biodiesel reaction (Biodiesel, Glycerol and Solid Residue) in vitro and in vivo. Analysis of the reaction products from 263K scrapie infected MBM led to no detectable immunoreactivity by Western Blot. Importantly, and in contrast to the biochemical results the solid MBM residue from the reaction retained infectivity when tested in an animal bioassay. Histochemical analysis of hamster brains inoculated with the solid residue showed typical spongiform degeneration and vacuolation. Re-inoculation of these brains into a new cohort of hamsters led to onset of clinical scrapie symptoms within 75 days, suggesting that the specific infectivity of the prion protein was not changed during the biodiesel process. The biodiesel reaction cannot be considered a viable prion decontamination method for MBM, although we observed increased survival time of hamsters and reduced infectivity greater than 6 log orders in the solid MBM residue. Furthermore, results from our study compare for the first time prion detection by Western Blot versus an infectivity bioassay for analysis of biodiesel reaction products. We could show that biochemical analysis alone is insufficient for detection of prion infectivity after a biodiesel process.	[Bruederle, Cathrin E.; Hnasko, Robert M.; Carter, John Mark] USDA ARS, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA; [Kraemer, Thomas] Saarland Univ, Inst Legal Med, Homburg, Germany; [Garcia, Rafael A.; Haas, Michael J.; Marmer, William N.] USDA ARS, ERRC, Fats, Oils & Anim Coproducts Res Unit, Wyndmoor, PA USA	United States Department of Agriculture (USDA); Universitatsklinikum des Saarlandes; United States Department of Agriculture (USDA)	Bruederle, CE (corresponding author), USDA ARS, WRRC, Foodborne Contaminants Res Unit, Albany, CA USA.	cathrin.bruederle@gmail.com	Garcia, Rafael A./D-2796-2009; Carter, John Mark/K-2485-2015; Carter, John Mark/P-9919-2019; Kraemer, Thomas/R-8407-2018	Garcia, Rafael A./0000-0002-5452-3929; Carter, John Mark/0000-0001-8251-4168; Carter, John Mark/0000-0001-8251-4168; Kraemer, Thomas/0000-0002-3283-606X	CRIS [5325-32000-007-00D, 5325-32000-008-00D]	CRIS	CRIS 5325-32000-007-00D and CRIS 5325-32000-008-00D	[Anonymous], 2000, LANCET, V356, P1535; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Fishbein L, 1998, SCI TOTAL ENVIRON, V217, P71, DOI 10.1016/S0048-9697(98)00164-8; Garcia RA, 2006, APPL ENG AGRIC, V22, P729; Haas MJ, 2007, J AM OIL CHEM SOC, V84, P963, DOI 10.1007/s11746-007-1119-4; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Huang ZW, 1996, FOLD DES, V1, P13, DOI 10.1016/S1359-0278(96)00007-7; JENDROSKA K, 1991, NEUROLOGY, V41, P1482, DOI 10.1212/WNL.41.9.1482; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Mittelbach M, 2007, EUR J LIPID SCI TECH, V109, P79, DOI 10.1002/ejlt.200600172; *OFF USGA, 2005, GAO05101 OFF USGA; Prusiner S B, 1981, Adv Exp Med Biol, V134, P385; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1994, PHILOS T ROY SOC B, V343, P447, DOI 10.1098/rstb.1994.0043; PRUSINER SB, 1993, DEV BIOL STAND, V80, P31; Seidel B, 2006, ENVIRON SCI POLLUT R, V13, P125, DOI 10.1065/espr2005.08.283; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; TAYLOR DM, 1991, DEV BIOLOGICALS, V75, P97; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thiry Etienne, 2004, Biotechnologie Agronomie Societe et Environnement, V8, P221; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199	22	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2969	10.1371/journal.pone.0002969	http://dx.doi.org/10.1371/journal.pone.0002969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698417	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600054
J	Correa, LGG; Riano-Pachon, DM; Schrago, CG; dos Santos, RV; Mueller-Roeber, B; Vincentz, M				Guedes Correa, Luiz Gustavo; Riano-Pachon, Diego Mauricio; Schrago, Carlos Guerra; dos Santos, Renato Vicentini; Mueller-Roeber, Bernd; Vincentz, Michel			The Role of bZIP Transcription Factors in Green Plant Evolution: Adaptive Features Emerging from Four Founder Genes	PLOS ONE			English	Article							MADS-BOX GENES; SIGNAL-TRANSDUCTION PATHWAY; RETICULUM STRESS-RESPONSE; ARABIDOPSIS-THALIANA; FUNCTIONAL-ANALYSIS; FAMILY EVOLUTION; LAND PLANTS; RICE GENOME; EUKARYOTIC TRANSCRIPTION; PHYLOGENETIC ANALYSES	Background: Transcription factors of the basic leucine zipper (bZIP) family control important processes in all eukaryotes. In plants, bZIPs are regulators of many central developmental and physiological processes including photomorphogenesis, leaf and seed formation, energy homeostasis, and abiotic and biotic stress responses. Here we performed a comprehensive phylogenetic analysis of bZIP genes from algae, mosses, ferns, gymnosperms and angiosperms. Methodology/Principal Findings: We identified 13 groups of bZIP homologues in angiosperms, three more than known before, that represent 34 Possible Groups of Orthologues (PoGOs). The 34 PoGOs may correspond to the complete set of ancestral angiosperm bZIP genes that participated in the diversification of flowering plants. Homologous genes dedicated to seed-related processes and ABA-mediated stress responses originated in the common ancestor of seed plants, and three groups of homologues emerged in the angiosperm lineage, of which one group plays a role in optimizing the use of energy. Conclusions/Significance: Our data suggest that the ancestor of green plants possessed four bZIP genes functionally involved in oxidative stress and unfolded protein responses that are bZIP-mediated processes in all eukaryotes, but also in light-dependent regulations. The four founder genes amplified and diverged significantly, generating traits that benefited the colonization of new environments.	[Guedes Correa, Luiz Gustavo; dos Santos, Renato Vicentini; Vincentz, Michel] Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil; [Guedes Correa, Luiz Gustavo; Riano-Pachon, Diego Mauricio; Mueller-Roeber, Bernd] Univ Potsdam, Dept Mol Biol, Potsdam, Germany; [Guedes Correa, Luiz Gustavo; Mueller-Roeber, Bernd] Max Planck Inst Mol Plant Physiol, Cooperat Res Grp, Potsdam, Germany; [Riano-Pachon, Diego Mauricio] Max Planck Inst Mol Plant Physiol, Bioinformat Grp, GabiPD Team, Potsdam, Germany; [Schrago, Carlos Guerra] Univ Fed Rio de Janeiro, Dept Genet, Lab Biodivers Mol, Rio De Janeiro, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; University of Potsdam; Max Planck Society; Max Planck Society; Universidade Federal do Rio de Janeiro	Correa, LGG (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, Ctr Biol Mol & Engn Genet, Campinas, SP, Brazil.	mgavince@unicamp.br	Riaño-Pachón, Diego Mauricio/B-4891-2014; Vicentini, Renato/C-5967-2012; Riaño-Pachón, Diego M/A-1755-2010; Mueller-Roeber, Bernd/Z-4052-2019; Schrago, Carlos/E-4612-2012	Riaño-Pachón, Diego Mauricio/0000-0001-9803-3465; Riaño-Pachón, Diego M/0000-0001-9803-3465; Schrago, Carlos/0000-0001-6257-8906; Vicentini, Renato/0000-0002-0527-1083; vincentz, michel/0000-0002-9850-1772	DAAD [A/04/34814, D/04/01336]; BMBF [FKZ 0315046]; Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies; DAAD/DFG International PhD Programme Integrative Plant Science; Fonds der Chemischen Industrie [0164389]	DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); BMBF(Federal Ministry of Education & Research (BMBF)); Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies; DAAD/DFG International PhD Programme Integrative Plant Science(Deutscher Akademischer Austausch Dienst (DAAD)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	L.G.G.C. thanks the DAAD for providing a scholarship (A/04/34814). D.M.R.P. acknowledges financial support from the BMBF (FKZ 0315046). This work was supported in part by grants from the Fundacao de Amparo a Ciencia do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) (to L.G.G.C and M.V.), the University of Potsdam Interdisciplinary Research Centre Advanced Protein Technologies (to B.M.-R.), the DAAD/DFG International PhD Programme Integrative Plant Science (DAAD D/04/01336; to B.M-R.), and the Fonds der Chemischen Industrie (N 0164389; to B.M.-R.).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Beckett D, 2001, J MOL BIOL, V314, P335, DOI 10.1006/jmbi.2001.5134; Bennetzen J, 2002, SCIENCE, V296, P60, DOI 10.1126/science.1071402; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Carlini LE, 1999, PLANT MOL BIOL, V41, P339, DOI 10.1023/A:1006338727053; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Ciceri P, 1999, PLANT PHYSIOL, V121, P1321, DOI 10.1104/pp.121.4.1321; CORREA LGG, 2004, THESIS U ESTADUAL CA; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; DAYHOFF MO, 1978, ATLAS PROTEIN SEQUEN, P301; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; Demuth JP, 2007, GENETICA, V129, P37, DOI 10.1007/s10709-006-0031-4; Deppmann CD, 2004, NUCLEIC ACIDS RES, V32, P3435, DOI 10.1093/nar/gkh653; Deppmann CD, 2006, MOL BIOL EVOL, V23, P1480, DOI 10.1093/molbev/msl022; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Derelle R, 2007, EVOL DEV, V9, P212, DOI 10.1111/j.1525-142X.2007.00153.x; Despres C, 2000, PLANT CELL, V12, P279, DOI 10.1105/tpc.12.2.279; Fassler J, 2002, GENOME RES, V12, P1190, DOI 10.1101/gr.67902; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Finkelstein RR, 2000, PLANT PHYSIOL, V122, P1179, DOI 10.1104/pp.122.4.1179; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Fukazawa J, 2000, PLANT CELL, V12, P901, DOI 10.1105/tpc.12.6.901; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Holm M, 2002, GENE DEV, V16, P1247, DOI 10.1101/gad.969702; Hsia CC, 2003, CURR OPIN GENET DEV, V13, P199, DOI 10.1016/S0959-437X(03)00017-0; HURST HC, 1995, PROTEIN PROFILE, V2, P105; Irish VF, 2003, BIOESSAYS, V25, P637, DOI 10.1002/bies.10292; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaminaka H, 2006, EMBO J, V25, P4400, DOI 10.1038/sj.emboj.7601312; Kamisugi Y, 2005, PLANT MOL BIOL, V59, P723, DOI 10.1007/s11103-005-0909-z; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kellogg EA, 2004, CURR OPIN PLANT BIOL, V7, P92, DOI 10.1016/j.pbi.2003.11.004; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lara P, 2003, J BIOL CHEM, V278, P21003, DOI 10.1074/jbc.M210538200; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Lawton-Rauh A, 2003, MOL PHYLOGENET EVOL, V29, P396, DOI 10.1016/j.ympev.2003.07.004; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Makino C, 2006, GENES CELLS, V11, P1239, DOI 10.1111/j.1365-2443.2006.01016.x; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Meshi T, 1995, PLANT CELL PHYSIOL, V36, P1405; Moreno-Risueno MA, 2007, MOL GENET GENOMICS, V277, P379, DOI 10.1007/s00438-006-0186-9; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Nei M., 2000, MOL EVOLUTION PHYLOG; Nieva C, 2005, PLANT MOL BIOL, V58, P899, DOI 10.1007/s11103-005-8407-x; Niggeweg R, 2000, PLANT MOL BIOL, V42, P775, DOI 10.1023/A:1006319113205; Niggeweg R, 2000, J BIOL CHEM, V275, P19897, DOI 10.1074/jbc.M909267199; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Pennacchio LA, 2003, MAMM GENOME, V14, P429, DOI 10.1007/s00335-002-4001-1; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pontier D, 2001, PLANT J, V27, P529, DOI 10.1046/j.1365-313X.2001.01086.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Riano-Pachon DM, 2008, GENETICS, V179, P31, DOI 10.1534/genetics.107.086090; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Richardt S, 2007, PLANT PHYSIOL, V143, P1452, DOI 10.1104/pp.107.095760; Riechmann JL, 2000, CURR OPIN PLANT BIOL, V3, P423, DOI 10.1016/S1369-5266(00)00107-2; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Satoh R, 2004, PLANT CELL PHYSIOL, V45, P309, DOI 10.1093/pcp/pch036; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen HS, 2007, BIOCHEM BIOPH RES CO, V362, P425, DOI 10.1016/j.bbrc.2007.08.026; Shigyo M, 2007, PLANT CELL PHYSIOL, V48, P179, DOI 10.1093/pcp/pcl044; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Silveira AB, 2007, PLANT SCI, V172, P1148, DOI 10.1016/j.plantsci.2007.03.003; Singer SD, 2007, PLANT CELL REP, V26, P1155, DOI 10.1007/s00299-007-0312-0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanabe Y, 2005, P NATL ACAD SCI USA, V102, P2436, DOI 10.1073/pnas.0409860102; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton JW, 2000, ANNU REV GENOM HUM G, V1, P41, DOI 10.1146/annurev.genom.1.1.41; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Vettore AL, 1998, PLANT MOL BIOL, V36, P249, DOI 10.1023/A:1005995806897; Vincentz M, 2004, PLANT PHYSIOL, V134, P951, DOI 10.1104/pp.103.033878; Vincentz M, 2003, J MOL EVOL, V56, P105, DOI 10.1007/s00239-002-2386-1; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Walsh J, 1998, GENE DEV, V12, P208, DOI 10.1101/gad.12.2.208; Warabi E, 2007, FREE RADICAL BIO MED, V42, P260, DOI 10.1016/j.freeradbiomed.2006.10.043; Warren AJ, 2002, CURR OPIN STRUC BIOL, V12, P107, DOI 10.1016/S0959-440X(02)00296-8; Wellmer F, 1999, J BIOL CHEM, V274, P29476, DOI 10.1074/jbc.274.41.29476; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Woolfe A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r53; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007; Yin YH, 1997, EMBO J, V16, P5247, DOI 10.1093/emboj/16.17.5247; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; ZHANG B, 1993, PLANT J, V4, P711, DOI 10.1046/j.1365-313X.1993.04040711.x; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	124	193	219	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2944	10.1371/journal.pone.0002944	http://dx.doi.org/10.1371/journal.pone.0002944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698409	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600030
J	Lee, REC; Puente, LG; Kaern, M; Megeney, LA				Lee, Robin E. C.; Puente, Lawrence G.; Kaern, Mads; Megeney, Lynn A.			A Non-Death Role of the Yeast Metacaspase: Yca1p Alters Cell Cycle Dynamics	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; APOPTOSIS; CASPASE; PROTEINS; GENE; DIFFERENTIATION; IDENTIFICATION; TRANSITION; ARREST; PHASE	Caspase proteases are a conserved protein family predominantly known for engaging and executing apoptotic cell death. Nevertheless, in higher eukaryotes, caspases also influence a variety of cell behaviors including differentiation, proliferation and growth control. S. cerevisiae expresses a primordial caspase, yca1, and exhibits apoptosis-like death under certain stresses; however, the benefit of a dedicated death program to single cell organisms is controversial. In the absence of a clear rationale to justify the evolutionary retention of a death only pathway, we hypothesize that yca1 also influences non-apoptotic events. We report that genetic ablation and/or catalytic inactivation of Yca1p leads to a longer G1/S transition accompanied by slower growth in fermentation conditions. Downregulation of Yca1p proteolytic activity also results in failure to arrest during nocodazole treatment, indicating that Yca1p participates in the G2/M mitotic checkpoint. 20s proteasome activity and ROS staining of the Delta yca1 strain is indistinguishable from its isogenic control suggesting that putative regulation of the oxidative stress response by Yca1p does not instigate the cell cycle phenotype. Our results demonstrate multiple non-death roles for yca1 in the cell cycle.	[Lee, Robin E. C.; Puente, Lawrence G.; Megeney, Lynn A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Regenerat Med Program, Ottawa, ON, Canada; [Lee, Robin E. C.; Kaern, Mads; Megeney, Lynn A.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Kaern, Mads; Megeney, Lynn A.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1N 6N5, Canada; [Kaern, Mads] Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Lee, REC (corresponding author), Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Regenerat Med Program, Ottawa, ON, Canada.	lmegeney@ohri.ca	Lee, Robin/X-6718-2019; Kaern, Mads/GVU-6867-2022	Kaern, Mads/0000-0002-9371-666X; Megeney, Lynn/0000-0002-6824-8569; Lee, Robin/0000-0001-7209-3929	Canadian Insitutes of Health Research; Ontario Graduate Scholarship	Canadian Insitutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This study was supported by grants from the Canadian Insitutes of Health Research to L.A.M., R.E.C.L. was supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Brachmann CB, 1998, YEAST, V14, P115; Buttner S, 2006, J CELL BIOL, V175, P521, DOI 10.1083/jcb.200608098; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Coquelle A, 2006, BIOCHEM PHARMACOL, V72, P1396, DOI 10.1016/j.bcp.2006.04.014; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006; Frohlich KU, 2000, FEBS LETT, V473, P6, DOI 10.1016/S0014-5793(00)01474-5; Gilot D, 2005, CARCINOGENESIS, V26, P2086, DOI 10.1093/carcin/bgi187; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Hsu SL, 2006, APOPTOSIS, V11, P765, DOI 10.1007/s10495-006-5880-x; Khan MAS, 2005, P NATL ACAD SCI USA, V102, P17326, DOI 10.1073/pnas.0508120102; Kim M, 2005, MOL CELL BIOL, V25, P9232, DOI 10.1128/MCB.25.21.9232-9248.2005; Koren A, 2006, IUBMB LIFE, V58, P203, DOI 10.1080/15216540600719606; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Li JY, 2007, NAT CELL BIOL, V9, P276, DOI 10.1038/ncb1541; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Ortolan TG, 2004, NUCLEIC ACIDS RES, V32, P6490, DOI 10.1093/nar/gkh987; Sattler M, 1999, BLOOD, V93, P2928; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vachova L, 2007, FEMS YEAST RES, V7, P12, DOI 10.1111/j.1567-1364.2006.00137.x; Verdoodt B, 1999, MUTAGENESIS, V14, P513, DOI 10.1093/mutage/14.5.513; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Wysocki R, 2004, J CELL BIOL, V166, P311, DOI 10.1083/jcb.200405016	33	75	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2956	10.1371/journal.pone.0002956	http://dx.doi.org/10.1371/journal.pone.0002956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698411	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600042
J	Wallis, RH; Collins, SC; Kaisaki, PJ; Argoud, K; Wilder, SP; Wallace, KJ; Ria, M; Ktorza, A; Rorsman, P; Bihoreau, MT; Gauguier, D				Wallis, Robert H.; Collins, Stephan C.; Kaisaki, Pamela J.; Argoud, Karene; Wilder, Steven P.; Wallace, Karin J.; Ria, Massimiliano; Ktorza, Alain; Rorsman, Patrik; Bihoreau, Marie-Therese; Gauguier, Dominique			Pathophysiological, Genetic and Gene Expression Features of a Novel Rodent Model of the Cardio-Metabolic Syndrome	PLOS ONE			English	Article								Background: Complex etiology and pathogenesis of pathophysiological components of the cardio-metabolic syndrome have been demonstrated in humans and animal models. Methodology/Principal Findings: We have generated extensive physiological, genetic and genome-wide gene expression profiles in a congenic strain of the spontaneously diabetic Goto-Kakizaki (GK) rat containing a large region (110 cM, 170 Mb) of rat chromosome 1 (RNO1), which covers diabetes and obesity quantitative trait loci (QTL), introgressed onto the genetic background of the normoglycaemic Brown Norway (BN) strain. This novel disease model, which by the length of the congenic region closely mirrors the situation of a chromosome substitution strain, exhibits a wide range of abnormalities directly relevant to components of the cardio-metabolic syndrome and diabetes complications, including hyperglycaemia, hyperinsulinaemia, enhanced insulin secretion both in vivo and in vitro, insulin resistance, hypertriglyceridemia and altered pancreatic and renal histological structures. Gene transcription data in kidney, liver, skeletal muscle and white adipose tissue indicate that a disproportionately high number (43-83%) of genes differentially expressed between congenic and BN rats map to the GK genomic interval targeted in the congenic strain, which represents less than 5% of the total length of the rat genome. Genotype analysis of single nucleotide polymorphisms (SNPs) in strains genetically related to the GK highlights clusters of conserved and strain-specific variants in RNO1 that can assist the identification of naturally occurring variants isolated in diabetic and hypertensive strains when different phenotype selection procedures were applied. Conclusions: Our results emphasize the importance of rat congenic models for defining the impact of genetic variants in well-characterised QTL regions on in vivo pathophysiological features and cis-/trans-regulation of gene expression. The congenic strain reported here provides a novel and sustainable model for investigating the pathogenesis and genetic basis of risks factors for the cardio-metabolic syndrome.			Wallis, RH (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	gdomi@well.ox.ac.uk	collins, stephan c/P-4409-2016; Rorsman, Patrik/A-4331-2016; Gauguier, Dominique/G-2190-2016	collins, stephan c/0000-0002-1533-3380; Rorsman, Patrik/0000-0001-7578-0767; Gauguier, Dominique/0000-0001-6156-9530; Wilder, Steven/0000-0001-8049-2559	Wellcome Trust Cardiovascular Functional Genomics Initiative [066780]; European Commission [LSHG-CT-2004-005235, LSHG-CT-2005-019015, LSHG-CT-2006-037683]; Wellcome Prize studentships; Swedish Research Council [524-2007-7839]; Wellcome Trust senior fellowship in basic biomedical science [057733]	Wellcome Trust Cardiovascular Functional Genomics Initiative(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Prize studentships; Swedish Research Council(Swedish Research CouncilEuropean Commission); Wellcome Trust senior fellowship in basic biomedical science(Wellcome Trust)	This work is supported by the Wellcome Trust Cardiovascular Functional Genomics Initiative (066780) and grants from the European Commission (STAR, LSHG-CT-2004-005235; EURATools, LSHG-CT-2005-019015; FGENTCARD, LSHG-CT-2006-037683). Part of this work was supported by Wellcome Prize studentships (to Stephan C Collins and Steven P Wilder). Massimiliano.Ria is supported by a postdoctoral fellowship from the Swedish Research Council (524-2007-7839). Dominique Gauguier holds a Wellcome Trust senior fellowship in basic biomedical science (057733).	Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; Brown DM, 1996, NAT GENET, V12, P44, DOI 10.1038/ng0196-44; Chung WK, 1997, GENOMICS, V41, P332, DOI 10.1006/geno.1997.4672; Collins SC, 2003, MAMM GENOME, V14, P350, DOI 10.1007/s00335-002-3058-6; Collins SC, 2006, MAMM GENOME, V17, P538, DOI 10.1007/s00335-005-0168-y; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Galli J, 1999, DIABETES, V48, P2463, DOI 10.2337/diabetes.48.12.2463; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, P1154; Granhall C, 2006, DIABETES, V55, P3494, DOI 10.2337/db06-0796; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Nadeau JH, 2000, NAT GENET, V24, P221, DOI 10.1038/73427; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Rubattu S, 1996, NAT GENET, V13, P429, DOI 10.1038/ng0896-429; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Thams P, 1999, EUR J ENDOCRINOL, V140, P87, DOI 10.1530/eje.0.1400087; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Watanabe TK, 2005, CLIN EXP PHARMACOL P, V32, P355, DOI 10.1111/j.1440-1681.2005.04196.x; Watanabe TK, 1999, GENOMICS, V58, P233, DOI 10.1006/geno.1999.5789	29	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2962	10.1371/journal.pone.0002962	http://dx.doi.org/10.1371/journal.pone.0002962			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698428	gold, Green Published, Green Submitted			2022-12-27	WOS:000264412600047
J	Wang, YH; Campbell, MA				Wang, Yi-Hong; Campbell, Michael A.			Agrobacterium-Mediated Transformation of Tomato Elicits Unexpected Flower Phenotypes with Similar Gene Expression Profiles	PLOS ONE			English	Article							MADS-BOX GENE; T-DNA INSERTION; ARABIDOPSIS-THALIANA; PLANTS; INTEGRATION; ETHYLENE	Background: Genetic transformation mediated by Agrobacterium tumefaciens is known to cause unexpected phenotypes. Mutations of a specific set of homeotic genes can result in alterred floral structure. Methodology/Principal Findings: Previously we identified two genes (LeTGA1 and SOLly GLB1) induced by nutrient availability in tomato. To further elucidate their function, we sought to knock out the genes using antisense RNAi. When antisense constructs for the two different tomato genes were each transformed into Micro-Tina tomato plants, one primary transformant with similar mutant flower phenotypes was identified from transformation of each construct. Microarray analysis shows that a similar set of genes were up- or downregulated in both mutants. Sequencing of insertion sites indicates that each is inserted into a repetitive region which could impact expression of affected genes but direct alteration of floral homeotic gene sequences was not detected. Conclusion: This is the first report that dominant flower mutations could be caused by genetic transformation designed to knock out two nutrient stress related genes.	[Wang, Yi-Hong; Campbell, Michael A.] Penn State Univ, Behrend Coll, Sch Sci, Erie, PA 16563 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Wang, YH (corresponding author), Penn State Univ, Behrend Coll, Sch Sci, Erie, PA 16563 USA.	yxw23@psu.edu	Campbell, Michael A/ABF-1509-2020	Campbell, Michael A/0000-0002-0739-8838	Penn State University Behrend College	Penn State University Behrend College	Penn State University Behrend College. The funders had no role other than financial in the work presented in the manuscript.	Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Ampomah-Dwamena C, 2002, PLANT PHYSIOL, V130, P605, DOI 10.1104/pp.005223; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Chen PY, 2003, MOL BREEDING, V11, P287, DOI 10.1023/A:1023475710642; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Filleur S, 2001, FEBS LETT, V489, P220, DOI 10.1016/S0014-5793(01)02096-8; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaya H, 2000, PLANT CELL PHYSIOL, V41, P1055, DOI 10.1093/pcp/pcd032; Krizek BA, 1996, DEVELOPMENT, V122, P11; Laufs P, 1999, PLANT J, V18, P131, DOI 10.1046/j.1365-313X.1999.00436.x; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Li JG, 2006, BIOCHEM BIOPH RES CO, V341, P1155, DOI 10.1016/j.bbrc.2006.01.077; Mao L, 2000, NATURE, V406, P910, DOI 10.1038/35022611; Mathews H, 2003, PLANT CELL, V15, P1689, DOI 10.1105/tpc.012963; Nacry P, 1998, GENETICS, V149, P641; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Ohta M, 2000, PLANT J, V22, P29, DOI 10.1046/j.1365-313x.2000.00709.x; Ray S, 1997, DEVELOPMENT, V124, P2489; Revenkova E, 1999, EMBO J, V18, P490, DOI 10.1093/emboj/18.2.490; Scott JW, 2000, HORTSCIENCE, V35, P774, DOI 10.21273/HORTSCI.35.4.774; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Somers DA, 2004, CURR OPIN BIOTECH, V15, P126, DOI 10.1016/j.copbio.2004.02.007; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Tzfira T, 2006, CURR OPIN BIOTECH, V17, P147, DOI 10.1016/j.copbio.2006.01.009; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang YH, 2003, PLANT CELL ENVIRON, V26, P673, DOI 10.1046/j.1365-3040.2003.01002.x; Wang YH, 2002, PLANT PHYSIOL, V130, P1361, DOI 10.1104/pp.008854; Wilson A, 2005, NAT BIOTECHNOL, V23, P785, DOI 10.1038/nbt0705-785b; Wilson Allison K, 2006, Biotechnol Genet Eng Rev, V23, P209; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2974	10.1371/journal.pone.0002974	http://dx.doi.org/10.1371/journal.pone.0002974			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698418	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600058
J	Gaillard, C; Borde, C; Gozlan, J; Marechal, V; Strauss, F				Gaillard, Claire; Borde, Chloe; Gozlan, Joel; Marechal, Vincent; Strauss, Francois			A High-Sensitivity Method for Detection and Measurement of HMGB1 Protein Concentration by High-Affinity Binding to DNA Hemicatenanes	PLOS ONE			English	Article								Background: Protein HMGB1, an abundant nuclear non-histone protein that interacts with DNA and has an architectural function in chromatin, was strikingly shown some years ago to also possess an extracellular function as an alarmin and a mediator of inflammation. This extracellular function has since been actively studied, both from a fundamental point of view and in relation to the involvement of HMGB1 in inflammatory diseases. A prerequisite for such studies is the ability to detect HMGB1 in blood or other biological fluids and to accurately measure its concentration. Methodology/Principal Findings: In addition to classical techniques (western blot, ELISA) that make use of specific anti-HMGB1 antibodies, we present here a new, extremely sensitive technique that is based on the fact that hemicatenated DNA loops (hcDNA) bind HMGB1 with extremely high affinity, higher than the affinity of specific antibodies, similar in that respect to DNA aptamers. DNA-protein complexes formed between HMGB1 and radiolabeled hcDNA are analyzed by electrophoresis on nondenaturing polyacrylamide gels using the band-shift assay method. In addition, using a simple and fast protocol to purify HMGB1 on the basis of its solubility in perchloric acid allowed us to increase the sensitivity by suppressing any nonspecific background. The technique can reliably detect HMGB1 at a concentration of 1 pg per microliter in complex fluids such as serum, and at much lower concentrations in less complex samples. It compares favorably with ELISA in terms of sensitivity and background, and is less prone to interference from masking proteins in serum. Conclusion: The new technique, which illustrates the potential of DNA nanoobjects and aptamers to form high-affinity complexes with selected proteins, should provide a valuable tool to further investigate the extracellular functions of HMGB1 and its involvement in inflammatory pathologies.	[Gaillard, Claire; Borde, Chloe; Gozlan, Joel; Marechal, Vincent; Strauss, Francois] Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Gaillard, C (corresponding author), Univ Paris 05, Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France.	francois.strauss@crc.jussieu.fr	marechal, vincent/P-7719-2017; GOZLAN, Joël/P-6014-2017	Strauss, Francois/0000-0003-4327-6827	Sidaction; ANRS; Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement Superieur et de la Recherche [fellowship]	Sidaction; ANRS(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	This work was made possible in part by grants from Sidaction and ANRS. C.G. and F.S. are members of the Centre National de la Recherche Scientifique (CNRS). C.B. is the recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	ADACHI Y, 1990, J CHROMATOGR-BIOMED, V530, P39, DOI 10.1016/S0378-4347(00)82300-2; Angus DC, 2007, CRIT CARE MED, V35, P1061, DOI 10.1097/01.CCM.0000259534.68873.2A; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P46, DOI 10.1189/jlb.1306200; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; GAILLARD C, 1994, SCIENCE, V264, P433, DOI 10.1126/science.8153633; GAILLARD C, 1990, NUCLEIC ACIDS RES, V18, P378, DOI 10.1093/nar/18.2.378; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gaillard C, 2006, J THEOR BIOL, V243, P604, DOI 10.1016/j.jtbi.2006.07.001; Gaillard Claire, 2002, BMC Struct Biol, V2, P7, DOI 10.1186/1472-6807-2-7; GOODWIN GH, 1973, EUR J BIOCHEM, V38, P14, DOI 10.1111/j.1432-1033.1973.tb03026.x; Harlow E., 1988, ANTIBODIES LAB MANUA; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jaouen S, 2005, J MOL BIOL, V353, P822, DOI 10.1016/j.jmb.2005.08.073; Jiang WW, 2005, J LEUKOCYTE BIOL, V78, P930, DOI 10.1189/jlb.0405208; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lyubchenko YL, 2002, NUCLEIC ACIDS RES, V30, P4902, DOI 10.1093/nar/gkf626; MARKHAM AE, 1941, J AM CHEM SOC, V63, P874; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; PARKKINEN J, 1993, J BIOL CHEM, V268, P19726; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; PAULL TT, 1993, GENE DEV, V7, P1521, DOI 10.1101/gad.7.8.1521; PIL PM, 1993, P NATL ACAD SCI USA, V90, P9465, DOI 10.1073/pnas.90.20.9465; Raucci A, 2007, AUTOIMMUNITY, V40, P285, DOI 10.1080/08916930701356978; Ronfani L, 2001, DEVELOPMENT, V128, P1265; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Scopes RK, 1993, PROTEIN PURIFICATION, V3rd; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Stros M, 2004, BIOCHEMISTRY-US, V43, P7215, DOI 10.1021/bi049928k; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Sunden-Cullberg J, 2006, CURR OPIN INFECT DIS, V19, P231, DOI 10.1097/01.qco.0000224816.96986.67; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Ugrinova I, 2007, BIOCHEMISTRY-US, V46, P2111, DOI 10.1021/bi0614479; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Urbonaviciute V, 2007, J LEUKOCYTE BIOL, V81, P67, DOI 10.1189/jlb.0306196; WAGNER JP, 1995, J BIOL CHEM, V270, P7394, DOI 10.1074/jbc.270.13.7394; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Waterer GW, 2007, CRIT CARE MED, V35, P1205, DOI 10.1097/01.CCM.0000259171.54501.B2; Webb M, 2001, J MOL BIOL, V309, P79, DOI 10.1006/jmbi.2001.4667; Yamada S, 2003, CLIN CHEM, V49, P1535, DOI 10.1373/49.9.1535; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yamada S, 2006, CLIN CHIM ACTA, V372, P173, DOI 10.1016/j.cca.2006.04.016; Zimmermann K, 2004, INFLAMMATION, V28, P221, DOI 10.1023/B:IFLA.0000049047.61014.e3	49	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2855	10.1371/journal.pone.0002855	http://dx.doi.org/10.1371/journal.pone.0002855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682735	gold, Green Submitted, Green Published			2022-12-27	WOS:000264366600011
J	Li, YH; Meissle, M; Romeis, J				Li, Yunhe; Meissle, Michael; Romeis, Joerg			Consumption of Bt Maize Pollen Expressing Cry1Ab or Cry3Bb1 Does Not Harm Adult Green Lacewings, Chrysoperla carnea (Neuroptera: Chrysopidae)	PLOS ONE			English	Article								Adults of the common green lacewing, Chrysoperla carnea (Stephens) (Neuroptera: Chrysopidae), are prevalent pollen-consumers in maize fields. They are therefore exposed to insecticidal proteins expressed in the pollen of insect-resistant, genetically engineered maize varieties expressing Cry proteins derived from Bacillus thuringiensis (Bt). Laboratory experiments were conducted to evaluate the impact of Cry3Bb1 or Cry1Ab-expressing transgenic maize (MON 88017, Event Bt176) pollen on fitness parameters of adult C. carnea. Adults were fed pollen from Bt maize varieties or their corresponding near isolines together with sucrose solution for 28 days. Survival, pre-oviposition period, fecundity, fertility and dry weight were not different between Bt or non-Bt maize pollen treatments. In order to ensure that adults of C. carnea are not sensitive to the tested toxins independent from the plant background and to add certainty to the hazard assessment, adult C. carnea were fed with artificial diet containing purified Cry3Bb1 or Cry1Ab at about a 10 times higher concentration than in maize pollen. Artificial diet containing Galanthus nivalis agglutinin (GNA) was included as a positive control. No differences were found in any life-table parameter between Cry protein containing diet treatments and control diet. However, the pre-oviposition period, daily and total fecundity and dry weight of C. carnea were significantly negatively affected by GNA-feeding. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources as well as the uptake by C. carnea was confirmed. These results show that adults of C. carnea are not affected by Bt maize pollen and are not sensitive to Cry1Ab and Cry3Bb1 at concentrations exceeding the levels in pollen. Consequently, Bt maize pollen consumption will pose a negligible risk to adult C. carnea.	[Li, Yunhe; Meissle, Michael; Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Li, YH (corresponding author), Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland.	joerg.romeis@art.admin.ch	Meissle, Michael/C-3127-2009; Romeis, Joerg/J-5360-2013	Meissle, Michael/0000-0002-5391-7715; Romeis, Joerg/0000-0003-3652-8360	National Center of Competence in Research (NCCR); Swiss National Science Foundation	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the National Center of Competence in Research (NCCR) Plant Survival, research program of the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2006, J ECON ENTOMOL, V99, P1085, DOI 10.1603/0022-0493-99.4.1085; Bigler F., 1984, BIOL CHRYSOPIDAE, P233; Blumel S., 2000, GUIDELINES EVALUATE; Brooks S.J., 1994, Bulletin of the Natural History Museum Entomology Series, V63, P137; Corey D, 1998, J KANSAS ENTOMOL SOC, V71, P11; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; Fearing PL, 1997, MOL BREEDING, V3, P169, DOI 10.1023/A:1009611613475; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; GOSS JA, 1968, BOT REV, V34, P333, DOI 10.1007/BF02985391; HAGEN KS, 1970, CAN ENTOMOL, V120, P806; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; Hellmich RL, 2001, P NATL ACAD SCI USA, V98, P11925, DOI 10.1073/pnas.211297698; Hilbeck A, 1998, ENVIRON ENTOMOL, V27, P1255, DOI 10.1093/ee/27.5.1255; Hogervorst PAM, 2007, FUNCT ECOL, V21, P936, DOI 10.1111/j.1365-2435.2007.01297.x; JONES SL, 1977, ANN ENTOMOL SOC AM, V70, P43, DOI 10.1093/aesa/70.1.43; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Lang A, 2006, BASIC APPL ECOL, V7, P296, DOI 10.1016/j.baae.2005.10.003; Lawo NC, 2008, BIOL CONTROL, V44, P389, DOI 10.1016/j.biocontrol.2007.12.002; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; McEwen PK, 2001, LACEWINGS CROP ENV; *MONS CO, 2003, SAF ASS YIELDGARD RO; *MONS CO, 2004, PET DET NONR STAT MO; NEW TR, 1975, T ROY ENT SOC LONDON, V127, P115; Oberhauser KS, 2001, P NATL ACAD SCI USA, V98, P11913, DOI 10.1073/pnas.211234298; Obrist LB, 2006, EXP APPL ACAROL, V38, P125, DOI 10.1007/s10493-006-0008-0; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; PRINCIPI MM, 1984, BIOL CHRYSOPIDAE, P76; Raps A, 2001, MOL ECOL, V10, P525, DOI 10.1046/j.1365-294x.2001.01236.x; Rodrigo-Simon A, 2006, APPL ENVIRON MICROB, V72, P1595, DOI 10.1128/AEM.72.2.1595-1603.2006; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2004, J INSECT PHYSIOL, V50, P175, DOI 10.1016/j.jinsphys.2003.11.004; Romeis Joerg, 2008, V5, P87, DOI 10.1007/978-1-4020-8373-0_4; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Roulston TH, 2000, EVOL ECOL RES, V2, P627; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; SHELDON J K, 1971, Psyche (Cambridge), V78, P107; Stanley RG., 1974, POLLEN, DOI [10.1007/978-3-642-65905-8, DOI 10.1007/978-3-642-65905-8]; SUNDBY R A, 1967, Entomophaga, V12, P475, DOI 10.1007/BF02376933; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; TREU R, 2000, POLLEN DISPERSAL CRO; US EPA (U.S. Environmental Protection Agency), 2001, BIOP REG ACT DOC BAC; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Vaughn T, 2005, CROP SCI, V45, P931, DOI 10.2135/cropsci2004.0304; Vogt H., 2000, Guidelines to evaluate side-effects of plant protection products to non-target arthropods, P27; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; ZEMEK R, 2008, IOBC WPRS B IN PRESS, V33	50	53	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2909	10.1371/journal.pone.0002909	http://dx.doi.org/10.1371/journal.pone.0002909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682800	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600065
J	Faigle, M; Seessle, J; Zug, S; El Kasmi, KC; Eltzschig, HK				Faigle, Marion; Seessle, Jessica; Zug, Stephanie; El Kasmi, Karim C.; Eltzschig, Holger K.			ATP Release from Vascular Endothelia Occurs Across Cx43 Hemichannels and Is Attenuated during Hypoxia	PLOS ONE			English	Article							PROTEIN-KINASE-C; CONNEXIN MIMETIC PEPTIDES; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE RECEPTORS; EXTRACELLULAR ATP; TISSUE-DAMAGE; PROTECTION; GAP; ECTONUCLEOTIDASES; CARDIOPROTECTION	Background: Extracellular ATP is an important signaling molecule for vascular adaptation to limited oxygen availability (hypoxia). Here, we pursued the contribution of vascular endothelia to extracellular ATP release under hypoxic conditions. Methodology, Principal Findings: We gained first insight from studying ATP release from endothelia (HMEC-1) pre-exposed to hypoxia. Surprisingly, we found that ATP release was significantly attenuated following hypoxia exposure (2% oxygen, 22 +/- 3% after 48 h). In contrast, intracellular ATP was unchanged. Similarly, lactate-dehydrogenase release into the supernatants was similar between normoxic or hypoxic endothelia, suggesting that differences in lytic ATP release between normoxia or hypoxia are minimal. Next, we used pharmacological strategies to study potential mechanisms for endothelial-dependent ATP release (eg, verapamil, dipyridamole, 18-alpha-glycyrrhetinic acid, anandamide, connexin-mimetic peptides). These studies revealed that endothelial ATP release occurs-at least in part-through connexin 43 (Cx43) hemichannels. A real-time RT-PCR screen of endothelial connexin expression showed selective repression of Cx43 transcript and additional studies confirmed time-dependent Cx43 mRNA, total and surface protein repression during hypoxia. In addition, hypoxia resulted in Cx43-serine368 phosphorylation, which is known to switch Cx43 hemi-channels from an open to a closed state. Conclusions/Significance: Taken together, these studies implicate endothelial Cx43 in hypoxia-associated repression of endothelial ATP release.	[Faigle, Marion; Seessle, Jessica; Zug, Stephanie; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesia & Intens Care Med, Tubingen, Germany; [El Kasmi, Karim C.; Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Eltzschig, HK (corresponding author), Univ Tubingen Hosp, Dept Anesthesia & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu			German Research Foundation (DFG) [EL274/1, EL274/4]; Foundation for Anesthesia Research and Education	German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation for Anesthesia Research and Education	This work was supported by grants from the German Research Foundation (DFG) (EL274/1 and EL274/4 to (H.K.E.) and the Foundation for Anesthesia Research and Education (H.K.E.).	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Baiu DC, 2008, FASEB J, V22; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; ECKLE T, 2007, BLOOD; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, METH MOL B, V341, P73; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Erlinge D, 2004, AM J PHYSIOL-CELL PH, V287, pC260, DOI 10.1152/ajpcell.00217.2004; Evans WH, 2001, BIOCHEM SOC T, V29, P606, DOI 10.1042/BST0290606; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 1997, GEN PHARMACOL-VASC S, V28, P345, DOI 10.1016/S0306-3623(96)00169-3; Gerasimovskaya EV, 2002, J BIOL CHEM, V277, P44638, DOI 10.1074/jbc.M203012200; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; HART ML, 2008, ARTERIOSCLER THROMB; HART ML, 2008, AM J PHYSL GASTROINT; Huang NK, 2001, J BIOL CHEM, V276, P13838, DOI 10.1074/jbc.M008589200; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Leybaert L, 2003, CELL COMMUN ADHES, V10, P251, DOI 10.1080/15419060390262985; Linden J, 2005, MOL PHARMACOL, V67, P1385, DOI 10.1124/mol.105.011783; Linden J, 2006, SCIENCE, V314, P1689, DOI 10.1126/science.1137190; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; MOROTEGARCIA JC, 2008, BLOOD; Novak I, 2003, NEWS PHYSIOL SCI, V18, P12, DOI 10.1152/nips.01409.2002; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; ROBINSON KA, 1995, ANGIOLOGY, V46, P107, DOI 10.1177/000331979504600203; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; Van Linden A, 2007, EXPERT OPIN BIOL TH, V7, P1437, DOI 10.1517/14712598.7.9.1437; Wang ECY, 2005, J CLIN INVEST, V115, P2412, DOI 10.1172/JCI24086; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Weissmuller Thomas, 2005, Purinergic Signal, V1, P229, DOI 10.1007/s11302-005-6323-9	51	114	115	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2801	10.1371/journal.pone.0002801	http://dx.doi.org/10.1371/journal.pone.0002801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665255	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300020
J	Oh, DY; Jessen, H; Kucherer, C; Neumann, K; Oh, N; Poggensee, G; Bartmeyer, B; Jessen, A; Pruss, A; Schumann, RR; Hamouda, O				Oh, Djin-Ye; Jessen, Heiko; Kuecherer, Claudia; Neumann, Konrad; Oh, Nari; Poggensee, Gabriele; Bartmeyer, Barbara; Jessen, Arne; Pruss, Axel; Schumann, Ralf R.; Hamouda, Osamah			CCR5 Delta 32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5 Delta 32 Homozygous Individual	PLOS ONE			English	Article								Background: Homozygosity (Delta 32/Delta 32) for the 32 bp deletion in the chemokine receptor 5 (CCR5) gene is associated with strong resistance against HIV infection. Heterozygosity is associated with protection of HIV-1 disease progression. Methodology/Principal Findings: We genotyped a population of 737 HIV-positive adults and 463 healthy controls for the CCR5 Delta 32 deletion and found heterozygous frequencies of 16.2% (HIV-negative) and 17.5% (HIV-positive) among Caucasian individuals. Analysis of CCR5 Delta 32 influence on disease progression showed notably lower viral setpoints and a longer time to a CD4 count of <200 mu l(-1) in seroconverters heterozygous for the deletion. Furthermore, we identified one HIV-positive man homozygous for the Delta 32 deletion. Conclusions/Significance: The protective effect of CCR5 Delta 32 heterozygosity is confimed in a large cohort of German seroconverters. The HIV-infected CCR5 Delta 32 homozygous individual, however, displays extremely rapid disease progression. This is the 12th case of HIV-infection in this genotype described worldwide.	[Oh, Djin-Ye; Schumann, Ralf R.] Charite Univ Med Ctr, Inst Microbiol & Hyg, Berlin, Germany; [Jessen, Heiko; Oh, Nari; Jessen, Arne] Gemeinschaftspraxis Jessen Jessen Stein, Berlin, Germany; [Kuecherer, Claudia; Poggensee, Gabriele; Bartmeyer, Barbara; Hamouda, Osamah] Robert Koch Inst, Berlin, Germany; [Neumann, Konrad] Charite Univ Med Ctr, Dept Med Biomet & Clin Epidemiol, Berlin, Germany; [Pruss, Axel] Charite Univ Med Ctr, Inst Transfusion Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Oh, DY (corresponding author), Charite Univ Med Ctr, Inst Microbiol & Hyg, Berlin, Germany.	doh@tuftsmedicalcenter.org	Jessen, Heiko/P-2192-2019	Oh, Djin-Ye/0000-0003-0541-6155	Charite-Universitatsmedizin Berlin; Deutsche Forschungsgemeinschaft (DFG)	Charite-Universitatsmedizin Berlin; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	D.-Y. O. is a recipient of a Rahel Hirsch Grant of the Charite-Universitatsmedizin Berlin. R.R.S. was supported by grants obtained from the Deutsche Forschungsgemeinschaft (DFG).	Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Balotta C, 1997, AIDS, V11, pF67, DOI 10.1097/00002030-199710000-00001; Bhaskaran K, 2004, AIDS, V18, P673, DOI [10.1097/01.aids.0000111464.61782.64, 10.1097/00002030-200403050-00012]; Biti R, 1997, NAT MED, V3, P252, DOI 10.1038/nm0397-252; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; Gorry PR, 2002, LANCET, V359, P1832, DOI 10.1016/S0140-6736(02)08681-6; Gray L, 2006, J VIROL, V80, P3684, DOI 10.1128/JVI.80.7.3684-3691.2006; Heiken H, 1999, AIDS, V13, P529, DOI 10.1097/00002030-199903110-00017; Hendel H, 1998, J ACQ IMMUN DEF SYND, V19, P381, DOI 10.1097/00042560-199812010-00009; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hummel M, 2007, TRANSPL IMMUNOL, V17, P223, DOI 10.1016/j.trim.2006.11.004; Ioannidis JPA, 2003, AIDS, V17, P1631, DOI 10.1097/00002030-200307250-00007; Iversen AKN, 2003, J INFECT DIS, V187, P215, DOI 10.1086/345881; Kaur G, 2007, HUM IMMUNOL, V68, P454, DOI 10.1016/j.humimm.2007.01.016; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Kreisberg JF, 2001, J VIROL, V75, P8842, DOI 10.1128/JVI.75.18.8842-8847.2001; Kristol D.M., 2001, ACM T INTERNET TECHN, V1, P151, DOI [DOI 10.1145/502152.502153, 10.1145/502152.502153]; Kuipers H, 1999, AIDS, V13, P433, DOI 10.1097/00002030-199902250-00025; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marmor M, 2001, J ACQ IMMUN DEF SYND, V27, P472, DOI 10.1097/00126334-200108150-00009; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Masquelier BND, 2005, JAIDS-J ACQ IMM DEF, V40, P505, DOI 10.1097/01.qai.0000186361.42834.61; Michael NL, 1998, J VIROL, V72, P6040, DOI 10.1128/JVI.72.7.6040-6047.1998; Misrahi M, 1998, JAMA-J AM MED ASSOC, V279, P277, DOI 10.1001/jama.279.4.277; Mulherin SA, 2003, AIDS, V17, P377, DOI 10.1097/00002030-200302140-00012; Neifer S, 2006, AIDS, V20, P2231, DOI 10.1097/QAD.0b013e328010ac6f; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; OBrien TR, 1997, LANCET, V349, P1219, DOI 10.1016/S0140-6736(97)24017-1; OH DY, 2008, J INFECT DI IN PRESS; Pasi KJ, 2000, BRIT J HAEMATOL, V111, P136, DOI 10.1046/j.1365-2141.2000.02325.x; Patke DS, 2002, J INFECT DIS, V186, P1177, DOI 10.1086/343811; Philpott S, 1999, J ACQ IMMUN DEF SYND, V21, P189, DOI 10.1097/00126334-199907010-00002; Pillay D, 2006, AIDS, V20, P21, DOI 10.1097/01.aids.0000196172.35056.b7; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Sheppard HW, 2002, J ACQ IMMUN DEF SYND, V29, P307, DOI 10.1097/00126334-200203010-00013; Speelmon EC, 2006, J VIROL, V80, P2463, DOI 10.1128/JVI.80.5.2463-2471.2006; Theodorou I, 1997, LANCET, V349, P1219; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389	46	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2747	10.1371/journal.pone.0002747	http://dx.doi.org/10.1371/journal.pone.0002747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648518	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900018
J	Pastori, C; Librizzi, L; Breschi, GL; Regondi, C; Frassoni, C; Panzica, F; Frigerio, S; Gelati, M; Parati, E; De Simoni, MG; de Curtis, M				Pastori, Chiara; Librizzi, Laura; Breschi, Gian Luca; Regondi, Cristina; Frassoni, Carolina; Panzica, Ferruccio; Frigerio, Simona; Gelati, Maurizio; Parati, Eugenio; De Simoni, Maria Grazia; de Curtis, Marco			Arterially Perfused Neurosphere-Derived Cells Distribute Outside the Ischemic Core in a Model of Transient Focal Ischemia and Reperfusion In Vitro	PLOS ONE			English	Article								Background: Treatment with neural stem cells represents a potential strategy to improve functional recovery of post-ischemic cerebral injury. The potential benefit of such treatment in acute phases of human ischemic stroke depends on the therapeutic viability of a systemic vascular delivery route. In spite of the large number of reports on the beneficial effects of intracerebral stem cells injection in experimental stroke, very few studies demonstrated the effectiveness of the systemic intravenous delivery approach. Metodology/Principal Findings: We utilized a novel in vitro model of transient focal ischemia to analyze the brain distribution of neurosphere-derived cells (NCs) in the early 3 hours that follow transient occlusion of the medial cerebral artery (MCA). NCs obtained from newborn C57/BL6 mice are immature cells with self-renewal properties that could differentiate into neurons, astrocytes and oligodendrocytes. MCA occlusion for 30 minutes in the in vitro isolated guinea pig brain preparation was followed by arterial perfusion with 1 x 10(6) NCs charged with a green fluorescent dye, either immediately or 60 minutes after reperfusion onset. Changes in extracellular pH and K+ concentration during and after MCAO were measured through ion-sensitive electrodes. Conclusion/Significance: It is demonstrated that NCs injected through the vascular system do not accumulate in the ischemic core and preferentially distribute in non-ischemic areas, identified by combined electrophysiological and morphological techniques. Direct measurements of extracellular brain ions during and after MCA occlusion suggest that anoxia-induced tissue changes, such as extracellular acidosis, may prevent NCs from entering the ischemic area in our in vitro model of transitory focal ischemia and reperfusion suggesting a role played by the surrounding microenviroment in driving NCs outside the ischemic core. These findings strongly suggest that the potential beneficial effect of NCs in experimental focal brain ischemia is not strictly dependent on their homing into the ischemic region, but rather through a bystander mechanism possibly mediated by the release of neuroprotective factors in the peri-infarct region.	[Pastori, Chiara; Librizzi, Laura; Breschi, Gian Luca; Regondi, Cristina; Frassoni, Carolina; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unita Neurofisiol & Epilettol Sperimentale, Milan, Italy; [Panzica, Ferruccio] Fdn Ist Neurol Carlo Besta, Unita Neurofisiopatol Epilettol diagnost, Milan, Italy; [Frigerio, Simona; Gelati, Maurizio; Parati, Eugenio] Fdn Ist Neurol Carlo Besta, SDS Neurobiol Terapie Neuroriparat, Milan, Italy; [De Simoni, Maria Grazia] Ist Ric Farmacol Mario Negri, Milan, Italy; [Pastori, Chiara] Univ Milano Bicocca, Neurol Residency Sch, Monza, Italy	IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; IRCCS Istituto Neurologico Besta; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milano-Bicocca	Pastori, C (corresponding author), Fdn Ist Neurol Carlo Besta, Unita Neurofisiol & Epilettol Sperimentale, Milan, Italy.	decurtis@istituto-besta.it	Parati, Eugenio A/G-8765-2011; Frassoni, Carolina CF/J-8337-2016; Gelati, Maurizio/T-4538-2019; de Curtis, Marco M/J-8704-2016; Pastori, Chiara/J-8826-2016; Librizzi, Laura/J-7889-2016; Frigerio, Simona/AAI-3264-2021; De Simoni, Maria Grazia/I-6021-2012; Parati, Eugenio Agostino/AAN-5893-2021; Panzica, Ferruccio/K-6711-2016; Regondi, Maria Cristina/AAJ-5601-2021	Frassoni, Carolina CF/0000-0002-9300-5139; Gelati, Maurizio/0000-0002-4828-9849; de Curtis, Marco M/0000-0001-7443-6737; Pastori, Chiara/0000-0002-9121-5087; Librizzi, Laura/0000-0002-2741-4452; Frigerio, Simona/0000-0001-7078-075X; De Simoni, Maria Grazia/0000-0001-6695-5297; Parati, Eugenio Agostino/0000-0001-5020-6523; Panzica, Ferruccio/0000-0002-0105-943X; Regondi, Maria Cristina/0000-0002-1398-7591; de Curtis, Marco/0000-0002-5608-929X	CARIPLO Foundation [2002.1915/10.4898]; Italian Health Ministry	CARIPLO Foundation(Fondazione Cariplo); Italian Health Ministry(Ministry of Health, Italy)	The study was partially funded by a CARIPLO Foundation grant (N. 2002.1915/10.4898) and by the Italian Health Ministry.	Barone FC, 1999, J CEREBR BLOOD F MET, V19, P819, DOI 10.1097/00004647-199908000-00001; BERNHARDT R, 1984, J COMP NEUROL, V226, P203, DOI 10.1002/cne.902260205; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Cho T, 2002, NEUROREPORT, V13, P1447, DOI 10.1097/00001756-200208070-00020; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Chu K, 2004, BRAIN RES, V1016, P145, DOI 10.1016/j.brainres.2004.04.038; de Curtis M, 1998, J NEUROSCI, V18, P7543; de Curtis M, 1991, Hippocampus, V1, P341, DOI 10.1002/hipo.450010402; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; DELZOPPO GJ, 1994, CEREBROVAS BRAIN MET, V6, P47; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gritti A, 1999, J NEUROSCI, V19, P3287; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jiang FX, 2001, REPROD FERT DEVELOP, V13, P609, DOI 10.1071/RD01059; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kataoka H, 2004, J CEREBR BLOOD F MET, V24, P668, DOI 10.1097/01.WCB.0000117812.35136.5B; KATSURA K, 1994, J CEREBR BLOOD F MET, V14, P243, DOI 10.1038/jcbfm.1994.31; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kempski O, 1990, Adv Neurol, V52, P39; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; KRAIG RP, 1983, J NEUROPHYSIOL, V49, P831, DOI 10.1152/jn.1983.49.3.831; Li Y, 1998, STROKE, V29, P1972, DOI 10.1161/01.STR.29.9.1972; Librizzi L, 2000, NEUROSCIENCE, V101, P283, DOI 10.1016/S0306-4522(00)00365-1; Librizzi L, 2006, NEUROSCIENCE, V137, P1211, DOI 10.1016/j.neuroscience.2005.10.041; Librizzi L, 1999, J COMP NEUROL, V411, P674, DOI 10.1002/(SICI)1096-9861(19990906)411:4<674::AID-CNE11>3.0.CO;2-O; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; LLINAS R, 1981, FED PROC, V40, P2240; Lo KC, 2003, J UROLOGY, V170, P2453, DOI 10.1097/01.ju.0000087170.97532.ff; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mazzetti S, 2004, BRAIN RES, V999, P81, DOI 10.1016/j.brainres.2003.11.032; Meairs S, 2006, CEREBROVASC DIS, V22, P75, DOI 10.1159/000093098; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P131, DOI 10.1007/BF00693778; PALJARVI L, 1983, ACTA NEUROPATHOL, V60, P232, DOI 10.1007/BF00691871; Pastori C, 2007, EXP NEUROL, V204, P95, DOI 10.1016/j.expneurol.2006.09.023; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Pluchino S, 2005, J NEUROL SCI, V233, P117, DOI 10.1016/j.jns.2005.03.026; PLUM F, 1983, NEUROLOGY, V33, P222, DOI 10.1212/WNL.33.2.222; Savitz Sean I, 2004, NeuroRx, V1, P406; Umegaki M, 2005, J NEUROSCI, V25, P1387, DOI 10.1523/JNEUROSCI.4182-04.2005; VANHARREVELD A, 1953, AM J PHYSIOL, V173, P171, DOI 10.1152/ajplegacy.1953.173.1.171; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; Wong D, 1999, J NEUROPATH EXP NEUR, V58, P138, DOI 10.1097/00005072-199902000-00004; YOUNG JN, 1992, BRAIN RES, V573, P70, DOI 10.1016/0006-8993(92)90114-O	53	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2754	10.1371/journal.pone.0002754	http://dx.doi.org/10.1371/journal.pone.0002754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648648	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900024
J	Aidoudi, S; Bujakowska, K; Kieffer, N; Bikfalvi, A				Aidoudi, Sallouha; Bujakowska, Kinga; Kieffer, Nelly; Bikfalvi, Andreas			The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis	PLOS ONE			English	Article								The human CXC-chemokine CXCL4 is a potent inhibitor of tumor-induced angiogenesis. Considering that CXCL4 is sequestered in platelet alpha-granules and released following platelet activation in the vicinity of vessel wall injury, we tested the hypothesis that CXCL4 might function as a ligand for integrins. Integrins are a family of adhesion receptors that play a crucial role in angiogenesis by regulating early angiogenic processes, such as endothelial cell adhesion and migration. Here, we show that CXCL4 interacts with alpha v beta 3 on the surface of alpha v beta 3-CHO. More importantly, human umbilical vein endothelial cells adhere to immobilized CXCL4 through alpha v beta 3 integrin, and also through other integrins, such as alpha v beta 5 and alpha 5 beta 1. We further demonstrate that CXCL4-integrin interaction is of functional significance in vitro, since immobilized CXCL4 supported endothelial cell spreading and migration in an integrin-dependent manner. Soluble CXCL4, in turn, inhibits integrin-dependent endothelial cell adhesion and migration. As a whole, our study identifies integrins as novel receptors for CXCL4 that may contribute to its antiangiogenic effect.	[Aidoudi, Sallouha; Bujakowska, Kinga; Bikfalvi, Andreas] INSERM, U920, Talence, France; [Aidoudi, Sallouha; Bujakowska, Kinga; Bikfalvi, Andreas] Univ Bordeaux, Talence, France; [Kieffer, Nelly] Univ Luxembourg, Lab Biol Physiol Integree, CNRS GDRE ITI, Luxembourg, Luxembourg	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Luxembourg	Aidoudi, S (corresponding author), INSERM, U920, Talence, France.	salouaaidoudi@yahoo.fr; a.bikfalvi@angio.u-bordeaux1.fr	Bujakowska, Kinga Maria/AGL-1293-2022	Bujakowska, Kinga/0000-0001-6809-9818	Agence Nationale de la Recherche (ANR); National French Cancer Institute (INCA); Ligue Nationale du Cancer; Association pour la Recherche sur le Cancer (ARC)	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); National French Cancer Institute (INCA)(Institut National du Cancer (INCA) France); Ligue Nationale du Cancer; Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work has been supported by grants from the Agence Nationale de la Recherche (ANR), the National French Cancer Institute (INCA), the Ligue Nationale du Cancer and the Association pour la Recherche sur le Cancer (ARC) to A.B. The sponsors had no role in designing the study or approving the manuscript.	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Ashton AW, 2004, CIRC RES, V94, P735, DOI 10.1161/01.RES.0000122043.11286.57; Bello L, 2002, CLIN CANCER RES, V8, P3539; Borgstrom P, 1998, ANTICANCER RES, V18, P4035; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De S, 2005, P NATL ACAD SCI USA, V102, P7589, DOI 10.1073/pnas.0502935102; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; FUKAMI MH, 2001, HEMOSTASIS THROMBOSI, P561; Gao J, 1997, EMBO J, V16, P6414, DOI 10.1093/emboj/16.21.6414; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Gentilini G, 1999, BLOOD, V93, P25, DOI 10.1182/blood.V93.1.25.401a47_25_33; Hagedorn M, 2001, FASEB J, V15, P550; HANSELL P, 1995, AM J PHYSIOL, V269, P829; Hsu AR, 2007, RECENT PAT ANTI-CANC, V2, P143, DOI 10.2174/157489207780832469; Humphries MJ, 1996, CURR OPIN CELL BIOL, V8, P632, DOI 10.1016/S0955-0674(96)80104-9; Jouan V, 1999, BLOOD, V94, P984, DOI 10.1182/blood.V94.3.984.415k31_984_993; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; KOLBER DL, 1995, J NATL CANCER I, V87, P304, DOI 10.1093/jnci/87.4.304; Lasagni L, 2003, J EXP MED, V197, P1537, DOI 10.1084/jem.20021897; LEAVESLEY DI, 1993, J CELL BIOL, V121, P163, DOI 10.1083/jcb.121.1.163; LEVINE SP, 1976, J BIOL CHEM, V251, P324; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; Maeshima Y, 2002, SCIENCE, V295, P140, DOI 10.1126/science.1065298; Magnon C, 2005, CANCER RES, V65, P4353, DOI 10.1158/0008-5472.CAN-04-3536; MAIONE TE, 1991, CANCER RES, V51, P2077; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; SATO Y, 1990, BIOCHEM BIOPH RES CO, V172, P595, DOI 10.1016/0006-291X(90)90715-Y; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; Shiraga M, 1999, J CELL BIOL, V147, P1419, DOI 10.1083/jcb.147.7.1419; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Sudhakar A, 2005, J CLIN INVEST, V115, P2801, DOI 10.1172/JCI24813; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Sulpice E, 2004, EUR J BIOCHEM, V271, P3310, DOI 10.1111/j.1432-1033.2004.04263.x; Tanaka T, 1997, NAT MED, V3, P437, DOI 10.1038/nm0497-437; Trikha M, 2002, CANCER RES, V62, P2824; VUORI K, 1993, J BIOL CHEM, V268, P21459; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Yoshida A, 1996, GROWTH FACTORS, V13, P57, DOI 10.3109/08977199609034566	54	35	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2657	10.1371/journal.pone.0002657	http://dx.doi.org/10.1371/journal.pone.0002657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648521	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200003
J	Sanjuan, R; Nebot, MR				Sanjuan, Rafael; Nebot, Miguel R.			A Network Model for the Correlation between Epistasis and Genomic Complexity	PLOS ONE			English	Article								The study of genetic interactions (epistasis) is central to the understanding of genome organization and evolution. A general correlation between epistasis and genomic complexity has been recently shown, such that in simpler genomes epistasis is antagonistic on average (mutational effects tend to cancel each other out), whereas a transition towards synergistic epistasis occurs in more complex genomes (mutational effects strengthen each other). Here, we use a simple network model to identify basic features explaining this correlation. We show that, in small networks with multifunctional nodes, lack of redundancy, and absence of alternative pathways, epistasis is antagonistic on average. In contrast, lack of multi-functionality, high connectivity, and redundancy favor synergistic epistasis. Moreover, we confirm the previous finding that epistasis is a covariate of mutational robustness: in less robust networks it tends to be antagonistic whereas in more robust networks it tends to be synergistic. We argue that network features associated with antagonistic epistasis are typically found in simple genomes, such as those of viruses and bacteria, whereas the features associated with synergistic epistasis are more extensively exploited by higher eukaryotes.	[Sanjuan, Rafael] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain; [Sanjuan, Rafael] Univ Valencia, Dept Genet, Valencia, Spain; [Sanjuan, Rafael] Inst Biol Mol Celular Plantas CSIC UPV, Valencia, Spain; [Nebot, Miguel R.] Inst Superior Tecn, Ctr Fis Teorica Parteculas CFTP, Lisbon, Portugal; [Nebot, Miguel R.] Univ Studi Roma Tre, Dipartimento Fis Edoardo Amaldi, Sezione Roma Tre, Ist Nazl Fis Nucleare INFN, Rome, Italy	University of Valencia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Universidade de Lisboa; Istituto Nazionale di Fisica Nucleare (INFN); Roma Tre University	Sanjuan, R (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolutiva, Valencia, Spain.	rafael.sanjuan@uv.es		Sanjuan, Rafael/0000-0002-1844-545X; Nebot Gomez, Miguel/0000-0001-9292-7855	Spanish Generalitat Valenciana [GV06/031]; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal); CFTP-FCT UNIT 777 Heptools network [MRTN-CT-2006-035505];  [PDCT/FP/63912/2005];  [PDCT/FP/63914/2005]	Spanish Generalitat Valenciana; Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); CFTP-FCT UNIT 777 Heptools network; ; 	Spanish Generalitat Valenciana (grant GV06/031) Fundacao para a Ciencia e a Tecnologia (FCT, Portugal), projects PDCT/FP/63912/2005, PDCT/FP/63914/2005, CFTP-FCT UNIT 777 Heptools network MRTN-CT-2006-035505	Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrett CL, 2005, P NATL ACAD SCI USA, V102, P19103, DOI 10.1073/pnas.0505231102; Belshaw R, 2008, TRENDS ECOL EVOL, V23, P188, DOI 10.1016/j.tree.2007.11.010; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Bruggeman FJ, 2000, BIOL CHEM, V381, P965, DOI 10.1515/BC.2000.119; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; BUTCHER D, 1995, GENETICS, V141, P431; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Cork JM, 2004, BIOESSAYS, V26, P479, DOI 10.1002/bies.20026; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; DeWinter W, 1997, BIOL PHILOS, V12, P149, DOI 10.1023/A:1006590002756; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Edlund JA, 2004, ARTIF LIFE, V10, P167, DOI 10.1162/106454604773563595; Frank SA, 1999, J THEOR BIOL, V197, P281, DOI 10.1006/jtbi.1998.0872; Freilich S, 2005, J MOL BIOL, V349, P745, DOI 10.1016/j.jmb.2005.04.027; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Holmes EC, 2003, TRENDS MICROBIOL, V11, P543, DOI 10.1016/j.tim.2003.10.006; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; KACSER H, 1984, J MOL EVOL, V20, P38, DOI 10.1007/BF02101984; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1991, NATURE, V351, P314, DOI 10.1038/351314a0; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2002, SCIENCE, V297, P945, DOI 10.1126/science.1075472; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Omholt SW, 2000, GENETICS, V155, P969; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Sanjuan R, 2006, MOL BIOL EVOL, V23, P2123, DOI 10.1093/molbev/msl083; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner GP, 1998, GENETICA, V102-3, P569, DOI 10.1023/A:1017088321094; Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wolf J.B., 2000, EPISTASIS EVOLUTIONA; Wright S., 1968, GENETIC BIOMETRIC FD	49	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2663	10.1371/journal.pone.0002663	http://dx.doi.org/10.1371/journal.pone.0002663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648534	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200009
J	Cironi, L; Riggi, N; Provero, P; Wolf, N; Suva, ML; Suva, D; Kindler, V; Stamenkovic, I				Cironi, Luisa; Riggi, Nicolo; Provero, Paolo; Wolf, Natalie; Suva, Mario-Luca; Suva, Domizio; Kindler, Vincent; Stamenkovic, Ivan			IGF1 Is a Common Target Gene of Ewing's Sarcoma Fusion Proteins in Mesenchymal Progenitor Cells	PLOS ONE			English	Article								Background: The EWS-FLI-1 fusion protein is associated with 85-90% of Ewing's sarcoma family tumors (ESFT), the remaining 10-15% of cases expressing chimeric genes encoding EWS or FUS fused to one of several ets transcription factor family members, including ERG-1, FEV, ETV1 and ETV6. ESFT are dependent on insulin-like growth factor-1 (IGF-1) for growth and survival and recent evidence suggests that mesenchymal progenitor/stem cells constitute a candidate ESFT origin. Methodology/Principal Findings: To address the functional relatedness between ESFT-associated fusion proteins, we compared mouse progenitor cell (MPC) permissiveness for EWS-FLI-1, EWS-ERG and FUS-ERG expression and assessed the corresponding expression profile changes. Whereas all MPC isolates tested could stably express EWS-FLI-1, only some sustained stable EWS- ERG expression and none could express FUS-ERG for more than 3-5 days. Only 14% and 4% of the total number of genes that were respectively induced and repressed in MPCs by the three fusion proteins were shared. However, all three fusion proteins, but neither FLI-1 nor ERG-1 alone, activated the IGF1 promoter and induced IGF1 expression. Conclusion/Significance: Whereas expression of different ESFT-associated fusion proteins may require distinct cellular microenvironments and induce transcriptome changes of limited similarity, IGF1 induction may provide one common mechanism for their implication in ESFT pathogenesis.	[Cironi, Luisa; Riggi, Nicolo; Wolf, Natalie; Suva, Mario-Luca; Stamenkovic, Ivan] Univ Lausanne, CHUV, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland; [Provero, Paolo] Univ Turin, Dept Biol Genet & Biochem, Turin, Italy; [Suva, Domizio; Kindler, Vincent] Univ Geneva, Univ Hosp, Dept Orthoped, Geneva, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Turin; University of Geneva	Cironi, L (corresponding author), Univ Lausanne, CHUV, Inst Pathol, Div Expt Pathol, Lausanne, Switzerland.	Ivan.Stamenkovic@chuv.ch	Provero, Paolo/AAC-1930-2019; Suva, Mario/AAY-7798-2020	Suva, Mario/0000-0001-9898-5351; Kindler, Vincent/0000-0002-5349-1857	SNSF [3100A0-105833]; OCS [01656-02-2005]; NCCR Molecular Oncology	SNSF(Swiss National Science Foundation (SNSF)); OCS; NCCR Molecular Oncology(Swiss National Science Foundation (SNSF))	This work was supported by SNSF grant 3100A0-105833, OCS grant 01656-02-2005 and the NCCR Molecular Oncology.	Alfieri CM, 2007, AM J PHYSIOL-CELL PH, V292, pC1887, DOI 10.1152/ajpcell.00506.2006; Araya N, 2003, J BIOL CHEM, V278, P5427, DOI 10.1074/jbc.M210234200; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Baird K, 2005, CANCER RES, V65, P9226, DOI 10.1158/0008-5472.CAN-05-1699; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Deneen B, 2001, ONCOGENE, V20, P6731, DOI 10.1038/sj.onc.1204875; Gascoyne DM, 2004, ONCOGENE, V23, P3830, DOI 10.1038/sj.onc.1207497; Gerald WL, 2005, SEMIN CANCER BIOL, V15, P197, DOI 10.1016/j.semcancer.2005.01.005; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Knoop LL, 2000, J BIOL CHEM, V275, P24865, DOI 10.1074/jbc.M001661200; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; LESSNICK SL, 1995, ONCOGENE, V10, P423; May WA, 1997, NAT GENET, V17, P495, DOI 10.1038/ng1297-495; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mittanck DW, 1997, MOL CELL ENDOCRINOL, V126, P153, DOI 10.1016/S0303-7207(96)03979-2; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Scherf M, 2000, J MOL BIOL, V297, P599, DOI 10.1006/jmbi.2000.3589; Scotlandi K, 2005, CANCER RES, V65, P3868, DOI 10.1158/0008-5472.CAN-04-3192; Scotlandi K, 1998, CANCER RES, V58, P4127; Scotlandi K, 2002, INT J CANCER, V101, P11, DOI 10.1002/ijc.10537; Shing DC, 2003, CANCER RES, V63, P4568; Suva D, 2004, J CELL PHYSIOL, V198, P110, DOI 10.1002/jcp.10396; SUVA D, 2007, J CELL PHYSL; Thompson AD, 1999, ONCOGENE, V18, P5506, DOI 10.1038/sj.onc.1202928; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toretsky JA, 1997, J BIOL CHEM, V272, P30822, DOI 10.1074/jbc.272.49.30822; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Wynes MW, 2005, AM J PHYSIOL-LUNG C, V288, pL1089, DOI 10.1152/ajplung.00352.2004; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Zhang D, 1998, J BIOL CHEM, V273, P18086, DOI 10.1074/jbc.273.29.18086; Zwerner JP, 2003, EXP CELL RES, V290, P414, DOI 10.1016/S0014-4827(03)00371-9	39	82	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2634	10.1371/journal.pone.0002634	http://dx.doi.org/10.1371/journal.pone.0002634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648544	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800036
J	Galgano, A; Forrer, M; Jaskiewicz, L; Kanitz, A; Zavolan, M; Gerber, AP				Galgano, Alessia; Forrer, Michael; Jaskiewicz, Lukasz; Kanitz, Alexander; Zavolan, Mihaela; Gerber, Andre P.			Comparative Analysis of mRNA Targets for Human PUF Family Proteins Suggests Extensive Interaction with the miRNA Regulatory System	PLOS ONE			English	Article							BINDING PROTEIN; GENOME-WIDE; POSTTRANSCRIPTIONAL REGULATION; MITOCHONDRIAL BIOGENESIS; TRANSLATIONAL REPRESSION; MOLECULAR-MECHANISMS; HUMAN PUMILIO-2; STEM-CELLS; RIP-CHIP; GENE	Genome-wide identification of mRNAs regulated by RNA-binding proteins is crucial to uncover post-transcriptional gene regulatory systems. The conserved PUF family RNA-binding proteins repress gene expression post-transcriptionally by binding to sequence elements in 39-UTRs of mRNAs. Despite their well-studied implications for development and neurogenesis in metazoa, the mammalian PUF family members are only poorly characterized and mRNA targets are largely unknown. We have systematically identified the mRNAs associated with the two human PUF proteins, PUM1 and PUM2, by the recovery of endogenously formed ribonucleoprotein complexes and the analysis of associated RNAs with DNA microarrays. A largely overlapping set comprised of hundreds of mRNAs were reproducibly associated with the paralogous PUM proteins, many of them encoding functionally related proteins. A characteristic PUF-binding motif was highly enriched among PUM bound messages and validated with RNA pull-down experiments. Moreover, PUF motifs as well as surrounding sequences exhibit higher conservation in PUM bound messages as opposed to transcripts that were not found to be associated, suggesting that PUM function may be modulated by other factors that bind conserved elements. Strikingly, we found that PUF motifs are enriched around predicted miRNA binding sites and that high-confidence miRNA binding sites are significantly enriched in the 39-UTRs of experimentally determined PUM1 and PUM2 targets, strongly suggesting an interaction of human PUM proteins with the miRNA regulatory system. Our work suggests extensive connections between the RBP and miRNA post-transcriptional regulatory systems and provides a framework for deciphering the molecular mechanism by which PUF proteins regulate their target mRNAs.	[Galgano, Alessia; Forrer, Michael; Kanitz, Alexander; Gerber, Andre P.] ETH, Inst Pharmaceut Sci, Zurich, Switzerland; [Jaskiewicz, Lukasz; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Galgano, A (corresponding author), ETH, Inst Pharmaceut Sci, Zurich, Switzerland.	andre.gerber@pharma.ethz.ch	Zavolan, Mihaela/S-3888-2016; Kanitz, Alexander/AAG-7842-2021	Kanitz, Alexander/0000-0002-3468-0652; Zavolan, Mihaela/0000-0002-8832-2041	SNF [3100A0-114001]; Bonizzi-Theler Foundation; International Human Frontier Science Program Organization (HFSP) [CDA0048/2005]	SNF; Bonizzi-Theler Foundation; International Human Frontier Science Program Organization (HFSP)(Human Frontier Science Program)	L.J. was supported by SNF grant #3100A0-114001 to M.Z. A.K. was supported by a grant from the Bonizzi-Theler Foundation to A.P.G. A.P.G. is the recipient of a Career Development Award (CDA0048/2005) from the International Human Frontier Science Program Organization (HFSP).	Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580; Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478; Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forbes A, 1998, DEVELOPMENT, V125, P679; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; George Ajish D, 2006, RNA Biol, V3, P57; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100; Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gupta YK, 2008, STRUCTURE, V16, P549, DOI 10.1016/j.str.2008.01.006; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; Lin HF, 1997, DEVELOPMENT, V124, P2463; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54; Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Miller MT, 2008, NAT STRUCT MOL BIOL, V15, P397, DOI 10.1038/nsmb.1390; Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08; Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urano J, 2005, MOL REPROD DEV, V71, P290, DOI 10.1002/mrd.20270; van Nimwegen E, 2006, PLOS GENET, V2, P587, DOI 10.1371/journal.pgen.0020024; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054; Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17	80	203	205	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3164	10.1371/journal.pone.0003164	http://dx.doi.org/10.1371/journal.pone.0003164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776931	gold, Green Published, Green Submitted			2022-12-27	WOS:000264424300008
J	Lindell, DM; Berlin, AA; Schaller, MA; Lukacs, NW				Lindell, Dennis M.; Berlin, Aaron A.; Schaller, Matthew A.; Lukacs, Nicholas W.			B Cell Antigen Presentation Promotes Th2 Responses and Immunopathology during Chronic Allergic Lung Disease	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INDUCED AIRWAY HYPERRESPONSIVENESS; DENDRITIC CELLS; T-CELL; IN-VIVO; ASTHMA; IL-4; INFLAMMATION; MICE; LYMPHOCYTES	Background: The role of B cells in allergic asthma remains undefined. One mechanism by which B cells clearly contribute to allergic disease is via the production of specific immunoglobulin, and especially IgE. Cognate interactions with specific T cells result in T cell help for B cells, resulting in differentiation and immunoglobulin secretion. Proximal to (and required for) T cell-dependent immunoglobulin production, however, is antigen presentation by B cells. While interaction with T cells clearly has implications for B cell function and differentiation, this study investigated the role that B cells have in shaping the T cell response during chronic allergic lung disease. Methodology/Principal Findings: In these studies, we used a clinically relevant mouse model of chronic allergic lung disease to study the role of B cells and B cell antigen presentation in this disease. In these studies we present several novel findings: 1) Lung B cells from chronically allergen challenged mice up-regulated MHC II and costimulatory molecules CD40, CD80 and CD86. 2) Using in vitro studies, B cells from the lungs of allergen challenged mice could present antigen to T cells, as assessed by T cell proliferation and the preferential production of Th2 cytokines. 3) Following chronic allergen challenge, the levels of Th2 cytokines IL-4 and IL-5 in the lungs and airways were significantly attenuated in B cell -/- mice, relative to controls. 4) B cell driven Th2 responses and mucus hyper secretion in the lungs were dependent upon MHC II expression by B cells. Conclusions/Significance: Collectively, these results provide evidence for antigen presentation as a novel mechanism by which B cells contribute to chronic allergic disease. These findings give new insight into the mechanisms by which B cells promote asthma and other chronic diseases.	[Lindell, Dennis M.; Berlin, Aaron A.; Schaller, Matthew A.; Lukacs, Nicholas W.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lindell, DM (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	denmklin@umich.edu	Schaller, Matthew/AAL-7640-2020; Lukacs, Nicholas W/ABH-5583-2020		National Institutes of Health [HL031963, HL059178, T32HL007749]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059178, T32HL007749, P01HL031963] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL031963, HL059178 (NWL), and T32HL007749 (DML). The sponsors played no role in the design, conduct, collection, analysis, interpretation, review, or approval of the manuscript.	ABERG N, 1995, CLIN EXP ALLERGY, V25, P815, DOI 10.1111/j.1365-2222.1995.tb00023.x; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Arnaboldi PM, 2005, J IMMUNOL, V175, P1276, DOI 10.4049/jimmunol.175.2.1276; Bandukwala HS, 2007, J EXP MED, V204, P1875, DOI 10.1084/jem.20061134; Berlin AA, 2006, LAB INVEST, V86, P557, DOI 10.1038/labinvest.3700419; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Christensen JP, 2003, J IMMUNOL, V171, P4733, DOI 10.4049/jimmunol.171.9.4733; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; DEBRUIJN MLH, 1992, EUR J IMMUNOL, V22, P3013, DOI 10.1002/eji.1830221137; Garcia-Marcos L, 2004, ALLERGY, V59, P1301, DOI 10.1111/j.1398-9995.2004.00562.x; Gosman MME, 2006, EUR RESPIR J, V27, P60, DOI 10.1183/09031936.06.00007005; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guery JC, 1996, J EXP MED, V183, P751, DOI 10.1084/jem.183.3.751; GUERY JC, 1995, J IMMUNOL, V154, P536; Haczku A, 1999, AM J RESP CRIT CARE, V159, P1638, DOI 10.1164/ajrccm.159.5.9711040; Hamelmann E, 1999, AM J RESP CELL MOL, V21, P480, DOI 10.1165/ajrcmb.21.4.3659; Harris DP, 2005, J IMMUNOL, V175, P7103, DOI 10.4049/jimmunol.175.11.7103; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hashimoto K, 2005, J ALLERGY CLIN IMMUN, V116, P550, DOI 10.1016/j.jaci.2005.03.051; Hashimoto K, 2004, AM J RESP CRIT CARE, V170, P306, DOI 10.1164/rccm.200301-030OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Inoue S, 2006, CANCER RES, V66, P7741, DOI 10.1158/0008-5472.CAN-05-3766; John AE, 2005, EUR J IMMUNOL, V35, P108, DOI 10.1002/eji.200425439; Kitamura K, 2007, J IMMUNOL, V178, P480, DOI 10.4049/jimmunol.178.1.480; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; LACK C, 1995, AM J RESP CRIT CARE, V152, P1765, DOI 10.1164/ajrccm.152.6.8520735; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; LEVIN D, 1993, J IMMUNOL, V151, P6742; Linton PJ, 2003, J EXP MED, V197, P875, DOI 10.1084/jem.20021290; Lund FE, 2006, J IMMUNOL, V176, P6147, DOI 10.4049/jimmunol.176.10.6147; Lundy SK, 2005, INFLAMM RES, V54, P514, DOI 10.1007/s00011-005-1387-0; Lundy SK, 2005, J IMMUNOL, V174, P2054, DOI 10.4049/jimmunol.174.4.2054; Macaubas Claudia, 2003, Current Drug Targets - Inflammation and Allergy, V2, P175, DOI 10.2174/1568010033484304; Martinez-Gamboa L, 2006, AUTOIMMUN REV, V5, P437, DOI 10.1016/j.autrev.2006.02.004; Masten BJ, 1999, J IMMUNOL, V162, P1310; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Miller AL, 2003, J IMMUNOL, V170, P3348, DOI 10.4049/jimmunol.170.6.3348; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Noorchashm H, 2006, J IMMUNOL, V177, P7715, DOI 10.4049/jimmunol.177.11.7715; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Renz H, 2002, EUR RESPIR J, V19, P158, DOI 10.1183/09031936.02.00254202; Schaller MA, 2005, EUR J IMMUNOL, V35, P2061, DOI 10.1002/eji.200425715; Schaller MA, 2008, AM J PATHOL, V172, P386, DOI 10.2353/ajpath.2008.070537; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Smit JJ, 2007, AM J PATHOL, V171, P1944, DOI 10.2353/ajpath.2007.070578; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Tomkinson A, 2001, J IMMUNOL, V166, P5792, DOI 10.4049/jimmunol.166.9.5792; Tournoy KG, 2001, J IMMUNOL, V166, P6982, DOI 10.4049/jimmunol.166.11.6982; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; Venkayya R, 2002, AM J RESP CELL MOL, V26, P202, DOI 10.1165/ajrcmb.26.2.4600; von Mutius E, 1998, LANCET, V351, P862, DOI 10.1016/S0140-6736(97)10100-3; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Watanabe T, 2004, AM J RESP CRIT CARE, V169, P105, DOI 10.1164/rccm.200302-239OC; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Yu P, 2002, J IMMUNOL, V168, P5117, DOI 10.4049/jimmunol.168.10.5117; Zhong GM, 1997, J EXP MED, V186, P673, DOI 10.1084/jem.186.5.673; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu J, 2007, AM J RESP CRIT CARE, V175, P1125, DOI 10.1164/rccm.200602-161OC; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561	66	58	58	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3129	10.1371/journal.pone.0003129	http://dx.doi.org/10.1371/journal.pone.0003129			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769622	Green Published, gold, Green Submitted			2022-12-27	WOS:000264418300010
J	Hennig, P; Moller, R; Egelhaaf, M				Hennig, Patrick; Moeller, Ralf; Egelhaaf, Martin			Distributed Dendritic Processing Facilitates Object Detection: A Computational Analysis on the Visual System of the Fly	PLOS ONE			English	Article							FIGURE-GROUND DISCRIMINATION; MOTION SENSITIVE INTERNEURONS; NEURONAL BASIS; RELATIVE MOTION; SUPERIOR COLLICULUS; SENSORY ANALYZER; OPTOMOTOR SYSTEM; HORIZONTAL CELLS; RECEPTIVE-FIELD; LOBULA PLATE	Background: Detecting objects is an important task when moving through a natural environment. Flies, for example, may land on salient objects or may avoid collisions with them. The neuronal ensemble of Figure Detection cells (FD-cells) in the visual system of the fly is likely to be involved in controlling these behaviours, as these cells are more sensitive to objects than to extended background structures. Until now the computations in the presynaptic neuronal network of FD-cells and, in particular, the functional significance of the experimentally established distributed dendritic processing of excitatory and inhibitory inputs is not understood. Methodology/Principal Findings: We use model simulations to analyse the neuronal computations responsible for the preference of FD-cells for small objects. We employed a new modelling approach which allowed us to account for the spatial spread of electrical signals in the dendrites while avoiding detailed compartmental modelling. The models are based on available physiological and anatomical data. Three models were tested each implementing an inhibitory neural circuit, but differing by the spatial arrangement of the inhibitory interaction. Parameter optimisation with an evolutionary algorithm revealed that only distributed dendritic processing satisfies the constraints arising from electrophysiological experiments. In contrast to a direct dendro-dendritic inhibition of the FD-cell (Direct Distributed Inhibition model), an inhibition of its presynaptic retinotopic elements (Indirect Distributed Inhibition model) requires smaller changes in input resistance in the inhibited neurons during visual stimulation. Conclusions/Significance: Distributed dendritic inhibition of retinotopic elements as implemented in our Indirect Distributed Inhibition model is the most plausible wiring scheme for the neuronal circuit of FD-cells. This microcircuit is computationally similar to lateral inhibition between the retinotopic elements. Hence, distributed inhibition might be an alternative explanation of perceptual phenomena currently explained by lateral inhibition networks.	[Hennig, Patrick] Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany; [Moeller, Ralf] Univ Bielefeld, Ctr Excellence, Dept Comp Engn, D-4800 Bielefeld, Germany; [Egelhaaf, Martin] Univ Bielefeld, Ctr Excellence, Dept Neurobiol, Fak Biol, D-4800 Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Hennig, P (corresponding author), Univ Bielefeld, Dept Neurobiol, Bielefeld, Germany.	phennig@uni-bielefeld.de	Möller, Ralf/B-9717-2017; Egelhaaf, Martin/A-9824-2010	Egelhaaf, Martin/0000-0002-9336-4270; Moller, Ralf/0000-0001-7389-3696	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Barnett PD, 2007, CURR BIOL, V17, P569, DOI 10.1016/j.cub.2007.02.039; Bekesy GV, 1967, SENSORY INHIBITION; BORST A, 1993, BRAIN THEORY, P47; COLLETT T, 1972, J COMP PHYSIOL, V78, P396, DOI 10.1007/BF01417943; COLLETT T, 1971, NATURE, V232, P127, DOI 10.1038/232127a0; Collett T., 1975, P437; Cuntz H, 2003, P NATL ACAD SCI USA, V100, P11082, DOI 10.1073/pnas.1830705100; DAVIDSON RM, 1991, J NEUROPHYSIOL, V65, P1115, DOI 10.1152/jn.1991.65.5.1115; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; EGELHAAF M, 1993, J NEUROPHYSIOL, V69, P340, DOI 10.1152/jn.1993.69.2.340; EGELHAAF M, 1985, BIOL CYBERN, V52, P195; EGELHAAF M, 1985, BIOL CYBERN, V52, P123, DOI 10.1007/BF00364003; EGELHAAF M, 1993, VISUAL MOTION ITS RO; Egelhaaf M, 2006, INVERTEBRATE VISION, P399; FROST BJ, 1988, J COMP PHYSIOL A, V162, P639, DOI 10.1007/BF01342639; FROST BJ, 1981, EXP BRAIN RES, V43, P173; FROST BJ, 1983, SCIENCE, V220, P744, DOI 10.1126/science.6836313; Gauck V, 1997, J COMP NEUROL, V381, P489; Gauck V, 1999, J COMP NEUROL, V406, P51, DOI 10.1002/(SICI)1096-9861(19990329)406:1<51::AID-CNE4>3.0.CO;2-I; Geurten BRH, 2007, J EXP BIOL, V210, P3277, DOI 10.1242/jeb.008425; Grewe J, 2006, J NEUROPHYSIOL, V96, P1838, DOI 10.1152/jn.00170.2006; Haag J, 2002, J NEUROSCI, V22, P3227, DOI 10.1523/JNEUROSCI.22-08-03227.2002; HAUSEN K, 1982, BIOL CYBERN, V46, P67, DOI 10.1007/BF00335352; HAUSEN K, 1982, BIOL CYBERN, V45, P143, DOI 10.1007/BF00335241; HAUSEN K, 1976, Z NATURFORSCH C, V31, P629; HAUSEN K, 1976, THESIS U TUEBINGEN; HENGSTENBERG R, 1980, NEUROANATOMICAL TECH, P307; Higgins CM, 2004, BIOL CYBERN, V91, P417, DOI 10.1007/s00422-004-0518-y; Kimmerle B, 2000, J COMP PHYSIOL A, V186, P21, DOI 10.1007/s003590050003; Kimmerle B, 1997, J COMP PHYSIOL A, V181, P247, DOI 10.1007/s003590050111; KOCH C, 1983, P NATL ACAD SCI-BIOL, V80, P2799, DOI 10.1073/pnas.80.9.2799; KOCH C, 1999, BIOPHYS COMPUTATION; KOCH C, 1998, METHOODS NEURAL MODE; Krapp HG, 2001, J NEUROPHYSIOL, V85, P724, DOI 10.1152/jn.2001.85.2.724; Kretzberg J, 2001, J COMPUT NEUROSCI, V10, P79, DOI 10.1023/A:1008972111122; MACH E, 1865, WIRKUNG RAUMLICHEN V, P131; MANDL G, 1985, VISION RES, V25, P267, DOI 10.1016/0042-6989(85)90119-1; MASON R, 1979, EXP BRAIN RES, V37, P231; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OLBERG RM, 1986, J COMP PHYSIOL A, V159, P827, DOI 10.1007/BF00603736; OLBERG RM, 1981, J COMP PHYSIOL, V141, P327, DOI 10.1007/BF00609935; Price K. V., 1999, INTRO DIFFERENTIAL E, P79; REICHARDT W, 1983, BIOL CYBERN, V46, P1, DOI 10.1007/BF00595226; RIZZOLATTI G, 1977, EXP BRAIN RES, V29, P107; ROWELL CHF, 1977, J EXP BIOL, V68, P157; ROWELL CHF, 1976, J EXP BIOL, V65, P617; Single S, 1997, J NEUROSCI, V17, P6023; STERLING P, 1969, J NEUROPHYSIOL, V32, P1, DOI 10.1152/jn.1969.32.1.1; TANAKA K, 1986, J NEUROSCI, V6, P134; TSAI HJ, 1990, J COMP PHYSIOL A, V167, P857; VONGRUNAU M, 1983, EXP BRAIN RES, V49, P84, DOI 10.1007/BF00235544; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329	53	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3092	10.1371/journal.pone.0003092	http://dx.doi.org/10.1371/journal.pone.0003092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769475	gold, Green Published, Green Submitted			2022-12-27	WOS:000264796600010
J	Fitzpatrick, SM; Nelson, GC; Clark, G				Fitzpatrick, Scott M.; Nelson, Greg C.; Clark, Geoffrey			Small Scattered Fragments Do Not a Dwarf Make: Biological and Archaeological Data Indicate that Prehistoric Inhabitants of Palau Were Normal Sized	PLOS ONE			English	Article							SOUTH-AFRICA; ISLANDS; MICRONESIA; PACIFIC; SITE; SKELETAL; FLORES	Current archaeological evidence from Palau in western Micronesia indicates that the archipelago was settled around 3000-3300 BP by normal sized populations; contrary to recent claims, they did not succumb to insular dwarfism. Background: Previous and ongoing archaeological research of both human burial and occupation sites throughout the Palauan archipelago during the last 50 years has produced a robust data set to test hypotheses regarding initial colonization and subsequent adaptations over the past three millennia. Principal Findings: Close examination of human burials at the early (ca. 3000 BP) and stratified site of Chelechol ra Orrak indicates that these were normal sized individuals. This is contrary to the recent claim of contemporaneous "small-bodied'' individuals found at two cave sites by Berger et al. (2008). As we argue, their analyses are flawed on a number of different analytical levels. First, their sample size is too small and fragmentary to adequately address the variation inherent in modern humans within and outside of Palau. Second, the size and stature of all other prehistoric (both older and contemporaneous) skeletal assemblages found in Palau fall within the normal parameters of modern human variation in the region, indicating this was not a case of insular dwarfism or a separate migratory group. Third, measurements taken on several skeletal elements by Berger et al. may appear to be from smaller-bodied individuals, but the sizes of these people compares well with samples from Chelechol ra Orrak. Last, archaeological, linguistic, and historical evidence demonstrates a great deal of cultural continuity in Palau through time as expected if the same population was inhabiting the archipelago. Conclusions: Prehistoric Palauan populations were normal sized and exhibit traits that fall within the normal variation for Homo sapiens-they do not support the claims by Berger et al. (2008) that there were smaller-bodied populations living in Palau or that insular dwarfism took place such as may be the case for Homo floresiensis.	[Fitzpatrick, Scott M.] N Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA; [Nelson, Greg C.] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Clark, Geoffrey] Australian Natl Univ, Res Sch Pacific & Asian Stud, Div Soc & Environm, Acton, Australia	University of North Carolina; North Carolina State University; University of Oregon; Australian National University	Fitzpatrick, SM (corresponding author), N Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA.	scott_fitzpatrick@ncsu.edu		Clark, Geoffrey/0000-0002-9055-655X	National Science Foundation; Sigma Xi	National Science Foundation(National Science Foundation (NSF)); Sigma Xi	National Science Foundation, Sigma Xi	Anderson A, 2005, RADIOCARBON, V47, P1; Anderson A, 2001, INT J OSTEOARCHAEOL, V11, P14, DOI 10.1002/oa.542; ANDERSON AJ, 2001, RECORDS AUSTR MUSE S, V27; [Anonymous], ARCHAEOLOGICAL SURVE; Athens J.S., 2005, PALAU COMPACT ROAD A; Athens JS, 2004, REC AUST MUS, P15; Athens JS, 2001, PACIFIC 2000: PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON EASTER ISLAND AND THE PACIFIC, P165; ATHENS JS, 1999, ARCHAEOLOGICAL DATA; Auerbach BM, 2004, AM J PHYS ANTHROPOL, V125, P331, DOI 10.1002/ajpa.20032; Bedford S, 2006, ANTIQUITY, V80, P812, DOI 10.1017/S0003598X00094448; BENNETT KA, 1975, PUBLICATIONS ARCHA F, V7; Berger LR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001780; Blust R, 2000, OCEAN LINGUIST, V39, P83, DOI 10.2307/3623218; BRACE CL, 1981, CURR ANTHROPOL, V22, P549, DOI 10.1086/202726; BRACE CL, 1990, MICRONESICA S, V2, P323; BRAZAITIS P, 1992, US TRUST TERRITORY P, P42; BROWN M, 1981, CHILDRENS UNDERSTAND, V11, P23; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Callaghan R, 2007, INT J NAUT ARCHAEOL, V36, P353, DOI 10.1111/j.1095-9270.2007.00147.x; Callieri M, 2008, IEEE COMPUT GRAPH, V28, P44, DOI 10.1109/MCG.2008.20; Carucci J., 1992, THESIS SO ILLINOIS U; Clark G, 2005, ASIAN PERSPECT, V44, P349, DOI DOI 10.1353/ASI.2005.0020; CLARK G, 2007, VASTLY INGENIOUS ARC, P173; CLARK G, 2003, CAHIERS ARCHEOLOGIE, V15, P85; Clark Geoffery, 2005, Micronesica, V38, P67; Clark Geoffrey, 2004, Archaeology in Oceania, V39, P26; Clark GR., 2006, J ISL COAST ARCHAEOL, V1, P215, DOI [10.1080/15564890600831705, DOI 10.1080/15564890600831705]; CORWIN CG, 1956, MILITARY GEOLOGY PAL; Dickinson WR., 2007, J ISL COAST ARCHAEOL, V2, P175, DOI [10.1080/15564890701623639, DOI 10.1080/15564890701623639]; Donaldson Terry J., 1996, Pacific Science, V50, P285; Donaldson TJ, 2002, ENVIRON BIOL FISH, V65, P241, DOI 10.1023/A:1020067931910; Donaldson TJ, 2002, ENVIRON BIOL FISH, V65, P139, DOI 10.1023/A:1020050931158; Douglas MT, 1997, AM J PHYS ANTHROPOL, V104, P291; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Fitzpatrick SM, 2008, INT J OSTEOARCHAEOL, V18, P439, DOI 10.1002/oa.951; Fitzpatrick SM, 2007, CORAL REEFS, V26, P915, DOI 10.1007/s00338-007-0226-x; Fitzpatrick SM, 2008, J ANTHROPOL ARCHAEOL, V27, P131, DOI 10.1016/j.jaa.2007.12.002; Fitzpatrick Scott M., 2003, Journal of Ethnobiology, V23, P101; Fitzpatrick SM, 2003, ANTIQUITY, V77, P719, DOI 10.1017/S0003598X00061664; Fitzpatrick SM, 2003, J ARCHAEOL SCI, V30, P1175, DOI 10.1016/S0305-4403(03)00014-1; Fitzpatrick SM, 2002, RADIOCARBON, V44, P217, DOI 10.1017/S003382220006481X; FITZPATRICK SM, STABLE ISOTOPE UNPUB; FITZPATRICK SM, 2002, RADIOCARBON, V44, P1; FITZPATRICK SM, 2003, THESIS U OREGON; Hanihara T, 1996, AM J PHYS ANTHROPOL, V99, P389, DOI 10.1002/(SICI)1096-8644(199603)99:3<389::AID-AJPA3>3.0.CO;2-S; Hazell LC, 2006, ARCHAEOL OCEAN, V41, P12, DOI 10.1002/j.1834-4453.2006.tb00601.x; Hillson S., 1996, DENTAL ANTHROPOLOGY; Howells W. W, 1989, SKULL SHAPES MAP CRA; Johannes R.E., 1981, WORDS LAGOON FISHING; KIRCH PV, 1989, AM J PHYS ANTHROPOL, V79, P63, DOI 10.1002/ajpa.1330790107; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Liston J, 2005, RADIOCARBON, V47, P295, DOI 10.1017/S0033822200019780; LISTON J, 1998, HIST PRESERVATION IN, V2; Liston J., 2006, ARCHAEOLOGY WARFARE, P148; Lucking L.J., 1984, THESIS U MINNESOTA M; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; Maragos JE, 1995, CORAL REEFS, V14, P237; MARAGOS JE, 1993, RAPID ECOLOGICAL A 1; MARAGOS JE, 1994, SYNTHESIS REPORT RAP; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Masse WB, 2006, QUATERN INT, V151, P106, DOI 10.1016/j.quaint.2006.01.017; MASSE WB, 1989, ARCHAEOLOGY ECOLOG U; MASSE WB, 1990, MICRONESICA S, V2, P213; MASSE WB, 1989, ARCHAEOLOGY ECOLOG 2; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Morwood MJ, 1999, ANTIQUITY, V73, P273, DOI 10.1017/S0003598X00088244; Morwood MJ, 1998, NATURE, V392, P173, DOI 10.1038/32401; Myers RF, 1999, MICRONESIAN REEF FIS, V3rd; NELSON GC, 1992, AM J PHYS ANTHROPOL, V88, P135, DOI 10.1002/ajpa.1330880203; NELSON GC, 1998, OCCLUSAL VARIATION M; NELSON GC, SKELETAL REMAI UNPUB; Nelson GC, 2006, ANTHROPOL SCI, V114, P1, DOI 10.1537/ase.040710; OSBORNE D, 1958, ARCHAEOLOGY, V11, P162; OSBORNE D, 1979, MICRONESICA S1; Osborne D., 1966, BISHOP MUSEUM B, V230; *PAL INT COR REEF, 2007, COR REEFS PAL; PALKOVICH AM, 1980, ARROYO HONDO SKELETA, V3; Parmentier Richard J., 1987, SACRED REMAINS MYTH; PATEL S, 2008, DISCOVERY FUELS HOBB; PAWLEY A, 1999, SEL PAP 8 INT C AUST; PHEAR S, 2003, CAHIERS ARCHEOLOGIE, V15, P241; PIETRUSEWSKY M, 1990, AM J PHYS ANTHROPOL, V82, P319, DOI 10.1002/ajpa.1330820309; Pietrusewsky M, 1997, AM J PHYS ANTHROPOL, V104, P315; Pietrusewsky M., 2006, BIOARCHAEOLOGY SE AS, P59; Pietrusewsky M., 2008, BIOL ANTHR HUMAN SKE, P487; Pietrusewsky M., 2005, PEOPLING E ASIA PUTT, P203; PIETRUSEWSKY M, 1990, MICRONESICA S, V2, P373; Pietrusewsky M., 1990, MICRONESICA S, V2, P317; Pietrusewsky Michael, 2006, AUSTRONESIAN DIASPOR, P320; RIETH TM, 2001, ARCHAEOLOGICAL DATA; Sem G., 1994, IMPLICATIONS CLIMATE; SNYDER D, 1997, MICRONESIAN RESOURCE; SNYDER DM, 1989, CHRONOMETRIC MODELS; Specht J, 2006, ASIAN PERSPECT, V45, P24; WICKLER S, 2002, PACIFIC LANDSCAPES A, P63; YESNER DR, 1980, CURR ANTHROPOL, V21, P727, DOI 10.1086/202568; ZOBEL E, 2002, PACIFIC LINGUISTICS, V518, P405	98	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3015	10.1371/journal.pone.0003015	http://dx.doi.org/10.1371/journal.pone.0003015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728774	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796400001
J	Inoue, T; Meyer, T				Inoue, Takanari; Meyer, Tobias			Synthetic Activation of Endogenous PI3K and Rac Identifies an AND-Gate Switch for Cell Polarization and Migration	PLOS ONE			English	Article								Phosphatidylinositol 3-OH kinase (PI3K) has been widely studied as a principal regulator of cell polarization, migration, and chemotaxis [1,2,3,4]. Surprisingly, recent studies showed that mammalian neutrophils and Dictyostelium discoideum cells can polarize and migrate in the absence of PI3K activity [5,6,7]. Here we directly probe the roles of PI3K and its downstream effector, Rac, in HL-60 neutrophils by using a chemical biology approach whereby the endogenously present enzymes are synthetically activated in less than one minute [8,9,10]. We show that uniform activation of endogenous PI3K is sufficient to polarize previously unpolarized neutrophils and trigger effective cell migration. After a delay following symmetrical phosphatidylinositol (3,4,5)-triphosphate (PIP3) production, a polarized distribution of PIP3 was induced by positive feedback requiring actin polymerization. Pharmacological studies argue that this process does not require receptor-coupled trimeric G proteins. Contrary to the current working model, rapid activation of endogenous Rac proteins triggered effective actin polymerization but failed to feed back to PI3K to generate PIP3 or induce cell polarization. Thus, the increase in PIP3 concentration at the leading edge is generated by positive feedback with an AND gate logic with a PI3K-Rac-actin polymerization pathway as a first input and a PI3K initiated non-Rac pathway as a second input. This AND-gate control for cell polarization can explain how Rac can be employed for both PI3K-dependent and -independent signaling pathways coexisting in the same cell.	[Inoue, Takanari; Meyer, Tobias] Stanford Univ, Bio X Program, Stanford, CA 94305 USA	Stanford University	Inoue, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Inst Basic Biomed Sci,Ctr Cell Dynam, Baltimore, MD 21218 USA.	jctinoue@jhmi.edu; tobias1@stanford.edu		Meyer, Tobias/0000-0003-4339-3804	 [GM063702];  [PN2 EY1018241]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063702] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	GM063702 and PN2 EY1018241 to TM	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Burridge K, 1999, SCIENCE, V283, P2028, DOI 10.1126/science.283.5410.2028; Chen DF, 2007, MICROFLUID NANOFLUID, V3, P603, DOI 10.1007/s10404-007-0151-x; de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072; Derman MP, 1997, J BIOL CHEM, V272, P6465, DOI 10.1074/jbc.272.10.6465; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Franca-Koh J, 2007, NAT CELL BIOL, V9, P15, DOI 10.1038/ncb0107-15; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hauert AB, 2002, INT J BIOCHEM CELL B, V34, P838, DOI 10.1016/S1357-2725(02)00010-9; Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Meinhardt H, 1999, J CELL SCI, V112, P2867; Niggli V, 2000, FEBS LETT, V473, P217, DOI 10.1016/S0014-5793(00)01534-9; Niggli V, 2003, INT J BIOCHEM CELL B, V35, P1619, DOI 10.1016/S1357-2725(03)00144-4; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Peyrollier K, 2000, BIOCHEM J, V352, P617, DOI 10.1042/0264-6021:3520617; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Es S, 1999, CELL MOL LIFE SCI, V55, P1341, DOI 10.1007/s000180050374; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134; Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	37	101	106	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3068	10.1371/journal.pone.0003068	http://dx.doi.org/10.1371/journal.pone.0003068			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728784	Green Published, gold			2022-12-27	WOS:000264796400008
J	Burgess, HJ; Fogg, LF				Burgess, Helen J.; Fogg, Louis F.			Individual Differences in the Amount and Timing of Salivary Melatonin Secretion	PLOS ONE			English	Article							PLASMA MELATONIN; CIRCADIAN PHASE; MENSTRUAL-CYCLE; BREAST-CANCER; BRIGHT LIGHT; SUPPRESS MELATONIN; URINARY MELATONIN; HEALTHY-SUBJECTS; ACTION SPECTRUM; SLEEP	Background: The aim of this study was to examine individual differences in a large sample of complete melatonin profiles not suppressed by light and search for possible associations between the amount and timing of melatonin secretion and a multitude of lifestyle variables. The melatonin profiles were derived from saliva samples collected every 30 minutes in dim light from 85 healthy women and 85 healthy men aged 18-45 years. There was a large individual variability in the amount of melatonin secreted with peak values ranging from 2 to 84 pg/ml. The onset of melatonin secretion ranged from 18: 13 to 00: 26 hours. The use of hormonal birth control, reduced levels of employment, a smaller number of days on a fixed sleep schedule, increased day length and lower weight were associated with an increased amplitude of melatonin secretion. The use of hormonal birth control, contact lenses, a younger age, and lower ratings of mania and paranoia were associated with a longer duration of melatonin secretion. An earlier occurrence of the onset of melatonin secretion was associated with an earlier wake time, more morningness and the absence of a bed partner. Lifestyle and behavioral variables were only able to explain about 15% of the individual variability in the amount of melatonin secretion, which is likely because of a substantial genetic influence on the levels of melatonin secretion.	[Burgess, Helen J.; Fogg, Louis F.] Rush Univ, Biol Rhythms Res Lab, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA	Rush University	Burgess, HJ (corresponding author), Rush Univ, Biol Rhythms Res Lab, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA.	Helen_J_Burgess@rush.edu			National Institutes of Health (NIH) [R01 NR07677, R01 OH003954, R01 NS35695, R01 NS23421]; Centers for Disease Control and Prevention (CDC); National Institute of Occupational Safety and Health (NIOSH); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH003954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035695, R01NS023421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR007677] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Occupational Safety and Health (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was made possible by grants from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and the National Institute of Occupational Safety and Health (NIOSH) including R01 NR07677, R01 OH003954, R01 NS35695 and R01 NS23421 to Charmane I. Eastman, Ph.D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, CDC or NIOSH. The NIH, CDC and NIOSH had no role in study design, data collection and analysis, interpretation of the data, and in the preparation, review or approval of manuscript.	Babkoff H, 2002, AVIAT SPACE ENVIR MD, V73, P341; Baskett JJ, 2001, SLEEP, V24, P418, DOI 10.1093/sleep/24.4.418; BERGA SL, 1990, NEUROENDOCRINOLOGY, V51, P606, DOI 10.1159/000125398; Blask DE, 2005, CANCER RES, V65, P11174, DOI 10.1158/0008-5472.CAN-05-1945; BOJKOWSKI CJ, 1988, ACTA ENDOCRINOL-COP, V117, P470, DOI 10.1530/acta.0.1170470; Brainard GC, 2001, J NEUROSCI, V21, P6405; Brunet AG, 2002, J ENDOCRINOL, V172, P397, DOI 10.1677/joe.0.1720397; BRZEZINSKI A, 1988, J CLIN ENDOCR METAB, V66, P891, DOI 10.1210/jcem-66-5-891; Burgess HJ, 2006, NEUROSCI LETT, V395, P191, DOI 10.1016/j.neulet.2005.10.082; Butcher J.N., 1989, MMPI2 MINNESOTA MULT; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; CARDINALI DP, 1987, J STEROID BIOCHEM, V27, P565, DOI 10.1016/0022-4731(87)90355-4; CLAUSTRAT B, 1986, J PINEAL RES, V3, P301, DOI 10.1111/j.1600-079X.1986.tb00753.x; Cole RJ, 1995, J BIOL RHYTHM, V10, P324, DOI 10.1177/074873049501000406; Drapeau C, 2005, SLEEP, V28, pA49; Eastman CI, 2000, CHRONOBIOL INT, V17, P807, DOI 10.1081/CBI-100102116; EKMAN AC, 1993, J CLIN ENDOCR METAB, V77, P780, DOI 10.1210/jc.77.3.780; Graham JR, 1990, MMPI 2 ASSESSING PER; Hallam KT, 2006, PSYCHONEUROENDOCRINO, V31, P867, DOI 10.1016/j.psyneuen.2006.04.004; Hebert M, 2002, J PINEAL RES, V33, P198, DOI 10.1034/j.1600-079X.2002.01885.x; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; ILLNEROVA H, 1985, BRAIN RES, V328, P186, DOI 10.1016/0006-8993(85)91342-3; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kantermann T, 2007, CURR BIOL, V17, P1996, DOI 10.1016/j.cub.2007.10.025; Kayumov L, 2005, J CLIN ENDOCR METAB, V90, P2755, DOI 10.1210/jc.2004-2062; Kennaway DJ, 1999, J PINEAL RES, V27, P210, DOI 10.1111/j.1600-079X.1999.tb00617.x; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Knight JA, 2005, AM J EPIDEMIOL, V162, P1114, DOI 10.1093/aje/kwi327; Kostoglou-Athanassiou I, 1998, CLIN ENDOCRINOL, V49, P209, DOI 10.1046/j.1365-2265.1998.00504.x; Kunz D, 1999, NEUROPSYCHOPHARMACOL, V21, P765, DOI 10.1016/S0893-133X(99)00069-X; Lee C, 2006, CHRONOBIOL INT, V23, P859, DOI 10.1080/07420520600827160; Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lewy AJ, 1999, J BIOL RHYTHM, V14, P227, DOI 10.1177/074873099129000641; Magkos F, 2005, CRIT REV FOOD SCI, V45, P535, DOI 10.1080/1040-830491379245; Mahlberg R, 2006, PSYCHONEUROENDOCRINO, V31, P634, DOI 10.1016/j.psyneuen.2006.01.009; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; Moore R.Y., 1978, PROGRESS IN REPRODUCTIVE BIOLOGY, V4, P1; Murphy Patricia J., 1996, Physiology and Behavior, V59, P133, DOI 10.1016/0031-9384(95)02036-5; Park SJ, 1999, CHRONOBIOL INT, V16, P359, DOI 10.3109/07420529909116864; Parry BL, 1997, J BIOL RHYTHM, V12, P47, DOI 10.1177/074873049701200107; Quesnel Nadia-Marie, 2001, CLAO Journal, V27, P23; Rahman SA, 2006, SLEEP, V29, pA58; Revell VL, 2005, J PINEAL RES, V39, P195, DOI 10.1111/j.1600-079X.2005.00236.x; Revell VL, 2005, J BIOL RHYTHM, V20, P353, DOI 10.1177/0748730405277233; Roenneberg T, 2007, CURR BIOL, V17, pR44, DOI 10.1016/j.cub.2006.12.011; ROSENTHAL FS, 1986, AM J PUBLIC HEALTH, V76, P1216, DOI 10.2105/AJPH.76.10.1216; Rubin DB, 2004, MULTIPLE IMPUTATION; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Salas Einarhille S.L, 1982, CALCULUS ONE SEVERAL, Vfourth; Sasseville A, 2006, J PINEAL RES, V41, P73, DOI 10.1111/j.1600-079X.2006.00332.x; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2005, J NATL CANCER I, V97, P1084, DOI 10.1093/jnci/dji190; Sharkey KM, 2002, AM J PHYSIOL-REG I, V282, pR454, DOI 10.1152/ajpregu.00135.2001; SMITH MR, SLEEP MED IN PRESS; Stevens RG, 2000, EPIDEMIOLOGY, V11, P660, DOI 10.1097/00001648-200011000-00008; Takasu NN, 2006, AM J PHYSIOL-REG I, V291, pR1799, DOI 10.1152/ajpregu.00211.2006; TESSONNEAUD A, 1995, J NEUROENDOCRINOL, V7, P145, DOI 10.1111/j.1365-2826.1995.tb00677.x; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Ursing C, 2003, J ENDOCRINOL INVEST, V26, P403, DOI 10.1007/BF03345194; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Wehr TA, 2001, ARCH GEN PSYCHIAT, V58, P1108, DOI 10.1001/archpsyc.58.12.1108; WEHR TA, 1995, AM J PHYSIOL-REG I, V269, pR173, DOI 10.1152/ajpregu.1995.269.1.R173; WEHR TA, 1993, AM J PHYSIOL, V265, pR846, DOI 10.1152/ajpregu.1993.265.4.R846; Wetterberg L, 1999, PSYCHONEUROENDOCRINO, V24, P209, DOI 10.1016/S0306-4530(98)00076-6; Wright KP, 1997, BRAIN RES, V747, P78, DOI 10.1016/S0006-8993(96)01268-1; Wright KP, 1999, BEHAV BRAIN RES, V103, P185, DOI 10.1016/S0166-4328(99)00042-X; Zarazaga LA, 1998, AM J PHYSIOL-ENDOC M, V274, pE1086, DOI 10.1152/ajpendo.1998.274.6.E1086; Zeitzer JM, 2007, SLEEP, V30, P1437, DOI 10.1093/sleep/30.11.1437; Zeitzer JM, 1999, AM J MED, V107, P432, DOI 10.1016/S0002-9343(99)00266-1; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695, DOI 10.1111/j.1469-7793.2000.00695.x	72	160	176	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3055	10.1371/journal.pone.0003055	http://dx.doi.org/10.1371/journal.pone.0003055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725972	Green Published, gold			2022-12-27	WOS:000264796300002
J	Lesica, NA; Ishii, T; Stanley, GB; Hosoya, T				Lesica, Nicholas A.; Ishii, Toshiyuki; Stanley, Garrett B.; Hosoya, Toshihiko			Estimating Receptive Fields from Responses to Natural Stimuli with Asymmetric Intensity Distributions	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; INFORMATION-TRANSMISSION; SIMPLE CELLS; STATISTICS; NEURONS; ADAPTATION; CONTRAST; SOUNDS; IMAGES	The reasons for using natural stimuli to study sensory function are quickly mounting, as recent studies have revealed important differences in neural responses to natural and artificial stimuli. However, natural stimuli typically contain strong correlations and are spherically asymmetric (i.e. stimulus intensities are not symmetrically distributed around the mean), and these statistical complexities can bias receptive field (RF) estimates when standard techniques such as spike-triggered averaging or reverse correlation are used. While a number of approaches have been developed to explicitly correct the bias due to stimulus correlations, there is no complementary technique to correct the bias due to stimulus asymmetries. Here, we develop a method for RF estimation that corrects reverse correlation RF estimates for the spherical asymmetries present in natural stimuli. Using simulated neural responses, we demonstrate how stimulus asymmetries can bias reverse-correlation RF estimates (even for uncorrelated stimuli) and illustrate how this bias can be removed by explicit correction. We demonstrate the utility of the asymmetry correction method under experimental conditions by estimating RFs from the responses of retinal ganglion cells to natural stimuli and using these RFs to predict responses to novel stimuli.	[Lesica, Nicholas A.; Ishii, Toshiyuki; Hosoya, Toshihiko] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Lesica, Nicholas A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ishii, Toshiyuki] Toho Univ, Funabashi, Chiba, Japan; [Stanley, Garrett B.] Emory Univ, Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30322 USA	RIKEN; Harvard University; Toho University; Emory University; University System of Georgia; Georgia Institute of Technology	Lesica, NA (corresponding author), Bernstein Ctr Computat Neurosci, Munich, Germany.	lesica@zi.biologie.uni-muenchen.de	Hosoya, Toshihiko/Q-2514-2018; Ishii, Toshiyuki/ABD-1165-2020	Hosoya, Toshihiko/0000-0001-8559-8344; Stanley, Garrett/0000-0003-2039-7706; Lesica, Nicholas/0000-0001-5238-4462	Sigma Xi Grant-In-Aid of Research; Japan Society for the Promotion of Science [Post-doctoral Fellowship]; National Geospatial-Intelligence Agency [HM1582-05-C-0009]; RIKEN Research Fund	Sigma Xi Grant-In-Aid of Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Geospatial-Intelligence Agency; RIKEN Research Fund	NAL was supported by a Sigma Xi Grant-In-Aid of Research, a Post-doctoral Fellowship from the Japan Society for the Promotion of Science, and National Geospatial-Intelligence Agency Grant HM1582-05-C-0009. TI and TH were supported by the RIKEN Research Fund.	Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Bussgang J. J., 1952, 216 MIT RES LAB EL; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Christianson GB, 2008, J NEUROSCI, V28, P446, DOI 10.1523/JNEUROSCI.1775-07.2007; Clifford CWG, 2007, VISION RES, V47, P3125, DOI 10.1016/j.visres.2007.08.023; Dan Y, 1996, J NEUROSCI, V16, P3351; David SV, 2007, NETWORK-COMP NEURAL, V18, P191, DOI 10.1080/09548980701609235; David SV, 2005, NETWORK-COMP NEURAL, V16, P239, DOI 10.1080/09548980500464030; David SV, 2004, J NEUROSCI, V24, P6991, DOI 10.1523/JNEUROSCI.1422-04.2004; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Escabi MA, 2003, J NEUROSCI, V23, P11489; Felsen G, 2005, PLOS BIOL, V3, P1819, DOI 10.1371/journal.pbio.0030342; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Hosoya T, 2005, NATURE, V436, P71, DOI 10.1038/nature03689; Hsu A, 2004, J NEUROSCI, V24, P9201, DOI 10.1523/JNEUROSCI.2449-04.2004; Klug A, 2002, J NEUROPHYSIOL, V88, P1941, DOI 10.1152/jn.2002.88.4.1941; Lesica NA, 2005, IEEE T NEUR SYS REH, V13, P194, DOI 10.1109/TNSRE.2005.848339; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001655; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; Lesica NA, 2006, NETWORK-COMP NEURAL, V17, P43, DOI 10.1080/09548980500328409; Machens CK, 2004, J NEUROSCI, V24, P1089, DOI 10.1523/JNEUROSCI.4445-03.2004; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; Paninski L, 2004, NETWORK-COMP NEURAL, V15, P243, DOI 10.1088/0954-898X/15/4/002; Paninski L, 2003, NETWORK-COMP NEURAL, V14, P437, DOI 10.1088/0954-898X/14/3/304; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ringach DL, 2002, J VISION, V2, P12, DOI 10.1167/2.1.2; Ringach DL, 2004, J PHYSIOL-LONDON, V558, P717, DOI 10.1113/jphysiol.2004.065771; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; Sahani M, 2002, ADV NEURAL INFORM PR, V15, P317; Schwartz O, 2006, J VISION, V6, P484, DOI 10.1167/6.4.13; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; SIMONCELLI EP, 2003, COGNITIVE NEUROSCIEN; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Smyth D, 2003, J NEUROSCI, V23, P4746; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289, DOI 10.1088/0954-898X/12/3/304; Thomson MGA, 1999, NETWORK-COMP NEURAL, V10, P123, DOI 10.1088/0954-898X/10/2/302; Touryan J, 2005, NEURON, V45, P781, DOI 10.1016/j.neuron.2005.01.029; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P2315, DOI 10.1098/rspb.1998.0577; VanHateren JH, 1997, VISION RES, V37, P3407, DOI 10.1016/S0042-6989(97)00105-3; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Willmore B, 2003, NETWORK-COMP NEURAL, V14, P553, DOI 10.1088/0954-898X/14/3/309	46	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3060	10.1371/journal.pone.0003060	http://dx.doi.org/10.1371/journal.pone.0003060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725977	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796300006
J	Moroni, L; Hamann, D; Paoluzzi, L; Pieper, J; de Wijn, JR; van Blitterswijk, CA				Moroni, Lorenzo; Hamann, Doreen; Paoluzzi, Luca; Pieper, Jeroen; de Wijn, Joost R.; van Blitterswijk, Clemens A.			Regenerating Articular Tissue by Converging Technologies	PLOS ONE			English	Article							FIBER-DEPOSITED SCAFFOLDS; DEMINERALIZED BONE-MATRIX; IN-VITRO; OSTEOCHONDRAL DEFECTS; CELL-DIFFERENTIATION; DESIGN; OSTEOINDUCTION; ARCHITECTURE; OXYGEN; REPAIR	Scaffolds for osteochondral tissue engineering should provide mechanical stability, while offering specific signals for chondral and bone regeneration with a completely interconnected porous network for cell migration, attachment, and proliferation. Composites of polymers and ceramics are often considered to satisfy these requirements. As such methods largely rely on interfacial bonding between the ceramic and polymer phase, they may often compromise the use of the interface as an instrument to direct cell fate. Alternatively, here, we have designed hybrid 3D scaffolds using a novel concept based on biomaterial assembly, thereby omitting the drawbacks of interfacial bonding. Rapid prototyped ceramic particles were integrated into the pores of polymeric 3D fiber-deposited (3DF) matrices and infused with demineralized bone matrix (DBM) to obtain constructs that display the mechanical robustness of ceramics and the flexibility of polymers, mimicking bone tissue properties. Ostechondral scaffolds were then fabricated by directly depositing a 3DF structure optimized for cartilage regeneration adjacent to the bone scaffold. Stem cell seeded scaffolds regenerated both cartilage and bone in vivo.	[Moroni, Lorenzo; Hamann, Doreen; de Wijn, Joost R.; van Blitterswijk, Clemens A.] Univ Twente, BMTI, NL-7500 AE Enschede, Netherlands; [Paoluzzi, Luca] Univ Politecn Marche, Mech Engn Inst, Ancona, Italy; [Pieper, Jeroen] Isotis OrthoBiologics SA, Irvine, CA USA; [Moroni, Lorenzo] MuscoloSkeletal Cell & Tissue Bank, Rizzoli Orthopaed Inst, Bologna, Italy	University of Twente; Marche Polytechnic University; IRCCS Istituto Ortopedico Rizzoli	Moroni, L (corresponding author), Univ Twente, BMTI, POB 217, NL-7500 AE Enschede, Netherlands.	lmoroni@gmail.com	Moroni, Lorenzo/D-2826-2014	Moroni, Lorenzo/0000-0003-1298-6025; van Blitterswijk, Clemens/0000-0003-2371-4615	European Community project Intelliscaf [GSRD_2002_00697]	European Community project Intelliscaf	This project was funded by the European Community project Intelliscaf GSRD_2002_00697.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083; BAKKER D, 1988, BIOMATERIALS, V9, P14, DOI 10.1016/0142-9612(88)90064-6; Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023; BEUMER GJ, 1994, BIOMATERIALS, V15, P551, DOI 10.1016/0142-9612(94)90022-1; BEUMER GJ, 1994, J BIOMED MATER RES, V28, P545, DOI 10.1002/jbm.820280504; Bezemer JM, 1999, J CONTROL RELEASE, V62, P393, DOI 10.1016/S0168-3659(99)00170-4; Bulstra SK, 1996, J BONE JOINT SURG BR, V78B, P892, DOI 10.1302/0301-620X78B6.6806; Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778; Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495; Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099; Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7; FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104; Garcia VP, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/63518; Guldberg V. M., 1992, BONE IMPLANT GRAFTIN, P9; Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712; Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727; Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801; Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010; Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114; Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1; Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792; Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19; Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020; Mensik I., 2002, Cell and Tissue Banking, V3, P245; Moroni L, 2007, TISSUE ENG, V13, P361, DOI 10.1089/ten.2006.0127; Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023; Moroni L, 2006, J BIOMED MATER RES A, V78A, P605, DOI 10.1002/jbm.a.30716; Moroni L, 2005, J BIOMED MATER RES A, V75A, P957, DOI 10.1002/jbm.a.30499; Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251; Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016; REDDI AH, 1981, COLLAGEN REL RES, V1, P209; Reuss A, 1929, Z ANGEW MATH MECH, V9, P49, DOI 10.1002/zamm.19290090104; Rice JM, 2003, CALCIFIED TISSUE INT, V72, P726, DOI 10.1007/s00223-002-2045-y; Schek R M, 2005, Orthod Craniofac Res, V8, P313, DOI 10.1111/j.1601-6343.2005.00354.x; Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539; Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040; Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5; URIST MR, 1983, SCIENCE, V220, P680, DOI 10.1126/science.6403986; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; VONDERMARK K, 1979, CLIN ORTHOP RELAT R, P185; Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324; Wilson CE, 2006, BIOMATERIALS, V27, P302, DOI 10.1016/j.biomaterials.2005.06.041; Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056; Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047; Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0	51	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3032	10.1371/journal.pone.0003032	http://dx.doi.org/10.1371/journal.pone.0003032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716660	gold, Green Published			2022-12-27	WOS:000264426800009
J	Reynolds, PJ; Simms, JR; Duronio, RJ				Reynolds, Patrick J.; Simms, Jeffrey R.; Duronio, Robert J.			Identifying Determinants of Cullin Binding Specificity Among the Three Functionally Different Drosophila melanogaster Roc Proteins via Domain Swapping	PLOS ONE			English	Article								Background: Cullin-dependent E3 ubiquitin ligases (CDL) are key regulators of protein destruction that participate in a wide range of cell biological processes. The Roc subunit of CDL contains an evolutionarily conserved RING domain that binds ubiquitin charged E2 and is essential for ubiquitylation. Drosophila melanogaster contains three highly related Roc proteins: Roc1a and Roc2, which are conserved in vertebrates, and Roc1b, which is specific to Drosophila. Our previous genetic data analyzing Roc1a and Roc1b mutants suggested that Roc proteins are functionally distinct, but the molecular basis for this distinction is not known. Methodology/Principal Findings: Using co-immunoprecipitation studies we show that Drosophila Roc proteins bind specific Cullins: Roc1a binds Cul1-4, Roc1b binds Cul3, and Roc2 binds Cul5. Through domain swapping experiments, we demonstrate that Cullin binding specificity is strongly influenced by the Roc NH(2)-terminal domain, which forms an intermolecular beta sheet with the Cullin. Substitution of the Roc1a RING domain with that of Roc1b results in a protein with similar Cullin binding properties to Roc1a that is active as an E3 ligase but cannot complement Roc1a mutant lethality, indicating that the identity of the RING domain can be an important determinant of CDL function. In contrast, the converse chimeric protein with a substitution of the Roc1b RING domain with that of Roc1a can rescue the male sterility of Roc1b mutants, but only when expressed from the endogenous Roc1b promoter. We also identified mutations of Roc2 and Cul5 and show that they cause no overt developmental phenotype, consistent with our finding that Roc2 and Cul5 proteins are exclusive binding partners, which others have observed in human cells as well. Conclusions: The Drosophila Roc proteins are highly similar, but have diverged during evolution to bind a distinct set of Cullins and to utilize RING domains that have overlapping, but not identical, function in vivo.	[Reynolds, Patrick J.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Simms, Jeffrey R.; Duronio, Robert J.] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC USA; [Duronio, Robert J.] Univ N Carolina, Lineberger Comprehensive Canc Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Reynolds, PJ (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	duronio@med.unc.edu		Duronio, Robert/0000-0001-6469-6965	American Cancer Society [RSG-04-179-01-DDC]	American Cancer Society(American Cancer Society)	This study was supported by American Cancer Society grant RSG-04-179-01-DDC. ACS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Arama E, 2007, PLOS BIOL, V5, P2745, DOI 10.1371/journal.pbio.0050251; Aso T, 2000, BIOCHEM BIOPH RES CO, V276, P355, DOI 10.1006/bbrc.2000.3451; Ayyub C, 2005, DEV DYNAM, V232, P865, DOI 10.1002/dvdy.20322; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Chen A, 2000, J BIOL CHEM, V275, P15432, DOI 10.1074/jbc.M907300199; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Dadgostar H, 1998, J BIOL CHEM, V273, P24775, DOI 10.1074/jbc.273.38.24775; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Donaldson TD, 2004, MOL BIOL CELL, V15, P4892, DOI 10.1091/mbc.E04-03-0180; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Furukawa M, 2002, J BIOL CHEM, V277, P15758, DOI 10.1074/jbc.M108565200; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Ho MS, 2006, J BIOMED SCI, V13, P181, DOI 10.1007/s11373-005-9058-2; Hori T, 1999, ONCOGENE, V18, P6829, DOI 10.1038/sj.onc.1203093; HU J, 2008, GENES DEV IN PRESS; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Liu HL, 2007, BIOTECHNOL PROGR, V23, P1231, DOI 10.1021/bp0701665; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Pelzer C, 2007, J BIOL CHEM, V282, P23010, DOI 10.1074/jbc.C700111200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sasagawa Y, 2007, FEBS LETT, V581, P145, DOI 10.1016/j.febslet.2006.12.009; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; von Arnim AG, 2003, CURR OPIN PLANT BIOL, V6, P520, DOI 10.1016/j.pbi.2003.09.006; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	50	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2918	10.1371/journal.pone.0002918	http://dx.doi.org/10.1371/journal.pone.0002918			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698375	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600006
J	Surolia, I; Sinha, S; Sarkar, DP; Reddy, PY; Reddy, GB; Surolia, A				Surolia, Ira; Sinha, Sharmistha; Sarkar, Debi Prasad; Reddy, P. Yadagiri; Reddy, G. Bhanuprakash; Surolia, Avadhesha			Concurrence of Danish Dementia and Cataract: Insights from the Interactions of Dementia Associated Peptides with Eye Lens alpha-Crystallin	PLOS ONE			English	Article								Familial Danish Dementia (FDD) is an autosomal disease, which is distinguished by gradual loss of vision, deafness, progressive ataxia and dementia. Cataract is the first manifestation of the disease. In this article, we demonstrate a specific correlation between the poisoning of the chaperone activity of the rat eye lens alpha-crystallins, loss of lens transparency in organ culture by the pathogenic form of the Danish dementia peptide, i.e. the reduced Danish dementia peptide (redADan peptide), by a combination of ex vivo, in vitro, biophysical and biochemical techniques. The interaction of redADan peptide and lens crystallins are very specific when compared with another chaperone, HSP-70, underscoring the specificity of the pathogenic form of Danish dementia peptide, redADan, for the early onset of cataract in this disease.	[Surolia, Ira; Sarkar, Debi Prasad] Univ Delhi, Dept Biochem, New Delhi, India; [Sinha, Sharmistha; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore, Karnataka, India; [Reddy, P. Yadagiri; Reddy, G. Bhanuprakash] Natl Inst Nutr, Hyderabad, Andhra Pradesh, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi, India	University of Delhi; Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Surolia, I (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	surolia@nii.res.in	Reddy, G Bhanuprakash/AAJ-3494-2020	Reddy, G Bhanuprakash/0000-0003-4787-3944; Sinha, Sharmistha/0000-0003-2459-650X; Sarkar, Debi P/0000-0002-8886-8415	Dept. of Biotechnology, Government of India; Department of Science and Technology, Government of India	Dept. of Biotechnology, Government of India; Department of Science and Technology, Government of India(Department of Science & Technology (India))	This work is supported by grants from the Dept. of Biotechnology, Government of India, and from the Department of Science and Technology, Government of India, to AS.	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Bek T, 2000, BRIT J OPHTHALMOL, V84, P1298, DOI 10.1136/bjo.84.11.1298; Bera S, 2002, BIOCHEMISTRY-US, V41, P12421, DOI 10.1021/bi0204140; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Buchner J, 1996, FASEB J, V10, P10, DOI 10.1096/fasebj.10.1.8566529; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; de Jong WW, 1998, INT J BIOL MACROMOL, V22, P151, DOI 10.1016/S0141-8130(98)00013-0; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Gibson G, 2004, J NEUROCHEM, V88, P281, DOI 10.1046/j.1471-4159.2003.02134.x; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Harding J J, 1991, Lens Eye Toxic Res, V8, P245; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; KLEMENZ R, 1991, MOL CELL BIOL, V11, P803, DOI 10.1128/MCB.11.2.803; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; Liang JJN, 2000, FEBS LETT, V484, P98, DOI 10.1016/S0014-5793(00)02136-0; Raman B, 1997, J BIOL CHEM, V272, P23559, DOI 10.1074/jbc.272.38.23559; Ramya TNC, 2006, BIOCHEM BIOPH RES CO, V348, P585, DOI 10.1016/j.bbrc.2006.07.082; Rao G, 2008, MOL VIS, V14, P666; Reddy GB, 2000, J BIOL CHEM, V275, P4565, DOI 10.1074/jbc.275.7.4565; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; Stege GJJ, 1999, BIOCHEM BIOPH RES CO, V262, P152, DOI 10.1006/bbrc.1999.1167; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; STROMGREN E, 1970, ACTA NEUROL SCAN S43, V46; SUROLIA I, 2008, BIOCH BIOPH IN PRESS; Surolia I, 2006, J NEUROCHEM, V99, P537, DOI 10.1111/j.1471-4159.2006.04072.x; Suryanarayana P, 2004, MOL VIS, V10, P148; SWAMY MS, 1987, INVEST OPHTH VIS SCI, V28, P1693; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097	33	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2927	10.1371/journal.pone.0002927	http://dx.doi.org/10.1371/journal.pone.0002927			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698348	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600013
J	Chang, YM; Kong, QM; Shan, X; Tian, GL; Ilieva, H; Cleveland, DW; Rothstein, JD; Borchelt, DR; Wong, PC; Lin, CLG				Chang, Yueming; Kong, Qiongman; Shan, Xiu; Tian, Guilian; Ilieva, Hristelina; Cleveland, Don W.; Rothstein, Jeffrey D.; Borchelt, David R.; Wong, Philip C.; Lin, Chien-liang Glenn			Messenger RNA Oxidation Occurs Early in Disease Pathogenesis and Promotes Motor Neuron Degeneration in ALS	PLOS ONE			English	Article								Background: Accumulating evidence indicates that RNA oxidation is involved in a wide variety of neurological diseases and may be associated with neuronal deterioration during the process of neurodegeneration. However, previous studies were done in postmortem tissues or cultured neurons. Here, we used transgenic mice to demonstrate the role of RNA oxidation in the process of neurodegeneration. Methodology/Principal Findings: We demonstrated that messenger RNA (mRNA) oxidation is a common feature in amyotrophic lateral sclerosis (ALS) patients as well as in many different transgenic mice expressing familial ALS-linked mutant copper-zinc superoxide dismutase (SOD1). In mutant SOD1 mice, increased mRNA oxidation primarily occurs in the motor neurons and oligodendrocytes of the spinal cord at an early, pre-symptomatic stage. Identification of oxidized mRNA species revealed that some species are more vulnerable to oxidative damage, and importantly, many oxidized mRNA species have been implicated in the pathogenesis of ALS. Oxidative modification of mRNA causes reduced protein expression. Reduced mRNA oxidation by vitamin E restores protein expression and partially protects motor neurons. Conclusion/Significance: These findings suggest that mRNA oxidation is an early event associated with motor neuron deterioration in ALS, and may be also a common early event preceding neuron degeneration in other neurological diseases.	[Chang, Yueming; Kong, Qiongman; Shan, Xiu; Tian, Guilian; Lin, Chien-liang Glenn] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Chang, Yueming; Tian, Guilian; Lin, Chien-liang Glenn] Ohio State Univ, Ohio State Biochem Program, Columbus, OH USA; [Ilieva, Hristelina; Cleveland, Don W.] Univ Calif San Diego, Dept Med & Neurosci, San Diego, CA USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA; [Borchelt, David R.] Univ Florida, Dept Neurosci, Gainesville, FL USA; [Wong, Philip C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Johns Hopkins University; State University System of Florida; University of Florida; Johns Hopkins University	Chang, YM (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	lin.492@osu.edu	Lin, Chien-liang G/E-3513-2011; Cleveland, Don/AAN-9783-2021; rothstein, jeffrey d/C-9470-2013	Cleveland, Don/0000-0002-1934-3682	ALS Association; NIH [AG17317]; Neuroscience Education and Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG017317] Funding Source: NIH RePORTER	ALS Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Education and Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by ALS Association, NIH (grant AG17317), and the Neuroscience Education and Research Foundation.	Andrus PK, 1998, J NEUROCHEM, V71, P2041; Ascherio A, 2005, ANN NEUROL, V57, P104, DOI 10.1002/ana.20316; BANIK NL, 1987, NEUROCHEM PATHOL, V7, P57, DOI 10.1007/BF02834292; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Borthwick GM, 1999, ANN NEUROL, V46, P787, DOI 10.1002/1531-8249(199911)46:5<787::AID-ANA17>3.0.CO;2-8; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; COLLARD JF, 1995, NATURE, V375, P61, DOI 10.1038/375061a0; Ding QX, 2005, J NEUROSCI, V25, P9171, DOI 10.1523/JNEUROSCI.3040-05.2005; Ekegren T, 2006, J PROTEOME RES, V5, P2364, DOI 10.1021/pr060237f; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; FIALA ES, 1989, CANCER RES, V49, P5518; Gard AL, 2001, MICROSC RES TECHNIQ, V52, P709, DOI 10.1002/jemt.1055; Gong YH, 2000, EXP NEUROL, V162, P27, DOI 10.1006/exnr.2000.7323; Graf M, 2005, J NEURAL TRANSM, V112, P649, DOI 10.1007/s00702-004-0220-1; Guentchev M, 2002, NEUROBIOL DIS, V9, P275, DOI 10.1006/nbdi.2002.0477; Guo H, 2002, MOL CELL NEUROSCI, V21, P546, DOI 10.1006/mcne.2002.1198; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hayashi M, 2002, J CHILD NEUROL, V17, P725, DOI 10.1177/08830738020170101101; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Julien JP, 2006, BBA-MOL BASIS DIS, V1762, P1013, DOI 10.1016/j.bbadis.2006.03.006; Jung CW, 2002, J NEUROCHEM, V83, P535, DOI 10.1046/j.1471-4159.2002.01112.x; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Khatri P, 2002, GENOMICS, V79, P266, DOI 10.1006/geno.2002.6698; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; Liu DX, 1999, FASEB J, V13, P2318, DOI 10.1096/fasebj.13.15.2318; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Nagano S, 2001, EUR J NEUROSCI, V13, P1363, DOI 10.1046/j.0953-816x.2001.01512.x; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nunomura A, 1999, ANN NY ACAD SCI, V893, P362, DOI 10.1111/j.1749-6632.1999.tb07855.x; Nunomura A, 2004, NEUROBIOL DIS, V17, P108, DOI 10.1016/j.nbd.2004.06.003; Nunomura A, 2002, NEUROREPORT, V13, P2035, DOI 10.1097/00001756-200211150-00009; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Shan X, 2006, NEUROBIOL AGING, V27, P657, DOI 10.1016/j.neurobiolaging.2005.03.022; Shan X, 2003, J NEUROSCI, V23, P4913; Shan X, 2007, FASEB J, V21, P2753, DOI 10.1096/fj.07-8200com; Shefner JM, 1999, NEUROLOGY, V53, P1239, DOI 10.1212/WNL.53.6.1239; Smith AP, 2007, AMYOTROPH LATERAL SC, V8, P131, DOI 10.1080/17482960701249241; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Wamer WG, 1997, FREE RADICAL BIO MED, V23, P851, DOI 10.1016/S0891-5849(97)00068-3; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Yamamoto Y, 1999, EUR J NEUROSCI, V11, P847, DOI 10.1046/j.1460-9568.1999.00490.x; Zhang J, 1999, AM J PATHOL, V154, P1423, DOI 10.1016/S0002-9440(10)65396-5	54	152	155	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2849	10.1371/journal.pone.0002849	http://dx.doi.org/10.1371/journal.pone.0002849			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682740	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600005
J	Lyon, JA; Angov, E; Fay, MP; Sullivan, JS; Girourd, AS; Robinson, SJ; Bergmann-Leitner, ES; Duncan, EH; Darko, CA; Collins, WE; Long, CA; Barnwell, JW				Lyon, Jeffrey A.; Angov, Evelina; Fay, Michael P.; Sullivan, Joann S.; Girourd, Autumn S.; Robinson, Sally J.; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Darko, Christian A.; Collins, William E.; Long, Carole A.; Barnwell, John W.			Protection Induced by Plasmodium falciparum MSP1(42) Is Strain-Specific, Antigen and Adjuvant Dependent, and Correlates with Antibody Responses	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; CARBOXYL-TERMINAL FRAGMENT; MALARIA PARASITE; AOTUS-NANCYMAI; MURINE MALARIA; IMMUNIZATION; INVASION; VACCINE; GROWTH; CHALLENGE	Vaccination with Plasmodium falciparum MSP1(42)/complete Freund's adjuvant (FA) followed by MSP1(42)/incomplete FA is the only known regimen that protects Aotus nancymaae monkeys against infection by erythrocytic stage malaria parasites. The role of adjuvant is not defined; however complete FA cannot be used in humans. In rodent models, immunity is strain-specific. We vaccinated Aotus monkeys with the FVO or 3D7 alleles of MSP1(42) expressed in Escherichia coli or with the FVO allele expressed in baculovirus (bv) combined with complete and incomplete FA, Montanide ISA-720 (ISA-720) or AS02A. Challenge with FVO strain P. falciparum showed that suppression of cumulative day 11 parasitemia was strain-specific and could be induced by E. coli expressed MSP1(42) in combination with FA or ISA-720 but not with AS02A. The coli42-FVO antigen induced a stronger protective effect than the bv42-FVO antigen, and FA induced a stronger protective effect than ISA-720. ELISA antibody (Ab) responses at day of challenge (DOC) were strain-specific and correlated inversely with c-day 11 parasitemia (r = -0.843). ELISA Ab levels at DOC meeting a titer of at least 115,000 ELISA Ab units identified the vaccinees not requiring treatment (noTx) with a true positive rate of 83.3% and false positive rate of 14.3%. Correlation between functional growth inhibitory Ab levels (GIA) and cumulative day 11 parasitemia was weaker (r = -0.511), and was not as predictive for a response of noTx. The lowest false positive rate for GIA was 30% when requiring a true positive rate of 83.3%. These inhibition results along with those showing that antigen/FA combinations induced a stronger protective immunity than antigen/ISA-720 or antigen/AS02 combinations are consistent with protection as ascribed to MSP1-specific cytophilic antibodies. Development of an effective MSP1(42) vaccine against erythrocytic stage P. falciparum infection will depend not only on antigen quality, but also upon the selection of an optimal adjuvant component.	[Lyon, Jeffrey A.; Angov, Evelina; Girourd, Autumn S.; Robinson, Sally J.; Bergmann-Leitner, Elke S.; Duncan, Elizabeth H.; Darko, Christian A.] Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA; [Fay, Michael P.] NIAID, NIH, Biostat Res Branch, Bethesda, MD USA; [Sullivan, Joann S.; Collins, William E.; Barnwell, John W.] CDC, Natl Ctr Zoonot, Vector Borne & Enter Dis, Div Parasit Dis, Malaria Branch, Atlanta, GA USA; [Long, Carole A.] NIAID, NIH, Dept Malaria & Vector Res, Bethesda, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Lyon, JA (corresponding author), Walter Reed Army Inst Res, Div Malaria Vaccine Dev, Silver Spring, MD 20910 USA.	evelina.angov@us.army.mil	Bergmann-Leitner, Elke/I-5431-2019; Bergmann-Leitner, Elke S./B-3548-2011; Fay, Michael P/A-2974-2008	Bergmann-Leitner, Elke/0000-0002-8571-8956; Bergmann-Leitner, Elke S./0000-0002-8571-8956; Fay, Michael P/0000-0002-8643-9625	U.S. Agency for International Development [936?6001, AAG-P- 00-98-00006, AAG-P-00-98-00005]; National Institutes of Health and Centers for Disease Control and Prevention [NIAID YIAI-0438-03/ CDC C100-042]; United States Army Medical Research and Materiel Command; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020, Z01AI001020] Funding Source: NIH RePORTER	U.S. Agency for International Development(United States Agency for International Development (USAID)); National Institutes of Health and Centers for Disease Control and Prevention; United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the U.S. Agency for International Development under project number 936?6001, award number AAG-P- 00-98-00006, and award number AAG-P-00-98-00005, by the National Institutes of Health and Centers for Disease Control and Prevention Interagency Agreement under grant number NIAID YIAI-0438-03/ CDC C100-042, and by the United States Army Medical Research and Materiel Command.	Angov E, 2003, MOL BIOCHEM PARASIT, V128, P195, DOI 10.1016/S0166-6851(03)00077-X; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Bergmann-Leitner ES, 2008, AM J TROP MED HYG, V78, P468, DOI 10.4269/ajtmh.2008.78.468; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; BLACKMAN MJ, 1992, MOL BIOCHEM PARASIT, V50, P307, DOI 10.1016/0166-6851(92)90228-C; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Brunham KP., 2002, MODEL SELECTION MULT; BURNS JM, 1989, J IMMUNOL, V143, P2670; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHAPPEL JA, 1993, MOL BIOCHEM PARASIT, V60, P303, DOI 10.1016/0166-6851(93)90141-J; CHULAY JD, 1981, J INFECT DIS, V144, P270, DOI 10.1093/infdis/144.3.270; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DIGGS CL, 1993, PARASITOL TODAY, V9, P300, DOI 10.1016/0169-4758(93)90130-8; FARLEY PJ, 1995, EXP PARASITOL, V80, P328, DOI 10.1006/expr.1995.1040; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; HALDAR K, 1985, J BIOL CHEM, V260, P4969; Hirunpetcharat C, 2003, VACCINE, V21, P2923, DOI 10.1016/S0264-410X(03)00132-4; HOLDER AA, 1984, PHILOS T ROY SOC B, V307, P171, DOI 10.1098/rstb.1984.0117; HOLDER AA, 1994, PARASITOLOGY, V108, pS5, DOI 10.1017/S0031182000075673; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Janeway C.A., 2004, IMMUNOBIOLOGY IMMUNE; JIN B, 2007, IMMUNOLOGY; KUMAR S, 1995, MOL MED, V1, P325, DOI 10.1007/BF03401557; Ling IT, 1997, VACCINE, V15, P1562, DOI 10.1016/S0264-410X(97)00076-5; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; LYON JA, 1987, J IMMUNOL, V138, P895; MAJARIAN WR, 1984, J IMMUNOL, V132, P3131; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2007, INFECT IMMUN, V75, P5827, DOI 10.1128/IAI.00593-07; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; PERKINS ME, 1988, J IMMUNOL, V141, P3190; Pichyangkul S, 2004, VACCINE, V22, P3831, DOI 10.1016/j.vaccine.2004.07.023; Rotman HL, 1998, J IMMUNOL, V161, P1908; Sachdeva S, 2006, VACCINE, V24, P2007, DOI 10.1016/j.vaccine.2005.11.041; Sachdeva S, 2004, INFECT IMMUN, V72, P5775, DOI 10.1128/IAI.72.10.5775-5782.2004; Segal BM, 2000, J IMMUNOL, V164, P5683, DOI 10.4049/jimmunol.164.11.5683; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Singh S, 2003, INFECT IMMUN, V71, P6766, DOI 10.1128/IAI.71.12.6766-6774.2003; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Uthaipibull C, 2001, J MOL BIOL, V307, P1381, DOI 10.1006/jmbi.2001.4574; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; Yip HC, 1999, J IMMUNOL, V162, P3942	52	65	66	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2830	10.1371/journal.pone.0002830	http://dx.doi.org/10.1371/journal.pone.0002830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665258	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300049
J	Yao, YH; Richman, L; Morehouse, C; de los Reyes, M; Higgs, BW; Boutrin, A; White, B; Coyle, A; Krueger, J; Kiener, PA; Jallal, B				Yao, Yihong; Richman, Laura; Morehouse, Chris; de los Reyes, Melissa; Higgs, Brandon W.; Boutrin, Anmarie; White, Barbara; Coyle, Anthony; Krueger, James; Kiener, Peter A.; Jallal, Bahija			Type I Interferon: Potential Therapeutic Target for Psoriasis?	PLOS ONE			English	Article								Background: Psoriasis is an immune-mediated disease characterized by aberrant epidermal differentiation, surface scale formation, and marked cutaneous inflammation. To better understand the pathogenesis of this disease and identify potential mediators, we used whole genome array analysis to profile paired lesional and nonlesional psoriatic skin and skin from healthy donors. Methodology/Principal Findings: We observed robust overexpression of type I interferon (IFN)-inducible genes and genomic signatures that indicate T cell and dendritic cell infiltration in lesional skin. Up-regulation of mRNAs for IFN-alpha subtypes was observed in lesional skin compared with nonlesional skin. Enrichment of mature dendritic cells and 2 type I IFN-inducible proteins, STAT1 and ISG15, were observed in the majority of lesional skin biopsies. Concordant overexpression of IFN-gamma and TNF-alpha-inducible gene signatures occurred at the same disease sites. Conclusions/Significance: Up-regulation of TNF-alpha and elevation of the TNF-alpha-inducible gene signature in lesional skin underscore the importance of this cytokine in psoriasis; these data describe a molecular basis for the therapeutic activity of anti-TNF-alpha agents. Furthermore, these findings implicate type I IFNs in the pathogenesis of psoriasis. Consistent and significant up-regulation of type I IFNs and their associated gene signatures in psoriatic skin suggest that type I IFNs may be potential therapeutic targets in psoriasis treatment.	[Yao, Yihong; Richman, Laura; Morehouse, Chris; de los Reyes, Melissa; Higgs, Brandon W.; Boutrin, Anmarie; White, Barbara; Coyle, Anthony; Kiener, Peter A.; Jallal, Bahija] MedImmune Inc, Gaithersburg, MD USA; [Krueger, James] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY USA	AstraZeneca; Medimmune; Rockefeller University	Yao, YH (corresponding author), MedImmune Inc, Gaithersburg, MD USA.	YaoY@MedImmune.com		Higgs, Brandon/0000-0002-2951-0245				Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Bave U, 2005, ARTHRITIS RHEUM-US, V52, P1185, DOI 10.1002/art.20998; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chamian F, 2005, P NATL ACAD SCI USA, V102, P2075, DOI 10.1073/pnas.0409569102; Chamian F, 2004, CURR OPIN RHEUMATOL, V16, P331, DOI 10.1097/01.bor.0000129715.35024.50; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Downs AMR, 2000, CLIN EXP DERMATOL, V25, P351, DOI 10.1046/j.1365-2230.2000.00655-4.x; Eriksen KW, 2005, J INVEST DERMATOL, V125, P936, DOI 10.1111/j.0022-202X.2005.23864.x; FUNK J, 1991, BRIT J DERMATOL, V125, P463, DOI 10.1111/j.1365-2133.1991.tb14774.x; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Greenberg SA, 2005, ANN NEUROL, V57, P664, DOI 10.1002/ana.20464; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; Hida S, 2000, IMMUNITY, V13, P643, DOI 10.1016/S1074-7613(00)00064-9; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Ketikoglou I, 2005, EUR J DERMATOL, V15, P107; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; Lebwohl M, 2003, LANCET, V361, P1197, DOI 10.1016/S0140-6736(03)12954-6; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Lew W, 2004, TRENDS IMMUNOL, V25, P295, DOI 10.1016/j.it.2004.03.006; LIVDEN JK, 1989, ARCH DERMATOL RES, V281, P392, DOI 10.1007/BF00455323; *MEDIMMUNE, DAT FIL; Mee JB, 2006, CYTOKINE, V33, P72, DOI 10.1016/j.cyto.2005.12.001; Nestle FO, 2005, J INVEST DERMATOL, V125, pXIV, DOI 10.1111/j.0022-202X.2005.23923.x; Nestle FO, 2005, J EXP MED, V202, P135, DOI 10.1084/jem.20050500; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; PAULUZZI P, 1993, ACTA DERM-VENEREOL, V73, P395; SCHMID P, 1994, J INTERFERON RES, V14, P229, DOI 10.1089/jir.1994.14.229; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Van der Fits L, 2004, J INVEST DERMATOL, V122, P51, DOI 10.1046/j.0022-202X.2003.22113.x; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	38	211	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2737	10.1371/journal.pone.0002737	http://dx.doi.org/10.1371/journal.pone.0002737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648529	gold, Green Submitted, Green Published			2022-12-27	WOS:000264057200073
J	Inderjit; Pollock, JL; Callaway, RM; Holben, W				Inderjit; Pollock, Jarrod L.; Callaway, Ragan M.; Holben, William			Phytotoxic Effects of (+/-)-Catechin In vitro, in Soil, and in the Field	PLOS ONE			English	Article							CENTAUREA-MACULOSA; ALLELOCHEMICAL (+/-)-CATECHIN; INVASIVE PLANT; ALLELOPATHY; WEAPONS; WEED; DYNAMICS	Background: Exploring the residence time of allelochemicals released by plants into different soils, episodic exposure of plants to allelochemicals, and the effects of allelochemicals in the field has the potential to improve our understanding of interactions among plants. Methodology/Principal Findings: We conducted experiments in India and the USA to understand the dynamics of soil concentrations and phytotoxicity of (+/-)-catechin, an allelopathic compound exuded from the roots of Centaurea maculosa, to other plants in vitro and in soil. Experiments with single and pulsed applications into soil were conducted in the field. Experimental application of (+/-)-catechin to soils always resulted in concentrations that were far lower than the amounts added but within the range of reported natural soil concentrations. Pulses replenished (+/-)-catechin levels in soils, but consistently at concentrations much lower than were applied, and even pulsed concentrations declined rapidly. Different natural soils varied substantially in the retention of (+/-)-catechin after application but consistent rapid decreases in concentrations over time suggested that applied experimental concentrations may overestimate concentrations necessary for phytotoxicity by over an order of magnitude. (+/-)-Catechin was not phytotoxic to Bambusa arundinacea in natural Indian soil in a single pulse, but soil concentrations at the time of planting seeds were either undetectable or very low. However, a single dose of (+/-)-catechin suppressed the growth of bamboo in sand, in soil mixed with organic matter, and Koeleria macrantha in soils from Montana and Romania, and in field applications at 40 mu g l(-1). Multiple pulses of (+/-)-catechin were inhibitory at very low concentrations in Indian soil. Conclusions/Significance: Our results demonstrate that (+/-)-catechin is highly dynamic in natural soils, but is phytotoxic well below natural concentrations measured in some soils and applied at low concentrations in the field. However, there is substantial conditionality in the effects of the allelochemical.	[Inderjit] Univ Delhi, CEMDE, Delhi 110007, India; [Pollock, Jarrod L.; Callaway, Ragan M.; Holben, William] Univ Montana, Div Biol Sci, Missoula, MT USA	University of Delhi; University of Montana System; University of Montana	Inderjit (corresponding author), Univ Delhi, CEMDE, Delhi 110007, India.	inderjit@cemde.du.ac.in	Pollock, Jarrod/F-4925-2010		University of Delhi, India; Ministry of Environment and Forests, India; Research Office at The University of Montana; Aldo Leopold Wilderness Center; USFS Fire Sciences Laboratory; Rocky Mountain Research Station; USDA; DoD SERDP; National Science Foundation; Civilian Research and Development Foundation	University of Delhi, India(University of Delhi); Ministry of Environment and Forests, India; Research Office at The University of Montana; Aldo Leopold Wilderness Center; USFS Fire Sciences Laboratory; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); USDA(United States Department of Agriculture (USDA)); DoD SERDP; National Science Foundation(National Science Foundation (NSF)); Civilian Research and Development Foundation	This work was supported by the University of Delhi, India; Ministry of Environment and Forests, India; Research Office at The University of Montana, the Aldo Leopold Wilderness Center, the USFS Fire Sciences Laboratory and Rocky Mountain Research Station, the USDA, DoD SERDP, the National Science Foundation, and the Civilian Research and Development Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alford ER, 2007, SOIL BIOL BIOCHEM, V39, P1812, DOI 10.1016/j.soilbio.2007.01.020; Allen SE, 1989, CHEM ANAL ECOLOGICAL; An M, 2002, PLANT SOIL, V246, P11, DOI 10.1023/A:1021581412982; APPEL HM, 1993, J CHEM ECOL, V19, P1521, DOI 10.1007/BF00984895; Arunachalam M, 2003, MICROBIOL RES, V158, P37, DOI 10.1078/0944-5013-00174; Bais HP, 2002, PLANT PHYSIOL, V128, P1173, DOI 10.1104/pp.011019; Bais HP, 2003, SCIENCE, V301, P1377, DOI 10.1126/science.1083245; Blair AC, 2005, ECOL LETT, V8, P1039, DOI 10.1111/j.1461-0248.2005.00805.x; Blair AC, 2006, J CHEM ECOL, V32, P2327, DOI 10.1007/s10886-006-9168-y; BUTA JG, 1985, PHYTOCHEMISTRY, V25, P93, DOI 10.1016/S0031-9422(00)94508-4; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P341; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; D'Abrosca B, 2006, J CHEM ECOL, V32, P81, DOI 10.1007/s10886-006-9354-y; Djurisic AB, 2004, APPL PHYS A-MATER, V78, P375, DOI 10.1007/s00339-002-1915-5; Furubayashi A, 2007, J CHEM ECOL, V33, P239, DOI 10.1007/s10886-006-9218-5; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Huang ZQ, 2003, J CHEM ECOL, V29, P2263, DOI 10.1023/A:1026222414059; HUNECK S, 1986, PLANTA MED, V5, P343; Inderjit, 2006, TRENDS PLANT SCI, V11, P574, DOI 10.1016/j.tplants.2006.10.004; INDERJIT, 1994, AM J BOT, V81, P799, DOI 10.2307/2445760; Inderjit, 2001, AGRON J, V93, P79; INDERJIT, 2005, PLANT SOIL, V53, P97; Iqbal Z, 2003, WEED SCI, V51, P657, DOI 10.1614/0043-1745(2003)051[0657:AAOBIA]2.0.CO;2; KELSEY RG, 1987, J CHEM ECOL, V13, P19, DOI 10.1007/BF01020348; Mallik AU, 2000, J CHEM ECOL, V26, P2197, DOI 10.1023/A:1005528701927; MARCO JA, 1992, PHYTOCHEMISTRY, V31, P3527, DOI 10.1016/0031-9422(92)83721-A; Paveto C, 2004, ANTIMICROB AGENTS CH, V48, P69, DOI 10.1128/AAC.48.1.69-74.2004; Pedrol N, 2006, ALLELOPATHY: A PHYSIOLOGICAL PROCESS WITH ECOLOGICAL IMPLICATIONS, P171, DOI 10.1007/1-4020-4280-9_9; Perry LG, 2007, J CHEM ECOL, V33, P2337, DOI 10.1007/s10886-007-9383-1; Perry LG, 2005, RESTOR ECOL, V13, P725, DOI 10.1111/j.1526-100X.2005.00092.x; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Piper C.S., 1966, SOIL PLANT ANAL; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; RABOTNOV TA, 1982, EKOLOGIA         MAY, P5; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; RIDENOUR WM, ECOLOGY IN PRESS; Rudrappa T, 2007, J CHEM ECOL, V33, P1898, DOI 10.1007/s10886-007-9353-7; Simoes K, 2008, J CHEM ECOL, V34, P681, DOI 10.1007/s10886-008-9443-1; SPSS Inc., 2006, SPSS BAS 15 0 WIND U; Stinson KA, 2006, PLOS BIOL, V4, P727, DOI 10.1371/journal.pbio.0040140; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; Thelen GC, 2005, ECOL LETT, V8, P209, DOI 10.1111/j.1461-0248.2004.00713.x; THORPE A, 2006, THESIS U MONTANA MIS; Thorpe AS, 2006, APPL SOIL ECOL, V32, P118, DOI 10.1016/j.apsoil.2005.02.018; Vivanco JM, 2004, ECOL LETT, V7, P285, DOI 10.1111/j.1461-0248.2004.00576.x; Weidenhamer J, 2005, J CHEM ECOL, V31, P221, DOI 10.1007/s10886-005-1337-x; Weir TL, 2006, PLANTA, V223, P785, DOI 10.1007/s00425-005-0192-x; Weir TL, 2003, J CHEM ECOL, V29, P2397, DOI 10.1023/A:1026313031091	51	64	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2536	10.1371/journal.pone.0002536	http://dx.doi.org/10.1371/journal.pone.0002536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648546	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200008
J	O'Riordan, P; Schwab, U; Logan, S; Cooke, G; Wilkinson, RJ; Davidson, RN; Bassett, P; Wall, R; Pasvol, G; Flanagan, KL				O'Riordan, Philly; Schwab, Uli; Logan, Sarah; Cooke, Graham; Wilkinson, Robert J.; Davidson, Robert N.; Bassett, Paul; Wall, Robert; Pasvol, Geoffrey; Flanagan, Katie L.			Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study	PLOS ONE			English	Article							SURVEILLANCE; SITUATION; RISK	Background: Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often delayed, increasing the risk of spread to the community and health care workers. Treatment is prolonged, and the total cost of treating a single case is high. Diagnosis has traditionally relied upon clinical suspicion, based on risk factors and culture with sensitivity testing, a process that can take weeks or months. Rapid diagnostic molecular techniques have the potential to shorten the time to commencing appropriate therapy, but have not been put to the test under field conditions. Methodology/Principal Findings: This retrospective case-control study aimed to identify risk factors for MDR-TB, and analyse the impact of testing for rifampicin resistance using RNA polymerase B (rpoB) mutations as a surrogate for MDR-TB. Forty two MDR-TB cases and 84 fully sensitive TB controls were matched by date of diagnosis; and factors including demographics, clinical presentation, microbiology findings, management and outcome were analysed using their medical records. Conventionally recognised risk factors for MDR-TB were absent in almost half (43%) of the cases, and 15% of cases were asymptomatic. A significant number of MDR-TB cases were identified in new entrants to the country. Using rpoB mutation testing, the time to diagnosis of MDR-TB was dramatically shortened by a median of 6 weeks, allowing patients to be commenced on appropriate therapy a median of 51 days earlier than those diagnosed by conventional culture and sensitivity testing. Conclusions/Significance: MDR-TB is frequently an unexpected finding, may be asymptomatic, and is particularly prevalent among TB infected new entrants to the country. Molecular resistance testing of all acid fast bacilli positive specimens has the potential to rapidly identify MDR-TB patients and commence them on appropriate therapy significantly earlier than by conventional methods.	[O'Riordan, Philly; Schwab, Uli; Logan, Sarah; Cooke, Graham; Wilkinson, Robert J.; Davidson, Robert N.; Bassett, Paul; Pasvol, Geoffrey; Flanagan, Katie L.] Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England; [Wilkinson, Robert J.; Pasvol, Geoffrey] Imperial Coll London, Wellcome Ctr Clin Trop Med, Div Med, London, England; [Wall, Robert] Northwick Park Hosp, Dept Med Microbiol, Harrow, Middx, England	Imperial College London; Imperial College London	O'Riordan, P (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Dept Infect & Trop Med, Harrow HA1 3UJ, Middx, England.	kflanagan@mrc.gm		Cooke, Graham/0000-0001-6475-5056; Bassett, Paul/0000-0001-7830-4563; Wilkinson, Robert/0000-0002-2753-1800; Flanagan, Katie/0000-0002-1575-1953	MRC [MC_U117588499] Funding Source: UKRI; Medical Research Council [MC_U117588499] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Callister MEJ, 2002, THORAX, V57, P152, DOI 10.1136/thorax.57.2.152; Caws M, 2001, ANN NY ACAD SCI, V953, P138, DOI 10.1111/j.1749-6632.2001.tb11371.x; Cohn DL, 1997, CLIN INFECT DIS, V24, pS121, DOI 10.1093/clinids/24.Supplement_1.S121; DEBEENHOUWER H, 1995, J CLIN MICROBIOL, V33, P2994, DOI 10.1128/JCM.33.11.2994-2998.1995; Drobniewski F, 2002, THORAX, V57, P810, DOI 10.1136/thorax.57.9.810; El Sahly HM, 2006, J INFECTION, V53, P5, DOI 10.1016/j.jinf.2005.10.002; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; HARDIE RM, 1993, BRIT MED J, V307, P1539, DOI 10.1136/bmj.307.6918.1539; HAYWARD A, 1996, THORAX S, V3, pS31; *HLTH PROT AG LOND, 2005, UK MYC SURV NETW REP; *HLTH PROT AG LOND, 2006, FOC TUB ANN SURV REP; Ormerod LP, 1998, J INFECTION, V37, P39, DOI 10.1016/S0163-4453(98)90432-7; Ormerod P, 2001, ANN NY ACAD SCI, V953, P185, DOI 10.1111/j.1749-6632.2001.tb11376.x; Rajbhandary SS, 2004, INT J TUBERC LUNG D, V8, P1012; Sam IC, 2006, EMERG INFECT DIS, V12, P752, DOI 10.3201/eid1205.041339; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; White VLC, 2000, THORAX, V55, P962, DOI 10.1136/thorax.55.11.962; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2003, TREATM TUB GUID NAT	23	34	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3173	10.1371/journal.pone.0003173	http://dx.doi.org/10.1371/journal.pone.0003173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779863	gold, Green Submitted, Green Published			2022-12-27	WOS:000264425100009
J	Bernatavichute, YV; Zhang, XY; Cokus, S; Pellegrini, M; Jacobsen, SE				Bernatavichute, Yana V.; Zhang, Xiaoyu; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.			Genome-Wide Association of Histone H3 Lysine Nine Methylation with CHG DNA Methylation in Arabidopsis thaliana	PLOS ONE			English	Article								Methylation of histone H3 lysine 9 (H3K9) is a hallmark of transcriptional silencing in many organisms. In Arabidopsis thaliana, dimethylation of H3K9 (H3K9m2) is important in the silencing of transposons and in the control of DNA methylation. We constructed a high-resolution genome-wide map of H3K9m2 methylation by using chromatin immunoprecipitation coupled with whole genome Roche Nimblegen microarrays (ChIP-chip). We observed a very high coincidence between H3K9m2 and CHG methylation (where H is either A, T or C) throughout the genome. The coding regions of genes that are associated exclusively with methylation in a CG context did not contain H3K9m2. In addition, we observed two distinct patterns of H3K9m2. Transposons and other repeat elements present in the euchromatic arms contained small islands of H3K9m2 present at relatively low levels. In contrast, pericentromeric/centromeric regions of Arabidopsis chromosomes contained long, rarely interrupted blocks of H3K9m2 present at much higher average levels than seen in the chromosome arms. These results suggest a complex interplay between H3K9m2 and different types of DNA methylation and suggest that distinct mechanisms control H3K9m2 in different compartments of the genome.	[Bernatavichute, Yana V.; Jacobsen, Steven E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Bernatavichute, Yana V.; Cokus, Shawn; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol, Cell & Dev Biol, Los Angeles, CA 90024 USA; [Zhang, Xiaoyu] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University System of Georgia; University of Georgia; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Pellegrini, M (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	matteop@mcdb.ucla.edu; jacobsen@ucla.edu	Zhang, xiaoyu/GXA-3206-2022	Pellegrini, Matteo/0000-0001-9355-9564	USPHS National Research Sevice Award [GM07104]; Jonsson Cancer Center Foundation [fellowship]; NIH [GM60398]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	USPHS National Research Sevice Award; Jonsson Cancer Center Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Y.V.B. was supported by USPHS National Research Sevice Award GM07104. X.Z. was supported by a fellowship from the Jonsson Cancer Center Foundation. Jacobsen lab research was supported by NIH grant GM60398. S.E.J. is an investigator of the Howard Hughes Medical Institute.	Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; FINNEGAN EJ, 1993, NUCLEIC ACIDS RES, V21, P2383, DOI 10.1093/nar/21.10.2383; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Jasencakova Z, 2003, PLANT J, V33, P471, DOI 10.1046/j.1365-313X.2003.01638.x; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kankel MW, 2003, GENETICS, V163, P1109; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; TURCK F, 2007, IN PRESS PLOS GENET, DOI DOI 10.1371/JOURNAL.PGEN.0030086.EOR; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	51	238	246	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3156	10.1371/journal.pone.0003156	http://dx.doi.org/10.1371/journal.pone.0003156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776934	Green Published, gold			2022-12-27	WOS:000264424300003
J	Buijs, RM; van der Vliet, J; Garidou, ML; Huitinga, I; Escobar, C				Buijs, Ruud M.; van der Vliet, Jan; Garidou, Mari-Laure; Huitinga, Inge; Escobar, Carolina			Spleen Vagal Denervation Inhibits the Production of Antibodies to Circulating Antigens	PLOS ONE			English	Article								Background: Recently the vagal output of the central nervous system has been shown to suppress the innate immune defense to pathogens. Here we investigated by anatomical and physiological techniques the communication of the brain with the spleen and provided evidence that the brain has the capacity to stimulate the production of antigen specific antibodies by its parasympathetic autonomic output. Methodology/Principal Findings: This conclusion was reached by successively demonstrating that: 1. The spleen receives not only sympathetic input but also parasympathetic input. 2. Intravenous trinitrophenyl-ovalbumin (TNP-OVA) does not activate the brain and does not induce an immune response. 3. Intravenous TNP-OVA with an inducer of inflammation; lipopolysaccharide (LPS), activates the brain and induces TNP-specific IgM. 4. LPS activated neurons are in the same areas of the brain as those that provide parasympathetic autonomic information to the spleen, suggesting a feed back circuit between brain and immune system. Consequently we investigated the interaction of the brain with the spleen and observed that specific parasympathetic denervation but not sympathetic denervation of the spleen eliminates the LPS-induced antibody response to TNP-OVA. Conclusions/Significance: These findings not only show that the brain can stimulate antibody production by its autonomic output, it also suggests that the power of LPS as adjuvant to stimulate antibody production may also depend on its capacity to activate the brain. The role of the autonomic nervous system in the stimulation of the adaptive immune response may explain why mood and sleep have an influence on antibody production.	[Buijs, Ruud M.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [van der Vliet, Jan; Garidou, Mari-Laure; Huitinga, Inge] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Escobar, Carolina] Univ Nacl Autonoma Mexico, Fac Med, Dept Anat, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Universidad Nacional Autonoma de Mexico	Buijs, RM (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	ruudbuijs@gmail.com	Escobar, Carolina/AAX-2354-2020; Buijs, Rudolf/AAD-5707-2020	Escobar, Carolina/0000-0002-2974-7875; 	DGAPA PAPIIT [IN215308-3]	DGAPA PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This study was supported in part by DGAPA PAPIIT IN215308-3.	Batocchi AP, 2003, J NEUROIMMUNOL, V139, P150, DOI 10.1016/S0165-5728(03)00154-1; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Buijs RM, 2001, J COMP NEUROL, V431, P405, DOI 10.1002/1096-9861(20010319)431:4<405::AID-CNE1079>3.0.CO;2-D; Cottrell GT, 2004, REGUL PEPTIDES, V117, P11, DOI 10.1016/j.regpep.2003.09.004; COVERT JB, 1971, INFECT IMMUN, V4, P452, DOI 10.1128/IAI.4.4.452-455.1971; DELREY A, 2006, P NATL ACAD SCI US; ENQUIST LW, 1994, SEMIN VIROL, V5, P221, DOI 10.1006/smvy.1994.1024; Fry M, 2007, EXP BIOL MED, V232, P14; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; Goehler LE, 2006, NEUROSCIENCE, V140, P1415, DOI 10.1016/j.neuroscience.2006.03.048; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Hansen MK, 2000, AUTON NEUROSCI-BASIC, V85, P83, DOI 10.1016/S1566-0702(00)00224-1; Hopkins Stephen J, 2007, Acta Biomed, V78 Suppl 1, P231; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Kalsbeek A, 1996, J NEUROENDOCRINOL, V8, P299, DOI 10.1046/j.1365-2826.1996.04597.x; Kreier F, 2002, J CLIN INVEST, V110, P1243, DOI 10.1172/JCI200215736; Laflamme N, 2001, FASEB J, V15, P155, DOI 10.1096/fj.00-0339com; LANG CH, 1995, AM J PHYSIOL-REG I, V269, pR437, DOI 10.1152/ajpregu.1995.269.2.R437; LIND RW, 1985, NEUROENDOCRINOLOGY, V40, P2; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Rivest S, 2001, PSYCHONEUROENDOCRINO, V26, P761, DOI 10.1016/S0306-4530(01)00064-6; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosenkranz MA, 2005, P NATL ACAD SCI USA, V102, P13319, DOI 10.1073/pnas.0504365102; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Ruggiero DA, 1996, J COMP NEUROL, V364, P51; Sakaguchi T, 2002, AUTON NEUROSCI-BASIC, V99, P54, DOI 10.1016/S1566-0702(02)00060-7; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Schafer MKH, 1998, NEUROSCIENCE, V84, P361, DOI 10.1016/S0306-4522(97)80196-0; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Straub RH, 2004, TRENDS PHARMACOL SCI, V25, P640, DOI 10.1016/j.tips.2004.10.007; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Turek VF, 2005, PHARMACOL BIOCHEM BE, V80, P115, DOI 10.1016/j.pbb.2004.10.013; VANDERKOOY D, 1983, J COMP NEUROL, V219, P328, DOI 10.1002/cne.902190307; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339	36	78	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3152	10.1371/journal.pone.0003152	http://dx.doi.org/10.1371/journal.pone.0003152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773078	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420100009
J	Vallerie, SN; Furuhashi, M; Fucho, R; Hotamisligil, GS				Vallerie, Sara N.; Furuhashi, Masato; Fucho, Raquel; Hotamisligil, Goekhan S.			A Predominant Role for Parenchymal c-Jun Amino Terminal Kinase (JNK) in the Regulation of Systemic Insulin Sensitivity	PLOS ONE			English	Article								It has been established that c-Jun N-terminal kinase 1 (JNK1) is essential to the pathogenesis of insulin resistance and type 2 diabetes. Although JNK influences inflammatory signaling pathways, it remains unclear whether its activity in macrophages contributes to adipose tissue inflammation and ultimately to the regulation of systemic metabolism. To address whether the action of this critical inflammatory kinase in bone marrow-derived elements regulates inflammatory responses in obesity and is sufficient and necessary for the deterioration of insulin sensitivity, we performed bone marrow transplantation studies with wild type and JNK1-deficient mice. These studies illustrated that JNK1-deficiency in the bone marrow-derived elements (BMDE) was insufficient to impact macrophage infiltration or insulin sensitivity despite modest changes in the inflammatory profile of adipose tissue. Only when the parenchymal elements lacked JNK1 could we demonstrate a significant increase in systemic insulin sensitivity. These data indicate that while the JNK1 activity in BMDE is involved in metabolic regulation and adipose milieu, it is epistatic to JNK1 activity in the parenchymal tissue for regulation of metabolic homeostasis.	[Vallerie, Sara N.; Furuhashi, Masato; Fucho, Raquel; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Vallerie, SN (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Fucho, Raquel/A-6684-2016	Furuhashi, Masato/0000-0002-0145-3541; Fucho, Raquel/0000-0002-1774-9099	National Institutes of Health, USA [DK52539]; Irene M. and Frederick J. Stare Nutrition Education Fund; Japan Society for the Promotion of Science and American Diabetes Association [postdoctoral fellowships];  [T90 DK70078];  [F31 DK072556]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052539, F31DK072556, T90DK070078] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irene M. and Frederick J. Stare Nutrition Education Fund; Japan Society for the Promotion of Science and American Diabetes Association; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by a grant from the National Institutes of Health, USA, to GSH (DK52539). SNV received support from the Irene M. and Frederick J. Stare Nutrition Education Fund and the T90 DK70078 Interdisciplinary Training Grant in Genetics & Complex Diseases. SNV is currently supported by a F31 DK072556 Predoctoral Fellowship to Promote Diversity in Health-Related Research. MF is supported by postdoctoral fellowships from the Japan Society for the Promotion of Science and American Diabetes Association.	Ablamunits V, 2007, OBESITY, V15, P1419, DOI 10.1038/oby.2007.170; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; COUSE JF, 1994, BIOTECHNIQUES, V17, P1030; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fujii N, 2004, AM J PHYSIOL-CELL PH, V287, pC200, DOI 10.1152/ajpcell.00415.2003; Furuhashi M, 2008, J CLIN INVEST, V118, P2640, DOI 10.1172/JCI34750; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Witczak CA, 2006, BIOCHEM BIOPH RES CO, V350, P1063, DOI 10.1016/j.bbrc.2006.09.158; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang R, 2007, J BIOL CHEM, V282, P22765, DOI 10.1074/jbc.M700790200; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	41	83	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3151	10.1371/journal.pone.0003151	http://dx.doi.org/10.1371/journal.pone.0003151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773087	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420100008
J	Dehmer, M; Borgert, S; Emmert-Streib, F				Dehmer, Matthias; Borgert, Stephan; Emmert-Streib, Frank			Entropy Bounds for Hierarchical Molecular Networks	PLOS ONE			English	Article							INFORMATION-CONTENT; GRAPH ENTROPY; COMPLEXITY; SIMILARITY; SUPERTREE; INDEX	In this paper we derive entropy bounds for hierarchical networks. More precisely, starting from a recently introduced measure to determine the topological entropy of non-hierarchical networks, we provide bounds for estimating the entropy of hierarchical graphs. Apart from bounds to estimate the entropy of a single hierarchical graph, we see that the derived bounds can also be used for characterizing graph classes. Our contribution is an important extension to previous results about the entropy of non-hierarchical networks because for practical applications hierarchical networks are playing an important role in chemistry and biology. In addition to the derivation of the entropy bounds, we provide a numerical analysis for two special graph classes, rooted trees and generalized trees, and demonstrate hereby not only the computational feasibility of our method but also learn about its characteristics and interpretability with respect to data analysis.	[Dehmer, Matthias] Univ Vienna Technol, Inst Discrete Math & Geomet, A-1010 Vienna, Austria; [Borgert, Stephan] Univ Siegen, Dept Phys, Siegen, Germany; [Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Dept Biomed Sci, Belfast BT7 1NN, Antrim, North Ireland	Technische Universitat Wien; Universitat Siegen; Queens University Belfast	Dehmer, M (corresponding author), Univ Coimbra, Ctr Math, Coimbra, Portugal.	mdehmer@geometrie.tuwien.ac.at	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641	European FP6-NEST-Adventure Programme [028875]	European FP6-NEST-Adventure Programme(European Commission)	Matthias Dehmer has been supported by the European FP6-NEST-Adventure Programme, contract No. 028875.	[Anonymous], MINING GRAPH DATA; [Anonymous], P INT C INT MATH CHE; [Anonymous], INT J MATH STAT SCI; [Anonymous], ELECT RES ANNOUNCEME; Aringhieri R, 2001, J CHEM INF COMP SCI, V41, P958, DOI 10.1021/ci0001536; Aringhieri R, 2003, 4OR-Q J OPER RES, V1, P67, DOI 10.1007/s10288-002-0008-9; BangJensen Jorgen, 2002, DIGRAPHS THEORY ALGO; Barabasi A.L., 2003, LINKED EVERYTHING IS; Benigni R, 2003, QUANTITATIVE STRUCTU; BOHANEC S, 1993, J CHEM INF COMP SCI, V33, P719, DOI 10.1021/ci00015a010; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Bonchev D, 2000, J CHEM INF COMP SCI, V40, P934, DOI 10.1021/ci990120u; BONCHEV D, 1989, THEOCHEM-J MOL STRUC, V54, P155, DOI 10.1016/0166-1280(89)85011-0; Bonchev D., 2003, COMPLEXITY INTRO FUN, DOI DOI 10.1201/9781482288247; Bonchev D., 1991, CHEM GRAPH THEORY IN; Bonchev D., 2005, COMPLEXITY CHEM BIOL, DOI 10.1007/b136300; Bonchev D, 1983, INFORM THEORETIC IND; Brillouin L., 1956, SCI INFORM THEORY; Brinkmeier M, 2005, LECT NOTES COMPUT SC, V3418, P293; Bunke H, 2000, INT C PATT RECOG, P117, DOI 10.1109/ICPR.2000.906030; BUNKE H, 1983, B EATCS, V20, P35; Chepoi V, 1996, J CHEM INF COMP SCI, V36, P1169, DOI 10.1021/ci9600869; Dancoff SM, 1953, ESSAYS USE INFORM TH, P263; DEHMER M, 2006, INT J COMPUTATIONAL, V3, P1; Dehmer M, 2008, APPL MATH COMPUT, V201, P82, DOI 10.1016/j.amc.2007.12.010; Dehmer M, 2008, COMPUT BIOL CHEM, V32, P131, DOI 10.1016/j.compbiolchem.2007.09.007; Devillers J., 2000, TOPOLOGICAL INDICES; Diudea M.V., 2001, MOL TOPOLOGY; Diudea MV., 2001, MOL TOPOLOGY; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Elk SB, 1990, J MATH CHEM, V4, P55, DOI 10.1007/BF01170004; Emmert-Streib F, 2005, DMIN '05: PROCEEDINGS OF THE 2005 INTERNATIONAL CONFERENCE ON DATA MINING, P200; EMMERTSTREIB F, 2006, INT J BIOMEDICAL SCI, V1, P17; Felsenstein J, 2004, INFERRING PHYLOGENIE; Foulds L.R, 1992, GRAPH THEORY APPL; GAMBIN A, 2005, CR BIOL, V328, P1; Gutman I., 1986, MATH CONCEPTS ORGANI, DOI [10.1007/978-3-642-70982-1, DOI 10.1007/978-3-642-70982-1]; HALIN R, 1989, GRAPHENTHEORIE; Harary F., 1969, GRAPH THEORY; Hochsmann M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P159, DOI 10.1109/CSB.2003.1227315; HORVATH T, 2005, P 2004 ACM SIGKDD IN, P158; KADEN F, AKAD WISS DDR, V2, P1; Korner J., 1973, T 6 PRAG C INF THEOR, P411; LINSHITZ H, 1953, ESSAYS USE INFORM TH, P14; Liu SC, 2000, INT J QUANTUM CHEM, V78, P331, DOI 10.1002/(SICI)1097-461X(2000)78:5<331::AID-QUA4>3.0.CO;2-V; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; MATULA DW, 1968, SIAM REV, V10, P273; MEHLER A, 2004, P 4 INT WORKSH INN I, V3473, P136; MORIHIRO H, 2006, IPSJ SIG TECHNICAL R, V99, P1; Morowitz H, 1953, B MATH BIOPHYS, V17, P81; MOWSHOWI.A, 1968, B MATH BIOPHYS, V30, P533, DOI 10.1007/BF02476673; MOWSHOWI A, 1968, B MATH BIOPHYS, V30, P387, DOI 10.1007/BF02476603; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; MULLER WR, 1995, J CHEM INF COMP SCI, V35, P211; Quastler Henry, 1953, B MATH BIOL; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; Rupp M, 2007, J CHEM INF MODEL, V47, P2280, DOI 10.1021/ci700274r; SAHU PK, 2008, CHEM PHYS L IN PRESS; Semple C, 2000, DISCRETE APPL MATH, V105, P147, DOI 10.1016/S0166-218X(00)00202-X; Semple C., 2003, GRADUATE SERIES MATH; Shannon CE, 1997, MATH THEORY COMMUNIC; SHAPIRO BA, 1990, COMPUT APPL BIOSCI, V6, P309; Simonyi G, 2001, WIL INT S D, P293; Skorobogatov VA, 1988, MATCH-COMMUN MATH CO, V23, P105; Skvortsova MI, 1998, J CHEM INF COMP SCI, V38, P785, DOI 10.1021/ci970037b; Sobik F, 1982, AKAD WISS DDR, V2, P63; SOBIK F, 1986, AKAD WISS DDR, V4, P104; Steel M, 2000, SYST BIOL, V49, P363, DOI 10.1093/sysbio/49.2.363; Trinajstic N., 2018, CHEM GRAPH THEORY; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Visco DP, 2002, J MOL GRAPH MODEL, V20, P429, DOI 10.1016/S1093-3263(01)00144-9; Zelinka A, 1975, CASOPIS PEST MAT, V100, P371, DOI DOI 10.21136/CPM.1975.117890; ZHU P, 2005, 16 BRIT MACH VIS C O; Zmazek B, 2007, CROAT CHEM ACTA, V80, P75	75	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3079	10.1371/journal.pone.0003079	http://dx.doi.org/10.1371/journal.pone.0003079			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769487	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796600001
J	MacArthur, BD; Please, CP; Oreffo, ROC				MacArthur, Ben D.; Please, Colin P.; Oreffo, Richard O. C.			Stochasticity and the Molecular Mechanisms of Induced Pluripotency	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LINEAGE SPECIFICATION; POSITIVE-FEEDBACK; SELF-RENEWAL; IN-VITRO; DIFFERENTIATION; MOUSE; MODEL	The generation of induced pluripotent stem cells from adult somatic cells by ectopic expression of key transcription factors holds significant medical promise. However, current techniques for inducing pluripotency rely on viral infection and are therefore not, at present, viable within a clinical setting. Thus, there is now a need to better understand the molecular basis of stem cell pluripotency and lineage specification in order to investigate alternative methods to induce pluripotency for clinical application. However, the complexity of the underlying molecular circuitry makes this a conceptually difficult task. In order to address these issues, we considered a computational model of transcriptional control of cell fate specification. The model comprises two mutually interacting sub-circuits: a central pluripotency circuit consisting of interactions between stem-cell specific transcription factors OCT4, SOX2 and NANOG coupled to a differentiation circuit consisting of interactions between lineage-specifying master genes. The molecular switches which arise from feedback loops within these circuits give rise to a well-defined sequence of successive gene restrictions corresponding to a controlled differentiation cascade in response to environmental stimuli. Furthermore, we found that this differentiation cascade is strongly unidirectional: once silenced, core transcription factors cannot easily be reactivated. In the context of induced pluripotency, this indicates that differentiated cells are robustly resistant to reprogramming to a more primitive state. However, our model suggests that under certain circumstances, amplification of low-level fluctuations in transcriptional status (transcriptional "noise'') may be sufficient to trigger reactivation of the core pluripotency switch and reprogramming to a pluripotent state. This interpretation offers an explanation of a number of experimental observations concerning the molecular mechanisms of cellular reprogramming by defined factors and suggests a role for stochasticity in reprogramming of somatic cells to pluripotency.	[MacArthur, Ben D.; Oreffo, Richard O. C.] Univ Southampton, Inst Dev Sci, Ctr Human Dev, Bone & Joint Res Grp, Southampton, Hants, England; [MacArthur, Ben D.; Please, Colin P.] Univ Southampton, Sch Math, Southampton, Hants, England	University of Southampton; University of Southampton	MacArthur, BD (corresponding author), Univ Southampton, Inst Dev Sci, Ctr Human Dev, Bone & Joint Res Grp, Southampton, Hants, England.	bdm@soton.ac.uk	Please, Colin/G-6247-2011; Oreffo, Richard OC/A-4615-2011	Oreffo, Richard OC/0000-0001-5995-6726; MacArthur, Ben/0000-0002-5396-9750; Please, Colin/0000-0001-8917-8574	EPSRC [EP/C003497/1]; Engineering and Physical Sciences Research Council [EP/C003497/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by EPSRC grant number EP/C003497/1.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Cinquin O, 2005, J THEOR BIOL, V233, P391, DOI 10.1016/j.jtbi.2004.10.027; Cinquin O, 2007, B MATH BIOL, V69, P483, DOI 10.1007/s11538-006-9114-8; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; *ED, 2008, NATURE, V452, P913; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Furusawa C, 2001, J THEOR BIOL, V209, P395, DOI 10.1006/jtbi.2001.2264; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; HALL PA, 1989, DEVELOPMENT, V106, P619; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang Sui, 2006, Breast Dis, V26, P27; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jeon MJ, 2003, J BIOL CHEM, V278, P23270, DOI 10.1074/jbc.M211610200; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Khan E, 2003, J LAB CLIN MED, V142, P29, DOI 10.1016/S0022-2143(03)00058-1; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirkland MA, 2004, EXP HEMATOL, V32, P511, DOI 10.1016/j.exphem.2004.02.013; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Preisler HD, 1999, LEUKEMIA RES, V23, P685, DOI 10.1016/S0145-2126(99)00077-6; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rothenberg EV, 1999, BIOESSAYS, V21, P726, DOI 10.1002/(SICI)1521-1878(199909)21:9<726::AID-BIES4>3.0.CO;2-S; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Soule C, 2006, CR BIOL, V329, P13, DOI 10.1016/j.crvi.2005.10.002; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Theise ND, 2003, NATURE, V425, P21, DOI 10.1038/425021a; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Waddington C., 1957, STRATEGY GENES; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	96	71	71	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3086	10.1371/journal.pone.0003086	http://dx.doi.org/10.1371/journal.pone.0003086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769478	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000264796600005
J	Blais, C; Jack, RE; Scheepers, C; Fiset, D; Caldara, R				Blais, Caroline; Jack, Rachael E.; Scheepers, Christoph; Fiset, Daniel; Caldara, Roberto			Culture Shapes How We Look at Faces	PLOS ONE			English	Article							EYE-MOVEMENTS; ENVIRONMENT; CONTEXT; MEMORY; OWN	Background: Face processing, amongst many basic visual skills, is thought to be invariant across all humans. From as early as 1965, studies of eye movements have consistently revealed a systematic triangular sequence of fixations over the eyes and the mouth, suggesting that faces elicit a universal, biologically-determined information extraction pattern. Methodology/Principal Findings: Here we monitored the eye movements of Western Caucasian and East Asian observers while they learned, recognized, and categorized by race Western Caucasian and East Asian faces. Western Caucasian observers reproduced a scattered triangular pattern of fixations for faces of both races and across tasks. Contrary to intuition, East Asian observers focused more on the central region of the face. Conclusions/Significance: These results demonstrate that face processing can no longer be considered as arising from a universal series of perceptual events. The strategy employed to extract visual information from faces differs across cultures.	[Blais, Caroline; Jack, Rachael E.; Scheepers, Christoph; Fiset, Daniel; Caldara, Roberto] Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland; [Blais, Caroline; Fiset, Daniel] Univ Montreal, Dept Psychol, Montreal, PQ, Canada	University of Glasgow; Universite de Montreal	Blais, C (corresponding author), Univ Glasgow, Dept Psychol, Glasgow, Lanark, Scotland.	r.caldara@psy.gla.ac.uk	Jack, Rachael/A-4692-2012; Fiset, Daniel/Y-7799-2019; Caldara, Roberto/H-1929-2011	Jack, Rachael/0000-0003-3687-0799; Caldara, Roberto/0000-0002-8260-9949	Economic and Social Research Council and Medical Research Council (ESRC) [RES-060-25-0010, PTA-031-2006-00192]; Fonds Quebecois de Recherche en Nature et Technologies (FQRNT) [PhD studentship, post-doctoral fellowship]; Economic and Social Research Council [ES/E020933/1] Funding Source: researchfish; ESRC [ES/E020933/1] Funding Source: UKRI	Economic and Social Research Council and Medical Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Fonds Quebecois de Recherche en Nature et Technologies (FQRNT)(FQRNT); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by The Economic and Social Research Council and Medical Research Council (ESRC) (RES-060-25-0010). REJ was supported by a PhD studentship awarded by ESRC (PTA-031-2006-00192), CB by a PhD studentship provided by the Fonds Quebecois de Recherche en Nature et Technologies (FQRNT) and DF by a FQRNT post-doctoral fellowship.	Althoff RR, 1999, J EXP PSYCHOL LEARN, V25, P997, DOI 10.1037/0278-7393.25.4.997; Argyle M., 1976, GAZE MUTUAL GAZE; Bang S., 2001, ASIAN FACE IMAGE DAT; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2004, NEUROREPORT, V15, P905, DOI 10.1097/00001756-200404090-00034; Caldara R, 2006, NEUROIMAGE, V31, P313, DOI 10.1016/j.neuroimage.2005.12.011; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J.E., 1988, STAT POWER ANAL BEHA; Feingold GA, 1914, J AM INST CRIM LAW C, V5, P39, DOI 10.2307/1133283; Findlay J. M., 2003, ACTIVE VISION PSYCHO; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P191, DOI 10.3758/BF03335056; GOLDSTEIN AG, 1979, B PSYCHONOMIC SOC, V13, P187, DOI 10.3758/BF03335055; Groner R, 1984, THEORETICAL APPL ASP, P523; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; HENDERSON JM, 2001, FRAGMENTS OBJECTS SE, P463, DOI DOI 10.1016/S0166-4115(01)80034-0; JANIK SW, 1978, PERCEPT MOTOR SKILL, V47, P857, DOI 10.2466/pms.1978.47.3.857; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Simoncelli EP, 2003, CURR OPIN NEUROBIOL, V13, P144, DOI 10.1016/S0959-4388(03)00047-3; WALKERSMITH GJ, 1977, PERCEPTION, V6, P313, DOI 10.1068/p060313; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	30	335	348	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3022	10.1371/journal.pone.0003022	http://dx.doi.org/10.1371/journal.pone.0003022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422IM	18714387	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000264420900044
J	Plessy, C; Fagiolini, M; Wagatsuma, A; Harasawa, N; Kuji, T; Asaka-Oba, A; Kanzaki, Y; Fujishima, S; Waki, K; Nakahara, H; Hensch, TK; Carninci, P				Plessy, Charles; Fagiolini, Michela; Wagatsuma, Akiko; Harasawa, Norihiro; Kuji, Takenobu; Asaka-Oba, Atsuko; Kanzaki, Yukari; Fujishima, Sayaka; Waki, Kazunori; Nakahara, Hiroyuki; Hensch, Takao K.; Carninci, Piero			A Resource for Transcriptomic Analysis in the Mouse Brain	PLOS ONE			English	Article							LENGTH CDNA SEQUENCES; GENE-EXPRESSION; CAP ANALYSIS; GENOME; PARVALBUMIN; NEURONS; INTERNEURONS; COMPLEXITY; CALRETININ; DISCOVERY	Background: The transcriptome of the cerebral cortex is remarkably homogeneous, with variations being stronger between individuals than between areas. It is thought that due to the presence of many distinct cell types, differences within one cell population will be averaged with the noise from others. Studies of sorted cells expressing the same transgene have shown that cell populations can be distinguished according to their transcriptional profile. Methodology: We have prepared a low-redundancy set of 16,209 full-length cDNA clones which represents the transcriptome of the mouse visual cortex in its coding and non-coding aspects. Using an independent tag-based approach, CAGE, we confirmed the cortical expression of 72% of the clones. Clones were amplified by PCR and spotted on glass slides, and we interrogated the microarrays with RNA from flow-sorted fluorescent cells from the cerebral cortex of parvalbumin-egfp transgenic mice. Conclusions: We provide an annotated cDNA clone collection which is particularly suitable for transcriptomic analysis in the mouse brain. Spotting it on microarrays, we compared the transcriptome of EGFP positive and negative cells in a parvalbumin-egfp transgenic background and showed that more than 30% of clones are differentially expressed. Our clone collection will be a useful resource for the study of the transcriptome of single cell types in the cerebral cortex.	[Plessy, Charles; Carninci, Piero] RIKEN, Yokohama Inst, Funct Genom Technol Team, Om Sci Ctr, Kanagawa, Japan; [Fagiolini, Michela; Wagatsuma, Akiko; Kuji, Takenobu; Asaka-Oba, Atsuko; Kanzaki, Yukari; Fujishima, Sayaka; Hensch, Takao K.] RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama, Japan; [Harasawa, Norihiro; Nakahara, Hiroyuki] RIKEN, Brain Sci Inst, Lab Integrated Theoretical Neurosci, Wako, Saitama, Japan; [Waki, Kazunori] RIKEN, Wako Inst, Discovery & Res Inst, Genome Sci Lab, Wako, Saitama, Japan	RIKEN; RIKEN; RIKEN; RIKEN	Plessy, C (corresponding author), RIKEN, Yokohama Inst, Funct Genom Technol Team, Om Sci Ctr, Kanagawa, Japan.	hensch@riken.jp; carninci@riken.jp	Hensch, Takao/L-4182-2019; Plessy, Charles/N-5054-2015; Carninci, Piero/K-1568-2014; Nakahara, Hiroyuki/N-5411-2015; Waki, Kazunori/T-6444-2019	Plessy, Charles/0000-0001-7410-6295; Carninci, Piero/0000-0001-7202-7243; Nakahara, Hiroyuki/0000-0001-6891-1175; fagiolini, michela/0000-0003-2807-803X; Waki, Kazunori/0000-0001-7311-7208	6th Framework of the EU commission to the NFG consortium; RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [Grant-in-Aid, 18020034]; Japanese Society for the Promotion of Science (JSPS) [P05880, 17680029]	6th Framework of the EU commission to the NFG consortium; RIKEN; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant of the 6th Framework of the EU commission to the NFG consortium (to PC), a RIKEN presidential grant for collaborative research (to PC and TKH), a Grant-in-Aid for Scientific Research on Priority Areas - Integrative Brain Research - from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to TKH), a Japanese Society for the Promotion of Science (JSPS) grant. CP was supported by a fellowship from the JSPS (number P05880). HN is supported by Grant-in-Aids on Priority Area Research (C) from MEXT (number 18020034), and for Young Scientists (A) from JSPS, Japan (number 17680029).	Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Burke J, 1998, GENOME RES, V8, P276, DOI 10.1101/gr.8.3.276; Burke J, 1999, GENOME RES, V9, P1135, DOI 10.1101/gr.9.11.1135; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Forrest ARR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r5; Fukunishi Y, 2001, PHYSIOL GENOMICS, V5, P81, DOI 10.1152/physiolgenomics.2001.5.2.81; GUIGO R, 1992, J MOL BIOL, V226, P141, DOI 10.1016/0022-2836(92)90130-C; Gustincich S, 2003, GENOME RES, V13, P1395, DOI 10.1101/gr.1135303; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hirozane-Kishikawa T, 2003, BIOTECHNIQUES, V35, P510, DOI 10.2144/03353st04; Hof PR, 1999, J CHEM NEUROANAT, V16, P77, DOI 10.1016/S0891-0618(98)00065-9; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Meyer AH, 2002, J NEUROSCI, V22, P7055; Miller RT, 1999, GENOME RES, V9, P1143, DOI 10.1101/gr.9.11.1143; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pearson WR, 1998, J MOL BIOL, V276, P71, DOI 10.1006/jmbi.1997.1525; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; R Development Core Team, 2007, R LANG ENV STAT COMP; Shibata K, 2000, GENOME RES, V10, P1757, DOI 10.1101/gr.152600; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Xiang CC, 2002, NAT BIOTECHNOL, V20, P738, DOI 10.1038/nb0702-738; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3012	10.1371/journal.pone.0003012	http://dx.doi.org/10.1371/journal.pone.0003012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714383	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900037
J	Chen, HQ; Ma, YY; Yang, J; O'Brien, CJ; Lee, SL; Mazurkiewicz, JE; Haataja, S; Yan, JH; Gao, GF; Zhang, JR				Chen, Huaiqing; Ma, Yueyun; Yang, Jun; O'Brien, Christopher J.; Lee, Scott L.; Mazurkiewicz, Joseph E.; Haataja, Sauli; Yan, Jing-Hua; Gao, George F.; Zhang, Jing-Ren			Genetic Requirement for Pneumococcal Ear Infection	PLOS ONE			English	Article								Background: Ear infection or otitis media (OM) accounts for most bacterial respiratory infections in children in both developed and developing nations. Streptococcus pneumoniae, nontypeable Haemophilus influenzae, and Moraxella catarrhalis are the major OM pathogens. However, little is known about the genetic basis of bacterial OM largely due to practical difficulties in conducting research in ear infection models and genetically manipulating clinical isolates. Here, we report the first genome-scale in vivo screen for bacterial genes required for ear infection in a chinchilla model by signature tagged mutagenesis (STM), a high throughput mutant screen technique. Methodology/Principal Findings: STM strains were constructed with a multi-drug resistant OM isolate ST556 (serotype 19F) and screened in a chinchilla OM model. Out of 5,280 mutants tested, 248 mutants were substantially underrepresented in the mutant pools recovered from the middle ear fluids of the infected chinchillas, indicating the impaired ability to survive and replicate in the middle ears due to genetic disruptions in the chromosome of strain ST556. Further DNA sequencing analysis mapped the mutations to 169 pneumococcal genes. Surprisingly, only 52 of these genes were required for pneumococcal nasopharyngeal colonization in a murine model. This infection site-specific gene requirement was verified by targeted mutagenesis in the selected genes. Conclusions/Significance: These findings suggest that there are a subset of pneumococcal genes required for ear infection and that these may be distinct from those required for nasal colonization. Our data thus provide comprehensive gene targets for mechanistic understanding of pneumococcal ear infection. Finally, this study has also developed a model for future genome-scale search for virulence determinants in other pathogens associated with ear infections.	[Chen, Huaiqing; Ma, Yueyun; Yang, Jun; O'Brien, Christopher J.; Zhang, Jing-Ren] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Lee, Scott L.] Albany Med Coll, Div Otolaryngol Head & Neck Surg, Albany, NY 12208 USA; [Mazurkiewicz, Joseph E.] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Haataja, Sauli] Univ Turku, Dept Med Biochem & Mol Biol, SF-20500 Turku, Finland; [Ma, Yueyun] Fourth Mil Med Univ, Xijing Hosp, Ctr Clin Mol Biol, Xian, Peoples R China; [Yan, Jing-Hua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, Ctr Mol Immunol, Beijing 100864, Peoples R China	Albany Medical College; Albany Medical College; Albany Medical College; University of Turku; Air Force Military Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Chen, HQ (corresponding author), Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.	zhangj@mail.amc.edu	ma, yue/GXE-9897-2022; Gao, George Fu/ABD-5229-2021; Haataja, Sauli/AAR-5103-2020		NIH/NIDCD [DC006917]; China Natural Sciences Foundation (NSFC) [30728014]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006917] Funding Source: NIH RePORTER	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); China Natural Sciences Foundation (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant (to J.-R.Z.) from NIH/NIDCD (DC006917). Collaboration between J.-R.Z. and G.F.G. was supported by a grant from the China Natural Sciences Foundation (NSFC) (Grant No. 30728014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguedas A, 1998, PEDIATR INFECT DIS J, V17, P680, DOI 10.1097/00006454-199808000-00004; AUSTRIAN R, 1986, CHEMOTHERAPY, V18, pS35; Balachandran P, 2002, INFECT IMMUN, V70, P2526, DOI 10.1128/IAI.70.5.2526-2534.2002; Barenkamp SJ, 2005, ANN OTO RHINOL LARYN, V114, P60, DOI 10.1177/00034894051140S109; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Basset A, 2007, J CLIN MICROBIOL, V45, P1684, DOI 10.1128/JCM.00265-07; Chen S, 2005, FEMS MICROBIOL LETT, V253, P151, DOI 10.1016/j.femsle.2005.09.052; Chiang SL, 1999, ANNU REV MICROBIOL, V53, P129, DOI 10.1146/annurev.micro.53.1.129; de Cordoba SR, 2004, MOL IMMUNOL, V41, P355, DOI 10.1016/j.molimm.2004.02.005; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Elm C, 2004, J BIOL CHEM, V279, P6296, DOI 10.1074/jbc.M310528200; Freid V M, 1998, Vital Health Stat 13, P1; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Giebink GS, 1999, MICROB DRUG RESIST, V5, P57, DOI 10.1089/mdr.1999.5.57; GIEBINK GS, 1978, ANNU REV MED, V29, P285, DOI 10.1146/annurev.me.29.020178.001441; Giebink GS, 2001, NEW ENGL J MED, V345, P1177, DOI 10.1056/NEJMra010462; GIEBINK GS, 1976, J INFECT DIS, V134, P595, DOI 10.1093/infdis/134.6.595; Giefing C, 2008, J EXP MED, V205, P117, DOI 10.1084/jem.20071168; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Hava DL, 2003, J BACTERIOL, V185, P413, DOI 10.1128/JB.185.2.413-421.2003; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Jarva H, 2003, MOL IMMUNOL, V40, P95, DOI 10.1016/S0161-5890(03)00108-1; Joloba ML, 2001, CLIN INFECT DIS, V33, P1489, DOI 10.1086/323027; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Lim DJ, 2005, ANN OTO RHINOL LARYN, V114, P31; Lu L, 2006, J BIOL CHEM, V281, P15464, DOI 10.1074/jbc.M602404200; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Novotny LA, 2005, INFECT IMMUN, V73, P609, DOI 10.1128/IAI.73.1.609-611.2005; Pallova P, 2007, BIOCHEM BIOPH RES CO, V355, P526, DOI 10.1016/j.bbrc.2007.01.184; Park IH, 2007, INFECT IMMUN, V75, P4482, DOI 10.1128/IAI.00510-07; PATON JC, GRAM POSITIVE PATHOG, P241; Pettigrew MM, 2005, INFECT IMMUN, V73, P2805, DOI 10.1128/IAI.73.5.2805-2811.2005; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1; Ren B, 2004, J IMMUNOL, V173, P7506, DOI 10.4049/jimmunol.173.12.7506; Rosenow C, 1997, MOL MICROBIOL, V25, P819, DOI 10.1111/j.1365-2958.1997.mmi494.x; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Smith BL, 2000, J INFECT DIS, V182, P497, DOI 10.1086/315722; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tong HH, 1999, MICROB PATHOGENESIS, V26, P111, DOI 10.1006/mpat.1998.0257; Tong HH, 2000, INFECT IMMUN, V68, P921, DOI 10.1128/IAI.68.2.921-924.2000; Tuomanen EI, 2000, VACCINE, V19, pS38, DOI 10.1016/S0264-410X(00)00276-0; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wu HY, 1997, MICROB PATHOGENESIS, V23, P127, DOI 10.1006/mpat.1997.0142; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	52	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2950	10.1371/journal.pone.0002950	http://dx.doi.org/10.1371/journal.pone.0002950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18670623	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600036
J	Jabbi, M; Bastiaansen, J; Keysers, C				Jabbi, Mbemba; Bastiaansen, Jojanneke; Keysers, Christian			A Common Anterior Insula Representation of Disgust Observation, Experience and Imagination Shows Divergent Functional Connectivity Pathways	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; OLD-WORLD MONKEY; MOTOR IMAGERY; EMPATHY; PERCEPTION; ACTIVATION; MECHANISMS; BRAIN; ORGANIZATION; RECOGNITION	Similar brain regions are involved when we imagine, observe and execute an action. Is the same true for emotions? Here, the same subjects were scanned while they (a) experience, (b) view someone else experiencing and (c) imagine experiencing gustatory emotions (through script-driven imagery). Capitalizing on the fact that disgust is repeatedly inducible within the scanner environment, we scanned the same participants while they (a) view actors taste the content of a cup and look disgusted (b) tasted unpleasant bitter liquids to induce disgust, and (c) read and imagine scenarios involving disgust and their neutral counterparts. To reduce habituation, we inter-mixed trials of positive emotions in all three scanning experiments. We found voxels in the anterior Insula and adjacent frontal operculum to be involved in all three modalities of disgust, suggesting that simulation in the context of social perception and mental imagery of disgust share a common neural substrates. Using effective connectivity, this shared region however was found to be embedded in distinct functional circuits during the three modalities, suggesting why observing, imagining and experiencing an emotion feels so different.	[Jabbi, Mbemba] NIMH, Sect Integrat Neuroimaging, Cognit Brain Disorders Branch, Bethesda, MD 20892 USA; [Jabbi, Mbemba; Bastiaansen, Jojanneke; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Social Brain Lab, Groningen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Groningen	Jabbi, M (corresponding author), NIMH, Sect Integrat Neuroimaging, Cognit Brain Disorders Branch, Bethesda, MD 20892 USA.	jabbim@mail.nih.gov; c.m.keysers@rug.nl	Keysers, Christian/H-6251-2013; Bastiaansen, Jojanneke/F-4849-2013	Keysers, Christian/0000-0002-2845-5467; Bastiaansen, Jojanneke/0000-0003-4831-6402; Lauwereyns, Jan/0000-0003-0551-2550; Jabbi, Mbemba/0000-0001-5263-5321	European Marie Curie Excellence; Nederlands Wetenschappelijk Organisatie NWO; Dutch science foundation; VIDI	European Marie Curie Excellence; Nederlands Wetenschappelijk Organisatie NWO; Dutch science foundation(Netherlands Organization for Scientific Research (NWO)); VIDI(Netherlands Organization for Scientific Research (NWO))	This work has been funded by the European Marie Curie Excellence and the Nederlands Wetenschappelijk Organisatie (NWO; Dutch science foundation) VIDI grants to Christian Keysers. However, the funding bodies have no further role in any part of this work or the decision to submit the manuscript to PloS ONE.	Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2003, BRAIN COGNITION, V52, P61, DOI 10.1016/S0278-2626(03)00009-5; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bonthius DJ, 2005, J NEUROPATH EXP NEUR, V64, P910, DOI 10.1097/01.jnen.0000182983.87106.d1; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chikama M, 1997, J NEUROSCI, V17, P9686; Craig A. D., 2008, HDB EMOTIONS, P272; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A. R., 2003, LOOKING SPINOZA JOY; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; DIMBERG U, 1990, PSYCHOPHYSIOLOGY, V27, P481, DOI 10.1111/j.1469-8986.1990.tb01962.x; Fadiga L, 2004, J CLIN NEUROPHYSIOL, V21, P157, DOI 10.1097/00004691-200405000-00004; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fudge JL, 2005, J COMP NEUROL, V490, P101, DOI 10.1002/cne.20660; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2007, CURR BIOL, V17, P1235, DOI 10.1016/j.cub.2007.06.045; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grafton ST, 1996, EXP BRAIN RES, V112, P103; Gray MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000546; HESS U, 1999, SOCIAL CONTEXT NONVE; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jabbi M, 2007, NEUROIMAGE, V34, P1744, DOI 10.1016/j.neuroimage.2006.10.032; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Jeannerod M, 1999, CURR OPIN NEUROBIOL, V9, P735, DOI 10.1016/S0959-4388(99)00038-0; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2006, PROG BRAIN RES, V156, P379, DOI 10.1016/S0079-6123(06)56021-2; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kikuchi S, 2005, NEUROREPORT, V16, P281, DOI 10.1097/00001756-200502280-00016; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Pfeifer JH, 2008, NEUROIMAGE, V39, P2076, DOI 10.1016/j.neuroimage.2007.10.032; Porro CA, 1996, J NEUROSCI, V16, P7688; Preston SD, 2007, SOC NEUROSCI-UK, V2, P254, DOI 10.1080/17470910701376902; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Rekkas PV, 2005, J COGNITIVE NEUROSCI, V17, P1950, DOI 10.1162/089892905775008652; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Sacco K, 2006, NEUROIMAGE, V32, P1441, DOI 10.1016/j.neuroimage.2006.05.018; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Small DM, 2005, EXP BRAIN RES, V166, P345, DOI 10.1007/s00221-005-2376-9; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; van der Gaag C, 2007, SOC NEUROSCI-UK, V2, P179, DOI 10.1080/17470910701376878; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2	60	216	223	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2939	10.1371/journal.pone.0002939	http://dx.doi.org/10.1371/journal.pone.0002939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698355	gold, Green Submitted, Green Published			2022-12-27	WOS:000264412600025
J	Adamo, A; Pinney, JW; Kunova, A; Westhead, DR; Meyer, P				Adamo, Alessio; Pinney, John W.; Kunova, Andrea; Westhead, David R.; Meyer, Peter			Heat Stress Enhances the Accumulation of Polyadenylated Mitochondrial Transcripts in Arabidopsis thaliana	PLOS ONE			English	Article							COEXPRESSION TOOL ACT; MESSENGER-RNA; GENE; DEGRADATION; POLY(A); CHROMOSOME-2; CHLOROPLAST; CORDYCEPIN; NUCLEUS	Background: Polyadenylation of RNA has a decisive influence on RNA stability. Depending on the organisms or subcellular compartment, it either enhances transcript stability or targets RNAs for degradation. In plant mitochondria, polyadenylation promotes RNA degradation, and polyadenylated mitochondrial transcripts are therefore widely considered to be rare and unstable. We followed up a surprising observation that a large number of mitochondrial transcripts are detectable in microarray experiments that used poly(A)-specific RNA probes, and that these transcript levels are significantly enhanced after heat treatment. Methodology/Principal Findings: As the Columbia genome contains a complete set of mitochondrial genes, we had to identify polymorphisms to differentiate between nuclear and mitochondrial copies of a mitochondrial transcript. We found that the affected transcripts were uncapped transcripts of mitochondrial origin, which were polyadenylated at multiple sites within their 39region. Heat-induced enhancement of these transcripts was quickly restored during a short recovery period. Conclusions/Significance: Our results show that polyadenylated transcripts of mitochondrial origin are more stable than previously suggested, and that their steady-state levels can even be significantly enhanced under certain conditions. As many microarrays contain mitochondrial probes, due to the frequent transfer of mitochondrial genes into the genome, these effects need to be considered when interpreting microarray data.	[Adamo, Alessio; Kunova, Andrea; Meyer, Peter] Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England; [Pinney, John W.; Westhead, David R.] Univ Leeds, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds	Adamo, A (corresponding author), Univ Leeds, Ctr Plant Sci, Leeds, W Yorkshire, England.	p.meyer@leeds.ac.uk	Kunova, Andrea/AAB-8717-2022; Kunova, Andrea/F-3769-2016	Kunova, Andrea/0000-0002-9210-4792; Kunova, Andrea/0000-0002-9210-4792; Westhead, David/0000-0002-0519-3820	BBSRC [studentship, BB/C52101X/1]; Epigenome Network of Excellence; MRC [studentship]; Biotechnology and Biological Sciences Research Council [BB/C52101X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Epigenome Network of Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A.A. and A.K. were supported by BBSRC studentships and by the Epigenome Network of Excellence. JWP was supported by an MRC studentship and DRW acknowledges a BBSRC Research Development Fellowship (BB/C52101X/1).	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Adams KL, 2001, GENETICS, V158, P1289; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Forner J, 2007, NUCLEIC ACIDS RES, V35, P3676, DOI 10.1093/nar/gkm270; Gagliardi D, 1999, EMBO J, V18, P3757, DOI 10.1093/emboj/18.13.3757; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; HIRSCH M, 1974, J MOL BIOL, V83, P131, DOI 10.1016/0022-2836(74)90384-2; Holec S, 2006, MOL CELL BIOL, V26, P2869, DOI 10.1128/MCB.26.7.2869-2876.2006; Huang CY, 2005, PLANT PHYSIOL, V138, P1723, DOI 10.1104/pp.105.060327; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Kudla J, 1996, EMBO J, V15, P7137, DOI 10.1002/j.1460-2075.1996.tb01105.x; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupold DS, 1999, PLANT CELL, V11, P1565, DOI 10.1105/tpc.11.8.1565; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Perez-Martinez X, 2000, J BIOL CHEM, V275, P30144, DOI 10.1074/jbc.M003940200; Rikhvanov EG, 2007, PLANT J, V52, P763, DOI 10.1111/j.1365-313X.2007.03275.x; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Shatkin AJ, 2000, NAT STRUCT BIOL, V7, P838, DOI 10.1038/79583; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Souret FF, 2004, MOL CELL, V15, P173, DOI 10.1016/j.molcel.2004.06.006; Stupar RM, 2001, P NATL ACAD SCI USA, V98, P5099, DOI 10.1073/pnas.091110398; Thomadaki H, 2008, CANCER CHEMOTH PHARM, V61, P703, DOI 10.1007/s00280-007-0533-5; Xiao YL, 2005, PLANT PHYSIOL, V139, P1323, DOI 10.1104/pp.105.063479	28	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2889	10.1371/journal.pone.0002889	http://dx.doi.org/10.1371/journal.pone.0002889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682831	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600045
J	Sprigg, N; Gray, LJ; England, T; Willmot, MR; Zhao, L; Sare, GM; Bath, PMW				Sprigg, Nikola; Gray, Laura J.; England, Tim; Willmot, Mark R.; Zhao, Lian; Sare, Gillian M.; Bath, Philip M. W.			A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility	PLOS ONE			English	Article								Background: Aspirin, dipyridamole and clopidogrel are effective in secondary vascular prevention. Combination therapy with three antiplatelet agents might maximise the benefit of antiplatelet treatment in the secondary prevention of ischaemic stroke. Methodology/Principal Findings: A randomised, parallel group, observer-blinded phase II trial compared the combination of aspirin, clopidogrel and dipyridamole with aspirin alone. Adult patients with ischaemic stroke or transient ischaemic attack (TIA) within 5 years were included. The primary outcome was tolerability to treatment assessed as the number of patients completing randomised treatment. Recruitment was halted prematurely after publication of the ESPRIT trial (which confirmed that combined aspirin and dipyridamole is more effective than aspirin alone). 17 patients were enrolled: male 12 (71%), mean age 62 (SD 13) years, lacunar stroke syndrome 12 (71%), median stroke/TIA onset to randomisation 8 months. Treatment was discontinued in 4 of 9 (44%) patients receiving triple therapy vs. none of 8 taking aspirin (p = 0.08). One recurrent stroke occurred in a patient in the triple group who was noncompliant of all antiplatelet medications. The number of patients with adverse events and bleeding complications, and their severity, were significantly greater in the triple therapy group (p<0.01). Conclusions/Significance: Long term triple antiplatelet therapy was asociated with a significant increase in adverse events and bleeding rates, and their severity, and a trend to increased discontinuations. However, the patients had a low risk of recurrence and future trials should focus on short term therapy in high risk patients characterised by a very recent event or failure of dual antiplatelet therapy. Trial Registration: Controlled-Trials. com ISRCTN83673558	[Sprigg, Nikola; Gray, Laura J.; England, Tim; Willmot, Mark R.; Zhao, Lian; Sare, Gillian M.; Bath, Philip M. W.] Univ Nottingham, Stroke Trials Unit, Inst Neurosci, Nottingham NG7 2RD, England	University of Nottingham	Sprigg, N (corresponding author), Univ Nottingham, Stroke Trials Unit, Inst Neurosci, Nottingham NG7 2RD, England.	philip.bath@nottingham.ac.uk	England, Timothy J/AAD-3100-2021; Bath, Philip/F-9020-2011	England, Timothy J/0000-0001-5330-8584; Bath, Philip/0000-0003-2734-5132; Gray, Laura/0000-0002-9284-9321	British Heart Foundation [PG/08/083/25779] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BATH PMW, 2008, STROKE IN PRESS; BHATT D, 2006, NEW ENGLAND J MED, V354; Bhatt DL, 2000, CEREBROVASC DIS, V10, P34, DOI 10.1159/000047602; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Diener HC, 1996, J NEUROL SCI, V143, P1, DOI 10.1016/S0022-510X(96)00308-5; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gryglewski RJ, 2000, J PHYSIOL PHARMACOL, V51, P683; Halkes PHA, 2006, LANCET, V367, P1665; Hegedus K, 1997, J NEUROL SCI, V148, P153, DOI 10.1016/S0022-510X(96)05352-X; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Leonardi-Bee J, 2005, STROKE, V36, P162, DOI 10.1161/01.STR.0000149621.95215.ea; LOWENTHAL A, 1990, STROKE, V21, P1122; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; (NICE) NIfHaCE, 2005, CLOP MOD DIP PREV OC; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Weir CJ, 2003, STAT MED, V22, P705, DOI 10.1002/sim.1366; Willmot Mark, 2004, J Stroke Cerebrovasc Dis, V13, P138, DOI 10.1016/j.jstrokecerebrovasdis.2004.03.001; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zhao L, 2006, PLATELETS, V17, P100, DOI 10.1080/09537100500235966; Zhao L, 2005, THROMB HAEMOSTASIS, V93, P527, DOI 10.1160/TH04-09-0559; Zhao L, 2001, BRIT J PHARMACOL, V134, P353, DOI 10.1038/sj.bjp.0704248	22	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2852	10.1371/journal.pone.0002852	http://dx.doi.org/10.1371/journal.pone.0002852			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682741	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600008
J	Wegner, KM				Wegner, K. Mathias			Clustering of Drosophila melanogaster Immune Genes in Interplay with Recombination Rate	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NATURAL-SELECTION; LINKAGE-DISEQUILIBRIUM; EVOLUTIONARY DYNAMICS; RED QUEEN; ADAPTATION; ORGANIZATION; ARCHITECTURE; POLYMORPHISM; EXPRESSION	Background: Gene order in eukaryotic chromosomes is not random and has been linked to coordination of gene expression, chromatin structure and also recombination rate. The evolution of recombination rate is especially relevant for genes involved in immunity because host-parasite co-evolution could select for increased recombination rate (Red Queen hypothesis). To identify patterns left by the intimate interaction between hosts and parasites, I analysed the genomic parameters of the immune genes from 24 gene families/groups of Drosophila melanogaster. Principal Findings: Immune genes that directly interact with the pathogen (i.e. recognition and effector genes) clustered in regions of higher recombination rates. Out of these, clustered effector genes were transcribed fastest indicating that transcriptional control might be one major cause for cluster formation. The relative position of clusters to each other, on the other hand, cannot be explained by transcriptional control per se. Drosophila immune genes that show epistatic interactions can be found at an average distance of 15.44 +/- 2.98 cM, which is considerably closer than genes that do not interact (30.64 +/- 1.95 cM). Conclusions: Epistatically interacting genes rarely belong to the same cluster, which supports recent models of optimal recombination rates between interacting genes in antagonistic host-parasite co-evolution. These patterns suggest that formation of local clusters might be a result of transcriptional control, but that in the condensed genome of D. melanogaster relative position of these clusters may be a result of selection for optimal rather than maximal recombination rates between these clusters.	[Wegner, K. Mathias] ETH, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Wegner, KM (corresponding author), ETH, Inst Integrat Biol, Zurich, Switzerland.	mathias.wegner@env.ethz.ch	Wegner, Mathias/B-6674-2009; Wegner, K. Mathias/P-1149-2015	Wegner, K. Mathias/0000-0002-2410-8898				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Batada NN, 2007, NAT GENET, V39, P945, DOI 10.1038/ng2071; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Durand D, 2003, J COMPUT BIOL, V10, P453, DOI 10.1089/10665270360688129; Fischer O, 2005, BIOL LETTERS, V1, P193, DOI 10.1098/rsbl.2005.0296; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hey J, 2002, GENETICS, V160, P595; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; JAENIKE J, 1978, Evolutionary Theory, V3, P191; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; Kouyos RD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-211; Kover PX, 2001, MOL ECOL, V10, P1, DOI 10.1046/j.1365-294X.2001.01124.x; Lazzaro BP, 2005, GENETICS, V169, P2023, DOI 10.1534/genetics.104.034249; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; NEI M, 1967, GENETICS, V57, P625; Otto SP, 1998, TRENDS ECOL EVOL, V13, P145, DOI 10.1016/S0169-5347(97)01260-3; Peters AD, 2007, J EVOLUTION BIOL, V20, P1206, DOI 10.1111/j.1420-9101.2006.01283.x; Peters AD, 1999, AM NAT, V154, P393, DOI 10.1086/303247; Presgraves DC, 2005, CURR BIOL, V15, P1651, DOI 10.1016/j.cub.2005.07.065; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Schlenke TA, 2005, GENETICS, V169, P2013, DOI 10.1534/genetics.104.035337; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Yi G, 2007, BIOINFORMATICS, V23, P1053, DOI 10.1093/bioinformatics/btl673; Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177	41	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2835	10.1371/journal.pone.0002835	http://dx.doi.org/10.1371/journal.pone.0002835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665272	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300054
J	Yu, Y; Zhang, HM; Tian, F; Zhang, WS; Fang, HB; Song, JZ				Yu, Ying; Zhang, Huanmin; Tian, Fei; Zhang, Wensheng; Fang, Hongbin; Song, Jiuzhou			An Integrated Epigenetic and Genetic Analysis of DNA Methyltransferase Genes (DNMTs) in Tumor Resistant and Susceptible Chicken Lines	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PROMOTER METHYLATION; MAREKS-DISEASE; DE-NOVO; CANCER; EXPRESSION; EVOLUTION; VARIANTS; PATTERNS; STRAINS	Both epigenetic alterations and genetic variations play essential roles in tumorigenesis. The epigenetic modification of DNA methylation is catalyzed and maintained by the DNA methyltransferases (DNMT3a, DNMT3b and DNMT1). DNA mutations and DNA methylation profiles of DNMTs themselves and their relationships with chicken neoplastic disease resistance and susceptibility are not yet defined. In the present study, we analyzed the complexity of the DNA methylation variations and DNA mutations in the first exon of three DNMTs genes over generations, tissues, and ages among chickens of two highly inbred White Leghorn lines, Marek's disease-resistant line 6(3) and -susceptible line 7(2), and six recombinant congenic strains (RCSs). Among them, tissue-specific methylation patterns of DNMT3a were disclosed in spleen, liver, and hypothalamus in lines 6(3) and 7(2). The methylation level of DNMT3b on four CpG sites was not significantly different among four tissues of the two lines. However, two line-specific DNA transition mutations, CpG -> TpG (Chr20:10203733 and 10203778), were discovered in line 72 compared to the line 63 and RCSs. The methylation contents of DNMT1 in blood cell showed significant epimutations in the first CpG site among the two inbred lines and the six RCSs (P<0.05). Age-specific methylation of DNMT1 was detected in comparisons between 15 month-old and 2 month-old chickens in both lines except in spleen samples from line 72. No DNA mutations were discovered on the studied regions of DNMT1 and DNMT3a among the two lines and the six RCSs. Moreover, we developed a novel method that can effectively test the significance of DNA methylation patterns consisting of continuous CpG sites. Taken together, these results highlight the potential of epigenetic alterations in DNMT1 and DNMT3a, as well as the DNA mutations in DNMT3b, as epigenetic and genetic factors to neoplastic diseases of chickens.	[Yu, Ying; Tian, Fei; Zhang, Wensheng; Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Zhang, Huanmin] USDA, ARS, Avian Dis & Oncol Lab, E Lansing, MI USA; [Fang, Hongbin] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Div Biostat, Baltimore, MD USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland Baltimore	Yu, Y (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	songj88@umd.edu	Song, Jiuzhou/AAD-6440-2020; Zhang, Huanmin/M-9792-2019	Zhang, Huanmin/0000-0003-4896-2391	Maryland State Funds	Maryland State Funds	Maryland State Funds	Bacon LD, 2004, AVIAN PATHOL, V33, P233, DOI 10.1080/0307943042000195731; Bacon LD, 2001, CURR TOP MICROBIOL, V255, P121; Bacon LD, 2000, POULTRY SCI, V79, P1082, DOI 10.1093/ps/79.8.1082; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; BESTOR TH, 1994, CURR OPIN CELL BIOL, V6, P380, DOI 10.1016/0955-0674(94)90030-2; Bonsch D, 2006, J NEURAL TRANSM, V113, P1299, DOI 10.1007/s00702-005-0413-2; Burgess SC, 2004, P NATL ACAD SCI USA, V101, P13879, DOI 10.1073/pnas.0305789101; CHENG XD, 1995, ANNU REV BIOPH BIOM, V24, P293, DOI 10.1146/annurev.bb.24.060195.001453; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Fadly A, 2003, DIS POULTRY, V11, P465; Gokul G, 2007, EPIGENETICS-US, V2, P80, DOI 10.4161/epi.2.2.3692; Jones JS, 2006, CANCER EPIDEM BIOMAR, V15, P886, DOI 10.1158/1055-9965.EPI-05-0644; Kanai Y, 2007, CARCINOGENESIS, V28, P2434, DOI 10.1093/carcin/bgm206; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; LAUTER J, 1995, BIOMETRICS, P964; Lyko F, 1999, NAT GENET, V23, P363, DOI 10.1038/15551; McGarvey KM, 2007, CANCER RES, V67, P5097, DOI 10.1158/0008-5472.CAN-06-2029; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nair V, 2005, VET J, V170, P175, DOI 10.1016/j.tvjl.2004.05.009; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Ogino S, 2007, CARCINOGENESIS, V28, P1985, DOI 10.1093/carcin/bgm160; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okano M, 1998, NUCLEIC ACIDS RES, V26, P2536, DOI 10.1093/nar/26.11.2536; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Piyathilake CJ, 2001, HUM PATHOL, V32, P856, DOI 10.1053/hupa.2001.26471; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ray D, 2006, J GERONTOL A-BIOL, V61, P115, DOI 10.1093/gerona/61.2.115; Santos-Reboucas CB, 2007, EUR J HUM GENET, V15, P10, DOI 10.1038/sj.ejhg.5201727; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Seligman SJ, 2006, J INFECT DIS, V193, P1187, DOI 10.1086/501504; Szyf M, 2006, B CANCER, V93, P961; Tebbutt SJ, 2007, CHEST, V131, P1216, DOI 10.1378/chest.06-2252; TOST J, 2008, EPIGENETICS CAISTER; Tost Jorg, 2007, V373, P89; Turek-Plewa J, 2005, CELL MOL BIOL LETT, V10, P631; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang YZ, 2007, CANCER CELL, V11, P308, DOI 10.1016/j.ccr.2007.03.017; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weisenberger DJ, 2002, GENE, V298, P91, DOI 10.1016/S0378-1119(02)00976-9; Whitelaw NC, 2006, HUM MOL GENET, V15, pR131, DOI 10.1093/hmg/ddl200; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Yu Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001731; Zhang HM, 2007, AVIAN PATHOL, V36, P283, DOI 10.1080/03079450701449248; Zhang HM, 2006, POULTRY SCI, V85, P844, DOI 10.1093/ps/85.5.844; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	50	21	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2672	10.1371/journal.pone.0002672	http://dx.doi.org/10.1371/journal.pone.0002672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648519	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200017
J	Zineh, I; Beitelshees, AL; Welder, GJ; Hou, W; Chegini, N; Wu, J; Cresci, S; Province, MA; Spertus, JA				Zineh, Issam; Beitelshees, Amber L.; Welder, Gregory J.; Hou, Wei; Chegini, Nasser; Wu, Jun; Cresci, Sharon; Province, Michael A.; Spertus, John A.			Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins	PLOS ONE			English	Article								Endothelial inflammation with chemokine involvement contributes to acute coronary syndromes (ACS). We tested the hypothesis that variation in the chemokine gene CXCL5, which encodes epithelial neutrophil-activating peptide (ENA-78), is associated with ACS prognosis. We also investigated whether statin use, a potent modulator of inflammation, modifies CXCL5's association with outcomes and characterized the in vitro effect of atorvastatin on endothelial ENA-78 production. Using a prospective cohort of ACS patients (n = 704) the association of the CXCL5 2156 G. C polymorphism (rs352046) with 3-year all-cause mortality was estimated with hazard ratios (HR). Models were stratified by genotype and race. To characterize the influence of statins on this association, a statin*genotype interaction was tested. To validate ENA-78 as a statin target in inflammation typical of ACS, endothelial cells (HUVECs) were treated with IL-1 beta and atorvastatin with subsequent quantification of CXCL5 expression and ENA-78 protein concentrations. C/C genotype was associated with a 2.7-fold increase in 3-year all-cause mortality compared to G/G+G/C (95% CI 1.19-5.87; p = 0.017). Statins significantly reduced mortality in G/G individuals only (58% relative risk reduction; p = 0.0009). In HUVECs, atorvastatin dose-dependently decreased IL-1 beta-stimulated ENA-78 concentrations (p<0.0001). Drug effects persisted over 48 hours (p<0.01). CXCL5 genotype is associated with outcomes after ACS with potential statin modification of this effect. Atorvastatin lowered endothelial ENA-78 production during inflammation typical of ACS. These findings implicate CXCL5/ENA-78 in ACS and the statin response.	[Zineh, Issam; Beitelshees, Amber L.; Welder, Gregory J.] Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA; [Hou, Wei] Univ Florida, Coll Med, Dept Epidemiol & Hlth Policy Res, Gainesville, FL USA; [Chegini, Nasser] Univ Florida, Coll Med, Dept Obstet & Gynecol, Gainesville, FL USA; [Wu, Jun; Province, Michael A.] Washington Univ, Sch Med, Ctr Genome Sci, Div Stat Genom, St Louis, MO USA; [Cresci, Sharon] Washington Univ, Sch Med, Dept Med, St Louis, MO USA; [Spertus, John A.] Mid America Heart Inst, Kansas City, MO USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Washington University (WUSTL); Washington University (WUSTL); Saint Luke's Mid America Heart Institute	Zineh, I (corresponding author), Univ Florida, Coll Pharm, Ctr Pharmacogenom, Gainesville, FL 32610 USA.	zineh@cop.ufl.edu	Spertus, John/ABD-3075-2021; hou, wei/GWM-4800-2022		American Heart Association [0435278B]; NIH [RR17568, HL077113]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR017568] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077113] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Florida/Puerto Rico Affiliate Scientist Development Grant 0435278B, NIH C06 Grant RR17568, and NIH P50 Grant HL077113. The sponsors did not have a role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aarons CB, 2007, ANN SURG, V245, P176, DOI 10.1097/01.sla.0000236627.07927.7c; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Chello M, 2007, ANN THORAC SURG, V83, P1374, DOI 10.1016/j.athoracsur.2006.10.065; Cowled PA, 2007, J SURG RES, V141, P267, DOI 10.1016/j.jss.2006.11.021; Damas JK, 2000, CARDIOVASC RES, V45, P428, DOI 10.1016/S0008-6363(99)00262-X; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; de Lemos JA, 2007, J AM COLL CARDIOL, V50, P2117, DOI 10.1016/j.jacc.2007.06.057; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; DINARELLO CA, 1991, BLOOD, V77, P1627; Furman C, 2004, ATHEROSCLEROSIS, V174, P93, DOI 10.1016/j.atherosclerosis.2004.01.009; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Haller MJ, 2006, J PEDIATR ENDOCR MET, V19, P267; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Imaizumi T, 2003, PROSTAG LEUKOTR ESS, V69, P323, DOI 10.1016/S0952-3278(03)00145-5; Kiener PA, 2001, INT IMMUNOPHARMACOL, V1, P105, DOI 10.1016/S0162-3109(00)00272-1; Kruk M, 2008, CIRC J, V72, P205, DOI 10.1253/circj.72.205; Lanfear DE, 2005, JAMA-J AM MED ASSOC, V294, P1526, DOI 10.1001/jama.294.12.1526; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lindholm MW, 2007, VASC PHARMACOL, V46, P91, DOI 10.1016/j.vph.2006.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandey SHL, 2006, ARTHRITIS RHEUM-US, V54, P3690, DOI 10.1002/art.22194; Marino F, 2007, J CARDIOVASC PHARM, V49, P299, DOI 10.1097/FJC.0b013e31803d35ce; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Nijm J, 2005, AM J CARDIOL, V95, P452, DOI 10.1016/j.amjcard.2004.10.009; Ota K, 2005, METABOLISM, V54, P142, DOI 10.1016/j.metabol.2004.06.018; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; SCHMOUDER RL, 1995, TRANSPLANTATION, V59, P118, DOI 10.1097/00007890-199501150-00021; Schwartz GG, 2005, AM J CARDIOL, V96, p45F, DOI 10.1016/j.amjcard.2005.06.026; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Smith C, 2006, J AM COLL CARDIOL, V48, P1591, DOI 10.1016/j.jacc.2006.06.060; STRIETER RM, 1992, IMMUNOL INVEST, V21, P589, DOI 10.3109/08820139209069393; Sugano R, 2005, ARTERIOSCL THROM VAS, V25, P1262, DOI 10.1161/01.ATV.0000163842.91226.ba; Takeshita S, 1997, ATHEROSCLEROSIS, V135, P187, DOI 10.1016/S0021-9150(97)00160-3; WALZ A, 1991, J EXP MED, V174, P1355, DOI 10.1084/jem.174.6.1355; Zaremba J., 2006, Folia Morphologica, V65, P1; Zineh I, 2006, CYTOKINE, V33, P258, DOI 10.1016/j.cyto.2006.02.008; Zineh I, 2006, PHARMACOTHERAPY, V26, P333; Zineh I, 2007, DIABETES CARE, V30, P689, DOI 10.2337/dc06-1697; Zineh I, 2006, CLIN CHIM ACTA, V370, P72, DOI 10.1016/j.cca.2006.01.025	43	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3117	10.1371/journal.pone.0003117	http://dx.doi.org/10.1371/journal.pone.0003117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769620	Green Submitted, Green Published, gold			2022-12-27	WOS:000264418300008
J	Brody, T; Yavatkar, AS; Lin, Y; Ross, J; Kuzin, A; Kundu, M; Fann, Y; Odenwald, WF				Brody, Thomas; Yavatkar, Amarendra S.; Lin, Yong; Ross, Jermaine; Kuzin, Alexander; Kundu, Mukta; Fann, Yang; Odenwald, Ward F.			Horizontal Gene Transfers Link a Human MRSA Pathogen to Contagious Bovine Mastitis Bacteria	PLOS ONE			English	Article								Background: Acquisition of virulence factors and antibiotic resistance by many clinically important bacteria can be traced to horizontal gene transfer (HGT) between related or evolutionarily distant microflora. Comparative genomic analysis has become an important tool for identifying HGT DNA in emerging pathogens. We have adapted the multi-genome alignment tool EvoPrinter to facilitate discovery of HGT DNA sequences within bacterial genomes and within their mobile genetic elements. Principal Findings: EvoPrinter analysis of 13 different Staphylococcus aureus genomes revealed that one of the human isolates, the hospital epidemic methicillin-resistant MRSA252 strain, uniquely shares multiple putative HGT DNA sequences with different causative agents of bovine mastitis that are not found in the other human S. aureus isolates. MRSA252 shares over 14 different DNA sequence blocks with the bovine mastitis ET3 S. aureus strain RF122, and many of the HGT DNAs encode virulence factors. EvoPrinter analysis of the MRSA252 chromosome also uncovered virulence-factor encoding HGT events with the genome of Listeria monocytogenes and a Staphylococcus saprophyticus associated plasmid. Both bacteria are also causal agents of contagious bovine mastitis. Conclusions: EvoPrinter analysis reveals that the human MRSA252 strain uniquely shares multiple DNA sequence blocks with different causative agents of bovine mastitis, suggesting that HGT events may be occurring between these pathogens. These findings have important implications with regard to animal husbandry practices that inadvertently enhance the contact of human and livestock bacterial pathogens.	[Brody, Thomas; Ross, Jermaine; Kuzin, Alexander; Kundu, Mukta; Odenwald, Ward F.] NIH, Neural Cell Fate Determinants Sect, Bethesda, MD 20892 USA; [Yavatkar, Amarendra S.; Lin, Yong; Fann, Yang] NINDS, NIH, Div Intramural Res Informat Technol Program, Bethesda, MD USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Brody, T (corresponding author), NIH, Neural Cell Fate Determinants Sect, Bldg 10, Bethesda, MD 20892 USA.	brodyt@ninds.nih.gov; ward@codon.nih.gov			Intramural Research Program of the NIH, NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIHNS002820, ZIANS002820, Z01NS002820] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the NIH, NINDS.	Adams MA, 2006, J MOL BIOL, V359, P455, DOI 10.1016/j.jmb.2006.03.053; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; BOURRY A, 1995, J MED MICROBIOL, V43, P125, DOI 10.1099/00222615-43-2-125; Boyd EF, 2001, TRENDS MICROBIOL, V9, P137, DOI 10.1016/S0966-842X(01)01960-6; BROWN DFJ, 1980, FEBS LETT, V122, P275, DOI 10.1016/0014-5793(80)80455-8; COOKSEY DA, 1994, FEMS MICROBIOL REV, V14, P381, DOI 10.1016/0168-6445(94)90056-6; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diep BA, 2006, J INFECT DIS, V193, P1495, DOI 10.1086/503777; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Field J, 2000, MOL MICROBIOL, V38, P446, DOI 10.1046/j.1365-2958.2000.02143.x; Guinane CM, 2008, J INFECT DIS, V197, P205, DOI 10.1086/524689; Haveri M, 2007, J APPL MICROBIOL, V103, P993, DOI 10.1111/j.1365-2672.2007.03356.x; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Hinnebusch BJ, 2002, MOL MICROBIOL, V46, P349, DOI 10.1046/j.1365-2958.2002.03159.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Hughes AL, 2005, J BACTERIOL, V187, P2698, DOI 10.1128/JB.187.8.2698-2704.2005; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Loisel-Meyer S, 2006, INFECT IMMUN, V74, P1973, DOI 10.1128/IAI.74.3.1973-1976.2006; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Moon JS, 2007, J DAIRY SCI, V90, P1716, DOI 10.3168/jds.2006-512; Moubareck C, 2003, ANTIMICROB AGENTS CH, V47, P2993, DOI 10.1128/AAC.47.9.2993-2996.2003; Nakaminami H, 2007, BIOL PHARM BULL, V30, P1412, DOI 10.1248/bpb.30.1412; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; NOVICK RP, 1968, J BACTERIOL, V95, P1335, DOI 10.1128/JB.95.4.1335-1342.1968; Nwaneshiudu AI, 2007, J BACTERIOL, V189, P6074, DOI 10.1128/JB.00349-07; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pittman MS, 2007, MOL MICROBIOL, V63, P575, DOI 10.1111/j.1365-2958.2006.05532.x; PORTER FD, 1982, ANTIMICROB AGENTS CH, V22, P852, DOI 10.1128/AAC.22.5.852; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; ROWLAND SJ, 1990, MOL MICROBIOL, V4, P961, DOI 10.1111/j.1365-2958.1990.tb00669.x; Saiman L, 2003, CLIN INFECT DIS, V37, P1313, DOI 10.1086/379022; Sigurdardottir B, 2006, INFECT CONT HOSP EP, V27, P913, DOI 10.1086/507278; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0; Yavatkar AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-106; Zaneveld JR, 2008, MICROBIOL-SGM, V154, P1, DOI 10.1099/mic.0.2007/011833-0; Zhu LX, 2007, J CLIN MICROBIOL, V45, P3514, DOI 10.1128/JCM.02340-06	47	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3074	10.1371/journal.pone.0003074	http://dx.doi.org/10.1371/journal.pone.0003074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728754	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796400014
J	Fukushima, S; Coppen, SR; Lee, J; Yamahara, K; Felkin, LE; Terracciano, CMN; Barton, PJR; Yacoub, MH; Suzuki, K				Fukushima, Satsuki; Coppen, Steven R.; Lee, Joon; Yamahara, Kenichi; Felkin, Leanne E.; Terracciano, Cesare M. N.; Barton, Paul J. R.; Yacoub, Magdi H.; Suzuki, Ken			Choice of Cell-Delivery Route for Skeletal Myoblast Transplantation for Treating Post-Infarction Chronic Heart Failure in Rat	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; STEM-CELLS; FOLLOW-UP; INJECTION; CARDIOMYOCYTES; INCREASES; INJURY	Background: Intramyocardial injection of skeletal myoblasts (SMB) has been shown to be a promising strategy for treating post-infarction chronic heart failure. However, insufficient therapeutic benefit and occurrence of ventricular arrhythmias are concerns. We hypothesised that the use of a retrograde intracoronary route for SMB-delivery might favourably alter the behaviour of the grafted SMB, consequently modulating the therapeutic effects and arrhythmogenicity. Methods and Results: Three weeks after coronary artery ligation in female wild-type rats, 5x10(6) GFP-expressing SMB or PBS only (control) were injected via either the intramyocardial or retrograde intracoronary routes. Injection of SMB via either route similarly improved cardiac performance and physical activity, associated with reduced cardiomyocyte-hypertrophy and fibrosis. Grafted SMB via either route were only present in low numbers in the myocardium, analysed by real-time PCR for the Y-chromosome specific gene, Sry. Cardiomyogenic differentiation of grafted SMB was extremely rare. Continuous ECG monitoring by telemetry revealed that only intramyocardial injection of SMB produced spontaneous ventricular tachycardia up to 14 days, associated with local myocardial heterogeneity generated by clusters of injected SMB and accumulated inflammatory cells. A small number of ventricular premature contractions with latent ventricular tachycardia were detected in the late-phase of SMB injection regardless of the injection-route. Conclusion: Retrograde intracoronary injection of SMB provided significant therapeutic benefits with attenuated early-phase arrhythmogenicity in treating ischaemic cardiomyopathy, indicating the promising utility of this route for SMB-delivery. Late-phase arrhythmogenicity remains a concern, regardless of the delivery route.	[Fukushima, Satsuki; Lee, Joon; Yamahara, Kenichi; Felkin, Leanne E.; Terracciano, Cesare M. N.; Barton, Paul J. R.; Yacoub, Magdi H.; Suzuki, Ken] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Harefield, Middx, England; [Coppen, Steven R.; Suzuki, Ken] Barts & London Queen Marys Sch Med & Dent, Barts a& The London, William Harvey Res Inst, London, England	Imperial College London; University of London; Queen Mary University London	Fukushima, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Harefield Heart Sci Ctr, Harefield, Middx, England.	ken.suzuki@qmul.ac.uk		Barton, Paul/0000-0002-1165-7767; Felkin, Leanne/0000-0003-1402-8314	Magdi Yacoub Institute; UK Medical Research Council; Heart Research UK; Great Britain Sasakawa Foundation; MRC [G116/158] Funding Source: UKRI; Medical Research Council [G116/158] Funding Source: researchfish	Magdi Yacoub Institute; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart Research UK; Great Britain Sasakawa Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Magdi Yacoub Institute, The UK Medical Research Council, Heart Research UK and Great Britain Sasakawa Foundation, UK/Japan contributed to the study financially without any other roles	Abraham MR, 2005, CIRC RES, V97, P159, DOI 10.1161/01.RES.0000174794.22491.a0; Bonaros Nikolaos, 2008, Interact Cardiovasc Thorac Surg, V7, P249; Bonaros N, 2006, J THORAC CARDIOV SUR, V132, P1321, DOI 10.1016/j.jtcvs.2006.07.023; Chachques JC, 2004, INT J CARDIOL, V95, pS29, DOI 10.1016/S0167-5273(04)90009-5; Coppen SR, 1999, J HISTOCHEM CYTOCHEM, V47, P907, DOI 10.1177/002215549904700708; Dib N, 2005, CIRCULATION, V112, P1748, DOI 10.1161/CIRCULATIONAHA.105.547810; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Felkin LE, 2006, J HEART LUNG TRANSPL, V25, P1413, DOI 10.1016/j.healun.2006.09.006; Fernandes S, 2006, CARDIOVASC RES, V69, P348, DOI 10.1016/j.cardiores.2005.10.003; Fouts K, 2006, HEART RHYTHM, V3, P452, DOI 10.1016/j.hrthm.2005.12.016; Fukushima S, 2007, CIRCULATION, V115, P2254, DOI 10.1161/CIRCULATIONAHA.106.662577; Hagege AA, 2006, CIRCULATION, V114, pI108, DOI 10.1161/CIRCULATIONAHA.105.000521; HERING S, 1983, J MOL CELL CARDIOL, V15, P431, DOI 10.1016/0022-2828(83)90263-8; Howarth FC, 2006, CLIN EXP PHARMACOL P, V33, P327, DOI 10.1111/j.1440-1681.2006.04370.x; Kovacs SJ, 1997, HYPERTENSION, V30, P788, DOI 10.1161/01.HYP.30.4.788; MacDonnell SM, 2005, CIRCULATION, V111, P3420, DOI 10.1161/CIRCULATIONAHA.104.505784; Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Niagara MI, 2007, CIRC RES, V100, P545, DOI 10.1161/01.RES.0000258460.41160.ef; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Orofino MG, 2006, TRANSPLANTATION, V82, P1529, DOI 10.1097/01.tp.0000235822.46197.61; Ott HC, 2005, EUR J CARDIO-THORAC, V27, P1017, DOI 10.1016/j.ejcts.2005.01.065; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Siminiak T, 2004, AM HEART J, V148, P531, DOI 10.1016/j.ahj.2004.03.043; Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017; Suzuki K, 2000, CIRCULATION, V102, P359; Suzuki K, 1997, J CLIN INVEST, V99, P1645, DOI 10.1172/JCI119327; Suzuki K, 2004, CIRCULATION, V110, pII225, DOI 10.1161/01.CIR.0000138191.11580.e3; Suzuki K, 2001, CIRCULATION, V104, pI207; Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Zheng ZZ, 2006, MOL MED, V12, P214, DOI 10.2119/2006-00037.Zheng	33	49	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3071	10.1371/journal.pone.0003071	http://dx.doi.org/10.1371/journal.pone.0003071			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728781	Green Submitted, gold, Green Published			2022-12-27	WOS:000264796400011
J	Levina, V; Marrangoni, AM; DeMarco, R; Gorelik, E; Lokshin, AE				Levina, Vera; Marrangoni, Adele M.; DeMarco, Richard; Gorelik, Elieser; Lokshin, Anna E.			Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties	PLOS ONE			English	Article								Background: Cancer stem cells (CSCs) are thought to be responsible for tumor regeneration after chemotherapy, although direct confirmation of this remains forthcoming. We therefore investigated whether drug treatment could enrich and maintain CSCs and whether the high tumorogenic and metastatic abilities of CSCs were based on their marked ability to produce growth and angiogenic factors and express their cognate receptors to stimulate tumor cell proliferation and stroma formation. Methodology/Findings: Treatment of lung tumor cells with doxorubicin, cisplatin, or etoposide resulted in the selection of drug surviving cells (DSCs). These cells expressed CD133, CD117, SSEA-3, TRA1-81, Oct-4, and nuclear beta-catenin and lost expression of the differentiation markers cytokeratins 8/18 (CK 8/18). DSCs were able to grow as tumor spheres, maintain self-renewal capacity, and differentiate. Differentiated progenitors lost expression of CD133, gained CK 8/18 and acquired drug sensitivity. In the presence of drugs, differentiation of DSCs was abrogated allowing propagation of cells with CSC-like characteristics. Lung DSCs demonstrated high tumorogenic and metastatic potential following inoculation into SCID mice, which supported their classification as CSCs. Luminex analysis of human and murine cytokines in sonicated lysates of parental- and CSC-derived tumors revealed that CSC-derived tumors contained two- to three-fold higher levels of human angiogenic and growth factors (VEGF, bFGF, IL-6, IL-8, HGF, PDGF-BB, G-CSF, and SCGF-beta). CSCs also showed elevated levels of expression of human VEGFR2, FGFR2, CXCR1, 2 and 4 receptors. Moreover, human CSCs growing in SCID mice stimulated murine stroma to produce elevated levels of angiogenic and growth factors. Conclusions/Significance: These findings suggest that chemotherapy can lead to propagation of CSCs and prevention of their differentiation. The high tumorigenic and metastatic potentials of CSCs are associated with efficient cytokine network production that may represent a target for increased efficacy of cancer therapy.	[Levina, Vera; Marrangoni, Adele M.; DeMarco, Richard; Gorelik, Elieser; Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Dept Med, Pittsburgh, PA 15260 USA; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA 15260 USA; [Gorelik, Elieser] Univ Pittsburgh, Inst Canc, Dept Immunol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levina, V (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.	levinav@upmc.edu			NIH/NCI [RO1 CA098642, R01 CA108990]; Susan Komen Foundation; Harry Lloyd Charitable Trust; Hillman Foundation; Pennsylvania Department of Health;  [DOD BC051720]; NATIONAL CANCER INSTITUTE [R01CA108990, R01CA098642] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation); Harry Lloyd Charitable Trust; Hillman Foundation; Pennsylvania Department of Health; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grants from RO1 CA098642, R01 CA108990, Avon (NIH/NCI), Susan Komen Foundation (AEL), and DOD BC051720 grant, grants from Harry Lloyd Charitable Trust, Hillman Foundation and Pennsylvania Department of Health (E.G).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Almeida GM, 2008, INT J CANCER, V122, P1810, DOI 10.1002/ijc.23188; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bouck N, 1996, ADV CANCER RES, V69, P135, DOI 10.1016/S0065-230X(08)60862-3; Buccheri G, 2001, LUNG CANCER, V34, pS65, DOI 10.1016/S0169-5002(01)00347-6; Collins AT, 2006, EUR J CANCER, V42, P1213, DOI 10.1016/j.ejca.2006.01.037; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; GABRILOVE JL, 1994, BLOOD, V83, P907; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Hassan R, 2006, CLIN CANCER RES, V12, P447, DOI 10.1158/1078-0432.CCR-05-1477; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kanaji N, 2007, LUNG CANCER, V55, P295, DOI 10.1016/j.lungcan.2006.11.004; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Korkaya H, 2007, BIODRUGS, V21, P299, DOI 10.2165/00063030-200721050-00002; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; LEVINA V, 2008, INT J CANC IN PRESS; Levina V, 2008, EXP CELL RES, V314, P1605, DOI 10.1016/j.yexcr.2007.12.027; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Miedouge M, 1999, BRIT J CANCER, V81, P1059, DOI 10.1038/sj.bjc.6690807; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Morales-Arias J, 2007, CANCER-AM CANCER SOC, V110, P1568, DOI 10.1002/cncr.22964; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roninson IB, 2003, CANCER RES, V63, P2705; Rosen LS, 2001, CANCER J, V7, pS120; Samara RN, 2007, CANCER RES, V67, P4774, DOI 10.1158/0008-5472.CAN-06-4315; Schopperle WM, 2007, STEM CELLS, V25, P723, DOI 10.1634/stemcells.2005-0597; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Strieter RM, 2004, ANN NY ACAD SCI, V1028, P351, DOI 10.1196/annals.1322.041; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zhu ZY, 2001, CANCER RES, V61, P1707	59	343	367	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3077	10.1371/journal.pone.0003077	http://dx.doi.org/10.1371/journal.pone.0003077			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728788	Green Accepted, gold, Green Published			2022-12-27	WOS:000264796400017
J	Gilbert, JA; Field, D; Huang, Y; Edwards, R; Li, WZ; Gilna, P; Joint, I				Gilbert, Jack A.; Field, Dawn; Huang, Ying; Edwards, Rob; Li, Weizhong; Gilna, Paul; Joint, Ian			Detection of Large Numbers of Novel Sequences in the Metatranscriptomes of Complex Marine Microbial Communities	PLOS ONE			English	Article							RNA; DNA; PROKARYOTES; EXPRESSION; PROTEIN	Background: Sequencing the expressed genetic information of an ecosystem (metatranscriptome) can provide information about the response of organisms to varying environmental conditions. Until recently, metatranscriptomics has been limited to microarray technology and random cloning methodologies. The application of high-throughput sequencing technology is now enabling access to both known and previously unknown transcripts in natural communities. Methodology/Principal Findings: We present a study of a complex marine metatranscriptome obtained from random whole-community mRNA using the GS-FLX Pyrosequencing technology. Eight samples, four DNA and four mRNA, were processed from two time points in a controlled coastal ocean mesocosm study (Bergen, Norway) involving an induced phytoplankton bloom producing a total of 323,161,989 base pairs. Our study confirms the finding of the first published metatranscriptomic studies of marine and soil environments that metatranscriptomics targets highly expressed sequences which are frequently novel. Our alternative methodology increases the range of experimental options available for conducting such studies and is characterized by an exceptional enrichment of mRNA (99.92%) versus ribosomal RNA. Analysis of corresponding metagenomes confirms much higher levels of assembly in the metatranscriptomic samples and a far higher yield of large gene families with >100 members, similar to 91% of which were novel. Conclusions/Significance: This study provides further evidence that metatranscriptomic studies of natural microbial communities are not only feasible, but when paired with metagenomic data sets, offer an unprecedented opportunity to explore both structure and function of microbial communities-if we can overcome the challenges of elucidating the functions of so many never-seen-before gene families.	[Gilbert, Jack A.; Joint, Ian] Plymouth Marine Lab, Plymouth, Devon, England; [Field, Dawn] CEH Oxford, NERC Ctr Ecol & Hydrol, Oxford, England; [Huang, Ying; Li, Weizhong; Gilna, Paul] Univ Calif San Diego, Calif Inst Telecommun & Informat Technol, La Jolla, CA 92093 USA; [Edwards, Rob] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Rob] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL USA	Plymouth Marine Laboratory; UK Centre for Ecology & Hydrology (UKCEH); University of California System; University of California San Diego; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Gilbert, JA (corresponding author), Plymouth Marine Lab, Prospect Pl, Plymouth, Devon, England.	jagi@pml.ac.uk	Gilbert, Jack/AAF-3270-2019; Edwards, Robert/Q-1691-2019; Gilna, Paul/I-3608-2016; Field, Dawn/C-1653-2010; Li, Weizhong/A-9735-2008	Edwards, Robert/0000-0001-8383-8949; Gilna, Paul/0000-0002-6542-0191; Li, Weizhong/0000-0003-1804-9403	Natural Environment Research Council [NE/C507902/1]; Plymouth Marine Laboratory; Biodiversity Program of the Centre for Ecology and Hydrology [Science Budget award]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400042C]; Gordon and Betty Moore Foundation; NERC [NBAF010002] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biodiversity Program of the Centre for Ecology and Hydrology; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is supported by a grant from the Natural Environment Research Council (NE/C507902/1) and is part of the core research program of the Plymouth Marine Laboratory, a collaborative centre of NERC. Supplementary funds for pyrosequencing were from a Science Budget award from the Biodiversity Program of the Centre for Ecology and Hydrology. The project has been partially funded with US Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN266200400042C. Funding for CAMERA was provided by the Gordon and Betty Moore Foundation. No sponsors or funding agencies were involved in any of the design, or conduct of the study, nor the collection, analysis or interpretation of the data, nor the preparation, review or approval of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; GILBERT JA, 2008, ENV MI IN PRESS 0720; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Handelsman J., 2007, NEW SCI METAGENOMICS, DOI 10.17226/11902; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lipman DJ, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-20; Neufeld JD, 2007, ISME J, V1, P480, DOI 10.1038/ismej.2007.65; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Parro V, 2007, ENVIRON MICROBIOL, V9, P453, DOI 10.1111/j.1462-2920.2006.01162.x; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sansone SA, 2008, OMICS, V12, P143, DOI 10.1089/omi.2008.0019; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Wendisch VF, 2001, ANAL BIOCHEM, V290, P205, DOI 10.1006/abio.2000.4982; Wilson GA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000324; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	24	252	268	2	142	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3042	10.1371/journal.pone.0003042	http://dx.doi.org/10.1371/journal.pone.0003042			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725995	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264428800008
J	Cohen, CD; Lindenmeyer, MT; Eichinger, F; Hahn, A; Seifert, M; Moll, AG; Schmid, H; Kiss, E; Grone, E; Grone, HJ; Kretzler, M; Werner, T; Nelson, PJ				Cohen, Clemens D.; Lindenmeyer, Maja T.; Eichinger, Felix; Hahn, Alexander; Seifert, Martin; Moll, Anton G.; Schmid, Holger; Kiss, Eva; Groene, Elisabeth; Groene, Hermann-Josef; Kretzler, Matthias; Werner, Thomas; Nelson, Peter J.			Improved Elucidation of Biological Processes Linked to Diabetic Nephropathy by Single Probe-Based Microarray Data Analysis	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS	Background: Diabetic nephropathy (DN) is a complex and chronic metabolic disease that evolves into a progressive fibrosing renal disorder. Effective transcriptomic profiling of slowly evolving disease processes such as DN can be problematic. The changes that occur are often subtle and can escape detection by conventional oligonucleotide DNA array analyses. Methodology/Principal Findings: We examined microdissected human renal tissue with or without DN using Affymetrix oligonucleotide microarrays (HG-U133A) by standard Robust Multi-array Analysis (RMA). Subsequent gene ontology analysis by Database for Annotation, Visualization and Integrated Discovery (DAVID) showed limited detection of biological processes previously identified as central mechanisms in the development of DN ( e. g. inflammation and angiogenesis). This apparent lack of sensitivity may be associated with the gene-oriented averaging of oligonucleotide probe signals, as this includes signals from cross-hybridizing probes and gene annotation that is based on out of date genomic data. We then examined the same CEL file data using a different methodology to determine how well it could correlate transcriptomic data with observed biology. ChipInspector (CI) is based on single probe analysis and de novo gene annotation that bypasses probe set definitions. Both methods, RMA and CI, used at default settings yielded comparable numbers of differentially regulated genes. However, when verified by RT-PCR, the single probe based analysis demonstrated reduced background noise with enhanced sensitivity and fewer false positives. Conclusions/Significance: Using a single probe based analysis approach with de novo gene annotation allowed an improved representation of the biological processes linked to the development and progression of DN. The improved analysis was exemplified by the detection of Wnt signaling pathway activation in DN, a process not previously reported to be involved in this disease.	Univ Hosp, Ctr Integrat Human Physiol, Nephrol Clin, Zurich, Switzerland; Univ Hosp, Ctr Integrat Human Physiol, Inst Physiol, Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; Univ Munich, Med Policlin, Clin Biochem Grp, D-80539 Munich, Germany; Univ Michigan, Dept Med, Div Nephrol, Ann Arbor, MI 48109 USA; Genomatix Software GmbH, Munich, Germany; German Canc Res Ctr, Cellular & Mol Pathol, Heidelberg, Germany; [Cohen, Clemens D.] Univ Hosp & Univ, Ctr Integrat Human Physiol, Inst Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University of Munich; University of Michigan System; University of Michigan; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Cohen, CD (corresponding author), Univ Hosp, Ctr Integrat Human Physiol, Nephrol Clin, Zurich, Switzerland.	peter.nelson@med.uni-muenchen.de	Seifert, Martin/GSE-3648-2022	Lindenmeyer, Maja/0000-0003-4162-9107; , Eva/0000-0003-4052-2797	Else Kroner-Fresenius Foundation; DFG [SFB 571]; BMBF Biochance [0313724A]; F6 EU INNOCHEM	Else Kroner-Fresenius Foundation; DFG(German Research Foundation (DFG)); BMBF Biochance(Federal Ministry of Education & Research (BMBF)); F6 EU INNOCHEM	The work was supported by the Else Kroner-Fresenius Foundation to CDC, DFG funding from SFB 571 to PJN and CDC, and BMBF Biochance grant 0313724A to TW, PJN and HJG and F6 EU INNOCHEM to PJN and HJG.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabletz T, 1999, AM J PATHOL, V155, P1033, DOI 10.1016/S0002-9440(10)65204-2; Breyer MD, 2005, ADV CHRONIC KIDNEY D, V12, P128, DOI 10.1053/j.ackd.2005.01.004; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Galkina E, 2006, J AM SOC NEPHROL, V17, P368, DOI 10.1681/ASN.2005080859; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lindenmeyer MT, 2007, J AM SOC NEPHROL, V18, P1765, DOI 10.1681/ASN.2006121304; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-108; McLennan SV, 2007, KIDNEY INT, V72, P481, DOI 10.1038/sj.ki.5002357; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498	27	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2937	10.1371/journal.pone.0002937	http://dx.doi.org/10.1371/journal.pone.0002937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698414	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600023
J	Ruhwald, M; Petersen, J; Kofoed, K; Nakaoka, H; Cuevas, LE; Lawson, L; Squire, SB; Eugen-Olsen, J; Ravn, P				Ruhwald, Morten; Petersen, Janne; Kofoed, Kristian; Nakaoka, Hiroshi; Cuevas, Luis Eduardo; Lawson, Lovett; Squire, Stephen Bertil; Eugen-Olsen, Jesper; Ravn, Pernille			Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a Diagnostic Test Based on IP-10	PLOS ONE			English	Article							GAMMA-INDUCIBLE PROTEIN-10; LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; WHOLE-BLOOD; IFN-GAMMA; SKIN-TEST; RESPONSES; CHEMOKINES; CHILDREN	Background: There is a need for simple tools such as the M. tuberculosis specific IFN-gamma release assays (IGRA) to improve diagnosis of M. tuberculosis-infection in children. The aim of the study was to evaluate the performance of an IP-10 and IL-2 based tests for the diagnosis of M. tuberculosis-infection in recently exposed children from Nigeria. Methodology and Principal Findings: Samples were obtained from 59 children at high risk of infection with M. tuberculosis (contacts of adults with smear and culture-positive tuberculosis) and 61 at low risk (contacts of smear-negative/culture-positive tuberculosis or community controls). IP-10 and IL-2 was measured in plasma after stimulation of whole-blood with M. tuberculosis specific antigens and mitogen. Previously developed criteria for positive IP-10 and IL-2 tests were used and the diagnostic performances of the IP-10 and IL-2 tests were compared with the Quantiferon In-Tube (QFT-IT) and the Tuberculin Skin Tests (TST). In response to M. tuberculosis specific antigens, the high-risk children expressed significantly higher levels of IP-10 (1358 pg/ml[IQR 278-2535 pg/ml]) and IL-2 (164 pg/ml[11-590 pg/ml]) than low risk groups 149 pg/ml( 25-497 pg/ml), and 0 pg/ml(0-3 pg/ml), respectively. There was excellent agreement (>89%, k>0.80) between IP-10, IL-2 tests and QFT-IT, better than with TST (>74%, k>0.49). The IP-10 and IL-2 responses were strongly associated with M. tuberculosis exposure and with grade of infectiousness of the index cases (p<0.0001). IP-10, IL-2, and TST but not QFT-IT was associated with age of the child in the low risk groups (p<0.02). Conclusions/Significance: IP-10 is expressed in high levels and results of the IP-10 test were comparable to the QFT-IT. IL-2 was released in low amounts in response to the antigens and not in response to the mitogen therefore IL-2 seems a less useful marker. We have demonstrated that IP-10 and possibly IL-2 could be alternative or adjunct markers to IFN-gamma in the diagnosis infection with M. tuberculosis.	[Ruhwald, Morten] Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis 144, DK-2650 Hvidovre, Denmark; [Ruhwald, Morten; Petersen, Janne; Kofoed, Kristian; Eugen-Olsen, Jesper; Ravn, Pernille] Univ Copenhagen, Hvidovre Hosp, Clin Res Ctr 136, Hvidovre, Denmark; [Nakaoka, Hiroshi; Cuevas, Luis Eduardo; Squire, Stephen Bertil] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Lawson, Lovett] Zankli Med Ctr, Abuja, Nigeria; [Ravn, Pernille] Univ Copenhagen, Herlev Hosp, Dept Internal Med, Infect Dis Unit, Herlev, Denmark	University of Copenhagen; University of Copenhagen; Liverpool School of Tropical Medicine; University of Copenhagen; Herlev & Gentofte Hospital	Ruhwald, M (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Infect Dis 144, DK-2650 Hvidovre, Denmark.	mruhwald@mail.dk	Ruhwald, Morten/E-5757-2012; Cuevas, Luis E/I-3697-2015	Cuevas, Luis E/0000-0002-6581-0587; Eugen-Olsen, Jesper/0000-0002-4630-4275; Petersen, Janne/0000-0001-7323-2548; Lawson, Lovett/0000-0001-9019-7537; Squire, Stephen/0000-0001-7173-9038	Danish Lung Association; The Copenhagen University Hospital, Hvidovre; AugustinusFonden; Aase and Einar Danielsens Foundation; The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen; Capital Region of Denmark	Danish Lung Association; The Copenhagen University Hospital, Hvidovre; AugustinusFonden; Aase and Einar Danielsens Foundation; The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen; Capital Region of Denmark	This work was supported by the Danish Lung Association; The Copenhagen University Hospital, Hvidovre, Annual Research Grant; AugustinusFonden, Aase and Einar Danielsens Foundation, The Danish Rheumatism Society; Thorvald Madsen Foundation; Asta og Justesens fond, Cluster of International Health; University of Copenhagen. MR is a PhD candidate receiving a Scholarship from the Capital Region of Denmark.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berktas M, 2004, J INT MED RES, V32, P324, DOI 10.1177/147323000403200313; Bourgarit A, 2006, AIDS, V20, pF1, DOI 10.1097/01.aids.0000202648.18526.bf; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Connell TG, 2006, EXPERT REV MOL DIAGN, V6, P663, DOI 10.1586/14737159.6.5.663; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Ferrero E, 2003, IMMUNOLOGY, V108, P365, DOI 10.1046/j.1365-2567.2003.01600.x; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Kang YA, 2005, JAMA-J AM MED ASSOC, V293, P2756, DOI 10.1001/jama.293.22.2756; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kibiki GS, 2007, CLIN EXP IMMUNOL, V148, P254, DOI 10.1111/j.1365-2249.2007.03330.x; Lawson L, 2005, INT J TUBERC LUNG D, V9, P933; LUETKEMEYER AF, 2007, AM J RESP CRIT CARE; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; NAKAOKA H, 2006, EMERGING INFECT DIS; Nakaoka H, 2006, EMERG INFECT DIS, V12, P1383, DOI 10.3201/eid1209.051606; Okamoto M, 2005, J LAB CLIN MED, V145, P88, DOI 10.1016/j.lab.2004.11.013; Pai M, 2007, INFECTION, V35, P98, DOI 10.1007/s15010-007-6114-z; PAI M, 2008, ANN INTERN MED; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; Ravn P, 1999, J INFECT DIS, V179, P637, DOI 10.1086/314640; Ruhwald M, 2007, MICROBES INFECT, V9, P806, DOI 10.1016/j.micinf.2007.02.021; SCHAUF V, 1993, J INFECT DIS, V168, P1056, DOI 10.1093/infdis/168.4.1056; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Tsiouris SJ, 2006, J CLIN MICROBIOL, V44, P2844, DOI 10.1128/JCM.02411-05; Walrath E, 2005, AM J RESP CELL MOL, V33, P48, DOI 10.1165/rcmb.2005-0060OC; *WHO, 2006, GLOB TUB CONTR SURV	35	86	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2858	10.1371/journal.pone.0002858	http://dx.doi.org/10.1371/journal.pone.0002858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682747	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600014
J	Vieira, OV; Hartmann, DO; Cardoso, CMP; Oberdoerfer, D; Baptista, M; Santos, MAS; Almeida, L; Ramalho-Santos, J; Vaz, WLC				Vieira, Otilia V.; Hartmann, Diego O.; Cardoso, Carla M. P.; Oberdoerfer, Daniel; Baptista, Marta; Santos, Manuel A. S.; Almeida, Luis; Ramalho-Santos, Joao; Vaz, Winchil L. C.			Surfactants as Microbicides and Contraceptive Agents: A Systematic In Vitro Study	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHOSPHATIDYLCHOLINE BILAYERS; CONTROLLED-TRIAL; NONOXYNOL 9; HIV; C31G; SOLUBILIZATION; DELIVERY; INCREASE; SULFATE	Background: The urgent need for cheap and easy-to-use protection against both unwanted pregnancies and sexually transmitted diseases has stimulated considerable interest in the use of surfactants as microbicides, anti-viral, and contraceptive agents in recent years. In the present study we report a systematic in vitro evaluation of the microbicidal, antiviral and contraceptive potential of cationic, anionic, zwitterionic, and non-ionic surfactants. Methodology/Principal Findings: Toxicity was evaluated in mammalian columnar epithelial (MDCK) cells, human sperm cells, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, Neisseria gonorrhoeae, Streptococcus agalactiae and Enterococcus faecalis. The inhibition of adenovirus and lentivirus infection of MDCK cells was also tested. A homologous series of cationic surfactants, alkyl-N,N,N-trimethylammonium bromides (C(n)TAB), with varying alkyl chains were shown to be bactericidal and fungicidal at doses that were related to the surfactant critical micelle concentrations (CMC), all of them at concentrations significantly below the CMC. In general, bacteria were more susceptible to this surfactant group than C. albicans and this organism, in turn, was more susceptible than MDCK cells. This suggests that the C(n)TAB may be useful as vaginal disinfectants only in so far as bacterial and fungal infections are concerned. None of the surfactants examined, including those that have been used in pre-clinical studies, showed inhibition of adenovirus or lentivirus infection of MDCK cells or spermicidal activity at doses that were sub-toxic to MDCK cells. Conclusions/Significance: The results of this study lead us to propose that systematic analysis of surfactant toxicity, such as we report in the present work, be made a mandatory pre-condition for the use of these substances in pre-clinical animal and/or human studies.	[Vieira, Otilia V.; Hartmann, Diego O.; Cardoso, Carla M. P.; Oberdoerfer, Daniel; Baptista, Marta; Almeida, Luis; Ramalho-Santos, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Santos, Manuel A. S.] Univ Aveiro, Dept Biol, CESAM, Aveiro, Portugal; [Almeida, Luis] Univ Coimbra, Fac Pharm, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Coimbra, Dept Zool, Coimbra, Portugal; [Ramalho-Santos, Joao] Univ Hosp Coimbra, Dept Maternal Fetal Med, Genet & Human Reproduct, Coimbra, Portugal; [Vaz, Winchil L. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Universidade de Coimbra; Universidade de Aveiro; Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Vieira, OV (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	vieira@cnc.cj.uc.pt	Vieira, Otilia V/O-8660-2017; Hartmann, Diego O/E-6904-2013; Vieira, O V/C-4860-2013; Santos, João/HHZ-5595-2022; Santos, Manuel/E-6704-2010; de Almeida, Luis Pereira/O-8196-2019; de Almeida, Luis Pereira/A-4605-2009; Ramalho-Santos, João/F-8641-2012; Vaz, Winchil/N-4320-2013	Vieira, Otilia V/0000-0003-4924-1780; Hartmann, Diego O/0000-0002-6399-5020; Santos, Manuel/0000-0002-0437-1146; de Almeida, Luis Pereira/0000-0001-5831-3307; de Almeida, Luis Pereira/0000-0001-5831-3307; Ramalho-Santos, João/0000-0002-1172-4018; Vaz, Winchil/0000-0002-3797-4330; Cardoso, Carla/0000-0002-0985-7487	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education [PTDC/SAU-MII/66285/2006, SFRH/BPD/34713/2007]	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education	Research grant PTDC/SAU-MII/66285/2006 from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT). CMPC is a holder of a post-doctoral fellowship (ref.: SFRH/BPD/34713/2007) from the FCT.	Ahlstrom B, 1999, APMIS, V107, P318, DOI 10.1111/j.1699-0463.1999.tb01560.x; Ahlstrom B, 1997, ANTIMICROB AGENTS CH, V41, P544, DOI 10.1128/AAC.41.3.544; Ahyayauch H, 2006, BBA-BIOMEMBRANES, V1758, P190, DOI 10.1016/j.bbamem.2006.01.016; Bergmeyer H.U., 1974, UV ASSAY PYRUVATE NA, P574; BRITO RMM, 1986, ANAL BIOCHEM, V152, P250, DOI 10.1016/0003-2697(86)90406-9; Catalone BJ, 2005, ANTIMICROB AGENTS CH, V49, P1509, DOI 10.1128/AAC.49.4.1509-1520.2005; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Dias RS, 2005, J PHYS CHEM B, V109, P10458, DOI 10.1021/jp0444464; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; GARNER DL, 1994, J ANDROL, V15, P620; JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; KELLOGG DS, 1963, J BACTERIOL, V85, P1274, DOI 10.1128/JB.85.6.1274-1279.1963; Krebs FC, 1999, ANTIVIR RES, V43, P157, DOI 10.1016/S0166-3542(99)00044-3; Krebs FC, 2000, ANTIMICROB AGENTS CH, V44, P1954, DOI 10.1128/AAC.44.7.1954-1960.2000; KREISS J, 1992, JAMA-J AM MED ASSOC, V268, P477, DOI 10.1001/jama.268.4.477; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Roddy RE, 1998, NEW ENGL J MED, V339, P504, DOI 10.1056/NEJM199808203390803; Sampaio JL, 2005, BIOPHYS J, V88, P4064, DOI 10.1529/biophysj.104.054007; Sander F. V., 1941, HUM FERTIL, V6, P134; Schnitzer E, 2005, CHEM PHYS LIPIDS, V135, P69, DOI 10.1016/j.chemphyslip.2005.02.002; Stephenson J, 2000, JAMA-J AM MED ASSOC, V284, P949, DOI 10.1001/jama.284.8.949; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Tanford C., 1991, HYDROPHOBIC EFFECT F, pix; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th	32	50	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2913	10.1371/journal.pone.0002913	http://dx.doi.org/10.1371/journal.pone.0002913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682796	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600068
J	Huge, V; Lauchart, M; Forderreuther, S; Kaufhold, W; Valet, M; Azad, SC; Beyer, A; Magerl, W				Huge, Volker; Lauchart, Meike; Foerderreuther, Stefanie; Kaufhold, Wibke; Valet, Michael; Azad, Shahnaz Christina; Beyer, Antje; Magerl, Walter			Interaction of Hyperalgesia and Sensory Loss in Complex Regional Pain Syndrome Type I (CRPS I)	PLOS ONE			English	Article							REFLEX SYMPATHETIC DYSTROPHY; FACILITATED NEUROGENIC INFLAMMATION; CORTICAL REORGANIZATION; NERVOUS-SYSTEM; SYMPTOMS; ABNORMALITIES; ISCHEMIA; PATTERNS; MODEL; SIGNS	Background: Sensory abnormalities are a key feature of Complex Regional Pain Syndrome (CRPS). In order to characterise these changes in patients suffering from acute or chronic CRPS I, we used Quantitative Sensory Testing (QST) in comparison to an age and gender matched control group. Methods: 61 patients presenting with CRPS I of the upper extremity and 56 healthy subjects were prospectively assessed using QST. The patients' warm and cold detection thresholds (WDT; CDT), the heat and cold pain thresholds (HPT; CPT) and the occurrence of paradoxical heat sensation (PHS) were observed. Results: In acute CRPS I, patients showed warm and cold hyperalgesia, indicated by significant changes in HPT and CPT. WDT and CDT were significantly increased as well, indicating warm and cold hypoaesthesia. In chronic CRPS, thermal hyperalgesia declined, but CDT as well as WDT further deteriorated. Solely patients with acute CRPS displayed PHS. To a minor degree, all QST changes were also present on the contralateral limb. Conclusions: We propose three pathomechanisms of CRPS I, which follow a distinct time course: Thermal hyperalgesia, observed in acute CRPS, indicates an ongoing aseptic peripheral inflammation. Thermal hypoaesthesia, as detected in acute and chronic CRPS, signals a degeneration of A-delta and C-fibres, which further deteriorates in chronic CRPS. PHS in acute CRPS I indicates that both inflammation and degeneration are present, whilst in chronic CRPS I, the pathomechanism of degeneration dominates, signalled by the absence of PHS. The contralateral changes observed strongly suggest the involvement of the central nervous system.	[Huge, Volker; Lauchart, Meike; Kaufhold, Wibke; Azad, Shahnaz Christina; Beyer, Antje] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Foerderreuther, Stefanie] Univ Munich, Dept Neurol, Munich, Germany; [Valet, Michael] Tech Univ Munich, Dept Neurol, Munich, Germany; [Magerl, Walter] Heidelberg Univ, Medi Fac Mannheim, Dept Neurobiol, Ctr Biomed & Med Technol CBTM, Mannheim, Germany; [Magerl, Walter] Johannes Gutenberg Univ Mainz, Dept Physiol & Pathophysiol, Mainz, Germany	University of Munich; University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Huge, V (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	vhuge@med.uni-muenchen.de		Valet, Michael/0000-0003-3828-9164	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) [01EM0118]	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF)(Federal Ministry of Education & Research (BMBF))	German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung - BMBF) (01EM0118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht PJ, 2006, PAIN, V120, P244, DOI 10.1016/j.pain.2005.10.035; Atherton DD, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-21; Birklein F, 1998, CLIN AUTON RES, V8, P79, DOI 10.1007/BF02267817; Birklein F, 2000, ACTA NEUROL SCAND, V101, P262, DOI 10.1034/j.1600-0404.2000.101004262x./; Birklein F, 2001, NEUROLOGY, V57, P2179, DOI 10.1212/WNL.57.12.2179; Blumberg H, 1997, BEHAV BRAIN SCI, V20, P426, DOI 10.1017/S0140525X97271487; Bonica J.J., 1990, MANAGEMENT PAIN, P220; Bruehl S, 1999, PAIN, V81, P147, DOI 10.1016/S0304-3959(99)00011-1; Bruehl S, 2002, PAIN, V95, P119, DOI 10.1016/S0304-3959(01)00387-6; Coderre TJ, 2004, PAIN, V112, P94, DOI 10.1016/j.pain.2004.08.001; CRAIG AD, 1994, SCIENCE, V265, P252, DOI 10.1126/science.8023144; Darian-Smith C, 2000, NAT NEUROSCI, V3, P476, DOI 10.1038/74852; Eisenberg E, 2005, PAIN, V113, P99, DOI 10.1016/j.pain.2004.09.030; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; FRUHSTORFER H, 1984, PAIN, V20, P355, DOI 10.1016/0304-3959(84)90112-X; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; GEBER C, 2008, PAIN; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Gradl G, 2006, NEUROSCI LETT, V402, P267, DOI 10.1016/j.neulet.2006.04.007; Hautzinger M., 1993, ALLGEMEINE DEPRESSIO; Helyes Z, 2004, ARTHRITIS RHEUM-US, V50, P1677, DOI 10.1002/art.20184; Janig W, 2003, LANCET NEUROL, V2, P687, DOI 10.1016/S1474-4422(03)00557-X; Kosek E, 2002, EUR J PAIN, V6, P413, DOI 10.1016/S1090-3801(02)00041-1; Leis S, 2004, NEUROSCI LETT, V359, P163, DOI 10.1016/j.neulet.2004.02.025; LEVINE JD, 1985, J IMMUNOL, V135, pS843; LEVINE JD, 1985, J NEUROSCI, V5, P1380; Loseth S, 2006, EUR J NEUROL, V13, P105, DOI 10.1111/j.1468-1331.2006.01232.x; Ludwig J, 2007, EUR J PAIN, V11, P677, DOI 10.1016/j.ejpain.2006.10.005; Magerl W, 2004, NEUROSCI LETT, V361, P136, DOI 10.1016/j.neulet.2003.12.001; Maihofner C, 2003, NEUROLOGY, V61, P1707, DOI 10.1212/01.WNL.0000098939.02752.8E; Moriwaki K, 1999, PAIN, V81, P1, DOI 10.1016/S0304-3959(98)00257-7; NOLANO M, 2008, BRAIN; Oaklander AL, 2006, PAIN, V120, P235, DOI 10.1016/j.pain.2005.09.036; Oaklander AL, 2004, ANN NEUROL, V55, P639, DOI 10.1002/ana.20048; Oaklander AL, 1998, ANN NEUROL, V44, P789, DOI 10.1002/ana.410440513; OAKLANDER AL, 2006, CRPS CURRENT DIAGNOS, P59; Pleger B, 2005, ANN NEUROL, V57, P425, DOI 10.1002/ana.20394; Pleger B, 2006, NEUROIMAGE, V32, P503, DOI 10.1016/j.neuroimage.2006.03.045; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rolke R, 2006, EUR J PAIN, V10, P77, DOI 10.1016/j.ejpain.2005.02.003; Rommel O, 2001, PAIN, V93, P279, DOI 10.1016/S0304-3959(01)00332-3; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Sinay VJ, 2003, CEPHALALGIA, V23, P541, DOI 10.1046/j.1468-2982.2003.00581.x; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Susser E, 1999, BRAIN, V122, P239, DOI 10.1093/brain/122.2.239; Thimineur M, 1998, CLIN J PAIN, V14, P256, DOI 10.1097/00002508-199809000-00013; Treede RD, 2004, PROG PAIN RES MANAG, V30, P3; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; VERDUGO R, 1992, BRAIN, V115, P893, DOI 10.1093/brain/115.3.893; Vlckova-Moravcova E, 2008, MUSCLE NERVE, V37, P50, DOI 10.1002/mus.20889; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Weber M, 2001, PAIN, V91, P251, DOI 10.1016/S0304-3959(00)00445-0; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; YARNITSKY D, 1991, BRAIN, V114, P907, DOI 10.1093/brain/114.2.907	56	56	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2742	10.1371/journal.pone.0002742	http://dx.doi.org/10.1371/journal.pone.0002742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648647	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900013
J	Salmi, C; Loncle, C; Vidal, N; Letourneux, Y; Fantini, J; Maresca, M; Taieb, N; Pages, JM; Brunel, JM				Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Letourneux, Yves; Fantini, Jacques; Maresca, Marc; Taieb, Nadira; Pages, Jean-Marie; Brunel, Jean Michel			Squalamine: An Appropriate Strategy against the Emergence of Multidrug Resistant Gram-Negative Bacteria?	PLOS ONE			English	Article							TOLC EFFLUX PUMP; OUTER-MEMBRANE; ANTIBIOTIC SUSCEPTIBILITY; PERMEABILITY BARRIER; PEPTIDES; LIPOPOLYSACCHARIDE; INHIBITOR; SPERMINE; COLISTIN; INCREASE	We reported that squalamine is a membrane-active molecule that targets the membrane integrity as demonstrated by the ATP release and dye entry. In this context, its activity may depend on the membrane lipid composition. This molecule shows a preserved activity against bacterial pathogens presenting a noticeable multi-resistance phenotype against antibiotics such as polymyxin B. In this context and because of its structure, action and its relative insensitivity to efflux resistance mechanisms, we have demonstrated that squalamine appears as an alternate way to combat MDR pathogens and by pass the gap regarding the failure of new active antibacterial molecules.	[Salmi, Chanaz; Loncle, Celine; Vidal, Nicolas; Letourneux, Yves; Pages, Jean-Marie] Fac Med & Pharm, UMR MD1, Marseille, France; [Brunel, Jean Michel] Univ Mediterranee, Fac Med, URMITE, UMR 6236, Marseille, France; [Fantini, Jacques; Maresca, Marc; Taieb, Nadira] Univ Paul Cezanne, Fac Sci St Jerome, CRN2M, CNRS UMR 6231, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Salmi, C (corresponding author), Fac Med & Pharm, UMR MD1, Marseille, France.	bruneljm@yahoo.fr	PAGES, jean-marie/F-2555-2013; Maresca, Marc/AAG-9148-2019	PAGES, jean-marie/0000-0001-7092-7977; Maresca, Marc/0000-0002-3585-4765; Fantini, Jacques/0000-0001-8653-5521; jean michel, brunel/0000-0002-9355-8980				Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Armstrong D, 1995, MICROB DRUG RESIST, V1, P1, DOI 10.1089/mdr.1995.1.1; Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; BOMAN HG, 1991, CELL, V65, P205, DOI 10.1016/0092-8674(91)90154-Q; Brunel JM, 2005, CURR CANCER DRUG TAR, V5, P267, DOI 10.2174/1568009054064642; Brunel JM, 2003, EUR J ORG CHEM, V2003, P3897, DOI 10.1002/ejoc.200300167; Burns MR, 2005, BIOORGAN MED CHEM, V13, P2523, DOI 10.1016/j.bmc.2005.01.038; Dean CR, 2005, ANTIMICROB AGENTS CH, V49, P3129, DOI 10.1128/AAC.49.8.3129-3135.2005; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Garmy N, 2005, J LIPID RES, V46, P36, DOI 10.1194/jlr.M400199-JLR200; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; Hayrinen J, 2002, MOL IMMUNOL, V39, P399, DOI 10.1016/S0161-5890(02)00202-X; Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0; Kwon DH, 2006, ANTIMICROB AGENTS CH, V50, P1623, DOI 10.1128/AAC.50.5.1623-1627.2006; Kwon DH, 2007, ANTIMICROB AGENTS CH, V51, P2070, DOI 10.1128/AAC.01472-06; LABISCHINSKI H, 1985, J BACTERIOL, V162, P9, DOI 10.1128/JB.162.1.9-20.1985; Li J, 2006, LANCET INFECT DIS, V6, P589, DOI 10.1016/S1473-3099(06)70580-1; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Murata T, 2007, J BACTERIOL, V189, P7213, DOI 10.1128/JB.00973-07; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; Niven GW, 1998, J APPL MICROBIOL, V84, P90, DOI 10.1046/j.1365-2672.1997.00316.x; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Pradel E, 2002, ANTIMICROB AGENTS CH, V46, P2640, DOI 10.1128/AAC.46.8.2640-2643.2002; Rao MN, 2000, J NAT PROD, V63, P631, DOI 10.1021/np990514f; Selinsky BS, 1998, BBA-BIOMEMBRANES, V1370, P218, DOI 10.1016/S0005-2736(97)00265-4; Sol V, 2004, BIOORG MED CHEM LETT, V14, P4207, DOI 10.1016/j.bmcl.2004.06.016; STONE R, 1993, SCIENCE, V259, P1125, DOI 10.1126/science.8438163; Thiolas A, 2005, ANTIMICROB AGENTS CH, V49, P1354, DOI 10.1128/AAC.49.4.1354-1358.2005; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Yasuda K, 2004, INT J ANTIMICROB AG, V24, P67, DOI 10.1016/j.ijantimicag.2004.01.006; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U; ZASLOFF M, 1994, PHYLOGENET PERSPECT, P31; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357	41	39	47	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2765	10.1371/journal.pone.0002765	http://dx.doi.org/10.1371/journal.pone.0002765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648511	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900035
J	Davidson, RJ; Davis, I; Willey, BM; Rizg, K; Bolotin, S; Porter, V; Polsky, J; Daneman, N; McGeer, A; Yang, P; Scolnik, D; Rowsell, R; Imas, O; Silverman, MS				Davidson, Ross J.; Davis, Ian; Willey, Barbara M.; Rizg, Keyro; Bolotin, Shelly; Porter, Vanessa; Polsky, Jane; Daneman, Nick; McGeer, Allison; Yang, Paul; Scolnik, Dennis; Rowsell, Roy; Imas, Olga; Silverman, Michael S.			Antimalarial Therapy Selection for Quinolone Resistance among Escherichia coli in the Absence of Quinolone Exposure, in Tropical South America	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; FLUOROQUINOLONE RESISTANCE; ANTIBIOTIC-RESISTANCE; SALMONELLA-ENTERICA; DNA; INHIBITION; ASSOCIATION; CHLOROQUINE; PNEUMONIAE; AGENTS	Background: Bacterial resistance to antibiotics is thought to develop only in the presence of antibiotic pressure. Here we show evidence to suggest that fluoroquinolone resistance in Escherichia coli has developed in the absence of fluoroquinolone use. Methods: Over 4 years, outreach clinic attendees in one moderately remote and five very remote villages in rural Guyana were surveyed for the presence of rectal carriage of ciprofloxacin-resistant Gram-negative bacilli (GNB). Drinking water was tested for the presence of resistant GNB by culture, and the presence of antibacterial agents and chloroquine by HPLC. The development of ciprofloxacin resistance in E. coli was examined after serial exposure to chloroquine. Patient and laboratory isolates of E. coli resistant to ciprofloxacin were assessed by PCR-sequencing for quinolone-resistance-determining-region (QRDR) mutations. Results: In the very remote villages, 4.8% of patients carried ciprofloxacin-resistant E. coli with QRDR mutations despite no local availability of quinolones. However, there had been extensive local use of chloroquine, with higher prevalence of resistance seen in the villages shortly after a Plasmodium vivax epidemic (p<0.01). Antibacterial agents were not found in the drinking water, but chloroquine was demonstrated to be present. Chloroquine was found to inhibit the growth of E. coli in vitro. Replica plating demonstrated that 2-step QRDR mutations could be induced in E. coli in response to chloroquine. Conclusions: In these remote communities, the heavy use of chloroquine to treat malaria likely selected for ciprofloxacin resistance in E. coli. This may be an important public health problem in malarious areas.	[Davidson, Ross J.] Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada; [Davidson, Ross J.; Rizg, Keyro] Dalhousie Univ, Halifax, NS, Canada; [Davis, Ian; Rowsell, Roy; Silverman, Michael S.] Lakeridge Hlth Ctr, Oshawa, Canada; [Davis, Ian; Bolotin, Shelly; Daneman, Nick; McGeer, Allison; Scolnik, Dennis; Silverman, Michael S.] Univ Toronto, Toronto, ON, Canada; [Willey, Barbara M.; Porter, Vanessa; McGeer, Allison; Imas, Olga] Mt Sinai Hosp, Dept Microbiol, Toronto Med Lab, Toronto, ON, Canada; [Polsky, Jane] St Michaels Hosp, Dept Family Community Med, Toronto, ON, Canada; [Yang, Paul] Ontario Minist Environm, Etobicoke, Canada	Dalhousie University; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Davidson, RJ (corresponding author), Dalhousie Univ, Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada.	msilverman@rogers.com	mcgeer, allison/H-7747-2014; Silverman, Michael/J-3776-2014; McGeer, Allison/AAB-6885-2020	mcgeer, allison/0000-0001-5647-6137; Silverman, Michael/0000-0002-0389-7656; McGeer, Allison/0000-0001-5647-6137				[Anonymous], 2003, AFR MAL REP 2003; ANSELMO L, 1988, STAT PAR VILL CAPT M; Appelbaum PC, 2000, INT J ANTIMICROB AG, V16, P5, DOI 10.1016/S0924-8579(00)00192-8; Arrow KJ, 2005, NEW ENGL J MED, V353, P333, DOI 10.1056/NEJMp058168; BARRETT TJ, 1994, J CLIN MICROBIOL, V32, P3013, DOI 10.1128/JCM.32.12.3013-3017.1994; Brenwald NP, 1997, J ANTIMICROB CHEMOTH, V40, P458, DOI 10.1093/jac/40.3.458; *BRIT GUYAN, 1959, 91 AM DIS BRIT GUYAN; BYRD TF, 1991, J CLIN INVEST, V88, P351, DOI 10.1172/JCI115301; *CDCP DEP HLTH HUM, GUID TREATM MAL US; Ciarrocchi G, 1999, ANTIMICROB AGENTS CH, V43, P2766, DOI 10.1128/AAC.43.11.2766; Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB STA; COHEN SN, 1965, P NATL ACAD SCI USA, V54, P521, DOI 10.1073/pnas.54.2.521; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hakanen A, 2001, EMERG INFECT DIS, V7, P996, DOI 10.3201/eid0706.010613; Hao CY, 2006, ANAL BIOANAL CHEM, V384, P505, DOI 10.1007/s00216-005-0199-y; Hart CA, 1998, BRIT MED J, V317, P647, DOI 10.1136/bmj.317.7159.647; Jacoby GA, 2003, ANTIMICROB AGENTS CH, V47, P559, DOI 10.1128/AAC.47.2.559-562.2003; Jain Sudhir K., 2003, Indian Journal of Microbiology, V43, P147; JAMES T, 2003, IND RIGHTS COMM CAR; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lautenbach E, 2005, CLIN INFECT DIS, V41, P923, DOI 10.1086/432940; LESHER GY, 1962, J MED PHARMACEUT CH, V5, P1063, DOI 10.1021/jm01240a021; Leslie T, 2007, JAMA-J AM MED ASSOC, V297, P2201, DOI 10.1001/jama.297.20.2201; Liesegang A, 2002, INT J MED MICROBIOL, V291, P645, DOI 10.1078/1438-4221-00180; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Popelka P, 2003, B VET I PULAWY, V47, P203; Ruiz-Irastorza G, 2000, EXPERT OPIN INV DRUG, V9, P1581, DOI 10.1517/13543784.9.7.1581; SMITH KT, 1989, ARCH MICROBIOL, V152, P251, DOI 10.1007/BF00409659; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Turnidge J, 2005, LANCET, V365, P548; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; WILLEMS TE, 2007, 47 INT C ANT AG CHEM, pA1290; 1991, 2 C AM PEOPL GUYAN A	36	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2727	10.1371/journal.pone.0002727	http://dx.doi.org/10.1371/journal.pone.0002727			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648533	gold, Green Published, Green Submitted			2022-12-27	WOS:000264057200065
J	Dluzewski, AR; Ling, IT; Hopkins, JM; Grainger, M; Margos, G; Mitchell, GH; Holder, AA; Bannister, LH				Dluzewski, Anton R.; Ling, Irene T.; Hopkins, John M.; Grainger, Munira; Margos, Gabriele; Mitchell, Graham H.; Holder, Anthony A.; Bannister, Lawrence H.			Formation of the Food Vacuole in Plasmodium falciparum: A Potential Role for the 19 kDa Fragment of Merozoite Surface Protein 1 (MSP1(19))	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE; CHLOROQUINE RESISTANCE; ERYTHROCYTIC STAGES; DIGESTIVE VACUOLE; MEMBRANE-PROTEIN; RING-STAGE; EXPRESSION; ANTIBODIES; PROTEASES	Plasmodium falciparum Merozoite Surface Protein 1 ( MSP1) is synthesized during schizogony as a 195-kDa precursor that is processed into four fragments on the parasite surface. Following a second proteolytic cleavage during merozoite invasion of the red blood cell, most of the protein is shed from the surface except for the C-terminal 19-kDa fragment (MSP1(19)), which is still attached to the merozoite via its GPI-anchor. We have examined the fate of MSP1(19) during the parasite's subsequent intracellular development using immunochemical analysis of metabolically labeled MSP1(19), fluorescence imaging, and immuno-electronmicroscopy. Our data show that MSP1(19) remains intact and persists to the end of the intracellular cycle. This protein is the first marker for the biogenesis of the food vacuole; it is rapidly endocytosed into small vacuoles in the ring stage, which coalesce to form the single food vacuole containing hemozoin, and persists into the discarded residual body. The food vacuole is marked by the presence of both MSP1(19) and the chloroquine resistance transporter (CRT) as components of the vacuolar membrane. Newly synthesized MSP1 is excluded from the vacuole. This behavior indicates that MSP1(19) does not simply follow a classical lysosome-like clearance pathway, instead, it may play a significant role in the biogenesis and function of the food vacuole throughout the intra-erythrocytic phase.	[Dluzewski, Anton R.; Hopkins, John M.; Margos, Gabriele; Mitchell, Graham H.] Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Immunobiol, London SE1 9RT, England; [Hopkins, John M.; Margos, Gabriele; Bannister, Lawrence H.] Guys Hosp, Guys Kings & St Thomas Sch Biomed & Life Sci, Ctr Ultrastruct Imag, London, England; [Dluzewski, Anton R.; Ling, Irene T.; Grainger, Munira; Holder, Anthony A.] NIMR, Div Parasitol, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; MRC National Institute for Medical Research	Dluzewski, AR (corresponding author), Guys Hosp, Guys Kings & St Thomas Sch Med, Dept Immunobiol, London SE1 9RT, England.	anton.dluzewski@nimr.mrc.ac.uk	Mitchell, Graham/AAA-5654-2020; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; MARGOS, Gabriele/0000-0001-5304-9615; Mitchell, G.H./0000-0002-4922-8044	UK Medical Research Council; Wellcome Trust [069515]; European Commission [QLK2-CT-1999-01293]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme [LSHP-CT-2004-503578]; MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded in part by the UK Medical Research Council, The Wellcome Trust (Grant No. 069515) and the European Commission (Euromalvac QLK2-CT-1999-01293). This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the 6th Framework Programme.	AIKAWA M, 1966, MIL MED, V131, P969, DOI 10.1093/milmed/131.suppl_9.969; Akompong T, 2002, J BIOL CHEM, V277, P28923, DOI 10.1074/jbc.M201968200; AMOT DE, 2008, CLIN VACCINE IMMUNOL; Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320; Bannister LH, 2004, MICROSC MICROANAL, V10, P551, DOI 10.1017/S1431927604040917; Bergmann-Leitner ES, 2006, AM J TROP MED HYG, V75, P437, DOI 10.4269/ajtmh.2006.75.437; Black CG, 2001, MOL BIOCHEM PARASIT, V114, P217, DOI 10.1016/S0166-6851(01)00265-1; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Burns JM, 2000, INFECT IMMUN, V68, P6189, DOI 10.1128/IAI.68.11.6189-6195.2000; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; DLUZEWSKI AR, 1984, T ROY SOC TROP MED H, V78, P622, DOI 10.1016/0035-9203(84)90221-9; Dowse T, 2004, CURR OPIN MICROBIOL, V7, P388, DOI 10.1016/j.mib.2004.06.013; Drew DR, 2005, INFECT IMMUN, V73, P3912, DOI 10.1128/IAI.73.7.3912-3922.2005; Egan TJ, 2008, MOL BIOCHEM PARASIT, V157, P127, DOI 10.1016/j.molbiopara.2007.11.005; Egan TJ, 2002, BIOCHEM J, V365, P343, DOI 10.1042/BJ20020793; Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; HALL R, 1983, MOL BIOCHEM PARASIT, V7, P247, DOI 10.1016/0166-6851(83)90025-7; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; HEIDRICH HG, 1986, Z PARASITENKD, V72, P681, DOI 10.1007/BF00925490; HEMPELMANN E, 1981, MOL BIOCHEM PARASIT, V2, P197, DOI 10.1016/0166-6851(81)90100-6; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hiller NL, 2003, J BIOL CHEM, V278, P48413, DOI 10.1074/jbc.M307266200; HOLDER AA, 1992, MEM I OSWALDO CRUZ, V87, P37, DOI 10.1590/S0074-02761992000700004; HOLDER AA, 1982, J EXP MED, V156, P1528, DOI 10.1084/jem.156.5.1528; HOLDER AA, 1987, PARASITOLOGY, V94, P199, DOI 10.1017/S0031182000053889; Howell SA, 2005, MOL MICROBIOL, V57, P1342, DOI 10.1111/j.1365-2958.2005.04772.x; Jackson KE, 2004, MOL MICROBIOL, V54, P109, DOI 10.1111/j.1365-2958.2004.04284.x; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150; LING IT, 1995, PARASITE IMMUNOL, V17, P425, DOI 10.1111/j.1365-3024.1995.tb00910.x; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; O'Donnell RA, 2005, CURR OPIN MICROBIOL, V8, P422, DOI 10.1016/j.mib.2005.06.018; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; OKA M, 1984, AM J TROP MED HYG, V33, P342, DOI 10.4269/ajtmh.1984.33.342; Pachebat JA, 2007, MOL BIOCHEM PARASIT, V151, P59, DOI 10.1016/j.molbiopara.2006.10.006; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Pisciotta JM, 2007, BIOCHEM J, V402, P197, DOI 10.1042/BJ20060986; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rosenthal PJ, 2004, INT J PARASITOL, V34, P1489, DOI 10.1016/j.ijpara.2004.10.003; Saliba KJ, 2003, J BIOL CHEM, V278, P5605, DOI 10.1074/jbc.M208648200; Shi QF, 2006, MOL BIOCHEM PARASIT, V149, P231, DOI 10.1016/j.molbiopara.2006.06.002; SLOMIANNY C, 1990, BLOOD CELLS, V16, P369; SLOMIANNY C, 1985, PARASITOLOGY, V90, P579, DOI 10.1017/S0031182000055578; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Tran CV, 2004, MICROBIOL-SGM, V150, P1, DOI 10.1099/mic.0.26818-0; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wang L, 2003, MOL BIOCHEM PARASIT, V130, P149, DOI 10.1016/S0166-6851(03)00165-8; Waterkeyn JG, 2001, EXP PARASITOL, V97, P115, DOI 10.1006/expr.2000.4593; Woehlbier U, 2006, INFECT IMMUN, V74, P1313, DOI 10.1128/IAI.74.2.1313-1322.2006; YAYON A, 1984, J PROTOZOOL, V31, P367, DOI 10.1111/j.1550-7408.1984.tb02981.x	67	63	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3085	10.1371/journal.pone.0003085	http://dx.doi.org/10.1371/journal.pone.0003085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769730	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796800002
J	Lundberg, G; Rosengren, AH; Hakanson, U; Stewenius, H; Jin, YS; Stewenius, Y; Pahlman, S; Gisselsson, D				Lundberg, Gisela; Rosengren, Anders H.; Hakanson, Ulf; Stewenius, Henrik; Jin, Yuesheng; Stewenius, Ylva; Pahlman, Sven; Gisselsson, David			Binomial Mitotic Segregation of MYCN-Carrying Double Minutes in Neuroblastoma Illustrates the Role of Randomness in Oncogene Amplification	PLOS ONE			English	Article								Background: Amplification of the oncogene MYCN in double minutes (DMs) is a common finding in neuroblastoma ( NB). Because DMs lack centromeric sequences it has been unclear how NB cells retain and amplify extrachromosomal MYCN copies during tumour development. Principal Findings: We show that MYCN-carrying DMs in NB cells translocate from the nuclear interior to the periphery of the condensing chromatin at transition from interphase to prophase and are preferentially located adjacent to the telomere repeat sequences of the chromosomes throughout cell division. However, DM segregation was not affected by disruption of the telosome nucleoprotein complex and DMs readily migrated from human to murine chromatin in human/mouse cell hybrids, indicating that they do not bind to specific positional elements in human chromosomes. Scoring DM copy-numbers in ana/telophase cells revealed that DM segregation could be closely approximated by a binomial random distribution. Colony-forming assay demonstrated a strong growth-advantage for NB cells with high DM (MYCN) copy-numbers, compared to NB cells with lower copy-numbers. In fact, the overall distribution of DMs in growing NB cell populations could be readily reproduced by a mathematical model assuming binomial segregation at cell division combined with a proliferative advantage for cells with high DM copy-numbers. Conclusion: Binomial segregation at cell division explains the high degree of MYCN copy-number variability in NB. Our findings also provide a proof-of-principle for oncogene amplification through creation of genetic diversity by random events followed by Darwinian selection.	[Lundberg, Gisela; Jin, Yuesheng; Stewenius, Ylva; Gisselsson, David] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden; [Rosengren, Anders H.] Lund Univ, Dept Clin Sci Malmo, S-22100 Lund, Sweden; [Hakanson, Ulf] Lund Univ, Div Solid State Phys, Nanometer Struct Consortium, S-22100 Lund, Sweden; [Stewenius, Henrik] Lund Univ, Dept Math, S-22100 Lund, Sweden; [Pahlman, Sven] Lund Univ, Dept Mol Med, S-22100 Lund, Sweden; [Gisselsson, David] Univ Lund Hosp, Dept Pathol, Lund, Sweden	Lund University; Skane University Hospital; Lund University; Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Lundberg, G (corresponding author), Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden.	david.gisselsson@med.lu.se	Rosengren, Anders/E-8371-2012; Hakanson, Ulf/A-1862-2009	Rosengren, Anders/0000-0002-9333-5736; 	Swedish Children's Cancer Foundation; Swedish Cancer Society; Swedish Research Council; Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Medical Faculty at Lund University	Swedish Children's Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Medical Society; Lund University Hospital Donation Funds; Gunnar Nilsson Cancer Foundation; Crafoord Foundation; Erik-Philip Sorensen Foundation; Lundgren Foundation; Medical Faculty at Lund University	This study was supported by the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Medical Society, the Lund University Hospital Donation Funds, the Gunnar Nilsson Cancer Foundation, the Crafoord Foundation, the Erik-Philip Sorensen Foundation, the Lundgren Foundation, and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER PE, 1980, EXP CELL RES, V130, P353, DOI 10.1016/0014-4827(80)90012-9; BARKER PE, 1982, CANCER GENET CYTOGEN, V5, P81, DOI 10.1016/0165-4608(82)90043-7; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Choi LMR, 2000, MED PEDIATR ONCOL, V35, P647, DOI 10.1002/1096-911X(20001201)35:6<647::AID-MPO35>3.0.CO;2-I; Deng XY, 2006, BIOCHEM BIOPH RES CO, V346, P1228, DOI 10.1016/j.bbrc.2006.06.041; Gisselsson David, 2001, Methods in Cell Science, V23, P23, DOI 10.1023/A:1013129212367; Itoh N, 1998, J CELL SCI, V111, P3275; Jin YS, 2007, CLIN CANCER RES, V13, P1703, DOI 10.1158/1078-0432.CCR-06-2705; Kanda T, 2001, J CELL SCI, V114, P49; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kanda T, 2000, J CELL BIOCHEM, P107; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; LEVAN A, 1978, HEREDITAS, V88, P81; LEVAN G, 1976, HEREDITAS, V83, P83; Mejia MD, 2002, ARCH MED RES, V33, P466, DOI 10.1016/S0188-4409(02)00384-3; Moreau LA, 2006, CLIN CANCER RES, V12, P5693, DOI 10.1158/1078-0432.CCR-06-1500; Narath R, 2007, GENE CHROMOSOME CANC, V46, P130, DOI 10.1002/gcc.20393; Norris MD, 1997, EUR J CANCER, V33, P1911, DOI 10.1016/S0959-8049(97)00284-0; Oshimura M, 1997, EUR J CANCER, V33, P710, DOI 10.1016/S0959-8049(97)00090-7; Paffhausen T, 2007, CANCER LETT, V250, P17, DOI 10.1016/j.canlet.2006.09.010; Schneiderman J, 2008, J CLIN ONCOL, V26, P913, DOI 10.1200/JCO.2007.13.9493; Schoenlein PV, 2003, INT J RADIAT ONCOL, V55, P1051, DOI 10.1016/S0360-3016(02)04473-5; SCHWEIGERER L, 1990, CANCER RES, V50, P4411; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Seimiya H, 2002, MOL CANCER THER, V1, P657; Shohet JM, 2002, CANCER RES, V62, P1123; Smith LL, 2003, NAT CELL BIOL, V5, P474, DOI 10.1038/ncb985; Solovei I, 2000, GENE CHROMOSOME CANC, V29, P297, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1046>3.0.CO;2-H; Stallings RL, 2007, CYTOGENET GENOME RES, V118, P110, DOI 10.1159/000108291; Stock C, 2008, AM J PATHOL, V172, P203, DOI 10.2353/ajpath.2008.061263; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Thorner PS, 2006, AM J SURG PATHOL, V30, P635, DOI 10.1097/01.pas.0000202163.82525.5c; Tonelli R, 2005, MOL CANCER THER, V4, P779, DOI 10.1158/1535-7163.MCT-04-0213; TSUDA T, 1987, CANCER, V60, P820, DOI 10.1002/1097-0142(19870815)60:4<820::AID-CNCR2820600418>3.0.CO;2-Y; Yaari S, 2005, CLIN CANCER RES, V11, P4321, DOI 10.1158/1078-0432.CCR-04-2071	37	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3099	10.1371/journal.pone.0003099	http://dx.doi.org/10.1371/journal.pone.0003099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769732	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796800006
J	Chakravarthy, S; Keck, T; Roelandse, M; Hartman, R; Jeromin, A; Perry, S; Hofer, SB; Mrsic-Flogel, T; Levelt, CN				Chakravarthy, Sridhara; Keck, Tara; Roelandse, Martijn; Hartman, Robin; Jeromin, Andreas; Perry, Sean; Hofer, Sonja B.; Mrsic-Flogel, Thomas; Levelt, Christiaan N.			Cre-Dependent Expression of Multiple Transgenes in Isolated Neurons of the Adult Forebrain	PLOS ONE			English	Article								Background: Transgenic mice with mosaic, Golgi-staining-like expression of enhanced green fluorescent protein (EGFP) have been very useful in studying the dynamics of neuronal structure and function. In order to further investigate the molecular events regulating structural plasticity, it would be useful to express multiple proteins in the same sparse neurons, allowing co-expression of functional proteins or co-labeling of subcellular compartments with other fluorescent proteins. However, it has been difficult to obtain reproducible expression in the same subset of neurons for direct comparison of neurons expressing different functional proteins. Principal Findings: Here we describe a Cre-transgenic line that allows reproducible expression of transgenic proteins of choice in a small number of neurons of the adult cortex, hippocampus, striatum, olfactory bulb, subiculum, hypothalamus, superior colliculus and amygdala. We show that using these Cre-transgenic mice, multiple Cre-dependent transgenes can be expressed together in the same isolated neurons. We also describe a Cre-dependent transgenic line expressing a membrane associated EGFP (EGFP-F). Crossed with the Cre-transgenic line, EGFP-F expression starts in the adolescent forebrain, is present in dendrites, dendritic protrusions, axons and boutons and is strong enough for acute or chronic in vivo imaging. Significance: This triple transgenic approach will aid the morphological and functional characterization of neurons in various Cre-dependent transgenic mice.	[Chakravarthy, Sridhara; Roelandse, Martijn; Hartman, Robin; Perry, Sean; Levelt, Christiaan N.] Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands; [Keck, Tara; Hofer, Sonja B.; Mrsic-Flogel, Thomas] Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Martinsried, Germany; [Jeromin, Andreas] Allen Inst Brain Sci, Seattle, WA USA	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Max Planck Society; Allen Institute for Brain Science	Chakravarthy, S (corresponding author), Netherlands Inst Neurosci, Mol Visual Plast Grp, Amsterdam, Netherlands.	c.levelt@nin.knaw.nl	Roelandse, Martijn/B-7154-2013	Roelandse, Martijn/0000-0001-5596-8084; Keck, Tara/0000-0001-6623-1037; Mrsic-Flogel, Tom/0000-0002-8947-408X	Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; KWF Kanker Bestijding [NORI 2003-2789]; Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research [VIDI]; SenterNovem [Bsik]	Rotterdamse Vereniging Blindenbelangen; Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid; Stichting Blindenhulp; KWF Kanker Bestijding; Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); SenterNovem	S.C. was supported by Rotterdamse Vereniging Blindenbelangen, Algemeen Nederlandse Vereeniging ter Voorkoming van Blindheid and Stichting Blindenhulp. M.R. is supported by KWF Kanker Bestijding (NORI 2003-2789). C.N.L. is supported by the Royal Netherlands Academy of Arts and Sciences (K.N.A.W.), A VIDI grant from the Netherlands Organization for Scientific Research (N.W.O.), and a "Bsik" grant from SenterNovem. None of the funders were involved either in the design and implementation of the experiments or in the preparation of the manuscript.	Badea TC, 2003, J NEUROSCI, V23, P2314; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; CATTANACH BM, 1974, GENET RES, V23, P291, DOI 10.1017/S0016672300014932; Chakravarthy S, 2006, P NATL ACAD SCI USA, V103, P1071, DOI 10.1073/pnas.0506305103; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Dynes JL, 1998, NEURON, V20, P1081, DOI 10.1016/S0896-6273(00)80490-0; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GOLGI C, 1989, J MICROSC-OXFORD, V155, P3, DOI 10.1111/j.1365-2818.1989.tb04294.x; HAMILTON DL, 1984, J MOL BIOL, V178, P481, DOI 10.1016/0022-2836(84)90154-2; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Huang ZJ, 2002, GENESIS, V32, P209, DOI 10.1002/gene.10054; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Potter SM, 1996, GENE, V173, P25, DOI 10.1016/0378-1119(95)00681-8; Rensing N, 2005, ANN NEUROL, V58, P888, DOI 10.1002/ana.20658; Sakamoto H, 2003, ENDOCRINOLOGY, V144, P4466, DOI 10.1210/en.2003-0307; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	37	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3059	10.1371/journal.pone.0003059	http://dx.doi.org/10.1371/journal.pone.0003059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725976	Green Published, gold			2022-12-27	WOS:000264796300005
J	Coleman, AS; Yang, XL; Kumar, M; Zhang, XY; Promnares, K; Shroder, D; Kenedy, MR; Anderson, JF; Akins, DR; Pal, U				Coleman, Adam S.; Yang, Xiuli; Kumar, Manish; Zhang, Xinyue; Promnares, Kamoltip; Shroder, Deborah; Kenedy, Melisha R.; Anderson, John F.; Akins, Darrin R.; Pal, Utpal			Borrelia burgdorferi Complement Regulator-Acquiring Surface Protein 2 Does Not Contribute to Complement Resistance or Host Infectivity	PLOS ONE			English	Article								Borrelia burgdorferi, the pathogen of Lyme disease, cycles in nature through Ixodes ticks and mammalian hosts. At least five Complement Regulator-Acquiring Surface Proteins ( BbCRASPs) are produced by B. burgdorferi, which are thought to assist spirochetes in host immune evasion. Recent studies established that BbCRASP-2 is preferentially expressed in mammals, and elicits robust antibody response in infected hosts, including humans. We show that BbCRASP-2 is ubiquitously expressed in diverse murine tissues, but not in ticks, reinforcing a role of BbCRASP-2 in conferring B. burgdorferi defense against persistent host immune threats, such as complement. BbCRASP-2 immunization, however, fails to protect mice from B. burgdorferi infection and does not modify disease, as reflected by the development of arthritis. An infectious BbCRASP-2 mutant was generated, therefore, to examine the precise role of the gene product in spirochete infectivity. Similar to wild type B. burgdorferi, BbCRASP-2 mutants remain insensitive to complement-mediated killing in vitro, retain full murine infectivity and induce arthritis. Quantitative RT-PCR assessment indicates that survivability of BbCRASP-2-deficient B. burgdorferi is not due to altered expression of other BbCRASPs. Together, these results suggest that the function of a selectively expressed B. burgdorferi gene, BbCRASP-2, is not essential for complement resistance or infectivity in the murine host.	[Coleman, Adam S.; Yang, Xiuli; Kumar, Manish; Zhang, Xinyue; Promnares, Kamoltip; Shroder, Deborah; Pal, Utpal] Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA; [Kenedy, Melisha R.; Akins, Darrin R.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Norman, OK 73019 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT USA	University System of Maryland; University of Maryland College Park; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; Connecticut Agricultural Experiment Station	Coleman, AS (corresponding author), Univ Maryland, Dept Vet Med, College Pk, MD 20742 USA.	upal@umd.edu	Pal, Utpal/I-5265-2015; Promnares, Kamoltip/S-6106-2019; KUMAR, MANISH/AAE-3489-2021	KUMAR, MANISH/0000-0001-7997-5676	Arthritis Foundation, Maryland Chapter; National Institutes of Health [AR055323, AI059373, AI064629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064629, R01AI059373, R56AI059373, R01AI080615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR055323] Funding Source: NIH RePORTER	Arthritis Foundation, Maryland Chapter; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by grants from Arthritis Foundation, Maryland Chapter (U.P), National Institutes of Health AR055323 (U.P), AI059373 (D.R.A) and AI064629 (D.R.A).	Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Barthold S.W., 1992, LYME DIS MOL IMMUNOL, P223; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; BARTHOLD SW, 1993, AM J PATHOL, V143, P959; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Brooks CS, 2006, INFECT IMMUN, V74, P296, DOI 10.1128/IAI.74.1.296-304.2006; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; BYKOWSKI T, INT J MED MICROBIOL; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Cassatt DR, 1998, INFECT IMMUN, V66, P5379, DOI 10.1128/IAI.66.11.5379-5387.1998; deSilva AM, 1997, J CLIN INVEST, V99, P377, DOI 10.1172/JCI119169; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Feng SL, 2000, INFECT IMMUN, V68, P4169, DOI 10.1128/IAI.68.7.4169-4173.2000; Feng SL, 2003, INFECT IMMUN, V71, P7211, DOI 10.1128/IAI.71.12.7211-7214.2003; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gilmore RD, 2007, INFECT IMMUN, V75, P2753, DOI 10.1128/IAI.00037-07; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hanson MS, 1998, INFECT IMMUN, V66, P2143, DOI 10.1128/IAI.66.5.2143-2153.1998; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; HAUPT K, INT J MOL MICROBIOL; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Iyer R, 2003, INFECT IMMUN, V71, P3699, DOI 10.1128/IAI.71.7.3699-3706.2003; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Kraiczy P, 2004, INT J MED MICROBIOL, V293, P152, DOI 10.1016/S1433-1128(04)80029-9; Kraiczy P, 2008, CLIN VACCINE IMMUNOL, V15, P484, DOI 10.1128/CVI.00415-07; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; LI X, 2007, MOL MICROBIOL; Li X, 2007, INFECT IMMUN, V75, P4237, DOI 10.1128/IAI.00632-07; Liang FT, 2002, J EXP MED, V196, P275, DOI 10.1084/jem.20020770; Maruskova M, 2008, INFECT IMMUN, V76, P391, DOI 10.1128/IAI.01118-07; McDowell JV, 2006, INFECT IMMUN, V74, P3030, DOI 10.1128/IAI.74.5.3030-3034.2006; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; McDowell JV, 2001, INFECT IMMUN, V69, P3670, DOI 10.1128/IAI.69.6.3670-3677.2001; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Neelakanta G, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030033; ORLOSKI KA, 1998, MMWR-MORBID MORTAL W, V49, P1; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Pal U, 2008, J EXP MED, V205, P133, DOI 10.1084/jem.20070962; Pal U, 2008, J INFECT DIS, V197, P148, DOI 10.1086/523764; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 1999, MOL IMMUNOL, V36, P915, DOI 10.1016/S0161-5890(99)00114-5; Rogers EA, 2007, INFECT IMMUN, V75, P5272, DOI 10.1128/IAI.00850-07; Rosa P, 2005, NAT MED, V11, P831, DOI 10.1038/nm0805-831; SCHAIBLE UE, 1991, EUR J IMMUNOL, V21, P2397, DOI 10.1002/eji.1830211016; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; SIMON MM, 1991, IMMUNOL TODAY, V12, P11, DOI 10.1016/0167-5699(91)90106-4; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stewart PE, 2008, INFECT IMMUN, V76, P1970, DOI 10.1128/IAI.00714-07; Wang XH, 2005, INFECT IMMUN, V73, P657, DOI 10.1128/IAI.73.1.657-660.2005; Woodman ME, 2007, INFECT IMMUN, V75, P3131, DOI 10.1128/IAI.01923-06; Yang XFF, 2004, J EXP MED, V199, P641, DOI 10.1084/jem.20031960	61	53	54	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							3010e	10.1371/journal.pone.0003010	http://dx.doi.org/10.1371/journal.pone.0003010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714378	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900035
J	Costa, R; Ferreira-da-Silva, F; Saraiva, MJ; Cardoso, I				Costa, Rita; Ferreira-da-Silva, Frederico; Saraiva, Maria J.; Cardoso, Isabel			Transthyretin Protects against A-Beta Peptide Toxicity by Proteolytic Cleavage of the Peptide: A Mechanism Sensitive to the Kunitz Protease Inhibitor	PLOS ONE			English	Article								Alzheimer's disease (AD) is a neurodegenerative disorder characterized by the deposition of amyloid beta-peptide (A-Beta) in the brain. Transthyretin (TTR) is a tetrameric protein of about 55 kDa mainly produced in the liver and choroid plexus of the brain. The known physiological functions of TTR are the transport of thyroid hormone T-4 and retinol, through binding to the retinol binding protein. TTR has also been established as a cryptic protease able to cleave ApoA-I in vitro. It has been described that TTR is involved in preventing A-Beta fibrilization, both by inhibiting and disrupting A-Beta fibrils, with consequent abrogation of toxicity. We further characterized the nature of the TTR/A-Beta interaction and found that TTR, both recombinant or isolated from human sera, was able to proteolytically process A-Beta, cleaving the peptide after aminoacid residues 1, 2, 3, 10, 13, 14,16, 19 and 27, as determined by mass spectrometry, and reversed phase chromatography followed by N-terminal sequencing. A-Beta peptides (1-14) and (15-42) showed lower amyloidogenic potential than the full length counterpart, as assessed by thioflavin binding assay and ultrastructural analysis by transmission electron microscopy. A-Beta cleavage by TTR was inhibited in the presence of an alpha APP peptide containing the Kunitz Protease Inhibitor (KPI) domain but not in the presence of the secreted alpha APP derived from the APP isoform 695 without the KPI domain. TTR was also able to degrade aggregated forms of A-Beta peptide. Our results confirmed TTR as a protective molecule in AD, and prompted A-Beta proteolysis by TTR as a protective mechanism in this disease. TTR may prove to be a useful therapeutic agent for preventing or retarding the cerebral amyloid plaque formation implicated in AD pathology.	[Costa, Rita; Saraiva, Maria J.; Cardoso, Isabel] IBMC Inst Biol Mol & Celular, Oporto, Portugal; [Ferreira-da-Silva, Frederico] IBMC Inst Biol Mol & Celular, Protein Product & Purificat Unit, Oporto, Portugal; [Saraiva, Maria J.] Univ Porto, ICBAS, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Costa, R (corresponding author), IBMC Inst Biol Mol & Celular, Oporto, Portugal.	icardoso@ibmc.up.pt	Costa, Ana Rita AR/G-6341-2016; Cardoso, Isabel/K-3903-2013; Silva, Frederico F/K-3820-2013; Saraiva, Maria João/K-3907-2013	Costa, Ana Rita AR/0000-0002-2855-0472; Cardoso, Isabel/0000-0003-2472-7055; Silva, Frederico F/0000-0002-8890-4228; Saraiva, Maria João/0000-0002-3360-6899	Portuguese Foundation for Science and Technology (FCT) [POCI/SAU-NEU/57761/2004, PTDC/SAU-NEU/64593/2006]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology (FCT) through POCI/SAU-NEU/57761/2004 and PTDC/SAU-NEU/64593/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Bellucci C, 2007, MOL MED, V13, P542, DOI 10.2119/2007-00034.Bellucci; Buxbaum JN, 2008, P NATL ACAD SCI USA, V105, P2681, DOI 10.1073/pnas.0712197105; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Castano EM, 2006, NEUROL RES, V28, P155, DOI 10.1179/016164106X98035; Caswell MD, 1999, EUR J BIOCHEM, V266, P509, DOI 10.1046/j.1432-1327.1999.00886.x; Cerini C, 1999, KIDNEY INT, V55, P1776, DOI 10.1046/j.1523-1755.1999.00426.x; Chauhan VPS, 1999, BIOCHEM BIOPH RES CO, V258, P241, DOI 10.1006/bbrc.1999.0623; Choi SH, 2007, J NEUROSCI, V27, P7006, DOI 10.1523/JNEUROSCI.1919-07.2007; Costa R, 2008, FEBS LETT, V582, P936, DOI 10.1016/j.febslet.2008.02.034; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Eckman EA, 2006, J BIOL CHEM, V281, P30471, DOI 10.1074/jbc.M605827200; FURUYA H, 1991, BIOCHEMISTRY-US, V30, P2415, DOI 10.1021/bi00223a017; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Ho LB, 1996, J BIOL CHEM, V271, P30929, DOI 10.1074/jbc.271.48.30929; Lansbury PT, 2000, CHEM BIOL, V7, pR9, DOI 10.1016/S1074-5521(00)00068-5; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Liz MA, 2004, J BIOL CHEM, V279, P21431, DOI 10.1074/jbc.M402212200; Liz MA, 2007, J LIPID RES, V48, P2385, DOI 10.1194/jlr.M700158-JLR200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALITO E, 2008, CELL MOL LI IN PRESS; Menendez-Gonzalez M, 2005, NEURODEGENER DIS, V2, P277, DOI 10.1159/000092315; Moir Robert D., 2005, Current Alzheimer Research, V2, P269, DOI 10.2174/1567205053585918; Nazer B, 2008, NEUROBIOL DIS, V30, P94, DOI 10.1016/j.nbd.2007.12.005; Palha JA, 1996, NEUROSCI LETT, V204, P212, DOI 10.1016/0304-3940(96)12334-X; Rago JV, 2000, INFECT IMMUN, V68, P2366, DOI 10.1128/IAI.68.4.2366-2368.2000; Schwarzman AL, 1996, CIBA F SYMP, V199, P146; SCHWARZMAN AL, 1994, P NATL ACAD SCI USA, V91, P8368, DOI 10.1073/pnas.91.18.8368; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Serot JM, 1997, J NEUROL NEUROSUR PS, V63, P506, DOI 10.1136/jnnp.63.4.506; SHIRAHAMA T, 1982, AM J PATHOL, V107, P41; SOPRANO DR, 1985, J BIOL CHEM, V260, P1793; Sparks DL, 2007, CURR ALZHEIMER RES, V4, P165; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Stein TD, 2002, J NEUROSCI, V22, P7380; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; VETRIVEL KS, 2008, J BIOL CHEM IN PRESS; Vidal R, 1999, NATURE, V399, P776; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang DS, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/58406; Wang YJ, 2006, DRUG DISCOV TODAY, V11, P931, DOI 10.1016/j.drudis.2006.08.004; WOEBER KA, 1968, J CLIN INVEST, V47, P1710, DOI 10.1172/JCI105861	44	90	93	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2899	10.1371/journal.pone.0002899	http://dx.doi.org/10.1371/journal.pone.0002899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682830	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600055
J	Monahan, PJ; de Souza, K; Idsardi, WJ				Monahan, Philip J.; de Souza, Kevin; Idsardi, William J.			Neuromagnetic Evidence for Early Auditory Restoration of Fundamental Pitch	PLOS ONE			English	Article							EVOKED M100; PERCEPTION; REPRESENTATION; REFLECTIONS; LATENCY; CORTEX	Background: Understanding the time course of how listeners reconstruct a missing fundamental component in an auditory stimulus remains elusive. We report MEG evidence that the missing fundamental component of a complex auditory stimulus is recovered in auditory cortex within 100 ms post stimulus onset. Methodology: Two outside tones of four-tone complex stimuli were held constant (1200 Hz and 2400 Hz), while two inside tones were systematically modulated (between 1300 Hz and 2300 Hz), such that the restored fundamental (also knows as "virtual pitch'') changed from 100 Hz to 600 Hz. Constructing the auditory stimuli in this manner controls for a number of spectral properties known to modulate the neuromagnetic signal. The tone complex stimuli only diverged on the value of the missing fundamental component. Principal Findings: We compared the M100 latencies of these tone complexes to the M100 latencies elicited by their respective pure tone (spectral pitch) counterparts. The M100 latencies for the tone complexes matched their pure sinusoid counterparts, while also replicating the M100 temporal latency response curve found in previous studies. Conclusions: Our findings suggest that listeners are reconstructing the inferred pitch by roughly 100 ms after stimulus onset and are consistent with previous electrophysiological research suggesting that the inferential pitch is perceived in early auditory cortex.	[Monahan, Philip J.; de Souza, Kevin; Idsardi, William J.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA; [Idsardi, William J.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Monahan, PJ (corresponding author), Univ Maryland, Dept Linguist, College Pk, MD 20742 USA.	pmonahan@umd.edu		Lauwereyns, Jan/0000-0003-0551-2550; Idsardi, William/0000-0003-4461-2685; Monahan, Philip/0000-0001-8637-1889	NIH [R01 05660]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH R01 05660 to David Poeppel and William J. Idsardi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Boersma Paul, 2002, GLOT INT, V5, P341; Cedolin L, 2005, J NEUROPHYSIOL, V94, P347, DOI 10.1152/jn.01114.2004; Chait M, 2006, CEREB CORTEX, V16, P835, DOI 10.1093/cercor/bhj027; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; Fujioka T, 2003, EUR J NEUROSCI, V18, P432, DOI 10.1046/j.1460-9568.2003.02769.x; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; Gage N, 1998, BRAIN RES, V814, P236, DOI 10.1016/S0006-8993(98)01058-0; Gage NM, 2000, NEUROREPORT, V11, P2723, DOI 10.1097/00001756-200008210-00023; GOLDSTEIN JL, 1973, J ACOUST SOC AM, V54, P1496, DOI 10.1121/1.1914448; HEFFNER H, 1976, J ACOUST SOC AM, V59, P915, DOI 10.1121/1.380951; Matsuwaki Y, 2004, AURIS NASUS LARYNX, V31, P208, DOI 10.1016/j.anl.2004.03.016; Meddis R, 2006, J ACOUST SOC AM, V120, P3861, DOI 10.1121/1.2372595; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; Roberts TPL, 1996, NEUROREPORT, V7, P1138, DOI 10.1097/00001756-199604260-00007; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; Shamma S, 2000, J ACOUST SOC AM, V107, P2631, DOI 10.1121/1.428649; SMOORENBURG GF, 1970, J ACOUST SOC AM, V48, P924, DOI 10.1121/1.1912232; Smoorenburg GF., 1970, FREQUENCY ANAL PERIO, P41; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; TOMLINSON RWW, 1988, J ACOUST SOC AM, V84, P560, DOI 10.1121/1.396833; Winkler I, 1997, J ACOUST SOC AM, V102, P1072, DOI 10.1121/1.419860	24	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2900	10.1371/journal.pone.0002900	http://dx.doi.org/10.1371/journal.pone.0002900			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682843	Green Submitted, gold, Green Published			2022-12-27	WOS:000264366600056
J	Facella, P; Lopez, L; Carbone, F; Galbraith, DW; Giuliano, G; Perrotta, G				Facella, Paolo; Lopez, Loredana; Carbone, Fabrizio; Galbraith, David W.; Giuliano, Giovanni; Perrotta, Gaetano			Diurnal and Circadian Rhythms in the Tomato Transcriptome and Their Modulation by Cryptochrome Photoreceptors	PLOS ONE			English	Article							BLUE-LIGHT PHOTORECEPTOR; CLOCK-CONTROLLED GENE; FLOWERING TIME; ARABIDOPSIS; EXPRESSION; PHYTOCHROME; GIGANTEA; PROTEIN; ELF3; RESPONSES	Background: Circadian clocks are internal molecular time-keeping mechanisms that provide living organisms with the ability to adjust their growth and physiology and to anticipate diurnal environmental changes. Circadian clocks, without exception, respond to light and, in plants, light is the most potent and best characterized entraining stimulus. The capacity of plants to respond to light is achieved through a number of photo-perceptive proteins including cryptochromes and phytochromes. There is considerable experimental evidence demonstrating the roles of photoreceptors in providing light input to the clock. Methodology: In order to identify genes regulated by diurnal and circadian rhythms, and to establish possible functional relations between photoreceptors and the circadian clock in tomato, we monitored the temporal transcription pattern in plants entrained to long-day conditions, either by large scale comparative profiling, or using a focused approach over a number of photosensory and clock-related genes by QRT-PCR. In parallel, focused transcription analyses were performed in cry1a-and in CRY2-OX tomato genotypes. Conclusions: We report a large series of transcript oscillations that shed light on the complex network of interactions among tomato photoreceptors and clock-related genes. Alteration of cryptochrome gene expression induced major changes in the rhythmic oscillations of several other gene transcripts. In particular, over-expression of CRY2 had an impact not only on day/night fluctuations but also on rhythmicity under constant light conditions. Evidence was found for widespread diurnal oscillations of transcripts encoding specific enzyme classes (e. g. carotenoid biosynthesis enzymes) as well as for post-transcriptional diurnal and circadian regulation of the CRY2 transcript.	[Facella, Paolo; Lopez, Loredana; Carbone, Fabrizio; Perrotta, Gaetano] ENEA, Trisaia Res Ctr, Rotondella, MT, Italy; [Giuliano, Giovanni] ENEA, Casaccia Res Ctr, Rome, Italy; [Galbraith, David W.] Univ Arizona, BIO5 Inst Collaborative Biores, Dept Plant Sci, Tucson, AZ USA	Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Arizona	Perrotta, G (corresponding author), ENEA, Trisaia Res Ctr, Rotondella, MT, Italy.	gaetano.perrotta@trisaia.enea.it	Giuliano, Giovanni/A-2701-2012; Galbraith, David/AAG-8891-2021; Carbone, Fabrizio/O-2443-2017; Facella, Paolo/HHC-1895-2022; Carbone, Fabrizio/AAE-1065-2019	Giuliano, Giovanni/0000-0002-2486-0510; Carbone, Fabrizio/0000-0002-0393-7099; Facella, Paolo/0000-0001-9076-3754; Carbone, Fabrizio/0000-0002-0393-7099; Perrotta, Gaetano/0000-0003-2037-1063	Italian Ministry of Research [GEPROT DM1570]; EU	Italian Ministry of Research(Ministry of Education, Universities and Research (MIUR)); EU(European Commission)	Work supported by the Italian Ministry of Research Project GEPROT DM1570, and by the EU (EUSOL project).	Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Audran C, 1998, PLANT PHYSIOL, V118, P1021, DOI 10.1104/pp.118.3.1021; Bruno AK, 2004, J EXP BOT, V55, P2541, DOI 10.1093/jxb/erh273; Casal JJ, 2005, INT J DEV BIOL, V49, P501, DOI 10.1387/ijdb.051973jc; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Facella P, 2006, FEBS LETT, V580, P4618, DOI 10.1016/j.febslet.2006.07.044; FOLTA KM, 2007, J EXP BOT, V146, P227; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Franklin KA, 2007, NAT GENET, V39, P1410, DOI 10.1038/ng.2007.3; Gardner MJ, 2006, BIOCHEM J, V397, P15, DOI 10.1042/BJ20060484; Giliberto L, 2005, PLANT PHYSIOL, V137, P199, DOI 10.1104/pp.104.051987; GIULIANO G, 1988, EMBO J, V7, P3635, DOI 10.1002/j.1460-2075.1988.tb03244.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hauser BA, 1998, PLANT J, V14, P431, DOI 10.1046/j.1365-313X.1998.00144.x; Hauser BA, 1995, PLANT MOL BIOL, V29, P1143, DOI 10.1007/BF00020458; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Ishikawa M, 2006, PLANT J, V46, P736, DOI 10.1111/j.1365-313X.2006.02737.x; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Laubinger S, 2006, DEVELOPMENT, V133, P3213, DOI 10.1242/dev.02481; Ledger S, 2001, PLANT J, V26, P14; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Martin-Tryon EL, 2007, PLANT PHYSIOL, V143, P473, DOI 10.1104/pp.106.088757; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Millar AJ, 1999, NEW PHYTOL, V141, P175, DOI 10.1046/j.1469-8137.1999.00349.x; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Neff MM, 2000, GENE DEV, V14, P257; Nelson DC, 2000, CELL, V101, P331, DOI 10.1016/S0092-8674(00)80842-9; Paltiel J, 2006, PLANTA, V224, P1255, DOI 10.1007/s00425-006-0305-1; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Perrotta G, 2000, PLANT MOL BIOL, V42, P765, DOI 10.1023/A:1006371130043; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; Reed JW, 2000, PLANT PHYSIOL, V122, P1149, DOI 10.1104/pp.122.4.1149; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; vonLintig J, 1997, PLANT J, V12, P625, DOI 10.1046/j.1365-313X.1997.00625.x; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Weller JL, 2001, PLANT J, V25, P427, DOI 10.1046/j.1365-313x.2001.00978.x; Yanovsky MJ, 2000, CURR BIOL, V10, P1013, DOI 10.1016/S0960-9822(00)00651-5; ZERR DM, 1990, J NEUROSCI, V10, P2749	69	50	54	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2798	10.1371/journal.pone.0002798	http://dx.doi.org/10.1371/journal.pone.0002798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665253	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300017
J	Gohar, M; Faegri, K; Perchat, S; Ravnum, S; Okstad, OA; Gominet, M; Kolsto, AB; Lereclus, D				Gohar, Michel; Faegri, Karoline; Perchat, Stephane; Ravnum, Solveig; Okstad, Ole Andreas; Gominet, Myriam; Kolsto, Anne-Brit; Lereclus, Didier			The PlcR Virulence Regulon of Bacillus cereus	PLOS ONE			English	Article								PlcR is a Bacillus cereus transcriptional regulator, which activates gene expression by binding to a nucleotidic sequence called the 'PlcR box'. To build a list of all genes included in the PlcR regulon, a consensus sequence was identified by directed mutagenesis. The reference strain ATCC14579 sequenced genome was searched for occurrences of this consensus sequence to produce a virtual regulon. PlcR control of these genes was confirmed by comparing gene expression in the reference strain and its isogenic Delta-plcR strain using DNA microarrays, lacZ fusions and proteomics methods. The resulting list included 45 genes controlled by 28 PlcR boxes. Forty of the PlcR controlled proteins were exported, of which 22 were secreted in the extracellular medium and 18 were bound or attached to cell wall structures (membrane or peptidoglycan layer). The functions of these proteins were related to food supply (phospholipases, proteases, toxins), cell protection (bacteriocins, toxins, transporters, cell wall biogenesis) and environment-sensing (two-component sensors, chemotaxis proteins, GGDEF family regulators). Four genes coded for cytoplasmic regulators. The PlcR regulon appears to integrate a large range of environmental signals, including food deprivation and self cell-density, and regulate the transcription of genes designed to overcome obstacles that hinder B. cereus growth within the host: food supply, host barriers, host immune defenses, and competition with other bacterial species. PlcR appears to be a key component in the efficient adaptation of B. cereus to its host environment.	[Gohar, Michel; Perchat, Stephane; Lereclus, Didier] INRA, Genet Microbienne & Environm, Guyancourt, France; [Gohar, Michel] INRA, Microbiol Genet Mol, Thiverval Grignon, France; [Faegri, Karoline; Ravnum, Solveig; Okstad, Ole Andreas; Kolsto, Anne-Brit] Univ Oslo, Dept Pharm Biosci, Oslo, Norway; [Gominet, Myriam] Inst Pasteur, Paris, France	INRAE; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gohar, M (corresponding author), INRA, Genet Microbienne & Environm, Guyancourt, France.	michel.gohar@jouy.inra.fr	Lereclus, Didier/AAD-8293-2019; Okstad, Ole Andreas/ABE-4202-2020	Lereclus, Didier/0000-0001-9047-9104; Okstad, Ole Andreas/0000-0001-9351-8535	ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine [ANR-05-PNRA-013]	ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine(French National Research Agency (ANR))	This work was carried out with the financial support of the ANR Agence Nationale de la Recherche - The French National Research Agency under the Programme National de Recherche en Alimentation et nutrition humaine , project ANR-05-PNRA-013, B.CEREUS .	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; AGAISSE H, 1994, MOL MICROBIOL, V13, P97, DOI 10.1111/j.1365-2958.1994.tb00405.x; AGAISSE H, 1994, J BACTERIOL, V176, P4734, DOI 10.1128/JB.176.15.4734-4741.1994; Beecher DJ, 2000, MICROBIOL-UK, V146, P3033, DOI 10.1099/00221287-146-12-3033; Bouillaut L, 2005, APPL ENVIRON MICROB, V71, P8903, DOI 10.1128/AEM.71.12.8903-8910.2005; Brillard J, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-52; Callegan MC, 2003, INFECT IMMUN, V71, P3116, DOI 10.1128/IAI.71.6.3116-3124.2003; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; DALHAMMAR G, 1984, EUR J BIOCHEM, V139, P247, DOI 10.1111/j.1432-1033.1984.tb08000.x; Declerck N, 2007, P NATL ACAD SCI USA, V104, P18490, DOI 10.1073/pnas.0704501104; Duport C, 2006, J BACTERIOL, V188, P6640, DOI 10.1128/JB.00702-06; Fedhila S, 2003, J BACTERIOL, V185, P2820, DOI 10.1128/JB.185.9.2820-2825.2003; Fedhila S, 2002, J BACTERIOL, V184, P3296, DOI 10.1128/JB.184.12.3296-3304.2002; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fouet A, 2000, J BACTERIOL, V182, P5036, DOI 10.1128/JB.182.18.5036-5045.2000; Gaur AH, 2001, CLIN INFECT DIS, V32, P1456, DOI 10.1086/320154; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gominet M, 2001, MOL MICROBIOL, V40, P963, DOI 10.1046/j.1365-2958.2001.02440.x; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; Hajaij-Ellouze M, 2006, FEMS MICROBIOL LETT, V260, P9, DOI 10.1111/j.1574-6968.2006.00289.x; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Hsueh YH, 2006, APPL ENVIRON MICROB, V72, P5089, DOI 10.1128/AEM.00573-06; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Lereclus D, 2000, INT J MED MICROBIOL, V290, P295, DOI 10.1016/S1438-4221(00)80024-7; Matamouros S, 2007, MOL MICROBIOL, V64, P1274, DOI 10.1111/j.1365-2958.2007.05739.x; McGann P, 2007, APPL ENVIRON MICROB, V73, P2919, DOI 10.1128/AEM.02664-06; Miao L, 2007, BIOCHEM BIOPH RES CO, V357, P641, DOI 10.1016/j.bbrc.2007.03.171; Mignot T, 2001, ENVIRON MICROBIOL, V3, P493, DOI 10.1046/j.1462-2920.2001.00220.x; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Nadon CA, 2002, INFECT IMMUN, V70, P3948, DOI 10.1128/IAI.70.7.3948-3952.2002; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pomerantsev AP, 2003, INFECT IMMUN, V71, P6591, DOI 10.1128/IAI.71.11.6591-6606.2003; R Development Core Team, 2005, R LANG ENV STAT COMP; Ramarao N, 2006, MICROBES INFECT, V8, P1483, DOI 10.1016/j.micinf.2006.01.005; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Salamitou S, 2000, MICROBIOL-UK, V146, P2825, DOI 10.1099/00221287-146-11-2825; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; Vetting MW, 2005, J BIOL CHEM, V280, P22108, DOI 10.1074/jbc.M502401200; Vetting MW, 2005, ARCH BIOCHEM BIOPHYS, V433, P212, DOI 10.1016/j.abb.2004.09.003	50	201	209	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2793	10.1371/journal.pone.0002793	http://dx.doi.org/10.1371/journal.pone.0002793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665214	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300012
J	Kaye, TG; Gaugler, G; Sawlowicz, Z				Kaye, Thomas G.; Gaugler, Gary; Sawlowicz, Zbigniew			Dinosaurian Soft Tissues Interpreted as Bacterial Biofilms	PLOS ONE			English	Article							CELLULAR PRESERVATION	A scanning electron microscope survey was initiated to determine if the previously reported findings of "dinosaurian soft tissues'' could be identified in situ within the bones. The results obtained allowed a reinterpretation of the formation and preservation of several types of these "issues'' and their content. Mineralized and non-mineralized coatings were found extensively in the porous trabecular bone of a variety of dinosaur and mammal species across time. They represent bacterial biofilms common throughout nature. Biofilms form endocasts and once dissolved out of the bone, mimic real blood vessels and osteocytes. Bridged trails observed in biofilms indicate that a previously viscous film was populated with swimming bacteria. Carbon dating of the film points to its relatively modern origin. A comparison of infrared spectra of modern biofilms with modern collagen and fossil bone coatings suggests that modern biofilms share a closer molecular make-up than modern collagen to the coatings from fossil bones. Blood cell size iron-oxygen spheres found in the vessels were identified as an oxidized form of formerly pyritic framboids. Our observations appeal to a more conservative explanation for the structures found preserved in fossil bone.	[Kaye, Thomas G.] Burke Museum Nat Hist, Dept Paleontol, Seattle, WA USA; [Gaugler, Gary] Microtechnics Inc, Granite Bay, CA USA; [Sawlowicz, Zbigniew] Jagiellonian Univ, Dept Geol, Krakow, Poland	Jagiellonian University	Kaye, TG (corresponding author), Burke Museum Nat Hist, Dept Paleontol, Seattle, WA USA.	tomkaye@u.washington.edu		Sawlowicz, Zbigniew/0000-0001-8372-8205; Kaye, Thomas/0000-0001-7996-618X				Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; FLORA JRV, 1995, BIOTECHNOL BIOENG, V46, P43, DOI 10.1002/bit.260460107; Fratesi SE, 2004, J SEDIMENT RES, V74, P858, DOI 10.1306/042604740858; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Higby Schweitzer Mary, 1999, Annales de Paleontologie, V85, P179, DOI 10.1016/S0753-3969(99)80013-5; Konhauser KO, 1997, FEMS MICROBIOL REV, V20, P315, DOI 10.1016/S0168-6445(97)00014-4; LEDFORD H, 2007, DINOSAUR PROTEIN SEQ, DOI DOI 10.1038/NEWS070409-070411; Martill DM, 1997, PALAEONTOLOGY, V40, P619; Ohfuji H, 2005, EARTH-SCI REV, V71, P147, DOI 10.1016/j.earscirev.2005.02.001; RASMUSSEN M, 2003, J BIOL CHEM; ROBINSON RW, 1984, APPL ENVIRON MICROB, V48, P127, DOI 10.1128/AEM.48.1.127-136.1984; Sawlowicz Z., 2000, MINERAL WORK, V88, P1; Sawlowicz Z, 2006, MINERALOGIA POLONICA, V29, P184; SCHAECHTER M, 2004, DESK ENCY MICROBIOLO, P1152; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Strassberg D, 2005, EDN, V50, P24; SUK D, 1990, NATURE, V345, P611, DOI 10.1038/345611a0; Yuan XL, 2001, PRECAMBRIAN RES, V107, P253, DOI 10.1016/S0301-9268(00)00144-3	21	69	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2808	10.1371/journal.pone.0002808	http://dx.doi.org/10.1371/journal.pone.0002808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665236	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300027
J	Fujimoto, K; Ishihara, S; Kaneko, K				Fujimoto, Koichi; Ishihara, Shuji; Kaneko, Kunihiko			Network Evolution of Body Plans	PLOS ONE			English	Article								One of the major goals in evolutionary developmental biology is to understand the relationship between gene regulatory networks and the diverse morphologies and their functionalities. Are the diversities solely triggered by random events, or are they inevitable outcomes of an interplay between evolving gene networks and natural selection? Segmentation in arthropod embryogenesis represents a well-known example of body plan diversity. Striped patterns of gene expression that lead to the future body segments appear simultaneously or sequentially in long and short germ-band development, respectively. Moreover, a combination of both is found in intermediate germ-band development. Regulatory genes relevant for stripe formation are evolutionarily conserved among arthropods, therefore the differences in the observed traits are thought to have originated from how the genes are wired. To reveal the basic differences in the network structure, we have numerically evolved hundreds of gene regulatory networks that produce striped patterns of gene expression. By analyzing the topologies of the generated networks, we show that the characteristics of stripe formation in long and short germ-band development are determined by Feed-Forward Loops (FFLs) and negative Feed-Back Loops (FBLs) respectively, and those of intermediate germ-band development are determined by the interconnections between FFL and negative FBL. Network architectures, gene expression patterns and knockout responses exhibited by the artificially evolved networks agree with those reported in the fly Drosophila melanogaster and the beetle Tribolium castaneum. For other arthropod species, principal network architectures that remain largely unknown are predicted. Our results suggest that the emergence of the three modes of body segmentation in arthropods is an inherent property of the evolving networks.	[Fujimoto, Koichi; Kaneko, Kunihiko] Japan Sci & Technol Agcy, ERATO Complex Syst Biol Project, Tokyo, Japan; [Fujimoto, Koichi; Ishihara, Shuji; Kaneko, Kunihiko] Univ Tokyo, Dept Basic Sci, Tokyo, Japan; [Ishihara, Shuji] Natl Inst Basic Biol, Div Theoretical Biol, Okazaki, Aichi, Japan	Japan Science & Technology Agency (JST); University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Fujimoto, K (corresponding author), Japan Sci & Technol Agcy, ERATO Complex Syst Biol Project, Tokyo, Japan.	fujimoto@complex.c.u-tokyo.ac.jp	Fujimoto, Koichi/J-8454-2013	Fujimoto, Koichi/0000-0001-6473-7990	ERATO Complex Systems Biology Project, JST	ERATO Complex Systems Biology Project, JST(Japan Science & Technology Agency (JST))	This work was supported by ERATO Complex Systems Biology Project, JST.	Alon U., 2006, INTRO SYSTEMS BIOL D; ARTHUR W, 1998, ORIGIN ANIMAL BODY P; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Bornholdt S, 2000, P ROY SOC B-BIOL SCI, V267, P2281, DOI 10.1098/rspb.2000.1280; Brown SJ, 1996, SEMIN CELL DEV BIOL, V7, P553, DOI 10.1006/scdb.1996.0069; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Carroll S. B., 2001, DNA DIVERSITY MOL GE; Cerny AC, 2005, DEVELOPMENT, V132, P5353, DOI 10.1242/dev.02154; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Copf T, 2003, DEVELOPMENT, V130, P5915, DOI 10.1242/dev.00835; Cordero OX, 2006, MOL BIOL EVOL, V23, P1931, DOI 10.1093/molbev/msl060; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; Darcy, 2003, 2003 OFFSHORE TECHNO; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davis GK, 2005, DEV BIOL, V285, P169, DOI 10.1016/j.ydbio.2005.06.014; Davis GK, 2002, ANNU REV ENTOMOL, V47, P669, DOI 10.1146/annurev.ento.47.091201.145251; Davis GK, 2001, DEVELOPMENT, V128, P3445; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dearden PK, 2001, DEVELOPMENT, V128, P3435; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; Francois P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100192; Goltsev Y, 2004, DEV BIOL, V275, P435, DOI 10.1016/j.ydbio.2004.08.021; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; ISHIHARA S, 2008, J THEOR BIOL; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaynes JB, 2004, DEV BIOL, V269, P609, DOI 10.1016/j.ydbio.2004.03.001; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kauffman S.A., 1993, ORIGINS ORDER; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; KRAFT R, 1994, P NATL ACAD SCI USA, V91, P6634, DOI 10.1073/pnas.91.14.6634; Lau KY, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051907; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu PZ, 2005, EVOL DEV, V7, P629, DOI 10.1111/j.1525-142X.2005.05066.x; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Liu PZ, 2004, DEVELOPMENT, V131, P4567, DOI 10.1242/dev.01311; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; Meinhardt H., 1982, MODELS BIOL PATTERN; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mito T, 2006, DEV BIOL, V294, P471, DOI 10.1016/j.ydbio.2005.12.057; Monod J., 1972, CHANCE NECESSITY; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; NUSSLEINVOLHARD C, 1985, COLD SPRING HARB SYM, V50, P145, DOI 10.1101/SQB.1985.050.01.020; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Salazar-Ciudad I, 2001, EVOL DEV, V3, P95, DOI 10.1046/j.1525-142x.2001.003002095.x; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Schroder R, 2003, NATURE, V422, P621, DOI 10.1038/nature01536; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; SOMMER RJ, 1993, NATURE, V361, P448, DOI 10.1038/361448a0; Stollewerk A, 2003, NATURE, V423, P863, DOI 10.1038/nature01682; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Wall ME, 2004, NAT REV GENET, V5, P34, DOI 10.1038/nrg1244; Wittkopp PJ, 2007, J EXP BIOL, V210, P1567, DOI 10.1242/jeb.002592	75	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2772	10.1371/journal.pone.0002772	http://dx.doi.org/10.1371/journal.pone.0002772			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648662	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900042
J	Schirra, HJ; Anderson, CG; Wilson, WJ; Kerr, L; Craik, DJ; Waters, MJ; Lichanska, AM				Schirra, Horst Joachim; Anderson, Cameron G.; Wilson, William J.; Kerr, Linda; Craik, David J.; Waters, Michael J.; Lichanska, Agnieszka M.			Altered Metabolism of Growth Hormone Receptor Mutant Mice: A Combined NMR Metabonomics and Microarray Study	PLOS ONE			English	Article								Background: Growth hormone is an important regulator of post-natal growth and metabolism. We have investigated the metabolic consequences of altered growth hormone signalling in mutant mice that have truncations at position 569 and 391 of the intracellular domain of the growth hormone receptor, and thus exhibit either low (around 30% maximum) or no growth hormone-dependent STAT5 signalling respectively. These mutations result in altered liver metabolism, obesity and insulin resistance. Methodology/Principal Findings: The analysis of metabolic changes was performed using microarray analysis of liver tissue and NMR metabonomics of urine and liver tissue. Data were analyzed using multivariate statistics and Gene Ontology tools. The metabolic profiles characteristic for each of the two mutant groups and wild-type mice were identified with NMR metabonomics. We found decreased urinary levels of taurine, citrate and 2-oxoglutarate, and increased levels of trimethylamine, creatine and creatinine when compared to wild-type mice. These results indicate significant changes in lipid and choline metabolism, and were coupled with increased fat deposition, leading to obesity. The microarray analysis identified changes in expression of metabolic enzymes correlating with alterations in metabolite concentration both in urine and liver. Similarity of mutant 569 to the wild-type was seen in young mice, but the pattern of metabolites shifted to that of the 391 mutant as the 569 mice became obese after six months age. Conclusions/Significance: The metabonomic observations were consistent with the parallel analysis of gene expression and pathway mapping using microarray data, identifying metabolites and gene transcripts involved in hepatic metabolism, especially for taurine, choline and creatinine metabolism. The systems biology approach applied in this study provides a coherent picture of metabolic changes resulting from impaired STAT5 signalling by the growth hormone receptor, and supports a potentially important role for taurine in enhancing beta-oxidation.	[Schirra, Horst Joachim; Anderson, Cameron G.; Kerr, Linda; Craik, David J.; Waters, Michael J.; Lichanska, Agnieszka M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Wilson, William J.] CSIRO Math & Informat Sci, Stat Bioinformat, N Ryde, NSW, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Schirra, HJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	h.schirra@uq.edu.au	Wilson, William/A-3631-2009; Stitt, Alan/A-9842-2009; Schirra, Horst Joachim/B-4210-2009; Craik, David/B-1695-2010; waters, michael j/C-9582-2014	Wilson, William/0000-0001-5658-0997; Stitt, Alan/0000-0002-8647-9918; Schirra, Horst Joachim/0000-0002-7541-246X; Craik, David/0000-0003-0007-6796; 	Australian Research Council (ARC) [Professorial Fellow]; National Health and Medical Research Council (NHMRC) [Senior Principal Research Fellow]; Queensland Smart State Fellow; Queensland State Govenment	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart State Fellow; Queensland State Govenment	This work was supported by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC). HJS is a Queensland Smart State Fellow. DJC is an ARC Professorial Fellow. MJW is a NHMRC Senior Principal Research Fellow. The 700 MHz wide-bore NMR spectrometer is part of the Queensland NMR Network, which was established with funding from the Queensland State Govenment.	ASATOOR AM, 1965, BIOCHIM BIOPHYS ACTA, V111, P384, DOI 10.1016/0304-4165(65)90048-6; BAKER JR, 1962, J BIOL CHEM, V237, P1309; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; BESSMAN SP, 1981, SCIENCE, V211, P448, DOI 10.1126/science.6450446; Birdsall T C, 1998, Altern Med Rev, V3, P128; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; Bouillanne O, 1996, FUNDAM CLIN PHARM, V10, P416, DOI 10.1111/j.1472-8206.1996.tb00596.x; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CAVANAGH J, 1990, J MAGN RESON, V87, P110, DOI 10.1016/0022-2364(90)90089-R; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Cheng J, 2004, BIOINFORMATICS, V20, P1462, DOI 10.1093/bioinformatics/bth087; Clayton TA, 2004, ARCH TOXICOL, V78, P86, DOI 10.1007/s00204-003-0515-2; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Connor SC, 2004, BIOMARKERS, V9, P156, DOI 10.1080/13547500410001720767; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Flores-Morales A, 2001, ENDOCRINOLOGY, V142, P3163, DOI 10.1210/en.142.7.3163; FRANCONI F, 1995, AM J CLIN NUTR, V61, P1115, DOI 10.1093/ajcn/61.5.1115; Gavaghan CL, 2000, FEBS LETT, V484, P169, DOI 10.1016/S0014-5793(00)02147-5; HARVEY S, 1995, GROWTH HORMONE, P1; Herrington J, 2001, TRENDS ENDOCRIN MET, V12, P252, DOI 10.1016/S1043-2760(01)00423-4; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Ho Ken K. Y., 1996, Endocrine Journal, V43, pS57; Holmes E, 1997, J PHARMACEUT BIOMED, V15, P1647, DOI 10.1016/S0731-7085(97)00066-6; Holmes E, 2002, ANALYST, V127, P1549, DOI 10.1039/b208254n; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; KAISAKIA PJ, 1995, BBA-GENE STRUCT EXPR, V1262, P79, DOI 10.1016/0167-4781(95)00058-O; Kiiveri HT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-195; Lang DH, 2000, BRIT J CLIN PHARMACO, V50, P311, DOI 10.1046/j.1365-2125.2000.00265.x; Lang DH, 1998, BIOCHEM PHARMACOL, V56, P1005, DOI 10.1016/S0006-2952(98)00218-4; Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006; Marion A.F., 1883, ANN MUS HIST NAT M, V1, P1; Mizushima S, 1996, ADV EXP MED BIOL, V403, P615; MOLLER N, 1991, HORM RES, V36, P32, DOI 10.1159/000182185; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; NICHOLSON JK, 1989, PROG NUCL MAG RES SP, V21, P449, DOI 10.1016/0079-6565(89)80008-1; Norrelund H, 2003, AM J PHYSIOL-ENDOC M, V285, pE737, DOI 10.1152/ajpendo.00092.2003; Norrelund H, 2001, J CLIN ENDOCR METAB, V86, P3120, DOI 10.1210/jc.86.7.3120; Norrelund H, 2001, DIABETES, V50, P96, DOI 10.2337/diabetes.50.1.96; NORWOOD TJ, 1990, J MAGN RESON, V87, P488, DOI 10.1016/0022-2364(90)90306-T; Olsson B, 2003, AM J PHYSIOL-ENDOC M, V285, pE504, DOI 10.1152/ajpendo.00444.2002; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; Pandey R, 2004, BIOINFORMATICS, V20, P2156, DOI 10.1093/bioinformatics/bth215; Parini P, 1999, ARTERIOSCL THROM VAS, V19, P832, DOI 10.1161/01.ATV.19.4.832; Park E, 2002, BBA-GENE STRUCT EXPR, V1574, P403, DOI 10.1016/S0167-4781(01)00364-5; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Richelsen B., 1999, Journal of Endocrinological Investigation, V22, P10; Richelsen B, 1997, HORM RES, V48, P105, DOI 10.1159/000191338; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Rudling M, 1999, GROWTH HORM IGF RES, V9, P1, DOI 10.1016/S1096-6374(99)80002-1; SATOH H, 1994, ADV EXP MED BIOL, V359, P181; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; SCHUETZ EG, 1990, J BIOL CHEM, V265, P1188; SIMPSON DP, 1983, AM J PHYSIOL, V244, pF223, DOI 10.1152/ajprenal.1983.244.3.F223; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Timbrell JA, 1996, ADV EXP MED BIOL, V403, P125; Tollet-Egnell P, 2001, MOL ENDOCRINOL, V15, P308, DOI 10.1210/me.15.2.308; Tollet-Egnell P, 2004, PHYSIOL GENOMICS, V16, P261, DOI 10.1152/physiolgenomics.00093.2002; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; Voet D., 2005, BIOCHEMISTRY-US; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	66	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2764	10.1371/journal.pone.0002764	http://dx.doi.org/10.1371/journal.pone.0002764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648510	gold, Green Submitted, Green Published			2022-12-27	WOS:000264302900034
J	Solomon, SE; Bacci, M; Martins, J; Vinha, GG; Mueller, UG				Solomon, Scott E.; Bacci, Mauricio, Jr.; Martins, Joaquim, Jr.; Vinha, Giovanna Goncalves; Mueller, Ulrich G.			Paleodistributions and Comparative Molecular Phylogeography of Leafcutter Ants (Atta spp.) Provide New Insight into the Origins of Amazonian Diversity	PLOS ONE			English	Article							LEAF-CUTTING ANTS; CLIMATE-CHANGE; GENETIC-STRUCTURE; HISTORICAL DIVERSIFICATION; SPECIES DISTRIBUTIONS; POPULATION-GROWTH; RIVERINE BARRIERS; PLANT DIVERSITY; RACE FORMATION; SOUTH-AMERICA	The evolutionary basis for high species diversity in tropical regions of the world remains unresolved. Much research has focused on the biogeography of speciation in the Amazon Basin, which harbors the greatest diversity of terrestrial life. The leading hypotheses on allopatric diversification of Amazonian taxa are the Pleistocene refugia, marine incursion, and riverine barrier hypotheses. Recent advances in the fields of phylogeography and species-distribution modeling permit a modern re-evaluation of these hypotheses. Our approach combines comparative, molecular phylogeographic analyses using mitochondrial DNA sequence data with paleodistribution modeling of species ranges at the last glacial maximum (LGM) to test these hypotheses for three co-distributed species of leafcutter ants (Atta spp.). The cumulative results of all tests reject every prediction of the riverine barrier hypothesis, but are unable to reject several predictions of the Pleistocene refugia and marine incursion hypotheses. Coalescent dating analyses suggest that population structure formed recently (Pleistocene-Pliocene), but are unable to reject the possibility that Miocene events may be responsible for structuring populations in two of the three species examined. The available data therefore suggest that either marine incursions in the Miocene or climate changes during the Pleistocene-or both-have shaped the population structure of the three species examined. Our results also reconceptualize the traditional Pleistocene refugia hypothesis, and offer a novel framework for future research into the area.	[Solomon, Scott E.; Mueller, Ulrich G.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Solomon, Scott E.] Smithsonian Inst, Dept Entomol, Washington, DC USA; [Solomon, Scott E.; Bacci, Mauricio, Jr.; Martins, Joaquim, Jr.; Vinha, Giovanna Goncalves] Sao Paulo State Univ, Ctr Study Social, Sao Paulo, Brazil	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade Estadual Paulista	Solomon, SE (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	solomons@si.edu	Martins, Joaquim/G-1319-2010; Bacci, Mauricio/C-4960-2013	Martins, Joaquim/0000-0002-6559-8045; Bacci, Mauricio/0000-0002-5619-1411; Solomon, Scott/0000-0002-6376-5671	National Science Foundation [DEB 0407772]; The University of Texas at Austin [graduate fellowships]; Amazon Conservation Association; NSF [07012333]; FAPESP [06/00185-7, 05/54250-1]; CAPES [Aux-UT-165/2005]; CNPq [310826/2006-3, 479990/2006-9];  [DEB-0110073]	National Science Foundation(National Science Foundation (NSF)); The University of Texas at Austin; Amazon Conservation Association; NSF(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	S.E.S. was funded by a DDIG grant from the National Science Foundation (DEB 0407772), the IGERT program in computational phylogenetics at The University of Texas at Austin, graduate fellowships from the Section of Integrative Biology at The University of Texas at Austin, and a grant from the Amazon Conservation Association and the NSF International Reseach Fellowship Program (IRFP #07012333). MBJ was funded by FAPESP (06/00185-7), CAPES (Aux-UT-165/2005) and CNPq (310826/2006-3 and 479990/2006-9). J.M.J. was funded by CAPES (Brazil). G.G.V was funded by FAPESP (05/54250-1). Additional funding was provided by NSF IRCEB Grant DEB-0110073 to U.G.M.	Aleixo A, 2004, EVOLUTION, V58, P1303, DOI 10.1111/j.0014-3820.2004.tb01709.x; Aleixo A, 2006, BIOL J LINN SOC, V89, P383, DOI 10.1111/j.1095-8312.2006.00703.x; Anderson RP, 2003, J BIOGEOGR, V30, P591, DOI 10.1046/j.1365-2699.2003.00867.x; [Anonymous], 2006, THESIS U TEXAS AUSTI; AUTUORI M, 1947, ARQUIVOS I BIOL SAO, V187, P39; Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BERMINGHAM E, 2005, TROPICAL RAINFORESTS; Bonaccorso E, 2006, DIVERS DISTRIB, V12, P157, DOI 10.1111/j.1366-9516.2005.00212.x; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brower AVZ, 1996, EVOLUTION, V50, P195, DOI 10.1111/j.1558-5646.1996.tb04486.x; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown K.S. Jr, 1982, P255; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; BUSH MB, 1994, J BIOGEOGR, V21, P5, DOI 10.2307/2845600; Bush MB, 2004, J QUATERNARY SCI, V19, P677, DOI 10.1002/jqs.883; CARNAVAL AC, 2008, J BIOGEOGRAPHY  0328; Carnaval AC, 2007, EVOLUTION, V61, P2942, DOI 10.1111/j.1558-5646.2007.00241.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Cherrett J.M., 1986, P165; Cherrett J.M., 1986, P10; CHERRETT JM, 1976, ANN APPL BIOL, V84, P124, DOI 10.1111/j.1744-7348.1976.tb01741.x; CHERRETT JM, 1986, BIOL PEST STATUS CON, P1; Cheviron ZA, 2005, MOL PHYLOGENET EVOL, V36, P338, DOI 10.1016/j.ympev.2005.01.015; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Colinvaux PA, 2001, PALAEOGEOGR PALAEOCL, V166, P51, DOI 10.1016/S0031-0182(00)00201-7; Colinvaux PA, 2001, AMAZONIANA, V16, P609; Coyne J.A., 2004, SPECIATION; Dick CW, 2004, MOL ECOL, V13, P3775, DOI 10.1111/j.1365-294X.2004.02374.x; Dudik M, 2004, LECT NOTES COMPUT SC, V3120, P472, DOI 10.1007/978-3-540-27819-1_33; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; ERWIN TL, 1991, CONSERV BIOL, V5, P330, DOI 10.1111/j.1523-1739.1991.tb00145.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FJELDSA J, 1994, BIODIVERS CONSERV, V3, P207, DOI 10.1007/BF00055939; Funk WC, 2007, MOL PHYLOGENET EVOL, V44, P825, DOI 10.1016/j.ympev.2007.01.012; Gamble T, 2008, MOL PHYLOGENET EVOL, V46, P269, DOI 10.1016/j.ympev.2007.08.013; Garrettson M, 1998, J TROP ECOL, V14, P17, DOI 10.1017/S0266467498000029; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Gonalves CR, 1967, ATAS S BIOTA AMAZON, V5; GONCALVES CR, 1960, DIVULGACAO AGRONOMIC, V12, P2; Goulding M, 2003, SMITHSONIAN ATLAS AM; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 2001, AMAZONIANA, V16, P579; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Hall JPW, 2002, EVOLUTION, V56, P1489; Hardman M, 2008, SYST BIOL, V57, P116, DOI 10.1080/10635150801902193; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hayes FE, 2004, J BIOGEOGR, V31, P1809, DOI 10.1111/j.1365-2699.2004.01139.x; Hershkovitz P., 1977, LIVING NEW WORLD MON; Hey J, 2005, PLOS BIOL, V3, P965, DOI 10.1371/journal.pbio.0030193; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hillis David M., 1996, P515; Holldobler B., 1990, pi; Hovikoski J, 2005, GEOLOGY, V33, P177, DOI 10.1130/G21102.1; Hovikoski J, 2007, PALAEOGEOGR PALAEOCL, V243, P23, DOI 10.1016/j.palaeo.2006.07.013; Hugall A, 2002, P NATL ACAD SCI USA, V99, P6112, DOI 10.1073/pnas.092538699; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Knowles LL, 2004, J EVOLUTION BIOL, V17, P1, DOI 10.1046/j.1420-9101.2003.00644.x; KOSCINSKI D, MOL ECOLOGY, V17, P2012; Latrubesse EM, 2007, J S AM EARTH SCI, V23, P61, DOI 10.1016/j.jsames.2006.09.021; Lewinsohn TM, 2005, CONSERV BIOL, V19, P640, DOI 10.1111/j.1523-1739.2005.00682.x; Losos JB, 2003, TRENDS ECOL EVOL, V18, P220, DOI 10.1016/S0169-5347(03)00037-5; Lougheed SC, 1999, P ROY SOC B-BIOL SCI, V266, P1829, DOI 10.1098/rspb.1999.0853; Lovejoy NR, 2006, J S AM EARTH SCI, V21, P5, DOI 10.1016/j.jsames.2005.07.009; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; MANTEL N, 1967, CANCER RES, V27, P209; Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x; Matocq MD, 2000, EVOLUTION, V54, P1423; Mayhew PJ, 2008, P ROY SOC B-BIOL SCI, V275, P47, DOI 10.1098/rspb.2007.1302; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; MAYR E, 1986, EVOLUTION, V40, P55, DOI 10.1111/j.1558-5646.1986.tb05717.x; Moreira AA, 2004, STUD NEOTROP FAUNA E, V39, P109, DOI 10.1080/01650520412331333756; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; MOSER JC, 1967, INSECT SOC, V14, P295, DOI 10.1007/BF02252831; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; NELSON BW, 1990, NATURE, V345, P714, DOI 10.1038/345714a0; Nielsen R, 2001, GENETICS, V158, P885; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PATTON JL, 1994, EVOLUTION, V48, P1314, DOI 10.1111/j.1558-5646.1994.tb05315.x; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Peres CA, 1996, FOLIA PRIMATOL, V67, P113, DOI 10.1159/000157213; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Quek SP, 2004, EVOLUTION, V58, P554, DOI 10.1111/j.0014-3820.2004.tb01678.x; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruegg KC, 2006, J BIOGEOGR, V33, P1172, DOI 10.1111/j.1365-2699.2006.01517.x; Schneider S, 1999, GENETICS, V152, P1079; SCHULTZ TR, 2008, P NATL ACAD SCI 0324; SCHULTZ TR, 2008, P NATL ACAD IN PRESS; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SIMPSON BB, 1978, ANNU REV ECOL SYST, V9, P497, DOI 10.1146/annurev.es.09.110178.002433; SLATKIN M, 1991, GENETICS, V129, P555; Smith TB, 2001, GENETICA, V112, P383, DOI 10.1023/A:1013312510860; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P597; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; TOLLEY KA, 2008, J BIOGEOGRAPHY  0328; VASCONCELOS HL, 1995, STUD NEOTROP FAUNA E, V30, P107, DOI 10.1080/01650529509360947; Vonhof HB, 2003, GEOL SOC AM BULL, V115, P983, DOI 10.1130/B25058.1; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; WEBB SD, 1995, SCIENCE, V269, P361, DOI 10.1126/science.269.5222.361; WEBER NA, 1969, ECOLOGY, V50, P141; Weber NA., 1972, GARDENING ANTS; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; Wilf P, 2003, SCIENCE, V300, P122, DOI 10.1126/science.1080475; Wilson EO, 1999, DIVERSITY LIFE; Wilson RJ, 2007, GLOBAL CHANGE BIOL, V13, P1873, DOI 10.1111/j.1365-2486.2007.01418.x; WILSON S, 1987, METHODS COMPUTATIONA, V1, P251; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wright S, 2006, P NATL ACAD SCI USA, V103, P7718, DOI 10.1073/pnas.0510383103	133	75	76	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2738	10.1371/journal.pone.0002738	http://dx.doi.org/10.1371/journal.pone.0002738			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648512	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900009
J	Allsopp, MH; de Lange, WJ; Veldtman, R				Allsopp, Mike H.; de Lange, Willem J.; Veldtman, Ruan			Valuing Insect Pollination Services with Cost of Replacement	PLOS ONE			English	Article							ECOSYSTEM SERVICES; BEE POLLINATION; ECONOMIC VALUE; CROP POLLINATION; APIS-MELLIFERA; HONEY-BEES; FRUIT-SET; CONSERVATION; BIODIVERSITY; MCINTOSH	Value estimates of ecosystem goods and services are useful to justify the allocation of resources towards conservation, but inconclusive estimates risk unsustainable resource allocations. Here we present replacement costs as a more accurate value estimate of insect pollination as an ecosystem service, although this method could also be applied to other services. The importance of insect pollination to agriculture is unequivocal. However, whether this service is largely provided by wild pollinators (genuine ecosystem service) or managed pollinators (commercial service), and which of these requires immediate action amidst reports of pollinator decline, remains contested. If crop pollination is used to argue for biodiversity conservation, clear distinction should be made between values of managed- and wild pollination services. Current methods either under-estimate or over-estimate the pollination service value, and make use of criticised general insect and managed pollinator dependence factors. We apply the theoretical concept of ascribing a value to a service by calculating the cost to replace it, as a novel way of valuing wild and managed pollination services. Adjusted insect and managed pollinator dependence factors were used to estimate the cost of replacing insect- and managed pollination services for the Western Cape deciduous fruit industry of South Africa. Using pollen dusting and hand pollination as suitable replacements, we value pollination services significantly higher than current market prices for commercial pollination, although lower than traditional proportional estimates. The complexity associated with inclusive value estimation of pollination services required several defendable assumptions, but made estimates more inclusive than previous attempts. Consequently this study provides the basis for continued improvement in context specific pollination service value estimates.	[Allsopp, Mike H.] Plant Protect Res Inst, Agr Res Council, ZA-0001 Pretoria, South Africa; [de Lange, Willem J.] Council Sci & Industrial Res, Environm & Resource Econ Grp, Stellenbosch, South Africa; [Veldtman, Ruan] Kirstenbosch Res Ctr, S African Natl Biodivers Inst, Cape Town, South Africa	Agricultural Research Council of South Africa; South African National Biodiversity Institute	Allsopp, MH (corresponding author), Plant Protect Res Inst, Agr Res Council, Private Bag X134, ZA-0001 Pretoria, South Africa.	Veldtman@sanbi.org	De Lange, Willem/GYU-4982-2022; Veldtman, Ruan/I-1131-2019	De Lange, Willem/0000-0001-5369-7049; 				Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Allsopp M.H., 2004, ASSESSMENT IMPACT BE; Benedek P, 2003, FLORAL BIOLOGY : POLLINATION AND FERTILISATION IN TEMPERATE ZONE FRUIT SPECIES AND GRAPE, P531; Bos MM, 2007, ECOL APPL, V17, P1841, DOI 10.1890/06-1763.1; Buchmann SL, 1996, FORGOTTEN POLLINATOR; Burgett M, 2004, AM BEE J, V144, P269; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; CALDERONE NW, 2006, BEE CULT, V134, P31; Calzoni GL, 1998, SCI HORTIC-AMSTERDAM, V72, P227, DOI 10.1016/S0304-4238(97)00132-5; CHAGNON M, 1993, J ECON ENTOMOL, V86, P416, DOI 10.1093/jee/86.2.416; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Curtis IA, 2004, ECOL ECON, V50, P163, DOI 10.1016/j.ecolecon.2004.02.003; Dag A, 2001, ACTA HORTIC, P61, DOI 10.17660/ActaHortic.2001.561.8; DEGRANDI H, 2000, AM BEE J, V137, P565; *DFPT, 2005, KEY DEC FRUIT STAT; *FIRM POLL CO, 2007, PRIC; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gill R. A., 1991, The Sixth International Symposium on Pollination, Tilburg, Netherlands, 27-31 August 1990., P62; Gill RA, 1985, 371 IND ASS COMM; Goodstein E., 2008, EC ENV; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hassan R., 2005, ECOSYSTEMS HUMAN WEL; Heazlewood JE, 2004, VITIS, V43, P65; Howpage D, 2001, NEW ZEAL J CROP HORT, V29, P51, DOI 10.1080/01140671.2001.9514160; JOHANNSMEIER MF, 2001, PLANT PROTECTION RES, V14, P232; JOHNSON DB, 1973, J LAW ECON, V16, P35, DOI 10.1086/466754; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, AM J BOT, V90, P153, DOI 10.3732/ajb.90.1.153; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; KUBERSKY U, 2001, APIDOLOGIE, V32, P463; Lange W. J. de, 2007, Agrekon, V46, P371; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; McGregor, 1976, USDA AGR HDB, V496; McLaren GF, 1996, NEW ZEAL J CROP HORT, V24, P55, DOI 10.1080/01140671.1996.9513935; Moritz RFA, 2007, J INSECT CONSERV, V11, P391, DOI 10.1007/s10841-006-9054-5; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; OLMSTEAD AL, 1987, AM J AGR ECON, V69, P56, DOI 10.2307/1241306; PEARCE DW, 1993, EC VALUES ENV; Pritchard KD, 2006, J HORTIC SCI BIOTECH, V81, P78, DOI 10.1080/14620316.2006.11512032; RANDALL A, 1983, NAT RESOUR J, V23, P131; Razeto B, 2005, INT J FRUIT SCI, V5, P37, DOI 10.1300/J492v05n02_05; Richards AJ, 2001, ANN BOT-LONDON, V88, P165, DOI 10.1006/anbo.2001.1463; RICHARDS KW, 1993, REV SUISSE ZOOL, V100, P807, DOI 10.5962/bhl.part.79885; ROBINSON WS, 1989, AM BEE J, V129, P477; Schupp JR, 1997, HORTSCIENCE, V32, P742, DOI 10.21273/HORTSCI.32.4.742; Sheffield CS, 2005, ANN BOT-LONDON, V95, P583, DOI 10.1093/aob/mci058; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turpie JK, 2003, BIOL CONSERV, V112, P233, DOI 10.1016/S0006-3207(02)00398-1; van Wilgen BW, 1997, S AFR J SCI, V93, P404; Williams Ingrid H., 1996, Linnean Society Symposium Series, V18, P63; Winfree R, 2007, ECOL LETT, V10, P1105, DOI 10.1111/j.1461-0248.2007.01110.x; Ya T., 2003, HAND POLLINATION PEA	58	165	171	4	213	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3128	10.1371/journal.pone.0003128	http://dx.doi.org/10.1371/journal.pone.0003128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781196	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425700001
J	Aharonowiz, M; Einstein, O; Fainstein, N; Lassmann, H; Reubinoff, B; Ben-Hur, T				Aharonowiz, Michal; Einstein, Ofira; Fainstein, Nina; Lassmann, Hans; Reubinoff, Benjamin; Ben-Hur, Tamir			Neuroprotective Effect of Transplanted Human Embryonic Stem Cell-Derived Neural Precursors in an Animal Model of Multiple Sclerosis	PLOS ONE			English	Article								Background: Multiple sclerosis (MS) is an immune mediated demyelinating disease of the central nervous system (CNS). A potential new therapeutic approach for MS is cell transplantation which may promote remyelination and suppress the inflammatory process. Methods: We transplanted human embryonic stem cells (hESC)-derived early multipotent neural precursors (NPs) into the brain ventricles of mice induced with experimental autoimmune encephalomyelitis (EAE), the animal model of MS. We studied the effect of the transplanted NPs on the functional and pathological manifestations of the disease. Results: Transplanted hESC-derived NPs significantly reduced the clinical signs of EAE. Histological examination showed migration of the transplanted NPs to the host white matter, however, differentiation to mature oligodendrocytes and remyelination were negligible. Time course analysis of the evolution and progression of CNS inflammation and tissue injury showed an attenuation of the inflammatory process in transplanted animals, which was correlated with the reduction of both axonal damage and demyelination. Co-culture experiments showed that hESC-derived NPs inhibited the activation and proliferation of lymph node-derived T cells in response to nonspecific polyclonal stimuli. Conclusions: The therapeutic effect of transplantation was not related to graft or host remyelination but was mediated by an immunosuppressive neuroprotective mechanism. The attenuation of EAE by hESC-derived NPs, demonstrated here, may serve as the first step towards further developments of hESC for cell therapy in MS.	[Aharonowiz, Michal; Reubinoff, Benjamin] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cells Res Ctr, Jerusalem, Israel; [Aharonowiz, Michal; Einstein, Ofira; Fainstein, Nina; Ben-Hur, Tamir] Hadassah Hebrew Univ, Med Ctr, Agnes Ginges Ctr Human Neurogenesis, Dept Neurol, Jerusalem, Israel; [Reubinoff, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Gynecol, Jerusalem, Israel; [Lassmann, Hans] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Medical University of Vienna	Aharonowiz, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cells Res Ctr, Jerusalem, Israel.	benjaminr@ekmd.huji.ac.il; TAMIR@hadassah.org.il	Einstein, Ofira/AAE-2869-2019; Lassmann, Hans/Z-2269-2019	Einstein, Ofira/0000-0003-0819-3057; Lassmann, Hans/0000-0001-8617-5052; Reubinoff, Benjamin/0000-0003-0353-1299	Israel Science Foundation [140/05]; Legacy Heritage Fund	Israel Science Foundation(Israel Science Foundation); Legacy Heritage Fund	This work was supported in part by the Israel Science Foundation (Grant 140/05) and by the Legacy Heritage Fund. Both funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Ben-Hur T, 2007, MAGN RESON MED, V57, P164, DOI 10.1002/mrm.21116; Bronstein-Sitton N, 2003, NAT IMMUNOL, V4, P957, DOI 10.1038/ni975; Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307; Einstein O, 2006, GLIA, V53, P449, DOI 10.1002/glia.20305; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Gironi M., 2000, Neurological Sciences, V21, pS871, DOI 10.1007/s100720070029; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; GUY J, 1989, J COMP NEUROL, V287, P446, DOI 10.1002/cne.902870404; Hemmer B, 2002, CURR OPIN NEUROL, V15, P227, DOI 10.1097/00019052-200206000-00001; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Lassmann H, 2002, CLIN NEUROL NEUROSUR, V104, P168, DOI 10.1016/S0303-8467(02)00033-1; Lovas G, 2000, BRAIN, V123, P308, DOI 10.1093/brain/123.2.308; Lu F, 2005, RADIAT RES, V163, P63, DOI 10.1667/RR3285; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wang QY, 2007, IUTAM BOOKSER, V2, P323, DOI 10.1007/978-1-4020-6332-9_33; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	31	156	157	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3145	10.1371/journal.pone.0003145	http://dx.doi.org/10.1371/journal.pone.0003145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773082	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420100003
J	Gilad, S; Meiri, E; Yogev, Y; Benjamin, S; Lebanony, D; Yerushalmi, N; Benjamin, H; Kushnir, M; Cholakh, H; Melamed, N; Bentwich, Z; Hod, M; Goren, Y; Chajut, A				Gilad, Shlomit; Meiri, Eti; Yogev, Yariv; Benjamin, Sima; Lebanony, Danit; Yerushalmi, Noga; Benjamin, Hila; Kushnir, Michal; Cholakh, Hila; Melamed, Nir; Bentwich, Zvi; Hod, Moshe; Goren, Yaron; Chajut, Ayelet			Serum MicroRNAs Are Promising Novel Biomarkers	PLOS ONE			English	Article							EXPRESSION PROFILES; NUCLEIC-ACIDS; CANCER; IDENTIFICATION; RNA	Background: Circulating nucleic acids (CNAs) offer unique opportunities for early diagnosis of clinical conditions. Here we show that microRNAs, a family of small non-coding regulatory RNAs involved in human development and pathology, are present in bodily fluids and represent new effective biomarkers. Methods and Results: After developing protocols for extracting and quantifying microRNAs in serum and other body fluids, the serum microRNA profiles of several healthy individuals were determined and found to be similar, validating the robustness of our methods. To address the possibility that the abundance of specific microRNAs might change during physiological or pathological conditions, serum microRNA levels in pregnant and non pregnant women were compared. In sera from pregnant women, microRNAs associated with human placenta were significantly elevated and their levels correlated with pregnancy stage. Conclusions and Significance: Considering the central role of microRNAs in development and disease, our results highlight the medically relevant potential of determining microRNA levels in serum and other body fluids. Thus, microRNAs are a new class of CNAs that promise to serve as useful clinical biomarkers.	[Gilad, Shlomit; Meiri, Eti; Benjamin, Sima; Lebanony, Danit; Yerushalmi, Noga; Benjamin, Hila; Kushnir, Michal; Cholakh, Hila; Bentwich, Zvi; Goren, Yaron; Chajut, Ayelet] Rosetta Genom Ltd, Rehovot, Israel; [Yogev, Yariv; Melamed, Nir; Hod, Moshe] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Div Maternal Fetal Med, IL-49100 Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Gilad, S (corresponding author), Rosetta Genom Ltd, Rehovot, Israel.	zbentwich@rosettagenomics.com; ayelet_ch@rosettagenomics.com			Rosetta Genomics	Rosetta Genomics	Rosetta Genomics is a commercial for-profit company, which provided funding for the study. Most key investigators are employees of the company.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Koonin L M, 1997, MMWR CDC Surveill Summ, V46, P17; Kopreski MS, 2001, ANN NY ACAD SCI, V945, P172; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Li JH, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-36; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Pheasant M, 2007, GENOME RES, V17, P1245, DOI 10.1101/gr.6406307; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; SOIFER HS, 2007, MOL THER; Swaminathan R, 2006, ANN NY ACAD SCI, V1075, P1, DOI 10.1196/annals.1368.001; Swarup V, 2007, FEBS LETT, V581, P795, DOI 10.1016/j.febslet.2007.01.051; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103	24	1088	1212	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3148	10.1371/journal.pone.0003148	http://dx.doi.org/10.1371/journal.pone.0003148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773077	gold, Green Published			2022-12-27	WOS:000264420100006
J	Gahr, M; Metzdorf, R; Schmidl, D; Wickler, W				Gahr, Manfred; Metzdorf, Reinhold; Schmidl, Dieter; Wickler, Wolfgang			Bi-Directional Sexual Dimorphisms of the Song Control Nucleus HVC in a Songbird with Unison Song	PLOS ONE			English	Article							AFRICAN FOREST WEAVER; DIFFERENTIATION; TESTOSTERONE; EXPRESSION; PLASTICITY; DIFFERENCE; SYSTEM; BDNF; SIZE	Sexually dimorphic anatomy of brain areas is thought to be causally linked to sex differences in behaviour and cognitive functions. The sex with the regional size advantage (male or female) differs between brain areas and species. Among adult songbirds, males have larger brain areas such as the HVC (proper name) and RA (robust nucleus of the arcopallium) that control the production of learned songs. Forest weavers (Ploceus bicolor) mated pairs sing a unison duet in which male and female mates learn to produce identical songs. We show with histological techniques that the volume and neuron numbers of HVC and RA were >= 1.5 times larger in males than in females despite their identical songs. In contrast, using in-situ hybridizations, females have much higher (30-70%) expression levels of mRNA of a number of synapse-related proteins in HVC and/or RA than their male counterparts. Male-typical and female-typical sexual differentiation appears to act on different aspects of the phenotypes within the same brain areas, leading females and males to produce the same behaviour using different cellular mechanisms.	[Gahr, Manfred; Metzdorf, Reinhold; Schmidl, Dieter; Wickler, Wolfgang] Max Planck Inst Ornithol, Seewiesen, Germany	Max Planck Society	Gahr, M (corresponding author), Max Planck Inst Ornithol, Seewiesen, Germany.	gahr@orn.mpg.de			Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was financed by the Max Planck Society.	ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bolhuis JJ, 2001, TRENDS COGN SCI, V5, P426, DOI 10.1016/S1364-6613(00)01753-8; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cyrus D, 1980, BIRD ATLAS NATAL; de Courten-Myers GM, 1999, J NEUROPATH EXP NEUR, V58, P217; DEVOOGD TJ, 1988, J NEUROBIOL, V19, P199, DOI 10.1002/neu.480190303; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Fusani L, 2003, J NEUROBIOL, V54, P370, DOI 10.1002/neu.10141; Gahr M, 1998, J NEUROSCI, V18, P1124; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gahr M, 2004, ANN NY ACAD SCI, V1016, P684, DOI 10.1196/annals.1298.025; Gahr M, 1999, J NEUROSCI, V19, P2628; Gahr Manfred, 1994, P273; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; GERNOUD C, 2004, J NEUROSCI, V24, P2394; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hartley RS, 1997, NEUROBIOL LEARN MEM, V67, P248, DOI 10.1006/nlme.1996.3759; Horch HW, 2004, REV NEUROSCIENCE, V15, P117; Itoh Yuichiro, 2007, Journal of Biology, V6, pUnpaginated, DOI 10.1186/jbiol53; Kittelberger JM, 2005, J NEUROBIOL, V62, P406, DOI 10.1002/neu.20109; Lang Thorsten, 2008, V184, P107; Langmore NE, 1998, TRENDS ECOL EVOL, V13, P136, DOI 10.1016/S0169-5347(97)01241-X; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Lucas JR, 2004, P ROY SOC B-BIOL SCI, V271, P2423, DOI 10.1098/rspb.2004.2912; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; MCNEALEN P, 2005, BRAIN RES, V1032, P50; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; NIKOLAKOPOULOUA AM, 2003, P NATL ACAD SCI USA, V100, P4873; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; RAISMAN G, 1971, SCIENCE, V173, P731, DOI 10.1126/science.173.3998.731; Rutkowska J, 2005, HORM BEHAV, V47, P585, DOI 10.1016/j.yhbeh.2004.12.006; SEARCY WA, 1988, ECOLOGY, V69, P85, DOI 10.2307/1943163; Seibt U, 2002, BEHAVIOUR, V139, P1237, DOI 10.1163/15685390260437362; Stamatakis A, 2004, J COMP NEUROL, V474, P173, DOI 10.1002/cne.20066; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Voigt C, 2004, J COMP NEUROL, V475, P83, DOI 10.1002/cne.20151; VOIGT C, 2005, THESIS LUDWIG MAXIMI; Voigt C, 2007, P ROY SOC B-BIOL SCI, V274, P2645, DOI 10.1098/rspb.2007.0858; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; WICKLER W, 1980, Z TIERPSYCHOL, V52, P217; Wickler W, 2006, J ORNITHOL, V147, P87, DOI 10.1007/s10336-005-0025-5; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	48	28	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3073	10.1371/journal.pone.0003073	http://dx.doi.org/10.1371/journal.pone.0003073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728787	gold, Green Published, Green Submitted			2022-12-27	WOS:000264796400013
J	Pignatta, D; Dilkes, B; Wroblewski, T; Michelmore, RW; Comai, L				Pignatta, Daniela; Dilkes, Brian; Wroblewski, Tadeusz; Michelmore, Richard W.; Comai, Luca			Transgene-Induced Gene Silencing Is Not Affected by a Change in Ploidy Level	PLOS ONE			English	Article								Background: Whole genome duplication, which results in polyploidy, is a common feature of plant populations and a recurring event in the evolution of flowering plants. Polyploidy can result in changes to gene expression and epigenetic instability. Several epigenetic phenomena, occurring at the transcriptional or post-transcriptional level, have been documented in allopolyploids (polyploids derived from species hybrids) of Arabidopsis thaliana, yet findings in autopolyploids (polyploids derived from the duplication of the genome of a single species) are limited. Here, we tested the hypothesis that an increase in ploidy enhances transgene-induced post-transcriptional gene silencing using autopolyploids of A. thaliana. Methodology/Principal Findings: Diploid and tetraploid individuals of four independent homozygous transgenic lines of A. thaliana transformed with chalcone synthase (CHS) inverted repeat (hairpin) constructs were generated. For each line diploids and tetraploids were compared for efficiency in post-transcriptional silencing of the endogenous CHS gene. The four lines differed substantially in their silencing efficiency. Yet, diploid and tetraploid plants derived from these plants and containing therefore identical transgene insertions showed no difference in the efficiency silencing CHS as assayed by visual scoring, anthocyanin assays and quantification of CHS mRNA. Conclusions/Significance: Our results in A. thaliana indicated that there is no effect of ploidy level on transgene-induced post-transcriptional gene silencing. Our findings that post-transcriptional mechanisms were equally effective in diploids and tetraploids supports the use of transgene-driven post-transcriptional gene silencing as a useful mechanism to modify gene expression in polyploid species.	[Pignatta, Daniela; Dilkes, Brian; Comai, Luca] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Wroblewski, Tadeusz; Michelmore, Richard W.] Univ Calif Davis, Genome Ctr, Dept Plant Sci, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Pignatta, D (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.	lcomai@ucdavis.edu	Comai, Luca/F-4279-2010; Dilkes, Brian/C-9293-2012	Comai, Luca/0000-0003-2642-6619; Dilkes, Brian/0000-0003-2799-954X	NSF Plant Genome Program award [DBI 0733857]	NSF Plant Genome Program award	This work was supported by NSF Plant Genome Program award DBI 0733857, Functional genomics of plant polyploids, to L.C. The agency or any other entity not listed as an author had no role in experimental design and interpretation.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Comai L, 2000, PLANT CELL, V12, P1551, DOI 10.1105/tpc.12.9.1551; Davies GJ, 1997, PLANT J, V12, P791, DOI 10.1046/j.1365-313X.1997.12040791.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Guo M, 1996, GENETICS, V142, P1349; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Henry IM, 2005, GENETICS, V170, P1979, DOI 10.1534/genetics.104.037788; Henry IM, 2006, PLANT J, V48, P307, DOI 10.1111/j.1365-313X.2006.02871.x; Josefsson C, 2006, CURR BIOL, V16, P1322, DOI 10.1016/j.cub.2006.05.045; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Liu B, 2001, GENOME, V44, P321, DOI 10.1139/gen-44-3-321; Madlung A, 2002, PLANT PHYSIOL, V129, P733, DOI 10.1104/pp.003095; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Scheid OM, 2003, NAT GENET, V34, P450, DOI 10.1038/ng1210; Scheid OM, 1996, P NATL ACAD SCI USA, V93, P7114, DOI 10.1073/pnas.93.14.7114; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; STUDENT, 1908, BIOMETRIKA; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; TSUKAYA H, 1991, PLANT PHYSIOL, V97, P1414, DOI 10.1104/pp.97.4.1414; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wade HK, 2001, PLANT J, V25, P675, DOI 10.1046/j.1365-313x.2001.01001.x; Wang JL, 2004, GENETICS, V167, P1961, DOI 10.1534/genetics.104.027896	33	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3061	10.1371/journal.pone.0003061	http://dx.doi.org/10.1371/journal.pone.0003061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725969	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796300007
J	Choi, JK; Hwang, S; Kim, YJ				Choi, Jung Kyoon; Hwang, Sohyun; Kim, Young-Joon			Stochastic and Regulatory Role of Chromatin Silencing in Genomic Response to Environmental Changes	PLOS ONE			English	Article								Phenotypic diversity and fidelity can be balanced by controlling stochastic molecular mechanisms. Epigenetic silencing is one that has a critical role in stress response. Here we show that in yeast, incomplete silencing increases stochastic noise in gene expression, probably owing to unstable chromatin structure. Telomere position effect is suggested as one mechanism. Expression diversity in a population achieved in this way may render a subset of cells to readily respond to various acute stresses. By contrast, strong silencing tends to suppress noisy expression of genes, in particular those involved in life cycle control. In this regime, chromatin may act as a noise filter for precisely regulated responses to environmental signals that induce huge phenotypic changes such as a cell fate transition. These results propose modulation of chromatin stability as an important determinant of environmental adaptation and cellular differentiation.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Hwang, Sohyun] Korea Res Inst Biosci & Biotechnol, Taejon, South Korea	Yonsei University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, JK (corresponding author), Yonsei Univ, Dept Biochem, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011		Korean Ministry of Science and Technology	Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by grants from the Korean Ministry of Science and Technology to Y.-J.K. (Epigenomic Research of Human Disease and Global Research Lab).	Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Attfield PV, 2001, MOL MICROBIOL, V40, P1000, DOI 10.1046/j.1365-2958.2001.02444.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; EDO K, 2005, SCIENCE, V309, P2075; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gao Lu, 2006, Briefings in Functional Genomics & Proteomics, V5, P280, DOI 10.1093/bfgp/ell035; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Pedram M, 2006, MOL CELL BIOL, V26, P1865, DOI 10.1128/MCB.26.5.1865-1878.2006; Perez-Martin J, 1999, EMBO J, V18, P2580, DOI 10.1093/emboj/18.9.2580; Pirrotta V, 2005, MOL CELL, V18, P395, DOI 10.1016/j.molcel.2005.04.013; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Sandell L L, 1992, Trends Cell Biol, V2, P10, DOI 10.1016/0962-8924(92)90138-D; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571; Sumner ER, 2002, MICROBIOL-SGM, V148, P345, DOI 10.1099/00221287-148-2-345; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	44	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3002	10.1371/journal.pone.0003002	http://dx.doi.org/10.1371/journal.pone.0003002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714342	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900027
J	Hoffmann, S; Falkenstein, M				Hoffmann, Sven; Falkenstein, Michael			The Correction of Eye Blink Artefacts in the EEG: A Comparison of Two Prominent Methods	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; EOG CORRECTION; REMOVAL; MOVEMENT; DYNAMICS	Background: The study investigated the residual impact of eyeblinks on the electroencephalogram (EEG) after application of different correction procedures, namely a regression method (eye movement correction procedure, EMCP) and a component based method (Independent Component Analysis, ICA). Methodology/Principle Findings: Real and simulated data were investigated with respect to blink-related potentials and the residual mutual information of uncorrected vertical electrooculogram (EOG) and corrected EEG, which is a measure of residual EOG contribution to the EEG. The results reveal an occipital positivity that peaks at about 250ms after the maximum blink excursion following application of either correction procedure. This positivity was not observable in the simulated data. Mutual information of vertical EOG and EEG depended on the applied regression procedure. In addition, different correction results were obtained for real and simulated data. ICA yielded almost perfect correction in all conditions. However, under certain conditions EMCP yielded comparable results to the ICA approach. Conclusion: In conclusion, for EMCP the quality of correction depended on the EMCP variant used and the structure of the data, whereas ICA always yielded almost perfect correction. However, its disadvantage is the much more complex data processing, and that it requires a suitable amount of data.	[Hoffmann, Sven; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Project Grp Ageing & CNS Aalterat, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Hoffmann, S (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Project Grp Ageing & CNS Aalterat, Dortmund, Germany.	shoffmann@ifado.de	Falkenstein, Michael/ABA-7497-2020	Hoffmann, Sven/0000-0002-4521-8332	Leibniz research centre for working environment and human factors	Leibniz research centre for working environment and human factors	Leibniz research centre for working environment and human factors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM A, 2003, ADLERS PHYSL EYE; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P58, DOI 10.1016/0013-4694(94)90113-9; BERG P, 1986, PSYCHOPHYSIOLOGY, V23, P354, DOI 10.1111/j.1469-8986.1986.tb00646.x; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Croft RJ, 2005, PSYCHOPHYSIOLOGY, V42, P16, DOI 10.1111/j.1468-8986.2005.00264.x; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Croft RJ, 2002, INT J PSYCHOPHYSIOL, V44, P187, DOI 10.1016/S0167-8760(01)00201-X; Croft RJ, 1998, ELECTROEN CLIN NEURO, V107, P395, DOI 10.1016/S0013-4694(98)00087-X; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; HYVARINEN A, 1999, P 1 INT WORKSH ICA S, P473; Iriarte J, 2003, J CLIN NEUROPHYSIOL, V20, P249, DOI 10.1097/00004691-200307000-00004; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1111/j.1469-8986.2003.00141.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Makeig S., 1996, ADV NEURAL INFORM PR, V8; VERLEGER R, 1991, ELECTROEN CLIN NEURO, V78, P240, DOI 10.1016/0013-4694(91)90039-7; Zhou WD, 2005, EPILEPSIA, V46, P409, DOI 10.1111/j.0013-9580.2005.50704.x	28	177	177	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3004	10.1371/journal.pone.0003004	http://dx.doi.org/10.1371/journal.pone.0003004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714341	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900029
J	Linsel-Nitschke, P; Gotz, A; Erdmann, J; Braenne, I; Braund, P; Hengstenberg, C; Stark, K; Fischer, M; Schreiber, S; El Mokhtari, NE; Schaefer, A; Schrezenmeier, J; Rubin, D; Hinney, A; Reinehr, T; Roth, C; Ortlepp, J; Hanrath, P; Hall, AS; Mangino, M; Lieb, W; Lamina, C; Heid, IM; Doering, A; Gieger, C; Peters, A; Meitinger, T; Wichmann, HE; Konig, IR; Ziegler, A; Kronenberg, F; Samani, NJ; Schunkert, H				Linsel-Nitschke, Patrick; Goetz, Anika; Erdmann, Jeanette; Braenne, Ingrid; Braund, Peter; Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus; Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne; Schrezenmeier, Juergen; Rubin, Diana; Hinney, Anke; Reinehr, Thomas; Roth, Christian; Ortlepp, Jan; Hanrath, Peter; Hall, Alistair S.; Mangino, Massimo; Lieb, Wolfgang; Lamina, Claudia; Heid, Iris M.; Doering, Angela; Gieger, Christian; Peters, Annette; Meitinger, Thomas; Wichmann, H. -Erich; Koenig, Inke R.; Ziegler, Andreas; Kronenberg, Florian; Samani, Nilesh J.; Schunkert, Heribert		WTCCC; Cardiogenics Consortium	Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease-A Mendelian Randomisation Study	PLOS ONE			English	Article							ASSOCIATION; POLYMORPHISM; HYPERCHOLESTEROLEMIA; METAANALYSIS; PREVALENCE; PHENOTYPE; THERAPY; EVENTS	Background: Rare mutations of the low-density lipoprotein receptor gene (LDLR) cause familial hypercholesterolemia, which increases the risk for coronary artery disease (CAD). Less is known about the implications of common genetic variation in the LDLR gene regarding the variability of cholesterol levels and risk of CAD. Methods: Imputed genotype data at the LDLR locus on 1 644 individuals of a population-based sample were explored for association with LDL-C level. Replication of association with LDL-C level was sought for the most significant single nucleotide polymorphism (SNP) within the LDLR gene in three European samples comprising 6 642 adults and 533 children. Association of this SNP with CAD was examined in six case-control studies involving more than 15 000 individuals. Findings: Each copy of the minor T allele of SNP rs2228671 within LDLR (frequency 11%) was related to a decrease of LDL-C levels by 0.19 mmol/L (95% confidence interval (CI) [0.13-0.24] mmol/L, p = 1.5x10(-10)). This association with LDL-C was uniformly found in children, men, and women of all samples studied. In parallel, the T allele of rs2228671 was associated with a significantly lower risk of CAD (Odds Ratio per copy of the T allele: 0.82, 95% CI [0.76-0.89], p = 2.1x10(-7)). Adjustment for LDL-C levels by logistic regression or Mendelian Randomisation models abolished the significant association between rs2228671 with CAD completely, indicating a functional link between the genetic variant at the LDLR gene locus, change in LDL-C and risk of CAD. Conclusion: A common variant at the LDLR gene locus affects LDL-C levels and, thereby, the risk for CAD.	[Linsel-Nitschke, Patrick; Goetz, Anika; Erdmann, Jeanette; Braenne, Ingrid; Lieb, Wolfgang; Schunkert, Heribert] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Goetz, Anika; Koenig, Inke R.; Ziegler, Andreas] Univ Lubeck, Inst Med Biometr & Stat, D-2400 Lubeck, Germany; [Braund, Peter; Mangino, Massimo; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE1 7RH, Leics, England; [Hengstenberg, Christian; Stark, Klaus; Fischer, Marcus] Univ Regensburg, Klin & Poliklin Innere Med II, D-8400 Regensburg, Germany; [Schreiber, Stefan; El Mokhtari, Nour Eddine; Schaefer, Arne] Univ Kiel, Inst Klin Molekularbiol, D-24098 Kiel, Germany; [Schrezenmeier, Juergen; Rubin, Diana] Inst Physiol Biochem Ernahrung, Bundesforschungsanstalt Ernahrung Lebensmittel, Kiel, Germany; [Hinney, Anke] Univ Duisburg Essen, Jugendalters, Rheinische Klin Essen, Klin Psychiat Psychotherap Kindes, D-4100 Essen, Germany; [Reinehr, Thomas] Univ Witten Herdecke, Vestische Kinder Jugendklinik, Witten, Germany; [Roth, Christian] Univ Bonn, Zentrum Kinderheilkunde, D-5300 Bonn, Germany; [Roth, Christian] Univ Washington, Childrens Hosp, Regional Med Ctr, Seattle, WA 98195 USA; [Ortlepp, Jan; Hanrath, Peter] Rheinisch Westfalische Tech Hsch, Klin Innere Med, Aachen, Germany; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet & Therapeut, C NET Group, Leeds LS2 9JT, W Yorkshire, England; [Lamina, Claudia; Heid, Iris M.; Doering, Angela; Gieger, Christian; Peters, Annette; Wichmann, H. -Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Kronenberg, Florian] Med Univ Innsbruck, Dept Med Genet, Mol & Clin Pharmacol, Innsbruck, Austria; [Meitinger, Thomas] Tech Univ Munich, Inst Humangenet, D-8000 Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Lubeck; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Regensburg; University of Kiel; University of Duisburg Essen; Witten Herdecke University; University of Bonn; Seattle Children's Hospital; University of Washington; University of Washington Seattle; RWTH Aachen University; University of Leeds; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Innsbruck; Technical University of Munich	Linsel-Nitschke, P (corresponding author), Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany.	heribert.schunkert@innere2.uni-luebeck.de	Hall, Alistair/K-1953-2019; Lieb, Wolfgang/AAC-7650-2022; Hinney, Anke/D-6953-2011; Meitinger, Thomas/O-1318-2015; Lamina, Claudia/F-7608-2010; Erdmann, Jeanette/P-7513-2014; Peters, Annette/A-6117-2011; Stark, Klaus/D-3813-2009; Wichmann, Heinz Erich/AAA-5695-2022; Kronenberg, Florian/B-1736-2008; Hengstenberg, Christian/U-5485-2019; Erdmann, Jeanette/A-4417-2009; König, Inke R/A-4544-2009; Stark, Klaus/L-7367-2013; Mangino, Massimo/F-5134-2011; Ziegler, Andreas/G-4246-2012	Hinney, Anke/0000-0001-5659-0706; Lamina, Claudia/0000-0002-5398-5806; Erdmann, Jeanette/0000-0002-4486-6231; Peters, Annette/0000-0001-6645-0985; Stark, Klaus/0000-0002-7832-1942; Kronenberg, Florian/0000-0003-2229-1120; König, Inke R/0000-0003-0504-6465; Stark, Klaus/0000-0002-7832-1942; Mangino, Massimo/0000-0002-2167-7470; Ziegler, Andreas/0000-0002-8386-5397; Meitinger, Thomas/0000-0002-8838-8403; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X; Schaefer, Arne/0000-0001-5816-6765; Gieger, Christian/0000-0001-6986-9554	European Union [LSHM-CT 2006-037593, LSHMCT-2003-503041]; National Genome Network [01GS0418, 01GR0466, 01GS0482]; National Genome Network Plus; German Federal Ministry of Education and Research (BMBF) [01GS0820]; British Heart Foundation; UK Medical Research Council; Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany; Munich Center of Health Sciences; Bonfor Research Foundation, University of Bonn, Germany	European Union(European Commission); National Genome Network; National Genome Network Plus; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany; Munich Center of Health Sciences; Bonfor Research Foundation, University of Bonn, Germany	This study was funded by the European Union sponsored projects Cardiogenics (LSHM-CT 2006-037593) and Diabesity (LSHMCT-2003-503041), by the National Genome Network (01GS0418 to Drs Schunkert, Erdmann, and Hengstenberg; 01GR0466 to Dr. Ziegler; 01GS0482 to Dr. Hinney) and by the National Genome Network Plus to Dr. Hinney (01GS0820) sponsored by the German Federal Ministry of Education and Research (BMBF). Recruitment for the WTCCC Study CAD collection was funded by grants from the British Heart Foundation and the UK Medical Research Council. The MONICA/KORA Augsburg studies were financed by the Helmhotz Zentrum Munchen (former GSF)-National Research Center for Environmental Health, Neuherberg, Germany and supported by grants from the BMBF and Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. Recruitment of the Bonn Childhood Obesity Cohort was funded by the Bonfor Research Foundation, University of Bonn, Germany. This work was also supported by the "Genomics of Lipid-associated Disorders GOLD" of the "Austrian Genome Research Programme GEN-AU" (to F.K.).	[Anonymous], 2002, LANCET, V360, P7; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Baessler A, 2005, INT J CARDIOL, V101, P293, DOI 10.1016/j.ijcard.2004.03.053; Bagos PG, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1281; Bauerfeind A, 2006, HUM HERED, V61, P123, DOI 10.1159/000093773; Bautista LE, 2006, ANN EPIDEMIOL, V16, P675, DOI 10.1016/j.annepidem.2006.02.001; BENN M, 2007, J CLIN ENDOCRINOL ME; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Costanza MC, 2005, AM J EPIDEMIOL, V161, P714, DOI 10.1093/aje/kwi103; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; KATHIRESAN S, 2008, NAT GENET; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lewis SJ, 1998, J AM COLL CARDIOL, V32, P140, DOI 10.1016/S0735-1097(98)00202-2; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Meisinger C, 2004, DIABETES CARE, V27, P2985, DOI 10.2337/diacare.27.12.2985; Minelli C, 2005, INT J EPIDEMIOL, V34, P1319, DOI 10.1093/ije/dyi169; Ortlepp JR, 2003, EUR J CLIN INVEST, V33, P106, DOI 10.1046/j.1365-2362.2003.01124.x; Reinehr T, 2007, J PEDIATR-US, V150, P618, DOI 10.1016/j.jpeds.2007.01.042; Rubin D, 2006, J HUM GENET, V51, P567, DOI 10.1007/s10038-006-0400-y; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; SCHUNKERT H, 2008, CIRCULATION IN PRESS; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Thomas DC, 2004, INT J EPIDEMIOL, V33, P21, DOI 10.1093/ije/dyh048; THOMAS DC, 2007, ANN EPIDEMIOLOGY; Tybjaerg-Hansen A, 1998, NEW ENGL J MED, V338, P1577, DOI 10.1056/NEJM199805283382203; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; WILLER CJ, 2008, NAT GENET; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124; ZIEGLER A, 2008, STAT MED, DOI DOI 10.1002/SIM.3034; METABOLIC MOL BASES	42	125	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2986	10.1371/journal.pone.0002986	http://dx.doi.org/10.1371/journal.pone.0002986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714375	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900012
J	Penteriani, V; Delgado, MD				Penteriani, Vincenzo; del Mar Delgado, Maria			Owls May Use Faeces and Prey Feathers to Signal Current Reproduction	PLOS ONE			English	Article							SCENT-MARKING; VOCAL DISPLAYS; VISUAL CUES; BEHAVIOR; DEFENSE; BADGE; NESTS	Background: Many animals communicate by marking focal elements of their home range with different kinds of materials. Visual signaling has been demonstrated to play a previously unrecognized role in the intraspecific communication of eagle owls (Bubo bubo), in both territorial and parent-offspring contexts. Visual signals may play a role in a variety of circumstances in this crepuscular and nocturnal species. Methodology/ Principal Findings: Here, we report that a large amount of extremely visible white faeces and prey feathers appear during the breeding season on posts and plucking sites in proximity to the nest, potentially representing a way for eagle owls to mark their territory. We present descriptive and experimental evidence showing that faeces and prey remains could act as previously unrecognized visual signals in a nocturnal avian predator. This novel signaling behavior could indicate the owls' current reproductive status to potential intruders, such as other territorial owls or non-breeding floaters. Faeces and prey feather markings may also advertise an owl's reproductive status or function in mate-mate communication. Conclusions/Significance: We speculate that faeces marks and plucking may represent an overlooked but widespread method for communicating current reproduction to conspecifics. Such marking behavior may be common in birds, and we may now be exploring other questions and mechanisms in territoriality.	[Penteriani, Vincenzo; del Mar Delgado, Maria] CSIC, Dept Conservat Biol, Estac Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Penteriani, V (corresponding author), CSIC, Dept Conservat Biol, Estac Biol Donana, E-41080 Seville, Spain.	penteriani@ebd.csic.es		Delgado, Maria del Mar/0000-0002-3009-738X	Spanish Ministry of Education and Science [CGL2004-02780/BOS]; LICOR43; Junta de Andalucia (Consejeria de Educacion y Ciencia); Junta de Andalucia Consejeria de Medio Ambiente [SCFFS-AFR/GGG RS-260/02, SCFFS-AFR/CMM RS-1904/02]	Spanish Ministry of Education and Science(Spanish Government); LICOR43; Junta de Andalucia (Consejeria de Educacion y Ciencia)(Junta de Andalucia); Junta de Andalucia Consejeria de Medio Ambiente(Junta de Andalucia)	Funding for this study was provided by research project No. CGL2004-02780/BOS of the Spanish Ministry of Education and Science and LICOR43 (Diego Zamora S.A.). During this work, M.M. Delgado was supported by a doctoral grant from the Junta de Andalucia (Consejeria de Educacion y Ciencia). We manipulated and marked owls under Junta de Andalucia Consejeria de Medio Ambiente permits No. SCFFS-AFR/GGG RS-260/02 and SCFFS-AFR/CMM RS-1904/02.	ALBERTS AC, 1992, AM NAT, V139, pS62, DOI 10.1086/285305; Bradbury Jack W., 1998, pi; Brashares JS, 1999, ANIM BEHAV, V57, P11, DOI 10.1006/anbe.1998.0942; Bravery BD, 2006, J AVIAN BIOL, V37, P77; Brouwer L, 2004, ANIM BEHAV, V67, P539, DOI 10.1016/j.anbehav.2003.07.005; Brown RE., 1985, SOCIAL ODOURS MAMMAL; Chou IC, 2005, ANIM BEHAV, V69, P1055, DOI 10.1016/j.anbehav.2004.09.010; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Gese EM, 1997, ANIM BEHAV, V54, P1155, DOI 10.1006/anbe.1997.0561; GOSLING LM, 1982, Z TIERPSYCHOL, V60, P89; GOSLING LM, 1981, Z TIERPSYCHOL, V56, P305; Gosling LM, 2001, ADV STUD BEHAV, V30, P169, DOI 10.1016/S0065-3454(01)80007-3; Gwinner H, 1997, BEHAVIOUR, V134, P337, DOI 10.1163/156853997X00575; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Lewis RJ, 2006, AM J PRIMATOL, V68, P622, DOI 10.1002/ajp.20256; Newton I., 1979, POPULATION ECOLOGY R; Ostlund-Nilsson S, 2003, BEHAV ECOL SOCIOBIOL, V53, P214, DOI 10.1007/s00265-002-0574-z; OVASKA K, 1992, ANIM BEHAV, V43, P931, DOI 10.1016/0003-3472(92)90006-U; Penteriani V, 2003, IBIS, V145, pE127, DOI 10.1046/j.1474-919X.2003.00173.x; Penteriani V, 2002, ETHOL ECOL EVOL, V14, P275; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2005, J FIELD ORNITHOL, V76, P237, DOI 10.1648/0273-8570-76.3.237; Penteriani V, 2007, ETHOLOGY, V113, P934, DOI 10.1111/j.1439-0310.2007.01414.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; PIGOZZI G, 1990, ANIM BEHAV, V39, P1000, DOI 10.1016/S0003-3472(05)80972-8; ROBERT SC, 1977, J ZOOL LOND, V243, P565; SMITH JLD, 1989, ANIM BEHAV, V37, P1; Soler M, 1996, ANIM BEHAV, V51, P247, DOI 10.1006/anbe.1996.0025; Veiga JP, 2005, BIOL LETT-UK, V1, P334, DOI 10.1098/rsbl.2005.0329; Wronski T, 2006, BEHAV ECOL SOCIOBIOL, V60, P368, DOI 10.1007/s00265-006-0174-4	32	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3014	10.1371/journal.pone.0003014	http://dx.doi.org/10.1371/journal.pone.0003014			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714382	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900039
J	Cladel, NM; Hu, JF; Balogh, KK; Christensen, ND				Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.			CRPV Genomes with Synonymous Codon Optimizations in the CRPV E7 Gene Show Phenotypic Differences in Growth and Altered Immunity upon E7 Vaccination	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; MESSENGER-RNA STABILITY; PROTEIN EXPRESSION; COTTONTAIL RABBIT; IN-VITRO; PROTECTIVE IMMUNITY; DNA VACCINATION; MUTATIONS; USAGE; BIAS	Papillomaviruses use rare codons relative to their hosts. Recent studies have demonstrated that synonymous codon changes in viral genes can lead to increased protein production when the codons are matched to those of cells in which the protein is being expressed. We theorized that the immunogenicity of the virus would be enhanced by matching codons of selected viral genes to those of the host. We report here that synonymous codon changes in the E7 oncogene are tolerated in the context of the cottontail rabbit papillomavirus (CRPV) genome. Papilloma growth rates differ depending upon the changes made indicating that synonymous codons are not necessarily neutral. Immunization with wild type E7 DNA yielded significant protection from subsequent challenge by both wild type and codon-modified genomes. The reduction in growth was most dramatic with the genome containing the greatest number of synonymous codon changes.	[Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.] Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA; [Cladel, Nancy M.; Hu, Jiafen; Balogh, Karla K.; Christensen, Neil D.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Christensen, Neil D.] Penn State Univ, Coll Med, Dept Microbiol & Immunol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cladel, NM (corresponding author), Penn State Univ, Coll Med, Jake Gittlen Canc Res Fdn, Hershey, PA 17033 USA.	ndc1@psu.edu			NCI [CA47622]; National Institutes of Health; Jake Gittlen Memorial Golf Tournament; NATIONAL CANCER INSTITUTE [R01CA047622] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jake Gittlen Memorial Golf Tournament; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA47622 from the National Institutes of Health, and the Jake Gittlen Memorial Golf Tournament.	Alunni-Fabbroni M, 2000, ONCOGENE, V19, P2277, DOI 10.1038/sj.onc.1203570; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Carlini DB, 2004, J EVOLUTION BIOL, V17, P779, DOI 10.1111/j.1420-9101.2004.00725.x; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; CHEN L, 1999, P NATL ACAD SCI USA, V88, P110; Cid-Arregui A, 2003, J VIROL, V77, P4928, DOI 10.1128/JVI.77.8.4928-4937.2003; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Duan JB, 2003, J MOL EVOL, V57, P694, DOI 10.1007/s00239-003-2519-1; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Embers ME, 2002, J VIROL, V76, P9798, DOI 10.1128/JVI.76.19.9798-9805.2002; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Gao F, 2003, AIDS RES HUM RETROV, V19, P817, DOI 10.1089/088922203769232610; Gu WY, 2007, NUCLEIC ACIDS RES, V35, P4820, DOI 10.1093/nar/gkm496; Gu WY, 2004, NUCLEIC ACIDS RES, V32, P4448, DOI 10.1093/nar/gkh748; Hallez S, 2004, CANCER IMMUNOL IMMUN, V53, P642, DOI 10.1007/s00262-004-0501-4; Han R, 2000, J VIROL, V74, P9712, DOI 10.1128/JVI.74.20.9712-9716.2000; Han RC, 1999, J VIROL, V73, P7039, DOI 10.1128/JVI.73.8.7039-7043.1999; Hu JF, 2002, J VIROL, V76, P6453, DOI 10.1128/JVI.76.13.6453-6459.2002; Hu JF, 2007, VIROLOGY, V358, P384, DOI 10.1016/j.virol.2006.08.045; Hu JF, 2006, J IMMUNOL, V177, P8037, DOI 10.4049/jimmunol.177.11.8037; Kim TG, 2004, IMMUNOLOGY, V112, P117, DOI 10.1111/j.1365-2567.2004.01851.x; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Leachman SA, 2002, J VIROL, V76, P7616, DOI 10.1128/JVI.76.15.7616-7624.2002; Lemm I, 2002, MOL CELL BIOL, V22, P3959, DOI 10.1128/MCB.22.12.3959-3969.2002; Liu WJ, 2002, VIROLOGY, V301, P43, DOI 10.1006/viro.2002.1584; Mossadegh N, 2004, VIROLOGY, V326, P57, DOI 10.1016/j.virol.2004.04.050; Mueller S, 2006, J VIROL, V80, P9687, DOI 10.1128/JVI.00738-06; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Parmley JL, 2007, BIOESSAYS, V29, P515, DOI 10.1002/bies.20592; Samorski R, 2006, IMMUNOL LETT, V107, P41, DOI 10.1016/j.imlet.2006.07.003; Sauna ZE, 2007, PHARMACOGENOMICS, V8, P527, DOI 10.2217/14622416.8.6.527; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Zhao KN, 2005, MOL CELL BIOL, V25, P8643, DOI 10.1128/MCB.25.19.8643-8655.2005; Zhao KN, 2003, VIRUS RES, V98, P95, DOI 10.1016/j.virusres.2003.08.019; Zhou J, 1999, J VIROL, V73, P4972, DOI 10.1128/JVI.73.6.4972-4982.1999	43	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2947	10.1371/journal.pone.0002947	http://dx.doi.org/10.1371/journal.pone.0002947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698362	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600033
J	Felicisimo, AM; Munoz, J; Gonzalez-Solis, J				Felicisimo, Angel M.; Munoz, Jesus; Gonzalez-Solis, Jacob			Ocean Surface Winds Drive Dynamics of Transoceanic Aerial Movements	PLOS ONE			English	Article								Global wind patterns influence dispersal and migration processes of aerial organisms, propagules and particles, which ultimately could determine the dynamics of colonizations, invasions or spread of pathogens. However, studying how wind-mediated movements actually happen has been hampered so far by the lack of high resolution global wind data as well as the impossibility to track aerial movements. Using concurrent data on winds and actual pathways of a tracked seabird, here we show that oceanic winds define spatiotemporal pathways and barriers for large-scale aerial movements. We obtained wind data from NASA SeaWinds scatterometer to calculate wind cost ( impedance) models reflecting the resistance to the aerial movement near the ocean surface. We also tracked the movements of a model organism, the Cory's shearwater (Calonectris diomedea), a pelagic bird known to perform long distance migrations. Cost models revealed that distant areas can be connected through "wind highways'' that do not match the shortest great circle routes. Bird routes closely followed the low-cost "wind-highways'' linking breeding and wintering areas. In addition, we found that a potential barrier, the near surface westerlies in the Atlantic sector of the Intertropical Convergence Zone (ITCZ), temporally hindered meridional trans-equatorial movements. Once the westerlies vanished, birds crossed the ITCZ to their winter quarters. This study provides a novel approach to investigate wind-mediated movements in oceanic environments and shows that large-scale migration and dispersal processes over the oceans can be largely driven by spatiotemporal wind patterns.	[Felicisimo, Angel M.] Univ Extremadura, Escuela Politecn, Caceres, Spain; [Munoz, Jesus] Real Jardin Botanico CSIC, Madrid, Spain; [Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Anim Vertebrats, Barcelona, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; University of Barcelona	Felicisimo, AM (corresponding author), Univ Extremadura, Escuela Politecn, Caceres, Spain.	jmunoz@rjb.csic.es	Felicisimo, Angel/B-4138-2008; Munoz, Jesus/B-7809-2008; Gonzalez-Solis, Jacob/C-3942-2008; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/AAZ-5338-2021	Felicisimo, Angel/0000-0002-9953-8614; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Munoz, Jesus/0000-0002-9266-2268	Spanish Ministry of Education and Research [BOS2003-01960, CGL2006-01315/BOS, CGL2007-60247/BOS]; Fundacion Banco Bilbao Vizcaya Argentaria; Generalitat de Catalunya [2005-SGR00744-GEN.CATA]	Spanish Ministry of Education and Research(Spanish Government); Fundacion Banco Bilbao Vizcaya Argentaria; Generalitat de Catalunya(Generalitat de Catalunya)	This work was funded by the Spanish Ministry of Education and Research grants BOS2003-01960 and CGL2006-01315/BOS (JG-S), CGL2007-60247/BOS (AMF), the Fundacion Banco Bilbao Vizcaya Argentaria (AMF, JM, JG-S), and the 2005-SGR00744-GEN.CATA grant from the Generalitat de Catalunya (JG-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyev Vsevolod, 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P227; Alerstam T, 1990, BIRD MIGRATION; Bacles CFE, 2006, SCIENCE, V311, P628, DOI 10.1126/science.1121543; BROOKE M, 1990, MANX SHEARWATER; Gauthreaux Sidney A. Jr, 2005, P182; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Greene DF, 2008, ECOLOGY, V89, P118, DOI 10.1890/06-0781.1; Gregory PH, 1973, MICROBIOLOGY ATMOSPH; Grodsky SA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017867; Grodsky SA, 2003, J CLIMATE, V16, P723, DOI 10.1175/1520-0442(2003)016<0723:TICZIT>2.0.CO;2; Grodsky SA, 2001, GEOPHYS RES LETT, V28, P1503, DOI 10.1029/2000GL012601; Igual JM, 2005, MAR BIOL, V146, P619, DOI 10.1007/s00227-004-1461-0; Jenni L, 2003, AVIAN MIGRATION, P155; *JET PROP LAB, 2006, QUIKSCAT SCI DAT PRO; Jet Propulsion Laboratory, 2001, SEAWINDS QUIKSCAT LE; Kellogg CA, 2006, TRENDS ECOL EVOL, V21, P638, DOI 10.1016/j.tree.2006.07.004; Levin DA, 2006, SYST BOT, V31, P443, DOI 10.1600/036364406778388692; Liechti F, 2006, J ORNITHOL, V147, P202, DOI 10.1007/s10336-006-0061-9; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Munoz J, 2004, SCIENCE, V304, P1144, DOI 10.1126/science.1095210; Murray MD, 2003, EMU, V103, P111, DOI 10.1071/MU01068; Murray MD, 2003, EMU, V103, P59, DOI 10.1071/MU01011; Murray MD, 2002, EMU, V102, P377, DOI 10.1071/MU01010; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nicholls DG, 1997, EMU, V97, P240; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Reinke K, 1998, AUST J ZOOL, V46, P171, DOI 10.1071/ZO97046; Ritchie SA, 2001, EMERG INFECT DIS, V7, P900; Schaub M, 2004, ANIM BEHAV, V67, P229, DOI 10.1016/j.anbehav.2003.03.011; Serventy D. L., 1954, Proceedings 7th Pacific Science Congress, V4, P394; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Weber TP, 2000, J THEOR BIOL, V205, P95, DOI 10.1006/jtbi.2000.2047; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241	34	106	111	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2928	10.1371/journal.pone.0002928	http://dx.doi.org/10.1371/journal.pone.0002928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698354	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600014
J	Finer, M; Jenkins, CN; Pimm, SL; Keane, B; Ross, C				Finer, Matt; Jenkins, Clinton N.; Pimm, Stuart L.; Keane, Brian; Ross, Carl			Oil and Gas Projects in the Western Amazon: Threats to Wilderness, Biodiversity, and Indigenous Peoples	PLOS ONE			English	Article							RAIN-FOREST; DEFORESTATION; CONSERVATION; ECUADOR; FATE	Background: The western Amazon is the most biologically rich part of the Amazon basin and is home to a great diversity of indigenous ethnic groups, including some of the world's last uncontacted peoples living in voluntary isolation. Unlike the eastern Brazilian Amazon, it is still a largely intact ecosystem. Underlying this landscape are large reserves of oil and gas, many yet untapped. The growing global demand is leading to unprecedented exploration and development in the region. Methodology/Principal Findings: We synthesized information from government sources to quantify the status of oil development in the western Amazon. National governments delimit specific geographic areas or "blocks'' that are zoned for hydrocarbon activities, which they may lease to state and multinational energy companies for exploration and production. About 180 oil and gas blocks now cover, 688,000 km(2) of the western Amazon. These blocks overlap the most species-rich part of the Amazon. We also found that many of the blocks overlap indigenous territories, both titled lands and areas utilized by peoples in voluntary isolation. In Ecuador and Peru, oil and gas blocks now cover more than two-thirds of the Amazon. In Bolivia and western Brazil, major exploration activities are set to increase rapidly. Conclusions/Significance: Without improved policies, the increasing scope and magnitude of planned extraction means that environmental and social impacts are likely to intensify. We review the most pressing oil- and gas-related conservation policy issues confronting the region. These include the need for regional Strategic Environmental Impact Assessments and the adoption of roadless extraction techniques. We also consider the conflicts where the blocks overlap indigenous peoples' territories.	[Finer, Matt; Ross, Carl] Save Amer Forests, Washington, DC USA; [Jenkins, Clinton N.; Pimm, Stuart L.] Duke Univ, Nicholas Sch Environm, Durham, NC USA; [Keane, Brian] Land Is Life, Somerville, MA USA	Duke University	Finer, M (corresponding author), Save Amer Forests, Washington, DC USA.	matt@saveamericasforests.org	Jenkins, Clinton/D-6134-2011; pimm, stuart/ABF-1082-2020	Jenkins, Clinton/0000-0003-2198-0637; 	Forrest C. and Frances H. Lattner Foundation Inc	Forrest C. and Frances H. Lattner Foundation Inc	This work was supported by the Forrest C. and Frances H. Lattner Foundation Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIDESEP, 2006, RES SEG CONS COORD A; [Anonymous], 2008, LOS ANGELES TIMES; BAKER DR, 2008, CHEVRON COULD LOSE B; BALBI NCL, 2007, SUPERPOSICION IRREGU; BALBIN CG, 2006, REGIMEN ESPECIAL TRA; BARDALES E, 2008, RESERVAS PROBABLES I; Bilsborrow Richard E., 2004, Acta Amaz., V34, P635, DOI 10.1590/S0044-59672004000400015; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; *COM, 2007, LIO OP SIG BLOQ; *CONAIE, 2008, 3 C NAC PUEBL EC; Dew JL, 2003, AM J PHYS ANTHROPOL, P89; *EARTHRIGHTS INT R, 2007, LEG HARM OCC PETR IN; *EL COM, 2008, MIN INV DERR CRUD OR; *EN INF ADM, 2008, COUNT AN BRIEFS AC; ERWIN TL, 2004, P CALIF ACAD SCI, V0056, P00072; FORERO J, 2004, SAFEGUARDING COLOMBI; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Greenberg JA, 2005, REMOTE SENS ENVIRON, V96, P202, DOI 10.1016/j.rse.2005.02.010; GRIFFITHS T, 2007, EXIGIENDO RESPONSABI; *GRUP INT TRAB AS, 2007, PUEBL IND AISL VOL C; HEARN K, 2008, PERUS INDIANS LAWSUI; HOY DR, 1963, GEOGR REV, V53, P580, DOI 10.2307/212387; *I BIEN COM, 2008, TITL NAT COMM EX PRO; *IUCN, GLOB AMPH ASS VERS 1; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; Kimerling J., 1991, AMAZON CRUDE; LARAZON, 2007, GOBIERNO REHACE PLAN; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Laurance WF, 2001, SCIENCE, V291, P438, DOI 10.1126/science.291.5503.438; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Napolitano DA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045005; Nunez-Iturri G, 2007, BIOTROPICA, V39, P348, DOI 10.1111/j.1744-7429.2007.00276.x; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Oliveira PJC, 2007, SCIENCE, V317, P1233, DOI 10.1126/science.1146324; Martinez M, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045006; Parker TA III, 1996, NEOTROPICAL BIRDS EC; PATTERSON BD, 2005, DIGITAL DISTRIBUTION; PERRAULT A, 2007, PARTNERSHIPS SUCCESS, V19, P475; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Ridgely R. S., 2005, DIGITAL DISTRIBUTION, V2.1; ROHTER L, 2007, VAST PIPELINES AMAZO; ROSENFELD AB, 2001, REINVENTING WELL APP; San Sebastian M, 2004, REV PANAM SALUD PUBL, V15, P205; Sawyer S., 2004, CRUDE CHRONICLES IND; Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; The Energy & Biodiversity Initiative, 2003, INT BIOD CONS OIL GA; Thomsen JB, 2001, FOOTPRINTS JUNGLE; Williams B, 1999, OIL GAS J, V97, P19; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x; WUNDER S, 2003, OIL WEALTH FATE FORE; Young B.E., 2004, DISAPPEARING JEWELS; 2002, DECISIONS MEETINGS C	56	313	322	2	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2932	10.1371/journal.pone.0002932	http://dx.doi.org/10.1371/journal.pone.0002932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18716679	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600018
J	Alirezaei, M; Kiosses, WB; Flynn, CT; Brady, NR; Fox, HS				Alirezaei, Mehrdad; Kiosses, William B.; Flynn, Claudia T.; Brady, Nathan R.; Fox, Howard S.			Disruption of Neuronal Autophagy by Infected Microglia Results in Neurodegeneration	PLOS ONE			English	Article								There is compelling evidence to support the idea that autophagy has a protective function in neurons and its disruption results in neurodegenerative disorders. Neuronal damage is well-documented in the brains of HIV-infected individuals, and evidence of inflammation, oxidative stress, damage to synaptic and dendritic structures, and neuronal loss are present in the brains of those with HIV-associated dementia. We investigated the role of autophagy in microglia-induced neurotoxicity in primary rodent neurons, primate and human models. We demonstrate here that products of simian immunodeficiency virus (SIV)-infected microglia inhibit neuronal autophagy, resulting in decreased neuronal survival. Quantitative analysis of autophagy vacuole numbers in rat primary neurons revealed a striking loss from the processes. Assessment of multiple biochemical markers of autophagic activity confirmed the inhibition of autophagy in neurons. Importantly, autophagy could be induced in neurons through rapamycin treatment, and such treatment conferred significant protection to neurons. Two major mediators of HIV-induced neurotoxicity, tumor necrosis factor-alpha and glutamate, had similar effects on reducing autophagy in neurons. The mRNA level of p62 was increased in the brain in SIV encephalitis and as well as in brains from individuals with HIV dementia, and abnormal neuronal p62 dot structures immunoreactivity was present and had a similar pattern with abnormal ubiquitinylated proteins. Taken together, these results identify that induction of deficits in autophagy is a significant mechanism for neurodegenerative processes that arise from glial, as opposed to neuronal, sources, and that the maintenance of autophagy may have a pivotal role in neuroprotection in the setting of HIV infection.	[Alirezaei, Mehrdad; Flynn, Claudia T.; Fox, Howard S.] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA USA; [Brady, Nathan R.] BIOQUANT, Deutsches Krebsforschungszentrum, Heidelberg, Germany	Scripps Research Institute; Scripps Research Institute; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Alirezaei, M (corresponding author), Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA.	hfox@unmc.edu	Brady, Nathan/H-2452-2013	Fox, Howard/0000-0003-2032-374X	NIH [F32 NS048767, DA024467, MH073490, MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545, P30MH062261, R01MH073490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS048767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH NRSA F32 NS048767 (to MA), and DA024467, MH073490 and MH062261 (to HSF).	Alirezaei M, 2007, J NEUROSCI, V27, P11047, DOI 10.1523/JNEUROSCI.2733-07.2007; Anderson E, 2002, JAIDS-J ACQ IMM DEF, V31, pS43, DOI 10.1097/00126334-200210012-00004; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland Barry, 2006, Molecular Aspects of Medicine, V27, P503, DOI 10.1016/j.mam.2006.08.009; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Gelman BB, 2004, J NEUROVIROL, V10, P98, DOI 10.1080/13550280490279816; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; GRAY F, 1991, ACTA NEUROPATHOL, V82, P229, DOI 10.1007/BF00294450; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; HANADA T, 2007, J BIOL CHEM; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ishii T, 1997, BIOCHEM BIOPH RES CO, V232, P33, DOI 10.1006/bbrc.1997.6221; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kuusisto E, 2001, BIOCHEM BIOPH RES CO, V280, P223, DOI 10.1006/bbrc.2000.4107; Lamark T, 2003, J BIOL CHEM, V278, P34568, DOI 10.1074/jbc.M303221200; LANE TE, 1995, VIROLOGY, V212, P458, DOI 10.1006/viro.1995.1503; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marcondes MCG, 2007, J IMMUNOL, V178, P5812, DOI 10.4049/jimmunol.178.9.5812; Marcondes MCG, 2001, J IMMUNOL, V167, P5429, DOI 10.4049/jimmunol.167.9.5429; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; MASLIAH E, 1992, ANN NEUROL, V32, P321, DOI 10.1002/ana.410320304; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; O'Donnell LA, 2006, J NEUROSCI, V26, P981, DOI 10.1523/JNEUROSCI.4617-05.2006; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Tan JM, 2007, AUTOPHAGY, V4; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang Y, 2007, J NEUROCHEM, V103, P439, DOI 10.1111/j.1471-4159.2007.04746.x; WATRY D, 1995, AM J PATHOL, V146, P914; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	55	119	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2906	10.1371/journal.pone.0002906	http://dx.doi.org/10.1371/journal.pone.0002906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682838	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600062
J	Atijosan, O; Rischewski, D; Simms, V; Kuper, H; Linganwa, B; Nuhi, A; Foster, A; Lavy, C				Atijosan, Oluwarantimi; Rischewski, Dorothea; Simms, Victoria; Kuper, Hannah; Linganwa, Bonaventure; Nuhi, Assuman; Foster, Allen; Lavy, Chris			A National Survey of Musculoskeletal Impairment in Rwanda: Prevalence, Causes and Service Implications	PLOS ONE			English	Article								Background: Accurate information on the prevalence and causes of musculoskeletal impairment (MSI) is lacking in low income countries. We present a new survey methodology that is based on sound epidemiological principles and is linked to the World Health Organisation's International Classification of Functioning. Methods: Clusters were selected with probability proportionate to size. Households were selected within clusters through compact segment sampling. 105 clusters of 80 people (all ages) were included. All participants were screened for MSI by a physiotherapist and medical assistant. Possible cases plus a random sample of 10% of non-MSI cases were examined further to ascertain diagnosis, aetiology, quality of life, and treatment needs. Findings: 6757 of 8368 enumerated individuals (80.8%) were screened. There were 352 cases, giving an overall prevalence for MSI of 5.2%. (95% CI 4.5-5.9) The prevalence of MSI increased with age and was similar in men and women. Extrapolating these estimates, there are approximately 488,000 MSI diagnoses in Rwanda. Only 8.2% of MSI cases were severe, while the majority were moderate (43.7%) or mild (46.3%). Diagnostic categories comprised 11.5% congenital, 31.3% trauma, 3.8% infection, 9.0% neurological, and 44.4% non-traumatic non infective acquired. The most common individual diagnoses were joint disease (13.3%), angular limb deformity (9.7%) and fracture mal- and non-union (7.2%). 96% of all cases required further treatment. Interpretation: This survey demonstrates a large burden of MSI in Rwanda, which is mostly untreated. The survey methodology will be useful in other low income countries, to assist with planning services and monitoring trends.	[Atijosan, Oluwarantimi; Rischewski, Dorothea; Simms, Victoria; Kuper, Hannah; Foster, Allen; Lavy, Chris] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Linganwa, Bonaventure; Nuhi, Assuman] CBMI, Kigali, Rwanda; [Lavy, Chris] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Atijosan, O (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	christopher.lavy@ndos.ox.ac.uk	Simms, Victoria/C-3278-2009; Simms, Victoria/AAU-4134-2021	Simms, Victoria/0000-0002-4897-458X; Foster, Allen/0000-0003-2368-4436	CBMI	CBMI	CBMI was the main funder of this study, but was not involved in the work or writing of the paper.	[Anonymous], 1999, PREJUDICE DIGNITY IN; Atijosan O, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-30; Biritwum R B, 2001, West Afr J Med, V20, P249; Chopra A, 2004, J RHEUMATOL, V31, P2320; DISLER PB, 1986, S AFR MED J, V69, P349; *GOV RWAND, 2003, 3 GEN CENS POP HOUS; McLaren P A, 1987, Int Rehabil Med, V8, P98; *MIN REH INT SOC H, 1995, EN NAT AMPL HAND RWA; MKANDAWIRE NC, 2004, E CENTRAL AFRICAN J, V2, P2; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Tamrat G, 2001, DISABIL REHABIL, V23, P799; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; *UN, 2008, HUM FUNCT DIS; WHO, 2001, WHO INT CLASS FUNCT; World Health Organisation, 2002, DIS REH FUT TRENDS C	15	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2851	10.1371/journal.pone.0002851	http://dx.doi.org/10.1371/journal.pone.0002851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682849	Green Published, Green Accepted, gold			2022-12-27	WOS:000264366600007
J	Gao, Z; Tseng, CH; Strober, BE; Pei, ZH; Blaser, MJ				Gao, Zhan; Tseng, Chi-hong; Strober, Bruce E.; Pei, Zhiheng; Blaser, Martin J.			Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions	PLOS ONE			English	Article							MOLECULAR ANALYSIS; HUMAN SKIN; MICROBIOTA; DIVERSITY; SEQUENCE; INFECTIONS; MICROFLORA; COMMENSAL; DISEASE; ARCHAEA	For psoriasis, an idiopathic inflammatory disorder of the skin, the microbial biota has not been defined using cultivation-independent methods. We used broad-range 16S rDNA PCR for archaea and bacteria to examine the microbiota of normal and psoriatic skin. From 6 patients, 19 cutaneous samples (13 from diseased skin and 6 from normal skin) were obtained. Extracted DNA was subjected to the broad range PCR, and 1,925 cloned products were compared with 2,038 products previously reported from healthy persons. Using 98% sequence identity as a species boundary, 1,841 (95.6%) clones were similar to known bacterial 16S rDNA, representing 6 phyla, 86 genera, or 189 species-level operational taxonomic unit (SLOTU); 84 (4.4%) clones with <98% identity probably represented novel species. The most abundant and diverse phylum populating the psoriatic lesions was Firmicutes (46.2%), significantly (P<0.001) overrepresented, compared to the samples from uninvolved skin of the patients (39.0%) and healthy persons (24.4%). In contrast, Actinobacteria, the most prevalent and diverse phylum in normal skin samples from both healthy persons (47.6%) and the patients (47.8%), was significantly (P<0.01) underrepresented in the psoriatic lesion samples (37.3%). Representation of Propionibacterium species were lower in the psoriatic lesions (2.9+/-5.5%) than from normal persons (21.1+/-18.2%; P<0.001), whereas normal skin from the psoriatic patients showed intermediate levels (12.3+/-21.6%). We conclude that psoriasis is associated with substantial alteration in the composition and representation of the cutaneous bacterial biota.	[Gao, Zhan; Tseng, Chi-hong; Pei, Zhiheng; Blaser, Martin J.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Tseng, Chi-hong] NYU, Sch Med, Dept Environm Med, New York, NY USA; [Strober, Bruce E.] NYU, Sch Med, Dept Dermatol, New York, NY USA; [Pei, Zhiheng] NYU, Sch Med, Dept Pathol, New York, NY USA; [Blaser, Martin J.] NYU, Sch Med, Dept Microbiol, New York, NY USA; [Pei, Zhiheng; Blaser, Martin J.] New York Harbor Vet Affairs Med Ctr, New York, NY USA	New York University; New York University; New York University; New York University; New York University	Gao, Z (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10016 USA.	Martin.blaser@med.nyu.edu	Strober, Bruce/AAQ-6953-2020	Strober, Bruce/0000-0002-8394-2057; Pei, Zhiheng/0000-0001-8570-6747	Ellison Medical Foundation [Senior Scholar Award]; Diane Belfer Program in Human Microbial Ecology in Health and Disease; NIH/NCRR [M01 RR00096];  [R01 GM63270];  [CA97946];  [AI063477]; NATIONAL CANCER INSTITUTE [R01CA097946] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Diane Belfer Program in Human Microbial Ecology in Health and Disease; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Senior Scholar Award from the Ellison Medical Foundation; by Diane Belfer Program in Human Microbial Ecology in Health and Disease; Grants R01 GM63270, CA97946, and AI063477; and by General Clinical Research Center Core Grant NIH/NCRR M01 RR00096 from the National Institutes of Health.	Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Blaser MJ, 2007, NATURE, V449, P843, DOI 10.1038/nature06198; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Davies CE, 2001, WOUND REPAIR REGEN, V9, P332, DOI 10.1046/j.1524-475x.2001.00332.x; Dekio I, 2005, J MED MICROBIOL, V54, P1231, DOI 10.1099/jmm.0.46075-0; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Eady E. A., 1994, Reviews in Medical Microbiology, V5, P163; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Fearon U, 2001, CLIN EXP DERMATOL, V26, P333, DOI 10.1046/j.1365-2230.2001.00792.x; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Ghoreschi K, 2007, CLIN DERMATOL, V25, P574, DOI 10.1016/j.clindermatol.2007.08.012; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kremers HM, 2007, J AM ACAD DERMATOL, V57, P347, DOI 10.1016/j.jaad.2007.02.007; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; Okubo Y, 2002, J DERMATOL, V29, P547, DOI 10.1111/j.1346-8138.2002.tb00179.x; Paulino LC, 2006, J CLIN MICROBIOL, V44, P2933, DOI 10.1128/JCM.00785-06; Pavoine S, 2004, J THEOR BIOL, V228, P523, DOI 10.1016/j.jtbi.2004.02.014; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Siqueira JF, 2005, J ENDODONT, V31, P719, DOI 10.1097/01.don.0000155224.00781.6c; Skov L, 2000, CLIN EXP DERMATOL, V25, P57; Talanin NY, 1997, ACTA DERM-VENEREOL, V77, P175; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Tomi NS, 2005, J AM ACAD DERMATOL, V53, P67, DOI 10.1016/j.jaad.2005.02.034; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; VALDIMARSSON H, 1995, IMMUNOL TODAY, V16, P145, DOI 10.1016/0167-5699(95)80132-4; Weisenseel P, 2005, ARCH DERMATOL RES, V296, P573, DOI 10.1007/s00403-005-0559-7	42	284	301	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2719	10.1371/journal.pone.0002719	http://dx.doi.org/10.1371/journal.pone.0002719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648509	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900006
J	Sevillano, D; Aguilar, L; Alou, L; Gimenez, MJ; Gonzalez, N; Torrico, M; Cafini, F; Fenoll, A; Coronel, P; Prieto, J				Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Fenoll, Asuncion; Coronel, Pilar; Prieto, Jose			High Protein Binding and Cidal Activity against Penicillin-Resistant S. pneumoniae: A Cefditoren In Vitro Pharmacodynamic Simulation	PLOS ONE			English	Article								Although protein binding is a reversible phenomenon, it is assumed that antibacterial activity is exclusively exerted by the free (unbound) fraction of antibiotics. Methodology/Principal Findings: Activity of cefditoren, a highly protein bound 3(rd) generation cephalosporin, over 24h after an oral 400 mg cefditoren-pivoxil bid regimen was studied against six S. pneumoniae strains (penicillin/cefditoren MICs; mu g/ml): S1 (0.12/0.25), S2 (0.25/0.25), S3 and S4 (0.5/0.5), S5 (1/0.5) and S6 (4/0.5). A computerized pharmacodynamic simulation with media consisting in 75% human serum and 25% broth (mean albumin concentrations = 4.85 +/- 60.12 g/dL) was performed. Protein binding was measured. The cumulative percentage of a 24h-period that drug concentrations exceeded the MIC for total (T>MIC) and unbound concentrations (fT>MIC), expressed as percentage of the dosing interval, were determined. Protein binding was 87.1%. Bactericidal activity (>= 99.9% initial inocula reduction) was obtained against strains S1 and S2 at 24h (T>MIC = 77.6%, fT>MIC = 23.7%). With T>MIC of 61.6% (fT>MIC = 1.7%), reductions against S3 and S4 ranged from 90% to 97% at 12h and 24h; against S5, reduction was 45.1% at 12h and up to 85.0% at 24h; and against S6, reduction was 91.8% at 12h, but due to regrowth of 52.9% at 24h. Cefditoren physiological concentrations exerted antibacterial activity against strains exhibiting MICs of 0.25 and 0.5 mu g/ml under protein binding conditions similar to those in humans. Conclusions/Significance: The results of this study suggest that, from the pharmacodynamic perspective, the presence of physiological albumin concentrations may not preclude antipneumococcal activity of highly bound cephalosporins as cefditoren.	[Sevillano, David; Aguilar, Lorenzo; Alou, Luis; Gimenez, Maria-Jose; Gonzalez, Natalia; Torrico, Martha; Cafini, Fabio; Prieto, Jose] Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain; [Fenoll, Asuncion] Inst Salud Carlos III, Spanish Natl Reference Pneumococcal Lab, Madrid, Spain; [Coronel, Pilar] Tedec Meiji Farma SA, Sci Dept, Madrid, Spain	Complutense University of Madrid; Instituto de Salud Carlos III	Sevillano, D (corresponding author), Univ Complutense, Dept Microbiol, Sch Med, E-28040 Madrid, Spain.	laguilar@med.ucm.es	Hidalgo, Natalia González/X-6840-2018; Sevillano, David/G-5661-2010; Prieto, José/G-5644-2010; Alou, Luis/B-8170-2011; Cafini, Fabio/AAA-7938-2020; Gimenez, Maria Jose/GXF-2237-2022	Hidalgo, Natalia González/0000-0002-6874-954X; Alou, Luis/0000-0002-0859-008X; Cafini, Fabio/0000-0002-5442-1674; Gimenez, Maria Jose/0000-0003-0830-4095; Sevillano Fernandez, David/0000-0003-0212-2194	Tedec-Meiji Farma S.A., Madrid, Spain	Tedec-Meiji Farma S.A., Madrid, Spain	This study was supported by an unrestricted grant from Tedec-Meiji Farma S.A., Madrid, Spain. The sponsor had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alou L, 2007, J ANTIMICROB CHEMOTH, V59, P652, DOI 10.1093/jac/dkm015; Alvarez-Sala JL, 2006, ANTIMICROB AGENTS CH, V50, P1762, DOI 10.1128/AAC.50.5.1762-1767.2006; Andrews J.M., 1999, CLIN ANTIMICROBIAL A, P35; AzoulayDupuis E, 1996, ANTIMICROB AGENTS CH, V40, P941, DOI 10.1128/AAC.40.4.941; Boswell FJ, 2002, J ANTIMICROB CHEMOTH, V50, P525, DOI 10.1093/jac/dkf155; Casal J, 2002, J ANTIMICROB CHEMOTH, V50, P83, DOI 10.1093/jac/dkf502; Casal J, 2002, ANTIMICROB AGENTS CH, V46, P1340, DOI 10.1128/AAC.46.5.1340-1344.2002; Cha R, 2004, J ANTIMICROB CHEMOTH, V54, P259, DOI 10.1093/jac/dkh259; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Clinical and Laboratory Standards Institute (CLSI), 2006, M7A5 CLSI; CRAIG W. A., 1991, ANTIBIOTICS LAB MED, P367, DOI Williams & Wilkins; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Fenoll A, 2007, J ANTIMICROB CHEMOTH, V60, P323, DOI 10.1093/jac/dkm209; Fenoll A, 2007, INT J ANTIMICROB AG, V29, P224, DOI 10.1016/j.ijantimicag.2006.08.046; Firsov AA, 2006, J ANTIMICROB CHEMOTH, V58, P1185, DOI 10.1093/jac/dkl387; Granizo JJ, 2008, INT J ANTIMICROB AG, V31, P396, DOI 10.1016/j.ijantimicag.2007.10.024; GRASSO S, 1978, ANTIMICROB AGENTS CH, V13, P570, DOI 10.1128/AAC.13.4.570; Granizo JJ, 2006, CLIN THER, V28, P2061, DOI 10.1016/j.clinthera.2006.12.010; MacGowan AP, 2004, ANTIMICROB AGENTS CH, V48, P2599, DOI 10.1128/AAC.48.7.2599-2603.2004; MOELLERING RC, 2005, MANDELL DOUGLAS BENN, P242; MULFORD D, 2000, 40 INT C ANT AG CHEM; PALMER SM, 1995, ANTIMICROB AGENTS CH, V39, P1764, DOI 10.1128/AAC.39.8.1764; Perez-Trallero E, 2007, CLIN MICROBIOL INFEC, V13, P937, DOI 10.1111/j.1469-0691.2007.01777.x; Sadaba B, 2007, REV ESP QUIM, V20, P51; Sevillano D, 2007, J ANTIMICROB CHEMOTH, V60, P156, DOI 10.1093/jac/dkm115; Sevillano D, 2004, J ANTIMICROB CHEMOTH, V54, P1148, DOI 10.1093/jac/dkh463; Wellington K, 2004, DRUGS, V64, P2597, DOI 10.2165/00003495-200464220-00009	28	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2717	10.1371/journal.pone.0002717	http://dx.doi.org/10.1371/journal.pone.0002717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648650	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900004
J	Pantano, S; Zonta, F; Mammano, F				Pantano, Sergio; Zonta, Francesco; Mammano, Fabio			A Fully Atomistic Model of the Cx32 Connexon	PLOS ONE			English	Article								Connexins are plasma membrane proteins that associate in hexameric complexes to form channels named connexons. Two connexons in neighboring cells may dock to form a "gap junction'' channel, i.e. an intercellular conduit that permits the direct exchange of solutes between the cytoplasm of adjacent cells and thus mediate cell-cell ion and metabolic signaling. The lack of high resolution data for connexon structures has hampered so far the study of the structure-function relationships that link molecular effects of disease-causing mutations with their observed phenotypes. Here we present a combination of modeling techniques and molecular dynamics (MD) to infer side chain positions starting from low resolution structures containing only C alpha atoms. We validated this procedure on the structure of the KcsA potassium channel, which is solved at atomic resolution. We then produced a fully atomistic model of a homotypic Cx32 connexon starting from a published model of the C alpha carbons arrangement for the connexin transmembrane helices, to which we added extracellular and cytoplasmic loops. To achieve structural relaxation within a realistic environment, we used MD simulations inserted in an explicit solvent-membrane context and we subsequently checked predictions of putative side chain positions and interactions in the Cx32 connexon against a vast body of experimental reports. Our results provide new mechanistic insights into the effects of numerous spontaneous mutations and their implication in connexin-related pathologies. This model constitutes a step forward towards a structurally detailed description of the gap junction architecture and provides a structural platform to plan new biochemical and biophysical experiments aimed at elucidating the structure of connexin channels and hemichannels.	[Pantano, Sergio] Inst Pasteur Montevideo, Montevideo, Uruguay; [Pantano, Sergio; Zonta, Francesco; Mammano, Fabio] Venetian Inst Mol Med, Padua, Italy; [Pantano, Sergio; Zonta, Francesco; Mammano, Fabio] Consorzio Nazl Interuniver Sci Fisiche Materia, Rome, Italy; [Mammano, Fabio] Univ Padua, Dipartimento Fis, Padua, Italy	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Veneto Institute Molecular Medicine; University of Padua	Pantano, S (corresponding author), Inst Pasteur Montevideo, Montevideo, Uruguay.	spantano@pasteur.edu.uy; fabio.mammano@unipd.it	Zonta, Francesco/GXW-1979-2022; Mammano, Fabio/AAM-3902-2020; Mammano, Fabio/I-5064-2012	Zonta, Francesco/0000-0001-8729-1071; Mammano, Fabio/0000-0003-3751-1691; Mammano, Fabio/0000-0003-3751-1691; Pantano, Sergio/0000-0001-6435-4543	Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy [GGP05131]; European commission FP6 Integrated Project EuroHear [LSHG-CT-20054-512063]	Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy(Fondazione TelethonFondazione Cariparo); European commission FP6 Integrated Project EuroHear(European CommissionEuropean Commission Joint Research Centre)	This work has been funded by grants to F.M. from Fondazione Cariparo (Progetti di Eccellenza 2006), Telethon Italy (GGP05131) and the European commission FP6 Integrated Project EuroHear (LSHG-CT-20054-512063) under the Sixth Research Frame Program of The European Union. Computer simulations were performed at the CINECA supercomputer center thanks to computer-time grants from the Italian CNISM (Consorzio Nazionale Interuniversitario per le Scienze fisiche della Materia).	Abrams CK, 2001, BRAIN RES, V900, P9, DOI 10.1016/S0006-8993(00)03327-8; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Bicego M, 2006, NEUROBIOL DIS, V21, P607, DOI 10.1016/j.nbd.2005.09.005; Bicego M, 2006, HUM MOL GENET, V15, P2569, DOI 10.1093/hmg/ddl184; Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Carrasquillo MM, 1997, HUM MOL GENET, V6, P2163, DOI 10.1093/hmg/6.12.2163; CASCIO M, 1995, J BIOL CHEM, V270, P18643, DOI 10.1074/jbc.270.31.18643; CASE DA, 2004, AMBER 8 0; Chen YY, 2005, FASEB J, V19, P1516, DOI 10.1096/fj.04-3491fje; Common JEA, 2002, BIOCHEM BIOPH RES CO, V298, P651, DOI 10.1016/S0006-291X(02)02517-2; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eiberger J, 2001, CELL COMMUN ADHES, V8, P163, DOI 10.3109/15419060109080717; Faraldo-Gomez JD, 2004, PROTEINS, V57, P783, DOI 10.1002/prot.20257; Fleishman SJ, 2006, J BIOL CHEM, V281, P28958, DOI 10.1074/jbc.M605764200; Fleishman SJ, 2004, MOL CELL, V15, P879, DOI 10.1016/j.molcel.2004.08.016; Foote CI, 1998, J CELL BIOL, V140, P1187, DOI 10.1083/jcb.140.5.1187; Frei K, 2002, EUR J HUM GENET, V10, P427, DOI 10.1038/sj.ejhg.5200826; Gerido DA, 2004, BBA-BIOMEMBRANES, V1662, P159, DOI 10.1016/j.bbamem.2003.10.017; Gong XQ, 2001, CELL COMMUN ADHES, V8, P187, DOI 10.3109/15419060109080721; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Guidoni L, 1999, BIOCHEMISTRY-US, V38, P8599, DOI 10.1021/bi990540c; Harris AL, 2001, Q REV BIOPHYS, V34, P325, DOI 10.1017/S0033583501003705; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; Hernandez VH, 2007, NAT METHODS, V4, P353, DOI 10.1038/NMETH1031; HOROVITZ A, 1990, J MOL BIOL, V216, P1031, DOI 10.1016/S0022-2836(99)80018-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Janssen EAM, 1997, HUM GENET, V99, P501, DOI 10.1007/s004390050396; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kovacs JA, 2007, PROG BIOPHYS MOL BIO, V94, P15, DOI 10.1016/j.pbiomolbio.2007.03.013; Kronengold J, 2003, CELL COMMUN ADHES, V10, P193, DOI 10.1080/15419060390264325; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LEE SW, 1992, J CELL BIOL, V118, P1213, DOI 10.1083/jcb.118.5.1213; Locke D, 2005, BIOCHEMISTRY-US, V44, P13027, DOI 10.1021/bi050495a; MCGREGOR MJ, 1987, J MOL BIOL, V198, P295, DOI 10.1016/0022-2836(87)90314-7; MILKS LC, 1988, EMBO J, V7, P2967, DOI 10.1002/j.1460-2075.1988.tb03159.x; Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365; Murgia A, 1999, J MED GENET, V36, P829; Nelis E, 1999, HUM MUTAT, V13, P11, DOI 10.1002/(SICI)1098-1004(1999)13:1<11::AID-HUMU2>3.0.CO;2-A; Nelis E, 1997, HUM MUTAT, V9, P47, DOI 10.1002/(SICI)1098-1004(1997)9:1<47::AID-HUMU8>3.3.CO;2-N; Nunn RS, 2001, MICROSC RES TECHNIQ, V52, P344, DOI 10.1002/1097-0029(20010201)52:3<344::AID-JEMT1018>3.3.CO;2-W; Oh S, 1997, NEURON, V19, P927, DOI 10.1016/S0896-6273(00)80973-3; Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200; Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104; Palmada M, 2006, NEUROBIOL DIS, V22, P112, DOI 10.1016/j.nbd.2005.10.005; Pantano S, 2004, EUR BIOPHYS J BIOPHY, V33, P344, DOI 10.1007/s00249-003-0358-z; Pantano S, 2007, PROTEINS, V66, P930, DOI 10.1002/prot.21239; Park HJ, 2000, LARYNGOSCOPE, V110, P1535, DOI 10.1097/00005537-200009000-00023; Purnick PEM, 2000, ARCH BIOCHEM BIOPHYS, V381, P181, DOI 10.1006/abbi.2000.1989; Ressot C, 1996, HUM GENET, V98, P172, DOI 10.1007/s004390050183; Ressot C, 1998, J NEUROSCI, V18, P4063; Ri Y, 1999, BIOPHYS J, V76, P2887, DOI 10.1016/S0006-3495(99)77444-8; Richard G, 1998, NAT GENET, V20, P366, DOI 10.1038/3840; Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100; Rouger H, 1997, HUM MUTAT, V10, P443, DOI 10.1002/(SICI)1098-1004(1997)10:6<443::AID-HUMU5>3.3.CO;2-K; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALI A, 1995, CURR OPIN BIOTECH, V6, P437, DOI 10.1016/0958-1669(95)80074-3; Sansom MSP, 2005, BIOCHEM SOC T, V33, P916, DOI 10.1042/BST0330916; Silander K, 1997, HUM GENET, V100, P391, DOI 10.1007/s004390050522; Skerrett IM, 2002, J CELL BIOL, V159, P349, DOI 10.1083/jcb.200207060; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Tan CC, 1996, HUM MUTAT, V7, P167, DOI 10.1002/(SICI)1098-1004(1996)7:2<167::AID-HUMU14>3.3.CO;2-#; Thonnissen E, 2002, HUM GENET, V111, P190, DOI 10.1007/s00439-002-0750-2; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Yeager M, 1996, CURR OPIN STRUC BIOL, V6, P183, DOI 10.1016/S0959-440X(96)80073-X; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4	77	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2614	10.1371/journal.pone.0002614	http://dx.doi.org/10.1371/journal.pone.0002614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648547	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200063
J	Bill, BR; Balciunas, D; McCarra, JA; Young, ED; Xiong, T; Spahn, AM; Garcia-Lecea, M; Korzh, V; Ekker, SC; Schimmenti, LA				Bill, Brent R.; Balciunas, Darius; McCarra, Joshua A.; Young, Eric D.; Xiong, Toua; Spahn, Ashley M.; Garcia-Lecea, Marta; Korzh, Vladimir; Ekker, Stephen C.; Schimmenti, Lisa A.			Development and Notch Signaling Requirements of the Zebrafish Choroid Plexus	PLOS ONE			English	Article								Background: The choroid plexus (CP) is an epithelial and vascular structure in the ventricular system of the brain that is a critical part of the blood-brain barrier. The CP has two primary functions, 1) to produce and regulate components of the cerebral spinal fluid, and 2) to inhibit entry into the brain of exogenous substances. Despite its importance in neurobiology, little is known about how this structure forms. Methodology and Principal Findings: Here we show that the transposon-mediated enhancer trap zebrafish line Et-Mn16 expresses green fluorescent protein within a population of cells that migrate toward the midline and coalesce to form the definitive CP. We further demonstrate the development of the integral vascular network of the definitive CP. Utilizing pharmacologic pan-notch inhibition and specific morpholino-mediated knockdown, we demonstrate a requirement for Notch signaling in choroid plexus development. We identify three Notch signaling pathway members as mediating this effect, notch1b, deltaA, and deltaD. Conclusions and Significance: This work is the first to identify the zebrafish choroid plexus and to characterize its epithelial and vasculature integration. This study, in the context of other comparative anatomical studies, strongly indicates a conserved mechanism for development of the CP. Finally, we characterize a requirement for Notch signaling in the developing CP. This establishes the zebrafish CP as an important new system for the determination of key signaling pathways in the formation of this essential component of the vertebrate brain.	[Bill, Brent R.; Balciunas, Darius; McCarra, Joshua A.; Young, Eric D.; Xiong, Toua; Spahn, Ashley M.; Ekker, Stephen C.] Univ Minnesota, Dept Genet Cell & Dev, Minneapolis, MN 55455 USA; [Bill, Brent R.; Balciunas, Darius; Ekker, Stephen C.; Schimmenti, Lisa A.] Univ Minnesota, Dev Biol Ctr, Minneapolis, MN USA; [Bill, Brent R.; Ekker, Stephen C.; Schimmenti, Lisa A.] Univ Minnesota, Inst Human Genet, Minneapolis, MN USA; [Balciunas, Darius] Temple Univ, Dept Biol, Philadelphia, PA USA; [Garcia-Lecea, Marta; Korzh, Vladimir] Agcy Sci, Technol & Res, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Lab Fish Dev Biol, Singapore, Singapore; [Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Schimmenti, Lisa A.] Univ Minnesota, Dept Pediat, Genet & Metabolism, Minneapolis, MN USA; [Schimmenti, Lisa A.] Univ Minnesota, Dept Ophthalmol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bill, BR (corresponding author), Univ Minnesota, Dept Genet Cell & Dev, Minneapolis, MN 55455 USA.	ekker.stephen@mayo.edu; las@umn.edu	Balciunas, Darius/AAD-1420-2019; Korzh, Vladimir P/H-1596-2011	Korzh, Vladimir P/0000-0002-6580-7986; Schimmenti, Lisa/0000-0003-3154-4249; Balciunas, Darius/0000-0003-1938-3243; Bill, Brent/0000-0002-3436-1969; Young, Eric/0000-0002-0014-1482; Ekker, Stephen/0000-0003-0726-4212	National Institute of Health [T32 EY007133-12, GM63904, DA14546]; University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics; Undergraduate Research Opportunities Program; Agency for Science, Technology and Research (A-STAR) of Singapore; Mayo Foundation; University of Minnesota, Department of Pediatrics; Minnesota Medical Foundation; The Graduate Division of the University of Minnesota; The University of Minnesota Medical School; NATIONAL EYE INSTITUTE [T32EY007133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063904, R56GM063904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014546] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics; Undergraduate Research Opportunities Program; Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); Mayo Foundation; University of Minnesota, Department of Pediatrics(University of Minnesota System); Minnesota Medical Foundation; The Graduate Division of the University of Minnesota; The University of Minnesota Medical School; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by National Institute of Health T32 EY007133-12-P.I. McLoon, University of Minnesota Department of Genetics, Cell, and Development, and Department of Pediatrics (BRB), Undergraduate Research Opportunities Program (JAM & EDY), Agency for Science, Technology and Research (A-STAR) of Singapore (VK). National Institute of Health R01 [GM63904 and DA14546 to SCE], Mayo Foundation (SCE), University of Minnesota, Department of Pediatrics (LAS), Minnesota Medical Foundation (LAS) and The Graduate Division of the University of Minnesota (LAS), and The University of Minnesota Medical School (Zebrafish Core Facility) (LAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Barreto ASCD, 2004, ARQ NEURO-PSIQUIAT, V62, P600, DOI 10.1590/S0004-282X2004000400007; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Candal E, 2005, DEV BRAIN RES, V160, P157, DOI 10.1016/j.devbrainres.2005.08.009; GARCIALECEA M, PLOS BIOL IN PRESS; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Holley SA, 2002, DEVELOPMENT, V129, P1175; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jacobsen M, 1982, Brain Res, V255, P239; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Liu Y, 2007, DEVELOPMENT, V134, P1111, DOI 10.1242/dev.02806; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; MARCUS RC, 1995, J COMP NEUROL, V359, P365, DOI 10.1002/cne.903590302; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Netsky MG, 1975, CHOROID PLEXUS HLTH; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; STRONG LH, 1956, AM J ANAT, V99, P249, DOI 10.1002/aja.1000990204; STURROCK RR, 1979, J ANAT, V129, P777; Tanaka M, 2007, HISTOCHEM CELL BIOL, V127, P449, DOI 10.1007/s00418-006-0260-8; Tennyson V M, 1968, Prog Brain Res, V29, P63; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wright GJ, 2004, DEVELOPMENT, V131, P5659, DOI 10.1242/dev.01417; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	35	34	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3114	10.1371/journal.pone.0003114	http://dx.doi.org/10.1371/journal.pone.0003114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769591	Green Published, Green Submitted, gold			2022-12-27	WOS:000264418300006
J	Chen, XS; White, WTJ; Collins, LJ; Penny, D				Chen, Xiaowei Sylvia; White, W. Timothy J.; Collins, Lesley J.; Penny, David			Computational Identification of Four Spliceosomal snRNAs from the Deep-Branching Eukaryote Giardia intestinalis	PLOS ONE			English	Article							DYNAMIC-PROGRAMMING ALGORITHM; RNA SECONDARY STRUCTURE; SMALL NUCLEAR RNAS; TRICHOMONAS-VAGINALIS; TRYPANOSOMA-BRUCEI; U2; GENE; PROTEIN; INTRON; SEQUENCE	RNAs processing other RNAs is very general in eukaryotes, but is not clear to what extent it is ancestral to eukaryotes. Here we focus on pre-mRNA splicing, one of the most important RNA-processing mechanisms in eukaryotes. In most eukaryotes splicing is predominantly catalysed by the major spliceosome complex, which consists of five uridine-rich small nuclear RNAs (U-snRNAs) and over 200 proteins in humans. Three major spliceosomal introns have been found experimentally in Giardia; one Giardia U-snRNA (U5) and a number of spliceosomal proteins have also been identified. However, because of the low sequence similarity between the Giardia ncRNAs and those of other eukaryotes, the other U-snRNAs of Giardia had not been found. Using two computational methods, candidates for Giardia U1, U2, U4 and U6 snRNAs were identified in this study and shown by RT-PCR to be expressed. We found that identifying a U2 candidate helped identify U6 and U4 based on interactions between them. Secondary structural modelling of the Giardia U-snRNA candidates revealed typical features of eukaryotic U-snRNAs. We demonstrate a successful approach to combine computational and experimental methods to identify expected ncRNAs in a highly divergent protist genome. Our findings reinforce the conclusion that spliceosomal small-nuclear RNAs existed in the last common ancestor of eukaryotes.	[Chen, Xiaowei Sylvia; White, W. Timothy J.; Collins, Lesley J.; Penny, David] Massey Univ, IMBS, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand	Massey University	Chen, XS (corresponding author), Massey Univ, IMBS, Allan Wilson Ctr Mol Ecol & Evolut, Palmerston North, New Zealand.	sylvia.x.chen@gmail.com	Penny, David/E-9410-2011		Marsden Fund New Zealand Allan Wilson Centre	Marsden Fund New Zealand Allan Wilson Centre	Marsden Fund New Zealand Allan Wilson Centre The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Ambrosio DL, 2007, MEM I OSWALDO CRUZ, V102, P97, DOI 10.1590/S0074-02762007000100017; Best AA, 2004, GENOME RES, V14, P1537, DOI 10.1101/gr.2256604; BROWN JWS, 1989, NUCLEIC ACIDS RES, V17, P8991, DOI 10.1093/nar/17.22.8991; Chen XW, 2007, NUCLEIC ACIDS RES, V35, P4619, DOI 10.1093/nar/gkm474; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; COLLINS LJ, 2003, J INTEGRATIVE BIOINF, V1; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4; DATTA B, 1991, NATURE, V352, P821, DOI 10.1038/352821a0; Dix I, 1998, RNA, V4, P1674, DOI 10.1017/S1355838298412998; Eddy SR, 2006, COLD SPRING HARB SYM, V71, P117, DOI 10.1101/sqb.2006.71.003; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; EDLIND TD, 1987, NUCLEIC ACIDS RES, V15, P7889, DOI 10.1093/nar/15.19.7889; Fast NM, 1999, MOL BIOCHEM PARASIT, V99, P275, DOI 10.1016/S0166-6851(99)00017-1; FORTNER DM, 1994, GENE DEV, V8, P221, DOI 10.1101/gad.8.2.221; Grainger RJ, 2005, RNA, V11, P533, DOI 10.1261/rna.2220705; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; Hinas A, 2006, EUKARYOT CELL, V5, P924, DOI 10.1128/EC.00065-06; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFMANN CJB, 1992, MOL BIOL REP, V17, P21, DOI 10.1007/BF01006396; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; Irimia M, 2008, NUCLEIC ACIDS RES, V36, P1703, DOI 10.1093/nar/gkn012; Jeffares DC, 2006, TRENDS GENET, V22, P16, DOI 10.1016/j.tig.2005.10.006; Jensen RC, 1998, NUCLEIC ACIDS RES, V26, P616, DOI 10.1093/nar/26.2.616; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Keeling PJ, 2005, TRENDS ECOL EVOL, V20, P670, DOI 10.1016/j.tree.2005.09.005; KUNKEL GR, 1988, GENE DEV, V2, P196, DOI 10.1101/gad.2.2.196; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; Lucke S, 1997, EMBO J, V16, P4433, DOI 10.1093/emboj/16.14.4433; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Marquez SM, 2005, RNA, V11, P739, DOI 10.1261/rna.7211705; Martin W, 2007, SCIENCE, V316, P542; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; Mcmanus CJ, 2007, RNA, V13, P2252, DOI 10.1261/rna.699907; Miranda R, 1996, GENE, V180, P37, DOI 10.1016/S0378-1119(96)00397-6; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; NIU XH, 1994, MOL BIOCHEM PARASIT, V66, P49, DOI 10.1016/0166-6851(94)90035-3; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Palfi Z, 2005, NUCLEIC ACIDS RES, V33, P2493, DOI 10.1093/nar/gki548; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Sashital DG, 2004, NAT STRUCT MOL BIOL, V11, P1237, DOI 10.1038/nsmb863; Sashital DG, 2003, BIOCHEMISTRY-US, V42, P1470, DOI 10.1021/bi027137h; Seetharaman M, 2006, RNA, V12, P235, DOI 10.1261/rna.2237806; Simoes-Barbosa A, 2008, RNA, V14, P1617, DOI 10.1261/rna.1045408; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Valadkhan S, 2007, RNA, V13, P2300, DOI 10.1261/rna.626207; Vanacova S, 2005, P NATL ACAD SCI USA, V102, P4430, DOI 10.1073/pnas.0407500102; Vanacova S, 2003, INT J PARASITOL, V33, P235, DOI 10.1016/S0020-7519(02)00267-9; VANKAN P, 1988, NUCLEIC ACIDS RES, V16, P10425, DOI 10.1093/nar/16.22.10425; Yang CY, 2005, BIOCHEM BIOPH RES CO, V328, P1224, DOI 10.1016/j.bbrc.2005.01.077; YEAN SL, 1991, MOL CELL BIOL, V11, P5571, DOI 10.1128/MCB.11.11.5571; Yuan FQ, 2007, NUCLEIC ACIDS RES, V35, P2833, DOI 10.1093/nar/gkm134	61	18	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3106	10.1371/journal.pone.0003106	http://dx.doi.org/10.1371/journal.pone.0003106			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769729	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796800011
J	Sereno, PC; Garcea, EAA; Jousse, H; Stojanowski, CM; Saliege, JF; Maga, A; Ide, OA; Knudson, KJ; Mercuri, AM; Stafford, TW; Kaye, TG; Giraudi, C; N'siala, IM; Cocca, E; Moots, HM; Dutheil, DB; Stivers, JP				Sereno, Paul C.; Garcea, Elena A. A.; Jousse, Helene; Stojanowski, Christopher M.; Saliege, Jean-Francois; Maga, Abdoulaye; Ide, Oumarou A.; Knudson, Kelly J.; Mercuri, Anna Maria; Stafford, Thomas W., Jr.; Kaye, Thomas G.; Giraudi, Carlo; N'siala, Isabella Massamba; Cocca, Enzo; Moots, Hannah M.; Dutheil, Didier B.; Stivers, Jeffrey P.			Lakeside Cemeteries in the Sahara: 5000 Years of Holocene Population and Environmental Change	PLOS ONE			English	Article							NORTH-AFRICA; CLIMATE; EVOLUTION; SEDENTISM; STRONTIUM; DESERT; NIGER; BP	Background: Approximately two hundred human burials were discovered on the edge of a paleolake in Niger that provide a uniquely preserved record of human occupation in the Sahara during the Holocene (similar to 8000 B.C.E. to the present). Called Gobero, this suite of closely spaced sites chronicles the rapid pace of biosocial change in the southern Sahara in response to severe climatic fluctuation. Methodology/Principal Findings: Two main occupational phases are identified that correspond with humid intervals in the early and mid-Holocene, based on 78 direct AMS radiocarbon dates on human remains, fauna and artifacts, as well as 9 OSL dates on paleodune sand. The older occupants have craniofacial dimensions that demonstrate similarities with mid-Holocene occupants of the southern Sahara and Late Pleistocene to early Holocene inhabitants of the Maghreb. Their hyperflexed burials compose the earliest cemetery in the Sahara dating to similar to 7500 B. C. E. These early occupants abandon the area under arid conditions and, when humid conditions return similar to 4600 B. C. E., are replaced by a more gracile people with elaborated grave goods including animal bone and ivory ornaments. Conclusions/Significance: The principal significance of Gobero lies in its extraordinary human, faunal, and archaeological record, from which we conclude the following: (1) The early Holocene occupants at Gobero (7700-6200 B.C.E.) were largely sedentary hunter-fisher-gatherers with lakeside funerary sites that include the earliest recorded cemetery in the Sahara. (2) Principal components analysis of craniometric variables closely allies the early Holocene occupants at Gobero with a skeletally robust, trans-Saharan assemblage of Late Pleistocene to mid-Holocene human populations from the Maghreb and southern Sahara. (3) Gobero was abandoned during a period of severe aridification possibly as long as one millennium (6200-5200 B.C.E). (4) More gracile humans arrived in the mid-Holocene (5200 -2500 B. C. E.) employing a diversified subsistence economy based on clams, fish, and savanna vertebrates as well as some cattle husbandry. (5) Population replacement after a harsh arid hiatus is the most likely explanation for the occupational sequence at Gobero. (6) We are just beginning to understand the anatomical and cultural diversity that existed within the Sahara during the Holocene.	[Sereno, Paul C.; Moots, Hannah M.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Garcea, Elena A. A.] Univ Cassino, Dipartimento Filol Storia, Cassino, Italy; [Jousse, Helene] Naturhist Museum Wien, Vienna, Austria; [Stojanowski, Christopher M.; Knudson, Kelly J.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Saliege, Jean-Francois] Univ Pierre Marie Curie, Lab Oceanographie Climat Expt Approches Numeriques, Paris, France; [Maga, Abdoulaye] Ec Community W African States Commission, Direct Ed, Culture, Sci Technol, Abuja, Nigeria; [Maga, Abdoulaye; Ide, Oumarou A.] Univ Niamey, Inst Sci Humaines, Niamey, Niger; [Mercuri, Anna Maria; N'siala, Isabella Massamba] Univ Modena & Reggio Emilia, Dipartimento Museo Paleobiol Orto Botanico, Modena, Italy; [Stafford, Thomas W., Jr.] Stafford Res Lab Inc, Lafayette, CO USA; [Kaye, Thomas G.] Univ Washington, Burke Museum Nat Hist, Seattle, WA USA; [Giraudi, Carlo] Ente Nuove Tecnol, Rome, Italy; [Cocca, Enzo] Univ Roma La Sapienza, Dipartimento Sci Storiche, Antropol Archeol Antich, Rome, Italy; [Dutheil, Didier B.] Museum Natl Hist Nat, Paris, France	University of Chicago; University of Cassino; Arizona State University; Arizona State University-Tempe; UDICE-French Research Universities; Sorbonne Universite; Universita di Modena e Reggio Emilia; University of Washington; University of Washington Seattle; Sapienza University Rome; Museum National d'Histoire Naturelle (MNHN)	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Mercuri, Anna Maria/G-2085-2011	Mercuri, Anna Maria/0000-0001-6138-4165; Dutheil, Didier/0000-0002-4856-0918; Maga, Abdoulaye/0000-0002-4684-217X; Kaye, Thomas/0000-0001-7996-618X	National Geographic Society; National Science Foundation; Yates Foundation; The Island Fund of The New York Community Trust; Wenner-Gren Foundation for Anthropological Research; School of Human Evolution and Social Change, Arizona State University; Laboratoire d'Oceanographie et du Climat Experimentations et Approches Numeriques, Universite of Pierre et Marie Curie	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Yates Foundation; The Island Fund of The New York Community Trust; Wenner-Gren Foundation for Anthropological Research; School of Human Evolution and Social Change, Arizona State University; Laboratoire d'Oceanographie et du Climat Experimentations et Approches Numeriques, Universite of Pierre et Marie Curie	Fieldwork and lab work was supported by the National Geographic Society (to PCS, EAAG), the National Science Foundation (to CMS, KJK), the Yates Foundation and The Island Fund of The New York Community Trust (to PCS), the Wenner-Gren Foundation for Anthropological Research (to CMS, EAAG), and the School of Human Evolution and Social Change, Arizona State University (to CMS, KJK). Preparation of samples for radiocarbon dating was supported by Laboratoire d'Oceanographie et du Climat Experimentations et Approches Numeriques, Universite of Pierre et Marie Curie (to J-FS).	Aitken M.J., 1998, INTRO OPTICAL DATING; Balter V, 2002, ARCHAEOMETRY, V44, P329, DOI 10.1111/1475-4754.t01-1-00065; BLACK R, 1994, GEOLOGY, V22, P641, DOI 10.1130/0091-7613(1994)022<0641:PADTIT>2.3.CO;2; Boyd B, 2006, WORLD ARCHAEOL, V38, P164, DOI 10.1080/00438240600688398; Brooks N, 2006, QUATERN INT, V151, P29, DOI 10.1016/j.quaint.2006.01.013; CHAMLA MC, 1968, POPULATIONS ANCIENNE, P249; Clark J.D., 1973, QUATERNARIA, V17, P245; CLARK JD, ADRAR BOUS ARCHAEOLO; Cremaschi M., 1999, AFR ARCHAEOL REV, V16, P211, DOI DOI 10.1023/A:1021609623737; de Noblet-Ducoudre N, 2000, CLIM DYNAM, V16, P643, DOI 10.1007/s003820000074; DUPUY C, 1993, GEOCHEM J, V27, P131, DOI 10.2343/geochemj.27.131; Dutour O, 1989, HOMMES FOSSILES SAHA, P342; FOWLER B, 2004, NY TIMES        0127; Garcea, 2020, CULTURAL DYNAMICS SA; Garcea EAA, 2006, WORLD ARCHAEOL, V38, P197, DOI 10.1080/00438240600693968; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; GASSE F, 1994, EARTH PLANET SC LETT, V126, P435, DOI 10.1016/0012-821X(94)90123-6; GAYET M, 1983, SAHARA SAHEL, P183; GRENFELL HR, 1995, REV PALAEOBOT PALYNO, V84, P201, DOI 10.1016/0034-6667(94)00134-6; GRIMM EC, 1991, TILIA V 2 0; Haaland R, 1997, ANTIQUITY, V71, P374, DOI 10.1017/S0003598X00084982; Haour AC, 2003, J WORLD PREHIST, V17, P181, DOI 10.1023/A:1025806923358; HASSAN FA, 2002, DROUGHTS FOOD CULTUR; HERMES OD, 1997, GEOARCHAEOLOGY, V12, P1; Huysecom E, 2004, ANTIQUITY, V78, P579, DOI 10.1017/S0003598X00113237; Irish JD, 2000, J HUM EVOL, V39, P393, DOI 10.1006/jhev.2000.0430; Jousse H, 2006, QUATERN INT, V151, P63, DOI 10.1016/j.quaint.2006.01.015; Kobusiewicz M, 2004, ANTIQUITY, V78, P566, DOI 10.1017/S0003598X00113225; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Kutzbach J, 1998, QUATERNARY SCI REV, V17, P473, DOI 10.1016/S0277-3791(98)00009-2; Leblanc M, 2006, PALAEOGEOGR PALAEOCL, V239, P16, DOI 10.1016/j.palaeo.2006.01.003; LEGER JM, 1985, J AFR EARTH SCI, V3, P89, DOI 10.1016/0899-5362(85)90026-0; Lubell D., 2001, ENCY PREHISTORY, V1, P129; MACDONALD KC, 1999, ARCHAEOLOGY LANGUAGE, V2, P33; Maley J., 2004, EVOLUTION VEGETATION, P179; Marshall F, 2002, J WORLD PREHIST, V16, P99, DOI 10.1023/A:1019954903395; Mauny R., 1961, B IFAN, V23b, P388; MCDONALD MMA, 1992, AFRICAN COMMITMENT P, P51; MCINTOSH SK, 1986, J AFR HIST, V27, P413, DOI 10.1017/S0021853700023252; Mercuri AM, 2008, J ARID ENVIRON, V72, P1950, DOI 10.1016/j.jaridenv.2008.04.008; Murray A.S., 2002, GEOCHRONOMETRIA, V21, P1; PETITMAIRE N, SAHARA SAHEL QUATERN, P473; Petters S.W., 1991, REGIONAL GEOLOGY AFR, P220; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; SATO H, 1997, GEOCHIM COSMOCHIM AC, V61, P3975; Schaaf P, 2002, METEORIT PLANET SCI, V37, P565, DOI 10.1111/j.1945-5100.2002.tb00839.x; SCHULZ E, 1991, HYDROBIOLOGIA, V214, P359, DOI 10.1007/BF00050971; Schulz E., 1987, PALAEOECOL AFR, P143; Servant M., 1980, SAHARA NILE, P133; SUTTON JEG, 1977, ANTIQUITY, V51, P25, DOI 10.1017/S0003598X00100559; Tafuri MA, 2006, J ANTHROPOL ARCHAEOL, V25, P390, DOI 10.1016/j.jaa.2006.01.002; Tillet T., 1985, AFR ARCHAEOL REV, V3, P163; Tixier J., 1962, MISSIONS BERLIET TEN, P333; van Neer W., 1989, Palaeoecology of Africa and the Surrounding Islands, V20, P1	55	116	120	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2008	3	8							e2995	10.1371/journal.pone.0002995	http://dx.doi.org/10.1371/journal.pone.0002995			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422GH	18701936	Green Published, gold, Green Submitted			2022-12-27	WOS:000264415000001
J	He, F; Wu, DD; Kong, QP; Zhang, YP				He, Fang; Wu, Dong-Dong; Kong, Qing-Peng; Zhang, Ya-Ping			Intriguing Balancing Selection on the Intron 5 Region of LMBR1 in Human Population	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCE ANALYSES; RANGE SHH ENHANCER; MOLECULAR EVOLUTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; TRIPHALANGEAL THUMB; STATISTICAL-METHOD; SONIC-HEDGEHOG; HUMAN GENOME; GENE	Background: The intron 5 of gene LMBR1 is the cis-acting regulatory module for the sonic hedgehog (SHH) gene. Mutation in this non-coding region is associated with preaxial polydactyly, and may play crucial roles in the evolution of limb and skeletal system. Methodology/Principal Findings: We sequenced a region of the LMBR1 gene intron 5 in East Asian human population, and found a significant deviation of Tajima's D statistics from neutrality taking human population growth into account. Data from HapMap also demonstrated extended linkage disequilibrium in the region in East Asian and European population, and significantly low degree of genetic differentiation among human populations. Conclusion/Significance: We proposed that the intron 5 of LMBR1 was presumably subject to balancing selection during the evolution of modern human.	[He, Fang; Wu, Dong-Dong; Kong, Qing-Peng; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Ya-Ping] Yunnan Univ, Laboratory for Conservat & Utilizat Bio Resource, Kunming, Peoples R China; [He, Fang; Wu, Dong-Dong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, F (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp1@263.net.cn	Wu, Dong-Dong/AAR-5615-2020		Key State Research Program of China [2006CB943900]; Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China	Key State Research Program of China; Science and Technology Committee of Yunnan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key State Research Program of China (2006CB943900), Science and Technology Committee of Yunnan Province and the National Natural Science Foundation of China.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Allerston CK, 2007, PHARMACOGENET GENOM, V17, P827, DOI 10.1097/FPC.0b013e328256b198; Armelagos GJ, 2005, EVOL ANTHROPOL, V14, P68, DOI 10.1002/evan.20047; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Clark RM, 2001, GENETICS, V159, P715; Dorus S, 2006, HUM MOL GENET, V15, P2031, DOI 10.1093/hmg/ddl123; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2005, ANN HUM GENET, V69, P389, DOI 10.1046/j.1529-8817.2005.00163.x; Grigorova M, 2007, ANN HUM GENET, V71, P18, DOI 10.1111/j.1469-1809.2006.00299.x; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ianakiev P, 2001, AM J HUM GENET, V68, P38, DOI 10.1086/316955; Koda Y, 2003, HUM GENET, V113, P534, DOI 10.1007/s00439-003-1013-6; Kreitman M, 2004, TRENDS GENET, V20, P300, DOI 10.1016/j.tig.2004.05.002; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; LEWONTIN RC, 1964, GENETICS, V49, P49; Nakajima T, 2005, GENES IMMUN, V6, P398, DOI 10.1038/sj.gene.6364215; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Soejima M, 2005, ANN HUM GENET, V69, P239, DOI 10.1046/j.1529-8817.2005.00165.x; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wang ZQ, 2007, BIOCHEM BIOPH RES CO, V355, P312, DOI 10.1016/j.bbrc.2007.01.129; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wooding S, 2004, AM J HUM GENET, V74, P637, DOI 10.1086/383092; Wooding S, 2002, GENETICS, V161, P1641	41	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2948	10.1371/journal.pone.0002948	http://dx.doi.org/10.1371/journal.pone.0002948			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698406	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600034
J	Hoffmann, M; Chang, HH; Huang, S; Ingber, DE; Loeffler, M; Galle, J				Hoffmann, Martin; Chang, Hannah H.; Huang, Sui; Ingber, Donald E.; Loeffler, Markus; Galle, Joerg			Noise-Driven Stem Cell and Progenitor Population Dynamics	PLOS ONE			English	Article								Background: The balance between maintenance of the stem cell state and terminal differentiation is influenced by the cellular environment. The switching between these states has long been understood as a transition between attractor states of a molecular network. Herein, stochastic fluctuations are either suppressed or can trigger the transition, but they do not actually determine the attractor states. Methodology/Principal Findings: We present a novel mathematical concept in which stem cell and progenitor population dynamics are described as a probabilistic process that arises from cell proliferation and small fluctuations in the state of differentiation. These state fluctuations reflect random transitions between different activation patterns of the underlying regulatory network. Importantly, the associated noise amplitudes are state-dependent and set by the environment. Their variability determines the attractor states, and thus actually governs population dynamics. This model quantitatively reproduces the observed dynamics of differentiation and dedifferentiation in promyelocytic precursor cells. Conclusions/Significance: Consequently, state-specific noise modulation by external signals can be instrumental in controlling stem cell and progenitor population dynamics. We propose follow-up experiments for quantifying the imprinting influence of the environment on cellular noise regulation.	[Hoffmann, Martin; Galle, Joerg] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Chang, Hannah H.; Ingber, Donald E.] Harvard Med Sch, Childrens Hosp, Dept Pathol & Surg, Vasc Biol Program, Boston, MA USA; [Chang, Hannah H.] Harvard Univ, Program Biophys, Boston, MA USA; [Chang, Hannah H.] Harvard Med Sch, MD PhD Program, Boston, MA USA; [Huang, Sui] Univ Calgary, Inst Biocomplexity & Informat, Calgary, AB, Canada; [Loeffler, Markus] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Leipzig University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; University of Calgary; Leipzig University	Hoffmann, M (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany.	hoffmann@izbi.uni-leipzig.de	Ingber, Donald E/AAC-5894-2019		German Research Foundation [AU 132/3-1, BIZ-6 1/1]; Federal Ministry of Education and Research of Germany [0313836]; Air Force Office of Scientific Research [F49550-05-1-0078]; National Institutes of Health (NIH) [R21CA123284, CA55833]; DoD Breast Cancer Innovator Award; Harvard University [Ashford Fellowship]; NATIONAL CANCER INSTITUTE [R21CA123284, R01CA055833] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research of Germany(Federal Ministry of Education & Research (BMBF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD Breast Cancer Innovator Award(United States Department of Defense); Harvard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a joint grant from the German Research Foundation (DFG; AU 132/3-1, IZBI). MH was supported by the Federal Ministry of Education and Research of Germany through grant 0313836 (MS CartPro). JG was supported by DFG-grant BIZ-6 1/1. SH was supported by grant F49550-05-1-0078 from the Air Force Office of Scientific Research and grant R21CA123284 from the National Institutes of Health (NIH). DEI was supported by NIH grant CA55833 and a DoD Breast Cancer Innovator Award. HHC was supported by the Presidential Scholarship and the Ashford Fellowship of Harvard University.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ao P, 2007, COMPLEXITY, V12, P19, DOI 10.1002/cplx.20171; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Brown G, 2002, EXP CELL RES, V281, P28, DOI 10.1006/excr.2002.5654; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Drayson MT, 2001, EXP CELL RES, V266, P126, DOI 10.1006/excr.2001.5200; El-Samad H, 2006, BIOPHYS J, V90, P3749, DOI 10.1529/biophysj.105.060491; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fange D, 2006, PLOS COMPUT BIOL, V2, P637, DOI 10.1371/journal.pcbi.0020080; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Gibbs JD, 2007, CELL CYCLE, V6, P1205, DOI 10.4161/cc.6.10.4258; Glauche I, 2007, STEM CELLS, V25, P1791, DOI 10.1634/stemcells.2007-0025; GOSH K, 2007, MICROMECHANICAL CONT; GOSH K, 2007, ADV DRUG DELIV REV; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Holtz MS, 2002, BLOOD, V99, P3792, DOI 10.1182/blood.V99.10.3792; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Ingber DE, 2007, DEVELOPMENT, V134, P2541, DOI 10.1242/dev.003707; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kerszberg M, 2004, CURR OPIN GENET DEV, V14, P440, DOI 10.1016/j.gde.2004.06.001; Kitajima K, 2001, BIOCHEM BIOPH RES CO, V288, P1182, DOI 10.1006/bbrc.2001.5892; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leon K, 2004, J THEOR BIOL, V229, P455, DOI 10.1016/j.jtbi.2004.04.011; Loeffler M, 2004, CURR OPIN HEMATOL, V11, P81, DOI 10.1097/01.moh.0000133648.83991.af; Loeffler M, 2002, CELLS TISSUES ORGANS, V171, P8, DOI 10.1159/000057688; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Merino E, 2008, CURR OPIN MICROBIOL, V11, P78, DOI 10.1016/j.mib.2008.02.005; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Press W. H., 1992, ART SCI COMPUTING; Quesenberry PJ, 2005, STEM CELL REV, V1, P29, DOI 10.1385/SCR:1:1:029; Rando OJ, 2006, DEV CELL, V11, P134, DOI 10.1016/j.devcel.2006.07.012; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Roeder I, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/84656; Roeder I, 2006, STEM CELL REV, V2, P171, DOI 10.1007/s12015-006-0045-4; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tabaka M, 2008, J MOL BIOL, V377, P1002, DOI 10.1016/j.jmb.2008.01.060; Thattai M, 2002, BIOPHYS J, V82, P2943, DOI 10.1016/S0006-3495(02)75635-X; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; van Kampen N., 2004, STOCHASTIC PROCESSES; Viswanathan S, 2005, BIOTECHNOL APPL BIOC, V42, P119, DOI 10.1042/BA20040207; Waddington C.H., 1956, PRINCIPLES EMBRYOLOG; Wang J, 2006, PLOS COMPUT BIOL, V2, P1385, DOI 10.1371/journal.pcbi.0020147; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu EY, 2006, MOL CELL, V23, P219, DOI 10.1016/j.molcel.2006.05.035; Zwaka TP, 2006, CELL, V127, P1301, DOI 10.1016/j.cell.2006.12.011	65	81	84	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2922	10.1371/journal.pone.0002922	http://dx.doi.org/10.1371/journal.pone.0002922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698344	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600008
J	Love, CJ; Zhang, SG; Mershin, A				Love, Christopher J.; Zhang, Shuguang; Mershin, Andreas			Source of Sustained Voltage Difference between the Xylem of a Potted Ficus benjamina Tree and Its Soil	PLOS ONE			English	Article								It has long been known that there is a sustained electrical potential (voltage) difference between the xylem of many plants and their surrounding soil, but the mechanism behind this voltage has remained controversial. After eliminating any extraneous capacitive or inductive couplings and ground-mediated electric current flows, we have measured sustained differences of 50-200 mV between the xylem region of a Faraday-caged, intact, potted Ficus benjamina tree and its soil, as well as between its cut branches and soils and ionic solutions standardized to various pH values. Using identical platinum electrodes, no correlation between the voltage and time of day, illumination, sap flow, electrode elevation, or ionic composition of soil was found, suggesting no direct connection to simple dissimilar-metal redox reactions or transpirational activity. Instead, a clear relationship between the voltage polarity and magnitude and the pH difference between xylem and soil was observed. We attribute these sustained voltages to a biological concentration cell likely set up by the homeostatic mechanisms of the tree. Potential applications of this finding are briefly explored.	[Love, Christopher J.; Zhang, Shuguang; Mershin, Andreas] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Love, CJ (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mershin@mit.edu		Love, Christopher/0000-0002-7989-2376; Zhang, Shuguang/0000-0002-3856-3752	Magcap, LLC	Magcap, LLC	Stella Karavas and Chris Lagadinos of Magcap, LLC provided an unrestricted gift of $10,000USD to cover Christopher J Love's UROP stipend and in part fund this project. Neither they nor MagCap played any role in the design and conduct of the study, or in the collection, analysis, or interpretation of the data, or the preparation, review, or approval of this manuscript	CALNAN C, 2006, PLUGGED STARTUP HOPE; FENSOM D. S., 1963, CANADIAN JOUR BOT, V41, P831, DOI 10.1139/b63-068; GENSLER W, 1988, J ELECTROCHEM SOC, V135, P2991, DOI 10.1149/1.2095475; Gibert D, 2006, PLANT SCI, V171, P572, DOI 10.1016/j.plantsci.2006.06.012; GREGORI G, 1986, TELLURIC CURRENTS NA, P232; GRODZINSKY AJ, 2003, FIELDS FORCES FLOWS; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; Koppan A, 2000, CR ACAD SCI III-VIE, V323, P559, DOI 10.1016/S0764-4469(00)00179-7; Koppan Andras, 2002, Acta Biologica Szegediensis, V46, P37; Ksenzhek O., 2004, Bulgarian Journal of Plant Physiology, V30, P61; Labady A, 2002, BIOELECTROCHEMISTRY, V57, P47, DOI 10.1016/S1567-5394(01)00175-X; MORAT P, 1994, CR ACAD SCI III-VIE, V317, P98; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; NOBEL PS, 2005, PHYSICOCHEMICAL ENV, P106; Reich PB, 2006, NATURE, V439, P457, DOI 10.1038/nature04282; Wegner LH, 1998, PLANT CELL ENVIRON, V21, P849, DOI 10.1046/j.1365-3040.1998.00335.x; WRIGHT JP, 1981, PLANT PHYSIOL, V67, P845, DOI 10.1104/pp.67.4.845; Yang J, 2003, J MICROMECH MICROENG, V13, P963, DOI 10.1088/0960-1317/13/6/320	18	31	31	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2963	10.1371/journal.pone.0002963	http://dx.doi.org/10.1371/journal.pone.0002963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698415	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600048
J	Miao, HX; Chen, L; Riordan, SM; Li, WJ; Juarez, S; Crabb, AM; Lukas, TJ; Du, P; Lin, SM; Wise, A; Agapova, OA; Yang, P; Gu, CC; Hernandez, MR				Miao, Haixi; Chen, Lin; Riordan, Sean M.; Li, Wenjun; Juarez, Santiago; Crabb, Andrea M.; Lukas, Thomas J.; Du, Pan; Lin, Simon M.; Wise, Alexandria; Agapova, Olga A.; Yang, Ping; Gu, Charles C.; Hernandez, M. Rosario			Gene Expression and Functional Studies of the Optic Nerve Head Astrocyte Transcriptome from Normal African Americans and Caucasian Americans Donors	PLOS ONE			English	Article								Purpose: To determine whether optic nerve head (ONH) astrocytes, a key cellular component of glaucomatous neuropathy, exhibit differential gene expression in primary cultures of astrocytes from normal African American (AA) donors compared to astrocytes from normal Caucasian American (CA) donors. Methods: We used oligonucleotide Affymetrix microarray (HG U133A & HG U133A 2.0 chips) to compare gene expression levels in cultured ONH astrocytes from twelve CA and twelve AA normal age matched donor eyes. Chips were normalized with Robust Microarray Analysis (RMA) in R using Bioconductor. Significant differential gene expression levels were detected using mixed effects modeling and Statistical Analysis of Microarray (SAM). Functional analysis and Gene Ontology were used to classify differentially expressed genes. Differential gene expression was validated by quantitative real time RT-PCR. Protein levels were detected by Western blots and ELISA. Cell adhesion and migration assays tested physiological responses. Glutathione (GSH) assay detected levels of intracellular GSH. Results: Multiple analyses selected 87 genes differentially expressed between normal AA and CA (P<0.01). The most relevant genes expressed in AA were categorized by function, including: signal transduction, response to stress, ECM genes, migration and cell adhesion. Conclusions: These data show that normal astrocytes from AA and CA normal donors display distinct expression profiles that impact astrocyte functions in the ONH. Our data suggests that differences in gene expression in ONH astrocytes may be specific to the development and/or progression of glaucoma in AA.	[Miao, Haixi; Chen, Lin; Riordan, Sean M.; Li, Wenjun; Juarez, Santiago; Crabb, Andrea M.; Hernandez, M. Rosario] Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; [Lukas, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL USA; [Du, Pan; Lin, Simon M.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehensive Canc Ctr, Chicago, IL USA; [Wise, Alexandria] CUNY City Coll, Dept Biol, New York, NY USA; [Agapova, Olga A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO USA; [Yang, Ping] Washington Univ, Sch Med, Dept Pediat, St Louis, MO USA; [Gu, Charles C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; City University of New York (CUNY) System; City College of New York (CUNY); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Miao, HX (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	m-hernandez-neufeld@northwestern.edu	Riordan, Sean Michael/A-9053-2012; Gu, C. Charles/A-7934-2010	Riordan, Sean Michael/0000-0001-5727-1221; Gu, C. Charles/0000-0002-8527-8145	NIH [EY-06416]; NATIONAL EYE INSTITUTE [R01EY006416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grant EY-06416 and an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova OA, 2001, GLIA, V33, P205, DOI 10.1002/1098-1136(200103)33:3<205::AID-GLIA1019>3.0.CO;2-D; Agapova OA, 2003, BRAIN RES, V967, P132, DOI 10.1016/S0006-8993(02)04234-8; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Beattie J, 2006, BIOCHEM J, V395, P1, DOI 10.1042/BJ20060086; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flores C, 2007, GENET EPIDEMIOL, V31, P296, DOI 10.1002/gepi.20210; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; GALLAGHER PJ, 1992, J BIOL CHEM, V267, P9450; Gao L, 2006, AM J RESP CELL MOL, V34, P487, DOI 10.1165/rcmb.2005-0404OC; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Gris P, 2007, GLIA, V55, P1145, DOI 10.1002/glia.20537; Gutjahr MC, 2005, EXP CELL RES, V308, P422, DOI 10.1016/j.yexcr.2005.05.001; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Heckbert SR, 2003, CIRCULATION, V107, P2021, DOI 10.1161/01.CIR.0000065231.07729.92; Hernandez MR, 2002, GLIA, V38, P45, DOI 10.1002/glia.10051; Hernandez MR, 1997, ARCH OPHTHALMOL-CHIC, V115, P389, DOI 10.1001/archopht.1997.01100150391013; Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Juronen E, 2000, EXP EYE RES, V71, P447, DOI 10.1006/exer.2000.0899; Karonen T, 1997, BRIT J DERMATOL, V137, P51, DOI 10.1046/j.1365-2133.1997.17671859.x; Ke N, 2007, MOL CANCER THER, V6, P1840, DOI 10.1158/1535-7163.MCT-07-0066; Kobayashi S, 1997, GLIA, V20, P262, DOI 10.1002/(SICI)1098-1136(199707)20:3<262::AID-GLIA10>3.0.CO;2-S; Leclerc N, 2000, J NEUROSCI RES, V60, P602, DOI 10.1002/(SICI)1097-4547(20000601)60:5<602::AID-JNR5>3.0.CO;2-F; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Liang YB, 2005, FEBS J, V272, P791, DOI 10.1111/j.1742-4658.2004.04516.x; Liu B, 2006, J NEUROSCI, V26, P7532, DOI 10.1523/JNEUROSCI.1004-06.2006; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Mense SM, 2006, PHYSIOL GENOMICS, V25, P435, DOI 10.1152/physiolgenomics.00315.2005; Mi HY, 1999, J NEUROSCI, V19, P1049; Milner R, 2001, MOL CELL NEUROSCI, V18, P108, DOI 10.1006/mcne.2001.1003; Morrison John C, 2006, Trans Am Ophthalmol Soc, V104, P453; Nemesure B, 2003, HUM GENET, V112, P600, DOI 10.1007/s00439-003-0910-z; NETLAND PA, 1995, OPHTHALMOLOGY, V102, P878, DOI 10.1016/S0161-6420(95)30939-6; Neufeld AH, 1997, ARCH OPHTHALMOL-CHIC, V115, P497, DOI 10.1001/archopht.1997.01100150499009; Ohlmann AV, 2005, CURR EYE RES, V30, P27, DOI 10.1080/02713680490894333; Onishi Y, 2003, CLIN EXP METASTAS, V20, P51, DOI 10.1023/A:1022594503657; Pena JDO, 1999, BRIT J OPHTHALMOL, V83, P209, DOI 10.1136/bjo.83.2.209; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; QUIGLEY HA, 1983, AM J OPHTHALMOL, V95, P673, DOI 10.1016/0002-9394(83)90389-6; RANSOHOFF RM, 1991, ARCH NEUROL-CHICAGO, V48, P1244, DOI 10.1001/archneur.1991.00530240048017; Ricard CS, 2000, MOL BRAIN RES, V81, P62, DOI 10.1016/S0169-328X(00)00150-9; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rotimi CN, 2006, INVEST OPHTH VIS SCI, V47, P3262, DOI 10.1167/iovs.05-1537; Rudzinski MN, 2008, ARCH OPHTHALMOL-CHIC, V126, P679, DOI 10.1001/archopht.126.5.679; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Saharinen J, 1999, CYTOKINE GROWTH F R, V10, P99, DOI 10.1016/S1359-6101(99)00010-6; Salvador-Silva M, 2004, GLIA, V45, P364, DOI 10.1002/glia.10342; Sappington RM, 2006, INVEST OPHTH VIS SCI, V47, P3860, DOI 10.1167/iovs.05-1408; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmidt JF, 2007, BRIT J OPHTHALMOL, V91, P1219, DOI 10.1136/bjo.2006.112185; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Tezel G, 2000, J NEUROSCI, V20, P8693; Tezel G, 2006, PROG RETIN EYE RES, V25, P490, DOI 10.1016/j.preteyeres.2006.07.003; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; Tschumperlin DJ, 2004, NATURE, V429, P83, DOI 10.1038/nature02543; Tu HM, 2002, J BIOL CHEM, V277, P23092, DOI 10.1074/jbc.M107583200; Unal M, 2007, BRIT J OPHTHALMOL, V91, P527, DOI 10.1136/bjo.2006.102418; Urban Z, 2007, INVEST OPHTH VIS SCI, V48, P3209, DOI 10.1167/iovs.07-0107; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Vuori K, 1999, NAT CELL BIOL, V1, pE85, DOI 10.1038/12081; Wax MB, 2000, BRIT J OPHTHALMOL, V84, P423, DOI 10.1136/bjo.84.4.423; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wordinger R, 2003, MOL VIS, V9, P249; Yang P, 2003, BRAIN RES PROTOC, V12, P67, DOI 10.1016/S1385-299X(03)00073-4; Yildirim O, 2005, GRAEF ARCH CLIN EXP, V243, P327, DOI 10.1007/s00417-004-1013-9	76	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2847	10.1371/journal.pone.0002847	http://dx.doi.org/10.1371/journal.pone.0002847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716680	Green Published, gold			2022-12-27	WOS:000264366600003
J	Pamonsinlapatham, P; Hadj-Slimane, R; Raynaud, F; Bickle, M; Corneloup, C; Barthelaix, A; Lepelletier, Y; Mercier, P; Schapira, M; Samson, J; Mathieu, AL; Hugo, N; Moncorge, O; Mikaelian, I; Dufour, S; Garbay, C; Colas, P				Pamonsinlapatham, Perayot; Hadj-Slimane, Reda; Raynaud, Francoise; Bickle, Marc; Corneloup, Claudine; Barthelaix, Audrey; Lepelletier, Yves; Mercier, Perrine; Schapira, Matthieu; Samson, Jerome; Mathieu, Anne-Laure; Hugo, Nicolas; Moncorge, Olivier; Mikaelian, Ivan; Dufour, Sylvie; Garbay, Christiane; Colas, Pierre			A RasGAP SH3 Peptide Aptamer Inhibits RasGAP-Aurora Interaction and Induces Caspase-Independent Tumor Cell Death	PLOS ONE			English	Article								The Ras GTPase-activating protein RasGAP catalyzes the conversion of active GTP-bound Ras into inactive GDP-bound Ras. However, RasGAP also acts as a positive effector of Ras and exerts an anti-apoptotic activity that is independent of its GAP function and that involves its SH3 (Src homology) domain. We used a combinatorial peptide aptamer approach to select a collection of RasGAP SH3 specific ligands. We mapped the peptide aptamer binding sites by performing yeast two-hybrid mating assays against a panel of RasGAP SH3 mutants. We examined the biological activity of a peptide aptamer targeting a pocket delineated by residues D295/7, L313 and W317. This aptamer shows a caspase-independent cytotoxic activity on tumor cell lines. It disrupts the interaction between RasGAP and Aurora B kinase. This work identifies the above-mentioned pocket as an interesting therapeutic target to pursue and points its cognate peptide aptamer as a promising guide to discover RasGAP small-molecule drug candidates.	[Pamonsinlapatham, Perayot; Hadj-Slimane, Reda; Raynaud, Francoise; Samson, Jerome; Garbay, Christiane] Univ Paris 05, UFR Biomed, INSERM, Lab Pharmacochim Mol & Cellulaire,U648, Paris, France; [Bickle, Marc; Corneloup, Claudine; Barthelaix, Audrey; Mercier, Perrine; Schapira, Matthieu; Mathieu, Anne-Laure; Hugo, Nicolas; Moncorge, Olivier; Mikaelian, Ivan; Colas, Pierre] Aptanomics, Lyon, France; [Lepelletier, Yves] Univ Paris 05, Hop Necker, CNRS, UMR 8147, Paris, France; [Dufour, Sylvie] Inst Curie, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Pamonsinlapatham, P (corresponding author), Univ Paris 05, UFR Biomed, INSERM, Lab Pharmacochim Mol & Cellulaire,U648, Paris, France.	christiane.garbay@univ-paris5.fr	Moncorge, Olivier/E-3233-2017; DUFOUR, Sylvie/G-2253-2019; lepelletier, yves/AAF-1546-2020	Moncorge, Olivier/0000-0003-0512-1824; lepelletier, yves/0000-0001-7746-5170; Dufour, Sylvie/0000-0002-6663-0676; Colas, Pierre/0000-0001-7436-3718; Mathieu, Anne-Laure/0000-0002-2893-7001	French Ministry of Research [02L0521]; "Ligue Nationale Contre le Cancer", Equipe Labellisee	French Ministry of Research(Ministry of Research, FranceEuropean Commission); "Ligue Nationale Contre le Cancer", Equipe Labellisee(Ligue nationale contre le cancer)	This work was funded by the French Ministry of Research (AC2002 "Molecules et cibles therapeutiques" -n 02L0521). INSERM U648 is supported by the "Ligue Nationale Contre le Cancer", Equipe Labellisee 2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed N, 2007, MOL CELL PROTEOMICS, V6, P2110, DOI 10.1074/mcp.M700105-MCP200; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Appels NMGM, 2005, ONCOLOGIST, V10, P565, DOI 10.1634/theoncologist.10-8-565; Baines IC, 2006, DRUG DISCOV TODAY, V11, P334, DOI 10.1016/j.drudis.2006.02.007; Bickle MBT, 2006, NAT PROTOC, V1, P1066, DOI 10.1038/nprot.2006.32; Colas P, 1996, NATURE, V380, P548, DOI 10.1038/380548a0; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Goto S, 2002, J TURBUL, V3; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hoppe-Seyler F, 2004, CURR MOL MED, V4, P529, DOI 10.2174/1566524043360519; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Leblanc V, 1999, ONCOGENE, V18, P4884, DOI 10.1038/sj.onc.1202855; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Michod D, 2004, ONCOGENE, V23, P8971, DOI 10.1038/sj.onc.1207999; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; Parker F, 1996, MOL CELL BIOL, V16, P2561; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tomai E, 2006, J BIOL CHEM, V281, P21345, DOI 10.1074/jbc.M604258200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x	25	12	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2902	10.1371/journal.pone.0002902	http://dx.doi.org/10.1371/journal.pone.0002902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682833	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600058
J	Dani, FR; Francese, S; Mastrobuoni, G; Felicioli, A; Caputo, B; Simard, F; Pieraccini, G; Moneti, G; Coluzzi, M; della Torre, A; Turillazzi, S				Dani, Francesca R.; Francese, Simona; Mastrobuoni, Guido; Felicioli, Antonio; Caputo, Beniamino; Simard, Frederic; Pieraccini, Giuseppe; Moneti, Gloriano; Coluzzi, Mario; della Torre, Alessandra; Turillazzi, Stefano			Exploring Proteins in Anopheles gambiae Male and Female Antennae through MALDI Mass Spectrometry Profiling	PLOS ONE			English	Article								MALDI profiling and imaging mass spectrometry (IMS) are novel techniques for direct analysis of peptides and small proteins in biological tissues. In this work we applied them to the study of Anopheles gambiae antennae, with the aim of analysing expression of soluble proteins involved in olfaction perireceptor events. MALDI spectra obtained by direct profiling on single antennae and by the analysis of extracts, showed similar profiles, although spectra obtained through profiling had a richer ion population and higher signal to noise ratio. Male and female antennae showed distinct protein profiles. MALDI imaging experiments were also performed and differences were observed in the localization of some proteins. Two proteins were identified through high resolution measurement and top-down MS/MS experiments. A 8 kDa protein only present in the male antennae matched with an unannotated sequence of the An. gambiae genome, while the presence of odorant binding protein 9 (OBP-9) was confirmed through experiments of 2-DE, followed by MS and MS/MS analysis of digested spots. This work shows that MALDI MS profiling is a technique suitable for the analysis of proteins of small and medium MW in insect appendices, and allows obtaining data for several specimens which can be investigated for differences between groups. Proteins of interest can be identified through other complementary MS approaches.	[Dani, Francesca R.; Francese, Simona; Mastrobuoni, Guido; Pieraccini, Giuseppe; Moneti, Gloriano; Turillazzi, Stefano] Univ Florence, Ctr Interdipartimentale Spettrometria Massa, Florence, Italy; [Felicioli, Antonio] Univ Pisa, Dipartimento Anatom, Biochim Fisiol Vet, Pisa, Italy; [Caputo, Beniamino; Coluzzi, Mario; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sezione Parassitol, Rome, Italy; [Simard, Frederic] Inst Rech Dev, Montpellier, France; [Simard, Frederic] Org Coordinat Lutte Endemies Afrique, Yaounde, Cameroon	University of Florence; University of Pisa; Sapienza University Rome; Institut de Recherche pour le Developpement (IRD)	Dani, FR (corresponding author), Univ Florence, Ctr Interdipartimentale Spettrometria Massa, Florence, Italy.	francescaromana.dani@unifi.it	Caputo, Beniamino/I-2880-2015; mastrobuoni, guido/J-3660-2012; Felicioli, Antonio/AAT-2167-2021; Dani, Francesca Romana/O-9120-2018; Frederic, SIMARD/AFV-5001-2022; SIMARD, Frederic/J-9489-2016	Caputo, Beniamino/0000-0002-5650-8773; Dani, Francesca Romana/0000-0002-2939-2103; Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Mastrobuoni, Guido/0000-0003-4509-1295; Pieraccini, Giuseppe/0000-0003-3103-3924	Italian Ministry for University and Research; PRIN 2006 programme; Ente Cassa di Risparmio di Firenze	Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); PRIN 2006 programme(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	Financial support was provided by Italian Ministry for University and Research, PRIN 2006 programme, and by the Ente Cassa di Risparmio di Firenze (within the grants 2003 and 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], [No title captured]; Biessmann H, 2005, INSECT MOL BIOL, V14, P575, DOI 10.1111/j.1365-2583.2005.00590.x; Campbell PM, 2005, SYST ENTOMOL, V30, P186, DOI 10.1111/j.1365-3113.2004.00279.x; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Clynen E, 2001, EUR J BIOCHEM, V268, P1929, DOI 10.1046/j.1432-1327.2001.02067.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Hummon AB, 2006, MASS SPECTROM REV, V25, P77, DOI 10.1002/mas.20055; Justice RW, 2003, INSECT MOL BIOL, V12, P581, DOI 10.1046/j.1365-2583.2003.00443.x; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Perera MR, 2005, ENTOMOL EXP APPL, V117, P243, DOI 10.1111/j.1570-7458.2005.00353.x; Rubakhin SS, 2003, ANAL CHEM, V75, P5374, DOI 10.1021/ac034498+; Rubakhin SS, 2000, NAT BIOTECHNOL, V18, P172, DOI 10.1038/72622; Scarselli R, 2005, PROTEOMICS, V5, P769, DOI 10.1002/pmic.200401149; Schwartz SA, 2004, CLIN CANCER RES, V10, P981, DOI 10.1158/1078-0432.CCR-0927-3; SEELEY EH, 2008, J AM SOC MA IN PRESS; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Turillazzi S, 2007, J MASS SPECTROM, V42, P199, DOI 10.1002/jms.1152; Verhaert PD, 2007, INT J MASS SPECTROM, V260, P177, DOI 10.1016/j.ijms.2006.11.008; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yew JY, 2003, RAPID COMMUN MASS SP, V17, P2693, DOI 10.1002/rcm.1240; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	24	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2822	10.1371/journal.pone.0002822	http://dx.doi.org/10.1371/journal.pone.0002822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665262	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300041
J	Li, NYK; Verdolini, K; Clermont, G; Mi, Q; Rubinstein, EN; Hebda, PA; Vodovotz, Y				Li, Nicole Y. K.; Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Rubinstein, Elaine N.; Hebda, Patricia A.; Vodovotz, Yoram			A Patient-Specific in silico Model of Inflammation and Healing Tested in Acute Vocal Fold Injury	PLOS ONE			English	Article							CLINICAL-TRIALS; LIGAMENT; MARKERS; IMMOBILIZATION; MOBILIZATION; NEUTROPHILS; VALIDATION; COMPLEXITY; SECRETIONS; DISORDERS	The development of personalized medicine is a primary objective of the medical community and increasingly also of funding and registration agencies. Modeling is generally perceived as a key enabling tool to target this goal. Agent-Based Models (ABMs) have previously been used to simulate inflammation at various scales up to the whole-organism level. We extended this approach to the case of a novel, patient-specific ABM that we generated for vocal fold inflammation, with the ultimate goal of identifying individually optimized treatments. ABM simulations reproduced trajectories of inflammatory mediators in laryngeal secretions of individuals subjected to experimental phonotrauma up to 4 hrs post-injury, and predicted the levels of inflammatory mediators 24 hrs post-injury. Subject-specific simulations also predicted different outcomes from behavioral treatment regimens to which subjects had not been exposed. We propose that this translational application of computational modeling could be used to design patient-specific therapies for the larynx, and will serve as a paradigm for future extension to other clinical domains.	[Li, Nicole Y. K.; Verdolini, Katherine; Hebda, Patricia A.; Vodovotz, Yoram] Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA; [Verdolini, Katherine; Hebda, Patricia A.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA USA; [Verdolini, Katherine] Univ Pittsburgh, Univ Pittsburgh Voice Ctr, Pittsburgh, PA USA; [Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Vodovotz, Yoram] Univ Pittsburgh, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA USA; [Clermont, Gilles] Univ Pittsburgh, Dept Critical Care Med, Pittsburgh, PA USA; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Verdolini, Katherine; Clermont, Gilles; Mi, Qi; Hebda, Patricia A.; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Rubinstein, Elaine N.] Univ Pittsburgh, Office Measurement & Evaluat Teach, Pittsburgh, PA USA; [Hebda, Patricia A.] Childrens Hosp Pittsburgh, Otolaryngol Wound Heal Lab, Pittsburgh, PA USA; [Hebda, Patricia A.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Verdolini, K (corresponding author), Univ Pittsburgh, Dept Commun Sci & Disorders, Pittsburgh, PA 15260 USA.	kittie@csd.pitt.edu		Li-Jessen, Nicole/0000-0003-2963-4763	National Institutes of Health [R01-DC-005643, R01-DC-008290]; National Institute on Deafness and Other Communication Disorders; National Institute of General Medical Sciences [P50-GM-53789-09]; National Institute for Disability Rehabilitation Research [H133E070024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM053789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008290, R01DC005643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Disability Rehabilitation Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported in part by the National Institutes of Health grants R01-DC-005643 and R01-DC-008290 to K. Verdolini from the National Institute on Deafness and Other Communication Disorders; grant P50-GM-53789-09 (Project V) from the National Institute of General Medical Sciences to Y. Vodovotz and G. Clermont, and grant H133E070024 (Developmental Project 1) from the National Institute for Disability Rehabilitation Research to Y. Vodovotz and Q. Mi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An G, 2005, CRIT CARE MED, V33, P253, DOI 10.1097/01.CCM.0000150753.86953.10; An G, 2004, CRIT CARE MED, V32, P2050, DOI 10.1097/01.CCM.0000139707.13729.7D; An G, 2001, SHOCK, V16, P266, DOI 10.1097/00024382-200116040-00006; An G, 2008, J BURN CARE RES, V29, P277, DOI 10.1097/BCR.0b013e31816677c8; BARCELLOSHOFF MH, 1995, AM J PATHOL, V147, P1228; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Branski RC, 2004, ANN OTO RHINOL LARYN, V113, P23, DOI 10.1177/000348940411300105; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105; BRANSKI RC, 2006, J VOICE; BRANSKI RC, 2005, THESIS U PITTSBURGH, P1; BURROUGHS P, 1990, AM J SPORT MED, V18, P376, DOI 10.1177/036354659001800407; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Calvin M, 1998, WOUNDS, V10, P12; Catten M, 1998, OTOLARYNG HEAD NECK, V118, P663, DOI 10.1177/019459989811800516; Chong HY, 1999, J CELL PHYSIOL, V178, P275, DOI 10.1002/(SICI)1097-4652(199903)178:3<275::AID-JCP1>3.3.CO;2-H; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; CLARK RAF, 1988, PROG DERMATOL, V22, P1; Clark RAF, 1998, MOL CELLULAR BIOL WO; Clermont G, 2004, CRIT CARE MED, V32, P2061, DOI 10.1097/01.CCM.0000142394.28791.C3; COCKBILL S, 2002, HOSP PHARM, V9, P255; Courey MS, 1996, ANN OTO RHINOL LARYN, V105, P525, DOI 10.1177/000348949610500706; DAY J, 2006, J THEOR BIOL; de Melo ECM, 2003, LARYNGOSCOPE, V113, P2187; EIFF MP, 1994, AM J SPORT MED, V22, P83, DOI 10.1177/036354659402200115; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; ERMENTROUT GB, 1993, J THEOR BIOL, V160, P97, DOI 10.1006/jtbi.1993.1007; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Goldring SR, 2003, CALCIFIED TISSUE INT, V73, P97, DOI 10.1007/s00223-002-1049-y; GRAY S, 1988, ANN OTO RHINOL LARYN, V97, P381, DOI 10.1177/000348948809700410; Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115; GRAY SD, 1995, ANN OTO RHINOL LARYN, V104, P13, DOI 10.1177/000348949510400103; GRAY SD, 1987, J VOICE, V1, P109; GRAY SD, 2000, OTOLARYNGOLOGIC CLIN; GRAY SD, 1991, BASEMENT MEMBRANE ZO, P1; Gunter HE, 2004, J BIOMECH, V37, P1119, DOI 10.1016/j.jbiomech.2003.11.007; Gunter HE, 2003, J ACOUST SOC AM, V113, P994, DOI 10.1121/1.1534100; Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311; HARDY MA, 1989, PHYS THER, V69, P1014, DOI 10.1093/ptj/69.12.1014; Hart J, 2002, J Wound Care, V11, P245; Hart J, 2002, J Wound Care, V11, P205; Hirschi SD, 2002, J VOICE, V16, P310, DOI 10.1016/S0892-1997(02)00102-9; Jacobson BH, 1997, AM J SPEECH LANGUAGE, V6, P66, DOI DOI 10.1044/1058-0360.0603.66; Jiang JJ, 1998, ANN OTO RHINOL LARYN, V107, P603, DOI 10.1177/000348949810700711; Kerkhoffs G.M.M.J., 2002, COCHRANE DB SYST REV, pCD002938, DOI [10.1002/14651858.CD002938, DOI 10.1002/14651858.CD002938]; Kerkhoffs GMMJ, 2003, ACTA ORTHOP SCAND, V74, P69, DOI 10.1080/00016470310013699; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; KUMAR R, MATH SIMULA IN PRESS; Kvist J, 2004, SPORTS MED, V34, P269, DOI 10.2165/00007256-200434040-00006; LI NYK, 2006, SIMULATING ACUTE PHO; Ma EPM, 2001, J SPEECH LANG HEAR R, V44, P511, DOI 10.1044/1092-4388(2001/040); Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; MI Q, WOUND REPAI IN PRESS; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Morrison M, 1994, MANAGEMENT VOICE DIS; MULLIGAN B, 1995, MANUAL THERAPY NAGS, P78; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NEVES BMJ, 2004, BRAZILLIAN J OTOLARY, V70, P439; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; Paungmali A, 2003, PHYS THER, V83, P374, DOI 10.1093/ptj/83.4.374; PETERSON KL, 1994, ANN OTO RHINOL LARYN, V103, P335, DOI 10.1177/000348949410300501; Pijnenburg ACM, 2000, J BONE JOINT SURG AM, V82A, P761, DOI 10.2106/00004623-200006000-00002; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Raaijmakers MF, 1998, FOLIA PHONIATR LOGO, V50, P71, DOI 10.1159/000021452; Railsback Steven F., 2001, Natural Resource Modeling, V14, P465; Redd MJ, 2004, PHILOS T R SOC B, V359, P777, DOI 10.1098/rstb.2004.1466; REYNOLDS A, 2006, J THEOR BIOL; ROBERTS AB, 1996, MOL CELLULAR BIOL WO, P275; Robson MC, 2001, CURR PROB SURG, V38, P65; SALTER RB, 1994, HAND CLIN, V10, P211; Salter RB, 1996, HAND CLIN, V12, P1; SATALOFF RT, 1997, VOICE REST, P453; Smallwood RH, 2004, J MOL HISTOL, V35, P659; Smith E., 1996, J MED SPEECH-LANG PA, V4, P223; STEMPLE JC, 1994, J VOICE, V8, P271, DOI 10.1016/S0892-1997(05)80299-1; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P469, DOI 10.1177/000348940611500612; Taylor KR, 2004, J BIOL CHEM, V279, P17079, DOI 10.1074/jbc.M310859200; Thibeault SL, 2003, J VOICE, V17, P377, DOI 10.1067/S0892-1997(03)00064-X; Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4; Thibeault SL, 2002, ANN OTO RHINOL LARYN, V111, P302, DOI 10.1177/000348940211100404; Thomson SL, 2005, J ACOUST SOC AM, V118, P1689, DOI 10.1121/1.2000787; Thornton GM, 2003, J ORTHOPAED RES, V21, P716, DOI 10.1016/S0736-0266(03)00051-2; THRELKELD AJ, 1992, MANUAL THERAPY AM PH, P59; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007; Toumi H, 2006, J ANAT, V208, P459, DOI 10.1111/j.1469-7580.2006.00543.x; Verdolini K, 1998, J VOICE, V12, P315, DOI 10.1016/S0892-1997(98)80021-0; Verdolini K, 2003, ANN OTO RHINOL LARYN, V112, P1021, DOI 10.1177/000348940311201205; VERDOLINI K, 2000, CASE STUDY RESONANT, P46; VERDOLINI K, EFFECT TARGETE UNPUB; VERDOLINI K, EFFECT RESONAN UNPUB; VERDOLINIMARSTON K, 1995, J VOICE, V9, P74, DOI 10.1016/S0892-1997(05)80225-5; Visser NA, 1998, CONNECT TISSUE RES, V37, P295, DOI 10.3109/03008209809002446; Vodovotz Y, 2006, SHOCK, V25, P39, DOI 10.1097/00024382-200606001-00118; Vodovotz Y, 1999, CANCER RES, V59, P2142; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; Vodovotz Yoram, 2004, Curr Opin Crit Care, V10, P383, DOI 10.1097/01.ccx.0000139360.30327.69; Vodovotz Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000014; Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680; Walter J.B., 1987, GEN PATHOLOGY, V6th; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Whitcomb DC, 2005, DIGEST DIS SCI, V50, P2195, DOI 10.1007/s10620-005-3033-7; WILLIAMS JM, 1994, CLIN ORTHOP RELAT R, V304, P252; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1	106	65	68	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2789	10.1371/journal.pone.0002789	http://dx.doi.org/10.1371/journal.pone.0002789			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665229	gold, Green Published, Green Accepted			2022-12-27	WOS:000264304300008
J	Sadikovic, B; Yoshimoto, M; Al-Romaih, K; Maire, G; Zielenska, M; Squire, JA				Sadikovic, Bekim; Yoshimoto, Maisa; Al-Romaih, Khaldoun; Maire, Georges; Zielenska, Maria; Squire, Jeremy A.			In Vitro Analysis of Integrated Global High-Resolution DNA Methylation Profiling with Genomic Imbalance and Gene Expression in Osteosarcoma	PLOS ONE			English	Article								Genetic and epigenetic changes contribute to deregulation of gene expression and development of human cancer. Changes in DNA methylation are key epigenetic factors regulating gene expression and genomic stability. Recent progress in microarray technologies resulted in developments of high resolution platforms for profiling of genetic, epigenetic and gene expression changes. OS is a pediatric bone tumor with characteristically high level of numerical and structural chromosomal changes. Furthermore, little is known about DNA methylation changes in OS. Our objective was to develop an integrative approach for analysis of high-resolution epigenomic, genomic, and gene expression profiles in order to identify functional epi/genomic differences between OS cell lines and normal human osteoblasts. A combination of Affymetrix Promoter Tilling Arrays for DNA methylation, Agilent array-CGH platform for genomic imbalance and Affymetrix Gene 1.0 platform for gene expression analysis was used. As a result, an integrative high-resolution approach for interrogation of genome-wide tumour-specific changes in DNA methylation was developed. This approach was used to provide the first genomic DNA methylation maps, and to identify and validate genes with aberrant DNA methylation in OS cell lines. This first integrative analysis of global cancer-related changes in DNA methylation, genomic imbalance, and gene expression has provided comprehensive evidence of the cumulative roles of epigenetic and genetic mechanisms in deregulation of gene expression networks.	[Sadikovic, Bekim; Zielenska, Maria] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Sadikovic, Bekim; Zielenska, Maria] Hosp Sick Children, Genet & Genome Biol Program, Toronto, ON, Canada; [Sadikovic, Bekim; Yoshimoto, Maisa; Al-Romaih, Khaldoun; Maire, Georges; Squire, Jeremy A.] UHN, OCI, Dept Res, Div Cellular & Mol Biol, Toronto, ON, Canada; [Squire, Jeremy A.] Queens Univ, Richardson Labs, Dept Pathol & Mol Med, Kingston, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Queens University - Canada	Sadikovic, B (corresponding author), Hosp Sick Children, Dept Pediat Lab Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	squirej@queensu.ca	Squire, Jeremy A/F-4437-2012; Squire, Jeremy A/A-9352-2012	Squire, Jeremy A/0000-0002-9863-468X	National Cancer Institute of Canada [16215]; Canadian Cancer Society; Terry Fox Foundation [Post Doctoral Fellowship]; Hospital for Sick Children, Toronto, Canada [Restracomp Fellowship]	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Hospital for Sick Children, Toronto, Canada	This work was funded by the National Cancer Institute of Canada grant #16215 with funds from the Canadian Cancer Society. BS is a recipient of the Post Doctoral Fellowship form the Terry Fox Foundation, and the National Cancer Institute of Canada and the Restracomp Fellowship from The Hospital for Sick Children, Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Romaih K, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-14; Al-Romaih K, 2008, NEOPLASIA, V10, P471, DOI 10.1593/neo.08174; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Batanian JR, 2002, J CLIN PATHOL-MOL PA, V55, P389, DOI 10.1136/mp.55.6.389; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; BEDFORD MT, 1987, CANCER RES, V47, P5274; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; DiNardo DNM, 2001, ONCOGENE, V20, P5331, DOI 10.1038/sj.onc.1204697; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; FEINBERG AP, 1983, BIOCHEM BIOPH RES CO, V111, P47, DOI 10.1016/S0006-291X(83)80115-6; Figueroa ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001882; FORUS A, 1995, GENE CHROMOSOME CANC, V14, P15, DOI 10.1002/gcc.2870140104; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2002, ONCOGENE, V21, P4345, DOI 10.1038/sj.onc.1205446; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jurgens B, 1996, CANCER RES, V56, P5698; KIM YI, 1994, CANCER, V74, P893, DOI 10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; Kindich R, 2006, EUR UROL, V49, P169, DOI 10.1016/j.eururo.2005.09.012; Lim G, 2005, GENE CHROMOSOME CANC, V42, P392, DOI 10.1002/gcc.20157; Lim G, 2004, CANCER GENET CYTOGEN, V153, P158, DOI 10.1016/j.cancergencyto.2004.01.016; Lin CH, 2001, CANCER RES, V61, P4238; Lock GSH, 1998, T CAN SOC MECH ENG, V22, P207; Maire G, 2003, GENE CHROMOSOME CANC, V37, P389, DOI 10.1002/gcc.10223; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Mancini DN, 1998, ONCOGENE, V16, P1161, DOI 10.1038/sj.onc.1201630; Momparler RL, 2000, J CELL PHYSIOL, V183, P145, DOI 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Ozaki T, 2003, CANCER GENET CYTOGEN, V140, P145, DOI 10.1016/S0165-4608(02)00685-4; Papaggeli P C, 2003, J BUON, V8, P341; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Roman-Gomez J, 2008, LEUKEMIA RES, V32, P487, DOI 10.1016/j.leukres.2007.07.021; Ryhanen S, 1997, J CELL BIOCHEM, V66, P404, DOI 10.1002/(SICI)1097-4644(19970901)66:3<404::AID-JCB12>3.0.CO;2-E; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sandberg AA, 2003, CANCER GENET CYTOGEN, V145, P1, DOI 10.1016/S0165-4608(03)00105-5; Schulz WA, 2002, GENE CHROMOSOME CANC, V35, P58, DOI 10.1002/gcc.10092; Selvarajah S, 2007, CANCER GENET CYTOGEN, V179, P52, DOI 10.1016/j.cancergencyto.2007.08.003; SHANN YJ, 2008, GENOME RES; SINGH VP, 1993, J SOC INF DISPLAY, V1, P135; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Sugihara T, 2007, NEC TECH J, V2, P26; Tarkkanen M, 1999, INT J CANCER, V84, P114, DOI 10.1002/(SICI)1097-0215(19990420)84:2<114::AID-IJC4>3.0.CO;2-Q; TSUKAMOTO N, 1992, EXP HEMATOL, V20, P1061; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Ulaner GA, 2003, HUM MOL GENET, V12, P535, DOI 10.1093/hmg/ddg034; Villagra A, 2002, J CELL BIOCHEM, V85, P112, DOI 10.1002/jcb.10113; WAHLFORS J, 1992, BLOOD, V80, P2074; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wong N, 2001, AM J PATHOL, V159, P465, DOI 10.1016/S0002-9440(10)61718-X; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zielenska M, 2004, CYTOGENET GENOME RES, V107, P77, DOI 10.1159/000079574; Zielenska M, 2001, CANCER GENET CYTOGEN, V130, P14, DOI 10.1016/S0165-4608(01)00461-7	55	61	64	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2834	10.1371/journal.pone.0002834	http://dx.doi.org/10.1371/journal.pone.0002834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18698372	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300053
J	Pickar, D; Vinik, J; Bartko, JJ				Pickar, David; Vinik, Jessie; Bartko, John J.			Pharmacotherapy of Schizophrenic Patients: Preponderance of Off-Label Drug Use	PLOS ONE			English	Article							LATEST ANTIPSYCHOTIC-DRUGS; COST-UTILITY; POLYPHARMACY; MEDICATIONS; 2ND-GENERATION; DEPRESSION; OLANZAPINE; PROMOTION; GUIDANCE; AGENTS	Multiple drug class combinations are often prescribed for the treatment of schizophrenia, although antipsychotic monotherapy reflects FDA labeling and scientific justification for combinations is highly variable. This study was performed to gain current data regarding drug treatment of schizophrenia as practiced in the community and to assess the frequencies of off-label drug class combinations. 200 DSM IV-diagnosed schizophrenic patients recruited from community treatment sources participated in this cross-sectional study of community based schizophrenic patients. Drug class categories include First and Second Generation Antipsychotic drugs (FGA and SGA, respectively), mood stabilizers, antidepressants and anti-anxiety drugs. 25.5% of patients received antipsychotic monotherapy; 70% of patients received an antipsychotic and another drug class. A total of 42.5% of patients received more than one antipsychotic drug. The most common drug class combination was antipsychotic and a mood stabilizer. Stepwise linear discriminant function analysis identified the diagnosis of schizoaffective schizophrenia, history of having physically hurt someone and high scores on the General Portion of the PANSS rating scale predicted the combined use of an antipsychotic drug and a mood stabilizer. "Real world'' pharmacotherapy of schizophrenia has developed its own established practice that is predominantly off-label and may have outstripped current data support. The economic implications for public sector payers are substantial as well as for the revenue of the pharmaceutical industry, whose promotion of off-label drug use is an increasingly problematic. These data are consistent with the recognition of the therapeutic limitations of both first and second generation antipsychotic drugs.	[Pickar, David; Vinik, Jessie] Gabriel Sci LLC, Cabin John, MD USA; [Pickar, David] Johns Hopkins Med Sch, Dept Psychiat, Baltimore, MD 21287 USA; [Pickar, David] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Bartko, John J.] Univ Maryland, Sch Med, Dept Stat, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; University System of Maryland; University of Maryland Baltimore	Pickar, D (corresponding author), Gabriel Sci LLC, Cabin John, MD USA.	dpickar@gabrielpharma.com		Pickar, David/0000-0002-8596-3687	NIH SBIR [R44MH67351-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R44MH067351] Funding Source: NIH RePORTER	NIH SBIR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH SBIR Grant # R44MH67351-02. This funding source had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, DIAGN STAT MAN MENT; Barbui C, 2006, INT CLIN PSYCHOPHARM, V21, P355, DOI 10.1097/01.yic.0000224785.68040.43; Buchanan RW, 2002, AM J PSYCHIAT, V159, P1035, DOI 10.1176/appi.ajp.159.6.1035; Casey DE, 2003, NEUROPSYCHOPHARMACOL, V28, P182, DOI 10.1038/sj.npp.1300023; Centorrino F, 2004, AM J PSYCHIAT, V161, P700, DOI 10.1176/appi.ajp.161.4.700; Chakos MH, 2006, PSYCHIAT SERV, V57, P1094, DOI 10.1176/appi.ps.57.8.1094; Clark RE, 2002, SCHIZOPHRENIA BULL, V28, P75, DOI 10.1093/oxfordjournals.schbul.a006928; Correll CU, 2007, SCHIZOPHR RES, V89, P91, DOI 10.1016/j.schres.2006.08.017; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; DeMonaco HJ, 2006, PHARMACOTHERAPY, V26, P323, DOI 10.1592/phco.26.3.323; Glick ID, 2004, J CLIN PSYCHIAT, V65, P679, DOI 10.4088/jcp.v65n0513; Glick ID, 2006, J CLIN PSYCHIAT, V67, P1261, DOI 10.4088/JCP.v67n0813; Henney JE, 2006, ANN INTERN MED, V145, P305, DOI 10.7326/0003-4819-145-4-200608150-00013; Jones PB, 2006, ARCH GEN PSYCHIAT, V63, P1079, DOI 10.1001/archpsyc.63.10.1079; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kreyenbuhl J, 2006, SCHIZOPHR RES, V84, P90, DOI 10.1016/j.schres.2006.02.023; Levinson DF, 1999, AM J PSYCHIAT, V156, P1138; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lieberman JA, 2006, ARCH GEN PSYCHIAT, V63, P1069, DOI 10.1001/archpsyc.63.10.1069; *MICR, 2002, MICR HEALTHC SER; Mitka M, 2008, JAMA-J AM MED ASSOC, V299, P1759, DOI 10.1001/jama.299.15.1759; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; PATICK V, 2006, PSYCHIAT SERV, V57, P21; PICKAR D, 1995, LANCET, V345, P557, DOI 10.1016/S0140-6736(95)90469-7; Procyshyn RM, 2001, CAN J PSYCHIAT, V46, P334, DOI 10.1177/070674370104600404; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rosenheck RA, 2006, ARCH GEN PSYCHIAT, V63, P1074, DOI 10.1001/archpsyc.63.10.1074; Rosenheck RA, 2006, PSYCHIAT SERV, V57, P1093, DOI 10.1176/appi.ps.57.8.1093; Siris SG, 2000, AM J PSYCHIAT, V157, P1379, DOI 10.1176/appi.ajp.157.9.1379; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; Stahl SM, 1999, J CLIN PSYCHIAT, V60, P425, DOI 10.4088/JCP.v60n0701; Steinman MA, 2006, ANN INTERN MED, V145, P284, DOI 10.7326/0003-4819-145-4-200608150-00008; Swartz MS, 2007, AM J PSYCHIAT, V164, P428, DOI 10.1176/appi.ajp.164.3.428; TAPP A, 1999, PSYCHIAT SERV, V54, P55; Tempier RP, 2003, J CLIN PSYCHIAT, V64, P673, DOI 10.4088/JCP.v64n0609; THOMSON PDR, 2007, PHYS DESK REFERENCE, P2184; THOMSON PDR, 2007, PHYS DESK REFERENCE; Wassef AA, 2000, J CLIN PSYCHOPHARM, V20, P357, DOI 10.1097/00004714-200006000-00011; WOLKOWITZ OM, 1991, AM J PSYCHIAT, V148, P714; 2004, FDA CONSUM, V4, P36; 2008, FED REG, V74, P9342; 2006, WALL STREET J   1123	43	45	47	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3150	10.1371/journal.pone.0003150	http://dx.doi.org/10.1371/journal.pone.0003150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422KD	18781198	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425700005
J	Fulurija, A; Lutz, TA; Sladko, K; Osto, M; Wielinga, PY; Bachmann, MF; Saudan, P				Fulurija, Alma; Lutz, Thomas A.; Sladko, Katja; Osto, Melania; Wielinga, Peter Y.; Bachmann, Martin F.; Saudan, Philippe			Vaccination against GIP for the Treatment of Obesity	PLOS ONE			English	Article								Background: According to the WHO, more than 1 billion people worldwide are overweight and at risk of developing chronic illnesses, including cardiovascular disease, type 2 diabetes, hypertension and stroke. Current therapies show limited efficacy and are often associated with unpleasant side-effect profiles, hence there is a medical need for new therapeutic interventions in the field of obesity. Gastric inhibitory peptide (GIP, also known as glucose-dependent insulinotropic polypeptide) has recently been postulated to link over-nutrition with obesity. In fact GIP receptor-deficient mice (GIPR(-/-)) were shown to be completely protected from diet-induced obesity. Thus, disrupting GIP signaling represents a promising novel therapeutic strategy for the treatment of obesity. Methodology/Principal Findings: In order to block GIP signaling we chose an active vaccination approach using GIP peptides covalently attached to virus-like particles (VLP-GIP). Vaccination of mice with VLP-GIP induced high titers of specific antibodies and efficiently reduced body weight gain in animals fed a high fat diet. The reduction in body weight gain could be attributed to reduced accumulation of fat. Moreover, increased weight loss was observed in obese mice vaccinated with VLP-GIP. Importantly, despite the incretin action of GIP, VLP-GIP-treated mice did not show signs of glucose intolerance. Conclusions/Significance: This study shows that vaccination against GIP was safe and effective. Thus active vaccination may represent a novel, long-lasting treatment for obesity. However further preclinical safety/ toxicology studies will be required before the therapeutic concept can be addressed in humans.	[Fulurija, Alma; Sladko, Katja; Bachmann, Martin F.; Saudan, Philippe] Cytos Biotechnol AG, Schlieren, Switzerland; [Lutz, Thomas A.; Osto, Melania; Wielinga, Peter Y.] Univ Zurich, Vetsuisse Fac, Ctr Integrat Human Physiol, Inst Vet Physiol, Zurich, Switzerland	University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Fulurija, A (corresponding author), Cytos Biotechnol AG, Schlieren, Switzerland.	philippe.saudan@cytos.com		Fulurija, Alma/0000-0003-1776-785X	Cytos Biotechnology AG	Cytos Biotechnology AG	Most of the work was carried out and financed by Cytos Biotechnology AG.	Ahren B, 2002, DIABETES CARE, V25, P869, DOI 10.2337/diacare.25.5.869; Ambuhl PM, 2007, J HYPERTENS, V25, P63, DOI 10.1097/HJH.0b013e32800ff5d6; ANDERSEN DK, 1978, J CLIN INVEST, V62, P152, DOI 10.1172/JCI109100; Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284; BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784; Blackburn G., 1995, OBES RES S2, V3, P211; Bosello O, 1997, INT J OBESITY, V21, pS10; Chackerian B, 1999, P NATL ACAD SCI USA, V96, P2373, DOI 10.1073/pnas.96.5.2373; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Deacon CF, 2004, HORM METAB RES, V36, P761, DOI 10.1055/s-2004-826160; DUPRE J, 1973, J CLIN ENDOCR METAB, V37, P826, DOI 10.1210/jcem-37-5-826; EBERT R, 1991, HORM METAB RES, V23, P517, DOI 10.1055/s-2007-1003745; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Gault VA, 2002, J ENDOCRINOL, V175, P525, DOI 10.1677/joe.0.1750525; GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397; Greenway Frank L, 2005, Expert Opin Drug Saf, V4, P1083, DOI 10.1517/14740338.4.6.1083; Hansotia T, 2007, J CLIN INVEST, V117, P143, DOI 10.1172/JCI25483; Heijboer AC, 2006, J NEUROENDOCRINOL, V18, P883, DOI 10.1111/j.1365-2826.2006.01492.x; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Ioannides-Demos LL, 2005, DRUGS, V65, P1391, DOI 10.2165/00003495-200565100-00006; Irwin N, 2007, DIABETOLOGIA, V50, P1532, DOI 10.1007/s00125-007-0692-2; Irwin N, 2004, BIOL CHEM, V385, P845, DOI 10.1515/BC.2004.110; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; JOHNSON RN, 1983, CLIN CHIM ACTA, V127, P87, DOI 10.1016/0009-8981(83)90078-5; Kieffer TJ, 2003, TRENDS PHARMACOL SCI, V24, P110, DOI 10.1016/S0165-6147(03)00031-2; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; KOZLOVSKA TM, 1993, GENE, V137, P133, DOI 10.1016/0378-1119(93)90261-Z; Leung WYS, 2003, CLIN THER, V25, P58, DOI 10.1016/S0149-2918(03)90009-9; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Meier JJ, 2001, DIABETES, V50, P2497, DOI 10.2337/diabetes.50.11.2497; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Spohn G, 2005, J IMMUNOL, V175, P6211, DOI 10.4049/jimmunol.175.9.6211; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; WASADA T, 1981, J CLIN INVEST, V68, P1106, DOI 10.1172/JCI110335; Yamada Y, 2004, HORM METAB RES, V36, P771, DOI 10.1055/s-2004-826162; Yip RGC, 1998, ENDOCRINOLOGY, V139, P4004, DOI 10.1210/en.139.9.4004; Yip RGC, 1999, LIFE SCI, V66, P91, DOI 10.1016/S0024-3205(99)00314-8; YUE DK, 1980, DIABETES, V29, P296, DOI 10.2337/diab.29.4.296	48	77	95	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3163	10.1371/journal.pone.0003163	http://dx.doi.org/10.1371/journal.pone.0003163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779862	Green Submitted, Green Published, gold			2022-12-27	WOS:000264425100002
J	Vannoni, E; McElligott, AG				Vannoni, Elisabetta; McElligott, Alan G.			Low Frequency Groans Indicate Larger and More Dominant Fallow Deer (Dama dama) Males	PLOS ONE			English	Article							VOCAL-TRACT LENGTH; BABOON LOUD CALLS; BODY-SIZE; RED DEER; ACOUSTIC FEATURES; SEXUAL SELECTION; MATING SUCCESS; DESCENDED LARYNX; MALE QUALITY; VOICE PITCH	Background: Models of honest advertisement predict that sexually selected calls should signal male quality. In most vertebrates, high quality males have larger body sizes that determine higher social status and in turn higher reproductive success. Previous research has emphasised the importance of vocal tract resonances or formant frequencies of calls as cues to body size in mammals. However, the role of the acoustic features of vocalisations as cues to other quality-related phenotypic characteristics of callers has rarely been investigated. Methodology/Principal Findings: We examined whether the acoustic structure of fallow deer groans provides reliable information on the quality of the caller, by exploring the relationships between male quality (body size, dominance rank, and mating success) and the frequency components of calls (fundamental frequency, formant frequencies, and formant dispersion). We found that body size was not related to the fundamental frequency of groans, whereas larger males produced groans with lower formant frequencies and lower formant dispersion. Groans of high-ranking males were characterised by lower minimum fundamental frequencies and to a lesser extent, by lower formant dispersions. Dominance rank was the factor most strongly related to mating success, with higher-ranking males having higher mating success. The minimum fundamental frequency and the minimum formant dispersion were indirectly related to male mating success (through dominance rank). Conclusion/Significance: Our study is the first to show that sexually selected vocalisations can signal social dominance in mammals other than primates, and reveals that independent acoustic components encode accurate information on different phenotypic aspects of male quality.	[Vannoni, Elisabetta; McElligott, Alan G.] Univ Zurich, Zool Inst, Zurich, Switzerland	University of Zurich	Vannoni, E (corresponding author), Univ Nottingham, Sch Biol, Nottingham, Switzerland.	evannoni@gmail.com; amcellig1@yahoo.ie	McElligott, Alan G./ABC-1179-2020	McElligott, Alan G./0000-0001-5770-4568	Forschungskommission der Universitat Zurich; Swiss Academy of Sciences	Forschungskommission der Universitat Zurich; Swiss Academy of Sciences	This study was funded by grants from the Forschungskommission der Universitat Zurich to A. G. McElligott, and from the Swiss Academy of Sciences to E. Vannoni. These organizations had no role in the study design, data collection and analysis or preparation of the manuscript.	Alberts SC, 2006, ANIM BEHAV, V72, P1177, DOI 10.1016/j.anbehav.2006.05.001; Altwegg R, 2005, OIKOS, V110, P55, DOI 10.1111/j.0030-1299.2001.13723.x; Andersson Malte, 1994; [Anonymous], 2003, ANIMAL SIGNALS; Apicella CL, 2007, BIOL LETTERS, V3, P682, DOI 10.1098/rsbl.2007.0410; BECKFORD NS, 1985, ANN OTO RHINOL LARYN, V94, P634, DOI 10.1177/000348948509400622; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Beehner JC, 2006, BEHAV ECOL SOCIOBIOL, V59, P469, DOI 10.1007/s00265-005-0071-2; Blanckenhorn WU, 2004, FUNCT ECOL, V18, P414, DOI 10.1111/j.0269-8463.2004.00864.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Christie PJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P341, DOI 10.1007/s00265-003-0711-3; Collins SA, 2003, ANIM BEHAV, V65, P997, DOI 10.1006/anbe.2003.2123; Coltman DW, 1999, AM NAT, V154, P730, DOI 10.1086/303274; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; DAVID HA, 1987, BIOMETRIKA, V74, P432, DOI 10.2307/2336160; DAVIES NB, 1978, NATURE, V274, P683, DOI 10.1038/274683a0; Doty GV, 2001, BEHAV ECOL SOCIOBIOL, V49, P150, DOI 10.1007/s002650000291; Fant G., 1960, ACOUSTIC THEORY SPEE; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 1999, J ACOUST SOC AM, V106, P1511, DOI 10.1121/1.427148; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Galeotti P, 1997, ANIM BEHAV, V53, P687, DOI 10.1006/anbe.1996.0304; Gammell MP, 2003, ANIM BEHAV, V66, P601, DOI 10.1006/anbe.2003.2226; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; HOGG JT, 1987, ETHOLOGY, V75, P119; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Mainguy J, 2008, J MAMMAL, V89, P626, DOI 10.1644/07-MAMM-A-234R.1; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MCCOMB KE, 1988, THESIS U CAMBRIDGE U; McElligott AG, 2006, J ZOOL, V270, P340, DOI 10.1111/j.1469-7998.2006.00144.x; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; McElligott AG, 1998, ETHOLOGY, V104, P789; McElligott AG, 1999, ANIM BEHAV, V58, P1095, DOI 10.1006/anbe.1999.1237; McElligott AG, 2003, EVOL ECOL RES, V5, P1239; McElligott AG, 2002, P ROY SOC B-BIOL SCI, V269, P1129, DOI 10.1098/rspb.2002.1993; McElligott AG, 2001, BEHAV ECOL SOCIOBIOL, V49, P266, DOI 10.1007/s002650000293; McElligott AG, 2001, BEHAV ECOL, V12, P41, DOI 10.1093/oxfordjournals.beheco.a000376; McElligott AG, 2000, BEHAV ECOL SOCIOBIOL, V48, P203, DOI 10.1007/s002650000234; Modig AO, 1996, ANIM BEHAV, V51, P1295, DOI 10.1006/anbe.1996.0134; Pfefferle D, 2007, J ACOUST SOC AM, V121, P3947, DOI 10.1121/1.2722507; Pfefferle D, 2006, ANIM BEHAV, V72, P43, DOI 10.1016/j.anbehav.2005.08.021; Price JJ, 2006, ANIM BEHAV, V71, P799, DOI 10.1016/j.anbehav.2005.05.025; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; R Development Core Team, 2006, R LANG ENV STAT COMP; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ADV STUD BEHAV, V33, P231, DOI 10.1016/S0065-3454(03)33005-0; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Reby D, 2001, ETHOLOGY, V107, P951, DOI 10.1046/j.1439-0310.2001.00732.x; Rendall D, 2005, J ACOUST SOC AM, V117, P944, DOI 10.1121/1.1848011; Riede T, 1999, J EXP BIOL, V202, P2859; RYAN MJ, 1985, AM NAT, V126, P87, DOI 10.1086/284398; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Saunders FC, 2005, ACTA ETHOL, V8, P103, DOI 10.1007/s10211-005-0006-y; Say L, 2003, MOL ECOL, V12, P2793, DOI 10.1046/j.1365-294X.2003.01945.x; Titze IR, 1994, PRINCIPLES VOICE PRO; Torriani MVG, 2006, AM NAT, V168, P412, DOI 10.1086/506971; VANNONI E, 2007, THESIS U ZURICH SWIT; Vannoni E., 2005, COGN BRAIN BEHAV, V9, P551; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vehrencamp Sandra L., 2000, P277; Venables WN., 2002, MODERN APPL STAT S 4	71	117	117	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3113	10.1371/journal.pone.0003113	http://dx.doi.org/10.1371/journal.pone.0003113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422HM	18769619	gold, Green Published, Green Submitted			2022-12-27	WOS:000264418300005
J	Damgaard, IN; Jensen, TK; Petersen, JH; Skakkebk, NE; Toppari, J; Main, KM				Damgaard, Ida N.; Jensen, Tina K.; Petersen, Jorgen H.; Skakkebk, Niels E.; Toppari, Jorma; Main, Katharina M.		Nordic Cryptorchidism Study Grp	Risk Factors for Congenital Cryptorchidism in a Prospective Birth Cohort Study	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; GESTATIONAL FACTORS; CLOMIPHENE CITRATE; REPRODUCTIVE-TRACT; TESTICULAR CANCER; PREVALENCE; HYPOSPADIAS; PREGNANCY; DIETHYLSTILBESTROL; ABNORMALITIES	Background: Risk factors for congenital cryptorchidism were investigated in a prospective birth cohort study in Denmark and Finland from 1997 to 2001. Methodology and Principal Findings: In total, 2,496 boys were examined for cryptorchidism at birth (cryptorchid/healthy: 128/2,368) and three months old (33/2,215). Information on risk factors was obtained antenatally (questionnaire/interview) or at birth from birth records. Use of nicotine substitutes during pregnancy (n = 40) and infertility treatment by intrauterine insemination (n = 49) were associated with an increased risk for cryptorchidism, adjusted odds ratio (95% confidence interval) (OR (95% CI)) 3.04 (95% CI 1.00-9.27) and 3.01 (95% CI 1.27-7.15), respectively. No association was seen for mothers (n = 79) who had infertility treatment in form of intracytoplasmic sperm injection (ICSI) or in vitro fertilization (IVF) treatment (OR 0.71 95% CI 0.21-2.38). In total, 728 (29%) reported to have smoked during pregnancy, however, no increased risk among maternal smokers was found. Furthermore, we found statistically significant associations between cryptorchidism and low birth weight, prematurity, being small for gestational age, substantial vaginal bleeding, and breech presentation, which are in accordance with other studies. Conclusions and Significance: Our study revealed two novel risk factors for cryptorchidism: intrauterine insemination and the use of nicotine substitutes in pregnancy. This suggests that cryptorchidism may not only be associated to genetic factors, but also to maternal lifestyle and exposure.	[Damgaard, Ida N.; Jensen, Tina K.; Petersen, Jorgen H.; Skakkebk, Niels E.; Toppari, Jorma; Main, Katharina M.] GR5064 Rigshosp, Univ Dept Growth & Reprod, Copenhagen, Denmark; [Toppari, Jorma] Univ Turku, Dept Physiol & Pediat, Turku, Finland; [Petersen, Jorgen H.] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Rigshospitalet; University of Turku; University of Copenhagen	Damgaard, IN (corresponding author), GR5064 Rigshosp, Univ Dept Growth & Reprod, Copenhagen, Denmark.	ind@rh.dk		Jensen, Tina Kold/0000-0003-2311-5778; Petersen, Jorgen Holm/0000-0003-3979-7443; Boisen, Kirsten A./0000-0002-3374-6621; Main, Katharina Maria/0000-0001-7259-1039	University of Copenhagen [9700833, 9700909]; Danish Medical Research Council [9700833, 9700909]; Svend Andersens Foundation; Novo Nordisk Foundation; Academy of Finland; Sigrid Juselius Foundation; Turku University Central Hospital; European Commission;  [BMH4-CT96-0314];  [QLK4-CT1999-01422];  [QLK4-2001-00269];  [QLK4-CT2002-00603]	University of Copenhagen; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Svend Andersens Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Central Hospital; European Commission(European CommissionEuropean Commission Joint Research Centre); ; ; ; 	This work was supported by The University of Copenhagen, The Danish Medical Research Council (no. 9700833 and 9700909), Svend Andersens Foundation, Novo Nordisk Foundation, The Academy of Finland, Sigrid Juselius Foundation, Turku University Central Hospital and the European Commission (contracts BMH4-CT96-0314, QLK4-CT1999-01422, QLK4-2001-00269 and QLK4-CT2002-00603). The Danish National Research Foundation has established the Danish Epidemiology Science Center that initiated and created the DNBC. The cohort is furthermore a result of a major grant from this foundation. Additional support for the DNBC is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation and the Health Foundation. The authors are solely responsible for the contents of the manuscript. The sponsors had no part in the study neither in design, data collection, analysis nor in interpretation or in writing the paper. The European Community received annual reports concerning the progression of the study but is not responsible for any use that may be made of data appearing therein.	Adham IM, 2004, INT J ANDROL, V27, P257, DOI 10.1111/j.1365-2605.2004.00481.x; Akre O, 1999, EPIDEMIOLOGY, V10, P364, DOI 10.1097/00001648-199907000-00005; Albertsen K, 2004, AM J EPIDEMIOL, V159, P155, DOI 10.1093/aje/kwh034; Andersen AN, 2006, INT J ANDROL, V29, P12, DOI 10.1111/j.1365-2605.2005.00577.x; BEARD CM, 1984, AM J EPIDEMIOL, V120, P707, DOI 10.1093/oxfordjournals.aje.a113938; BERKOWITZ GS, 1993, PEDIATRICS, V92, P44; Berkowitz GS, 1996, PAEDIATR PERINAT EP, V10, P39, DOI 10.1111/j.1365-3016.1996.tb00024.x; BERKOWITZ GS, 1995, EPIDEMIOLOGY, V6, P127, DOI 10.1097/00001648-199503000-00007; Biggs ML, 2002, EPIDEMIOLOGY, V13, P197, DOI 10.1097/00001648-200203000-00015; Boisen KA, 2004, LANCET, V363, P1264, DOI 10.1016/S0140-6736(04)15998-9; Casper RF, 2006, J CLIN ENDOCR METAB, V91, P760, DOI 10.1210/jc.2005-1923; CHILVERS C, 1986, J PEDIATR SURG, V21, P691, DOI 10.1016/S0022-3468(86)80389-X; CHILVERS CED, 1992, ARCH DIS CHILD, V67, P892; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; COSGROVE MD, 1977, J UROLOGY, V117, P220, DOI 10.1016/S0022-5347(17)58407-4; CUNHA GR, 1987, HUM PATHOL, V18, P1132, DOI 10.1016/S0046-8177(87)80381-7; Damgaard IN, 2007, ENVIRON HEALTH PERSP, V115, P272, DOI 10.1289/ehp.9608; DAVIES TW, 1986, INT J EPIDEMIOL, V15, P197, DOI 10.1093/ije/15.2.197; DEPUE RH, 1987, AM J OBSTET GYNECOL, V156, P1137, DOI 10.1016/0002-9378(87)90126-8; DEPUE RH, 1984, INT J EPIDEMIOL, V13, P311, DOI 10.1093/ije/13.3.311; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; GILL WB, 1977, J UROLOGY, V117, P477, DOI 10.1016/S0022-5347(17)58502-X; GIWERCMAN A, 1989, J UROLOGY, V142, P998, DOI 10.1016/S0022-5347(17)38967-X; HJERTKVIST M, 1989, J EPIDEMIOL COMMUN H, V43, P324, DOI 10.1136/jech.43.4.324; Kurahashi N, 2005, MED SCI MONITOR, V11, pCR274; Larsen T, 2001, DAN MED BULL, V48, P256; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyh363; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mayr JM, 1999, ACTA PAEDIATR, V88, P1089, DOI 10.1080/08035259950168144; MCBRIDE ML, 1991, INT J EPIDEMIOL, V20, P964, DOI 10.1093/ije/20.4.964; Meijer WM, 2006, BIRTH DEFECTS RES A, V76, P249, DOI 10.1002/bdra.20243; Moller H, 1997, CANCER CAUSE CONTROL, V8, P904, DOI 10.1023/A:1018472530653; Moller H, 1996, INT J CANCER, V66, P287, DOI 10.1002/(SICI)1097-0215(19960503)66:3<287::AID-IJC2>3.0.CO;2-V; Morales-Suarez-Varela MM, 2006, OBSTET GYNECOL, V107, P51, DOI 10.1097/01.AOG.0000194079.66834.d5; Mori Mitsuru, 1992, Kurume Medical Journal, V39, P53; Nagao T, 2001, TERATOGEN CARCIN MUT, V21, P213, DOI 10.1002/tcm.1010; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597; Pereira OCM, 2003, COMP BIOCHEM PHYS A, V134, P545, DOI 10.1016/S1095-6433(02)00355-0; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; Pihkala J, 1989, Duodecim, V105, P1540; Preiksa RT, 2005, HUM REPROD, V20, P1928, DOI 10.1093/humrep/deh887; ROTHMAN KJ, 1978, NEW ENGL J MED, V299, P522, DOI 10.1056/NEJM197809072991006; STILLMAN RJ, 1982, AM J OBSTET GYNECOL, V142, P905, DOI 10.1016/S0002-9378(16)32540-6; Suomi AM, 2006, J CLIN ENDOCR METAB, V91, P953, DOI 10.1210/jc.2004-2318; SWERDLOW AJ, 1983, J EPIDEMIOL COMMUN H, V37, P238, DOI 10.1136/jech.37.3.238; Thorup J, 2006, J UROLOGY, V176, P734, DOI 10.1016/j.juro.2006.03.042; Toppari J, 1999, HORM RES, V51, P261, DOI 10.1159/000023412; Toppari J, 2001, HUM REPROD UPDATE, V7, P282, DOI 10.1093/humupd/7.3.282; TORFS CP, 1981, AM J EPIDEMIOL, V113, P563, DOI 10.1093/oxfordjournals.aje.a113133; Weidner IS, 1999, J UROLOGY, V161, P1606, DOI 10.1016/S0022-5347(05)68992-6; *WORLD MED ASS, 2004, WORLD MENT ASS DECL; Young SL, 1999, FERTIL STERIL, V71, P639, DOI 10.1016/S0015-0282(98)00537-8	53	67	67	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3051	10.1371/journal.pone.0003051	http://dx.doi.org/10.1371/journal.pone.0003051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725961	Green Published, Green Submitted, gold			2022-12-27	WOS:000264429000004
J	Zhu, WS; Fan, ZP; Zhang, C; Guo, ZX; Zhao, Y; Zhou, YX; Li, K; Xing, ZH; Chen, GQ; Liang, YM; Jin, L; Xiao, JH				Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Xing, Zhenghong; Chen, Guoqiang; Liang, Yinming; Jin, Li; Xiao, Junhua			A Dominant X-Linked QTL Regulating Pubertal Timing in Mice Found by Whole Genome Scanning and Modified Interval-Specific Congenic Strain Analysis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENETIC INFLUENCES; POSTNATAL-GROWTH; OBESITY; ONSET; CHROMOSOME; EPISTASIS; BACKCROSS; C57BL/6J; CYCLE	Background: Pubertal timing in mammals is triggered by reactivation of the hypothalamic-pituitary-gonadal (HPG) axis and modulated by both genetic and environmental factors. Strain-dependent differences in vaginal opening among inbred mouse strains suggest that genetic background contribute significantly to the puberty timing, although the exact mechanism remains unknown. Methodology/Principal Findings: We performed a genome-wide scanning for linkage in reciprocal crosses between two strains, C3H/HeJ (C3H) and C57BL6/J (B6), which differed significantly in the pubertal timing. Vaginal opening (VO) was used to characterize pubertal timing in female mice, and the age at VO of all female mice (two parental strains, F1 and F2 progeny) was recorded. A genome-wide search was performed in 260 phenotypically extreme F2 mice out of 464 female progeny of the F1 intercrosses to identify quantitative trait loci (QTLs) controlling this trait. A QTL significantly associated was mapped to the DXMit166 marker (15.5 cM, LOD = 3.86, p<0.01) in the reciprocal cross population (C3HB6F2). This QTL contributed 2.1 days to the timing of VO, which accounted for 32.31% of the difference between the original strains. Further study showed that the QTL was B6-dominant and explained 10.5% of variation to this trait with a power of 99.4% at an alpha level of 0.05. The location of the significant ChrX QTL found by genome scanning was then fine-mapped to a region of similar to 2.5 cM between marker DXMit68 and rs29053133 by generating and phenotyping a panel of 10 modified interval-specific congenic strains (mISCSs). Conclusions/Significance: Such findings in our study lay a foundation for positional cloning of genes regulating the timing of puberty, and also reveal the fact that chromosome X (the sex chromosome) does carry gene(s) which take part in the regulative pathway of the pubertal timing in mice.	[Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Liang, Yinming; Xiao, Junhua] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Songjiang, Peoples R China; [Zhu, Wangsheng; Fan, Zhongpeng; Zhang, Chao; Guo, Zhengxia; Zhao, Ying; Zhou, Yuxun; Li, Kai; Xing, Zhenghong; Chen, Guoqiang; Liang, Yinming; Jin, Li; Xiao, Junhua] Joint Lab Model Anim Biodivers, Shanghai, Peoples R China; [Zhao, Ying; Xing, Zhenghong; Chen, Guoqiang] Shanghai British SIPPR, BK Lab Anim Ltd, Shanghai, Peoples R China; [Jin, Li] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China	Donghua University; Fudan University	Zhu, WS (corresponding author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai, Songjiang, Peoples R China.	xiaojunhua@dhu.edu.cn	Jin, Li/M-5063-2019; Liang, Yinming/AAM-6226-2020; Jin, Li/C-1468-2009; Yang, Wei/HIA-0360-2022	Liang, Yinming/0000-0001-9174-4037; Jin, Li/0000-0002-4546-2415; Zhu, Wangsheng/0000-0001-7773-3438	National Nature Science Foundation of China [30771191]; Key Programs of the Science and Technology Commission Foundation of Shanghai [071409004]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Programs of the Science and Technology Commission Foundation of Shanghai	grants from the National Nature Science Foundation of China (grant no. 30771191) and Key Programs of the Science and Technology Commission Foundation of Shanghai (grant no. 071409004)	Brockmann GA, 2000, GENOME RES, V10, P1941, DOI 10.1101/gr.GR1499R; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; Carruth LL, 2002, NAT NEUROSCI, V5, P933, DOI 10.1038/nn922; Chehab FF, 1997, SCIENCE, V275, P88, DOI 10.1126/science.275.5296.88; Cheverud James M., 1994, P67; Cocchia M, 2000, GENOMICS, V68, P305, DOI 10.1006/geno.2000.6302; Darvasi A, 1997, MAMM GENOME, V8, P163, DOI 10.1007/s003359900382; DARVASI A, 1995, GENETICS, V141, P1199; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Devi AS, 1998, FERTIL STERIL, V70, P89, DOI 10.1016/S0015-0282(98)00122-8; GARDNER HA, 1983, AM J MED GENET, V14, P647, DOI 10.1002/ajmg.1320140408; GEERKENS C, 1994, AM J MED GENET, V50, P105, DOI 10.1002/ajmg.1320500202; GROSSO S, 1999, J MED GENET, V30, P966; Haston CK, 2002, HUM MOL GENET, V11, P1855, DOI 10.1093/hmg/11.16.1855; Hemberger MC, 1999, GENETICS, V153, P383; HOCKEY A, 1986, AM J MED GENET, V23, P127, DOI 10.1002/ajmg.1320230107; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Ibanez L, 2006, PEDIATRICS, V117, P117, DOI 10.1542/peds.2005-0664; Ishikawa A, 2000, MAMM GENOME, V11, P824, DOI 10.1007/s003350010145; Ishikawa A, 2005, GENET RES, V85, P127, DOI 10.1017/S001667230500738X; Ishikawa A, 2004, GENES GENET SYST, V79, P27, DOI 10.1266/ggs.79.27; JARVELA IE, 1993, J MED GENET, V30, P966, DOI 10.1136/jmg.30.11.966; Jarvis JP, 2005, J LIPID RES, V46, P1692, DOI 10.1194/jlr.M500073-JLR200; Kadlubar FF, 2003, CANCER EPIDEM BIOMAR, V12, P327; Kadlubar Fred F., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P408; KENNEDY GC, 1963, J PHYSIOL-LONDON, V166, P395, DOI 10.1113/jphysiol.1963.sp007111; Krewson TD, 2004, ENDOCRINOLOGY, V145, P4447, DOI 10.1210/en.2004-0543; LANDER ES, 1989, GENETICS, V121, P185; Manichaikul A, 2007, GENETICS, V177, P1963, DOI 10.1534/genetics.107.080093; Maraschio P, 1996, HUM GENET, V97, P375, DOI 10.1007/s004390050056; Mark HFL, 1996, CLIN PEDIATR, V35, P62; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Nathan BM, 2006, ENDOCRINOLOGY, V147, P5132, DOI 10.1210/en.2006-0745; NELSON JF, 1992, J REPROD FERTIL, V94, P261, DOI 10.1530/jrf.0.0940261; NELSON JF, 1990, BIOL REPROD, V42, P649, DOI 10.1095/biolreprod42.4.649; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Rabbee N, 2004, GENET RES, V84, P103, DOI 10.1017/S0016672304007086; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Talaban R, 2005, CYTOGENET GENOME RES, V109, P480, DOI 10.1159/000084206; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; THERMAN E, 1990, HUM GENET, V85, P455; Wallace JM, 2004, BIOL REPROD, V71, P1055, DOI 10.1095/biolreprod.104.030965; Wolf JB, 2002, HEREDITY, V89, P300, DOI 10.1038/sj.hdy.6800140; Xiao ZX, 2006, HEPATOL RES, V34, P150, DOI 10.1016/j.hepres.2005.12.007; Yang RC, 2004, GENETICS, V167, P1493, DOI 10.1534/genetics.103.020016; Zhou YX, 2007, J ENDOCRINOL, V193, P405, DOI 10.1677/joe.1.07049	50	4	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3021	10.1371/journal.pone.0003021	http://dx.doi.org/10.1371/journal.pone.0003021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725948	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428800001
J	Gurzov, EN; Ortis, F; Bakiri, L; Wagner, EF; Eizirik, DL				Gurzov, Esteban N.; Ortis, Fernanda; Bakiri, Latifa; Wagner, Erwin F.; Eizirik, Decio L.			JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells	PLOS ONE			English	Article								Cytokines contribute to pancreatic beta-cell apoptosis in type 1 diabetes (T1D) by modulation of beta-cell gene expression networks. The transcription factor Activator Protein-1 (AP-1) is a key regulator of inflammation and apoptosis. We presently evaluated the function of the AP-1 subunit JunB in cytokine-mediated beta-cell dysfunction and death. The cytokines IL-1 beta+IFN-gamma induced an early and transitory upregulation of JunB by NF-kappa B activation. Knockdown of JunB by RNA interference increased cytokine-mediated expression of inducible nitric oxide synthase (iNOS) and endoplasmic reticulum (ER) stress markers, leading to increased apoptosis in an insulin-producing cell line (INS-1E) and in purified rat primary beta-cells. JunB knockdown beta-cells and junB(-/-) fibroblasts were also more sensitive to the chemical ER stressor cyclopiazonic acid (CPA). Conversely, adenoviral-mediated overexpression of JunB diminished iNOS and ER markers expression and protected beta-cells from cytokine-induced cell death. These findings demonstrate a novel and unexpected role for JunB as a regulator of defense mechanisms against cytokine- and ER stress-mediated apoptosis.	[Gurzov, Esteban N.; Ortis, Fernanda; Eizirik, Decio L.] Free Univ Brussels, Expt Med Lab, Brussels, Belgium; [Bakiri, Latifa; Wagner, Erwin F.] Ctr Nacl Investigac Oncol, Madrid, Spain	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Gurzov, EN (corresponding author), Free Univ Brussels, Expt Med Lab, Brussels, Belgium.	egurzov@ulb.ac.be	Bakiri, Latifa/AAP-1674-2020; Ortis, Fernanda/K-7917-2014; Bakiri, Latifa/N-5780-2014	bakiri, latifa/0000-0002-6300-2420; Gurzov, Esteban/0000-0003-4642-0273; Ortis, Fernanda/0000-0002-9551-2839; Wagner, Erwin F/0000-0001-7872-0196	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium; Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; European Union [036903]	Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC); Fonds National de la Recherche Scientifique (FNRS) Belgium(Fonds de la Recherche Scientifique - FNRS); Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State; European Union(European Commission)	This work has been supported by grants from the Communaute Francaise de Belgique-Actions de Recherche Concertees (ARC), Fonds National de la Recherche Scientifique (FNRS) Belgium, the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgium State (IUAP P6/40) and European Union (STREP Savebeta, contract n 036903, in the Framework Programme 6 of the European Community).	AKERFELDT MC, 2008, DIABETES; Ammendrup A, 2000, DIABETES, V49, P1468, DOI 10.2337/diabetes.49.9.1468; Cardozo AK, 2005, DIABETES, V54, P452, DOI 10.2337/diabetes.54.2.452; Chambers KT, 2008, DIABETES, V57, P124, DOI 10.2337/db07-0944; Chu SC, 1998, BIOCHEM BIOPH RES CO, V248, P871, DOI 10.1006/bbrc.1998.9062; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Eizirik DL, 2008, BIOCHEM SOC T, V36, P321, DOI 10.1042/BST0360321; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gurzov EN, 2008, ONCOGENE, V27, P641, DOI 10.1038/sj.onc.1210690; Hasselblatt P, 2007, P NATL ACAD SCI USA, V104, P17105, DOI 10.1073/pnas.0706272104; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Karlsen AE, 2004, DIABETOLOGIA, V47, P1998, DOI 10.1007/s00125-004-1568-3; Karlsen AE, 2001, P NATL ACAD SCI USA, V98, P12191, DOI 10.1073/pnas.211445998; KAWAKAMI Z, 1992, NUCLEIC ACIDS RES, V20, P914, DOI 10.1093/nar/20.4.914; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kim HS, 2005, BIOCHEM BIOPH RES CO, V336, P847, DOI 10.1016/j.bbrc.2005.08.183; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Krappmann D, 2004, MOL CELL BIOL, V24, P6488, DOI 10.1128/MCB.24.14.6488-6500.2004; Kutlu B, 2003, DIABETES, V52, P2701, DOI 10.2337/diabetes.52.11.2701; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mokhtari D, 2008, ENDOCRINOLOGY, V149, P3046, DOI 10.1210/en.2007-0438; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Passegue E, 2000, EMBO J, V19, P2969, DOI 10.1093/emboj/19.12.2969; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Pirot P, 2007, DIABETES, V56, P1069, DOI 10.2337/db06-1253; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Wang M, 2007, INT J BIOCHEM CELL B, V39, P2076, DOI 10.1016/j.biocel.2007.05.022; Ylipaasto P, 2005, DIABETOLOGIA, V48, P1510, DOI 10.1007/s00125-005-1839-7; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	40	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3030	10.1371/journal.pone.0003030	http://dx.doi.org/10.1371/journal.pone.0003030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716665	gold, Green Submitted, Green Published			2022-12-27	WOS:000264426800008
J	Paauw, A; Caspers, MPM; Schuren, FHJ; Leverstein-van Hall, MA; Deletoile, A; Montijn, RC; Verhoef, J; Fluit, AC				Paauw, Armand; Caspers, Martien P. M.; Schuren, Frank H. J.; Leverstein-van Hall, Maurine A.; Deletoile, Alexis; Montijn, Roy C.; Verhoef, Jan; Fluit, Ad C.			Genomic Diversity within the Enterobacter cloacae Complex	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; PYRROLOQUINOLINE-QUINONE; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; EVOLUTIONARY GENOMICS; GENETIC DIVERSITY; SP-NOV; DNA; RESISTANCE; STRAINS	Background: Isolates of the Enterobacter cloacae complex have been increasingly isolated as nosocomial pathogens, but phenotypic identification of the E. cloacae complex is unreliable and irreproducible. Identification of species based on currently available genotyping tools is already superior to phenotypic identification, but the taxonomy of isolates belonging to this complex is cumbersome. Methodology/Principal Findings: This study shows that multilocus sequence analysis and comparative genomic hybridization based on a mixed genome array is a powerful method for studying species assignment within the E. cloacae complex. The E. cloacae complex is shown to be evolutionarily divided into two clades that are genetically distinct from each other. The younger first clade is genetically more homogenous, contains the Enterobacter hormaechei species and is the most frequently cultured Enterobacter species in hospitals. The second and older clade consists of several (sub) species that are genetically more heterogonous. Genetic markers were identified that could discriminate between the two clades and cluster 1. Conclusions/Significance: Based on genomic differences it is concluded that some previously defined (clonal and heterogenic) (sub) species of the E. cloacae complex have to be redefined because of disagreements with known or proposed nomenclature. However, further improved identification of the redefined species will be possible based on novel markers presented here.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Caspers, Martien P. M.; Schuren, Frank H. J.; Montijn, Roy C.] TNO Dept Microbiol, Zeist, Netherlands; [Deletoile, Alexis] Inst Pasteur, Unite Biodivers Bacteries Pathogenes Emergentes, Paris, France	Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	A.Paauw@umcutrecht.nl			Microbiology Department of the UMCU	Microbiology Department of the UMCU	The study was funded by the Microbiology Department of the UMCU.	ADAMOWICZ M, 1991, APPL ENVIRON MICROB, V57, P2012, DOI 10.1128/AEM.57.7.2012-2015.1991; Akopyants NS, 2001, MOL BIOCHEM PARASIT, V113, P337, DOI 10.1016/S0166-6851(01)00227-4; Borucki MK, 2004, J CLIN MICROBIOL, V42, P5270, DOI 10.1128/JCM.42.11.5270-5276.2004; BRENNER DJ, 1986, J CLIN MICROBIOL, V23, P1114, DOI 10.1128/JCM.23.6.1114-1120.1986; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P1133, DOI 10.1128/JCM.15.6.1133-1140.1982; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dobrindt U, 2003, J BACTERIOL, V185, P1831, DOI 10.1128/JB.185.6.1831-1840.2003; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fitzgerald JR, 2003, INFECT IMMUN, V71, P2827, DOI 10.1128/IAI.71.5.2827-2838.2003; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Fu YX, 1997, GENETICS, V147, P915; Fukiya S, 2004, J BACTERIOL, V186, P3911, DOI 10.1128/JB.186.12.3911-3921.2004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoffmann H, 2005, J CLIN MICROBIOL, V43, P3297, DOI 10.1128/JCM.43.7.3297-3303.2005; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P196, DOI 10.1016/j.syapm.2004.12.010; Hoffmann H, 2005, SYST APPL MICROBIOL, V28, P206, DOI 10.1016/j.syapm.2004.12.009; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Kampfer P, 2008, INT J HYG ENVIR HEAL, V211, P374, DOI 10.1016/j.ijheh.2007.07.021; Kim CC, 2002, GENOME BIOL, V3; Kosako Y, 1996, CURR MICROBIOL, V33, P261, DOI 10.1007/s002849900110; Leavis HL, 2007, PLOS PATHOG, V3, P75, DOI 10.1371/journal.ppat.0030007; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Lindsay JA, 2006, J BACTERIOL, V188, P669, DOI 10.1128/JB.188.2.669-676.2006; Mehlen A, 2004, SYST APPL MICROBIOL, V27, P689, DOI 10.1078/0723202042369875; Misra HS, 2004, FEBS LETT, V578, P26, DOI 10.1016/j.febslet.2004.10.061; Paauw A, 2006, EMERG INFECT DIS, V12, P807; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Salerno A, 2007, J BACTERIOL, V189, P7808, DOI 10.1128/JB.00796-07; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Streit JM, 2004, INT J ANTIMICROB AG, V24, P111, DOI 10.1016/j.ijantimicag.2003.12.019; TAJIMA F, 1989, GENETICS, V123, P585; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Vlaminckx BJM, 2007, INFECT IMMUN, V75, P2603, DOI 10.1128/IAI.01291-06; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	43	93	98	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3018	10.1371/journal.pone.0003018	http://dx.doi.org/10.1371/journal.pone.0003018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716657	gold, Green Published, Green Submitted			2022-12-27	WOS:000264426800003
J	Sasaki, S; He, XS; Holmes, TH; Dekker, CL; Kemble, GW; Arvin, AM; Greenberg, HB				Sasaki, Sanae; He, Xiao-Song; Holmes, Tyson H.; Dekker, Cornelia L.; Kemble, George W.; Arvin, Ann. M.; Greenberg, Harry B.			Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses	PLOS ONE			English	Article							IMMUNE-RESPONSES; ANNUAL IMMUNIZATION; VIRUS VACCINES; WORKING ADULTS; DOSE-RESPONSE; LIVE; TRIVALENT; EFFICACY; CHILDREN; YOUNG	Currently two vaccines, trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV), are licensed in the USA. Despite previous studies on immune responses induced by these two vaccines, a comparative study of the influence of prior influenza vaccination on serum antibody and B-cell responses to new LAIV or TIV vaccination has not been reported. During the 2005/6 influenza season, we quantified the serum antibody and B-cell responses to LAIV or TIV in adults with differing influenza vaccination histories in the prior year: LAIV, TIV, or neither. Blood samples were collected on days 0, 7-9 and 21-35 after immunization and used for serum HAI assay and B-cell assays. Total and influenza-specific circulating IgG and IgA antibody secreting cells (ASC) in PBMC were detected by direct ELISPOT assay. Memory B cells were also tested by ELISPOT after polyclonal stimulation of PBMC in vitro. Serum antibody, effector, and memory B-cell responses were greater in TIV recipients than LAIV recipients. Prior year TIV recipients had significantly higher baseline HAI titers, but lower HAI response after vaccination with either TIV or LAIV, and lower IgA ASC response after vaccination with TIV than prior year LAIV or no vaccination recipients. Lower levels of baseline HAI titer were associated with a greater fold-increase of HAI titer and ASC number after vaccination, which also differed by type of vaccine. Our findings suggest that the type of vaccine received in the prior year affects the serum antibody and the B-cell responses to subsequent vaccination. In particular, prior year TIV vaccination is associated with sustained higher HAI titer one year later but lower antibody response to new LAIV or TIV vaccination, and a lower effector B-cell response to new TIV but not LAIV vaccination.	[Sasaki, Sanae; He, Xiao-Song; Greenberg, Harry B.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Sasaki, Sanae; Arvin, Ann. M.; Greenberg, Harry B.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [He, Xiao-Song; Greenberg, Harry B.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Holmes, Tyson H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Div Biostat, Stanford, CA 94305 USA; [Dekker, Cornelia L.; Arvin, Ann. M.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Kemble, George W.] MedImmune Vaccines Inc, Mountain View, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; AstraZeneca; Medimmune	Sasaki, S (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.	harry.greenberg@stanford.edu		greenberg, harry/0000-0002-2128-9080				Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Atmar RL, 2007, VACCINE, V25, P5367, DOI 10.1016/j.vaccine.2007.05.002; Belshe RB, 2000, J INFECT DIS, V181, P1133, DOI 10.1086/315323; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Beyer WEP, 2004, VIRUS RES, V103, P125, DOI 10.1016/j.virusres.2004.02.024; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; *CDC, 2005, MMWR-MORBID MORTAL W, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; CLEMENTS ML, 1986, J CLIN MICROBIOL, V24, P157, DOI 10.1128/JCM.24.1.157-160.1986; CLEMENTS ML, 1983, INFECT IMMUN, V40, P1044, DOI 10.1128/IAI.40.3.1044-1051.1983; Couch R B, 1975, Dev Biol Stand, V28, P295; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015; El-Madhun AS, 1998, J INFECT DIS, V178, P933, DOI 10.1086/515656; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Gross PA, 1996, VACCINE, V14, P1280, DOI 10.1016/S0264-410X(96)00004-7; Gross PA, 1999, VACCINE, V17, P2284, DOI 10.1016/S0264-410X(98)00478-2; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HOLM S, 1979, SCAND J STAT, V6, P65; HOSKINS TW, 1979, LANCET, V1, P33; Iorio AM, 2006, VACCINE, V24, P6615, DOI 10.1016/j.vaccine.2006.05.037; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; KRYSTAL M, 1983, P NATL ACAD SCI-BIOL, V80, P4527, DOI 10.1073/pnas.80.14.4527; Kunzel W, 1996, VACCINE, V14, P1108, DOI 10.1016/0264-410X(96)00061-8; Lee MS, 2004, PEDIATR INFECT DIS J, V23, P852, DOI 10.1097/01.inf.0000137566.87691.3b; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McDonald NJ, 2007, J GEN VIROL, V88, P3209, DOI 10.1099/vir.0.83184-0; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; Nichol KL, 2003, VACCINE, V21, P2207, DOI 10.1016/S0264-410X(03)00029-X; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Noble G R, 1977, Dev Biol Stand, V39, P253; Nolan T, 2003, VACCINE, V21, P1224, DOI 10.1016/S0264-410X(02)00484-X; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; PHILIP R, 1985, J MED VIROL, V17, P325; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; SHETH KJ, 1979, JAMA-J AM MED ASSOC, V242, P1752, DOI 10.1001/jama.242.16.1752; Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 1999, VACCINE, V18, P899, DOI 10.1016/S0264-410X(99)00334-5; Zeman AM, 2007, PEDIATR INFECT DIS J, V26, P107, DOI 10.1097/01.inf.0000253251.03785.9b; [No title captured]	46	170	171	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2975	10.1371/journal.pone.0002975	http://dx.doi.org/10.1371/journal.pone.0002975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714352	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900002
J	Morrell, NT; Leucht, P; Zhao, LD; Kim, JB; ten Berge, D; Ponnusamy, K; Carre, AL; Dudek, H; Zachlederova, M; McElhaney, M; Brunton, S; Gunzner, J; Callow, M; Polakis, P; Costa, M; Zhang, XM; Helms, JA; Nusse, R				Morrell, Nathan T.; Leucht, Philipp; Zhao, Ludan; Kim, Jae-Beom; ten Berge, Derk; Ponnusamy, Karthik; Carre, A. Lyonel; Dudek, Henryk; Zachlederova, Marie; McElhaney, Michael; Brunton, Shirley; Gunzner, Janet; Callow, Marinella; Polakis, Paul; Costa, Mike; Zhang, Xiaoyan M.; Helms, Jill A.; Nusse, Roel			Liposomal Packaging Generates Wnt Protein with In Vivo Biological Activity	PLOS ONE			English	Article							BETA-CATENIN; REGENERATION; WINGLESS; HEDGEHOG; GROWTH; CELLS	Wnt signals exercise strong cell-biological and regenerative effects of considerable therapeutic value. There are, however, no specific Wnt agonists and no method for in vivo delivery of purified Wnt proteins. Wnts contain lipid adducts that are required for activity and we exploited this lipophilicity by packaging purified Wnt3a protein into lipid vesicles. Rather than being encapsulated, Wnts are tethered to the liposomal surface, where they enhance and sustain Wnt signaling in vitro. Molecules that effectively antagonize soluble Wnt3a protein but are ineffective against the Wnt3a signal presented by a cell in a paracrine or autocrine manner are also unable to block liposomal Wnt3a activity, suggesting that liposomal packaging mimics the biological state of active Wnts. When delivered subcutaneously, Wnt3a liposomes induce hair follicle neogenesis, demonstrating their robust biological activity in a regenerative context.	[Morrell, Nathan T.; Leucht, Philipp; Zhao, Ludan; Kim, Jae-Beom; Ponnusamy, Karthik; Carre, A. Lyonel; Helms, Jill A.] Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA; [ten Berge, Derk; Nusse, Roel] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA USA; [Dudek, Henryk; Zachlederova, Marie; McElhaney, Michael; Zhang, Xiaoyan M.] Curis Inc, Cambridge, MA USA; [Brunton, Shirley] Evotec Ltd, Abingdon, Oxon, England; [Gunzner, Janet] Genentech Inc, Dept Med Chem, San Francisco, CA USA; [Callow, Marinella; Polakis, Paul; Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA USA	Stanford University; Stanford University; Evotec; Roche Holding; Genentech; Roche Holding; Genentech	Morrell, NT (corresponding author), Stanford Univ, Dept Surg, Div Plast & Reconstruct Surg, Stanford, CA 94305 USA.	jhelms@stanford.edu; rnusse@stanford.edu	Berge, Derk ten/C-1967-2012; Berge, Derk ten/ABF-2591-2020; Leucht, Philipp/H-7238-2019	Berge, Derk ten/0000-0002-5863-0860; Leucht, Philipp/0000-0002-8409-8513; Helms, Jill/0000-0002-0463-396X; Zachlederova, Marie/0000-0003-4929-0275	NIH [RO1 PA-02-011]; Air Force Office of Research [FOS-2004-0025A]; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	NIH RO1 PA-02-011 and Air Force Office of Research FOS-2004-0025A (JAH); R. Nusse is a Howard Hughes Medical Institute Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2001, J BIOMATER APPL, V16, P3, DOI 10.1106/RA7U-1V9C-RV7C-8QXL; Cattel L, 2004, J CHEMOTHERAPY, V16, P94, DOI 10.1179/joc.2004.16.Supplement-1.94; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Koning GA, 2006, ARTHRITIS RHEUM-US, V54, P1198, DOI 10.1002/art.21719; Liu J, 2005, ANGEW CHEM INT EDIT, V44, P1987, DOI 10.1002/anie.200462552; Luo JY, 2007, LAB INVEST, V87, P97, DOI 10.1038/labinvest.3700509; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Needham D, 2001, ADV DRUG DELIVER REV, V53, P285, DOI 10.1016/S0169-409X(01)00233-2; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Park JW, 2002, BREAST CANCER RES, V4, P93; Ponce AM, 2006, FUTURE LIPIDOL, V1, P25, DOI 10.2217/17460875.1.1.25; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Schiffelers R, 2001, J ANTIMICROB CHEMOTH, V48, P333, DOI 10.1093/jac/48.3.333; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200; ZHANG Q, 2007, P NATL ACAD SCI US	33	59	75	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2930	10.1371/journal.pone.0002930	http://dx.doi.org/10.1371/journal.pone.0002930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698373	gold, Green Published, Green Submitted			2022-12-27	WOS:000264412600016
J	Shiffman, D; Kane, JP; Louie, JZ; Arellano, AR; Ross, DA; Catanese, JJ; Malloy, MJ; Ellis, SG; Devlin, JJ				Shiffman, Dov; Kane, John P.; Louie, Judy Z.; Arellano, Andre R.; Ross, David A.; Catanese, Joseph J.; Malloy, Mary J.; Ellis, Stephen G.; Devlin, James J.			Analysis of 17,576 Potentially Functional SNPs in Three Case-Control Studies of Myocardial Infarction	PLOS ONE			English	Article								Myocardial infarction (MI) is a common complex disease with a genetic component. While several single nucleotide polymorphisms (SNPs) have been reported to be associated with risk of MI, they do not fully explain the observed genetic component of MI. We have been investigating the association between MI and SNPs that are located in genes and have the potential to affect gene function or expression. We have previously published studies that tested about 12,000 SNPs for association with risk of MI, early-onset MI, or coronary stenosis. In the current study we tested 17,576 SNPs that could affect gene function or expression. In order to use genotyping resources efficiently, we staged the testing of these SNPs in three case -control studies of MI. In the first study (762 cases, 857 controls) we tested 17,576 SNPs and found 1,949 SNPs that were associated with MI (P<0.05). We tested these 1,949 SNPs in a second study (579 cases and 1159 controls) and found that 24 SNPs were associated with MI (1-sided P<0.05) and had the same risk alleles in the first and second study. Finally, we tested these 24 SNPs in a third study (475 cases and 619 controls) and found that 5 SNPs in 4 genes (ENO1, FXN (2 SNPs), HLA-DPB2, and LPA) were associated with MI in the third study (1-sided P<0.05), and had the same risk alleles in all three studies. The false discovery rate for this group of 5 SNPs was 0.23. Thus, we have identified 5 SNPs that merit further examination for their potential association with MI. One of these SNPs (in LPA), has been previously shown to be associated with risk of cardiovascular disease in other studies.	[Shiffman, Dov; Kane, John P.; Louie, Judy Z.; Arellano, Andre R.; Ross, David A.; Catanese, Joseph J.; Devlin, James J.] Celera, Alameda, CA USA; [Malloy, Mary J.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Ellis, Stephen G.] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH USA	University of California System; University of California San Francisco; Cleveland Clinic Foundation	Shiffman, D (corresponding author), Celera, Alameda, CA USA.	dov.shiffman@celera.com			University of California; State of California; Celera; Medical Research Council [G0700837] Funding Source: researchfish; MRC [G0700837] Funding Source: UKRI	University of California(University of California System); State of California; Celera; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study received funding from the University of California Discovery Grant Program, which is jointly funded by the University of California and the State of California with matching funds from Celera.	Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; *AM HEART ASS, 2002, HEART DIS STROK STAT; Bennet A, 2008, ARCH INTERN MED, V168, P598, DOI 10.1001/archinte.168.6.598; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Shiffman D, 2005, AM J HUM GENET, V77, P596, DOI 10.1086/491674; Shiffman D, 2008, ARTERIOSCL THROM VAS, V28, P173, DOI 10.1161/ATVBAHA.107.153981; Shiffman D, 2006, CURR OPIN MOL THER, V8, P493; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910	19	30	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2895	10.1371/journal.pone.0002895	http://dx.doi.org/10.1371/journal.pone.0002895			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682748	Green Published, gold			2022-12-27	WOS:000264366600051
J	Smith, JN; Dyszel, JL; Soares, JA; Ellermeier, CD; Altier, C; Lawhon, SD; Adams, LG; Konjufca, V; Curtiss, R; Slauch, JM; Ahmer, BMM				Smith, Jenee N.; Dyszel, Jessica L.; Soares, Jitesh A.; Ellermeier, Craig D.; Altier, Craig; Lawhon, Sara D.; Adams, L. Garry; Konjufca, Vjollca; Curtiss, Roy, III; Slauch, James M.; Ahmer, Brian M. M.			SdiA, an N-Acylhomoserine Lactone Receptor, Becomes Active during the Transit of Salmonella enterica through the Gastrointestinal Tract of Turtles	PLOS ONE			English	Article								Background: LuxR-type transcription factors are typically used by bacteria to determine the population density of their own species by detecting N-acylhomoserine lactones (AHLs). However, while Escherichia and Salmonella encode a LuxR-type AHL receptor, SdiA, they cannot synthesize AHLs. In vitro, it is known that SdiA can detect AHLs produced by other bacterial species. Methodology/Principal Findings: In this report, we tested the hypothesis that SdiA detects the AHL-production of other bacterial species within the animal host. SdiA did not detect AHLs during the transit of Salmonella through the gastrointestinal tract of a guinea pig, a rabbit, a cow, 5 mice, 6 pigs, or 12 chickens. However, SdiA was activated during the transit of Salmonella through turtles. All turtles examined were colonized by the AHL-producing species Aeromonas hydrophila. Conclusions/Significance: We conclude that the normal gastrointestinal microbiota of most animal species do not produce AHLs of the correct type, in an appropriate location, or in sufficient quantities to activate SdiA. However, the results obtained with turtles represent the first demonstration of SdiA activity in animals.	[Smith, Jenee N.; Dyszel, Jessica L.; Soares, Jitesh A.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Ellermeier, Craig D.; Slauch, James M.] Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL USA; [Altier, Craig] North Carolina State Univ, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Lawhon, Sara D.; Adams, L. Garry] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX USA; [Konjufca, Vjollca; Curtiss, Roy, III] Washington Univ, Dept Biol, St Louis, MO USA	University System of Ohio; Ohio State University; University of Illinois System; University of Illinois Urbana-Champaign; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station; Washington University (WUSTL)	Smith, JN (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010; Lawhon, Sara D./G-5147-2011	Ahmer, Brian M. M./0000-0002-4267-7322; Lawhon, Sara D./0000-0001-9154-8909; Konjufca, Vjollca/0000-0002-7736-5097; Ellermeier, Craig/0000-0002-8953-5081; Slauch, James/0000-0003-4634-9702	Public Health Service [AI0500002, AI073971, AI63230, 5K08AI060933-02, AI24533]; Roy J. Carver Charitable Trust [00-25]; USDA NRICGP [2002-35204-11624]; National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2005-35201-16270]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063230, K08AI060933, R01AI024533, R01AI050002, R01AI073971] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Roy J. Carver Charitable Trust; USDA NRICGP(United States Department of Agriculture (USDA)); National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.M.M.A. was supported by Public Health Service grants AI0500002 and AI073971. J.M.S. and C.D.E. were supported by grant 00-25 from the Roy J. Carver Charitable Trust and by Public Health Service grant AI63230. S.D.L was supported by Public Health Service grant 5K08AI060933-02. L.G.A. was supported by USDA NRICGP grant 2002-35204-11624. C.A. was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant number 2005-35201-16270. R.C. was supported by Public Health Service grant AI24533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Baumler AJ, 1996, INFECT IMMUN, V64, P61; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Camilli A, 1995, MOL MICROBIOL, V18, P671, DOI 10.1111/j.1365-2958.1995.mmi_18040671.x; CAMILLI A, 1994, P NATL ACAD SCI USA, V91, P2634, DOI 10.1073/pnas.91.7.2634; *CDC CFDC, 1999, SALM SURV ANN TAB SU; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CIPRIANO RC, 2001, 68 US DEP INT FISH W; Cirillo DM, 1996, INFECT IMMUN, V64, P2019, DOI 10.1128/IAI.64.6.2019-2023.1996; Crago AM, 1999, FEMS MICROBIOL LETT, V176, P495, DOI 10.1111/j.1574-6968.1999.tb13703.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong YH, 2005, J MICROBIOL, V43, P101; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Erickson DL, 2002, CAN J MICROBIOL, V48, P374, DOI 10.1139/w02-022; FRIEDRICH MJ, 1993, MOL MICROBIOL, V8, P543, DOI 10.1111/j.1365-2958.1993.tb01599.x; Fuqua C, 1996, ANNU REV MICROBIOL, V50, P727, DOI 10.1146/annurev.micro.50.1.727; Fuqua C, 1999, CELL-CELL SIGNALING IN BACTERIA, P211; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; HACKETT J, 1987, J INFECT DIS, V155, P540, DOI 10.1093/infdis/155.3.540; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; HEFFERNAN EJ, 1992, J BACTERIOL, V174, P84, DOI 10.1128/jb.174.1.84-91.1992; HEFFERNAN EJ, 1992, J CLIN INVEST, V90, P953, DOI 10.1172/JCI115972; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Kirke DF, 2004, FEMS MICROBIOL LETT, V241, P109, DOI 10.1016/j.femsle.2004.10.011; Kodjo A, 1997, J VET MED B, V44, P625, DOI 10.1111/j.1439-0450.1997.tb01016.x; Kozinska A, 2007, J FISH DIS, V30, P293, DOI 10.1111/j.1365-2761.2007.00813.x; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin D, 2008, J BACTERIOL, V190, P87, DOI 10.1128/JB.01323-07; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Maloy SR., 1996, GENETIC ANAL PATHOGE; MCGAREY DJ, 1991, EXPERIENTIA, V47, P441; Merighi M, 2005, J BACTERIOL, V187, P7407, DOI 10.1128/JB.187.21.7407-7416.2005; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; Milton DL, 2001, J BACTERIOL, V183, P3537, DOI 10.1128/JB.183.12.3537-3547.2001; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Nicholson B, 2000, MOL MICROBIOL, V35, P728, DOI 10.1046/j.1365-2958.2000.01743.x; Pasmans F, 2002, VET REC, V150, P692, DOI 10.1136/vr.150.22.692; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Roche DM, 2004, MICROBIOL-SGM, V150, P2023, DOI 10.1099/mic.0.26977-0; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Sen K, 2007, CAN J MICROBIOL, V53, P261, DOI 10.1139/W06-095; SHANE SM, 1990, EPIDEMIOL INFECT, V105, P307, DOI 10.1017/S0950268800047907; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Slauch JM, 2000, METHOD ENZYMOL, V326, P73; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Swift S, 1999, CELL-CELL SIGNALING IN BACTERIA, P291; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; Swift S, 1997, J BACTERIOL, V179, P5271, DOI 10.1128/jb.179.17.5271-5281.1997; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2000, J BACTERIOL, V182, P1779, DOI 10.1128/JB.182.7.1779-1787.2000; Wang YJ, 2005, APPL ENVIRON MICROB, V71, P1291, DOI 10.1128/AEM.71.3.1291-1299.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Yao Y, 2006, J MOL BIOL, V355, P262, DOI 10.1016/j.jmb.2005.10.041	61	75	79	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2826	10.1371/journal.pone.0002826	http://dx.doi.org/10.1371/journal.pone.0002826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665275	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300045
J	Winter, J; Roepcke, S; Krause, S; Muller, EC; Otto, A; Vingron, M; Schweiger, S				Winter, Jennifer; Roepcke, Stefan; Krause, Sven; Mueller, Eva-Christina; Otto, Albrecht; Vingron, Martin; Schweiger, Susann			Comparative 3 ' UTR Analysis Allows Identification of Regulatory Clusters that Drive Eph/ephrin Expression in Cancer Cell Lines	PLOS ONE			English	Article								Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ephrins, they fulfill multiple biological functions. Aberrant expression of Ephs/ephrins leading to increased Eph receptor to ephrin ligand ratios is a critical factor in tumorigenesis, indicating that tight regulation of Eph and ephrin expression is essential for normal cell behavior. The 3'-untranslated regions (3'UTRs) of transcripts play an important yet widely underappreciated role in the control of protein expression. Based on the assumption that paralogues of large gene families might exhibit a conserved organization of regulatory elements in their 3'UTRs we applied a novel bioinformatics/molecular biology approach to the 3'UTR sequences of Eph/ephrin transcripts. We identified clusters of motifs consisting of cytoplasmic polyadenylation elements (CPEs), AU-rich elements (AREs) and HuR binding sites. These clusters bind multiple RNA-stabilizing and destabilizing factors, including HuR. Surprisingly, despite its widely accepted role as an mRNA-stabilizing protein, we further show that binding of HuR to these clusters actually destabilizes Eph/ephrin transcripts in tumor cell lines. Consequently, knockdown of HuR greatly modulates expression of multiple Ephs/ephrins at both the mRNA and protein levels. Together our studies suggest that overexpression of HuR as found in many progressive tumors could be causative for disarranged Eph receptor to ephrin ligand ratios leading to a higher degree of tissue invasiveness.	[Winter, Jennifer; Roepcke, Stefan; Krause, Sven; Vingron, Martin; Schweiger, Susann] Max Planck Inst Mol Genet, Berlin, Germany; [Mueller, Eva-Christina; Otto, Albrecht] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Schweiger, Susann] Charite Hosp, Dept Dermatol, Berlin, Germany; [Schweiger, Susann] Univ Dundee, Coll Med, Dept Neurosci & Pathol, Dundee, Scotland	Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Dundee	Winter, J (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	winter@immunbio.mpg.de			Deutsche Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 577, A6]	Deutsche Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by the Deutsche Volkswagenstiftung and the Deutsche Forschungsgemeinschaft (SFB 577, project A6 to SS).	Akhmedov AT, 2000, NUCLEIC ACIDS RES, V28, P3022, DOI 10.1093/nar/28.16.3022; Bajenova O, 2003, EXP CELL RES, V291, P228, DOI 10.1016/S0014-4827(03)00373-2; Bajenova OV, 2001, J BIOL CHEM, V276, P31067, DOI 10.1074/jbc.M104093200; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bashirullah A, 2001, P NATL ACAD SCI USA, V98, P7025, DOI 10.1073/pnas.111145698; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Carosa E, 2002, J BIOL CHEM, V277, P656, DOI 10.1074/jbc.M107004200; Chen J, 1998, J BIOL CHEM, V273, P24670, DOI 10.1074/jbc.273.38.24670; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; Chung HJ, 2006, MOL CELL BIOL, V26, P6584, DOI 10.1128/MCB.00754-06; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Davy A, 2005, DEV DYNAM, V232, P1, DOI 10.1002/dvdy.20200; DeMaria CT, 1996, J BIOL CHEM, V271, P12179, DOI 10.1074/jbc.271.21.12179; Dobi A, 2006, J BIOL CHEM, V281, P28889, DOI 10.1074/jbc.M511858200; Dohn M, 2001, ONCOGENE, V20, P6503, DOI 10.1038/sj.onc.1204816; Drescher U, 2002, CURR OPIN GENET DEV, V12, P397, DOI 10.1016/S0959-437X(02)00316-7; Du L, 2005, RNA, V11, P1340, DOI 10.1261/rna.2870505; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; DUNCAN R, 1994, GENE DEV, V8, P465, DOI 10.1101/gad.8.4.465; Enokizono Yoshiaki, 2003, Nucleic Acids Res Suppl, P231; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; HARIHARAN N, 1989, GENE DEV, V3, P1789, DOI 10.1101/gad.3.11.1789; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2007, CURR OPIN CELL BIOL, V19, P534, DOI 10.1016/j.ceb.2007.08.004; Hovhannisyan RH, 2007, J BIOL CHEM, V282, P36265, DOI 10.1074/jbc.M704188200; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huang YS, 2007, METHOD ENZYMOL, V431, P143, DOI 10.1016/S0076-6879(07)31008-2; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Jackson AP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-137; Jacobs GH, 2006, NUCLEIC ACIDS RES, V34, pD37, DOI 10.1093/nar/gkj159; Jansen RP, 2001, NAT REV MOL CELL BIO, V2, P247, DOI 10.1038/35067016; Kafasla P, 2002, BIOCHEM J, V363, P793, DOI 10.1042/0264-6021:3630793; Katsanou V, 2005, MOL CELL, V19, P777, DOI 10.1016/j.molcel.2005.08.007; Kozmik Z, 2008, EVOL DEV, V10, P52, DOI 10.1111/j.1525-142X.2007.00213.x; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Lal A, 2005, EMBO J, V24, P1852, DOI 10.1038/sj.emboj.7600661; Lisbin MJ, 2001, GENE DEV, V15, P2546, DOI 10.1101/gad.903101; Lopez de Silanes I., 2005, RNA BIOL, V2, P11, DOI DOI 10.4161/RNA.2.1.1552; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Meisner NC, 2004, CHEMBIOCHEM, V5, P1432, DOI 10.1002/cbic.200400219; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Muralidharan V, 1997, J CELL BIOCHEM, V66, P524, DOI 10.1002/(SICI)1097-4644(19970915)66:4<524::AID-JCB11>3.0.CO;2-B; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pesole G, 1997, GENE, V205, P95, DOI 10.1016/S0378-1119(97)00407-1; Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118; Rehbein M, 2002, J NEUROCHEM, V82, P1039, DOI 10.1046/j.1471-4159.2002.01058.x; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Shim S, 2007, MOL CELL BIOL, V27, P1614, DOI 10.1128/MCB.01429-06; Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Theil T, 1998, DEVELOPMENT, V125, P443; Zelinski DP, 2002, J CELL BIOCHEM, V85, P714, DOI 10.1002/jcb.10186; ZHANG W, 1993, MOL CELL BIOL, V13, P7652, DOI 10.1128/MCB.13.12.7652; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	18	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2780	10.1371/journal.pone.0002780	http://dx.doi.org/10.1371/journal.pone.0002780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648668	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000264302900050
J	Li, WJ; Kurata, H				Li, Weijiang; Kurata, Hiroyuki			Visualizing Global Properties of Large Complex Networks	PLOS ONE			English	Article								For complex biological networks, graphical representations are highly desired for understanding some design principles, but few drawing methods are available that capture topological features of a large and highly heterogeneous network, such as a protein interaction network. Here we propose the circular perspective drawing (CPD) method to visualize global structures of large complex networks. The presented CPD combines the quasi-continuous search (QCS) analogous to the steepest descent method with a random node swapping strategy for an enhanced calculation speed. The CPD depicts a network in an aesthetic manner by showing connection patterns between different parts of the network instead of detailed links between nodes. Global structural features of networks exhibited by CPD provide clues toward a comprehensive understanding of the network organizations. Availability: Software is freely available at http://www.cadlive.jp	[Li, Weijiang] So Yangtze Univ, Sch Biotechnol, Wuxi, Peoples R China; [Li, Weijiang] So Yangtze Univ, Key Lab Industrial Biotechnol, Minist Ed, Wuxi, Peoples R China; [Kurata, Hiroyuki] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka, Japan	Jiangnan University; Jiangnan University; Kyushu Institute of Technology	Li, WJ (corresponding author), So Yangtze Univ, Sch Biotechnol, Wuxi, Peoples R China.	kurata@bio.kyutech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO); The Ministry of Education, Science, Sports and Culture, Japan	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); The Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	New Energy and Industrial Technology Development Organization (NEDO); The Ministry of Education, Science, Sports and Culture, Japan	Adai AT, 2004, J MOL BIOL, V340, P179, DOI 10.1016/j.jmb.2004.04.047; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BAUR M, 2004, BAD HONNEF, P332; Dogrusoz U., 1996, LNCS, V1190, P92; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Karp P.D., 1994, P 3 INT C BIOINF GEN, P225; Kurata H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm769; Li WJ, 2005, BIOINFORMATICS, V21, P2036, DOI 10.1093/bioinformatics/bti290; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Romano SA, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.031901; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; [No title captured]	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2541	10.1371/journal.pone.0002541	http://dx.doi.org/10.1371/journal.pone.0002541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648531	gold, Green Published, Green Submitted			2022-12-27	WOS:000263288200013
J	Fujihara, M; Nagai, N; Sussan, TE; Biswal, S; Handa, JT				Fujihara, Masashi; Nagai, Norihiro; Sussan, Thomas E.; Biswal, Shyam; Handa, James T.			Chronic Cigarette Smoke Causes Oxidative Damage and Apoptosis to Retinal Pigmented Epithelial Cells in Mice	PLOS ONE			English	Article								The purpose of this study was to determine whether mice exposed to chronic cigarette smoke develop features of early age-related macular degeneration (AMD). Two month old C57Bl6 mice were exposed to either filtered air or cigarette smoke in a smoking chamber for 5 h/day, 5 days/week for 6 months. Eyes were fixed in 2.5% glutaraldehyde/2% paraformaldehyde and examined for ultrastructural changes by transmission electron microscopy. The contralateral eye was fixed in 2% paraformaldehyde and examined for oxidative injury to the retinal pigmented epithelium (RPE) by 8-oxo-7,8-dihydro-29-deoxyguanosine (8-OHdG) immunolabeling and apoptosis by TUNEL labeling. Mice exposed to cigarette smoke had immunolabeling for 8-OHdG in 85 +/- 63.7% of RPE cells counted compared to 9.5 +/- 63.9% in controls (p < 0.00001). Bruch membrane was thicker in mice exposed to smoke (1086 +/- 332 nm) than those raised in air (543 +/- 132 nm; p = 0.0069). The two most pronounced ultrastructural changes (severity grading scale from 0- 3) seen were a loss of basal infoldings (mean difference in grade = 1.98; p < 0.0001), and an increase in intracellular vacuoles (mean difference in grade = 1.7; p < 0.0001). Ultrastructural changes to Bruch membrane in cigarette-smoke exposed mice were smaller in magnitude but consistently demonstrated significantly higher grade injury in cigarette- exposed mice, including basal laminar deposits (mean difference in grade = 0.54; p, 0.0001), increased outer collagenous layer deposits (mean difference in grade = 0.59; p = 0.002), and increased basal laminar deposit continuity (mean difference in grade = 0.4; p, 0.0001). TUNEL assay showed a higher percentage of apoptotic RPE from mice exposed to cigarette smoke (average 8.0 +/- 1.1%) than room air (average 0 +/- 0%; p = 0.043). Mice exposed to chronic cigarette smoke develop evidence of oxidative damage with ultrastructural degeneration to the RPE and Bruch membrane, and RPE cell apoptosis. This model could be useful for studying the mechanism of smoke induced changes during early AMD.	[Fujihara, Masashi; Nagai, Norihiro; Handa, James T.] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA; [Sussan, Thomas E.; Biswal, Shyam] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Fujihara, M (corresponding author), Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA.	jthanda@jhmi.edu		Sussan, Thomas/0000-0002-5240-4299	QLT, Inc; NIH [EY14005, HL081205]; Thomas Orton Jones Fellowship in Age-related Macular Degeneration; NIH/NHLBI SCCOR [P50HL084945]; Flight Attendant Medical Research Institute; NIEHS [ES07141]; Wilmer Eye Institute [EY01765]; NATIONAL EYE INSTITUTE [P30EY001765, R01EY014005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL081205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER	QLT, Inc; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas Orton Jones Fellowship in Age-related Macular Degeneration; NIH/NHLBI SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Flight Attendant Medical Research Institute; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wilmer Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a grant from QLT, Inc., NIH EY14005 to JTH; Thomas Orton Jones Fellowship in Age-related Macular Degeneration (JTH); NIH HL081205, NIH/NHLBI SCCOR grant P50HL084945, research grant from Flight Attendant Medical Research Institute to SB. TES is supported by the NIEHS training grant ES07141; EY01765 (Microscopy Module Core Grant) and Research to Prevent Blindness to the Wilmer Eye Institute; and generous gifts from Ric and Sandy Forsythe, the Kwok family, the Merlau family, and Aleda Wright. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Canter JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002091; Cousins SW, 2002, EXP EYE RES, V75, P543, DOI 10.1006/exer.2002.2047; Curcio CA, 1999, ARCH OPHTHALMOL-CHIC, V117, P329, DOI 10.1001/archopht.117.3.329; Del Priore LV, 2002, INVEST OPHTH VIS SCI, V43, P3312; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; DRUEKE T, 1990, KIDNEY INT, V37, P1438, DOI 10.1038/ki.1990.134; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; FEENEYBURNS L, 1990, AM J OPHTHALMOL, V109, P265, DOI 10.1016/S0002-9394(14)74549-0; Ferrington DA, 2006, EXP EYE RES, V83, P638, DOI 10.1016/j.exer.2006.03.003; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; GOTTSCH JD, 1993, ARCH OPHTHALMOL-CHIC, V111, P126, DOI 10.1001/archopht.1993.01090010130039; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; Ida H, 2004, INVEST OPHTH VIS SCI, V45, P2348, DOI 10.1167/iovs.03-1337; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kimura K, 2000, AM J OPHTHALMOL, V130, P769, DOI 10.1016/S0002-9394(00)00552-3; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Leu ST, 2002, EXP EYE RES, V74, P141, DOI 10.1006/exer.2001.1112; LOFFLER KU, 1986, GRAEF ARCH CLIN EXP, V224, P493, DOI 10.1007/BF02154735; Lu L, 2006, J CELL PHYSIOL, V206, P119, DOI 10.1002/jcp.20439; Milton RC, 2005, OPHTHALMOLOGY, V112, P533, DOI 10.1016/j.ophtha.2004.10.047; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Moriarty-Craige SE, 2005, AM J OPHTHALMOL, V140, P1020, DOI 10.1016/j.ajo.2005.06.043; NEWSOME DA, 1987, AM J OPHTHALMOL, V104, P373, DOI 10.1016/0002-9394(87)90227-3; OLSEN S, 1989, MEDICINE, V68, P173, DOI 10.1097/00005792-198905000-00005; OLSEN TS, 1986, ULTRASTRUCT PATHOL, V10, P1; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Spraul CW, 1997, ARCH OPHTHALMOL-CHIC, V115, P267, DOI 10.1001/archopht.1997.01100150269022; Spraul CW, 1996, INVEST OPHTH VIS SCI, V37, P2724; Tanaka T, 1997, LAB INVEST, V77, P145; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Toyokuni S, 1997, LAB INVEST, V76, P365; VANDERSCHAFT TL, 1994, GRAEF ARCH CLIN EXP, V232, P40, DOI 10.1007/BF00176436; Wang JA, 2007, FREE RADICAL BIO MED, V43, P408, DOI 10.1016/j.freeradbiomed.2007.04.020; Weigel AL, 2002, FREE RADICAL BIO MED, V33, P1419, DOI 10.1016/S0891-5849(02)01082-1	46	114	118	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3119	10.1371/journal.pone.0003119	http://dx.doi.org/10.1371/journal.pone.0003119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769672	Green Published, Green Submitted, gold			2022-12-27	WOS:000264416600007
J	Kamei, H; Lu, L; Jiao, S; Li, Y; Gyrup, C; Laursen, LS; Oxvig, C; Zhou, JF; Duan, CM				Kamei, Hiroyasu; Lu, Ling; Jiao, Shuang; Li, Yun; Gyrup, Claus; Laursen, Lisbeth S.; Oxvig, Claus; Zhou, Jianfeng; Duan, Cunming			Duplication and Diversification of the Hypoxia-Inducible IGFBP-1 Gene in Zebrafish	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; A PAPP-A; GENOME DUPLICATION; GROWTH-RETARDATION; HOX CLUSTERS; IGF; EXPRESSION; MUTAGENESIS; RADIATION; ROLES	Background: Gene duplication is the primary force of new gene evolution. Deciphering whether a pair of duplicated genes has evolved divergent functions is often challenging. The zebrafish is uniquely positioned to provide insight into the process of functional gene evolution due to its amenability to genetic and experimental manipulation and because it possess a large number of duplicated genes. Methodology/Principal Findings: We report the identification and characterization of two hypoxia-inducible genes in zebrafish that are co-ortholgs of human IGF binding protein-1 (IGFBP-1). IGFBP-1 is a secreted protein that binds to IGF and modulates IGF actions in somatic growth, development, and aging. Like their human and mouse counterparts, in adult zebrafish igfbp-1a and igfbp-1b are exclusively expressed in the liver. During embryogenesis, the two genes are expressed in overlapping spatial domains but with distinct temporal patterns. While zebrafish IGFBP-1a mRNA was easily detected throughout embryogenesis, IGFBP-1b mRNA was detectable only in advanced stages. Hypoxia induces igfbp-1a expression in early embryogenesis, but induces the igfbp-1b expression later in embryogenesis. Both IGFBP-1a and -b are capable of IGF binding, but IGFBP-1b has much lower affinities for IGF-I and -II because of greater dissociation rates. Overexpression of IGFBP-1a and -1b in zebrafish embryos caused significant decreases in growth and developmental rates. When tested in cultured zebrafish embryonic cells, IGFBP-1a and -1b both inhibited IGF-1-induced cell proliferation but the activity of IGFBP-1b was significantly weaker. Conclusions/Significance: These results indicate subfunction partitioning of the duplicated IGFBP-1 genes at the levels of gene expression, physiological regulation, protein structure, and biological actions. The duplicated IGFBP-1 may provide additional flexibility in fine-tuning IGF signaling activities under hypoxia and other catabolic conditions.	[Kamei, Hiroyasu; Zhou, Jianfeng; Duan, Cunming] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Lu, Ling; Jiao, Shuang; Li, Yun; Duan, Cunming] Ocean Univ China, Sch Med & Pharm, Lab Mol Med, Qingdao, Peoples R China; [Gyrup, Claus; Laursen, Lisbeth S.; Oxvig, Claus] Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark	University of Michigan System; University of Michigan; Ocean University of China; Aarhus University	Kamei, H (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	cduan@umich.edu		KAMEI, HIROYASU/0000-0001-7123-040X; Laursen, Lisbeth Schmidt/0000-0002-8676-5869; Oxvig, Claus/0000-0002-4715-9719	NSF [IOB 0110864]; Changjiang Scholars Program [fellowship]	NSF(National Science Foundation (NSF)); Changjiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by NSF Research Grant IOB 0110864 and by a fellowship from the Changjiang Scholars Program.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Ben Lagha N, 2006, ENDOCRINOLOGY, V147, P4730, DOI 10.1210/en.2006-0171; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Butler AA, 2001, ENDOCRINOLOGY, V142, P1685, DOI 10.1210/en.142.5.1685; Chen BK, 2002, ENDOCRINOLOGY, V143, P1199, DOI 10.1210/en.143.4.1199; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; Cresko WA, 2003, DEV DYNAM, V228, P480, DOI 10.1002/dvdy.10424; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; Duan C, 2000, CIRC RES, V86, P15, DOI 10.1161/01.RES.86.1.15; Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022; EHRENBORG E, 1992, GENOMICS, V12, P497, DOI 10.1016/0888-7543(92)90440-4; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Force A, 1999, GENETICS, V151, P1531; Froment P, 2002, ENDOCRINOLOGY, V143, P1801, DOI 10.1210/en.143.5.1801; Gay E, 1997, ENDOCRINOLOGY, V138, P2937, DOI 10.1210/en.138.7.2937; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Hukriede N, 2001, GENOME RES, V11, P2127, DOI 10.1101/gr.210601; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kajimura S, 2007, J FISH BIOL, V71, P309, DOI 10.1111/j.1095-8649.2007.01606.x; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Laursen LS, 2002, BIOCHEM J, V367, P31, DOI 10.1042/BJ20020831; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lee PDK, 1997, P SOC EXP BIOL MED, V216, P319; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Ohno S., 1970, P1; Overgaard MT, 2001, J BIOL CHEM, V276, P21849, DOI 10.1074/jbc.M102191200; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; RAJKUMAR K, 1995, ENDOCRINOLOGY, V136, P4029, DOI 10.1210/en.136.9.4029; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Watson CS, 2006, ENDOCRINOLOGY, V147, P1175, DOI 10.1210/en.2005-0606; Wood AW, 2005, INT REV CYTOL, V243, P215, DOI 10.1016/S0074-7696(05)43004-1; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yan YL, 2005, DEVELOPMENT, V132, P1069, DOI 10.1242/dev.01674; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou R, 2003, J ENDOCRINOL, V178, P177, DOI 10.1677/joe.0.1780177	46	79	84	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3091	10.1371/journal.pone.0003091	http://dx.doi.org/10.1371/journal.pone.0003091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769480	Green Published, gold			2022-12-27	WOS:000264796600009
J	Scattoni, ML; Gandhy, SU; Ricceri, L; Crawley, JN				Scattoni, Maria Luisa; Gandhy, Shruti U.; Ricceri, Laura; Crawley, Jacqueline N.			Unusual Repertoire of Vocalizations in the BTBR T plus tf/J Mouse Model of Autism	PLOS ONE			English	Article							BEHAVIORAL TASKS RELEVANT; ULTRASONIC VOCALIZATIONS; MATERNAL-BEHAVIOR; INBRED STRAINS; LABORATORY RATS; DEVELOPMENTAL INFLUENCES; COMMUNICATION CALLS; MENTAL-RETARDATION; SOCIAL-INTERACTION; SPECTRUM DISORDER	BTBR T+ tf/J (BTBR) is an inbred mouse strain that displays social abnormalities and repetitive behaviors analogous to the first and third diagnostic symptoms of autism. Here we investigate ultrasonic vocalizations in BTBR, to address the second diagnostic symptom of autism, communication deficits. As compared to the commonly used C57BL/6J (B6) strain, BTBR pups called more loudly and more frequently when separated from their mothers and siblings. Detailed analysis of ten categories of calls revealed an unusual pattern in BTBR as compared to B6. BTBR emitted high levels of harmonics, two-syllable, and composite calls, but minimal numbers of chevron-shaped syllables, upward, downward, and short calls. Because body weights were higher in BTBR than B6 pups, one possible explanation was that larger thoracic size was responsible for the louder calls and different distribution of syllable categories. To test this possibility, we recorded separation calls from FVB/NJ, a strain with body weights similar to BTBR, and 129X1/SvJ, a strain with body weights similar to B6. BTBR remained the outlier on number of calls, displaying low numbers of complex, upward, chevron, short, and frequency steps calls, along with high harmonics and composites. Further, developmental milestones and growth rates were accelerated in BTBR, indicating an unusual neurodevelopmental trajectory. Overall, our findings demonstrate strain-specific patterns of ultrasonic calls that may represent different lexicons, or innate variations in complex vocal repertoires, in genetically distinct strains of mice. Particularly intriguing is the unusual pattern of vocalizations and the more frequent, loud harmonics evident in the BTBR mouse model of autism that may resemble the atypical vocalizations seen in some autistic infants.	[Scattoni, Maria Luisa; Gandhy, Shruti U.; Crawley, Jacqueline N.] NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA; [Scattoni, Maria Luisa; Ricceri, Laura] Ist Superiore Sanita, Dept Cell Biol & Neurosci, Behav Neurosci Sect, Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Istituto Superiore di Sanita (ISS)	Scattoni, ML (corresponding author), NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA.	marialuisa.scattoni@iss.it	Scattoni, Maria Luisa/K-4116-2016; Ricceri, Laura/N-9168-2017	Scattoni, Maria Luisa/0000-0002-6659-0280; Ricceri, Laura/0000-0001-9850-2284	National Institute of Mental Health Intramural Research Program [Z01-MH-002498-17, ISS-NIH 0F14]; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002498, ZIAMH002179] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by the National Institute of Mental Health Intramural Research Program (Z01-MH-002498-17, JNC), and ISS-NIH 0F14 Neurobehavioral phenotyping of genetically modified mouse models of mental retardation(LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this article do not necessarily represent the views of the NIMH, NIH, or the United States Government.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; BELL RW, 1972, BEHAV BIOL, V7, P805, DOI 10.1016/S0091-6773(72)80172-X; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; Bolivar VJ, 2007, BEHAV BRAIN RES, V176, P21, DOI 10.1016/j.bbr.2006.09.007; Branchi I, 2004, DEV PSYCHOBIOL, V44, P37, DOI 10.1002/dev.10150; Branchi I, 2003, NEUROSCI BIOBEHAV R, V27, P141, DOI 10.1016/S0149-7634(03)00016-2; Branchi I, 2002, GENES BRAIN BEHAV, V1, P135, DOI 10.1034/j.1601-183X.2002.10301.x; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; BROUETTELAHLOU I, 1992, BEHAV BRAIN RES, V50, P147, DOI 10.1016/S0166-4328(05)80296-7; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1993, PHYSIOL BEHAV, V54, P215, DOI 10.1016/0031-9384(93)90102-L; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Brunelli SA, 2007, BEHAV BRAIN RES, V182, P193, DOI 10.1016/j.bbr.2007.04.014; Burgdorf J, 2005, BEHAV GENET, V35, P67, DOI 10.1007/s10519-004-0856-5; Calamandrei G, 1999, NEUROTOXICOL TERATOL, V21, P29, DOI 10.1016/S0892-0362(98)00035-X; Covington HE, 2003, EUR J PHARMACOL, V467, P1, DOI 10.1016/S0014-2999(03)01558-9; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; D'Amato FR, 2005, BEHAV GENET, V35, P103, DOI 10.1007/s10519-004-0860-9; Dissanayake C, 2006, DEV PSYCHOPATHOL, V18, P381, DOI 10.1017/S0954579406060202; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2002, P NATL ACAD SCI USA, V99, P479, DOI 10.1073/pnas.012361999; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; Farrell WJ, 2002, J COMP PSYCHOL, V116, P297, DOI 10.1037//0735-7036.116.3.297; FOX M. W., 1965, ANIM BEHAV, V13, P234; Gaub S, 2005, J COMP PHYSIOL A, V191, P1131, DOI 10.1007/s00359-005-0036-y; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Hahn ME, 1997, BEHAV GENET, V27, P133, DOI 10.1023/A:1025637408900; Hashimoto H, 2001, EXP ANIM TOKYO, V50, P307, DOI 10.1538/expanim.50.307; Hefner K, 2007, BEHAV BRAIN RES, V182, P344, DOI 10.1016/j.bbr.2007.03.032; HENNESSY MB, 1980, DEV PSYCHOBIOL, V13, P573, DOI 10.1002/dev.420130603; Hofer MA, 1996, BEHAV NEUROSCI, V110, P1158, DOI 10.1037/0735-7044.110.5.1158; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Johnson CP, 2008, PEDIATR REV, V29, P86, DOI 10.1542/pir.29-3-86; KANNER L, 1971, J AUTISM CHILD SCHIZ, V1, P119, DOI 10.1007/BF01537953; Klin A, 2007, J AUTISM DEV DISORD, V37, P748, DOI 10.1007/s10803-006-0229-4; Kramer KM, 2003, PHYSIOL BEHAV, V79, P775, DOI 10.1016/S0031-9384(03)00175-6; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Mills JL, 2007, CLIN ENDOCRINOL, V67, P230, DOI 10.1111/j.1365-2265.2007.02868.x; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moy SS, 2008, BEHAV BRAIN RES, V191, P118, DOI 10.1016/j.bbr.2008.03.015; Moy SS, 2008, BEHAV BRAIN RES, V188, P178, DOI 10.1016/j.bbr.2007.10.029; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nadig AS, 2007, ARCH PEDIAT ADOL MED, V161, P378, DOI 10.1001/archpedi.161.4.378; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; Nyby JG, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P3; Ognibene E, 2007, BEHAV BRAIN RES, V177, P142, DOI 10.1016/j.bbr.2006.10.027; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Oswald JN, 2007, J ACOUST SOC AM, V122, P587, DOI 10.1121/1.2743157; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Picker JD, 2006, NEUROREPORT, V17, P541, DOI 10.1097/01.wnr.0000208995.38695.2f; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Ricceri L, 2007, BEHAV BRAIN RES, V176, P40, DOI 10.1016/j.bbr.2006.08.024; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; SALES GD, 1978, DEV PSYCHOBIOL, V11, P595, DOI 10.1002/dev.420110609; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Sheinkopf SJ, 2000, J AUTISM DEV DISORD, V30, P345, DOI 10.1023/A:1005531501155; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; van Daalen E, 2007, PEDIATR NEUROL, V37, P324, DOI 10.1016/j.pediatrneurol.2007.06.006; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Yang M, 2007, INT J DEV NEUROSCI, V25, P515, DOI 10.1016/j.ijdevneu.2007.09.008; Zimmerberg B, 2003, DEV PSYCHOBIOL, V42, P52, DOI 10.1002/dev.10086; Zippelius H. M., 1956, Naturwissenschaften, V43, P502; Zwaigenbaum L, 2005, INT J DEV NEUROSCI, V23, P143, DOI 10.1016/j.ijdevneu.2004.05.001	78	363	366	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3067	10.1371/journal.pone.0003067	http://dx.doi.org/10.1371/journal.pone.0003067			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728777	gold, Green Published, Green Submitted			2022-12-27	WOS:000264796400007
J	Guidobaldi, HA; Teves, ME; Unates, DR; Anastasia, A; Giojalas, LC				Alejandro Guidobaldi, Hector; Eugenia Teves, Maria; Rafael Unates, Diego; Anastasia, Agustin; Cecilia Giojalas, Laura			Progesterone from the Cumulus Cells Is the Sperm Chemoattractant Secreted by the Rabbit Oocyte Cumulus Complex	PLOS ONE			English	Article							FERTILIZING-CAPACITY; HUMAN SPERMATOZOA; FOLLICULAR-FLUID; RECEPTOR; CHEMOTAXIS; BOAR; IDENTIFICATION; AVAILABILITY; PENETRATION; EGGS	Sperm chemotaxis in mammals have been identified towards several female sources as follicular fluid (FF), oviduct fluid, and conditioned medium from the cumulus oophorus (CU) and the oocyte (O). Though several substances were confirmed as sperm chemoattractant, Progesterone (P) seems to be the best chemoattractant candidate, because: 1) spermatozoa express a cell surface P receptor, 2) capacitated spermatozoa are chemotactically attracted in vitro by gradients of low quantities of P; 3) the CU cells produce and secrete P after ovulation; 4) a gradient of P may be kept stable along the CU; and 5) the most probable site for sperm chemotaxis in vivo could be near and/or inside the CU. The aim of this study was to verify whether P is the sperm chemoattractant secreted by the rabbit oocyte-cumulus complex (OCC) in the rabbit, as a mammalian animal model. By means of videomicroscopy and computer image analysis we observed that only the CU are a stable source of sperm attractants. The CU produce and secrete P since the hormone was localized inside these cells by immunocytochemistry and in the conditioned medium by enzyme immunoassay. In addition, rabbit spermatozoa express a cell surface P receptor detected by western blot and localized over the acrosomal region by immunocytochemistry. To confirm that P is the sperm chemoattractant secreted by the CU, the sperm chemotactic response towards the OCC conditioned medium was inhibited by three different approaches: P from the OCC conditioned medium was removed with an anti-P antibody, the attractant gradient of the OCC conditioned medium was disrupted by a P counter gradient, and the sperm P receptor was blocked with a specific antibody. We concluded that only the CU but not the oocyte secretes P, and the latter chemoattract spermatozoa by means of a cell surface receptor. Our findings may be of interest in assisted reproduction procedures in humans, animals of economic importance and endangered species.	[Alejandro Guidobaldi, Hector; Eugenia Teves, Maria; Rafael Unates, Diego; Anastasia, Agustin; Cecilia Giojalas, Laura] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina	National University of Cordoba	Guidobaldi, HA (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, Ctr Biol Celular & Mol, RA-5000 Cordoba, Argentina.	lcgiojalas@com.uncor.edu	Teves, Maria/AAJ-9523-2020; Guidobaldi, Héctor Alejandro/K-6724-2017	Teves, Maria/0000-0001-7035-2202; Guidobaldi, Héctor Alejandro/0000-0002-5033-2981; Anastasia, Agustin/0000-0001-7238-9041; Giojalas, Laura/0000-0002-1036-1251	SECYT-UNC; CONICET; FONCYT (Argentina)	SECYT-UNC(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCYT (Argentina)(FONCyT)	This work was supported by SECYT-UNC, CONICET and FONCYT (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; AITKEN RJ, 1988, J ANDROL, V9, P367; AUSTIN CR, 1982, GERM CELLS FERTILIZA, P46; Baltes P, 1998, ANDROLOGIA, V30, P249; BARAMI S, 1989, BIOL REPROD, V41, P761, DOI 10.1095/biolreprod41.4.761; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BREDDERMAN PJ, 1964, J REPROD FERTIL, V7, P401, DOI 10.1530/jrf.0.0070401; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; CHANG MC, 1955, NATURE, V175, P1036, DOI 10.1038/1751036a0; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Chian RC, 1999, FERTIL STERIL, V71, P61, DOI 10.1016/S0015-0282(98)00416-6; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Fabro G, 2002, BIOL REPROD, V67, P1565, DOI 10.1095/biolreprod.102.006395; GIL PI, 2008, ANIMAL REPR IN PRESS; Giojalas LC, 2004, FERTIL STERIL, V82, P247, DOI 10.1016/j.fertnstert.2003.11.046; HANSEN C, 1991, MOL REPROD DEV, V30, P148, DOI 10.1002/mrd.1080300211; HARPER MJK, 1973, BIOL REPROD, V8, P441, DOI 10.1093/biolreprod/8.4.441; HARPER MJK, 1970, J EXP ZOOL, V173, P47, DOI 10.1002/jez.1401730104; HARPER MJK, 1982, GERM CELLS FERTILIZA, P102; HAUSER R, 1992, INT J ANDROL, V15, P498, DOI 10.1111/j.1365-2605.1992.tb01143.x; Jang S, 2005, J ENDOCRINOL, V184, P417, DOI 10.1677/joe.1.05607; Luconi A, 2004, STEROIDS, V69, P553, DOI 10.1016/j.steroids.2004.05.013; Luconi M, 1998, J CLIN ENDOCR METAB, V83, P877, DOI 10.1210/jc.83.3.877; MILLER RL, 1977, ADV INVERTEBRATE REP, P99; Pietrobon EO, 2003, J ANDROL, V24, P612; Pintado B, 2000, J REPROD FERTIL, V118, P145, DOI 10.1530/reprod/118.1.145; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Sabeur K, 1996, BIOL REPROD, V54, P993, DOI 10.1095/biolreprod54.5.993; Schumacher M, 1999, BEHAV BRAIN RES, V105, P37, DOI 10.1016/S0166-4328(99)00081-9; Shah C, 2005, INT J ANDROL, V28, P360, DOI 10.1111/j.1365-2605.2005.00566.x; Sun F, 2005, HUM REPROD, V20, P761, DOI 10.1093/humrep/deh657; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; VANDERHYDEN BC, 1995, BIOL REPROD, V53, P1243, DOI 10.1095/biolreprod53.6.1243; Wu JT, 2005, REPROD FERT DEVELOP, V17, P733, DOI 10.1071/RD05074; Wu JT, 2006, ANIM REPROD SCI, V93, P34, DOI 10.1016/j.anireprosci.2005.06.007; Yamano S, 2004, FERTIL STERIL, V81, P605, DOI 10.1016/j.fertnstert.2003.07.036; Yamashita Y, 2003, BIOL REPROD, V68, P1193, DOI 10.1095/biolreprod.102.010934	39	100	102	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3040	10.1371/journal.pone.0003040	http://dx.doi.org/10.1371/journal.pone.0003040			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725941	gold, Green Submitted, Green Published			2022-12-27	WOS:000264428800006
J	Barcia, C; Sanderson, NR; Barrett, RJ; Wawrowsky, K; Kroeger, KM; Puntel, M; Liu, CY; Castro, MG; Lowenstein, PR				Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Wawrowsky, Kolja; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.			T Cells' Immunological Synapses Induce Polarization of Brain Astrocytes In Vivo and In Vitro: A Novel Astrocyte Response Mechanism to Cellular Injury	PLOS ONE			English	Article								Background: Astrocytes usually respond to trauma, stroke, or neurodegeneration by undergoing cellular hypertrophy, yet, their response to a specific immune attack by T cells is poorly understood. Effector T cells establish specific contacts with target cells, known as immunological synapses, during clearance of virally infected cells from the brain. Immunological synapses mediate intercellular communication between T cells and target cells, both in vitro and in vivo. How target virally infected astrocytes respond to the formation of immunological synapses established by effector T cells is unknown. Findings: Herein we demonstrate that, as a consequence of T cell attack, infected astrocytes undergo dramatic morphological changes. From normally multipolar cells, they become unipolar, extending a major protrusion towards the immunological synapse formed by the effector T cells, and withdrawing most of their finer processes. Thus, target astrocytes become polarized towards the contacting T cells. The MTOC, the organizer of cell polarity, is localized to the base of the protrusion, and Golgi stacks are distributed throughout the protrusion, reaching distally towards the immunological synapse. Thus, rather than causing astrocyte hypertrophy, antiviral T cells cause a major structural reorganization of target virally infected astrocytes. Conclusions: Astrocyte polarization, as opposed to hypertrophy, in response to T cell attack may be due to T cells providing a very focused attack, and thus, astrocytes responding in a polarized manner. A similar polarization of Golgi stacks towards contacting T cells was also detected using an in vitro allogeneic model. Thus, different T cells are able to induce polarization of target astrocytes. Polarization of target astrocytes in response to immunological synapses may play an important role in regulating the outcome of the response of astrocytes to attacking effector T cells, whether during antiviral (e. g. infected during HIV, HTLV-1, HSV-1 or LCMV infection), anti-transplant, autoimmune, or anti-tumor immune responses in vivo and in vitro.	[Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Cedars Sinai Med Ctr, Dept Med, Board Governors Gene Therapeut Res Inst, Los Angeles, CA 90048 USA; [Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Med, Los Angeles, CA 90024 USA; [Barcia, Carlos; Sanderson, NicholasS. R.; Barrett, Robert J.; Kroeger, Kurt M.; Puntel, Mariana; Liu, Chunyan; Castro, Maria G.; Lowenstein, Pedro R.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehensive Canc Ctr, Brain Res Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; [Wawrowsky, Kolja] Cedars Sinai Med Ctr, Dept Endocrinol, Los Angeles, CA USA	Cedars Sinai Medical Center; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Barcia, C (corresponding author), Cedars Sinai Med Ctr, Dept Med, Board Governors Gene Therapeut Res Inst, Los Angeles, CA 90048 USA.	lowensteinp@cshs.org	Castro, Maria/ABC-5182-2021; sanderson, nicholas/GQH-2848-2022; Barrett, Robert/AAG-1941-2021; Barcia, Carlos/I-8205-2014	Castro, Maria/0000-0003-2237-2756; sanderson, nicholas/0000-0003-1711-7275; Barcia, Carlos/0000-0003-0976-4245	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) [1R01 NS44556.01, NS445561.01, 1R21-NSO54143.01, 1UO1 NS052465.01, 1 RO3 TW006273-01, 1 RO1 NS 054193.01, RO1 NS 42893.01, 1 R01 NS06117-01, U54 NS045309-01, 1R21 NS047298-01]; Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER [R03TW006273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044556, R01NS054193, R21NS047298, U54NS045309, R01NS042893, R01NS061107, U01NS052465] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medallions Group Endowed Chairs in Gene Therapeutics; The Linda Tallen & David Paul Kane Foundation; Board of Governors at CSMC; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Institutes of Health/National Institute of Neurological Disorders & Stroke (NIH/NINDS) Grant 1R01 NS44556.01, Minority Supplement NS445561.01; 1R21-NSO54143.01; 1UO1 NS052465.01, 1 RO3 TW006273-01 to M.G.C.; NIH/NINDS Grants 1 RO1 NS 054193.01; RO1 NS 42893.01, 1 R01 NS06117-01, U54 NS045309-01 and 1R21 NS047298-01 to P.R.L.. The Bram and Elaine Goldsmith and the Medallions Group Endowed Chairs in Gene Therapeutics to PRL and MGC, respectively, The Linda Tallen & David Paul Kane Foundation Annual Fellowship and the Board of Governors at CSMC.	Barcia C, 2008, J IMMUNOL, V180, P1344, DOI 10.4049/jimmunol.180.3.1344; Barcia C, 2007, MOL THER, V15, P2154, DOI 10.1038/sj.mt.6300305; Barcia C, 2006, NEURON GLIA BIOL, V2, P309, DOI 10.1017/S1740925X07000579; Barcia C, 2006, J EXP MED, V203, P2095, DOI 10.1084/jem.20060420; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Blanchard N, 2002, IMMUNITY, V17, P389, DOI 10.1016/S1074-7613(02)00421-1; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Brossard C, 2005, EUR J IMMUNOL, V35, P1741, DOI 10.1002/eji.200425857; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Bushong EA, 2004, INT J DEV NEUROSCI, V22, P73, DOI 10.1016/j.ijdevneu.2003.12.008; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Chvatal A, 2007, J ANAT, V210, P671, DOI 10.1111/j.1469-7580.2007.00724.x; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dewey RA, 1999, NAT MED, V5, P1256, DOI 10.1038/15207; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Dustin ML, 2005, SEMIN IMMUNOL, V17, P400, DOI 10.1016/j.smim.2005.09.002; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2006, METHOD ENZYMOL, V406, P565, DOI 10.1016/S0076-6879(06)06044-7; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; FURER M, 1993, CELL ADHES COMMUN, V1, P223, DOI 10.3109/15419069309097256; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Holdorf AD, 2002, NAT IMMUNOL, V3, P259, DOI 10.1038/ni761; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huse M, 2006, NAT IMMUNOL, V7, P247, DOI 10.1038/ni1304; Igakura T, 2003, SCIENCE, V299, P1713, DOI 10.1126/science.1080115; KAIZUKA Y, 2007, P NATL ACAD SCI US; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kuhn JR, 2002, IMMUNITY, V16, P111, DOI 10.1016/S1074-7613(02)00262-5; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lee JSH, 2005, MOL BIOL CELL, V16, P871, DOI 10.1091/mbc.e03-12-0910; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Lettau M, 2006, P NATL ACAD SCI USA, V103, P5911, DOI 10.1073/pnas.0508562103; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; O'Keefe JP, 2005, J IMMUNOL, V175, P5581, DOI 10.4049/jimmunol.175.9.5581; Osmani N, 2006, CURR BIOL, V16, P2395, DOI 10.1016/j.cub.2006.10.026; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rey M, 2007, FRONT BIOSCI-LANDMRK, V12, P437, DOI 10.2741/2073; Sattler R, 2006, HANDB EXP PHARM, V175, P277; Shi L, 2005, J IMMUNOL, V174, P5456, DOI 10.4049/jimmunol.174.9.5456; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Southgate TD, 1999, METAB BRAIN DIS, V14, P205, DOI 10.1023/A:1020728924026; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Taner SB, 2004, TRAFFIC, V5, P651, DOI 10.1111/j.1600-0854.2004.00214.x; Thomas CE, 2000, P NATL ACAD SCI USA, V97, P7482, DOI 10.1073/pnas.120474397; Trautmann A, 2003, CURR OPIN IMMUNOL, V15, P249, DOI 10.1016/S0952-7915(03)00040-2; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; XIA P, 2008, CELL RES; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	69	44	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2977	10.1371/journal.pone.0002977	http://dx.doi.org/10.1371/journal.pone.0002977			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714338	Green Submitted, gold, Green Published			2022-12-27	WOS:000264420900004
J	Singaravelan, N; Grishkan, I; Beharav, A; Wakamatsu, K; Ito, S; Nevo, E				Singaravelan, Natarajan; Grishkan, Isabella; Beharav, Alex; Wakamatsu, Kazumasa; Ito, Shosuke; Nevo, Eviatar			Adaptive Melanin Response of the Soil Fungus Aspergillus niger to UV Radiation Stress at "Evolution Canyon'', Mount Carmel, Israel	PLOS ONE			English	Article							B RADIATION; ULTRAVIOLET; ADAPTATION; DECOMPOSITION; BIOSYNTHESIS; BIODIVERSITY; LITTER; COLOR	Background: Adaptation is an evolutionary process in which traits in a population are tailored by natural selection to better meet the challenges presented by the local environment. The major discussion relating to natural selection concerns the portraying of the cause and effect relationship between a presumably adaptive trait and selection agents generating it. Therefore, it is necessary to identify trait(s) that evolve in direct response to selection, enhancing the organism's fitness. "Evolution Canyon'' (EC) in Israel mirrors a microcosmic evolutionary system across life and is ideal to study natural selection and local adaptation under sharply, microclimatically divergent environments. The south-facing, tropical, sunny and xeric "African'' slope (AS) receives 200%-800% higher solar radiation than the north-facing, temperate, shady and mesic "European'' slope (ES), 200 meters apart. Thus, solar ultraviolet radiation (UVR) is a major selection agent in EC influencing the organism-environment interaction. Melanin is a trait postulated to have evolved for UV-screening in microorganisms. Here we investigate the cause and effect relationship between differential UVR on the opposing slopes of EC and the conidial melanin concentration of the filamentous soil fungus Aspergillus niger. We test the working hypothesis that the AS strains exhibit higher melanin content than strains from the ES resulting in higher UV resistance. Methodology/Principal Findings: We measured conidial melanin concentration of 80 strains from the EC using a spectrophotometer. The results indicated that mean conidial melanin concentration of AS strains were threefold higher than ES strains and the former resisted UVA irradiation better than the latter. Comparisons of melanin in the conidia of A. niger strains from sunny and shady microniches on the predominantly sunny AS and predominantly shady ES indicated that shady conditions on the AS have no influence on the selection on melanin; in contrast, the sunny strains from the ES displayed higher melanin concentrations. Conclusions/Significance: We conclude that melanin in A. niger is an adaptive trait against UVR generated by natural selection.	[Singaravelan, Natarajan; Grishkan, Isabella; Beharav, Alex; Nevo, Eviatar] Univ Haifa, Inst Evolut, Har Hakarmel, Israel; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Sch Hlth Sci, Toyoake, Aichi, Japan	University of Haifa; Fujita Health University	Singaravelan, N (corresponding author), Univ Haifa, Inst Evolut, Har Hakarmel, Israel.	nevo@research.haifa.ac.il	Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount BankChair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) [20591357]; University of Haifa [postdoctoral fellowship]; Council of Higher Education, Israel	Ancell Teicher Research Foundation for Genetics and Molecular Evolution; Israel Discount BankChair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Haifa; Council of Higher Education, Israel	EN acknowledges the financial support of the Ancell Teicher Research Foundation for Genetics and Molecular Evolution, and the Israel Discount BankChair of Evolutionary Biology. KW & SI acknowledge the funding support by Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 20591357). NS acknowledges postdoctoral fellowship support by University of Haifa and Council of Higher Education, Israel.	Anderson TH., 1980, COMPENDIUM SOIL FUNG, V1; BELL AA, 1986, ANNU REV PHYTOPATHOL, V24, P411, DOI 10.1146/annurev.py.24.090186.002211; BOS CJ, 1988, MUTAT RES, V197, P67, DOI 10.1016/0027-5107(88)90141-8; Braga GUL, 2001, PHOTOCHEM PHOTOBIOL, V74, P734, DOI 10.1562/0031-8655(2001)074&lt;0734:BSUAUR&gt;2.0.CO;2; Butler MJ, 1998, CAN J MICROBIOL, V44, P1115, DOI 10.1139/cjm-44-12-1115; Christensen M., 1981, FUNGAL COMMUNITY ITS, P201; Ciccarone C., 1998, Plant Biosystems, V132, P17; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; Darwin, ORIGIN SPECIES MEANS; Davet P, 2000, DETECTION ISOLATION; GEHRKE C, 1995, OIKOS, V72, P213, DOI 10.2307/3546223; Goncalves RDR, 2005, BIOL PHARM BULL, V28, P1129, DOI 10.1248/bpb.28.1129; Grishkan I, 2008, BIOL J LINN SOC, V93, P157, DOI 10.1111/j.1095-8312.2007.00918.x; Gunasekera TS, 1997, PLANT PATHOL, V46, P179, DOI 10.1046/j.1365-3059.1997.d01-216.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hughes KA, 2003, APPL ENVIRON MICROB, V69, P1488, DOI 10.1128/AEM.69.3.1488-1491.2003; IGNOFFO CM, 1992, ENVIRON ENTOMOL, V21, P913, DOI 10.1093/ee/21.4.913; Klich MA, 2002, MYCOLOGIA, V94, P21, DOI 10.2307/3761842; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; LAMB BC, 1992, GENET LIFE SCI ADV, V11, P153; Majerus M, 1998, MELANISM EVOLUTION A; Moody SA, 1999, MYCOL RES, V103, P1469, DOI 10.1017/S0953756299008783; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Newsham KK, 1997, OIKOS, V79, P592, DOI 10.2307/3546903; OZEKI H, 1995, J INVEST DERMATOL, V105, P361, DOI 10.1111/1523-1747.ep12320792; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; PROTA G, 1992, MELANINS MELANOGENES, P290; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; RAY AC, 1975, APPL MICROBIOL, V30, P909, DOI 10.1128/AEM.30.6.909-915.1975; REEVE HK, 1993, Q REV BIOL, V68, P1, DOI 10.1086/417909; ROTEM J, 1985, PHYTOPATHOLOGY, V75, P510, DOI 10.1094/Phyto-75-510; Samson RA, 2006, MED MYCOL, V44, pS133, DOI 10.1080/13693780600913224; Sikorski J, 2005, P NATL ACAD SCI USA, V102, P15924, DOI 10.1073/pnas.0507944102; *SURV ISR, 1985, ATL ISR; Wasser, 2001, SOIL MICROFUNGI ISRA; Williams G. C., 1966, P307; Zhdanova NN, 1988, MELANIN CONTAINING F	41	88	93	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2993	10.1371/journal.pone.0002993	http://dx.doi.org/10.1371/journal.pone.0002993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714346	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900019
J	Malik, SB; Pightling, AW; Stefaniak, LM; Schurko, AM; Logsdon, JM				Malik, Shehre-Banoo; Pightling, Arthur W.; Stefaniak, Lauren M.; Schurko, Andrew M.; Logsdon, John M., Jr.			An Expanded Inventory of Conserved Meiotic Genes Provides Evidence for Sex in Trichomonas vaginalis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX-FORMATION; SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; PHYLOGENETIC ANALYSIS; RIBOSOMAL-RNA; GENOME SEQUENCE; TRANSPOSABLE ELEMENTS; MOLECULAR PHYLOGENY; TRYPANOSOMA-BRUCEI; CROSSOVER CONTROL	Meiosis is a defining feature of eukaryotes but its phylogenetic distribution has not been broadly determined, especially among eukaryotic microorganisms (i.e. protists)-which represent the majority of eukaryotic 'supergroups'. We surveyed genomes of animals, fungi, plants and protists for meiotic genes, focusing on the evolutionarily divergent parasitic protist Trichomonas vaginalis. We identified homologs of 29 components of the meiotic recombination machinery, as well as the synaptonemal and meiotic sister chromatid cohesion complexes. T. vaginalis has orthologs of 27 of 29 meiotic genes, including eight of nine genes that encode meiosis-specific proteins in model organisms. Although meiosis has not been observed in T. vaginalis, our findings suggest it is either currently sexual or a recent asexual, consistent with observed, albeit unusual, sexual cycles in their distant parabasalid relatives, the hypermastigotes. T. vaginalis may use meiotic gene homologs to mediate homologous recombination and genetic exchange. Overall, this expanded inventory of meiotic genes forms a useful "meiosis detection toolkit''. Our analyses indicate that these meiotic genes arose, or were already present, early in eukaryotic evolution; thus, the eukaryotic cenancestor contained most or all components of this set and was likely capable of performing meiotic recombination using near-universal meiotic machinery.	[Malik, Shehre-Banoo; Pightling, Arthur W.; Stefaniak, Lauren M.; Schurko, Andrew M.; Logsdon, John M., Jr.] Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol, Iowa City, IA USA	University of Iowa	Malik, SB (corresponding author), Univ Iowa, Roy J Carver Ctr Comparative Genom, Dept Biol, Iowa City, IA USA.	john-logsdon@uiowa.edu	PIGHTLING, ARTHUR/AAD-6621-2020; Logsdon, John M/B-7812-2009	Malik, Shehre-Banoo/0000-0003-0833-0648	National Science Foundation [MCB-0437442, 0216702]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB-0437442/ 0216702 to JML.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSEN RA, 2000, SOC PROTOZOOLOGISTS; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P284, DOI 10.1016/S0968-0004(98)01257-2; Arisue N, 2005, MOL BIOL EVOL, V22, P409, DOI 10.1093/molbev/msi023; Arkhipova I, 2005, BIOESSAYS, V27, P76, DOI 10.1002/bies.20159; Arkhipova IR, 2005, CYTOGENET GENOME RES, V110, P372, DOI 10.1159/000084969; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bhui-Kaur A, 1998, MOL CELL BIOL, V18, P1436, DOI 10.1128/MCB.18.3.1436; Birky CW, 2005, CURR BIOL, V15, pR56, DOI 10.1016/j.cub.2004.12.055; Birky CW, 1996, GENETICS, V144, P427; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Borts RH, 2000, MUTAT RES-FUND MOL M, V451, P129, DOI 10.1016/S0027-5107(00)00044-0; BUTTERFIELD NJ, 1990, SCIENCE, V250, P104, DOI 10.1126/science.11538072; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2003, INT J SYST EVOL MICR, V53, P1741, DOI 10.1099/ijs.0.02548-0; Cavalier-Smith T, 2002, HEREDITY, V88, P125, DOI 10.1038/sj.hdy.6800034; Chen CB, 2005, PLANT J, V43, P321, DOI 10.1111/j.1365-313X.2005.02461.x; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chuma I, 2003, CURR GENET, V43, P191, DOI 10.1007/s00294-003-0390-7; CLEVELAND LR, 1947, SCIENCE, V105, P287, DOI 10.1126/science.105.2724.287; CLEVELAND LR, 1951, J MORPHOL, V88, P385, DOI 10.1002/jmor.1050880302; CLEVELAND LR, 1956, J PROTOZOOL, V3, P161, DOI 10.1111/j.1550-7408.1956.tb02452.x; CLEVELAND LR, 1947, SCIENCE, V105, P16, DOI 10.1126/science.105.2714.16; Cobbe N, 2000, J STRUCT BIOL, V129, P123, DOI 10.1006/jsbi.2000.4255; Cobbe N, 2004, MOL BIOL EVOL, V21, P332, DOI 10.1093/molbev/msh023; Cooper MA, 2007, CURR BIOL, V17, P1984, DOI 10.1016/j.cub.2007.10.020; Dacks JB, 2001, CELL, V107, P419, DOI 10.1016/S0092-8674(01)00584-0; Dacks JB, 2008, PARASITOL INT, V57, P97, DOI 10.1016/j.parint.2007.11.004; Derelle E, 2006, P NATL ACAD SCI USA, V103, P11647, DOI 10.1073/pnas.0604795103; Drmota T, 1997, EUR J PROTISTOL, V33, P131, DOI 10.1016/S0932-4739(97)80030-2; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Gaunt MW, 2003, NATURE, V421, P936, DOI 10.1038/nature01438; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gerton JL, 2002, P NATL ACAD SCI USA, V99, P6895, DOI 10.1073/pnas.102167899; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HAIG D, 1993, J THEOR BIOL, V163, P15, DOI 10.1006/jtbi.1993.1104; Hampl V, 2006, INT J SYST EVOL MICR, V56, P305, DOI 10.1099/ijs.0.63754-0; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hampl V, 2004, MOL PHYLOGENET EVOL, V32, P711, DOI 10.1016/j.ympev.2004.03.005; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Hampl V, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-11; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HONIGBERG BM, 1989, TRICHOMONADS PARASIT, P5; Hopfner KP, 2000, J BACTERIOL, V182, P6036, DOI 10.1128/JB.182.21.6036-6041.2000; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keelig PJ, 2002, EUR J PROTISTOL, V38, P279, DOI 10.1078/0932-4739-00874; Keeling PJ, 2000, NATURE, V405, P635, DOI 10.1038/35015167; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kleina P, 2004, INT J PARASITOL, V34, P963, DOI 10.1016/j.ijpara.2004.04.004; Kunz C, 2004, CURR BIOL, V14, pR962, DOI 10.1016/j.cub.2004.10.043; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Logsdon JM, 2008, CURR BIOL, V18, pR66, DOI 10.1016/j.cub.2007.11.019; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Lyons EJ, 2004, TRENDS PARASITOL, V20, P204, DOI 10.1016/j.pt.2004.03.005; MacLeod A, 2005, MOL BIOCHEM PARASIT, V143, P12, DOI 10.1016/j.molbiopara.2005.04.009; MADDISON WP, 2005, MACCLADE 4 07; Malik SB, 2007, MOL BIOL EVOL, V24, P2827, DOI 10.1093/molbev/msm217; Marcon E, 2005, BIOESSAYS, V27, P795, DOI 10.1002/bies.20264; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merino ST, 2000, P NATL ACAD SCI USA, V97, P10477, DOI 10.1073/pnas.190346097; MOCHIZUKI K, 2008, J CELL SCI; Moreau S, 1999, MOL CELL BIOL, V19, P556; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nassonova ES, 2005, EUR J PROTISTOL, V41, P175, DOI 10.1016/j.ejop.2005.02.001; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; Ohkuma M, 2005, MOL PHYLOGENET EVOL, V35, P646, DOI 10.1016/j.ympev.2005.02.013; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pereira-Neves A, 2003, PROTIST, V154, P313, DOI 10.1078/143446103322454095; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; Prieto I, 2002, EMBO REP, V3, P543, DOI 10.1093/embo-reports/kvf108; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; RAIKOV IB, 1995, EUR J PROTISTOL, V31, P1, DOI 10.1016/S0932-4739(11)80349-4; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ribeiro KC, 2000, J EUKARYOT MICROBIOL, V47, P481, DOI 10.1111/j.1550-7408.2000.tb00077.x; Richard GF, 2005, MOL BIOL EVOL, V22, P1011, DOI 10.1093/molbev/msi083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schurko AM, 2008, BIOESSAYS, V30, P579, DOI 10.1002/bies.20764; Schwebke JR, 2006, ANTIMICROB AGENTS CH, V50, P4209, DOI 10.1128/AAC.00814-06; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Sutton M, 2007, CLIN INFECT DIS, V45, P1319, DOI 10.1086/522532; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van der Laan R, 2000, GENOMICS, V69, P86, DOI 10.1006/geno.2000.6220; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; Wang F, 2003, MOL CELL BIOL, V23, P7698, DOI 10.1128/MCB.23.21.7698-7707.2003; Watkins RF, 2008, PROTIST, V159, P269, DOI 10.1016/j.protis.2007.12.001; Weitzer S, 2003, CURR BIOL, V13, P1930, DOI 10.1016/j.cub.2003.10.030; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whitby MC, 2005, BIOCHEM SOC T, V33, P1451, DOI 10.1042/BST0331451; Wolfe K, 2004, CURR BIOL, V14, pR392, DOI 10.1016/j.cub.2004.05.015; Xu HL, 2004, EMBO REP, V5, P378, DOI 10.1038/sj.embor.7400121; Yidiz O, 2004, GENETICS, V167, P263, DOI 10.1534/genetics.167.1.263	127	159	162	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2879	10.1371/journal.pone.0002879	http://dx.doi.org/10.1371/journal.pone.0002879			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18663385	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600035
J	Salam, N; Gupta, S; Sharma, S; Pahujani, S; Sinha, A; Saxena, RK; Natarajan, K				Salam, Nasir; Gupta, Shashank; Sharma, Sachin; Pahujani, Shweta; Sinha, Aprajita; Saxena, Rajiv K.; Natarajan, Krishnamurthy			Protective Immunity to Mycobacterium tuberculosis Infection by Chemokine and Cytokine Conditioned CFP-10 Differentiated Dendritic Cells	PLOS ONE			English	Article								Background: Dendritic cells (DCs) play major roles in mediating immune responses to mycobacteria. A crucial aspect of this is the priming of T cells via chemokines and cytokines. In this study we investigated the roles of chemokines RANTES and IP-10 in regulating protective responses from Mycobacterium tuberculosis (M. tb) 10 kDa Culture Filtrate Protein-10 (CFP-10) differentiated DCs (CFP10-DCs). Methods and Findings: Infection of CFP10-DCs with mycobacteria down-modulated RANTES and IP-10 levels. Pathway specific microarray analyses showed that in addition to RANTES and IP-10, mycobacteria infected CFP10-DCs showed reduced expression of many Th1 promoting chemokines and chemokine receptors. Importantly, T cells co-cultured with RANTES and IP-10 conditioned CFP10-DCs mediated killing of mycobacteria from infected macrophages. Similarly, T cells recruited by RANTES and IP-10 conditioned CFP10-DCs mediated significant killing of mycobacteria from infected macrophages. IFN-gamma treatment of CFP10-DCs restored RANTES and IP-10 levels and T cells activated by these DCs mediated significant killing of virulent M. tb inside macrophages. Adoptive transfer of either RANTES and IP-10 or IL-12 and IFN-gamma conditioned CFP10-DCs cleared an established M. tb infection in mice. The extent of clearance was similar to that obtained with drug treatment. Conclusions: These results indicate that chemokine and cytokine secretion by DCs differentiated by M. tb antigens such as CFP-10 play major roles in regulating protective immune responses at sites of infection.	[Salam, Nasir; Gupta, Shashank; Sharma, Sachin; Pahujani, Shweta; Sinha, Aprajita; Natarajan, Krishnamurthy] Int Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi, India; [Saxena, Rajiv K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Jawaharlal Nehru University, New Delhi	Salam, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi, India.	natrajan@icgeb.res.in	Salam, Nasir/C-8049-2015; Gupta, Shashank/E-7382-2016	Salam, Nasir/0000-0001-9133-1304; Gupta, Shashank/0000-0003-0445-5195	Department of Biotechnology Government of India; Tropical Diseases Research of WHO	Department of Biotechnology Government of India(Department of Biotechnology (DBT) India); Tropical Diseases Research of WHO	This work was funded by grants from the Department of Biotechnology Government of India and the Tropical Diseases Research of WHO to KN.	Algood HMS, 2004, J IMMUNOL, V173, P3287; Azouaou N, 1997, IMMUNOLOGY, V91, P414, DOI 10.1046/j.1365-2567.1997.00282.x; Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675; Balkhi MY, 2004, J INFECT DIS, V189, P1598, DOI 10.1086/383328; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brodin P, 2005, J BIOL CHEM, V280, P33953, DOI 10.1074/jbc.M503515200; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.0.CO;2-1; Dheenadhayalan V, 2001, INFECT IMMUN, V69, P5635, DOI 10.1128/IAI.69.9.5635-5642.2001; Dieli F, 2000, SCAND J IMMUNOL, V52, P96; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Fahy OL, 2006, INFECT IMMUN, V74, P6885, DOI 10.1128/IAI.01065-06; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fujii H, 2004, J DERMATOL SCI, V35, P43, DOI 10.1016/j.jdermsci.2004.03.001; Ghosh S, 2004, EXP MOL MED, V36, P387, DOI 10.1038/emm.2004.51; Grohmann U, 1998, IMMUNITY, V9, P315, DOI 10.1016/S1074-7613(00)80614-7; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Latchumanan VK, 2005, TUBERCULOSIS, V85, P377, DOI 10.1016/j.tube.2005.08.007; Latchumanan VK, 2002, J IMMUNOL, V169, P6856, DOI 10.4049/jimmunol.169.12.6856; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Marei A, 2005, INT IMMUNOL, V17, P1439, DOI 10.1093/intimm/dxh322; Marino S, 2004, J IMMUNOL, V173, P494, DOI 10.4049/jimmunol.173.1.494; McRae BL, 1998, J IMMUNOL, V160, P4298; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Nagayama H, 2000, J IMMUNOL, V165, P59, DOI 10.4049/jimmunol.165.1.59; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; Nikonenko BV, 2004, ANTIMICROB AGENTS CH, V48, P4550, DOI 10.1128/AAC.48.12.4550-4555.2004; Noble A, 2000, J IMMUNOL, V164, P1807, DOI 10.4049/jimmunol.164.4.1807; Ohrui T, 2000, CLIN EXP IMMUNOL, V122, P13, DOI 10.1046/j.1365-2249.2000.01291.x; Park MK, 2001, INFECT IMMUN, V69, P6755, DOI 10.1128/IAI.69.11.6755-6768.2001; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; RHOADES ER, 1995, INFECT IMMUN, V63, P3871, DOI 10.1128/IAI.63.10.3871-3877.1995; ROOK GAW, 1994, IMMUNOBIOLOGY, V191, P478, DOI 10.1016/S0171-2985(11)80454-7; Rubakova E, 2007, TUBERCULOSIS, V87, P134, DOI 10.1016/j.tube.2006.06.002; Saukkonen JJ, 2002, INFECT IMMUN, V70, P1684, DOI 10.1128/IAI.70.4.1684-1693.2002; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Skwor TA, 2004, J LEUKOCYTE BIOL, V76, P1229, DOI 10.1189/jlb.0704414; Somoskovi A, 1999, EUR CYTOKINE NETW, V10, P135; Sousa CRE, 2001, IMMUNITY, V14, P495; Steinman R. M, 1999, FUNDAMENTAL IMMUNOLO, P547; SURCEL HM, 1994, IMMUNOLOGY, V81, P171; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; Tian T, 2005, J IMMUNOL, V175, P3268, DOI 10.4049/jimmunol.175.5.3268; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Wang XL, 2002, J POLYM SCI POL CHEM, V40, P70, DOI 10.1002/pola.10088; *WHO, 2002, WHO FACT SHEET; Wickremasinghe MI, 1999, J IMMUNOL, V163, P3936; Wiley RE, 2001, J IMMUNOL, V166, P2750, DOI 10.4049/jimmunol.166.4.2750; Wilsher M. L., 1999, Tubercle and Lung Disease, V79, P371, DOI 10.1054/tuld.1999.0223	51	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2869	10.1371/journal.pone.0002869	http://dx.doi.org/10.1371/journal.pone.0002869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682728	gold, Green Submitted, Green Published			2022-12-27	WOS:000264366600025
J	Voss, M; Ingram, JN; Wolpert, DM; Haggard, P				Voss, Martin; Ingram, James N.; Wolpert, Daniel M.; Haggard, Patrick			Mere Expectation to Move Causes Attenuation of Sensory Signals	PLOS ONE			English	Article								When a part of the body moves, the sensation evoked by a probe stimulus to that body part is attenuated. Two mechanisms have been proposed to explain this robust and general effect. First, feedforward motor signals may modulate activity evoked by incoming sensory signals. Second, reafferent sensation from body movements may mask the stimulus. Here we delivered probe stimuli to the right index finger just before a cue which instructed subjects to make left or right index finger movements. When left and right cues were equiprobable, we found attenuation for stimuli to the right index finger just before this finger was cued (and subsequently moved). However, there was no attenuation in the right finger just before the left finger was cued. This result suggests that the movement made in response to the cue caused 'postdictive' attenuation of a sensation occurring prior to the cue. In a second experiment, the right cue was more frequent than the left. We now found attenuation in the right index finger even when the left finger was cued and moved. This attenuation linked to a movement that was likely but did not in fact occur, suggests a new expectation-based mechanism, distinct from both feedforward motor signals and postdiction. Our results suggest a new mechanism in motor-sensory interactions in which the motor system tunes the sensory inputs based on expectations about future possible actions that may not, in fact, be implemented.	[Voss, Martin; Ingram, James N.; Wolpert, Daniel M.] Inst Neurol, Sobell Dept Motor Neurosci, London WC1N 3BG, England; [Voss, Martin] Humboldt Univ, Charite Univ Hosp, St Hedwig Hosp, Dept Psychiat, Berlin, Germany; [Ingram, James N.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Cambridge, England; [Haggard, Patrick] Inst Cognitive Neurosci, Dept Psychol, London, England	University of London; University College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cambridge; University of London; University College London	Voss, M (corresponding author), Inst Neurol, Sobell Dept Motor Neurosci, Queen Sq, London WC1N 3BG, England.	martin.voss@charite.de	Haggard, Patrick/A-5081-2010	Haggard, Patrick/0000-0001-7798-793X; Wolpert, Daniel/0000-0003-2011-2790; Voss, Martin/0000-0002-5221-4647; Lauwereyns, Jan/0000-0003-0551-2550	Human Frontiers Science Programme; Wellcome Trust; RIKEN Institute; German Academic Exchange Programme (DAAD); ESRC [RES-000-23-1571] Funding Source: UKRI; Economic and Social Research Council [RES-000-23-1571] Funding Source: researchfish	Human Frontiers Science Programme(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); RIKEN Institute; German Academic Exchange Programme (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Human Frontiers Science Programme, the Wellcome Trust and the RIKEN Institute. M. Voss was funded by a grant from the German Academic Exchange Programme (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEL RW, 1982, EXP NEUROL, V77, P266, DOI 10.1016/0014-4886(82)90244-8; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; BELL CC, 1981, SCIENCE, V214, P450, DOI 10.1126/science.7291985; CHAPMAN CE, 1988, EXP BRAIN RES, V72, P316; CHAPMAN CE, 1987, EXP BRAIN RES, V68, P516; COHEN LG, 1987, BRAIN, V110, P451, DOI 10.1093/brain/110.2.451; Cullen KE, 2004, CURR OPIN NEUROBIOL, V14, P698, DOI 10.1016/j.conb.2004.10.002; de Jong R, 2006, BRAIN RES, V1105, P73, DOI 10.1016/j.brainres.2006.03.030; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Kida T, 2006, EXP BRAIN RES, V175, P609, DOI 10.1007/s00221-006-0578-4; Macaluso E, 2005, TRENDS NEUROSCI, V28, P264, DOI 10.1016/j.tins.2005.03.008; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Shimazu H, 1999, NEUROREPORT, V10, P2457, DOI 10.1097/00001756-199908200-00004; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Walsh E, 2007, EXP BRAIN RES, V183, P405, DOI 10.1007/s00221-007-1128-4; Wasaka T, 2003, NEUROIMAGE, V20, P1830, DOI 10.1016/S1053-8119(03)00442-7; Williams SR, 1998, J NEUROPHYSIOL, V79, P947, DOI 10.1152/jn.1998.79.2.947; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968	18	75	75	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2866	10.1371/journal.pone.0002866	http://dx.doi.org/10.1371/journal.pone.0002866			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682736	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600022
J	Kuriya, B; Schneid, EC; Bell, CM				Kuriya, Bindee; Schneid, Elana C.; Bell, Chaim M.			Quality of Pharmaceutical Industry Press Releases Based on Original Research	PLOS ONE			English	Article							SCIENTIFIC MEETINGS; PRESCRIPTION DRUGS; JOURNAL ARTICLES; MEDIA; INFORMATION; NEWS	Background: Press releases are a popular vehicle to disseminate health information to the lay media. While the quality of press releases issued by scientific conferences and medical journals has been questioned, no efforts to assess pharmaceutical industry press releases have been made. Therefore, we sought to systematically examine pharmaceutical company press releases about original research for measures of quality. Methodolgy/Principal Findings: Press releases issued by the ten top selling, international pharmaceutical companies in the year 2005 were selected for evaluation. A total of 1028 electronic press releases were issued and 235 were based on original research. More than half (59%) reported results presented at a scientific meeting. Twenty-one percent of releases were not explicit about the source of original data. While harms or adverse events were commonly cited (76%), study limitations were rarely noted (6%). Almost one-third (29%) of releases did not quantify study results. Studies presented in abstract form were subsequently published within at least 20 months in 53% of cases. Conclusions: Pharmaceutical company press releases frequently report basic study details. However, readers should be cautioned by the preliminary nature of the data and lack of identified limitations. Methods to improve the reporting and interpretation of drug company press releases are desirable to prevent misleading media coverage.	[Kuriya, Bindee] Univ Toronto, Dept Rheumatol, Toronto, ON, Canada; [Schneid, Elana C.] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Bell, Chaim M.] St Michaels Hosp, Fac Med, Inst Clin Evaluat Sci, Dept Med & Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Kuriya, B (corresponding author), Univ Toronto, Dept Rheumatol, Toronto, ON, Canada.	bindee.kuriya@utoronto.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research, Institute of Aging [New Investigator Award]	Canadian Institutes of Health Research, Institute of Aging(Canadian Institutes of Health Research (CIHR))	Dr. Bell is the recipient of a Canadian Institutes of Health Research, Institute of Aging New Investigator Award. The funding agencies had no role in the design and conduct of the study; collection, management, analysis, or interpretation of the data; or preparation, review, or approval of the manuscript.	de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; Guyatt G, 2002, USERS GUIDES MED LIT; Hiebert RE, 1966, COURTIER CROWD STORY; *ISI WEB KNOWL, ISI WEB KNOWL J CIT; LANDIS JR, 1977, BIOMETRICS, V33, P174; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Schwartz LM, 2002, JAMA-J AM MED ASSOC, V287, P2859, DOI 10.1001/jama.287.21.2859; Stryker JE, 2002, PREV MED, V35, P519, DOI 10.1006/pmed.2002.1102; Toma M, 2006, JAMA-J AM MED ASSOC, V295, P1281, DOI 10.1001/jama.295.11.1281; VANTRIGT AM, 1994, SOC SCI MED, V38, P637, DOI 10.1016/0277-9536(94)90261-5; Woloshin S, 2001, LANCET, V358, P1141, DOI 10.1016/S0140-6736(01)06254-7; Woloshin S, 2006, JNCI-J NATL CANCER I, V98, P372, DOI 10.1093/jnci/djj115; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; Woloshin S, 2006, MED J AUSTRALIA, V184, P576, DOI 10.5694/j.1326-5377.2006.tb00384.x; 2004, FORTUNE, V149, pF26; SCRIP 100 FRESH LOOK	17	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2828	10.1371/journal.pone.0002828	http://dx.doi.org/10.1371/journal.pone.0002828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18716675	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300047
J	McGuire, AM; Galagan, JE				McGuire, Abigail Manson; Galagan, James E.			Conserved Secondary Structures in Aspergillus	PLOS ONE			English	Article							NONCODING RNA GENES; PRE-MESSENGER-RNA; COMPARATIVE GENOMICS; CODING REGIONS; COMPUTATIONAL IDENTIFICATION; CAENORHABDITIS-ELEGANS; PREDICTION; SEQUENCES; HUMAN-CHROMOSOME-21; TRANSCRIPTOME	Background: Recent evidence suggests that the number and variety of functional RNAs (ncRNAs as well as cis-acting RNA elements within mRNAs) is much higher than previously thought; thus, the ability to computationally predict and analyze RNAs has taken on new importance. We have computationally studied the secondary structures in an alignment of six Aspergillus genomes. Little is known about the RNAs present in this set of fungi, and this diverse set of genomes has an optimal level of sequence conservation for observing the correlated evolution of base-pairs seen in RNAs. Methodology/Principal Findings: We report the results of a whole-genome search for evolutionarily conserved secondary structures, as well as the results of clustering these predicted secondary structures by structural similarity. We find a total of 7450 predicted secondary structures, including a new predicted,60 bp long hairpin motif found primarily inside introns. We find no evidence for microRNAs. Different types of genomic regions are over-represented in different classes of predicted secondary structures. Exons contain the longest motifs ( primarily long, branched hairpins), 59 UTRs primarily contain groupings of short hairpins located near the start codon, and 39 UTRs contain very little secondary structure compared to other regions. There is a large concentration of short hairpins just inside the boundaries of exons. The density of predicted intronic RNAs increases with the length of introns, and the density of predicted secondary structures within mRNA coding regions increases with the number of introns in a gene. Conclusions/Sigificance: There are many conserved, high-confidence RNAs of unknown function in these Aspergillus genomes, as well as interesting spatial distributions of predicted secondary structures. This study increases our knowledge of secondary structure in these aspergillus organisms.	[McGuire, Abigail Manson; Galagan, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	McGuire, AM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.	amcguire@broad.mit.edu; jgalag@mit.edu	Manson, Abigail/B-7132-2016	Manson, Abigail/0000-0002-3800-0714; Galagan, James/0000-0003-0542-3291	NSF [MCB-0450812]; NIAID [HHSN26620040001C]	NSF(National Science Foundation (NSF)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding sources for this study were NSF grant for Comparative Fungal Genomics (MCB-0450812) and an NIAID Contract for Microbial Genome Centers (HHSN26620040001C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Babak T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-33; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006; Coventry A, 2004, P NATL ACAD SCI USA, V101, P12102, DOI 10.1073/pnas.0404193101; di Bernardo D, 2003, BIOINFORMATICS, V19, P1606, DOI 10.1093/bioinformatics/btg229; Dsouza M, 1997, TRENDS GENET, V13, P497, DOI 10.1016/S0168-9525(97)01347-4; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Howe KJ, 1997, P NATL ACAD SCI USA, V94, P12467, DOI 10.1073/pnas.94.23.12467; Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Katz L, 2003, GENOME RES, V13, P2042, DOI 10.1101/gr.1257503; Kochetov AV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-318; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; Kreahling JM, 2005, MOL CELL BIOL, V25, P10251, DOI 10.1128/MCB.25.23.10251-10260.2005; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LIBRI D, 1991, SCIENCE, V252, P1842, DOI 10.1126/science.2063196; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; McCutcheon JP, 2003, NUCLEIC ACIDS RES, V31, P4119, DOI 10.1093/nar/gkg438; Meyer IM, 2005, NUCLEIC ACIDS RES, V33, P6338, DOI 10.1093/nar/gki923; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Missal K, 2006, J EXP ZOOL PART B, V306B, P379, DOI 10.1002/jez.b.21086; Miyaso H, 2003, J BIOL CHEM, V278, P15825, DOI 10.1074/jbc.M209271200; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; PARKIN NT, 1992, J VIROL, V66, P5147, DOI 10.1128/JVI.66.8.5147-5151.1992; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pedersen JS, 2004, NUCLEIC ACIDS RES, V32, P4925, DOI 10.1093/nar/gkh839; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Rivas E, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-8; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Walczak R, 1996, RNA, V2, P367; Washietl S, 2004, J MOL BIOL, V342, P19, DOI 10.1016/j.jmb.2004.07.018; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Washietl S, 2007, GENOME RES, V17, P852, DOI 10.1101/gr.5650707; Weile C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-244; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Yao Z, 2007, PLOS COMPUT BIOL, V3, P1212, DOI 10.1371/journal.pcbi.0030126; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	62	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2812	10.1371/journal.pone.0002812	http://dx.doi.org/10.1371/journal.pone.0002812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665251	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300031
J	Bruce, MC; Macheso, A; Kelly-Hope, LA; Nkhoma, S; McConnachie, A; Molyneux, ME				Bruce, Marian C.; Macheso, Allan; Kelly-Hope, Louise A.; Nkhoma, Standwell; McConnachie, Alex; Molyneux, Malcolm E.			Effect of Transmission Setting and Mixed Species Infections on Clinical Measures of Malaria in Malawi	PLOS ONE			English	Article								Background: In malaria endemic regions people are commonly infected with multiple species of malaria parasites but the clinical impact of these Plasmodium co-infections is unclear. Differences in transmission seasonality and transmission intensity between endemic regions have been suggested as important factors in determining the effect of multiple species co-infections. Principal Findings: In order to investigate the impact of multiple-species infections on clinical measures of malaria we carried out a cross-sectional community survey in Malawi, in 2002. We collected clinical and parasitological data from 2918 participants aged >6 months, and applied a questionnaire to measure malaria morbidity. We examined the effect of transmission seasonality and intensity on fever, history of fever, haemoglobin concentration ([Hb]) and parasite density, by comparing three regions: perennial transmission (PT), high intensity seasonal transmission (HIST) and low intensity seasonal transmission (LIST). These regions were defined using multi-level modelling of PCR prevalence data and spatial and geoclimatic measures. The three Plasmodium species (P. falciparum, P. malariae and P. ovale) were randomly distributed amongst all children but not adults in the LIST and PT regions. Mean parasite density in children was lower in the HIST compared with the other two regions. Mixed species infections had lower mean parasite density compared with single species infections in the PT region. Fever rates were similar between transmission regions and were unaffected by mixed species infections. A history of fever was associated with single species infections but only in the HIST region. Reduced mean [Hb] and increased anaemia was associated with perennial transmission compared to seasonal transmission. Children with mixed species infections had higher [Hb] in the HIST region. Conclusions: Our study suggests that the interaction of Plasmodium co-infecting species can have protective effects against some clinical outcomes of malaria but that this is dependent on the seasonality and intensity of malaria transmission.	[Bruce, Marian C.] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland; [Macheso, Allan] Gov Malawi, Minist Hlth & Populat, Lilongwe, Malawi; [Kelly-Hope, Louise A.; Molyneux, Malcolm E.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Nkhoma, Standwell; Molyneux, Malcolm E.] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programme, Blantyre, Malawi; [McConnachie, Alex] Glasgow Univ, Robertson Ctr Biostat, Glasgow, Lanark, Scotland	University of Glasgow; Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of Glasgow	Bruce, MC (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland.	m.bruce@bio.gla.ac.uk			Wellcome Trust Junior Biodiversity Fellowship [060446]	Wellcome Trust Junior Biodiversity Fellowship(Wellcome Trust)	This research was funded by a Wellcome Trust Junior Biodiversity Fellowship to Marian Bruce, Reference 060446.	Alifrangis M, 1999, PARASITOLOGY, V119, P337, DOI 10.1017/S0031182099004825; Binka F, 2006, CURR MOL MED, V6, P261, DOI 10.2174/156652406776055203; BLACK J, 1994, LANCET, V343, P1095, DOI 10.1016/S0140-6736(94)90203-8; Bowie C, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-49; Brabin BJ, 2004, ANN TROP MED PARASIT, V98, P71, DOI 10.1179/000349804225003055; Bruce MC, 2007, PARASITOLOGY, V134, P637, DOI 10.1017/S0031182006001958; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Bruce MC, 2000, PARASITOLOGY, V121, P247, DOI 10.1017/S0031182099006344; Bruce MC, 2000, PARASITOLOGY, V121, P257, DOI 10.1017/S0031182099006356; Bruce MC, 2003, TRENDS PARASITOL, V19, P271, DOI 10.1016/S1471-4922(03)00116-8; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Farnert A, 1997, AM J TROP MED HYG, V56, P538, DOI 10.4269/ajtmh.1997.56.538; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Fraser-Hurt N, 1999, T ROY SOC TROP MED H, V93, pS47, DOI 10.1016/S0035-9203(99)90327-9; Garnham PCC., 1966, MALARIA PARASITES OT; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; *GOV MAL DEP SURV, 1984, NAT ATL MAL; HAWLEY W, 1992, MALARIA VECTOR ASSES; Haworth J., 1988, P1379; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Jakeman GN, 1999, PARASITOLOGY, V119, P127, DOI 10.1017/S0031182099004564; JANOVY J, 1995, ECOL MODEL, V77, P189, DOI 10.1016/0304-3800(93)E0087-J; Kawamoto F, 1999, PARASITOL TODAY, V15, P422, DOI 10.1016/S0169-4758(99)01511-2; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Maguire JD, 2002, LANCET, V360, P58, DOI 10.1016/S0140-6736(02)09336-4; Maitland K, 1997, PARASITOL TODAY, V13, P227, DOI 10.1016/S0169-4758(97)01061-2; Mathanga DP, 2006, TROP MED INT HEALTH, V11, P1367, DOI 10.1111/j.1365-3156.2006.01684.x; May J, 2000, T ROY SOC TROP MED H, V94, P399, DOI 10.1016/S0035-9203(00)90119-6; McKenzie FE, 2002, AM J TROP MED HYG, V67, P411, DOI 10.4269/ajtmh.2002.67.411; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; Mehlotra RK, 2002, AM J TROP MED HYG, V67, P555, DOI 10.4269/ajtmh.2002.67.555; *MIN HLTH POP, 2004, HIV AIDS MAL TB 5 5; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; MZILAHOWA T, 2005, THESIS U LIVERPOOL; NORTHRUP N, 1986, INT J AFR HIST STUD, V19, P59, DOI 10.2307/218695; PELLETIER DL, 1991, SOC SCI MED, V32, P887, DOI 10.1016/0277-9536(91)90244-7; Peragallo MS, 1997, T ROY SOC TROP MED H, V91, P343, DOI 10.1016/S0035-9203(97)90101-2; PHILLIPS RE, 1986, Q J MED, V58, P305; Plowe CV, 2004, BRIT MED J, V328, P545, DOI 10.1136/bmj.37977.653750.EE; Richter J, 2004, T ROY SOC TROP MED H, V98, P751, DOI 10.1016/j.trstmh.2004.06.004; RITCHIE TL, 1988, PARASITOLOGY, V96, P607; Rosenberg R, 2007, TRENDS PARASITOL, V23, P193, DOI 10.1016/j.pt.2007.02.009; Scopel KKG, 2004, ACTA TROP, V90, P61, DOI 10.1016/j.actatropica.2003.11.002; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith T, 2001, AM J TROP MED HYG, V64, P262, DOI 10.4269/ajtmh.2001.64.262; SMITH T, 1995, AM J TROP MED HYG, V52, P306, DOI 10.4269/ajtmh.1995.52.306; Smith T, 1999, T ROY SOC TROP MED H, V93, pS53, DOI 10.1016/S0035-9203(99)90328-0; Smith T, 2006, AM J TROP MED HYG, V75, P56, DOI 10.4269/ajtmh.2006.75.56; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stevens W, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-22; Tanomsing N, 2007, ANTIMICROB AGENTS CH, V51, P3523, DOI 10.1128/AAC.00234-07; Thorold Alan, 1993, MUSLIM IDENTITY SOCI, P79; Tobian AAR, 2000, J INFECT DIS, V182, P558, DOI 10.1086/315729	56	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2775	10.1371/journal.pone.0002775	http://dx.doi.org/10.1371/journal.pone.0002775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648666	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000264302900045
J	Sugui, JA; Kim, HS; Zarember, KA; Chang, YC; Gallin, JI; Nierman, WC; Kwon-Chung, KJ				Sugui, Janyce A.; Kim, H. Stanley; Zarember, Kol A.; Chang, Yun C.; Gallin, John I.; Nierman, Willian C.; Kwon-Chung, Kyung J.			Genes Differentially Expressed in Conidia and Hyphae of Aspergillus fumigatus upon Exposure to Human Neutrophils	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; TRANSCRIPTIONAL RESPONSE; GLYOXYLATE CYCLE; BETA-OXIDATION; PARACOCCIDIOIDES-BRASILIENSIS; INVASIVE ASPERGILLOSIS; IRON ASSIMILATION; UP-REGULATION; INTERNALIZATION	Background: Aspergillus fumigatus is the most common etiologic agent of invasive aspergillosis in immunocompromised patients. Several studies have addressed the mechanism involved in host defense but only few have investigated the pathogen's response to attack by the host cells. To our knowledge, this is the first study that investigates the genes differentially expressed in conidia vs hyphae of A. fumigatus in response to neutrophils from healthy donors as well as from those with chronic granulomatous disease (CGD) which are defective in the production of reactive oxygen species. Methodology/Principal Findings: Transcriptional profiles of conidia and hyphae exposed to neutrophils, either from normal donors or from CGD patients, were obtained by using the genome-wide microarray. Upon exposure to either normal or CGD neutrophils, 244 genes were up-regulated in conidia but not in hyphae. Several of these genes are involved in the degradation of fatty acids, peroxisome function and the glyoxylate cycle which suggests that conidia exposed to neutrophils reprogram their metabolism to adjust to the host environment. In addition, the mRNA levels of four genes encoding proteins putatively involved in iron/copper assimilation were found to be higher in conidia and hyphae exposed to normal neutrophils compared to those exposed to CGD neutrophils. Deletants in several of the differentially expressed genes showed phenotypes related to the proposed functions, i.e. deletants of genes involved in fatty acid catabolism showed defective growth on fatty acids and the deletants of iron/copper assimilation showed higher sensitivity to the oxidative agent menadione. None of these deletants, however, showed reduced resistance to neutrophil attack. Conclusion: This work reveals the complex response of the fungus to leukocytes, one of the major host factors involved in antifungal defense, and identifies fungal genes that may be involved in establishing or prolonging infections in humans.	[Sugui, Janyce A.; Chang, Yun C.; Kwon-Chung, Kyung J.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Kim, H. Stanley] Korea Univ, Coll Med, Dept Med, Seoul, South Korea; [Zarember, Kol A.; Gallin, John I.] NIAID, Lab Host Defenses, NIH, Bethesda, MD USA; [Nierman, Willian C.] J Craig Venter Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); J. Craig Venter Institute	Sugui, JA (corresponding author), NIAID, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	june_kwon-chung@nih.gov		Zarember, Kol/0000-0002-9624-7096	Clinical Center of the National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000155, ZIAAI000155] Funding Source: NIH RePORTER	Clinical Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the Clinical Center of the National Institutes of Health and the intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.	Almyroudis NG, 2005, MED MYCOL, V43, pS247, DOI 10.1080/13693780400025203; ANDERSON GJ, 1992, J INORG BIOCHEM, V47, P249, DOI 10.1016/0162-0134(92)84070-4; Arechabala B, 1999, J APPL TOXICOL, V19, P163, DOI 10.1002/(SICI)1099-1263(199905/06)19:3<163::AID-JAT561>3.0.CO;2-H; ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; BABICH H, 1991, APPL ENVIRON MICROB, V57, P2101, DOI 10.1128/AEM.57.7.2101-2103.1991; Blaiseau PL, 2001, J BIOL CHEM, V276, P34221, DOI 10.1074/jbc.M104987200; Bojunga N, 1998, MOL GEN GENET, V260, P453, DOI 10.1007/s004380050916; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Calera JA, 1997, INFECT IMMUN, V65, P4718, DOI 10.1128/IAI.65.11.4718-4724.1997; Chang YC, 1998, J CLIN INVEST, V101, P1843, DOI 10.1172/JCI2301; DANCIS A, 1994, CELL, V76, P393, DOI 10.1016/0092-8674(94)90345-X; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Denning DW, 2002, LANCET INFECT DIS, V2, P251, DOI 10.1016/S1473-3099(02)00243-8; Derengowski LS, 2008, MED MYCOL, V46, P125, DOI 10.1080/13693780701670509; Dinauer Mary C., 2000, Hematology Am Soc Hematol Educ Program, P303; Ebel F, 2006, FUNGAL GENET BIOL, V43, P476, DOI 10.1016/j.fgb.2006.01.015; Tavares AHFP, 2007, MICROBES INFECT, V9, P583, DOI 10.1016/j.micinf.2007.01.024; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; HEARN VM, 1992, J MED MICROBIOL, V36, P61, DOI 10.1099/00222615-36-1-61; Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005; Hynes MJ, 2006, EUKARYOT CELL, V5, P794, DOI 10.1128/EC.5.5.794-805.2006; KIONKA C, 1985, J BACTERIOL, V161, P153, DOI 10.1128/JB.161.1.153-157.1985; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; Magnani T, 2007, FEMS MICROBIOL LETT, V271, P230, DOI 10.1111/j.1574-6968.2007.00716.x; MASON DL, 1979, MYCOPATHOLOGIA, V68, P183, DOI 10.1007/BF00578528; Munoz P, 2006, CLIN MICROBIOL INFEC, V12, P24, DOI 10.1111/j.1469-0691.2006.01603.x; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Palmieri L, 1997, FEBS LETT, V417, P114, DOI 10.1016/S0014-5793(97)01269-6; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; REX JH, 1990, J INFECT DIS, V162, P523, DOI 10.1093/infdis/162.2.523; Schadeck RJG, 2003, FEMS MICROBIOL LETT, V218, P277, DOI 10.1111/j.1574-6968.2003.tb11529.x; Schobel F, 2007, INFECT IMMUN, V75, P1237, DOI 10.1128/IAI.01416-06; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Spikes S, 2008, J INFECT DIS, V197, P479, DOI 10.1086/525044; Sugui JA, 2005, APPL ENVIRON MICROB, V71, P1798, DOI 10.1128/AEM.71.4.1798-1802.2005; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Wasylnka JA, 2005, MED MYCOL, V43, pS27, DOI 10.1080/13693780400029247; Weber RWS, 1999, HISTOCHEM J, V31, P293, DOI 10.1023/A:1003713901179; Yamamoto A, 2007, EUKARYOT CELL, V6, P1373, DOI 10.1128/EC.00098-07; Yun CW, 2001, J BIOL CHEM, V276, P10218, DOI 10.1074/jbc.M010065200; Zarember KA, 2007, J IMMUNOL, V178, P6367, DOI 10.4049/jimmunol.178.10.6367	53	91	354	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2655	10.1371/journal.pone.0002655	http://dx.doi.org/10.1371/journal.pone.0002655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648542	Green Published, Green Submitted, gold			2022-12-27	WOS:000264065800057
J	Leppanen, OV; Sievanen, H; Jokihaara, J; Pajamaki, I; Kannus, P; Jarvinen, TLN				Leppanen, Olli V.; Sievanen, Harri; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.			Pathogenesis of Age-Related Osteoporosis: Impaired Mechano-Responsiveness of Bone Is Not the Culprit	PLOS ONE			English	Article								Background: According to prevailing understanding, skeletal mechano-responsiveness declines with age and this apparent failure of the mechano-sensory feedback system has been attributed to the gradual bone loss with aging (age-related osteoporosis). The objective of this study was to evaluate whether the capacity of senescent skeleton to respond to increased loading is indeed reduced as compared to young mature skeleton. Methods and Findings: 108 male and 101 female rats were randomly assigned into Exercise and Control groups. Exercise groups were subjected to treadmill training either at peak bone mass between 47-61 weeks of age ( Mature) or at senescence between 75-102 weeks of age ( Senescent). After the training intervention, femoral necks and diaphysis were evaluated with peripheral quantitative computed tomography (pQCT) and mechanical testing; the proximal tibia was assessed with microcomputed tomography (mu CT). The mu CT analysis revealed that the senescent bone tissue was structurally deteriorated compared to the mature bone tissue, confirming the existence of age-related osteoporosis. As regards the mechano-responsiveness, the used loading resulted in only marginal increases in the bones of the mature animals, while significant exercise-induced increases were observed virtually in all bone traits among the senescent rats. Conclusion: The bones of senescent rats displayed a clear ability to respond to an exercise regimen that failed to initiate an adaptive response in mature animals. Thus, our observations suggest that the pathogenesis of age-related osteoporosis is not attributable to impaired mechano-responsiveness of aging skeleton. It also seems that strengthening of even senescent bones is possible - naturally provided that safe and efficient training methods can be developed for the oldest old.	[Leppanen, Olli V.; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Leppanen, Olli V.; Jokihaara, Jarkko; Pajamaki, Ilari; Kannus, Pekka; Jarvinen, Teppo L. N.] Tampere Univ Hosp, Dept Trauma, Musculoskel Surg & Rehab, Div Orthopaed & Traumatol, Tampere, Finland; [Sievanen, Harri; Kannus, Pekka] UKK Inst, Bone Res Grp, Tampere, Finland; [Jokihaara, Jarkko] Univ British Columbia, Dept Orthopaed, Vancouver, BC, Canada	Tampere University; Tampere University; Tampere University Hospital; UKK Institute; University of British Columbia	Leppanen, OV (corresponding author), Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.	teppo.jarvinen@uta.fi	Jokihaara, Jarkko/C-5817-2017; Järvinen, Teppo/B-8189-2013	Jokihaara, Jarkko/0000-0001-6153-2180; Järvinen, Teppo/0000-0003-3713-956X; Leppanen, Olli/0000-0002-9782-8730	Competitive research funding of the Pirkanmaa Hospital District; Research Council for Physical Education and Sports; Ministry of Education; Academy of Finland; Sigrid Juselius Foundation; AO Research Fund, Switzerland	Competitive research funding of the Pirkanmaa Hospital District; Research Council for Physical Education and Sports; Ministry of Education; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); AO Research Fund, Switzerland	This study was supported by grants from the Competitive research funding of the Pirkanmaa Hospital District, the Research Council for Physical Education and Sports, Ministry of Education, the Academy of Finland, Sigrid Juselius Foundation, and the AO Research Fund, Switzerland. The study sponsors had no role in study design; collection, analysis, or interpretation of data; writing of the paper; or decision to submit it for publication.	Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003; Bailey DA, 1999, J BONE MINER RES, V14, P1672, DOI 10.1359/jbmr.1999.14.10.1672; Bass S, 1998, J BONE MINER RES, V13, P500, DOI 10.1359/jbmr.1998.13.3.500; BIKLE DD, 1994, J BONE MINER RES, V9, P1789; Buhl KM, 2001, J APPL PHYSIOL, V90, P1359, DOI 10.1152/jappl.2001.90.4.1359; BUREK JD, 1979, PATHOLOGY AGING RATS; Burr DB, 1997, J BONE MINER RES, V12, P1547, DOI 10.1359/jbmr.1997.12.10.1547; Cheng MZ, 1996, J BONE MINER RES, V11, P502; Cheng MZ, 1997, J BONE MINER RES, V12, P1424, DOI 10.1359/jbmr.1997.12.9.1424; FROST HM, 1988, CALCIFIED TISSUE INT, V42, P145, DOI 10.1007/BF02556327; Frost HM, 1997, J BONE MINER RES, V12, P1539, DOI 10.1359/jbmr.1997.12.10.1539; Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119; Haapasalo H, 1998, J BONE MINER RES, V13, P310, DOI 10.1359/jbmr.1998.13.2.310; HALLORAN BP, 1995, J BONE MINER RES, V10, P1168; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Heinonen A, 2000, OSTEOPOROSIS INT, V11, P1010, DOI 10.1007/s001980070021; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hoshi A, 1998, TOHOKU J EXP MED, V185, P15, DOI 10.1620/tjem.185.15; Hoshi A, 1998, BIOMED ENVIRON SCI, V11, P243; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; Jarvinen TL, 2003, J BONE MINER RES, V18, P1921, DOI 10.1359/jbmr.2003.18.11.1921; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; Jarvinen TLN, 1998, J BONE MINER RES, V13, P1475, DOI 10.1359/jbmr.1998.13.9.1475; Jarvinen TLN, 1998, BONE, V22, P551, DOI 10.1016/S8756-3282(98)00025-8; Jarvinen TLN, 2003, J BONE MINER RES, V18, P1292, DOI 10.1359/jbmr.2003.18.7.1292; Joldersma M, 2001, AM J PHYSIOL-ENDOC M, V280, pE436, DOI 10.1152/ajpendo.2001.280.3.E436; KANNUS P, 1994, J BONE MINER RES, V9, P1613; Kannus P, 1996, J BONE MINER RES, V11, P1339; KANNUS P, 1995, ANN INTERN MED, V123, P27, DOI 10.7326/0003-4819-123-1-199507010-00003; Keenan KP, 1997, J NUTR, V127, pS851, DOI 10.1093/jn/127.5.851S; Khan K, 2000, J Sci Med Sport, V3, P150, DOI 10.1016/S1440-2440(00)80077-8; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kodama Y, 2000, CALCIFIED TISSUE INT, V66, P298, DOI 10.1007/s002230010060; Kontulainen S, 2002, J BONE MINER RES, V17, P2281, DOI 10.1359/jbmr.2002.17.12.2281; Kostenuik PJ, 1999, J BONE MINER RES, V14, P21, DOI 10.1359/jbmr.1999.14.1.21; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; Leppanen O, 2006, J BONE MINER RES, V21, P1231, DOI 10.1359/JBMR.060511; Leppanen OV, 2008, J BIOMECH, V41, P1623, DOI 10.1016/j.jbiomech.2008.03.017; MacKelvie KJ, 2001, J PEDIATR-US, V139, P501, DOI 10.1067/mpd.2001.118190; McKay HA, 2000, J PEDIATR-US, V136, P156, DOI 10.1016/S0022-3476(00)70095-3; Mosley JR, 2002, BONE, V30, P314, DOI 10.1016/S8756-3282(01)00626-3; Pajamaki I, 2003, J BONE MINER RES, V18, P544, DOI 10.1359/jbmr.2003.18.3.544; PELKER R R, 1984, Journal of Orthopaedic Research, V1, P405; PENG MT, 1984, PHYSIOL BEHAV, V33, P615, DOI 10.1016/0031-9384(84)90380-9; PRISBY RD, 2007, J BONE MINER RES; RAAB DM, 1990, J APPL PHYSIOL, V68, P130, DOI 10.1152/jappl.1990.68.1.130; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; SEDLIN ED, 1966, ACTA ORTHOP SCAND, V37, P29, DOI 10.3109/17453676608989401; Seeman E, 2004, CALCIFIED TISSUE INT, V75, P100, DOI 10.1007/s00223-004-0289-4; SOGAARD CH, 1994, J BONE MINER RES, V9, P409; Szulc P, 2007, OSTEOPOROSIS INT, V18, P495, DOI 10.1007/s00198-006-0254-3; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; TURNER CH, 1994, J BONE MINER RES, V9, P87; TURNER CH, 1995, J BONE MINER RES, V10, P1544; Turner RT, 1999, LUPUS, V8, P388, DOI 10.1177/096120339900800512; UMEMURA Y, 1995, INT J SPORTS MED, V16, P364, DOI 10.1055/s-2007-973021; Vasselli JR, 2005, OBES RES, V13, P693, DOI 10.1038/oby.2005.78; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Westerlind KC, 1997, P NATL ACAD SCI USA, V94, P4199, DOI 10.1073/pnas.94.8.4199	65	47	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2540	10.1371/journal.pone.0002540	http://dx.doi.org/10.1371/journal.pone.0002540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648530	gold, Green Published			2022-12-27	WOS:000263288200012
J	Noor, MAF; Parnell, RS; Grant, BS				Noor, Mohamed A. F.; Parnell, Robin S.; Grant, Bruce S.			A Reversible Color Polyphenism in American Peppered Moth (Biston betularia cognataria) Caterpillars	PLOS ONE			English	Article								Insect body color polyphenisms enhance survival by producing crypsis in diverse backgrounds. While color polyphenisms are often indirectly induced by temperature, rearing density, or diet, insects can benefit from immediate crypsis if they evolve polyphenisms directly induced by exposure to the background color, hence immediately deriving protection from predation. Here, we examine such a directly induced color polyphenism in caterpillars of the geometrid peppered moth (Biston betularia). This larval color polyphenism is unrelated to the genetic polymorphism for melanic phenotypes in adult moths. B. betularia caterpillars are generalist feeders and develop body colors that closely match the brown or green twigs of their host plant. We expand on previous studies examining the proximal cues that stimulate color development. Under controlled rearing conditions, we manipulated diets and background reflectance, using both natural and artificial twigs, and show that visual experience has a much stronger effect than does diet in promoting precise color matching. Their induced body color was not a simple response to reflectance or light intensity but instead specifically matched the wavelength of light to which they were exposed. We also show that the potential to change color is retained until the final ( sixth) larval instar. Given their broad host range, this directly induced color polyphenism likely provides the caterpillars with strong protection from bird predation.	[Noor, Mohamed A. F.; Parnell, Robin S.; Grant, Bruce S.] Coll William & Mary, Biol Dept, Williamsburg, VA 23187 USA	William & Mary	Noor, MAF (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	NOOR@DUKE.EDU		Noor, Mohamed/0000-0002-5400-4408				COCKAYNE EA, 1928, P S LOND ENT NAT HIS, P55; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; DERUITER L, 1952, BEHAVIOUR, V4, P222; DYAR HG, 1903, PSYCHE, V10, P78; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Grant BS, 2004, J HERED, V95, P97, DOI 10.1093/jhered/esh022; Grant BS, 2002, J HERED, V93, P86, DOI 10.1093/jhered/93.2.86; Grant BS, 1999, EVOLUTION, V53, P980; GRAYSON J, 1989, BIOL J LINN SOC, V37, P263, DOI 10.1111/j.1095-8312.1989.tb01904.x; GREENE E, 1989, SCIENCE, V243, P643, DOI 10.1126/science.243.4891.643; Greene E, 1996, BIOL J LINN SOC, V58, P277, DOI 10.1006/bijl.1996.0036; HARRIS M, 1766, AURELIAN; HUDSON A, 1966, CAN J ZOOLOG, V44, P541, DOI 10.1139/z66-058; Kettlewell H.B.D., 1973, EVOLUTION MELANISM; LYMBERY AJ, 1992, BIOL J LINN SOC, V45, P71, DOI 10.1111/j.1095-8312.1992.tb00632.x; Nijhout H.F., 1994, INSECT HORMONES; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; POULTON EB, 1892, T ENTOMOL SOC LONDON, P293; Tanaka S, 2004, ANN ENTOMOL SOC AM, V97, P293, DOI 10.1603/0013-8746(2004)097[0293:ECOBPI]2.0.CO;2; Tanaka S, 2006, J INSECT PHYSIOL, V52, P1054, DOI 10.1016/j.jinsphys.2006.07.004; Tietz H. M, 1972, INDEX DESCRIBED LIFE; Verma KK, 2007, J BIOSCIENCES, V32, P415, DOI 10.1007/s12038-007-0039-7	22	35	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3142	10.1371/journal.pone.0003142	http://dx.doi.org/10.1371/journal.pone.0003142			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769543	gold, Green Published, Green Submitted			2022-12-27	WOS:000264419100009
J	Tsigelny, IF; Crews, L; Desplats, P; Shaked, GM; Sharikov, Y; Mizuno, H; Spencer, B; Rockenstein, E; Trejo, M; Platoshyn, O; Yuan, JXJ; Masliah, E				Tsigelny, Igor F.; Crews, Leslie; Desplats, Paula; Shaked, Gideon M.; Sharikov, Yuriy; Mizuno, Hideya; Spencer, Brian; Rockenstein, Edward; Trejo, Margarita; Platoshyn, Oleksandr; Yuan, Jason X. -J.; Masliah, Eliezer			Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; LEWY-BODY-DISEASE; PROTOFIBRILLAR ALPHA-SYNUCLEIN; MOLECULAR-DYNAMICS SIMULATION; BODIES DLB REPORT; LIPID RAFTS; A-BETA; PRECURSOR PROTEIN; IN-VITRO; VESICLE PERMEABILIZATION	Background: Misfolding and pathological aggregation of neuronal proteins has been proposed to play a critical role in the pathogenesis of neurodegenerative disorders. Alzheimer's disease (AD) and Parkinson's disease (PD) are frequent neurodegenerative diseases of the aging population. While progressive accumulation of amyloid beta protein (A beta) oligomers has been identified as one of the central toxic events in AD, accumulation of alpha-synuclein (alpha-syn) resulting in the formation of oligomers and protofibrils has been linked to PD and Lewy body Disease (LBD). We have recently shown that A beta promotes alpha-syn aggregation and toxic conversion in vivo, suggesting that abnormal interactions between misfolded proteins might contribute to disease pathogenesis. However the molecular characteristics and consequences of these interactions are not completely clear. Methodology/Principal Findings: In order to understand the molecular mechanisms involved in potential A beta/alpha-syn interactions, immunoblot, molecular modeling, and in vitro studies with alpha-syn and A beta were performed. We showed in vivo in the brains of patients with AD/PD and in transgenic mice, A beta and alpha-synuclein co-immunoprecipitate and form complexes. Molecular modeling and simulations showed that A beta binds alpha-syn monomers, homodimers, and trimers, forming hybrid ringlike pentamers. Interactions occurred between the N-terminus of A beta and the N-terminus and C-terminus of alpha-syn. Interacting alpha-syn and A beta dimers that dock on the membrane incorporated additional alpha-syn molecules, leading to the formation of more stable pentamers and hexamers that adopt a ring-like structure. Consistent with the simulations, under in vitro cell-free conditions, A beta interacted with alpha-syn, forming hybrid pore-like oligomers. Moreover, cells expressing alpha-syn and treated with A beta displayed increased current amplitudes and calcium influx consistent with the formation of cation channels. Conclusion/Significance: These results support the contention that A beta directly interacts with alpha-syn and stabilized the formation of hybrid nanopores that alter neuronal activity and might contribute to the mechanisms of neurodegeneration in AD and PD. The broader implications of such hybrid interactions might be important to the pathogenesis of other disorders of protein misfolding.	[Tsigelny, Igor F.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Desplats, Paula; Shaked, Gideon M.; Mizuno, Hideya; Spencer, Brian; Rockenstein, Edward; Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA USA; [Crews, Leslie; Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA; [Platoshyn, Oleksandr; Yuan, Jason X. -J.] Univ Calif San Diego, Dept Med, La Jolla, CA USA; [Tsigelny, Igor F.; Sharikov, Yuriy] Univ Calif San Diego, San Diego Super Comp Ctr, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsigelny, IF (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	emasliah@UCSD.edu	Desplats, Paula/AFW-5030-2022; Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067; Desplats, Paula/0000-0002-4758-4280	NIH; DOE;  [AG18440];  [HL066012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, R37AG018440] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG18440, HL066012, and DOE INCITE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P137, DOI 10.1177/0891988704267470; ARISPE N, 1993, P NATL ACAD SCI USA, V90, P567, DOI 10.1073/pnas.90.2.567; Arispe N, 1996, P NATL ACAD SCI USA, V93, P1710, DOI 10.1073/pnas.93.4.1710; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; BARON P, 2008, J NEUROCHEM IN PRESS; Bennett MC, 2005, PHARMACOL THERAPEUT, V105, P311, DOI 10.1016/j.pharmthera.2004.10.010; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Furukawa K, 2006, J NEUROCHEM, V97, P1071, DOI 10.1111/j.1471-4159.2006.03803.x; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Glabe CG, 2006, NEUROLOGY, V66, pS74, DOI 10.1212/01.wnl.0000192103.24796.42; Grubmuller H, 1991, MOL SIMULAT, V6, P121, DOI 10.1080/08927029108022142; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Janvin CC, 2006, MOVEMENT DISORD, V21, P337, DOI 10.1002/mds.20726; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; Jellinger KA, 2006, ACTA NEUROPATHOL, V112, P253, DOI 10.1007/s00401-006-0088-2; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Krishnan S, 2003, BIOCHEMISTRY-US, V42, P829, DOI 10.1021/bi026528t; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Kurata T, 2007, J NEUROSCI RES, V85, P2246, DOI 10.1002/jnr.21352; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa Sara M, 2005, Am J Alzheimers Dis Other Demen, V20, P315, DOI 10.1177/153331750502000506; Litvan I, 1998, ARCH NEUROL-CHICAGO, V55, P969, DOI 10.1001/archneur.55.7.969; Mandal PK, 2006, NEUROCHEM RES, V31, P1153, DOI 10.1007/s11064-006-9140-9; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; McKeith IG, 2006, J ALZHEIMERS DIS, V9, P417, DOI 10.1212/wnl.47.5.1113; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Mishizen-Eberz AJ, 2005, BIOCHEMISTRY-US, V44, P7818, DOI 10.1021/bi047846q; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Mustard D, 2005, PROTEINS, V60, P269, DOI 10.1002/prot.20569; Narayanan V, 2001, BIOCHEMISTRY-US, V40, P9927, DOI 10.1021/bi002952n; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; PETTEGREW J, 1989, BIOL MARKERS ALZHEIM, P83; Pletnikova O, 2005, NEUROBIOL AGING, V26, P1183, DOI 10.1016/j.neurobiolaging.2004.10.006; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Sharikov Y, 2008, NAT METHODS, V5, P119, DOI 10.1038/nmeth0208-119; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; SOTO C, 1994, J NEUROCHEM, V63, P1191; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tu K, 1995, BIOPHYS J, V69, P2558, DOI 10.1016/S0006-3495(95)80126-8; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Uversky VN, 2001, J BIOL CHEM, V276, P43495, DOI 10.1074/jbc.C100551200; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Williamson R, 2008, FASEB J, V22, P1552, DOI 10.1096/fj.07-9766com; Yang FS, 2000, BRAIN RES, V853, P381, DOI 10.1016/S0006-8993(99)02207-6; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; YU J, 2008, J NEUROIMMUNE PHARM; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	112	203	213	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3135	10.1371/journal.pone.0003135	http://dx.doi.org/10.1371/journal.pone.0003135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769546	Green Published, gold, Green Submitted			2022-12-27	WOS:000264419100005
J	Benjak, A; Forneck, A; Casacuberta, JM				Benjak, Andrej; Forneck, Astrid; Casacuberta, Josep M.			Genome-Wide Analysis of the "Cut-and-Paste'' Transposons of Grapevine	PLOS ONE			English	Article							VITIS-VINIFERA L.; MUTATOR-LIKE ELEMENTS; ARABIDOPSIS-THALIANA; GENE FRAGMENTS; PIF-LIKE; FAMILY; SEQUENCE; EVOLUTION; RICE; DIVERSITY	Background: The grapevine is a widely cultivated crop and a high number of different varieties have been selected since its domestication in the Neolithic period. Although sexual crossing has been a major driver of grapevine evolution, its vegetative propagation enhanced the impact of somatic mutations and has been important for grapevine diversity. Transposable elements are known to be major contributors to genome variability and, in particular, to somatic mutations. Thus, transposable elements have probably played a major role in grapevine domestication and evolution. The recent publication of the complete grapevine genome opens the possibility for an in deep analysis of its transposon content. Principal Findings: We present here a detailed analysis of the "cut-and-paste'' class II transposons present in the genome of grapevine. We characterized 1160 potentially complete grapevine transposons as well as 2086 defective copies. We report on the structure of each element, their potentiality to encode a functional transposase, and the existence of matching ESTs that could suggest their transcription. Conclusions: Our results show that these elements have transduplicated and amplified cellular sequences and some of them have been domesticated and probably fulfill cellular functions. In addition, we provide evidences that the mobility of these elements has contributed to the genomic variability of this species.	[Benjak, Andrej; Casacuberta, Josep M.] CRAG, Dept Genet Mol Vegetal, Barcelona, Spain; [Benjak, Andrej; Forneck, Astrid] Univ Nat Resources & Appl Life Sci, Inst Horticulture & Viticulture, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); University of Barcelona; University of Natural Resources & Life Sciences, Vienna	Benjak, A (corresponding author), CRAG, Dept Genet Mol Vegetal, Barcelona, Spain.	jcsgmp@cid.csic.es	forneck, astrid/C-2946-2008	Benjak, Andrej/0000-0003-4522-6575; Casacuberta, josep/0000-0002-5609-4152	Ministerio de Educacion y Ciencia [BFU2006-04005]; Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya; EMBO [ASTF 115-07]	Ministerio de Educacion y Ciencia(Spanish Government); Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya(Generalitat de Catalunya); EMBO(European Molecular Biology Organization (EMBO))	This work was partially funded by a grant of the Ministerio de Educacion y Ciencia (Grant BFU2006-04005) and the Xarxa de Referencia en Biotecnologia from the Generalitat de Catalunya to J.M.C. A.B. was partially funded by an EMBO Short Term Fellowship (ASTF 115-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Bundock P, 2005, NATURE, V436, P282, DOI 10.1038/nature03667; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; Cowan RK, 2005, MOL BIOL EVOL, V22, P2084, DOI 10.1093/molbev/msi202; Feschotte C, 2005, NUCLEIC ACIDS RES, V33, P2153, DOI 10.1093/nar/gki509; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FORNECK A, 2005, PROGR BOT, P165; Franks T, 2002, THEOR APPL GENET, V104, P192, DOI 10.1007/s001220100683; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoen DR, 2006, MOL BIOL EVOL, V23, P1254, DOI 10.1093/molbev/msk015; Holligan D, 2006, GENETICS, V174, P2215, DOI 10.1534/genetics.106.062752; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Juretic N, 2005, GENOME RES, V15, P1292, DOI 10.1101/gr.4064205; JURKA J, 2005, REPBASE REPORTS, V5, P201; JURKA J, 2005, REPBASE REPORTS, V5, P205; Kapitonov VV, 1999, GENETICA, V107, P27, DOI 10.1023/A:1004030922447; Kapitonov VV, 2004, DNA CELL BIOL, V23, P311, DOI 10.1089/104454904323090949; Kawasaki S, 2004, PLANT CELL PHYSIOL, V45, P933, DOI 10.1093/pcp/pch109; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LE Q, 2007, MOL GENET GENOMICS, V278, P1617; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Miura A, 2004, MOL GENET GENOMICS, V270, P524, DOI 10.1007/s00438-003-0943-y; Muehlbauer GJ, 2006, MOL GENET GENOMICS, V275, P553, DOI 10.1007/s00438-006-0098-8; Pelsy F, 2002, THEOR APPL GENET, V105, P614, DOI 10.1007/s00122-002-0969-2; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; Rubin E, 2001, GENETICS, V158, P949; Saccaro NJ, 2007, GENE, V392, P117, DOI 10.1016/j.gene.2006.11.017; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; van Leeuwen H, 2007, MOL GENET GENOMICS, V277, P357, DOI 10.1007/s00438-006-0194-9; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Verries C, 2000, GENOME, V43, P366, DOI 10.1139/gen-43-2-366; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wicker T, 2003, PLANT PHYSIOL, V132, P52, DOI 10.1104/pp.102.015743; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu ZN, 2004, PLANT CELL, V16, P1105, DOI 10.1105/tpc.019802; Yu ZH, 2000, GENETICS, V156, P2019; Zabala G, 2005, PLANT CELL, V17, P2619, DOI 10.1105/tpc.105.033506; Zabala G, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-38; Zhang XY, 2004, P NATL ACAD SCI USA, V101, P5589, DOI 10.1073/pnas.0401243101; Zhang XY, 2004, GENETICS, V166, P971, DOI 10.1534/genetics.166.2.971	56	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3107	10.1371/journal.pone.0003107	http://dx.doi.org/10.1371/journal.pone.0003107			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769592	Green Published, gold			2022-12-27	WOS:000264418300002
J	Kivimaki, M; Lawlor, DA; Smith, GD; Kumari, M; Donald, A; Britton, A; Casas, JP; Shah, T; Brunner, E; Timpson, NJ; Halcox, JPJ; Miller, MA; Humphries, SE; Deanfield, J; Marmot, MG; Hingorani, AD				Kivimaeki, Mika; Lawlor, Debbie A.; Smith, George Davey; Kumari, Meena; Donald, Ann; Britton, Annie; Casas, Juan P.; Shah, Tina; Brunner, Eric; Timpson, Nicholas J.; Halcox, Julian P. J.; Miller, Michelle A.; Humphries, Steve E.; Deanfield, John; Marmot, Michael G.; Hingorani, Aroon D.			Does High C-reactive Protein Concentration Increase Atherosclerosis? The Whitehall II Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; CRP GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; INTERINDIVIDUAL VARIABILITY; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; METABOLIC-SYNDROME; PROMOTER REGION; WEIGHT-LOSS	Background: C-reactive protein (CRP), a marker of systemic inflammation, is associated with risk of coronary events and subclinical measures of atherosclerosis. Evidence in support of this link being causal would include an association robust to adjustments for confounders (multivariable standard regression analysis) and the association of CRP gene polymorphisms with atherosclerosis (Mendelian randomization analysis). Methodology/Principal Findings: We genotyped 3 tag single nucleotide polymorphisms (SNPs) [+ 1444T>C (rs1130864); +2303G>A (rs1205) and +4899T>G (rs 3093077)] in the CRP gene and assessed CRP and carotid intima-media thickness (CIMT), a structural marker of atherosclerosis, in 4941 men and women aged 50-74 (mean 61) years (the Whitehall II Study). The 4 major haplotypes from the SNPs were consistently associated with CRP level, but not with other risk factors that might confound the association between CRP and CIMT. CRP, assessed both at mean age 49 and at mean age 61, was associated both with CIMT in age and sex adjusted standard regression analyses and with potential confounding factors. However, the association of CRP with CIMT attenuated to the null with adjustment for confounding factors in both prospective and cross-sectional analyses. When examined using genetic variants as the instrument for serum CRP, there was no inferred association between CRP and CIMT. Conclusions/Significance: Both multivariable standard regression analysis and Mendelian randomization analysis suggest that the association of CRP with carotid atheroma indexed by CIMT may not be causal.	[Kivimaeki, Mika; Kumari, Meena; Britton, Annie; Brunner, Eric; Marmot, Michael G.; Hingorani, Aroon D.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Lawlor, Debbie A.; Smith, George Davey; Timpson, Nicholas J.] Univ Bristol, Dept Social Med, Ctr Causal Anal Translat Epidemiol, Med Res Council, Bristol BS8 1TH, Avon, England; [Donald, Ann; Halcox, Julian P. J.; Deanfield, John] UCL, Inst Child Hlth, Vasc Physiol Unit, London WC1E 6BT, England; [Donald, Ann; Deanfield, John] Great Ormond St Hosp NHS Trust, London, England; [Casas, Juan P.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Shah, Tina; Hingorani, Aroon D.] UCL, Dept Med, London WC1E 6BT, England; [Miller, Michelle A.] Univ Warwick, Warwick Med Sch, Clin Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Humphries, Steve E.] UCL, Ctr Cardiovasc Genet, London WC1E 6BT, England	University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Bristol; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Warwick; University of London; University College London	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	m.kivimaki@ucl.ac.uk	Fox, Laura J/C-6249-2016; Marmot, M G/Y-3920-2019; Timpson, Nicholas John/O-7548-2015; Kivimaki, Mika/B-3607-2012; Attrill, Lauren/V-1688-2018; Miller, Michelle A/D-1840-2009; Davey Smith, George/A-7407-2013; Brunner, Eric/H-2114-2011	Marmot, M G/0000-0002-2431-6419; Timpson, Nicholas John/0000-0002-7141-9189; Kivimaki, Mika/0000-0002-4699-5627; Miller, Michelle A/0000-0002-6696-0923; Davey Smith, George/0000-0002-1407-8314; Brunner, Eric/0000-0002-0595-4474; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hingorani, Aroon/0000-0001-8365-0081; Humphries, Stephen E/0000-0002-8221-6547; Shah, Tina/0000-0001-7724-7210; Halcox, Julian/0000-0001-6926-2947; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Kumari, Meena/0000-0001-9716-1035; Deanfield, John/0000-0001-8806-6052	Medical Research Council [Research Professorship]; British Heart Foundation [PG2005/014, FS/02/086/14760]; Health and Safety Executive; Department of Health [Career Scientist Award]; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Academy of Finland [117604]; MRC; British Heart Foundation (BHF); British Heart Foundation [RG/07/008/23674, RG/08/008/25291] Funding Source: researchfish; Medical Research Council [G0600705, G0100222, G8802774, G19/35] Funding Source: researchfish; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; MRC [G0600705] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; Academy of Finland(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation (BHF)(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. Mi.K. is supported by the Academy of Finland (Projects no. 117604), D.A.L. by a UK Department of Health Career Scientist Award, M.G.M. by a MRC Research Professorship. A.D.H. holds a British Heart Foundation Senior Research Fellowship, and S.E.H. and J.E.D. received Chair support from the British Heart Foundation (BHF). S.E.H. and T.S. are supported by the BHF (PG2005/014 and (FS/02/086/14760). Funders had no role in the design and conduct of the study, in the collection, analysis, interpretation of the data, or in the preparation, review, or approval of the manuscript.	Bots ML, 2006, CURR MED RES OPIN, V22, P2181, DOI 10.1185/030079906X148472; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Danesh J, 2008, EUR J EPIDEMIOL, V23, P531, DOI 10.1007/s10654-008-9249-z; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2007, ARTERIOSCL THROM VAS, V27, P978, DOI 10.1161/01.ATV.0000258869.48076.14; Kivimaki M, 2007, AM J EPIDEMIOL, V166, P760, DOI 10.1093/aje/kwm151; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; LAWLOR DA, 2008, PLOS ONE IN PRESS; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lorenz MW, 2007, STROKE, V38, P1774, DOI 10.1161/STROKEAHA.106.476135; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; O'Brien KD, 2005, J CLIN ENDOCR METAB, V90, P2244, DOI 10.1210/jc.2004-1011; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pepys MB, 2005, CIRC RES, V97, pE97, DOI 10.1161/01.RES.0000193595.03608.08; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Reilly MP, 2003, ARTERIOSCL THROM VAS, V23, P1851, DOI 10.1161/01.ATV.0000092327.60858.4A; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rose G, 1982, CARDIOVASCULAR SURVE; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2005, RHEUMATOLOGY, V44, P864, DOI 10.1093/rheumatology/keh613; Timpson NJ, 2006, CIRCULATION, V114, pE256, DOI 10.1161/CIRCULATIONAHA.106.638387; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; Verma S, 2006, CIRCULATION, V113, P2135; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wang TJ, 2002, ARTERIOSCL THROM VAS, V22, P1662, DOI 10.1161/01.ATV.0000034543.78801.69; Yeh ETH, 2003, CIRCULATION, V107, P370, DOI 10.1161/01.CIR.0000053731.05365.5A; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	56	36	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3013	10.1371/journal.pone.0003013	http://dx.doi.org/10.1371/journal.pone.0003013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714381	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900038
J	Raizada, N; Chauhan, LS; Khera, A; Sokhey, J; Wares, DF; Sahu, S; Thakur, R; Dewan, PK				Raizada, Neeraj; Chauhan, Lakbir Singh; Khera, Ajay; Sokhey, Jotna; Wares, D. Fraser; Sahu, Suvanand; Thakur, Rahul; Dewan, Puneet Kumar			HIV Seroprevalence among Tuberculosis Patients in India, 2006-2007	PLOS ONE			English	Article								Background: Little information exists regarding the burden of HIV among tuberculosis patients in India, and no population-based surveys have been previously reported. A community-based HIV prevalence survey was conducted among tuberculosis patients treated by the national tuberculosis control programme to evaluate the HIV prevalence among tuberculosis patients in India. Methodology/Principal Findings: Fifteen districts (total population: 40.2 million) across 8 states were stratified by HIV prevalence in antenatal clinic HIV surveillance sites and randomly selected. From December 2006 to May 2007, remnant serum was collected from patients' clinical specimens taken after 2 months of anti-tuberculosis treatment and subjected to anonymous, unlinked HIV testing. Specimens were obtained and successfully tested for 5,995 (73%) of 8,217 tuberculosis patients eligible for the survey. HIV prevalence ranged widely among the 15 surveyed districts, from 1% in Koch Bihar, West Bengal, to 13.8% in Guntur, Andhra Pradesh. HIV infection was 1.3 times more likely among male TB patients than among female patients. Relative to smear-positive tuberculosis, HIV infection was 1.4 times more likely among smear-negative patients and 1.3 times more likely among extrapulmonary patients. In 4 higher-HIV prevalence districts, which had been previously surveyed in 2005-2006, no significant change in HIV prevalence was detected. Conclusions: The burden of HIV among tuberculosis patients varies widely in India. Programme efforts to implement comprehensive TB-HIV services should be targeted to areas with the highest HIV burden. Surveillance through routine reporting or special surveys is necessary to detect areas requiring intensification of TB-HIV collaborative activities.	[Raizada, Neeraj; Wares, D. Fraser; Sahu, Suvanand; Thakur, Rahul] Off WHO Representat India, New Delhi, India; [Chauhan, Lakbir Singh] Directorate Gen Hlth Serv, Cent Tuberculosis Div, New Delhi, India; [Khera, Ajay; Sokhey, Jotna] Minist Hlth & Family Welfare, Natl AIDS Control Org, New Delhi, India; [Dewan, Puneet Kumar] WHO, Southeast Asia Region Office, New Delhi, India	World Health Organization; World Health Organization	Raizada, N (corresponding author), Off WHO Representat India, New Delhi, India.	dewanp@searo.who.int		Raizada, Neeraj/0000-0003-2116-332X				Burman William J, 2003, Semin Respir Infect, V18, P263; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; DECOCK KM, 1992, JAMA-J AM MED ASSOC, V268, P1581, DOI 10.1001/jama.1992.03490120095035; Dey S K, 2003, Indian J Public Health, V47, P37; Hussain T, 2006, TUBERCULOSIS, V86, P54, DOI 10.1016/j.tube.2005.07.001; Hussain T, 2007, TUBERCULOSIS, V87, P7, DOI 10.1016/j.tube.2006.01.001; Lienhardt C, 1997, INT J TUBERC LUNG D, V1, P196; Mawar N, 2005, INDIAN J MED RES, V122, P471; Mehrotra Ravi, 2006, Indian J Pathol Microbiol, V49, P302; *MIN HLTH FAM WELF, 2008, NAT FRAM JOINT TB HI; *MIN HLTH FAM WELF, 2006, RNTCP STAT REP; *MIN HLTH FAM WELF, TECH REP IND HIV EST; *MIN HLTH FAM WELF, 2005, TECHN OP GUID TB CON; *MIN HLTH FAM WELF, TB IND 2007 RNTCP ST; Ministry of Health and Family Welfare Government of India 2008, 2006, HIV SENT SURV HIV ES; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Panjabi R, 2007, INT J TUBERC LUNG D, V11, P828; Piramanayagam P, 2007, INDIAN J MED RES, V125, P163; Ramachandran R, 2003, INDIAN J MED RES, V118, P147; Shah I, 2007, HIV MED, V8, P265, DOI 10.1111/j.1468-1293.2007.00457.x; Sharma SK, 2003, INDIAN J MED RES, V117, P239; *WHO, 2004, INT POL COLL TB HIV; *WHO, 2004, WHOHTMTB2004339; WHO, 2007, WHOHTMTB2007376	24	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2970	10.1371/journal.pone.0002970	http://dx.doi.org/10.1371/journal.pone.0002970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714335	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900001
J	Brookes, RH; Hill, PC; Owiafe, PK; Ibanga, HB; Jeffries, DJ; Donkor, SA; Fletcher, HA; Hammond, AS; Lienhardt, C; Adegbola, RA; McShane, H; Hill, AVS				Brookes, Roger H.; Hill, Philip C.; Owiafe, Patrick K.; Ibanga, Hannah B.; Jeffries, David J.; Donkor, Simon A.; Fletcher, Helen A.; Hammond, Abdulrahman S.; Lienhardt, Christian; Adegbola, Richard A.; McShane, Helen; Hill, Adrian V. S.			Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; MYCOBACTERIUM-TUBERCULOSIS; VIRUS ANKARA; SKIN-TEST; ENHANCED IMMUNOGENICITY; PROTECTIVE EFFICACY; CLINICAL-TRIALS; BCG VACCINATION; INFECTION; IMMUNITY	Background: Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers. Methods and Findings: We vaccinated 21 healthy adult male subjects (11 BCG scar negative and 10 BCG scar positive) with MVA85A after screening for evidence of prior exposure to mycobacteria. We monitored them over six months, observing for clinical, haematological and biochemical adverse events, together with assessment of the vaccine induced cellular immune response using ELISPOT and flow cytometry. MVA85A was well tolerated with no significant adverse events. Mild local and systemic adverse events were consistent with previous UK trials. Marked immunogenicity was found whether individuals had a previous BCG scar or not. There was not enhanced immunogenicity in those with a BCG scar, and induced T cell responses were better maintained in apparently BCG-naive Gambians than previously studied BCG-naive UK vaccinees. Although responses were predominantly attributable to CD4+ T cells, we also identified antigen specific CD8+ T cell responses, in subjects who were HLA B-35 and in whom enough blood was available for more detailed immunological analysis. Conclusions: These data on the safety and immunogenicity of MVA85A in West Africa support its accelerated development as a promising booster vaccine for tuberculosis.	[Brookes, Roger H.; Hill, Philip C.; Owiafe, Patrick K.; Ibanga, Hannah B.; Jeffries, David J.; Donkor, Simon A.; Hammond, Abdulrahman S.; Adegbola, Richard A.] MRC Labs, TB Div, Bacterial Dis Programme, Banjul, Gambia; [Fletcher, Helen A.; McShane, Helen; Hill, Adrian V. S.] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Lienhardt, Christian] Inst Rech Dev, Paris, France; [Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England	MRC Laboratory Molecular Biology; University of Oxford; Institut de Recherche pour le Developpement (IRD); University of Oxford; Wellcome Centre for Human Genetics	Brookes, RH (corresponding author), MRC Labs, TB Div, Bacterial Dis Programme, Banjul, Gambia.	helen.mcshane@ndm.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Hammond, Abdulrahman/F-1541-2011; Fletcher, Helen/D-1470-2011	Lienhardt, Christian/0000-0003-0233-893X; Brookes, Roger/0000-0002-5361-0617; Fletcher, Helen/0000-0002-0435-1006; McShane, Helen/0000-0002-2126-5142; Kwasi Owiafe, Patrick/0000-0002-4287-3577	Medical Research Council (UK); European Commission [AFTBVAC-ICA4-CT-2002-10052]; Medical Research Council [MC_U190071468] Funding Source: researchfish; MRC [MC_U190071468] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Medical Research Council (UK) and the European Commission (AFTBVAC-ICA4-CT-2002-10052). Neither funder had any role in the design of the study or the preparation of the manuscript.	Ahmed RKS, 2005, SCAND J IMMUNOL, V61, P63, DOI 10.1111/j.0300-9475.2005.01530.x; ANDERSEN P, 1995, J IMMUNOL, V154, P3359; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Black GF, 2002, LANCET, V359, P1393, DOI 10.1016/S0140-6736(02)08353-8; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; Hallander HO, 2002, VACCINE, V21, P138, DOI 10.1016/S0264-410X(02)00348-1; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000068; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Klein MR, 2001, J INFECT DIS, V183, P928, DOI 10.1086/319267; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; LEE SP, 1995, EUR J IMMUNOL, V25, P102, DOI 10.1002/eji.1830250119; Levine MM, 2006, VACCINE, V24, P3865, DOI 10.1016/j.vaccine.2006.03.039; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; Moorthy VS, 2004, J INFECT DIS, V189, P2213, DOI 10.1086/421118; Mwau M, 2004, J GEN VIROL, V85, P911, DOI 10.1099/vir.0.19701-0; Pathan AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001052; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Williams A, 2005, INFECT IMMUN, V73, P3814, DOI 10.1128/IAI.73.6.3814-3816.2005; YOUNG TK, 1992, TUBERCLE LUNG DIS, V73, P94, DOI 10.1016/0962-8479(92)90062-O	34	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2921	10.1371/journal.pone.0002921	http://dx.doi.org/10.1371/journal.pone.0002921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698342	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000264412600007
J	Hashimoto, T; Hussien, R; Cho, HS; Kaufer, D; Brooks, GA				Hashimoto, Takeshi; Hussien, Rajaa; Cho, Hyung-Sook; Kaufer, Daniela; Brooks, George A.			Evidence for the Mitochondrial Lactate Oxidation Complex in Rat Neurons: Demonstration of an Essential Component of Brain Lactate Shuttles	PLOS ONE			English	Article								To evaluate the presence of components of a putative Intracellular Lactate Shuttle (ILS) in neurons, we attempted to determine if monocarboxylate ( e. g. lactate) transporter isoforms (MCT1 and -2) and lactate dehydrogenase (LDH) are coexpressed in neuronal mitochondria of rat brains. Immunohistochemical analyses of rat brain cross-sections showed MCT1, MCT2, and LDH to colocalize with the mitochondrial inner membrane marker cytochrome oxidase ( COX) in cortical, hippocampal, and thalamic neurons. Immunoblotting after immunoprecipitation (IP) of mitochondria from brain homogenates supported the histochemical observations by demonstrating that COX coprecipitated MCT1, MCT2, and LDH. Additionally, using primary cultures from rat cortex and hippocampus as well as immunohistochemistry and immunocoprecipitation techniques, we demonstrated that MCT2 and LDH are coexpressed in mitochondria of cultured neurons. These findings can be interpreted to mean that, as in skeletal muscle, neurons contain a mitochondrial lactate oxidation complex (mLOC) that has the potential to facilitate both intracellular and cell-cell lactate shuttles in brain.	[Hashimoto, Takeshi; Hussien, Rajaa; Cho, Hyung-Sook; Kaufer, Daniela; Brooks, George A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hashimoto, T (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	gbrooks@berkeley.edu		Brooks, George A./0000-0002-1389-1629	NIH [R01 AR050459]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050459] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIH R01 AR050459	ABILOVA G A, 1991, Byulleten' Eksperimental'noi Biologii i Meditsiny, V111, P462; Atlante A, 2007, BBA-BIOENERGETICS, V1767, P1285, DOI 10.1016/j.bbabio.2007.08.003; Bergman BC, 1999, J APPL PHYSIOL, V87, P1684, DOI 10.1152/jappl.1999.87.5.1684; Bliss TM, 2004, J NEUROSCI, V24, P6202, DOI 10.1523/JNEUROSCI.0805-04.2004; BRANDT RB, 1987, ARCH BIOCHEM BIOPHYS, V259, P412, DOI 10.1016/0003-9861(87)90507-8; BROOKS GA, 1986, MED SCI SPORT EXER, V18, P360, DOI 10.1249/00005768-198606000-00019; Brooks GA, 1998, COMP BIOCHEM PHYS B, V120, P89, DOI 10.1016/S0305-0491(98)00025-X; Brooks GA, 2002, BIOCHEM SOC T, V30, P258, DOI 10.1042/bst0300258; Brooks GA, 1999, P NATL ACAD SCI USA, V96, P1129, DOI 10.1073/pnas.96.3.1129; BROOKS GA, 1991, J APPL PHYSIOL, V71, P333, DOI 10.1152/jappl.1991.71.1.333; BROOKS GA, 1985, GLYCOLYTIC END PRODU, P202; Brooks GEA, 2007, J PHYSIOL-LONDON, V584, P705, DOI 10.1113/jphysiol.2007.142992; CASPER D, 1991, J NEUROSCI RES, V30, P372, DOI 10.1002/jnr.490300213; Dalsgaard MK, 2004, J PHYSIOL-LONDON, V554, P571, DOI 10.1113/jphysiol.2003.055053; de Bari L, 2004, BIOCHEM J, V380, P231, DOI 10.1042/BJ20031981; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; FRIEDMAN L, 1987, NEUROSCI LETT, V79, P65, DOI 10.1016/0304-3940(87)90673-2; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Hanu R, 2000, AM J PHYSIOL-CELL PH, V278, pC921, DOI 10.1152/ajpcell.2000.278.5.C921; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2008, MED SCI SPORT EXER, V40, P486, DOI [10.1249/MSS.0b013e31815fcb04, 10.1249/mss.0b013e31815fcb04]; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HEVNER RF, 1995, NEUROSCIENCE, V65, P313, DOI 10.1016/0306-4522(94)00514-6; Holloway R, 2007, ACTA NEUROCHIR, V149, P919, DOI 10.1007/s00701-007-1241-y; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Laughton JD, 2000, NEUROSCIENCE, V96, P619, DOI 10.1016/S0306-4522(99)00580-1; Lemire J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001550; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Richardson RS, 1998, J APPL PHYSIOL, V85, P627, DOI 10.1152/jappl.1998.85.2.627; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Schurr A, 2006, J CEREBR BLOOD F MET, V26, P142, DOI 10.1038/sj.jcbfm.9600174; SCHURR A, 1988, BRAIN RES, V438, P311, DOI 10.1016/0006-8993(88)91354-6; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Valenti D, 2002, BIOCHEM J, V364, P101, DOI 10.1042/bj3640101; WILSON EJ, 1987, NEUROCHEM RES, V12, P831; Wimmer VC, 2006, J NEUROSCI, V26, P109, DOI 10.1523/JNEUROSCI.3268-05.2006	41	122	131	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2915	10.1371/journal.pone.0002915	http://dx.doi.org/10.1371/journal.pone.0002915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698340	gold, Green Published, Green Submitted			2022-12-27	WOS:000264412600003
J	Plagnol, V; Uz, E; Wallace, C; Stevens, H; Clayton, D; Ozcelik, T; Todd, JA				Plagnol, Vincent; Uz, Elif; Wallace, Chris; Stevens, Helen; Clayton, David; Ozcelik, Tayfun; Todd, John A.			Extreme Clonality in Lymphoblastoid Cell Lines with Implications for Allele Specific Expression Analyses	PLOS ONE			English	Article								Lymphoblastoid cell lines (LCL) are being actively and extensively used to examine the expression of specific genes and genome-wide expression profiles, including allele specific expression assays. However, it has recently been shown that approximately 10% of human genes exhibit random patterns of monoallelic expression within single clones of LCLs. Consequently allelic imbalance studies could be significantly compromised if bulk populations of donor cells are clonal, or near clonal. Here, using X chromosome inactivation as a readout, we confirm and quantify widespread near monoclonality in two independent sets of cell lines. Consequently, we recommend where possible the use of bulk, non cell line, ex vivo cells for allele specific expression assays.	[Plagnol, Vincent; Stevens, Helen; Clayton, David; Todd, John A.] Univ Cambridge, JDRF WT Diabet & Inflammat Lab, Cambridge, England; [Uz, Elif] Bilkent Univ, Fac Sci, Dept Mol Biol & Genet, Ankara, Turkey; [Wallace, Chris] William Harvey Res Inst, Barts & The London, London, England; [Ozcelik, Tayfun] Bilkent Univ, Inst Mat Sci & Nanotechnol UNAM, Ankara, Turkey	University of Cambridge; Ihsan Dogramaci Bilkent University; University of London; Queen Mary University London; Ihsan Dogramaci Bilkent University	Plagnol, V (corresponding author), Univ Cambridge, JDRF WT Diabet & Inflammat Lab, Cambridge, England.	vincent.plagnol@cimr.cam.ac.uk	Uz, Elif/A-4666-2012; Todd, John A/A-3542-2010; Plagnol, Vincent/A-5667-2011	Todd, John A/0000-0003-2740-8148; Wallace, Chris/0000-0001-9755-1703; Plagnol, Vincent/0000-0002-5597-9215	Juvenile Diabetes Research Foundation [postdoctoral fellow]; National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre; Wellcome Trust [079895]; British Heart Foundation [FS/05/061/19501]; Scientifical and Technical Research Council of Turkey [TUBITAK-SBAG3334]; International Centre for Genetic Engineering and Biotechnology [ICGEB-CRP/TUR04-01]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cambridge Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Scientifical and Technical Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); International Centre for Genetic Engineering and Biotechnology	We thank the Juvenile Diabetes Research Foundation, the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre and the Wellcome Trust for funding. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). CW is funded by the British Heart Foundation (FS/05/061/19501). VP is a Juvenile Diabetes Research Foundation postdoctoral fellow. EU and TO are supported by grants from the Scientifical and Technical Research Council of Turkey (TUBITAK-SBAG3334) an International Centre for Genetic Engineering and Biotechnology (ICGEB-CRP/TUR04-01, to TO).	ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Bione S, 2006, AM J MED GENET A, V140A, P1349, DOI 10.1002/ajmg.a.31312; Bretherick KL, 2007, AM J MED GENET A, V143A, P945, DOI 10.1002/ajmg.a.31679; Brix TH, 2005, J CLIN ENDOCR METAB, V90, P5949, DOI 10.1210/jc.2005-1366; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Forton JT, 2007, GENOME RES, V17, P82, DOI 10.1101/gr.5663007; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Lanasa MC, 2001, AM J OBSTET GYNECOL, V185, P563, DOI 10.1067/mob.2001.117670; MIGEON BR, 1988, AM J HUM GENET, V42, P742; Ozbalkan Z, 2005, ARTHRITIS RHEUM-US, V52, P1564, DOI 10.1002/art.21026; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TRAINOR KJ, 1990, BLOOD, V75, P2220	18	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2966	10.1371/journal.pone.0002966	http://dx.doi.org/10.1371/journal.pone.0002966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698422	gold, Green Submitted, Green Published			2022-12-27	WOS:000264412600051
J	Shrivastava, S; Mande, SS				Shrivastava, Sakshi; Mande, Sharmila S.			Identification and Functional Characterization of Gene Components of Type VI Secretion System in Bacterial Genomes	PLOS ONE			English	Article							PROTEIN SECRETION	A new secretion system, called the Type VI Secretion system (T6SS), was recently reported in Vibrio cholerae, Pseudomonas aeruginosa and Burkholderia mallei. A total of 18 genes have been identified to be belonging to this secretion system in V. cholerae. Here we attempt to identify presence of T6SS in other bacterial genomes. This includes identification of orthologous sequences, conserved motifs, domains, families, 3D folds, genomic islands containing T6SS components, phylogenetic profiles and protein-protein association of these components. Our analysis indicates presence of T6SS in 42 bacteria and its absence in most of their non-pathogenic species, suggesting the role of T6SS in imparting pathogenicity to an organism. Analysis of genomic regions containing T6SS components, phylogenetic profiles and protein-protein association of T6SS components indicate few additional genes which could be involved in this secretion system. Based on our studies, functional annotations were assigned to most of the components. Except one of the genes, we could group all the other genes of T6SS into those belonging to the puncturing device, and those located in the outer membrane, transmembrane and inner membrane. Based on our analysis, we have proposed a model of T6SS and have compared the same with the other bacterial secretion systems.	[Shrivastava, Sakshi; Mande, Sharmila S.] Tata Consultancy Serv, Adv Technol Ctr, Biosci Div, Madhapur, Andhra Pradesh, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Shrivastava, S (corresponding author), Tata Consultancy Serv, Adv Technol Ctr, Biosci Div, Madhapur, Andhra Pradesh, India.	sharmila@atc.tcs.com						Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Rajan I, 2007, BIOINFORMATICS, V23, P2672, DOI 10.1093/bioinformatics/btm405; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Yellaboina S, 2007, GENOME RES, V17, P527, DOI 10.1101/gr.5900607; Zusman T, 2004, INFECT IMMUN, V72, P3398, DOI 10.1128/IAI.72.6.3398-3409.2004	16	123	135	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2955	10.1371/journal.pone.0002955	http://dx.doi.org/10.1371/journal.pone.0002955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698408	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600041
J	Miles, DJC; van der Sande, M; Jeffries, D; Kaye, S; Ojuola, O; Sanneh, M; Cox, M; Palmero, MS; Touray, ES; Waight, P; Rowland-Jones, S; Whittle, H; Marchant, A				Miles, David J. C.; van der Sande, Marianne; Jeffries, David; Kaye, Steve; Ojuola, Olubukola; Sanneh, Mariama; Cox, Momodou; Palmero, Melba S.; Touray, Ebrima S.; Waight, Pauline; Rowland-Jones, Sarah; Whittle, Hilton; Marchant, Arnaud			Maintenance of Large Subpopulations of Differentiated CD8 T-Cells Two Years after Cytomegalovirus Infection in Gambian Infants	PLOS ONE			English	Article							LYMPHOCYTE SUBPOPULATIONS; GAMMA-INTERFERON; PROTEIN PP65; 1ST YEAR; MEMORY; CD4(+); ASSOCIATION; FREQUENCIES; EXPRESSION; EFFECTOR	Background: In a previously published study, we found that large differentiated subpopulations of CD8 T-cells emerged rapidly after CMV infection in young infants and persisted throughout the following year. Here we describe a follow-up study conducted on the same infants to establish whether the differentiated subpopulations continued through the second year post-infection. Methodology/Principal Findings: CMV-specific cells identified using tetramers remained more activated and differentiated than the overall CD8 population. The large subpopulation of differentiated cytotoxic (CD28(-)CD62L(-)Bcl-2(low)CD95(+)perforin(+)) cells that emerged rapidly after infection remained stable after two years. No similar subpopulation was found in CMV-uninfected infants indicating that two years after infection, CMV remained a major factor in driving CD8 T-cell differentiation. Although markers of activation (CD45R0 and HLA-D) declined throughout the first year, HLA-D expression continued to decline during the second year and CD45R0 expression increased slightly. The age-related increase in IFN gamma response observed during the first year continued but was non-significant during the second year, indicating that the rate of functional improvement had slowed substantially. Conclusions/Significance: The large differentiated subpopulations of CD8 T-cells that had emerged immediately after CMV infection persisted through the second year post-infection, while levels of activation and functional capacity remained fairly constant.	[Miles, David J. C.; Jeffries, David; Sanneh, Mariama; Cox, Momodou; Palmero, Melba S.; Touray, Ebrima S.; Rowland-Jones, Sarah; Whittle, Hilton] MRC Labs Gambia, Banjul, Gambia; [van der Sande, Marianne] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Kaye, Steve] Imperial Coll London, Jefferiss Trust Lab, London, England; [Ojuola, Olubukola] Bronx Lebanon Hosp Ctr, Dept Pediat, Bronx, NY USA; [Waight, Pauline] Hlth Protect Agcy Ctr Infect, Immunisat Dept, London, England; [Marchant, Arnaud] Free Univ Brussels, Inst Med Immunol, Charleroi, Belgium	Netherlands National Institute for Public Health & the Environment; Imperial College London; BronxCare Health System; Health Protection Agency	Miles, DJC (corresponding author), MRC Labs Gambia, Banjul, Gambia.	djcm1@liverpool.ac.uk		van der Sande, Marianne AB/0000-0002-4778-6739	GSK Biologicals; Medical Research Council; Fonds National de la Recherche Scientifique, Belgium; MRC [MC_U190081978, MC_U190085854] Funding Source: UKRI; Medical Research Council [MC_U190081978, MC_U190085854] Funding Source: researchfish	GSK Biologicals(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by GSK Biologicals and the Medical Research Council. Arnaud Marchant is a senior research associate at the Fonds National de la Recherche Scientifique, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKBAR AN, 1993, J EXP MED, V178, P427, DOI 10.1084/jem.178.2.427; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BELLO C, 1991, J CLIN PATHOL, V44, P366, DOI 10.1136/jcp.44.5.366; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Chen SF, 2004, J INFECT DIS, V189, P1619, DOI 10.1086/383249; de Vries E, 2000, PEDIATR RES, V47, P528, DOI 10.1203/00006450-200004000-00019; Gamadia LE, 2003, BLOOD, V101, P2686, DOI 10.1182/blood-2002-08-2502; GAVIN MA, 1993, J IMMUNOL, V151, P3971; GERDES J, 1984, J IMMUNOL, V133, P1710; Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000; GRATAMA JW, 1987, BLOOD, V70, P516; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hamann D, 1999, IMMUNOL TODAY, V20, P177, DOI 10.1016/S0167-5699(99)01444-9; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Jaimes MC, 2002, J VIROL, V76, P4741, DOI 10.1128/JVI.76.10.4741-4749.2002; JEFFRIES D, CYTOMETRY IN PRESS; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; KAYE S, 2008, J INFECT DIS, P197; Kern F, 1999, J VIROL, V73, P8179, DOI 10.1128/JVI.73.10.8179-8184.1999; Khan N, 2007, J IMMUNOL, V178, P4455, DOI 10.4049/jimmunol.178.7.4455; Komatsu Haruki, 2006, Immun Ageing, V3, P11, DOI 10.1186/1742-4933-3-11; Kuijpers TW, 2003, J IMMUNOL, V170, P4342, DOI 10.4049/jimmunol.170.8.4342; Lohman BL, 2005, J VIROL, V79, P8121, DOI 10.1128/JVI.79.13.8121-8130.2005; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Marchant A, 2003, J CLIN INVEST, V111, P1747, DOI 10.1172/JCI17470; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; Olsson J, 2000, MECH AGEING DEV, V121, P187; PASS RF, 1985, J INFECT DIS, V152, P243, DOI 10.1093/infdis/152.2.243; Retiere C, 2000, J VIROL, V74, P3948, DOI 10.1128/JVI.74.9.3948-3952.2000; Sandberg JK, 2003, J IMMUNOL, V170, P4403, DOI 10.4049/jimmunol.170.8.4403; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Seder RA, 2003, NAT IMMUNOL, V4, P835, DOI 10.1038/ni969; Solache A, 1999, J IMMUNOL, V163, P5512; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Tomiyama H, 2004, EUR J IMMUNOL, V34, P999, DOI 10.1002/eji.200324478; Tomiyama H, 2002, J IMMUNOL, V168, P5538, DOI 10.4049/jimmunol.168.11.5538; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; UTZ U, 1992, J IMMUNOL, V149, P214; van Leeuwen EMM, 2006, J IMMUNOL, V177, P4998, DOI 10.4049/jimmunol.177.8.4998; van Lier RAW, 2003, NAT REV IMMUNOL, V3, P931, DOI 10.1038/nri1228; WALTER EA, 1995, NEW ENGL J MED, V333, P1038, DOI 10.1056/NEJM199510193331603; Weekes MP, 1999, J VIROL, V73, P2099, DOI 10.1128/JVI.73.3.2099-2108.1999; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996	45	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2905	10.1371/journal.pone.0002905	http://dx.doi.org/10.1371/journal.pone.0002905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682836	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600061
J	Toh, SY; Gong, JY; Du, GL; Li, JZ; Yang, SQ; Ye, J; Yao, HL; Zhang, YX; Xue, BF; Li, Q; Yang, HY; Wen, ZL; Li, P				Toh, Shen Yon; Gong, Jingyi; Du, Guoli; Li, John Zhong; Yang, Shuqun; Ye, Jing; Yao, Huilan; Zhang, Yinxin; Xue, Bofu; Li, Qing; Yang, Hongyuan; Wen, Zilong; Li, Peng			Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice	PLOS ONE			English	Article								Fsp27, a member of the Cide family proteins, was shown to localize to lipid droplet and promote lipid storage in adipocytes. We aimed to understand the biological role of Fsp27 in regulating adipose tissue differentiation, insulin sensitivity and energy balance. Fsp27(-/-) mice and Fsp27/lep double deficient mice were generated and we examined the adiposity, whole body metabolism, BAT and WAT morphology, insulin sensitivity, mitochondrial activity, and gene expression changes in these mouse strains. Furthermore, we isolated mouse embryonic fibroblasts (MEFs) from wildtype and Fsp27(-/-) mice, followed by their differentiation into adipocytes in vitro. We found that Fsp27 is expressed in both brown adipose tissue (BAT) and white adipose tissue (WAT) and its levels were significantly elevated in the WAT and liver of leptin-deficient ob/ob mice. Fsp27(-/-) mice had increased energy expenditure, lower levels of plasma triglycerides and free fatty acids. Furthermore, Fsp27(-/-) and Fsp27/lep double-deficient mice are resistant to diet-induced obesity and display increased insulin sensitivity. Moreover, white adipocytes in Fsp27(-/-) mice have reduced triglycerides accumulation and smaller lipid droplets, while levels of mitochondrial proteins, mitochondrial size and activity are dramatically increased. We further demonstrated that BAT-specific genes and key metabolic controlling factors such as FoxC2, PPAR and PGC1 alpha were all markedly upregulated. In contrast, factors inhibiting BAT differentiation such as Rb, p107 and RIP140 were down-regulated in the WAT of Fsp27(-/-) mice. Remarkably, Fsp27(-/-) MEFs differentiated in vitro show many brown adipocyte characteristics in the presence of the thyroid hormone triiodothyronine (T3). Our data thus suggest that Fsp27 acts as a novel regulator in vivo to control WAT identity, mitochondrial activity and insulin sensitivity.	[Toh, Shen Yon] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Toh, Shen Yon; Gong, Jingyi; Du, Guoli; Li, John Zhong; Yang, Shuqun; Ye, Jing; Yao, Huilan; Zhang, Yinxin; Li, Peng] Tsinghua Univ, Dept Biol Sci & Biotechnol, Protein Sci Lab Minist Ed, Beijing, Peoples R China; [Toh, Shen Yon; Li, John Zhong; Xue, Bofu] Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Peoples R China; [Ye, Jing; Li, Qing] Fourth Mil Med Univ, Dept Pathol, Xian, Peoples R China; [Yang, Hongyuan] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Wen, Zilong] Hong Kong Univ Sci & Technol, Dept Biochem, Clear Water Bay, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; Tsinghua University; Hong Kong University of Science & Technology; Air Force Military Medical University; University of New South Wales Sydney; Hong Kong University of Science & Technology	Toh, SY (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	li-peng@mail.tsinghua.edu.cn	zhang, yinxin/D-8896-2013; Li, Zhong/U-2157-2017; Yang, Hongyuan/AAR-1326-2020; Li, John Zhong/S-2118-2019; Zhang, Yinxin/I-9996-2019	Yang, Hongyuan/0000-0002-8482-6031; Li, John Zhong/0000-0003-4991-9563; Zhang, Yinxin/0000-0001-5909-3676; Wen, Zilong/0000-0002-4260-7682; Toh, Shen Yon/0000-0002-6421-0862	Ministry of Education of China [704002]; National Natural Science Foundation of China [30530350]; National Basic Research program of China [2006CB503900, 2007CB914404]; Ministry of Science and Technology of China	Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants (704002 to PL) from Ministry of Education of China; (30530350 to PL) from National Natural Science Foundation of China; and National Basic Research program of China (2006CB503900, 2007CB914404) from Ministry of Science and Technology of China. PL is a Cheung Kong Scholar of the Ministry of Education of China. This work was also supported by Program for Changjiang Scholars and Innovative Research Team in University from Ministry of Education in China.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; BOUILLAUD F, 1984, J BIOL CHEM, V259, P1583; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brock DA, 2003, EUKARYOT CELL, V2, P788, DOI 10.1128/EC.2.4.788-797.2003; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Castro-Chavez F, 2003, DIABETES, V52, P2666, DOI 10.2337/diabetes.52.11.2666; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; DANESCH U, 1992, J BIOL CHEM, V267, P7185; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FERRE P, 2004, DIABETES METAB, V53; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; Gray SL, 2006, ENDOCRINOLOGY, V147, P5708, DOI 10.1210/en.2006-0684; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; LIN J, 2005, CELL METABOLISM, V1; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; MOON A, 1987, J CLIN INVEST, V79, P59, DOI 10.1172/JCI112808; Phan J, 2004, J BIOL CHEM, V279, P29558, DOI 10.1074/jbc.M403506200; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCIME A, 2005, CELL METAB, V2, P107; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; SILVA JE, 1983, NATURE, V305, P712, DOI 10.1038/305712a0; Smith SA, 2003, BIOCHIMIE, V85, P1219, DOI 10.1016/j.biochi.2003.10.010; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; VONRAALTE DH, 2004, PHARM RES, V21; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yoshida T, 1998, AM J PHYSIOL-ENDOC M, V274, pE469, DOI 10.1152/ajpendo.1998.274.3.E469; ZHOU Z, 2003, NATURE GENETICS, V35	45	209	221	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2890	10.1371/journal.pone.0002890	http://dx.doi.org/10.1371/journal.pone.0002890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682832	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600046
J	Vleeshouwers, VGAA; Rietman, H; Krenek, P; Champouret, N; Young, C; Oh, SK; Wang, MQ; Bouwmeester, K; Vosman, B; Visser, RGF; Jacobsen, E; Govers, F; Kamoun, S; Van der Vossen, EAG				Vleeshouwers, Vivianne G. A. A.; Rietman, Hendrik; Krenek, Pavel; Champouret, Nicolas; Young, Carolyn; Oh, Sang-Keun; Wang, Miqia; Bouwmeester, Klaas; Vosman, Ben; Visser, Richard G. F.; Jacobsen, Evert; Govers, Francine; Kamoun, Sophien; Van der Vossen, Edwin A. G.			Effector Genomics Accelerates Discovery and Functional Profiling of Potato Disease Resistance and Phytophthora Infestans Avirulence Genes	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; LATE BLIGHT RESISTANCE; SOLANUM-BULBOCASTANUM; IPIO GENE; PLANT; DNA; ORGANIZATION; RECOGNITION; PROTEINS; SERIES	Potato is the world's fourth largest food crop yet it continues to endure late blight, a devastating disease caused by the Irish famine pathogen Phytophthora infestans. Breeding broad-spectrum disease resistance (R) genes into potato (Solanum tuberosum) is the best strategy for genetically managing late blight but current approaches are slow and inefficient. We used a repertoire of effector genes predicted computationally from the P. infestans genome to accelerate the identification, functional characterization, and cloning of potentially broad-spectrum R genes. An initial set of 54 effectors containing a signal peptide and a RXLR motif was profiled for activation of innate immunity (avirulence or Avr activity) on wild Solanum species and tentative Avr candidates were identified. The RXLR effector family IpiO induced hypersensitive responses (HR) in S. stoloniferum, S. papita and the more distantly related S. bulbocastanum, the source of the R gene Rpi-blb1. Genetic studies with S. stoloniferum showed cosegregation of resistance to P. infestans and response to IpiO. Transient co-expression of IpiO with Rpi-blb1 in a heterologous Nicotiana benthamiana system identified IpiO as Avr-blb1. A candidate gene approach led to the rapid cloning of S. stoloniferum Rpi-sto1 and S. papita Rpi-pta1, which are functionally equivalent to Rpi-blb1. Our findings indicate that effector genomics enables discovery and functional profiling of late blight R genes and Avr genes at an unprecedented rate and promises to accelerate the engineering of late blight resistant potato varieties.	[Vleeshouwers, Vivianne G. A. A.; Rietman, Hendrik; Krenek, Pavel; Champouret, Nicolas; Wang, Miqia; Vosman, Ben; Visser, Richard G. F.; Jacobsen, Evert; Van der Vossen, Edwin A. G.] Wageningen UR Plant Breeding, Wageningen, Netherlands; [Young, Carolyn; Oh, Sang-Keun; Kamoun, Sophien] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH USA; [Bouwmeester, Klaas; Govers, Francine] Wageningen Univ, Lab Phytopathol, Wageningen, Netherlands; [Kamoun, Sophien] John Innes Ctr, Sainsbury Lab, Norwich, Norfolk, England	Wageningen University & Research; University System of Ohio; Ohio State University; Wageningen University & Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Vleeshouwers, VGAA (corresponding author), Wageningen UR Plant Breeding, Wageningen, Netherlands.	Vivianne.Vleeshouwers@wur.nl	Govers, Francine/A-5616-2009; Visser, Richard GF/B-3423-2012; Young, Carolyn Anne/Q-2963-2019; Vleeshouwers, Vivianne/AAF-2965-2020; Bouwmeester, Klaas/A-4081-2011; Vosman, Ben/C-5494-2013; Kamoun, Sophien/B-3529-2009; Bouwmeester, Klaas/AAF-3647-2020	Govers, Francine/0000-0001-5311-929X; Visser, Richard GF/0000-0002-0213-4016; Young, Carolyn Anne/0000-0003-0406-8398; Bouwmeester, Klaas/0000-0002-8141-3880; Vosman, Ben/0000-0003-4942-8342; Kamoun, Sophien/0000-0002-0290-0315; Bouwmeester, Klaas/0000-0002-8141-3880; Vleeshouwers, Vivianne/0000-0002-8160-4556; Krenek, Pavel/0000-0002-0206-4978	WUR Plant Breeding, Wageningen; Czech University of Agriculture; Center of Biosystems Genomics (CBSG); NSF Plant Genome Research Program [DBI-0211659]; Gatsby Charitable Foundation	WUR Plant Breeding, Wageningen; Czech University of Agriculture; Center of Biosystems Genomics (CBSG); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Gatsby Charitable Foundation	This research was financed by WUR Plant Breeding, Wageningen. The Czech University of Agriculture has financially supported PK, and the Center of Biosystems Genomics (CBSG) has financially supported the retrieving of resistant germplasm. CY and SKO were funded by NSF Plant Genome Research Program grant DBI-0211659. SK was supported by the Gatsby Charitable Foundation.	*APPL GM FIELD TRI, 2005, POT IMPR RES PHYT IN; Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bendahmane A, 2000, PLANT J, V21, P73, DOI 10.1046/j.1365-313x.2000.00654.x; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; FILLATTI JJ, 1987, BIO-TECHNOL, V5, P726, DOI 10.1038/nbt0787-726; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; HAWKES JG, 1990, POTATO EVOLUTION BIO; HOEKEMA A, 1989, BIO-TECHNOL, V7, P273, DOI 10.1038/nbt0389-273; HOLSTERS M, 1980, PLASMID, V3, P212, DOI 10.1016/0147-619X(80)90110-9; Huang S, 2005, PLANT DIS, V89, P1263, DOI 10.1094/PD-89-1263; Huang SW, 2005, PLANT J, V42, P251, DOI 10.1111/j.1365-313X.2005.02365.x; Jacobsen E, 2006, POTATO DEV CHANGING, P46; Jacobsen E, 2007, TRENDS BIOTECHNOL, V25, P219, DOI 10.1016/j.tibtech.2007.03.008; Jones JDG, 2001, CURR OPIN PLANT BIOL, V4, P281, DOI 10.1016/S1369-5266(00)00174-6; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kamoun S, 2007, CURR OPIN PLANT BIOL, V10, P358, DOI 10.1016/j.pbi.2007.04.017; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; MCKEE RK, 1962, EUPHYTICA, V11, P42, DOI 10.1007/BF00044803; MULLER K. O., 1952, Zeitschrift fur Pflanzenzuchtung, V31, P305; PIETERSE CMJ, 1994, GENE, V138, P67, DOI 10.1016/0378-1119(94)90784-6; Randall TA, 2005, MOL PLANT MICROBE IN, V18, P229, DOI 10.1094/MPMI-18-0229; Riely BK, 2001, P NATL ACAD SCI USA, V98, P2059, DOI 10.1073/pnas.98.4.2059; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Spooner DM, 1997, AM J BOT, V84, P671, DOI 10.2307/2445904; SPOONER DM, 2004, SYSTEMIC BOT MONOGRA; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; van der Vossen EAG, 2005, PLANT J, V44, P208, DOI 10.1111/j.1365-313X.2005.02527.x; van West P, 1998, FUNGAL GENET BIOL, V23, P126, DOI 10.1006/fgbi.1998.1036; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vleeshouwers VGAA, 1999, EUR J PLANT PATHOL, V105, P241, DOI 10.1023/A:1008710700363; Vleeshouwers VGAA, 2006, MOL PLANT PATHOL, V7, P499, DOI 10.1111/j.1364-3703.2006.00355.X; Wang M, 2008, THEOR APPL GENET, V116, P933, DOI 10.1007/s00122-008-0725-3; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; WHITHAM S, 1994, CELL, V78, P1101, DOI 10.1016/0092-8674(94)90283-6; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593	42	260	284	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2875	10.1371/journal.pone.0002875	http://dx.doi.org/10.1371/journal.pone.0002875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682852	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600031
J	Walls, JR; Coultas, L; Rossant, J; Henkelman, RM				Walls, Johnathon R.; Coultas, Leigh; Rossant, Janet; Henkelman, R. Mark			Three-Dimensional Analysis of Vascular Development in the Mouse Embryo	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; RECEPTOR TYROSINE KINASES; BLOOD-VESSELS; NEURAL CREST; ARTERIOVENOUS-MALFORMATIONS; SIGNALING PATHWAY; SONIC HEDGEHOG; VEGF; ANGIOGENESIS; EXPRESSION	Key vasculogenic (de-novo vessel forming) and angiogenic (vessel remodelling) events occur in the mouse embryo between embryonic days (E) 8.0 and 10.0 of gestation, during which time the vasculature develops from a simple circulatory loop into a complex, fine structured, three-dimensional organ. Interpretation of vascular phenotypes exhibited by signalling pathway mutants has historically been hindered by an inability to comprehensively image the normal sequence of events that shape the basic architecture of the early mouse vascular system. We have employed Optical Projection Tomography (OPT) using frequency distance relationship (FDR)-based deconvolution to image embryos immunostained with the endothelial specific marker PECAM-1 to create a high resolution, three-dimensional atlas of mouse vascular development between E8.0 and E10.0 (5 to 30 somites). Analysis of the atlas has provided significant new information regarding normal development of intersomitic vessels, the perineural vascular plexus, the cephalic plexus and vessels connecting the embryonic and extraembryonic circulation. We describe examples of vascular remodelling that provide new insight into the mechanisms of sprouting angiogenesis, vascular guidance cues and artery/vein identity that directly relate to phenotypes observed in mouse mutants affecting vascular development between E8.0 and E10.0. This atlas is freely available at http://www.mouseimaging.ca/research/mouse_atlas.html and will serve as a platform to provide insight into normal and abnormal vascular development.	[Walls, Johnathon R.; Henkelman, R. Mark] Hosp Sick Children, Toronto Ctr Phenogenom, Mouse Imaging Ctr MICe, Toronto, ON M5G 1X8, Canada; [Walls, Johnathon R.; Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Coultas, Leigh; Rossant, Janet] Hosp Sick Children, Res Inst, Dev & Stem Cell Biol Program, Toronto, ON, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Walls, JR (corresponding author), Hosp Sick Children, Toronto Ctr Phenogenom, Mouse Imaging Ctr MICe, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	mhenkel@phenogenomics.ca	HENKELMAN, MARK/W-6847-2019		Canadian Foundation for Innovation; Ontario Research and Development Challenge Fund; National Cancer Institute of Canada Terry Fox Foundation; Canada Research Chair in Imaging; Canadian Institutes of Health Research [distinguished investigator]; National Health and Medical Research Council (Canberra) [C.J. Martin postdoctoral fellow]; Hospital for Sick Children [Restracomp Scholarship]	Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research and Development Challenge Fund(General Electric); National Cancer Institute of Canada Terry Fox Foundation; Canada Research Chair in Imaging(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (Canberra)(National Health and Medical Research Council (NHMRC) of Australia); Hospital for Sick Children	This work was supported by grants from Canadian Foundation for Innovation, the Ontario Research and Development Challenge Fund and the National Cancer Institute of Canada Terry Fox Foundation. RMH holds a Canada Research Chair in Imaging, JR is a distinguished investigator of the Canadian Institutes of Health Research, LC is a C.J. Martin postdoctoral fellow of the National Health and Medical Research Council (Canberra), and JRW is funded with a Hospital for Sick Children Restracomp Scholarship.	Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Ambler CA, 2001, DEV BIOL, V234, P352, DOI 10.1006/dbio.2001.0267; Astorga J, 2007, DEVELOPMENT, V134, P3753, DOI 10.1242/dev.004432; BURKE AC, 1995, DEVELOPMENT, V121, P333; Byrd N, 2002, DEVELOPMENT, V129, P361; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chaturvedi K, 2006, NEUROENDOCRINOLOGY, V83, P387, DOI 10.1159/000096049; Childs S, 2002, DEVELOPMENT, V129, P973; COFFIN JD, 1988, DEVELOPMENT, V102, P735; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; COULY G, 1995, MECH DEVELOP, V53, P97, DOI 10.1016/0925-4773(95)00428-9; Dale KJ, 2000, BIOESSAYS, V22, P72, DOI 10.1002/(SICI)1521-1878(200001)22:1<72::AID-BIES12>3.0.CO;2-S; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Drake CJ, 2000, BLOOD, V95, P1671, DOI 10.1182/blood.V95.5.1671.005k39_1671_1679; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Evans HM, 1909, ANAT REC, V3, P498, DOI 10.1002/ar.1090030903; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Fisher ME, 2008, DEV BIOL, V317, P13, DOI 10.1016/j.ydbio.2008.01.031; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gerety SS, 2002, DEVELOPMENT, V129, P1397; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hajihosseini MK, 2008, MOL CELL NEUROSCI, V37, P857, DOI 10.1016/j.mcn.2008.01.008; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hiruma T, 2002, J ANAT, V201, P15, DOI 10.1046/j.1469-7580.2002.00071.x; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Hogan KA, 2004, DEVELOPMENT, V131, P1503, DOI 10.1242/dev.01039; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Inman KE, 2007, GENESIS, V45, P237, DOI 10.1002/dvg.20281; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jones CA, 2007, CURR OPIN GENET DEV, V17, P332, DOI 10.1016/j.gde.2007.07.004; Kaufman M.H., 1999, ANATOMICAL BASIS MOU; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Krull CE, 2001, MECH DEVELOP, V105, P37, DOI 10.1016/S0925-4773(01)00395-1; Kuan CYK, 2004, MECH DEVELOP, V121, P1055, DOI 10.1016/j.mod.2004.05.001; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; McGurk L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000834; Mu JW, 2006, AM J PHYSIOL-HEART C, V291, pH1421, DOI 10.1152/ajpheart.00031.2006; Nagase T, 2005, GENES CELLS, V10, P595, DOI 10.1111/j.1365-2443.2005.00861.x; NAKAO T, 1988, ANAT RECORD, V221, P663, DOI 10.1002/ar.1092210212; NIESSEN K, 2007, AM J PHYSIOL-CELL PH, V293, P1; Nikolova G, 2003, CELL TISSUE RES, V314, P33, DOI 10.1007/s00441-003-0739-8; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sauka-Spengler T, 2006, CURR OPIN GENET DEV, V16, P360, DOI 10.1016/j.gde.2006.06.006; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Slaney M., 1988, PRINCIPLES COMPUTERI; Sorensen LK, 2003, DEV BIOL, V261, P235, DOI 10.1016/S0012-1606(03)00158-1; Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Thurston G, 2003, CELL TISSUE RES, V314, P61, DOI 10.1007/s00441-003-0749-6; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tucker RP, 1999, DEV DYNAM, V214, P312, DOI 10.1002/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Vokes SA, 2004, DEVELOPMENT, V131, P4371, DOI 10.1242/dev.01304; Walls JR, 2007, PHYS MED BIOL, V52, P2775, DOI 10.1088/0031-9155/52/10/010; Walls JR, 2005, PHYS MED BIOL, V50, P4645, DOI 10.1088/0031-9155/50/19/015; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; WILTING J, 1995, DEV DYNAM, V202, P165, DOI 10.1002/aja.1002020208; Wood HB, 1997, BLOOD, V90, P2300; XIA WS, 1995, IEEE T MED IMAGING, V14, P100, DOI 10.1109/42.370406; Zhang XQ, 2001, BLOOD, V98, P1028, DOI 10.1182/blood.V98.4.1028; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	93	152	155	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2853	10.1371/journal.pone.0002853	http://dx.doi.org/10.1371/journal.pone.0002853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682734	gold, Green Published			2022-12-27	WOS:000264366600009
J	Ahn, SM; Byun, K; Cho, K; Kim, JY; Yoo, JS; Kim, D; Paek, SH; Kim, SU; Simpson, RJ; Lee, B				Ahn, Sung-Min; Byun, Kyunghee; Cho, Kun; Kim, Jin Young; Yoo, Jong Shin; Kim, Deokhoon; Paek, Sun Ha; Kim, Seung U.; Simpson, Richard J.; Lee, Bonghee			Human Microglial Cells Synthesize Albumin in Brain	PLOS ONE			English	Article								Albumin, an abundant plasma protein with multifunctional properties, is mainly synthesized in the liver. Albumin has been implicated in Alzheimer's disease (AD) since it can bind to and transport amyloid beta (A beta), the causative agent of AD; albumin is also a potent inhibitor of A beta polymerization. Despite evidence of non-hepatic transcription of albumin in many tissues including kidney and pancreas, non-hepatic synthesis of albumin at the protein level has been rarely confirmed. In a pilot phase study of Human Brain Proteome Project, we found evidence that microglial cells in brain may synthesize albumin. Here we report, for the first time, the de novo synthesis of albumin in human microglial cells in brain. Furtherore, we demonstrate that the synthesis and secretion of albumin from microglial cells is enhanced upon microgial activation by A beta(1-42)- or lipopolysaccharide (LPS)-treatment. These data indicate that microglial cells may play a beneficial role in AD by secreting albumin that not only inhibits A beta polymerization but also increases its clearance.	[Ahn, Sung-Min; Byun, Kyunghee; Kim, Deokhoon; Lee, Bonghee] Gachon Univ Med & Sci, Ctr Genom & Prote, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea; [Cho, Kun; Kim, Jin Young; Yoo, Jong Shin; Kim, Deokhoon] Korea Basic Sci Inst, Mass Spectrometry Anal Grp, Taejon, South Korea; [Paek, Sun Ha] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Clin Res Inst, Seoul, South Korea; [Kim, Seung U.] Gachon Univ Med & Sci, Gachon Inst Regenerat Med, Inchon, South Korea; [Simpson, Richard J.] Walter & Eliza Hall Inst Med Res, Ludwig Inst Canc Res, Joint Proteomics Lab, Melbourne, Vic, Australia; [Kim, Seung U.] Univ British Columbia, Dept Med, Vancouver, BC, Canada	Gachon University; Korea Basic Science Institute (KBSI); Seoul National University (SNU); Seoul National University Hospital; Gachon University; Ludwig Institute for Cancer Research; Walter & Eliza Hall Institute; University of British Columbia	Ahn, SM (corresponding author), Gachon Univ Med & Sci, Ctr Genom & Prote, Lee Gil Ya Canc & Diabet Inst, Inchon, South Korea.	Richard.simpson@ludwig.edu.au; bhlee@gachon.ac.kr	Paek, Sun Ha/J-2760-2012; Simpson, Richard/A-6947-2012; Cho, Kun/B-9319-2012	Cho, Kun/0000-0003-1154-4065; Ahn, Sung-Min/0000-0002-5031-1929; Simpson, Richard/0000-0002-9834-0796	Korea Science and Engineering Foundation [2006-04090]; 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council [280912]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); 21ST frontier science program SC-2110 of Korea stem cell research center; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Korea Science and Engineering Foundation grant (#2006-04090), 21ST frontier science program SC-2110 of Korea stem cell research center, and a National Health & Medical Research Council Program Grant (#280912, R.J.S).	Ahn SM, 2007, PROTEOM CLIN APPL, V1, P1004, DOI 10.1002/prca.200700217; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; DEVIJLDER JJM, 1992, ENDOCRINOLOGY, V131, P578, DOI 10.1210/en.131.2.578; DZIARSKI R, 1994, J BIOL CHEM, V269, P20431; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Interewicz B, 2004, LYMPHOLOGY, V37, P65; Kalaria R N, 1999, Curr Opin Hematol, V6, P15, DOI 10.1097/00062752-199901000-00004; Kim JY, 2005, PROTEOMICS, V5, P3376, DOI 10.1002/pmic.200401220; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; MURRARY RK, 1999, HARPERS BIOCH; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nakajima Kazuyuki, 2004, Curr Drug Targets Cardiovasc Haematol Disord, V4, P65, DOI 10.2174/1568006043481284; Peters Theodore Jr., 1996; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Reiber H, 2001, CLIN CHIM ACTA, V310, P173, DOI 10.1016/S0009-8981(01)00573-3; ROEPSTORFF P, 1994, BIOCHEM SOC T, V22, P533, DOI 10.1042/bst0220533; Schenk DB, 2002, NEUROBIOL AGING, V23, P677, DOI 10.1016/S0197-4580(02)00034-9; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Yamaguchi M, 2003, J CELL BIOCHEM, V89, P356, DOI 10.1002/jcb.10510; Yuan XL, 2002, ELECTROPHORESIS, V23, P1185, DOI 10.1002/1522-2683(200204)23:7/8<1185::AID-ELPS1185>3.0.CO;2-G; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	29	54	56	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2829	10.1371/journal.pone.0002829	http://dx.doi.org/10.1371/journal.pone.0002829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665237	Green Published, gold			2022-12-27	WOS:000264304300048
J	Alieva, NO; Konzen, KA; Field, SF; Meleshkevitch, EA; Hunt, ME; Beltran-Ramirez, V; Miller, DJ; Wiedenmann, J; Salih, A; Matz, MV				Alieva, Naila O.; Konzen, Karen A.; Field, Steven F.; Meleshkevitch, Ella A.; Hunt, Marguerite E.; Beltran-Ramirez, Victor; Miller, David J.; Wiedenmann, Joerg; Salih, Anya; Matz, Mikhail V.			Diversity and Evolution of Coral Fluorescent Proteins	PLOS ONE			English	Article								GFP-like fluorescent proteins (FPs) are the key color determinants in reef-building corals (class Anthozoa, order Scleractinia) and are of considerable interest as potential genetically encoded fluorescent labels. Here we report 40 additional members of the GFP family from corals. There are three major paralogous lineages of coral FPs. One of them is retained in all sampled coral families and is responsible for the non-fluorescent purple-blue color, while each of the other two evolved a full complement of typical coral fluorescent colors (cyan, green, and red) and underwent sorting between coral groups. Among the newly cloned proteins are a "chromo-red'' color type from Echinopora forskaliana (family Faviidae) and pink chromoprotein from Stylophora pistillata (Pocilloporidae), both evolving independently from the rest of coral chromoproteins. There are several cyan FPs that possess a novel kind of excitation spectrum indicating a neutral chromophore ground state, for which the residue E167 is responsible (numeration according to GFP from A. victoria). The chromoprotein from Acropora millepora is an unusual blue instead of purple, which is due to two mutations: S64C and S183T. We applied a novel probabilistic sampling approach to recreate the common ancestor of all coral FPs as well as the more derived common ancestor of three main fluorescent colors of the Faviina suborder. Both proteins were green such as found elsewhere outside class Anthozoa. Interestingly, a substantial fraction of the all-coral ancestral protein had a chromohore apparently locked in a non-fluorescent neutral state, which may reflect the transitional stage that enabled rapid color diversification early in the history of coral FPs. Our results highlight the extent of convergent or parallel evolution of the color diversity in corals, provide the foundation for experimental studies of evolutionary processes that led to color diversification, and enable a comparative analysis of structural determinants of different colors.	[Alieva, Naila O.; Field, Steven F.; Hunt, Marguerite E.; Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Konzen, Karen A.; Meleshkevitch, Ella A.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL USA; [Beltran-Ramirez, Victor; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Wiedenmann, Joerg] Univ Southampton, Natl Oceanography Ctr, Southampton, Hants, England; [Wiedenmann, Joerg] Univ Ulm, Inst Gen Zool & Endocrinol, Ulm, Germany; [Salih, Anya] Univ W Sydney, Sch Nat Sci, Penrith, NSW, Australia	University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; James Cook University; NERC National Oceanography Centre; University of Southampton; Ulm University; Western Sydney University	Alieva, NO (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819	NIH [R01 GM66243]; Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies; Deutsche Forschungsgemeinschaft [Wi1990 2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grant R01 GM66243 to M.V.M., the Australian Research Council (ARC) via the Centre of Excellence for Coral Reef Studies to D.J.M, Deutsche Forschungsgemeinschaft grant Wi1990 2-1 to J.W., and ARC/NHMRC Network FABLS Australia (collaborative grant to A.S. et al.)	Agmon N, 2005, BIOPHYS J, V88, P2452, DOI 10.1529/biophysj.104.055541; Agmon N, 2007, J PHYS CHEM B, V111, P7870, DOI 10.1021/jp071403p; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Chan MCY, 2006, J BIOL CHEM, V281, P37813, DOI 10.1074/jbc.M606921200; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P452, DOI 10.1038/nbt0403-452a; CODY CW, 1993, BIOCHEMISTRY-US, V32, P1212, DOI 10.1021/bi00056a003; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Field SF, 2006, J MOL EVOL, V62, P332, DOI 10.1007/s00239-005-0129-9; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-6; Gurskaya NG, 2001, FEBS LETT, V507, P16, DOI 10.1016/S0014-5793(01)02930-1; Henderson JN, 2005, P NATL ACAD SCI USA, V102, P12712, DOI 10.1073/pnas.0502250102; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KARAN M, 2002, CELL VISUAL CHARACTE; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; KAWAGUTI S, 1966, BIOL J OKAYAMA U, V2, P11; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Lukyanov KA, 2006, METHOD BIOCHEM ANAL, V47, P121; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Matz M. V., 2003, GENERATION CDNA LIB; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Miller DJ, 2000, BIOESSAYS, V22, P291, DOI 10.1002/(SICI)1521-1878(200003)22:3<291::AID-BIES11>3.0.CO;2-2; Mizuno H, 2003, MOL CELL, V12, P1051, DOI 10.1016/S1097-2765(03)00393-9; Oswald F, 2007, FEBS J, V274, P1102, DOI 10.1111/j.1742-4658.2007.05661.x; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Prescott M, 2003, STRUCTURE, V11, P275, DOI 10.1016/S0969-2126(03)00028-5; Quillin ML, 2005, BIOCHEMISTRY-US, V44, P5774, DOI 10.1021/bi047644u; Remington SJ, 2005, BIOCHEMISTRY-US, V44, P202, DOI 10.1021/bi048383r; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shkrob MA, 2005, BIOCHEM J, V392, P649, DOI 10.1042/BJ20051314; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Sun Y, 2004, FEBS LETT, V570, P175, DOI 10.1016/j.febslet.2004.06.043; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Ugalde JA, 2004, SCIENCE, V305, P1433, DOI 10.1126/science.1099597; Wachter RM, 2006, PHOTOCHEM PHOTOBIOL, V82, P339, DOI 10.1562/2005-10-02-IR-708; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101; Wiedenmann J, 2000, P NATL ACAD SCI USA, V97, P14091, DOI 10.1073/pnas.97.26.14091; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	60	215	221	7	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2680	10.1371/journal.pone.0002680	http://dx.doi.org/10.1371/journal.pone.0002680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648549	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000264057200024
J	Wang, YP; Wang, YE; Cotticelli, MG; Wilson, RB				Wang, Yongping; Wang, Yun E.; Cotticelli, M. Grazia; Wilson, Robert B.			A Random shRNA-Encoding Library for Phenotypic Selection and Hit-Optimization	PLOS ONE			English	Article							SMALL INTERFERING RNA; CAENORHABDITIS-ELEGANS; SIRNA; ACTIVATION; MICRORNAS; POTENCY; SCREEN; GENES	RNA interference (RNAi) is a mechanism for inhibiting gene expression through the action of small, non-coding RNAs. Most existing RNAi libraries target single genes through canonical pathways. Endogenous microRNAs (miRNAs), however, often target multiple genes and can act through non-canonical pathways, including pathways that activate gene expression. To interrogate all possible functions, we designed, synthesized, and validated the first shRNA-encoding library that is completely random at the nucleotide level. Screening in an IL3-dependent cell line, FL5.12, yielded shRNA-encoding sequences that double cell survival upon IL3 withdrawal. Using random mutagenesis and re-screening under more stringent IL3-starvation conditions, we hit-optimized one of the sequences; a specific nucleotide change and the creation of a mismatch between the two halves of the stem both contributed to the improved potency. Our library allows unbiased selection and optimization of shRNA-encoding sequences that confer phenotypes of interest, and could be used for the development of therapeutics and tools in many fields of biology.	[Wang, Yongping; Cotticelli, M. Grazia; Wilson, Robert B.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wang, Yun E.] Univ Penn, Sch Arts & Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Wang, YP (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	wilsonr@mail.med.upenn.edu			National Institute for Neurological Disorders and Stroke [R21-NS-053546]; Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053546] Funding Source: NIH RePORTER	National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by research grants (to R.B.W.) from the National Institute for Neurological Disorders and Stroke (R21-NS-053546) and the Friedreich's Ataxia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Blow N, 2007, NATURE, V450, P1120, DOI 10.1038/4501120a; Blow N, 2007, NATURE, V450, P1117, DOI 10.1038/4501117a; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen MH, 2005, P NATL ACAD SCI USA, V102, P2356, DOI 10.1073/pnas.0401549101; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; HILL DE, 1987, METHOD ENZYMOL, V155, P558; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; JANOWSKI BA, 2007, NAT CHEM BIOL; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; McAnuff MA, 2007, J PHARM SCI-US, V96, P2922, DOI 10.1002/jps.20968; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Vander Heiden MG, 1999, MOL CELL, V3, P159; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499	32	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3171	10.1371/journal.pone.0003171	http://dx.doi.org/10.1371/journal.pone.0003171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779859	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000264425100007
J	Hornig, M; Briese, T; Buie, T; Bauman, ML; Lauwers, G; Siemetzki, U; Hummel, K; Rota, PA; Bellini, WJ; O'Leary, JJ; Sheils, O; Alden, E; Pickering, L; Lipkin, WI				Hornig, Mady; Briese, Thomas; Buie, Timothy; Bauman, Margaret L.; Lauwers, Gregory; Siemetzki, Ulrike; Hummel, Kimberly; Rota, Paul A.; Bellini, William J.; O'Leary, John J.; Sheils, Orla; Alden, Errol; Pickering, Larry; Lipkin, W. Ian			Lack of Association between Measles Virus Vaccine and Autism with Enteropathy: A Case-Control Study	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; MUMPS-RUBELLA VACCINATION; LYMPHOCYTE CYTOKINE PROFILES; INFLAMMATORY-BOWEL-DISEASE; SPECTRUM DISORDER; NO EVIDENCE; GASTROINTESTINAL SYMPTOMS; NODULAR HYPERPLASIA; CAUSAL ASSOCIATION; REGRESSIVE AUTISM	Background: The presence of measles virus (MV) RNA in bowel tissue from children with autism spectrum disorders (ASD) and gastrointestinal (GI) disturbances was reported in 1998. Subsequent investigations found no associations between MV exposure and ASD but did not test for the presence of MV RNA in bowel or focus on children with ASD and GI disturbances. Failure to replicate the original study design may contribute to continued public concern with respect to the safety of the measles, mumps, and rubella (MMR) vaccine. Methodology/Principal Findings: The objective of this case-control study was to determine whether children with GI disturbances and autism are more likely than children with GI disturbances alone to have MV RNA and/or inflammation in bowel tissues and if autism and/or GI episode onset relate temporally to receipt of MMR. The sample was an age-matched group of US children undergoing clinically-indicated ileocolonoscopy. Ileal and cecal tissues from 25 children with autism and GI disturbances and 13 children with GI disturbances alone (controls) were evaluated by real-time reverse transcription (RT)-PCR for presence of MV RNA in three laboratories blinded to diagnosis, including one wherein the original findings suggesting a link between MV and ASD were reported. The temporal order of onset of GI episodes and autism relative to timing of MMR administration was examined. We found no differences between case and control groups in the presence of MV RNA in ileum and cecum. Results were consistent across the three laboratory sites. GI symptom and autism onset were unrelated to MMR timing. Eighty-eight percent of ASD cases had behavioral regression. Conclusions/Significance: This study provides strong evidence against association of autism with persistent MV RNA in the GI tract or MMR exposure. Autism with GI disturbances is associated with elevated rates of regression in language or other skills and may represent an endophenotype distinct from other ASD.	[Hornig, Mady; Briese, Thomas; Siemetzki, Ulrike; Lipkin, W. Ian] Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA; [Buie, Timothy] Massachusetts Gen Hosp, Div Pediat Gastroenterol & Nutr, Boston, MA USA; [Bauman, Margaret L.] Massachusetts Gen Hosp, Dept Neurol, Dept Pediat, LADDERS, Boston, MA USA; [Lauwers, Gregory] Massachusetts Gen Hosp, Harvard Med Sch, Dept Pathol, Boston, MA USA; [Hummel, Kimberly; Rota, Paul A.; Bellini, William J.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpesvirus Lab Branch, Atlanta, GA USA; [O'Leary, John J.; Sheils, Orla] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [Alden, Errol] American Acad Pediat, Elk Grove Village, IL USA; [Pickering, Larry] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Columbia University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Centers for Disease Control & Prevention - USA; Trinity College Dublin; American Academy of Pediatrics; Centers for Disease Control & Prevention - USA	Hornig, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Ctr Infect & Immun, New York, NY 10027 USA.	mady.hornig@columbia.edu; wil2001@columbia.edu	Lipkin, W. Ian/ABE-6216-2020; Hornig, Mady/AAE-8431-2020; Sheils, Orla Sheils M/B-8461-2015	Lipkin, W. Ian/0000-0002-8768-9386; Hornig, Mady/0000-0001-7572-3092; Sheils, Orla Sheils M/0000-0002-4493-9496; O'Leary, John/0000-0001-7311-9326; Bauman, Margaret/0000-0002-3229-0458	CDC [U50 CCU522351]; National Institutes of Health [AI57158, HL083850, NS47537]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	CDC(Centre National de la Recherche Scientifique (CNRS)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by CDC grant U50 CCU522351 to AAP and by National Institutes of Health awards AI57158 (Northeast Biodefense Center-Lipkin), HL083850, and NS47537. Role of Study Sponsors: Members of the funding organization (AAP) and its sponsor (CDC) participated along with experts in virology and neurovirology, autism pathogenesis, and vaccine design and safety; representatives of the autism advocacy community; and study collaborators in an Oversight Committee that reviewed and agreed to all aspects of study design prior to data collection. The final decision to submit for publication was the responsibility of all study collaborators.	Afzal MA, 2006, J MED VIROL, V78, P623, DOI 10.1002/jmv.20585; *AM AC PED COMM IN, 2008, PEDIATRICS, V121, P219; APA, 2000, DIAGN STAT MAN MENT; Ashwood P, 2006, J NEUROIMMUNOL, V173, P126, DOI 10.1016/j.jneuroim.2005.12.007; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Ashwood P, 2003, J CLIN IMMUNOL, V23, P504, DOI 10.1023/B:JOCI.0000010427.05143.bb; BAIRD G, 2008, ARCH DIS CHILD; Barlow WE, 2001, NEW ENGL J MED, V345, P656, DOI 10.1056/NEJMoa003077; Chen W, 2004, PSYCHOL MED, V34, P543, DOI 10.1017/S0033291703001259; D'Souza Y, 2006, PEDIATRICS, V118, P1664, DOI 10.1542/peds.2006-1262; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; DeStefano F, 2004, PEDIATRICS, V113, P259, DOI 10.1542/peds.113.2.259; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; Fenson L., 1989, MACARTHUR COMMUNICAT; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Fombonne E, 2006, PEDIATRICS, V118, pE139, DOI 10.1542/peds.2005-2993; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Honda H, 2005, J CHILD PSYCHOL PSYC, V46, P572, DOI 10.1111/j.1469-7610.2005.01425.x; Kawashima H, 2000, DIGEST DIS SCI, V45, P723, DOI 10.1023/A:1005443726670; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Klagge IM, 2004, J GEN VIROL, V85, P3239, DOI 10.1099/vir.0.80125-0; Lingam R, 2003, ARCH DIS CHILD, V88, P666, DOI 10.1136/adc.88.8.666; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Luyster R, 2005, DEV NEUROPSYCHOL, V27, P311, DOI 10.1207/s15326942dn2703_2; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957; Molloy CA, 2006, J AUTISM DEV DISORD, V36, P317, DOI 10.1007/s10803-005-0071-0; Niehus R, 2006, J DEV BEHAV PEDIATR, V27, pS120, DOI 10.1097/00004703-200604002-00010; O'Leary JJ, 2003, J CLIN PATHOL-MOL PA, V56, P248, DOI 10.1136/mp.56.4.248; Oleary JJ, 2000, LANCET, V356, P772, DOI 10.1016/S0140-6736(05)73676-X; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Peltola H, 1998, LANCET, V351, P1327, DOI 10.1016/S0140-6736(98)24018-9; Richler J, 2006, J AUTISM DEV DISORD, V36, P299, DOI 10.1007/s10803-005-0070-1; Rima BK, 2006, J PATHOL, V208, P199, DOI 10.1002/path.1873; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; Smeeth L, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-2; Smeeth L, 2004, LANCET, V364, P963, DOI 10.1016/S0140-6736(04)17020-7; Takahashi H, 2001, JPN J INFECT DIS, V54, P78; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Torrente F, 2002, MOL PSYCHIATR, V7, P375, DOI 10.1038/sj/mp/4001077; Uchiyama T, 2007, J AUTISM DEV DISORD, V37, P210, DOI 10.1007/s10803-006-0157-3; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Wakefield A, 2002, MOL PSYCHIATR, V7, pS44, DOI 10.1038/sj.mp.4001178; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2005, EUR J GASTROEN HEPAT, V17, P827, DOI 10.1097/00042737-200508000-00009; Wakefield AJ, 2002, ALIMENT PHARM THER, V16, P663, DOI 10.1046/j.1365-2036.2002.01206.x; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265	49	68	73	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3140	10.1371/journal.pone.0003140	http://dx.doi.org/10.1371/journal.pone.0003140			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422HU	18769550	Green Published, gold, Green Submitted			2022-12-27	WOS:000264419100008
J	Boorsma, A; Lu, XJ; Zakrzewska, A; Klis, FM; Bussemaker, HJ				Boorsma, Andre; Lu, Xiang-Jun; Zakrzewska, Anna; Klis, Frans M.; Bussemaker, Harmen J.			Inferring Condition-Specific Modulation of Transcription Factor Activity in Yeast through Regulon-Based Analysis of Genomewide Expression	PLOS ONE			English	Article								Background: A key goal of systems biology is to understand how genomewide mRNA expression levels are controlled by transcription factors (TFs) in a condition-specific fashion. TF activity is frequently modulated at the post-translational level through ligand binding, covalent modification, or changes in sub-cellular localization. In this paper, we demonstrate how prior information about regulatory network connectivity can be exploited to infer condition-specific TF activity as a hidden variable from the genomewide mRNA expression pattern in the yeast Saccharomyces cerevisiae. Methodology/Principal Findings: We first validate experimentally that by scoring differential expression at the level of gene sets or "regulons'' comprised of the putative targets of a TF, we can accurately predict modulation of TF activity at the post-translational level. Next, we create an interactive database of inferred activities for a large number of TFs across a large number of experimental conditions in S. cerevisiae. This allows us to perform TF-centric analysis of the yeast regulatory network. Conclusions/Significance: We analyze the degree to which the mRNA expression level of each TF is predictive of its regulatory activity. We also organize TFs into "co-modulation networks'' based on their inferred activity profile across conditions, and find that this reveals functional and mechanistic relationships. Finally, we present evidence that the PAC and rRPE motifs antagonize TBP-dependent regulation, and function as core promoter elements governed by the transcription regulator NC2. Regulon-based monitoring of TF activity modulation is a powerful tool for analyzing regulatory network function that should be applicable in other organisms. Tools and results are available online at http://bussemakerlab.org/RegulonProfiler/.	[Boorsma, Andre; Zakrzewska, Anna; Klis, Frans M.] Univ Amsterdam, Swammerdam Inst Life Sci, BioCtr Amsterdam, Amsterdam, Netherlands; [Lu, Xiang-Jun; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10027 USA	University of Amsterdam; Columbia University; Columbia University	Boorsma, A (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, BioCtr Amsterdam, Amsterdam, Netherlands.	hjb2004@columbia.edu	Klis, Frans M/B-9085-2008	Klis, Frans M/0000-0003-0079-9492	Netherlands Foundation for Technical Research; National Institutes of Health [R01HG003008, U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER	Netherlands Foundation for Technical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the Netherlands Foundation for Technical Research (STW) to F.K. (APB.5504) and from the National Institutes of Health (R01HG003008 and U54CA121852) to HJB.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Boorsma A, 2004, YEAST, V21, P413, DOI 10.1002/yea.1109; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Bussemaker HJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S6; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JAMSA E, 1994, YEAST, V10, P355, DOI 10.1002/yea.320100308; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kellis M, 2004, J COMPUT BIOL, V11, P319, DOI 10.1089/1066527041410319; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee TI, 1998, MOL CELL BIOL, V18, P4455, DOI 10.1128/MCB.18.8.4455; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; McCord RP, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100140; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; Nevitt T, 2004, YEAST, V21, P1365, DOI 10.1002/yea.1188; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102; Willy PJ, 2000, SCIENCE, V290, P982, DOI 10.1126/science.290.5493.982; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200	56	28	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3112	10.1371/journal.pone.0003112	http://dx.doi.org/10.1371/journal.pone.0003112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769540	Green Published, gold, Green Submitted			2022-12-27	WOS:000264418300004
J	Lehmann, K; Lowel, S				Lehmann, Konrad; Loewel, Siegrid			Age-Dependent Ocular Dominance Plasticity in Adult Mice	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MONOCULAR DEPRIVATION; CRITICAL-PERIOD; POSTNATAL-DEVELOPMENT; INTRINSIC SIGNAL; SENSITIVE PERIOD; EYE CLOSURE; EXPERIENCE; VISION; ACUITY	Background: Short monocular deprivation (4 days) induces a shift in the ocular dominance of binocular neurons in the juvenile mouse visual cortex but is ineffective in adults. Recently, it has been shown that an ocular dominance shift can still be elicited in young adults (around 90 days of age) by longer periods of deprivation (7 days). Whether the same is true also for fully mature animals is not yet known. Methodology/Principal Findings: We therefore studied the effects of different periods of monocular deprivation (4, 7, 14 days) on ocular dominance in C57Bl/6 mice of different ages (25 days, 90-100 days, 109-158 days, 208-230 days) using optical imaging of intrinsic signals. In addition, we used a virtual optomotor system to monitor visual acuity of the open eye in the same animals during deprivation. We observed that ocular dominance plasticity after 7 days of monocular deprivation was pronounced in young adult mice (90-100 days) but significantly weaker already in the next age group (109-158 days). In animals older than 208 days, ocular dominance plasticity was absent even after 14 days of monocular deprivation. Visual acuity of the open eye increased in all age groups, but this interocular plasticity also declined with age, although to a much lesser degree than the optically detected ocular dominance shift. Conclusions/Significance: These data indicate that there is an age-dependence of both ocular dominance plasticity and the enhancement of vision after monocular deprivation in mice: ocular dominance plasticity in binocular visual cortex is most pronounced in young animals, reduced but present in adolescence and absent in fully mature animals older than 110 days of age. Mice are thus not basically different in ocular dominance plasticity from cats and monkeys which is an absolutely essential prerequisite for their use as valid model systems of human visual disorders.	[Lehmann, Konrad; Loewel, Siegrid] Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany	Friedrich Schiller University of Jena	Lehmann, K (corresponding author), Univ Jena, Inst Allgemeine Zool & Tierphysiol, Jena, Germany.	siegrid.loewel@uni-jena.de	Lehmann, Konrad/AAJ-1017-2020	Lehmann, Konrad/0000-0001-8215-5804	HFSP; BMBF	HFSP(Human Frontier Science Program); BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by grants from HFSP and BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 1999, J NEUROSCI, V19, P4388; BANKS MS, 1975, SCIENCE, V190, P675, DOI 10.1126/science.1188363; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DRAGER UC, 1978, J NEUROPHYSIOL, V41, P28, DOI 10.1152/jn.1978.41.1.28; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fischer QS, 2007, LEARN MEMORY, V14, P277, DOI 10.1101/lm.392107; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Gordon JA, 1996, J NEUROSCI, V16, P3274; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Heimel JA, 2007, EUR J NEUROSCI, V25, P795, DOI 10.1111/j.1460-9568.2007.05333.x; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Iny K, 2006, J NEUROSCI, V26, P7368, DOI 10.1523/JNEUROSCI.0124-06.2006; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Lauten SD, 2000, COMPARATIVE MED, V50, P175; Moodie KL, 2001, VET OPHTHALMOL, V4, P267, DOI 10.1046/j.1463-5216.2001.00198.x; Morishita H, 2008, CURR OPIN NEUROBIOL, V18, P101, DOI 10.1016/j.conb.2008.05.009; OLSON CR, 1980, EXP BRAIN RES, V39, P17; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Prusky GT, 2006, J NEUROSCI, V26, P11554, DOI 10.1523/JNEUROSCI.3396-06.2006; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Vetencourt JFM, 2008, SCIENCE, V320, P1588; WATANABE H, 1992, J PHARMACOL EXP THER, V263, P1036; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1029, DOI 10.1152/jn.1965.28.6.1029	37	112	113	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3120	10.1371/journal.pone.0003120	http://dx.doi.org/10.1371/journal.pone.0003120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769674	Green Published, gold			2022-12-27	WOS:000264416600008
J	Toiber, D; Berson, A; Greenberg, D; Melamed-Book, N; Diamant, S; Soreq, H				Toiber, Debra; Berson, Amit; Greenberg, David; Melamed-Book, Naomi; Diamant, Sophia; Soreq, Hermona			N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease	PLOS ONE			English	Article								Background: Alzheimer's disease (AD) involves loss of cholinergic neurons and Tau protein hyper-phosphorylation. Here, we report that overexpression of an N-terminally extended "synaptic'' acetylcholinesterase variant, N-AChE-S is causally involved in both these phenomena. Methodology and Principal Findings: In transfected primary brain cultures, N-AChE-S induced cell death, morphological impairments and caspase 3 activation. Rapid internalization of fluorescently labeled fasciculin-2 to N-AChE-S transfected cells indicated membranal localization. In cultured cell lines, N-AChE-S transfection activated the Tau kinase GSK3, induced Tau hyper-phosphorylation and caused apoptosis. N-AChE-S-induced cell death was suppressible by inhibiting GSK3 or caspases, by enforced overexpression of the anti-apoptotic Bcl2 proteins, or by AChE inhibition or silencing. Moreover, inherent N-AChE-S was upregulated by stressors inducing protein misfolding and calcium imbalances, both characteristic of AD; and in cortical tissues from AD patients, N-AChE-S overexpression coincides with Tau hyper-phosphorylation. Conclusions: Together, these findings attribute an apoptogenic role to N-AChE-S and outline a potential value to AChE inhibitor therapeutics in early AD.	[Toiber, Debra; Berson, Amit; Greenberg, David; Melamed-Book, Naomi; Diamant, Sophia; Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel; [Soreq, Hermona] Hebrew Univ Jerusalem, Interdisciplinary Ctr Neuron Computat ICNC, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Toiber, D (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Jerusalem, Israel.	soreq@cc.huji.ac.il		Greenberg, David/0000-0001-8959-8640; Soreq, Hermona/0000-0002-0955-526X	European Union's Network of Excellence [LSH-2004-1.1.5-3]; STREP [LSHG-CT-2006-037277]; The German Ministry of Science; German-Israel Project; DIP-G 3.2; Israel Ministry of Science; Interdisciplinary Center for Neuronal Computation (ICNC); The ROSETREES Foundation, UK	European Union's Network of Excellence; STREP; The German Ministry of Science; German-Israel Project; DIP-G 3.2; Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Interdisciplinary Center for Neuronal Computation (ICNC); The ROSETREES Foundation, UK	This research was supported by the European Union's Network of Excellence (LSH-2004-1.1.5-3) and STREP (LSHG-CT-2006-037277), The German Ministry of Science and German-Israel Project, DIP-G 3.2, the Israel Ministry of Science, the Interdisciplinary Center for Neuronal Computation (ICNC) and The ROSETREES Foundation, UK.	ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Ben-Ari S, 2006, J NEUROCHEM, V97, P24, DOI 10.1111/j.1471-4159.2006.03725.x; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Carroll RT, 1999, NEUROREPORT, V10, P127, DOI 10.1097/00001756-199901180-00023; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Deng R, 2006, ONCOGENE, V25, P7070, DOI 10.1038/sj.onc.1209686; Dickson DW, 2004, J CLIN INVEST, V114, P23, DOI 10.1172/JC1200422317; Eggers C, 2006, NEUROSCI LETT, V408, P46, DOI 10.1016/j.neulet.2006.08.061; Higgins MK, 2002, TRENDS BIOCHEM SCI, V27, P257, DOI 10.1016/S0968-0004(02)02089-3; Hu W, 2003, J NEUROCHEM, V86, P470, DOI 10.1046/j.1471-4159.2003.01855.x; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang HC, 2006, CURR DRUG TARGETS, V7, P1389, DOI 10.2174/1389450110607011389; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kehat R, 2007, INVEST OPHTH VIS SCI, V48, P1290, DOI 10.1167/iovs.06-0847; Killiany RJ, 2000, ANN NEUROL, V47, P430, DOI 10.1002/1531-8249(200004)47:4<430::AID-ANA5>3.0.CO;2-I; LANDWEHRMEYER B, 1993, NEUROSCIENCE, V57, P615, DOI 10.1016/0306-4522(93)90010-D; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MC IR, 1959, J PHARMACOL EXP THER, V126, P9; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2002, SCIENCE, V295, P508, DOI 10.1126/science.1066752; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Millard CB, 1999, BIOCHEMISTRY-US, V38, P7032, DOI 10.1021/bi982678l; Nguyen HN, 2005, ARCH PHARM RES, V28, P1073, DOI 10.1007/BF02977404; Nordberg A, 2006, ALZ DIS ASSOC DIS, V20, pS12, DOI 10.1097/01.wad.0000213804.59187.2d; Park SE, 2004, CANCER RES, V64, P2652, DOI 10.1158/0008-5472.CAN-04-0649; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Recanatini M, 2004, CURR PHARM DESIGN, V10, P3157, DOI 10.2174/1381612043383313; Russ C, 2001, MOL PSYCHIATR, V6, P320, DOI 10.1038/sj.mp.4000852; Sberna G, 1997, J NEUROCHEM, V69, P1177; Sklan EH, 2004, P NATL ACAD SCI USA, V101, P5512, DOI 10.1073/pnas.0307659101; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Toiber D, 2005, NEUROCHEM RES, V30, P909, DOI 10.1007/s11064-005-6963-8; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Zhu H, 2007, INT J BIOCHEM CELL B, V39, P93, DOI 10.1016/j.biocel.2006.06.012	46	83	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3108	10.1371/journal.pone.0003108	http://dx.doi.org/10.1371/journal.pone.0003108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769671	gold, Green Submitted, Green Published			2022-12-27	WOS:000264416600004
J	Anuwatnonthakate, A; Limsomboon, P; Nateniyom, S; Wattanaamornkiat, W; Komsakorn, S; Moolphate, S; Chiengsorn, N; Kaewsa-ard, S; Sombat, P; Siangphoe, U; Mock, PA; Varma, JK				Anuwatnonthakate, Amornrat; Limsomboon, Pranom; Nateniyom, Sriprapa; Wattanaamornkiat, Wanpen; Komsakorn, Sittijate; Moolphate, Saiyud; Chiengsorn, Navarat; Kaewsa-ard, Samroui; Sombat, Potjaman; Siangphoe, Umaporn; Mock, Philip A.; Varma, Jay K.			Directly Observed Therapy and Improved Tuberculosis Treatment Outcomes in Thailand	PLOS ONE			English	Article							OBSERVED TREATMENT DOT	Background: The World Health Organization (WHO) recommends that tuberculosis (TB) patients receive directly observed therapy (DOT). Randomized controlled trials have not consistently shown that this practice improves TB treatment success rates. In Thailand, one of 22 WHO-designated high burden TB countries, patients may have TB treatment observed by a health care worker (HCW), family member, or no one. We studied whether DOT improved TB treatment outcomes in a prospective, observational cohort. Methods and Findings: We prospectively collected epidemiologic data about TB patients treated at public and private facilities in four provinces in Thailand and the national infectious diseases hospital from 2004-2006. Public health staff recorded the type of observed therapy that patients received during the first two months of TB treatment. We limited our analysis to pulmonary TB patients never previously treated for TB and not known to have multidrug-resistant TB. We analyzed the proportion of patients still on treatment at the end of two months and with treatment success at the end of treatment according to DOT type. We used propensity score analysis to control for factors associated with DOT and treatment outcome. Of 8,031 patients eligible for analysis, 24% received HCW DOT, 59% family DOT, and 18% self-administered therapy (SAT). Smear-positive TB was diagnosed in 63%, and 21% were HIV-infected. Of patients either on treatment or that defaulted at two months, 1601/1636 (98%) patients that received HCW DOT remained on treatment at two months compared with 1096/1268 (86%) patients that received SAT (adjusted OR [aOR] 3.8; 95% confidence interval [CI] 2.4-6.0) and 3782/3987 (95%) patients that received family DOT (aOR 2.1; CI, 1.4-3.1). Of patients that had treatment success or that defaulted at the end of treatment, 1369/1477 (93%) patients that received HCW DOT completed treatment compared with 744/1074 (69%) patients that received SAT (aOR 3.3; CI, 2.4-4.5) and 3130/3529 (89%) patients that received family DOT (aOR 1.5; 1.2-1.9). The benefit of HCW DOT compared with SAT was similar, but smaller, when comparing patients with treatment success to those with death, default, or failure. Conclusions: In Thailand, two months of DOT was associated with lower odds of default during treatment. The magnitude of benefit was greater for DOT provided by a HCW compared with a family member. Thailand should consider increasing its use of HCW DOT during TB treatment.	[Anuwatnonthakate, Amornrat; Sombat, Potjaman; Siangphoe, Umaporn; Mock, Philip A.; Varma, Jay K.] Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand; [Limsomboon, Pranom] Phuket Provincial Publ Hlth Office, Phuket, Thailand; [Nateniyom, Sriprapa] Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Wattanaamornkiat, Wanpen] Office Dis Prevent & Control 7, Ubon ratchathani, Thailand; [Komsakorn, Sittijate] Chiang Rai Provincial Publ Hlth Office, Chiang Rai, Thailand; [Moolphate, Saiyud] Res Inst Tuberculosis, Tokyo, Japan; [Chiengsorn, Navarat] Bangkok Metropolitan Hlth Admin, Bangkok, Thailand; [Kaewsa-ard, Samroui] Bamrasnaradura Inst, Nonthaburi, Thailand; [Varma, Jay K.] US Ctr Dis Control & Prevent, Atlanta, GA USA	Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Anuwatnonthakate, A (corresponding author), Thailand MOPH US CDC Collaborat, Nonthaburi, Thailand.	jvarma@cdc.gov		Siangphoe, Uma/0000-0002-0560-6314	United States Centers for Disease Control and Prevention (U.S. CDC); United States Agency for International Development 2 (USAID)	United States Centers for Disease Control and Prevention (U.S. CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development 2 (USAID)(United States Agency for International Development (USAID))	This project was supported by the United States Centers for Disease Control and Prevention (U.S. CDC) and United States Agency for International Development 2 (USAID). Some authors from this publication are employed by the U.S. CDC. USAID was not involved in the design, analysis, or writing of this manuscript.	Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; BAYER R, 1995, LANCET, V345, P1545, DOI 10.1016/S0140-6736(95)91090-5; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Frieden T, 2002, INT J TUBERC LUNG D, V6, P371; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Kamolratanakul P, 1999, T ROY SOC TROP MED H, V93, P552, DOI 10.1016/S0035-9203(99)90379-6; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762; Pungrassami P, 2002, INT J TUBERC LUNG D, V6, P389; Pungrassami P, 2002, TROP MED INT HEALTH, V7, P271, DOI 10.1046/j.1365-3156.2002.00849.x; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rusen ID, 2007, INT J TUBERC LUNG D, V11, P120; Varma JK, 2007, B WORLD HEALTH ORGAN, V85, P586, DOI 10.2471/BLT.06.038067; VOLMINK J, 2006, COCHRANE DB SYST REV, V2; WHO, 2007, WHOHTMTB2007376; *WHO S E AS REG OF, 2004, REV NAT TUB PROGR TH, V3; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2; Zignol M, 2007, CLIN INFECT DIS, V44, P61, DOI 10.1086/509328	24	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3089	10.1371/journal.pone.0003089	http://dx.doi.org/10.1371/journal.pone.0003089			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769479	gold, Green Published			2022-12-27	WOS:000264796600008
J	Graham, NAJ; McClanahan, TR; MacNeil, MA; Wilson, SK; Polunin, NVC; Jennings, S; Chabanet, P; Clark, S; Spalding, MD; Letourneur, Y; Bigot, L; Galzin, R; Ohman, MC; Garpe, KC; Edwards, AJ; Sheppard, CRC				Graham, Nicholas A. J.; McClanahan, Tim R.; MacNeil, M. Aaron; Wilson, Shaun K.; Polunin, Nicholas V. C.; Jennings, Simon; Chabanet, Pascale; Clark, Susan; Spalding, Mark D.; Letourneur, Yves; Bigot, Lionel; Galzin, Rene; Ohman, Marcus C.; Garpe, Kajsa C.; Edwards, Alasdair J.; Sheppard, Charles R. C.			Climate Warming, Marine Protected Areas and the Ocean-Scale Integrity of Coral Reef Ecosystems	PLOS ONE			English	Article								Coral reefs have emerged as one of the ecosystems most vulnerable to climate variation and change. While the contribution of a warming climate to the loss of live coral cover has been well documented across large spatial and temporal scales, the associated effects on fish have not. Here, we respond to recent and repeated calls to assess the importance of local management in conserving coral reefs in the context of global climate change. Such information is important, as coral reef fish assemblages are the most species dense vertebrate communities on earth, contributing critical ecosystem functions and providing crucial ecosystem services to human societies in tropical countries. Our assessment of the impacts of the 1998 mass bleaching event on coral cover, reef structural complexity, and reef associated fishes spans 7 countries, 66 sites and 26 degrees of latitude in the Indian Ocean. Using Bayesian meta-analysis we show that changes in the size structure, diversity and trophic composition of the reef fish community have followed coral declines. Although the ocean scale integrity of these coral reef ecosystems has been lost, it is positive to see the effects are spatially variable at multiple scales, with impacts and vulnerability affected by geography but not management regime. Existing no-take marine protected areas still support high biomass of fish, however they had no positive affect on the ecosystem response to large-scale disturbance. This suggests a need for future conservation and management efforts to identify and protect regional refugia, which should be integrated into existing management frameworks and combined with policies to improve system-wide resilience to climate variation and change.	[Graham, Nicholas A. J.; MacNeil, M. Aaron; Wilson, Shaun K.; Polunin, Nicholas V. C.] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne, Tyne & Wear, England; [McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [MacNeil, M. Aaron] NOAA, Panama City Lab, Natl Res Council, Panama City, FL USA; [Wilson, Shaun K.] James Cook Univ, ARC Ctr Excellence Coral Reef Stud, Townsville, Qld, Australia; [Jennings, Simon] Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft, Suffolk, England; [Jennings, Simon] Univ E Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Chabanet, Pascale] Inst Rech Dev, Noumea, New Caledonia; [Chabanet, Pascale; Bigot, Lionel] Univ La Reunion, Lab Ecol Marine ECOMAR, St Denis, France; [Clark, Susan] Bridgewater House, Manchester, Lancs, England; [Spalding, Mark D.] Nature Conservancy, Newmarket, Suffolk, England; [Letourneur, Yves] Univ Mediterranee, Ctr Oceanol Marseille, UMR CNRS, 6540 DIMAR, Marseille, France; [Galzin, Rene] Univ Perpignan, CNRS EPHE UPVD, UMR 5244, Perpignan, France; [Ohman, Marcus C.; Garpe, Kajsa C.] Stockholm Univ, Dept Zool, Stockholm, Sweden; [Edwards, Alasdair J.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England; [Sheppard, Charles R. C.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	Newcastle University - UK; Wildlife Conservation Society; National Academies of Sciences, Engineering & Medicine; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia; Institut de Recherche pour le Developpement (IRD); University of La Reunion; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Universite de Montpellier; Stockholm University; Newcastle University - UK; University of Warwick	Graham, NAJ (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne, Tyne & Wear, England.	a.j.graham@ncl.ac.uk	Letourneur, Yves/V-6843-2019; MacNeil, M. Aaron/ABD-6444-2021; MacNeil, Aaron/E-8196-2017; McClanahan, Tim/K-4998-2019; Chabanet, Pascale/L-9470-2017; Edwards, Alasdair J/C-9558-2009; Spalding, Mark/GVU-0739-2022; MacNeil, M Aaron/F-4680-2010; Jennings, Simon/F-5085-2012; LETOURNEUR, Yves/B-4387-2012; Graham, Nicholas AJ/C-8360-2014	Letourneur, Yves/0000-0003-3157-1976; MacNeil, M. Aaron/0000-0001-8406-325X; MacNeil, Aaron/0000-0001-8406-325X; Edwards, Alasdair J/0000-0002-2979-7389; Jennings, Simon/0000-0002-2390-7225; LETOURNEUR, Yves/0000-0003-3157-1976; Graham, Nicholas AJ/0000-0002-0304-7467; McClanahan, Timothy/0000-0001-5821-3584; Chabanet, Pascale/0000-0001-7600-943X; sheppard, charles/0000-0002-2579-5124; Wilson, Shaun/0000-0002-4590-0948; Polunin, Nick/0000-0002-1480-8794; Spalding, Mark/0000-0001-9456-4533	Leverhulme Trust; Western Indian Ocean Marine Science Association; World Bank Targeted Research Group on Coral Bleaching; Fisheries Society of the British Isles; Eppley and Tiffany Foundations; National Science and Engineering Research Council of Canada; British Overseas Development Administration (now DFID); British Foreign and Commonwealth Office	Leverhulme Trust(Leverhulme Trust); Western Indian Ocean Marine Science Association; World Bank Targeted Research Group on Coral Bleaching; Fisheries Society of the British Isles; Eppley and Tiffany Foundations; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); British Overseas Development Administration (now DFID); British Foreign and Commonwealth Office	This research was funded through grants from the Leverhulme Trust, Western Indian Ocean Marine Science Association, World Bank Targeted Research Group on Coral Bleaching, the Fisheries Society of the British Isles, the Eppley and Tiffany Foundations, the National Science and Engineering Research Council of Canada, the British Overseas Development Administration (now DFID) and the British Foreign and Commonwealth Office.	Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Cote IM, 2005, PHILOS T R SOC B, V360, P385, DOI 10.1098/rstb.2004.1591; Diaz-Pulido G, 2002, MAR ECOL PROG SER, V232, P115, DOI 10.3354/meps232115; Dorenbosch M, 2005, MAR ECOL PROG SER, V302, P63, DOI 10.3354/meps302063; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; Gelman A., 2004, BAYESIAN DATA ANAL; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gurevitch J, 1999, ECOLOGY, V80, P1142, DOI 10.1890/0012-9658(1999)080[1142:SIIEMA]2.0.CO;2; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 2004, SYMBIOSIS, V37, P1; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kaiser MJ, 2006, MAR ECOL PROG SER, V311, P1, DOI 10.3354/meps311001; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Nystrom M, 2001, ECOSYSTEMS, V4, P406, DOI 10.1007/s10021-001-0019-y; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sheppard C, 2005, J NAT HIST, V39, P103, DOI 10.1080/00222930310001657900; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SHEPPARD CRC, 2000, SEAS MILLENNIUM ENV, V2, P221; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilkinson C., 2005, STATUS CORAL REEFS T; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	52	198	202	4	178	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3039	10.1371/journal.pone.0003039	http://dx.doi.org/10.1371/journal.pone.0003039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728776	gold, Green Accepted, Green Published			2022-12-27	WOS:000264796400003
J	She, QB; Chandarlapaty, S; Ye, Q; Lobo, J; Haskell, KM; Leander, KR; DeFeo-Jones, D; Huber, HE; Rosen, N				She, Qing-Bai; Chandarlapaty, Sarat; Ye, Qing; Lobo, Jose; Haskell, Kathleen M.; Leander, Karen R.; DeFeo-Jones, Deborah; Huber, Hans E.; Rosen, Neal			Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling	PLOS ONE			English	Article								Background: Dysregulated PI3K/Akt signaling occurs commonly in breast cancers and is due to HER2 amplification, PI3K mutation or PTEN inactivation. The objective of this study was to determine the role of Akt activation in breast cancer as a function of mechanism of activation and whether inhibition of Akt signaling is a feasible approach to therapy. Methodology/Principal Findings: A selective allosteric inhibitor of Akt kinase was used to interrogate a panel of breast cancer cell lines characterized for genetic lesions that activate PI3K/Akt signaling: HER2 amplification or PI3K or PTEN mutations in order to determine the biochemical and biologic consequences of inhibition of this pathway. A variety of molecular techniques and tissue culture and in vivo xenograft models revealed that tumors with mutational activation of Akt signaling were selectively dependent on the pathway. In sensitive cells, pathway inhibition resulted in D-cyclin loss, G1 arrest and induction of apoptosis, whereas cells without pathway activation were unaffected. Most importantly, the drug effectively inhibited Akt kinase and its downstream effectors in vivo and caused complete suppression of the growth of breast cancer xenografts with PI3K mutation or HER2 amplification, including models of the latter selected for resistance to Herceptin. Furthermore, chronic administration of the drug was well-tolerated, causing only transient hyperglycemia without gross toxicity to the host despite the pleiotropic normal functions of Akt. Conclusions/Significance: These data demonstrate that breast cancers with PI3K mutation or HER2 amplification are selectively dependent on Akt signaling, and that effective inhibition of Akt in tumors is feasible and effective in vivo. These findings suggest that direct inhibition of Akt may represent a therapeutic strategy for breast and other cancers that are addicted to the pathway including tumors with resistant to Herceptin.	[She, Qing-Bai; Chandarlapaty, Sarat; Ye, Qing; Lobo, Jose; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Haskell, Kathleen M.; Leander, Karen R.; DeFeo-Jones, Deborah; Huber, Hans E.] Merck Res Lab, Dept Canc Res, West Point, PA USA	Memorial Sloan Kettering Cancer Center; Merck & Company	She, QB (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	rosenn@mskcc.org	Rosen, Neal/ABF-2677-2020	She, Qing-Bai/0000-0002-7207-0599	NIH [P01CA94060]; Breast Cancer Research Foundation; Taub Foundation; NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Taub Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH P01CA94060 (NR), the Breast Cancer Research Foundation (NR), and the Taub Foundation (NR). The funders played no role in the study design, execution, analysis or preparation of the paper.	Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bilodeau MT, 2008, BIOORG MED CHEM LETT, V18, P3178, DOI 10.1016/j.bmcl.2008.04.074; Butler M, 2002, DIABETES, V51, P1028, DOI 10.2337/diabetes.51.4.1028; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; DeFeo-Jones D, 2005, MOL CANCER THER, V4, P271; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; Garcia JM, 2004, GENE CHROMOSOME CANC, V41, P117, DOI 10.1002/gcc.20062; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Johnston S, 2008, J CLIN ONCOL, V26, P1066, DOI 10.1200/JCO.2007.13.9949; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lindsley CW, 2008, CURR CANCER DRUG TAR, V8, P7, DOI 10.2174/156800908783497096; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; NUSSE M, 1990, CYTOMETRY, V11, P813, DOI 10.1002/cyto.990110707; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Robertson GP, 2005, CANCER METAST REV, V24, P273, DOI 10.1007/s10555-005-1577-9; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weng LP, 1999, CANCER RES, V59, P5808; Wu XY, 1998, P NATL ACAD SCI USA, V95, P15587, DOI 10.1073/pnas.95.26.15587	39	233	248	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3065	10.1371/journal.pone.0003065	http://dx.doi.org/10.1371/journal.pone.0003065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725974	Green Submitted, gold, Green Published			2022-12-27	WOS:000264796300011
J	Khaldi, N; Wolfe, KH				Khaldi, Nora; Wolfe, Kenneth H.			Elusive Origins of the Extra Genes in Aspergillus oryzae	PLOS ONE			English	Article							GENOME DUPLICATION; SACCHAROMYCES-CEREVISIAE; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; YEAST GENOME; SEQUENCE; EUKARYOTES; DIVERGENCE; EVOLUTION; FUMIGATUS	The genome sequence of Aspergillus oryzae revealed unexpectedly that this species has approximately 20% more genes than its congeneric species A. nidulans and A. fumigatus. Where did these extra genes come from? Here, we evaluate several possible causes of the elevated gene number. Many gene families are expanded in A. oryzae relative to A. nidulans and A. fumigatus, but we find no evidence of ancient whole-genome duplication or other segmental duplications, either in A. oryzae or in the common ancestor of the genus Aspergillus. We show that the presence of divergent pairs of paralogs is a feature peculiar to A. oryzae and is not shared with A. nidulans or A. fumigatus. In phylogenetic trees that include paralog pairs from A. oryzae, we frequently find that one of the genes in a pair from A. oryzae has the expected orthologous relationship with A. nidulans, A. fumigatus and other species in the subphylum Eurotiomycetes, whereas the other A. oryzae gene falls outside this clade but still within the Ascomycota. We identified 456 such gene pairs in A. oryzae. Further phylogenetic analysis did not however indicate a single consistent evolutionary origin for the divergent members of these pairs. Approximately one-third of them showed phylogenies that are suggestive of horizontal gene transfer (HGT) from Sordariomycete species, and these genes are closer together in the A. oryzae genome than expected by chance, but no unique Sordariomycete donor species was identifiable. The postulated HGTs from Sordariomycetes still leave the majority of extra A. oryzae genes unaccounted for. One possible explanation for our observations is that A. oryzae might have been the recipient of many separate HGT events from diverse donors.	[Khaldi, Nora; Wolfe, Kenneth H.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland	Trinity College Dublin	Khaldi, N (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	khwolfe@tcd.ie		Wolfe, Kenneth/0000-0003-4992-4979	Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This study was supported by Science Foundation Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cai JJ, 2006, J MOL EVOL, V63, P1, DOI 10.1007/s00239-004-0372-5; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Geiser DM, 1998, P NATL ACAD SCI USA, V95, P388, DOI 10.1073/pnas.95.1.388; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hamada T., 1992, APPL BIOTECHNOLOGY T, P114; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Langkjaer RB, 2003, NATURE, V421, P848, DOI 10.1038/nature01419; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishida H, 2006, BIOSCI BIOTECH BIOCH, V70, P2646, DOI 10.1271/bbb.60251; Nixon Andrew E., 2002, Current Pharmaceutical Biotechnology, V3, P1; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Tamano K, 2008, FUNGAL GENET BIOL, V45, P139, DOI 10.1016/j.fgb.2007.09.005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	40	27	98	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3036	10.1371/journal.pone.0003036	http://dx.doi.org/10.1371/journal.pone.0003036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725939	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428800003
J	Syed, ZA; Hard, T; Uv, A; van Dijk-Hard, IF				Syed, Zulfeqhar A.; Hard, Torleif; Uv, Anne; van Dijk-Hard, Iris F.			A Potential Role for Drosophila Mucins in Development and Physiology	PLOS ONE			English	Article							PERITROPHIC MATRIX; INTESTINAL MUCIN; MELANOGASTER; IDENTIFICATION; EXPRESSION; MAINTAIN	Vital vertebrate organs are protected from the external environment by a barrier that to a large extent consists of mucins. These proteins are characterized by poorly conserved repeated sequences that are rich in prolines and potentially glycosylated threonines and serines (PTS). We have now used the characteristics of the PTS repeat domain to identify Drosophila mucins in a simple bioinformatics approach. Searching the predicted protein database for proteins with at least 4 repeats and a high ST content, more than 30 mucin-like proteins were identified, ranging from 300-23000 amino acids in length. We find that Drosophila mucins are present at all stages of the fly life cycle, and that their transcripts localize to selective organs analogous to sites of vertebrate mucin expression. The results could allow for addressing basic questions about human mucin-related diseases in this model system. Additionally, many of the mucins are expressed in selective tissues during embryogenesis, thus revealing new potential functions for mucins as apical matrix components during organ morphogenesis.	[Syed, Zulfeqhar A.; Hard, Torleif; van Dijk-Hard, Iris F.] Univ Gothenburg, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden; [Uv, Anne] Gothenburg Univ, Inst Biomed, Dept Med Genet, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Syed, ZA (corresponding author), Univ Gothenburg, Dept Med Chem & Cell Biol, Inst Biomed, Gothenburg, Sweden.	iris.hard@gu.se		Hard, Torleif/0000-0001-9813-9913	Swedish Research Council; Swedish Foundation for Strategic Research (SSF) Center MIVAC	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research (SSF) Center MIVAC(Swedish Foundation for Strategic Research)	This work was supported by grants from the Swedish Research Council (VR) to Torleif Hard and Anne Uv, and by the Swedish Foundation for Strategic Research (SSF) Center MIVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Fraichard S, 2006, GENE EXPR PATTERNS, V6, P772, DOI 10.1016/j.modgep.2006.01.007; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Korayem AM, 2004, INSECT BIOCHEM MOLEC, V34, P1297, DOI 10.1016/j.ibmb.2004.09.001; Lang T, 2004, GLYCOBIOLOGY, V14, P521, DOI 10.1093/glycob/cwh066; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lehane MJ, 1997, ANNU REV ENTOMOL, V42, P525, DOI 10.1146/annurev.ento.42.1.525; Li YQ, 2001, J BIOL CHEM, V276, P35239, DOI 10.1074/jbc.C100359200; Muller R, 2005, FEBS J, V272, P4295, DOI 10.1111/j.1742-4658.2005.04838.x; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Pocock M., 2000, SIGBIO Newsletter, V20, P10, DOI 10.1145/360262.360266; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Shi XZ, 2004, INSECT BIOCHEM MOLEC, V34, P1101, DOI 10.1016/j.ibmb.2004.06.015; Theopold U, 2001, INSECT BIOCHEM MOLEC, V31, P189, DOI 10.1016/S0965-1748(00)00117-X; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tian E, 2006, GLYCOBIOLOGY, V16, P83, DOI 10.1093/glycob/cwj051; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Wang P, 2004, INSECT BIOCHEM MOLEC, V34, P215, DOI 10.1016/j.ibmb.2003.10.001; Wang P, 1997, J BIOL CHEM, V272, P16663, DOI 10.1074/jbc.272.26.16663; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6	21	57	58	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3041	10.1371/journal.pone.0003041	http://dx.doi.org/10.1371/journal.pone.0003041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725942	Green Submitted, gold, Green Published			2022-12-27	WOS:000264428800007
J	Beres, SB; Sesso, R; Pinto, SWL; Hoe, NP; Porcella, SF; Deleo, FR; Musser, JM				Beres, Stephen B.; Sesso, Ricardo; Pinto, Sergio Wyton L.; Hoe, Nancy P.; Porcella, Stephen F.; Deleo, Frank R.; Musser, James M.			Genome Sequence of a Lancefield Group C Streptococcus zooepidemicus Strain Causing Epidemic Nephritis: New Information about an Old Disease	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS; SHOCK-LIKE SYNDROME; TRANSFER-RNA GENES; ALPHA-ENOLASE; PLASMIN RECEPTOR; INVASIVE STRAINS; SIGNAL PEPTIDES; BINDING-PROTEIN; SEROTYPE M1	Outbreaks of disease attributable to human error or natural causes can provide unique opportunities to gain new information about host-pathogen interactions and new leads for pathogenesis research. Poststreptococcal glomerulonephritis (PSGN), a sequela of infection with pathogenic streptococci, is a common cause of preventable kidney disease worldwide. Although PSGN usually occurs after infection with group A streptococci, organisms of Lancefield group C and G also can be responsible. Despite decades of study, the molecular pathogenesis of PSGN is poorly understood. As a first step toward gaining new information about PSGN pathogenesis, we sequenced the genome of Streptococcus equi subsp. zooepidemicus strain MGCS10565, a group C organism that caused a very large and unusually severe epidemic of nephritis in Brazil. The genome is a circular chromosome of 2,024,171 bp. The genome shares extensive gene content, including many virulence factors, with genetically related group A streptococci, but unexpectedly lacks prophages. The genome contains many apparently foreign genes interspersed around the chromosome, consistent with the presence of a full array of genes required for natural competence. An inordinately large family of genes encodes secreted extracellular collagen-like proteins with multiple integrin-binding motifs. The absence of a gene related to speB rules out the long-held belief that streptococcal pyrogenic exotoxin B or antibodies reacting with it singularly cause PSGN. Many proteins previously implicated in GAS PSGN, such as streptokinase, are either highly divergent in strain MGCS10565 or are not more closely related between these species than to orthologs present in other streptococci that do not commonly cause PSGN. Our analysis provides a comparative genomics framework for renewed appraisal of molecular events underlying APSGN pathogenesis.	[Beres, Stephen B.; Musser, James M.] Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, Houston, TX 77030 USA; [Sesso, Ricardo] Univ Fed Sao Paulo, Escola Paulista Med, Div Nephrol, Sao Paulo, Brazil; [Pinto, Sergio Wyton L.] Hosp Sao Joao Deus, Div Nephrol, Divinopolis, Brazil; [Hoe, Nancy P.] NIH, Off Res Serv, Div Occupat Hlth & Safety, Hamilton, MT USA; [Porcella, Stephen F.; Deleo, Frank R.] NIH, NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogenesis, Hamilton, MT USA	The Methodist Hospital System; The Methodist Hospital - Houston; Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Beres, SB (corresponding author), Methodist Hosp, Ctr Mol & Translat Human Infect Dis Res, Res Inst, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sesso, Ricardo C C/B-4767-2013	DeLeo, Frank/0000-0003-3150-2516; Sesso, Ricardo/0000-0002-1062-0073; Beres, Stephen/0000-0003-3041-0185	National Institute of Allergy and Infectious Diseases [UO1-60595]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI001079, Z01AI001052, Z01AI001079] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by grant UO1-60595 from the National Institute of Allergy and Infectious Diseases (to JMM).	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Albarracin C, 1998, W V Med J, V94, P90; Alber J, 2005, VET MICROBIOL, V109, P135, DOI 10.1016/j.vetmic.2005.05.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Artiushin SC, 2002, MICROB PATHOGENESIS, V32, P71, DOI 10.1006/mpat.2001.0482; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Balter S, 2000, LANCET, V355, P1776, DOI 10.1016/S0140-6736(00)02265-0; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; BARNHAM M, 1983, LANCET, V1, P945; BARNHAM M, 1987, EPIDEMIOL INFECT, V98, P171, DOI 10.1017/S0950268800061884; BARNHAM M, 1996, ADV EXPT MED BIOL, P149; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BARRETT NJ, 1986, J INFECTION, V12, P265, DOI 10.1016/S0163-4453(86)94320-3; Batsford SR, 2005, KIDNEY INT, V68, P1120, DOI 10.1111/j.1523-1755.2005.00504.x; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bordes-Benitez A, 2006, EUR J CLIN MICROBIOL, V25, P242, DOI 10.1007/s10096-006-0119-x; Boucher C, 2002, CAN VET J, V43, P123; BRADLEY SF, 1991, REV INFECT DIS, V13, P270; Burts ML, 2005, P NATL ACAD SCI USA, V102, P1169, DOI 10.1073/pnas.0405620102; Carragoso A, 2007, ACTA REUMATOL PORT, V32, P287; Caswell CC, 2007, MOL MICROBIOL, V64, P1319, DOI 10.1111/j.1365-2958.2007.05741.x; Catanho Marcos, 2006, Appl Bioinformatics, V5, P49, DOI 10.2165/00822942-200605010-00007; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Claverys JP, 2003, TRENDS MICROBIOL, V11, P161, DOI 10.1016/S0966-842X(03)00064-7; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dirix G, 2004, PEPTIDES, V25, P1425, DOI 10.1016/j.peptides.2003.10.028; Downar J, 2001, J CLIN MICROBIOL, V39, P2358, DOI 10.1128/JCM.39.6.2358-2359.2001; Duca E, 1971, Rev Med Chir Soc Med Nat Iasi, V75, P105; EARLE D P, 1957, J Chronic Dis, V5, P3, DOI 10.1016/0021-9681(57)90120-0; EDWARDS AT, 1988, EPIDEMIOL INFECT, V101, P43, DOI 10.1017/S0950268800029204; Eisen JA, 2000, GENOME BIOL, V1; Ferrandiere M, 1998, EUR J CLIN MICROBIOL, V17, P290, DOI 10.1007/BF01699990; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fontan PA, 2000, J INFECT DIS, V182, P1712, DOI 10.1086/317604; FRANCIS AJ, 1993, J INFECTION, V27, P317, DOI 10.1016/0163-4453(93)92358-4; Fujino M, 2007, J NEPHROL, V20, P364; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; HAASE A, 1994, FEMS IMMUNOL MED MIC, V10, P75, DOI 10.1111/j.1574-695X.1994.tb00013.x; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x; Hoe NP, 2007, FEMS MICROBIOL LETT, V277, P142, DOI 10.1111/j.1574-6968.2007.00955.x; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igwe EI, 2003, FEMS MICROBIOL LETT, V229, P259, DOI 10.1016/S0378-1097(03)00842-5; JOHNSTON KH, 1986, J EXP MED, V163, P697, DOI 10.1084/jem.163.3.697; JOHNSTON KH, 1991, GENETICS AND MOLECULAR BIOLOGY OF STREPTOCOCCI, LACTOCOCCI, AND ENTEROCOCCI, P190; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; KAPUR V, 1995, MOL MICROBIOL, V16, P509, DOI 10.1111/j.1365-2958.1995.tb02415.x; KEFALIDES NA, 1986, J EXP MED, V163, P588, DOI 10.1084/jem.163.3.588; KLEINMAN H, 1954, Minn Med, V37, P479; KODAMA T, 1958, Yokohama Med Bull, V9, P105; KOHLER W, 1976, SCAND J INFECT DIS, V8, P217, DOI 10.3109/inf.1976.8.issue-3.19; Korman TM, 2004, J CLIN MICROBIOL, V42, P2866, DOI 10.1128/JCM.42.6.2866-2869.2004; Kuusi M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-36; Lange K, 1976, Clin Nephrol, V5, P207; Lanie JA, 2007, J BACTERIOL, V189, P38, DOI 10.1128/JB.01148-06; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LATORRE M, 1993, CLIN INFECT DIS, V17, P932, DOI 10.1093/clinids/17.5.932; Lee AS, 2004, MED J AUSTRALIA, V180, P366, DOI 10.5694/j.1326-5377.2004.tb05979.x; LOW DE, 1980, ARCH INTERN MED, V140, P977, DOI 10.1001/archinte.140.7.977; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; MARTINEZLUENGAS F, 1982, CAN MED ASSOC J, V127, P13; MCARTHUR JD, 2008, FASEB J; MCKEAGE MJ, 1990, AUST NZ J MED, V20, P177, DOI 10.1111/j.1445-5994.1990.tb01299.x; MEZZANO S, 1992, CLIN NEPHROL, V38, P305; Migliorini P., 2002, Autoimmunity Reviews, V1, P168, DOI 10.1016/S1568-9972(02)00028-9; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; MUNOZ AY, 1990, REV CLIN ESP, V187, P255; MUSSER JM, 1991, P NATL ACAD SCI USA, V88, P2668, DOI 10.1073/pnas.88.7.2668; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nicholson ML, 2000, J CLIN MICROBIOL, V38, P4126, DOI 10.1128/JCM.38.11.4126-4130.2000; Nordstrand A, 1999, SCAND J INFECT DIS, V31, P523, DOI 10.1080/00365549950164382; OHKUNI H, 1983, CLIN EXP IMMUNOL, V54, P185; Pallen MJ, 2002, TRENDS MICROBIOL, V10, P209, DOI 10.1016/S0966-842X(02)02345-4; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Parra G, 1998, KIDNEY INT, V54, P509, DOI 10.1046/j.1523-1755.1998.00012.x; Pati S, 2007, CLIN NEUROL NEUROSUR, V109, P475, DOI 10.1016/j.clineuro.2007.01.014; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; POONKING R, 1993, J EXP MED, V178, P759, DOI 10.1084/jem.178.2.759; POONKING T, 1967, NEW ENGL J MED, V277, P728, DOI 10.1056/NEJM196710052771403; Poyart C, 1998, J CLIN MICROBIOL, V36, P41, DOI 10.1128/JCM.36.1.41-47.1998; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; RAMMELKAMP C H Jr, 1957, J Chronic Dis, V5, P28, DOI 10.1016/0021-9681(57)90122-4; RAMMELKAMP CH, 1952, T ASSOC AM PHYSICIAN, V65, P168; RAMMELKAMP CH, 1953, J CLIN INVEST, V32, P345, DOI 10.1172/JCI102745; RAMMELKAMP CH, 1954, T ASSOC AM PHYSICIAN, V67, P276; Rasmussen M, 2003, J BIOL CHEM, V278, P32313, DOI 10.1074/jbc.M304709200; Rastogi P A, 2000, Methods Mol Biol, V132, P47; REID HFM, 1990, J MED MICROBIOL, V32, P111, DOI 10.1099/00222615-32-2-111; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Iturbe B, 2007, KIDNEY INT, V71, P1094, DOI 10.1038/sj.ki.5002169; Rodriguez-Iturbe B, 1976, Clin Nephrol, V5, P197; ROSE HD, 1980, J CLIN MICROBIOL, V11, P76, DOI 10.1128/JCM.11.1.76-78.1980; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salazar L, 1994, Enferm Infecc Microbiol Clin, V12, P223; Shah SS, 2001, PEDIATR INFECT DIS J, V20, P445, DOI 10.1097/00006454-200104000-00016; SHARP JCM, 1985, BRIT MED J, V291, P463, DOI 10.1136/bmj.291.6493.463; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Suarez PR, 2001, ARCH BRONCONEUMOL, V37, P267, DOI 10.1016/S0300-2896(01)75066-1; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; TALAY S, 2008, 17 LANC INT S STRE S; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Terrier B, 2007, AUTOIMMUN REV, V6, P176, DOI 10.1016/j.autrev.2006.10.004; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; TEWODROS W, 1995, MICROB PATHOGENESIS, V18, P53; Thorley AM, 2007, PEDIATR NEPHROL, V22, P597, DOI 10.1007/s00467-006-0364-3; Timoney JF, 2004, VET RES, V35, P397, DOI 10.1051/vetres:2004025; Ural O, 2003, SCAND J INFECT DIS, V35, P206, DOI 10.1080/00365540310000076; Valve K, 1992, Duodecim, V108, P1270; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; VILLARREAL H, 1979, J EXP MED, V149, P459, DOI 10.1084/jem.149.2.459; WERTHEIM AR, 1953, J CLIN INVEST, V32, P359, DOI 10.1172/JCI102746; WONG J, 1982, AUST NZ J SURG, V52, P576, DOI 10.1111/j.1445-2197.1982.tb06115.x; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Yamakami K, 2000, METHODS, V21, P185, DOI 10.1006/meth.2000.0990; YOSHIZAWA N, 1992, J IMMUNOL, V148, P3110; Yoshizawa N, 2004, J AM SOC NEPHROL, V15, P1785, DOI 10.1097/01.ASN.0000130624.94920.6B; YU CE, 1991, INFECT IMMUN, V59, P211, DOI 10.1128/IAI.59.1.211-215.1991; YUEN KY, 1990, J INFECTION, V21, P241, DOI 10.1016/0163-4453(90)93885-V; 1994, COMMUN DIS REP CDR W, V4, P241	142	91	327	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3026	10.1371/journal.pone.0003026	http://dx.doi.org/10.1371/journal.pone.0003026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716664	Green Published, Green Submitted, gold			2022-12-27	WOS:000264426800005
J	Gao, HC; Pattison, D; Yan, TF; Klingeman, DM; Wang, XH; Petrosino, J; Hemphill, L; Wan, XF; Leaphart, AB; Weinstock, GM; Palzkill, T; Zhou, JZ				Gao, Haichun; Pattison, Donna; Yan, Tingfen; Klingeman, Dawn M.; Wang, Xiaohu; Petrosino, Joseph; Hemphill, Lisa; Wan, Xiufeng; Leaphart, Adam B.; Weinstock, George M.; Palzkill, Timothy; Zhou, Jizhong			Generation and Validation of a Shewanella oneidensis MR-1 Clone Set for Protein Expression and Phage Display	PLOS ONE			English	Article							GLOBAL TRANSCRIPTOME ANALYSIS; ANTIBIOTIC-RESISTANCE; ANAEROBIC RESPIRATION; RAPID CONSTRUCTION; RECOMBINANT-DNA; SHOCK RESPONSE; IDENTIFICATION; GENES; REPOSITORY; SEQUENCE	A comprehensive gene collection for S. oneidensis was constructed using the lambda recombinase (Gateway) cloning system. A total of 3584 individual ORFs (85%) have been successfully cloned into the entry plasmids. To validate the use of the clone set, three sets of ORFs were examined within three different destination vectors constructed in this study. Success rates for heterologous protein expression of S. oneidensis His-or His/GST-tagged proteins in E. coli were approximately 70%. The ArcA and NarP transcription factor proteins were tested in an in vitro binding assay to demonstrate that functional proteins can be successfully produced using the clone set. Further functional validation of the clone set was obtained from phage display experiments in which a phage encoding thioredoxin was successfully isolated from a pool of 80 different clones after three rounds of biopanning using immobilized anti-thioredoxin antibody as a target. This clone set complements existing genomic (e. g., whole-genome microarray) and other proteomic tools (e. g., mass spectrometry-based proteomic analysis), and facilitates a wide variety of integrated studies, including protein expression, purification, and functional analyses of proteins both in vivo and in vitro.	[Gao, Haichun; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Gao, Haichun; Yan, Tingfen; Klingeman, Dawn M.; Wan, Xiufeng; Leaphart, Adam B.; Zhou, Jizhong] Oak Ridge Natl Lab, Environm Sci Div, Oak Ridge, TN USA; [Pattison, Donna; Wang, Xiaohu; Petrosino, Joseph; Hemphill, Lisa; Weinstock, George M.; Palzkill, Timothy] Baylor Coll Med, Houston, TX USA	University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Oak Ridge National Laboratory; Baylor College of Medicine	Gao, HC (corresponding author), Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA.	timothyp@bcm.tmc.edu; jzhou@ou.edu	Gao, Haichun/AFU-4588-2022; 吴, 昊/AAB-1620-2020; Weinstock, George M/C-6314-2013; Gao, Haichun/A-2160-2014; Petrosino, Joseph F./AAF-1621-2019; Klingeman, Dawn M/B-9415-2012	Gao, Haichun/0000-0002-2647-6563; Weinstock, George M/0000-0002-2997-4592; Gao, Haichun/0000-0002-2647-6563; Klingeman, Dawn M/0000-0002-4307-2560	U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science; Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy [DOE-AC05-00OR22725]	U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science(United States Department of Energy (DOE)); Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy	This research was supported by The U.S. Department of Energy under the Genomics: GTL Program through Shewanella Federation, Office of Biological and Environmental Research, Office of Science. Oak Ridge National Laboratory is managed by University of Tennessee-Battelle LLC for the Department of Energy under contract DOE-AC05-00OR22725.	Aguiar JC, 2004, GENOME RES, V14, P2076, DOI 10.1101/gr.2416604; Arezi B, 2003, ANAL BIOCHEM, V321, P226, DOI 10.1016/S0003-2697(03)00465-2; Beliaev AS, 2005, J BACTERIOL, V187, P7138, DOI 10.1128/JB.187.20.7138-7145.2005; Bencheikh-Latmani R, 2005, APPL ENVIRON MICROB, V71, P7453, DOI 10.1128/AEM.71.11.7453-7460.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SD, 2006, APPL ENVIRON MICROB, V72, P890, DOI 10.1128/AEM.72.1.890-900.2006; Brown SD, 2006, MOL CELL PROTEOMICS, V5, P1054, DOI 10.1074/mcp.M500394-MCP200; Choudhury G, 2006, STOCH ANAL APPL, V24, P1, DOI 10.1080/07362990500397277; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; DARWIN AJ, 1995, J BACTERIOL, V177, P3865, DOI 10.1128/jb.177.13.3865-3869.1995; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Forstner M, 2007, EXPERT REV PROTEOMIC, V4, P67, DOI 10.1586/14789450.4.1.67; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gao HC, 2006, J BACTERIOL, V188, P4560, DOI 10.1128/JB.01908-05; Gao HC, 2004, J BACTERIOL, V186, P7796, DOI 10.1128/JB.186.22.7796-7803.2004; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Hu YH, 2007, GENOME RES, V17, P536, DOI 10.1101/gr.6037607; Huang WZ, 2000, GENE, V251, P187, DOI 10.1016/S0378-1119(00)00210-9; Kehoe JW, 2005, CHEM REV, V105, P4056, DOI 10.1021/cr000261r; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Korenevsky AA, 2002, APPL ENVIRON MICROB, V68, P4653, DOI 10.1128/AEM.68.9.4653-4657.2002; LaBaer J, 2004, GENOME RES, V14, P2190, DOI 10.1101/gr.2482804; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Liu YQ, 2005, J BACTERIOL, V187, P2501, DOI 10.1128/JB.187.7.2501-2507.2005; Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001; Marsischky G, 2004, GENOME RES, V14, P2020, DOI 10.1101/gr.2528804; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Park J, 2005, P NATL ACAD SCI USA, V102, P8114, DOI 10.1073/pnas.0503141102; Phizicky EM, 2006, CRIT REV BIOCHEM MOL, V41, P315, DOI 10.1080/10409230600872872; Qiu XY, 2006, J BACTERIOL, V188, P1199, DOI 10.1128/JB.188.3.1199-1204.2006; Qiu XY, 2005, J BACTERIOL, V187, P3556, DOI 10.1128/JB.187.10.3556-3564.2005; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Romine MF, 2008, APPL ENVIRON MICROB, V74, P3257, DOI 10.1128/AEM.02720-07; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Salamat-Miller N, 2006, MOL CELL PROTEOMICS, V5, P2263, DOI 10.1074/mcp.M600240-MCP200; Schwalb C, 2003, BIOCHEMISTRY-US, V42, P9491, DOI 10.1021/bi034456f; Tang XT, 2007, J PROTEOME RES, V6, P724, DOI 10.1021/pr060480e; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; TYSON KL, 1994, MOL MICROBIOL, V13, P1045, DOI 10.1111/j.1365-2958.1994.tb00495.x; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Xu D, 2002, BIOINFORMATICS, V18, P1432, DOI 10.1093/bioinformatics/18.11.1432; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu XW, 2007, GENE DEV, V21, P1010, DOI 10.1101/gad.1528707	55	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2983	10.1371/journal.pone.0002983	http://dx.doi.org/10.1371/journal.pone.0002983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714347	gold, Green Published, Green Submitted			2022-12-27	WOS:000264420900010
J	Esteve-Lanao, J; Lucia, A; Dekoning, JJ; Foster, C				Esteve-Lanao, Jonathan; Lucia, Alejandro; dekoning, Jos J.; Foster, Carl			How Do Humans Control Physiological Strain during Strenuous Endurance Exercise?	PLOS ONE			English	Article							ENERGY-EXPENDITURE; OXYGEN-UPTAKE; HEART-RATE; NEURAL REGULATION; DISTANCE; FATIGUE; PERFORMANCE; ACCUMULATION; INTENSITY; RUNNERS	Background: Distance running performance is a viable model of human locomotion. Methodology/Principal Findings: To evaluate the physiologic strain during competitions ranging from 5-100 km, we evaluated heart rate (HR) records of competitive runners (n=211). We found evidence that: 1) physiologic strain (% of maximum HR (% HRmax)) increased in proportional manner relative to distance completed, and was regulated by variations in running pace; 2) the % HRmax achieved decreased with relative distance; 3) slower runners had similar % HRmax response within a racing distance compared to faster runners, and despite differences in pace, the profile of % HRmax during a race was very similar in runners of differing ability; and 4) in cases where there was a discontinuity in the running performance, there was evidence that physiologic effort was maintained for some time even after the pace had decreased. Conclusions/Significance: The overall results suggest that athletes are actively regulating their relative physiologic strain during competition, although there is evidence of poor regulation in the case of competitive failures.	[Esteve-Lanao, Jonathan; Lucia, Alejandro] European Univ Madrid, Dept Exercise Physiol, Madrid, Spain; [dekoning, Jos J.] Vrije Univ Amsterdam, Fac MOVE, Amsterdam, Netherlands; [Foster, Carl] Univ Wisconsin, Dept Exercise & Sport Sci, La Crosse, WI USA	European University of Madrid; Vrije Universiteit Amsterdam; University of Wisconsin System	Esteve-Lanao, J (corresponding author), European Univ Madrid, Dept Exercise Physiol, Madrid, Spain.	alejandro.lucia@uem.es	Lucia, Alejandro/M-2759-2014; Rodríguez, Ferran A. A/H-4892-2011	Lucia, Alejandro/0000-0002-3025-2060; Rodríguez, Ferran A. A/0000-0002-2280-8962; Lucia, Alejandro/0000-0002-5565-0997; de Koning, Jos J/0000-0002-5596-0282				AMANN M, 2007, J PHYSL         1025; Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; AMMAN M, 2007, J PHYSL, V581, P389; AMMAN M, 2008, J PHYSL, V586, P161; Ansley L, 2004, MED SCI SPORT EXER, V36, P309, DOI 10.1249/01.MSS.0000113474.31529.C6; Banister EW, 1999, EUR J APPL PHYSIOL O, V79, P182, DOI 10.1007/s004210050493; Banister EW, 1991, PHYSL TESTING ELITE, P403; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Billat VL, 2006, J PHYSIOL SCI, V56, P103, DOI 10.2170/physiolsci.R2028; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; Calbet JAL, 2006, J PHYSIOL-LONDON, V575, P688, DOI 10.1113/jphysiol.2006.116087; COSTILL DL, 1973, MED SCI SPORT EXER, V5, P248; Cottin F, 2002, EUR J APPL PHYSIOL, V87, P17, DOI 10.1007/s00421-002-0582-8; de Koning JJ, 2005, J APPL PHYSIOL, V98, P227, DOI 10.1152/japplphysiol.01095.2003; Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86; Esteve-Lanao J, 2007, J STRENGTH COND RES, V21, P943, DOI 10.1519/00124278-200708000-00048; Eston R, 2007, PSYCHOPHYSIOLOGY, V44, P779, DOI 10.1111/j.1469-8986.2007.00558.x; FARRELL PA, 1979, MED SCI SPORT EXER, V11, P338; Foster C, 2005, MED SCI SPORT EXER, V37, P670, DOI 10.1249/01.MSS.0000158183.64465.BF; Foster C, 2004, INT J SPORTS MED, V25, P198, DOI 10.1055/s-2003-45260; FOSTER C, 1978, EUR J APPL PHYSIOL O, V39, P73, DOI 10.1007/BF00421711; Gibson ASC, 2007, SPORTS MED, V37, P1029; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Gilman MB, 1996, SPORTS MED, V21, P73, DOI 10.2165/00007256-199621020-00001; Hettinga FJ, 2007, MED SCI SPORT EXER, V39, P2212, DOI 10.1249/mss.0b013e318156e8d4; Jeukendrup A E, 2000, J Sci Med Sport, V3, P414, DOI 10.1016/S1440-2440(00)80008-0; Joseph T, 2008, MED SCI SPORT EXER, V40, P381, DOI 10.1249/mss.0b013e31815a83f6; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Lieberman DE, 2007, SPORTS MED, V37, P288, DOI 10.2165/00007256-200737040-00004; Lucia A, 1999, INT J SPORTS MED, V20, P167, DOI 10.1055/s-2007-971112; Lucia A, 2003, SCAND J MED SCI SPOR, V13, P275, DOI 10.1034/j.1600-0838.2003.00345.x; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; MARON MB, 1976, J APPL PHYSIOL, V40, P836, DOI 10.1152/jappl.1976.40.5.836; Martin DT, 2001, SPORTS MED, V31, P469, DOI 10.2165/00007256-200131070-00002; MENDEZVILLANUEV.A, 2008, EUR J APPL PHYS 0327; Mujika I, 2001, SPORTS MED, V31, P479, DOI 10.2165/00007256-200131070-00003; Noakes TD, 2005, BRIT J SPORT MED, V39, P120, DOI 10.1136/bjsm.2003.010330; Pollock M L, 1977, Ann N Y Acad Sci, V301, P310, DOI 10.1111/j.1749-6632.1977.tb38209.x; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Spencer MR, 2001, MED SCI SPORT EXER, V33, P157; Stevinson CD, 1998, BRIT J SPORT MED, V32, P229, DOI 10.1136/bjsm.32.3.229; Thomas C, 2005, INT J SPORTS MED, V26, P268, DOI 10.1055/s-2004-820998; Ulmer HV, 1996, EXPERIENTIA, V52, P416, DOI 10.1007/BF01919309; Wike Jeffrey, 2005, Curr Sports Med Rep, V4, P76; XU F, 1999, SPORTS MED, V2, P14	45	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2943	10.1371/journal.pone.0002943	http://dx.doi.org/10.1371/journal.pone.0002943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698405	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600029
J	Makidon, PE; Bielinska, AU; Nigavekar, SS; Janczak, KW; Knowlton, J; Scott, AJ; Mank, N; Cao, ZY; Rathinavelu, S; Beer, MR; Wilkinson, JE; Blanco, LP; Landers, JJ; Baker, JR				Makidon, Paul E.; Bielinska, Anna U.; Nigavekar, Shraddha S.; Janczak, Katarzyna W.; Knowlton, Jessica; Scott, Alison J.; Mank, Nicholas; Cao, Zhengyi; Rathinavelu, Sivaprakash; Beer, Michael R.; Wilkinson, J. Erby; Blanco, Luz P.; Landers, Jeffrey J.; Baker, James R., Jr.			Pre-Clinical Evaluation of a Novel Nanoemulsion-Based Hepatitis B Mucosal Vaccine	PLOS ONE			English	Article							T-LYMPHOCYTE RESPONSES; LONG-TERM PERSISTENCE; SURFACE-ANTIGEN; IMMUNE-RESPONSES; INTRANASAL IMMUNIZATION; ALUMINUM-HYDROXIDE; ANTIBODY AVIDITY; POTENT ENHANCER; DNA VACCINES; VIRUS	Background: Hepatitis B virus infection remains an important global health concern despite the availability of safe and effective prophylactic vaccines. Limitations to these vaccines include requirement for refrigeration and three immunizations thereby restricting use in the developing world. A new nasal hepatitis B vaccine composed of recombinant hepatitis B surface antigen (HBsAg) in a novel nanoemulsion (NE) adjuvant (HBsAg-NE) could be effective with fewer administrations. Methodology and Principal Findings: Physical characterization indicated that HBsAg-NE consists of uniform lipid droplets (349+/-17 nm) associated with HBsAg through electrostatic and hydrophobic interactions. Immunogenicity of HBsAg-NE vaccine was evaluated in mice, rats and guinea pigs. Animals immunized intranasally developed robust and sustained systemic IgG, mucosal IgA and strong antigen-specific cellular immune responses. Serum IgG reached >= 10(6) titers and was comparable to intramuscular vaccination with alum-adjuvanted vaccine (HBsAg-Alu). Normalization showed that HBsAg-NE vaccination correlates with a protective immunity equivalent or greater than 1000 IU/ml. Th1 polarized immune response was indicated by IFN-gamma and TNF-alpha cytokine production and elevated levels of IgG(2) subclass of HBsAg-specific antibodies. The vaccine retains full immunogenicity for a year at 4 degrees C, 6 months at 25 degrees C and 6 weeks at 40 degrees C. Comprehensive pre-clinical toxicology evaluation demonstrated that HBsAg-NE vaccine is safe and well tolerated in multiple animal models. Conclusions: Our results suggest that needle-free nasal immunization with HBsAg-NE could be a safe and effective hepatitis B vaccine, or provide an alternative booster administration for the parenteral hepatitis B vaccines. This vaccine induces a Th1 associated cellular immunity and also may provide therapeutic benefit to patients with chronic hepatitis B infection who lack cellular immune responses to adequately control viral replication. Long-term stability of this vaccine formulation at elevated temperatures suggests a direct advantage in the field, since potential excursions from cold chain maintenance could be tolerated without a loss in therapeutic efficacy.	[Makidon, Paul E.; Bielinska, Anna U.; Nigavekar, Shraddha S.; Janczak, Katarzyna W.; Knowlton, Jessica; Scott, Alison J.; Mank, Nicholas; Cao, Zhengyi; Rathinavelu, Sivaprakash; Beer, Michael R.; Blanco, Luz P.; Landers, Jeffrey J.; Baker, James R., Jr.] Univ Michigan, M NIMBS, Ann Arbor, MI 48109 USA; [Makidon, Paul E.; Wilkinson, J. Erby] Univ Michigan, Unit Lab Anim Med ULAM, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Makidon, PE (corresponding author), Univ Michigan, M NIMBS, Ann Arbor, MI 48109 USA.	jbakerjr@umich.edu	Rathinavelu, Sivaprakash/AAT-2526-2021	Scott, Alison/0000-0001-6969-4707; /0000-0002-8468-6518	Bill & Melinda Gates Foundation [Grand Challenges in Global Health Initiative 37868]; Natl Ctr Research Resourses of NIH [T32 RR07008]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR007008] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Natl Ctr Research Resourses of NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by Bill & Melinda Gates Foundation through Grand Challenges in Global Health Initiative 37868. P. Makidon is supported by T32 RR07008 from Natl Ctr Research Resourses of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JC, 2004, IMMUNOL CELL BIOL, V82, P539, DOI 10.1111/j.0818-9641.2004.01278.x; Aguilar JC, 2003, BIOCHEM BIOPH RES CO, V310, P59, DOI 10.1016/j.bbrc.2003.08.120; Anttila M, 1999, CLIN EXP IMMUNOL, V118, P402; Assad S, 1999, VACCINE, V18, P57, DOI 10.1016/S0264-410X(99)00179-6; BETANCOURT AA, 2007, INT J INFEC IN PRESS; Bielinska AU, 2008, CLIN VACCINE IMMUNOL, V15, P348, DOI 10.1128/CVI.00440-07; Bielinska AU, 2008, AIDS RES HUM RETROV, V24, P271, DOI 10.1089/aid.2007.0148; Bielinska AU, 2007, INFECT IMMUN, V75, P4020, DOI 10.1128/IAI.00070-07; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P868; Chen HM, 2000, J CONTROL RELEASE, V67, P117, DOI 10.1016/S0168-3659(00)00199-1; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; CLASSEN DC, 1987, J CLIN MICROBIOL, V25, P600, DOI 10.1128/JCM.25.4.600-604.1987; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Debin A, 2002, VACCINE, V20, P2752, DOI 10.1016/S0264-410X(02)00191-3; Egan MA, 2004, VACCINE, V22, P3774, DOI 10.1016/j.vaccine.2004.03.011; Floreani A, 2004, VACCINE, V22, P607, DOI 10.1016/j.vaccine.2003.09.001; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Geissler M, 1997, GASTROENTEROLOGY, V112, P1307, DOI 10.1016/S0016-5085(97)70145-8; GESEMANN M, 1995, VACCINE, V13, P443, DOI 10.1016/0264-410X(94)00010-K; Gherardi RK, 2001, BRAIN, V124, P1821, DOI 10.1093/brain/124.9.1821; Gilbert RJC, 2005, P NATL ACAD SCI USA, V102, P14783, DOI 10.1073/pnas.0505062102; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Graham BS, 2006, PLOS MED, V3, P18, DOI 10.1371/journal.pmed.0030057; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hamouda T, 2000, J APPL MICROBIOL, V89, P397, DOI 10.1046/j.1365-2672.2000.01127.x; Hamouda T, 2001, MICROBIOL RES, V156, P1, DOI 10.1078/0944-5013-00069; Hamouda T, 1999, J INFECT DIS, V180, P1939, DOI 10.1086/315124; Harandi Ali M, 2003, Curr Opin Investig Drugs, V4, P156; *HEP B FDN, 2007, HEP B CLIN TRIALS; HERBERT RA, 1999, PATHOLOGY MOUSE; Hilleman MR, 2001, VACCINE, V19, P1837, DOI 10.1016/S0264-410X(00)00364-9; HogenEsch H, 2002, VACCINE, V20, pS34, DOI 10.1016/S0264-410X(02)00169-X; Illum L, 2001, ADV DRUG DELIVER REV, V51, P1; Isaka M, 2001, VACCINE, V19, P1460, DOI 10.1016/S0264-410X(00)00348-0; Iyer S, 2004, VACCINE, V22, P1475, DOI 10.1016/j.vaccine.2003.10.023; Jaganathan KS, 2006, VACCINE, V24, P4201, DOI 10.1016/j.vaccine.2006.01.011; Katare YK, 2006, VACCINE, V24, P3599, DOI 10.1016/j.vaccine.2006.01.066; Khajuria A, 2007, VACCINE, V25, P4586, DOI 10.1016/j.vaccine.2007.03.051; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; LEROUXROELS G, 1994, VACCINE, V12, P812, DOI 10.1016/0264-410X(94)90290-9; Little SF, 2004, BIOLOGICALS, V32, P62, DOI 10.1016/j.biologicals.2004.02.001; Lobaina Y, 2003, BIOCHEM BIOPH RES CO, V300, P745, DOI 10.1016/S0006-291X(02)02897-8; MAKHATADZE GI, 1990, J MOL BIOL, V213, P375, DOI 10.1016/S0022-2836(05)80197-4; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; McCluskie MJ, 1998, J IMMUNOL, V161, P4463; Michel ML, 2005, J CLIN VIROL, V34, pS108, DOI 10.1016/S1386-6532(05)80019-8; *MICROCAL LLC, 2007, VP ITC MICR US MAN; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Myc A, 2003, VACCINE, V21, P3801, DOI 10.1016/S0264-410X(03)00381-5; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Niu MT, 1998, J CLIN EPIDEMIOL, V51, P503, DOI 10.1016/S0895-4356(98)00014-6; Park MH, 2003, TISSUE ANTIGENS, V62, P505, DOI 10.1046/j.1399-0039.2003.00141.x; Payette PJ, 2006, INTERVIROLOGY, V49, P144, DOI 10.1159/000089375; PETERSON DL, 1987, BIOESSAYS, V6, P258, DOI 10.1002/bies.950060604; Pittman PR, 2002, VACCINE, V20, pS48, DOI 10.1016/S0264-410X(02)00172-X; Poland GA, 2004, NEW ENGL J MED, V351, P2832, DOI 10.1056/NEJMcp041507; Saraf S, 2006, VACCINE, V24, P45, DOI 10.1016/j.vaccine.2005.07.053; Sato A, 2003, J IMMUNOL, V171, P3684, DOI 10.4049/jimmunol.171.7.3684; Schirmbeck R, 2001, J IMMUNOL, V166, P1405, DOI 10.4049/jimmunol.166.2.1405; SCHIRMBECK R, 1994, J IMMUNOL, V152, P1110; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; TALARO K, 1993, FDN MICROBIOLOGY, P806; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; Van Herck K, 1998, VACCINE, V16, P1933, DOI 10.1016/S0264-410X(98)00126-1; Vanlandschoot P, 2003, TRENDS IMMUNOL, V24, P144, DOI 10.1016/S1471-4906(03)00026-7; Vermont CL, 2002, INFECT IMMUN, V70, P584, DOI 10.1128/IAI.70.2.584-590.2002; *WHO, 2000, 204 WHO; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Woo WP, 2006, J VIROL, V80, P3975, DOI 10.1128/JVI.80.8.3975-3984.2006; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Zuckerman JN, 2006, J MED VIROL, V78, P169, DOI 10.1002/jmv.20524; 2005, GATES FDN GRAND CHAL	75	112	129	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2954	10.1371/journal.pone.0002954	http://dx.doi.org/10.1371/journal.pone.0002954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698426	Green Submitted, gold, Green Published			2022-12-27	WOS:000264412600040
J	Rodriguez, JJ; Jones, VC; Tabuchi, M; Allan, SM; Knight, EM; LaFerla, FM; Oddo, S; Verkhratsky, A				Rodriguez, Jose J.; Jones, Victoria C.; Tabuchi, Masashi; Allan, Stuart M.; Knight, Elysse M.; LaFerla, Frank M.; Oddo, Salvatore; Verkhratsky, Alexei			Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article								It has become generally accepted that new neurones are added and integrated mainly in two areas of the mammalian CNS, the subventricular zone and the subgranular zone (SGZ) of the dentate gyrus (DG) of the hippocampus, which is of central importance in learning and memory. The newly generated cells display neuronal morphology, are able to generate action potentials and receive functional synaptic inputs, i.e. their properties are similar to those found in mature neurones. Alzheimer's disease ( AD) is the primary and widespread cause of dementia and is an age-related, progressive and irreversible neurodegenerative disease that deteriorates cognitive functions. Here, we have used male and female triple transgenic mice (3xTg-AD) harbouring three mutant genes (beta-amyloid precursor protein, presenilin-1 and tau) and their respective non-transgenic (non-Tg) controls at 2, 3, 4, 6, 9 and 12 months of age to establish the link between AD and neurogenesis. Using immunohistochemistry we determined the area density of proliferating cells within the SGZ of the DG, measured by the presence of phosphorylated Histone H3 (HH3), and their possible co-localisation with GFAP to exclude a glial phenotype. Less than 1% of the HH3 labeled cells co-localised with GFAP. Both non-Tg and 3xTg-AD showed an age-dependent decrease in neurogenesis. However, male 3xTg-AD mice demonstrated a further reduction in the production of new neurones from 9 months of age (73% decrease) and a complete depletion at 12 months, when compared to controls. In addition, female 3xTg-AD mice showed an earlier but equivalent decrease in neurogenesis at 4 months (reduction of 63%) with an almost inexistent rate at 12 months (88% decrease) compared to controls. This reduction in neurogenesis was directly associated with the presence of beta-amyloid plaques and an increase in the number of beta-amyloid containing neurones in the hippocampus; which in the case of 3xgTg females was directly correlated. These results suggest that 3xTg-AD mice have an impaired ability to generate new neurones in the DG of the hippocampus, the severity of which increases with age and might be directly associated with the known cognitive impairment observed from 6 months of age onwards. The earlier reduction of neurogenesis in females, from 4 months, is in agreement with the higher prevalence of AD in women than in men. Thus it is conceivable to speculate that a recovery in neurogenesis rates in AD could help to rescue cognitive impairment.	[Rodriguez, Jose J.; Jones, Victoria C.; Tabuchi, Masashi; Allan, Stuart M.; Knight, Elysse M.; Verkhratsky, Alexei] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [LaFerla, Frank M.; Oddo, Salvatore] Univ Calif Irvine, Dept Neurobiol & Behaviour, Irvine, CA USA; [Verkhratsky, Alexei] ASCR, Inst Expt Med, Prague, Czech Republic	University of Manchester; University of California System; University of California Irvine; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Rodriguez, JJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	Jose.Rodriguez-arellano@manchester.ac.uk	Verkhratsky, Alexei/J-4527-2013; Jones, Vicky/J-2958-2017; Allan, Stuart/AAL-1245-2020	Verkhratsky, Alexei/0000-0003-2592-9898; Jones, Vicky/0000-0001-8401-5223; knight, Elysse/0000-0001-8372-1214; Allan, Stuart/0000-0001-9646-4456; Oddo, Salvatore/0000-0001-7304-7430; Tabuchi, Masashi/0000-0002-8734-6922	Alzheimer's Research Trust Programme [ART/PG2004A/1]	Alzheimer's Research Trust Programme	Alzheimer's Research Trust Programme Grant (ART/PG2004A/1) to JJR and AV.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Baum LW, 2005, J GERONTOL A-BIOL, V60, P736, DOI 10.1093/gerona/60.6.736; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chevallier NL, 2005, AM J PATHOL, V167, P151, DOI 10.1016/S0002-9440(10)62962-8; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Cooper-Kuhn CM, 2002, DEV BRAIN RES, V134, P13, DOI 10.1016/S0165-3806(01)00243-7; Dong H, 2004, NEUROSCIENCE, V127, P601, DOI 10.1016/j.neuroscience.2004.05.040; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; Feng RB, 2001, NEURON, V32, P911, DOI 10.1016/S0896-6273(01)00523-2; Frazer ME, 2008, MOL THER, V16, P845, DOI 10.1038/mt.2008.39; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Galea LAM, 2006, HIPPOCAMPUS, V16, P225, DOI 10.1002/hipo.20154; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Haughey NJ, 2002, NEUROMOL MED, V1, P125, DOI 10.1385/NMM:1:2:125; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P580; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lagace DC, 2007, HIPPOCAMPUS, V17, P175, DOI 10.1002/hipo.20265; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Manly JJ, 2000, NEUROLOGY, V54, P833, DOI 10.1212/WNL.54.4.833; Mayo W, 2005, NEUROBIOL AGING, V26, P103, DOI 10.1016/j.neurobiolaging.2004.03.013; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; PATERSON JA, 1973, J COMP NEUROL, V149, P83, DOI 10.1002/cne.901490106; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Price D L, 1986, Res Publ Assoc Res Nerv Ment Dis, V64, P209; Rakic P, 2002, J NEUROSCI, V22, P614, DOI 10.1523/JNEUROSCI.22-03-00614.2002; *RAM CAJ S, 1913, EST DEG REG SIST NER; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Tanapat P, 1999, J NEUROSCI, V19, P5792, DOI 10.1523/JNEUROSCI.19-14-05792.1999; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Taupin P, 2002, J NEUROSCI RES, V69, P745, DOI 10.1002/jnr.10378; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, J NEUROSCI, V27, P6771, DOI 10.1523/JNEUROSCI.5564-06.2007; Wang R, 2004, NEUROSCIENCE, V126, P305, DOI 10.1016/j.neuroscience.2004.03.048; Webber KM, 2005, ALZ DIS ASSOC DIS, V19, P95, DOI 10.1097/01.wad.0000165512.90864.3f; Wen PH, 2002, NEUROBIOL DIS, V10, P8, DOI 10.1006/nbdi.2002.0490; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	54	254	259	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2935	10.1371/journal.pone.0002935	http://dx.doi.org/10.1371/journal.pone.0002935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698410	Green Published, gold, Green Accepted			2022-12-27	WOS:000264412600021
J	Su, HR; He, M; Li, HM; Liu, Q; Wang, J; Wang, YQ; Gao, WW; Zhou, L; Liao, JY; Young, AA; Wang, MW				Su, Haoran; He, Min; Li, Hongmei; Liu, Qing; Wang, Jia; Wang, Yiqian; Gao, Weiwei; Zhou, Ling; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei			Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice	PLOS ONE			English	Article							ACTING RELEASE FORMULATION; INSULIN SENSITIVITY; BODY-WEIGHT; ZUCKER RATS; FOOD-INTAKE; GLUCOSE; EXENDIN-4; EXENATIDE; GLP-1; DB/DB	Background: Our recent discovery of the substituted cyclobutane Boc5, one of the first non-peptidic agonists at glucagon-like peptide-1 receptors, offers the potential of combining oral availability with full agonism capable of eliciting antidiabetic and antiobesity effects. The present study was aimed at determining the in vivo pharmacologic properties of Boc5 in both normal and diabetic mice following chronic administration, with emphasis on glycemic control and weight loss. Methodology/Principal Findings: C57BL/6J and db/db mice were treated daily with Boc5 for 4 weeks and a range of pharmacologic parameters, including hemoglobin A1c, intraperitoneal glucose tolerance, insulin tolerance, fasting insulin and leptin levels, food intake, body weight and fat mass, were assessed before and after the treatment. Effects on food intake, gastric emptying, and insulinogenic index were also investigated in animals acutely administered with Boc5. Boc5 (3 mg) was able to induce a durable restoration of glycemic control (normalization of both hemoglobin A1c and intraperitoneal glucose tolerance) in db/db mice, following 4 weeks of daily administration. As with peptidic glucagon-like peptide-1 receptor agonists, its glycemic benefit and weight (fat) loss were associated with dose-dependent effects that included reduction in food intake, slowing of gastric emptying (both of which reduce nutrient-drive at beta-cells), stimulation of insulin secretion (which was glucose-dependent), and elevation in insulin sensitivity. There was little effect on normal mice treated in the same manner. Conclusions/Significance: Our findings suggest that Boc5 is the only non-peptidic molecule reported thus far to simultaneously activate this spectrum of antidiabetic effects.	[Su, Haoran; He, Min; Li, Hongmei; Liu, Qing; Wang, Jia; Wang, Yiqian; Gao, Weiwei; Zhou, Ling; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [Liu, Qing; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Su, HR (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.	wangmw@mail.shcnc.ac.cn	Liu, Qing/AAO-8151-2020	Liu, Qing/0000-0003-1825-6760	Ministry of Science and Technology [2004CB518902]; Chinese Academy of Sciences [KSCX1-YW-02-2, KSCX2-YW-R-17]; Natural Science Foundation of China [30628024]; Shanghai Science and Technology Development Fund [074319114]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund	This work was supported in part by grants from the Ministry of Science and Technology (2004CB518902), the Chinese Academy of Sciences (KSCX1-YW-02-2 and KSCX2-YW-R-17), the Natural Science Foundation of China (30628024) and Shanghai Science and Technology Development Fund (074319114).	Ahren B, 1999, AM J PHYSIOL-ENDOC M, V277, pE996, DOI 10.1152/ajpendo.1999.277.6.E996; Ahren B, 2007, REGUL PEPTIDES, V143, P97, DOI 10.1016/j.regpep.2007.03.008; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BERGER W, 1986, SCHWEIZ MED WSCHR, V116, P145; Blanck H. M., 2006, Morbidity and Mortality Weekly Report, V55, P985; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Carey DG, 2002, OBES RES, V10, P1008, DOI 10.1038/oby.2002.137; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Han GC, 2007, J AGR FOOD CHEM, V55, P10641, DOI 10.1021/jf0722598; Harris RBS, 1999, ENDOCRINOLOGY, V140, P138, DOI 10.1210/en.140.1.138; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Irwin N, 2006, EXP GERONTOL, V41, P151, DOI 10.1016/j.exger.2005.11.006; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Macdonald IA, 1996, DIABETIC MED, V13, pS11; Maggs D, 2006, DIABETOLOGIA, V49, P3; Mizuno A, 1997, METABOLISM, V46, P745, DOI 10.1016/S0026-0495(97)90117-7; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; MOJSOV S, 1987, J CLIN INVEST, V79, P616, DOI 10.1172/JCI112855; Nielsen L, 2007, DIABETES, V56, pA149; Orskov L, 1996, DIABETOLOGIA, V39, P1227, DOI 10.1007/BF02658511; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Parkes D, 2005, DIABETES, V54, pA368; PEDERSON RA, 1975, CAN J PHYSIOL PHARM, V53, P217, DOI 10.1139/y75-032; RABINOVITCH A, 1975, DIABETES, V24, P1094, DOI 10.2337/diabetes.24.12.1094; Rachman J, 1997, DIABETOLOGIA, V40, P205, DOI 10.1007/s001250050664; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SCHEPP W, 1994, EUR J PHARM-MOLEC PH, V269, P183, DOI 10.1016/0922-4106(94)90085-X; STONEHOUSE A, 2007, OBESITY          SPR; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; TANGCHRISTENSEN E, 2002, 7755 SOC NEUR; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Unger RH, 1999, P NATL ACAD SCI USA, V96, P2327, DOI 10.1073/pnas.96.5.2327; Wang Q, 2002, DIABETOLOGIA, V45, P1263, DOI 10.1007/s00125-002-0828-3; WELBORN TA, 1966, LANCET, V1, P1336; YOUNG A, 2007, PEPTIDE DRUG DISCOVE, P272; Young AA, 1996, METABOLISM, V45, P1, DOI 10.1016/S0026-0495(96)90192-4; Young AA, 2002, FRONT ANIM DIAB RES, V5, P235; YOUNG AA, 1995, DIABETOLOGIA, V38, P642, DOI 10.1007/BF00401833; Young AA, 1999, DIABETES, V48, P1026, DOI 10.2337/diabetes.48.5.1026; Young Andrew, 2005, Adv Pharmacol, V52, P67, DOI 10.1016/S1054-3589(05)52004-0; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7	54	34	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2892	10.1371/journal.pone.0002892	http://dx.doi.org/10.1371/journal.pone.0002892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682834	Green Published, gold			2022-12-27	WOS:000264366600048
J	Crewther, SG; Murphy, MJ; Crewther, DP				Crewther, Sheila G.; Murphy, Melanie J.; Crewther, David P.			Potassium Channel and NKCC Cotransporter Involvement in Ocular Refractive Control Mechanisms	PLOS ONE			English	Article								Myopia affects well over 30% of adult humans globally. However, the underlying physiological mechanism is little understood. This study tested the hypothesis that ocular growth and refractive compensation to optical defocus can be controlled by manipulation of potassium and chloride ion-driven transretinal fluid movements to the choroid. Chicks were raised with +/- 10D or zero power optical defocus rendering the focal plane of the eye in front of, behind, or at the level of the retinal photoreceptors respectively. Intravitreal injections of barium chloride, a non-specific inhibitor of potassium channels in the retina and RPE or bumetanide, a selective inhibitor of the sodium-potassium-chloride cotransporter were made, targeting fluid control mechanisms. Comparison of refractive compensation to 5mM Ba2+ and 10(-5) M bumetanide compared with control saline injected eyes shows significant change for both positive and negative lens defocus for Ba2+ but significant change only for negative lens defocus with bumetanide (Rx(SAL)(-10D) = -8.6 +/-.9D; Rx(Ba2+)(-10D) = -2.9 +/-.9D; Rx(Bum)(-10D) = -2.9 +/-.9D; Rx(SAL)(+10D) = +8.2 +/-.9D; Rx(Ba2+)(+10D) = +2.8 +/- 1.3D; Rx(Bum)(+10D) = +8.0 +/-.7D). Vitreous chamber depths showed a main effect for drug conditions with less depth change in response to defocus shown for Ba2+ relative to Saline, while bumetanide injected eyes showed a trend to increased depth without a significant interaction with applied defocus. The results indicate that both K channels and the NKCC cotransporter play a role in refractive compensation with NKCC blockade showing far more specificity for negative, compared with positive, lens defocus. Probable sites of action relevant to refractive control include the apical retinal pigment epithelium membrane and the photoreceptor/ON bipolar synapse. The similarities between the biometric effects of NKCC inhibition and biometric reports of the blockade of the retinal ON response, suggest a possible common mechanism. The selective inhibition of refractive compensation to negative lens in chick by loop diuretics such as bumetanide suggests that these drugs may be effective in the therapeutic management of human myopia.	[Crewther, Sheila G.; Murphy, Melanie J.] La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [Crewther, David P.] Swinburne Univ Technol, Brain Sci Inst, Melbourne, Vic, Australia	La Trobe University; Swinburne University of Technology	Crewther, SG (corresponding author), La Trobe Univ, Sch Psychol Sci, Melbourne, Vic, Australia.	s.crewther@latrobe.edu.au	Crewther, Sheila G/A-2165-2008; Murphy, Melanie/S-8805-2018	Murphy, Melanie/0000-0002-5145-4593	NHMRC Australia	NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge the receipt of a Development Grant from the NHMRC Australia. This is a national competitive granting process in Australia, with the source of funding the National Health and Medical Research Council of Australia. No private funding was received nor inputs to the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	ADORANTE JS, 1990, J GEN PHYSIOL, V96, P1153, DOI 10.1085/jgp.96.6.1153; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Bello RA, 1998, J GEN PHYSIOL, V111, P343, DOI 10.1085/jgp.111.2.343; Beresford JA, 2001, OPTOMETRY VISION SCI, V78, P40, DOI 10.1097/00006324-200101010-00013; Civan MM, 2004, EXP EYE RES, V78, P625, DOI 10.1016/j.exer.2003.09.021; Crewther DP, 2002, NEUROREPORT, V13, P1029, DOI 10.1097/00001756-200206120-00010; Crewther DP, 2000, PROG RETIN EYE RES, V19, P421, DOI 10.1016/S1350-9462(00)00004-5; Crewther SG, 2003, NEUROREPORT, V14, P1233, DOI 10.1097/00001756-200307010-00009; Crewther SG, 2006, P NATL ACAD SCI USA, V103, P15663, DOI 10.1073/pnas.0607241103; Curtin BJ, 1985, THE MYOPIAS, V1; Dmitriev AV, 2007, VISUAL NEUROSCI, V24, P635, DOI 10.1017/S0952523807070629; Dmitriev AV, 1999, VISUAL NEUROSCI, V16, P1157, DOI 10.1017/S095252389916615X; EDELMAN JL, 1994, AM J PHYSIOL, V266, pC957, DOI 10.1152/ajpcell.1994.266.4.C957; Ehrlich D, 1990, CIBA F SYMP, V155, P84; Gabelt BT, 1997, INVEST OPHTH VIS SCI, V38, P1700; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; GRISSMER S, 1993, J GEN PHYSIOL, V102, P601, DOI 10.1085/jgp.102.4.601; Hamann S, 2005, J PHYSIOL-LONDON, V568, P123, DOI 10.1113/jphysiol.2005.093526; Hamann S, 2002, INT REV CYTOL, V215, P395; Junghans BM, 1996, AUST NZ J OPHTHALMOL, V24, P47, DOI 10.1111/j.1442-9071.1996.tb00993.x; Junghans BM, 1999, OPTOMETRY VISION SCI, V76, P796, DOI 10.1097/00006324-199911000-00028; Krupin T, 1996, EXP EYE RES, V62, P231, DOI 10.1006/exer.1996.0028; Lei B, 1999, VISUAL NEUROSCI, V16, P743, DOI 10.1017/S0952523899164137; LI JD, 1994, INVEST OPHTH VIS SCI, V35, P2700; Liang H, 2004, INVEST OPHTH VIS SCI, V45, P2463, DOI 10.1167/iovs.03-1009; Marmor M.F., 1998, RETINAL PIGMENT EPIT, P103; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; Pardue MT, 2008, INVEST OPHTH VIS SCI, V49, P706, DOI 10.1167/iovs.07-0643; Park JB, 2003, J GEN PHYSIOL, V121, P375, DOI 10.1085/jgp.200208746; Phillips JR, 2000, INVEST OPHTH VIS SCI, V41, P2028; ROHRER B, 1994, EXP EYE RES, V58, P553, DOI 10.1006/exer.1994.1049; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Seet B, 2001, BRIT J OPHTHALMOL, V85, P521, DOI 10.1136/bjo.85.5.521; SHIMAZAKI H, 1986, J GEN PHYSIOL, V87, P633, DOI 10.1085/jgp.87.4.633; SHIMAZAKI H, 1984, J GEN PHYSIOL, V84, P475, DOI 10.1085/jgp.84.3.475; STEINBERG RH, 1980, J NEUROPHYSIOL, V44, P897, DOI 10.1152/jn.1980.44.5.897; Vardi N, 2000, J NEUROSCI, V20, P7657; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Wallman J, 2004, NEURON, V43, P447, DOI 10.1016/j.neuron.2004.08.008; Walter SJ, 2001, EXP PHYSIOL, V86, P469, DOI 10.1113/eph8602210; WILDSOET C, 1995, VISION RES, V35, P1175, DOI 10.1016/0042-6989(94)00233-C; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002	44	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2839	10.1371/journal.pone.0002839	http://dx.doi.org/10.1371/journal.pone.0002839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665233	Green Published, gold			2022-12-27	WOS:000264304300058
J	Ge, JQ; Han, SH				Ge, Jianqiao; Han, Shihui			Distinct Neurocognitive Strategies for Comprehensions of Human and Artificial Intelligence	PLOS ONE			English	Article							NEURAL BASIS; SELF; MIND; BRAIN; PERSPECTIVE; DEACTIVATE; SIMULATION; THINKING; AUTISM; OTHERS	Although humans have inevitably interacted with both human and artificial intelligence in real life situations, it is unknown whether the human brain engages homologous neurocognitive strategies to cope with both forms of intelligence. To investigate this, we scanned subjects, using functional MRI, while they inferred the reasoning processes conducted by human agents or by computers. We found that the inference of reasoning processes conducted by human agents but not by computers induced increased activity in the precuneus but decreased activity in the ventral medial prefrontal cortex and enhanced functional connectivity between the two brain areas. The findings provide evidence for distinct neurocognitive strategies of taking others' perspective and inhibiting the process referenced to the self that are specific to the comprehension of human intelligence.	[Ge, Jianqiao; Han, Shihui] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Han, Shihui] Peking Univ, Funct Imaging Ctr, Beijing, Peoples R China; [Han, Shihui] Peking Univ, Key Lab Machine Percept, Beijing, Peoples R China	Peking University; Peking University; Peking University	Han, SH (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	shan@pku.edu.cn		Lauwereyns, Jan/0000-0003-0551-2550	National Natural Science Foundation of China [30630025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Project 30630025).	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Franklin S., 1999, ARTIFICIAL MINDS; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gardner H., 1993, MULTIPLE INTELLIGENC; Goel V, 2004, J COGNITIVE NEUROSCI, V16, P654, DOI 10.1162/089892904323057362; Gruber O, 2001, CEREB CORTEX, V11, P350, DOI 10.1093/cercor/11.4.350; Han SH, 2005, NEUROIMAGE, V24, P928, DOI 10.1016/j.neuroimage.2004.09.046; Han SH, 2008, SOC NEUROSCI-UK, V3, P1, DOI 10.1080/17470910701469681; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Knauff M, 2003, J COGNITIVE NEUROSCI, V15, P559, DOI 10.1162/089892903321662949; Knauff M, 2002, COGNITIVE BRAIN RES, V13, P203, DOI 10.1016/S0926-6410(01)00116-1; LYCAN W, 1996, 20 QUESTIONS INTRO P, P201; Meltzoff A. N., 2001, INTENTIONS INTENTION, P171; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Murray D. K. C., 1997, AUTISM LEARNING GUID, P100; Perner J., 2005, OTHER MINDS HUMANS B, P174; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT NEUROSCI, V7, P85, DOI 10.1038/nn1168; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Samson D, 2005, BRAIN, V128, P1102, DOI 10.1093/brain/awh464; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Searle J., 1984, MINDS BRAINS SCI; STERNBERG RJ, 1986, INTELLIGENCE, V10, P281, DOI 10.1016/0160-2896(86)90001-2; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Von Neumann J., 2012, COMPUTER BRAIN; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	39	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2797	10.1371/journal.pone.0002797	http://dx.doi.org/10.1371/journal.pone.0002797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665211	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300016
J	Dugatkin, LA; Dugatkin, AD; Atlas, RM; Perlin, MH				Dugatkin, Lee Alan; Dugatkin, Aaron D.; Atlas, Ronald M.; Perlin, Michael H.			Cheating on the Edge	PLOS ONE			English	Article							GROUP-BENEFICIAL TRAITS; SOCIAL EVOLUTION; COOPERATION	We present the results of an individual agent-based model of antibiotic resistance in bacteria. Our model examines antibiotic resistance when two strategies exist: "producers''-who secrete a substance that breaks down antibiotics-and nonproducers ("cheats'') who do not secrete, or carry the machinery associated with secretion. The model allows for populations of up to 10,000, in which bacteria are affected by their nearest neighbors, and we assume cheaters die when there are no producers in their neighborhood. Each of 10,000 slots on our grid (a torus) could be occupied by a producer or a nonproducer, or could (temporarily) be unoccupied. The most surprising and dramatic result we uncovered is that when producers and nonproducers coexist at equilibrium, nonproducers are almost always found on the edges of clusters of producers.	[Dugatkin, Lee Alan; Atlas, Ronald M.; Perlin, Michael H.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Dugatkin, Aaron D.] Murray Hill Acad, Louisville, KY USA	University of Louisville	Dugatkin, LA (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	lee.dugatkin@louisville.edu			National Institutes of Health [1 R15 AI060667-01A1]; Office of the Vice President for Research at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI060667] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Vice President for Research at the University of Louisville; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Partly funded by AREA grant 1 R15 AI060667-01A1 from the National Institutes of Health and by a grant from the Office of the Vice President for Research at the University of Louisville. Funding agencies had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Czaran TL, 2003, P ROY SOC B-BIOL SCI, V270, P1373, DOI 10.1098/rspb.2003.2338; Darwin C., 1871, P423; Dawkins Richard, 1976, SELFISH GENE; Dugatkin LA, 2005, J THEOR BIOL, V236, P392, DOI 10.1016/j.jtbi.2005.03.021; Dugatkin LA, 2005, P ROY SOC B-BIOL SCI, V272, P79, DOI 10.1098/rspb.2004.2916; Dugatkin LA, 2003, J THEOR BIOL, V220, P67, DOI 10.1006/jtbi.2003.3149; Ellis RJ, 2007, ISME J, V1, P92, DOI 10.1038/ismej.2007.11; Fiegna F, 2003, P ROY SOC B-BIOL SCI, V270, P1527, DOI 10.1098/rspb.2003.2387; GREIG D, 2004, BIOL LETT, V271, pS25, DOI DOI 10.1098/RSBL.2003.0083; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; LEVIN BR, 1988, PHILOS T R SOC B, V319, P459, DOI 10.1098/rstb.1988.0059; Massey RC, 2002, CURR BIOL, V12, pR686, DOI 10.1016/S0960-9822(02)01205-8; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Sober E, 1998, UNTO OTHERS; Velicer GJ, 2002, ANTON LEEUW INT J G, V81, P155, DOI 10.1023/A:1020546130033; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Wilensky U., 1999, NETLOGO; Williams G. C., 1966, P307; Wilson D. S., 1980, NATURAL SELECTION PO	25	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2763	10.1371/journal.pone.0002763	http://dx.doi.org/10.1371/journal.pone.0002763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648645	gold, Green Submitted, Green Published			2022-12-27	WOS:000264302900033
J	Hong, S; Optican, LM				Hong, Simon; Optican, Lance M.			Interaction between Purkinje Cells and Inhibitory Interneurons May Create Adjustable Output Waveforms to Generate Timed Cerebellar Output	PLOS ONE			English	Article							LONG-TERM DEPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR; NICTITATING-MEMBRANE RESPONSES; CONDITIONED EYELID RESPONSE; INFERIOR OLIVE; REVERSIBLE INACTIVATIONS; INTERPOSITUS NUCLEUS; DECEREBRATE FERRET; NEURONAL-ACTIVITY; CLIMBING FIBERS	We develop a new model that explains how the cerebellum may generate the timing in classical delay eyeblink conditioning. Recent studies show that both Purkinje cells (PCs) and inhibitory interneurons (INs) have parallel signal processing streams with two time scales: an AMPA receptor-mediated fast process and a metabotropic glutamate receptor (mGluR)-mediated slow process. Moreover, one consistent finding is an increased excitability of PC dendrites (in Larsell's lobule HVI) in animals when they acquire the classical delay eyeblink conditioning naturally, in contrast to in vitro studies, where learning involves long-term depression (LTD). Our model proposes that the delayed response comes from the slow dynamics of mGluR-mediated IP3 activation, and the ensuing calcium concentration change, and not from LTP/LTD. The conditioned stimulus (tone), arriving on the parallel fibers, triggers this slow activation in INs and PC spines. These excitatory (from PC spines) and inhibitory (from INs) signals then interact at the PC dendrites to generate variable waveforms of PC activation. When the unconditioned stimulus (puff), arriving on the climbing fibers, is coupled frequently with this slow activation the waveform is amplified (due to an increased excitability) and leads to a timed pause in the PC population. The disinhibition of deep cerebellar nuclei by this timed pause causes the delayed conditioned response. This suggested PC-IN interaction emphasizes a richer role of the INs in learning and also conforms to the recent evidence that mGluR in the cerebellar cortex may participate in slow motor execution. We show that the suggested mechanism can endow the cerebellar cortex with the versatility to learn almost any temporal pattern, in addition to those that arise in classical conditioning.	[Hong, Simon; Optican, Lance M.] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Hong, S (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	LanceOptican@nih.gov			Intramural Research Program of the National Eye Institute, NIH, DHHS; NATIONAL EYE INSTITUTE [ZIAEY000302, Z01EY000302] Funding Source: NIH RePORTER	Intramural Research Program of the National Eye Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Intramural Research Program of the National Eye Institute, NIH, DHHS. No role of sponsor in any aspect of this work.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; AKSENOV D, 2005, SOC NEUR 35 ANN M WA; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1966, J PHYSIOL-LONDON, V187, P553, DOI 10.1113/jphysiol.1966.sp008108; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; BATINI C, 1985, EXP BRAIN RES, V59, P404; BILLARD JM, 1988, NEUROSCI LETT, V88, P21, DOI 10.1016/0304-3940(88)90309-6; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; BULLOCK D, 1994, NEURAL NETWORKS, V7, P1101, DOI 10.1016/S0893-6080(05)80161-3; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Casado M, 2002, NEURON, V33, P123, DOI 10.1016/S0896-6273(01)00568-2; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHEN C, 1995, LEARN MEMORY, V2, P185, DOI 10.1101/lm.2.3-4.185; Chen ZH, 2000, J CENT SOUTH UNIV T, V7, P201, DOI 10.1007/s11771-000-0054-4; Choi JS, 2003, BEHAV NEUROSCI, V117, P1211, DOI 10.1037/0735-7044.117.6.1211; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; DESMOND JE, 1988, BIOL CYBERN, V58, P405, DOI 10.1007/BF00361347; DESPERATI C, 1993, NEUROSCIENCE, V53, P139, DOI 10.1016/0306-4522(93)90292-N; DETWEILER K, 2005, SOC NEUR 35 ANN M WA; DeZeeuw CI, 1997, NEUROSCIENCE, V80, P981; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Fiala JC, 1996, J NEUROSCI, V16, P3760; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GELLMAN R, 1983, J COMP NEUROL, V215, P228, DOI 10.1002/cne.902150210; Gibson AR, 2004, CEREBELLUM, V3, P212, DOI 10.1080/14734220410018995; Gibson AR, 2002, ANN NY ACAD SCI, V978, P219, DOI 10.1111/j.1749-6632.2002.tb07569.x; Gould TJ, 1996, NEUROBIOL LEARN MEM, V65, P17, DOI 10.1006/nlme.1996.0003; Green JT, 2005, LEARN MEMORY, V12, P260, DOI 10.1101/lm.89505; GRUART A, 1995, J NEUROPHYSIOL, V74, P226, DOI 10.1152/jn.1995.74.1.226; Hamori J, 1996, ACTA BIOL HUNG, V47, P181; Hardiman MJ, 1996, EXP BRAIN RES, V110, P235; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Heck D, 2003, NEUROSCI LETT, V341, P79, DOI 10.1016/S0304-3940(03)00132-0; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HOANG C, 2005, SOC NEUR 35 ANN M WA; HOEHLER FK, 1976, PAVLOVIAN J BIOL SCI, V11, P180; HONG S, 2008, PROGR BRAIN IN PRESS; HORN KM, 2005, SOC NEUR WASH DC; HUGUENARD JR, 1992, J NEUROPHYSIOL, V68, P1373, DOI 10.1152/jn.1992.68.4.1373; Ito M, 1984, CEREBELLUM NEURAL CO; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jow F, 2004, P NATL ACAD SCI USA, V101, P15535, DOI 10.1073/pnas.0402081101; Karakossian MH, 2004, J NEUROPHYSIOL, V92, P1558, DOI 10.1152/jn.00300.2004; Kenyon GT, 1998, J COMPUT NEUROSCI, V5, P17, DOI 10.1023/A:1008874209991; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; Kotani S, 2006, BRAIN RES, V1068, P70, DOI 10.1016/j.brainres.2005.10.090; Kotani S, 2003, BRAIN RES, V994, P193, DOI 10.1016/j.brainres.2003.09.036; Kreiner L, 2004, CEREBELLUM, V3, P112, DOI 10.1080/14734220410031990; Krupa DJ, 2003, J NEUROSCI, V23, P10577; KRUPA DJ, 1995, P NATL ACAD SCI USA, V92, P5097, DOI 10.1073/pnas.92.11.5097; LAVOND DG, 1989, BEHAV BRAIN RES, V33, P113, DOI 10.1016/S0166-4328(89)80047-6; LAVOND DG, 1987, EXP BRAIN RES, V67, P569; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Manor Y, 1997, J NEUROPHYSIOL, V77, P2736, DOI 10.1152/jn.1997.77.5.2736; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; PERRETT SP, 1995, J NEUROSCI, V15, P2074, DOI 10.1523/JNEUROSCI.15-03-02074.1995; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Ramnani N, 1996, J PHYSIOL-LONDON, V495, P159, DOI 10.1113/jphysiol.1996.sp021581; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Rhodes BJ, 2002, APPL INTELL, V17, P35, DOI 10.1023/A:1015736004189; Ringach DL, 2002, J NEUROPHYSIOL, V88, P455, DOI 10.1152/jn.2002.88.1.455; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; SCHEIBEL ME, 1954, J COMP NEUROL, V101, P733, DOI 10.1002/cne.901010305; SCHNEIDERMAN N, 1962, SCIENCE, V136, P650, DOI 10.1126/science.136.3516.650; Schreurs BG, 1996, J NEUROPHYSIOL, V75, P1051, DOI 10.1152/jn.1996.75.3.1051; Schreurs BG, 1998, J NEUROSCI, V18, P5498, DOI 10.1523/JNEUROSCI.18-14-05498.1998; SCHREURS BG, 1991, BRAIN RES, V548, P18, DOI 10.1016/0006-8993(91)91100-F; Schreurs BG, 1997, J NEUROPHYSIOL, V77, P86, DOI 10.1152/jn.1997.77.1.86; Schweighofer N, 2004, P NATL ACAD SCI USA, V101, P4655, DOI 10.1073/pnas.0305966101; Schweighofer N, 2001, NEUROSCIENCE, V103, P35, DOI 10.1016/S0306-4522(00)00548-0; Schweighofer N, 1999, J NEUROPHYSIOL, V82, P804, DOI 10.1152/jn.1999.82.2.804; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Shinkman PG, 1996, BEHAV NEUROSCI, V110, P914, DOI 10.1037/0735-7044.110.5.914; Shinoda Y, 1997, PROG BRAIN RES, V114, P193; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; STEINMETZ JE, 1990, PSYCHOL SCI, V1, P378, DOI 10.1111/j.1467-9280.1990.tb00245.x; STEINMETZ JE, 1986, BEHAV NEUROSCI, V100, P878, DOI 10.1037/0735-7044.100.6.878; Steuber V, 2004, J COMPUT NEUROSCI, V17, P149, DOI 10.1023/B:JCNS.0000037678.26155.b5; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Svensson P, 2006, EXP BRAIN RES, V168, P241, DOI 10.1007/s00221-005-0086-y; Svensson P, 1997, LEARN MEMORY, V4, P105, DOI 10.1101/lm.4.1.105; Svensson P, 1999, EUR J NEUROSCI, V11, P4333, DOI 10.1046/j.1460-9568.1999.00862.x; Takehara K, 2003, J NEUROSCI, V23, P9897; THOMPSON RF, 1990, PHILOS T ROY SOC B, V329, P161, DOI 10.1098/rstb.1990.0161; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; WETMORE DZ, 2007, LOCK AND KEY MECH CE; Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004; WOODRUFFPAK DS, 1985, BRAIN RES, V348, P249, DOI 10.1016/0006-8993(85)90443-3; YEO CH, 1985, EXP BRAIN RES, V60, P87, DOI 10.1007/BF00237022	105	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2770	10.1371/journal.pone.0002770	http://dx.doi.org/10.1371/journal.pone.0002770			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648667	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900040
J	Flierl, MA; Rittirsch, D; Chen, AJ; Nadeau, BA; Day, DE; Sarma, JV; Huber-Lang, MS; Ward, PA				Flierl, Michael A.; Rittirsch, Daniel; Chen, Anthony J.; Nadeau, Brian A.; Day, Danielle E.; Sarma, J. Vidya; Huber-Lang, Markus S.; Ward, Peter A.			The Complement Anaphylatoxin C5a Induces Apoptosis in Adrenomedullary Cells during Experimental Sepsis	PLOS ONE			English	Article							INNATE IMMUNITY; UNITED-STATES; SEPTIC SHOCK; RECEPTOR; DEATH; ANTI-C5A; NERVE; EPIDEMIOLOGY; DYSFUNCTION; RESPONSES	Sepsis remains a poorly understood, enigmatic disease. One of the cascades crucially involved in its pathogenesis is the complement system. Especially the anaphylatoxin C5a has been shown to have numerous harmful effects during sepsis. We have investigated the impact of high levels of C5a on the adrenal medulla following cecal ligation and puncture (CLP)-induced sepsis in rats as well as the role of C5a on catecholamine production from pheochromocytoma-derived PC12 cells. There was significant apoptosis of adrenal medulla cells in rats 24 hrs after CLP, as assessed by the TUNEL technique. These effects could be reversed by dual-blockade of the C5a receptors, C5aR and C5L2. When rats were subjected to CLP, levels of C5a and norepinephrine were found to be antipodal as a function of time. PC12 cell production of norepinephrine and dopamine was significantly blunted following exposure to recombinant rat C5a in a time-dependent and dose-dependent manner. This impaired production could be related to C5a-induced initiation of apoptosis as defined by binding of Annexin V and Propidium Iodine to PC12 cells. Collectively, we describe a C5a-dependent induction of apoptotic events in cells of adrenal medulla in vivo and pheochromocytoma PC12 cells in vitro. These data suggest that experimental sepsis induces apoptosis of adrenomedullary cells, which are responsible for the bulk of endogenous catecholamines. Septic shock may be linked to these events. Since blockade of both C5a receptors virtually abolished adrenomedullary apoptosis in vivo, C5aR and C5L2 become promising targets with implications on future complement-blocking strategies in the clinical setting of sepsis.	[Flierl, Michael A.; Rittirsch, Daniel; Chen, Anthony J.; Nadeau, Brian A.; Day, Danielle E.; Sarma, J. Vidya; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Huber-Lang, Markus S.] Univ Ulm, Med Sch, Dept Trauma, Hand & Reconstruct Surg, Ulm, Germany	University of Michigan System; University of Michigan; Ulm University	Flierl, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020	Rittirsch, Daniel/0000-0002-1185-2431	NIH [GM29507, GM61656, HL-31963]; Deutsche Forschungsgemeinschaft [HU 823/202, HU 823/2-3]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R37GM029507, R01GM061656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by NIH grants GM29507, GM61656 and HL-31963 (P.A.W.) and Deutsche Forschungsgemeinschaft grants DFG HU 823/202 and HU 823/2-3 (M.H.-L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2003, AM J RESP CRIT CARE, V168, P165, DOI 10.1164/rccm.2201087; Ayala A, 1996, SHOCK, V6, pS27, DOI 10.1097/00024382-199610001-00007; BAKER CC, 1983, SURGERY, V94, P331; BARDAKHCH'YAN E A, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V102, P97; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; CHEADLE WG, 1993, J TRAUMA, V35, P844, DOI 10.1097/00005373-199312000-00007; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Gao HW, 2005, FASEB J, V19, P1003, DOI 10.1096/fj.04-3424fje; Gerard C, 2003, NEW ENGL J MED, V348, P167, DOI 10.1056/NEJMcibr022995; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; HOFFMANN R, 1977, J COMP PATHOL, V87, P231, DOI 10.1016/0021-9975(77)90010-X; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Huber-Lang M, 2005, J IMMUNOL, V174, P1104, DOI 10.4049/jimmunol.174.2.1104; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; Huber-Lang MS, 2001, FASEB J, V15, P568; Kochanek Kenneth D, 2004, Natl Vital Stat Rep, V52, P1; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Laudes IJ, 2002, AM J PATHOL, V160, P1867, DOI 10.1016/S0002-9440(10)61133-9; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Mahidhara R, 2000, CRIT CARE MED, V28, pN105, DOI 10.1097/00003246-200004001-00013; NAKAE H, 1994, RES COMMUN CHEM PATH, V84, P189; Nakae H, 1996, SURG TODAY, V26, P225, DOI 10.1007/BF00311579; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tinsley KW, 2003, J IMMUNOL, V171, P909, DOI 10.4049/jimmunol.171.2.909; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1987, SURG GYNECOL OBSTET, V164, P415; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Ward PA, 2004, NAT REV IMMUNOL, V4, P133, DOI 10.1038/nri1269	46	42	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2560	10.1371/journal.pone.0002560	http://dx.doi.org/10.1371/journal.pone.0002560			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648551	Green Submitted, gold, Green Published			2022-12-27	WOS:000263288200027
J	Manukyan, GP; Ghazaryan, KA; Ktsoyan, ZA; Khachatryan, ZA; Arakelova, KA; Kelly, D; Grant, G; Aminov, RI				Manukyan, Gayane P.; Ghazaryan, Karine A.; Ktsoyan, Zhanna A.; Khachatryan, Zaruhi A.; Arakelova, Karine A.; Kelly, Denise; Grant, George; Aminov, Rustam I.			Elevated Systemic Antibodies towards Commensal Gut Microbiota in Autoinflammatory Condition	PLOS ONE			English	Article								Background: Familial Mediterranean fever (FMF) is an autoinflammatory condition, which is characterized by acute, self-limiting episodes of fever and serositis and chronic subclinical inflammation in remission. Here we investigated the consequence of this condition on the level of systemic antibodies directed towards common intestinal bacteria. Methodology/Principal Findings: The level of systemic antibodies towards the antigens of Bacteroides, Parabacteroides, Escherichia, Enteroccocus and Lactobaccilus was measured by ELISA in FMF patients at various stages of the disease and in healthy controls. The difference between remission and attack was not significant. IgG antibodies against the antigens of Bacteroides, Parabacteroides, Escherichia and Enteroccocus were significantly increased in FMF compared to control while IgA levels were not significantly affected. Western blot analyses demonstrated the IgG reactivity against multiple antigens of commensal bacteria in FMF. Serological expression cloning was performed to identify these antigens. No single dominant antigen was identified; the response was generalized and directed against a variety of proteins from Bacteroides, Parabacteroides, Escherichia, and other gut commensals. Conclusions/Significance: This autoinflammatory syndrome is characterized by the increased systemic reactivity against commensal gut microbiota. This is probably the consequence of hypersensitivity of the inflammasome in FMF that triggers the inflammation and contributes to the excessive translocation of bacteria and bacterial antigens through the gut barrier.	[Manukyan, Gayane P.; Ghazaryan, Karine A.; Ktsoyan, Zhanna A.; Khachatryan, Zaruhi A.; Arakelova, Karine A.] Natl Acad Sci, Inst Mol Biol, Yerevan, Armenia; [Kelly, Denise; Grant, George; Aminov, Rustam I.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Aberdeen	Manukyan, GP (corresponding author), Natl Acad Sci, Inst Mol Biol, Yerevan, Armenia.	r.aminov@rowett.ac.uk	Aminov, Rustam/AAF-9052-2019; Aminov, Rustam/C-8764-2016; Manukyan, Gayane/AAR-7421-2020	Aminov, Rustam/0000-0002-5811-8322; Manukyan, Gayane/0000-0001-7541-5743	ISTC [A-1055]; RERAD	ISTC; RERAD	This work was funded by the ISTC (project A-1055). RIA is supported by the RERAD. Funders did not participate in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; Aksentijevich I, 1997, CELL, V90, P797; Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Bernot A, 1997, NAT GENET, V17, P25; Brydges S, 2006, CURR TOP MICROBIOL, V305, P127, DOI 10.1007/3-540-29714-6_7; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Davtyan TK, 2006, PATHOBIOLOGY, V73, P26, DOI 10.1159/000093089; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kastner DL, 1998, HOSP PRACT, V33, P131, DOI 10.3810/hp.1998.04.90; Keith MP, 2007, AM J MED, V120, P221, DOI 10.1016/j.amjmed.2006.02.044; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lodes Michael J, 2004, Methods Mol Med, V94, P91; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manukyan GP, 2008, CLIN BIOCHEM, V41, P920, DOI 10.1016/j.clinbiochem.2008.03.017; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Nadler EP, 2000, PEDIATR SURG INT, V16, P165, DOI 10.1007/s003830050714; Nazli A, 2006, INFECT IMMUN, V74, P192, DOI 10.1128/IAI.74.1.192-201.2006; Notarnicola C, 2002, ARTHRITIS RHEUM-US, V46, P2785, DOI 10.1002/art.10575; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002; SEDMAN PC, 1994, GASTROENTEROLOGY, V107, P643, DOI 10.1016/0016-5085(94)90110-4; Sitaraman SV, 2005, AM J PHYSIOL-GASTR L, V288, pG403, DOI 10.1152/ajpgi.00357.2004; Suzuki K, 2007, SEMIN IMMUNOL, V19, P127, DOI 10.1016/j.smim.2006.10.001; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Touitou I, 2001, EUR J HUM GENET, V9, P473, DOI 10.1038/sj.ejhg.5200658; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; van Egmond M, 2001, TRENDS IMMUNOL, V22, P205, DOI 10.1016/S1471-4906(01)01873-7; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Xu DZ, 2002, SHOCK, V17, P139, DOI 10.1097/00024382-200202000-00010; Yang RK, 2003, AM J PHYSIOL-GASTR L, V285, pG621, DOI 10.1152/ajpgi.00177.2003	51	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3172	10.1371/journal.pone.0003172	http://dx.doi.org/10.1371/journal.pone.0003172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779861	gold, Green Published, Green Submitted			2022-12-27	WOS:000264425100008
J	Bobashev, G; Morris, RJ; Goedecke, DM				Bobashev, Georgiy; Morris, Robert J.; Goedecke, D. Michael			Sampling for Global Epidemic Models and the Topology of an International Airport Network	PLOS ONE			English	Article								Mathematical models that describe the global spread of infectious diseases such as influenza, severe acute respiratory syndrome (SARS), and tuberculosis (TB) often consider a sample of international airports as a network supporting disease spread. However, there is no consensus on how many cities should be selected or on how to select those cities. Using airport flight data that commercial airlines reported to the Official Airline Guide (OAG) in 2000, we have examined the network characteristics of network samples obtained under different selection rules. In addition, we have examined different size samples based on largest flight volume and largest metropolitan populations. We have shown that although the bias in network characteristics increases with the reduction of the sample size, a relatively small number of areas that includes the largest airports, the largest cities, the most-connected cities, and the most central cities is enough to describe the dynamics of the global spread of influenza. The analysis suggests that a relatively small number of cities ( around 200 or 300 out of almost 3000) can capture enough network information to adequately describe the global spread of a disease such as influenza. Weak traffic flows between small airports can contribute to noise and mask other means of spread such as the ground transportation.	[Bobashev, Georgiy; Morris, Robert J.; Goedecke, D. Michael] RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Bobashev, G (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	bobashev@rti.org			National Institute of General Medical Sciences [U01GM070698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070698] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant Number U01GM070698 from the National Institute of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; Ghani AC, 1998, J ROY STAT SOC A STA, V161, P227, DOI 10.1111/1467-985X.00101; Ghani AC, 1998, STAT MED, V17, P2079, DOI 10.1002/(SICI)1097-0258(19980930)17:18&lt;2079::AID-SIM902&gt;3.0.CO;2-H; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Hollingsworth TD, 2006, NAT MED, V12, P497, DOI 10.1038/nm0506-497; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Kerneis S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001478; Kossinets G, 2006, SOC NETWORKS, V28, P247, DOI 10.1016/j.socnet.2005.07.002; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Liljeros F, 2003, MICROBES INFECT, V5, P189, DOI 10.1016/S1286-4579(02)00058-8; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Stumpf MPH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036118; Stumpf MPH, 2005, P NATL ACAD SCI USA, V102, P4221, DOI 10.1073/pnas.0501179102; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Yoon S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046114	22	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3154	10.1371/journal.pone.0003154	http://dx.doi.org/10.1371/journal.pone.0003154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776932	gold, Green Submitted, Green Published			2022-12-27	WOS:000264424300002
J	Blanco, YC; Farias, AS; Goelnitz, U; Lopes, SCP; Arrais-Silva, WW; Carvalho, BO; Amino, R; Wunderlich, G; Santos, LMB; Giorgio, S; Costa, FTM				Blanco, Yara C.; Farias, Alessandro S.; Goelnitz, Uta; Lopes, Stefanie C. P.; Arrais-Silva, Wagner W.; Carvalho, Bruna O.; Amino, Rogerio; Wunderlich, Gerhard; Santos, Leonilda M. B.; Giorgio, Selma; Costa, Fabio T. M.			Hyperbaric Oxygen Prevents Early Death Caused by Experimental Cerebral Malaria	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SEVERE FALCIPARUM-MALARIA; T-CELLS; INTERFERON-GAMMA; BRAIN TRAUMA; ISCHEMIA; CYTOKINES; EXPRESSION; PRESSURE; THERAPY	Background: Cerebral malaria (CM) is a syndrome characterized by neurological signs, seizures and coma. Despite the fact that CM presents similarities with cerebral stroke, few studies have focused on new supportive therapies for the disease. Hyperbaric oxygen (HBO) therapy has been successfully used in patients with numerous brain disorders such as stroke, migraine and atherosclerosis. Methodology/Principal Findings: C57BL/6 mice infected with Plasmodium berghei ANKA (PbA) were exposed to daily doses of HBO (100% O-2, 3.0 ATA, 1-2 h per day) in conditions well-tolerated by humans and animals, before or after parasite establishment. Cumulative survival analyses demonstrated that HBO therapy protected 50% of PbA-infected mice and delayed CM-specific neurological signs when administrated after patent parasitemia. Pressurized oxygen therapy reduced peripheral parasitemia, expression of TNF-alpha, IFN-gamma and IL-10 mRNA levels and percentage of gamma delta and alpha beta CD4(+) and CD8(+) T lymphocytes sequestered in mice brains, thus resulting in a reduction of blood-brain barrier (BBB)dysfunction and hypothermia. Conclusions/Significance: The data presented here is the first indication that HBO treatment could be used as supportive therapy, perhaps in association with neuroprotective drugs, to prevent CM clinical outcomes, including death.	[Blanco, Yara C.; Farias, Alessandro S.; Lopes, Stefanie C. P.; Carvalho, Bruna O.; Santos, Leonilda M. B.; Costa, Fabio T. M.] State Univ Campinas UNICAMP, Dept Microbiol & Immunol, Campinas, SP, Brazil; [Blanco, Yara C.; Lopes, Stefanie C. P.; Arrais-Silva, Wagner W.; Carvalho, Bruna O.; Giorgio, Selma; Costa, Fabio T. M.] State Univ Campinas UNICAMP, Dept Parasitol, Sao Paulo, Brazil; [Goelnitz, Uta; Wunderlich, Gerhard] Univ Sao Paulo, Dept Parasitol ICB, Sao Paulo, Brazil; [Amino, Rogerio] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Blanco, YC (corresponding author), State Univ Campinas UNICAMP, Dept Microbiol & Immunol, Campinas, SP, Brazil.	costaftm@unicamp.br	Costa, Fabio/E-1181-2012; Wunderlich, Gerhard/G-8245-2012; Farias, Alessandro/AAH-2228-2020; Giorgio, Selma/A-6701-2013; Farias, Alessandro/C-6879-2012; Lopes, Stefanie/A-8314-2012	Costa, Fabio/0000-0001-9969-7300; Wunderlich, Gerhard/0000-0003-1724-0337; Farias, Alessandro/0000-0001-6759-1819; Farias, Alessandro/0000-0001-6759-1819; Lopes, Stefanie/0000-0002-6981-2192	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2004/00638-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), grant n 2004/00638-6, and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). YCB, WWA, ASF and SCPL were supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and UG was sponsored by a FAPESP fellowship. GW, SG and FTMC are CNPq fellows.	Al-Waili NS, 2006, THESCIENTIFICWORLDJO, V6, P425, DOI 10.1100/tsw.2006.78; Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Arrais-Silva WW, 2006, ACTA TROP, V98, P130, DOI 10.1016/j.actatropica.2006.03.001; Arrais-Silva WW, 2005, PARASITOL INT, V54, P1, DOI 10.1016/j.parint.2004.07.002; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Benson RM, 2003, CLIN EXP IMMUNOL, V134, P57, DOI 10.1046/j.1365-2249.2003.02248.x; Buras JA, 2000, AM J PHYSIOL-CELL PH, V278, pC292, DOI 10.1152/ajpcell.2000.278.2.C292; Calvert JW, 2002, BRAIN RES, V951, P1, DOI 10.1016/S0006-8993(02)03094-9; Carter JA, 2005, TROP MED INT HEALTH, V10, P3, DOI 10.1111/j.1365-3156.2004.01345.x; Day NPJ, 1999, J INFECT DIS, V180, P1288, DOI 10.1086/315016; DEKOSSODO S, 1993, J IMMUNOL, V151, P4811; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; GADD MA, 1990, CRIT CARE MED, V18, P974, DOI 10.1097/00003246-199009000-00014; Gillman BM, 2004, INFECT IMMUN, V72, P6359, DOI 10.1128/IAI.72.11.6359-6366.2004; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Granowitz EV, 2002, UNDERSEA HYPERBAR M, V29, P216; GUDEWICZ TM, 1987, AVIAT SPACE ENVIR MD, V58, P673; Hermsen CC, 1997, PARASITE IMMUNOL, V19, P571, DOI 10.1046/j.1365-3024.1997.d01-175.x; Hink J, 2001, MED HYPOTHESES, V57, P764, DOI 10.1054/mehy.2001.1488; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; IRANI DN, 1991, J IMMUNOL METHODS, V139, P223, DOI 10.1016/0022-1759(91)90192-I; Jennings VM, 1997, INFECT IMMUN, V65, P4883, DOI 10.1128/IAI.65.11.4883-4887.1997; Jennings VM, 1998, INFECT IMMUN, V66, P5972, DOI 10.1128/IAI.66.12.5972-5979.1998; Kaide CG, 2008, EMERG MED CLIN N AM, V26, P571, DOI 10.1016/j.emc.2008.01.005; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; KAPP JP, 1981, SURG NEUROL, V15, P43, DOI 10.1016/S0090-3019(81)80089-4; Lahat N, 1995, CLIN EXP IMMUNOL, V102, P655; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Li Y, 2005, EXP NEUROL, V191, P198, DOI 10.1016/j.expneurol.2004.08.036; Lou M, 2004, STROKE, V35, P578, DOI 10.1161/01.STR.0000111599.77426.A0; Medana IM, 1997, AM J PATHOL, V150, P1473; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Newton CRJC, 1998, PHARMACOL THERAPEUT, V79, P1, DOI 10.1016/S0163-7258(98)00008-4; NEWTON CRJC, 1994, ARCH DIS CHILD, V70, P281, DOI 10.1136/adc.70.4.281; Newton CRJC, 1996, PEDIATR NEUROL, V15, P41, DOI 10.1016/0887-8994(96)00115-4; Niklas A, 2004, J NEUROL SCI, V219, P77, DOI 10.1016/j.jns.2003.12.013; Nitcheu J, 2003, J IMMUNOL, V170, P2221, DOI 10.4049/jimmunol.170.4.2221; Ohganli Y, 2008, BRAIN RES BULL, V75, P668, DOI 10.1016/j.brainresbull.2007.11.002; Ostrowski RP, 2005, J CEREBR BLOOD F MET, V25, P554, DOI 10.1038/sj.jcbfm.9600048; Overbergh L, 2003, J Biomol Tech, V14, P33; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Patankar TF, 2002, RADIOLOGY, V224, P811, DOI 10.1148/radiol.2243010588; Piguet PF, 2001, AM J PATHOL, V159, P733, DOI 10.1016/S0002-9440(10)61744-0; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Prakash D, 2006, J INFECT DIS, V194, P198, DOI 10.1086/504720; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; RENCRICCA NJ, 1981, AVIAT SPACE ENVIR MD, V52, P85; Renia L, 2006, INT J PARASITOL, V36, P547, DOI 10.1016/j.ijpara.2006.02.007; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Rudin W, 1997, EUR J IMMUNOL, V27, P810, DOI 10.1002/eji.1830270403; Schabitz WR, 2004, STROKE, V35, P1175, DOI 10.1161/01.STR.0000125868.86298.8e; Sobolewski P, 2005, INFECT IMMUN, V73, P6704, DOI 10.1128/IAI.73.10.6704-6710.2005; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Thackham JA, 2008, WOUND REPAIR REGEN, V16, P321, DOI 10.1111/j.1524-475X.2008.00372.x; Veltkamp R, 2005, BRAIN RES, V1037, P134, DOI 10.1016/j.brainres.2005.01.006; Veltkamp R, 2005, STROKE, V36, P1679, DOI 10.1161/01.STR.0000173408.94728.79; WARRELL DA, 1988, LANCET, V2, P534; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245; WHITE NJ, 1985, LANCET, V1, P776; Yang ZJ, 2001, EUR J APPL PHYSIOL, V85, P96, DOI 10.1007/s004210100391; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Yin W, 2002, BRAIN RES, V926, P165, DOI 10.1016/S0006-8993(01)03304-2; Zhang QX, 2008, J INVEST DERMATOL, V128, P2102, DOI 10.1038/jid.2008.53	64	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3126	10.1371/journal.pone.0003126	http://dx.doi.org/10.1371/journal.pone.0003126			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769544	Green Submitted, Green Published, gold			2022-12-27	WOS:000264419100001
J	Dong, BH; Silverman, RH; Kandel, ES				Dong, Beihua; Silverman, Robert H.; Kandel, Eugene S.			A Natural Human Retrovirus Efficiently Complements Vectors Based on Murine Leukemia Virus	PLOS ONE			English	Article								Background: Murine Leukemia Virus (MLV) is a rodent gammaretrovirus that serves as the backbone for common gene delivery tools designed for experimental and therapeutic applications. Recently, an infectious gammaretrovirus designated XMRV has been identified in prostate cancer patients. The similarity between the MLV and XMRV genomes suggests a possibility that the two viruses may interact when present in the same cell. Methodology/Principal Findings: We tested the ability of XMRV to complement replication-deficient MLV vectors upon coinfection of cultured human cells. We observed that XMRV can facilitate the spread of these vectors from infected to uninfected cells. This functional complementation occurred without any gross rearrangements in the vector structure, and the co-infected cells produced as many as 10(4) infectious vector particles per milliliter of culture medium. Conclusions/Significance: The possibility of encountering a helper virus when delivering MLV-based vectors to human cells in vitro and in vivo needs to be considered to ensure the safety of such procedures.	[Dong, Beihua; Silverman, Robert H.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Kandel, Eugene S.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet & Virol, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Dong, BH (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA.	eugenekandel@yahoo.com			NIH/NCI [CA098176, CA116060, CA103943]; Prostate Cancer Foundation; Mal and Lea Bank Chair; NATIONAL CANCER INSTITUTE [R01CA103943, R21CA116060, K01CA098176] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; Mal and Lea Bank Chair; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI grants CA098176 and CA116060 to E.K. and an NIH/NCI grant CA103943, a Prostate Cancer Foundation grant, and the Mal and Lea Bank Chair to R.H.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONOFF R, 1991, J VIROL, V65, P71, DOI 10.1128/JVI.65.1.71-80.1991; Barquinero J, 2004, GENE THER, V11, pS3, DOI 10.1038/sj.gt.3302363; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; DORNBURG R, 1988, MOL CELL BIOL, V8, P2328, DOI 10.1128/MCB.8.6.2328; DOUGHERTY JP, 1989, J VIROL, V63, P3209, DOI 10.1128/JVI.63.7.3209-3212.1989; EMBRETSON JE, 1987, J VIROL, V61, P2675, DOI 10.1128/JVI.61.9.2675-2683.1987; GREZ M, 1991, J VIROL, V65, P4691, DOI 10.1128/JVI.65.9.4691-4698.1991; HUANG CC, 1986, CELL, V44, P935, DOI 10.1016/0092-8674(86)90016-4; Kandel ES, 2005, P NATL ACAD SCI USA, V102, P6425, DOI 10.1073/pnas.0502463102; Kandel ES, 2002, MOL CELL, V10, P1495, DOI 10.1016/S1097-2765(02)00777-3; Kandel ES, 1997, SOMAT CELL MOLEC GEN, V23, P325, DOI 10.1007/BF02674280; Li MF, 1996, CANCER RES, V56, P4464; MANN R, 1985, J VIROL, V54, P401, DOI 10.1128/JVI.54.2.401-407.1985; ROSSON D, 1987, P NATL ACAD SCI USA, V84, P3171, DOI 10.1073/pnas.84.10.3171; Schott B, 1997, NUCLEIC ACIDS RES, V25, P2940, DOI 10.1093/nar/25.14.2940; SCHWARTZ JR, 1995, P NATL ACAD SCI USA, V92, P2460, DOI 10.1073/pnas.92.7.2460; SWAIN A, 1992, SCIENCE, V255, P841, DOI 10.1126/science.1371365; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025	18	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3144	10.1371/journal.pone.0003144	http://dx.doi.org/10.1371/journal.pone.0003144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769545	Green Published, Green Submitted, gold			2022-12-27	WOS:000264419100011
J	Pagnoni, G; Cekic, M; Guo, Y				Pagnoni, Giuseppe; Cekic, Milos; Guo, Ying			"Thinking about Not-Thinking": Neural Correlates of Conceptual Processing during Zen Meditation	PLOS ONE			English	Article							EVENT-RELATED FMRI; DEFAULT MODE; PREFRONTAL CORTEX; RESTING-STATE; HUMAN BRAIN; BASE-LINE; WORD; SELF; INFORMATION; ATTENTION	Recent neuroimaging studies have identified a set of brain regions that are metabolically active during wakeful rest and consistently deactivate in a variety the performance of demanding tasks. This "default network'' has been functionally linked to the stream of thoughts occurring automatically in the absence of goal-directed activity and which constitutes an aspect of mental behavior specifically addressed by many meditative practices. Zen meditation, in particular, is traditionally associated with a mental state of full awareness but reduced conceptual content, to be attained via a disciplined regulation of attention and bodily posture. Using fMRI and a simplified meditative condition interspersed with a lexical decision task, we investigated the neural correlates of conceptual processing during meditation in regular Zen practitioners and matched control subjects. While behavioral performance did not differ between groups, Zen practitioners displayed a reduced duration of the neural response linked to conceptual processing in regions of the default network, suggesting that meditative training may foster the ability to control the automatic cascade of semantic associations triggered by a stimulus and, by extension, to voluntarily regulate the flow of spontaneous mentation.	[Pagnoni, Giuseppe] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; [Cekic, Milos] Emory Univ, Sch Med, Atlanta, GA USA; [Guo, Ying] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA USA	Emory University; Emory University; Emory University; Rollins School Public Health	Pagnoni, G (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.	gpagnon@emory.edu	Pagnoni, Giuseppe/F-3398-2015; Cekic, Milos/AAR-8250-2020	Pagnoni, Giuseppe/0000-0002-8272-8091; 	Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases, National Institute of Health [P30-AT00609]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT000609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079251] Funding Source: NIH RePORTER	Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases, National Institute of Health; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Emory Center for Research on Complementary and Alternative Medicine in Neurodegenerative Diseases (National Institute of Health Grant P30-AT00609).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 1997, BRAIN RES REV, V25, P381, DOI 10.1016/S0165-0173(97)00053-2; ANTROBUS JS, 1968, BRIT J PSYCHOL, V59, P423, DOI 10.1111/j.2044-8295.1968.tb01157.x; Austin JamesH, 1998, ZEN BRAIN UNDERSTAND; Barinaga M, 2003, SCIENCE, V302, P44, DOI 10.1126/science.302.5642.44; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Binder JR, 2005, NEUROIMAGE, V27, P677, DOI 10.1016/j.neuroimage.2005.04.029; Binder JR, 2005, J COGNITIVE NEUROSCI, V17, P905, DOI 10.1162/0898929054021102; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; Binder JR, 2001, HDB FUNCTIONAL NEURO, P187; BINDER JR, 2008, EPILEPSIA; BREFCZYNSKILEWI.JA, 2007, P NATL ACAD SCI US; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Chan D, 2007, J ALTERN COMPLEM MED, V13, P651, DOI 10.1089/acm.2007.7022; Clark D, 2003, NEUROPSYCHOLOGIA, V41, P304, DOI 10.1016/S0028-3932(02)00163-X; Clayton IC, 1999, J ABNORM PSYCHOL, V108, P171, DOI 10.1037/0021-843X.108.1.171; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; GESCHWIN.N, 1965, BRAIN, V88, P237, DOI 10.1093/brain/88.2.237; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hasson U, 2007, CEREB CORTEX, V17, P2899, DOI 10.1093/cercor/bhm016; Hofmann Stefan G., 2007, Cognitive Behaviour Therapy, V36, P193, DOI 10.1080/16506070701421313; Humphries C, 2006, J COGNITIVE NEUROSCI, V18, P665, DOI 10.1162/jocn.2006.18.4.665; Humphries C, 2007, NEUROIMAGE, V36, P924, DOI 10.1016/j.neuroimage.2007.03.059; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Kim, 2004, EIHEI DOGEN MYSTICAL; Knight J, 2004, NATURE, V432, P670, DOI 10.1038/432670a; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McGuire PK, 1996, NEUROREPORT, V7, P2095; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Nishitani Keiji, 1982, RELIG NOTHINGNESS; Pagnoni G, 2007, NEUROBIOL AGING, V28, P1623, DOI 10.1016/j.neurobiolaging.2007.06.008; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Smallwood J, 2008, J COGNITIVE NEUROSCI, V20, P458, DOI 10.1162/jocn.2008.20037; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Stark CEL, 2001, P NATL ACAD SCI USA, V98, P12760, DOI 10.1073/pnas.221462998; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wicker B, 2003, BRAIN RES REV, V43, P224, DOI 10.1016/j.brainresrev.2003.08.003; Xiao ZW, 2005, HUM BRAIN MAPP, V25, P212, DOI 10.1002/hbm.20105	62	108	110	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3083	10.1371/journal.pone.0003083	http://dx.doi.org/10.1371/journal.pone.0003083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422HM	18769538	Green Published, Green Submitted, gold			2022-12-27	WOS:000264418300001
J	Maithreye, R; Sarkar, RR; Parnaik, VK; Sinha, S				Maithreye, R.; Sarkar, Ram Rup; Parnaik, Veena K.; Sinha, Somdatta			Delay-Induced Transient Increase and Heterogeneity in Gene Expression in Negatively Auto-Regulated Gene Circuits	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; POSITIVE FEEDBACK; NOISE-PROPAGATION; NETWORK MOTIFS; CELL-FATE; STOCHASTICITY; TIME; OSCILLATIONS; BEHAVIOR; LOOP	A generic feature in all intracellular biochemical processes is the time required to complete the whole sequence of reactions to yield any observable quantity-from gene expression to circadian rhythms. This widespread phenomenon points towards the importance of time delay in biological functions. Theoretically time delay is known to be the source of instability, and has been attributed to lead to oscillations or transient dynamics in several biological functions. Negative feedback loops, common in biochemical pathways, have been shown to provide stability and withstand considerable variations and random perturbations of biochemical parameters. The interaction of these two opposing factors-of instability and homeostasis-are features that are widespread in intracellular processes. To test the effect of these divergent forces in the dynamics of gene expression, we have designed and constructed simple negatively auto-regulated gene circuits consisting of a basic regulator and transcriptional repressor module, and compared it with one, which has delayed repression. We show, both theoretically and experimentally, that delayed repression induces transient increase and heterogeneity in gene expression before the gain of stability effected by the negative feedback. This design, therefore, seems to be suitable for conferring both stability and variability in cells required for adaptive response to a noisy environment.	[Maithreye, R.; Sarkar, Ram Rup; Parnaik, Veena K.; Sinha, Somdatta] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Maithreye, R (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	sinha@ccmb.res.in		SARKAR, RAM RUP/0000-0001-7115-163X	UGC-CSIR (Govt. of India);  [fellowships]	UGC-CSIR (Govt. of India)(Council of Scientific & Industrial Research (CSIR) - IndiaUniversity Grants Commission, India); 	R. Maithreye was supported with fellowships from the UGC-CSIR (Govt. of India) for Ph.D.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; ALPERS DH, 1966, J BIOL CHEM, V241, P4434; Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Banerjee B, 2004, BIOPHYS J, V86, P3052, DOI 10.1016/S0006-3495(04)74354-4; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Chen LN, 2005, BIOINFORMATICS, V21, P2722, DOI 10.1093/bioinformatics/bti392; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; FREEDMAN HI, 1986, B MATH BIOL, V48, P485, DOI 10.1007/BF02462319; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBERGER RF, 1965, P NATL ACAD SCI USA, V54, P279, DOI 10.1073/pnas.54.1.279; GOODWIN BRIAN C., 1965, ADVANCE ENZYME REGULAT, V3, P425, DOI 10.1016/0065-2571(65)90067-1; Gopalsamy K., 1992, STABILITY OSCILLATIO; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Le TT, 2006, BIOPHYS J, V90, P3315, DOI 10.1529/biophysj.105.073353; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maeda YT, 2006, J MOL BIOL, V359, P1107, DOI 10.1016/j.jmb.2006.03.064; Maithreye R, 2007, PHYS BIOL, V4, P48, DOI 10.1088/1478-3975/4/1/006; Maithreye R, 2004, MATH BIOSCI INTERACT, P251; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; MICHAELIS G, 1967, MOL GEN GENET, V100, P210, DOI 10.1007/BF00333607; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; NELSON DL, 2007, LEHNINGER PRINCIPLES; Niculescu S.-I., 1998, IMA Journal of Mathematical Control and Information, V15, P331, DOI 10.1093/imamci/15.4.331; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Ptashne M, 2004, GENETIC SWITCH PHAGE; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; RAPP P E, 1975, Mathematical Biosciences, V25, P165, DOI 10.1016/0025-5564(75)90059-0; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roenneberg T, 2003, CURR BIOL, V13, pR198, DOI 10.1016/S0960-9822(03)00124-6; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; Segel LA., 1980, MATH MODELS MOL CELL; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; SINHA S, 1988, J THEOR BIOL, V132, P307, DOI 10.1016/S0022-5193(88)80217-0; Smolen P, 2000, NEURON, V26, P567, DOI 10.1016/S0896-6273(00)81194-0; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; THIEFFRY D, 1995, B MATH BIOL, V57, P277, DOI 10.1016/0092-8240(94)00037-D; Tiana G, 2007, PHYS BIOL, V4, pR1, DOI 10.1088/1478-3975/4/2/R01; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; van Hoek MJA, 2006, BIOPHYS J, V91, P2833, DOI [10.1529/biophysj.105.077420, 10.1529/biophysj.106.077420]; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	71	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2972	10.1371/journal.pone.0002972	http://dx.doi.org/10.1371/journal.pone.0002972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698420	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600056
J	Michael, E; Malecela, MN; Zervos, M; Kazura, JW				Michael, Edwin; Malecela, Mwele N.; Zervos, Mihail; Kazura, James W.			Global Eradication of Lymphatic Filariasis: The Value of Chronic Disease Control in Parasite Elimination Programmes	PLOS ONE			English	Article							WUCHERERIA-BANCROFTI INFECTION; PAPUA-NEW-GUINEA; MASS TREATMENT; MATHEMATICAL-MODELS; COST-EFFECTIVENESS; VENOUS-BLOOD; 4 STRATEGIES; DIETHYLCARBAMAZINE; PREVALENCE; THRESHOLD	The ultimate goal of the global programme against lymphatic filariasis is eradication through irrevocable cessation of transmission using 4 to 6 years of annual single dose mass drug administration. The costs of eradication, managerial impediments to executing national control programmes, and scientific uncertainty about transmission endpoints, are challenges to the success of this effort, especially in areas of high endemicity where financial resources are limited. We used a combined analysis of empirical community data describing the association between infection and chronic disease prevalence, mathematical modelling, and economic analyses to identify and evaluate the feasibility of setting an infection target level at which the chronic pathology attributable to lymphatic filariasis - lymphoedema of the extremities and hydroceles - becomes negligible in the face of continuing transmission as a first stage option in achieving the elimination of this parasitic disease. The results show that microfilaria prevalences below a threshold of 3.55% at a blood sampling volume of 1 ml could constitute readily achievable and sustainable targets to control lymphatic filarial disease. They also show that as a result of the high marginal cost of curing the last few individuals to achieve elimination, maximal benefits can occur at this threshold. Indeed, a key finding from our coupled economic and epidemiological analysis is that when initial uncertainty regarding eradication occurs and prospects for resolving this uncertainty over time exist, it is economically beneficial to adopt a flexible, sequential, eradication strategy based on controlling chronic disease initially.	[Michael, Edwin] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Malecela, Mwele N.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Zervos, Mihail] London Sch Econom & Polit Sci, Math Dept, London, England; [Kazura, James W.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH USA	Imperial College London; National Institute of Medical Research; University of London; London School Economics & Political Science; Case Western Reserve University	Michael, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	jxk14@case.edu	Michael, Edwin/D-3388-2014		United States Public Health Service NIH [R01 AI69387-01A1, U19 AI065717]; British Council Higher Education Link Programme; United States Public Health Service NIH ICIDR [U19 AI33061]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI033061, R01AI069387, U19AI065717] Funding Source: NIH RePORTER	United States Public Health Service NIH(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); British Council Higher Education Link Programme; United States Public Health Service NIH ICIDR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	E.M. gratefully acknowledges the financial support of a United States Public Health Service NIH grant R01 AI69387-01A1 for facilitating this work. E.M. and M.N.M. are grateful to the British Council Higher Education Link Programme for supporting research collaboration in carrying out this study. Collaboration between E.M. and J.W.K. was made possible by a United States Public Health Service NIH ICIDR grant U19 AI33061. Contributions by J.W.K. were in part also supported by the United States Public Health Service NIH grant U19 AI065717. The funders are not responsible for any statements in the manuscript.	ARROW KJ, 1974, Q J ECON, V88, P312, DOI 10.2307/1883074; Barrett S, 2004, B WORLD HEALTH ORGAN, V82, P683; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Bockarie MJ, 2002, NEW ENGL J MED, V347, P1841, DOI 10.1056/NEJMoa021309; Bockarie MJ, 2002, MED VET ENTOMOL, V16, P116, DOI 10.1046/j.0269-283x.2002.00352.x; Burkot T, 2002, TRENDS PARASITOL, V18, P109, DOI 10.1016/S1471-4922(01)02221-8; Burkot T R, 2006, Filaria J, V5, P10, DOI 10.1186/1475-2883-5-10; Chan MS, 1998, AM J TROP MED HYG, V59, P606, DOI 10.4269/ajtmh.1998.59.606; Chen H-T, 1990, THEORY DRIVEN EVALUA; DAWSON S, 1992, ANAL ORG; DESOWITZ R S, 1973, Southeast Asian Journal of Tropical Medicine and Public Health, V4, P329; Dixit A.K., 1994, INVESTMENT UNCERTAIN, DOI DOI 10.1515/9781400830176; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Dreyer G, 1996, TROP MED INT HEALTH, V1, P264; EVANS DB, 1993, ACTA TROP, V53, P1, DOI 10.1016/0001-706X(93)90002-S; Gallopin GC, 2001, INT SOC SCI J, V53, P219, DOI 10.1111/1468-2451.00311; Geoffard PY, 1997, AM ECON REV, V87, P222; Gersovitz M, 2003, WORLD BANK RES OBSER, V18, P129, DOI 10.1093/wbro/lkg011; Gollier C, 2003, J RISK UNCERTAINTY, V27, P77, DOI 10.1023/A:1025576823096; *GOV TANZ NAT BUR, 2002, UN REP TANZ 2002 POP; Hunt DL, 2005, J APPL TOXICOL, V25, P435, DOI 10.1002/jat.1092; Krishnamoorthy K, 2002, ANN TROP MED PARASIT, V96, pS77, DOI 10.1179/000349802125002428; Krishnamoorthy K, 2000, INDIAN J MED RES, V111, P81; Lindsey JK, 2001, NONLINEAR MODELS MED; LIPSEY RG, 1956, REV ECON STUD, V24, P11, DOI 10.2307/2296233; Little MP, 2004, J INFECT DIS, V189, P1932, DOI 10.1086/383326; Mataika JU, 1998, B WORLD HEALTH ORGAN, V76, P575; MCMAHON JE, 1979, ANN TROP MED PARASIT, V73, P457, DOI 10.1080/00034983.1979.11687285; Meyrowitsch DW, 1996, T ROY SOC TROP MED H, V90, P423, DOI 10.1016/S0035-9203(96)90534-9; Michael E, 1996, TROP MED INT HEALTH, V1, P414, DOI 10.1046/j.1365-3156.1996.d01-82.x; Michael E, 2004, LANCET INFECT DIS, V4, P223, DOI 10.1016/S1473-3099(04)00973-9; Michael E, 1996, PARASITOLOGY, V112, P409, DOI 10.1017/S0031182000066646; Michael E, 2006, TRENDS PARASITOL, V22, P529, DOI 10.1016/j.pt.2006.08.011; Michael E, 2006, TRENDS PARASITOL, V22, P226, DOI 10.1016/j.pt.2006.03.005; MOULIAPELAT JP, 1992, TROP MED PARASITOL, V43, P146; NG NK, 1983, WELFARE EC INTRO DEV; Norman RA, 2000, EPIDEMIOL INFECT, V124, P529, DOI 10.1017/S0950268899003702; Oh Y., 1995, INT ECON J, V9, P89; Onapa AW, 2001, ACTA TROP, V78, P171, DOI 10.1016/S0001-706X(00)00185-6; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ramaiah KD, 2004, TRENDS PARASITOL, V20, P499, DOI 10.1016/j.pt.2004.08.010; Ramaiah KD, 2002, TROP MED INT HEALTH, V7, P767, DOI 10.1046/j.1365-3156.2002.00935.x; Ramzy Reda M R, 2005, Filaria J, V4, P7, DOI 10.1186/1475-2883-4-7; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; SABRY M, 1991, T ROY SOC TROP MED H, V85, P506, DOI 10.1016/0035-9203(91)90237-S; SCOTT B, 2004, B WORLD HEALTH ORGAN, V82, P683; Sculpher M., 2005, HLTH POLICY EC OPPOR, P8; Seim A R, 1999, Rev Soc Bras Med Trop, V32, P325, DOI 10.1590/S0037-86821999000300022; Simonsen PE, 2004, AM J TROP MED HYG, V70, P63, DOI 10.4269/ajtmh.2004.70.63; Thompson KM, 2007, LANCET, V369, P1363, DOI 10.1016/S0140-6736(07)60532-7; Thylefors B, 2004, TROP MED INT HEALTH, V9, pA1, DOI 10.1111/j.1365-3156.2004.01226.x; ULM K, 1991, STAT MED, V10, P341, DOI 10.1002/sim.4780100306; van der Werf MJ, 2002, ACTA TROP, V82, P127, DOI 10.1016/S0001-706X(02)00007-4; Vaqas Babar, 2003, Filaria J, V2, P4, DOI 10.1186/1475-2883-2-4; WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620; Whitehead N, 2002, AM J EPIDEMIOL, V155, P117, DOI 10.1093/aje/155.2.117	56	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2936	10.1371/journal.pone.0002936	http://dx.doi.org/10.1371/journal.pone.0002936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698350	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600022
J	Sohal, D; Yeatts, A; Ye, K; Pellagatti, A; Zhou, L; Pahanish, P; Mo, YK; Bhagat, T; Mariadason, J; Boultwood, J; Melnick, A; Greally, J; Verma, A				Sohal, Davendra; Yeatts, Andrew; Ye, Kenny; Pellagatti, Andrea; Zhou, Li; Pahanish, Perry; Mo, Yongkai; Bhagat, Tushar; Mariadason, John; Boultwood, Jacqueline; Melnick, Ari; Greally, John; Verma, Amit			Meta-Analysis of Microarray Studies Reveals a Novel Hematopoietic Progenitor Cell Signature and Demonstrates Feasibility of Inter-Platform Data Integration	PLOS ONE			English	Article								Microarray-based studies of global gene expression (GE) have resulted in a large amount of data that can be mined for further insights into disease and physiology. Meta-analysis of these data is hampered by technical limitations due to many different platforms, gene annotations and probes used in different studies. We tested the feasibility of conducting a meta-analysis of GE studies to determine a transcriptional signature of hematopoietic progenitor and stem cells. Data from studies that used normal bone marrow-derived hematopoietic progenitors was integrated using both RefSeq and UniGene identifiers. We observed that in spite of variability introduced by experimental conditions and different microarray platforms, our meta-analytical approach can distinguish biologically distinct normal tissues by clustering them based on their cell of origin. When studied in terms of disease states, GE studies of leukemias and myelodysplasia progenitors tend to cluster with normal progenitors and remain distinct from other normal tissues, further validating the discriminatory power of this meta-analysis. Furthermore, analysis of 57 normal hematopoietic stem and progenitor cell GE samples was used to determine a gene expression signature characteristic of these cells. Genes that were most uniformly expressed in progenitors and at the same time differentially expressed when compared to other normal tissues were found to be involved in important biological processes such as cell cycle regulation and hematopoiesis. Validation studies using a different microarray platform demonstrated the enrichment of several genes such as SMARCE, Septin 6 and others not previously implicated in hematopoiesis. Most interestingly, alpha-integrin, the only common stemness gene discovered in a recent comparative murine analysis (Science 302(5644): 393) was also enriched in our dataset, demonstrating the usefulness of this analytical approach.	[Sohal, Davendra; Yeatts, Andrew; Ye, Kenny; Zhou, Li; Pahanish, Perry; Mo, Yongkai; Bhagat, Tushar; Mariadason, John; Melnick, Ari; Greally, John; Verma, Amit] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Pellagatti, Andrea; Boultwood, Jacqueline] John Radcliffe Hosp, Oxford, England	Yeshiva University; Albert Einstein College of Medicine; University of Oxford	Sohal, D (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	averma@aecom.yu.edu	Mariadason, John/N-2003-2013; Yeatts, Andrew/H-9344-2012; Ye, Kenny/U-2341-2019; Greally, John/AAF-9540-2019; Ye, Kenny/GSM-7731-2022; Melnick, Ari/AAA-5763-2020	Ye, Kenny/0000-0002-1466-855X; Greally, John/0000-0001-6069-7960; Boultwood, Jacqueline/0000-0002-4330-2928; Mariadason, John/0000-0001-9123-7684; Pellagatti, Andrea/0000-0002-6122-0221	NIH [1R01HL082946, RO1AG02913801]; Community foundation for Southwestern Michigan JP McCarthy, Immunooncology Training Program [T32 CA009173]; NATIONAL CANCER INSTITUTE [T32CA009173] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Community foundation for Southwestern Michigan JP McCarthy, Immunooncology Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NIH 1R01HL082946, NIH RO1AG02913801, Community foundation for Southwestern Michigan JP McCarthy grant, Immunooncology Training Program T32 CA009173 and a gift from Janet and Arthur N. Hershaft.	*AFF INC, AFF ANN FIL; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Breit S, 2004, BRIT J HAEMATOL, V126, P231, DOI 10.1111/j.1365-2141.2004.05017.x; Chen JG, 2005, MOL CELL BIOL, V25, P9016, DOI 10.1128/MCB.25.20.9016-9027.2005; Chen YZ, 2003, J CELL BIOL, V163, P27, DOI 10.1083/jcb.200304003; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Dettling M, 2002, GENOME BIOL, V3; Dobbin KK, 2005, CLIN CANCER RES, V11, P565; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Eisenstein M, 2006, NATURE, V442, P1067, DOI [10.1038/4421067a, 10.1038/4421067b]; Fortunel NO, 2003, SCIENCE, V302, P393; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Heaney ML, 1999, NEW ENGL J MED, V340, P1649, DOI 10.1056/NEJM199905273402107; Hernandez JM, 2005, LEUKEMIA, V19, P1088, DOI 10.1038/sj.leu.2403753; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Ji Yuan, 2006, Appl Bioinformatics, V5, P89, DOI 10.2165/00822942-200605020-00003; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Kuo WP, 2002, BIOINFORMATICS, V18, P405, DOI 10.1093/bioinformatics/18.3.405; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lindsey R, 2006, CURR OPIN MICROBIOL, V9, P559, DOI 10.1016/j.mib.2006.10.009; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Mermel CH, 2006, BLOOD, V108, P2562, DOI 10.1182/blood-2006-05-024307; *NCBL, NAT CTR BIOT INF NLO; Oswald J, 2006, STEM CELLS, V24, P494, DOI 10.1634/stemcells.2005-0276; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Petersen D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-63; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sternberg A, 2005, BLOOD, V106, P2982, DOI 10.1182/blood-2005-04-1543; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Ruissen F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-91; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	42	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2965	10.1371/journal.pone.0002965	http://dx.doi.org/10.1371/journal.pone.0002965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698424	Green Published, gold			2022-12-27	WOS:000264412600050
J	Andreasen, CH; Mogensen, MS; Borch-Johnsen, K; Sandbaek, A; Lauritzen, T; Sorensen, TIA; Hansen, L; Almind, K; Jorgensen, T; Pedersen, O; Hansen, T				Andreasen, Camilla H.; Mogensen, Mette S.; Borch-Johnsen, Knut; Sandbaek, Annelli; Lauritzen, Torsten; Sorensen, Thorkild I. A.; Hansen, Lars; Almind, Katrine; Jorgensen, Torben; Pedersen, Oluf; Hansen, Torben			Non-Replication of Genome-Wide Based Associations between Common Variants in INSIG2 and PFKP and Obesity in Studies of 18,014 Danes	PLOS ONE			English	Article							BODY-MASS INDEX; FTO GENE; FAT MASS; ADIPOCYTE DIFFERENTIATION; EXTREME OBESITY; POLYMORPHISM; CHILDHOOD; RS7566605; ADULT; OVERWEIGHT	Background: The INSIG2 rs7566605 and PFKP rs6602024 polymorphisms have been identified as obesity gene variants in genome-wide association (GWA) studies. However, replication has been contradictory for both variants. The aims of this study were to validate these obesity-associations through case-control studies and analyses of obesity-related quantitative traits. Moreover, since environmental and genetic factors may modulate the impact of a genetic variant, we wanted to perform such interaction analyses. We focused on physical activity as an environmental risk factor, and on the GWA identified obesity variants in FTO (rs9939609) and near MC4R (rs17782313) as genetic risk factors. Materials and Methods: The four variants were genotyped in a combined study sample comprising a total of 18,014 subject ascertained from, the population-based Inter99 cohort (n = 6,514), the ADDITION screening cohort (n = 8,662), a population-based study sample (n = 680) and a type 2 diabetic patient group (n = 2,158) from Steno Diabetes Center. Results: No association with overweight, obesity or obesity-related measures was shown for either the INSIG2 rs7566605 or the PFKP rs6602024 variants. However, an interaction between the INSIG2 rs7566605 variant and the level of self-reported physical activity (p(Int) = 0.004) was observed. A BMI difference of 0.53 (SE 0.42) kg/m(2) was found when comparing physically passive homozygous C-allele carriers with physically passive G-allele carriers. No interactions between the two variants and FTO rs9939609 and MC4R rs17782313 were observed. Conclusions: The INSIG2 rs7566605 and PFKP rs6602024 polymorphisms play no apparent role in the development of common forms of obesity in the Danish population. However, if replicated, the INSIG2 rs7566605 may influence the level of BMI in combination with the level of physical activity.	[Andreasen, Camilla H.; Mogensen, Mette S.; Borch-Johnsen, Knut; Pedersen, Oluf; Hansen, Torben] Steno Diabet Ctr, Copenhagen, Denmark; [Andreasen, Camilla H.; Almind, Katrine] Novo Nordisk A S, Med & Sci Dev Projects, Bagsvaerd, Denmark; [Borch-Johnsen, Knut; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, Aarhus, Denmark; [Hansen, Lars] Bristol Myers Squibb Co, Princeton, NJ USA; [Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark	Steno Diabetes Center; Novo Nordisk; University of Copenhagen; Aarhus University; Aarhus University; Bristol-Myers Squibb; University of Copenhagen	Andreasen, CH (corresponding author), Steno Diabet Ctr, Copenhagen, Denmark.	cila@novonordisk.com	Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830	Danish Medical Research Council; Danish Diabetes Association; Gerda and Aage Haensch Foundation; A.P. Moller Foundation for the Advancement of Medical Science; University of Copenhagen; Velux Foundation; European Commission [LSHM-CT-2005-018734]; The Danish Obesity Research centre; The Danish Council for Strategic Research [2101-06-0005]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Diabetes Association; Gerda and Aage Haensch Foundation; A.P. Moller Foundation for the Advancement of Medical Science; University of Copenhagen; Velux Foundation(Velux Fonden); European Commission(European CommissionEuropean Commission Joint Research Centre); The Danish Obesity Research centre; The Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Danish Medical Research Council, the Danish Diabetes Association, the Gerda and Aage Haensch Foundation, the A.P. Moller Foundation for the Advancement of Medical Science, University of Copenhagen, and the Velux Foundation. This work is part of the project "Hepatic and adipose tissue and functions in the metabolic syndrome" (HEPADIP www.hepadip.org), which is supported by the European Commission as an integrated project under the 6th Framework Programme (LSHM-CT-2005-018734). The study also received support from The Danish Obesity Research centre (DanORC; www.danorc.dk), which is supported by The Danish Council for Strategic Research (Grant No 2101-06-0005).	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; BELFIORE F, 1976, METABOLISM, V25, P483, DOI 10.1016/0026-0495(76)90001-9; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Feng Y, 2007, HUM GENET, V120, P743, DOI 10.1007/s00439-006-0258-2; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Glumer C, 2003, DIABETES CARE, V26, P2335, DOI 10.2337/diacare.26.8.2335; Hall DH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-83; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; Kumar J, 2007, CLIN GENET, V71, P415, DOI 10.1111/j.1399-0004.2007.00795.x; Kuzuya M, 2007, OBESITY, V15, P2531, DOI 10.1038/oby.2007.301; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Lyon HN, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030061; Nakajima Hiromu, 2002, Current Molecular Medicine (Hilversum), V2, P197, DOI 10.2174/1566524024605734; Price RA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-4; R Core Team, 2018, R LANG ENV STAT COMP; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smith AJP, 2007, INT J OBESITY, V31, P1753, DOI 10.1038/sj.ijo.0803645; Tabara Y, 2008, OBESITY, V16, P211, DOI 10.1038/oby.2007.25; World Health Organization, 1999, WHONCDNCS992	36	42	43	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2872	10.1371/journal.pone.0002872	http://dx.doi.org/10.1371/journal.pone.0002872			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682847	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600028
J	Franqueville, L; Henning, P; Magnusson, M; Vigne, E; Schoehn, G; Blair-Zajdel, ME; Habib, N; Lindholm, L; Blair, GE; Hong, SS; Boulanger, P				Franqueville, Laure; Henning, Petra; Magnusson, Maria; Vigne, Emmanuelle; Schoehn, Guy; Blair-Zajdel, Maria E.; Habib, Nagy; Lindholm, Leif; Blair, G. Eric; Hong, Saw See; Boulanger, Pierre			Protein Crystals in Adenovirus Type 5-Infected Cells: Requirements for Intranuclear Crystallogenesis, Structural and Functional Analysis	PLOS ONE			English	Article								Intranuclear crystalline inclusions have been observed in the nucleus of epithelial cells infected with Adenovirus serotype 5 (Ad5) at late steps of the virus life cycle. Using immuno-electron microscopy and confocal microscopy of cells infected with various Ad5 recombinants modified in their penton base or fiber domains, we found that these inclusions represented crystals of penton capsomers, the heteromeric capsid protein formed of penton base and fiber subunits. The occurrence of protein crystals within the nucleus of infected cells required the integrity of the fiber knob and part of the shaft domain. In the knob domain, the region overlapping residues 489-492 in the FG loop was found to be essential for crystal formation. In the shaft, a large deletion of repeats 4 to 16 had no detrimental effect on crystal inclusions, whereas deletion of repeats 8 to 21 abolished crystal formation without altering the level of fiber protein expression. This suggested a crucial role of the five penultimate repeats in the crystallisation process. Chimeric pentons made of Ad5 penton base and fiber domains from different serotypes were analyzed with respect to crystal formation. No crystal was found when fiber consisted of shaft (S) from Ad5 and knob (K) from Ad3 (heterotypic S5-K3 fiber), but occurred with homotypic S3K3 fiber. However, less regular crystals were observed with homotypic S35-K35 fiber. TB5, a monoclonal antibody directed against the Ad5 fiber knob was found by immunofluorescence microscopy to react with high efficiency with the intranuclear protein crystals in situ. Data obtained with Ad fiber mutants indicated that the absence of crystalline inclusions correlated with a lower infectivity and/or lower yields of virus progeny, suggesting that the protein crystals might be involved in virion assembly. Thus, we propose that TB5 staining of Ad-infected 293 cells can be used as a prognostic assay for the viability and productivity of fiber-modified Ad5 vectors.	[Franqueville, Laure; Hong, Saw See; Boulanger, Pierre] Univ Lyon 1, Fac Med Laennec, Lab Virol & Pathol Humaine, CNRS,FRE 3011, F-69365 Lyon, France; [Henning, Petra; Magnusson, Maria] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Henning, Petra; Magnusson, Maria; Lindholm, Leif] Got A Gene AB, Kullavik, Sweden; [Vigne, Emmanuelle] Ctr Rech Vitry, Sanofi Avantis, Vitry Sur Seine, France; [Schoehn, Guy] Univ Grenoble Joseph Fourier UJF, Inst Biol Structurale Jean Pierre Ebel, Unit Virus Host Cell Interact, UMR 5233 UJF EMBL CNRS, Grenoble, France; [Blair-Zajdel, Maria E.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield, S Yorkshire, England; [Habib, Nagy] Imperial Coll, Dept Surg Oncol & Technol, London, England; [Blair, G. Eric] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Boulanger, Pierre] Hosp Civils Lyon, Ctr Biol Pathol Est, Lab Virol Med, Bron, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Gothenburg; Sanofi-Aventis; Sanofi France; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Sheffield Hallam University; Imperial College London; University of Leeds; CHU Lyon	Franqueville, L (corresponding author), Univ Lyon 1, Fac Med Laennec, Lab Virol & Pathol Humaine, CNRS,FRE 3011, F-69365 Lyon, France.	Pierre.Boulanger@sante.univ-lyon1.fr	Blair, George Eric/A-5906-2008; Hong, Saw See/M-9818-2017; Boulanger, Pierre/AFV-2750-2022	Blair, George Eric/0000-0003-0440-1795; Hong, Saw See/0000-0001-8871-0901; Schoehn, Guy/0000-0002-1459-3201; Magnusson, Maria/0000-0002-8888-4968; Henning, Petra/0000-0002-9330-6265	Centre National de la Recherche Scientifique; French Foundation for Research on Cystic Fibrosis [TG0702]; Association Francaise contre les Myopathies [MNM2 D-2006-12155]; European Community [QLK3-CT-1999-01262, GIANT]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); French Foundation for Research on Cystic Fibrosis; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Community(European Commission)	The work in Lyon was supported in part by the Centre National de la Recherche Scientifique and by grants from the French Foundation for Research on Cystic Fibrosis ("Vaincre la Mucoviscidose", VLM Contract TG0702) and from the Association Francaise contre les Myopathies (AFM Contract N MNM2 D-2006-12155). The work in Goteborg was supported by the European Community (Contracts N QLK3-CT-1999-01262 and GIANT).	Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0; BOUDIN ML, 1983, EMBO J, V2, P1921, DOI 10.1002/j.1460-2075.1983.tb01680.x; BOUDIN ML, 1982, VIROLOGY, V116, P589, DOI 10.1016/0042-6822(82)90151-9; BOUDIN ML, 1979, VIROLOGY, V92, P125, DOI 10.1016/0042-6822(79)90219-8; BOULANGE.PA, 1973, EUR J BIOCHEM, V39, P37, DOI 10.1111/j.1432-1033.1973.tb03100.x; Boulanger P A, 1974, Intervirology, V2, P56; BOULANGER PA, 1970, J GEN VIROL, V6, P329, DOI 10.1099/0022-1317-6-2-329; Cauet G, 2005, BIOCHEMISTRY-US, V44, P5453, DOI 10.1021/bi047702b; CEPKO CL, 1982, CELL, V31, P407, DOI 10.1016/0092-8674(82)90134-9; CHROBOCZEL K, 1995, MOL REPERTOIRE ADENO, P163; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Coulibaly F, 2007, NATURE, V446, P97, DOI 10.1038/nature05628; Crouzet J, 1997, P NATL ACAD SCI USA, V94, P1414, DOI 10.1073/pnas.94.4.1414; DHALLUIN JC, 1995, MOL REPERTOIRE ADENO, P47; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gaden F, 2004, J VIROL, V78, P7227, DOI 10.1128/JVI.78.13.7227-7247.2004; Galfre G, 1981, Methods Enzymol, V73, P3; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Henning P, 2005, GENE THER, V12, P211, DOI 10.1038/sj.gt.3302408; Henning P, 2002, HUM GENE THER, V13, P1427, DOI 10.1089/10430340260185067; Henning P, 2006, J GEN VIROL, V87, P3151, DOI 10.1099/vir.0.81992-0; HENRY CJ, 1971, VIROLOGY, V44, P215, DOI 10.1016/0042-6822(71)90167-X; HENRY CJ, 1971, J VIROL, V8, P842, DOI 10.1128/JVI.8.6.842-849.1971; HONG JS, 1991, VIROLOGY, V185, P758; Hong JS, 1996, J VIROL, V70, P7071, DOI 10.1128/JVI.70.10.7071-7078.1996; Hong SS, 1999, VIROLOGY, V262, P163, DOI 10.1006/viro.1999.9864; Hong SS, 2005, J MOL BIOL, V352, P125, DOI 10.1016/j.jmb.2005.06.070; Hong SS, 2003, MOL THER, V7, P692, DOI 10.1016/S1525-0016(03)00067-4; HONG SS, 1995, EMBO J, V14, P4714, DOI 10.1002/j.1460-2075.1995.tb00153.x; HORWITZ MS, 1986, FUNDAMENTAL VIROLOGY, P563; Huvent I, 1998, J GEN VIROL, V79, P1069, DOI 10.1099/0022-1317-79-5-1069; Karayan L, 1997, J VIROL, V71, P8678, DOI 10.1128/JVI.71.11.8678-8689.1997; KARAYAN L, 1994, VIROLOGY, V202, P782, DOI 10.1006/viro.1994.1400; Kirby I, 1999, J VIROL, V73, P9508, DOI 10.1128/JVI.73.11.9508-9514.1999; Kovacs GM, 2004, J GEN VIROL, V85, P2799, DOI 10.1099/vir.0.80225-0; Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017; Legrand V, 1999, J VIROL, V73, P907, DOI 10.1128/JVI.73.2.907-919.1999; Leissner P, 2001, GENE THER, V8, P49, DOI 10.1038/sj.gt.3301343; Li JL, 2006, J VIROL, V80, P12324, DOI 10.1128/JVI.01331-06; LIFCHITZ A, 1975, ACTA CRYSTALLOGR B, V31, P441, DOI 10.1107/S0567740875002981; Magnusson MK, 2007, CANCER GENE THER, V14, P468, DOI 10.1038/sj.cgt.7701027; Magnusson MK, 2002, J GENE MED, V4, P356, DOI 10.1002/jgm.285; Magnusson MK, 2001, J VIROL, V75, P7280, DOI 10.1128/JVI.75.16.7280-7289.2001; MARTIN GR, 1978, J GEN VIROL, V41, P303, DOI 10.1099/0022-1317-41-2-303; Martin K, 2003, MOL THER, V8, P485, DOI 10.1016/S1525-0016(03)00182-5; MARUSYK R, 1972, J GEN VIROL, V14, P261, DOI 10.1099/0022-1317-14-3-261; Miyazawa N, 1999, J VIROL, V73, P6056, DOI 10.1128/JVI.73.7.6056-6065.1999; Miyazawa N, 2001, J VIROL, V75, P1387, DOI 10.1128/JVI.75.3.1387-1400.2001; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; MORGAN C, 1960, J EXP MED, V112, P373, DOI 10.1084/jem.112.2.373; NEUMANN R, 1988, GENE, V69, P153, DOI 10.1016/0378-1119(88)90389-7; NILSSON B, 1987, PROTEIN ENG, V1, P107, DOI 10.1093/protein/1.2.107; NOVELLI A, 1991, J BIOL CHEM, V266, P9299; NOVELLI A, 1991, VIROLOGY, V185, P365, DOI 10.1016/0042-6822(91)90784-9; Puvion-Dutilleul F, 1999, BIOL CELL, V91, P617, DOI 10.1016/S0248-4900(00)88526-3; Rey FA, 2007, NATURE, V446, P35, DOI 10.1038/446035a; RUIGROK RWH, 1990, J MOL BIOL, V215, P589, DOI 10.1016/S0022-2836(05)80170-6; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Santis G, 1999, J GEN VIROL, V80, P1519, DOI 10.1099/0022-1317-80-6-1519; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Shayakhmetov DM, 2003, J VIROL, V77, P3712, DOI 10.1128/JVI.77.6.3712-3723.2003; Souquere-Besse S, 2002, MICROSC RES TECHNIQ, V56, P465, DOI 10.1002/jemt.10060; Vigne E, 2003, GENE THER, V10, P153, DOI 10.1038/sj.gt.3301845; Violot S, 2003, J VIROL, V77, P12507, DOI 10.1128/JVI.77.23.12507-12522.2003; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Waszak P, 2007, MOL THER, V15, P2008, DOI 10.1038/sj.mt.6300254; WEBER J, 1969, CAN J MICROBIOL, V15, P841, DOI 10.1139/m69-150; WEBER J, 1978, CAN J MICROBIOL, V24, P1381, DOI 10.1139/m78-221; WILLS EJ, 1973, J GEN VIROL, V20, P407, DOI 10.1099/0022-1317-20-3-407; Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003; Zubieta C, 2006, FEBS J, V273, P4336, DOI 10.1111/j.1742-4658.2006.05430.x	73	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2894	10.1371/journal.pone.0002894	http://dx.doi.org/10.1371/journal.pone.0002894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682854	gold, Green Published, Green Accepted			2022-12-27	WOS:000264366600050
J	Ong, CT; Sedy, JR; Murphy, KM; Kopan, R				Ong, Chin-Tong; Sedy, John R.; Murphy, Kenneth M.; Kopan, Raphael			Notch and Presenilin Regulate Cellular Expansion and Cytokine Secretion but Cannot Instruct Th1/Th2 Fate Acquisition	PLOS ONE			English	Article								Recent reports suggested that Delta1, 4 and Jagged1, 2 possessed the ability to instruct CD4(+) T cell into selection of Th1 or Th2 fates, respectively, although the underlying mechanism endowing the cleaved Notch receptor with memory of ligand involved in its activation remains elusive. To examine this, we prepared artificial antigen-presenting cells expressing either DLL1 or Jag1. Although both ligands were efficient in inducing Notch2 cleavage and activation in CD4(+) T or reporter cells, the presence of Lunatic Fringe in CD4(+) T cells inhibited Jag1 activation of Notch1 receptor. Neither ligand could induce Th1 or Th2 fate choice independently of cytokines or redirect cytokine-driven Th1 or Th2 development. Instead, we find that Notch ligands only augment cytokine production during T cell differentiation in the presence of polarizing IL-12 and IL-4. Moreover, the differentiation choices of naive CD4(+) T cells lacking gamma-secretase, RBP-J, or both in response to polarizing cytokines revealed that neither presenilin proteins nor RBP-J were required for cytokine-induced Th1/Th2 fate selection. However, presenilins facilitate cellular proliferation and cytokine secretion in an RBP-J ( and thus, Notch) independent manner. The controversies surrounding the role of Notch and presenilins in Th1/Th2 polarization may reflect their role as genetic modifiers of T-helper cells differentiation.	[Ong, Chin-Tong; Kopan, Raphael] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA; [Sedy, John R.; Murphy, Kenneth M.] Washington Univ, Sch Med, Ctr Immunol, Dept Pathol, St Louis, MO USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO USA; [Kopan, Raphael] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Ong, CT (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA.	kmurphy@wustl.edu; kopan@beckermail.wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Ong, Chin-Tong/0000-0002-5450-4760; Kopan, Raphael/0000-0002-0350-2730; Sedy, John/0000-0002-6428-1054	National Institutes of Health [GM55479, HD044056]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055479] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health GM55479 (R.K.) and HD044056 (C.T.O), and Howard Hughes Medical Institute (K.M.M. and J.R.S).	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Adler SH, 2003, J IMMUNOL, V171, P2896, DOI 10.4049/jimmunol.171.6.2896; Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Anastasi E, 2003, J IMMUNOL, V171, P4504, DOI 10.4049/jimmunol.171.9.4504; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ben-Sasson SZ, 2001, J IMMUNOL, V166, P112, DOI 10.4049/jimmunol.166.1.112; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014; DE SB, 1999, NATURE, V398, P518; Dong C, 2003, IMMUNOL RES, V28, P39, DOI 10.1385/IR:28:1:39; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Farrar JD, 2001, J EXP MED, V193, P643, DOI 10.1084/jem.193.5.643; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Ge CH, 2008, P NATL ACAD SCI USA, V105, P1539, DOI 10.1073/pnas.0702846105; Glimcher LH, 2007, NAT IMMUNOL, V8, P448, DOI 10.1038/ni0507-448; Glimcher LH, 2004, NAT REV IMMUNOL, V4, P900, DOI 10.1038/nri1490; GORDON WR, 2007, NAT STRUCT MOL BIOL; GRIDLEY T, 2007, DEVELOPMENT; Hadland BK, 2001, P NATL ACAD SCI USA, V98, P7487, DOI 10.1073/pnas.131202798; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Ilagan Maria Xenia G, 2007, Cell, V128, P1246; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2006, CHEM IMMUNOL ALLERGY, V90, P65, DOI 10.1159/000088881; Khandelwal A, 2007, P NATL ACAD SCI USA, V104, P13337, DOI 10.1073/pnas.0702038104; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Minato Y, 2005, INT J HEMATOL, V82, P302, DOI 10.1532/IJH97.05095; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mowen KA, 2004, IMMUNOL REV, V202, P203, DOI 10.1111/j.0105-2896.2004.00209.x; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; O'Garra A, 2004, ADV IMMUNOL, V83, P133; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; O'Shea JJ, 2002, NAT IMMUNOL, V3, P506, DOI 10.1038/ni0602-506; OGARRA A, 1994, CURR OPIN IMMUNOL, V6, P458, DOI 10.1016/0952-7915(94)90128-7; Osborne BA, 2007, NAT REV IMMUNOL, V7, P64, DOI 10.1038/nri1998; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Palaga T, 2003, J IMMUNOL, V171, P3019, DOI 10.4049/jimmunol.171.6.3019; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ranganath S, 1998, J IMMUNOL, V161, P3822; Reinhardt RL, 2006, CURR OPIN IMMUNOL, V18, P271, DOI 10.1016/j.coi.2006.03.003; Richter A, 1999, J EXP MED, V190, P1439, DOI 10.1084/jem.190.10.1439; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Rutz S, 2005, EUR J IMMUNOL, V35, P2443, DOI 10.1002/eji.200526294; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tanigaki K, 2007, NAT IMMUNOL, V8, P451, DOI 10.1038/ni1453; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Thomas MD, 2006, CELL IMMUNOL, V239, P92, DOI 10.1016/j.cellimm.2006.04.007; Tsuji M, 2007, P NATL ACAD SCI USA, V104, P1610, DOI 10.1073/pnas.0610520104; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Witt CM, 2003, J IMMUNOL, V171, P2783, DOI 10.4049/jimmunol.171.6.2783; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002	95	76	78	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2823	10.1371/journal.pone.0002823	http://dx.doi.org/10.1371/journal.pone.0002823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665263	Green Published, gold			2022-12-27	WOS:000264304300042
J	Kioussi, C; Gross, MK				Kioussi, Chrissa; Gross, Michael K.			How to Build Transcriptional Network Models of Mammalian Pattern Formation	PLOS ONE			English	Article								Background: Genetic regulatory networks of sequence specific transcription factors underlie pattern formation in multicellular organisms. Deciphering and representing the mammalian networks is a central problem in development, neurobiology, and regenerative medicine. Transcriptional networks specify intermingled embryonic cell populations during pattern formation in the vertebrate neural tube. Each embryonic population gives rise to a distinct type of adult neuron. The homeodomain transcription factor Lbx1 is expressed in five such populations and loss of Lbx1 leads to distinct respecifications in each of the five populations. Methodology/Principal Findings: We have purified normal and respecified pools of these five populations from embryos bearing one or two copies of the null Lbx1(GFP) allele, respectively. Microarrays were used to show that expression levels of 8% of all transcription factor genes were altered in the respecified pool. These transcription factor genes constitute 20-30% of the active nodes of the transcriptional network that governs neural tube patterning. Half of the 141 regulated nodes were located in the top 150 clusters of ultraconserved non-coding regions. Generally, Lbx1 repressed genes that have expression patterns outside of the Lbx1-expressing domain and activated genes that have expression patterns inside the Lbx1-expressing domain. Conclusions/Significance: Constraining epistasis analysis of Lbx1 to only those cells that normally express Lbx1 allowed unprecedented sensitivity in identifying Lbx1 network interactions and allowed the interactions to be assigned to a specific set of cell populations. We call this method ANCEA, or active node constrained epistasis analysis, and think that it will be generally useful in discovering and assigning network interactions to specific populations. We discuss how ANCEA, coupled with population partitioning analysis, can greatly facilitate the systematic dissection of transcriptional networks that underlie mammalian patterning.	[Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Gross, Michael K.] Oregon State Univ, Coll Sci, Dept Biochem & Biophys, Corvallis, OR USA	Oregon State University; Oregon State University	Kioussi, C (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	grossm@onid.orst.edu		Kioussi, Chrissa/0000-0001-8226-9908	Department of Biochemistry and Biophysics and the College of Science; Medical Research Foundation at OHSU [0308]; Environmental Health and Sciences Center at OSU [P30ES00210]; March of Dimes [1-FY05-120]; American Heart Association [0550179Z]; NIH/NIAMS [RO1AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	Department of Biochemistry and Biophysics and the College of Science; Medical Research Foundation at OHSU; Environmental Health and Sciences Center at OSU; March of Dimes(March of Dimes); American Heart Association(American Heart Association); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Work was funded by start-up funds from the Department of Biochemistry and Biophysics and the College of Science, grants from the Medical Research Foundation at OHSU (0308) and the Environmental Health and Sciences Center at OSU (P30ES00210) to MKG, as well as grants from the March of Dimes (1-FY05-120) and American Heart Association (0550179Z) to CK, and the NIH/NIAMS (RO1AR054406) to CK and MKG.	Bailey PJ, 2006, EXP CELL RES, V312, P3108, DOI 10.1016/j.yexcr.2006.06.017; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bolouri H, 2002, BIOESSAYS, V24, P1118, DOI 10.1002/bies.10189; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Bolouri H, 2002, DEV BIOL, V246, P2, DOI 10.1006/dbio.2002.0617; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Caspary T, 2003, NAT REV NEUROSCI, V4, P289, DOI 10.1038/nrn1073; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2003, P NATL ACAD SCI USA, V100, P1475, DOI 10.1073/pnas.0437746100; Ding YQ, 2004, DEVELOPMENT, V131, P3693, DOI 10.1242/dev.01250; Ensini M, 1998, DEVELOPMENT, V125, P969; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRAHAM A, 1991, DEVELOPMENT, V112, P255; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Gross MK, 2000, DEVELOPMENT, V127, P413; Hargrave M, 2000, DEV BIOL, V219, P142, DOI 10.1006/dbio.1999.9581; Hedlund E, 2004, J NEUROSCI RES, V75, P307, DOI 10.1002/jnr.10844; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; John A, 2005, DEV DYNAM, V234, P767, DOI 10.1002/dvdy.20568; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Lee SK, 2001, NAT NEUROSCI, V4, P1183, DOI 10.1038/nn750; Levine M, 2005, P NATL ACAD SCI USA, V102, P4936, DOI 10.1073/pnas.0408031102; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Longabaugh WJR, 2005, DEV BIOL, V283, P1, DOI 10.1016/j.ydbio.2005.04.023; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; Mizuhara E, 2005, J BIOL CHEM, V280, P3645, DOI 10.1074/jbc.M411652200; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; OLIVER G, 1988, EMBO J, V7, P3199, DOI 10.1002/j.1460-2075.1988.tb03187.x; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Smith E, 2002, DEV DYNAM, V224, P231, DOI 10.1002/dvdy.10093; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang WD, 2000, MECH DEVELOP, V99, P123, DOI 10.1016/S0925-4773(00)00488-3	45	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 14	2008	3	5							e2179	10.1371/journal.pone.0002179	http://dx.doi.org/10.1371/journal.pone.0002179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	390OE	18769640	Green Published, Green Submitted, gold			2022-12-27	WOS:000262172800044
J	Middleton, LE; Mitnitski, A; Fallah, N; Kirkland, SA; Rockwood, K				Middleton, Laura E.; Mitnitski, Arnold; Fallah, Nader; Kirkland, Susan A.; Rockwood, Kenneth			Changes in Cognition and Mortality in Relation to Exercise in Late Life: A Population Based Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; PHYSICAL-ACTIVITY; HEALTH; DEMENTIA; DECLINE; RISK; TRANSITIONS; IMPAIRMENT; BRAIN; ACCUMULATION	Background: On average, cognition declines with age but this average hides considerable variability, including the chance of improvement. Here, we investigate how exercise is associated with cognitive change and mortality in older people and, particularly, whether exercise might paradoxically increase the risk of dementia by allowing people to live longer. Methods and Principal Findings: In the Canadian Study of Health and Aging (CSHA), of 8403 people who had baseline cognition measured and exercise reported at CSHA-1, 2219 had died and 5376 were re-examined at CSHA-2. We used a parametric Markov chain model to estimate the probabilities of cognitive improvement, decline, and death, adjusted for age and education, from any cognitive state as measured by the Modified Mini-Mental State Examination. High exercisers (at least three times per week, at least as intense as walking, n = 3264) had more frequent stable or improved cognition (42.3%, 95% confidence interval: 40.6-44.0) over 5 years than did low/ no exercisers (all other exercisers and non exercisers, n = 4331) (27.8% (95% CI 26.4-29.2)). The difference widened as baseline cognition worsened. The proportion whose cognition declined was higher amongst the high exercisers but was more similar between exercise groups (39.4% (95% CI 37.7-41.1) for high exercisers versus 34.8% (95% CI 33.4-36.2) otherwise). People who did not exercise were also more likely to die (37.5% (95% CI 36.0-39.0) versus 18.3% (95% CI 16.9-19.7)). Even so, exercise conferred its greatest mortality benefit to people with the highest baseline cognition. Conclusions: Exercise is strongly associated with improving cognition. As the majority of mortality benefit of exercise is at the highest level of cognition, and declines as cognition declines, the net effect of exercise should be to improve cognition at the population level, even with more people living longer.	[Middleton, Laura E.; Mitnitski, Arnold; Fallah, Nader; Rockwood, Kenneth] Ctr Hlth Care Elderly, Geriatr Med Res Unit, Halifax, NS, Canada; [Kirkland, Susan A.] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada	Dalhousie University	Middleton, LE (corresponding author), Ctr Hlth Care Elderly, Geriatr Med Res Unit, Halifax, NS, Canada.	kenneth.rockwood@dal.ca	Mitnitski, Arnold/C-7543-2012; Middleton, Laura/ABG-8940-2021; Rockwood, Kenneth/AAD-8951-2019; Fallah, Nader/D-4145-2012; Middleton, Laura/C-6024-2009	Fallah, Nader/0000-0002-7746-4773; Middleton, Laura/0000-0001-8624-3123; Kirkland, Susan/0000-0002-8182-2369	National Health Research Development Program [6606-3954-MC(S)]; Canadian Institutes of Health Research [MOP-62823]; Killam Foundation; Dalhousie Medical Research Foundation; Fountain Innovation Fund of the QEII Research Foundation	National Health Research Development Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Killam Foundation; Dalhousie Medical Research Foundation; Fountain Innovation Fund of the QEII Research Foundation	All the data reported here was gathered using public funding from the National Health Research Development Program, which administrated a grant from the Seniors' Independence Research program (6606-3954-MC(S)). Funding for these analyses came from the Canadian Institutes of Health Research through an operating grant (MOP-62823). Additional support came from the Killam Foundation (a doctoral student award to LEM), the Dalhousie Medical Research Foundation (career support to KR as Kathryn Allen Weldon Professor of Alzheimer Research) and the Fountain Innovation Fund of the QEII Research Foundation. The decision to submit this paper was entirely the decision of the authors and not the sponsors, who had no role in design, analysis or writing of the paper.	Andrade E, 2008, J SEX MED, V5, P9; Broe GA, 1998, AUST NZ J PUBL HEAL, V22, P621, DOI 10.1111/j.1467-842X.1998.tb01449.x; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Finkel D, 2003, DEV PSYCHOL, V39, P535, DOI 10.1037/0012-1649.39.3.535; Finkel D, 2007, J GERONTOL B-PSYCHOL, V62, pP286, DOI 10.1093/geronb/62.5.P286; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Jones TG, 2002, ARCH CLIN NEUROPSYCH, V17, P171, DOI 10.1016/S0887-6177(00)00108-6; KAY DWK, 1991, INT J GERIATR PSYCH, V6, P827, DOI 10.1002/gps.930061202; Kramer AF, 2007, ALZHEIMERS DEMENT, V3, pS45, DOI 10.1016/j.jalz.2007.01.008; Kryscio RJ, 2006, NEUROLOGY, V66, P828, DOI 10.1212/01.wnl.0000203264.71880.45; Kulminski A, 2006, MECH AGEING DEV, V127, P840, DOI 10.1016/j.mad.2006.08.005; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lytle ME, 2004, ALZ DIS ASSOC DIS, V18, P57, DOI 10.1097/01.wad.0000126614.87955.79; MacDonald SWS, 2003, J GERONTOL B-PSYCHOL, V58, pP187, DOI 10.1093/geronb/58.3.P187; Manini TM, 2006, JAMA-J AM MED ASSOC, V296, P171, DOI 10.1001/jama.296.2.171; McDowell I, 1997, J CLIN EPIDEMIOL, V50, P377, DOI 10.1016/S0895-4356(97)00060-7; McDowell I, 2001, INT PSYCHOGERIATR, V13, P19, DOI 10.1017/S1041610202007950; McDowell I, 2001, AGING CLIN EXP RES, V13, P143, DOI 10.1007/BF03351474; Middleton LE, 2007, J AM GERIATR SOC, V55, P1095, DOI 10.1111/j.1532-5415.2007.01238.x; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Mitnitski A, 2007, EXP GERONTOL, V42, P1109, DOI 10.1016/j.exger.2007.08.002; Mitnitski Arnold, 2008, BMC Geriatr, V8, P3, DOI 10.1186/1471-2318-8-3; Ravaglia G, 2008, NEUROLOGY, V70, P1786, DOI 10.1212/01.wnl.0000296276.50595.86; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Rockwood K, 2007, NEUROLOGY, V69, P1896, DOI 10.1212/01.wnl.0000265399.77681.40; Rockwood K, 2007, REV CLIN GERONTOL, V17, P1, DOI 10.1017/S0959259807002353; SCHAIE KW, 1989, PSYCHOL AGING, V4, P443, DOI 10.1037/0882-7974.4.4.443; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Scuteri A, 2005, AGING CLIN EXP RES, V17, P367; Sliwinski M, 1999, PSYCHOL AGING, V14, P18, DOI 10.1037/0882-7974.14.1.18; Sumic A, 2007, J AGING HEALTH, V19, P242, DOI 10.1177/0898264307299299; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703	37	91	92	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3124	10.1371/journal.pone.0003124	http://dx.doi.org/10.1371/journal.pone.0003124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422GW	18769616	Green Submitted, Green Published, gold			2022-12-27	WOS:000264416600012
J	Shepard, BD; De Forni, D; McNamara, DR; Foli, A; Rizza, SA; Abraham, RS; Knutson, K; Wettstein, PJ; Lori, F; Badley, AD				Shepard, Brett D.; De Forni, Davide; McNamara, David R.; Foli, Andrea; Rizza, Stacey A.; Abraham, Roshini S.; Knutson, Keith; Wettstein, Peter J.; Lori, Franco; Badley, Andrew D.			Beneficial Effect of TRAIL on HIV Burden, without Detectable Immune Consequences	PLOS ONE			English	Article								Background: During uncontrolled HIV disease, both TNF-related apoptosis inducing ligand ( TRAIL) and TRAIL receptor expression are increased. Enhanced TRAIL sensitivity is due to TRAIL receptor up-regulation induced by gp120. As a result of successful antiretroviral therapy TRAIL is down-regulated, and there are fewer TRAIL-sensitive cells. In this setting, we hypothesized that all cells that contain virus, including those productively- and latently-infected, have necessarily been "primed" by gp120 and remain TRAIL-sensitive, whereas uninfected cells remain relatively TRAIL-resistant. Methods and Findings: We evaluated the immunologic and antiviral effects of TRAIL in peripheral blood lymphocytes collected from HIV-infected patients with suppressed viral replication. The peripheral blood lymphocytes were treated with recombinant TRAIL or an equivalent amount of bovine serum albumin as a negative control. Treated cells were then analyzed by quantitative flow cytometry, ELISPOT for CD4+ and CD8+ T-cell function, and limiting dilution microculture for viral burden. Alterations in the cytokine milieu of treated cells were assessed with a multiplex cytokine assay. Treatment with recombinant TRAIL in vitro reduced viral burden in lymphocytes collected from HIV-infected patients with suppressed viral load. TRAIL treatment did not alter the cytokine milieu of treated cells. Moreover, treatment with recombinant TRAIL had no adverse effect on either the quantity or function of immune cells from HIV-infected patients with suppressed viral replication. Conclusions: TRAIL treatment may be an important adjunct to antiretroviral therapy, even in patients with suppressed viral replication, perhaps by inducing apoptosis in cells with latent HIV reservoirs. The absence of adverse effect on the quantity or function of immune cells from HIV-infected patients suggests that there is not a significant level of "bystander death" in uninfected cells.	[Shepard, Brett D.; McNamara, David R.; Rizza, Stacey A.; Abraham, Roshini S.; Knutson, Keith; Wettstein, Peter J.; Badley, Andrew D.] Mayo Clin, Rochester, MN 55905 USA; [De Forni, Davide] Virostatics srl, Sassari, Italy; [Foli, Andrea] Fdn Ist Ricovero Cura Carattere Sci Policlin San, Pavia, Italy; [Lori, Franco] Res Inst Genet & Human Therapy, Pavia, Italy	Mayo Clinic	Shepard, BD (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	badley.andrew@mayo.edu	badley, andrew d/O-9022-2014	Badley, Andrew/0000-0001-7796-7680	National Institutes of Health [R01 AI62261, R01 AI403840]; Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research [1005160]; National Institutes of Health Exploratory/Developmental Research Award (R21) [1R21DK077575-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077575] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); National Institutes of Health Exploratory/Developmental Research Award (R21); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Andrew Badley is supported by grants from the National Institutes of Health (R01 AI62261 and R01 AI403840) and the Burroughs Wellcome Fund's Clinical Scientist Award in Translational Research (ID#1005160). Dr. Stacey Rizza is supported by a grant from the National Institutes of Health Exploratory/Developmental Research Award (R21) (1R21DK077575-01).	Audige A, 2006, J IMMUNOL, V177, P6227, DOI 10.4049/jimmunol.177.9.6227; Badley AD, 1996, J VIROL, V70, P199, DOI 10.1128/JVI.70.1.199-206.1996; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Balestrieri E, 2007, J MED VIROL, V79, P111, DOI 10.1002/jmv.20768; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Ganten TM, 2006, CLIN CANCER RES, V12, P2640, DOI 10.1158/1078-0432.CCR-05-2635; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Gibellini D, 2007, J MED VIROL, V79, P1446, DOI 10.1002/jmv.20938; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Jo M, 2000, NAT MED, V6, P564, DOI 10.1038/75045; Koschny R, 2007, J MOL MED, V85, P923, DOI 10.1007/s00109-007-0194-1; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Lum JJ, 2004, J VIROL, V78, P6033, DOI 10.1128/JVI.78.11.6033-6042.2004; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; Miura Y, 2001, J EXP MED, V193, P651, DOI 10.1084/jem.193.5.651; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Swingler S, 2007, PLOS PATHOG, V3, P1281, DOI 10.1371/journal.ppat.0030134; Zhang MJ, 2001, J BIOMED SCI, V8, P290, DOI 10.1159/000054045; Zheng L, 2007, INTERVIROLOGY, V50, P224, DOI 10.1159/000100565	24	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3096	10.1371/journal.pone.0003096	http://dx.doi.org/10.1371/journal.pone.0003096			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769477	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796600013
J	Landman, KZ; Ostermann, J; Crump, JA; Mgonja, A; Mayhood, MK; Itemba, DK; Tribble, AC; Ndosi, EM; Chu, HY; Shao, JF; Bartlett, JA; Thielman, NM				Landman, Keren Z.; Ostermann, Jan; Crump, John A.; Mgonja, Anna; Mayhood, Meghan K.; Itemba, Dafrosa K.; Tribble, Alison C.; Ndosi, Evaline M.; Chu, Helen Y.; Shao, John F.; Bartlett, John A.; Thielman, Nathan M.			Gender Differences in the Risk of HIV Infection among Persons Reporting Abstinence, Monogamy, and Multiple Sexual Partners in Northern Tanzania	PLOS ONE			English	Article								Background: Monogamy, together with abstinence, partner reduction, and condom use, is widely advocated as a key behavioral strategy to prevent HIV infection in sub-Saharan Africa. We examined the association between the number of sexual partners and the risk of HIV seropositivity among men and women presenting for HIV voluntary counseling and testing (VCT) in northern Tanzania. Methodology/Principal Findings: Clients presenting for HIV VCT at a community-based AIDS service organization in Moshi, Tanzania were surveyed between November 2003 and December 2007. Data on sociodemographic characteristics, reasons for testing, sexual behaviors, and symptoms were collected. Men and women were categorized by number of lifetime sexual partners, and rates of seropositivity were reported by category. Factors associated with HIV seropositivity among monogamous males and females were identified by a multivariate logistic regression model. Of 6,549 clients, 3,607 (55%) were female, and the median age was 30 years (IQR 24-40). 939 (25%) females and 293 (10%) males (p < 0.0001) were HIV seropositive. Among 1,244 (34%) monogamous females and 423 (14%) monogamous males, the risk of HIV infection was 19% and 4%, respectively (p < 0.0001). The risk increased monotonically with additional partners up to 45% ( p < 0.001) and 15% (p < 0.001) for women and men, respectively with 5 or more partners. In multivariate analysis, HIV seropositivity among monogamous women was most strongly associated with age (p < 0.0001), lower education (p < 0.004), and reporting a partner with other partners (p=0.015). Only age was a significant risk factor for monogamous men (p=0.0004). Interpretation: Among women presenting for VCT, the number of partners is strongly associated with rates of seropositivity; however, even women reporting lifetime monogamy have a high risk for HIV infection. Partner reduction should be coupled with efforts to place tools in the hands of sexually active women to reduce their risk of contracting HIV.	[Landman, Keren Z.; Ostermann, Jan; Crump, John A.; Mayhood, Meghan K.; Tribble, Alison C.; Ndosi, Evaline M.; Chu, Helen Y.; Bartlett, John A.; Thielman, Nathan M.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Ostermann, Jan; Crump, John A.; Bartlett, John A.; Thielman, Nathan M.] Duke Univ, Duke Glob Hlth Inst, Durham, NC 27706 USA; [Crump, John A.; Shao, John F.; Bartlett, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Crump, John A.; Itemba, Dafrosa K.; Shao, John F.; Bartlett, John A.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Mgonja, Anna] KIWAKKUKI, Moshi, Tanzania	Duke University; Duke University; Kilimanjaro Christian Medical Centre	Landman, KZ (corresponding author), Duke Univ, Med Ctr, Durham, NC 27706 USA.	n.thielman@duke.edu	Ostermann, Jan/GQB-4743-2022; Crump, John A./AAZ-6412-2020; Thielman, Nathan/R-5142-2019; Crump, John A./AAZ-6289-2020	Crump, John A./0000-0002-4529-102X; Thielman, Nathan/0000-0001-8152-2879; Crump, John A./0000-0002-4529-102X; Ostermann, Jan/0000-0002-8236-9500; Chu, Helen/0000-0001-8502-9600	Roche; AIDS Clinical Trials Group [U01 AI-39156]; Mid-career Investigator Award [K24 AI-0744-01]; International Studies of AIDS -associated Co-infections Award [U01 AI 062563-04]; Duke University Center for AIDS Research [P30 AI64516-03]; National Institute of Allergy and Infectious Diseases; U.S. Department of State Fulbright Program; Fogarty International Center's AIDS International Training and Research Program [D43 TW006732]; Hubert Yeargan Center for Global Health; Duke University Medical Center; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI039156, Z01AI000744, U01AI062563] Funding Source: NIH RePORTER	Roche(Roche Holding); AIDS Clinical Trials Group; Mid-career Investigator Award; International Studies of AIDS -associated Co-infections Award; Duke University Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of State Fulbright Program; Fogarty International Center's AIDS International Training and Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Hubert Yeargan Center for Global Health; Duke University Medical Center; University of Rochester Medical Center; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Roche. Additional support was obtained from AIDS Clinical Trials Group (U01 AI-39156; Drs. Bartlett, Crump, and Thielman), Mid-career Investigator Award (K24 AI-0744-01; Dr. Bartlett), International Studies of AIDS -associated Co-infections Award (U01 AI 062563-04; Drs. Bartlett, Crump, and Thielman) and the Duke University Center for AIDS Research (P30 AI64516-03; Drs. Bartlett and Crump) from the National Institute of Allergy and Infectious Diseases, from the U.S. Department of State Fulbright Program (Dr. Thielman), from the Fogarty International Center's AIDS International Training and Research Program (D43 TW006732, Drs. Bartlett, Crump, and Thielman), from the Hubert Yeargan Center for Global Health, Duke University Medical Center (Dr. Tribble) and from the University of Rochester Medical Center (Dr. Landman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Chu HY, 2005, INT J STD AIDS, V16, P691, DOI 10.1258/095646205774357307; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Doherty IA, 2006, SEX TRANSM DIS, V33, P368, DOI 10.1097/01.olq.0000194586.66409.7a; Drumright LN, 2004, SEX TRANSM DIS, V31, P437, DOI 10.1097/01.olq.0000129949.30114.37; Ferry B, 2001, AIDS, V15, pS41, DOI 10.1097/00002030-200108004-00005; Gersovitz M, 1998, J AM STAT ASSOC, V93, P875, DOI 10.2307/2669826; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Mayer KH, 2003, AIDS, V17, P321, DOI 10.1097/00002030-200302140-00005; *MIN HLTH, 2005, 19 MIN HLTH; Mitsunaga TM, 2005, JAIDS-J ACQ IMM DEF, V39, P478, DOI 10.1097/01.qai.0000152396.60014.69; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; O'Farrell N, 2001, SEX TRANSM DIS, V28, P84, DOI 10.1097/00007435-200102000-00005; Shelton JD, 2004, BMJ-BRIT MED J, V328, P891, DOI 10.1136/bmj.328.7444.891; Singh S, 2003, A B C UGANDA ROLES A; Slaymaker E, 2004, SEX TRANSM INFECT, V80, P85, DOI 10.1136/sti.2004.012054; Smith RJ, 2005, AIDS, V19, P413, DOI 10.1097/01.aids.0000161771.44276.92; Thielman NM, 2006, AM J PUBLIC HEALTH, V96, P114, DOI 10.2105/AJPH.2004.056796	24	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3075	10.1371/journal.pone.0003075	http://dx.doi.org/10.1371/journal.pone.0003075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728779	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796400015
J	Khachatryan, ZA; Ktsoyan, ZA; Manukyan, GP; Kelly, D; Ghazaryan, KA; Aminov, RI				Khachatryan, Zaruhi A.; Ktsoyan, Zhanna A.; Manukyan, Gayane P.; Kelly, Denise; Ghazaryan, Karine A.; Aminov, Rustam I.			Predominant Role of Host Genetics in Controlling the Composition of Gut Microbiota	PLOS ONE			English	Article								Background: The human gastrointestinal tract is inhabited by a very diverse symbiotic microbiota, the composition of which depends on host genetics and the environment. Several studies suggested that the host genetics may influence the composition of gut microbiota but no genes involved in host control were proposed. We investigated the effects of the wild type and mutated alleles of the gene, which encodes the protein called pyrin, one of the regulators of innate immunity, on the composition of gut commensal bacteria. Mutations in MEFV lead to the autoinflammatory disorder, familial Mediterranean fever (FMF, MIM249100), which is characterized by recurrent self-resolving attacks of fever and polyserositis, with no clinical signs of disease in remission. Methodology/Principal Findings: A total of 19 FMF patients and eight healthy individuals were genotyped for mutations in the MEFV gene and gut bacterial diversity was assessed by sequencing 16S rRNA gene libraries and FISH analysis. These analyses demonstrated significant changes in bacterial community structure in FMF characterized by depletion of total numbers of bacteria, loss of diversity, and major shifts in bacterial populations within the Bacteroidetes, Firmicutes and Proteobacteria phyla in attack. In remission with no clinical signs of disease, bacterial diversity values were comparable with control but still, the bacterial composition was substantially deviant from the norm. Discriminant function analyses of gut bacterial diversity revealed highly specific, well-separated and distinct grouping, which depended on the allele carrier status of the host. Conclusions/Significance: This is the first report that clearly establishes the link between the host genotype and the corresponding shifts in the gut microbiota (the latter confirmed by two independent techniques). It suggests that the host genetics is a key factor in host-microbe interaction determining a specific profile of commensal microbiota in the human gut.	[Khachatryan, Zaruhi A.; Ktsoyan, Zhanna A.] Armenian Natl Acad Sci, Mol Genet Lab, Inst Mol Biol, Yerevan, Armenia; [Manukyan, Gayane P.; Ghazaryan, Karine A.] Armenian Natl Acad Sci, Inst Mol Biol, Grp Mol & Cellular Immunol, Yerevan, Armenia; [Kelly, Denise; Aminov, Rustam I.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB9 1FX, Scotland	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Aberdeen	Khachatryan, ZA (corresponding author), Armenian Natl Acad Sci, Mol Genet Lab, Inst Mol Biol, Yerevan, Armenia.	r.aminov@rowett.ac.uk	Manukyan, Gayane/AAR-7421-2020; Aminov, Rustam/AAF-9052-2019; Aminov, Rustam/C-8764-2016	Manukyan, Gayane/0000-0001-7541-5743; Aminov, Rustam/0000-0002-5811-8322; 	ISTC; RERAD	ISTC; RERAD	This work was funded by the ISTC (project A-1055). RIA is supported by the RERAD.	ADAMS RJ, 2007, AM J GASTROENTE 1006; Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493; Aksentijevich I, 1997, CELL, V90, P797; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Aminov RI, 2006, APPL ENVIRON MICROB, V72, P6371, DOI 10.1128/AEM.00701-06; Aypar E, 2003, J RHEUMATOL, V30, P2011; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bernot A, 1997, NAT GENET, V17, P25; Bonnet R, 2002, INT J SYST EVOL MICR, V52, P757, DOI 10.1099/00207713-52-3-757; Booth DR, 2000, QJM-INT J MED, V93, P217, DOI 10.1093/qjmed/93.4.217; Brydges S, 2006, CURR TOP MICROBIOL, V305, P127, DOI 10.1007/3-540-29714-6_7; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Centola M, 2000, BLOOD, V95, P3223, DOI 10.1182/blood.V95.10.3223; Chae JJ, 2006, P NATL ACAD SCI USA, V103, P9982, DOI 10.1073/pnas.0602081103; Chae JJ, 2003, MOL CELL, V11, P591, DOI 10.1016/S1097-2765(03)00056-X; Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469; Csordas A, 1996, EUR J CANCER PREV, V5, P221, DOI 10.1097/00008469-199608000-00002; Davtyan TK, 2006, PATHOBIOLOGY, V73, P26, DOI 10.1159/000093089; Diaz A, 2004, ARTHRITIS RHEUM-US, V50, P3679, DOI 10.1002/art.20600; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gershoni-Baruch R, 2001, EUR J HUM GENET, V9, P634, DOI 10.1038/sj.ejhg.5200672; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAGUE A, 1995, EUR J CANCER PREV, V4, P359, DOI 10.1097/00008469-199510000-00005; Harmsen Hermie J.M., 1999, Microbial Ecology in Health and Disease, V11, P3, DOI 10.1080/089106099435862; Harmsen HJM, 2000, APPL ENVIRON MICROB, V66, P4523, DOI 10.1128/AEM.66.10.4523-4527.2000; Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Kaparakis M, 2007, IMMUNOL CELL BIOL, V85, P495, DOI 10.1038/sj.icb.7100105; Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018; Kogan A, 2001, AM J MED GENET, V102, P272, DOI 10.1002/ajmg.1438; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; LANGENDIJK PS, 1995, APPL ENVIRON MICROB, V61, P3069, DOI 10.1128/AEM.61.8.3069-3075.1995; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manukyan GP, 2008, CLIN BIOCHEM, V41, P920, DOI 10.1016/j.clinbiochem.2008.03.017; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Matzner Y, 2000, BLOOD, V96, P727; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meng D, 2007, AM J PHYSIOL-GASTR L, V293, pG780, DOI 10.1152/ajpgi.00010.2007; Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560; Notarnicola C, 2002, ARTHRITIS RHEUM-US, V46, P2785, DOI 10.1002/art.10575; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ootsubo M, 2002, J APPL MICROBIOL, V93, P60, DOI 10.1046/j.1365-2672.2002.01668.x; Papin S, 2007, CELL DEATH DIFFER, V14, P1457, DOI 10.1038/sj.cdd.4402142; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poland DCW, 2001, ANN RHEUM DIS, V60, P777, DOI 10.1136/ard.60.8.777; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salminen S, 1998, BRIT J NUTR, V80, pS147, DOI 10.1079/BJN19980108; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0; Stoffman N, 2000, EUR J HUM GENET, V8, P307, DOI 10.1038/sj.ejhg.5200446; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Tajima K, 2001, APPL ENVIRON MICROB, V67, P2766, DOI 10.1128/AEM.67.6.2766-2774.2001; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Toivanen P, 2001, INFECT IMMUN, V69, P2372, DOI 10.1128/IAI.69.4.2372-2377.2001; Tunca M, 1999, LANCET, V353, P1415, DOI 10.1016/S0140-6736(99)00990-3; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yilmaz E, 2001, EUR J HUM GENET, V9, P553, DOI 10.1038/sj.ejhg.5200674; Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669	91	215	229	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3064	10.1371/journal.pone.0003064	http://dx.doi.org/10.1371/journal.pone.0003064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725973	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796300010
J	Medina, PMB; Worthen, RJ; Forsberg, LJ; Brenman, JE				Medina, Paul M. B.; Worthen, Ryan J.; Forsberg, Lawrence J.; Brenman, Jay E.			The Actin-Binding Protein Capulet Genetically Interacts with the Microtubule Motor Kinesin to Maintain Neuronal Dendrite Homeostasis	PLOS ONE			English	Article							CYCLASE-ASSOCIATED PROTEINS; AXONAL-TRANSPORT; ALZHEIMERS-DISEASE; CYTOPLASMIC ACTIN; MEDIATED NEURODEGENERATION; CYTOSKELETAL DYNAMICS; TYROSINE KINASE; COFILIN; DROSOPHILA; PROFILIN	Background: Neurons require precise cytoskeletal regulation within neurites, containing microtubule tracks for cargo transport in axons and dendrites or within synapses containing organized actin. Due to the unique architecture and specialized function of neurons, neurons are particularly susceptible to perturbation of the cytoskeleton. Numerous actinbinding proteins help maintain proper cytoskeletal regulation. Methodology/Principal Findings: From a Drosophila forward genetic screen, we identified a mutation in capulet-encoding a conserved actin-binding protein-that causes abnormal aggregates of actin within dendrites. Through interaction studies, we demonstrate that simultaneous genetic inactivation of capulet and kinesin heavy chain, a microtubule motor protein, produces elongate cofilin-actin rods within dendrites but not axons. These rods resemble actin-rich structures induced in both mammalian neurodegenerative and Drosophila Alzheimer's models, but have not previously been identified by loss of function mutations in vivo. We further demonstrate that mitochondria, which are transported by Kinesin, have impaired distribution along dendrites in a capulet mutant. While Capulet and Cofilin may biochemically cooperate in certain circumstances, in neuronal dendrites they genetically antagonize each other. Conclusions/Significance: The present study is the first molecularly defined loss of function demonstration of actin-cofilin rods in vivo. This study suggests that simultaneous, seemingly minor perturbations in neuronal dendrites can synergize producing severe abnormalities affecting actin, microtubules and mitochondria/energy availability in dendrites. Additionally, as >90% of Alzheimer's and Parkinson's cases are sporadic this study suggests mechanisms by which multiple mutations together may contribute to neurodegeneration instead of reliance on single mutations to produce disease.	[Medina, Paul M. B.; Worthen, Ryan J.; Forsberg, Lawrence J.; Brenman, Jay E.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA; [Brenman, Jay E.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Medina, PMB (corresponding author), Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC 27515 USA.	brenman@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022	Worthen, Ryan Joseph/0000-0002-2010-5876	NIMH; Whitehall Foundation for Neurobiology	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Whitehall Foundation for Neurobiology	Funding to J.E.B. from NIMH and Whitehall Foundation for Neurobiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguda AH, 2006, STRUCTURE, V14, P469, DOI 10.1016/j.str.2005.12.011; Andersen R, 2005, J NEUROSCI, V25, P8878, DOI 10.1523/JNEUROSCI.2005-05.2005; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Benlali A, 2000, CELL, V101, P271, DOI 10.1016/S0092-8674(00)80837-5; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Chen H, 2004, BIOCHEMISTRY-US, V43, P7127, DOI 10.1021/bi049797n; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Didry D, 1998, J BIOL CHEM, V273, P25602, DOI 10.1074/jbc.273.40.25602; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gallo G, 2007, NAT CELL BIOL, V9, P133, DOI 10.1038/ncb0207-133; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Hurd DD, 1996, GENETICS, V144, P1075; Ichetovkin I, 2002, CURR BIOL, V12, P79, DOI 10.1016/S0960-9822(01)00629-7; Idrissi FZ, 2002, MOL BIOL CELL, V13, P4074, DOI 10.1091/mbc.02-04-0052; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Lace GL, 2007, CLIN NEUROPATHOL, V26, P43; Maciver SK, 2002, GENOME BIOL, V3; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761; Martin M, 2005, MOL BIOL CELL, V16, P4225, DOI 10.1091/mbc.E05-02-0116; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Medina PMB, 2006, GENETICS, V172, P2325, DOI 10.1534/genetics.105.051276; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Moriyama K, 2002, J CELL SCI, V115, P1591; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Suetsugu S, 1998, EMBO J, V17, P6516, DOI 10.1093/emboj/17.22.6516; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Yeoh S, 2002, J MOL BIOL, V315, P911, DOI 10.1006/jmbi.2001.5280	57	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3054	10.1371/journal.pone.0003054	http://dx.doi.org/10.1371/journal.pone.0003054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725959	Green Published, gold, Green Submitted			2022-12-27	WOS:000264429000007
J	Lobner-Olesen, A; Slominska-Wojewodzka, M; Hansen, FG; Marinus, MG				Lobner-Olesen, Anders; Slominska-Wojewodzka, Monika; Hansen, Flemming G.; Marinus, Martin G.			DnaC Inactivation in Escherichia coli K-12 Induces the SOS Response and Expression of Nucleotide Biosynthesis Genes	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; CHROMOSOME-REPLICATION; TRANSCRIPTION; PROTEIN; INITIATOR; CYCLE; ORIGIN; DAM; IDENTIFICATION; MECHANISM	Background: Initiation of chromosome replication in E. coli requires the DnaA and DnaC proteins and conditionally-lethal dnaA and dnaC mutants are often used to synchronize cell populations. Methodology/Principal Findings: DNA microarrays were used to measure mRNA steady-state levels in initiation-deficient dnaA46 and dnaC2 bacteria at permissive and non-permissive temperatures and their expression profiles were compared to MG1655 wildtype cells. For both mutants there was altered expression of genes involved in nucleotide biosynthesis at the non-permissive temperature. Transcription of the dnaA and dnaC genes was increased at the non-permissive temperature in the respective mutant strains indicating auto-regulation of both genes. Induction of the SOS regulon was observed in dnaC2 cells at 38 degrees C and 42 degrees C. Flow cytometric analysis revealed that dnaC2 mutant cells at non-permissive temperature had completed the early stages of chromosome replication initiation. Conclusion/Significance: We suggest that in dnaC2 cells the SOS response is triggered by persistent open-complex formation at oriC and/or by arrested forks that require DnaC for replication restart.	[Lobner-Olesen, Anders] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Slominska-Wojewodzka, Monika] Univ Gdansk, Dept Mol Biol, PL-80952 Gdansk, Poland; [Hansen, Flemming G.] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, Lyngby, Denmark; [Marinus, Martin G.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA USA	Roskilde University; Fahrenheit Universities; University of Gdansk; Technical University of Denmark; University of Massachusetts System; University of Massachusetts Worcester	Lobner-Olesen, A (corresponding author), Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark.	martin.marinus@umassmed.edu	Løbner-Olesen, Anders/K-4344-2014	Løbner-Olesen, Anders/0000-0002-0344-6417; Slominska-Wojewodzka, Monika/0000-0001-6609-6381	Danish Natural Science Research Council; Danish Medical Research Council; Novo Nordisk Foundation; US National Institutes of Health [GM63790]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063790] Funding Source: NIH RePORTER	Danish Natural Science Research Council(Danish Natural Science Research Council); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Danish Natural Science Research Council, The Danish Medical Research Council, The Novo Nordisk Foundation and the US National Institutes of Heath grant GM63790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRAJ JA, 1983, J BACTERIOL, V153, P562, DOI 10.1128/JB.153.1.562-565.1983; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; Bruand C, 2001, MOL MICROBIOL, V42, P245, DOI 10.1046/j.1365-2958.2001.02631.x; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; CHIARAMELLO AE, 1990, J BACTERIOL, V172, P2013, DOI 10.1128/jb.172.4.2013-2019.1990; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Davey MJ, 2002, EMBO J, V21, P3148, DOI 10.1093/emboj/cdf308; FILPULA D, 1977, J BACTERIOL, V130, P107, DOI 10.1128/JB.130.1.107-113.1977; FREE A, 1995, MOL MICROBIOL, V18, P101, DOI 10.1111/j.1365-2958.1995.mmi_18010101.x; GIBERT I, 1990, MOL GEN GENET, V220, P400, DOI 10.1007/BF00391745; GILLE H, 1991, EMBO J, V10, P1579, DOI 10.1002/j.1460-2075.1991.tb07678.x; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; Herrick J, 2007, MOL MICROBIOL, V63, P22, DOI 10.1111/j.1365-2958.2006.05493.x; Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191; Ishigo-oka D, 2001, J BACTERIOL, V183, P2148, DOI 10.1128/JB.183.6.2148-2150.2001; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Lobner-Olesen A, 2003, P NATL ACAD SCI USA, V100, P4672, DOI 10.1073/pnas.0538053100; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; MASAI H, 1988, J BIOL CHEM, V263, P15083; McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; OGAWA T, 1994, J BACTERIOL, V176, P1609, DOI 10.1128/jb.176.6.1609-1615.1994; Park K, 1998, J BIOL CHEM, V273, P24906, DOI 10.1074/jbc.273.38.24906; PLATT T, 1980, OPERON, P263; Podkovyrov SM, 1996, NUCLEIC ACIDS RES, V24, P1747, DOI 10.1093/nar/24.9.1747; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; SUN L, 1992, MOL BIOL CELL, V3, P1095, DOI 10.1091/mbc.3.10.1095; SUN L, 1994, J BACTERIOL, V176, P2415, DOI 10.1128/JB.176.8.2415-2426.1994; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998; Zhang WK, 2006, J BACTERIOL, V188, P5487, DOI 10.1128/JB.00339-06; Zhou P, 1997, J BACTERIOL, V179, P163, DOI 10.1128/jb.179.1.163-169.1997; ZHOU P, 1994, J BACTERIOL, V176, P6100, DOI 10.1128/jb.176.19.6100-6106.1994	47	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2984	10.1371/journal.pone.0002984	http://dx.doi.org/10.1371/journal.pone.0002984			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714349	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900011
J	Gounaris, E; Tung, CH; Restaino, C; Maehr, R; Kohler, R; Joyce, JA; Plough, HL; Barrett, TA; Weissleder, R; Khazaie, K				Gounaris, Elias; Tung, Ching H.; Restaino, Clifford; Maehr, Rene; Kohler, Rainer; Joyce, Johanna A.; Plough, Hidde L.; Barrett, Terrence A.; Weissleder, Ralph; Khazaie, Khashayarsha			Live Imaging of Cysteine-Cathepsin Activity Reveals Dynamics of Focal Inflammation, Angiogenesis, and Polyp Growth	PLOS ONE			English	Article							INTESTINAL ADENOMAS; TARGET; CANCER; APC; PROTEASES; MODELS; ROLES; CELLS	It has been estimated that up to 30% of detectable polyps in patients regress spontaneously. One major challenge in the evaluation of effective therapy of cancer is the readout for tumor regression and favorable biological response to therapy. Inducible near infra-red (NIR) fluorescent probes were utilized to visualize intestinal polyps of mice hemizygous for a novel truncation of the Adenomatous Polyposis coli (APC) gene. Laser Scanning Confocal Microscopy in live mice allowed visualization of cathepsin activity in richly vascularized benign dysplastic lesions. Using biotinylated suicide inhibitors we quantified increased activities of the Cathepsin B & Z in the polyps. More than 3/4 of the probe signal was localized in CD11b(+)Gr1(+) myeloid derived suppressor cells (MDSC) and CD11b(+)F4/80(+) macrophages infiltrating the lesions. Polyposis was attenuated through genetic ablation of cathepsin B, and suppressed by neutralization of TNF alpha in mice. In both cases, diminished probe signal was accounted for by loss of MDSC. Thus, in vivo NIR imaging of focal cathepsin activity reveals inflammatory reactions etiologically linked with cancer progression and is a suitable approach for monitoring response to therapy.	[Gounaris, Elias; Tung, Ching H.; Restaino, Clifford; Kohler, Rainer; Weissleder, Ralph; Khazaie, Khashayarsha] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Gounaris, Elias; Barrett, Terrence A.; Khazaie, Khashayarsha] Northwestern Univ, Robert Lurie Comprehensive Canc Ctr, Feinberg Sch Med, Div Gastroenterol, Chicago, IL USA; [Joyce, Johanna A.] Memorial Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY USA; [Plough, Hidde L.] MIT, Whitehead Inst, Cambridge, MA USA; [Tung, Ching H.] Weill Cornell Med Coll, Methodist Hosp Res Inst, Houston, TX USA; [Maehr, Rene] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA USA; [Maehr, Rene] Howard Hughes Med Inst, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Massachusetts Institute of Technology (MIT); Whitehead Institute; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; Harvard University; Howard Hughes Medical Institute	Gounaris, E (corresponding author), Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA.	khazaie@northwestern.edu	Gounaris, Elias/B-3184-2011; Tung, Ching-Hsuan/AHC-5070-2022; Tung, Ching-Hsuan/AIE-6009-2022	Tung, Ching-Hsuan/0000-0001-6648-6195; Tung, Ching-Hsuan/0000-0001-6648-6195; Gounaris, Elias/0000-0001-8679-9711; Barrett, Terrence/0000-0001-6428-3271; /0000-0003-0828-4143	NIH [R01 CA104547-03, R01-CA125162]; American Cancer Society [113422]; NATIONAL CANCER INSTITUTE [R01CA104547, R01CA125162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIH R01 CA104547-03 (KK), and American Cancer Society Research Scholar Grant, 113422 RSG (KK), NIH R01-CA125162 (JAJ).	Aggarwal BB, 2006, E SCHERING RES FDN W, V56, P161; Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Bertagnolli MM, 1999, ANN NY ACAD SCI, V889, P32, DOI 10.1111/j.1749-6632.1999.tb08721.x; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Bremer C, 2001, NAT MED, V7, P743, DOI 10.1038/89126; Carothers AM, 2006, CANCER RES, V66, P6432, DOI 10.1158/0008-5472.CAN-06-0992; Chen Wei-Tsung, 2005, Mol Imaging, V4, P67; Choo-Kang BSW, 2005, TRENDS IMMUNOL, V26, P518, DOI 10.1016/j.it.2005.07.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Erdman SE, 2005, CANCER RES, V65, P3998, DOI 10.1158/0008-5472.CAN-04-3104; Feng D, 2000, MICROVASC RES, V59, P24, DOI 10.1006/mvre.1999.2207; FUVONIC M, 2003, MOL IMAGING, V2, P350; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gounaris E, 2007, P NATL ACAD SCI USA, V104, P19977, DOI 10.1073/pnas.0704620104; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Hang HC, 2006, ACS CHEM BIOL, V1, P713, DOI 10.1021/cb600431a; Jacoby RF, 1996, CANCER RES, V56, P710; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kollias G, 2005, SEMIN ARTHRITIS RHEU, V34, P3, DOI 10.1016/j.semarthrit.2005.01.002; Lennon-Dumenil AM, 2002, J EXP MED, V196, P529, DOI 10.1084/jem.20020327; Marten K, 2002, GASTROENTEROLOGY, V122, P406, DOI 10.1053/gast.2002.30990; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Rao VP, 2006, CANCER RES, V66, P7395, DOI 10.1158/0008-5472.CAN-06-0558; Sadaghiani AM, 2007, CHEM BIOL, V14, P499, DOI 10.1016/j.chembiol.2007.03.010; Sloane BF, 2005, SEMIN CANCER BIOL, V15, P149, DOI 10.1016/j.semcancer.2004.08.001; Szlosarek PW, 2003, LANCET ONCOL, V4, P565, DOI 10.1016/S1470-2045(03)01196-3; Tung CH, 2000, CANCER RES, V60, P4953; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463	32	91	97	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2916	10.1371/journal.pone.0002916	http://dx.doi.org/10.1371/journal.pone.0002916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698347	Green Published, gold			2022-12-27	WOS:000264412600004
J	Mardulyn, P; Vaesen, MA; Milinkovitch, MC				Mardulyn, Patrick; Vaesen, Marie-Anne; Milinkovitch, Michel C.			Controlling Population Evolution in the Laboratory to Evaluate Methods of Historical Inference	PLOS ONE			English	Article							MIGRATION RATES; CONSERVATION GENETICS; MAXIMUM-LIKELIHOOD; SIZE; POLYMORPHISM; PERFORMANCE; BOTTLENECKS; DROSOPHILA; EXPANSION; FLOW	Natural populations of known detailed past demographic history are extremely valuable to evaluate methods of historical inference, yet are extremely rare. As an alternative approach, we have generated multiple replicate microsatellite data sets from laboratory-cultured populations of a gonochoric free-living nematode, Caenorhabditis remanei, that were constrained to pre-defined demographic histories featuring different levels of migration among populations or bottleneck events of different magnitudes. These data sets were then used to evaluate the performances of two recently developed population genetics methods, BAYESASS+, that estimates recent migration rates among populations, and BOTTLENECK, that detects the occurrence of recent bottlenecks. Migration rates inferred by BAYESASS+ were generally over-estimates, although these were often included within the confidence interval. Analyses of data sets simulated in-silico, using a model mimicking the laboratory experiments, produced less biased estimates of the migration rates, and showed increased efficiency of the program when the number of loci and sampled genotypes per population was higher. In the replicates for which the prebottleneck laboratory-cultured populations did not significantly depart from a mutation/drift equilibrium, an important assumption of the program BOTTLENECK, only a portion of the bottleneck events were detected. This result was confirmed by in-silico simulations mirroring the laboratory bottleneck experiments. More generally, our study demonstrates the feasibility, and highlights some of the limits, of the approach that consists in generating molecular genetic data sets by controlling the evolution of laboratory-reared nematode populations, for the purpose of validating methods inferring population history.	[Mardulyn, Patrick; Vaesen, Marie-Anne; Milinkovitch, Michel C.] Free Univ Brussels, Lab Evolutionary Genet, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel	Mardulyn, P (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	pmarduly@ulb.ac.be		Milinkovitch, Michel/0000-0002-2553-0724				Abdo ZAID, 2004, MOL ECOL, V13, P837, DOI 10.1111/j.1365-294X.2004.02132.x; BAIRD SE, 1992, EVOLUTION, V46, P585, DOI [10.2307/2409629, 10.1111/j.1558-5646.1992.tb02067.x]; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2002, GENETICS, V162, P2025; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Caldicott IM, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 1, P398; Cornuet JM, 1996, GENETICS, V144, P2001; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Dolgin ES, 2007, EVOLUTION, V61, P1339, DOI 10.1111/j.1558-5646.2007.00118.x; Excoffier L, 2006, NAT REV GENET, V7, P745, DOI 10.1038/nrg1904; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Frankham R, 1999, HEREDITAS, V130, P195, DOI 10.1111/j.1601-5223.1999.00195.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Graustein A, 2002, GENETICS, V161, P99; Hahn MW, 2002, GENETICS, V161, P11; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; HILLIS DM, 1992, SCIENCE, V255, P589, DOI 10.1126/science.1736360; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Nei M., 1987, MOL EVOLUTIONARY GEN; Pearse DE, 2004, CONSERV GENET, V5, P585, DOI 10.1007/s10592-003-1863-4; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Wang JL, 2003, GENETICS, V163, P429; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Williamson-Natesan EG, 2005, CONSERV GENET, V6, P551, DOI 10.1007/s10592-005-9009-5; Wilson GA, 2003, GENETICS, V163, P1177; WOODWORTH LM, 1994, MOL ECOL, V3, P393, DOI 10.1111/j.1365-294X.1994.tb00079.x; Wright S, 1931, GENETICS, V16, P0097	34	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2960	10.1371/journal.pone.0002960	http://dx.doi.org/10.1371/journal.pone.0002960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698364	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600045
J	Yoon, YJ; Kominami, H; Trimarchi, T; Martin-Caraballo, M				Yoon, Yone Jung; Kominami, Hisashi; Trimarchi, Thomas; Martin-Caraballo, Miguel			Inhibition of Electrical Activity by Retroviral Infection with Kir2.1 Transgenes Disrupts Electrical Differentiation of Motoneurons	PLOS ONE			English	Article								Network-driven spontaneous electrical activity in the chicken spinal cord regulates a variety of developmental processes including neuronal differentiation and formation of neuromuscular structures. In this study we have examined the effect of chronic inhibition of spinal cord activity on motoneuron survival and differentiation. Early spinal cord activity in chick embryos was blocked using an avian replication-competent retroviral vector RCASBP(B) carrying the inward rectifier potassium channel Kir2.1. Chicken embryos were infected with one of the following constructs: RCASBP(B), RCASBP(B)Kir2.1, or RCASBP(B)-GFP. Infection of chicken embryos at E2 resulted in widespread expression of the viral protein marker p27 gag throughout the spinal cord. Electrophysiological recordings revealed the presence of functional Kir2.1 channels in RCASBP(B)-Kir2.1 but not in RCASBP(B)-infected embryos. Kir2.1 expression significantly reduced the generation of spontaneous motor movements in chicken embryos developing in ovo. Suppression of spontaneous electrical activity was not due to a reduction in the number of surviving motoneurons or the number of synapses in hindlimb muscle tissue. Disruption of the normal pattern of activity in chicken embryos resulted in a significant downregulation in the functional expression of large-conductance Ca(2+)-dependent K(+) channels. Reduction of spinal cord activity also generates a significant acceleration in the inactivation rate of A-type K(+) currents without any significant change in current density. Kir2.1 expression did not affect the expression of voltage-gated Na(+) channels or cell capacitance. These experiments demonstrate that chronic inhibition of chicken spinal cord activity causes a significant change in the electrical properties of developing motoneurons.	[Yoon, Yone Jung; Kominami, Hisashi; Trimarchi, Thomas; Martin-Caraballo, Miguel] Univ Vermont, Dept Biol, Burlington, VT USA	University of Vermont	Yoon, YJ (corresponding author), Univ Vermont, Dept Biol, Burlington, VT USA.	miguel.martin-caraballo@uvm.edu		Yoon, YoneJung/0000-0002-1608-2122	NIH [P20 RR016435]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH grant P20 RR016435 from the National Center for Research Resources.	Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Caldero J, 1997, J COMP NEUROL, V387, P73; Caldero J, 1998, J NEUROSCI, V18, P356; Casavant RH, 2004, J NEUROPHYSIOL, V92, P2644, DOI 10.1152/jn.00307.2004; Chen L, 2004, EUR J NEUROSCI, V20, P956, DOI 10.1111/j.1460-9568.2004.03553.x; Chub N, 2006, J NEUROPHYSIOL, V95, P323, DOI 10.1152/jn.00162.2005; Chub N, 1998, J NEUROSCI, V18, P294; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; CHUWANG IW, 1978, J COMP NEUROL, V177, P33, DOI 10.1002/cne.901770105; DAHM LM, 1991, J NEUROSCI, V11, P238; Dhamoon AS, 2005, HEART RHYTHM, V2, P316, DOI 10.1016/j.hrthm.2004.11.012; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Finn TP, 1998, J NEUROBIOL, V34, P283, DOI 10.1002/(SICI)1097-4695(19980215)34:3<283::AID-NEU7>3.0.CO;2-Z; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HAMBURGER V, 1963, DEV BIOL, V7, P533, DOI 10.1016/0012-1606(63)90140-4; Hanson MG, 2006, J NEUROSCI, V26, P12769, DOI 10.1523/JNEUROSCI.4170-06.2006; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; HO S, 1993, J NEUROSCI, V13, P1354; Hollenbeck PJ, 2003, METHOD CELL BIOL, V71, P369, DOI 10.1016/S0091-679X(03)01018-5; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Hughes SH, 2004, FOLIA BIOL-PRAGUE, V50, P107; Jarvis JC, 1996, AM J PHYSIOL-CELL PH, V270, pC306, DOI 10.1152/ajpcell.1996.270.1.C306; Johns DC, 1999, J NEUROSCI, V19, P1691; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; LANDMESSER LT, 1986, J PHYSIOL-LONDON, V380, P157, DOI 10.1113/jphysiol.1986.sp016278; LERAY CF, 1993, J NEUROBIOL, V24, P1142, DOI 10.1002/neu.480240903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLean JN, 2005, J NEUROPHYSIOL, V94, P3601, DOI 10.1152/jn.00281.2005; MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2; Martin-Caraballo M, 2000, J NEUROPHYSIOL, V83, P3497, DOI 10.1152/jn.2000.83.6.3497; Martin-Caraballo M, 2002, J NEUROSCI, V22, P73, DOI 10.1523/JNEUROSCI.22-01-00073.2002; Martin-Caraballo M, 1999, J NEUROPHYSIOL, V81, P1365, DOI 10.1152/jn.1999.81.3.1365; MCCOBB DP, 1990, J NEUROSCI, V10, P2974; Mellor JR, 1998, J NEUROSCI, V18, P2822; Milner LD, 1999, J NEUROSCI, V19, P3007; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Ni X, 2007, DEV NEUROBIOL, V67, P1419, DOI 10.1002/dneu.20517; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; Oppenheim RW, 2003, MOL CELL NEUROSCI, V22, P331, DOI 10.1016/S1044-7431(02)00020-9; Oppenheim RW, 1997, J COMP NEUROL, V381, P353, DOI 10.1002/(SICI)1096-9861(19970512)381:3<353::AID-CNE7>3.0.CO;2-1; Oppenheim RW, 2000, J NEUROSCI, V20, P6117, DOI 10.1523/JNEUROSCI.20-16-06117.2000; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; PERSSON M, 1983, J ANAT, V137, P591; PHILLIPS WD, 1987, J NEUROCYTOL, V16, P1, DOI 10.1007/BF02456693; PHILLIPS WD, 1987, J NEUROCYTOL, V16, P785, DOI 10.1007/BF01611986; Sato N, 2002, J NEUROBIOL, V53, P381, DOI 10.1002/neu.10108; Soler RM, 1998, J NEUROSCI, V18, P1230; TANG JC, 1993, J NEUROSCI, V13, P3095; Topert C, 1998, J NEUROSCI, V18, P4096; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Usiak MF, 1999, J NEUROSCI, V19, P7925	55	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2971	10.1371/journal.pone.0002971	http://dx.doi.org/10.1371/journal.pone.0002971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698433	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600055
J	Heisel, SE; Zhang, YJ; Allen, E; Guo, L; Reynolds, TL; Yang, X; Kovalic, D; Roberts, JK				Heisel, Sara E.; Zhang, Yuanji; Allen, Edwards; Guo, Liang; Reynolds, Tracey L.; Yang, Xiao; Kovalic, David; Roberts, James K.			Characterization of Unique Small RNA Populations from Rice Grain	PLOS ONE			English	Article							REGULATORY ROLES; MICRORNAS; DNA; BIOGENESIS; GENES; ACCUMULATION; ARGONAUTE4; RESOURCE; SIRNAS; DICER	Small RNAs (similar to 20 to 24 nucleotides) function as naturally occurring molecules critical in developmental pathways in plants and animals [1,2]. Here we analyze small RNA populations from mature rice grain and seedlings by pyrosequencing. Using a clustering algorithm to locate regions producing small RNAs, we classified hotspots of small RNA generation within the genome. Hotspots here are defined as 1 kb regions within which small RNAs are significantly overproduced relative to the rest of the genome. Hotspots were identified to facilitate characterization of different categories of small RNA regulatory elements. Included in the hotspots, we found known members of 23 miRNA families representing 92 genes, one trans acting siRNA (ta-siRNA) gene, novel siRNA-generating coding genes and phased siRNA generating genes. Interestingly, over 20% of the small RNA population in grain came from a single foldback structure, which generated eight phased 21-nt siRNAs. This is reminiscent of a newly arising miRNA derived from duplication of progenitor genes [3,4]. Our results provide data identifying distinct populations of small RNAs, including phased small RNAs, in mature grain to facilitate characterization of small regulatory RNA expression in monocot species.	[Heisel, Sara E.; Zhang, Yuanji; Allen, Edwards; Guo, Liang; Reynolds, Tracey L.; Yang, Xiao; Kovalic, David; Roberts, James K.] Monsanto Co, Chesterfield, MO USA	Monsanto	Heisel, SE (corresponding author), Monsanto Co, Chesterfield, MO USA.	ed.m.allen@monsanto.com		Allen, Edwards/0000-0002-8318-6319	Monsanto Company	Monsanto Company	This work was funded by Monsanto Company.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gale MD, 1998, SCIENCE, V282, P656, DOI 10.1126/science.282.5389.656; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Hong BJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni109; Johnson C, 2007, NUCLEIC ACIDS RES, V35, pD829, DOI 10.1093/nar/gkl991; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kagaya Y, 2005, PLANT CELL PHYSIOL, V46, P399, DOI 10.1093/pcp/pci048; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Katiyar-Agarwal S, 2007, GENE DEV, V21, P3123, DOI 10.1101/gad.1595107; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Liu B, 2007, PLANT CELL, V19, P2705, DOI 10.1105/tpc.107.052209; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2006, GENOME RES, V16, P1276, DOI 10.1101/gr.5530106; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; LURIN C, 2004, PLANT CELL TPC, V104; MALLORY AC, 2006, NAT GENT S, V38; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037; Meyers BC, 2004, PLANT PHYSIOL, V135, P801, DOI 10.1104/pp.104.039495; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Qi YJ, 2006, NATURE, V443, P1008, DOI 10.1038/nature05198; QIU S, 2005, NUCL ACIDS RES, V33; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Wang Y, 2004, PLANT PHYSIOL, V135, P400, DOI 10.1104/pp.103.037945; XIE Z, 2005, PLANT PHYSL; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	46	59	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2871	10.1371/journal.pone.0002871	http://dx.doi.org/10.1371/journal.pone.0002871			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18716673	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600027
J	Neena, J; Rachel, J; Praveen, V; Murthy, GVS				Neena, John; Rachel, Jose; Praveen, Vashist; Murthy, Gudlavalleti V. S.		RAAB India Study Grp	Rapid Assessment of Avoidable Blindness in India	PLOS ONE			English	Article							CATARACT BLINDNESS; EYE SURVEY; VISUAL IMPAIRMENT; VISION IMPAIRMENT; OLDER ADULTS; DISTRICT; POPULATION; PREVALENCE	Background: Rapid assessment of avoidable blindness provides valid estimates in a short period of time to assess the magnitude and causes of avoidable blindness. The study determined magnitude and causes of avoidable blindness in India in 2007 among the 50+ population. Methods and Findings: Sixteen randomly selected districts where blindness surveys were undertaken 7 to 10 years earlier were identified for a follow up survey. Stratified cluster sampling was used and 25 clusters (20 rural and 5 urban) were randomly picked in each district.. After a random start, 100 individuals aged 50+ were enumerated and examined sequentially in each cluster. All those with presenting vision <6/18 were dilated and examined by an ophthalmologist. 42722 individuals aged >=50 years were enumerated, and 94.7% examined. Based on presenting vision,, 4.4% (95% Confidence Interval[CI]: 4.1,4.8) were severely visually impaired (vision <6/60 to 3/60 in the better eye) and 3.6% (95% CI: 3.3,3.9) were blind (vision<3/60 in the better eye). Prevalence of low vision (< 6/18 to 6/60 in the better eye) was 16.8% (95% CI: 16.0,17.5). Prevalence of blindness and severe visual impairment (<6/60 in the better eye) was higher among rural residents (8.2%; 95% CI: 7.9,8.6) compared to urban (7.1%; 95% CI: 5.0, 9.2), among females (9.2%; 95% CI: 8.6,9.8) compared to males (6.5%; 95% CI: 6.0,7.1) and people above 70 years (20.6%; 95% CI: 19.1,22.0) compared to people aged 50-54 years (1.3%; 95% CI: 1.1,1.6). Of all blindness, 88.2% was avoidable. of which 81.9% was due to cataract and 7.1% to uncorrected refractive errors/uncorrected aphakia. Conclusions: Cataract and refractive errors are major causes of blindness and low vision and control strategies should prioritize them. Most blindness and low vision burden is avoidable.	[Neena, John; Praveen, Vashist; Murthy, Gudlavalleti V. S.] All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, Community Ophthalmol Unit, New Delhi, India; [Rachel, Jose] Gov India, Minist Hlth & Family Welfare, Hlth Serv, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Neena, J (corresponding author), All India Inst Med Sci, Dr RP Ctr Ophthalm Sci, Community Ophthalmol Unit, New Delhi, India.	gvsmurthy2000@yahoo.com			National Programme for Control of Blindness; Ministry of Health and Family Welfare; Government of India	National Programme for Control of Blindness; Ministry of Health and Family Welfare; Government of India	The survey was funded by the National Programme for Control of Blindness, Ministry of Health and Family Welfare, Government of India.	Amansakhatov S, 2002, BRIT J OPHTHALMOL, V86, P1207, DOI 10.1136/bjo.86.11.1207; [Anonymous], 1998, Health Millions, V24, P20; Bachani D, 2000, Indian J Public Health, V44, P82; BANTHIA JK, 2004, CENSUS INDIA 2001 FI; Beltranena F, 2007, OPHTHALMOLOGY, V114, P1558, DOI 10.1016/j.ophtha.2006.11.015; Chandrashekhar TS, 2007, TROP DOCT, V37, P18, DOI 10.1258/004947507779952113; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dineen B, 2006, OPHTHAL EPIDEMIOL, V13, P31, DOI 10.1080/09286580500473787; Duerksen R, 2003, OPHTHAL EPIDEMIOL, V10, P349, DOI 10.1076/opep.10.5.349.17326; Haider S, 2003, OPHTHALMIC EPIDEMIOL, V10, P249, DOI 10.1076/opep.10.4.249.15907; Jose R, 1995, Indian J Ophthalmol, V43, P35; Kuper Hannah, 2006, Community Eye Health, V19, P68; Kuper H, 2006, PLOS MED, V3, P2192, DOI 10.1371/journal.pmed.0030476; Limburg H, 1998, Ophthalmic Epidemiol, V5, P211, DOI 10.1076/opep.5.4.211.4193; Limburg H, 1996, BRIT J OPHTHALMOL, V80, P951, DOI 10.1136/bjo.80.11.951; Limburg H, 1997, INT J EPIDEMIOL, V26, P1049, DOI 10.1093/ije/26.5.1049; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Limburg Hans, 1996, Indian Journal of Ophthalmology, V44, P241; Mathenge W, 2007, PLOS MED, V4, P1187, DOI 10.1371/journal.pmed.0040217; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; MOHAN M, 1987, COLLABORATIVE STUDY; Mohan M., 1989, NATL SURVEY BLINDNES; Murthy GVS, 2001, OPHTHALMOLOGY, V108, P679, DOI 10.1016/S0161-6420(00)00579-0; Nirmalan PK, 2002, BRIT J OPHTHALMOL, V86, P505, DOI 10.1136/bjo.86.5.505; Prakash Indira Jai, 2003, J Aging Soc Policy, V15, P85, DOI 10.1300/J031v15n02_06; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Thulasiraj RD, 2003, OPHTHALMOLOGY, V110, P1491, DOI 10.1016/S0161-6420(03)00565-7; Thulasiraj RD, 2002, OPHTHALMIC EPIDEMIOL, V9, P299, DOI 10.1076/opep.9.5.299.10334; Venkata G, 2005, BRIT J OPHTHALMOL, V89, P257, DOI 10.1136/bjo.2004.056937; Vijaya L, 2006, BRIT J OPHTHALMOL, V90, P407, DOI 10.1136/bjo.2005.081406; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Wu Min, 2007, Community Eye Health, V20, P10	32	113	113	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2867	10.1371/journal.pone.0002867	http://dx.doi.org/10.1371/journal.pone.0002867			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682738	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000264366600023
J	Phiri, KS; Calis, JCJ; Faragher, B; Nkhoma, E; Ng'oma, K; Mangochi, B; Molyneux, ME; van Hensbroek, MB				Phiri, Kamija S.; Calis, Job C. J.; Faragher, Brian; Nkhoma, Ernest; Ng'oma, Kondwani; Mangochi, Bridget; Molyneux, Malcolm E.; van Hensbroek, Michael Boele			Long Term Outcome of Severe Anaemia in Malawian Children	PLOS ONE			English	Article								Background: Severe anaemia is a common, frequently fatal, condition in African children admitted to hospital, but its long term outcome is unknown. Early reports that survivors may be at risk of additional late morbidity and mortality may have significant implications for child survival in Africa. We assessed the short and long term outcome of severe anaemia in Malawian children and identified potential risk factors for death and further severe anaemia. Methodology and Findings: For 18 months, we followed up children (6-60 months old) presenting to hospital with severe anaemia (haemoglobin <= 5g/dl) and their hospital and community controls with the aim to compare all cause mortality and severe anaemia recurrence rates between the groups, and to identify risk factors for these adverse outcomes. A total of 377 cases, 377 hospital controls and 380 community controls were recruited. Among cases, the in-hospital mortality was 6.4% and post-discharge all cause mortality was 12.6%, which was significantly greater than in hospital controls (2.9%) or community controls (1.4%) (Log rank test, p<0.001). The incidence of recurrence of severe anaemia among the cases was 0.102 per child-year (95% Confidence Interval 0.075-0.138), and was significantly higher than the 0.007 per child-year (95% CI 0.003-0.015) in the combined controls (p<0.0001). HIV was the most important risk factor both for post-discharge mortality (Hazard Ratio 10.5, 95% CI 4.0-27.2) and for recurrence of severe anaemia (HR 5.6, 95% CI 1.6-20.1). Conclusions: Severe anaemia carries a high 'hidden' morbidity and mortality occurring in the months after initial diagnosis and treatment. Because severe anaemia is very common, this is likely to contribute importantly to overall under-five mortality. If not adequately addressed, severe anaemia may be an obstacle to achievement of the Millennium development goal No. 4 on child survival. Strategies to diagnose and properly treat HIV infected children early most likely will reduce the high post-discharge mortality in severe anaemia.	[Phiri, Kamija S.; Calis, Job C. J.; Nkhoma, Ernest; Ng'oma, Kondwani; Mangochi, Bridget; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Calis, Job C. J.; van Hensbroek, Michael Boele] Univ Amsterdam, Emma Childrens Hosp AMC, Amsterdam, Netherlands; [Faragher, Brian; Molyneux, Malcolm E.; van Hensbroek, Michael Boele] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England	University of Malawi; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine	Phiri, KS (corresponding author), Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi.	kamijaphiri@gmail.com		Phiri, Kamija/0000-0003-1753-2727; Boele van Hensbroek, Michael/0000-0003-1907-5427	Wellcome Trust [064772]; Numico and Ter Meulen foundation; Gates Malaria Partnership	Wellcome Trust(Wellcome TrustEuropean Commission); Numico and Ter Meulen foundation(Danone NutriciaRoyal Numico N.V.); Gates Malaria Partnership	The study was supported by a grant from the Wellcome Trust (Career Development Fellowship 064772 to Dr M. Boele van Hensbroek). There were further contributions from Numico and Ter Meulen foundation (for J. Calis) and Gates Malaria Partnership (for K. Phiri). The sponsor of the study had no role in the study design, data collection, data analysis, data interpretations, or writing of this report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Bojang KA, 1997, T ROY SOC TROP MED H, V91, P557, DOI 10.1016/S0035-9203(97)90025-0; Bojang KA, 1997, ANN TROP PAEDIATR, V17, P355, DOI 10.1080/02724936.1997.11747910; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Cross Continents Collaboration for Kids (3Cs4kids) Analysis and Writing Committee, 2008, AIDS, V22, P97; Deressa W, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-128; Dicko A, 2004, BLOOD, V104, P1198, DOI 10.1182/blood-2003-11-3884; Graham SM, 2000, PEDIATR INFECT DIS J, V19, P1189, DOI 10.1097/00006454-200012000-00016; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Koram KA, 2000, AM J TROP MED HYG, V62, P670, DOI 10.4269/ajtmh.2000.62.670; LACKRITZ EM, 1992, LANCET, V340, P524, DOI 10.1016/0140-6736(92)91719-O; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; May J, 2000, J INFECT DIS, V182, P1570, DOI 10.1086/315857; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Molyneux EM, 2003, ARCH DIS CHILD, V88, P1112, DOI 10.1136/adc.88.12.1112; MURRAY MJ, 1978, BRIT MED J, V2, P1113, DOI 10.1136/bmj.2.6145.1113; PHILLIPS J, 1998, PAEDIAT HDB MALAWI; PHIRI KS, 2006, THESIS U LIVERPOOL L; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Shaker Z A, 1994, J Egypt Soc Parasitol, V24, P656; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Verhoef H, 2001, AM J CLIN NUTR, V74, P767; Walsh AL, 2000, PEDIATR INFECT DIS J, V19, P312, DOI 10.1097/00006454-200004000-00010; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; World Health Organization, 2001, IR DEF ASS PREV CONT	27	65	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2903	10.1371/journal.pone.0002903	http://dx.doi.org/10.1371/journal.pone.0002903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682797	Green Submitted, gold, Green Published			2022-12-27	WOS:000264366600059
J	Trouw, LA; Okroj, M; Kupreishvili, K; Landberg, G; Johansson, B; Niessen, HWM; Blom, AM				Trouw, Leendert A.; Okroj, Marcin; Kupreishvili, Koba; Landberg, Goeran; Johansson, Bengt; Niessen, Hans W. M.; Blom, Anna M.			C4b-Binding Protein Is Present in Affected Areas of Myocardial Infarction during the Acute Inflammatory Phase and Covers a Larger Area than C3	PLOS ONE			English	Article								Background: During myocardial infarction reduced blood flow in the heart muscle results in cell death. These dying/dead cells have been reported to bind several plasma proteins such as IgM and C-reactive protein (CRP). In the present study we investigated whether fluid-phase complement inhibitor C4b-binding protein (C4BP) would also bind to the infarcted heart tissue. Methods and Findings: Initial studies using immunohistochemistry on tissue arrays for several cardiovascular disorders indicated that C4BP can be found in heart tissue in several cardiac diseases but that it is most abundantly found in acute myocardial infarction (AMI). This condition was studied in more detail by analyzing the time window and extent of C4BP positivity. The binding of C4BP correlates to the same locations as C3b, a marker known to correlate to the patterns of IgM and CRP staining. Based on criteria that describe the time after infarction we were able to pinpoint that C4BP binding is a relatively early marker of tissue damage in myocardial infarction with a peak of binding between 12 hours and 5 days subsequent to AMI, the phase in which infiltration of neutrophilic granulocytes in the heart is the most extensive. Conclusions: C4BP, an important fluid-phase inhibitor of the classical and lectin pathway of complement activation binds to jeopardized cardiomyocytes early after AMI and co-localizes to other well known markers such as C3b.	[Trouw, Leendert A.; Okroj, Marcin; Blom, Anna M.] Lund Univ, Dept Lab Med Med Protein Chem, Malmo, Sweden; [Kupreishvili, Koba; Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands; [Landberg, Goeran] Lund Univ, Dept Pathol, Malmo, Sweden; [Johansson, Bengt] Umea Univ, Norrlands Univ Hosp, Dept Cardiol, Umea, Sweden; [Niessen, Hans W. M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	Lund University; Vrije Universiteit Amsterdam; Lund University; Umea University; Vrije Universiteit Amsterdam	Trouw, LA (corresponding author), Lund Univ, Dept Lab Med Med Protein Chem, Malmo, Sweden.	Anna.Blom@med.lu.se	Blom, Anna/B-9607-2009; Blom, Anna/AFS-7369-2022; Trouw, Leendert/AGK-5202-2022	Blom, Anna/0000-0002-1348-1734; Trouw, Leendert/0000-0001-5186-2290; Niessen, Hans/0000-0001-9404-9822	Foundations of Tore Nilsson; Royal Physiographic Society in Lund; Swedish Foundation for Strategic Research (INGVAR); Swedish Research Council; Foundations of Kock; US Immunodeficiency Network; Cancerfonden; University Hospital in Malmo; Wenner-Gren Foundation; Anna-Greta Crafoord Foundation; NWO	Foundations of Tore Nilsson; Royal Physiographic Society in Lund; Swedish Foundation for Strategic Research (INGVAR)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Kock; US Immunodeficiency Network; Cancerfonden(Swedish Cancer Society); University Hospital in Malmo; Wenner-Gren Foundation; Anna-Greta Crafoord Foundation; NWO(Netherlands Organization for Scientific Research (NWO))	The authors acknowledge the financial support of Foundations of Tore Nilsson and the Royal Physiographic Society in Lund (L.T.), Swedish Foundation for Strategic Research (INGVAR), Swedish Research Council and Foundations of Kock, ysterlund, King Gustav V's 80th anniversary, US Immunodeficiency Network, Cancerfonden and a research grant from the University Hospital in Malmo (A.B.), LT was a recipient of postdoctoral stipends from foundations of Wenner-Gren, and Anna-Greta Crafoord and is currently supported by a NWO Zon-MW VENI-grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; ENTMAN ML, 1991, FASEB J, V5, P2529, DOI 10.1096/fasebj.5.11.1868978; FARB A, 1993, J AM COLL CARDIOL, V21, P1245, DOI 10.1016/0735-1097(93)90253-W; Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134; JIANG H, 1992, J EXP MED, V175, P1373, DOI 10.1084/jem.175.5.1373; Krijnen PAJ, 2005, J CLIN PATHOL, V58, P382, DOI 10.1136/jcp.2004.022988; Krijnen PAJ, 2002, J CLIN PATHOL, V55, P801, DOI 10.1136/jcp.55.11.801; Krijnen Paul A. J., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P113; Lagrand WK, 1997, CIRCULATION, V95, P97, DOI 10.1161/01.CIR.95.1.97; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Niessen HWM, 1999, CARDIOVASC RES, V41, P603, DOI 10.1016/S0008-6363(98)00236-3; Nijmeijer R, 2003, AM J PATHOL, V163, P269, DOI 10.1016/S0002-9440(10)63650-4; Nijmeijer R, 2003, AM J PHYSIOL-HEART C, V285, pH2218, DOI 10.1152/ajpheart.00887.2002; Nijmeijer R, 2001, INT IMMUNOPHARMACOL, V1, P403, DOI 10.1016/S1567-5769(00)00044-8; Oksjoki R, 2003, ARTERIOSCL THROM VAS, V23, P630, DOI 10.1161/01.ATV.0000057808.91263.A4; Oksjoki R, 2007, ATHEROSCLEROSIS, V192, P40, DOI 10.1016/j.atherosclerosis.2006.06.013; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Saraste A, 1997, CIRCULATION, V95, P320; Trouw LA, 2005, J EXP MED, V201, P1937, DOI 10.1084/jem.20050189; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Webb JH, 2003, BLOOD COAGUL FIBRIN, V14, P355, DOI 10.1097/00001721-200306000-00006; Webb JH, 2002, J IMMUNOL, V169, P2580, DOI 10.4049/jimmunol.169.5.2580; Wolbink GJ, 1998, J INFECT DIS, V177, P81, DOI 10.1086/513803; Yasojima K, 2001, ARTERIOSCL THROM VAS, V21, P1214, DOI 10.1161/hq0701.092160	26	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2886	10.1371/journal.pone.0002886	http://dx.doi.org/10.1371/journal.pone.0002886			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682851	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600042
J	Wahls, WP; Siegel, ER; Davidson, MK				Wahls, Wayne P.; Siegel, Eric R.; Davidson, Mari K.			Meiotic Recombination Hotspots of Fission Yeast Are Directed to Loci that Express Non-Coding RNA	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; HOT-SPOT; BINDING PROTEIN; HIS4 LOCUS; HYPERSENSITIVE SITES; DNA REVEALS; ADE6 GENE; R-LOOPS; MEIOSIS; TRANSCRIPTION	Background: Polyadenylated, mRNA-like transcripts with no coding potential are abundant in eukaryotes, but the functions of these long non-coding RNAs (ncRNAs) are enigmatic. In meiosis, Rec12 (Spo11) catalyzes the formation of dsDNA breaks (DSBs) that initiate homologous recombination. Most meiotic recombination is positioned at hotspots, but knowledge of the mechanisms is nebulous. In the fission yeast genome DSBs are located within 194 prominent peaks separated on average by 65-kbp intervals of DNA that are largely free of DSBs. Methodology/Principal Findings: We compared the genome-wide distribution of DSB peaks to that of polyadenylated ncRNA molecules of the prl class. DSB peaks map to ncRNA loci that may be situated within ORFs, near the boundaries of ORFs and intergenic regions, or most often within intergenic regions. Unconditional statistical tests revealed that this colocalization is non-random and robust (P <= 5.5x18(-8)). Furthermore, we tested and rejected the hypothesis that the ncRNA loci and DSB peaks localize preferentially, but independently, to a third entity on the chromosomes. Conclusions/Significance: Meiotic DSB hotspots are directed to loci that express polyadenylated ncRNAs. This reveals an unexpected, possibly unitary mechanism for what directs meiotic recombination to hotspots. It also reveals a likely biological function for enigmatic ncRNAs. We propose specific mechanisms by which ncRNA molecules, or some aspect of RNA metabolism associated with ncRNA loci, help to position recombination protein complexes at DSB hotspots within chromosomes.	[Wahls, Wayne P.; Davidson, Mari K.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Siegel, Eric R.] Univ Arkansas Med Sci, Dept Biostat, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Wahls, WP (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	wahlswaynep@uams.edu		Siegel, Eric/0000-0001-9824-6612	National Institute of General Medical Sciences [GM81766]; National Institute of Environmental Health Sciences [ES13787]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081766] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support provided by the National Institute of General Medical Sciences (GM81766 to WPW) and National Institute of Environmental Health Sciences (ES13787 to MKD). The sponsors had no role in the design and conduct of the study.	Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; Blitzblau HG, 2007, CURR BIOL, V17, P2003, DOI 10.1016/j.cub.2007.10.066; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cho YS, 2005, BIOL REPROD, V73, P840, DOI 10.1095/biolreprod.105.042788; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Gao J, 2008, NUCLEIC ACIDS RES, V36, P2838, DOI 10.1093/nar/gkn037; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Griffiths-Jones S, 2007, ANNU REV GENOM HUM G, V8, P279, DOI 10.1146/annurev.genom.8.080706.092419; GRIMM C, 1991, MOL CELL BIOL, V11, P289, DOI 10.1128/MCB.11.1.289; GROMIE GA, 2007, PLOS GENET, V3, pE141; Heckman DS, 2001, SCIENCE, V293, P1129, DOI 10.1126/science.1061457; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Jolivet S, 2006, GENES CELLS, V11, P615, DOI 10.1111/j.1365-2443.2006.00972.x; Kasama T, 2006, EUKARYOT CELL, V5, P1301, DOI 10.1128/EC.00099-06; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Maleki S, 2004, CELL, V118, P404, DOI 10.1016/j.cell.2004.08.008; Mattick JS, 2007, J EXP BIOL, V210, P1526, DOI 10.1242/jeb.005017; Mieczkowski PA, 2007, P NATL ACAD SCI USA, V104, P3955, DOI 10.1073/pnas.0700412104; Mizuno K, 1996, MAMM GENOME, V7, P490, DOI 10.1007/s003359900149; Molnar M, 2001, GENETICS, V157, P519; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Nilsen TW, 2007, MOL CELL, V28, P715, DOI 10.1016/j.molcel.2007.11.017; Nishant KT, 2006, BIOESSAYS, V28, P45, DOI 10.1002/bies.20349; Nishant KT, 2004, MOL CELL BIOL, V24, P5620, DOI 10.1128/MCB.24.12.5620-5634.2004; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; REABAN ME, 1990, NATURE, V348, P342, DOI 10.1038/348342a0; SCHAR P, 1994, EMBO J, V13, P5212, DOI 10.1002/j.1460-2075.1994.tb06852.x; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Steiner WW, 2005, MOL CELL BIOL, V25, P9054, DOI 10.1128/MCB.25.20.9054-9062.2005; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Wahls WP, 1998, CURR TOP DEV BIOL, V37, P37; Watanabe T, 2002, DNA RES, V9, P209, DOI 10.1093/dnares/9.6.209; Watanabe T, 2001, NUCLEIC ACIDS RES, V29, P2327, DOI 10.1093/nar/29.11.2327; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; WHITE MA, 1991, P NATL ACAD SCI USA, V88, P9755, DOI 10.1073/pnas.88.21.9755; WHITE MA, 1993, P NATL ACAD SCI USA, V90, P6621, DOI 10.1073/pnas.90.14.6621; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; ZAHNZABAL M, 1995, GENETICS, V140, P469	55	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2887	10.1371/journal.pone.0002887	http://dx.doi.org/10.1371/journal.pone.0002887			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682829	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600043
J	Diekmann, K; Hodkinson, TR; Fricke, E; Barth, S				Diekmann, Kerstin; Hodkinson, Trevor R.; Fricke, Evelyn; Barth, Susanne			An Optimized Chloroplast DNA Extraction Protocol for Grasses (Poaceae) Proves Suitable for Whole Plastid Genome Sequencing and SNP Detection	PLOS ONE			English	Article							RESISTANCE; EVOLUTIONARY; DIVERSITY	Background: Obtaining chloroplast genome sequences is important to increase the knowledge about the fundamental biology of plastids, to understand evolutionary and ecological processes in the evolution of plants, to develop biotechnological applications (e.g. plastid engineering) and to improve the efficiency of breeding schemes. Extraction of pure chloroplast DNA is required for efficient sequencing of chloroplast genomes. Unfortunately, most protocols for extracting chloroplast DNA were developed for eudicots and do not produce sufficiently pure yields for a shotgun sequencing approach of whole plastid genomes from the monocot grasses. Methodology/Principal Findings: We have developed a simple and inexpensive method to obtain chloroplast DNA from grass species by modifying and extending protocols optimized for the use in eudicots. Many protocols for extracting chloroplast DNA require an ultracentrifugation step to efficiently separate chloroplast DNA from nuclear DNA. The developed method uses two more centrifugation steps than previously reported protocols and does not require an ultracentrifuge. Conclusions/Significance: The described method delivered chloroplast DNA of very high quality from two grass species belonging to highly different taxonomic subfamilies within the grass family (Lolium perenne, Pooideae; Miscanthus x giganteus, Panicoideae). The DNA from Lolium perenne was used for whole chloroplast genome sequencing and detection of SNPs. The sequence is publicly available on EMBL/GenBank.	[Diekmann, Kerstin; Fricke, Evelyn; Barth, Susanne] Teagasc Crops Res Ctr, Carlow, Ireland; [Diekmann, Kerstin; Hodkinson, Trevor R.] Univ Dublin, Trinity Coll Dublin, Sch Nat Sci, Dept Bot, Dublin, Ireland	Teagasc; Trinity College Dublin	Diekmann, K (corresponding author), Teagasc Crops Res Ctr, Carlow, Ireland.	susanne.barth@teagasc.ie	Barth, Susanne/P-3366-2014; Hodkinson, Trevor/F-6850-2014	Barth, Susanne/0000-0002-4104-5964; Hodkinson, Trevor/0000-0003-1384-7270	Teagasc Walsh Fellowship Schema; Teagasc Vision programme	Teagasc Walsh Fellowship Schema; Teagasc Vision programme	KD was financed under the Teagasc Walsh Fellowship Schema. Project funding was obtained from the Teagasc Vision programme.	BOFFEY SA, 1982, PLANT PHYSIOL, V69, P1387, DOI 10.1104/pp.69.6.1387; BOOKJANS G, 1984, ANAL BIOCHEM, V141, P244, DOI 10.1016/0003-2697(84)90452-4; Chung SM, 2007, GENOME, V50, P215, DOI 10.1139/G07-003; CORRIVEAU JL, 1988, AM J BOT, V75, P1443, DOI 10.2307/2444695; Daniell H, 2005, TRENDS BIOTECHNOL, V23, P238, DOI 10.1016/j.tibtech.2005.03.008; Daniell H, 1998, NAT BIOTECHNOL, V16, P345, DOI 10.1038/nbt0498-345; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Gray JC, 2005, ANNU PLANT REV, V13, P237; GRAY MW, 2004, MOL BIOL BIOTECHNOLO, P87; HALLDEN C, 1993, PLANT BREEDING, V111, P185, DOI 10.1111/j.1439-0523.1993.tb00628.x; Hodkinson TR, 2007, SYST ASSOC SPEC VOL, V72, P275; Hodkinson TR, 2007, J PLANT RES, V120, P17, DOI 10.1007/s10265-006-0059-7; Jansen RK, 2005, METHOD ENZYMOL, V395, P348, DOI 10.1016/S0076-6879(05)95020-9; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Khan MS, 1999, NAT BIOTECHNOL, V17, P910, DOI 10.1038/12907; Kota M, 1999, P NATL ACAD SCI USA, V96, P1840, DOI 10.1073/pnas.96.5.1840; Lee SJ, 2006, NEPHROL DIAL TRANSPL, V21, P3; MARGULIS L, 1970, P349; McGrath S, 2007, HEREDITY, V99, P531, DOI 10.1038/sj.hdy.6801030; PALMER JD, 1986, METHOD ENZYMOL, V118, P167; SANDBRINK JM, 1989, BIOCHEM SYST ECOL, V17, P45, DOI 10.1016/0305-1978(89)90041-0; Sato S, 1999, DNA Res, V6, P283, DOI 10.1093/dnares/6.5.283; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Yukawa M, 2006, MOL GENET GENOMICS, V275, P367, DOI 10.1007/s00438-005-0092-6	24	40	106	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2813	10.1371/journal.pone.0002813	http://dx.doi.org/10.1371/journal.pone.0002813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665252	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300032
J	Dubbelink, KTEO; Felius, A; Verbunt, JPA; van Dijk, BW; Berendse, HW; Stam, CJ; de Waal, HAV				Dubbelink, Kim T. E. Olde; Felius, Abraham; Verbunt, Jeroen P. A.; van Dijk, Bob W.; Berendse, Henk W.; Stam, Cornelis J.; Delemarre-van de Waal, Henriette A.			Increased Resting-State Functional Connectivity in Obese Adolescents; A Magnetoencephalographic Pilot Study	PLOS ONE			English	Article							BODY-MASS INDEX; GENERALIZED SYNCHRONIZATION; LABILE BRAIN; FOLLOW-UP; RISK; OVERWEIGHT; EEG; TRANSIENTS; LIKELIHOOD; ADIPOSITY	Background: Obesity is not only associated with metabolic abnormalities, but also with cognitive dysfunction and changes in the central nervous system. The present pilot study was carried out to investigate functional connectivity in obese and non-obese adolescents using magnetoencephalography (MEG). Methodology/Principal Findings: Magnetoencephalographic recordings were performed in 11 obese (mean BMI 38.8 +/- 4.6 kg/m(2)) and 8 lean ( mean BMI 21.0 +/- 1.5 kg/m(2)) female adolescents (age 12-19 years) during an eyes-closed resting-state condition. From these recordings, the synchronization likelihood (SL), a common method that estimates both linear and non-linear interdependencies between MEG signals, was calculated within and between brain regions, and within standard frequency bands (delta, theta, alpha1, alpha2, beta and gamma). The obese adolescents had increased synchronization in delta (0.5-4 Hz) and beta (13-30 Hz) frequency bands compared to lean controls (P-delta (total) = 0.001; P-beta (total) = 0.002). Conclusions/Significance: This study identified increased resting-state functional connectivity in severe obese adolescents. Considering the importance of functional coupling between brain areas for cognitive functioning, the present findings strengthen the hypothesis that obesity may have a major impact on human brain function. The cause of the observed excessive synchronization is unknown, but might be related to disturbed motivational pathways, the recently demonstrated increase in white matter volume in obese subjects or altered metabolic processes like hyperinsulinemia. The question arises whether the changes in brain structure and communication are a dynamic process due to weight gain and whether these effects are reversible or not.	[Dubbelink, Kim T. E. Olde; Felius, Abraham; Delemarre-van de Waal, Henriette A.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat Endocrinol, Amsterdam, Netherlands; [Verbunt, Jeroen P. A.; van Dijk, Bob W.] Vrije Univ Amsterdam, Med Ctr, Dept Phys & Med Technol, Amsterdam, Netherlands; [Dubbelink, Kim T. E. Olde; Berendse, Henk W.; Stam, Cornelis J.] Vrije Univ Amsterdam, Med Ctr, Inst Clin & Expt Neurosci, Dept Clin Neurophysiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Dubbelink, KTEO (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Paediat Endocrinol, Amsterdam, Netherlands.	a.felius@lumc.nl		Berendse, Henk/0000-0002-9189-3662; Stam, Cornelis/0000-0001-9163-7274				Abbott RD, 2002, NEUROLOGY, V59, P1051, DOI 10.1212/WNL.59.7.1051; Baba R, 2007, CIRC J, V71, P722, DOI 10.1253/circj.71.722; BUZSAKI G, 2008, RYTHMS BRAIN; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Coutin-Churchman P, 2006, CLIN NEUROPHYSIOL, V117, P740, DOI 10.1016/j.clinph.2005.12.021; de Bruin EA, 2004, CLIN NEUROPHYSIOL, V115, P2048, DOI 10.1016/j.clinph.2004.04.010; Del Parigi A, 2002, ANN NY ACAD SCI, V967, P389; Drobes DJ, 2001, BIOL PSYCHOL, V57, P153, DOI 10.1016/S0301-0511(01)00093-X; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Friston KJ, 2000, PHILOS T ROY SOC B, V355, P237, DOI 10.1098/rstb.2000.0561; Gautier JF, 2001, OBES RES, V9, P676, DOI 10.1038/oby.2001.92; Green MC, 2005, POLIT PSYCHOL, V26, P1, DOI 10.1111/j.1467-9221.2005.00407.x; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Haltia LT, 2007, J CLIN ENDOCR METAB, V92, P3278, DOI 10.1210/jc.2006-2495; Herning RI, 1997, BIOL PSYCHIAT, V41, P1087, DOI 10.1016/S0006-3223(96)00258-2; Holsen LM, 2005, NEUROIMAGE, V27, P669, DOI 10.1016/j.neuroimage.2005.04.043; Hu G, 2006, NEUROLOGY, V67, P1955, DOI 10.1212/01.wnl.0000247052.18422.e5; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Karason K, 1999, AM J CARDIOL, V83, P1242, DOI 10.1016/S0002-9149(99)00066-1; LaBar KS, 2001, BEHAV NEUROSCI, V115, P493, DOI 10.1037//0735-7044.115.2.493; LAPPALAINEN R, 1994, PHYSIOL BEHAV, V56, P393, DOI 10.1016/0031-9384(94)90212-7; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; Lee L, 2003, NEUROIMAGE, V19, P457, DOI 10.1016/S1053-8119(03)00062-4; Magarey AM, 2003, INT J OBESITY, V27, P505, DOI 10.1038/sj.ijo.0802251; Montez T, 2006, NEUROIMAGE, V33, P1117, DOI 10.1016/j.neuroimage.2006.06.066; Rangaswamy M, 2002, BIOL PSYCHIAT, V52, P831, DOI 10.1016/S0006-3223(02)01362-8; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; RULKOV NF, 1995, PHYS REV E, V51, P980, DOI 10.1103/PhysRevE.51.980; Sarnthein J, 2007, J NEUROSCI, V27, P124, DOI 10.1523/JNEUROSCI.2411-06.2007; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; STOFFERS D, 2008, NEUROIMAGE IN PRESS; Tschritter O, 2006, P NATL ACAD SCI USA, V103, P12103, DOI 10.1073/pnas.0604404103; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Vega G L, 2004, Minerva Endocrinol, V29, P47; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Whitmer RA, 2007, CURR ALZHEIMER RES, V4, P117, DOI 10.2174/156720507780362065	41	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2827	10.1371/journal.pone.0002827	http://dx.doi.org/10.1371/journal.pone.0002827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665257	Green Published, gold			2022-12-27	WOS:000264304300046
J	Sauer, S; Freiwald, A; Maier, T; Kube, M; Reinhardt, R; Kostrzewa, M; Geider, K				Sauer, Sascha; Freiwald, Anja; Maier, Thomas; Kube, Michael; Reinhardt, Richard; Kostrzewa, Markus; Geider, Klaus			Classification and Identification of Bacteria by Mass Spectrometry and Computational Analysis	PLOS ONE			English	Article								Background: In general, the definite determination of bacterial species is a tedious process and requires extensive manual labour. Novel technologies for bacterial detection and analysis can therefore help microbiologists in minimising their efforts in developing a number of microbiological applications. Methodology: We present a robust, standardized procedure for automated bacterial analysis that is based on the detection of patterns of protein masses by MALDI mass spectrometry. We particularly applied the approach for classifying and identifying strains in species of the genus Erwinia. Many species of this genus are associated with disastrous plant diseases such as fire blight. Using our experimental procedure, we created a general bacterial mass spectra database that currently contains 2800 entries of bacteria of different genera. This database will be steadily expanded. To support users with a feasible analytical method, we developed and tested comprehensive software tools that are demonstrated herein. Furthermore, to gain additional analytical accuracy and reliability in the analysis we used genotyping of single nucleotide polymorphisms by mass spectrometry to unambiguously determine closely related strains that are difficult to distinguish by only relying on protein mass pattern detection. Conclusions: With the method for bacterial analysis, we could identify fire blight pathogens from a variety of biological sources. The method can be used for a number of additional bacterial genera. Moreover, the mass spectrometry approach presented allows the integration of data from different biological levels such as the genome and the proteome.	[Sauer, Sascha; Freiwald, Anja; Kube, Michael; Reinhardt, Richard] Max Planck Inst Mol Genet, Berlin, Germany; [Maier, Thomas; Kostrzewa, Markus] Bruker Daltonik GmbH, Leipzig, Germany; [Geider, Klaus] Julius Kuehn Inst Plant Protect Fruit Crops, Dossenheim, Germany	Max Planck Society; Bruker Corporation; Bruker Daltonik GmbH; Julius Kuhn-Institut	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Berlin, Germany.	sauer@molgen.mpg.de		Reinhardt, Richard/0000-0001-9376-2132	German Ministry of Education and Research; European Union; Max-Planck Society	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the German Ministry of Education and Research, the European Union and the Max-Planck Society.	Chong BE, 1997, RAPID COMMUN MASS SP, V11, P1900, DOI 10.1002/(SICI)1097-0231(199711)11:17<1900::AID-RCM95>3.0.CO;2-K; Claydon MA, 1996, NAT BIOTECHNOL, V14, P1584, DOI 10.1038/nbt1196-1584; CROSSE JE, 1958, NATURE, V182, P1530, DOI 10.1038/1821530a0; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Fenselau C, 2001, MASS SPECTROM REV, V20, P157, DOI 10.1002/mas.10004; Holland RD, 1996, RAPID COMMUN MASS SP, V10, P1227, DOI 10.1002/(SICI)1097-0231(19960731)10:10<1227::AID-RCM659>3.0.CO;2-6; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; Jock S, 2004, ENVIRON MICROBIOL, V6, P480, DOI 10.1111/j.1462-2920.2004.00583.x; JUKES T H, 1969, P21; Kim WS, 1999, INT J SYST BACTERIOL, V49, P899, DOI 10.1099/00207713-49-2-899; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sauer S, 2006, CLIN CHIM ACTA, V363, P95, DOI 10.1016/j.cccn.2005.05.040; Sauer S, 2005, NAT REV GENET, V6, P465, DOI 10.1038/nrg1618; Sauer S, 2006, NAT PROTOC, V1, P1761, DOI 10.1038/nprot.2006.257; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; STARR MP, 1972, ANNU REV MICROBIOL, V26, P389, DOI 10.1146/annurev.mi.26.100172.002133	16	231	247	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2843	10.1371/journal.pone.0002843	http://dx.doi.org/10.1371/journal.pone.0002843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665227	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000264304300062
J	Wu, QF; Kim, YC; Lu, J; Xuan, ZY; Chen, J; Zheng, YL; Zhou, T; Zhang, MQ; Wu, CI; Wang, SM				Wu, Qingfa; Kim, Yeong C.; Lu, Jian; Xuan, Zhenyu; Chen, Jun; Zheng, Yonglan; Zhou, Tom; Zhang, Michael Q.; Wu, Chung-I; Wang, San Ming			Poly A- Transcripts Expressed in HeLa Cells	PLOS ONE			English	Article							MESSENGER-RNA; SEQUENCES; GENES; IDENTIFICATION; METABOLISM; COMPLEXITY; NUCLEI; GENOME	Background: Transcripts expressed in eukaryotes are classified as poly A+ transcripts or poly A- transcripts based on the presence or absence of the 3' poly A tail. Most transcripts identified so far are poly A+ transcripts, whereas the poly A- transcripts remain largely unknown. Methodology/Principal Findings: We developed the TRD (Total RNA Detection) system for transcript identification. The system detects the transcripts through the following steps: 1) depleting the abundant ribosomal and small-size transcripts; 2) synthesizing cDNA without regard to the status of the 3' poly A tail; 3) applying the 454 sequencing technology for massive 3' EST collection from the cDNA; and 4) determining the genome origins of the detected transcripts by mapping the sequences to the human genome reference sequences. Using this system, we characterized the cytoplasmic transcripts from HeLa cells. Of the 13,467 distinct 3' ESTs analyzed, 24% are poly A-, 36% are poly A+, and 40% are bimorphic with poly A+ features but without the 3' poly A tail. Most of the poly A-3' ESTs do not match known transcript sequences; they have a similar distribution pattern in the genome as the poly A+ and bimorphic 3' ESTs, and their mapped intergenic regions are evolutionarily conserved. Experiments confirmed the authenticity of the detected poly A- transcripts. Conclusion/Significance: Our study provides the first large-scale sequence evidence for the presence of poly A- transcripts in eukaryotes. The abundance of the poly A-transcripts highlights the need for comprehensive identification of these transcripts for decoding the transcriptome, annotating the genome and studying biological relevance of the poly A-transcripts.	[Wu, Qingfa; Kim, Yeong C.; Chen, Jun; Zheng, Yonglan; Zhou, Tom; Wang, San Ming] Northwestern Univ, Feinberg Sch Med, ENH Res Inst, Dept Med,Ctr Funct Genom,Div Med Genet, Chicago, IL 60611 USA; [Lu, Jian; Wu, Chung-I] Univ Chicago, Dept Ecol & Evolution, Chicago, IL USA; [Xuan, Zhenyu; Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY USA; [Wang, San Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehensive Canc Ctr, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Chicago; Cold Spring Harbor Laboratory; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Wang, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, ENH Res Inst, Dept Med,Ctr Funct Genom,Div Med Genet, Chicago, IL 60611 USA.	swang1@northwestern.edu	Zheng, Yonglan/O-4112-2019; , san ming wang/ABG-4910-2020; Zheng, Yonglan/C-4236-2011	Zheng, Yonglan/0000-0001-6597-7072; Zhou, Tom/0000-0001-7416-5594; Xuan, Zhenyu/0000-0001-9344-8493	NIH [R01HG002600]; Daniel F. and Ada L. Rice Foundation; Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Daniel F. and Ada L. Rice Foundation; Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was funded by NIH grant R01HG002600, the Daniel F. and Ada L. Rice Foundation, Mazza Foundation, and the Chicago Biomedical Consortium supported by The Searle Funds at The Chicago Community Trust.	Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Chen J, 2008, GENOME RES, V18, P751, DOI 10.1101/gr.068304.107; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; DETKE S, 1978, NUCLEIC ACIDS RES, V5, P1515, DOI 10.1093/nar/5.5.1515; Dominski Z, 1999, GENE, V239, P1, DOI 10.1016/S0378-1119(99)00367-4; DUNCAN R, 1984, DIFFERENTIATION, V28, P24, DOI 10.1111/j.1432-0436.1984.tb00262.x; GALAU GA, 1981, J BIOL CHEM, V256, P2551; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRADY LJ, 1978, NUCLEIC ACIDS RES, V5, P697, DOI 10.1093/nar/5.3.697; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; KATINAKIS PK, 1980, FEBS LETT, V116, P1, DOI 10.1016/0014-5793(80)80515-1; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Lee S, 2002, GENOMICS, V79, P598, DOI 10.1006/geno.2002.6730; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MILCAREK C, 1974, CELL, V3, P1, DOI 10.1016/0092-8674(74)90030-0; MOFFETT RB, 1981, BIOCHIM BIOPHYS ACTA, V652, P177, DOI 10.1016/0005-2787(81)90221-5; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; NAKAZATO H, 1974, P NATL ACAD SCI USA, V71, P200, DOI 10.1073/pnas.71.1.200; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; SALDITTGEORGIEFF M, 1981, MOL CELL BIOL, V1, P179, DOI 10.1128/MCB.1.2.179; VANNESS J, 1979, CELL, V18, P1341, DOI 10.1016/0092-8674(79)90244-7; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; ZIMMERMAN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3148, DOI 10.1073/pnas.79.10.3148; ZIMMERMAN JL, 1980, GENETICS, V95, P673	28	68	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2803	10.1371/journal.pone.0002803	http://dx.doi.org/10.1371/journal.pone.0002803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665230	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000264304300022
J	Hoarau, C; Martin, L; Faugaret, D; Baron, C; Dauba, A; Aubert-Jacquin, C; Velge-Roussel, F; Lebranchu, Y				Hoarau, Cyrille; Martin, Laurence; Faugaret, Delphine; Baron, Christophe; Dauba, Audrey; Aubert-Jacquin, Cecile; Velge-Roussel, Florence; Lebranchu, Yvon			Supernatant from Bifidobacterium Differentially Modulates Transduction Signaling Pathways for Biological Functions of Human Dendritic Cells	PLOS ONE			English	Article								Background: Probiotic bacteria have been shown to modulate immune responses and could have therapeutic effects in allergic and inflammatory disorders. However, the signaling pathways engaged by probiotics are poorly understood. We have previously reported that a fermentation product from Bifidobacterium breve C50 (BbC50sn) could induce maturation, high IL-10 production and prolonged survival of DCs via a TLR2 pathway. We therefore studied the roles of mitogen-activated protein kinases (MAPK), glycogen synthase kinase-3 (GSK3) and phosphatidylinositol 3-kinase (PI3K) pathways on biological functions of human monocyte-derived DCs treated with BbC50sn. Methodology/Principal Findings: DCs were differentiated from human monocytes with IL-4 and GM-CSF for 5 days and cultured with BbC50sn, lipopolysaccharide (LPS) or Zymosan, with or without specific inhibitors of p38MAPK (SB203580), ERK (PD98059), PI3K (LY294002) and GSK3 (SB216763). We found that 1) the PI3K pathway was positively involved in the prolonged DC survival induced by BbC50sn, LPS and Zymosan in contrast to p38MAPK and GSK3 which negatively regulated DC survival; 2) p38MAPK and PI3K were positively involved in DC maturation, in contrast to ERK and GSK3 which negatively regulated DC maturation; 3) ERK and PI3K were positively involved in DC-IL-10 production, in contrast to GSK3 that was positively involved in DC-IL-12 production whereas p38MAPK was positively involved in both; 4) BbC50sn induced a PI3K/Akt phosphorylation similar to Zymosan and a p38MAPK phosphorylation similar to LPS. Conclusion/Significance: We report for the first time that a fermentation product of a bifidobacteria can differentially activate MAPK, GSK3 and PI3K in order to modulate DC biological functions. These results give new insights on the fine-tuned balance between the maintenance of normal mucosal homeostasis to commensal and probiotic bacteria and the specific inflammatory immune responses to pathogen bacteria.	[Hoarau, Cyrille; Martin, Laurence; Faugaret, Delphine; Baron, Christophe; Dauba, Audrey; Velge-Roussel, Florence; Lebranchu, Yvon] Univ Tours, UPRES EA Cellules Dendrit & Greffes 4245, Tours, France; [Aubert-Jacquin, Cecile] Dept Rech Dev Bledina, Villefranche, France; [Velge-Roussel, Florence] Univ Tours, UFR Sci Pharm, Tours, France	Universite de Tours; Universite de Tours	Hoarau, C (corresponding author), Univ Tours, UPRES EA Cellules Dendrit & Greffes 4245, Tours, France.	cdg@med.univ-tours.fr						Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Aiba S, 2003, J INVEST DERMATOL, V120, P390, DOI 10.1046/j.1523-1747.2003.12065.x; Akira S, 2003, CURR OPIN IMMUNOL, V15, P5, DOI 10.1016/S0952-7915(02)00013-4; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ardeshna KM, 2000, BLOOD, V96, P1039, DOI 10.1182/blood.V96.3.1039.015k04_1039_1046; Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837; Braat H, 2004, AM J CLIN NUTR, V80, P1618, DOI 10.1093/ajcn/80.6.1618; Braat H, 2004, J MOL MED, V82, P197, DOI 10.1007/s00109-003-0509-9; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Christensen HR, 2002, J IMMUNOL, V168, P171, DOI 10.4049/jimmunol.168.1.171; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dillon S, 2004, J IMMUNOL, V172, P4733, DOI 10.4049/jimmunol.172.8.4733; Dillon TJ, 2003, J BIOL CHEM, V278, P35940, DOI 10.1074/jbc.M301506200; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Drakes M, 2004, INFECT IMMUN, V72, P3299, DOI 10.1128/IAI.72.6.3299-3309.2004; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Foey AD, 1998, J IMMUNOL, V160, P920; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Fukao T, 2003, TRENDS IMMUNOL, V24, P358, DOI 10.1016/S1471-4906(03)00139-X; Hoarau C, 2006, J ALLERGY CLIN IMMUN, V117, P696, DOI 10.1016/j.jaci.2005.10.043; Hoarau C, 2007, J IMMUNOL, V179, P4754, DOI 10.4049/jimmunol.179.7.4754; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kalinski P, 2000, J IMMUNOL, V165, P1877, DOI 10.4049/jimmunol.165.4.1877; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Kim YG, 2006, MICROBES INFECT, V8, P994, DOI 10.1016/j.micinf.2005.10.019; Lievin V, 2000, GUT, V47, P646, DOI 10.1136/gut.47.5.646; Loscher CE, 2005, J IMMUNOL, V175, P4990, DOI 10.4049/jimmunol.175.8.4990; MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Menard S, 2004, GUT, V53, P821, DOI 10.1136/gut.2003.026252; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Moro G, 2007, ARCH DIS CHILD, V92, P655; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Puig-Kroger A, 2001, BLOOD, V98, P2175, DOI 10.1182/blood.V98.7.2175; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; Rodionova E, 2007, BLOOD, V109, P1584, DOI 10.1182/blood-2006-06-028951; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Strassheim D, 2004, J IMMUNOL, V172, P5727, DOI 10.4049/jimmunol.172.9.5727; Strobel S, 2006, CURR OPIN ALLERGY CL, V6, P207, DOI 10.1097/01.all.0000225162.98391.81; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tong L, 1997, NAT STRUCT BIOL, V4, P311, DOI 10.1038/nsb0497-311; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Xie J, 2005, EXP HEMATOL, V33, P564, DOI 10.1016/j.exphem.2005.03.001; Yu QG, 2004, J IMMUNOL, V172, P6047, DOI 10.4049/jimmunol.172.10.6047	51	57	84	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2753	10.1371/journal.pone.0002753	http://dx.doi.org/10.1371/journal.pone.0002753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648505	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900023
J	van Beveren, NJM; de Haan, L				van Beveren, Nico J. M.; de Haan, Lieuwe			A Visual Metaphor Describing Neural Dynamics in Schizophrenia	PLOS ONE			English	Article							TO-NOISE RATIO; NETWORK MODEL; HALLUCINATED VOICES; WORKING-MEMORY; PSYCHIATRY; DOPAMINE; PERCEPTION; BEHAVIOR; BIOLOGY; SYSTEMS	Background: In many scientific disciplines the use of a metaphor as an heuristic aid is not uncommon. A well known example in somatic medicine is the 'defense army metaphor' used to characterize the immune system. In fact, probably a large part of the everyday work of doctors consists of 'translating' scientific and clinical information (i.e. causes of disease, percentage of succes versus risk of side-effects) into information tailored to the needs and capacities of the individual patient. The ability to do so in an effective way is at least partly what makes a clinician a good communicator. Schizophrenia is a severe psychiatric disorder which affects approximately 1% of the population. Over the last two decades a large amount of molecular-biological, imaging and genetic data have been accumulated regarding the biological underpinnings of schizophrenia. However, it remains difficult to understand how the characteristic symptoms of schizophrenia such as hallucinations and delusions are related to disturbances on the molecular-biological level. In general, psychiatry seems to lack a conceptual framework with sufficient explanatory power to link the mental-and molecular-biological domains. Methodology/ Principal Findings: Here, we present an essay-like study in which we propose to use visualized concepts stemming from the theory on dynamical complex systems as a 'visual metaphor' to bridge the mental- and molecular-biological domains in schizophrenia. We first describe a computer model of neural information processing; we show how the information processing in this model can be visualized, using concepts from the theory on complex systems. We then describe two computer models which have been used to investigate the primary theory on schizophrenia, the neurodevelopmental model, and show how disturbed information processing in these two computer models can be presented in terms of the visual metaphor previously described. Finally, we describe the effects of dopamine neuromodulation, of which disturbances have been frequently described in schizophrenia, in terms of the same visualized metaphor. Conclusions/Significance: The conceptual framework and metaphor described offers a heuristic tool to understand the relationship between the mental- and molecular-biological domains in an intuitive way. The concepts we present may serve to facilitate communication between researchers, clinicians and patients.	[van Beveren, Nico J. M.] Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands; [de Haan, Lieuwe] Academ Med Ctr de Meren, Dept Psychiat, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	van Beveren, NJM (corresponding author), Erasmus Univ, Med Ctr, Dept Psychiat, Rotterdam, Netherlands.	l.dehaan@amc.uva.nl						Amit D. J., 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; Andreasen NC, 2000, BRAIN RES REV, V31, P106, DOI 10.1016/S0165-0173(99)00027-2; Arbib MA, 1995, HDB BRAIN THEORY NEU; Barch DM, 2006, NEUROSCIENCE, V139, P73, DOI 10.1016/j.neuroscience.2005.09.013; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Bender W, 2006, PHARMACOPSYCHIATRY, V39, pS4, DOI 10.1055/s-2006-931482; COHEN JD, 1993, SCHIZOPHRENIA BULL, V19, P85, DOI 10.1093/schbul/19.1.85; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Draaisma D, 2001, NATURE, V414, P153, DOI 10.1038/35102645; Draaisma Douwe, 1995, METAFORENMACHINE GES; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Durstewitz D, 2006, PHARMACOPSYCHIATRY, V39, pS72, DOI 10.1055/s-2006-931499; Durstewitz D, 2002, NEURAL NETWORKS, V15, P561, DOI 10.1016/S0893-6080(02)00049-7; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; ERDI P, 1993, THEOR MED, V14, P137, DOI 10.1007/BF00997272; FEINBERG I, 1983, J PSYCHIAT RES, V17, P319, DOI 10.1016/0022-3956(82)90038-3; FREEMAN WJ, 1991, SCI AM, V264, P78, DOI 10.1038/scientificamerican0291-78; Freeman WJ, 2000, J PHYSIOLOGY-PARIS, V94, P303, DOI 10.1016/S0928-4257(00)01090-1; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; GLOBUS GG, 1994, BIOL PSYCHIAT, V35, P352, DOI 10.1016/0006-3223(94)90039-6; GOODMAN A, 1991, AM J PSYCHIAT, V148, P553; Hertz J., 1995, HDB BRAIN THEORY NEU, P230; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P119, DOI 10.1093/schbul/19.1.119; HOFFMAN RE, 1989, SCHIZOPHRENIA BULL, V15, P477, DOI 10.1093/schbul/15.3.477; HOFFMAN RE, 1987, ARCH GEN PSYCHIAT, V44, P178; Hoffman RE, 1997, AM J PSYCHIAT, V154, P1683, DOI 10.1176/ajp.154.12.1683; HOFFMAN RE, 1995, J COGNITIVE NEUROSCI, V7, P479, DOI 10.1162/jocn.1995.7.4.479; Hoffman RE, 2001, NEUROSCIENTIST, V7, P441, DOI 10.1177/107385840100700513; HOFFMAN RE, 1993, SCHIZOPHRENIA BULL, V19, P15, DOI 10.1093/schbul/19.1.15; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jeffery KJ, 1997, AM J PSYCHIAT, V154, P156; Kapur S, 2001, AM J PSYCHIAT, V158, P360, DOI 10.1176/appi.ajp.158.3.360; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kelso J.A.S., 1995, DYNAMIC PATTERNS; MADORE BF, 1987, AM SCI, V75, P252; MANDELL J, 1992, BIOL PSYCHIAT, V32, P299, DOI 10.1016/0006-3223(92)90034-W; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; Ouzounis C, 2006, BIOSYSTEMS, V85, P6, DOI 10.1016/j.biosystems.2006.02.007; Peled A, 2004, MED HYPOTHESES, V63, P110, DOI 10.1016/j.mehy.2004.02.010; Peled A, 2000, MED HYPOTHESES, V54, P367, DOI 10.1054/mehy.1999.0853; Peled A, 2000, INT J NEUROSCI, V104, P49, DOI 10.3109/00207450009035008; PORT RF, 1995, MIND MOTION; PRIGOGINE Ilya, 1985, ORDER OUT CHAOS MANS; PRITCHARD WS, 1992, INT J NEUROSCI, V67, P31, DOI 10.3109/00207459208994774; ROBERTSON R, 1995, CHAOS THEORY PSYCHOL; Rumelhart D., 1986, PARALLEL DISTRIBUTED; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Tretter F, 2006, PHARMACOPSYCHIATRY, V39, pS26, DOI 10.1055/s-2006-931486; WANG X, 1995, HDB BRAIN THEORY NEU, P339; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002	50	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2577	10.1371/journal.pone.0002577	http://dx.doi.org/10.1371/journal.pone.0002577			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	417GZ	18648540	Green Published, gold			2022-12-27	WOS:000264065800001
J	Timmerman, SL; Pfingsten, JS; Kieft, JS; Krushel, LA				Timmerman, Stephanie L.; Pfingsten, Jennifer S.; Kieft, Jeffrey S.; Krushel, Les A.			The 5 ' Leader of the mRNA Encoding the Mouse Neurotrophin Receptor TrkB Contains Two Internal Ribosomal Entry Sites that Are Differentially Regulated	PLOS ONE			English	Article								A single internal ribosomal entry site (IRES) in conjunction with IRES transactivating factors (ITAFs) is sufficient to recruit the translational machinery to a eukaryotic mRNA independent of the cap structure. However, we demonstrate that the mouse TrkB mRNA contains two independent IRESes. The mouse TrkB mRNA consists of one of two 59 leaders (1428 nt and 448 nt), both of which include the common 39 exon (Ex2, 344 nt). Dicistronic RNA transfections and in vitro translation of monocistronic RNA demonstrated that both full-length 59 leaders, as well as Ex2, exhibit IRES activity indicating the IRES is located within Ex2. Additional analysis of the upstream sequences demonstrated that the first 260 nt of exon 1 (Ex1a) also contains an IRES. Dicistronic RNA transfections into SH-SY5Y cells showed the Ex1a IRES is constitutively active. However, the Ex2 IRES is only active in response to retinoic acid induced neural differentiation, a state which correlates with the synthesis of the ITAF polypyrimidine tract binding protein (PTB1). Correspondingly, addition or knock-down of PTB1 altered Ex2, but not Ex1a IRES activity in vitro and ex vivo, respectively. These results demonstrate that the two functionally independent IRESes within the mouse TrkB 59 leader are differentially regulated, in part by PTB1.	[Timmerman, Stephanie L.; Pfingsten, Jennifer S.; Kieft, Jeffrey S.; Krushel, Les A.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Krushel, Les A.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Timmerman, SL (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA.	Leslie.Krushel@uchsc.edu			NIH [AG028156]; NATIONAL INSTITUTE ON AGING [R01AG028156] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH grant AG028156	AHMED S, 1995, J NEUROSCI, V15, P5765; Barettino D, 1999, BBA-GENE STRUCT EXPR, V1446, P24, DOI 10.1016/S0167-4781(99)00056-1; Bastide A, 2008, NUCLEIC ACIDS RES, V36, P2434, DOI 10.1093/nar/gkn093; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Dobson T, 2005, NUCLEIC ACIDS RES, V33, P2929, DOI 10.1093/nar/gki605; Dumas E, 2003, NUCLEIC ACIDS RES, V31, P1275, DOI 10.1093/nar/gkg199; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Ferrer I, 1998, J COMP NEUROL, V394, P416; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Giraud S, 2001, J BIOL CHEM, V276, P5668, DOI 10.1074/jbc.M005928200; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Holcik M, 2000, MOL CELL BIOL, V20, P4648, DOI 10.1128/MCB.20.13.4648-4657.2000; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kingsbury TJ, 2003, J BIOL CHEM, V278, P40744, DOI 10.1074/jbc.M303082200; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1978, CELL, V15, P1109, DOI 10.1016/0092-8674(78)90039-9; LINDVALL O, 1992, P NATL ACAD SCI USA, V89, P648, DOI 10.1073/pnas.89.2.648; LUCARELLI E, 1995, J BIOL CHEM, V270, P24725, DOI 10.1074/jbc.270.42.24725; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Metsis M, 2001, CELL MOL LIFE SCI, V58, P1014, DOI 10.1007/PL00000916; Mitchell SA, 2005, GENE DEV, V19, P1556, DOI 10.1101/gad.339105; Mitchell SA, 2003, MOL CELL, V11, P757, DOI 10.1016/S1097-2765(03)00093-5; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; Nanbru C, 2001, ONCOGENE, V20, P4270, DOI 10.1038/sj.onc.1204548; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Perez I, 1997, RNA, V3, P764; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sawicka K, 2008, BIOCHEM SOC T, V36, P641, DOI 10.1042/BST0360641; SONENBERG N, 1981, J BIOL CHEM, V256, P4138; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tosetti P, 1998, J NEUROPHYSIOL, V79, P648, DOI 10.1152/jn.1998.79.2.648; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Van Eden ME, 2004, RNA, V10, P469, DOI 10.1261/rna.5156804; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3	53	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2008	3	9							e3242	10.1371/journal.pone.0003242	http://dx.doi.org/10.1371/journal.pone.0003242			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LF	18779873	gold, Green Published, Green Submitted			2022-12-27	WOS:000264428600002
J	Kumarasamy, A; Abraham, EC				Kumarasamy, Anbarasu; Abraham, Edathara C.			Interaction of C-Terminal Truncated Human alpha A-Crystallins with Target Proteins	PLOS ONE			English	Article								Background: Significant portion of alpha A-crystallin in human lenses exists as C-terminal residues cleaved at residues 172, 168, and 162. Chaperone activity, determined with alcohol dehydrogenase (ADH) and beta L-crystallin as target proteins, was increased in alpha A(1-172) and decreased in alpha A(1-168) and alpha A(1-162). The purpose of this study was to show whether the absence of the C-terminal residues influences protein-protein interactions with target proteins. Methodology/Principal Findings: Our hypothesis is that the chaperone-target protein binding kinetics, otherwise termed subunit exchange rates, are expected to reflect the changes in chaperone activity. To study this, we have relied on fluorescence resonance energy transfer (FRET) utilizing amine specific and cysteine specific fluorescent probes. The subunit exchange rate (k) for ADH and alpha A(1-172) was nearly the same as that of ADH and alpha A-wt, alpha A(1-168) had lower and alpha A(1-162) had the lowest k values. When beta L-crystallin was used as the target protein, alpha A(1-172) had slightly higher k value than alpha A-wt and alpha A(1-168) and alpha(A1-162) had lower k values. As expected from earlier studies, the chaperone activity of alpha A(1-172) was slightly better than that of alpha A-wt, the chaperone activity of alpha A(1-168) was similar to that of alpha A-wt and alpha A(1-162) had substantially decreased chaperone activity. Conclusions/Significance: Cleavage of eleven C-terminal residues including Arg-163 and the C-terminal flexible arm significantly affects the interaction with target proteins. The predominantly hydrophilic flexible arm appears to be needed to keep the chaperone-target protein complex soluble.	[Kumarasamy, Anbarasu; Abraham, Edathara C.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Kumarasamy, A (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ecabraham@uams.edu	Kumarasamy, Anbarasu/K-4703-2015	Kumarasamy, Anbarasu/0000-0002-1666-6742	National Institutes of Health [EY11352]; NATIONAL EYE INSTITUTE [R01EY011352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	EY11352 from the National Institutes of Health.	Aziz A, 2007, BIOCHEMISTRY-US, V46, P2510, DOI 10.1021/bi0618722; Bera S, 2002, BIOCHEMISTRY-US, V41, P297, DOI 10.1021/bi011010v; Colvis C, 2002, ARCH BIOCHEM BIOPHYS, V397, P319, DOI 10.1006/abbi.2001.2669; DEJONG WW, 1975, FEBS LETT, V58, P310, DOI 10.1016/0014-5793(75)80286-9; Ghahghaei A, 2007, BBA-PROTEINS PROTEOM, V1774, P102, DOI 10.1016/j.bbapap.2006.10.002; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P2360, DOI 10.1073/pnas.79.7.2360; Kallur LS, 2008, MOL CELL BIOCHEM, V308, P85, DOI 10.1007/s11010-007-9615-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lund AL, 1996, EXP EYE RES, V63, P661, DOI 10.1006/exer.1996.0160; Ma ZX, 1998, EXP EYE RES, V67, P21, DOI 10.1006/exer.1998.0482; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Rajan S, 2006, BIOCHEMISTRY-US, V45, P15684, DOI 10.1021/bi060705z; Rao PV, 1995, BBA-GEN SUBJECTS, V1245, P439, DOI 10.1016/0304-4165(95)00125-5; Schroff NP, 2001, MOL CELL BIOCHEM, V220, P127, DOI 10.1023/A:1010834107809; Shroff NP, 2000, BIOCHEMISTRY-US, V39, P1420, DOI 10.1021/bi991656b; Takemoto LJ, 1998, EXP EYE RES, V66, P263, DOI 10.1006/exer.1997.0411; TAKEMOTO LJ, 1995, CURR EYE RES, V14, P837, DOI 10.3109/02713689508995806; Thampi P, 2002, INVEST OPHTH VIS SCI, V43, P3265; VANDEROU.FJ, 1974, EUR J BIOCHEM, V49, P157; VANDEROU.FJ, 1973, EUR J BIOCHEM, V39, P207; WANG KY, 1994, J BIOL CHEM, V269, P13601; WISTOW G, 1985, FEBS LETT, V181, P1, DOI 10.1016/0014-5793(85)81102-9	23	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3175	10.1371/journal.pone.0003175	http://dx.doi.org/10.1371/journal.pone.0003175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779867	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425100011
J	Luca, F; Bubba, G; Basile, M; Brdicka, R; Michalodimitrakis, E; Rickards, O; Vershubsky, G; Quintana-Murci, L; Kozlov, AI; Novelletto, A				Luca, Francesca; Bubba, Giuseppina; Basile, Massimo; Brdicka, Radim; Michalodimitrakis, Emmanuel; Rickards, Olga; Vershubsky, Galina; Quintana-Murci, Lluis; Kozlov, Andrey I.; Novelletto, Andrea			Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations	PLOS ONE			English	Article							ARYLAMINE N-ACETYLTRANSFERASES; SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; POSITIVE SELECTION; NATURAL-SELECTION; BALANCING SELECTION; FREQUENCY-SPECTRUM; STATISTICAL-METHOD; DNA POLYMORPHISM	Background: Genetic variation at NAT2 has been long recognized as the cause of differential ability to metabolize a wide variety of drugs of therapeutic use. Here, we explore the pattern of genetic variation in 12 human populations that significantly extend the geographic range and resolution of previous surveys, to test the hypothesis that different dietary regimens and lifestyles may explain inter-population differences in NAT2 variation. Methodology/Principal Findings: The entire coding region was resequenced in 98 subjects and six polymorphic positions were genotyped in 150 additional subjects. A single previously undescribed variant was found (34T>C; 12Y>H). Several aspects of the data do not fit the expectations of a neutral model, as assessed by coalescent simulations. Tajima's D is positive in all populations, indicating an excess of intermediate alleles. The level of between-population differentiation is low, and is mainly accounted for by the proportion of fast vs. slow acetylators. However, haplotype frequencies significantly differ across groups of populations with different subsistence. Conclusions/Significance: Data on the structure of haplotypes and their frequencies are compatible with a model in which slow-causing variants were present in widely dispersed populations before major shifts to pastoralism and/or agriculture. In this model, slow-causing mutations gained a selective advantage in populations shifting from hunting-gathering to pastoralism/agriculture. We suggest the diminished dietary availability of folates resulting from the nutritional shift, as the possible cause of the fitness increase associated to haplotypes carrying mutations that reduce enzymatic activity.	[Brdicka, Radim] Natl Inst Haematol & Blood Transfus, Prague, Czech Republic; [Michalodimitrakis, Emmanuel] Inst Mol Biol & Biotechnol, Iraklion, Greece; [Rickards, Olga; Novelletto, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Vershubsky, Galina; Kozlov, Andrey I.] Arct An C Innovat Lab, Moscow, Russia; [Vershubsky, Galina] Russian Acad Educ, Inst Dev Physiol, Moscow, Russia; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA 3012, UP Human Evolutionary Genet, Paris, France; [Luca, Francesca; Bubba, Giuseppina; Basile, Massimo; Novelletto, Andrea] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy	University of Rome Tor Vergata; Institute for Developmental Physiology, Russian Academy of Education; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Calabria	Luca, F (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	novelletto@bio.uniroma2.it	Rickards, Olga/L-7878-2015; Luca, Francesca/B-4850-2019; Kozlov, Andrew/Z-2925-2019; Quintana-Murci, Lluis/AAB-7468-2022	Rickards, Olga/0000-0003-2880-7466; Luca, Francesca/0000-0001-8252-9052; Vershubskaya, Galina/0000-0003-2452-1532; Novelletto, Andrea/0000-0002-1146-7680; Quintana-Murci, Lluis/0000-0003-2429-6320	PRIN-MIUR; RFBR [05-06-80427]; NATO [980469]	PRIN-MIUR(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); RFBR(Russian Foundation for Basic Research (RFBR)); NATO(NATO (North Atlantic Treaty Organisation))	Work supported by grants PRIN-MIUR 2005 and 2007 to A.N. and RFBR 05-06-80427 to A.I.K. Russian samples were collected in the frame of an Italian-Russian scientific-technological project (3.RB3 to A.I.K.). A sampling campaign in Eastern Chukotka was supported by NATO Collaborative Linkage Grant Ref. 980469.	Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bakayev VV, 2004, EUR J CLIN PHARMACOL, V60, P467, DOI 10.1007/s00228-004-0799-z; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Boukouvala S, 2005, DRUG METAB REV, V37, P511, DOI 10.1080/03602530500251204; Bromley, 1988, PEOPLES WORLD; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CASCORBI I, 1995, AM J HUM GENET, V57, P581; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Currat M, 2006, SCIENCE, V313, P172, DOI 10.1126/science.1122712; De Stefano GF, 2002, ANN HUM BIOL, V29, P432, DOI 10.1080/03014460110101440; Deitz AC, 2000, CANCER EPIDEM BIOMAR, V9, P905; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO WHO, 2002, REP JOINT FAO WHO EX; Fay JC, 2001, CURR OPIN GENET DEV, V11, P642, DOI 10.1016/S0959-437X(00)00247-1; FERNANDESCOSTA FJ, 1984, AM J CLIN NUTR, V40, P1295, DOI 10.1093/ajcn/40.6.1295; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fuselli S, 2007, PHARMACOGENOMICS J, V7, P144, DOI 10.1038/sj.tpj.6500407; Garrigan D, 2006, NAT REV GENET, V7, P669, DOI 10.1038/nrg1941; Harding RM, 2004, CURR OPIN GENET DEV, V14, P667, DOI 10.1016/j.gde.2004.08.010; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Hein DW, 2006, ONCOGENE, V25, P1649, DOI 10.1038/sj.onc.1209374; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Husain A, 2007, DRUG METAB DISPOS, V35, P721, DOI 10.1124/dmd.106.014621; Jensen LE, 2006, HUM GENET, V120, P52, DOI 10.1007/s00439-006-0181-6; Kawamura A, 2005, BIOCHEM PHARMACOL, V69, P347, DOI 10.1016/j.bcp.2004.09.014; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Luca F, 2007, AM J PHYS ANTHROPOL, V132, P132, DOI 10.1002/ajpa.20500; Magalon H, 2008, EUR J HUM GENET, V16, P243, DOI 10.1038/sj.ejhg.5201963; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MINCHIN RF, 1995, BIOCHEM J, V307, P1; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Nielsen Rasmus, 2004, Human Genomics, V1, P218; Patin E, 2006, AM J HUM GENET, V78, P423, DOI 10.1086/500614; Patin E, 2006, HUM MUTAT, V27, P720, DOI 10.1002/humu.9438; Pennings PS, 2006, PLOS GENET, V2, P1998, DOI 10.1371/journal.pgen.0020186; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schierup MH, 2001, GENETICS, V159, P1833; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Sim E, 2000, HUM MOL GENET, V9, P2435, DOI 10.1093/hmg/9.16.2435; Sim E, 2003, BIOCHEM SOC T, V31, P615, DOI 10.1042/bst0310615; Sim E, 2007, EXPERT OPIN DRUG MET, V3, P169, DOI 10.1517/17425255.3.2.169; Soloway PD, 2006, NUTR REV, V64, pS52, DOI 10.1301/nr.2006.may.S52-S54; Solus JF, 2004, PHARMACOGENOMICS, V5, P895, DOI 10.1517/14622416.5.7.895; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAJIMA F, 1989, GENETICS, V123, P585; Tamura T, 2006, AM J CLIN NUTR, V83, P993, DOI 10.1093/ajcn/83.5.993; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wakeley J, 2001, AM J HUM GENET, V69, P1332, DOI 10.1086/324521; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; WEBER WW, 1985, PHARMACOL REV, V37, P25; WEBER WW, 1987, ACETYLATOR GENES DRU; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wong GKS, 2003, GENOME RES, V13, P1873, DOI 10.1101/gr.1324303; Word Health Organization, 2002, WHO LIB CAT IN PUBL; Zang Y, 2007, CARCINOGENESIS, V28, P1665, DOI 10.1093/carcin/bgm085	73	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3136	10.1371/journal.pone.0003136	http://dx.doi.org/10.1371/journal.pone.0003136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773084	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420100002
J	Young, SL; Wilson, MJ; Miller, D; Hillier, S				Young, Sera L.; Wilson, M. Jeffrey; Miller, Dennis; Hillier, Stephen			Toward a Comprehensive Approach to the Collection and Analysis of Pica Substances, with Emphasis on Geophagic Materials	PLOS ONE			English	Review							RAY-DIFFRACTION PATTERNS; IRON-ABSORPTION; CELL-CULTURE; IN-VITRO; QUANTITATIVE INTERPRETATION; DECREASED BIOAVAILABILITY; EVOLUTIONARY PERSPECTIVE; SOIL CONSUMPTION; POTENTIAL IMPACT; DIETARY TOXINS	Background: Pica, the craving and subsequent consumption of non-food substances such as earth, charcoal, and raw starch, has been an enigma for more than 2000 years. Currently, there are little available data for testing major hypotheses about pica because of methodological limitations and lack of attention to the problem. Methodology: In this paper we critically review procedures and guidelines for interviews and sample collection that are appropriate for a wide variety of pica substances. In addition, we outline methodologies for the physical, mineralogical, and chemical characterization of these substances, with particular focus on geophagic soils and clays. Many of these methods are standard procedures in anthropological, soil, or nutritional sciences, but have rarely or never been applied to the study of pica. Principal Findings: Physical properties of geophagic materials including color, particle size distribution, consistency and dispersion/flocculation (coagulation) should be assessed by appropriate methods. Quantitative mineralogical analyses by Xray diffraction should be made on bulk material as well as on separated clay fractions, and the various clay minerals should be characterized by a variety of supplementary tests. Concentrations of minerals should be determined using X-ray fluorescence for non-food substances and inductively coupled plasma-atomic emission spectroscopy for food-like substances. pH, salt content, cation exchange capacity, organic carbon content and labile forms of iron oxide should also be determined. Finally, analyses relating to biological interactions are recommended, including determination of the bioavailability of nutrients and other bioactive components from pica substances, as well as their detoxification capacities and parasitological profiles. Significance: This is the first review of appropriate methodologies for the study of human pica. The comprehensive and multi-disciplinary approach to the collection and analysis of pica substances detailed here is a necessary preliminary step to understanding the nutritional enigma of non-food consumption.	[Young, Sera L.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Young, Sera L.] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA; [Wilson, M. Jeffrey; Hillier, Stephen] Macaulay Land Use Res Inst, Soils Grp, Aberdeen AB9 2QJ, Scotland; [Miller, Dennis] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; University of California System; University of California Davis; James Hutton Institute; Cornell University	Young, SL (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	sera@younglucks.com	Hillier, Stephen/C-6555-2008	Hillier, Stephen/0000-0001-9652-9950; Young, Sera/0000-0002-1763-1218	Einaudi Center for International Studies at Cornell University; National Institutes of Health [5 T32 HD007331]; Macaulay Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007331] Funding Source: NIH RePORTER	Einaudi Center for International Studies at Cornell University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macaulay Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge funding for this research from the Einaudi Center for International Studies at Cornell University, the National Institutes of Health (TG #5 T32 HD007331) and the Macaulay Institute. The funders had no role in the study whatsoever.	Abrahams PW, 2006, APPL GEOCHEM, V21, P98, DOI 10.1016/j.apgeochem.2005.09.015; Adams F., 1849, GENUINE WORKS HIPPOC; ALLEN A, 1985, GASTROEN CLIN BIOL, V9, P9; Anell B, 1958, GEOPHAGICAL CUSTOMS; [Anonymous], 1906, NATURE, V74, P543; [Anonymous], 2000, OXFORD ENGLISH DICT; ARCASOY A, 1978, ACTA HAEMATOL-BASEL, V60, P76, DOI 10.1159/000207700; BATESON EM, 1978, MED J AUSTRALIA, V1, P1; Benito P, 1998, NUTR RES, V18, P581, DOI 10.1016/S0271-5317(98)00044-X; Bernard H. R., 2017, RES METHODS ANTHR; BITHONEY WG, 1985, AM J DIS CHILD, V139, P456, DOI 10.1001/archpedi.1985.02140070030023; BLACK DAK, 1956, LANCET, V271, P883; BLUM M, 1968, ANN INTERN MED, V68, P1165, DOI 10.7326/0003-4819-68-5-1165_1; Boyle J S, 1999, J Transcult Nurs, V10, P65, DOI 10.1177/104365969901000116; BROUILLARD MY, 1989, GASTROEN CLIN BIOL, V13, P18; BROUILLARD MY, 1988, ANN GASTROENT HEPATO, V24, P133; BROWN DD, 1976, NEW ENGL J MED, V295, P1034, DOI 10.1056/NEJM197611042951902; Brown G., 1980, CRYSTAL STRUCTURES C, V5, P439; Caius J. F., 1933, J BOMBAY NAT HIST SO, V37, P455; Chisholm J C Jr, 1981, J Natl Med Assoc, V73, P163; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P526, DOI 10.1107/S0021889874010387; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P519, DOI 10.1107/S0021889874010375; CHURCHMAN GJ, 1984, CLAY CLAY MINER, V32, P241, DOI 10.1346/CCMN.1984.0320401; CLAPP JF, 1988, AM J OBSTET GYNECOL, V159, P1456, DOI 10.1016/0002-9378(88)90574-1; COOKSEY NR, 1995, BIRTH-ISS PERINAT C, V22, P129, DOI 10.1111/j.1523-536X.1995.tb00688.x; Cooney DO, 1997, INT J PRIMATOL, V18, P235, DOI 10.1023/A:1026324703410; Cotting J. R, 1836, S MED SURG J, V1, P288; DANFORD DE, 1982, ANNU REV NUTR, V2, P303, DOI 10.1146/annurev.nu.02.070182.001511; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; DE CASTRO J., 1952, Geography of hunger; Diamond J, 1999, IBIS, V141, P181, DOI 10.1111/j.1474-919X.1999.tb07540.x; Dominy NJ, 2004, J EXP BIOL, V207, P319, DOI 10.1242/jeb.00758; DORNAI D, 1993, APPL ENVIRON MICROB, V59, P3123, DOI 10.1128/AEM.59.9.3123-3125.1993; EDWARDS AA, 1983, J NATL MED ASSOC, V75, P895; EDWARDS CECILE HOOVER, 1959, JOUR AMER DIETETIC ASSOC, V35, P810; EDWARDS CH, 1994, J NUTR, V124, pS954, DOI 10.1093/jn/124.suppl_6.954S; FERGUSON RB, 1984, SOIL SCI SOC AM J, V48, P578, DOI 10.2136/sssaj1984.03615995004800030022x; Fessler DMT, 2002, CURR ANTHROPOL, V43, P19, DOI 10.1086/324128; Flaxman SM, 2000, Q REV BIOL, V75, P113, DOI 10.1086/393377; FORMBY B, 1995, ENDOCRIN METAB CLIN, V24, P187, DOI 10.1016/S0889-8529(18)30059-8; FORSYTH CJ, 1989, DEVIANT BEHAV, V10, P61, DOI 10.1080/01639625.1989.9967801; FRATE DA, 1984, SCIENCES, V24, P34, DOI 10.1002/j.2326-1951.1984.tb02752.x; GARDINER KR, 1993, GUT, V34, P51, DOI 10.1136/gut.34.1.51; GARRETSON FD, 1967, P SOC EXP BIOL MED, V126, P304, DOI 10.3181/00379727-126-32431; Geissler PW, 1997, TROP MED INT HEALTH, V2, P624, DOI 10.1046/j.1365-3156.1997.d01-345.x; Geissler PW, 1999, SOC SCI MED, V48, P1069, DOI 10.1016/S0277-9536(98)00409-2; Geissler PW, 2000, AFRICA, V70, P653, DOI 10.3366/afr.2000.70.4.653; Gilardi JD, 1999, J CHEM ECOL, V25, P897, DOI 10.1023/A:1020857120217; GIUDICELLI J, 1992, ARCH FR PEDIATR, V49, P779; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glickman LT, 1999, INT J EPIDEMIOL, V28, P169, DOI 10.1093/ije/28.1.169; Gonzalez R, 2004, BRIT J PHARMACOL, V141, P951, DOI 10.1038/sj.bjp.0705710; Goodman D, 2007, AM J TROP MED HYG, V76, P725, DOI 10.4269/ajtmh.2007.76.725; Grant W.H., 1962, CLAY CLAY MINER, V11, P65, DOI [10.1346/ccmn.1962.0110106, DOI 10.1346/CCMN.1962.0110106]; Grey G., 1841, J 2 EXPEDITIONS DISC; Grigsby RK, 1999, SOUTHERN MED J, V92, P190, DOI 10.1097/00007611-199902000-00005; HALSTED JA, 1968, AM J CLIN NUTR, V21, P1384, DOI 10.1093/ajcn/21.12.1384; Henry J, 2003, DEVIANT BEHAV, V24, P353, DOI 10.1080/713840222; Hertz H, 1947, SOC FORCES, V25, P343, DOI 10.2307/3005676; Hesse P. R., 1971, TXB SOIL CHEM ANAL; Hillier S, 1999, CLAY MINER, V34, P127, DOI 10.1180/claymin.1999.034.1.14; Hillier S, 2000, CLAY MINER, V35, P291, DOI 10.1180/000985500546666; Hooda PS, 2004, SCI TOTAL ENVIRON, V333, P75, DOI 10.1016/j.scitotenv.2004.04.023; Hooda PS, 2002, ENVIRON GEOCHEM HLTH, V24, P305, DOI 10.1023/A:1020542810334; Houston DC, 2001, MAMMAL REV, V31, P249, DOI 10.1046/j.1365-2907.2001.00091.x; HOWARD L, 1993, NUTR RES, V13, P287, DOI 10.1016/S0271-5317(05)80425-7; Hui YH, 2001, FOODBORNE DIS HDB, V1; HUNTER JM, 1984, GEOGR REV, V74, P157, DOI 10.2307/214097; HUNTER JM, 1989, NATL GEOGR RES, V5, P281; HUNTER JM, 1973, GEOGR REV, V63, P170, DOI 10.2307/213410; Hunter JM, 1993, J CULT GEOGR, V14, P69, DOI [10.1080/08873639309478381, DOI 10.1080/08873639309478381]; JOHNS T, 1991, AM J CLIN NUTR, V53, P448, DOI 10.1093/ajcn/53.2.448; JOHNS T, 1991, ECOL FOOD NUTR, V25, P221, DOI 10.1080/03670244.1991.9991170; JOHNS T, 1986, J CHEM ECOL, V12, P635, DOI 10.1007/BF01012098; KEITH D, 1975, MT SINAI J MED, V42, P410; KEITH L, 1971, EXPERIENTIA, V27, P847, DOI 10.1007/BF02136903; Kohnke H., 1968, SOIL PHYS; Konert M, 1997, SEDIMENTOLOGY, V44, P523, DOI 10.1046/j.1365-3091.1997.d01-38.x; Kraemer S, 2002, SOUTHERN MED J, V95, P1228, DOI 10.1097/00007611-200210000-00030; LA BARRE Weston, 1948, AYMARA INDIANS LAKE; LAYMAN EM, 1963, PSYCHOL REC, V13, P249, DOI 10.1007/BF03393525; LEAKE BE, 1969, CHEM GEOL, V5, P7, DOI 10.1016/0009-2541(69)90002-3; LEONARD A, 1994, GASTROEN CLIN BIOL, V18, P609; LIPSON SM, 1983, APPL ENVIRON MICROB, V46, P673, DOI 10.1128/AEM.46.3.673-682.1983; Livingstone David, 1875, LAST J D LIVINGSTONE; LOTAN N, 1983, INT J ARTIF ORGANS, V6, P207; Luoba AI, 2004, T ROY SOC TROP MED H, V98, P734, DOI 10.1016/j.trstmh.2004.01.009; MacClancy J., 2007, CONSUMING INEDIBLE N, P17; Maekawa AA, 2006, J AGR FOOD CHEM, V54, P8362, DOI 10.1021/jf0615395; Mahaney WC, 2003, J CHEM ECOL, V29, P1503, DOI 10.1023/A:1024263627606; Mahaney WC, 2000, INT J ENVIRON HEAL R, V10, P93, DOI 10.1080/09603120050021100; MCELNAY JC, 1982, J TROP MED HYG, V85, P159; MCGINITY JW, 1975, J PHARM SCI, V64, P1566, DOI 10.1002/jps.2600640935; Miller D, 1998, FOOD CHEM LAB MANUAL; Miller D.D., 2003, FOOD ANAL, P401; MILLER DD, 1981, AM J CLIN NUTR, V34, P2248, DOI 10.1093/ajcn/34.10.2248; MINNICH V, 1968, AM J CLIN NUTR, V21, P78, DOI 10.1093/ajcn/21.1.78; MITCHELL D, 1976, PHYSIOL BEHAV, V17, P691, DOI 10.1016/0031-9384(76)90171-2; Moore D., 1997, XRAY DIFFRACTION IDE, VXVIII, P378; MOORE KL, 1998, DEV HUMAN CLINICALLY; MORE J, 1987, HISTOCHEM J, V19, P665, DOI 10.1007/BF01676173; MOUSTAFA MA, 1987, INT J PHARM, V34, P207, DOI 10.1016/0378-5173(87)90181-5; NORRISH K, 1969, GEOCHIM COSMOCHIM AC, V33, P431, DOI 10.1016/0016-7037(69)90126-4; Ofoefule S I, 1999, Boll Chim Farm, V138, P239; OKONEK S, 1983, J TOXICOL-CLIN TOXIC, V19, P807, DOI 10.3109/15563658208992514; OLYNYK F, 1982, NEW ENGL J MED, V306, P1056, DOI 10.1056/NEJM198204293061719; OROURKE DE, 1967, OBSTET GYNECOL, V29, P581; PATTERSON EC, 1977, J NUTR, V107, P2020, DOI 10.1093/jn/107.11.2020; Peech M., 1965, METHODS SOIL ANAL, VVolume 9, P914, DOI DOI 10.2134/AGRONMONOGR9.2.C9; Prasad AS, 2001, NUTRITION, V17, P685, DOI 10.1016/S0899-9007(01)00598-6; PRATHER TA, 1992, J NUTR, V122, P327, DOI 10.1093/jn/122.2.327; Profet M, 1992, ADAPTED MIND EVOLUTI, P327; RATEAU JG, 1982, CURR MED RES OPIN, V8, P233, DOI 10.1185/03007998209109772; Reid R M, 1992, Med Anthropol, V13, P337; Richardson John, 1851, ARCTIC SEARCHING EXP; Schubert ML, 2007, CURR OPIN GASTROEN, V23, P595, DOI 10.1097/MOG.0b013e3282f03462; Schwertmann U., 1989, Minerals in Soil Environments, SSSA Book Series, no. 1., P379; Sherman PW, 2002, AM J OBSTET GYNECOL, V186, pS190, DOI 10.1067/mob.2002.122593; Simpson E, 2000, WESTERN J MED, V173, P20, DOI 10.1136/ewjm.173.1.20; SINGHI S, 1981, CLIN PEDIATR, V20, P783, DOI 10.1177/000992288102001205; Smith B, 1998, J GEOCHEM EXPLOR, V65, P1, DOI 10.1016/S0375-6742(98)00066-1; Smith B, 2000, J GEOL SOC LONDON, V157, P885, DOI 10.1144/jgs.157.4.885; SMITH JC, 1970, J NUTR, V100, P973, DOI 10.1093/jn/100.8.973; SMULIAN JC, 1995, SOUTH MED J, V88, P1236, DOI 10.1097/00007611-199512000-00010; TALKINGTON KM, 1970, AM J OBSTET GYNECOL, V108, P262, DOI 10.1016/0002-9378(70)90308-X; THOMAS FB, 1976, GASTROENTEROLOGY, V71, P1028; TSAKALA M, 1990, J PHARM BELG, V45, P268; VERMEER DE, 1971, ETHNOLOGY, V10, P56, DOI 10.2307/3772799; VERMEER DE, 1979, AM J CLIN NUTR, V32, P2129, DOI 10.1093/ajcn/32.10.2129; von Bonsdorff B, 1977, Br J Haematol, V35, P476, DOI 10.1111/j.1365-2141.1977.tb00611.x; WAI KN, 1966, J PHARM SCI, V55, P1215, DOI 10.1002/jps.2600551110; Ward P, 1999, J Ren Nutr, V9, P14, DOI 10.1016/S1051-2276(99)90017-1; Wiley AS, 1998, CURR ANTHROPOL, V39, P532; Wilson MJ, 2003, J CHEM ECOL, V29, P1525, DOI 10.1023/A:1024262411676; WONG MS, 1993, J TROP PEDIATRICS, V39, P318, DOI 10.1093/tropej/39.5.318; WONG MS, 1988, T ROY SOC TROP MED H, V82, P621, DOI 10.1016/0035-9203(88)90532-9; WOODS SC, 1970, SCIENCE, V169, P1334, DOI 10.1126/science.169.3952.1334; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yasuda K, 2006, J NUTR, V136, P3033, DOI 10.1093/jn/136.12.3033; YOUDIM MBH, 1977, BRIT J HAEMATOL, V36, P298, DOI 10.1111/j.1365-2141.1977.tb00651.x; Young SL, 2007, T ROY SOC TROP MED H, V101, P766, DOI 10.1016/j.trstmh.2007.04.016; Yun SM, 2004, J NUTR, V134, P2717, DOI 10.1093/jn/134.10.2717; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	170	46	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3147	10.1371/journal.pone.0003147	http://dx.doi.org/10.1371/journal.pone.0003147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422IE	18773081	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420100005
J	Scherr, C; Simon, M; Spranger, J; Baumgartner, S				Scherr, Claudia; Simon, Meinhard; Spranger, Joerg; Baumgartner, Stephan			Test System Stability and Natural Variability of a Lemna Gibba L. Bioassay	PLOS ONE			English	Article								Background: In ecotoxicological and environmental studies Lemna spp. are used as test organisms due to their small size, rapid predominantly vegetative reproduction, easy handling and high sensitivity to various chemicals. However, there is not much information available concerning spatial and temporal stability of experimental set-ups used for Lemna bioassays, though this is essential for interpretation and reliability of results. We therefore investigated stability and natural variability of a Lemna gibba bioassay assessing area-related and frond number-related growth rates under controlled laboratory conditions over about one year. Methology/Principal Findings: Lemna gibba L. was grown in beakers with Steinberg medium for one week. Area-related and frond number-related growth rates (r((area)) and r((num))) were determined with a non-destructive image processing system. To assess inter-experimental stability, 35 independent experiments were performed with 10 beakers each in the course of one year. We observed changes in growth rates by a factor of two over time. These did not correlate well with temperature or relative humidity in the growth chamber. In order to assess intra-experimental stability, we analysed six systematic negative control experiments (nontoxicant tests) with 96 replicate beakers each. Evaluation showed that the chosen experimental set-up was stable and did not produce false positive results. The coefficient of variation was lower for r((area)) (2.99%) than for r((num)) (4.27%). Conclusions/Significance: It is hypothesised that the variations in growth rates over time under controlled conditions are partly due to endogenic periodicities in Lemna gibba. The relevance of these variations for toxicity investigations should be investigated more closely. Area-related growth rate seems to be more precise as non-destructive calculation parameter than number-related growth rate. Furthermore, we propose two new validity criteria for Lemna gibba bioassays: variability of average specific and section-by-section segmented growth rate, complementary to average specific growth rate as the only validity criterion existing in guidelines for duckweed bioassays.	[Scherr, Claudia; Spranger, Joerg] Res Inst Organ Agr, Frick, Switzerland; [Scherr, Claudia; Baumgartner, Stephan] Ins Hiscia, Soc Canc Res, Arlesheim, Switzerland; [Simon, Meinhard] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Oldenburg, Germany; [Baumgartner, Stephan] Univ Bern, Inst Complementary Med KIKOM, Bern, Switzerland	Carl von Ossietzky Universitat Oldenburg; University of Bern	Scherr, C (corresponding author), Res Inst Organ Agr, Frick, Switzerland.	scherr@vfk.ch			Research Institute of Organic Agriculture; Sampo Foundation, Dornach, Switzerland; Asta Blumfeld Foundation, Dornach, Switzerland	Research Institute of Organic Agriculture; Sampo Foundation, Dornach, Switzerland; Asta Blumfeld Foundation, Dornach, Switzerland	This work was financed by the official budget of the Research Institute of Organic Agriculture. Additional financial support was received from the Sampo Foundation, Dornach, Switzerland and the Asta Blumfeld Foundation, Dornach, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhtar TA, 2005, ENVIRON TOXICOL CHEM, V24, P1705, DOI 10.1897/04-352R.1; [Anonymous], [No title captured]; [Anonymous], 2004, E141591 ASTM; BORNKAMM R, 1966, PLANTA, V69, P178, DOI 10.1007/BF00399787; Brain RA, 2004, ENVIRON TOXICOL CHEM, V23, P371, DOI 10.1897/02-576; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P1676, DOI 10.1897/04-362R.1; Cedergreen N, 2004, ECOTOX ENVIRON SAFE, V57, P153, DOI 10.1016/S0147-6513(02)00145-8; Fenske C, 2006, INT J HYG ENVIR HEAL, V209, P275, DOI 10.1016/j.ijheh.2005.12.004; Greenberg B. M., 1992, J AQUAT ECOSYSTEM HL, V1, P147, DOI [10.1007/BF00044046, DOI 10.1007/BF00044046]; Grimme L.H., 1998, VORHERSAGBARKEIT BEU; HILLMAN WS, 1961, BOT REV, V27, P221, DOI 10.1007/BF02860083; International Organization for Standardization, 2005, 20079 ISO; Jansen MAK, 2001, PLANT PHYSIOL, V126, P1012, DOI 10.1104/pp.126.3.1012; KANDELER R, 1985, HDB FLOWERING, P251; LANDOLT E, 1986, FAMILY LEMNACEAE MON, V1, P566; Landolt E., 1987, BIOSYSTEMATIC INVEST; *LEMNATEC GMBH, 2002, IM AN SOFT SYST; Mader JC, 2004, J PLANT PHYSIOL, V161, P653, DOI 10.1078/0176-1617-01079; Michel A, 2004, ENVIRON TOXICOL CHEM, V23, P1074, DOI 10.1897/03-256; Miwa K, 2006, PLANT CELL PHYSIOL, V47, P601, DOI 10.1093/pcp/pcj027; Mkandawire M, 2005, AQUAT ECOL, V39, P151, DOI 10.1007/s10452-004-5411-1; Mkandawire M, 2005, SCI TOTAL ENVIRON, V336, P81, DOI 10.1016/j.scitotenv.2004.06.002; Naumann B, 2007, J PLANT PHYSIOL, V164, P1656, DOI 10.1016/j.jplph.2006.10.011; OECD, 2006, 221 OECD; Organisation for Economic Cooperation and Development (OECD), 2006, 201 OECD; PIRSON A., 1953, FLORA, V140, P485; Richards SM, 2004, ENVIRON TOXICOL CHEM, V23, P1035, DOI 10.1897/02-616; Scherr C, 2007, J ALTERN COMPLEM MED, V13, P931, DOI 10.1089/acm.2007.0506; StatSoft Inc. Statistica, 2001, DAT AN SOFTW SYST VE; Szabo S, 1998, AQUAT BOT, V60, P189, DOI 10.1016/S0304-3770(97)00080-6; TILLBERG E, 1979, PHYSIOL PLANTARUM, V46, P5, DOI 10.1111/j.1399-3054.1979.tb03177.x; Tkalec M, 2005, BIOELECTROMAGNETICS, V26, P185, DOI 10.1002/bem.20104; WANG WC, 1990, ENVIRON RES, V52, P7, DOI 10.1016/S0013-9351(05)80147-1; WANG WC, 1987, ENVIRON TOXICOL CHEM, V6, P953, DOI 10.1897/1552-8618(1987)6[953:CIAART]2.0.CO;2	34	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3133	10.1371/journal.pone.0003133	http://dx.doi.org/10.1371/journal.pone.0003133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769541	gold, Green Published, Green Submitted			2022-12-27	WOS:000264419100003
J	Shao, HL; Zheng, WW; Liu, PC; Wang, Q; Wang, JX; Zhao, XF				Shao, Hong-Lian; Zheng, Wei-Wei; Liu, Peng-Cheng; Wang, Qian; Wang, Jin-Xing; Zhao, Xiao-Fan			Establishment of a New Cell Line from Lepidopteran Epidermis and Hormonal Regulation on the Genes	PLOS ONE			English	Article								When an insect molts, old cuticle on the outside of the integument is shed by apolysis and a new cuticle is formed under the old one. This process is completed by the epidermal cells which are controlled by 20-hydroxyecdysone (20E) and juvenile hormone. To understand the molecular mechanisms of integument remolding and hormonal regulation on the gene expression, an epidermal cell line from the 5th instar larval integument of Helicoverpa armigera was established and named HaEpi. The cell line has been cultured continuously for 82 passages beginning on June 30, 2005 until now. Cell doubling time was 64 h. The chromosomes were granular and the chromosome mode was from 70 to 76. Collagenase I was used to detach the cells from the flask bottom. Non-self pathogen AcMNPV induced the cells to apoptosis. The cell line was proved to be an epidermal cell line based on its unique gene expression pattern. It responded to 20E and the non-steroidal ecdysone agonist RH-2485. Its gene expression could be knocked down using RNA interference. Various genes in the cell line were investigated based on their response to 20E. This new cell line represents a platform for investigating the 20E signaling transduction pathway, the immune response mechanism in lepidopteran epidermis and interactions of the genes.	[Shao, Hong-Lian; Zheng, Wei-Wei; Liu, Peng-Cheng; Wang, Qian; Wang, Jin-Xing; Zhao, Xiao-Fan] Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China	Shandong University	Shao, HL (corresponding author), Shandong Univ, Sch Life Sci, Jinan 250100, Peoples R China.	xfzhao@sdu.edu.cn	Wang, Jin-Xing/AAU-1514-2021	Liu, Pengcheng/0000-0003-1179-2296; Zhao, Xiao-Fan/0000-0003-1809-4730; Wang, Jin-Xing/0000-0003-0283-3930	National Natural Science Foundation of China [30710103901, 30670265, 30330070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No: 30710103901,30670265, 30330070).	BROOKHART GL, 1990, INSECT BIOCHEM, V20, P467, DOI 10.1016/0020-1790(90)90028-S; Dong DJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-73; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; HAYFLICK L, 1980, MECH AGEING DEV, V14, P59, DOI 10.1016/0047-6374(80)90106-2; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Hiruma K, 1997, GEN COMP ENDOCR, V107, P84, DOI 10.1006/gcen.1997.6901; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Jindra M, 1997, INSECT MOL BIOL, V6, P41, DOI 10.1046/j.1365-2583.1997.00153.x; KATO Y, 1987, DEVELOPMENT, V99, P137; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lan Q, 1997, INSECT MOL BIOL, V6, P3, DOI 10.1046/j.1365-2583.1997.00151.x; Langelan RE, 2000, DEV BIOL, V227, P481, DOI 10.1006/dbio.2000.9895; LYNN DE, 1983, J INSECT PHYSIOL, V29, P591, DOI 10.1016/0022-1910(83)90026-4; LYNN DE, 1982, P NATL ACAD SCI-BIOL, V79, P2589, DOI 10.1073/pnas.79.8.2589; OBERLANDER H, 1984, SCIENCE, V226, P162, DOI 10.1126/science.226.4671.162; Oberlander H, 2000, J INSECT PHYSIOL, V46, P259, DOI 10.1016/S0022-1910(99)00178-X; Palli SR, 1996, VIROLOGY, V222, P201, DOI 10.1006/viro.1996.0411; Riddiford LM, 1999, AM ZOOL, V39, P736; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; RIDDIFORD LM, 1981, AM ZOOL, V21, P751; SAMUELS RI, 1993, ARCH INSECT BIOCHEM, V24, P33, DOI 10.1002/arch.940240104; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Siaussat D, 2007, CELL MOL LIFE SCI, V64, P365, DOI 10.1007/s00018-007-6452-0; Sudeep A. B., 2002, Indian Journal of Experimental Biology, V40, P69; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Terashima J, 2006, CELL DEATH DIFFER, V13, P454, DOI 10.1038/sj.cdd.4401745; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; Wei Z, 2007, DEV GROWTH DIFFER, V49, P611, DOI 10.1111/j.1440-169X.2007.00957.x; Zhang H, 2006, J INVERTEBR PATHOL, V91, P9, DOI 10.1016/j.jip.2005.10.004; Zhao XF, 2004, INSECT MOL BIOL, V13, P407, DOI 10.1111/j.0962-1075.2004.00499.x; Zhao XF, 2003, CROP PROT, V22, P959, DOI 10.1016/S0261-2194(03)00111-X; Zhao XF, 1998, INSECT BIOCHEM MOLEC, V28, P259, DOI 10.1016/S0965-1748(98)00015-0	35	62	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3127	10.1371/journal.pone.0003127	http://dx.doi.org/10.1371/journal.pone.0003127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769621	Green Published, gold, Green Submitted			2022-12-27	WOS:000264418300009
J	Oren, M; Escande, ML; Paz, G; Fishelson, Z; Rinkevich, B				Oren, Matan; Escande, Marie-line; Paz, Guy; Fishelson, Zvi; Rinkevich, Baruch			Urochordate Histoincompatible Interactions Activate Vertebrate-Like Coagulation System Components	PLOS ONE			English	Article							BLOOD-COAGULATION; BOTRYLLUS-SCHLOSSERI; CIONA-INTESTINALIS; ARTHROPODS; INHIBITION; ASCIDIANS; REJECTION; IMMUNITY; HEPARIN; PLASMA	The colonial ascidian Botryllus schlosseri expresses a unique allorecognition system. When two histoincompatible Botryllus colonies come into direct contact, they develop an inflammatory-like rejection response. A surprising high number of vertebrates' coagulation genes and coagulation-related domains were disclosed in a cDNA library of differentially expressed sequence tags (ESTs), prepared for this allorejection process. Serine proteases, especially from the trypsin family, were highly represented among Botryllus library ortholgues and its "molecular function'' gene ontology analysis. These, together with the built-up clot-like lesions in the interaction area, led us to further test whether a vertebrate-like clotting system participates in Botryllus innate immunity. Three morphologically distinct clot types (points of rejection; POR) were followed. We demonstrated the specific expression of nine coagulation orthologue transcripts in Botryllus rejection processes and effects of the anti-coagulant heparin on POR formation and heartbeats. In situ hybridization of fibrinogen and von Willebrand factor orthologues elucidated enhanced expression patterns specific to histoincompatible reactions as well as common expressions not augmented by innate immunity. Immunohistochemistry for fibrinogen revealed, in naive and immune challenged colonies alike, specific antibody binding to a small population of Botryllus compartment cells. Altogether, molecular, physiological and morphological outcomes suggest the involvement of vertebrates-like coagulation elements in urochordate immunity, not assigned with vasculature injury.	[Oren, Matan; Paz, Guy; Rinkevich, Baruch] Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel; [Escande, Marie-line] Univ Pierre Marie Curie Paris 6, Lab Arago, Banyuls sur Mer, France; [Oren, Matan; Fishelson, Zvi] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, Tel Aviv, Israel	Israel Oceanographic & Limnological Research Institute; UDICE-French Research Universities; Sorbonne Universite; Tel Aviv University; Sackler Faculty of Medicine	Oren, M (corresponding author), Natl Inst Oceanog, Israel Oceanog & Limnol Res, IL-31080 Haifa, Israel.	matan@ocean.org.il	oren, matan/AAX-8770-2021	oren, matan/0000-0002-6162-324X	Marine Genomics Europe Network of Excellence; United States-Israel Bi-National Science Foundation [2003-010]; Israel Academy of Science [550-06]; MACPAD [HPMT-CT-2000-00211]	Marine Genomics Europe Network of Excellence; United States-Israel Bi-National Science Foundation(US-Israel Binational Science Foundation); Israel Academy of Science; MACPAD	This study was supported by grants from the Marine Genomics Europe Network of Excellence (EDD Node), the United States-Israel Bi-National Science Foundation (2003-010) and the Israel Academy of Science (550-06). Matan Oren was a recipient of a European fellowship "Marie Curie" training sites MACPAD contract n HPMT-CT-2000-00211 under the guidance of Anne-Marie Genevier.	ANUMANTHAIAH R, 2002, BLOOD CELL MOL DIS, V29, P57; Ballarin L, 1998, DEV COMP IMMUNOL, V22, P479, DOI 10.1016/S0145-305X(98)00035-4; BARRINGTON EJW, 1957, J MAR BIOL ASSOC UK, V36, P1, DOI 10.1017/S0025315400017021; BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581; Cardilo-Reis L, 2006, BRAZ J MED BIOL RES, V39, P1409, DOI 10.1590/S0100-879X2006001100004; Cavalcante MCM, 2000, J BIOL CHEM, V275, P36189, DOI 10.1074/jbc.M005830200; Cima F, 2003, CELL TISSUE RES, V312, P369, DOI 10.1007/s00441-003-0738-9; Davidson CJ, 2003, J THROMB HAEMOST, V1, P1487, DOI 10.1046/j.1538-7836.2003.00334.x; Doolittle RF, 2008, J MOL EVOL, V66, P185, DOI 10.1007/s00239-008-9074-8; Esmon CT, 2004, TRENDS IMMUNOL, V25, P536, DOI 10.1016/j.it.2004.08.003; GOODBODY I, 1974, ADV MAR BIOL, V12, P1; Grzesiak A, 2000, J BIOL CHEM, V275, P33346, DOI 10.1074/jbc.M006085200; Hirose E, 1997, BIOL BULL, V192, P53, DOI 10.2307/1542575; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jiang Y, 2003, P NATL ACAD SCI USA, V100, P7527, DOI 10.1073/pnas.0932632100; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Kenjo A, 2001, J BIOL CHEM, V276, P19959, DOI 10.1074/jbc.M011723200; Kulman JD, 2006, P NATL ACAD SCI USA, V103, P15794, DOI 10.1073/pnas.0607543103; Lapidot Z, 2003, MAR BIOTECHNOL, V5, P388, DOI 10.1007/s10126-002-0087-9; Lawler J, 2000, CURR OPIN CELL BIOL, V12, P634, DOI 10.1016/S0955-0674(00)00143-5; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Mellanby J, 1938, PROC R SOC SER B-BIO, V125, P204, DOI 10.1098/rspb.1938.0021; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Oren M, 2007, DEV COMP IMMUNOL, V31, P889, DOI 10.1016/j.dci.2006.12.009; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; Rinkevich B, 1998, AQUAT LIVING RESOUR, V11, P163, DOI 10.1016/S0990-7440(98)80113-7; RINKEVICH B, 1991, INT IMMUNOL, V3, P1265, DOI 10.1093/intimm/3.12.1265; RINKEVICH B, 1992, IMMUNOLOGY PATHOLOGY, V4, P17; Rinkevich Baruch, 1992, Animal Biology, V1, P17; Sasaki A, 2003, ZOOL SCI, V20, P1025, DOI 10.2108/zsj.20.1025; SCOFIELD VL, 1983, BIOL BULL, V165, P733, DOI 10.2307/1541475; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Shishikura F, 1997, COMP BIOCHEM PHYS B, V118, P131, DOI 10.1016/S0305-0491(97)00217-4; Shrivastava S, 2007, AM J TRANSPLANT, V7, P499, DOI 10.1111/j.1600-6143.2006.01653.x; TAKAHASHI H, 1994, BIOL BULL, V186, P247, DOI 10.2307/1542270; TANAKA K, 1973, CELL IMMUNOL, V7, P427, DOI 10.1016/0008-8749(73)90207-4; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tuszynski G P, 1988, Prog Clin Biol Res, V283, P211; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; WRITE RK, 1981, INVERTEBRATE BLOOD C, V2, P565	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3123	10.1371/journal.pone.0003123	http://dx.doi.org/10.1371/journal.pone.0003123			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769590	Green Published, Green Submitted, gold			2022-12-27	WOS:000264416600011
J	Fiske, IJ; Bruna, EM; Bolker, BM				Fiske, Ian J.; Bruna, Emilio M.; Bolker, Benjamin M.			Effects of Sample Size on Estimates of Population Growth Rates Calculated with Matrix Models	PLOS ONE			English	Article							COMPARATIVE DEMOGRAPHY; UNDERSTORY HERB; VIABILITY	Background: Matrix models are widely used to study the dynamics and demography of populations. An important but overlooked issue is how the number of individuals sampled influences estimates of the population growth rate (lambda) calculated with matrix models. Even unbiased estimates of vital rates do not ensure unbiased estimates of lambda-Jensen's Inequality implies that even when the estimates of the vital rates are accurate, small sample sizes lead to biased estimates of l due to increased sampling variance. We investigated if sampling variability and the distribution of sampling effort among size classes lead to biases in estimates of lambda. Methodology/Principal Findings: Using data from a long-term field study of plant demography, we simulated the effects of sampling variance by drawing vital rates and calculating lambda for increasingly larger populations drawn from a total population of 3842 plants. We then compared these estimates of lambda with those based on the entire population and calculated the resulting bias. Finally, we conducted a review of the literature to determine the sample sizes typically used when parameterizing matrix models used to study plant demography. Conclusions/Significance: We found significant bias at small sample sizes when survival was low (survival = 0.5), and that sampling with a more-realistic inverse J-shaped population structure exacerbated this bias. However our simulations also demonstrate that these biases rapidly become negligible with increasing sample sizes or as survival increases. For many of the sample sizes used in demographic studies, matrix models are probably robust to the biases resulting from sampling variance of vital rates. However, this conclusion may depend on the structure of populations or the distribution of sampling effort in ways that are unexplored. We suggest more intensive sampling of populations when individual survival is low and greater sampling of stages with high elasticities.	[Fiske, Ian J.; Bruna, Emilio M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Bruna, Emilio M.] Univ Florida, Ctr Latin American Stud, Gainesville, FL 32611 USA; [Bruna, Emilio M.] Smithsonian Trop Res Inst, Inst Nacl Pesquisas Amazonia, Biol Dynam Forest Fragments Project, Manaus, Amazonas, Brazil; [Bolker, Benjamin M.] Univ Florida, Dept Zool, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution; Smithsonian Tropical Research Institute; State University System of Florida; University of Florida	Fiske, IJ (corresponding author), N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA.	ianfiske@gmail.com	Bruna, Emilio M/H-2769-2012	Bruna, Emilio M/0000-0003-3381-8477; Bolker, Benjamin/0000-0002-2127-0443	National Science Foundation [DEB-0309819, INT 98-06351]; University of Florida	National Science Foundation(National Science Foundation (NSF)); University of Florida(University of Florida)	Financial support for collecting demographic data was provided by the National Science Foundation (award numbers DEB-0309819 and INT 98-06351) and the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barot S, 2000, J TROP ECOL, V16, P637, DOI 10.1017/S0266467400001620; Berry F., 1991, HELICONIA IDENTIFICA; BIERREGAARD RO, 2002, LESSONS AMAZONIA ECO; BOYCE MS, 1977, THEOR POPUL BIOL, V12, P366, DOI 10.1016/0040-5809(77)90050-8; Bruna EM, 2003, ECOLOGY, V84, P932, DOI 10.1890/0012-9658(2003)084[0932:APPIFH]2.0.CO;2; Bruna EM, 2002, CONSERV BIOL, V16, P1256, DOI 10.1046/j.1523-1739.2002.99494.x; Caswell, 2000, MATRIX POPULATION MO; DALEY DJ, 1979, THEOR POPUL BIOL, V15, P257, DOI 10.1016/0040-5809(79)90039-X; Dickinson KJM, 2007, AUSTRAL ECOL, V32, P155, DOI 10.1111/j.1442-9993.2006.01704.x; Dixon PM, 2005, ECOLOGY, V86, P1114, DOI 10.1890/04-0601; Doak DF, 2005, ECOLOGY, V86, P1154, DOI 10.1890/04-0611; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.1890/0012-9658(2000)081[0694:SSSAAN]2.0.CO;2; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Gelman A., 2004, BAYESIAN DATA ANAL; Gross K, 2006, POPUL ECOL, V48, P79, DOI 10.1007/s10144-005-0238-8; Gross K, 2002, ECOLOGY, V83, P1762, DOI 10.1890/0012-9658(2002)083[1762:EDCFEG]2.0.CO;2; Hilborn Ray, 1997, V28; HORVITZ CC, 1995, ECOL MONOGR, V65, P155, DOI 10.2307/2937136; HOULLIER F, 1989, MATH BIOSCI, V95, P161, DOI 10.1016/0025-5564(89)90030-8; Inouye BD, 2005, ECOLOGY, V86, P262, DOI 10.1890/03-3180; Jensen JLWV, 1906, ACTA MATH-DJURSHOLM, V30, P175, DOI 10.1007/BF02418571; Karban R, 1997, ECOLOGY, V78, P1351; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kendall BE, 2002, CONSERV BIOL, V16, P109, DOI 10.1046/j.1523-1739.2002.00036.x; LEFKOVITCH LP, 1965, BIOMETRICS, V21, P1, DOI 10.2307/2528348; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Linares C, 2007, ECOLOGY, V88, P918, DOI 10.1890/05-1931; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2005, ECOL MONOGR, V75, P119, DOI 10.1890/03-4116; Munzbergova Z, 2005, J APPL ECOL, V42, P1115, DOI 10.1111/j.1365-2664.2005.01099.x; OLI MK, 1994, J MAMMAL, V75, P998, DOI 10.2307/1382482; R Development Core Team, 2005, R LANG ENV STAT COMP; Rogers-Bennett L, 2006, ECOL MODEL, V195, P237, DOI 10.1016/j.ecolmodel.2005.11.019; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; THOMPSON SK, 2002, SAMPLING; Tuljapurkar S.D., 1990, POPULATION DYNAMICS; USHER MB, 1966, J APPL ECOL, V3, P355, DOI 10.2307/2401258; Wackerly D., 2001, MATH STAT APPL; White GC, 2000, METH C CONS, P288	41	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3080	10.1371/journal.pone.0003080	http://dx.doi.org/10.1371/journal.pone.0003080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769483	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796600002
J	Kool, M; Koster, J; Bunt, J; Hasselt, NE; Lakeman, A; van Sluis, P; Troost, D; Schouten-van Meeteren, N; Caron, HN; Cloos, J; Mrsic, A; Ylstra, B; Grajkowska, W; Hartmann, W; Pietsch, T; Ellison, D; Clifford, SC; Versteeg, R				Kool, Marcel; Koster, Jan; Bunt, Jens; Hasselt, Nancy E.; Lakeman, Arjan; van Sluis, Peter; Troost, Dirk; Schouten-van Meeteren, Netteke; Caron, Huib N.; Cloos, Jacqueline; Mrsic, Alan; Ylstra, Bauke; Grajkowska, Wieslawa; Hartmann, Wolfgang; Pietsch, Torsten; Ellison, David; Clifford, Steven C.; Versteeg, Rogier			Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMORS; S-ANTIGEN IMMUNOREACTIVITY; CHILDHOOD MEDULLOBLASTOMA; BETA-CATENIN; ARRAY CGH; IMMUNOCYTOCHEMICAL DEMONSTRATION; TRILATERAL RETINOBLASTOMA; PHOTORECEPTOR MARKERS; WNT/WINGLESS PATHWAY; RAS/MAPK PATHWAY	Background: Medulloblastoma is the most common malignant brain tumor in children. Despite recent improvements in cure rates, prediction of disease outcome remains a major challenge and survivors suffer from serious therapy-related side-effects. Recent data showed that patients with WNT-activated tumors have a favorable prognosis, suggesting that these patients could be treated less intensively, thereby reducing the side-effects. This illustrates the potential benefits of a robust classification of medulloblastoma patients and a detailed knowledge of associated biological mechanisms. Methods and Findings: To get a better insight into the molecular biology of medulloblastoma we established mRNA expression profiles of 62 medulloblastomas and analyzed 52 of them also by comparative genomic hybridization (CGH) arrays. Five molecular subtypes were identified, characterized by WNT signaling (A; 9 cases), SHH signaling (B; 15 cases), expression of neuronal differentiation genes (C and D; 16 and 11 cases, respectively) or photoreceptor genes (D and E; both 11 cases). Mutations in beta-catenin were identified in all 9 type A tumors, but not in any other tumor. PTCH1 mutations were exclusively identified in type B tumors. CGH analysis identified several fully or partly subtype-specific chromosomal aberrations. Monosomy of chromosome 6 occurred only in type A tumors, loss of 9q mostly occurred in type B tumors, whereas chromosome 17 aberrations, most common in medulloblastoma, were strongly associated with type C or D tumors. Loss of the inactivated X-chromosome was highly specific for female cases of type C, D and E tumors. Gene expression levels faithfully reflected the chromosomal copy number changes. Clinicopathological features significantly different between the 5 subtypes included metastatic disease and age at diagnosis and histology. Metastatic disease at diagnosis was significantly associated with subtypes C and D and most strongly with subtype E. Patients below 3 yrs of age had type B, D, or E tumors. Type B included most desmoplastic cases. We validated and confirmed the molecular subtypes and their associated clinicopathological features with expression data from a second independent series of 46 medulloblastomas. Conclusions: The new medulloblastoma classification presented in this study will greatly enhance the understanding of this heterogeneous disease. It will enable a better selection and evaluation of patients in clinical trials, and it will support the development of new molecular targeted therapies. Ultimately, our results may lead to more individualized therapies with improved cure rates and a better quality of life.	[Kool, Marcel; Koster, Jan; Bunt, Jens; Hasselt, Nancy E.; Lakeman, Arjan; van Sluis, Peter; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1105 AZ Amsterdam, Netherlands; [Troost, Dirk] Univ Amsterdam, Acad Med Ctr, Dept Neuropathol, NL-1012 WX Amsterdam, Netherlands; [Schouten-van Meeteren, Netteke; Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1012 WX Amsterdam, Netherlands; [Cloos, Jacqueline] VU Unive Med Ctr, Dept Pediat Oncol Hematol, Amsterdam, Netherlands; [Mrsic, Alan; Ylstra, Bauke] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Grajkowska, Wieslawa] Childrens Memorial Hlth Inst, Dept Pathol, Warsaw, Poland; [Hartmann, Wolfgang; Pietsch, Torsten] Univ Bonn, Dept Neuropathol, D-5300 Bonn, Germany; [Ellison, David] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN USA; [Clifford, Steven C.] Univ Newcastle, N Inst Canc Res, Newcastle Upon Tyne, Tyne & Wear, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Children's Memorial Health Institute; University of Bonn; St Jude Children's Research Hospital; Newcastle University - UK	Kool, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Human Genet, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.kool@amc.uva.nl	Ylstra, Bauke/D-2906-2012; Bunt, Jens/C-4775-2014; Kool, Marcel/H-2541-2013; Hartmann, Wolfgang/G-1893-2017; Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008	Ylstra, Bauke/0000-0001-9479-3010; Bunt, Jens/0000-0003-0397-2019; Hartmann, Wolfgang/0000-0002-7609-5021; Koster, Jan/0000-0002-0890-7585; Cloos, Jacqueline/0000-0001-9150-8026; Versteeg, Rogier/0000-0001-7172-0388; Grajkowska, Wieslawa/0000-0001-8318-5781; Clifford, Steve/0000-0003-4893-2184	Dutch Cancer Society [UVA-2001-2558]; Stichting Kindergeneeskundig Kankeronderzoek (SKK); KIKA foundation	Dutch Cancer Society(KWF Kankerbestrijding); Stichting Kindergeneeskundig Kankeronderzoek (SKK); KIKA foundation	Research was supported by grants from the Dutch Cancer Society (KWF grant no UVA-2001-2558), the Stichting Kindergeneeskundig Kankeronderzoek (SKK) and the KIKA foundation.	Aldosari N, 2002, ARCH PATHOL LAB MED, V126, P540; BADIALI M, 1991, TUMORI, V77, P118, DOI 10.1177/030089169107700205; Bayani J, 2000, J NEUROSURG, V93, P437, DOI 10.3171/jns.2000.93.3.0437; BONNIN JM, 1988, ACTA NEUROPATHOL, V76, P204, DOI 10.1007/BF00688104; Boon K, 2005, CANCER RES, V65, P703; Boon K, 2003, ONCOGENE, V22, P7687, DOI 10.1038/sj.onc.1207043; Clifford SC, 2006, CELL CYCLE, V5, P2666, DOI 10.4161/cc.5.22.3446; CZERWIONKA M, 1989, ACTA NEUROPATHOL, V78, P629, DOI 10.1007/BF00691290; Dahmen RP, 2001, CANCER RES, V61, P7039; de Haas T, 2006, J NEUROPATH EXP NEUR, V65, P176, DOI 10.1097/01.jnen.0000199576.70923.8a; Di CH, 2005, CANCER RES, V65, P919; DONOSO LA, 1985, INVEST OPHTH VIS SCI, V26, P568; DONOSO LA, 1986, ARCH OPHTHALMOL-CHIC, V104, P111, DOI 10.1001/archopht.1986.01050130125035; Eberhart CG, 2002, CANCER-AM CANCER SOC, V94, P552, DOI 10.1002/cncr.10189; Eberhart CG, 2000, J NEUROPATH EXP NEUR, V59, P333, DOI 10.1093/jnen/59.4.333; Elias WJ, 2001, J NEUROSURG, V95, P871, DOI 10.3171/jns.2001.95.5.0871; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Giangaspero F, 1999, J NEUROSURG, V91, P971, DOI 10.3171/jns.1999.91.6.0971; Giangaspero F, 2007, WHO CLASSIFICATION T, P132; Gilbertson R, 2001, BRIT J CANCER, V85, P705, DOI 10.1054/bjoc.2001.1987; Gilbertson RJ, 2006, EUR J CANCER, V42, P646, DOI 10.1016/j.ejca.2005.11.023; Gilbertson RJ, 2003, NAT GENET, V35, P197, DOI 10.1038/ng1103-197; GILBERTSON RJ, 1995, BRIT J CANCER, V71, P473, DOI 10.1038/bjc.1995.96; Grotzer MA, 2000, KLIN PADIATR, V212, P196, DOI 10.1055/s-2000-10044; Grotzer MA, 2001, CLIN CANCER RES, V7, P2425; Herms J, 2000, INT J CANCER, V89, P395; Huang HT, 2000, AM J PATHOL, V156, P433, DOI 10.1016/S0002-9440(10)64747-5; Hui ABY, 2005, CLIN CANCER RES, V11, P4707, DOI 10.1158/1078-0432.CCR-05-0128; IOLASCON A, 1991, MED PEDIATR ONCOL, V19, P240, DOI 10.1002/mpo.2950190406; JAFFEY PB, 1995, J NEUROPATH EXP NEUR, V54, P664, DOI 10.1097/00005072-199509000-00008; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koch A, 2001, INT J CANCER, V93, P445, DOI 10.1002/ijc.1342; KORF H, 1987, CANCER, V60, P1763, DOI 10.1002/1097-0142(19871015)60:8<1763::AID-CNCR2820600815>3.0.CO;2-3; KORF HW, 1990, J NEUROPATH EXP NEUR, V49, P424, DOI 10.1097/00005072-199007000-00006; KORF HW, 1992, ACTA NEUROPATHOL, V83, P482, DOI 10.1007/BF00310024; KORF HW, 1986, ACTA NEUROPATHOL, V69, P165, DOI 10.1007/BF00687054; KRAMM CM, 1991, ACTA NEUROPATHOL, V81, P296, DOI 10.1007/BF00305871; Lamont JM, 2004, CLIN CANCER RES, V10, P5482, DOI 10.1158/1078-0432.CCR-03-0721; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Marcus DM, 1998, SURV OPHTHALMOL, V43, P59, DOI 10.1016/S0039-6257(98)00019-8; Marino S, 2000, GENE DEV, V14, P994; McCabe MG, 2006, J NEUROPATH EXP NEUR, V65, P549, DOI 10.1097/00005072-200606000-00003; McManamy CS, 2007, BRAIN PATHOL, V17, P151, DOI 10.1111/j.1750-3639.2007.00058.x; Michiels EMC, 1999, PHYSIOL GENOMICS, V1, P83, DOI 10.1152/physiolgenomics.1999.1.2.83; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Olson MV, 2007, CANCER RES, V67, P4005, DOI 10.1158/0008-5472.CAN-06-2973; Pan E, 2005, CLIN CANCER RES, V11, P4733; PERENTES E, 1986, ACTA NEUROPATHOL, V71, P224, DOI 10.1007/BF00688043; Pietsch T, 2004, J NEURO-ONCOL, V70, P203, DOI 10.1007/s11060-004-2750-7; Pietsch T, 1997, CANCER RES, V57, P2085; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Raffel C, 1997, CANCER RES, V57, P842; Rossi MR, 2006, GENE CHROMOSOME CANC, V45, P290, DOI 10.1002/gcc.20292; Rutkowski S, 2005, NEW ENGL J MED, V352, P978, DOI 10.1056/NEJMoa042176; Rutkowski S, 2007, CLIN CANCER RES, V13, P2651, DOI 10.1158/1078-0432.CCR-06-1779; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; THEURING F, 1990, ONCOGENE, V5, P225; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; van de Wiel MA, 2007, BIOINFORMATICS, V23, P892, DOI 10.1093/bioinformatics/btm030; van den IJssel P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni191; Wolter M, 1997, CANCER RES, V57, P2581; Woo S., 2002, PRINCIPLES PRACTICE; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559; Yuki D, 2004, ONCOL REP, V12, P275; Zurawel RH, 1998, CANCER RES, V58, P896	68	516	536	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3088	10.1371/journal.pone.0003088	http://dx.doi.org/10.1371/journal.pone.0003088			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769486	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796600007
J	Wang, PHM; Campanholle, G; Cenedeze, MA; Feitoza, CQ; Goncalves, GM; Landgraf, RG; Jancar, S; Pesquero, JB; Pacheco-Silva, A; Camara, NOS				Wang, Pamella H. M.; Campanholle, Gabriela; Cenedeze, Marcos A.; Feitoza, Carla Q.; Goncalves, Giselle M.; Landgraf, Richardt G.; Jancar, Sonia; Pesquero, Joao B.; Pacheco-Silva, Alvaro; Camara, Niels O. S.			Brabykinin B1 Receptor Antagonism Is Beneficial in Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article								Previously we have demonstrated that bradykinin B1 receptor deficient mice (B1KO) were protected against renal ischemia and reperfusion injury (IRI). Here, we aimed to analyze the effect of B1 antagonism on renal IRI and to study whether B1R knockout or antagonism could modulate the renal expression of pro and anti-inflammatory molecules. To this end, mice were subjected to 45 minutes ischemia and reperfused at 4, 24, 48 and 120 hours. Wild-type mice were treated intra-peritoneally with antagonists of either B1 (R-954, 200 mg/kg) or B2 receptor (HOE140, 200 mg/kg) 30 minutes prior to ischemia. Blood samples were collected to ascertain serum creatinine level, and kidneys were harvested for gene transcript analyses by real-time PCR. Herein, B1R antagonism ( R-954) was able to decrease serum creatinine levels, whereas B2R antagonism had no effect. The protection seen under B1R deletion or antagonism was associated with an increased expression of GATA-3, IL-4 and IL-10 and a decreased T-bet and IL-1b transcription. Moreover, treatment with R-954 resulted in lower MCP-1, and higher HO-1 expression. Our results demonstrated that bradykinin B1R antagonism is beneficial in renal IRI.	[Wang, Pamella H. M.; Cenedeze, Marcos A.; Feitoza, Carla Q.; Goncalves, Giselle M.; Pacheco-Silva, Alvaro; Camara, Niels O. S.] Univ Fed Sao Paulo, Div Nephrol, Lab Imunol Clin & Expt, Sao Paulo, Brazil; [Campanholle, Gabriela; Camara, Niels O. S.] Univ Sao Paulo, Dept Immunol, Lab Imunobiol Transplant, BR-05508 Sao Paulo, Brazil; [Landgraf, Richardt G.; Jancar, Sonia] Univ Sao Paulo, Dept Immunol, Lab Imunofarmacol, BR-05508 Sao Paulo, Brazil; [Pesquero, Joao B.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Wang, PHM (corresponding author), Univ Fed Sao Paulo, Div Nephrol, Lab Imunol Clin & Expt, Sao Paulo, Brazil.	niels@icb.usp.br	Landgraf, Richardt/F-7146-2012; Camara, Niels OS/G-8336-2011; Jancar, Sonia/C-5153-2012; camara, niels olsen saraiva/AAX-3269-2020; Pacheco-Silva, Alvaro/K-3583-2013; Complexos, INCT Fluidos/H-9172-2013; Pesquero, Joao/C-1470-2012	Landgraf, Richardt/0000-0001-7774-7880; Camara, Niels OS/0000-0001-5436-1248; Jancar, Sonia/0000-0001-7983-3459; camara, niels olsen saraiva/0000-0001-5436-1248; Pesquero, Joao/0000-0002-4507-632X	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [04/08311-6, 05/50085-6, 06/03982-5, 07/07139-3]; CNPq [04/08311-6, 05/50085-6, 06/03982-5, 07/07139-3]	Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) and CNPq. Grant numbers: 04/08311-6, 05/50085-6, 06/03982-5 and 07/07139-3	AHLUWALIA A, 1994, EUR J PHARMACOL, V264, P407, DOI 10.1016/0014-2999(94)00503-6; Araujo RC, 2001, BIOL CHEM, V382, P91, DOI 10.1515/BC.2001.014; Chiang WC, 2006, FREE RADICAL BIO MED, V41, P1304, DOI 10.1016/j.freeradbiomed.2006.07.011; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; Duka I, 2003, HYPERTENSION, V42, P1021, DOI 10.1161/01.HYP.0000097550.98865.35; Emanueli C, 2002, CIRCULATION, V105, P360, DOI 10.1161/hc0302.102142; Feitoza CQ, 2005, INT IMMUNOPHARMACOL, V5, P79, DOI 10.1016/j.intimp.2004.09.024; Kakoki M, 2007, P NATL ACAD SCI USA, V104, P7576, DOI 10.1073/pnas.0701617104; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; Koyama S, 2000, AM J RESP CELL MOL, V22, P75, DOI 10.1165/ajrcmb.22.1.3752; Landgraf RG, 2004, INFLAMM RES, V53, P78, DOI 10.1007/s00011-003-1226-0; Landgraf RG, 2003, EUR J PHARMACOL, V460, P75, DOI 10.1016/S0014-2999(02)02880-7; Liesmaa I, 2005, AM J PHYSIOL-HEART C, V288, pH2317, DOI 10.1152/ajpheart.00815.2004; Liu MC, 2006, J AM SOC NEPHROL, V17, P765, DOI 10.1681/ASN.2005010102; Marceau F, 1998, CLIN REV ALLERG IMMU, V16, P385, DOI 10.1007/BF02737658; Marceau F, 1998, PHARMACOL REV, V50, P357; Marques VP, 2006, NEPHRON EXP NEPHROL, V104, pE48, DOI 10.1159/000093676; McLean PG, 1998, NEUROGASTROENT MOTIL, V10, P499; McLean PG, 2000, J EXP MED, V192, P367, DOI 10.1084/jem.192.3.367; Ni AG, 2003, J BIOL CHEM, V278, P219, DOI 10.1074/jbc.M209490200; PERRETTI M, 1993, AGENTS ACTIONS, V38, pC64, DOI 10.1007/BF01991139; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Pinheiro HS, 2007, BRAZ J MED BIOL RES, V40, P557, DOI 10.1590/S0100-879X2007000400015; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Rabb H, 2000, AM J PHYSIOL-RENAL, V279, pF525, DOI 10.1152/ajprenal.2000.279.3.F525; REGOLI D, 1980, PHARMACOL REV, V32, P1; Sacerdoti D, 2005, CELL MOL BIOL, V51, P363, DOI 10.1170/T639; Sato E, 1996, J IMMUNOL, V157, P3122; Schanstra JP, 1998, J CLIN INVEST, V101, P2080, DOI 10.1172/JCI1359; Shen XD, 2003, HEPATOLOGY, V37, P296, DOI 10.1053/jhep.2003.50066; Souza DG, 2004, J IMMUNOL, V172, P2542, DOI 10.4049/jimmunol.172.4.2542; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; TIFFANY CW, 1989, FEBS LETT, V247, P189, DOI 10.1016/0014-5793(89)81331-6; Wang PHM, 2006, INT IMMUNOPHARMACOL, V6, P1960, DOI 10.1016/j.intimp.2006.07.031; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yokota N, 2003, AM J PHYSIOL-RENAL, V285, pF319, DOI 10.1152/ajprenal.00432.2002; Yokota N, 2002, TRANSPLANTATION, V74, P759, DOI 10.1097/00007890-200209270-00005; Ysebaert DK, 2004, KIDNEY INT, V66, P491, DOI 10.1111/j.1523-1755.2004.761_4.x	40	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3050	10.1371/journal.pone.0003050	http://dx.doi.org/10.1371/journal.pone.0003050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725957	gold, Green Submitted, Green Published			2022-12-27	WOS:000264429000003
J	Yamanaka, N; Yamamoto, S; Zitnan, D; Watanabe, K; Kawada, T; Satake, H; Kaneko, Y; Hiruma, K; Tanaka, Y; Shinoda, T; Kataoka, H				Yamanaka, Naoki; Yamamoto, Sachie; Zitnan, Dusan; Watanabe, Ken; Kawada, Tsuyoshi; Satake, Honoo; Kaneko, Yu; Hiruma, Kiyoshi; Tanaka, Yoshiaki; Shinoda, Tetsuro; Kataoka, Hiroshi			Neuropeptide Receptor Transcriptome Reveals Unidentified Neuroendocrine Pathways	PLOS ONE			English	Article								Neuropeptides are an important class of molecules involved in diverse aspects of metazoan development and homeostasis. Insects are ideal model systems to investigate neuropeptide functions, and the major focus of insect neuropeptide research in the last decade has been on the identification of their receptors. Despite these vigorous efforts, receptors for some key neuropeptides in insect development such as prothoracicotropic hormone, eclosion hormone and allatotropin ( AT), remain undefined. In this paper, we report the comprehensive cloning of neuropeptide G protein-coupled receptors from the silkworm, Bombyx mori, and systematic analyses of their expression. Based on the expression patterns of orphan receptors, we identified the long-sought receptor for AT, which is thought to stimulate juvenile hormone biosynthesis in the corpora allata ( CA). Surprisingly, however, the AT receptor was not highly expressed in the CA, but instead was predominantly transcribed in the corpora cardiaca ( CC), an organ adjacent to the CA. Indeed, by using a reverse-physiological approach, we purified and characterized novel allatoregulatory peptides produced in AT receptor-expressing CC cells, which may indirectly mediate AT activity on the CA. All of the above findings confirm the effectiveness of a systematic analysis of the receptor transcriptome, not only in characterizing orphan receptors, but also in identifying novel players and hidden mechanisms in important biological processes. This work illustrates how using a combinatorial approach employing bioinformatic, molecular, biochemical and physiological methods can help solve recalcitrant problems in neuropeptide research.	[Yamanaka, Naoki; Yamamoto, Sachie; Watanabe, Ken; Kataoka, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Zitnan, Dusan] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Kawada, Tsuyoshi; Satake, Honoo] Suntory Inst Bioorgan Res, Osaka, Japan; [Kaneko, Yu; Hiruma, Kiyoshi] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Tanaka, Yoshiaki; Shinoda, Tetsuro] Natl Inst Agrobiol Sci, Ibaraki, Osaka, Japan	University of Tokyo; Slovak Academy of Sciences; Suntory Holdings Ltd; Hirosaki University; National Institute of Agrobiological Sciences - Japan	Yamanaka, N (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Howard Hughes Med Inst, Minneapolis, MN 55455 USA.	shinoda@affrc.go.jp; kataoka@k.u-tokyo.ac.jp	Kaneko, Yu/F-7460-2013; Yamanaka, Naoki/F-1358-2010	Yamanaka, Naoki/0000-0002-6244-2686	Japan Society for the Promotion of Science [Research Fellow]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Research for the Future Program of Japan Society for the Promotion of Science (JSPS); National Institute of Health, USA [GM 67310]; Agentura na podporu vyskumu a vyvoja [APVV-51-039105]; Vedecka grantova agentura [VEGA 2-6090-26]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067310] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN); Research for the Future Program of Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agentura na podporu vyskumu a vyvoja; Vedecka grantova agentura; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	N.Y. was a Research Fellow of the Japan Society for the Promotion of Science. This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), grants from Research for the Future Program of Japan Society for the Promotion of Science (JSPS), the National Institute of Health, USA (GM 67310), and Slovak grant agencies, Agentura na podporu vyskumu a vyvoja (APVV-51-039105) and Vedecka grantova agentura (VEGA 2-6090-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1995, COMP BIOCHEM PHYS A, V110, P87, DOI 10.1016/0300-9629(94)00132-D; BAKER FC, 1987, INSECT BIOCHEM, V17, P989, DOI 10.1016/0020-1790(87)90108-9; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Cazzamali G, 2002, P NATL ACAD SCI USA, V99, P12073, DOI 10.1073/pnas.192442799; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; De Loof A, 2001, ARCH INSECT BIOCHEM, V47, P129, DOI 10.1002/arch.1044; Egerod K, 2003, P NATL ACAD SCI USA, V100, P9808, DOI 10.1073/pnas.1632197100; Egerod K, 2003, BIOCHEM BIOPH RES CO, V306, P437, DOI 10.1016/S0006-291X(03)00997-5; Elekonich MM, 2003, PEPTIDES, V24, P1623, DOI 10.1016/j.peptides.2003.08.011; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garczynski SF, 2002, PEPTIDES, V23, P773, DOI 10.1016/S0196-9781(01)00647-7; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Ha SD, 2000, MOL CELLS, V10, P13, DOI 10.1007/s10059-000-0013-9; Hauser Frank, 2006, Briefings in Functional Genomics & Proteomics, V4, P321, DOI 10.1093/bfgp/eli003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Homma T, 2006, BIOCHEM BIOPH RES CO, V344, P386, DOI 10.1016/j.bbrc.2006.03.085; Hull JJ, 2004, J BIOL CHEM, V279, P51500, DOI 10.1074/jbc.M408142200; Huybrechts J, 2004, BIOCHEM BIOPH RES CO, V317, P909, DOI 10.1016/j.bbrc.2004.03.136; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P924, DOI 10.1016/S0006-291X(02)02798-5; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Johnson EC, 2005, J EXP BIOL, V208, P1239, DOI 10.1242/jeb.01529; Johnson EC, 2004, J EXP BIOL, V207, P743, DOI 10.1242/jeb.00818; Johnson EC, 2003, J BIOL CHEM, V278, P52172, DOI 10.1074/jbc.M306756200; Johnson EC, 2003, P NATL ACAD SCI USA, V100, P6198, DOI 10.1073/pnas.1030108100; Jorgensen LM, 2006, BIOCHEM BIOPH RES CO, V340, P696, DOI 10.1016/j.bbrc.2005.12.062; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; KATAOKA H, 1989, SCIENCE, V243, P1481, DOI 10.1126/science.243.4897.1481; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kim YJ, 2004, P NATL ACAD SCI USA, V101, P6704, DOI 10.1073/pnas.0305291101; Kim YJ, 2006, CURR BIOL, V16, P1395, DOI 10.1016/j.cub.2006.06.027; Kinjoh T, 2007, INSECT BIOCHEM MOLEC, V37, P808, DOI 10.1016/j.ibmb.2007.03.008; KRAMER SJ, 1991, P NATL ACAD SCI USA, V88, P9458, DOI 10.1073/pnas.88.21.9458; Kreienkamp HJ, 2002, J BIOL CHEM, V277, P39937, DOI 10.1074/jbc.M206931200; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; Larsen MJ, 2001, BIOCHEM BIOPH RES CO, V286, P895, DOI 10.1006/bbrc.2001.5476; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; LI XJ, 1992, J BIOL CHEM, V267, P9; LI XJ, 1991, EMBO J, V10, P3221, DOI 10.1002/j.1460-2075.1991.tb04885.x; Liu F, 2006, MOL CELL PROTEOMICS, V5, P510, DOI 10.1074/mcp.M400114-MCP200; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Meeusen T, 2002, P NATL ACAD SCI USA, V99, P15363, DOI 10.1073/pnas.252339599; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Metpally RPR, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-106; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; MONNIER D, 1992, J BIOL CHEM, V267, P1298; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Oda Y, 2000, ARCH INSECT BIOCHEM, V45, P156, DOI 10.1002/1520-6327(200012)45:4&lt;156::AID-ARCH3&gt;3.0.CO;2-E; Park Y, 2003, J BIOL CHEM, V278, P17710, DOI 10.1074/jbc.M301119200; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; PLANTEVIN G, 1984, GEN COMP ENDOCR, V56, P218, DOI 10.1016/0016-6480(84)90034-0; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; SAKURAI S, 1997, J INSECT PHYSL, V43, P875; Secher T, 2001, J BIOL CHEM, V276, P47052, DOI 10.1074/jbc.M106675200; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Stay B, 2002, PEPTIDES, V23, P1981, DOI 10.1016/S0196-9781(02)00185-7; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; Truman JW, 2006, P NATL ACAD SCI USA, V103, P8909, DOI 10.1073/pnas.0603252103; Truman JW, 2006, SCIENCE, V312, P1385, DOI 10.1126/science.1123652; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yamanaka N, 2005, J BIOL CHEM, V280, P14684, DOI 10.1074/jbc.M500308200; Yamanaka N, 2006, P NATL ACAD SCI USA, V103, P8622, DOI 10.1073/pnas.0511196103; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	78	151	158	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3048	10.1371/journal.pone.0003048	http://dx.doi.org/10.1371/journal.pone.0003048			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725956	gold, Green Published, Green Submitted			2022-12-27	WOS:000264429000001
J	Grills, C; Crawford, N; Chacko, A; Johnston, PG; O'Rourke, F; Fennell, DA				Grills, Claire; Crawford, Nyree; Chacko, Alex; Johnston, Patrick G.; O'Rourke, Francesca; Fennell, Dean A.			Dynamical Systems Analysis of Mitochondrial BAK Activation Kinetics Predicts Resistance to BH3 Domains	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; BCL-2 HOMOLOG BAK; ENDOPLASMIC-RETICULUM; CELL-DEATH; IN-VIVO; APOPTOSIS; PROTEINS; HELIX; PERMEABILIZATION; CHANNEL	Introduction: The molecular mechanism underlying mitochondrial BAK activation during apoptosis remains highly controversial. Two seemingly conflicting models have been proposed. In one, BAK requires so-called activating BH3 only proteins (aBH3) to initiate its conformation change. In the other, displacement from inhibitory pro-survival BCL-2 proteins (PBPs) and monomerization of BAK by PBP selective dissociator BH3-only proteins (dBH3) is sufficient. Methodology/Principal Findings: To better understand the kinetic implications of these conflicting but highly evidence-based models, we have conducted a deterministic, dynamical systems analysis to explore the kinetics underlying the first step of BAK activation, as a non-linear reaction system. We show that dBH3 induced BAK activation is efficient, even in the absence of aBH3s, provided constitutive interaction of PBPs with open conformation BAK occurs in an adenoviral E1B 19K-like manner. The pattern of PBP expression robustly predicts the efficacy of dBH3s. Conclusion: Our findings accommodate the prevailing BAK activation models as potentially coexisting mechanisms capable of initiating BAK activation, and supports a model based approach for predicting resistance to therapeutically relevant small molecule BH3 mimetics.	[Grills, Claire; O'Rourke, Francesca] Queens Univ Belfast, Sch Appl Math & Theoret Phys, Belfast, Antrim, North Ireland; [Crawford, Nyree; Chacko, Alex; Johnston, Patrick G.; O'Rourke, Francesca; Fennell, Dean A.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT7 1NN, Antrim, North Ireland; [Johnston, Patrick G.; Fennell, Dean A.] N Ireland Canc Ctr, Belfast, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Grills, C (corresponding author), Queens Univ Belfast, Sch Appl Math & Theoret Phys, Belfast, Antrim, North Ireland.	d.fennell@qub.ac.uk			Cancer Research UK [Clinician Scientist Fellowship]	Cancer Research UK(Cancer Research UK)	DAF is a recipient of a Cancer Research UK Clinician Scientist Fellowship.	Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Dejean LM, 2005, MOL BIOL CELL, V16, P2424, DOI 10.1091/mbc.E04-12-1111; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; KIEFER MC, 1995, NATURE, V374, P736, DOI 10.1038/374736a0; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pavlov EV, 2001, J CELL BIOL, V155, P725, DOI 10.1083/jcb.200107057; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001	32	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3038	10.1371/journal.pone.0003038	http://dx.doi.org/10.1371/journal.pone.0003038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725943	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428800005
J	Suidan, GL; Mcdole, JR; Chen, Y; Pirko, I; Johnson, AJ				Suidan, Georgette L.; Mcdole, Jeremiah R.; Chen, Yi; Pirko, Istvan; Johnson, Aaron J.			Induction of Blood Brain Barrier Tight Junction Protein Alterations by CD8 T Cells	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; HUMAN CEREBRAL MALARIA; ENDOTHELIAL-CELLS; INFLAMMATORY PAIN; MULTIPLE-SCLEROSIS; HEMORRHAGIC-FEVER; DISEASE SEVERITY; THEILERS VIRUS; PERMEABILITY; ASTROCYTES	Disruption of the blood brain barrier (BBB) is a hallmark feature of immune-mediated neurological disorders as diverse as viral hemorrhagic fevers, cerebral malaria and acute hemorrhagic leukoencephalitis. Although current models hypothesize that immune cells promote vascular permeability in human disease, the role CD8 T cells play in BBB breakdown remains poorly defined. Our laboratory has developed a novel murine model of CD8 T cell mediated central nervous system (CNS) vascular permeability using a variation of the Theiler's virus model of multiple sclerosis. In previous studies, we observed that MHC class II-/- (CD4 T cell deficient), IFN-gamma R-/-, TNF-alpha(-/-), TNFR1(-/-), TNFR2(-/-), and TNFR1/TNFR2 double knockout mice as well as those with inhibition of IL-1 and LT beta activity were susceptible to CNS vascular permeability. Therefore, the objective of this study was to determine the extent immune effector proteins utilized by CD8 T cells, perforin and FasL, contributed to CNS vascular permeability. Using techniques such as fluorescent activated cell sorting (FACS), T1 gadolinium-enhanced magnetic resonance imaging (MRI), FITC-albumin leakage assays, microvessel isolation, western blotting and immunofluorescent microscopy, we show that in vivo stimulation of CNS infiltrating antigen-specific CD8 T cells initiates astrocyte activation, alteration of BBB tight junction proteins and increased CNS vascular permeability in a non-apoptotic manner. Using the aforementioned techniques, we found that despite having similar expansion of CD8 T cells in the brain as wildtype and Fas Ligand deficient animals, perforin deficient mice were resistant to tight junction alterations and CNS vascular permeability. To our knowledge, this study is the first to demonstrate that CNS infiltrating antigen-specific CD8 T cells have the capacity to initiate BBB tight junction disruption through a non-apoptotic perforin dependent mechanism and our model is one of few that are useful for studies in this field. These novel findings are highly relevant to the development of therapies designed to control immune mediated CNS vascular permeability.	[Suidan, Georgette L.; Mcdole, Jeremiah R.; Pirko, Istvan; Johnson, Aaron J.] Univ Cincinnati, Coll Med, Dept Neurosci, Cincinnati, OH 45221 USA; [Suidan, Georgette L.; Mcdole, Jeremiah R.; Chen, Yi; Pirko, Istvan; Johnson, Aaron J.] Univ Cincinnati, Coll Med, Neurol Dept, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Suidan, GL (corresponding author), Univ Cincinnati, Coll Med, Dept Neurosci, Cincinnati, OH 45221 USA.	johna4@uc.edu			The Neuroscience Institute of Cincinnati, OH	The Neuroscience Institute of Cincinnati, OH	This work was funded by The Neuroscience Institute of Cincinnati, OH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brooks TA, 2005, AM J PHYSIOL-HEART C, V289, pH738, DOI 10.1152/ajpheart.01288.2004; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Cheng ML, 1999, FREE RADICAL BIO MED, V27, P470, DOI 10.1016/S0891-5849(99)00072-6; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Fontijn RD, 2006, EUR J CELL BIOL, V85, P1131, DOI 10.1016/j.ejcb.2006.07.005; Galea I, 2007, J EXP MED, V204, P2023, DOI 10.1084/jem.20070064; Hawkins BT, 2004, BRAIN RES, V1027, P48, DOI 10.1016/j.brainres.2004.08.043; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hayashi Y, 1997, GLIA, V19, P13, DOI 10.1002/(SICI)1098-1136(199701)19:1<13::AID-GLIA2>3.3.CO;2-E; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Huber JD, 2002, AM J PHYSIOL-HEART C, V283, pH1531, DOI 10.1152/ajpheart.00027.2002; Huber JD, 2001, AM J PHYSIOL-HEART C, V280, pH1241, DOI 10.1152/ajpheart.2001.280.3.H1241; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Jiang WG, 1999, J CELL PHYSIOL, V181, P319, DOI 10.1002/(SICI)1097-4652(199911)181:2<319::AID-JCP14>3.0.CO;2-S; Johnson AJ, 2005, J IMMUNOL, V174, P6854, DOI 10.4049/jimmunol.174.11.6854; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Kabakus N, 2005, J TROP PEDIATRICS, V51, P245, DOI 10.1093/tropej/fmh109; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; Kirk J, 2003, J PATHOL, V201, P319, DOI 10.1002/path.1434; Lyman MA, 2002, J VIROL, V76, P3125, DOI 10.1128/JVI.76.7.3125-3134.2002; Marti M, 2004, J NEUROSCI, V24, P6659, DOI 10.1523/JNEUROSCI.0987-04.2004; MAXWELL K, 1987, BRAIN RES, V410, P309, DOI 10.1016/0006-8993(87)90329-5; McCarthy KM, 1996, J CELL SCI, V109, P2287; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; NEUHAUS J, 1991, ANN NY ACAD SCI, V633, P578; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Ohtsuki S, 2007, J CELL PHYSIOL, V210, P81, DOI 10.1002/jcp.20823; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Potter S, 2006, INT J PARASITOL, V36, P485, DOI 10.1016/j.ijpara.2005.12.005; RODRIGUEZ M, 1987, CRIT REV IMMUNOL, V7, P325; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; SILBERGELD DL, 1991, J NEURO-ONCOL, V11, P49, DOI 10.1007/BF00166997; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; Sobue K, 1999, NEUROSCI RES, V35, P155, DOI 10.1016/S0168-0102(99)00079-6; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Suidan GL, 2006, NEUROL RES, V28, P250, DOI 10.1179/016164106X98116; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	45	76	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3037	10.1371/journal.pone.0003037	http://dx.doi.org/10.1371/journal.pone.0003037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725947	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428800004
J	Ventura, R; Latagliata, EC; Morrone, C; La Mela, I; Puglisi-Allegra, S				Ventura, Rossella; Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano			Prefrontal Norepinephrine Determines Attribution of "High" Motivational Salience	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; ENVIRONMENTAL STIMULI; INDUCED REWARD; CHRONIC STRESS; CORTEX; NORADRENALINE; BEHAVIOR; AMYGDALA; BRAIN	Intense motivational salience attribution is considered to have a major role in the development of different psychopathologies. Numerous brain areas are involved in "normal'' motivational salience attribution processes; however, it is not clear whether common or different neural mechanisms also underlie intense motivational salience attribution. To elucidate this a brain area and a neural system had to be envisaged that were involved only in motivational salience attribution to highly salient stimuli. Using intracerebral microdialysis, we found that natural stimuli induced an increase in norepinephrine release in the medial prefrontal cortex of mice proportional to their salience, and that selective prefrontal norepinephrine depletion abolished the increase of norepinephrine release in the medial prefrontal cortex induced by exposure to appetitive (palatable food) or aversive (light) stimuli independently of salience. However, selective norepinephrine depletion in the medial prefrontal cortex impaired the place conditioning induced exclusively by highly salient stimuli, thus indicating that prefrontal noradrenergic transmission determines approach or avoidance responses to both reward-and aversion-related natural stimuli only when the salience of the unconditioned natural stimulus is high enough to induce sustained norepinephrine outflow. This affirms that prefrontal noradrenergic transmission determines motivational salience attribution selectively when intense motivational salience is processed, as in conditions that characterize psychopathological outcomes.	[Ventura, Rossella; Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano] European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy; [Ventura, Rossella] Univ Aquila, Dipartimento Sci Tecnol Biomed, I-67100 Laquila, Italy; [Latagliata, Emanuele Claudio; Morrone, Cristina; La Mela, Immacolata; Puglisi-Allegra, Stefano] Univ Sapienza, Dipartimento Psicol & Ctr Daniel Bovet, Rome, Italy	IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of L'Aquila; Sapienza University Rome	Ventura, R (corresponding author), European Ctr Brain Res CERC, Santa Lucia Fdn, Rome, Italy.	rossella.ventura@cc.univaq.it	Latagliata, Emanuele Claudio/B-5011-2013; Puglisi-Allegra, Stefano/ABI-7468-2020; Morrone, Maria Concetta/C-6756-2014; Ventura, Rossella/AAA-8816-2019	Puglisi-Allegra, Stefano/0000-0002-9433-2000; Morrone, Maria Concetta/0000-0002-1025-0316; Ventura, Rossella/0000-0002-7601-8683; Emanuele Claudio, Latagliata/0000-0001-8402-2757; Lauwereyns, Jan/0000-0003-0551-2550				Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Beck KD, 1999, BRAIN RES, V830, P56, DOI 10.1016/S0006-8993(99)01380-3; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Borsook D, 2007, EUR J PAIN, V11, P7, DOI 10.1016/j.ejpain.2005.12.005; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CARLI M, 1983, BEHAV BRAIN RES, V9, P361, DOI 10.1016/0166-4328(83)90138-9; COLE BJ, 1992, NEUROPSYCHOPHARMACOL, V7, P129; DALLEY JW, 1995, J NEUROCHEM, V65, P2644; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Darracq L, 1998, J NEUROSCI, V18, P2729; Dazzi L, 2003, EUR J PHARMACOL, V476, P55, DOI 10.1016/S0014-2999(03)02130-7; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Feenstra MGP, 2000, NEUROSCIENCE, V100, P741, DOI 10.1016/S0306-4522(00)00319-5; Franklin K, 1998, MOUSE BRAIN STEREOTA; Grossberg S, 2000, BIOL PSYCHIAT, V48, P81, DOI 10.1016/S0006-3223(00)00903-3; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Killgore WDS, 2003, NEUROIMAGE, V19, P1381, DOI 10.1016/S1053-8119(03)00191-5; Leonhardt M, 2007, HORM BEHAV, V51, P77, DOI 10.1016/j.yhbeh.2006.08.008; Martin-Soelch C, 2007, NEUROSCI BIOBEHAV R, V31, P426, DOI 10.1016/j.neubiorev.2006.11.002; McGaugh JL, 2006, TRENDS COGN SCI, V10, P345, DOI 10.1016/j.tics.2006.06.001; McQuade R, 1999, PSYCHOPHARMACOLOGY, V145, P393, DOI 10.1007/s002130051073; Milstein JA, 2007, PSYCHOPHARMACOLOGY, V190, P51, DOI 10.1007/s00213-006-0594-x; Mingote S, 2004, J NEUROSCI, V24, P2475, DOI 10.1523/JNEUROSCI.4547-03.2004; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; Orsini C, 2005, PSYCHOPHARMACOLOGY, V181, P327, DOI 10.1007/s00213-005-2259-6; Pascucci T, 2007, CEREB CORTEX, V17, P2796, DOI 10.1093/cercor/bhm008; Pecina S, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-8; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; Roozendaal B, 2004, J NEUROSCI, V24, P1385, DOI 10.1523/JNEUROSCI.4664-03.2004; SARA SJ, 1991, PROG BRAIN RES, V88, P571; Spink AJ, 2001, PHYSIOL BEHAV, V73, P731, DOI 10.1016/S0031-9384(01)00530-3; Ventura R, 2005, CEREB CORTEX, V15, P1877, DOI 10.1093/cercor/bhi066; Ventura R, 2003, J NEUROSCI, V23, P1879; Ventura R, 2005, SYNAPSE, V58, P211, DOI 10.1002/syn.20197; Ventura R, 2007, P NATL ACAD SCI USA, V104, P5181, DOI 10.1073/pnas.0610178104; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026	44	56	57	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3044	10.1371/journal.pone.0003044	http://dx.doi.org/10.1371/journal.pone.0003044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725944	Green Published, Green Submitted, gold			2022-12-27	WOS:000264428800009
J	Schierwater, B; Kamm, K; Srivastava, M; Rokhsar, D; Rosengarten, RD; Dellaporta, SL				Schierwater, Bernd; Kamm, Kai; Srivastava, Mansi; Rokhsar, Daniel; Rosengarten, Rafael D.; Dellaporta, Stephen L.			The Early ANTP Gene Repertoire: Insights from the Placozoan Genome	PLOS ONE			English	Article								The evolution of ANTP genes in the Metazoa has been the subject of conflicting hypotheses derived from full or partial gene sequences and genomic organization in higher animals. Whole genome sequences have recently filled in some crucial gaps for the basal metazoan phyla Cnidaria and Porifera. Here we analyze the complete genome of Trichoplax adhaerens, representing the basal metazoan phylum Placozoa, for its set of ANTP class genes. The Trichoplax genome encodes representatives of Hox/ParaHox-like, NKL, and extended Hox genes. This repertoire possibly mirrors the condition of a hypothetical cnidarian-bilaterian ancestor. The evolution of the cnidarian and bilaterian ANTP gene repertoires can be deduced by a limited number of cis-duplications of NKL and "extended Hox'' genes and the presence of a single ancestral "ProtoHox'' gene.	[Schierwater, Bernd; Kamm, Kai] Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany; [Schierwater, Bernd; Rosengarten, Rafael D.; Dellaporta, Stephen L.] Yale Univ, Dept Mol, Cellular & Dev Biol, New Haven, CT USA; [Rokhsar, Daniel] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Srivastava, Mansi; Rokhsar, Daniel] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Veterinary Medicine Hannover, Foundation; Yale University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley	Schierwater, B (corresponding author), Stiftung Tieraerztliche Hsch Hannover, Div Ecol & Evolut, Hannover, Germany.	kai.kamm@ecolevol.de		Rokhsar, Daniel/0000-0002-8704-2224; Kamm, Kai/0000-0001-8038-2843	JGI; Human Frontier Science Program [RGP 0221]; Deutsche Forschungsgemeinschaft [Schi 277/20-2]; National Science Foundation [RR 19895, Graduate Research Fellowship]; Yale University Life Sciences Computing Center [RR 19895]; NIH [RR 19895]; University of California, Lawrence Livermore National Laboratory; Lawrence Berkeley National Laboratory; Los Alamos National Laboratory; Gordon and Betty Moore Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER	JGI; Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Yale University Life Sciences Computing Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Lawrence Livermore National Laboratory(University of California System); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We acknowledge financial support from JGI, Human Frontier Science Program (RGP 0221), Deutsche Forschungsgemeinschaft (Schi 277/20-2), National Science Foundation (NSF RR 19895), National Science Foundation Graduate Research Fellowship (R.D.R) and Yale University Life Sciences Computing Center and NIH grant: RR19895, which funded the instrumentation. Genome sequencing was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and supported by the University of California, Lawrence Livermore National Laboratory, Lawrence Berkeley National Laboratory, and Los Alamos National Laboratory. The Center for Integrative Genomics is supported by a grant from the Gordon and Betty Moore Foundation.	Banerjee-Basu S, 2001, NUCLEIC ACIDS RES, V29, P3258, DOI 10.1093/nar/29.15.3258; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Castro LFC, 2003, EVOL DEV, V5, P459, DOI 10.1046/j.1525-142X.2003.03052.x; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; Coulier F, 2000, J EXP ZOOL, V288, P345, DOI 10.1002/1097-010X(20001215)288:4<345::AID-JEZ7>3.0.CO;2-Y; de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; DeSalle R, 2007, INTEGR COMP BIOL, V47, P667, DOI 10.1093/icb/icm042; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Gall H, 1999, HAUTARZT, V50, P186, DOI 10.1007/s001050050887; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; Garcia-Fernandez J, 2005, HEREDITY, V94, P145, DOI 10.1038/sj.hdy.6800621; GEHRING WJ, 1985, CELL, V40, P3, DOI 10.1016/0092-8674(85)90300-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadrys T, 2005, MOL BIOL EVOL, V22, P1569, DOI 10.1093/molbev/msi150; Jakob W, 2004, DEV GENES EVOL, V214, P170, DOI 10.1007/s00427-004-0390-8; Kamm K, 2007, J EXP ZOOL PART B, V308B, P777, DOI 10.1002/jez.b.21196; Kamm K, 2006, J EXP ZOOL PART B, V306B, P589, DOI 10.1002/jez.b.21123; Kamm K, 2006, CURR BIOL, V16, P920, DOI 10.1016/j.cub.2006.03.036; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larroux C, 2007, CURR BIOL, V17, P706, DOI 10.1016/j.cub.2007.03.008; Luke GN, 2003, P NATL ACAD SCI USA, V100, P5292, DOI 10.1073/pnas.0836141100; Monteiro AS, 2006, EVOL DEV, V8, P174, DOI 10.1111/j.1525-142X.2006.00087.x; Peterson KJ, 2007, EVOL DEV, V9, P405, DOI 10.1111/j.1525-142X.2007.00179.x; Pollard SL, 2000, CURR BIOL, V10, P1059, DOI 10.1016/S0960-9822(00)00676-X; Popovici C, 2001, FEBS LETT, V491, P237, DOI 10.1016/S0014-5793(01)02187-1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Ryan JF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r64; SCHIERWATER B, HYPOTHESIS CUR UNPUB; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Signorovitch AY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030013; SRIVASTAVA M, NATURE UNPUB; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	34	39	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e2457	10.1371/journal.pone.0002457	http://dx.doi.org/10.1371/journal.pone.0002457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716659	Green Submitted, Green Published, gold			2022-12-27	WOS:000264426800001
J	Yoshiike, Y; Kimura, T; Yamashita, S; Furudate, H; Mizoroki, T; Murayama, M; Takashima, A				Yoshiike, Yuji; Kimura, Tetsuya; Yamashita, Shunji; Furudate, Hiroyuki; Mizoroki, Tatsuya; Murayama, Miyuki; Takashima, Akihiko			GABA(A) Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin	PLOS ONE			English	Article								Advanced age and mutations in the genes encoding amyloid precursor protein (APP) and presenilin (PS1) are two serious risk factors for Alzheimer's disease (AD). Finding common pathogenic changes originating from these risks may lead to a new therapeutic strategy. We observed a decline in memory performance and reduction in hippocampal long-term potentiation (LTP) in both mature adult (9-15 months) transgenic APP/PS1 mice and old (19-25 months) non-transgenic (nonTg) mice. By contrast, in the presence of bicuculline, a GABA(A) receptor antagonist, LTP in adult APP/PS1 mice and old nonTg mice was larger than that in adult nonTg mice. The increased LTP levels in bicuculline-treated slices suggested that GABA(A) receptor-mediated inhibition in adult APP/PS1 and old nonTg mice was upregulated. Assuming that enhanced inhibition of LTP mediates memory decline in APP/PS1 mice, we rescued memory deficits in adult APP/PS1 mice by treating them with another GABA(A) receptor antagonist, picrotoxin (PTX), at a non-epileptic dose for 10 days. Among the saline vehicle-treated groups, substantially higher levels of synaptic proteins such as GABA(A) receptor alpha 1 subunit, PSD95, and NR2B were observed in APP/PS1 mice than in nonTg control mice. This difference was insignificant among PTX-treated groups, suggesting that memory decline in APP/PS1 mice may result from changes in synaptic protein levels through homeostatic mechanisms. Several independent studies reported previously in aged rodents both an increased level of GABA(A) receptor alpha 1 subunit and improvement of cognitive functions by long term GABA(A) receptor antagonist treatment. Therefore, reduced LTP linked to enhanced GABA(A) receptor-mediated inhibition may be triggered by aging and may be accelerated by familial AD-linked gene products like A beta and mutant PS1, leading to cognitive decline that is pharmacologically treatable at least at this stage of disease progression in mice.	[Yoshiike, Yuji; Kimura, Tetsuya; Yamashita, Shunji; Mizoroki, Tatsuya; Murayama, Miyuki; Takashima, Akihiko] RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan; [Furudate, Hiroyuki] Saitama Univ, Fac Sci, Dept Regulat Biol, Lab Endocrinol & Neuroethol, Saitama, Japan	RIKEN; Saitama University	Yoshiike, Y (corresponding author), RIKEN, Brain Sci Inst, Lab Alzheimers Dis, Wako, Saitama, Japan.	kenneth@brain.riken.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We have no financial, personal, or professional conflicts of interests for the work presented in this manuscript. This work was partly supported by Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARISPE N, 1994, ANN NY ACAD SCI, V747, P256; Barnes CA, 2003, PHILOS T R SOC B, V358, P765, DOI 10.1098/rstb.2002.1244; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bourtchouladze R, 2003, P NATL ACAD SCI USA, V100, P10518, DOI 10.1073/pnas.1834280100; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Chapouthier Georges, 2002, Current Topics in Medicinal Chemistry, V2, P841, DOI 10.2174/1568026023393552; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cotman C.W, 2000, AGING MIND OPPORTUNI, P114; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Guo Q, 1999, NAT MED, V5, P101, DOI 10.1038/4789; Gutierrez A, 1996, NEUROSCIENCE, V74, P341, DOI 10.1016/0306-4522(96)00137-6; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Jankowsky JL, 2003, J NEUROPATH EXP NEUR, V62, P1220, DOI 10.1093/jnen/62.12.1220; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kimura T, 2007, EMBO J, V26, P5143, DOI 10.1038/sj.emboj.7601917; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lalonde R, 2005, NEUROSCI LETT, V390, P87, DOI 10.1016/j.neulet.2005.08.028; LANDFIELD PW, 1981, SCIENCE, V214, P581, DOI 10.1126/science.6270791; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Nyffeler M, 2007, NEUROBIOL AGING, V28, P143, DOI 10.1016/j.neurobiolaging.2005.11.003; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; Parsons CG, 2007, NEUROPHARMACOLOGY, V53, P699, DOI 10.1016/j.neuropharm.2007.07.013; Pybus R, 2003, NEUROBIOL DIS, V12, P212, DOI 10.1016/S0969-9961(03)00016-0; Rissman RA, 2007, J NEUROCHEM, V103, P1285, DOI 10.1111/j.1471-4159.2007.04832.x; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Ruano D, 2000, J BIOL CHEM, V275, P19585, DOI 10.1074/jbc.M000700200; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Schneider I, 2001, J BIOL CHEM, V276, P11539, DOI 10.1074/jbc.M010977200; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Smith-Swintosky V L, 1994, J Neural Transm Suppl, V44, P29; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Squire Larry R., 1994, P203; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Thibault O, 1996, SCIENCE, V272, P1017, DOI 10.1126/science.272.5264.1017; van Gaalen MM, 2000, BEHAV BRAIN RES, V115, P95, DOI 10.1016/S0166-4328(00)00240-0; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Wolf SA, 2006, BIOL PSYCHIAT, V60, P1314, DOI 10.1016/j.biopsych.2006.04.004; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271	49	82	84	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3029	10.1371/journal.pone.0003029	http://dx.doi.org/10.1371/journal.pone.0003029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716656	gold, Green Submitted, Green Published			2022-12-27	WOS:000264426800007
J	Harb, N; Archer, TK; Sato, N				Harb, Nicole; Archer, Trevor K.; Sato, Noboru			The Rho-Rock-Myosin Signaling Axis Determines Cell-Cell Integrity of Self-Renewing Pluripotent Stem Cells	PLOS ONE			English	Article							MOUSE EPIBLAST; DIFFERENTIATION; GTPASES; KINASE; ADHESION; CULTURE; LINES; CONTRACTION; MAINTENANCE; ACTIVATION	Background: Embryonic stem (ES) cells self-renew as coherent colonies in which cells maintain tight cell-cell contact. Although intercellular communications are essential to establish the basis of cell-specific identity, molecular mechanisms underlying intrinsic cell-cell interactions in ES cells at the signaling level remain underexplored. Methodology/Principal Findings: Here we show that endogenous Rho signaling is required for the maintenance of cell-cell contacts in ES cells. siRNA-mediated loss of function experiments demonstrated that Rock, a major effector kinase downstream of Rho, played a key role in the formation of cell-cell junctional assemblies through regulation of myosin II by controlling a myosin light chain phosphatase. Chemical engineering of this signaling axis by a Rock-specific inhibitor revealed that cell-cell adhesion was reversibly controllable and dispensable for self-renewal of mouse ES cells as confirmed by chimera assay. Furthermore, a novel culture system combining a single synthetic matrix, defined medium, and the Rock inhibitor fully warranted human ES cell self-renewal independent of animal-derived matrices, tight cell contacts, or fibroblastic niche-forming cells as determined by teratoma formation assay. Conclusions/Significance: These findings demonstrate an essential role of the Rho-Rock-Myosin signaling axis for the regulation of basic cell-cell communications in both mouse and human ES cells, and would contribute to advance in medically compatible xeno-free environments for human pluripotent stem cells.	[Harb, Nicole; Sato, Noboru] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Archer, Trevor K.] Natl Inst Environm Hlth Sci, Lab Mol Carcinogenesis, Res Triangle Pk, NC USA	University of California System; University of California Riverside; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Harb, N (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	saton@ucr.edu	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	University of California Riverside; Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [Z01 ES071006-09]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006] Funding Source: NIH RePORTER	University of California Riverside(University of California System); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	N.S. is supported by University of California Riverside. This research was supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH project #Z01 ES071006-09 (T.K.A.).	Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Carramusa L, 2007, J CELL SCI, V120, P3870, DOI 10.1242/jcs.014365; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; Clayton L, 1999, DEV BIOL, V205, P322, DOI 10.1006/dbio.1998.9117; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Debidda M, 2005, J BIOL CHEM, V280, P17275, DOI 10.1074/jbc.M413187200; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FLEMING TP, 1988, ANNU REV CELL BIOL, V4, P459, DOI 10.1146/annurev.cellbio.4.1.459; Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Larue L, 1996, DEVELOPMENT, V122, P3185; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagaoka M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000015; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Perez-Moreno M, 2006, DEV CELL, V11, P601, DOI 10.1016/j.devcel.2006.10.010; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ncb796; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sato N, 2006, METH MOL B, V331, P267; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Sutherland A, 2003, DEV BIOL, V258, P241, DOI 10.1016/S0012-1606(03)00130-1; Suzuki Atsushi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS114, DOI 10.1038/ncpcardio0442; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; WATANABE K, 2007, NAT BIOTECHNOL; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zwaka TP, 2005, STEM CELLS, V23, P146, DOI 10.1634/stemcells.2004-0248	62	125	166	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3001	10.1371/journal.pone.0003001	http://dx.doi.org/10.1371/journal.pone.0003001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714354	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900026
J	Yu, XM; Zhou, Q; Li, SC; Luo, QB; Cai, YM; Lin, WC; Chen, H; Yang, Y; Hu, SN; Yu, J				Yu, Xiaomin; Zhou, Qing; Li, Sung-Chou; Luo, Qibin; Cai, Yimei; Lin, Wen-chang; Chen, Huan; Yang, Yue; Hu, Songnian; Yu, Jun			The Silkworm (Bombyx mori) microRNAs and Their Expressions in Multiple Developmental Stages	PLOS ONE			English	Article							SMALL RNAS; REGULATORY ROLES; IDENTIFICATION; DROSOPHILA; REVEALS; CLONING; GENES; SEQUENCE; MIRNAS; LET-7	Background: MicroRNAs (miRNAs) play crucial roles in various physiological processes through post-transcriptional regulation of gene expressions and are involved in development, metabolism, and many other important molecular mechanisms and cellular processes. The Bombyx mori genome sequence provides opportunities for a thorough survey for miRNAs as well as comparative analyses with other sequenced insect species. Methodology/Principal Findings: We identified 114 non-redundant conserved miRNAs and 148 novel putative miRNAs from the B. mori genome with an elaborate computational protocol. We also sequenced 6,720 clones from 14 developmental stage-specific small RNA libraries in which we identified 35 unique miRNAs containing 21 conserved miRNAs (including 17 predicted miRNAs) and 14 novel miRNAs (including 11 predicted novel miRNAs). Among the 114 conserved miRNAs, we found six pairs of clusters evolutionarily conserved cross insect lineages. Our observations on length heterogeneity at 59 and/or 39 ends of nine miRNAs between cloned and predicted sequences, and three mature forms deriving from the same arm of putative pre-miRNAs suggest a mechanism by which miRNAs gain new functions. Analyzing development-related miRNAs expression at 14 developmental stages based on clone-sampling and stem-loop RT PCR, we discovered an unusual abundance of 33 sequences representing 12 different miRNAs and sharply fluctuated expression of miRNAs at larva-molting stage. The potential functions of several stage-biased miRNAs were also analyzed in combination with predicted target genes and silkworm's phenotypic traits; our results indicated that miRNAs may play key regulatory roles in specific developmental stages in the silkworm, such as ecdysis. Conclusions/Significance: Taking a combined approach, we identified 118 conserved miRNAs and 151 novel miRNA candidates from the B. mori genome sequence. Our expression analyses by sampling miRNAs and real-time PCR over multiple developmental stages allowed us to pinpoint molting stages as hotspots of miRNA expression both in sorts and quantities. Based on the analysis of target genes, we hypothesized that miRNAs regulate development through a particular emphasis on complex stages rather than general regulatory mechanisms.	[Yu, Xiaomin; Zhou, Qing; Luo, Qibin; Cai, Yimei; Chen, Huan; Yang, Yue; Hu, Songnian; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Yu, Xiaomin; Zhou, Qing; Cai, Yimei; Yang, Yue] Chinese Acad Sci, Grad Univ, Beijing 100864, Peoples R China; [Luo, Qibin; Chen, Huan] Zhejiang Univ, Watson Inst Genome Sci, Hangzhou, Peoples R China; [Li, Sung-Chou; Lin, Wen-chang] Natl Yang Ming Univ, Inst BioMed Informat, Taipei, Taiwan; [Li, Sung-Chou] Acad Sinica, Taiwan Int Grad Program, Bioinformat Program, Taipei, Taiwan; [Lin, Wen-chang] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Yu, XM (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Key Lab Genome Sci & Informat, Beijing, Peoples R China.	junyu@big.ac.cn	Lin, Wen-chang/B-3100-2011; Lin, Wen-chang/ABH-7976-2020; Yu, Xiaomin/I-6407-2016; Chen, Huan/CAH-8180-2022; Li, Sung-Chou/AGZ-8626-2022; Hu, Songnian/C-6509-2013	Lin, Wen-chang/0000-0003-0194-1745; Lin, Wen-chang/0000-0003-0194-1745; Li, Sung-Chou/0000-0002-3016-9718; Hu, Songnian/0000-0003-3966-3111	Ministry of Science and Technology of China [2006CB910400]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	A grant from the Ministry of Science and Technology of China (2006CB910400) awarded to Jun Yu.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Champlin DT, 1998, DEVELOPMENT, V125, P269; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He PA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-248; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iwasaki H, 1997, INSECT MOL BIOL, V6, P131, DOI 10.1111/j.1365-2583.1997.tb00081.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; KRAMER KJ, 1993, INSECT BIOCHEM MOLEC, V23, P691, DOI 10.1016/0965-1748(93)90043-R; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LI SC, 2007, NUCL ACIDS RES; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Liu SP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-88; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; MOLNAR A, 2007, NATURE; NAKAGAKI M, 1991, ROUX ARCH DEV BIOL, V200, P223, DOI 10.1007/BF00361341; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; SCHAFER A, 2007, VIROLOGY; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Shimizu I, 2001, BIOCHEM BIOPH RES CO, V287, P27, DOI 10.1006/bbrc.2001.5540; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Tong Chuan-zhou, 2006, J Zhejiang Univ Sci B, V7, P806, DOI 10.1631/jzus.2006.B0806; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	81	94	139	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2997	10.1371/journal.pone.0002997	http://dx.doi.org/10.1371/journal.pone.0002997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714353	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900022
J	Zampieri, M; Soranzo, N; Bianchini, D; Altafini, C				Zampieri, Mattia; Soranzo, Nicola; Bianchini, Daniele; Altafini, Claudio			Origin of Co-Expression Patterns in E. coli and S. cerevisiae Emerging from Reverse Engineering Algorithms	PLOS ONE			English	Article								Background: The concept of reverse engineering a gene network, i.e., of inferring a genome-wide graph of putative gene-gene interactions from compendia of high throughput microarray data has been extensively used in the last few years to deduce/integrate/validate various types of "physical'' networks of interactions among genes or gene products. Results: This paper gives a comprehensive overview of which of these networks emerge significantly when reverse engineering large collections of gene expression data for two model organisms, E. coli and S. cerevisiae, without any prior information. For the first organism the pattern of co-expression is shown to reflect in fine detail both the operonal structure of the DNA and the regulatory effects exerted by the gene products when co-participating in a protein complex. For the second organism we find that direct transcriptional control (e. g., transcription factor-binding site interactions) has little statistical significance in comparison to the other regulatory mechanisms (such as co-sharing a protein complex, colocalization on a metabolic pathway or compartment), which are however resolved at a lower level of detail than in E. coli. Conclusion: The gene co-expression patterns deduced from compendia of profiling experiments tend to unveil functional categories that are mainly associated to stable bindings rather than transient interactions. The inference power of this systematic analysis is substantially reduced when passing from E. coli to S. cerevisiae. This extensive analysis provides a way to describe the different complexity between the two organisms and discusses the critical limitations affecting this type of methodologies.	[Zampieri, Mattia; Soranzo, Nicola; Bianchini, Daniele; Altafini, Claudio] SISSA, ISAS, Int Sch Adv Studies, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Zampieri, M (corresponding author), SISSA, ISAS, Int Sch Adv Studies, I-34014 Trieste, Italy.	altafini@sissa.it	Zampieri, Mattia/ABF-5590-2020; Altafini, Claudio/AAL-4235-2020	Altafini, Claudio/0000-0003-4142-6502; Soranzo, Nicola/0000-0003-3627-5340; Zampieri, Mattia/0000-0002-9339-068X; Soranzo, Nicole/0000-0003-1095-3852	Illy Caffe, Trieste, Italy	Illy Caffe, Trieste, Italy	This work is supported by a grant from Illy Caffe, Trieste, Italy.	Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; BANSAL M, 2007, MOL SYST BIOL, V3; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bilu Y, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r103; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butte A J, 2000, Pac Symp Biocomput, P418; Chen YA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-101; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; Faith JJ, 2008, NUCLEIC ACIDS RES, V36, pD866, DOI 10.1093/nar/gkm815; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gan X, 2002, EUR J BIOCHEM, V269, P5203, DOI 10.1046/j.1432-1033.2002.03226.x; Gardner TS, 2005, PHYS LIFE REV, V2, P65, DOI 10.1016/j.plrev.2005.01.001; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Hershberg R, 2005, TRENDS GENET, V21, P138, DOI 10.1016/j.tig.2005.01.003; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Kim H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-165; Korbel JO, 2004, NAT BIOTECHNOL, V22, P911, DOI 10.1038/nbt988; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li Z, 2004, J BIOL CHEM, V279, P27124, DOI 10.1074/jbc.M403494200; Lin D, 1998, P INT C MACH LEARN; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; POTHEN A, 1990, ACM T MATH SOFTWARE, V16, P303, DOI 10.1145/98267.98287; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sabatti C, 2002, NUCLEIC ACIDS RES, V30, P2886, DOI 10.1093/nar/gkf388; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Simonis N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r33; Snel B, 2004, NUCLEIC ACIDS RES, V32, P4725, DOI 10.1093/nar/gkh815; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Teichmann SA, 2002, TRENDS BIOTECHNOL, V20, P407, DOI 10.1016/S0167-7799(02)02032-2; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; Wuchty S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-24; Yamanishi Y, 2004, BIOINFORMATICS, V20, P363, DOI 10.1093/bioinformatics/bth910; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006	48	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2981	10.1371/journal.pone.0002981	http://dx.doi.org/10.1371/journal.pone.0002981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714358	gold, Green Submitted, Green Published			2022-12-27	WOS:000264420900008
J	Camats, M; Guil, S; Kokolo, M; Bach-Elias, M				Camats, Maria; Guil, Sonia; Kokolo, Mariette; Bach-Elias, Montse			P68 RNA Helicase (DDX5) Alters Activity of Cis- and Trans-Acting Factors of the Alternative Splicing of H-Ras	PLOS ONE			English	Article								Background: H-Ras pre-mRNA undergoes an alternative splicing process to render two proteins, namely p21 H-Ras and p19 H-Ras, due to either the exclusion or inclusion of the alternative intron D exon (IDX), respectively. p68 RNA helicase ( p68) is known to reduce IDX inclusion. Principal Findings: Here we show that p68 unwinds the stem-loop IDX-rasISS1 structure and prevents binding of hnRNP H to IDX-rasISS1. We also found that p68 alters the dynamic localization of SC35, a splicing factor that promotes IDX inclusion. The knockdown of hnRNP A1, FUS/TLS and hnRNP H resulted in upregulation of the expression of the gene encoding the SC35-binding protein, SFRS2IP. Finally, FUS/TLS was observed to upregulate p19 expression and to stimulate IDX inclusion, and in vivo RNAi-mediated depletion of hnRNP H decreased p19 H-Ras abundance. Significance: Taken together, p68 is shown to be an essential player in the regulation of H-Ras expression as well as in a vital transduction signal pathway tied to cell proliferation and many cancer processes.	[Camats, Maria; Guil, Sonia; Kokolo, Mariette; Bach-Elias, Montse] CSIC, Inst Invest Biomed, Unidad Splicing, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB)	Camats, M (corresponding author), CSIC, Inst Invest Biomed, Unidad Splicing, Barcelona, Spain.	mbebmc@cid.csic.es	Guil, Sonia/M-8036-2015	Guil, Sonia/0000-0002-2257-3331	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC) [BFU2005-00701]; BEFI; FPU	Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA); Plan Nacional (MEC)(Spanish Government); BEFI; FPU(Spanish Government)	This work was supported by Fundacion de Investigacion Medica Mutua Madrilena Automovilista (Fundacion MMA) and by the Plan Nacional (MEC) BFU2005-00701. M.C., S.G and M.K. were recipients of a Fmed MMA, BEFI (Carlos III) and FPU (MEC) fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COHEN JB, 1989, CELL, V58, P461, DOI 10.1016/0092-8674(89)90427-3; Dereure O, 2006, ANN DERMATOL VENER, V133, P731, DOI 10.1016/S0151-9638(06)71003-1; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Donev R, 2007, MOL PSYCHIATR, V12, P681, DOI 10.1038/sj.mp.4001971; Enukashvily N, 2005, J CELL SCI, V118, P611, DOI 10.1242/jcs.01605; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Expert-Bezancon A, 2004, J BIOL CHEM, V279, P38249, DOI 10.1074/jbc.M405377200; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goke R, 2004, ANN NY ACAD SCI, V1014, P220, DOI 10.1196/annals.1294.024; Gripp KW, 2006, AM J MED GENET A, V140A, P2163, DOI 10.1002/ajmg.a.31456; Guil S, 2003, CANCER RES, V63, P5178; Guil S, 2003, MOL CELL BIOL, V23, P2927, DOI 10.1128/MCB.23.8.2927-2941.2003; Hallay H, 2006, J BIOL CHEM, V281, P37159, DOI 10.1074/jbc.M603864200; Jeong MH, 2006, J BIOL CHEM, V281, P8707, DOI 10.1074/jbc.M513853200; Li J, 2007, AM J MED GENET A, V143A, P1900, DOI 10.1002/ajmg.a.31855; Marshall CJ, 1996, CURR OPIN CELL BIOL, V8, P197, DOI 10.1016/S0955-0674(96)80066-4; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Sugiura T, 2007, EXP CELL RES, V313, P782, DOI 10.1016/j.yexcr.2006.11.014; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Van Herreweghe E, 2007, EMBO J, V26, P3570, DOI 10.1038/sj.emboj.7601783; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Zahler AM, 2004, J BIOL CHEM, V279, P10077, DOI 10.1074/jbc.M312743200; Zeng CQ, 1997, EMBO J, V16, P1401, DOI 10.1093/emboj/16.6.1401; Zhang SS, 2004, NUCLEIC ACIDS RES, V32, P1, DOI 10.1093/nar/gkg933; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000; Zukerberg LR, 2004, CANCER RES, V64, P202, DOI 10.1158/0008-5472.CAN-03-2833	30	48	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2926	10.1371/journal.pone.0002926	http://dx.doi.org/10.1371/journal.pone.0002926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698352	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600012
J	Doublet, V; Souty-Grosset, C; Bouchon, D; Cordaux, R; Marcade, I				Doublet, Vincent; Souty-Grosset, Catherine; Bouchon, Didier; Cordaux, Richard; Marcade, Isabelle			A Thirty Million Year-Old Inherited Heteroplasmy	PLOS ONE			English	Article								Due to essentially maternal inheritance and a bottleneck effect during early oogenesis, newly arising mitochondrial DNA (mtDNA) mutations segregate rapidly in metazoan female germlines. Consequently, heteroplasmy (i.e. the mixture of mtDNA genotypes within an organism) is generally resolved to homoplasmy within a few generations. Here, we report an exceptional transpecific heteroplasmy (predicting an alanine/valine alloacceptor tRNA change) that has been stably inherited in oniscid crustaceans for at least thirty million years. Our results suggest that this heteroplasmy is stably transmitted across generations because it occurs within mitochondria and therefore escapes the mtDNA bottleneck that usually erases heteroplasmy. Consistently, at least two oniscid species possess an atypical trimeric mitochondrial genome, which provides an adequate substrate for the emergence of a constitutive intra-mitochondrial heteroplasmy. Persistence of a mitochondrial polymorphism on such a deep evolutionary timescale suggests that balancing selection may be shaping mitochondrial sequence evolution in oniscid crustaceans.	[Doublet, Vincent; Souty-Grosset, Catherine; Bouchon, Didier; Cordaux, Richard; Marcade, Isabelle] Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Doublet, V (corresponding author), Univ Poitiers, Ecol Lab, CNRS, UMR 6556, Poitiers, France.	isabelle.marcade@univ-poitiers.fr	Bouchon, Didier/B-2419-2012; Doublet, Vincent/D-8050-2015	Bouchon, Didier/0000-0002-4938-408X; Doublet, Vincent/0000-0002-6313-1222	Centre National de la Recherche Scientifique (CNRS) [Young Investigator ATIP award]; French Ministere de l'Education Nationale; de l'Enseignement Superieur et de la Recherche; Region Poitou-Charentes [fellowship]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale; de l'Enseignement Superieur et de la Recherche; Region Poitou-Charentes(Region Nouvelle-Aquitaine)	This research was funded by the Centre National de la Recherche Scientifique (CNRS) and the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. VD was supported by a Ph.D. fellowship from Region Poitou-Charentes. RC was supported by a CNRS Young Investigator ATIP award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2006, NUCLEIC ACIDS RES, V34, pW389, DOI 10.1093/nar/gkl044; Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Bendall KE, 1997, AM J HUM GENET, V61, P1303, DOI 10.1086/301636; BENTON MJ, 1993, FOSS REC, V2, P845; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Chinnery PF, 2002, TRENDS GENET, V18, P173, DOI 10.1016/S0168-9525(01)02636-1; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; Khrapko K, 2008, NAT GENET, V40, P134, DOI 10.1038/ng0208-134; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380, DOI 10.1007/BF00178868; LEGRAND JJ, 2006, CRUSTACEA, P353; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Marcade I, 1999, HEREDITY, V83, P71, DOI 10.1038/sj.hdy.6885380; Marcade I, 2007, J MOL EVOL, V65, P651, DOI 10.1007/s00239-007-9037-5; Raimond R, 1999, GENETICS, V151, P203; SCHMALFUSS H, 2003, NATURK A, V654, P1; SOUTYGROSSET C, 1992, CR ACAD SCI III-VIE, V314, P119; Zouros E, 2000, GENES GENET SYST, V75, P313, DOI 10.1266/ggs.75.313	20	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2938	10.1371/journal.pone.0002938	http://dx.doi.org/10.1371/journal.pone.0002938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698356	Green Submitted, gold, Green Published			2022-12-27	WOS:000264412600024
J	Rauchs, G; Orban, P; Schmidt, C; Albouy, G; Balteau, E; Degueldre, C; Schnackers, C; Sterpenich, V; Tinguely, G; Luxen, A; Maquet, P; Peigneux, P				Rauchs, Geraldine; Orban, Pierre; Schmidt, Christina; Albouy, Genevieve; Balteau, Evelyne; Degueldre, Christian; Schnackers, Caroline; Sterpenich, Virginie; Tinguely, Gilberte; Luxen, Andre; Maquet, Pierre; Peigneux, Philippe			Sleep Modulates the Neural Substrates of Both Spatial and Contextual Memory Consolidation	PLOS ONE			English	Article							SLOW-WAVE SLEEP; LATE NOCTURNAL SLEEP; DECLARATIVE MEMORY; RETROGRADE-AMNESIA; HUMAN NAVIGATION; BRAIN; RECOLLECTION; HIPPOCAMPUS; SYSTEMS; TASK	It is known that sleep reshapes the neural representations that subtend the memories acquired while navigating in a virtual environment. However, navigation is not process-pure, as manifold learning components contribute to performance, notably the spatial and contextual memory constituents. In this context, it remains unclear whether post-training sleep globally promotes consolidation of all of the memory components embedded in virtual navigation, or rather favors the development of specific representations. Here, we investigated the effect of post-training sleep on the neural substrates of the consolidation of spatial and contextual memories acquired while navigating in a complex 3D, naturalistic virtual town. Using fMRI, we mapped regional cerebral activity during various tasks designed to tap either the spatial or the contextual memory component, or both, 72 h after encoding with or without sleep deprivation during the first post-training night. Behavioral performance was not dependent upon post-training sleep deprivation, neither in a natural setting that engages both spatial and contextual memory processes nor when looking more specifically at each of these memory representations. At the neuronal level however, analyses that focused on contextual memory revealed distinct correlations between performance and neuronal activity in frontal areas associated with recollection processes after post-training sleep, and in the parahippocampal gyrus associated with familiarity processes in sleep-deprived participants. Likewise, efficient spatial memory was associated with posterior cortical activity after sleep whereas it correlated with parahippocampal/medial temporal activity after sleep deprivation. Finally, variations in place-finding efficiency in a natural setting encompassing spatial and contextual elements were associated with caudate activity after post-training sleep, suggesting the automation of navigation. These data indicate that post-training sleep modulates the neural substrates of the consolidation of both the spatial and contextual memories acquired during virtual navigation.	[Rauchs, Geraldine; Orban, Pierre; Schmidt, Christina; Albouy, Genevieve; Balteau, Evelyne; Degueldre, Christian; Schnackers, Caroline; Sterpenich, Virginie; Tinguely, Gilberte; Luxen, Andre; Maquet, Pierre; Peigneux, Philippe] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Rauchs, Geraldine] Univ Caen Basse Normandie, Inserm, EPHE, Unite Rech U923, Caen, France; [Orban, Pierre] Univ Montreal, Funct Neuroimag Unit, Montreal, PQ H3C 3J7, Canada; [Peigneux, Philippe] Free Univ Brussels, Neuropsychol & Funct Neuroimag Res Unit, UR2NF, B-1050 Brussels, Belgium	University of Liege; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; Universite de Montreal; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Rauchs, G (corresponding author), Univ Liege, Cyclotron Res Ctr, Liege, Belgium.	Philippe.Peigneux@ulb.ac.be	ALBOUY, Genevieve/K-5350-2015; RAUCHS, Géraldine/L-7921-2015; ALBOUY, Genevieve/P-4723-2019	ALBOUY, Genevieve/0000-0002-5437-023X; RAUCHS, Géraldine/0000-0001-7128-2189; ALBOUY, Genevieve/0000-0002-5437-023X; Peigneux, Philippe/0000-0003-4745-1434; , Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X	Belgian Fonds de la Recherche Scientifique - FNRS; Fondation Medicale Reine Elisabeth; Special Research Funds of the University of Liege; Pole d Attraction Interuniversitaire [PAI/P5_04]; Fondation Fyssen; French Ministere de la Recherche; Belgian Fonds Leon Fredericq	Belgian Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth; Special Research Funds of the University of Liege; Pole d Attraction Interuniversitaire; Fondation Fyssen; French Ministere de la Recherche(Ministry of Research, France); Belgian Fonds Leon Fredericq	This study was supported by the Belgian Fonds de la Recherche Scientifique - FNRS, the Fondation Medicale Reine Elisabeth, the Special Research Funds of the University of Liege, and the Pole d Attraction Interuniversitaire PAI/P5_04. GR was supported by grants from the Fondation Fyssen and the FNRS. EB, PO, VS, GT, ChS and PM are supported by the FNRS. GA was supported by a PhD grant from the French Ministere de la Recherche. CS was supported by the FNRS and the Belgian Fonds Leon Fredericq. All funders had no role in the design and conduct of the study, in the collection, analysis and interpretation of the data, and in the preparation of the manuscript.	Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Chan AHD, 2004, NEUROIMAGE, V22, P1128, DOI 10.1016/j.neuroimage.2004.02.034; Cohen DA, 2005, P NATL ACAD SCI USA, V102, P18237, DOI 10.1073/pnas.0506072102; DEROVER M, 2007, HUM BRAIN MAPP 1019; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Drummond SPA, 2004, SLEEP, V27, P445; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ellenbogen JM, 2006, CURR BIOL, V16, P1290, DOI 10.1016/j.cub.2006.05.024; ELLIS BW, 1981, SLEEP, V4, P93, DOI 10.1093/sleep/4.1.93; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 2003, NEUROIMAGE, V19, P1240, DOI 10.1016/S1053-8119(03)00144-7; Gais S, 2004, P NATL ACAD SCI USA, V101, P2140, DOI 10.1073/pnas.0305404101; Gais S, 2007, P NATL ACAD SCI USA, V104, P18778, DOI 10.1073/pnas.0705454104; Gardini S, 2006, NEUROIMAGE, V30, P645, DOI 10.1016/j.neuroimage.2005.10.012; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iaria G, 2003, J NEUROSCI, V23, P5945; KAPUR S, 1995, NEUROREPORT, V6, P1880, DOI 10.1097/00001756-199510020-00014; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Levine B, 1998, BRAIN, V121, P1951, DOI 10.1093/brain/121.10.1951; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maquet P, 2003, J NEUROSCI, V23, P1432, DOI 10.1523/JNEUROSCI.23-04-01432.2003; MAQUET P, 2003, SLEEP BRAIN PLASTICI, P396; Marshall L, 2004, J NEUROSCI, V24, P9985, DOI 10.1523/JNEUROSCI.2725-04.2004; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; Moscovitch M, 2005, J ANAT, V207, P35, DOI 10.1111/j.1469-7580.2005.00421.x; Ojemann GA, 2002, NAT NEUROSCI, V5, P64, DOI 10.1038/nn785; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Packard MG, 1999, P NATL ACAD SCI USA, V96, P12881, DOI 10.1073/pnas.96.22.12881; Peigneux P, 2003, NEUROIMAGE, V20, P125, DOI 10.1016/S1053-8119(03)00278-7; Peigneux P, 2006, PLOS BIOL, V4, P647, DOI 10.1371/journal.pbio.0040100; Peigneux P, 2004, NEURON, V44, P535, DOI 10.1016/j.neuron.2004.10.007; Peigneux P, 2001, NEUROREPORT, V12, pA111, DOI 10.1097/00001756-200112210-00001; PENNY WD, 2003, HUMAN BRAIN FUNCTION, P843; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; RANGANATH C, 2003, COGNITIVE NEUROSCIEN, P83; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rauchs G, 2004, SLEEP, V27, P395, DOI 10.1093/sleep/27.3.395; Rauchs G, 2005, J SLEEP RES, V14, P123, DOI 10.1111/j.1365-2869.2005.00450.x; Rauchs G, 2008, HIPPOCAMPUS, V18, P503, DOI 10.1002/hipo.20411; Rauchs G, 2007, NEUROBIOL AGING, V28, P1410, DOI 10.1016/j.neurobiolaging.2006.06.005; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Takashima A, 2006, P NATL ACAD SCI USA, V103, P756, DOI 10.1073/pnas.0507774103; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Woodruff CC, 2005, NEUROPSYCHOLOGIA, V43, P1022, DOI 10.1016/j.neuropsychologia.2004.10.013; Wu JC, 2006, NEUROPSYCHOPHARMACOL, V31, P2783, DOI 10.1038/sj.npp.1301166; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864	62	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2949	10.1371/journal.pone.0002949	http://dx.doi.org/10.1371/journal.pone.0002949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422FK	18698363	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600035
J	Leslie, T; Mayan, I; Mohammed, N; Erasmus, P; Kolaczinski, J; Whitty, CJM; Rowland, M				Leslie, Toby; Mayan, Ismail; Mohammed, Nasir; Erasmus, Panna; Kolaczinski, Jan; Whitty, Christopher J. M.; Rowland, Mark			A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan	PLOS ONE			English	Article							MALARIA; CHLOROQUINE; ERYTHROCYTE; DEFICIENCY; BURDEN	Background: Vivax malaria remains a major cause of morbidity in the subtropics. To undermine the stability of the disease, drugs are required that prevent relapse and provide reservoir reduction. A 14-day course of primaquine (PQ) is effective but cannot safely be used in routine practice because of its interaction with glucose-6-phosphate dehydrogenase (G6PD) deficiency for which testing is seldom available. Safe and effective use of PQ without the need for G6PD testing would be ideal. The efficacy and safety of an 8-week, once weekly PQ regimen was compared with current standard treatment (chloroquine alone) and a 14-day PQ regimen. Methods and Principal Findings: 200 microscopically confirmed Plasmodium vivax patients were randomly assigned to either once weekly 8-week PQ (0.75mg/kg/week), once weekly 8-week placebo, or 14-day PQ (0.5mg/kg/day) in North West Frontier Province, Pakistan. All patients were treated with a standard chloroquine dose and tested for G6PD deficiency. Deficient patients were assigned to the 8-week PQ group. Failure was defined as any subsequent episode of vivax malaria over 11 months of observation. There were 22/71 (31.0%) failures in the placebo group and 1/55 (1.8%) and 4/75 (5.1%) failures in the 14-day and 8-week PQ groups, respectively. Adjusted odds ratios were: for 8-week PQ vs. placebo-0.05 (95% CI: 0.01-0.2, p<0.001) and for 14-day PQ vs. placebo-0.01 (95% CI: 0.002-0.1, p<0.001). Restricted analysis allowing for a post-treatment prophylactic effect confirmed that the 8-week regimen was superior to current treatment. Only one G6PD deficient patient presented. There were no serious adverse events. Conclusions: A practical radical treatment for vivax malaria is essential for control and elimination of the disease. The 8-week PQ course is more effective at preventing relapse than current treatment with chloroquine alone. Widespread use of the 8-week regimen could make an important contribution to reservoir reduction or regional elimination where G6PD testing is not available. Trial Registration: ClinicalTrials.gov NCT00158587	[Leslie, Toby; Kolaczinski, Jan; Whitty, Christopher J. M.; Rowland, Mark] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Leslie, Toby; Mayan, Ismail; Mohammed, Nasir; Erasmus, Panna] HealthNet TPO, Kabul, Afghanistan	University of London; London School of Hygiene & Tropical Medicine	Leslie, T (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	toby.leslie@lshtm.ac.uk	Whitty, Christopher/C-7740-2012	Whitty, Christopher/0000-0002-6076-5027	UNDP/World Bank/WHO/TDR Special Programme for Research and Training in Tropical Diseases [SGS04/09]; Gates Malaria Partnership; London School of Hygiene and Tropical Medicine	UNDP/World Bank/WHO/TDR Special Programme for Research and Training in Tropical Diseases(World Health Organization); Gates Malaria Partnership; London School of Hygiene and Tropical Medicine	This study was funded by the UNDP/World Bank/WHO/TDR Special Programme for Research and Training in Tropical Diseases (grant number SGS04/09) and by the Gates Malaria Partnership, London School of Hygiene and Tropical Medicine. Sponsors and funding agencies (UNDP/World Bank/WHO Special Program for Research in Tropical Diseases; Gates Malaria Partnership) had no role in study design; collection, analysis, and interpretation of data; writing of the paper; or decision to submit for publication.	AJDUKIEWICZ K, 2006, J INFECT; Ali Nadir, 2005, J Coll Physicians Surg Pak, V15, P137; ALVING A S, 1960, Bull World Health Organ, V22, P621; Baird JK, 2007, AM J TROP MED HYG, V76, P201, DOI 10.4269/ajtmh.2007.76.201; Barcus MJ, 2007, AM J TROP MED HYG, V77, P984, DOI 10.4269/ajtmh.2007.77.984; Bolchoz LJC, 2001, J PHARMACOL EXP THER, V297, P509; BOUMA MJ, 1995, T ROY SOC TROP MED H, V89, P62, DOI 10.1016/0035-9203(95)90661-4; BREWER GJ, 1967, B WORLD HEALTH ORGAN, V36, P303; CLYDE DF, 1981, B WORLD HEALTH ORGAN, V59, P391; FLETCHER KA, 1988, BIOCHEM PHARMACOL, V37, P2683, DOI 10.1016/0006-2952(88)90263-8; Galappaththy GNL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub2; GARNHAM PCC, 1988, TROP GEOGR MED, V40, P187; Gogtay NJ, 1999, ANN TROP MED PARASIT, V93, P809, DOI 10.1080/00034989957790; Goller JL, 2007, AM J TROP MED HYG, V76, P203, DOI 10.4269/ajtmh.2007.76.203; HAY C, 2005, LANCET INFECT DIS, V4, P327; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Krudsood S, 2008, AM J TROP MED HYG, V78, P736, DOI 10.4269/ajtmh.2008.78.736; Leslie T, 2004, T ROY SOC TROP MED H, V98, P168, DOI 10.1016/S0035-9203(03)00041-5; Leslie T, 2007, JAMA-J AM MED ASSOC, V297, P2201, DOI 10.1001/jama.297.20.2201; Looareesuwan S, 1997, ANN TROP MED PARASIT, V91, P939, DOI 10.1080/00034989760338; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; MIHALY GW, 1985, BRIT J CLIN PHARMACO, V19, P745, DOI 10.1111/j.1365-2125.1985.tb02709.x; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rowland M, 1999, T ROY SOC TROP MED H, V93, P641, DOI 10.1016/S0035-9203(99)90081-0; Rowland M, 2001, ANN TROP MED PARASIT, V95, P741, DOI 10.1080/00034980120103405; Rowland M, 2002, T ROY SOC TROP MED H, V96, P620, DOI 10.1016/S0035-9203(02)90331-7; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; *WHO, 2006, GUID COTR PROPH HIV, P64; World Health Organization, 1990, PRACT CHEM MAL; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x	31	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2861	10.1371/journal.pone.0002861	http://dx.doi.org/10.1371/journal.pone.0002861			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682739	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000264366600017
J	Lugo, E; Doti, R; Faubert, J				Lugo, Eduardo; Doti, Rafael; Faubert, Jocelyn			Ubiquitous Crossmodal Stochastic Resonance in Humans: Auditory Noise Facilitates Tactile, Visual and Proprioceptive Sensations	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; HUMAN-BRAIN; SYNCHRONIZATION; SENSITIVITY; STIMULI	Background: Stochastic resonance is a nonlinear phenomenon whereby the addition of noise can improve the detection of weak stimuli. An optimal amount of added noise results in the maximum enhancement, whereas further increases in noise intensity only degrade detection or information content. The phenomenon does not occur in linear systems, where the addition of noise to either the system or the stimulus only degrades the signal quality. Stochastic Resonance (SR) has been extensively studied in different physical systems. It has been extended to human sensory systems where it can be classified as unimodal, central, behavioral and recently crossmodal. However what has not been explored is the extension of this crossmodal SR in humans. For instance, if under the same auditory noise conditions the crossmodal SR persists among different sensory systems. Methodology/Principal Findings: Using physiological and psychophysical techniques we demonstrate that the same auditory noise can enhance the sensitivity of tactile, visual and propioceptive system responses to weak signals. Specifically, we show that the effective auditory noise significantly increased tactile sensations of the finger, decreased luminance and contrast visual thresholds and significantly changed EMG recordings of the leg muscles during posture maintenance. Conclusions/Significance: We conclude that crossmodal SR is a ubiquitous phenomenon in humans that can be interpreted within an energy and frequency model of multisensory neurons spontaneous activity. Initially the energy and frequency content of the multisensory neurons' activity (supplied by the weak signals) is not enough to be detected but when the auditory noise enters the brain, it generates a general activation among multisensory neurons of different regions, modifying their original activity. The result is an integrated activation that promotes sensitivity transitions and the signals are then perceived. A physiologically plausible model for crossmodal stochastic resonance is presented.	[Lugo, Eduardo; Doti, Rafael; Faubert, Jocelyn] Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada	Universite de Montreal	Lugo, E (corresponding author), Univ Montreal, Sch Optometry, Visual Psychophys & Percept Lab, Montreal, PQ, Canada.	jocelyn.faubert@umontreal.ca	Lugo, J. Eduardo Lugo/A-3372-2011; Faubert, Jocelyn/E-2207-2011		NSERC [Essilor Research Chair]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the NSERC-Essilor Research Chair and an NSERC operating grant.	Allard R, 2007, VISION RES, V47, P1129, DOI 10.1016/j.visres.2007.01.010; Allard R, 2006, J VISION, V6, P322, DOI 10.1167/6.4.3; Badzey RL, 2005, NATURE, V437, P995, DOI 10.1038/nature04124; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Calvert G., 2004, HDB MULTISENSORY PRO; Collins JJ, 1997, PHYS REV E, V56, P923, DOI 10.1103/PhysRevE.56.923; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gobbele R, 2003, NEUROIMAGE, V20, P503, DOI 10.1016/S1053-8119(03)00312-4; Gong YF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031904; GREEN DM, 1966, SIGNAL DETECTION THE, P87; HARPER DW, 1979, PERCEPT MOTOR SKILL, V48, P791, DOI 10.2466/pms.1979.48.3.791; Hidaka I, 2000, PHYS REV LETT, V85, P3740, DOI 10.1103/PhysRevLett.85.3740; Ivey C, 1998, J NEUROPHYSIOL, V79, P1879, DOI 10.1152/jn.1998.79.4.1879; Kadunce DC, 1997, J NEUROPHYSIOL, V78, P2834, DOI 10.1152/jn.1997.78.6.2834; Kitajo K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.218103; Kitajo K, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/40009; Laurienti PJ, 2006, NEUROBIOL AGING, V27, P1155, DOI 10.1016/j.neurobiolaging.2005.05.024; LUGO JE, 2008, PSYCHOL SCI IN PRESS; Manjarrez E, 2007, NEUROSCI LETT, V415, P231, DOI 10.1016/j.neulet.2007.01.030; Moss F, 2004, CLIN NEUROPHYSIOL, V115, P267, DOI 10.1016/j.clinph.2003.09.014; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Ries DT, 2007, HEARING RES, V228, P136, DOI 10.1016/j.heares.2007.01.027; Sato S, 2004, J SOUND VIB, V277, P511, DOI 10.1016/j.jsv.2004.03.012; SHULGIN B, 1995, PHYS REV LETT, V75, P4157, DOI 10.1103/PhysRevLett.75.4157; SIMIU E, 2002, PRIN SER APPL MATH, P1; SIMON A, 1992, PHYS REV LETT, V68, P3375, DOI 10.1103/PhysRevLett.68.3375; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; Stein B E, 1989, J Cogn Neurosci, V1, P12, DOI 10.1162/jocn.1989.1.1.12; STEIN BE, 1988, BRAIN RES, V448, P355, DOI 10.1016/0006-8993(88)91276-0; Stein BE., 1993, MERGING SENSES; WALLACE MT, 1992, EXP BRAIN RES, V91, P484; Wells C, 2005, PSYCHOL SCI, V16, P313, DOI 10.1111/j.0956-7976.2005.01533.x; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503; Zeng FG, 2000, BRAIN RES, V869, P251, DOI 10.1016/S0006-8993(00)02475-6	35	82	84	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2860	10.1371/journal.pone.0002860	http://dx.doi.org/10.1371/journal.pone.0002860			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682745	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600016
J	Fazekas, AJ; Burgess, KS; Kesanakurti, PR; Graham, SW; Newmaster, SG; Husband, BC; Percy, DM; Hajibabaei, M; Barrett, SCH				Fazekas, Aron J.; Burgess, Kevin S.; Kesanakurti, Prasad R.; Graham, Sean W.; Newmaster, Steven G.; Husband, Brian C.; Percy, Diana M.; Hajibabaei, Mehrdad; Barrett, Spencer C. H.			Multiple Multilocus DNA Barcodes from the Plastid Genome Discriminate Plant Species Equally Well	PLOS ONE			English	Article							LAND PLANTS; IDENTIFICATION; REGIONS; PHYLOGENIES; CONFIDENCE; IDENTIFY; TAXONOMY; RBCL	A universal barcode system for land plants would be a valuable resource, with potential utility in fields as diverse as ecology, floristics, law enforcement and industry. However, the application of plant barcoding has been constrained by a lack of consensus regarding the most variable and technically practical DNA region(s). We compared eight candidate plant barcoding regions from the plastome and one from the mitochondrial genome for how well they discriminated the monophyly of 92 species in 32 diverse genera of land plants (N = 251 samples). The plastid markers comprise portions of five coding (rpoB, rpoC1, rbcL, matK and 23S rDNA) and three non-coding (trnH-psbA, atpF-atpH, and psbK-psbI) loci. Our survey included several taxonomically complex groups, and in all cases we examined multiple populations and species. The regions differed in their ability to discriminate species, and in ease of retrieval, in terms of amplification and sequencing success. Single locus resolution ranged from 7% (23S rDNA) to 59% (trnH-psbA) of species with well-supported monophyly. Sequence recovery rates were related primarily to amplification success (85-100% for plastid loci), with matK requiring the greatest effort to achieve reasonable recovery (88% using 10 primer pairs). Several loci (matK, psbK-psbI, trnH-psbA) were problematic for generating fully bidirectional sequences. Setting aside technical issues related to amplification and sequencing, combining the more variable plastid markers provided clear benefits for resolving species, although with diminishing returns, as all combinations assessed using four to seven regions had only marginally different success rates (69-71%; values that were approached by several two-and three-region combinations). This performance plateau may indicate fundamental upper limits on the precision of species discrimination that is possible with DNA barcoding systems that include moderate numbers of plastid markers. Resolution to the contentious debate on plant barcoding should therefore involve increased attention to practical issues related to the ease of sequence recovery, global alignability, and marker redundancy in multilocus plant DNA barcoding systems.	[Fazekas, Aron J.; Kesanakurti, Prasad R.; Newmaster, Steven G.; Husband, Brian C.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Burgess, Kevin S.; Barrett, Spencer C. H.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Graham, Sean W.; Percy, Diana M.] Univ British Columbia, UBC Botanical Garden & Ctr Plant Res, Dept Bot, Vancouver, BC, Canada; [Hajibabaei, Mehrdad] Univ Guelph, Biodivers Inst Ontario, Dept Integrat Biol, Guelph, ON, Canada	University of Guelph; University of Toronto; University of British Columbia; University of Guelph	Fazekas, AJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	afazekas@uoguelph.ca	Barrett, Spencer CH/M-3751-2013; Kesanakurti, Prasad/GYQ-5526-2022; 赵, 鹏/B-8401-2009; Kesanakurti, Prasad/AAO-7478-2021; Barrett, Spencer C.H./S-5782-2019; Graham, Sean W/L-3944-2014	Barrett, Spencer C.H./0000-0002-7762-3455; Graham, Sean W/0000-0001-8209-5231	Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network	Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network(Genome Canada)	This research was funded by a grant from Genome Canada through the Ontario Genomics Institute to the Canadian Barcode of Life Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cho Y, 1998, P NATL ACAD SCI USA, V95, P14244, DOI 10.1073/pnas.95.24.14244; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Craft KJ, 2006, CAN J FOREST RES, V36, P206, DOI 10.1139/x05-234; Crisp Michael D., 1996, Telopea, V6, P813; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; FELSENSTEIN J, 1993, SYST BIOL, V42, P193, DOI 10.2307/2992541; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Graham SW, 2000, INT J PLANT SCI, V161, pS83, DOI 10.1086/317583; HALL T, 2007, IBIS BIOSCIENCES; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; *KEW, 2007, DNA BARC PHAS 2 UPD; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lee HL, 2007, 2 INT BARC LIF C TAI; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mort ME, 2000, SYST BIOL, V49, P160, DOI 10.1080/10635150050207456; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Noyes RD, 2000, GENETICS, V155, P379; OLMSTEAD RG, 1995, SYST BOT, V20, P623, DOI 10.2307/2419814; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Prance GT, 2001, TAXON, V50, P345, DOI 10.2307/1223885; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; RAMBAUT A, 2002, SE A1 SEQUENCE ALIGN; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; TABERLET P, 2006, NUCLEIC ACIDS RES, V35, pE1; Xiang LL, 2000, AM J BOT, V87, P1175, DOI 10.2307/2656654	43	449	511	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2802	10.1371/journal.pone.0002802	http://dx.doi.org/10.1371/journal.pone.0002802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665273	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300021
J	Banerjee, R; Mosley, RL; Reynolds, AD; Dhar, A; Jackson-Lewis, V; Gordon, PH; Przedborski, S; Gendelman, HE				Banerjee, Rebecca; Mosley, R. Lee; Reynolds, Ashley D.; Dhar, Alok; Jackson-Lewis, Vernice; Gordon, Paul H.; Przedborski, Serge; Gendelman, Howard E.			Adaptive Immune Neuroprotection in G93A-SOD1 Amyotrophic Lateral Sclerosis Mice	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; MOTOR-NEURON DEGENERATION; MOUSE MODEL; GLATIRAMER ACETATE; T-CELLS; MURINE MODEL; SPINAL-CORD; THERAPEUTIC IMMUNIZATION; LYMPHOCYTE POPULATIONS; DOPAMINERGIC-NEURONS	Background: Innate neuroimmune dysfunction is a pathobiological feature of amyotrophic lateral sclerosis (ALS). However, links, if any, between disease and adaptive immunity are poorly understood. Thus, the role of T cell immunity in disease was investigated in human G93A superoxide dismutase 1 (SOD1) transgenic (Tg) mice and subsequently in ALS patients. Methods and Findings: Quantitative and qualitative immune deficits in lymphoid cell and T cell function were seen in G93A-SOD1 Tg mice. Spleens of Tg animals showed reductions in size, weight, lymphocyte numbers, and morphological deficits at terminal stages of disease compared to their wild-type (Wt) littermates. Spleen sizes and weights of presymptomatic Tg mice were unchanged, but deficits were readily seen in T cell proliferation coincident with increased annexin-V associated apoptosis and necrosis of lymphocytes. These lymphoid deficits paralleled failure of Copolymer-1 (COP-1) immunization to affect longevity. In addition, among CD4(+) T cells in ALS patients, levels of CD45RA(+) (naive) T cells were diminished, while CD45RO(+) (memory) T cells were increased compared to age-matched caregivers. In attempts to correct mutant SOD1 associated immune deficits, we reconstituted SOD1 Tg mice with unfractionated naive lymphocytes or anti-CD3 activated CD4(+)CD25(+) T regulatory cells (Treg) or CD4(+)CD25(-) T effector cells (Teff) from Wt donor mice. While naive lymphocytes failed to enhance survival, both polyclonal-activated Treg and Teff subsets delayed loss of motor function and extended survival; however, only Treg delayed neurological symptom onset, whereas Teff increased latency between disease onset and entry into late stage. Conclusions: A profound and progressive immunodeficiency is operative in G93A-SOD1 mice and is linked to T cell dysfunction and the failure to elicit COP-1 neuroprotective immune responses. In preliminary studies T cell deficits were also observed in human ALS. These findings, taken together, suggest caution in ascribing vaccination outcomes when these animal models of human ALS are used for study. Nonetheless, the abilities to improve neurological function and life expectancy in G93A-SOD1 Tg mice by reconstitution with activated T cells do provide opportunities for therapeutic intervention.	[Banerjee, Rebecca; Mosley, R. Lee; Reynolds, Ashley D.; Dhar, Alok; Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA; [Jackson-Lewis, Vernice; Gordon, Paul H.; Przedborski, Serge] Columbia Univ, Eleanor & Lou Gehrig MDA ALS Res Ctr, Ctr Motor Neuron Biol & Dis, Dept Neurol, New York, NY USA	University of Nebraska System; University of Nebraska Medical Center; Columbia University	Banerjee, R (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Ctr Neurovirol & Neurodegenerat Disorders, Omaha, NE 68198 USA.	rlmosley@unmc.edu; SP30@Columbia.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012	Gordon, Paul/0000-0001-5714-9875	National Institute of Neurological Disorders and Stroke [NS36136, NS43985, NS007488, NS42269, NS38370, NS11766, NS049264]; National Institute of Mental Health [MH64570]; National Institute of Aging [AG021617]; National Institute of Environmental Health Sciences [ES013177]; U.S. Department of Defense [17-03-1]; Parkinson's Disease Foundation [CU51523606]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS011766, T32NS007488, P50NS038370, R21NS049264, P01NS043985, R01NS042269, P01NS011766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke Grants (NS36136, NS43985, NS007488, NS42269, NS38370, NS11766 and NS049264); National Institute of Mental Health (MH64570); National Institute of Aging (AG021617); National Institute of Environmental Health Sciences (ES013177); U.S. Department of Defense Grant (17-03-1); the Parkinson's Disease Foundation (CU51523606) and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni R, 2005, P NATL ACAD SCI USA, V102, P19045, DOI 10.1073/pnas.0509438102; Alexianu ME, 2001, NEUROLOGY, V57, P1282, DOI 10.1212/WNL.57.7.1282; Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100; Arnon R, 2003, J MOL RECOGNIT, V16, P412, DOI 10.1002/jmr.628; Avidan H, 2004, EUR J IMMUNOL, V34, P3434, DOI 10.1002/eji.200424883; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Bakalash S, 2005, J MOL MED, V83, P904, DOI 10.1007/s00109-005-0689-6; Bar-Or A, 2003, BRAIN, V126, P2738, DOI 10.1093/brain/awg285; Baron P, 2005, MUSCLE NERVE, V32, P541, DOI 10.1002/mus.20376; Bas J, 2001, J NEUROIMMUNOL, V113, P146, DOI 10.1016/S0165-5728(00)00422-7; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Boillee S, 2008, J CLIN INVEST, V118, P474, DOI [10.1172/JC134613, 10.1172/JCI34613]; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Buttarelli FR, 2006, EUR J NEUROL, V13, P416, DOI 10.1111/j.1468-1331.2006.01235.x; Casal JA, 2003, CLIN BIOCHEM, V36, P553, DOI 10.1016/S0009-9120(03)00093-6; Cereda C, 2006, NEUROL SCI, V27, P312, DOI 10.1007/s10072-006-0702-z; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cova E, 2006, NEUROSCI LETT, V399, P186, DOI 10.1016/j.neulet.2006.01.057; Curti D, 1996, NEUROLOGY, V47, P1060, DOI 10.1212/WNL.47.4.1060; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Filion LG, 2003, CLIN EXP IMMUNOL, V131, P324, DOI 10.1046/j.1365-2249.2003.02053.x; Goldknopf IL, 2006, BIOCHEM BIOPH RES CO, V342, P1034, DOI 10.1016/j.bbrc.2006.02.051; Gorantla S, 2008, GLIA, V56, P223, DOI 10.1002/glia.20607; Gorantla S, 2007, J IMMUNOL, V179, P4345, DOI 10.4049/jimmunol.179.7.4345; Gordon PH, 2006, NEUROLOGY, V66, P1117, DOI 10.1212/01.wnl.0000204235.81272.e2; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Habisch HJ, 2007, EXP NEUROL, V206, P288, DOI 10.1016/j.expneurol.2007.05.007; Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; HOFFMAN PM, 1983, J GERONTOL, V38, P414, DOI 10.1093/geronj/38.4.414; HOFFMAN PM, 1981, ANN NEUROL, V10, P193, DOI 10.1002/ana.410100210; HOFFMAN PM, 1978, NEW ENGL J MED, V299, P680, DOI 10.1056/NEJM197809282991302; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kipnis J, 2004, P NATL ACAD SCI USA, V101, P14663, DOI 10.1073/pnas.0404842101; Kipnis J, 2000, P NATL ACAD SCI USA, V97, P7446, DOI 10.1073/pnas.97.13.7446; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Kuzmenok OI, 2006, J NEUROIMMUNOL, V172, P132, DOI 10.1016/j.jneuroim.2005.11.015; Laurie C, 2007, J NEUROIMMUNOL, V183, P60, DOI 10.1016/j.jneuroim.2006.11.009; Liu J, 2007, EUR J IMMUNOL, V37, P3143, DOI 10.1002/eji.200737398; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; NAGATA T, 2007, NEUROL RES; Neuhaus O, 2001, NEUROLOGY, V56, P702, DOI 10.1212/WNL.56.6.702; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Poulopoulou C, 2005, ANN NEUROL, V58, P946, DOI 10.1002/ana.20675; PROVINCIALI L, 1988, ACTA NEUROL SCAND, V78, P449, DOI 10.1111/j.1600-0404.1988.tb03686.x; Rentzos M, 2007, AMYOTROPH LATERAL SC, V8, P283, DOI 10.1080/17482960701419232; REYNOLDS AD, 2007, J LEUKOC BIOL; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scali C, 2002, NEUROBIOL AGING, V23, P523, DOI 10.1016/S0197-4580(01)00346-3; Schori H, 2001, J NEUROIMMUNOL, V119, P199, DOI 10.1016/S0165-5728(01)00358-7; Schwartz M, 2003, TRENDS NEUROSCI, V26, P297, DOI 10.1016/S0166-2236(03)00126-7; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Sengun IS, 2003, J NEUROIMMUNOL, V142, P137, DOI 10.1016/S0165-5728(03)00263-7; SHALIT F, 1995, CLIN IMMUNOL IMMUNOP, V75, P246, DOI 10.1006/clin.1995.1078; Shi N, 2007, J NEUROIMMUNOL, V182, P232, DOI 10.1016/j.jneuroim.2006.10.001; Sinha S, 2004, J NEUROL SCI, V224, P97, DOI 10.1016/j.jns.2004.06.006; Teitelbaum D, 2003, MULT SCLER J, V9, P592, DOI 10.1191/1352458503ms963oa; Town T, 2002, J NEUROIMMUNOL, V132, P49, DOI 10.1016/S0165-5728(02)00307-7; TROOST D, 1990, NEUROPATH APPL NEURO, V16, P401, DOI 10.1111/j.1365-2990.1990.tb01276.x; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Verma A, 2006, J NEUROL SCI, V240, P59, DOI 10.1016/j.jns.2005.09.005; Weydt P, 2003, NEUROREPORT, V14, P1051, DOI 10.1097/01.wnr.0000073685.00308.89; Wilms H, 2003, J NEUROIMMUNOL, V144, P139, DOI 10.1016/j.jneuroim.2003.08.042; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Xiao Q, 2007, J NEUROCHEM, V102, P2008, DOI 10.1111/j.1471-4159.2007.04677.x; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhang RZ, 2005, J NEUROIMMUNOL, V159, P215, DOI 10.1016/j.jneuroim.2004.10.009; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x	81	141	148	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2740	10.1371/journal.pone.0002740	http://dx.doi.org/10.1371/journal.pone.0002740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648532	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900011
J	Wilson, KD; Li, ZJ; Wagner, R; Yue, P; Tsao, P; Nestorova, G; Huang, M; Hirschberg, DL; Yock, PG; Quertermous, T; Wu, JC				Wilson, Kitchener D.; Li, Zongjin; Wagner, Roger; Yue, Patrick; Tsao, Phillip; Nestorova, Gergana; Huang, Mei; Hirschberg, David L.; Yock, Paul G.; Quertermous, Thomas; Wu, Joseph C.			Transcriptome Alteration in the Diabetic Heart by Rosiglitazone: Implications for Cardiovascular Mortality	PLOS ONE			English	Article								Background: Recently, the type 2 diabetesmedication, rosiglitazone, has come under scrutiny for possibly increasing the risk of cardiac disease and death. To investigate the effects of rosiglitazone on the diabetic heart, we performed cardiac transcriptional profiling and imaging studies of a murine model of type 2 diabetes, the C57BL/KLS-lepr(db)/lepr(db) (db/db) mouse. Methods and Findings: We compared cardiac gene expression profiles from three groups: untreated db/db mice, db/db mice after rosiglitazone treatment, and non-diabetic db/+ mice. Prior to sacrifice, we also performed cardiac magnetic resonance (CMR) and echocardiography. As expected, overall the db/db gene expression signature was markedly different from control, but to our surprise was not significantly reversed with rosiglitazone. In particular, we have uncovered a number of rosiglitazone modulated genes and pathways that may play a role in the pathophysiology of the increase in cardiac mortality as seen in several recent meta-analyses. Specifically, the cumulative upregulation of (1) a matrix metalloproteinase gene that has previously been implicated in plaque rupture, (2) potassium channel genes involved in membrane potential maintenance and action potential generation, and (3) sphingolipid and ceramide metabolism-related genes, together give cause for concern over rosiglitazone's safety. Lastly, in vivo imaging studies revealed minimal differences between rosiglitazone-treated and untreated db/db mouse hearts, indicating that rosiglitazone's effects on gene expression in the heart do not immediately turn into detectable gross functional changes. Conclusions: This study maps the genomic expression patterns in the hearts of the db/db murine model of diabetes and illustrates the impact of rosiglitazone on these patterns. The db/db gene expression signature was markedly different from control, and was not reversed with rosiglitazone. A smaller number of unique and interesting changes in gene expression were noted with rosiglitazone treatment. Further study of these genes and molecular pathways will provide important insights into the cardiac decompensation associated with both diabetes and rosiglitazone treatment.	[Wilson, Kitchener D.; Li, Zongjin; Huang, Mei; Wu, Joseph C.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Wagner, Roger; Yue, Patrick; Tsao, Phillip; Yock, Paul G.; Quertermous, Thomas; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Div Cardiol, Stanford, CA USA; [Wilson, Kitchener D.; Yock, Paul G.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA USA; [Nestorova, Gergana; Hirschberg, David L.] Stanford Univ, Sch Med, Human Immune Monitoring Ctr, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Wilson, KD (corresponding author), Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Li, Zongjin/A-1115-2014; Li, Zongjin/G-3118-2010; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Li, Zongjin/0000-0002-4603-3743; Li, Zongjin/0000-0002-4603-3743; Quertermous, Thomas/0000-0002-7645-9067; Wu, Joseph/0000-0002-6068-8041; Nestorova, Gergana/0000-0002-9960-9435	Burroughs Wellcome Foundation Career Award in Medical Scientist; Stanford University Bio-X Graduate Student Fellowship; Society of Nuclear Medicine Student Fellowship	Burroughs Wellcome Foundation Career Award in Medical Scientist(Burroughs Wellcome Fund); Stanford University Bio-X Graduate Student Fellowship; Society of Nuclear Medicine Student Fellowship	Funding for this work was supplied in part by research grants from Burroughs Wellcome Foundation Career Award in Medical Scientist (JCW). KDW is a recipient of a Stanford University Bio-X Graduate Student Fellowship and Society of Nuclear Medicine Student Fellowship. This study was designed by JCW in collaboration with his academic colleagues. This investigation did not have separate industry funding. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aasum E, 2003, DIABETES, V52, P434, DOI 10.2337/diabetes.52.2.434; Albrektsen T, 2002, DIABETES, V51, P1042, DOI 10.2337/diabetes.51.4.1042; Baranowski M, 2007, PROSTAG OTH LIPID M, V83, P99, DOI 10.1016/j.prostaglandins.2006.10.004; Bauters C, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-1; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Beyzade S, 2003, J AM COLL CARDIOL, V41, P2130, DOI 10.1016/S0735-1097(03)00482-0; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Carley AN, 2004, AM J PHYSIOL-ENDOC M, V286, pE449, DOI 10.1152/ajpendo.00329.2003; Chatterjee S, 2006, CURR OPIN INVEST DR, V7, P219; Chen MM, 2003, CIRCULATION, V108, P1432, DOI 10.1161/01.CIR.0000091235.94914.75; Dargie HJ, 2007, J AM COLL CARDIOL, V49, P1696, DOI 10.1016/j.jacc.2006.10.077; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Gilde AJ, 2003, CIRC RES, V92, P518, DOI 10.1161/01.RES.0000060700.55247.7C; Guo L, 2006, MOL DIVERS, V10, P349, DOI 10.1007/s11030-006-9038-0; Heishi M, 2006, DIABETOLOGIA, V49, P1647, DOI 10.1007/s00125-006-0271-y; HENNEY AM, 1991, P NATL ACAD SCI USA, V88, P8154, DOI 10.1073/pnas.88.18.8154; Hug C, 2005, CURR OPIN PHARMACOL, V5, P129, DOI 10.1016/j.coph.2005.01.001; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Keen HL, 2004, PHYSIOL GENOMICS, V18, P33, DOI 10.1152/physiolgenomics.00027.2004; Kelly DP, 2003, CIRC RES, V92, P482, DOI 10.1161/01.RES.0000064382.46274.95; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Levade T, 2001, CIRC RES, V89, P957, DOI 10.1161/hh2301.100350; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu LS, 1998, ENDOCRINOLOGY, V139, P4531, DOI 10.1210/en.139.11.4531; Makino H, 2006, DIABETES, V55, P2747, DOI 10.2337/db05-1683; Marx N, 1998, CIRC RES, V83, P1097, DOI 10.1161/01.RES.83.11.1097; Natarajan R, 2008, J CARDIOVASC PHARM, V51, P178, DOI 10.1097/FJC.0b013e31815f248d; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Parton LE, 2004, AM J PHYSIOL-ENDOC M, V287, pE390, DOI 10.1152/ajpendo.00016.2004; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sears DD, 2007, BIOCHEM BIOPH RES CO, V364, P515, DOI 10.1016/j.bbrc.2007.10.057; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Shimoni Y, 2001, J PHYSIOL-LONDON, V537, P83, DOI 10.1111/j.1469-7793.2001.0083k.x; Sidell RJ, 2002, DIABETES, V51, P1110, DOI 10.2337/diabetes.51.4.1110; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Yue P, 2007, AM J PHYSIOL-HEART C, V292, pH2106, DOI 10.1152/ajpheart.00856.2006; Zhou YT, 2000, P NATL ACAD SCI USA, V97, P1784, DOI 10.1073/pnas.97.4.1784	45	45	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2008	3	7							e2609	10.1371/journal.pone.0002609	http://dx.doi.org/10.1371/journal.pone.0002609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417GZ	18648539	Green Submitted, Green Published, gold			2022-12-27	WOS:000264065800015
J	Gu, P; Reid, JG; Gao, XL; Shaw, CA; Creighton, C; Tran, PL; Zhou, XC; Drabek, RB; Steffen, DL; Hoang, DM; Weiss, MK; Naghavi, AO; El-Daye, J; Khan, MF; Legge, GB; Wheeler, DA; Gibbs, RA; Miller, JN; Cooney, AJ; Gunaratne, PH				Gu, Peili; Reid, Jeffrey G.; Gao, Xiaolian; Shaw, Chad A.; Creighton, Chad; Tran, Peter L.; Zhou, Xiaochuan; Drabek, Rafal B.; Steffen, David L.; Hoang, David M.; Weiss, Michelle K.; Naghavi, Arash O.; El-Daye, Jad; Khan, Mahjabeen F.; Legge, Glen B.; Wheeler, David A.; Gibbs, Richard A.; Miller, Jonathan N.; Cooney, Austin J.; Gunaratne, Preethi H.			Novel MicroRNA Candidates and miRNA-mRNA Pairs in Embryonic Stem (ES) Cells	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; DEVELOPMENTAL REGULATORS; SELF-RENEWAL; MOUSE; PLURIPOTENCY; EXPRESSION; DISCOVERY; GENES; DICER; SPECIFICATION	Background: MicroRNAs (miRNAs: a class of short non-coding RNAs) are emerging as important agents of post transcriptional gene regulation and integral components of gene networks. MiRNAs have been strongly linked to stem cells, which have a remarkable dual role in development. They can either continuously replenish themselves (self-renewal), or differentiate into cells that execute a limited number of specific actions (pluripotence). Methodology/Principal Findings: In order to identify novel miRNAs from narrow windows of development we carried out an in silico search for micro-conserved elements (MCE) in adult tissue progenitor transcript sequences. A plethora of previously unknown miRNA candidates were revealed including 545 small RNAs that are enriched in embryonic stem (ES) cells over adult cells. Approximately 20% of these novel candidates are down-regulated in ES (Dicer(-/-)) ES cells that are impaired in miRNA maturation. The ES-enriched miRNA candidates exhibit distinct and opposite expression trends from mmu-mirs (an abundant class in adult tissues) during retinoic acid (RA)-induced ES cell differentiation. Significant perturbation of trends is found in both miRNAs and novel candidates in ES (GCNF(-/-)) cells, which display loss of repression of pluripotence genes upon differentiation. Conclusion/Significance: Combining expression profile information with miRNA target prediction, we identified miRNA-mRNA pairs that correlate with ES cell pluripotence and differentiation. Perturbation of these pairs in the ES (GCNF(-/-)) mutant suggests a role for miRNAs in the core regulatory networks underlying ES cell self-renewal, pluripotence and differentiation.	[Gu, Peili; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Gao, Xiaolian; Tran, Peter L.; Drabek, Rafal B.; Hoang, David M.; Weiss, Michelle K.; Naghavi, Arash O.; El-Daye, Jad; Khan, Mahjabeen F.; Legge, Glen B.; Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Reid, Jeffrey G.; Gao, Xiaolian] Univ Houston, Dept Chem, Houston, TX USA; [Miller, Jonathan N.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX USA; [Reid, Jeffrey G.; Drabek, Rafal B.; Wheeler, David A.; Gibbs, Richard A.; Miller, Jonathan N.; Gunaratne, Preethi H.] Baylor Coll Med, Dept Human Genome Sequencing Ctr, Houston, TX USA; [Shaw, Chad A.; Steffen, David L.] Baylor Colle Med, Dept Mol & Human Genet, Houston, TX USA; [Steffen, David L.] Baylor Coll Med, Bioinformat Res Ctr, Houston, TX USA; [Creighton, Chad] Baylor Coll Med, Duncan Canc Ctr, Houston, TX USA; [Reid, Jeffrey G.] WM Keck Ctr Interdisciplin Biosci Training, Houston, TX USA; [Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Gu, Peili] Univ Texas, MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center	Gu, P (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA.	phgunaratne@uh.edu	Naghavi, Arash/AHB-4226-2022; Wheeler, David A/M-9740-2018; Miller, Jonathan/M-4389-2014; Steffen, David L/B-2751-2013	Wheeler, David A/0000-0002-9056-6299; Miller, Jonathan/0000-0003-2190-6824; Steffen, David L/0000-0001-9363-2629; Shaw, Chad/0000-0001-7267-5398	NIDDK/SCGAP [RFA-DK-02-027]; The Keck Center for Interdisciplinary Bioscience Training; NIH NIDDK [73524]; NIH/NHGRI [2 U54 HG003273-04]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER	NIDDK/SCGAP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); The Keck Center for Interdisciplinary Bioscience Training; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from NIDDK/SCGAP RFA-DK-02-027 to P.H.G, R.A.G. and D.L.S, The Keck Center for Interdisciplinary Bioscience Training to J.G.R, NIH NIDDK 73524 grant to A.J.C. and NIH/NHGRI 2 U54 HG003273-04 grant to D. A. W. and R.A.G.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bolstad BM, 2004, INT REV NEUROBIOL, V60, P25; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P21021, DOI 10.1073/pnas.0711071105; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chung ACK, 2001, MOL CELL BIOL, V21, P663, DOI 10.1128/MCB.21.2.663-677.2001; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; JOHN B, 2005, MIRANDA ALGORITHM HU; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Matsui Y, 2005, BIOESSAYS, V27, P136, DOI 10.1002/bies.20178; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Salerno W, 2006, P NATL ACAD SCI USA, V103, P13121, DOI 10.1073/pnas.0605735103; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Susens U, 1997, DEV NEUROSCI-BASEL, V19, P410, DOI 10.1159/000111238; Tran T, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl173; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhang BH, 2006, J CELL PHYSIOL, V209, P266, DOI 10.1002/jcp.20713; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; ZHU Q, METHODS MOL IN PRESS	55	43	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2548	10.1371/journal.pone.0002548	http://dx.doi.org/10.1371/journal.pone.0002548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648548	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288200017
J	Loarie, SR; Carter, BE; Hayhoe, K; McMahon, S; Moe, R; Knight, CA; Ackerly, DD				Loarie, Scott R.; Carter, Benjamin E.; Hayhoe, Katharine; McMahon, Sean; Moe, Richard; Knight, Charles A.; Ackerly, David D.			Climate Change and the Future of California's Endemic Flora	PLOS ONE			English	Article							BIOCLIMATE ENVELOPE MODELS; SPECIES DISTRIBUTIONS; EXTINCTION RISK; BIODIVERSITY; IMPACTS; RANGE; DIVERSITY; HABITAT; PLANTS; UNCERTAINTY	The flora of California, a global biodiversity hotspot, includes 2387 endemic plant taxa. With anticipated climate change, we project that up to 66% will experience >80% reductions in range size within a century. These results are comparable with other studies of fewer species or just samples of a region's endemics. Projected reductions depend on the magnitude of future emissions and on the ability of species to disperse from their current locations. California's varied terrain could cause species to move in very different directions, breaking up present-day floras. However, our projections also identify regions where species undergoing severe range reductions may persist. Protecting these potential future refugia and facilitating species dispersal will be essential to maintain biodiversity in the face of climate change.	[Loarie, Scott R.; McMahon, Sean] Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA; [Carter, Benjamin E.; Knight, Charles A.] Calif Polytechnic State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA USA; [Hayhoe, Katharine] Texas Tech Univ, Dept Geosci, Lubbock, TX USA; [Carter, Benjamin E.; Moe, Richard; Ackerly, David D.] Univ Calif Berkeley, Jepson Herbarium, Berkeley, CA USA; [Carter, Benjamin E.; Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA USA	Duke University; California State University System; California Polytechnic State University San Luis Obispo; Texas Tech University System; Texas Tech University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Loarie, SR (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27706 USA.	scott.loarie@duke.edu	Ackerly, David/A-1247-2009	Ackerly, David/0000-0002-1847-7398				Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Bakkenes M, 2002, GLOBAL CHANGE BIOL, V8, P390, DOI 10.1046/j.1354-1013.2001.00467.x; Barbour M, 1977, TERRESTRIAL VEGETATI; Bomhard B, 2005, GLOBAL CHANGE BIOL, V11, P1452, DOI 10.1111/j.1365-2486.2005.00997.x; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Chapin FS, 1997, CLIMATIC CHANGE, V35, P449, DOI 10.1023/A:1005337705025; CSUTI B, 1996, GAP ANAL LANDSCAPE A, P135; Daly C, 2000, ECOL APPL, V10, P449, DOI 10.1890/1051-0761(2000)010[0449:DSOTGI]2.0.CO;2; Dettinger M, 2005, SAN FRANCISCO ESTUAR, V3; Dole KP, 2003, GLOBAL PLANET CHANGE, V36, P137, DOI 10.1016/S0921-8181(02)00179-0; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gelman A., 2007, DATA ANAL USING REGR; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halpin PN, 1997, ECOL APPL, V7, P828; Hampe A, 2004, GLOBAL ECOL BIOGEOGR, V13, P469, DOI 10.1111/j.1466-822X.2004.00090.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Harrison S, 2006, ECOL MONOGR, V76, P41, DOI 10.1890/05-0910; Hayhoe K, 2004, P NATL ACAD SCI USA, V101, P12422, DOI 10.1073/pnas.0404500101; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hickman J. C., 1993, JEPSON MANUAL HIGHER; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Iverson LR, 1998, ECOL MONOGR, V68, P465, DOI 10.1890/0012-9615(1998)068[0465:PAOTSF]2.0.CO;2; Iverson LR, 2002, FOREST ECOL MANAG, V155, P205, DOI 10.1016/S0378-1127(01)00559-X; Kueppers LM, 2005, P NATL ACAD SCI USA, V102, P16281, DOI 10.1073/pnas.0501427102; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Maurer EP, 2002, J CLIMATE, V15, P3237, DOI [10.1175/1520-0442(2002)015<3237:ALTHBD>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3237:ALTHBD&gt;2.0.CO;2]; McMahon SM, 2007, ECOL LETT, V10, P437, DOI 10.1111/j.1461-0248.2007.01036.x; Midgley GF, 2003, BIOL CONSERV, V112, P87, DOI 10.1016/S0006-3207(02)00414-7; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakicenovic N., 2000, INTERGOVERNMENTAL PA, P599; *OSU HERB, 2004, CORV OR STAT U ONL H; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Raven P.H., 1978, ORIGIN RELATIONSHIPS; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; SCHNEIDER SH, 2001, WILDLIFE RESPONSES C; Seabloom EW, 2006, ECOL APPL, V16, P1338, DOI 10.1890/1051-0761(2006)016[1338:HIPIAI]2.0.CO;2; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x; STEBBINS GL, 1965, ECOL MONOGR, V35, P1, DOI 10.2307/1942216; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thornton PE, 1997, J HYDROL, V190, P214, DOI 10.1016/S0022-1694(96)03128-9; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Vetaas OR, 2002, J BIOGEOGR, V29, P545, DOI 10.1046/j.1365-2699.2002.00694.x; Washington WM, 2000, CLIM DYNAM, V16, P755, DOI 10.1007/s003820000079; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wiggins I. L., 1980, Flora of Baja California.; Williams P, 2005, CONSERV BIOL, V19, P1063, DOI 10.1111/j.1523-1739.2005.00080.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; ZWEIG MH, 1993, CLIN CHEM, V39, P561	65	310	322	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2008	3	6							e2502	10.1371/journal.pone.0002502	http://dx.doi.org/10.1371/journal.pone.0002502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IK	18648541	Green Published, gold, Green Submitted			2022-12-27	WOS:000263288000024
J	Agger, EM; Rosenkrands, I; Hansen, J; Brahimi, K; Vandahl, BS; Aagaard, C; Werninghaus, K; Kirschning, C; Lang, R; Christensen, D; Theisen, M; Follmann, F; Andersen, P				Agger, Else Marie; Rosenkrands, Ida; Hansen, Jon; Brahimi, Karima; Vandahl, Brian S.; Aagaard, Claus; Werninghaus, Kerstin; Kirschning, Carsten; Lang, Roland; Christensen, Dennis; Theisen, Michael; Follmann, Frank; Andersen, Peter			Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN-1; TUBERCULOSIS SUBUNIT VACCINE; BACILLUS-CALMETTE-GUERIN; T-CELL EPITOPES; PROTECTIVE IMMUNITY; CORD FACTOR; IMMUNIZATION; RESPONSES; IMMUNOGENICITY	Background: It is now emerging that for vaccines against a range of diseases including influenza, malaria and HIV, the induction of a humoral response is insufficient and a substantial complementary cell-mediated immune response is necessary for adequate protection. Furthermore, for some diseases such as tuberculosis, a cellular response seems to be the sole effector mechanism required for protection. The development of new adjuvants capable of inducing highly complex immune responses with strong antigen-specific T-cell responses in addition to antibodies is therefore urgently needed. Methods and Findings: Herein, we describe a cationic adjuvant formulation (CAF01) consisting of DDA as a delivery vehicle and synthetic mycobacterial cordfactor as immunomodulator. CAF01 primes strong and complex immune responses and using ovalbumin as a model vaccine antigen in mice, antigen specific cell-mediated-and humoral responses were obtained at a level clearly above a range of currently used adjuvants (Aluminium, monophosphoryl lipid A, CFA/IFA, Montanide). This response occurs through Toll-like receptor 2, 3, 4 and 7-independent pathways whereas the response is partly reduced in MyD88-deficient mice. In three animal models of diseases with markedly different immunological requirement; Mycobacterium tuberculosis (cell-mediated), Chlamydia trachomatis (cell-mediated/humoral) and malaria (humoral) immunization with CAF01-based vaccines elicited significant protective immunity against challenge. Conclusion: CAF01 is potentially a suitable adjuvant for a wide range of diseases including targets requiring both CMI and humoral immune responses for protection.	[Agger, Else Marie; Rosenkrands, Ida; Hansen, Jon; Brahimi, Karima; Vandahl, Brian S.; Aagaard, Claus; Christensen, Dennis; Theisen, Michael; Follmann, Frank; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Werninghaus, Kerstin; Kirschning, Carsten; Lang, Roland] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-8000 Munich, Germany	Statens Serum Institut; Technical University of Munich	Agger, EM (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	eag@ssi.dk	Lang, Roland/C-3287-2011; Christensen, Dennis/C-6378-2008	Christensen, Dennis/0000-0003-2382-8639; Andersen, Peter/0000-0002-5869-2551; Lang, Roland/0000-0003-0502-3677; Hansen, Jon Ulf/0000-0002-6410-5755; Follmann, Frank/0000-0002-8373-7774	European Commission [LSHP-CT-2003-503367]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was in part funded by the European Commission contract no. LSHP-CT-2003-503367.	Agger EM, 2006, VACCINE, V24, P5452, DOI 10.1016/j.vaccine.2006.03.072; Ahlborg N, 2000, INFECT IMMUN, V68, P2102, DOI 10.1128/IAI.68.4.2102-2109.2000; Bennekov T, 2006, EUR J IMMUNOL, V36, P3346, DOI 10.1002/eji.200636128; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; da Fonseca DM, 2007, IMMUNOLOGY, V121, P508, DOI 10.1111/j.1365-2567.2007.02597.x; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dietrich J, 2007, J IMMUNOL, V178, P3721, DOI 10.4049/jimmunol.178.6.3721; Gabizon AA, 2001, CANCER INVEST, V19, P424, DOI 10.1081/CNV-100103136; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007; Gluck R, 2004, EXPERT OPIN BIOL TH, V4, P1139, DOI 10.1517/14712598.4.7.1139; Gramzinski RA, 2001, INFECT IMMUN, V69, P1643, DOI 10.1128/IAI.69.3.1643-1649.2001; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hansen J, 2008, J INFECT DIS, V198, P758, DOI 10.1086/590670; Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kamath AT, 2008, EUR J IMMUNOL, V38, P1247, DOI 10.1002/eji.200737889; Kazzaz J, 2006, J CONTROL RELEASE, V110, P566, DOI 10.1016/j.jconrel.2005.10.010; Kim SK, 2000, J IMMUNOL, V165, P7285, DOI 10.4049/jimmunol.165.12.7285; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; Lee EAM, 2002, INFECT IMMUN, V70, P1417, DOI 10.1128/IAI.70.3.1417-1421.2002; Lipford GB, 1997, EUR J IMMUNOL, V27, P3420, DOI 10.1002/eji.1830271242; MCMICHAEL AJ, 1981, CLIN EXP IMMUNOL, V43, P276; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Olsen AW, 2006, J INFECT DIS, V194, P1258, DOI 10.1086/508203; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Ortiz L, 2000, INFECT IMMUN, V68, P1719, DOI 10.1128/IAI.68.3.1719-1723.2000; Pal S, 1997, INFECT IMMUN, V65, P3361, DOI 10.1128/IAI.65.8.3361-3369.1997; Pal S, 2005, INFECT IMMUN, V73, P8153, DOI 10.1128/IAI.73.12.8153-8160.2005; PIMM MV, 1979, INT J CANCER, V24, P780, DOI 10.1002/ijc.2910240614; Rafati S, 2005, VACCINE, V23, P3716, DOI 10.1016/j.vaccine.2005.02.009; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; Rosenkrands I, 2005, INFECT IMMUN, V73, P5817, DOI 10.1128/IAI.73.9.5817-5826.2005; Schellack C, 2006, VACCINE, V24, P5461, DOI 10.1016/j.vaccine.2006.03.071; Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618; SU H, 1995, VACCINE, V13, P1023, DOI 10.1016/0264-410X(95)00017-U; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Suzuki Y, 2004, CANCER RES, V64, P8754, DOI 10.1158/0008-5472.CAN-04-1691; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; THEISEN M, 1994, INFECT IMMUN, V62, P3270, DOI 10.1128/IAI.62.8.3270-3275.1994; Tian JH, 1997, INFECT IMMUN, V65, P3032, DOI 10.1128/IAI.65.8.3032-3036.1997; Valmori D, 2007, P NATL ACAD SCI USA, V104, P8947, DOI 10.1073/pnas.0703395104; VANDISSEL JT, LANCET UNPUB; Vangala A, 2006, J PHARM PHARMACOL, V58, P787, DOI 10.1211/jpp.58.6.0009; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335	53	222	230	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3116	10.1371/journal.pone.0003116	http://dx.doi.org/10.1371/journal.pone.0003116			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776936	Green Submitted, Green Published, gold			2022-12-27	WOS:000264424300001
J	De La Fuente, IM; Martinez, L; Perez-Samartin, AL; Ormaetxea, L; Amezaga, C; Vera-Lopez, A				De La Fuente, Ildefonso M.; Martinez, Luis; Perez-Samartin, Alberto L.; Ormaetxea, Leire; Amezaga, Cristian; Vera-Lopez, Antonio			Global Self-Organization of the Cellular Metabolic Structure	PLOS ONE			English	Article							CITRIC-ACID CYCLE; AUTONOMOUS OSCILLATIONS; CIRCADIAN OSCILLATIONS; WAVELET ANALYSIS; COMPLEX; COMPARTMENTATION; DEHYDROGENASE; NETWORKS; DYNAMICS; CULTURES	Background: Over many years, it has been assumed that enzymes work either in an isolated way, or organized in small catalytic groups. Several studies performed using "metabolic networks models'' are helping to understand the degree of functional complexity that characterizes enzymatic dynamic systems. In a previous work, we used "dissipative metabolic networks'' (DMNs) to show that enzymes can present a self-organized global functional structure, in which several sets of enzymes are always in an active state, whereas the rest of molecular catalytic sets exhibit dynamics of on-off changing states. We suggested that this kind of global metabolic dynamics might be a genuine and universal functional configuration of the cellular metabolic structure, common to all living cells. Later, a different group has shown experimentally that this kind of functional structure does, indeed, exist in several microorganisms. Methodology/Principal Findings: Here we have analyzed around 2.500.000 different DMNs in order to investigate the underlying mechanism of this dynamic global configuration. The numerical analyses that we have performed show that this global configuration is an emergent property inherent to the cellular metabolic dynamics. Concretely, we have found that the existence of a high number of enzymatic subsystems belonging to the DMNs is the fundamental element for the spontaneous emergence of a functional reactive structure characterized by a metabolic core formed by several sets of enzymes always in an active state. Conclusions/Significance: This self-organized dynamic structure seems to be an intrinsic characteristic of metabolism, common to all living cellular organisms. To better understand cellular functionality, it will be crucial to structurally characterize these enzymatic self-organized global structures.	[De La Fuente, Ildefonso M.; Martinez, Luis; Ormaetxea, Leire; Vera-Lopez, Antonio] Univ Basque Country, Fac Ciencias & Tecnol, Dept Matemat, Vizcaya, Spain; [Perez-Samartin, Alberto L.; Amezaga, Cristian] Univ Basque Country, Fac Med, Dept Neuroci, Vizcaya, Spain	University of Basque Country; University of Basque Country	De La Fuente, IM (corresponding author), Univ Basque Country, Fac Ciencias & Tecnol, Dept Matemat, Vizcaya, Spain.	luis.martinez@ehu.es	Martínez, Luis/G-6266-2012; Vera-López, Antonio/P-3022-2016; Samartín, Alberto Pérez/AAB-1336-2019; Ormaetxea, Leyre/F-9669-2016; Samartín, Alberto Pérez/AAB-6428-2019	Martínez, Luis/0000-0002-6297-1449; Samartín, Alberto Pérez/0000-0003-0834-0424; De la Fuente, Ildefonso/0000-0001-6548-7583; Vera-Lopez, Antonio/0000-0002-0351-2701	Spanish Ministry of Science and Education [MTM2005-01504, MTM2004-04665]; FEDER; Basque Government [IT252-07]	Spanish Ministry of Science and Education(Spanish Government); FEDER(European Commission); Basque Government(Basque Government)	This work has been supported by the Spanish Ministry of Science and Education Grants MTM2005-01504, MTM2004-04665, partly with FEDER funds, and by the Basque Government, Grant IT252-07.	Ainscow EK, 2002, DIABETES, V51, pS162, DOI 10.2337/diabetes.51.2007.S162; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Allegrini P, 1998, PHYS REV E, V57, P4558, DOI 10.1103/PhysRevE.57.4558; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Audit B, 2004, J BIOL PHYS, V30, P33, DOI 10.1023/B:JOBP.0000016438.86794.8e; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARNES SJ, 1986, FEBS LETT, V201, P267, DOI 10.1016/0014-5793(86)80621-4; Battogtokh D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.148102; BEECKMANS S, 1981, EUR J BIOCHEM, V117, P527; Bernhardsson S, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026104; Chen F, 2007, J PHYS A-MATH THEOR, V40, P5013, DOI 10.1088/1751-8113/40/19/006; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; Das M, 2003, J NEUROPHYSIOL, V89, P833, DOI 10.1152/jn.00757.2002; De la Fuente IM, 2006, ANN BIOMED ENG, V34, P295, DOI 10.1007/s10439-005-9026-z; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; De la Fuente IM, 1999, BIOSYSTEMS, V50, P83, DOI 10.1016/S0303-2647(98)00094-X; DelaFuente IM, 1996, BIOSYSTEMS, V39, P87, DOI 10.1016/0303-2647(95)01603-1; delaFuente IM, 1996, BIOPHYS J, V71, P2375, DOI 10.1016/S0006-3495(96)79431-6; DELAFUENTE MI, 1996, ACTA BIOTHEOR, V46, P37; DROSSEL B, 2008, ANN REV NON IN PRESS, V1; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eke A, 2002, PHYSIOL MEAS, V23, pR1, DOI 10.1088/0967-3334/23/1/201; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A., 1996, BIOCH OSCILLATIONS C; Goldbeter A., 1990, RYTHMES CHAOS SYSTEM; Gonze D, 2004, INT J QUANTUM CHEM, V98, P228, DOI 10.1002/qua.10875; Grimaldi B, 2007, NATURE, V447, P386, DOI 10.1038/447386a; Haimovich AD, 2006, J COMPUT BIOL, V13, P1289, DOI 10.1089/cmb.2006.13.1289; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Heinrich R., 1996, REGULATION CELLULAR; Hess B, 1997, Q REV BIOPHYS, V30, P121, DOI 10.1017/S003358359700334X; Hideshima T, 2006, BIOPHYS CHEM, V124, P100, DOI 10.1016/j.bpc.2006.04.017; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jorgensen K, 2005, CURR OPIN PLANT BIOL, V8, P280, DOI 10.1016/j.pbi.2005.03.014; Jovanovic S, 2007, J MOL BIOL, V371, P349, DOI 10.1016/j.jmb.2007.05.081; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Kapur N, 2007, AM J PHYSIOL-CELL PH, V292, pC1510, DOI 10.1152/ajpcell.00181.2006; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; Kazachenko VN, 2007, BIOCHEM MOSC SUPPL S, V1, P169, DOI 10.1134/S1990747807020109; KHOLODENKO BN, 1992, EUR J BIOCHEM, V210, P147, DOI 10.1111/j.1432-1033.1992.tb17402.x; Kim DH, 2005, PHYSICA A, V351, P671, DOI 10.1016/j.physa.2004.12.026; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; KURGANOV BI, 1993, TRENDS BIOCHEM SCI, V18, P405, DOI 10.1016/0968-0004(93)90133-8; KWANG G, 2002, P NATL ACAD SCI USA, V99, P12583; LELOUP JC, 2005, COMPUTATIONAL SYSTEM; Long MS, 2005, P NATL ACAD SCI USA, V102, P5920, DOI 10.1073/pnas.0409333102; Lunn JE, 2007, J EXP BOT, V58, P35, DOI 10.1093/jxb/erl134; Lyubarev AE, 1997, BIOSYSTEMS, V42, P103, DOI 10.1016/S0303-2647(96)01698-X; Ma HW, 2004, BIOINFORMATICS, V20, P1870, DOI 10.1093/bioinformatics/bth167; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Mair T, 2006, BIOSYSTEMS, V83, P188, DOI 10.1016/j.biosystems.2005.05.016; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; MOWBRAY J, 1976, EUR J BIOCHEM, V66, P25, DOI 10.1111/j.1432-1033.1976.tb10421.x; Nelson L. D., 2004, LEHNINGER PRINCIPLES; Newman MEJ, 2000, J STAT PHYS, V101, P819, DOI 10.1023/A:1026485807148; Nicolis G, 1977, SELF ORG NONEQUILIBR; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P83, DOI 10.1023/B:MCBI.0000009860.86969.72; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Ovadi J, 2000, INT REV CYTOL, V192, P255; PORPACZY Z, 1987, J BIOL CHEM, V262, P9509; Raman K, 2005, PLOS COMPUT BIOL, V1, P349, DOI 10.1371/journal.pcbi.0010046; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; RAPP PE, 1987, PROG NEUROBIOL, V29, P261, DOI 10.1016/0301-0082(87)90023-2; RAPP PE, 1979, J EXP BIOL, V81, P281; Reddy VN, 1996, COMPUT BIOL MED, V26, P9, DOI 10.1016/0010-4825(95)00042-9; Reisig W., 1985, PETRI NETS INTRO, V4, DOI 10.1007/978-3-642-69968-9; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351; SRERE PA, 1997, CHANNELING INTERMEDI; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Tsumoto K, 2006, J THEOR BIOL, V239, P101, DOI 10.1016/j.jtbi.2005.07.017; TU TB, 2006, NATURE REV MOL CELL, V7, P696; Viswanathan GM, 1997, BIOPHYS J, V72, P866, DOI 10.1016/S0006-3495(97)78721-6; WALTER H, 1999, MICROCOMPARTMENTATIO, V192; Winfree AT., 1980, GEOMETRY BIOL TIME; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; Zevedei-Oancea Ionela, 2003, In Silico Biology, V3, P323	83	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3100	10.1371/journal.pone.0003100	http://dx.doi.org/10.1371/journal.pone.0003100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769681	gold, Green Published			2022-12-27	WOS:000264796800007
J	Conte, C; Riant, E; Toutain, C; Pujol, F; Arnal, JF; Lenfant, F; Prats, AC				Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine			FGF2 Translationally Induced by Hypoxia Is Involved in Negative and Positive Feedback Loops with HIF-1 alpha	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; INTERNAL RIBOSOME ENTRY; MESSENGER-RNA TRANSLATION; SKELETAL-MUSCLE; GENE-EXPRESSION; CELL STRESS; IRES; SITE; INDUCTION; APOPTOSIS	Background: Fibroblast growth factor 2 (FGF2) is a major angiogenic factor involved in angiogenesis and arteriogenesis, however the regulation of its expression during these processes is poorly documented. FGF2 mRNA contains an internal ribosome entry site (IRES), a translational regulator expected to allow mRNA expression during cellular stress. Methodology/Principal Findings: In the present study, we have developed a skin ischemia model in transgenic mice expressing a reporter transgene under the control of the FGF2 IRES. The results reveal that FGF2 is induced at the protein level during ischemia, concomitant with HIF-1 alpha induction and a decrease in FGF2 mRNA. In addition, the FGF2 IRES is strongly activated under these ischemic conditions associated with hypoxia, whereas cap-dependent translation is repressed by 4E-BP hypophosphorylation. We also show that up-regulation of FGF2 protein expression in response to hypoxia correlates with the increase of FGF2 IRES activity in vitro, in human retinoblasts 911. The use of siRNAs targeting HIF or FGF2 indicates that FGF2 and HIF-1 alpha reciprocally regulate their expression/accumulation, by a negative feedback loop in early hypoxia, followed by a positive feedback loop in late hypoxia. Conclusion/Significance: FGF2 expression is up-regulated in vivo and in vitro in response to hypoxia. Strikingly, this up-regulation is not transcriptional. It seems to occur by an IRES-dependent mechanism, revealing new mechanistic aspects of the hypoxic response. In addition, our data show that FGF2 interacts with HIF-1 alpha in a unique crosstalk, with distinct stages in early and late hypoxia. These data reveal the physiological importance of IRES-dependent translation during hypoxic stress and underline the complexity of the cellular response to hypoxia, suggesting a novel role of FGF2 in the regulation of HIF-1 alpha during the induction of angiogenesis.	[Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine] Fac Med Toulouse, INSERM, U858, Toulouse, France; [Conte, Caroline; Riant, Elodie; Toutain, Celine; Pujol, Francoise; Arnal, Jean-Francois; Lenfant, Francoise; Prats, Anne-Catherine] Univ Toulouse 3, Inst Med Mol Rangueil, IFR31, F-31062 Toulouse, France; [Arnal, Jean-Francois] Ctr Hosp Univ Toulouse, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Conte, C (corresponding author), Fac Med Toulouse, INSERM, U858, Toulouse, France.	Anne-Catherine.Prats@inserm.fr	CONTE, Caroline/F-1445-2010; Prats, Anne-Catherine/E-5051-2016	CONTE, Caroline/0000-0001-6982-0478; Prats, Anne-Catherine/0000-0002-5282-3776; LENFANT, Francoise/0000-0003-0024-7241; ARNAL, Jean Francois/0000-0003-2229-6300	Agence Nationale pour la Recherche; Association Francaise contre les Myopathies; Association pour la Recherche sur le Cancer; Canceropole Grand Sud-Ouest; Conseil Regional Midi-Pyrenees; Fondation de l'Avenir; Ligue Contre le Cancer	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Canceropole Grand Sud-Ouest; Conseil Regional Midi-Pyrenees(Region Pays de la LoireRegion OccitanieRegion Ile-de-France); Fondation de l'Avenir; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from the Agence Nationale pour la Recherche, Association Francaise contre les Myopathies, Association pour la Recherche sur le Cancer, Canceropole Grand Sud-Ouest, Conseil Regional Midi-Pyrenees, Fondation de l'Avenir, Ligue Contre le Cancer.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Arnaud E, 1999, MOL CELL BIOL, V19, P505; BIKFALVI A, 1995, J CELL BIOL, V129, P233, DOI 10.1083/jcb.129.1.233; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Black SM, 2008, AM J PHYSIOL-CELL PH, V294, pC345, DOI 10.1152/ajpcell.00216.2007; Bornes S, 2007, CIRC RES, V100, P305, DOI 10.1161/01.RES.0000258873.08041.c9; Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; COUDERC B, 1991, CELL REGUL, V2, P709, DOI 10.1091/mbc.2.9.709; Creancier L, 2000, J CELL BIOL, V150, P275, DOI 10.1083/jcb.150.1.275; Delluc-Clavieres A, 2008, GENE THER, V15, P1090, DOI 10.1038/gt.2008.49; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; Garmy-Susini B, 2004, CIRC RES, V94, P1301, DOI 10.1161/01.RES.0000127719.13255.81; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gonzalez-Herrera IG, 2006, BIOCHEM SOC T, V34, P17, DOI 10.1042/BST0340017; Gonzalez-Herrera IG, 2006, FASEB J, V20, P476, DOI 10.1096/fj.04-3314fje; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; Holcik M, 2005, RNA, V11, P1605, DOI 10.1261/rna.2158605; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Javerzat S, 2002, TRENDS MOL MED, V8, P483, DOI 10.1016/S1471-4914(02)02394-8; Junemann C, 2007, J BIOL CHEM, V282, P132, DOI 10.1074/jbc.M608750200; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Lewis SM, 2005, CELL DEATH DIFFER, V12, P547, DOI 10.1038/sj.cdd.4401602; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prats AC, 2002, PROG NUCLEIC ACID RE, V72, P367, DOI 10.1016/S0079-6603(02)72075-8; PRATS H, 1989, P NATL ACAD SCI USA, V86, P1836, DOI 10.1073/pnas.86.6.1836; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Sorensen V, 2006, BIOESSAYS, V28, P504, DOI 10.1002/bies.20405; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Teshima-Kondo S, 2004, FASEB J, V18, P1583, DOI 10.1096/fj.03-1118fje; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; Touriol C, 1999, J BIOL CHEM, V274, P21402, DOI 10.1074/jbc.274.30.21402; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; VAGNER S, 1995, MOL CELL BIOL, V15, P35, DOI 10.1128/MCB.15.1.35; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208	42	58	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3078	10.1371/journal.pone.0003078	http://dx.doi.org/10.1371/journal.pone.0003078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728783	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796400018
J	Reed, LK; LaFlamme, BA; Markow, TA				Reed, Laura K.; LaFlamme, Brooke A.; Markow, Therese A.			Genetic Architecture of Hybrid Male Sterility in Drosophila: Analysis of Intraspecies Variation for Interspecies Isolation	PLOS ONE			English	Article							SHOWING SEGREGATION DISTORTION; MOLECULAR POPULATION-GENETICS; BEETLE TRIBOLIUM-CASTANEUM; MAXIMUM-LIKELIHOOD MODELS; REPRODUCTIVE ISOLATION; SPECIATION; MOJAVENSIS; SEX; DIFFERENTIATION; INCOMPATIBILITY	Background: The genetic basis of postzygotic isolation is a central puzzle in evolutionary biology. Evolutionary forces causing hybrid sterility or inviability act on the responsible genes while they still are polymorphic, thus we have to study these traits as they arise, before isolation is complete. Methodology/Principal Findings: Isofemale strains of D. mojavensis vary significantly in their production of sterile F-1 sons when females are crossed to D. arizonae males. We took advantage of the intraspecific polymorphism, in a novel design, to perform quantitative trait locus (QTL) mapping analyses directly on F-1 hybrid male sterility itself. We found that the genetic architecture of the polymorphism for hybrid male sterility (HMS) in the F-1 is complex, involving multiple QTL, epistasis, and cytoplasmic effects. Conclusions/Significance: The role of extensive intraspecific polymorphism, multiple QTL, and epistatic interactions in HMS in this young species pair shows that HMS is arising as a complex trait in this system. Directional selection alone would be unlikely to maintain polymorphism at multiple loci, thus we hypothesize that directional selection is unlikely to be the only evolutionary force influencing postzygotic isolation.	[Reed, Laura K.; LaFlamme, Brooke A.; Markow, Therese A.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; [Reed, Laura K.] North Carolina State Univ, Dept Genet, Raleigh, NC USA; [LaFlamme, Brooke A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Markow, Therese A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Arizona; University of North Carolina; North Carolina State University; Cornell University; University of California System; University of California San Diego	Reed, LK (corresponding author), Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA.	lkreed@ncsu.edu		LaFlamme, Brooke/0000-0003-3010-4209	National Science Foundation [DBI-9602249, DGE-0114420]; University of Arizona [DEB 0414184, DEB 95-10645, DEB 0075312]	National Science Foundation(National Science Foundation (NSF)); University of Arizona	National Science Foundation support for this work was provided by Interdisciplinary Research Training Group on Plant-Insect Interactions (DBI-9602249) to the University of Arizona and the Integrative Graduate Education and Research Training Grant in Evolutionary, Computational, and Molecular Approaches to Genome Structure and Function (DGE-0114420) to the University of Arizona, Doctoral Dissertation Improvement Grant (DEB 0414184) to LKR, and grants (DEB 95-10645 and DEB 0075312) to TAM. In addition, the Undergraduate Biological Research Program (UBRP) at the University of Arizona supported BAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1994, NAT GENET, V6, P119, DOI 10.1038/ng0294-119; AYALA FJ, 1974, EVOLUTION, V28, P24, DOI 10.1111/j.1558-5646.1974.tb00723.x; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Barbash DA, 2003, GENETICS, V163, P217; BASTEN CJ, 2002, QTL CARTOGRAPHER; BASTEN CJ, 1994, P 5 WORLD C GEN APPL, P65; Bateson W., 1909, DOI 10.1017/CBO9780511693953.007; BEAVIS WD, 1994, 49 ANN CORN SORGH RE, P252; Begun DJ, 2000, GENETICS, V156, P1879; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Carvajal AR, 1996, GENETICA, V98, P1, DOI 10.1007/BF00120214; CHRISTIE P, 1984, J HERED, V75, P510, DOI 10.1093/oxfordjournals.jhered.a110004; CHURCHILL GA, 1994, GENETICS, V138, P963; Coyne J.A., 2004, SPECIATION; Coyne JA, 2000, EVOLUTION, V54, P306, DOI 10.1111/j.0014-3820.2000.tb00033.x; COYNE JA, 1989, EVOLUTION, V43, P362, DOI [10.2307/2409213, 10.1111/j.1558-5646.1989.tb04233.x]; Coyne JA, 1997, EVOLUTION, V51, P295, DOI [10.1111/j.1558-5646.1997.tb02412.x, 10.2307/2410984]; Crow J. F., 1942, University of Texas Publications, Vno. 4228, P53; Demuth JP, 2007, EVOLUTION, V61, P494, DOI 10.1111/j.1558-5646.2007.00048.x; Demuth JP, 2007, EVOLUTION, V61, P694, DOI 10.1111/j.1558-5646.2007.00049.x; Demuth JP, 2005, AM NAT, V165, P524, DOI 10.1086/429276; Dobzhansky T., 1937; Falconer D. S., 1996, INTRO QUANTITATIVE G; FISHER RA, 1949, HEREDITY, V3, P215, DOI 10.1038/hdy.1949.13; Gasper J, 2006, AM J HUM GENET, V79, P820, DOI 10.1086/508473; Good JM, 2008, EVOLUTION, V62, P50, DOI 10.1111/j.1558-5646.2007.00257.x; Goodnight CJ, 2000, EVOLUTION, V54, P317, DOI 10.1111/j.0014-3820.2000.tb00034.x; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hamm D, 2007, AM J HUM GENET, V81, P44, DOI 10.1086/518695; Hollingshead L, 1930, GENETICS, V15, P114; Hutchinson JB, 1932, J GENET, V25, P281, DOI 10.1007/BF02984592; Huxley J, 1940, NEW SYSTEMATICS, P185; Kazianis S, 1998, GENE CHROMOSOME CANC, V22, P210, DOI 10.1002/(SICI)1098-2264(199807)22:3<210::AID-GCC6>3.0.CO;2-Z; KIMURA M, 1969, GENETICS, V61, P763; KIMURA M T, 1987, Kontyu, V55, P429; Kopp A, 2005, GENETICA, V125, P55, DOI 10.1007/s10709-005-4787-8; LANDER E, 1987, CYTOGENET CELL GENET, V46, P642; Levitan DR, 2006, SCIENCE, V312, P267, DOI 10.1126/science.1122183; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; Lynch M., 1998, GENETICS ANAL QUANTI; Macknight RH, 1939, GENETICS, V24, P180; Mainland G. B., 1942, University of Texas Publications, Vno. 4228, P74; Markow TA, 1998, ENDLESS FORMS, P234; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Masly JP, 2006, SCIENCE, V313, P1448, DOI 10.1126/science.1128721; Matzkin LM, 2004, MOL BIOL EVOL, V21, P276, DOI 10.1093/molbev/msh019; Mayr E, 1942, SYSTEMATICS ORIGIN S; MCLEAN RA, 1991, AM STAT, V45, P54, DOI 10.2307/2685241; Moehring AJ, 2004, GENETICS, V167, P1249, DOI 10.1534/genetics.103.024372; Morgan TJ, 2006, HEREDITY, V96, P232, DOI 10.1038/sj.hdy.6800786; Muller HJ, 1942, BIOL S, V6, P71; Nairn RS, 1996, P NATL ACAD SCI USA, V93, P13042, DOI 10.1073/pnas.93.23.13042; Nolte V, 2008, J EVOLUTION BIOL, V21, P551, DOI 10.1111/j.1420-9101.2007.01486.x; Orr HA, 2000, BIOESSAYS, V22, P1085, DOI 10.1002/1521-1878(200012)22:12&lt;1085::AID-BIES6&gt;3.0.CO;2-G; Orr HA, 2005, GENETICS, V169, P671, DOI 10.1534/genetics.104.033274; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, GENETICS, V158, P1089; PANTAZIDIS AC, 1988, HEREDITY, V60, P299, DOI 10.1038/hdy.1988.46; Patterson J. T., 1952, EVOLUTION GENUS DROS; Pontecorvo G, 1943, J GENET, V45, P51, DOI 10.1007/BF02982774; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Reed LK, 2007, MOL ECOL, V16, P1007, DOI 10.1111/j.1365-294X.2006.02941.x; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Ross CL, 2006, J EVOLUTION BIOL, V19, P1691, DOI 10.1111/j.1420-9101.2006.01111.x; Ross CL, 2003, MOL BIOL EVOL, V20, P1143, DOI 10.1093/molbev/msg137; RUIZ A, 1990, J HERED, V81, P30, DOI 10.1093/oxfordjournals.jhered.a110922; Schartl M, 1999, GENETICS, V153, P1385; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; Staten R, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-12; STEPHENS SG, 1950, J GENET, V50, P9, DOI 10.1007/BF02986790; Sweigart AL, 2006, GENETICS, V172, P2465, DOI 10.1534/genetics.105.053686; Sweigart AL, 2007, EVOLUTION, V61, P141, DOI 10.1111/j.1558-5646.2007.00011.x; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; TURELLI M, 1995, GENETICS, V140, P389; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; VIGNEAULT G, 1986, EVOLUTION, V40, P1160, DOI 10.1111/j.1558-5646.1986.tb05741.x; Wade MJ, 1997, GENETICS, V147, P1235; WADE MJ, 1994, HEREDITY, V72, P155, DOI 10.1038/hdy.1994.22; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; WU CI, 1992, EVOLUTION, V46, P1584, DOI 10.1111/j.1558-5646.1992.tb01152.x; Xu SZ, 2003, GENETICS, V163, P789; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zouros E., 1991, Molecular techniques in taxonomy., P233; ZOUROS E, 1988, EVOLUTION, V42, P1321, DOI 10.1111/j.1558-5646.1988.tb04191.x; ZOUROS E, 1981, DROS INFORM SERV, V56, P167	88	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3076	10.1371/journal.pone.0003076	http://dx.doi.org/10.1371/journal.pone.0003076			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728782	Green Published, gold			2022-12-27	WOS:000264796400016
J	Cuevas, JM; Torres-Puente, M; Jimenez-Hernandez, N; Bracho, MA; Garcia-Robles, I; Wrobel, B; Carnicer, F; del Olmo, J; Ortega, E; Moya, A; Gonzalez-Candelas, F				Cuevas, Jose Manuel; Torres-Puente, Manuela; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Garcia-Robles, Inmaculada; Wrobel, Boris; Carnicer, Fernando; del Olmo, Juan; Ortega, Enrique; Moya, Andres; Gonzalez-Candelas, Fernando			Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus Ribavirin	PLOS ONE			English	Article							SENSITIVITY-DETERMINING REGION; PKR PROTEIN-KINASE; HYPERVARIABLE REGION; NS5A PROTEIN; INITIAL TREATMENT; E2 GLYCOPROTEIN; NON-A; ENVELOPE; SEQUENCE; 1B	We present an analysis of the selective forces acting on two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral therapy. One includes the three hypervariable regions in the envelope E2 glycoprotein, and the other encompasses the PKR binding domain and the V3 domain in the NS5A region. We used a cohort of 22 non-responder patients to combined therapy (interferon alpha-2a plus ribavirin) for which samples were obtained before initiation of therapy and after 6 or/and 12 months of treatment. A range of 25-100 clones per patient, genome region and time sample were sequenced. These were used to detect general patterns of adaptation, to identify particular adaptation mechanisms and to analyze the patterns of evolutionary change in both genome regions. These analyses failed to detect a common adaptive mechanism for the lack of response to antiviral treatment in these patients. On the contrary, a wide range of situations were observed, from patients showing no positively selected sites to others with many, and with completely different topologies in the reconstructed phylogenetic trees. Altogether, these results suggest that viral strategies to evade selection pressure from the immune system and antiviral therapies do not result from a single mechanism and they are likely based on a range of different alternatives, in which several different changes, or their combination, along the HCV genome confer viruses the ability to overcome strong selective pressures.	[Cuevas, Jose Manuel; Torres-Puente, Manuela; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Garcia-Robles, Inmaculada; Wrobel, Boris; Moya, Andres; Gonzalez-Candelas, Fernando] Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain; [Cuevas, Jose Manuel; Jimenez-Hernandez, Nuria; Bracho, Maria Alma; Moya, Andres; Gonzalez-Candelas, Fernando] CIBERESP, Barcelona, Spain; [Carnicer, Fernando] Hosp Gen Alicante, Unidad de Hepatol, Alicante, Spain; [del Olmo, Juan] Hosp Clin Valencia, Serv Hepatol, Valencia, Spain; [Ortega, Enrique] Hosp Gen Valencia, Unidad Enfermedades Infecciosas, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; General University Hospital of Alicante	Cuevas, JM (corresponding author), Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia, Spain.	fernando.gonzalez@uv.es	Torres-Puente, Manuela/P-1791-2016; Candelas, Fernando Gonzalez/G-5681-2010; Moya, Andrés/A-8190-2008; Garcia-Robles, Inmaculada/J-7515-2012; Bracho, Maria/K-6018-2014; Cuevas, Jose M/C-6271-2016; Hernández, Nuria Jiménez/H-1982-2015; Wrobel, Borys/F-3471-2013; Garcia-Robles, Inmaculada/N-1599-2019	Torres-Puente, Manuela/0000-0002-8352-180X; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Moya, Andrés/0000-0002-2867-1119; Garcia-Robles, Inmaculada/0000-0002-0165-399X; Bracho, Maria/0000-0002-9204-5526; Cuevas, Jose M/0000-0003-2049-3554; Hernández, Nuria Jiménez/0000-0002-9107-056X; Wrobel, Borys/0000-0002-4759-725X; Garcia-Robles, Inmaculada/0000-0002-0165-399X	Conselleria de Sanitat i Consum; Generalitat Valenciana (Spain); Ministerio de Educacion y Ciencia, Spain [BFU2005-00503]	Conselleria de Sanitat i Consum; Generalitat Valenciana (Spain)(Center for Forestry Research & Experimentation (CIEF)); Ministerio de Educacion y Ciencia, Spain(Spanish Government)	This work was supported by the Conselleria de Sanitat i Consum, Generalitat Valenciana (Spain) and project BFU2005-00503 from Ministerio de Educacion y Ciencia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bracho MA, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-13; Alter HJ, 2000, SEMIN LIVER DIS, V20, P17, DOI 10.1055/s-2000-9505; Chambers TJ, 2005, J VIROL, V79, P3071, DOI 10.1128/JVI.79.5.3071-3083.2005; Chang KM, 1997, J CLIN INVEST, V100, P2376, DOI 10.1172/JCI119778; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Chayama K, 1997, HEPATOLOGY, V25, P745, DOI 10.1002/hep.510250342; Chevaliez S, 2007, J VIROL, V81, P7732, DOI 10.1128/JVI.00382-07; Ciccaglione AR, 1998, VIRUS RES, V55, P157, DOI 10.1016/S0168-1702(98)00041-0; Cocquerel L, 1999, J VIROL, V73, P2641, DOI 10.1128/JVI.73.4.2641-2649.1999; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2008, J VIRAL HEPATITIS, V15, P578, DOI 10.1111/j.1365-2893.2008.00991.x; Cuevas JM, 2002, GENETICS, V162, P533; Curran R, 2002, J GEN VIROL, V83, P11, DOI 10.1099/0022-1317-83-1-11; Dubuisson J, 2000, CURR TOP MICROBIOL, V242, P135; DURANTE ME, 2003, J MED VIROL, V70, P62; Duverlie G, 1998, J GEN VIROL, V79, P1373, DOI 10.1099/0022-1317-79-6-1373; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Farci P, 2000, SEMIN LIVER DIS, V20, P103; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2002, P NATL ACAD SCI USA, V99, P3081, DOI 10.1073/pnas.052712599; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; Flint M, 1999, J VIROL, V73, P6235, DOI 10.1128/JVI.73.8.6235-6244.1999; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gale MJ, 1998, CLIN DIAGN VIROL, V10, P157; Gale MJ, 1997, VIROLOGY, V230, P217, DOI 10.1006/viro.1997.8493; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Herion D, 1997, HEPATOLOGY, V25, P769, DOI 10.1002/hep.510250346; Hofmann WP, 2007, GASTROENTEROLOGY, V132, P921, DOI 10.1053/j.gastro.2006.12.005; INCHAUSPE G, 1991, P NATL ACAD SCI USA, V88, P10292, DOI 10.1073/pnas.88.22.10292; Jimenez-Hernandez N, 2007, J GEN VIROL, V88, P123, DOI 10.1099/vir.0.82277-0; KATO N, 1993, J VIROL, V67, P3923, DOI 10.1128/JVI.67.7.3923-3930.1993; KATO N, 1992, VIRUS RES, V22, P107, DOI 10.1016/0168-1702(92)90038-B; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lau JYN, 2002, HEPATOLOGY, V35, P1002, DOI 10.1053/jhep.2002.32672; Layden-Almer JE, 2005, J INFECT DIS, V192, P1078, DOI 10.1086/432760; Lee JW, 1999, J VIROL, V73, P11, DOI 10.1128/JVI.73.1.11-18.1999; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Liu WL, 2007, J INFECT DIS, V196, P425, DOI 10.1086/518894; Lusida MI, 2001, J CLIN MICROBIOL, V39, P3858, DOI 10.1128/JCM.39.11.3858-3864.2001; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Manzin A, 1998, J VIROL, V72, P6271, DOI 10.1128/JVI.72.7.6271-6276.1998; Mondelli MU, 2001, ANTIVIR RES, V52, P153, DOI 10.1016/S0166-3542(01)00180-2; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Nousbaum JB, 2000, J VIROL, V74, P9028, DOI 10.1128/JVI.74.19.9028-9038.2000; OKAMOTO H, 1992, VIROLOGY, V188, P331, DOI 10.1016/0042-6822(92)90762-E; Pascu M, 2004, GUT, V53, P1345, DOI 10.1136/gut.2003.031336; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Penin F, 2001, J VIROL, V75, P5703, DOI 10.1128/JVI.75.12.5703-5710.2001; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Puig-Basagoiti F, 2005, J GEN VIROL, V86, P1067, DOI 10.1099/vir.0.80526-0; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; TANIGUCHI S, 1993, VIROLOGY, V195, P297, DOI 10.1006/viro.1993.1378; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres-Puente M, 2008, J VIRAL HEPATITIS, V15, P188, DOI 10.1111/j.1365-2893.2007.00929.x; Torres-Puente M, 2008, INFECT GENET EVOL, V8, P74, DOI 10.1016/j.meegid.2007.10.005; Torres-Puente M, 2008, J MED VIROL, V80, P247, DOI 10.1002/jmv.21060; Troesch M, 2006, VIROLOGY, V352, P357, DOI 10.1016/j.virol.2006.05.015; WEINER AJ, 1991, VIROLOGY, V180, P842, DOI 10.1016/0042-6822(91)90104-J; WEINER AJ, 1992, P NATL ACAD SCI USA, V89, P3468, DOI 10.1073/pnas.89.8.3468; Yagnik AT, 2000, PROTEINS, V40, P355, DOI 10.1002/1097-0134(20000815)40:3<355::AID-PROT20>3.0.CO;2-K; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Young KC, 2003, HEPATOLOGY, V38, P869, DOI 10.1053/jhep.2003.50445; Zeuzem S, 2004, J HEPATOL, V40, P993, DOI [10.1016/S0168-8278(04)00060-1, 10.1016/j.jhep.2004.02.007]	75	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3058	10.1371/journal.pone.0003058	http://dx.doi.org/10.1371/journal.pone.0003058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725975	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796300004
J	Ferreira, JMS; Drumond, BP; Guedes, MIMC; Pascoal-Xavier, MA; Almeida-Leite, CM; Arantes, RME; Mota, BEF; Abrahao, JS; Alves, PA; Oliveira, FM; Ferreira, PCP; Bonjardim, CA; Lobato, ZIP; Kroon, EG				Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Portela Lobato, Zelia Ines; Kroon, Erna Geessien			Virulence in Murine Model Shows the Existence of Two Distinct Populations of Brazilian Vaccinia virus Strains	PLOS ONE			English	Article								Brazilian Vaccinia virus had been isolated from sentinel mice, rodents and recently from humans, cows and calves during outbreaks on dairy farms in several rural areas in Brazil, leading to high economic and social impact. Some phylogenetic studies have demonstrated the existence of two different populations of Brazilian Vaccinia virus strains circulating in nature, but little is known about their biological characteristics. Therefore, our goal was to study the virulence pattern of seven Brazilian Vaccinia virus strains. Infected BALB/c mice were monitored for morbidity, mortality and viral replication in organs as trachea, lungs, heart, kidneys, liver, brain and spleen. Based on the virulence potential, the Brazilian Vaccinia virus strains were grouped into two groups. One group contained GP1V, VBH, SAV and BAV which caused disease and death in infected mice and the second one included ARAV, GP2V and PSTV which did not cause any clinical signals or death in infected BALB/c mice. The subdivision of Brazilian Vaccinia virus strains into two groups is in agreement with previous genetic studies. Those data reinforce the existence of different populations circulating in Brazil regarding the genetic and virulence characteristics.	[Siqueira Ferreira, Jaqueline Maria; Drumond, Betania Paiva; Maldonado Coelho Guedes, Maria Isabel; Pascoal-Xavier, Marcelo Antonio; Fernandes Mota, Bruno Eduardo; Abrahao, Jonatas Santos; Alves, Pedro Augusto; Oliveira, Fernando Meireles; Peregrino Ferreira, Paulo Cesar; Bonjardim, Claudio Antonio; Kroon, Erna Geessien] Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Portela Lobato, Zelia Ines] Univ Fed Minas Gerais, Escola Vet, Dept Med Vet Prevent, Virus Lab, Belo Horizonte, MG, Brazil; [Almeida-Leite, Camila Megale; Esteves Arantes, Rosa Maria] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Lab Neuro Imuno Patol Expt, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Ferreira, JMS (corresponding author), Univ Fed Minas Gerais, Virus Lab, Dept Microbiol, Inst Ciencias Biol, Ave Antonio Carlos, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg	Alves, Pedro/T-7203-2019; Kroon, Erna/V-5444-2019; Abrahão, Jônatas/B-3895-2015; Arantes, Rosa ME/C-5749-2013; Ferreira, Jaqueline Maria Siqueira/E-4630-2018; Kroon, Erna Geessien/B-3631-2015; Bonjardim, Claudio A/J-2601-2014; brasileira, Inct Pecuaria/J-9542-2013	Alves, Pedro/0000-0002-9659-5621; Abrahão, Jônatas/0000-0001-9420-1791; Arantes, Rosa ME/0000-0003-1428-9717; Ferreira, Jaqueline Maria Siqueira/0000-0002-1779-1975; Kroon, Erna Geessien/0000-0003-2721-3826; Mota, Bruno/0000-0003-0348-4875; Lobato, Zelia/0000-0002-9399-3691	CNPq [fellowship]; CAPES [fellowship]; FAPEMIG; PCPF [fellowship]; CAB [fellowship]; ZILP [fellowship]; RMEA [fellowship]; EGK [fellowship]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PCPF; CAB; ZILP; RMEA; EGK	Sources of support was provided by CNPq, CAPES and FAPEMIG. J. M. S. Ferreira received fellowship from CAPES and PCPF, CAB, ZILP, RMEA and EGK are CNPq fellows.	Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012; ANDREW ME, 1989, IMMUNOL CELL BIOL, V67, P331, DOI 10.1038/icb.1989.48; Baxby D, 1981, J Hist Med Allied Sci, V36, P218; Brandt TA, 2001, J VIROL, V75, P850, DOI 10.1128/JVI.75.2.850-856.2001; Bray M, 2000, J INFECT DIS, V181, P10, DOI 10.1086/315190; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; BRIODY BA, 1959, BACTERIOL REV, V23, P61, DOI 10.1128/MMBR.23.2.61-95.1959; BULLER RML, 1985, CURR TOP MICROBIOL, V122, P148; CAMPOS MAD, 1993, REV MICROBIOL, V24, P104; da Fonseca FG, 2000, J VIROL, V74, P7508, DOI 10.1128/JVI.74.16.7508-7517.2000; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; DAMON IK, 2007, FIELDS VIROLOGY, P2947; Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005; FENNER R, 1988, SMALLPOX ITS ERADICA; Ferrier-Rembert A, 2007, VACCINE, V25, P4809, DOI 10.1016/j.vaccine.2007.04.011; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; Hayasaka D, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-22; Jacobs N, 2006, J GEN VIROL, V87, P1157, DOI 10.1099/vir.0.81556-0; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Karem KL, 2005, CLIN DIAGN LAB IMMUN, V12, P867, DOI 10.1128/CDLI.12.7.867-872.2005; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9; Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; MAIBORODA AD, 1982, ACTA VIROL, V26, P288; Morikawa S, 2005, J VIROL, V79, P11873, DOI 10.1128/JVI.79.18.11873-11891.2005; Nagasse-Sugahara Teresa Keico, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P315, DOI 10.1590/S0036-46652004000600004; Pahlitzsch R, 2006, CLIN INFECT DIS, V43, P737, DOI 10.1086/506937; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; SARKAR JK, 1973, B WORLD HEALTH ORGAN, V48, P523; SEHGAL C L, 1977, Journal of Communicable Diseases, V9, P171; Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GDS, 2007, J CLIN MICROBIOL, V45, P1370, DOI 10.1128/JCM.00920-06; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486; Trindade GS, 2004, J GEN VIROL, V85, P2015, DOI 10.1099/vir.0.79840-0; Tscharke DC, 2002, J GEN VIROL, V83, P1977, DOI 10.1099/0022-1317-83-8-1977; Turner G S, 1967, J Gen Virol, V1, P399, DOI 10.1099/0022-1317-1-3-399; UEDA Y, 1978, J GEN VIROL, V40, P263, DOI 10.1099/0022-1317-40-2-263	42	35	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3043	10.1371/journal.pone.0003043	http://dx.doi.org/10.1371/journal.pone.0003043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725979	Green Published, gold			2022-12-27	WOS:000264796300001
J	Nahm, ML; Pieper, CF; Cunningham, MM				Nahm, Meredith L.; Pieper, Carl F.; Cunningham, Maureen M.			Quantifying Data Quality for Clinical Trials Using Electronic Data Capture	PLOS ONE			English	Article							DATA-PROCESSING SYSTEM; DOUBLE DATA-ENTRY; FACE-TO-FACE; MYOCARDIAL-INFARCTION; IMPROVES QUALITY; CANCER REGISTRY; DATA MANAGEMENT; BIRTH REGISTRY; DRUG-USE; ACCURACY	Background: Historically, only partial assessments of data quality have been performed in clinical trials, for which the most common method of measuring database error rates has been to compare the case report form (CRF) to database entries and count discrepancies. Importantly, errors arising from medical record abstraction and transcription are rarely evaluated as part of such quality assessments. Electronic Data Capture (EDC) technology has had a further impact, as paper CRFs typically leveraged for quality measurement are not used in EDC processes. Methods and Principal Findings: The National Institute on Drug Abuse Treatment Clinical Trials Network has developed, implemented, and evaluated methodology for holistically assessing data quality on EDC trials. We characterize the average source-to-database error rate (14.3 errors per 10,000 fields) for the first year of use of the new evaluation method. This error rate was significantly lower than the average of published error rates for source-to-database audits, and was similar to CRF-to-database error rates reported in the published literature. We attribute this largely to an absence of medical record abstraction on the trials we examined, and to an outpatient setting characterized by less acute patient conditions. Conclusions: Historically, medical record abstraction is the most significant source of error by an order of magnitude, and should be measured and managed during the course of clinical trials. Source-to-database error rates are highly dependent on the amount of structured data collection in the clinical setting and on the complexity of the medical record, dependencies that should be considered when developing data quality benchmarks.	[Nahm, Meredith L.] Duke Translat Med Inst, Durham, NC USA; [Pieper, Carl F.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Cunningham, Maureen M.] Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University	Nahm, ML (corresponding author), Duke Translat Med Inst, Durham, NC USA.	meredith.nahm@duke.edu		Pieper, Carl/0000-0003-4809-1725	NIDA [HHSN271200522071C]	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by NIDA Contract No. HHSN271200522071C.	Adams WG, 2000, PEDIATRICS, V106, P489, DOI 10.1542/peds.106.3.489; Arts D, 2002, INTENS CARE MED, V28, P656, DOI 10.1007/s00134-002-1272-z; Arts DGT, 2003, CRIT CARE, V7, P179, DOI 10.1186/cc1886; Arts DGT, 2002, J AM MED INFORM ASSN, V9, P600, DOI 10.1197/jamia.M1087; BAGNIEWSKA A, 1986, CONTROL CLIN TRIALS, V7, P27, DOI 10.1016/0197-2456(86)90005-X; BLUMENSTEIN BA, 1993, STAT MED, V12, P1535, DOI 10.1002/sim.4780121702; Caloto T, 2001, BMC Med Res Methodol, V1, P14, DOI 10.1186/1471-2288-1-14; CHMELIK F, 1994, ANN ALLERGY, V73, P527; CHRISTIAN MC, 1995, NEW ENGL J MED, V333, P1469, DOI 10.1056/NEJM199511303332206; CLIVE RE, 1995, J SURG ONCOL, V58, P155; Cousley R R, 2000, J Orthod, V27, P319, DOI 10.1093/ortho/27.4.319; Cress RD, 2003, MED CARE, V41, P1006, DOI 10.1097/01.MLR.0000083740.12949.88; CROMBIE IK, 1986, COMPUT BIOMED RES, V19, P543, DOI 10.1016/0010-4809(86)90028-5; DAVIS JR, 1999, WORKSH REP ROUNDT RE; Dreisler E, 2001, INT J QUAL HEALTH C, V13, P51, DOI 10.1093/intqhc/13.1.51; DUCHENE AG, 1986, CONTROL CLIN TRIALS, V7, pS34; Favalli G, 2000, EUR J CANCER, V36, P1125, DOI 10.1016/S0959-8049(00)00090-3; Fleiss J.L., 2013, STAT METHODS RATES P; FORTMANN SP, 1986, AM J EPIDEMIOL, V123, P656, DOI 10.1093/oxfordjournals.aje.a114285; Gad S.C., 1996, HDB DATA RECORDING M; Ghali WA, 2000, AM HEART J, V140, P402, DOI 10.1067/mhj.2000.109222; Gibbs JL, 2004, BRIT MED J, V328, P611, DOI 10.1136/bmj.38027.613403.F6; GISSLER M, 1995, SCAND J SOC MED, V23, P75, DOI 10.1177/140349489502300113; Goldhill DR, 1998, ANAESTHESIA, V53, P937, DOI 10.1046/j.1365-2044.1998.00534.x; Hakansson I, 2001, ACTA OPHTHALMOL SCAN, V79, P518, DOI 10.1034/j.1600-0420.2001.790519.x; Helms RW, 2001, DRUG INF J, V35, P827, DOI 10.1177/009286150103500320; Herbert MA, 2004, ANN THORAC SURG, V77, P1960, DOI 10.1016/j.athoracsur.2003.12.018; HORBAR JD, 1995, CONTROL CLIN TRIALS, V16, P51, DOI 10.1016/0197-2456(94)00019-Y; Hunt JP, 2000, J TRAUMA, V49, P679, DOI 10.1097/00005373-200010000-00016; JANES ET, 1976, FDN PROBABILITY THEO, V6; Jenders RA, 1999, J AM MED INFORM ASSN, P286; Jonasson G, 1999, EUR RESPIR J, V14, P150, DOI 10.1034/j.1399-3003.1999.14a25.x; Jorgensen CK, 1998, COMPUT BIOL MED, V28, P659, DOI 10.1016/S0010-4825(98)00038-9; Kantonen I, 1997, EUR J VASC ENDOVASC, V14, P468, DOI 10.1016/S1078-5884(97)80126-8; Karam V, 2003, TRANSPLANTATION, V75, P2167, DOI 10.1097/01.TP.0000080271.20145.07; Kawado M, 2003, CONTROL CLIN TRIALS, V24, P560, DOI 10.1016/S0197-2456(03)00089-8; Knatterud GL, 1998, CONTROL CLIN TRIALS, V19, P477, DOI 10.1016/S0197-2456(98)00033-6; KRONMAL RA, 1978, COMPUT BIOMED RES, V11, P553, DOI 10.1016/0010-4809(78)90034-4; LANCASTER S, 1995, CONTROL CLIN TRIA S1, V16, P75; Lin CM, 2004, J FORMOS MED ASSOC, V103, P297; LINBLAD U, 1993, SKARABORG HYPERTENSI, V21, P3; Lorenzoni L, 1999, INT J QUAL HEALTH C, V11, P209, DOI 10.1093/intqhc/11.3.209; LOVISON G, 1989, METHOD INFORM MED, V28, P142; LOWEL H, 1991, J CLIN EPIDEMIOL, V44, P249, DOI 10.1016/0895-4356(91)90036-9; MAZZE RS, 1984, AM J MED, V77, P211, DOI 10.1016/0002-9343(84)90693-4; McEntegart DJ, 1999, DRUG INF J, V33, P101, DOI 10.1177/009286159903300113; MCGOVERN PG, 1993, STROKE, V24, P1640, DOI 10.1161/01.STR.24.11.1640; MCKINLAY SM, 1989, INT J EPIDEMIOL, V18, P67, DOI 10.1093/ije/18.1.67; Metzger DS, 2000, AM J EPIDEMIOL, V152, P99, DOI 10.1093/aje/152.2.99; Milgrom H, 1996, J ALLERGY CLIN IMMUN, V98, P1051, DOI 10.1016/S0091-6749(96)80190-4; Moro ML, 2004, J HOSP INFECT, V56, P239, DOI 10.1016/j.jhin.2003.12.022; Nagtegaal ID, 2000, J CLIN ONCOL, V18, P1771, DOI 10.1200/JCO.2000.18.8.1771; NAHM M, 2004, DATA BASICS, V10, P13; NEATON JD, 1990, STAT MED, V9, P115, DOI 10.1002/sim.4780090118; Newman JC, 2002, AM J PUBLIC HEALTH, V92, P294, DOI 10.2105/AJPH.92.2.294; NORTON SL, 1981, COMPUT BIOMED RES, V14, P179, DOI 10.1016/0010-4809(81)90035-5; O'Rourke MK, 1999, J EXPO ANAL ENV EPID, V9, P471, DOI 10.1038/sj.jea.7500043; PRUDHOMME GJ, 1989, CONTROL CLIN TRIALS, V10, pS84, DOI 10.1016/0197-2456(89)90044-5; Quan K Hue, 2003, J Palliat Med, V6, P401, DOI 10.1089/109662103322144718; Rawson NSB, 2000, CAN J PUBLIC HEALTH, V91, P390, DOI 10.1007/BF03404814; REYNOLDSHAERTLE RA, 1992, CONTROL CLIN TRIALS, V13, P487, DOI 10.1016/0197-2456(92)90205-E; ROSTAMI R, 2004, SOC CLIN DATA MANAGE; Simmons MS, 2000, CHEST, V118, P290, DOI 10.1378/chest.118.2.290; Society for Clinical Data Management, 2008, GOOD CLIN DAT MAN PR; SPECTOR SL, 1986, J ALLERGY CLIN IMMUN, V77, P65, DOI 10.1016/0091-6749(86)90325-8; STEWARD WP, 1993, EUR J CANCER, V29A, P943, DOI 10.1016/S0959-8049(05)80199-6; Stone EJ, 1996, PREV MED, V25, P384, DOI 10.1006/pmed.1996.0071; Straka RJ, 1997, PHARMACOTHERAPY, V17, P126; TENNIS P, 1993, J CLIN EPIDEMIOL, V46, P675, DOI 10.1016/0895-4356(93)90048-6; TEPERI J, 1993, J EPIDEMIOL COMMUN H, V47, P242, DOI 10.1136/jech.47.3.242; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; US Department of Health and Human Services Food and Drug Administration, 1996, GUID IND E6 GOOD CLI; VANDERPUTTEN E, 1987, CONTROL CLIN TRIALS, V8, P96, DOI 10.1016/0197-2456(87)90034-1; VANTONGELEN K, 1989, EUR J CANCER CLIN ON, V25, P1241, DOI 10.1016/0277-5379(89)90421-5; Velikova G, 1999, J CLIN ONCOL, V17, P998, DOI 10.1200/JCO.1999.17.3.998; Verschelden P, 1996, EUR RESPIR J, V9, P880, DOI 10.1183/09031936.96.09050880; Volk T, 1997, J THORAC CARDIOV SUR, V114, P903, DOI 10.1016/S0022-5223(97)70003-5; Wang F L, 2001, Chronic Dis Can, V22, P57; Williams ML, 2000, AIDS EDUC PREV, V12, P199; Wynn A, 2001, J TRAUMA, V51, P464, DOI 10.1097/00005373-200109000-00007	81	70	71	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3049	10.1371/journal.pone.0003049	http://dx.doi.org/10.1371/journal.pone.0003049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422LJ	18725958	gold, Green Published, Green Submitted			2022-12-27	WOS:000264429000002
J	Dahmen, N; Manderscheid, N; Helfrich, J; Musholt, PB; Forst, T; Pfutzner, A; Engel, A				Dahmen, Norbert; Manderscheid, Nina; Helfrich, Jana; Musholt, Petra B.; Forst, Thomas; Pfuetzner, Andreas; Engel, Alice			Elevated Peripheral Visfatin Levels in Narcoleptic Patients	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HYPOCRETIN OREXIN; SIGNIFICANT ASSOCIATION; ENERGY HOMEOSTASIS; PLASMA; INFLAMMATION; CATAPLEXY; SLEEP; GENE; DQB1-ASTERISK-0602	Objective: Narcolepsy is a severe sleep disorder that is characterized by excessive daytime sleepiness, cataplexies and a tendency towards obesity. Recent discoveries indicate that the major pathophysiology is a loss of hypocretin (orexin) producing neurons due to immunologically mediated degeneration. Visfatin is a recently described proinflammatory adipokine. It is identical to the immune modulating pre-B-cell colony enhancing factor (PBEF). Our study examines the hypothesis that visfatin levels are altered in narcoleptic patients. Methods: For the analysis, a total of n = 54 patients (n = 18 males and n = 36 females) with the diagnosis of narcolepsy according to DSM-IV and the International Classification of Sleep Disorders were examined (BMI mean 30.3+/-5.5, age mean 52.5+/-16.1 years). As a control group 39 unrelated (n = 12 males and n = 27 females) healthy volunteers with no sleep disorder according to DSM-IV were included (BMI mean 28.5+/-4.6, age mean 51.1+/-13.6 years). Peripheral visfatin levels were measured using a commercial enzyme immunoassay kit with a measurement range from 0.1-1000 ng/ml. Narcolepsy symptoms, severity and frequency of symptoms as well as the total duration of various aspects of the symptomatology were assessed by unstructured and structured clinical interviews in including the Stanford Center for Narcolepsy Sleep Inventory. Results: Circulating visfatin was found to be significantly increased in HLA DR2 positive narcoleptic patients compared to controls. Conclusion: Taken together, our results add to the evidence of disturbed immunological regulation in patients with narcolepsy.	[Dahmen, Norbert; Manderscheid, Nina; Helfrich, Jana; Engel, Alice] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Musholt, Petra B.; Forst, Thomas; Pfuetzner, Andreas] ikfe GmbH, Mainz, Germany	Johannes Gutenberg University of Mainz	Dahmen, N (corresponding author), Johannes Gutenberg Univ Mainz, Dept Psychiat, Untere Zahlbacher Str 8, D-6500 Mainz, Germany.	aliceengel@gmx.net						ALDRICH MS, 1990, NEW ENGL J MED, V323, P389; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Black JL, 2006, INT REV PSYCHIATR, V17, P461, DOI 10.1080/02646830500381492; Chan TF, 2007, FERTIL STERIL, V88, P401, DOI 10.1016/j.fertnstert.2006.11.120; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dahmen N, 2001, EUR ARCH PSY CLIN N, V251, P85, DOI 10.1007/s004060170057; Dauvilliers Y, 2004, ANN NEUROL, V56, P905, DOI 10.1002/ana.20339; Dauvilliers Y, 2001, MOL PSYCHIATR, V6, P367, DOI 10.1038/sj.mp.4000911; Dogru T, 2007, J HUM HYPERTENS, V21, P173, DOI 10.1038/sj.jhh.1002114; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fukuhara A, 2007, SCIENCE, V318, P565, DOI 10.1126/science.318.5850.565b; Guzik TJ, 2006, J PHYSIOL PHARMACOL, V57, P505; Hector J, 2007, HORM METAB RES, V39, P250, DOI 10.1055/s-2007-973075; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Himmerich H, 2006, ARCH INTERN MED, V166, P1739, DOI 10.1001/archinte.166.16.1739; Hinze-Selch D, 1998, NEUROLOGY, V50, P1149, DOI 10.1212/WNL.50.4.1149; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; Hohjoh H, 2000, TISSUE ANTIGENS, V56, P446, DOI 10.1034/j.1399-0039.2000.560508.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lopez-Bermejo A, 2006, DIABETES, V55, P2871, DOI 10.2337/db06-0259; Marcinkowska Magdalena, 2007, Endokrynol Pol, V58, P188; Martinez-Rodriguez JE, 2007, MED CLIN-BARCELONA, V128, P361, DOI 10.1157/13099970; MIGNOT E, 1995, ADV NEUROIMMUNOL, V5, P23, DOI 10.1016/0960-5428(94)00043-N; Mignot E, 1997, SLEEP, V20, P1012; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nishino S, 2001, ANN NEUROL, V50, P381, DOI 10.1002/ana.1130; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Okun ML, 2004, BRAIN BEHAV IMMUN, V18, P326, DOI 10.1016/j.bbi.2003.11.002; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Pfutzner A, 2007, HORM METAB RES, V39, P764, DOI 10.1055/s-2007-985867; Pilz S, 2007, J ENDOCRINOL INVEST, V30, P138, DOI 10.1007/BF03347412; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rogers AE, 1997, NEUROLOGY, V48, P1550, DOI 10.1212/WNL.48.6.1550; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; THORPY MJ, 1990, ICSD INT CLASSIFICAT; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Varma V, 2007, J CLIN ENDOCR METAB, V92, P666, DOI 10.1210/jc.2006-1303; Vgontzas AN, 2002, ENDOCRIN METAB CLIN, V31, P15, DOI 10.1016/S0889-8529(01)00005-6; Wieczorek S, 2003, TISSUE ANTIGENS, V61, P437, DOI 10.1034/j.1399-0039.2003.00068.x; Wurtman RJ, 2006, METABOLISM, V55, pS36, DOI 10.1016/j.metabol.2006.07.011	42	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2980	10.1371/journal.pone.0002980	http://dx.doi.org/10.1371/journal.pone.0002980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714344	gold, Green Published, Green Submitted			2022-12-27	WOS:000264420900007
J	Loi, P; Matsukawa, K; Ptak, G; Clinton, M; Fulka, J; Nathan, Y; Arav, A				Loi, Pasqualino; Matsukawa, Kazutsugu; Ptak, Grazyna; Clinton, Michael; Fulka, Josef, Jr.; Nathan, Yehudith; Arav, Amir			Freeze-Dried Somatic Cells Direct Embryonic Development after Nuclear Transfer	PLOS ONE			English	Article								The natural capacity of simple organisms to survive in a dehydrated state has long been exploited by man, with lyophylization the method of choice for the long term storage of bacterial and yeast cells. More recently, attempts have been made to apply this procedure to the long term storage of blood cells. However, despite significant progress, practical application in a clinical setting is still some way off. Conversely, to date there are no reports of attempts to lyophilize nucleated somatic cells for possible downstream applications. Here we demonstrate that lyophilised somatic cells stored for 3 years at room temperature are able to direct embryonic development following injection into enucleated oocytes. These remarkable results demonstrate that alternative systems for the long-term storage of cell lines are now possible, and open unprecedented opportunities in the fields of biomedicine and for conservation strategies.	[Loi, Pasqualino; Matsukawa, Kazutsugu; Ptak, Grazyna] Teramo Univ, Dept Comparat Biomed Sci, Teramo, Italy; [Clinton, Michael] Roslin Inst, Royal Sch Vet Stud, Edinburgh, Midlothian, Scotland; [Fulka, Josef, Jr.] Inst Anim Product, Prague, Czech Republic; [Nathan, Yehudith; Arav, Amir] Volcani Ctr, Inst Anim Sci, Agr Res Org, Bet Dagan, Israel	University of Teramo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Loi, P (corresponding author), Teramo Univ, Dept Comparat Biomed Sci, Teramo, Italy.	ploi@unite.it		Ptak, Grazyna/0000-0003-1437-4698	PRIN 2006; Teramo University; European Science Foundation [ERASCT-2003-980409]; BBSRC [BB/E015425/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E015425/2, BBS/E/R/00000681] Funding Source: researchfish	PRIN 2006(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Teramo University; European Science Foundation(European Science Foundation (ESF)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research in P.L. laboratory is supported by PRIN 2006, Teramo University Founds (60%) 2006, European Science Foundation, contract no. ERASCT-2003-980409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage S, 1999, BONE MARROW TRANSPL, V24, P139, DOI 10.1038/sj.bmt.1701881; Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x; Brumfiel G, 2004, NATURE, V428, P14, DOI 10.1038/428014a; Cairns J, 2002, P NATL ACAD SCI USA, V99, P10567, DOI 10.1073/pnas.162369899; CLARK P, 1974, BIOCHEMISTRY-US, V13, P5098, DOI 10.1021/bi00722a007; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Fischer Thomas H, 2002, Hematology, V7, P359, DOI 10.1080/1024533021000047954; Fuller W, 2004, PHILOS T R SOC B, V359, P1237, DOI 10.1098/rstb.2004.1501; Gacitua H, 2005, THERIOGENOLOGY, V63, P931, DOI 10.1016/j.theriogenology.2004.05.012; GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967; Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; HILTONTAYLOR C, 2004, IUCN RED LIST THREAT; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; LEHMAN CW, 1993, MOL CELL BIOL, V13, P6897, DOI 10.1128/MCB.13.11.6897; LESLIE SB, 1994, BBA-BIOMEMBRANES, V1192, P7, DOI 10.1016/0005-2736(94)90136-8; Loi P, 2002, BIOL REPROD, V67, P126, DOI 10.1095/biolreprod67.1.126; Loi P, 2001, NAT BIOTECHNOL, V19, P962, DOI 10.1038/nbt1001-962; Loi P, 2008, BIOESSAYS, V30, P66, DOI 10.1002/bies.20684; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PRESTRELSKI SJ, 1993, ARCH BIOCHEM BIOPHYS, V303, P465, DOI 10.1006/abbi.1993.1310; Ptak G, 2002, BIOL REPROD, V67, P1719, DOI 10.1095/biolreprod.102.006171; Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639; Ward WS, 1996, CRIT REV EUKAR GENE, V6, P139, DOI 10.1615/CritRevEukarGeneExpr.v6.i2-3.30; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILMUT I, 1997, NATURE, V385, P813; Wolf SA, 1999, AM J NURS, V99, P60, DOI 10.2307/3472191; Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0	32	66	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2978	10.1371/journal.pone.0002978	http://dx.doi.org/10.1371/journal.pone.0002978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714340	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900005
J	Grosskurth, SE; Bhattacharya, D; Wang, QC; Lin, JJC				Grosskurth, Shaun E.; Bhattacharya, Debashish; Wang, Qinchuan; Lin, Jim Jung-Ching			Emergence of Xin Demarcates a Key Innovation in Heart Evolution	PLOS ONE			English	Article							INTERCALATED DISK PROTEIN; CARDIAC-HYPERTROPHY; BLOOD-VESSELS; MXIN-ALPHA; VERTEBRATE; REVEALS; COMPLEX; GENES; CARDIOMYOPATHY; DUPLICATIONS	The mouse Xin repeat-containing proteins (mXin alpha and mXin beta) localize to the intercalated disc in the heart. mXin alpha is able to bundle actin filaments and to interact with beta-catenin, suggesting a role in linking the actin cytoskeleton to N-cadherin/beta-catenin adhesion. mXin alpha-null mouse hearts display progressively ultrastructural alterations at the intercalated discs, and develop cardiac hypertrophy and cardiomyopathy with conduction defects. The up-regulation of mXin beta in mXin alpha-deficient mice suggests a partial compensation for the loss of mXin alpha. To elucidate the evolutionary relationship between these proteins and to identify the origin of Xin, a phylogenetic analysis was done with 40 vertebrate Xins. Our results show that the ancestral Xin originated prior to the emergence of lamprey and subsequently underwent gene duplication early in the vertebrate lineage. A subsequent teleost-specific genome duplication resulted in most teleosts encoding at least three genes. All Xins contain a highly conserved beta-catenin-binding domain within the Xin repeat region. Similar to mouse Xins, chicken, frog and zebrafish Xins also co-localized with beta-catenin to structures that appear to be the intercalated disc. A putative DNA-binding domain in the N-terminus of all Xins is strongly conserved, whereas the previously characterized Mena/VASP-binding domain is a derived trait found only in Xin alpha s from placental mammals. In the C-terminus, Xin alpha s and Xin beta s are more divergent relative to each other but each isoform from mammals shows a high degree of within-isoform sequence identity. This suggests different but conserved functions for mammalian Xin alpha and Xin beta. Interestingly, the origin of Xin ca. 550 million years ago coincides with the genesis of heart chambers with complete endothelial and myocardial layers. We postulate that the emergence of the Xin paralogs and their functional differentiation may have played a key role in the evolutionary development of the heart.	[Grosskurth, Shaun E.; Bhattacharya, Debashish; Wang, Qinchuan; Lin, Jim Jung-Ching] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Grosskurth, SE (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	jim-lin@uiowa.edu	Wang, Qinchuan/AAH-5614-2021	Wang, Qinchuan/0000-0002-2359-3262	National Heart, Lung and blood Institute, National Institutes of Health [HL075015, ES013679]; National Science Foundation [EF-0625440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013679] Funding Source: NIH RePORTER	National Heart, Lung and blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Heart, Lung and blood Institute grant HL075015 from the National Institutes of Health to JJ-CL and grants from the National Science Foundation (EF-0625440) and the National Institutes of Health (ES013679) to DB.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AUGUSTINSSON KB, 1956, J PHYSIOL-LONDON, V131, P257, DOI 10.1113/jphysiol.1956.sp005461; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; BURNSTOCK G, 1969, PHARMACOL REV, V21, P247; Cherepanova O, 2006, J MOL BIOL, V356, P714, DOI 10.1016/j.jmb.2005.11.082; Choi HJ, 2005, J MOL BIOL, V346, P367, DOI 10.1016/j.jmb.2004.11.048; Choi SJ, 2007, J BIOL CHEM, V282, P36024, DOI 10.1074/jbc.M707639200; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gustafson-Wagner EA, 2007, AM J PHYSIOL-HEART C, V293, pH2680, DOI 10.1152/ajpheart.00806.2007; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hu N, 2000, ANAT REC, V260, P148, DOI 10.1002/1097-0185(20001001)260:2<148::AID-AR50>3.0.CO;2-X; Huang HT, 2006, J BIOL CHEM, V281, P39370, DOI 10.1074/jbc.M603244200; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jung-Ching Lin Jim, 2005, J Med Sci, V25, P215; KILARSKI WINCENTY, 1964, ACTA BIOL CRACOV SER ZOOL, V7, P75; KRIEBEL ME, 1970, AM J PHYSIOL, V218, P1194, DOI 10.1152/ajplegacy.1970.218.4.1194; Marian AJ, 2001, J MOL CELL CARDIOL, V33, P655, DOI 10.1006/jmcc.2001.1340; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MOLLER PC, 1973, J MORPHOL, V139, P389, DOI 10.1002/jmor.1051390403; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; NAKAO T, 1981, ANAT RECORD, V199, P555, DOI 10.1002/ar.1091990411; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; PERCY R, 1991, J ZOOL, V223, P49; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; Postlethwait JH, 2000, GENOME RES, V10, P1890, DOI 10.1101/gr.164800; RAHR H, 1981, ZOOMORPHOLOGY, V97, P53, DOI 10.1007/BF00310102; Rambaut A, 1995, SE AL SEQUENCE ALIGN; Randall D.J., 1980, HEARTS HEART LIKE OR, P41, DOI 10.1016/C2013-0-10405-9; Sinn HW, 2002, DEV DYNAM, V225, P1, DOI 10.1002/dvdy.10131; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Towbin J A, 2000, Curr Cardiol Rep, V2, P134, DOI 10.1007/s11886-000-0010-9; van der Ven PFM, 2006, EXP CELL RES, V312, P2154, DOI 10.1016/j.yexcr.2006.03.015; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; WALSH JB, 1985, GENETICS, V110, P345; Wang DZ, 1999, DEVELOPMENT, V126, P1281; WANG DZ, 1996, FRONT BIOSCI, V1, P15	48	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2857	10.1371/journal.pone.0002857	http://dx.doi.org/10.1371/journal.pone.0002857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682726	gold, Green Published			2022-12-27	WOS:000264366600013
J	Vrticka, P; Andersson, F; Grandjean, D; Sander, D; Vuilleumier, P				Vrticka, Pascal; Andersson, Frederic; Grandjean, Didier; Sander, David; Vuilleumier, Patrik			Individual Attachment Style Modulates Human Amygdala and Striatum Activation during Social Appraisal	PLOS ONE			English	Article							ADULT ATTACHMENT; ROMANTIC LOVE; ORBITOFRONTAL CORTEX; WORKING MODELS; REWARD; REPRESENTATIONS; REJECTION; EMOTION; FMRI; RESPONSIVITY	Adult attachment style refers to individual personality traits that strongly influence emotional bonds and reactions to social partners. Behavioral research has shown that adult attachment style reflects profound differences in sensitivity to social signals of support or conflict, but the neural substrates underlying such differences remain unsettled. Using functional magnetic resonance imaging (fMRI), we examined how the three classic prototypes of attachment style (secure, avoidant, anxious) modulate brain responses to facial expressions conveying either positive or negative feedback about task performance (either supportive or hostile) in a social game context. Activation of striatum and ventral tegmental area was enhanced to positive feedback signaled by a smiling face, but this was reduced in participants with avoidant attachment, indicating relative impassiveness to social reward. Conversely, a left amygdala response was evoked by angry faces associated with negative feedback, and correlated positively with anxious attachment, suggesting an increased sensitivity to social punishment. Secure attachment showed mirror effects in striatum and amygdala, but no other specific correlate. These results reveal a critical role for brain systems implicated in reward and threat processing in the biological underpinnings of adult attachment style, and provide new support to psychological models that have postulated two separate affective dimensions to explain these individual differences, centered on the ventral striatum and amygdala circuits, respectively. These findings also demonstrate that brain responses to face expressions are not driven by facial features alone but determined by the personal significance of expressions in current social context. By linking fundamental psychosocial dimensions of adult attachment with brain function, our results do not only corroborate their biological bases but also help understand their impact on behavior.	[Vrticka, Pascal; Grandjean, Didier; Sander, David; Vuilleumier, Patrik] Univ Geneva, Swiss Natl Ctr Affect Sci, Geneva, Switzerland; [Vrticka, Pascal; Andersson, Frederic; Vuilleumier, Patrik] Univ Med Ctr Geneva, Dept Neurosci Clin Neurol, Lab Neurol & Imaging Cognit, Geneva, Switzerland; [Grandjean, Didier; Sander, David] Univ Geneva, FPSE, Dept Psychol, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Vrticka, P (corresponding author), Univ Geneva, Swiss Natl Ctr Affect Sci, Geneva, Switzerland.	pascal.vrticka@medecine.unige.ch	Vuilleumier, Patrik/AAJ-1839-2021; Andersson, Frederic/P-6969-2016; Andersson, Frédéric/N-6927-2019; Vrticka, Pascal/U-9166-2018; Vrticka, Pascal/H-2209-2013	Vuilleumier, Patrik/0000-0002-8198-9214; Andersson, Frederic/0000-0002-2343-2450; Andersson, Frédéric/0000-0002-2343-2450; Vrticka, Pascal/0000-0002-8920-5509; Vrticka, Pascal/0000-0002-4806-9037; Grandjean, Didier/0000-0001-6125-4520; Sander, David/0000-0003-1266-9361	National Center of Competence in Research (NCCR); Swiss National Science Foundation [51NF40-104897]; University of Geneva	National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva	This research was supported by the National Center of Competence in Research (NCCR). Affective sciences financed by the Swiss National Science Foundation (n 51NF40-104897) and hosted by the University of Geneva, and grants of the Swiss National Science Foundation to DS and PV.	AINSWORTH MDS, 1978, BEHAV BRAIN SCI, V1, P436, DOI 10.1017/S0140525X00075828; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; BALDWIN MW, 1992, PSYCHOL BULL, V112, P461, DOI 10.1037/0033-2909.112.3.461; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; BARTHOLOMEW K, 1991, J PERS SOC PSYCHOL, V61, P226, DOI 10.1037/0022-3514.61.2.226; Bouthillier D, 1996, CAN J BEHAV SCI, V28, P74, DOI 10.1037/0008-400X.28.1.74; Bowlby J., 1982, ATTACHMENT LOSS, V2nd; Bowlby J., 1969, ATTACHMENT AND LOSS; Bray S, 2007, J NEUROPHYSIOL, V97, P3036, DOI 10.1152/jn.01211.2006; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chotai J, 2005, EUR PSYCHIAT, V20, P251, DOI 10.1016/j.eurpsy.2004.11.008; Collins NL, 2004, J PERS SOC PSYCHOL, V87, P363, DOI 10.1037/0022-3514.87.3.363; Collins NL., 1994, ATTACHMENT PROCESSES, P53; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DOZIER M, 1992, CHILD DEV, V63, P1473, DOI 10.2307/1131569; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; FEENEY JA, 1994, HEALTH PSYCHOL, V13, P334, DOI 10.1037/0278-6133.13.4.334; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fraley R.C., 1998, ATTACHMENT THEORY CL, P249; Fraley RC, 2006, J PERS, V74, P1163, DOI 10.1111/j.1467-6494.2006.00406.x; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fuendeling JM, 1998, J SOC PERS RELAT, V15, P291, DOI 10.1177/0265407598153001; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; GRIFFIN D, 1994, J PERS SOC PSYCHOL, V67, P430, DOI 10.1037/0022-3514.67.3.430; HAZAN C, 1987, J PERS SOC PSYCHOL, V52, P511, DOI 10.1037/0022-3514.52.3.511; Kashdan TB, 2007, CLIN PSYCHOL REV, V27, P348, DOI 10.1016/j.cpr.2006.12.003; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Kross E, 2007, J COGNITIVE NEUROSCI, V19, P945, DOI 10.1162/jocn.2007.19.6.945; Kurdek LA, 2002, J SOC PERS RELAT, V19, P811, DOI 10.1177/0265407502196005; Lemche E, 2006, HUM BRAIN MAPP, V27, P623, DOI 10.1002/hbm.20206; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Niedenthal PM, 2002, J PERS SOC PSYCHOL, V82, P419, DOI 10.1037//0022-3514.82.3.419; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Overall N, 2003, AUST J PSYCHOL, V55, P57; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; Rapee RM, 2004, CLIN PSYCHOL REV, V24, P737, DOI 10.1016/j.cpr.2004.06.004; Riggs SA, 2007, DEV PSYCHOPATHOL, V19, P263, DOI 10.1017/S0954579407070149; Rom E, 2003, J PERS SOC PSYCHOL, V84, P1220, DOI 10.1037/0022-3514.84.6.1220; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; SIMPSON JA, 1990, J PERS SOC PSYCHOL, V59, P971, DOI 10.1037/0022-3514.59.5.971; Simpson JA, 2002, PERS SOC PSYCHOL B, V28, P598, DOI 10.1177/0146167202288004; Simpson JA, 1996, J PERS SOC PSYCHOL, V71, P899, DOI 10.1037/0022-3514.71.5.899; Simpson JA, 2007, J PERS SOC PSYCHOL, V92, P355, DOI 10.1037/0022-3514.92.2.355; Somerville LH, 2006, NAT NEUROSCI, V9, P1007, DOI 10.1038/nn1728; Spielberger C. D., 1999, USE PSYCHOL TESTING, P993; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Van Emmichoven IAZ, 2003, DEV PSYCHOPATHOL, V15, P219, DOI 10.1017/S0954579403000129; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	52	177	184	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2868	10.1371/journal.pone.0002868	http://dx.doi.org/10.1371/journal.pone.0002868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682729	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600024
J	Ahlander, J; Chen, XB; Bosco, G				Ahlander, Joseph; Chen, Xiao-Bo; Bosco, Giovanni			The N-Terminal Domain of the Drosophila Retinoblastoma Protein Rbf1 Interacts with ORC and Associates with Chromatin in an E2F Independent Manner	PLOS ONE			English	Article								Background: The retinoblastoma (Rb) tumor suppressor protein can function as a DNA replication inhibitor as well as a transcription factor. Regulation of DNA replication may occur through interaction of Rb with the origin recognition complex (ORC). Principal Findings: We characterized the interaction of Drosophila Rb, Rbf1, with ORC. Using expression of proteins in Drosophila S2 cells, we found that an N-terminal Rbf1 fragment (amino acids 1-345) is sufficient for Rbf1 association with ORC but does not bind to dE2F1. We also found that the C-terminal half of Rbf1 (amino acids 345-845) interacts with ORC. We observed that the amino-terminal domain of Rbf1 localizes to chromatin in vivo and associates with chromosomal regions implicated in replication initiation, including colocalization with Orc2 and acetylated histone H4. Conclusions/Significance: Our results suggest that Rbf1 can associate with ORC and chromatin through domains independent of the E2F binding site. We infer that Rbf1 may play a role in regulating replication directly through its association with ORC and/or chromatin factors other than E2F. Our data suggest an important role for retinoblastoma family proteins in cell proliferation and tumor suppression through interaction with the replication initiation machinery.	[Ahlander, Joseph; Chen, Xiao-Bo; Bosco, Giovanni] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA	University of Arizona	Ahlander, J (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	gbosco@email.arizona.edu			National Institutes of Health [GM069462]; American Cancer Society [IRG7400128]; National Science Foundation [DGE-0638744]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health grant GM069462 (GB), the American Cancer Society grant IRG7400128 (GB), and the National Science Foundation grant DGE-0638744 (JA).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Austin RJ, 1999, GENE DEV, V13, P2639, DOI 10.1101/gad.13.20.2639; Avni D, 2003, MOL CELL, V12, P735, DOI 10.1016/S1097-2765(03)00355-1; Balasov M, 2007, MOL CELL BIOL, V27, P3143, DOI 10.1128/MCB.02382-06; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Beall EL, 2002, NATURE, V420, P833, DOI 10.1038/nature01228; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bosco G, 2001, NAT CELL BIOL, V3, P289, DOI 10.1038/35060086; Bosco G, 2007, GENETICS, V177, P1277, DOI 10.1534/genetics.107.075069; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Castano E, 1998, MOL CELL BIOL, V18, P5380, DOI 10.1128/MCB.18.9.5380; Cayirlioglu P, 2003, MOL CELL BIOL, V23, P2123, DOI 10.1128/MCB.23.6.2123-2134.2003; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; CHOUBEY D, 1995, J BIOL CHEM, V270, P6134, DOI 10.1074/jbc.270.11.6134; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Claycomb JM, 2002, J CELL BIOL, V159, P225, DOI 10.1083/jcb.200207046; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DEMAKOV SA, 1993, MOL GEN GENET, V238, P437, DOI 10.1007/BF00292003; Diffley TFX, 1996, GENE DEV, V10, P2819, DOI 10.1101/gad.10.22.2819; Dimova DK, 2003, GENE DEV, V17, P2308, DOI 10.1101/gad.1116703; Doostzadeh-Cizeron J, 1999, MOL BIOL CELL, V10, P3251, DOI 10.1091/mbc.10.10.3251; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Gladden AB, 2003, J BIOL CHEM, V278, P9754, DOI 10.1074/jbc.M212088200; Goo YH, 2004, J BIOL CHEM, V279, P7131, DOI 10.1074/jbc.M312563200; Goodrich DW, 2003, J CELL PHYSIOL, V197, P169, DOI 10.1002/jcp.10358; Hartl T, 2007, CHROMOSOMA, V116, P197, DOI 10.1007/s00412-006-0092-2; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hazelett DJ, 1998, DEVELOPMENT, V125, P3741; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kelly BL, 1998, P NATL ACAD SCI USA, V95, P2535, DOI 10.1073/pnas.95.5.2535; KELLY TJ, 1994, CURR BIOL, V4, P238, DOI 10.1016/S0960-9822(00)00053-1; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kennedy BK, 2001, P NATL ACAD SCI USA, V98, P8720, DOI 10.1073/pnas.151240898; Kirienko NV, 2007, DEV BIOL, V305, P674, DOI 10.1016/j.ydbio.2007.02.021; Knudsen ES, 2006, CURR MOL MED, V6, P749; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; LUND O, 2002, X3M COMPUTER PROGRAM; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Markey MP, 2002, CANCER RES, V62, P6587; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; MISHRA A, 1982, CHROMOSOMA, V85, P221, DOI 10.1007/BF00294967; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pennaneach V, 2001, MOL CELL, V7, P715, DOI 10.1016/S1097-2765(01)00217-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Riley DJ, 1997, MOL CELL BIOL, V17, P7342, DOI 10.1128/MCB.17.12.7342; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Royzman I, 1999, GENE DEV, V13, P827, DOI 10.1101/gad.13.7.827; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; SASS H, 1982, CHROMOSOMA, V86, P77, DOI 10.1007/BF00330731; Schmitz NMR, 2004, BIOCHEM BIOPH RES CO, V317, P779, DOI 10.1016/j.bbrc.2004.03.109; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHAO ZH, 1995, P NATL ACAD SCI USA, V92, P3115, DOI 10.1073/pnas.92.8.3115; Shao ZH, 1997, ONCOGENE, V15, P385, DOI 10.1038/sj.onc.1201204; SRINIVASAN SV, 2007, J BIOL CHEM; STAJICH J, 2006, PAIRWISE KAKS PERL S; Sterner JM, 1998, MOL CELL BIOL, V18, P2748, DOI 10.1128/MCB.18.5.2748; Stevaux O, 2002, EMBO J, V21, P4927, DOI 10.1093/emboj/cdf501; Takemura M, 1997, ONCOGENE, V15, P2483, DOI 10.1038/sj.onc.1201431; Takemura M, 2006, BBA-PROTEINS PROTEOM, V1764, P1447, DOI 10.1016/j.bbapap.2006.06.015; Tanny RE, 2006, MOL BIOL CELL, V17, P2415, DOI 10.1091/mbc.E05-11-1037; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; VLASSOVA IE, 1985, CHROMOSOMA, V91, P251, DOI 10.1007/BF00328220; Wang JYJ, 2001, ACTA ONCOL, V40, P689; WANG NP, 1990, CELL GROWTH DIFFER, V1, P233; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Whitaker LL, 1997, ONCOGENE, V15, P1069, DOI 10.1038/sj.onc.1201277; Xin SJ, 2002, DEVELOPMENT, V129, P1345; Yamane K, 2000, ONCOGENE, V19, P1982, DOI 10.1038/sj.onc.1203528; Zhimulev IF, 2004, INT REV CYTOL, V241, P203, DOI 10.1016/S0074-7696(04)41004-3	85	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2831	10.1371/journal.pone.0002831	http://dx.doi.org/10.1371/journal.pone.0002831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665226	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300050
J	Weis, JJ; Madrigal, DS; Cardinale, BJ				Weis, Jerome J.; Madrigal, Daniel S.; Cardinale, Bradley J.			Effects of Algal Diversity on the Production of Biomass in Homogeneous and Heterogeneous Nutrient Environments: A Microcosm Experiment	PLOS ONE			English	Article							SPECIES-DIVERSITY; ECOSYSTEM FUNCTION; PLANT DIVERSITY; COMPETITIVE COEXISTENCE; FRESH-WATER; LONG-TERM; BIODIVERSITY; NITROGEN; CONSEQUENCES; N-2-FIXATION	Background: One of the most common questions addressed by ecologists over the past decade has been-how does species richness impact the production of community biomass? Recent summaries of experiments have shown that species richness tends to enhance the production of biomass across a wide range of trophic groups and ecosystems; however, the biomass of diverse polycultures only rarely exceeds that of the single most productive species in a community ( a phenomenon called 'transgressive overyielding'). Some have hypothesized that the lack of transgressive overyielding is because experiments have generally been performed in overly-simplified, homogeneous environments where species have little opportunity to express the niche differences that lead to 'complementary' use of resources that can enhance biomass production. We tested this hypothesis in a laboratory experiment where we manipulated the richness of freshwater algae in homogeneous and heterogeneous nutrient environments. Methodology/Principal Findings: Experimental units were comprised of patches containing either homogeneous nutrient ratios (16:1 nitrogen to phosphorus (N:P) in all patches) or heterogeneous nutrient ratios ( ranging from 4:1 to 64:1 N:P across patches). After allowing 6-10 generations of algal growth, we found that algal species richness had similar impacts on biomass production in both homo- and heterogeneous environments. Although four of the five algal species showed a strong response to nutrient heterogeneity, a single species dominated algal communities in both types of environments. As a result, a 'selection effect'-where diversity maximizes the chance that a competitively superior species will be included in, and dominate the biomass of a community-was the primary mechanism by which richness influenced biomass in both homo- and heterogeneous environments. Conclusions/Significance: Our study suggests that spatial heterogeneity, by itself, is not sufficient to generate strong effects of biodiversity on productivity. Rather, heterogeneity must be coupled with variation in the relative fitness of species across patches in order for spatial niche differentiation to generate complementary resource use.	[Weis, Jerome J.; Madrigal, Daniel S.; Cardinale, Bradley J.] Univ Calif Santa Barbara, Dept Ecol, Evolution & Marine Biol, Santa Barbara, CA USA	University of California System; University of California Santa Barbara	Weis, JJ (corresponding author), Univ Calif Santa Barbara, Dept Ecol, Evolution & Marine Biol, Santa Barbara, CA USA.	jerome.weis@yale.edu	Cardinale, Bradley J/I-7076-2013; Madrigal, Daniel/AHA-0013-2022		National Science Foundation [DEB 0614428]	National Science Foundation(National Science Foundation (NSF))	This work was supported by a grant from the National Science Foundation to BJC (DEB 0614428). The National Science Foundation did not play any role in carrying out this experiment or preparing this manuscript.	Amarasekare P, 2003, ECOL LETT, V6, P1109, DOI 10.1046/j.1461-0248.2003.00530.x; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bengtsson J, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P209; BOLD HC, 1978, INTRO ALGAE STRUCTUR, pR14; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2006, J ANIM ECOL, V75, P497, DOI 10.1111/j.1365-2656.2006.01070.x; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; Chesson P, 2000, THEOR POPUL BIOL, V58, P211, DOI 10.1006/tpbi.2000.1486; DAILY GC, 1997, NATURES SERVICES SOC, pR20; Dimitrakopoulos PG, 2004, ECOL LETT, V7, P574, DOI 10.1111/j.1461-0248.2004.00607.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; FINDLAY DL, 1994, CAN J FISH AQUAT SCI, V51, P2254, DOI 10.1139/f94-229; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; Gause G.F., 1936, STRUGGLE EXISTENCE; Graham LE, 2000, ALGAE; Gross K, 2007, AM NAT, V170, P207, DOI 10.1086/518950; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HENDZEL LL, 1994, CAN J FISH AQUAT SCI, V51, P2247, DOI 10.1139/f94-228; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; KALFF J, 2002, LIMNOLOGY INLAND WAT, pR12; KINZIG AP, 2001, FUNCTIONAL CONSEQUEN; KOLASA J, ECOLOGICAL HETEROGEN, pR11; Loreau M., 2002, Biodiversity and ecosystem functioning: synthesis and perspectives; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Mouquet N, 2002, ECOL LETT, V5, P56, DOI 10.1046/j.1461-0248.2002.00281.x; Naeem S, 2002, ECOLOGY, V83, P1537, DOI 10.1890/0012-9658(2002)083[1537:ECOBLT]2.0.CO;2; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; REDFIELD AC, 1958, AM SCI, V46, P205; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schlapfer F, 1999, ECOL APPL, V9, P893, DOI 10.1890/1051-0761(1999)009[0893:EEOBAC]2.0.CO;2; SCHMID B, 2002, BIODIVERSITY ECOSYST, pR12; Schmid B, 2008, J PLANT ECOL, V1, P95, DOI 10.1093/jpe/rtn011; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; SMITH VH, 1983, SCIENCE, V221, P669, DOI 10.1126/science.221.4611.669; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; Stachowicz JJ, 2007, ANNU REV ECOL EVOL S, V38, P739, DOI 10.1146/annurev.ecolsys.38.091206.095659; Symstad AJ, 2003, BIOSCIENCE, V53, P89, DOI 10.1641/0006-3568(2003)053[0089:LTALSP]2.0.CO;2; Tilman D., 1982, Monographs in Population Biology, pi; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D., 1997, SPATIAL ECOLOGY ROLE; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; Weis JJ, 2007, ECOLOGY, V88, P929, DOI 10.1890/06-0943	58	54	55	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2825	10.1371/journal.pone.0002825	http://dx.doi.org/10.1371/journal.pone.0002825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665221	Green Published, gold			2022-12-27	WOS:000264304300044
J	Curran, KL; Larue, S; Bronson, B; Solis, J; Trow, A; Sarver, N; Zhu, HS				Curran, Kristen L.; LaRue, Silvia; Bronson, Brittany; Solis, Jessica; Trow, Aaron; Sarver, Nicole; Zhu, Haisun			Circadian Genes Are Expressed during Early Development in Xenopus laevis	PLOS ONE			English	Article								Circadian oscillators are endogenous time-keeping mechanisms that drive twenty four hour rhythmic changes in gene expression, metabolism, hormone levels, and physical activity. We have examined the developmental expression of genes known to regulate circadian rhythms in order to better understand the ontogeny of the circadian clock in a vertebrate. Methodology/Principal Findings: In this study, genes known to function together in part of the core circadian oscillator mechanism (xPeriod1, xPeriod2, and xBmal1) as well as a rhythmic, clock-controlled gene (xNocturnin) were analyzed using in situ hybridization in embryos from neurula to late tailbud stages. Each transcript was present in the developing nervous system in the brain, eye, olfactory pit, otic vesicle and at lower levels in the spinal cord. These genes were also expressed in the developing somites and heart, but at different developmental times in peripheral tissues (pronephros, cement gland, and posterior mesoderm). No difference was observed in transcript levels or localization when similarly staged embryos maintained in cyclic light were compared at two times of day (dawn and dusk) by in situ hybridization. Quantitation of xBmal1 expression in embryonic eyes was also performed using qRT-PCR. Eyes were isolated at dawn, midday, dusk, and midnight (cylic light). No difference in expression level between time-points was found in stage 31 eyes (p = 0.176) but stage 40 eyes showed significantly increased levels of xBmal1 expression at midnight (RQ = 1.98+/-0.094) when compared to dawn (RQ = 1+/-0.133; p = 0.0004). Conclusions/Significance: We hypothesize that when circadian genes are not co-expressed in the same tissue during development that it may indicate pleiotropic functions of these genes that are separate from the timing of circadian rhythm. Our results show that all circadian genes analyzed thus far are present during early brain and eye development, but rhythmic gene expression in the eye is not observed until after stage 31 of development.	[Curran, Kristen L.; Bronson, Brittany; Solis, Jessica; Trow, Aaron; Sarver, Nicole] Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA; [Curran, Kristen L.; LaRue, Silvia; Zhu, Haisun] Univ Virginia, Dept Biol, Charlottesville, VA USA	University of Wisconsin System; University of Virginia	Curran, KL (corresponding author), Univ Wisconsin, Dept Biol Sci, Whitewater, WI 53190 USA.	currank@uww.edu			NIH [MH61461]; NSF REU [0354140]; Beta Beta Beta Biological Society; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF REU(National Science Foundation (NSF)NSF - Office of the Director (OD)); Beta Beta Beta Biological Society; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was initially begun in the lab of Carla B. Green at the University of Virginia. She provided some lab space, reagents, and technician salary to help with tissue sectioning (NIH MH61461 (CBG)). After moving to University of Wisconsin-Whitewater I used my startup money as well as money from an internal grant (Faculty Development Grant) to continue the analysis. My summer salary, the salary of two students, and reagents for one summer (2005) was provided by an NSF REU 0354140 (Woller). More recent experiments were also funded by the Beta Beta Beta Biological Society. Experiments were discussed with CBG, but my project was independent from other projects going on in her laboratory (she did not pay me a salary to start these experiments). The NSF REU (Woller) was meant to give undergraduates research training during the summer and Woller had no input on the types of experiments performed. CBG kindly read and edited this manuscript.	Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Bell David A., 2005, NAT GENET, P1; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DONIACH T, 1995, MECH DEVELOP, V53, P403, DOI 10.1016/0925-4773(95)00457-2; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Freitas C, 2005, INT J DEV BIOL, V49, P317, DOI 10.1387/ijdb.041955cf; GABARINOPICO E, 2007, RNA, V13, P745; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Green CB, 1999, DEV BRAIN RES, V117, P109, DOI 10.1016/S0165-3806(99)00109-1; Green CB, 1996, P NATL ACAD SCI USA, V93, P14884, DOI 10.1073/pnas.93.25.14884; Green CB, 2001, MECH DEVELOP, V101, P105, DOI 10.1016/S0925-4773(00)00559-1; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Morgan R, 2002, INT J DEV BIOL, V46, P999; PENG HB, 1991, PRACTICAL USES CELL, V36, P657; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rida PCG, 2004, DEV BIOL, V265, P2, DOI 10.1016/j.ydbio.2003.07.003; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Vallone D, 2007, DEV DYNAM, V236, P142, DOI 10.1002/dvdy.20998; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zhu HS, 2000, MOL BRAIN RES, V75, P303, DOI 10.1016/S0169-328X(99)00309-5; Ziv L, 2006, P NATL ACAD SCI USA, V103, P4146, DOI 10.1073/pnas.0600571103; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	32	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2749	10.1371/journal.pone.0002749	http://dx.doi.org/10.1371/journal.pone.0002749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18716681	gold, Green Submitted, Green Published			2022-12-27	WOS:000264302900020
J	Cohen, KB; Palmer, M; Hunter, L				Cohen, K. Bretonnel; Palmer, Martha; Hunter, Lawrence			Nominalization and Alternations in Biomedical Language	PLOS ONE			English	Article							EXTRACTION; INFORMATION	Background: This paper presents data on alternations in the argument structure of common domain-specific verbs and their associated verbal nominalizations in the PennBioIE corpus. Alternation is the term in theoretical linguistics for variations in the surface syntactic form of verbs, e. g. the different forms of stimulate in FSH stimulates follicular development and follicular development is stimulated by FSH. The data is used to assess the implications of alternations for biomedical text mining systems and to test the fit of the sublanguage model to biomedical texts. Methodology/Principal Findings: We examined 1,872 tokens of the ten most common domain-specific verbs or their zero-related nouns in the PennBioIE corpus and labelled them for the presence or absence of three alternations. We then annotated the arguments of 746 tokens of the nominalizations related to these verbs and counted alternations related to the presence or absence of arguments and to the syntactic position of non-absent arguments. We found that alternations are quite common both for verbs and for nominalizations. We also found a previously undescribed alternation involving an adjectival present participle. Conclusions/Significance: We found that even in this semantically restricted domain, alternations are quite common, and alternations involving nominalizations are exceptionally diverse. Nonetheless, the sublanguage model applies to biomedical language. We also report on a previously undescribed alternation involving an adjectival present participle.	[Cohen, K. Bretonnel; Hunter, Lawrence] Univ Colorado, Sch Med, Ctr Computat Pharmacol, Aurora, CO USA; [Cohen, K. Bretonnel; Palmer, Martha] Univ Colorado, Dept Linguist, Boulder, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Cohen, KB (corresponding author), Univ Colorado, Sch Med, Ctr Computat Pharmacol, Aurora, CO USA.	kevin.cohen@gmail.com		Hunter, Lawrence/0000-0003-1455-3370; PALMER, MARTHA/0000-0001-9864-6974	NSF [CISE-CRI 0551615];  [G08LM009639];  [R01LM009254];  [R01LM008111];  [T15LM009451]; NATIONAL LIBRARY OF MEDICINE [G08LM009639, T15LM009451, R01LM008111, R01LM009254] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); ; ; ; ; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	K. Bretonnel Cohen's and Lawrence Hunter's work was supported by grants G08LM009639, R01LM009254, and R01LM008111. Martha Palmer's work was supported by NSF grant CISE-CRI 0551615. J. Gregory Caporaso is supported by training grant fellowship T15LM009451. No sponsors or funders were involved in the design or conduct of the study; in the collection, analysis, or interpretation of the data; or in the preparation, review, or approval of the manuscript.	ADAM M, 2004, P 2 ACL WORKSH MULT, P96; ADAM M, ANNOTATION GUI UNPUB; ADAM M, 2004, P LREC 2004, P803; ADAM M, 2004, NOMBANK PROJECT INTE, P24; BARBARA HP, 1993, MATH METHODS LINGUIS; BENGOERTZEL, 2006, P BIONLP 06 WORKSH L, P104; BETH L, 1993, ENGLISH VERB CLASSES; BRETONNEL CK, 2006, BMC BIOINFORMATIC S3, V7, pS5; Chou W.C., 2006, P WORKSH FRONT LING, P5; Christiane F., 1998, WORDNET ELECT LEXICA; Cohen KB, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040020; DEBORAH AD, 1987, P ASS COMP LING, P131; Douglas Biber, 1999, LONGMAN GRAMMAR SPOK; Fillmore CJ, 2003, INT J LEXICOGR, V16, P235, DOI 10.1093/ijl/16.3.235; Friedman C, 2002, J BIOMED INFORM, V35, P222, DOI 10.1016/S1532-0464(03)00012-1; Hripcsak G, 2005, J AM MED INFORM ASSN, V12, P296, DOI 10.1197/jamia.M1733; Hu ZZ, 2005, BIOINFORMATICS, V21, P2759, DOI 10.1093/bioinformatics/bti390; JONATHAN S, 2006, P BIONLP 06 WORKSH L, P82; KARIN V, 2006, INTRO BIONLP 06 LINK, pR3; Kim JD, 2003, BIOINFORMATICS, V19, pi180, DOI 10.1093/bioinformatics/btg1023; Ko JMY, 1998, CANCER LETT, V134, P169, DOI 10.1016/S0304-3835(98)00257-2; LAURIE B, 2002, CAMBRIDGE GRAMMAR EN, P1621; Leroy G, 2005, J AM SOC INF SCI TEC, V56, P457, DOI 10.1002/asi.20135; Leroy G, 2003, J BIOMED INFORM, V36, P145, DOI 10.1016/S1532-0464(03)00039-X; Leroy G., 2002, PACIFIC S BIOCOMPUTI, P350; LYNETTE H, 1982, AUTOMATIC INFORM FOR, P27; MARIA KT, 1993, NOMINALIZATIONS; MARTHA P, 1986, P ASS COMP LING, P10; MICHAEL J, 1995, AAAI SPRING S REPR A; MICHAEL J, 1996, P ACL SIGLEX WORKSH; MIRIAM B, 1998, PROJECTION ARGUMENTS; NAOMI S, 1972, AFIPS C P, V41, P9; Narayanaswamy M, 2005, BIOINFORMATICS, V21, pI319, DOI 10.1093/bioinformatics/bti1011; Ono T, 2001, BIOINFORMATICS, V17, P155, DOI 10.1093/bioinformatics/17.2.155; Palmer M, 2005, COMPUT LINGUIST, V31, P71, DOI 10.1162/0891201053630264; PHILIP VO, 2006, P 9 INT PROT C, P73; PHILIP VO, 2006, P HLT NAACL 2006 COM, P273; PING JZ, 2006, P 2006 C EMP METH NA, P138; PORTER MF, 1980, PROGRAM-AUTOM LIBR, V14, P130, DOI 10.1108/eb046814; Pustejovsky J, 2002, Pac Symp Biocomput, P362; Quirk Randolph, 1985, COMPREHENSIVE GRAMMA; RALPH G, 1986, ANAL LANGUAGE RESTRI; Rappaport Hovav M., 1998, PROJECTION ARGUMENTS, P97, DOI DOI 10.1093/J0S/FFQ007; RICHARD K, 1982, SUBLANGUAGE STUDIES; ROBERT BL, 1968, GRAMMAR ENGLISH NOMI; RON A, 2007, AGREEMENT MEASURES N; SAMEER P, 2004, PARSING ARGUMENTS NO, P141; SETH K, 2004, P BIOLINK 2004 LINK, P61; Shah PK, 2005, PLOS COMPUT BIOL, V1, P67, DOI 10.1371/journal.pcbi.0010010; THOMAS CR, 2000, P ANLP NAACL 2000 AS, P188; THOMAS H, 2004, VALENCY DICT ENGLISH; THOMAS R, 2006, P SAABR C NOM QUANT; TONY M, 2001, CORPUS LINGUISTICS; TSAI RTH, 2005, P BIONLP 06 WORKSH L, P57; Wattarujeekrit T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-155; YACOV K, 2005, AMIA 2005 S P, P410; Yuan X, 2006, BIOINFORMATICS, V22, P1668, DOI 10.1093/bioinformatics/btl159; YUKA T, 2004, ANNOTATION PREDICATE; ZELLIG H, 1989, FORM INFORM SCI ANAL; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	60	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3158	10.1371/journal.pone.0003158	http://dx.doi.org/10.1371/journal.pone.0003158			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779866	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425100001
J	Liu, YZ; Wilson, SG; Wang, L; Liu, XG; Guo, YF; Li, J; Yan, H; Deloukas, P; Soranzo, N; Chinnapen-Horsley, U; Cervino, A; Williams, FM; Xiong, DH; Zhang, YP; Jin, TB; Levy, S; Papasian, CJ; Drees, BM; Hamilton, JJ; Recker, RR; Spector, TD; Deng, HW				Liu, Yao-Zhong; Wilson, Scott G.; Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Li, Jian; Yan, Han; Deloukas, Panos; Soranzo, Nicole; Chinnapen-Horsley, Usha; Cervino, Alesandra; Williams, Frances M.; Xiong, Dong-Hai; Zhang, Yin-Ping; Jin, Tian-Bo; Levy, Shawn; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Recker, Robert R.; Spector, Tim D.; Deng, Hong-Wen			Identification of PLCL1 Gene for Hip Bone Size Variation in Females in a Genome-Wide Association Study	PLOS ONE			English	Article								Osteoporosis, the most prevalent metabolic bone disease among older people, increases risk for low trauma hip fractures (HF) that are associated with high morbidity and mortality. Hip bone size (BS) has been identified as one of the key measurable risk factors for HF. Although hip BS is highly genetically determined, genetic factors underlying the trait are still poorly defined. Here, we performed the first genome-wide association study (GWAS) of hip BS interrogating,380,000 SNPs on the Affymetrix platform in 1,000 homogeneous unrelated Caucasian subjects, including 501 females and 499 males. We identified a gene, PLCL1 (phospholipase c-like 1), that had four SNPs associated with hip BS at, or approaching, a genome-wide significance level in our female subjects; the most significant SNP, rs7595412, achieved a p value of 3.72 x 10(-7). The gene's importance to hip BS was replicated using the Illumina genotyping platform in an independent UK cohort containing 1,216 Caucasian females. Two SNPs of the PLCL1 gene, rs892515 and rs9789480, surrounded by the four SNPs identified in our GWAS, achieved p values of 8.62x10(-3) and 2.44x10(-3), respectively, for association with hip BS. Imputation analyses on our GWAS and the UK samples further confirmed the replication signals; eight SNPs of the gene achieved combined imputed p values, 10 25 in the two samples. The PLCL1 gene's relevance to HF was also observed in a Chinese sample containing 403 females, including 266 with HF and 177 control subjects. A SNP of the PLCL1 gene, rs3771362 that is only similar to 0.6 kb apart from the most significant SNP detected in our GWAS (rs7595412), achieved a p value of 7.66x10(-3) (odds ratio = 0.26) for association with HF. Additional biological support for the role of PLCL1 in BS comes from previous demonstrations that the PLCL1 protein inhibits IP3 (inositol 1,4,5-trisphosphate)-mediated calcium signaling, an important pathway regulating mechanical sensing of bone cells. Our findings suggest that PLCL1 is a novel gene associated with variation in hip BS, and provide new insights into the pathogenesis of HF.	[Liu, Yao-Zhong; Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Li, Jian; Yan, Han; Zhang, Yin-Ping; Jin, Tian-Bo; Papasian, Christopher J.; Drees, Betty M.; Hamilton, James J.; Deng, Hong-Wen] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Wilson, Scott G.] Univ Western Australia, Sch Med Pharmacol, Nedlands, WA, Australia; [Wilson, Scott G.] Sir Charles Gairder Hosp, Dept Endocrinol Diabetes, Nedlands, WA, Australia; [Wilson, Scott G.; Deloukas, Panos; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, St Thomas Hosp, Twin Res & Genet Epidemiol Unit, London WC2R 2LS, England; [Wang, Liang; Liu, Xiao-Gang; Guo, Yan-Fang; Yan, Han; Zhang, Yin-Ping; Jin, Tian-Bo; Deng, Hong-Wen] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Inst Mol Genet, Key Lab Biomed Informat Engn Minist Ed, Xian, Peoples R China; [Soranzo, Nicole; Chinnapen-Horsley, Usha; Cervino, Alesandra; Williams, Frances M.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Xiong, Dong-Hai; Recker, Robert R.; Deng, Hong-Wen] Creighton Univ, Osteoporosis Res, Omaha, NE 68178 USA; [Levy, Shawn] Vanderbilt Univ, Vanderbilt Microarray Shared Resource, Nashville, TN USA; [Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Peoples R China	University of Missouri System; University of Missouri Kansas City; University of Western Australia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Xi'an Jiaotong University; Wellcome Trust Sanger Institute; Creighton University; Vanderbilt University; Hunan Normal University	Liu, YZ (corresponding author), Univ Missouri, Sch Med, Kansas City, MO 64108 USA.	dengh@umkc.edu	Deloukas, Panos/B-2922-2013; Liu, Yaozhong/ABD-5544-2020; XIONG, DONGHAI/A-3691-2010; Li, Jian/G-4445-2015	Deloukas, Panos/0000-0001-9251-070X; Williams, Frances/0000-0002-2998-2744; Wilson, Scott/0000-0002-0357-1373; Deng, Hong-Wen/0000-0002-0387-8818; Soranzo, Nicole/0000-0003-1095-3852; Levy, Shawn/0000-0002-1369-5740	NIH [R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973, P50 AR055081]; National Science Foundation of China; Huo Ying Dong Education Foundation; HuNan Province; Xi'an Jiaotong University; Ministry of Education of China; Wellcome Trust; European Commission [QLK6-CT-2002-02629]; Arthritis Research Campaign; Chronic Disease Research Foundation; European Union FP-5 GenomEUtwin Project [QLG2-CT-2002-01254]; Australian National Health and Medical Research Council [294402, 343603]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050496, P50AR055081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026564, R21AG027110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA015973] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Huo Ying Dong Education Foundation; HuNan Province; Xi'an Jiaotong University(Xi'an Jiaotong University); Ministry of Education of China(Ministry of Education, China); Wellcome Trust(Wellcome TrustEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Arthritis Research Campaign(Versus Arthritis); Chronic Disease Research Foundation; European Union FP-5 GenomEUtwin Project; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Investigators of this work (Deng HW, Liu YZ, Wang L, Guo YF, Li J, Liu XG, Yan H, Xiong DH, Zhang YP, and Jing TB) were partially supported by grants from NIH (R01 AR050496-01, R21 AG027110, R01 AG026564, R21 AA015973 and P50 AR055081). The study also benefited from grants from National Science Foundation of China, Huo Ying Dong Education Foundation, HuNan Province, Xi'an Jiaotong University, and the Ministry of Education of China. Investigators from UK and Australia (Spector TD, Wilson SG, Deloukas P, Soranzo N, Chinnapen-Horsley U, Williams FM and Cervino A) were supported by Wellcome Trust; European Commission (QLK6-CT-2002-02629, GEFOS); the Arthritis Research Campaign; the Chronic Disease Research Foundation and the European Union FP-5 GenomEUtwin Project (QLG2-CT-2002-01254) and the Australian National Health and Medical Research Council (Project Grants 294402 and 343603).	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di XJ, 2005, BIOINFORMATICS, V21, P1958, DOI 10.1093/bioinformatics/bti275; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; EASTON DF, 2007, NATURE; Fang Y, 2007, J CLIN ENDOCR METAB, V92, P1491, DOI 10.1210/jc.2006-1134; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Genant HK, 1996, J BONE MINER RES, V11, P707; Havill LM, 2007, J BONE MINER RES, V22, P737, DOI 10.1359/JBMR.070213; HUNTER DJ, 2007, NAT GENET; Ioannidis JPA, 2007, J BONE MINER RES, V22, P173, DOI 10.1359/JBMR.060806; KALENDER WA, 1992, OSTEOPOROSIS INT, V2, P82, DOI 10.1007/BF01623841; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lei SF, 2005, BONE, V36, P533, DOI 10.1016/j.bone.2004.11.002; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; LIn XN, 2005, J BIOL CHEM, V280, P12820, DOI 10.1074/jbc.M411591200; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MAZESS RB, 1994, J BONE MINER RES, V9, P541; MORIN S, 2008, OSTEOPOROS INT; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; REICH KM, 1991, AM J PHYSIOL, V261, pC428, DOI 10.1152/ajpcell.1991.261.3.C428; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Riddle RC, 2006, AM J PHYSIOL-CELL PH, V290, pC776, DOI 10.1152/ajpcell.00082.2005; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Seeman E, 2001, J BONE MINER RES, V16, P120, DOI 10.1359/jbmr.2001.16.1.120; Shen H, 2006, J MED GENET, V43, P873, DOI 10.1136/jmg.2006.041251; Vega E, 1998, CALCIFIED TISSUE INT, V62, P465, DOI 10.1007/s002239900462; Xiao P, 2006, J BONE MINER RES, V21, P1536, DOI 10.1359/JBMR.060717; Xiong DH, 2006, J BONE MINER RES, V21, P424, DOI 10.1359/JBMR.051202; Yang RS, 1998, CALCIFIED TISSUE INT, V63, P86, DOI 10.1007/s002239900494; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Zmuda JM, 2001, J BONE MINER RES, V16, P911, DOI 10.1359/jbmr.2001.16.5.911	37	50	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3160	10.1371/journal.pone.0003160	http://dx.doi.org/10.1371/journal.pone.0003160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776929	Green Submitted, Green Published, gold			2022-12-27	WOS:000264424300005
J	Li, YC; Coelho, CM; Liu, T; Wu, S; Wu, JS; Zeng, YR; Li, YC; Hunter, B; Dante, RA; Larkins, BA; Wu, RL				Li, Yanchun; Coelho, Cintia M.; Liu, Tian; Wu, Song; Wu, Jiasheng; Zeng, Yanru; Li, Youchun; Hunter, Brenda; Dante, Ricardo A.; Larkins, Brian A.; Wu, Rongling			A Statistical Model for Estimating Maternal-Zygotic Interactions and Parent-of-Origin Effects of QTLs for Seed Development	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; MUSCLE MASS; ENDOSPERM DEVELOPMENT; PATTERN-FORMATION; LINKAGE; GENE; SIZE; GENOME; ENDOREDUPLICATION; SUSCEPTIBILITY	Proper development of a seed requires coordinated exchanges of signals among the three components that develop side by side in the seed. One of these is the maternal integument that encloses the other two zygotic components, i.e., the diploid embryo and its nurturing annex, the triploid endosperm. Although the formation of the embryo and endosperm contains the contributions of both maternal and paternal parents, maternally and paternally derived alleles may be expressed differently, leading to a so-called parent-of-origin or imprinting effect. Currently, the nature of how genes from the maternal and zygotic genomes interact to affect seed development remains largely unknown. Here, we present a novel statistical model for estimating the main and interaction effects of quantitative trait loci (QTLs) that are derived from different genomes and further testing the imprinting effects of these QTLs on seed development. The experimental design used is based on reciprocal backcrosses toward both parents, so that the inheritance of parent- specific alleles could be traced. The computing model and algorithm were implemented with the maximum likelihood approach. The new strategy presented was applied to study the mode of inheritance for QTLs that control endoreduplication traits in maize endosperm. Monte Carlo simulation studies were performed to investigate the statistical properties of the new model with the data simulated under different imprinting degrees. The false positive rate of imprinting QTL discovery by the model was examined by analyzing the simulated data that contain no imprinting QTL. The reciprocal design and a series of analytical and testing strategies proposed provide a standard procedure for genomic mapping of QTLs involved in the genetic control of complex seed development traits in flowering plants.	[Li, Yanchun; Wu, Jiasheng; Zeng, Yanru; Wu, Rongling] Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China; [Li, Yanchun] Fujian Acad Agr Sci, Agr Ecol Res Inst, Fuzhou, Peoples R China; [Coelho, Cintia M.; Li, Youchun; Hunter, Brenda; Dante, Ricardo A.; Larkins, Brian A.] Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; [Liu, Tian] Genome Inst Singapore, Human Genet Grp, Singapore, Singapore; [Wu, Song; Wu, Rongling] Univ Florida, Dept Stat, Gainesville, FL USA; [Wu, Rongling] Princeton Univ, Dept Operat Res & Financial Engn, Princeton, NJ USA	Zhejiang A&F University; Fujian Academy of Agricultural Sciences; University of Arizona; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); State University System of Florida; University of Florida; Princeton University	Li, YC (corresponding author), Zhejiang Forestry Univ, Sch Forestry & Biotechnol, Linan, Zhejiang, Peoples R China.	rongling@princeton.edu	Coelho, Cíntia M/M-9939-2017; li, yan/GTI-4638-2022; Dante, Ricardo A./F-9642-2012	Coelho, Cíntia M/0000-0002-8564-3587; Dante, Ricardo A./0000-0002-2738-4433	Department of Energy [DE-96ER20242]; NSF/NIH [0540745]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Department of Energy(United States Department of Energy (DOE)); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research described in this manuscript was supported by a grant from the Department of Energy (DE-96ER20242) to BAL and NSF/NIH grant (No. 0540745) to RLW. C.M.C. and R.A.D. were supported by scholarships from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/BF02172979; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; CHURCHILL GA, 1994, GENETICS, V138, P963; Clapcott SJ, 2000, PARASITE IMMUNOL, V22, P259, DOI 10.1046/j.1365-3024.2000.00308.x; Coelho CM, 2007, THEOR APPL GENET, V115, P1147, DOI 10.1007/s00122-007-0640-z; Cui YH, 2006, GENET RES, V87, P61, DOI 10.1017/S0016672306007956; Cui YH, 2006, GENOMICS, V87, P543, DOI 10.1016/j.ygeno.2005.11.021; Cui YH, 2005, GENET RES, V86, P65, DOI 10.1017/S0016672305007615; Cui YH, 2005, BIOINFORMATICS, V21, P2447, DOI 10.1093/bioinformatics/bti342; Cui YH, 2004, GENETICS, V167, P1017, DOI 10.1534/genetics.103.024398; Cui YH, 2007, GENETICA, V130, P227, DOI 10.1007/s10709-006-9101-x; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; de Koning DJ, 2002, GENETICS, V161, P931; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; Dilkes BP, 2002, GENETICS, V160, P1163; Evans MMS, 2001, GENETICS, V159, P303; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; Haghighi F, 2002, AM J HUM GENET, V70, P142, DOI 10.1086/324709; Hanson RL, 2001, AM J HUM GENET, V68, P951, DOI 10.1086/319508; Ingouff M, 2006, PLANT CELL, V18, P3491, DOI 10.1105/tpc.106.047266; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Knott SA, 1998, GENETICS, V149, P1069; LANDER ES, 1989, GENETICS, V121, P185; Lin M, 2003, GENETICS, V165, P901; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Mora-Garcia S, 2000, CURR BIOL, V10, pR71, DOI 10.1016/S0960-9822(00)00285-2; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nezer C, 2003, GENETICS, V165, P277; Nowack MK, 2006, NAT GENET, V38, P63, DOI 10.1038/ng1694; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Paterson AD, 1999, HUM HERED, V49, P197, DOI 10.1159/000022875; Pfeifer K, 2000, AM J HUM GENET, V67, P777, DOI 10.1086/303101; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reik W, 2001, NAT GENET, V27, P255, DOI 10.1038/85804; Shete S, 2002, AM J HUM GENET, V70, P751, DOI 10.1086/338931; Shete S, 2003, AM J HUM GENET, V73, P933, DOI 10.1086/378592; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Sundaresan V, 2005, P NATL ACAD SCI USA, V102, P17887, DOI 10.1073/pnas.0509021102; Tuiskula-Haavisto M, 2004, GENET RES, V84, P57, DOI 10.1017/S0016672304006950; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Vinkenoog R, 2003, MOL BIOTECHNOL, V25, P149, DOI 10.1385/MB:25:2:149; Wu R., 2007, STAT GENETICS QUANTI; Wu RL, 2002, P NATL ACAD SCI USA, V99, P11281, DOI 10.1073/pnas.112345699; Wu RL, 2002, GENETICS, V162, P875; Xiao WY, 2006, PLANT PHYSIOL, V142, P1160, DOI 10.1104/pp.106.088849	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3131	10.1371/journal.pone.0003131	http://dx.doi.org/10.1371/journal.pone.0003131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769549	Green Published, gold, Green Submitted			2022-12-27	WOS:000264419100002
J	Liu, LN; Elmalk, AT; Aartsma, TJ; Thomas, JC; Lamers, GEM; Zhou, BC; Zhang, YZ				Liu, Lu-Ning; Elmalk, Abdalmohsen T.; Aartsma, Thijs J.; Thomas, Jean-Claude; Lamers, Gerda E. M.; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Light-Induced Energetic Decoupling as a Mechanism for Phycobilisome-Related Energy Dissipation in Red Algae: A Single Molecule Study	PLOS ONE			English	Article								Background: Photosynthetic organisms have developed multiple protective mechanisms to prevent photodamage in vivo under high-light conditions. Cyanobacteria and red algae use phycobilisomes (PBsomes) as their major light-harvesting antennae complexes. The orange carotenoid protein in some cyanobacteria has been demonstrated to play roles in the photoprotective mechanism. The PBsome-itself-related energy dissipation mechanism is still unclear. Methodology/Principal Findings: Here, single-molecule spectroscopy is applied for the first time on the PBsomes of red alga Porphyridium cruentum, to detect the fluorescence emissions of phycoerythrins (PE) and PBsome core complex simultaneously, and the real-time detection could greatly characterize the fluorescence dynamics of individual PBsomes in response to intense light. Conclusions/Significance: Our data revealed that strong green-light can induce the fluorescence decrease of PBsome, as well as the fluorescence increase of PE at the first stage of photobleaching. It strongly indicated an energetic decoupling occurring between PE and its neighbor. The fluorescence of PE was subsequently observed to be decreased, showing that PE was photobleached when energy transfer in the PBsomes was disrupted. In contrast, the energetic decoupling was not observed in either the PBsomes fixed with glutaraldehyde, or the mutant PBsomes lacking B-PE and remaining b-PE. It was concluded that the energetic decoupling of the PBsomes occurs at the specific association between B-PE and b-PE within the PBsome rod. Assuming that the same process occurs also at the much lower physiological light intensities, such a decoupling process is proposed to be a strategy corresponding to PBsomes to prevent photodamage of the photosynthetic reaction centers. Finally, a novel photoprotective role of c-subunit-containing PE in red algae was discussed.	[Liu, Lu-Ning; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Liu, Lu-Ning; Elmalk, Abdalmohsen T.; Aartsma, Thijs J.] Leiden Univ, Biophys Dept, Huygens Lab, Leiden, Netherlands; [Thomas, Jean-Claude; Lamers, Gerda E. M.] CNRS, Ecole Normale Superieure, UMR 8186, Paris, France; Leiden Univ, Inst Biol, Leiden, Netherlands	Shandong University; Leiden University; Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Leiden University; Leiden University - Excl LUMC	Liu, LN (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn	Liu, Lu-Ning/B-1460-2009	Liu, Lu-Ning/0000-0002-8884-4819	National Natural Science Foundation of China [40676078]; Hi-Tech Research and Development program of China [2008AA09Z404]; Key International S&T Cooperation Project of China [2008DFA30440]; Netherlands Organization for Scientific Research (NWO); Foundation for Earth and Life Sciences (ALW)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development program of China(National High Technology Research and Development Program of China); Key International S&T Cooperation Project of China; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Foundation for Earth and Life Sciences (ALW)	The work was supported by the National Natural Science Foundation of China (40676078), Hi-Tech Research and Development program of China (2008AA09Z404), and Key International S&T Cooperation Project of China (2008DFA30440). This project is part of the research programme "From Molecule to Cell" funded by the Netherlands Organization for Scientific Research (NWO) and the Foundation for Earth and Life Sciences (ALW).	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; APT KE, 1995, J MOL BIOL, V248, P79, DOI 10.1006/jmbi.1995.0203; Arteni AA, 2008, PHOTOSYNTH RES, V95, P169, DOI 10.1007/s11120-007-9264-z; BIGGINS J, 1984, BIOCHIM BIOPHYS ACTA, V767, P138, DOI 10.1016/0005-2728(84)90088-4; Bopp MA, 1997, P NATL ACAD SCI USA, V94, P10630, DOI 10.1073/pnas.94.20.10630; Bopp MA, 1999, P NATL ACAD SCI USA, V96, P11271, DOI 10.1073/pnas.96.20.11271; FICNER R, 1993, EUR J BIOCHEM, V218, P103, DOI 10.1111/j.1432-1033.1993.tb18356.x; GANTT E, 1974, BIOCHEMISTRY-US, V13, P2960, DOI 10.1021/bi00711a027; GANTT E, 1972, J CELL BIOL, V54, P313, DOI 10.1083/jcb.54.2.313; GANTT E, 1976, BIOCHIM BIOPHYS ACTA, V430, P375, DOI 10.1016/0005-2728(76)90093-1; GLAZER AN, 1984, BIOCHIM BIOPHYS ACTA, V768, P29, DOI 10.1016/0304-4173(84)90006-5; Hofmann C, 2003, P NATL ACAD SCI USA, V100, P15534, DOI 10.1073/pnas.2533896100; Hofmann C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.013004; JONES RF, 1963, PHYSIOL PLANTARUM, V16, P636, DOI 10.1111/j.1399-3054.1963.tb08342.x; Kirilovsky D, 2007, PHOTOSYNTH RES, V93, P7, DOI 10.1007/s11120-007-9168-y; Lao KQ, 1996, P NATL ACAD SCI USA, V93, P5258, DOI 10.1073/pnas.93.11.5258; Liu LN, 2005, BBA-BIOENERGETICS, V1708, P133, DOI 10.1016/j.bbabio.2005.04.001; Luong AK, 2005, J PHYS CHEM B, V109, P15691, DOI 10.1021/jp050465h; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Mackowski S, 2007, BIOPHYS J, V93, P3249, DOI 10.1529/biophysj.107.112094; Rakhimberdieva MG, 2007, FEBS LETT, V581, P2429, DOI 10.1016/j.febslet.2007.04.056; Rakhimberdieva MG, 2004, FEBS LETT, V574, P85, DOI 10.1016/j.febslet.2004.07.087; Rinalducci S, 2008, BBA-BIOENERGETICS, V1777, P417, DOI 10.1016/j.bbabio.2008.02.005; SIVAN A, 1993, PHYCOLOGIA, V32, P68, DOI 10.2216/i0031-8884-32-1-68.1; SIVAN A, 1995, J PHYCOL, V31, P167, DOI 10.1111/j.0022-3646.1995.00167.x; Six C, 2007, PHOTOSYNTH RES, V92, P75, DOI 10.1007/s11120-007-9170-4; Stoitchkova K, 2007, BBA-BIOENERGETICS, V1767, P750, DOI 10.1016/j.bbabio.2007.03.002; SUTER GW, 1984, BIOCHIM BIOPHYS ACTA, V766, P269, DOI 10.1016/0005-2728(84)90241-X; Vacha F, 2005, MICRON, V36, P483, DOI 10.1016/j.micron.2005.04.004; van Oijen AM, 1999, SCIENCE, V285, P400, DOI 10.1126/science.285.5426.400; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wilson A, 2007, PLANT CELL, V19, P656, DOI 10.1105/tpc.106.045351; Wormke S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2737429; Wu M, 1996, J PHYS CHEM-US, V100, P17406, DOI 10.1021/jp9616775; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818; Ying LM, 1998, J PHYS CHEM B, V102, P10399, DOI 10.1021/jp983227d; Zehetmayer P, 2004, BBA-BIOENERGETICS, V1608, P35, DOI 10.1016/j.bbabio.2003.10.003; Zehetmayer P, 2002, BIOPHYS J, V83, P407, DOI 10.1016/S0006-3495(02)75178-3	38	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3134	10.1371/journal.pone.0003134	http://dx.doi.org/10.1371/journal.pone.0003134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769542	Green Published, gold			2022-12-27	WOS:000264419100004
J	Dwan, K; Altman, DG; Arnaiz, JA; Bloom, J; Chan, AW; Cronin, E; Decullier, E; Easterbrook, PJ; Von Elm, E; Gamble, C; Ghersi, D; Ioannidis, JPA; Simes, J; Williamson, PR				Dwan, Kerry; Altman, Douglas G.; Arnaiz, Juan A.; Bloom, Jill; Chan, An-Wen; Cronin, Eugenia; Decullier, Evelyne; Easterbrook, Philippa J.; Von Elm, Erik; Gamble, Carrol; Ghersi, Davina; Ioannidis, John P. A.; Simes, John; Williamson, Paula R.			Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias	PLOS ONE			English	Article							RANDOMIZED-TRIALS; CLINICAL-TRIALS; FOLLOW-UP; BIOMEDICAL-RESEARCH; SELECTION BIAS; TIME; COMPLETION; PROTOCOLS; ONCOLOGY; IMPACT	Background: The increased use of meta-analysis in systematic reviews of healthcare interventions has highlighted several types of bias that can arise during the completion of a randomised controlled trial. Study publication bias has been recognised as a potential threat to the validity of meta-analysis and can make the readily available evidence unreliable for decision making. Until recently, outcome reporting bias has received less attention. Methodology/Principal Findings: We review and summarise the evidence from a series of cohort studies that have assessed study publication bias and outcome reporting bias in randomised controlled trials. Sixteen studies were eligible of which only two followed the cohort all the way through from protocol approval to information regarding publication of outcomes. Eleven of the studies investigated study publication bias and five investigated outcome reporting bias. Three studies have found that statistically significant outcomes had a higher odds of being fully reported compared to nonsignificant outcomes (range of odds ratios: 2.2 to 4.7). In comparing trial publications to protocols, we found that 40-62% of studies had at least one primary outcome that was changed, introduced, or omitted. We decided not to undertake meta-analysis due to the differences between studies. Conclusions: Recent work provides direct empirical evidence for the existence of study publication bias and outcome reporting bias. There is strong evidence of an association between significant results and publication; studies that report positive or significant results are more likely to be published and outcomes that are statistically significant have higher odds of being fully reported. Publications have been found to be inconsistent with their protocols. Researchers need to be aware of the problems of both types of bias and efforts should be concentrated on improving the reporting of trials.	[Dwan, Kerry; Gamble, Carrol; Williamson, Paula R.] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Arnaiz, Juan A.] UASP Hosp Clin, Clin Pharmacol Unit, Barcelona, Spain; [Bloom, Jill] Moorfields Eye Hosp, London, England; [Chan, An-Wen] Canadian Inst Hlth Res, Randomized Controlled Trials Unit, Ottawa, ON, Canada; [Cronin, Eugenia] Healthier Communities Publ Hlth, Greenwich Council, London, England; [Decullier, Evelyne] DIM Hospices Civils Lyon, Clin Epidemiol Unit, Lyon, France; [Easterbrook, Philippa J.] Kings Coll London, Dept HIV, GUM, London, England; [Von Elm, Erik] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Von Elm, Erik] Univ Med Ctr Freiburg, Dept Med Biomet & Med Informat, German Cochrane Ctr, Freiburg, Germany; [Ghersi, Davina] NHMRC, Clin Trials Ctr, Camperdown, NSW, Australia; [Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Med Ctr, Dept Med, Inst Clin Res & Hlth Policy Stud, Medford, MA 02155 USA; [Simes, John] Univ Sydney, NHMRC, Clin Trials Ctr, Sydney, NSW 2006, Australia	University of Liverpool; University of Oxford; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Institute for Work & Health; CHU Lyon; University of London; King's College London; University of Bern; University of Freiburg; University of Sydney; University of Ioannina; Tufts University; University of Sydney	Dwan, K (corresponding author), Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England.	kerry.dwan@liverpool.ac.uk	Gamble, Carrol/AAE-9895-2019; Williamson, Paula R/B-6425-2016; decullier, evelyne/AAL-5861-2021; Dwan, Kerry/AFK-6469-2022; Simes, Robert John/P-1497-2014; Dwan, Kerry/AAG-4726-2022; Ioannidis, John P. A./G-9836-2011	Gamble, Carrol/0000-0002-3021-1955; Williamson, Paula R/0000-0001-9802-6636; Dwan, Kerry/0000-0001-6918-1215; Dwan, Kerry/0000-0001-6918-1215; von Elm, Erik/0000-0002-7412-0406; Easterbrook, Philippa/0000-0002-2603-5418	NICE Liverpool Reviews and Implementation Group; Cancer Research UK; MRC [G0200585] Funding Source: UKRI; Medical Research Council [G0200585] Funding Source: researchfish	NICE Liverpool Reviews and Implementation Group; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work forms part of the first author's PhD, funded by the NICE Liverpool Reviews and Implementation Group. Douglas Altman is supported by Cancer Research UK. Funders were not involved in the work.	Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; CHAPPELL L, 2005, P 5 INT C PEER REV B; Contopoulos-Ioannidis DG, 2006, PHARMACOGENET GENOM, V16, P705, DOI 10.1097/01.fpc.0000236332.11304.8f; Cooper H, 1997, PSYCHOL METHODS, V2, P447, DOI 10.1037/1082-989X.2.4.447; Cronin E, 2004, INT J TECHNOL ASSESS, V20, P351, DOI 10.1017/S0266462304001175; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-165; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; DICKERSIN K, 1993, J CURR CLIN TRAILS; Dubben HH, 2005, BRIT MED J, V331, P433, DOI 10.1136/bmj.38478.497164.F7; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Egger M., 2008, SYSTEMATIC REV HLTH; GHERSI D, 2006, THESIS U SYDNEY; Hahn S, 2002, J EVAL CLIN PRACT, V8, P353, DOI 10.1046/j.1365-2753.2002.00314.x; Haidich AB, 2001, AM J EPIDEMIOL, V154, P873, DOI 10.1093/aje/154.9.873; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hutton JL, 2000, J ROY STAT SOC C-APP, V49, P359, DOI 10.1111/1467-9876.00197; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P281, DOI 10.1001/jama.279.4.281; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Menzel S, 2007, DEUT MED WOCHENSCHR, V132, P2313, DOI 10.1055/s-2007-991648; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; OLSEN KL, 2001, COCHRANE DATABASE ME, DOI DOI 10.1002/14651858.MR000006; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Rothstein H, 2005, PUBLICATION BIAS IN META-ANALYSIS: PREVENTION, ASSESSMENT AND ADJUSTMENTS, pIX; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Soares HP, 2005, JAMA-J AM MED ASSOC, V293, P970, DOI 10.1001/jama.293.8.970; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; SONG F, 2000, HLTH TECHNOL ASSES, V4; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Tannock IF, 1996, J NATL CANCER I, V88, P206, DOI 10.1093/jnci/88.3-4.206; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Williamson PR, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-9; Williamson PR, 2005, STAT METHODS MED RES, V14, P515, DOI 10.1191/0962280205sm415oa; Williamson PR, 2005, STAT MED, V24, P1547, DOI 10.1002/sim.2025; WORMALD R, 1997, 2 INT C SCI BAS HLTH	45	1097	1104	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3081	10.1371/journal.pone.0003081	http://dx.doi.org/10.1371/journal.pone.0003081			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769481	Green Published, gold			2022-12-27	WOS:000264796600003
J	Scherbaum, WA; Ohmann, C; Abholz, HH; Dragano, N; Lankisch, M				Scherbaum, Werner A.; Ohmann, Christian; Abholz, Heinz-Harald; Dragano, Nico; Lankisch, Mark			Effect of the Frequency of Self-Monitoring Blood Glucose in Patients with Type 2 Diabetes Treated with Oral Antidiabetic Drugs-A Multi-Centre, Randomized Controlled Trial	PLOS ONE			English	Article								Objective: Recommendations on the frequency of self-monitoring of blood glucose (SMBG) vary widely among physicians treating patients with type 2 diabetes (T2D). Aim of this study was to investigate two testing regimen of SMBG in patients with stable metabolic control. Research Design and Methods: Patients with T2D treated with oral antidiabetic drugs were randomized to two groups: either one SMBG (low) or four SMBG (high) per week. Subjects were followed up after 3, 6 and 12 months. Primary outcome parameter was the change in HbA1c between baseline and 6 months. Primary outcome criterion was tested by a one-sided t- test for non- inferiority. Secondary outcome parameters were safety, compliance and HbA1c at 3 and 12 months. Results: There were no differences in the 202 subjects for demographic and sociodemographic parameters and drug treatment. HbA(1)c (%) at baseline was similar in both groups (7.2 +/- 1.4 vs. 7.2 +/- 1.0). Non- inferiority was demonstrated for the low group (p=0.0022) with a difference from baseline to 6 months of 0.24 in the low and of 0.16 in the high group. Compliance with the testing regimen was 82-90% in both groups. There were no statistical significant differences for compliance, HbA(1)c at 3 and 12 months and serious adverse events (SAE). Conclusion: One SMBG per week is as sufficient and safe as four SMBG per week to maintain HbA(1)c in non-insulin treated T2D close to metabolic target. The results of this study are in contrast to current international consensus guidelines.	[Scherbaum, Werner A.] Univ Hosp Dusseldorf, European Training Ctr Endocrinol & Metab, WHO Collaborating Ctr Diabet, Dept Endocrinol Diabet & Rheumatol, Dusseldorf, Germany; [Scherbaum, Werner A.; Lankisch, Mark] Univ Dusseldorf, German Diabetes Ctr Heinrich Heine, German Diabetes Clin, D-4000 Dusseldorf, Germany; [Ohmann, Christian] Univ Hosp Dusseldorf, Coordinat Ctr Clin Trials, Dusseldorf, Germany; [Abholz, Heinz-Harald] Univ Hosp Dusseldorf, Dept Gen Med, Dusseldorf, Germany; [Dragano, Nico] Univ Hosp Dusseldorf, Dept Med Sociol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Scherbaum, WA (corresponding author), Univ Hosp Dusseldorf, European Training Ctr Endocrinol & Metab, WHO Collaborating Ctr Diabet, Dept Endocrinol Diabet & Rheumatol, Dusseldorf, Germany.	scherbaum@uni-duesseldorf.de	Ohmann, Christian/AAV-8608-2020		Health Services Research Programme of the German Ministry of Education and Research (BMBF); Association of Compulsory Health Insurance (GKV)	Health Services Research Programme of the German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Association of Compulsory Health Insurance (GKV)	The Health Services Research Programme of the German Ministry of Education and Research (BMBF) and the Association of Compulsory Health Insurance (GKV)	ALLEN BT, 1990, DIABETES CARE, V13, P1044, DOI 10.2337/diacare.13.10.1044; Armitage P., 2002, STAT METHODS MED RES; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bergenstal RM, 2005, AM J MED, V118, p1S, DOI 10.1016/j.amjmed.2005.07.055; Davidson MB, 2005, AM J MED, V118, P422, DOI 10.1016/j.amjmed.2004.12.006; Davis WA, 2006, DIABETES CARE, V29, P1764, DOI 10.2337/dc06-0268; Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE; FONTBONNE A, 1989, DIABETES METAB, V15, P255; Guerci B, 2003, DIABETES METAB, V29, P587, DOI 10.1016/S1262-3636(07)70073-3; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Martin S, 2006, DIABETOLOGIA, V49, P271, DOI 10.1007/s00125-005-0083-5; MUCHMORE DB, 1994, ACTA DIABETOL, V31, P215, DOI 10.1007/BF00571954; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Owens D, 2004, DIABETES PRIM CARE, V6, P8; Schwedes U, 2002, DIABETES CARE, V25, P1928, DOI 10.2337/diacare.25.11.1928; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Soumerai SB, 2004, ARCH INTERN MED, V164, P645, DOI 10.1001/archinte.164.6.645; Welschen LMC, 2005, DIABETES CARE, V28, P1510, DOI 10.2337/diacare.28.6.1510	20	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3087	10.1371/journal.pone.0003087	http://dx.doi.org/10.1371/journal.pone.0003087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769484	Green Submitted, Green Published, gold			2022-12-27	WOS:000264796600006
J	Harshbarger, TB; Song, AW				Harshbarger, Todd B.; Song, Allen W.			Differentiating Sensitivity of Post-Stimulus Undershoot under Diffusion Weighting: Implication of Vascular and Neuronal Hierarchy	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SUPPLEMENTARY MOTOR AREAS; OXIDATIVE-METABOLISM; BRAIN ACTIVATION; TEMPORAL CHARACTERISTICS; SPATIAL LOCALIZATION; BALLOON MODEL; BOLD RESPONSE; FMRI SIGNAL; OXYGENATION	The widely used blood oxygenation level dependent (BOLD) signal during brain activation, as measured in typical fMRI methods, is composed of several distinct phases, the last of which, and perhaps the least understood, is the post-stimulus undershoot. Although this undershoot has been consistently observed, its hemodynamic and metabolic sources are still under debate, as evidences for sustained blood volume increases and metabolic activities have been presented. In order to help differentiate the origins of the undershoot from vascular and neuronal perspectives, we applied progressing diffusion weighting gradients to investigate the BOLD signals during visual stimulation. Three distinct regions were established and found to have fundamentally different properties in post-stimulus signal undershoot. The first region, with a small but focal spatial extent, shows a clear undershoot with decreasing magnitude under increasing diffusion weighting, which is inferred to represent intravascular signal from larger vessels with large apparent diffusion coefficients (ADC), or high mobility. The second region, with a large continuous spatial extent in which some surrounds the first region while some spreads beyond, also shows a clear undershoot but no change in undershoot amplitude with progressing diffusion weighting. This would indicate a source based on extravascular and small vessel signal with smaller ADC, or lower mobility. The third region shows no significant undershoot, and is largely confined to higher order visual areas. Given their intermediate ADC, it would likely include both large and small vessels. Thus the consistent observation of this third region would argue against a vascular origin but support a metabolic basis for the post-stimulus undershoot, and would appear to indicate a lack of sustained metabolic rate likely due to a lower oxygen metabolism in these higher visual areas. Our results are the first, to our knowledge, to suggest that the post-stimulus undershoots have a spatial dependence on the vascular and neuronal hierarchy, and that progressing flow-sensitized diffusion weighting can help delineate these dependences.	[Harshbarger, Todd B.; Song, Allen W.] Duke Univ, Brain Imaging & Anal Ctr, Uninc Orange Cty, NC USA	Duke University	Harshbarger, TB (corresponding author), Duke Univ, Brain Imaging & Anal Ctr, Uninc Orange Cty, NC USA.	harshbarger@biac.duke.edu	Harshbarger, Todd/AAR-1317-2020	harshbarger, todd/0000-0001-5030-465X	 [NS41328];  [NS50329]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050329, P01NS041328] Funding Source: NIH RePORTER	; ; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by research grants NS41328 and NS50329.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Aubert A, 2007, P NATL ACAD SCI USA, V104, P4188, DOI 10.1073/pnas.0605864104; Bandettini PA, 1997, HUM BRAIN MAPP, V5, P93; BEHZADI Y, 2006, 14 ANN M ISMRM SEATT, P373; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P4, DOI 10.1002/mrm.1910340103; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Buxton RB, 2001, NEUROIMAGE, V13, P953, DOI 10.1006/nimg.2001.0814; Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013; CHEN JJ, 2007, 15 ANN M ISMRM BERL, P262; Chen W, 1998, MAGN RESON MED, V39, P520, DOI 10.1002/mrm.1910390404; Chiarelli PA, 2007, MAGN RESON MED, V57, P538, DOI 10.1002/mrm.21171; Darquie A, 2001, P NATL ACAD SCI USA, V98, P9391, DOI 10.1073/pnas.151125698; Frahm J, 1996, MAGNET RESON MED, V35, P143, DOI 10.1002/mrm.1910350202; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gangstead SL, 2002, MAGNET RESON MED, V48, P385, DOI 10.1002/mrm.10189; Harrison RV, 2002, CEREB CORTEX, V12, P225, DOI 10.1093/cercor/12.3.225; Harshbarger TB, 2004, MAGN RESON MED, V52, P1432, DOI 10.1002/mrm.20293; Hoge RD, 1999, NEUROIMAGE, V9, P573, DOI 10.1006/nimg.1999.0443; Huettel SA, 2004, CEREB CORTEX, V14, P165, DOI 10.1093/cercor/bhg115; Ishii K, 1996, J NUCL MED, V37, P1086; JIN T, 2006, 14 ANN M ISMRM SEATT, P2762; Jones RA, 1999, NMR BIOMED, V12, P301, DOI 10.1002/(SICI)1099-1492(199908)12:5<299::AID-NBM566>3.0.CO;2-H; Jones RA, 1998, MAGNET RESON MED, V40, P112, DOI 10.1002/mrm.1910400116; Kamba M, 2007, J MAGN RESON IMAGING, V26, P1506, DOI 10.1002/jmri.21193; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kruger G, 1996, MAGNET RESON MED, V35, P797, DOI 10.1002/mrm.1910350602; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; Lu HZ, 2004, J CEREBR BLOOD F MET, V24, P764, DOI 10.1097/01.WCB.0000124322.60992.5C; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Marcar VL, 2004, MAGN RESON IMAGING, V22, P921, DOI 10.1016/j.mri.2004.02.013; Michelich CR, 2006, NMR BIOMED, V19, P566, DOI 10.1002/nbm.1035; Obata T, 2004, NEUROIMAGE, V21, P144, DOI 10.1016/j.neuroimage.2003.08.040; OBATA T, 2006, 14 ANN M ISMRM SEATT, P2785; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; POSER BA, 2007, 15 ANN M ISMRM BERL, P261; Schroeter ML, 2006, NEUROIMAGE, V30, P349, DOI 10.1016/j.neuroimage.2005.09.048; Song AW, 2002, NEUROIMAGE, V17, P742, DOI 10.1006/nimg.2002.1217; Song AW, 1996, MAGNET RESON MED, V35, P155, DOI 10.1002/mrm.1910350204; Tuunanen PI, 2006, MAGN RESON IMAGING, V24, P993, DOI 10.1016/j.mri.2006.04.017; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Wolf M, 2002, NEUROIMAGE, V16, P704, DOI 10.1006/nimg.2002.1128; Yacoub E, 2006, J CEREBR BLOOD F MET, V26, P634, DOI 10.1038/sj.jcbfm.9600239; Zhao FQ, 2007, NEUROIMAGE, V34, P1084, DOI 10.1016/j.neuroimage.2006.10.016; ZHENG D, 1991, J NEUROSCI, V11, P2622; Zhong JH, 1998, MAGNET RESON MED, V40, P526, DOI 10.1002/mrm.1910400405; ZHU XH, 2006, 14 ANN M ISMRM SEATT, P2786	49	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2914	10.1371/journal.pone.0002914	http://dx.doi.org/10.1371/journal.pone.0002914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698432	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600002
J	Kring, SII; Holst, C; Zimmermann, E; Jess, T; Berentzen, T; Toubro, S; Hansen, T; Astrup, A; Pedersen, O; Sorensen, TIA				Kring, Sofia I. I.; Holst, Claus; Zimmermann, Esther; Jess, Tine; Berentzen, Tina; Toubro, Soren; Hansen, Torben; Astrup, Arne; Pedersen, Oluf; Sorensen, Thorkild I. A.			FTO Gene Associated Fatness in Relation to Body Fat Distribution and Metabolic Traits throughout a Broad Range of Fatness	PLOS ONE			English	Article							INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; ADULT OBESITY; MASS INDEX; CHILDHOOD; VARIANTS; DISEASE; CLONING; WEIGHT; RISK	Background: A common single nucleotide polymorphism (SNP) of FTO (rs9939609, T/A) is associated with total body fatness. We investigated the association of this SNP with abdominal and peripheral fatness and obesity-related metabolic traits in middle-aged men through a broad range of fatness present already in adolescence. Methodology/Principal Findings: Obese young Danish men (n = 753, BMI >= 31.0 kg/m(2)) and a randomly selected group (n = 879) from the same population were examined in three surveys (mean age 35, 46 and 49 years, respectively). The traits included anthropometrics, body composition, oral glucose tolerance test, blood lipids, blood pressure, fibrinogen and aspartate aminotransferase. Logistic regression analysis was used to assess the age-adjusted association between the phenotypes and the odds ratios for the FTO rs9939609 (TT and TA genotype versus the AA genotype), for anthropometrics and body composition estimated per unit z-score. BMI was strongly associated with the AA genotype in all three surveys: OR = 1.17, p = 1.1*10(-6), OR = 1.20, p = 1.7*10(-7), OR = 1.17, p = 3.4*10(-3), respectively. Fat body mass index was also associated with the AA genotype (OR = 1.21, p = 4.6*10(-7) and OR = 1.21, p = 1.0*10(-3)). Increased abdominal fatness was associated with the AA genotype when measured as waist circumference (OR = 1.21, p = 2.2*10(-6) and OR = 1.19, p = 5.9*10(-3)), sagittal abdominal diameter (OR = 1.17, p = 1.3*10(-4) and OR = 1.18, p = 0.011) and intra-abdominal adipose tissue (OR = 1.21, p = 0.005). Increased peripheral fatness measured as hip circumference (OR = 1.19, p = 1.3*10(-5) and OR = 1.18, p = 0.004) and lower body fat mass (OR = 1.26, p = 0.002) was associated with the AA genotype. The AA genotype was significantly associated with decreased Stumvoll insulin sensitivity index (OR = 0.93, p = 0.02) and with decreased non-fasting plasma HDL-cholesterol (OR = 0.57, p = 0.037), but not with any other of the metabolic traits. However, all significant results for both body fat distribution and metabolic traits were explained by a mediating effect of total fat mass. Conclusion: The association of the examined FTO SNP to general fatness throughout the range of fatness was confirmed, and this association explains the relation between the SNP and body fat distribution and decreased insulin sensitivity and HDL-cholesterol. The SNP was not significantly associated with other metabolic traits suggesting that they are not derived from the general accumulation of body fat.	[Kring, Sofia I. I.; Holst, Claus; Zimmermann, Esther; Jess, Tine; Berentzen, Tina; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark; [Kring, Sofia I. I.] Univ Copenhagen, Panum Inst, Ctr Pharmacogenom, DK-1168 Copenhagen, Denmark; [Toubro, Soren] Hvidovre Univ Hosp, Reduce Res Clin Nutr, Hvidovre, Denmark; [Hansen, Torben; Pedersen, Oluf] Steno Diabetes Ctr, Copenhagen, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Astrup, Arne] Univ Copenhagen, Fac Life Sci, Inst Human Nutr, DK-1168 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Steno Diabetes Center; Aarhus University; University of Copenhagen	Kring, SII (corresponding author), Copenhagen Univ Hosp, Ctr Hlth & Soc, Inst Prevent Med, Copenhagen, Denmark.	si@ipm.regionh.dk	Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Palmer, David/E-6824-2010; Astrup, Arne/B-1407-2015	Pedersen, Oluf/0000-0002-3321-3972; Astrup, Arne/0000-0001-8968-8996; Hansen, Torben/0000-0001-8748-3831; Zimmermann, Esther/0000-0001-5854-0542	Center for Pharmacogenomics at the University of Copenhagen, Denmark	Center for Pharmacogenomics at the University of Copenhagen, Denmark	This study is financially supported by Center for Pharmacogenomics at the University of Copenhagen, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Benyamin B, 2007, DIABETOLOGIA, V50, P1880, DOI 10.1007/s00125-007-0758-1; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; Buemann B, 2005, INT J OBESITY, V29, P624, DOI 10.1038/sj.ijo.0802929; CLEMENT K, 2007, OBESITY GENOMICS POS, P19; CLEMENT K, 2007, OBESITY GENOMICS POS, P221; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Do R, 2008, DIABETES, V57, P1147, DOI 10.2337/db07-1267; Field SF, 2007, DIABETOLOGIA, V50, P2218, DOI 10.1007/s00125-007-0767-0; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; HEITMANN BL, 1994, EUR J CLIN NUTR, V48, P228; Kring SII, 2008, OBESITY FACTS, V1, P138, DOI 10.1159/000137665; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; SCHNOHR P, 2001, J EUROPEAN SOC CA SH, V3; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; SONNEHOLM S, 1989, BRIT MED J, V299, P767, DOI 10.1136/bmj.299.6702.767; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Thomas DC, 2004, STAT METHODS GENETIC; TREUTH MS, 1995, AM J CLIN NUTR, V62, P527, DOI 10.1093/ajcn/62.3.527; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	29	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2958	10.1371/journal.pone.0002958	http://dx.doi.org/10.1371/journal.pone.0002958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698412	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600043
J	Christiansen, P				Christiansen, Per			Evolution of Skull and Mandible Shape in Cats (Carnivora: Felidae)	PLOS ONE			English	Article							AFRICAN WILD DOGS; PREDATORY BEHAVIOR; LATE PLEISTOCENE; BITE FORCES; LA-BREA; ECOLOGY; MAMMALS; SABERTOOTHS; CHARACTERS; PATTERNS	The felid family consists of two major subgroups, the sabretoothed and the feline cats, to which all extant species belong, and are the most anatomically derived of all carnivores for predation on large prey with a precision killing bite. There has been much controversy and uncertainty about why the skulls and mandibles of sabretoothed and feline cats evolved to become so anatomically divergent, but previous models have focused on single characters and no unifying hypothesis of evolutionary shape changes has been formulated. Here I show that the shape of the skull and mandible in derived sabrecats occupy entirely different positions within overall morphospace from feline cats, and that the evolution of skull and mandible shape has followed very different paths in the two subgroups. When normalised for body-size differences, evolution of bite forces differ markedly in the two groups, and are much lower in derived sabrecats, and they show a significant relationship with size and cranial shape, whereas no such relationship is present in feline cats. Evolution of skull and mandible shape in modern cats has been governed by the need for uniform powerful biting irrespective of body size, whereas in sabrecats, shape evolution was governed by selective pressures for efficient predation with hypertrophied upper canines at high gape angles, and bite forces were secondary and became progressively weaker during sabrecat evolution. The current study emphasises combinations of new techniques for morphological shape analysis and biomechanical studies to formulate evolutionary hypotheses for difficult groups.	[Christiansen, Per] Zool Museum, Dept Vertibrates, DK-2100 Copenhagen, Denmark		Christiansen, P (corresponding author), Zool Museum, Dept Vertibrates, DK-2100 Copenhagen, Denmark.	p2christiansen@zmuc.ku.dk			Carlsberg Foundation	Carlsberg Foundation(Carlsberg Foundation)	Carlsberg Foundation; they had no part of the actual work conducted.	Akersten W.A, 1985, CONTRIB SCI NAT HIST, V356, P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; Bakker R.T., 1983, P350; Biknevicius AR, 1996, CARNIVORE BEHAV ECOL, VII, P393; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1996, P 1993 NATO ASI MORP, P131; Bryant Harold N., 1996, P283; BUCKLANDWRIGHT JC, 1978, J MORPHOL, V155, P35, DOI 10.1002/jmor.1051550104; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; CHRISTIANSEN P, 2008, BIOL J LINN SOC, V92; CHRISTIANSEN P, 2008, J MAMMAL EVOL; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; COOPER SM, 1991, AFR J ECOL, V29, P130, DOI 10.1111/j.1365-2028.1991.tb00993.x; Creel S, 2001, CONSERV BIOL, V15, P271, DOI 10.1046/j.1523-1739.2001.99534.x; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; Gorman ML, 1998, NATURE, V391, P479, DOI 10.1038/35131; Goswami A, 2006, EVOLUTION, V60, P169; Gray J. E., 1867, Proceedings of the Zoological Society, P258; Haltenorth T., 1936, Zeitschrift fuer Saugetierkunde Berlin, V11, P32; Haltenorth T., 1937, Z SAUGETIERKUNDE, V12, P97; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; Hunt Jr R. M., 1996, CARNIVORE BEHAV ECOL, V2, P485; KURTEN B, 1954, COMMENT BIOL SOC SCI, V13, P1; LEWIS M, 1996, J HUM EVOL, V32, P257; Leyhausen, 1979, CAT BEHAV; Marean CW, 1995, J HUM EVOL, V29, P515, DOI 10.1006/jhev.1995.1074; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; MILLER GJ, 1984, IMPERIAL VALLEY COLL, V7, P1; MILLS MGL, 1993, MAMMALS PREDATORS, P256; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; RADINSKY L, 1982, NAT HIST, V91, P50; Rawn-Schatzinger V., 1992, ILL STATE MUS REP IN, V47, P1; ROBERTS D, 1979, ACTA ANAT, V103, P422, DOI 10.1159/000145044; ROHLF F.J., 1993, CONTRIBUTIONS MORPHO, V8, P131; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Salles LO., 1992, AM MUS NOVIT, V3047, P1; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1130, P1; Sokal RR, 1995, BIOMETRY; Sunquist ME, 2002, WILD CATS WORLD; Therrien F, 2005, J ZOOL, V267, P249, DOI 10.1017/S0952836905007430; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; TUCKER R, 1954, AUST J ZOOL, V2, P381, DOI 10.1071/ZO9540381; Turner A., 1997, BIG CATS THEIR FOSSI; Van Valkenburgh Blaire, 1998, Illinois State Museum Scientific Papers, V27, P357; Van Valkenhurgh B, 2007, J MORPHOL, V268, P1144; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 1993, SCIENCE, V261, P456, DOI 10.1126/science.261.5120.456; WERDELIN L, 1983, BIOL J LINN SOC, V19, P375, DOI 10.1111/j.1095-8312.1983.tb00793.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; ZELDITCH ML, 1995, SYST BIOL, V44, P179, DOI 10.2307/2413705; [No title captured]	60	77	85	0	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2807	10.1371/journal.pone.0002807	http://dx.doi.org/10.1371/journal.pone.0002807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665225	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300026
J	Sun, FJ; Caetano-Anolles, G				Sun, Feng-Jie; Caetano-Anolles, Gustavo			Evolutionary Patterns in the Sequence and Structure of Transfer RNA: A Window into Early Translation and the Genetic Code	PLOS ONE			English	Article							SECONDARY STRUCTURE; AMINO-ACIDS; COEVOLUTION THEORY; CONFIDENCE-LIMITS; ORIGIN; SELENOCYSTEINE; PROTEINS; UGA; PHYLOGENY; SPECULATIONS	Transfer RNA (tRNA) molecules play vital roles during protein synthesis. Their acceptor arms are aminoacylated with specific amino acid residues while their anticodons delimit codon specificity. The history of these two functions has been generally linked in evolutionary studies of the genetic code. However, these functions could have been differentially recruited as evolutionary signatures were left embedded in tRNA molecules. Here we built phylogenies derived from the sequence and structure of tRNA, we forced taxa into monophyletic groups using constraint analyses, tested competing evolutionary hypotheses, and generated timelines of amino acid charging and codon discovery. Charging of Sec, Tyr, Ser and Leu appeared ancient, while specificities related to Asn, Met, and Arg were derived. The timelines also uncovered an early role of the second and then first codon bases, identified codons for Ala and Pro as the most ancient, and revealed important evolutionary take-overs related to the loss of the long variable arm in tRNA. The lack of correlation between ancestries of amino acid charging and encoding indicated that the separate discoveries of these functions reflected independent histories of recruitment. These histories were probably curbed by co-options and important take-overs during early diversification of the living world.	[Sun, Feng-Jie; Caetano-Anolles, Gustavo] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Caetano-Anolles, G (corresponding author), Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA.	gca@uiuc.edu			National Science Foundation [MCB-0343126]; University of Illinois Critical Research Initiative	National Science Foundation(National Science Foundation (NSF)); University of Illinois Critical Research Initiative	This work was supported by National Science Foundation grant MCB-0343126 and the University of Illinois Critical Research Initiative.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Amirnovin R, 1997, J MOL EVOL, V44, P473, DOI 10.1007/PL00006170; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Araiso Y, 2008, NUCLEIC ACIDS RES, V36, P1187, DOI 10.1093/nar/gkm1122; Ashby WR., 1956, INTRO CYBERNETICS, DOI [10.5962/bhl.title.5851, DOI 10.5962/BHL.TITLE.5851]; Billoud B, 2000, MOL BIOL EVOL, V17, P1435, DOI 10.1093/oxfordjournals.molbev.a026244; Bilokapic S, 2004, EUR J BIOCHEM, V271, P694, DOI 10.1111/j.1432-1033.2003.03971.x; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Bremer B, 1999, SYST BIOL, V48, P413, DOI 10.1080/106351599260085; Brooks DJ, 2004, BIOINFORMATICS, V20, P2251, DOI 10.1093/bioinformatics/bth235; Brooks DJ, 2002, MOL BIOL EVOL, V19, P1645, DOI 10.1093/oxfordjournals.molbev.a003988; Caetano-Anolles G, 2005, J MOL EVOL, V60, P635, DOI 10.1007/s00239-004-0244-z; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Caetano-Anolles G, 2002, J MOL EVOL, V54, P333, DOI 10.1007/s00239-001-0048-3; Chaley MB, 1999, J MOL EVOL, V48, P168, DOI 10.1007/PL00006455; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Copeland PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-221; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; de Pouplana LR, 1998, P NATL ACAD SCI USA, V95, P11295, DOI 10.1073/pnas.95.19.11295; Di Giulio M, 2004, J THEOR BIOL, V226, P89, DOI 10.1016/j.jtbi.2003.07.001; DIGIULIO M, 1995, ORIGINS LIFE EVOL B, V25, P549, DOI 10.1007/BF01582024; Doyle JA, 2006, J TORREY BOT SOC, V133, P169, DOI 10.3159/1095-5674(2006)133[169:SFATOO]2.0.CO;2; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fontana W, 2002, BIOESSAYS, V24, P1164, DOI 10.1002/bies.10190; Forsdyke DR, 2007, J THEOR BIOL, V248, P745, DOI 10.1016/j.jtbi.2007.07.008; Fournier GP, 2007, J MOL EVOL, V65, P425, DOI 10.1007/s00239-007-9024-x; GLADYSHEV GP, 1982, J THEOR BIOL, V94, P301, DOI 10.1016/0022-5193(82)90314-9; Gladyshev VN, 2001, BIOFACTORS, V14, P87, DOI 10.1002/biof.5520140112; Gultyaev AP, 2002, J MOL EVOL, V54, P1, DOI 10.1007/s00239-001-0010-4; HAIG D, 1991, J MOL EVOL, V33, P412, DOI 10.1007/BF02103132; HARTMAN H, 1995, J MOL EVOL, V40, P541; HARTMAN H, 1978, ORIGINS LIFE EVOL B, V9, P133, DOI 10.1007/BF00931410; HARTMAN H, 1975, J MOL EVOL, V4, P359, DOI 10.1007/BF01732537; HATFIELD D, 1993, TRENDS GENET, V9, P69, DOI 10.1016/0168-9525(93)90215-4; Hatfield D, 1999, COMPREHENSIVE NATURA, P353; Hauser DL, 1997, CLADISTICS, V13, P97, DOI 10.1111/j.1096-0031.1997.tb00243.x; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; HIGGS PG, 1993, J PHYS I, V3, P43, DOI 10.1051/jp1:1993116; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; HIGGS PG, 1995, J CHEM SOC FARADAY T, V91, P2531, DOI 10.1039/ft9959102531; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; Hohn MJ, 2006, P NATL ACAD SCI USA, V103, P18095, DOI 10.1073/pnas.0608762103; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kim HS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-351; KLUGE AG, 1993, CLADISTICS, V9, P183, DOI 10.1111/j.1096-0031.1993.tb00217.x; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; LE SY, 1989, J THEOR BIOL, V138, P495, DOI 10.1016/S0022-5193(89)80047-5; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; LOVETT PS, 1991, J BACTERIOL, V173, P1810, DOI 10.1128/jb.173.5.1810-1812.1991; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; MCCLAIN WH, 1993, FASEB J, V7, P72, DOI 10.1096/fasebj.7.1.8422977; MEYER F, 1991, P NATL ACAD SCI USA, V88, P3758, DOI 10.1073/pnas.88.9.3758; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528; NIRENBERG M, 1966, COLD SPRING HARB SYM, V31, P11, DOI 10.1101/SQB.1966.031.01.008; Nixon KC, 1996, CLADISTICS, V12, P221, DOI 10.1111/j.1096-0031.1996.tb00010.x; O'Donoghue P, 2003, MICROBIOL MOL BIOL R, V67, P550, DOI 10.1128/MMBR.67.4.550-573.2003; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992; Pollock DD, 2003, J MOL EVOL, V56, P375, DOI 10.1007/s00239-002-2456-4; Rodin S, 1996, P NATL ACAD SCI USA, V93, P4537, DOI 10.1073/pnas.93.10.4537; RODIN S, 1993, P NATL ACAD SCI USA, V90, P4723, DOI 10.1073/pnas.90.10.4723; Rodin SN, 2008, HEREDITY, V100, P341, DOI 10.1038/sj.hdy.6801086; Rodin SN, 2006, DNA CELL BIOL, V25, P365, DOI 10.1089/dna.2006.25.365; Ronneberg TA, 2000, P NATL ACAD SCI USA, V97, P13690, DOI 10.1073/pnas.250403097; Sanderson MJ, 2000, SYST BIOL, V49, P671, DOI 10.1080/106351500750049761; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHNEIDER ED, 1994, FUTURES, V26, P626, DOI 10.1016/0016-3287(94)90034-5; SCHNEIDER ED, 1994, MATH COMPUT MODEL, V19, P25, DOI 10.1016/0895-7177(94)90188-0; Schrdinger E., 1944; Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Schultes EA, 1999, J MOL EVOL, V49, P76, DOI 10.1007/PL00006536; Schultes Erik, 1999, Complexity, V4, P61; Sheppard K, 2008, J MOL BIOL, V377, P831, DOI 10.1016/j.jmb.2008.01.016; Sherrer RL, 2008, NUCLEIC ACIDS RES, V36, P1247, DOI 10.1093/nar/gkm1134; SJOSTROM M, 1985, J MOL EVOL, V22, P272, DOI 10.1007/BF02099756; SOLL D, 1995, TRNA STRUCTURE BIOSY, P225; Soltis PS, 2003, STAT SCI, V18, P256; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; STADTMAN TC, 1990, ANNU REV BIOCHEM, V59, P111, DOI 10.1146/annurev.bi.59.070190.000551; Steel M, 2004, APPL MATH LETT, V17, P785, DOI 10.1016/j.aml.2004.06.006; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; STEFFENS W, 1999, NUCLEIC ACIDS RES, V27, P1578; STEGER G, 1984, J BIOMOL STRUCT DYN, V2, P543; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Sun FJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000018; Sun FJ, 2008, J MOL EVOL, V66, P21, DOI 10.1007/s00239-007-9050-8; Sun FJ, 2007, TRENDS GENET, V23, P26, DOI 10.1016/j.tig.2006.11.005; Swain TD, 2003, P ROY SOC B-BIOL SCI, V270, P887, DOI 10.1098/rspb.2002.2297; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Szathmary E, 1999, TRENDS GENET, V15, P223, DOI 10.1016/S0168-9525(99)01730-8; Teichmann SA, 2001, TRENDS BIOTECHNOL, V19, P482, DOI 10.1016/S0167-7799(01)01813-3; Trifonov EN, 1997, GENE, V205, P1, DOI 10.1016/S0378-1119(97)00479-4; Trifonov EN, 2004, J BIOMOL STRUCT DYN, V22, P1; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wang M, 2007, GENOME RES, V17, P1572, DOI 10.1101/gr.6454307; Watanabe Kimitsuna, 1995, P225; WEINER AM, 1973, J MOL BIOL, V80, P837, DOI 10.1016/0022-2836(73)90213-1; Widmann J, 2005, J MOL EVOL, V61, P524, DOI 10.1007/s00239-004-0315-1; WOESE CR, 1965, P NATL ACAD SCI USA, V54, P1546, DOI 10.1073/pnas.54.6.1546; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; WOESE CR, 1973, NATURWISSENSCHAFTEN, V60, P447; WOESE CR, 1966, COLD SPRING HARB SYM, V31, P723, DOI 10.1101/SQB.1966.031.01.093; WONG JT, 1981, TRENDS BIOCHEM SCI, V6, P33; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; YARUS M, 1989, BIOCHEMISTRY-US, V28, P980, DOI 10.1021/bi00429a010; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zhang Y, 2007, NUCLEIC ACIDS RES, V35, P4952, DOI 10.1093/nar/gkm514; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156; ZUCKERKANDL E, 1971, J MOL BIOL, V59, P473, DOI 10.1016/0022-2836(71)90311-1	119	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2799	10.1371/journal.pone.0002799	http://dx.doi.org/10.1371/journal.pone.0002799			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665254	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300018
J	Kimura, H; Kwan, KM; Zhang, Z; Deng, JM; Darnay, BG; Behringer, RR; Nakamura, T; de Crombrugghe, B; Akiyama, H				Kimura, Hiroaki; Kwan, Kin Ming; Zhang, Zhaoping; Deng, Jian Min; Darnay, Bryant G.; Behringer, Richard R.; Nakamura, Takashi; de Crombrugghe, Benoit; Akiyama, Haruhiko			Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation	PLOS ONE			English	Article								Background: Bone mass is maintained by continuous remodeling through repeated cycles of bone resorption by osteoclasts and bone formation by osteoblasts. This remodeling process is regulated by many systemic and local factors. Methodology/Principal Findings: We identified collagen triple helix repeat containing-1 (Cthrc1) as a downstream target of bone morphogenetic protein-2 (BMP2) in osteochondroprogenitor-like cells by PCR-based suppression subtractive hybridization followed by differential hybridization, and found that Cthrc1 was expressed in bone tissues in vivo. To investigate the role of Cthrc1 in bone, we generated Cthrc1-null mice and transgenic mice which overexpress Cthrc1 in osteoblasts (Cthrc1 transgenic mice). Microcomputed tomography (micro-CT) and bone histomorphometry analyses showed that Cthrc1-null mice displayed low bone mass as a result of decreased osteoblastic bone formation, whereas Cthrc1 transgenic mice displayed high bone mass by increase in osteoblastic bone formation. Osteoblast number was decreased in Cthrc1-null mice, and increased in Cthrc1 transgenic mice, respectively, while osteoclast number had no change in both mutant mice. In vitro, colony-forming unit (CFU) assays in bone marrow cells harvested from Cthrc1-null mice or Cthrc1 transgenic mice revealed that Cthrc1 stimulated differentiation and mineralization of osteoprogenitor cells. Expression levels of osteoblast specific genes, ALP, Col1a1, and Osteocalcin, in primary osteoblasts were decreased in Cthrc1-null mice and increased in Cthrc1 transgenic mice, respectively. Furthermore, BrdU incorporation assays showed that Cthrc1 accelerated osteoblast proliferation in vitro and in vivo. In addition, overexpression of Cthrc1 in the transgenic mice attenuated ovariectomy-induced bone loss. Conclusions/Significance: Our results indicate that Cthrc1 increases bone mass as a positive regulator of osteoblastic bone formation and offers an anabolic approach for the treatment of osteoporosis.	[Kimura, Hiroaki; Nakamura, Takashi; Akiyama, Haruhiko] Kyoto Univ, Dept Orthopaed, Kyoto, Japan; [Kwan, Kin Ming; Zhang, Zhaoping; Deng, Jian Min; Behringer, Richard R.; de Crombrugghe, Benoit] Univ Texas MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX USA; [Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX USA; [Kwan, Kin Ming] Chinese Univ Hong Kong, Dept Biol, Shatin, Peoples R China	Kyoto University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Chinese University of Hong Kong	Kimura, H (corresponding author), Kyoto Univ, Dept Orthopaed, Kyoto, Japan.	hakiyama@kuhp.kyoto-u.ac.jp		Kwan, Kin Ming/0000-0002-1246-2398	Japanese Ministry of Education, Culture, Sports, Science, and Technology [18390413]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049072] Funding Source: NIH RePORTER	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (#18390413).	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abe E, 2006, ANN NY ACAD SCI, V1068, P41, DOI 10.1196/annals.1346.007; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; DEMPSTER DW, 1995, BONE, V16, P157, DOI 10.1016/S8756-3282(94)00024-7; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Durmus T, 2006, GENE EXPR PATTERNS, V6, P935, DOI 10.1016/j.modgep.2006.03.008; Garrett IR, 2007, CURR TOP DEV BIOL, V78, P127, DOI 10.1016/S0070-2153(06)78004-8; HAHN M, 1991, VIRCHOWS ARCH A, V418, P1, DOI 10.1007/BF01600238; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kimura H, 2007, BIOCHEM BIOPH RES CO, V356, P935, DOI 10.1016/j.bbrc.2007.03.071; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; LeClair RJ, 2007, CIRC RES, V100, P826, DOI 10.1161/01.RES.0000260806.99307.72; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakanishi R, 2006, J BONE MINER RES, V21, P1713, DOI 10.1359/JBMR.060719; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARFITT AM, 2002, DISORDERS BONE MINER, P469; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; TURNER RT, 1987, J BONE MINER RES, V2, P115; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WRONSKI TJ, 1988, CALCIFIED TISSUE INT, V43, P179, DOI 10.1007/BF02571317; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; ZHAO M, 2002, BONE MORPHOGENETIC P, P1049	33	70	76	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3174	10.1371/journal.pone.0003174	http://dx.doi.org/10.1371/journal.pone.0003174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779865	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425100010
J	Melzer, N; Meuth, SG; Torres-Salazar, D; Bittner, S; Zozulya, AL; Weidenfeller, C; Kotsiari, A; Stangel, M; Fahlke, C; Wiendl, H				Melzer, Nico; Meuth, Sven G.; Torres-Salazar, Delany; Bittner, Stefan; Zozulya, Alla L.; Weidenfeller, Christian; Kotsiari, Alexandra; Stangel, Martin; Fahlke, Christoph; Wiendl, Heinz			A beta-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article								In multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE), impairment of glial "Excitatory Amino Acid Transporters'' (EAATs) together with an excess glutamate-release by invading immune cells causes excitotoxic damage of the central nervous system (CNS). In order to identify pathways to dampen excitotoxic inflammatory CNS damage, we assessed the effects of a beta-lactam antibiotic, ceftriaxone, reported to enhance expression of glial EAAT2, in "Myelin Oligodendrocyte Glycoprotein'' (MOG)-induced EAE. Ceftriaxone profoundly ameliorated the clinical course of murine MOG-induced EAE both under preventive and therapeutic regimens. However, ceftriaxone had impact neither on EAAT2 protein expression levels in several brain areas, nor on the radioactive glutamate uptake capacity in a mixed primary glial cell-culture and the glutamate-induced uptake currents in a mammalian cell line mediated by EAAT2. Moreover, the clinical effect of ceftriaxone was preserved in the presence of the EAAT2-specific transport inhibitor, dihydrokainate, while dihydrokainate alone caused an aggravated EAE course. This demonstrates the need for sufficient glial glutamate uptake upon an excitotoxic autoimmune inflammatory challenge of the CNS and a molecular target of ceftriaxone other than the glutamate transporter. Ceftriaxone treatment indirectly hampered T cell proliferation and proinflammatory INF gamma and IL17 secretion through modulation of myelin-antigen presentation by antigen-presenting cells (APCs) e. g. dendritic cells (DCs) and reduced T cell migration into the CNS in vivo. Taken together, we demonstrate, that a beta-lactam antibiotic attenuates disease course and severity in a model of autoimmune CNS inflammation. The mechanisms are reduction of T cell activation by modulation of cellular antigen-presentation and impairment of antigen-specific T cell migration into the CNS rather than or modulation of central glutamate homeostasis.	[Melzer, Nico; Meuth, Sven G.; Bittner, Stefan; Zozulya, Alla L.; Weidenfeller, Christian; Wiendl, Heinz] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Torres-Salazar, Delany; Fahlke, Christoph] Hannover Med Sch, Dept Neurophysiol, D-30623 Hannover, Germany; [Kotsiari, Alexandra; Stangel, Martin] Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany; [Torres-Salazar, Delany] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA	University of Wurzburg; Hannover Medical School; Hannover Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Melzer, N (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	melzer_n1@klinik.uni-wuerzburg.de; heinz.wiendl@klinik.uni-wuerzburg.de	Stangel, Martin/AAH-5345-2020; Fahlke, Christoph/G-3635-2013; Melzer, Nico/HGE-2991-2022; Wiendl, Heinz/AAX-6041-2021; Meuth, Sven G/HHM-8941-2022	Fahlke, Christoph/0000-0001-8602-9952; Melzer, Nico/0000-0002-2420-701X; Meuth, Sven G/0000-0003-2571-3501; Torres-Salazar, Delany/0000-0002-6789-9810; Bittner, Stefan/0000-0003-2179-3655; Wiendl, Heinz/0000-0003-4310-3432	IZKF [Z-3/4, A54/1]	IZKF	This study was supported by university grants (IZKF Z-3/4) to NM and HW and (IZKF A54/1) to SGM and HW. All authors report no conflict of interest.	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; BASSO AS, 2008, J CLIN INVEST; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Brooks BM, 2005, J ANTIMICROB CHEMOTH, V56, P1122, DOI 10.1093/jac/dki373; Brooks BM, 2003, CLIN EXP IMMUNOL, V131, P268, DOI 10.1046/j.1365-2249.2003.02069.x; Brooks BM, 2001, BIOCHEM BIOPH RES CO, V288, P1175, DOI 10.1006/bbrc.2001.5896; Brundula V, 2002, BRAIN, V125, P1297, DOI 10.1093/brain/awf133; Canton T, 2001, J PHARMACOL EXP THER, V299, P314; CHANDRASEKAR PH, 1984, J ANTIMICROB CHEMOTH, V14, P427, DOI 10.1093/jac/14.4.427; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dixon W. J., 1969, INTRO STAT ANAL; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Furuta A, 1997, J NEUROSCI, V17, P8363; Garg SK, 2008, J IMMUNOL, V180, P3866, DOI 10.4049/jimmunol.180.6.3866; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Heine S, 2006, J NEUROIMMUNOL, V177, P173, DOI 10.1016/j.jneuroim.2006.04.016; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HERREROHERRANZ E, 2008, NEUROBIOL DIS; Kleinschnitz C., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P35; LEE SG, 2008, J BIOL CHEM; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Lipski J, 2007, NEUROSCIENCE, V146, P617, DOI 10.1016/j.neuroscience.2007.02.003; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Melzer N, 2003, J BIOL CHEM, V278, P50112, DOI 10.1074/jbc.M307990200; Meuth SG, 2008, J NEUROIMMUNOL, V194, P62, DOI 10.1016/j.jneuroim.2007.11.013; MILLER BR, 2008, NEUROSCIENCE; NAU R, 1993, ANTIMICROB AGENTS CH, V37, P1518, DOI 10.1128/AAC.37.7.1518; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; ORTLER S, 2008, EUR J IMMUNOL; Otis TS, 2000, J NEUROSCI, V20, P2749; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Padovan E, 1999, J IMMUNOL, V162, P1171; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Pitt D, 2000, NAT MED, V6, P67, DOI 10.1038/71555; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; ROTHSTEIN JD, 1995, J NEUROCHEM, V65, P643; Smith T, 2000, NAT MED, V6, P62, DOI 10.1038/71548; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spalloni A, 2004, NEUROBIOL DIS, V15, P340, DOI 10.1016/j.nbd.2003.11.012; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Tian GL, 2007, J BIOL CHEM, V282, P1727, DOI 10.1074/jbc.M609822200; WEISS ME, 1988, CLIN ALLERGY, V18, P515, DOI 10.1111/j.1365-2222.1988.tb02904.x; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Zanni MP, 1998, J CLIN INVEST, V102, P1591, DOI 10.1172/JCI3544; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	54	71	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3149	10.1371/journal.pone.0003149	http://dx.doi.org/10.1371/journal.pone.0003149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773080	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000264420100007
J	Mereghetti, L; Sitkiewicz, I; Green, NM; Musser, JM				Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.			Extensive Adaptive Changes Occur in the Transcriptome of Streptococcus agalactiae (Group B Streptococcus) in Response to Incubation with Human Blood	PLOS ONE			English	Article								To enhance understanding of how Streptococcus agalactiae (group B streptococcus, GBS) adapts during invasive infection, we performed a whole-genome transcriptome analysis after incubation with whole human blood. Global changes occurred in the GBS transcriptome rapidly in response to blood contact following shift from growth in a rich laboratory medium. Most (83%) of the significantly altered transcripts were down-regulated after 30 minutes of incubation in blood, and all functional categories of genes were abundantly represented. We observed complex dynamic changes in the expression of transcriptional regulators and stress response genes that allow GBS to rapidly adapt to blood. The transcripts of relatively few proven virulence genes were up-regulated during the first 90 minutes. However, a key discovery was that genes encoding proteins involved in interaction with the host coagulation/fibrinolysis system and bacterial-host interactions were rapidly up-regulated. Extensive transcript changes also occurred for genes involved in carbohydrate metabolism, including multi-functional proteins and regulators putatively involved in pathogenesis. Finally, we discovered that an incubation temperature closer to that occurring in patients with severe infection and high fever (40 degrees C) induced additional differences in the GBS transcriptome relative to normal body temperature (37 degrees C). Taken together, the data provide extensive new information about transcriptional adaptation of GBS exposed to human blood, a crucial step during GBS pathogenesis in invasive diseases, and identify many new leads for molecular pathogenesis research.	[Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.] Methodist Hosp, Dept Pathol, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Mereghetti, Laurent] Ctr Hosp Univ, Univ Francois Rabelais, Fac Med, EA3854, Tours, France	The Methodist Hospital System; The Methodist Hospital - Houston; CHU Tours	Mereghetti, L (corresponding author), Methodist Hosp, Dept Pathol, Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sitkiewicz, Izabela/G-5058-2011	Sitkiewicz, Izabela/0000-0001-8228-9917				Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Hughes MJG, 2002, INFECT IMMUN, V70, P1254, DOI 10.1128/IAI.70.3.1254-1259.2002; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Johri AK, 2003, INFECT IMMUN, V71, P6707, DOI 10.1128/IAI.71.12.6707-6711.2003; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Kinnby B, 2008, MICROBIOL-SGM, V154, P924, DOI 10.1099/mic.0.2007/013235-0; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Loughman JA, 2006, EMBO J, V25, P5414, DOI 10.1038/sj.emboj.7601393; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Malke H, 2007, J MED MICROBIOL, V56, P707, DOI 10.1099/jmm.0.46984-0; MCARTHUR JD, 2008, FASEB J; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002785; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Pietrocola G, 2005, BLOOD, V105, P1052, DOI 10.1182/blood-2004-06-2149; Pietrocola G, 2006, BIOCHEMISTRY-US, V45, P12840, DOI 10.1021/bi060696u; Poyart C, 2001, INFECT IMMUN, V69, P5098, DOI 10.1128/IAI.69.8.5098-5106.2001; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Rosenau A, 2007, INFECT IMMUN, V75, P1310, DOI 10.1128/IAI.00996-06; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schubert A, 2002, MOL MICROBIOL, V46, P557, DOI 10.1046/j.1365-2958.2002.03177.x; Schugk J, 1997, SCAND J INFECT DIS, V29, P233, DOI 10.3109/00365549709019034; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Shelburne SA, 2008, TRENDS MICROBIOL, V16, P318, DOI 10.1016/j.tim.2008.04.002; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; SITKIEWICZ I, 2008, 17 LANC INT S STREPT; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Stroeher UH, 2007, J INFECT DIS, V196, P1820, DOI 10.1086/523107; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Tu LN, 2007, INFECT IMMUN, V75, P2996, DOI 10.1128/IAI.01716-06; Vervloet MG, 1998, SEMIN THROMB HEMOST, V24, P33, DOI 10.1055/s-2007-995821; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; WARD PN, 2008, J MOL BIOL; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	56	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3143	10.1371/journal.pone.0003143	http://dx.doi.org/10.1371/journal.pone.0003143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769548	Green Published, Green Submitted, gold			2022-12-27	WOS:000264419100010
J	Lacour, S; Bechet, E; Cozzone, AJ; Mijakovic, I; Grangeasse, C				Lacour, Soline; Bechet, Emmanuelle; Cozzone, Alain J.; Mijakovic, Ivan; Grangeasse, Christophe			Tyrosine Phosphorylation of the UDP-Glucose Dehydrogenase of Escherichia coli Is at the Crossroads of Colanic Acid Synthesis and Polymyxin Resistance	PLOS ONE			English	Article								Background: In recent years, an idiosyncratic new class of bacterial enzymes, named BY-kinases, has been shown to catalyze protein-tyrosine phosphorylation. These enzymes share no structural and functional similarities with their eukaryotic counterparts and, to date, only few substrates of BY-kinases have been characterized. BY-kinases have been shown to participate in various physiological processes. Nevertheless, we are at a very early stage of defining their importance in the bacterial cell. In Escherichia coli, two BY-kinases, Wzc and Etk, have been characterized biochemically. Wzc has been shown to phosphorylate the UDP-glucose dehydrogenase Ugd in vitro. Not only is Ugd involved in the biosynthesis of extracellular polysaccharides, but also in the production of UDP-4-amino-4-deoxy-L-arabinose, a compound that renders E. coli resistant to cationic antimicrobial peptides. Methodology/Principal Findings: Here, we studied the role of Ugd phosphorylation. We first confirmed in vivo the phosphorylation of Ugd by Wzc and we demonstrated that Ugd is also phosphorylated by Etk, the other BY-kinase identified in E. coli. Tyrosine 71 (Tyr71) was characterized as the Ugd site phosphorylated by both Wzc and Etk. The regulatory role of Tyr71 phosphorylation on Ugd activity was then assessed and Tyr71 mutation was found to prevent Ugd activation by phosphorylation. Further, Ugd phosphorylation by Wzc or Etk was shown to serve distinct physiological purposes. Phosphorylation of Ugd by Wzc was found to participate in the regulation of the amount of the exopolysaccharide colanic acid, whereas Etk-mediated Ugd phosphorylation appeared to participate in the resistance of E. coli to the antibiotic polymyxin. Conclusions/Significance: Ugd phosphorylation seems to be at the junction between two distinct biosynthetic pathways, illustrating the regulatory potential of tyrosine phosphorylation in bacterial physiology.	[Lacour, Soline; Bechet, Emmanuelle; Cozzone, Alain J.; Grangeasse, Christophe] Univ Lyon, Inst Biol & Chim Prot, Lyon, France; [Mijakovic, Ivan] Tech Univ Denmark, BioCentrum, Ctr Microbial Biotechnol, Lyngby, Denmark	Technical University of Denmark	Lacour, S (corresponding author), Univ Lyon, Inst Biol & Chim Prot, Lyon, France.	c.grangeasse@ibcp.fr	Mijakovic, Ivan/Q-5583-2016	Mijakovic, Ivan/0000-0002-8860-6853; Grangeasse, Christophe/0000-0002-5484-4589; BECHET, Emmanuelle/0000-0001-5528-0263	CNRS; University of Lyon; Agence National de la Recherche [ANR-07-JCJC0125-01]; Danish Natural Research Council	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Lyon; Agence National de la Recherche(French National Research Agency (ANR)); Danish Natural Research Council(Danish Natural Science Research Council)	This work was supported by grants from the CNRS, the University of Lyon and the Agence National de la Recherche (ANR-07-JCJC0125-01). IM was supported by a grant from the Danish Natural Research Council (FNU).	Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Bakal CJ, 2000, TRENDS CELL BIOL, V10, P32, DOI 10.1016/S0962-8924(99)01681-5; Bender MH, 2003, J BACTERIOL, V185, P6057, DOI 10.1128/JB.185.20.6057-6066.2003; Bergmaier D, 2001, APPL MICROBIOL BIOT, V57, P401, DOI 10.1007/s002530100764; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DISCHE Z, 1951, J BIOL CHEM, V192, P579; Doublet P, 2002, J BIOL CHEM, V277, P37339, DOI 10.1074/jbc.M204465200; GOLDHAR J, 1980, MED MICROBIOL IMMUN, V169, P53, DOI 10.1007/BF02123712; GOTTESMAN S, 1985, J BACTERIOL, V162, P1111, DOI 10.1128/JB.162.3.1111-1119.1985; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Groisman EA, 1997, J BACTERIOL, V179, P7040, DOI 10.1128/jb.179.22.7040-7045.1997; Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; JERS C, 2008, EXPERT REV IN PRESS, V5; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Kolot M, 2008, VIROLOGY, V375, P383, DOI 10.1016/j.virol.2008.02.011; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; LEE DC, 2008, EMBO J; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; MACEK B, 2006, DECIPHERING PROKARYO; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Meredith TC, 2007, J BIOL CHEM, V282, P7790, DOI 10.1074/jbc.M611034200; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Mijakovic I, 2004, J MOL MICROB BIOTECH, V8, P19, DOI 10.1159/000082077; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; Moorthy S, 2002, J BACTERIOL, V184, P4033, DOI 10.1128/JB.184.14.4033-4038.2002; Morona JK, 2003, J BACTERIOL, V185, P3009, DOI 10.1128/JB.185.10.3009-3019.2003; Mouslim C, 2003, MOL MICROBIOL, V47, P335, DOI 10.1046/j.1365-2958.2003.03318.x; Nakamura T, 2003, RRD HUM PAT, V1, P185; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; OLIVARESILLANA V, 2008, PLOS BIOL; Pagni M, 1999, MICROBIOL-UK, V145, P1049, DOI 10.1099/13500872-145-5-1049; Peleg A, 2005, J BACTERIOL, V187, P5259, DOI 10.1128/JB.187.15.5259-5266.2005; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Reid AN, 2005, J BACTERIOL, V187, P5470, DOI 10.1128/JB.187.15.5470-5481.2005; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Stevenson G, 1996, J BACTERIOL, V178, P4885, DOI 10.1128/jb.178.16.4885-4893.1996; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tocilj A, 2008, NAT STRUCT MOL BIOL, V15, P130, DOI 10.1038/nsmb.1374; Trent MS, 2001, J BIOL CHEM, V276, P43122, DOI 10.1074/jbc.M106961200; Ventura CL, 2006, MOL MICROBIOL, V61, P723, DOI 10.1111/j.1365-2958.2006.05259.x; Vincent C, 2000, J MOL BIOL, V304, P311, DOI 10.1006/jmbi.2000.4217; Whitfield C, 2008, NAT STRUCT MOL BIOL, V15, P121, DOI 10.1038/nsmb0208-121; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x	56	66	67	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3053	10.1371/journal.pone.0003053	http://dx.doi.org/10.1371/journal.pone.0003053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725960	Green Published, gold, Green Submitted			2022-12-27	WOS:000264429000006
J	Arlt, D; Forslund, P; Jeppsson, T; Part, T				Arlt, Debora; Forslund, Par; Jeppsson, Tobias; Part, Tomas			Habitat-Specific Population Growth of a Farmland Bird	PLOS ONE			English	Article							BREEDING SUCCESS; AGRICULTURAL INTENSIFICATION; ENVIRONMENTAL STOCHASTICITY; TERRITORY QUALITY; FITNESS; CONSERVATION; SURVIVAL; SINKS; PERFORMANCE; DEMOGRAPHY	Background: To assess population persistence of species living in heterogeneous landscapes, the effects of habitat on reproduction and survival have to be investigated. Methodology/Principal Findings: We used a matrix population model to estimate habitat-specific population growth rates for a population of northern wheatears Oenanthe oenanthe breeding in farmland consisting of a mosaic of distinct habitat ( land use) types. Based on extensive long-term data on reproduction and survival, habitats characterised by tall field layers (spring- and autumn-sown crop fields, ungrazed grasslands) displayed negative stochastic population growth rates ( log lambda(s): -0.332, -0.429, -0.168, respectively), that were markedly lower than growth rates of habitats characterised by permanently short field layers (pastures grazed by cattle or horses, and farmyards, log lambda(s): -0.056, +0.081, -0.059). Although habitats differed with respect to reproductive performance, differences in habitat-specific population growth were largely due to differences in adult and first-year survival rates, as shown by a life table response experiment (LTRE). Conclusions/Significance: Our results show that estimation of survival rates is important for realistic assessments of habitat quality. Results also indicate that grazed grasslands and farmyards may act as source habitats, whereas crop fields and ungrazed grasslands with tall field layers may act as sink habitats. We suggest that the strong decline of northern wheatears in Swedish farmland may be linked to the corresponding observed loss of high quality breeding habitat, i.e. grazed semi-natural grasslands.	[Arlt, Debora; Forslund, Par; Jeppsson, Tobias; Part, Tomas] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Arlt, D (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	Debora.Arlt@ekol.slu.se	Jeppsson, Tobias/G-7606-2011; Jeppsson, Tobias/GSE-0414-2022	Jeppsson, Tobias/0000-0002-6671-8096; Part, Tomas/0000-0001-7388-6672	Swedish Research Council; Helge Ax:son Johnson's Foundation; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Helge Ax:son Johnson's Foundation; Royal Swedish Academy of Sciences; Alvin's Foundation; Swedish Ornithological Society	Financial support was obtained from the Swedish Research Council (to TP), Helge Ax:son Johnson's Foundation, Royal Swedish Academy of Sciences, Alvin's Foundation, and Swedish Ornithological Society (to DA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLT D, 2007, ECOLOGY, V77, P211; Arlt D, 2008, J ANIM ECOL, V77, P211, DOI 10.1111/j.1365-2656.2007.01329.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; BOWERS MA, 1994, OIKOS, V69, P327, DOI 10.2307/3546154; Brickle NW, 2000, J APPL ECOL, V37, P742, DOI 10.1046/j.1365-2664.2000.00542.x; BROWN JL, 1969, AM NAT, V103, P347, DOI 10.1086/282607; BURFIELD I, 2004, BIRDS EUROPE POPULAT, P374; Burnham KP., 2002, MODEL SELECTION MULT, P496; CARLSON A, 1988, VAR FAGELVARLD S, V12, P293; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed., P722; Clark ME, 2007, ECOL MODEL, V209, P110, DOI 10.1016/j.ecolmodel.2007.06.008; Cramp S., 1988, HDB BIRDS EUROPE MID, V5, P1136; DEBRUIJN O, 1994, ARDEA, V82, P1; Devereux CL, 2004, IBIS, V146, P115, DOI 10.1111/j.1474-919X.2004.00355.x; DOLIGEZ B, 2008, J ANIM ECOL IN PRESS; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Donovan TM, 2001, ECOL APPL, V11, P871; Dugger KM, 2005, CONDOR, V107, P863, DOI 10.1650/7824.1; Ehrlen J, 2003, AM NAT, V162, P796, DOI 10.1086/379350; Franklin AB, 2000, ECOL MONOGR, V70, P539, DOI 10.1890/0012-9615(2000)070[0539:CHQAFI]2.0.CO;2; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; GARDENFORS U, 2005, REDLIST SWEDISH SPEC, P496; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; HOWE RW, 1991, BIOL CONSERV, V57, P239, DOI 10.1016/0006-3207(91)90071-G; Kawecki Tadeusz J., 2004, P387, DOI 10.1016/B978-012323448-3/50018-0; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kristan WB, 2003, OIKOS, V103, P457; Lampila S, 2006, OECOLOGIA, V148, P405, DOI 10.1007/s00442-006-0386-3; MacDonald DW, 2004, BIOLOGIA, V59, P235; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Morris W.F., 2002, QUANTITATIVE CONSERV, P480; Morris WF, 2004, AM NAT, V163, P579, DOI 10.1086/382550; Murphy MT, 2001, ECOLOGY, V82, P1304, DOI 10.1890/0012-9658(2001)082[1304:HSDOAL]2.0.CO;2; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; PARKER GA, 1986, ANIM BEHAV, V34, P1222, DOI 10.1016/S0003-3472(86)80182-8; Part T, 2001, ANIM BEHAV, V62, P379, DOI 10.1006/anbe.2001.1754; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Pidgeon AM, 2006, BIOL CONSERV, V132, P199, DOI 10.1016/j.biocon.2006.03.024; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Saether B.-E., 1990, Current Ornithology, V7, P251; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Schiers J., 2000, P ROY SOC LOND B BIO, V267, P2065; Smith HG, 2002, AGR ECOSYST ENVIRON, V92, P107, DOI 10.1016/S0167-8809(01)00266-3; *STAT SWED, 1996, YB AGR STAT 1996; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; SUTHERLAND WJ, 1996, INDIVIDUAL BEHAV POP, P213; TYE A, 1992, IBIS, V134, P273, DOI 10.1111/j.1474-919X.1992.tb03810.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; WATKINSON AR, 1995, J ANIM ECOL, V64, P126, DOI 10.2307/5833; White GC, 2006, J WILDLIFE MANAGE, V70, P1521, DOI 10.2193/0022-541X(2006)70[1521:MSMATE]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wiens JD, 2005, J RAPTOR RES, V39, P210; Wilson JD, 1997, J APPL ECOL, V34, P1462, DOI 10.2307/2405262; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x	59	52	52	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3006	10.1371/journal.pone.0003006	http://dx.doi.org/10.1371/journal.pone.0003006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714351	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900031
J	Cui, Y; Ying, Y; van Hasselt, A; Ng, KM; Yu, J; Zhang, Q; Jin, J; Liu, DX; Rhim, JS; Rha, SY; Loyo, M; Chan, ATC; Srivastava, G; Tsao, GSW; Sellar, GC; Sung, JJY; Sidransky, D; Tao, Q				Cui, Yan; Ying, Ying; van Hasselt, Andrew; Ng, Ka Man; Yu, Jun; Zhang, Qian; Jin, Jie; Liu, Dingxie; Rhim, Johng S.; Rha, Sun Young; Loyo, Myriam; Chan, Anthony T. C.; Srivastava, Gopesh; Tsao, George S. W.; Sellar, Grant C.; Sung, Joseph J. Y.; Sidransky, David; Tao, Qian			OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation	PLOS ONE			English	Article								Background: Identification of tumor suppressor genes (TSGs) silenced by CpG methylation uncovers the molecular mechanism of tumorigenesis and potential tumor biomarkers. Loss of heterozygosity at 11q25 is common in multiple tumors including nasopharyngeal carcinoma (NPC). OPCML, located at 11q25, is one of the downregulated genes we identified through digital expression subtraction. Methodology/Principal Findings: Semi-quantitative RT-PCR showed frequent OPCML silencing in NPC and other common tumors, with no homozygous deletion detected by multiplex differential DNA-PCR. Instead, promoter methylation of OPCML was frequently detected in multiple carcinoma cell lines (nasopharyngeal, esophageal, lung, gastric, colon, liver, breast, cervix, prostate), lymphoma cell lines (non-Hodgkin and Hodgkin lymphoma, nasal NK/T-cell lymphoma) and primary tumors, but not in any non-tumor cell line and seldom weakly methylated in normal epithelial tissues. Pharmacological and genetic demethylation restored OPCML expression, indicating a direct epigenetic silencing. We further found that OPCML is stress-responsive, but this response is epigenetically impaired when its promoter becomes methylated. Ecotopic expression of OPCML led to significant inhibition of both anchorage-dependent and -independent growth of carcinoma cells with endogenous silencing. Conclusions/Significance: Thus, through functional epigenetics, we identified OPCML as a broad tumor suppressor, which is frequently inactivated by methylation in multiple malignancies.	[Cui, Yan; Ying, Ying; Ng, Ka Man; Chan, Anthony T. C.; Tao, Qian] Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Canc Epigenet Lab, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China; [van Hasselt, Andrew] Chinese Univ Hong Kong, Dept Surg, Sha Tin 100083, Peoples R China; [Yu, Jun; Sung, Joseph J. Y.] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Sha Tin 100083, Peoples R China; [Zhang, Qian; Jin, Jie] Peking Univ, Hlth Sci Ctr, Inst Urol, Peking Univ 1 Hosp, Dept Urol, Beijing, Peoples R China; [Liu, Dingxie; Tao, Qian] Johns Hopkins Singapore, Singapore, Singapore; [Rhim, Johng S.] Uniformed Serv Univ Hlth Sci, Ctr Prostate Dis Res, Bethesda, MD USA; [Rha, Sun Young] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea; [Loyo, Myriam; Sidransky, David] Johns Hopkins, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA; [Srivastava, Gopesh] Univ Hong Kong, Dept Pathol, Hong Kong, Peoples R China; [Tsao, George S. W.] Univ Hong Kong, Dept Anat, Hong Kong, Peoples R China; [Sellar, Grant C.] Univ Edinburgh, Canc Res Ctr, Canc Res UK Edinburgh Oncol Unit, Edinburgh EH8 9YL, Midlothian, Scotland	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Peking University; Johns Hopkins University; Johns Hopkins Medicine; Uniformed Services University of the Health Sciences - USA; Yonsei University; Yonsei University Health System; Johns Hopkins University; University of Hong Kong; University of Hong Kong; University of Edinburgh	Cui, Y (corresponding author), Chinese Univ Hong Kong, Hong Kong Canc Inst, Dept Clin Oncol,Canc Epigenet Lab, State Key Lab Oncol S China,Sir YK Pao Ctr Canc, Hong Kong, Hong Kong, Peoples R China.	qtao@clo.cuhk.edu.hk	Tao, Qian/T-4743-2018; Chan, Anthony Tak Cheung/R-3940-2018; Sung, Joseph J. Y./R-3203-2018; Yu, Jun/D-8569-2015	Tao, Qian/0000-0001-5383-4808; Chan, Anthony Tak Cheung/0000-0002-6912-8091; Sung, Joseph J. Y./0000-0003-3125-5199; Yu, Jun/0000-0001-5008-2153; Cui, Yan/0000-0002-6522-8343; Rha, Sun Young/0000-0002-2512-4531	Hong Kong RGC Central Allocation [CA06/07.SC03]; Chinese University of Hong Kong; MRC [G9826762, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G9826762] Funding Source: researchfish	Hong Kong RGC Central Allocation; Chinese University of Hong Kong(Chinese University of Hong Kong); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was supported by a Hong Kong RGC Central Allocation Grant (CA06/07.SC03 to QT) and a Chinese University of Hong Kong direct grant.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Chang HW, 2003, INT J CANCER, V105, P851, DOI 10.1002/ijc.11162; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Deng W, 2004, ONCOGENE, V23, P9090, DOI 10.1038/sj.onc.1208119; Eagleson KL, 2003, MOL CELL NEUROSCI, V24, P725, DOI 10.1016/S1044-7431(03)00237-9; Funatsu N, 1999, J BIOL CHEM, V274, P8224, DOI 10.1074/jbc.274.12.8224; Gil OD, 1998, J NEUROSCI, V18, P9312; Gil OD, 2002, J NEUROBIOL, V51, P190, DOI 10.1002/neu.10050; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Jin H, 2007, ONCOGENE, V26, P7490, DOI 10.1038/sj.onc.1210559; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kappler Stefanie, 2013, AFR STUD, V1.3, P349; Lo KW, 2001, CANCER RES, V61, P3877; Lodge AP, 2000, MOL BRAIN RES, V82, P84, DOI 10.1016/S0169-328X(00)00184-4; Lung HL, 2005, ONCOGENE, V24, P6525, DOI 10.1038/sj.onc.1208812; Lung HL, 2006, CANCER RES, V66, P9385, DOI 10.1158/0008-5472.CAN-06-0590; McNamee CJ, 2002, J NEUROCHEM, V80, P941, DOI 10.1046/j.0022-3042.2002.00798.x; Pimenta AF, 2004, GENOMICS, V83, P790, DOI 10.1016/j.ygeno.2003.11.013; Qiu GH, 2004, ONCOGENE, V23, P4793, DOI 10.1038/sj.onc.1207632; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Reed J, 2004, J CELL SCI, V117, P3961, DOI 10.1242/jcs.01261; Reed JE, 2007, NEUROPATH APPL NEURO, V33, P77, DOI 10.1111/j.1365-2990.2006.00786.x; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sellar GC, 2003, NAT GENET, V34, P337, DOI 10.1038/ng1183; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; SHARK KB, 1995, GENE, V155, P213, DOI 10.1016/0378-1119(94)00830-L; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Sun D, 2007, ORAL ONCOL, V43, P82, DOI 10.1016/j.oraloncology.2006.01.007; Tao Q, 1999, AM J PATHOL, V155, P619, DOI 10.1016/S0002-9440(10)65157-7; Tao Q, 1998, J VIROL, V72, P7075, DOI 10.1128/JVI.72.9.7075-7083.1998; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Tao Qian, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000312; Tao Q, 2006, FRONT BIOSCI-LANDMRK, V11, P2672, DOI 10.2741/2000; Tsao SW, 2002, BBA-MOL CELL RES, V1590, P150, DOI 10.1016/S0167-4889(02)00208-2; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Wang L, 2006, WORLD J GASTROENTERO, V12, P6949, DOI 10.3748/wjg.v12.i43.6949; Wong ML, 2006, INT J ONCOL, V28, P767; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267	44	96	104	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2990	10.1371/journal.pone.0002990	http://dx.doi.org/10.1371/journal.pone.0002990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714356	Green Submitted, gold, Green Published			2022-12-27	WOS:000264420900016
J	Lawlor, DA; Harbord, RM; Timpson, NJ; Lowe, GDO; Rumley, A; Gaunt, TR; Baker, I; Yarnell, JWG; Kivimaeki, M; Kumari, M; Norman, PE; Jamrozik, K; Hankey, GJ; Almeida, OP; Flicker, L; Warrington, N; Marmot, MG; Ben-Shlomo, Y; Palmer, LJ; Day, INM; Ebrahim, S; Smith, GD				Lawlor, Debbie A.; Harbord, Roger M.; Timpson, Nic J.; Lowe, Gordon D. O.; Rumley, Ann; Gaunt, Tom R.; Baker, Ian; Yarnell, John W. G.; Kivimaeki, Mika; Kumari, Meena; Norman, Paul E.; Jamrozik, Konrad; Hankey, Graeme J.; Almeida, Osvaldo P.; Flicker, Leon; Warrington, Nicole; Marmot, Michael G.; Ben-Shlomo, Yoav; Palmer, Lyle J.; Day, Ian N. M.; Ebrahim, Shah; Smith, George Davey			The Association of C-Reactive Protein and CRP Genotype with Coronary Heart Disease: Findings from Five Studies with 4,610 Cases amongst 18,637 Participants	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; GENE POLYMORPHISMS; MENDELIAN RANDOMIZATION; INTERINDIVIDUAL VARIABILITY; SOCIOECONOMIC POSITION; INFLAMMATORY MARKERS; CARDIOVASCULAR RISK; PROMOTER REGION; HEALTH; LDL	Background: It is unclear whether C-reactive protein (CRP) is causally related to coronary heart disease (CHD). Genetic variants that are known to be associated with CRP levels can be used to provide causal inference of the effect of CRP on CHD. Our objective was to examine the association between CRP genetic variant +1444C>T (rs1130864) and CHD risk in the largest study to date of this association. Methods and Results: We estimated the association of CRP genetic variant +1444C>T (rs1130864) with CRP levels and with CHD in five studies and then pooled these analyses (N= 18,637 participants amongst whom there were 4,610 cases). CRP was associated with potential confounding factors (socioeconomic position, physical activity, smoking and body mass) whereas genotype (rs1130864) was not associated with these confounders. The pooled odds ratio of CHD per doubling of circulating CRP level after adjustment for age and sex was 1.13 (95% CI: 1.06, 1.21), and after further adjustment for confounding factors it was 1.07 (95% CI: 1.02, 1.13). Genotype (rs1130864) was associated with circulating CRP; the pooled ratio of geometric means of CRP level among individuals with the TT genotype compared to those with the CT/CC genotype was 1.21 (95% CI: 1.15, 1.28) and the pooled ratio of geometric means of CRP level per additional T allele was 1.14 (95% CI: 1.11, 1.18), with no strong evidence in either analyses of between study heterogeneity (I-2 = 0%, p>0.9 for both analyses). There was no association of genotype (rs1130864) with CHD: pooled odds ratio 1.01 (95% CI: 0.88, 1.16) comparing individuals with TT genotype to those with CT/CC genotype and 0.96 (95% CI: 0.90, 1.03) per additional T allele (I-2<7.5%, p. 0.6 for both meta-analyses). An instrumental variables analysis (in which the proportion of CRP levels explained by rs1130864 was related to CHD) suggested that circulating CRP was not associated with CHD: the odds ratio for a doubling of CRP level was 1.04 (95% CI: 0.61, 1.80). Conclusions: We found no association of a genetic variant, which is known to be related to CRP levels, (rs1130864) and having CHD. These findings do not support a causal association between circulating CRP and CHD risk, but very large, extended, genetic association studies would be required to rule this out.	[Lawlor, Debbie A.; Timpson, Nic J.; Palmer, Lyle J.; Day, Ian N. M.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England; [Lawlor, Debbie A.; Harbord, Roger M.; Timpson, Nic J.; Gaunt, Tom R.; Baker, Ian; Ben-Shlomo, Yoav; Day, Ian N. M.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Lowe, Gordon D. O.; Rumley, Ann] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Yarnell, John W. G.] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Kivimaeki, Mika; Kumari, Meena; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Norman, Paul E.] Univ Western Australia, Sch Surg & Pathol, Nedlands, WA 6009, Australia; [Jamrozik, Konrad] Univ Queensland, Sch Populat Hlth, St Lucia, Qld 4067, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med Pharmacol, Nedlands, WA 6009, Australia; [Almeida, Osvaldo P.; Flicker, Leon] Univ Australia, Western Australian Ctr Hlth & Ageing, Perth, WA, Australia; [Warrington, Nicole; Palmer, Lyle J.] Western Australian Inst Med Res, Lab Genet Epidemiol, Perth, Australia; [Warrington, Nicole; Palmer, Lyle J.] Univ Western Australia, Ctr Med Res, Nedlands, WA 6009, Australia; [Ebrahim, Shah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England	University of Bristol; University of Bristol; University of Glasgow; Queens University Belfast; University of London; University College London; University of Western Australia; University of Queensland; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of London; London School of Hygiene & Tropical Medicine	Lawlor, DA (corresponding author), Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol, Avon, England.	d.a.lawlor@bristol.ac.uk	Norman, Paul E/C-5485-2013; Gaunt, Tom R/O-3918-2014; Fox, Laura J/C-6249-2016; Marmot, M G/Y-3920-2019; Flicker, Leon/A-9039-2008; Kivimaki, Mika/B-3607-2012; Harbord, Roger M/A-8699-2008; Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013; Palmer, Lyle John/N-1948-2019; Hankey, Graeme J/H-4968-2014; Attrill, Lauren/V-1688-2018; Almeida, Osvaldo P./A-4925-2008; Flicker, Leon/AAE-1530-2022; Palmer, Lyle John/K-3196-2014; Timpson, Nicholas John/O-7548-2015; Warrington, Nicole/P-4868-2014	Norman, Paul E/0000-0003-3406-0506; Gaunt, Tom R/0000-0003-0924-3247; Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Harbord, Roger M/0000-0002-2257-8271; Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Palmer, Lyle John/0000-0002-1628-3055; Hankey, Graeme J/0000-0002-6044-7328; Almeida, Osvaldo P./0000-0002-8689-6199; Flicker, Leon/0000-0002-3650-0475; Palmer, Lyle John/0000-0002-1628-3055; Timpson, Nicholas John/0000-0002-7141-9189; Warrington, Nicole/0000-0003-4195-775X; Kumari, Meena/0000-0001-9716-1035; Lawlor, Debbie A/0000-0002-6793-2262; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475	(UK) Department of Health (DOH) [PHCSA03]; British Heart Foundation (BHF) [FS/05/065]; Medical Research Council (MRC) of the United Kingdom [G9824960, G0601625]; Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH [HL36310]; National Institute on Aging, US, NIH [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Health and Medical Research Council of Australia [279408/379600, 458505]; Academy of Finland [117604, 124327, 124332]; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600705, G0601625] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G8802774, G0601625, G0600705, G0100222, G19/35] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R37AG013196] Funding Source: NIH RePORTER	(UK) Department of Health (DOH); British Heart Foundation (BHF)(British Heart Foundation); Medical Research Council (MRC) of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health and Safety Executive; National Heart Lung and Blood Institute, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Academy of Finland(Academy of Finland); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The British Women's Heart and Health Study is funded by the (UK) Department of Health (DOH) and the DNA extraction, genotyping and the CRP assay were funded by British Heart Foundation (BHF) grants. The Caerphilly study was funded by the Medical Research Council (MRC) of the United Kingdom. Funding for the Caerphilly DNA Bank was from an MRC grant (G9824960). The Whitehall II study has been supported by grants from the MRC; BHF; Health and Safety Executive; DOH; National Heart Lung and Blood Institute (HL36310), US, NIH: National Institute on Aging (AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio-economic Status and Health. The Health in Men Study has received funding from the National Health and Medical Research Council of Australia (279408/379600). DA Lawlor, G Davey Smith and INM Day work in the MRC CAiTE Centre and N Timspon is funded in full by the grant for this center (G0601625). DA Lawlor funded in part by a UK DOH career scientist award ((PHCSA03). R M Harbord is funded in part by an MRC grant (G0601625). T Gaunt is a BHF Intermediate Fellow (FS/05/065). M.Kivimaki is supported by the Academy of Finland (Projects no. 117604, 124327 and 124332). MG Marmot is an MRC Research Professor. PE Norman is supported by a National Health and Medical Research Council of Australia Practitioner Fellowship (458505). The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 2006, SCIENCE, V311, P1721, DOI 10.1126/science.1125884; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; *CRP CHD GEN COLL, 2008, EUROPEAN J EPIDEMIOL; D'Aiuto F, 2005, ATHEROSCLEROSIS, V179, P413, DOI 10.1016/j.atherosclerosis.2004.10.036; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Gimeno D, 2007, EUR J EPIDEMIOL, V22, P675, DOI 10.1007/s10654-007-9171-9; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hage FG, 2007, J AM COLL CARDIOL, V50, P1115, DOI 10.1016/j.jacc.2007.06.012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hingorani A, 2005, LANCET, V366, P1906, DOI 10.1016/S0140-6736(05)67767-7; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jamrozik K, 2000, MED J AUSTRALIA, V173, P345, DOI 10.5694/j.1326-5377.2000.tb125684.x; Jousilahti P, 2003, J EPIDEMIOL COMMUN H, V57, P730, DOI 10.1136/jech.57.9.730; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kivimaki M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003013; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2007, ARTERIOSCL THROM VAS, V27, P978, DOI 10.1161/01.ATV.0000258869.48076.14; Kivimaki M, 2007, AM J EPIDEMIOL, V166, P760, DOI 10.1093/aje/kwm151; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lawlor DA, 2006, EUR HEART J, V27, P1597, DOI 10.1093/eurheartj/ehi833; Lowe GDO, 2005, J THROMB HAEMOST, V3, P1618, DOI 10.1111/j.1538-7836.2005.01416.x; Lowe Gordon D O, 2006, Curr Atheroscler Rep, V8, P421, DOI 10.1007/s11883-006-0040-x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Rose G, 1982, CARDIOVASCULAR SURVE; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2006, J EPIDEMIOL COMMUN H, V60, P382, DOI 10.1136/jech.2004.031880; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, pE137; Smith GD, 2005, ARTERIOSCL THROM VAS, V25, P1051, DOI 10.1161/01.ATV.0000160351.95181.d0; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2006, ANN INTERN MED, V145, P70, DOI 10.7326/0003-4819-145-1-200607040-00130; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Timpson NJ, 2006, CIRCULATION, V114, pE256, DOI 10.1161/CIRCULATIONAHA.106.638387; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Wannamethee SG, 2005, EUR HEART J, V26, P1765, DOI 10.1093/eurheartj/ehi183; Wannamethee SG, 2002, CIRCULATION, V105, P1785, DOI 10.1161/01.CIR.0000016346.14762.71; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	56	75	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3011	10.1371/journal.pone.0003011	http://dx.doi.org/10.1371/journal.pone.0003011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714384	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000264420900036
J	Qu, A; Brulc, JM; Wilson, MK; Law, BF; Theoret, JR; Joens, LA; Konkel, ME; Angly, F; Dinsdale, EA; Edwards, RA; Nelson, KE; White, BA				Qu, Ani; Brulc, Jennifer M.; Wilson, Melissa K.; Law, Bibiana F.; Theoret, James R.; Joens, Lynn A.; Konkel, Michael E.; Angly, Florent; Dinsdale, Elizabeth A.; Edwards, Robert A.; Nelson, Karen E.; White, Bryan A.			Comparative Metagenomics Reveals Host Specific Metavirulomes and Horizontal Gene Transfer Elements in the Chicken Cecum Microbiome	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; BROILER-CHICKENS; CAMPYLOBACTER INFECTION; METHANOGENIC ARCHAEA; DIVERSITY; QUANTIFICATION; COLONIZATION; SUCCESSION; VIRUSES; PROJECT	Background: The complex microbiome of the ceca of chickens plays an important role in nutrient utilization, growth and well-being of these animals. Since we have a very limited understanding of the capabilities of most species present in the cecum, we investigated the role of the microbiome by comparative analyses of both the microbial community structure and functional gene content using random sample pyrosequencing. The overall goal of this study was to characterize the chicken cecal microbiome using a pathogen-free chicken and one that had been challenged with Campylobacter jejuni. Methodology/Principal Findings: Comparative metagenomic pyrosequencing was used to generate 55,364,266 bases of random sampled pyrosequence data from two chicken cecal samples. SSU rDNA gene tags and environmental gene tags (EGTs) were identified using SEED subsystems-based annotations. The distribution of phylotypes and EGTs detected within each cecal sample were primarily from the Firmicutes, Bacteroidetes and Proteobacteria, consistent with previous SSU rDNA libraries of the chicken cecum. Carbohydrate metabolism and virulence genes are major components of the EGT content of both of these microbiomes. A comparison of the twelve major pathways in the SEED Virulence Subsystem (metavirulome) represented in the chicken cecum, mouse cecum and human fecal microbiomes showed that the metavirulomes differed between these microbiomes and the metavirulomes clustered by host environment. The chicken cecum microbiomes had the broadest range of EGTs within the SEED Conjugative Transposon Subsystem, however the mouse cecum microbiomes showed a greater abundance of EGTs in this subsystem. Gene assemblies (32 contigs) from one microbiome sample were predominately from the Bacteroidetes, and seven of these showed sequence similarity to transposases, whereas the remaining sequences were most similar to those from catabolic gene families. Conclusion/Significance: This analysis has demonstrated that mobile DNA elements are a major functional component of cecal microbiomes, thus contributing to horizontal gene transfer and functional microbiome evolution. Moreover, the metavirulomes of these microbiomes appear to associate by host environment. These data have implications for defining core and variable microbiome content in a host species. Furthermore, this suggests that the evolution of host specific metavirulomes is a contributing factor in disease resistance to zoonotic pathogens.	[Qu, Ani; Brulc, Jennifer M.; Wilson, Melissa K.; White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Law, Bibiana F.; Theoret, James R.; Joens, Lynn A.] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ 85721 USA; [Konkel, Michael E.] Washington State Univ, Ctr Biotechnol, Sch Mol Biosci, Seattle, WA USA; [Angly, Florent; Dinsdale, Elizabeth A.; Edwards, Robert A.] San Diego State Univ, Dept Biol, San Diego, CA USA; [Angly, Florent] San Diego State Univ, Dept Computat Sci, San Diego, CA USA; [Dinsdale, Elizabeth A.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Edwards, Robert A.] San Diego State Univ, Ctr Microb Sci, San Diego, CA USA; [Edwards, Robert A.] San Diego State Univ, Dept Comp Sci, San Diego, CA USA; [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Arizona; Washington State University; California State University System; San Diego State University; California State University System; San Diego State University; Flinders University South Australia; California State University System; San Diego State University; California State University System; San Diego State University; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign	Qu, A (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Angly, Florent E/A-7717-2011; Edwards, Robert/Q-1691-2019	Angly, Florent E/0000-0002-8999-0738; Edwards, Robert/0000-0001-8383-8949; dinsdale, elizabeth/0000-0002-2177-203X; Konkel, Michael/0000-0002-8950-0903	Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2005-35212-15287]	Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	These studies were supported by the Food Safety Research Response Network, a Coordinated Agricultural Project, funded through the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, Grant number ##2005-35212-15287. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Apajalahti JHA, 2001, APPL ENVIRON MICROB, V67, P5656, DOI 10.1128/AEM.67.12.5656-5667.2001; BEERY JT, 1988, APPL ENVIRON MICROB, V54, P2365, DOI 10.1128/AEM.54.10.2365-2370.1988; Berndtson E, 1996, INT J FOOD MICROBIOL, V32, P35, DOI 10.1016/0168-1605(96)01102-6; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; BRULC JM, 2008, P NATL ACAD IN PRESS; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DOYLE MP, 1992, CAMPLYLOBACTER JEJUNI, P45; Edwards Robert A, 2006, BMC Genomics, V7, P57; Evans SJ, 2000, PREV VET MED, V46, P209, DOI 10.1016/S0167-5877(00)00143-4; Fairchild AS, 2005, APPL ENVIRON MICROB, V71, P5865, DOI 10.1128/AEM.71.10.5865-5872.2005; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Frigaard NU, 2006, NATURE, V439, P847, DOI 10.1038/nature04435; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HAMADY M, 2008, NATURE METHODS 0210, DOI DOI 10.1038/NMETH.1182; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; HYMAN ED, 1988, ANAL BIOCHEM, V174, P423, DOI 10.1016/0003-2697(88)90041-3; Konkel ME, 2007, APPL ENVIRON MICROB, V73, P2297, DOI 10.1128/AEM.02193-06; Krause L, 2008, NUCLEIC ACIDS RES, V36, P2230, DOI 10.1093/nar/gkn038; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Lan PTN, 2002, MICROBIOL IMMUNOL, V46, P371, DOI 10.1111/j.1348-0421.2002.tb02709.x; Legendre P., 1998, NUMERICAL ECOLOGY; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Li JR, 2003, APPL ENVIRON MICROB, V69, P901, DOI 10.1128/AEM.69.2.901-908.2003; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Saengkerdsub S, 2007, LETT APPL MICROBIOL, V45, P629, DOI 10.1111/j.1472-765X.2007.02243.x; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; Sahin O, 2001, APPL ENVIRON MICROB, V67, P3951, DOI 10.1128/AEM.67.9.3951-3957.2001; Sahin Orhan, 2002, Animal Health Research Reviews, V3, P95, DOI 10.1079/AHRR200244; Scupham AJ, 2007, J APPL MICROBIOL, V102, P401, DOI 10.1111/j.1365-2672.2006.03094.x; SCUPHAM AJ, 2008, MICROBIAL ECOLO 0108; Scupham AJ, 2007, ENVIRON MICROBIOL, V9, P1801, DOI 10.1111/j.1462-2920.2007.01300.x; Scupham AJ, 2007, FEMS MICROBIOL ECOL, V60, P136, DOI 10.1111/j.1574-6941.2006.00245.x; Shreeve JE, 2000, AVIAN DIS, V44, P983, DOI 10.2307/1593076; Smirnov A, 2005, J NUTR, V135, P187, DOI 10.1093/jn/135.2.187; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STERN NJ, 1992, CAMPLYLOBACTER JEJUNI, P49; Torsvik V, 2002, CURR OPIN MICROBIOL, V5, P240, DOI 10.1016/S1369-5274(02)00324-7; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wagenaar JA, 2006, REV SCI TECH OIE, V25, P581, DOI 10.20506/rst.25.2.1680; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wommack KE, 2008, APPL ENVIRON MICROB, V74, P1453, DOI 10.1128/AEM.02181-07; Yu ZT, 2006, ENVIRON MICROBIOL, V8, P603, DOI 10.1111/j.1462-2920.2005.00933.x; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	64	198	222	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2945	10.1371/journal.pone.0002945	http://dx.doi.org/10.1371/journal.pone.0002945			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698407	Green Published, gold			2022-12-27	WOS:000264412600031
J	Coello, Y; Bartolo, A; Amiri, B; Devanne, H; Houdayer, E; Derambure, P				Coello, Yann; Bartolo, Angela; Amiri, Bastien; Devanne, Herve; Houdayer, Elise; Derambure, Philippe			Perceiving What Is Reachable Depends on Motor Representations: Evidence from a Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; NEURAL-NETWORKS; FAR SPACE; PERCEPTION; MOVEMENTS; HAND; LOCALIZATION; SUPPRESSION; INHIBITION; ACTIVATION	Background: Visually determining what is reachable in peripersonal space requires information about the egocentric location of objects but also information about the possibilities of action with the body, which are context dependent. The aim of the present study was to test the role of motor representations in the visual perception of peripersonal space. Methodology: Seven healthy participants underwent a TMS study while performing a right-left decision (control) task or perceptually judging whether a visual target was reachable or not with their right hand. An actual grasping movement task was also included. Single pulse TMS was delivered 80% of the trials on the left motor and premotor cortex and on a control site (the temporo-occipital area), at 90% of the resting motor threshold and at different SOA conditions (50ms, 100ms, 200ms or 300ms). Principal Findings: Results showed a facilitation effect of the TMS on reaction times in all tasks, whatever the site stimulated and until 200ms after stimulus presentation. However, the facilitation effect was on average 34ms lower when stimulating the motor cortex in the perceptual judgement task, especially for stimuli located at the boundary of peripersonal space. Conclusion: This study provides the first evidence that brain motor area participate in the visual determination of what is reachable. We discuss how motor representations may feed the perceptual system with information about possible interactions with nearby objects and thus may contribute to the perception of the boundary of peripersonal space.	[Coello, Yann; Bartolo, Angela; Amiri, Bastien] Univ Lille Nord France, Lab URECA, EA 1059, Lille, France; [Coello, Yann] Univ Lille Nord France, UMR CNRS 8163 STL, Lille, France; [Devanne, Herve; Houdayer, Elise; Derambure, Philippe] Ctr Hosp Regional Univ, Hop Roger Salengro, Dept Neurophysiol Clin, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Coello, Y (corresponding author), Univ Lille Nord France, Lab URECA, EA 1059, Lille, France.	yann.coello@univ-lille3.fr	Devanne, Herve/M-7703-2016; Derambure, Philippe/AAK-8546-2020; Houdayer, Elise/K-1494-2016	Devanne, Herve/0000-0002-0296-9152; Bartolo, Angela/0000-0003-3034-6136; Houdayer, Elise/0000-0003-3153-0365	Region Nord-Pas-de-Calais; University Charles de Gaulle-Lille3; European Science Foundation; Eurocores CNCC CRP	Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); University Charles de Gaulle-Lille3; European Science Foundation(European Science Foundation (ESF)European Commission); Eurocores CNCC CRP	This work was supported by Region Nord-Pas-de-Calais, University Charles de Gaulle-Lille3, European Science Foundation, Eurocores CNCC CRP grant. These organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Barfield W, 1997, INT J AVIAT PSYCHOL, V7, P123, DOI 10.1207/s15327108ijap0702_2; Binsted G, 2007, P NATL ACAD SCI USA, V104, P12669, DOI 10.1073/pnas.0702307104; Bjoertomt O, 2002, BRAIN, V125, P2012, DOI 10.1093/brain/awf211; BOOTH D, 1992, EUR J DEV RES, V4, P1; BOURGEOIS Y, 2008, CONSCIOUS PERC UNPUB; Brain WR, 1941, BRAIN, V64, P244, DOI 10.1093/brain/64.4.244; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; Chouinard PA, 2003, J NEUROPHYSIOL, V90, P1071, DOI 10.1152/jn.01105.2002; Coello Y, 2006, PERCEPT PSYCHOPHYS, V68, P278, DOI 10.3758/BF03193675; Coello Y, 2007, CONSCIOUS COGN, V16, P667, DOI 10.1016/j.concog.2007.07.003; DAVEY NJ, 1992, J PHYSIOL-LONDON, V446, pP447; DAVEY NJ, 1994, J PHYSIOL-LONDON, V477, P223, DOI 10.1113/jphysiol.1994.sp020186; DAY BL, 1989, BRAIN, V112, P649, DOI 10.1093/brain/112.3.649; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Della-Maggiore V, 2004, J NEUROSCI, V24, P9971, DOI 10.1523/JNEUROSCI.2833-04.2004; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Devanne H, 2006, EUR J NEUROSCI, V23, P2467, DOI 10.1111/j.1460-9568.2006.04760.x; Diederich A, 2004, PERCEPT PSYCHOPHYS, V66, P1388, DOI 10.3758/BF03195006; DIEDERICH A, 1992, PERCEPT PSYCHOPHYS, V52, P714, DOI 10.3758/BF03211708; Fischer MH, 2000, HUM MOVEMENT SCI, V19, P297, DOI 10.1016/S0167-9457(00)00016-6; Foltys H, 2000, NEUROREPORT, V11, P147, DOI 10.1097/00001756-200001170-00029; Gabbard C, 2006, J MOTOR BEHAV, V38, P423, DOI 10.3200/JMBR.38.6.423-429; GARDENFORS P, 2007, EUR REV, V15, P223; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grealy MA, 2003, EXP BRAIN RES, V150, P356, DOI 10.1007/s00221-003-1426-4; Grush R, 2004, BEHAV BRAIN SCI, V27, P377, DOI 10.1017/S0140525X04000093; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; HEILMAN KM, 1990, BEHAV BRAIN SCI, V13, P552, DOI 10.1017/S0140525X00080134; Jeannerod M, 2003, BEHAV BRAIN RES, V142, P1, DOI 10.1016/S0166-4328(02)00384-4; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JEANNEROD M, 2006, MOTOR COGNITION, P209; JORDAN MI, 1995, J MOTOR BEHAV, V27, P179, DOI 10.1080/00222895.1995.9941709; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lee ES, 2002, YONSEI MED J, V43, P446, DOI 10.3349/ymj.2002.43.4.446; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Magne P, 2002, BEHAV BRAIN RES, V136, P277, DOI 10.1016/S0166-4328(02)00169-9; MENNEMEIER M, 1992, BRAIN, V115, P37, DOI 10.1093/brain/115.1.37; Milner A. D., 1995, VISUAL BRAIN ACTION; O'Shea J, 2007, CURR BIOL, V17, pR196, DOI 10.1016/j.cub.2007.01.030; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; PASCUALLEONE A, 1992, BRAIN, V115, P109, DOI 10.1093/brain/115.1.109; Paterson A, 1944, BRAIN, V67, P331, DOI 10.1093/brain/67.4.331; Petersen NT, 2001, J PHYSIOL-LONDON, V537, P651, DOI 10.1111/j.1469-7793.2001.00651.x; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Rizzolatti G, 1988, HDB NEUROPSYCHOLOGY, V1, P223; Robertson EM, 2003, J COGNITIVE NEUROSCI, V15, P948, DOI 10.1162/089892903770007344; Rochat P, 1997, J EXP PSYCHOL HUMAN, V23, P199, DOI 10.1037/0096-1523.23.1.199; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; SHELTON PA, 1990, BRAIN, V113, P191, DOI 10.1093/brain/113.1.191; Todd J. W., 1912, ARCH PSYCHOL, V25; Walsh V, 2003, BRADFORD BOOKS, P1; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5	59	56	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2862	10.1371/journal.pone.0002862	http://dx.doi.org/10.1371/journal.pone.0002862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682848	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600018
J	Terleph, TA; Lu, K; Vicario, DS				Terleph, Thomas A.; Lu, Kai; Vicario, David S.			Response Properties of the Auditory Telencephalon in Songbirds Change with Recent Experience and Season	PLOS ONE			English	Article							SONG-CONTROL; GENE-EXPRESSION; CAUDAL TELENCEPHALON; ZEBRA FINCHES; BRAIN; SYSTEM; FOREBRAIN; DYNAMICS; NEURONS; BAT	The caudomedial nidopallium (NCM) is a telencephalic auditory area that is selectively activated by conspecific vocalizations in zebra finches and canaries. We recently demonstrated that temporal and spectral dynamics of auditory tuning in NCM differ between these species [1]. In order to determine whether these differences reflect recent experience, we exposed separate groups of each species and sex to different housing conditions. Adult birds were housed either in an aviary with conspecifics (NORM), with heterospecifics (canary subjects in a zebra finch aviary, and vice versa: (CROSS)), or in isolation (ISO) for 9 days prior to testing. We then recorded extracellular multi-unit electrophysiological responses to simple pure tone stimuli (250-5000 Hz) in awake birds from each group and analyzed auditory tuning width using methods from our earlier studies. Relative to NORM birds, tuning was narrower in CROSS birds, and wider in ISO birds. The trend was greater in canaries, especially females. The date of recording was also included as a covariate in ANCOVAs that analyzed a larger set of the canary data, including data from birds tested outside of the breeding season, and treated housing condition and sex as independent variables. These tests show that tuning width was narrower early in the year and broader later. This effect was most pronounced in CROSS males. The degree of the short-term neural plasticity described here differs across sexes and species, and may reflect differences in NCM's anatomical and functional organization related to species differences in song characteristics, adult plasticity and/or social factors. More generally, NCM tuning is labile and may be modulated by recent experience to reflect the auditory processing required for behavioral adaptation to the current acoustic, social or seasonal context.	[Terleph, Thomas A.] Sacred Heart Univ, Dept Biol, Fairfield, CT USA; [Lu, Kai; Vicario, David S.] Rutgers State Univ, Psychol Dept, Piscataway, NJ USA	Sacred Heart University; Rutgers State University New Brunswick	Terleph, TA (corresponding author), Sacred Heart Univ, Dept Biol, Fairfield, CT USA.	terlepht@sacredheart.edu			 [DC 008043-01];  [MH40900];  [DC2853]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH040900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002853, R01DC002853, F32DC008043] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	DC 008043-01, MH40900, and DC2853. These funders had no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Leitner S, 2001, BEHAVIOUR, V138, P885, DOI 10.1163/156853901753172700; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; MELLO C, 1995, J NEUROSCI, V15, P6919; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; Pinaud R, 2006, J NEUROBIOL, V66, P182, DOI 10.1002/neu.20211; Pinaud R, 2004, INT J NEUROSCI, V114, P321, DOI 10.1080/00207450490264142; Pinaud R, 2007, J CHEM NEUROANAT, V34, P1, DOI 10.1016/j.jchemneu.2007.03.005; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; Terleph TA, 2006, J NEUROBIOL, V66, P281, DOI 10.1002/neu.20219; Terleph TA, 2007, DEV NEUROBIOL, V67, P1498, DOI 10.1002/dneu.20524; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; Vignal C, 2005, EUR J NEUROSCI, V22, P949, DOI 10.1111/j.1460-9568.2005.04254.x; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760; Zann RA., 1996, ZEBRA FINCH SYNTHESI; ZEIGLER HP, 2004, BEHAV NEUROBIOLOGY B; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	29	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2854	10.1371/journal.pone.0002854	http://dx.doi.org/10.1371/journal.pone.0002854			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682724	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600010
J	Yang, JX; Bridges, K; Chen, KY; Liu, AYC				Yang, Jingxian; Bridges, Kristen; Chen, Kuang Yu; Liu, Alice Y. -C.			Riluzole Increases the Amount of Latent HSF1 for an Amplified Heat Shock Response and Cytoprotection	PLOS ONE			English	Article								Background: Induction of the heat shock response (HSR) and increased expression of the heat shock proteins (HSPs) provide mechanisms to ensure proper protein folding, trafficking, and disposition. The importance of HSPs is underscored by the understanding that protein mis-folding and aggregation contribute centrally to the pathogenesis of neurodegenerative diseases. Methodology/Principal Findings: We used a cell-based hsp70-luciferease reporter gene assay system to identify agents that modulate the HSR and show here that clinically relevant concentrations of the FDA-approved ALS drug riluzole significantly increased the heat shock induction of hsp70-luciferse reporter gene. Immuno-Western and -cytochemical analysis of HSF1 show that riluzole increased the amount of cytosolic HSF1 to afford a greater activation of HSF1 upon heat shock. The increased HSF1 contributed centrally to the cytoprotective activity of riluzole as hsf1 gene knockout negated the synergistic activity of riluzole and conditioning heat shock to confer cell survival under oxidative stress. Evidence of a post-transcriptional mechanism for the increase in HSF1 include: quantitation of mRNA hsf1 by RT-PCR showed no effect of either heat shock or riluzole treatment; riluzole also increased the expression of HSF1 from a CMV-promoter; analysis of the turnover of HSF1 by pulse chase and immunoprecipitation show that riluzole slowed the decay of [(35)S] labeled-HSF1. The effect of riluzole on HSF1 was qualitatively different from that of MG132 and chloroquine, inhibitors of the proteasome and lysosome, respectively, and appeared to involve the chaperone-mediated autophagy pathway as RNAi-mediated knockdown of CMA negated its effect. Conclusion/Significance: We show that riluzole increased the amount of HSF1 to amplify the HSR for cytoprotection. Our study provides novel insight into the mechanism that regulates HSF1 turnover, and identifies the degradation of HSF1 as a target for therapeutics intervention.	[Yang, Jingxian; Bridges, Kristen; Liu, Alice Y. -C.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA; [Chen, Kuang Yu] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Yang, JX (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08855 USA.	liu@biology.rutgers.edu		Liu, Alice Y./0000-0002-6984-1671; Chen, Kuang Yu/0000-0002-5629-7785	NSF [MCB0240009]; NJ Commission on Spinal Cord Research [05-3037-SCR-E-0]	NSF(National Science Foundation (NSF)); NJ Commission on Spinal Cord Research	This work was supported in part by grants from the NSF (MCB0240009) and NJ Commission on Spinal Cord Research (05-3037-SCR-E-0).	ANANTHAN J, 1986, SCIENCE, V232, P522, DOI 10.1126/science.3083508; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baler R, 1996, CELL STRESS CHAPERON, V1, P33, DOI 10.1379/1466-1268(1996)001<0033:EFAROH>2.3.CO;2; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Batulan Z, 2003, J NEUROSCI, V23, P5789; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bush KT, 1997, J BIOL CHEM, V272, P9086; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; CLOS J, 1990, CELL, V63, P1085, DOI 10.1016/0092-8674(90)90511-C; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dice JF, 2007, AUTOPHAGY, V3, P295, DOI 10.4161/auto.4144; Du YZ, 2007, GLIA, V55, P463, DOI 10.1002/glia.20472; Farkas T, 1998, MOL CELL BIOL, V18, P906, DOI 10.1128/MCB.18.2.906; FIORENZA MT, 1995, NUCLEIC ACIDS RES, V23, P467, DOI 10.1093/nar/23.3.467; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Hargitai J, 2003, BIOCHEM BIOPH RES CO, V307, P689, DOI 10.1016/S0006-291X(03)01254-3; Heiser V, 2002, P NATL ACAD SCI USA, V99, P16400, DOI 10.1073/pnas.182426599; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; HUANG LE, 1994, J BIOL CHEM, V269, P30718; Ishiyama T, 2004, BRAIN RES, V1019, P226, DOI 10.1016/j.brainres.2004.06.002; JURIVICH DA, 1992, SCIENCE, V255, P1243, DOI 10.1126/science.1546322; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Khalil S, 2006, J CELL PHYSIOL, V207, P562, DOI 10.1002/jcp.20599; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Killestein J, 2005, J NEUROL SCI, V233, P113, DOI 10.1016/j.jns.2005.03.011; Kim D, 1999, BIOCHEM BIOPH RES CO, V254, P264, DOI 10.1006/bbrc.1998.9840; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lips J, 2000, ANESTHESIOLOGY, V93, P1303, DOI 10.1097/00000542-200011000-00025; Lubbers NL, 2002, EUR J PHARMACOL, V435, P79, DOI 10.1016/S0014-2999(01)01552-7; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; McMillan DR, 1998, J BIOL CHEM, V273, P7523, DOI 10.1074/jbc.273.13.7523; MIFFLIN LC, 1994, J BIOL CHEM, V269, P15710; Mizushima N, 2006, AUTOPHAGY, V2, P302, DOI 10.4161/auto.2945; Morimoto RI, 2006, NEW ENGL J MED, V355, P2254, DOI 10.1056/NEJMcibr065573; MOSSER DD, 1993, MOL CELL BIOL, V13, P5427, DOI 10.1128/MCB.13.9.5427; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Nirmalananthan N, 2005, CURR OPIN NEUROL, V18, P712, DOI 10.1097/01.wco.0000187248.21103.c5; NUNES SL, 1995, BIOCHEM BIOPH RES CO, V213, P1, DOI 10.1006/bbrc.1995.2090; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Polakowski JS, 2002, EUR J PHARMACOL, V435, P73, DOI 10.1016/S0014-2999(01)01551-5; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Schwartz G, 2001, J NEUROSURG, V94, P245, DOI 10.3171/spi.2001.94.2.0245; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Stover JF, 2000, J NEUROTRAUM, V17, P1171, DOI 10.1089/neu.2000.17.1171; van Damme P, 2005, NEURODEGENER DIS, V2, P147, DOI 10.1159/000089620; Vigh L, 1997, NAT MED, V3, P1150, DOI 10.1038/nm1097-1150; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Weng YC, 2007, EXP NEUROL, V204, P433, DOI 10.1016/j.expneurol.2006.12.003; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; WU B, 1985, MOL CELL BIOL, V5, P330, DOI 10.1128/MCB.5.2.330; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yanagida Y, 2000, J BIOTECHNOL, V79, P53, DOI 10.1016/S0168-1656(00)00214-5; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082	57	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2864	10.1371/journal.pone.0002864	http://dx.doi.org/10.1371/journal.pone.0002864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682744	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600020
J	Baba, K; Hoosen, AA; Langeland, N; Dyrhol-Riise, AM				Baba, Kamaldeen; Hoosen, Anwar A.; Langeland, Nina; Dyrhol-Riise, Anne M.			Adenosine Deaminase Activity Is a Sensitive Marker for the Diagnosis of Tuberculous Pleuritis in Patients with Very Low CD4 Counts	PLOS ONE			English	Article								Background: Adenosine Deaminase Activity (ADA) is a commonly used marker for the diagnosis of tuberculous pleural effusion. There has been concern about its usefulness in immunocompromised patients, especially HIV positive patients with very low CD4 counts. The objective of this study was to evaluate the sensitivity of ADA in pleural fluid in patients with low CD4 counts. Materials and Methods: This was a retrospective case control study. Medical files of patients with tuberculous pleuritis and non-tuberculous pleuritis were reviewed. Clinical characteristics, CD4 cell counts in blood and biochemical markers in pleural fluid, including ADA were recorded. Results: One ninety seven tuberculous pleuritis and 40 non-tuberculous pleuritis patients were evaluated. Using the cut-off value of 30 U/L, the overall sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of ADA was 94%, 95%, 19, and 0.06 respectively. The mean CD4 cell counts among TB pleuritis patients was 29 and 153 cells/microL in patients with CD4,50 cells/microL and < 50 cells/microL, (p < 0.05) respectively. The corresponding mean ADA values for these patients were 76 U/L and 72 U/L respectively (p > 0.5). There was no correlation between ADA values and CD4 cell counts (r =-0.120, p = 0.369). Conclusion: ADA analysis is a sensitive marker of tuberculous pleuritis even in HIV patients with very low CD4 counts in a high TB endemic region. The ADA assay is inexpensive, rapid, and simple to perform and is of great value for the immediate diagnosis of tuberculous pleuritis while waiting for culture result and this has a positive impact on patient outcome.	[Baba, Kamaldeen; Langeland, Nina; Dyrhol-Riise, Anne M.] Univ Bergen, Inst Med, Bergen, Norway; [Baba, Kamaldeen] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Baba, Kamaldeen; Hoosen, Anwar A.] Univ Limpopo, Dept Microbiol Pathol, Limpopo, South Africa; [Langeland, Nina; Dyrhol-Riise, Anne M.] Haukeland Hosp, Dept Med, Bergen, Norway	University of Bergen; University of Bergen; University of Limpopo; University of Bergen; Haukeland University Hospital	Baba, K (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	adeola12@yahoo.co.uk			University of Bergen, Norway [QUOTA fellowship programme]; Regional Health Authorities of Western Norway	University of Bergen, Norway; Regional Health Authorities of Western Norway	This study was funded by QUOTA fellowship programme at the University of Bergen, Norway and thanks to the Regional Health Authorities of Western Norway who funded the running costs. The funders did not play any role in the study design, data analysis and preparation of manuscript.	Alvarez GG, 2004, INT J TUBERC LUNG D, V8, P1472; BABA K, 2008, AIMM IN PRESS; BABA K, 1998, BMC INFECT IN PRESS; BAGANHA MF, 1990, CHEST, V97, P605, DOI 10.1378/chest.97.3.605; BLAKE J, 1982, S AFR MED J, V62, P19; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; BURGESS LJ, 1995, THORAX, V50, P672, DOI 10.1136/thx.50.6.672; Corral I, 2004, EUR J CLIN MICROBIOL, V23, P471, DOI 10.1007/s10096-004-1110-z; Diacon AH, 2003, EUR RESPIR J, V22, P589, DOI 10.1183/09031936.03.00017103a; Gaga M, 2005, RESPIRATION, V72, P160, DOI 10.1159/000084047; GAKIS C, 1991, CHEST, V99, P1555, DOI 10.1378/chest.99.6.1555; Goto M, 2003, ANN CLIN BIOCHEM, V40, P374, DOI 10.1258/000456303766477011; Hsu Wu-Huei, 1993, Journal of the Formosan Medical Association, V92, P668; Ibrahim WH, 2005, RESP MED, V99, P1038, DOI 10.1016/j.rmed.2004.12.012; Lee YCG, 2001, CHEST, V120, P356, DOI 10.1378/chest.120.2.356; Miller V, 1999, ANN INTERN MED, V130, P570, DOI 10.7326/0003-4819-130-7-199904060-00005; Perez-Rodriguez E, 1999, RESP MED, V93, P816, DOI 10.1016/S0954-6111(99)90267-6; PFALLER MA, 1994, AM J CLIN PATHOL, V101, P329, DOI 10.1093/ajcp/101.3.329; PIRAS MA, 1978, BRIT MED J, V2, P1751, DOI 10.1136/bmj.2.6154.1751-a; Reuter Helmuth, 2005, Cardiovasc J S Afr, V16, P143; Riantawan P, 1999, CHEST, V116, P97, DOI 10.1378/chest.116.1.97; Sharma S K, 2001, Indian J Chest Dis Allied Sci, V43, P149; Tarhan G, 2006, J INFECTION, V52, P264, DOI 10.1016/j.jinf.2005.06.009; UNGERER JPJ, 1994, CHEST, V106, P33, DOI 10.1378/chest.106.1.33; VALDES L, 1993, CHEST, V103, P458, DOI 10.1378/chest.103.2.458; Valdes L, 1998, ARCH INTERN MED, V158, P2017, DOI 10.1001/archinte.158.18.2017; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; Villena V, 1996, CLIN CHEM, V42, P218; Villena V, 1996, EUR RESPIR J, V9, P2635, DOI 10.1183/09031936.96.09122635; Villena V, 2003, AM J MED, V115, P365, DOI 10.1016/S0002-9343(03)00423-6; *WHO, 2005, WHOHTMTB2005349	31	45	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2788	10.1371/journal.pone.0002788	http://dx.doi.org/10.1371/journal.pone.0002788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665218	Green Published, gold			2022-12-27	WOS:000264304300007
J	Chen, L; Zheng, S				Chen, Liang; Zheng, Sika			Identify Alternative Splicing Events Based on Position-Specific Evolutionary Conservation	PLOS ONE			English	Article							SELECTION PRESSURE; IDENTIFICATION; DATABASE; GENOME; EXONS; PREDICTION	The evolution of eukaryotes is accompanied by the increased complexity of alternative splicing which greatly expands genome information. One of the greatest challenges in the post-genome era is a complete revelation of human transcriptome with consideration of alternative splicing. Here, we introduce a comparative genomics approach to systemically identify alternative splicing events based on the differential evolutionary conservation between exons and introns and the high-quality annotation of the ENCODE regions. Specifically, we focus on exons that are included in some transcripts but are completely spliced out for others and we call them conditional exons. First, we characterize distinguishing features among conditional exons, constitutive exons and introns. One of the most important features is the position-specific conservation score. There are dramatic differences in conservation scores between conditional exons and constitutive exons. More importantly, the differences are position-specific. For flanking intronic regions, the differences between conditional exons and constitutive exons are also position-specific. Using the Random Forests algorithm, we can classify conditional exons with high specificities (97% for the identification of conditional exons from intron regions and 95% for the classification of known exons) and fair sensitivities (64% and 32% respectively). We applied the method to the human genome and identified 39,640 introns that actually contain conditional exons and classified 8,813 conditional exons from the current RefSeq exon list. Among those, 31,673 introns containing conditional exons and 5,294 conditional exons classified from known exons cannot be inferred from RefSeq, UCSC or Ensembl annotations. Some of these de novo predictions were experimentally verified.	[Chen, Liang] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Zheng, Sika] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of Southern California; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Chen, L (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	liang.chen@usc.edu	Zheng, Sika/ABB-9203-2020	Zheng, Sika/0000-0002-0573-4981	USC	USC	This work was partially supported by the Faculty Setup Grant from USC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cooper TA, 2005, CELL, V120, P1, DOI 10.1016/j.cell.2004.12.030; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dror G, 2005, BIOINFORMATICS, V21, P897, DOI 10.1093/bioinformatics/bti132; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001; Leparc GG, 2007, NUCLEIC ACIDS RES, V35, P3192, DOI 10.1093/nar/gkm187; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288; Parmley JL, 2007, PLOS BIOL, V5, P343, DOI 10.1371/journal.pbio.0050014; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resch A, 2004, NUCLEIC ACIDS RES, V32, P1261, DOI 10.1093/nar/gkh284; Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Xing Y, 2006, NAT REV GENET, V7, P499, DOI 10.1038/nrg1896; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	24	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2806	10.1371/journal.pone.0002806	http://dx.doi.org/10.1371/journal.pone.0002806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665247	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300025
J	Khalil, A; Muttukrishna, S; Harrington, K; Jauniaux, E				Khalil, Asma; Muttukrishna, Shanthi; Harrington, Kevin; Jauniaux, Eric			Effect of Antihypertensive Therapy with Alpha Methyldopa on Levels of Angiogenic Factors in Pregnancies with Hypertensive Disorders	PLOS ONE			English	Article								Background: Antihypertensive drugs are believed to lower blood pressure in pre-eclampsia by direct or central vasodilatory mechanisms. However, they could also act by decreasing production of anti-angiogenic proteins involved in the pathophysiology of hypertension and proteinuria in pre-eclampsia (PE). The aim of our study was to evaluate the impact of antihypertensive therapy with alpha methyldopa on maternal circulating levels and placental production of soluble fms-like tyrosine kinase 1 (sFlt-1), soluble endoglin (sEng), vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in hypertensive disorders of pregnancy. Methodology/Principal Findings: In a study conducted at University College Hospital and the Homerton University Hospital in London, we recruited 51 women with PE, 29 with gestational hypertension (GH), and 80 matched normotensive controls. Eight (16%) of the women with PE had severe disease. Placental samples were obtained from a further 48 women (14 PE, 10 GH and 24 matched controls). Serum levels of angiogenic factors were measured before and 24-48 hours after commencing antihypertensive therapy with alpha methyldopa for clinical indications. The same parameters were measured in placental extracts. In both PE (P < 0.0001) and GH (P < 0.05), serum sFlt-1 was increased and PlGF reduced at all gestations (P < 0.001) compared to controls. Serum sEng levels were also increased in PE. Placental concentration of sFlt-1 and sEng was significantly higher in women with PE compared to controls and women with GH (P < 0.0001). The concentration of PlGF was significantly lower in the placental tissue of women with PE compared to GH (P = 0.008). Antihypertensive treatment was associated with a significant fall in serum and placental content of sFlt1 and sEng in PE only. Conclusions: Our data suggest that alpha methyldopa may have a specific effect on placental and/or endothelial cell function in pre-eclampsia patients, altering angiogenic proteins.	[Khalil, Asma; Harrington, Kevin] Univ London, Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London, England; [Muttukrishna, Shanthi; Jauniaux, Eric] UCL, UCL Inst Womens Hlth, Acad Dept Obstet & Gynaecol, London, England	University of London; Queen Mary University London; University of London; University College London	Khalil, A (corresponding author), Univ London, Queen Mary & Westfield Coll, Homerton Univ Hosp NHS Trust, London, England.	asmakhalil79@googlemail.com	Khall, Asma/AAC-1459-2020	Khall, Asma/0000-0003-2802-7670				Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Belgore FM, 2001, AM J CARDIOL, V87, P805, DOI 10.1016/S0002-9149(00)01512-5; BELGORE FM, 2001, AM J CARDIOL, V87, pA9; BOTTARI SP, 1983, J CLIN ENDOCR METAB, V57, P937, DOI 10.1210/jcem-57-5-937; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Celik-Ozenci C, 2004, MOL REPROD DEV, V67, P414, DOI 10.1002/mrd.20001; Celik-Ozenci C, 2003, HISTOCHEM CELL BIOL, V120, P383, DOI 10.1007/s00418-003-0586-4; Clark DE, 1998, J ENDOCRINOL, V159, P459, DOI 10.1677/joe.0.1590459; DAY MD, 1973, EUR J PHARMACOL, V21, P271, DOI 10.1016/0014-2999(73)90126-X; Failla CM, 2000, J INVEST DERMATOL, V115, P388, DOI 10.1046/j.1523-1747.2000.00085.x; FALKAY G, 1994, PLACENTA, V15, P661, DOI 10.1016/S0143-4004(05)80412-6; FALKAY G, 1994, J RECEPTOR RES, V14, P187, DOI 10.3109/10799899409066030; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Head GA, 1999, ANN NY ACAD SCI, V881, P279, DOI 10.1111/j.1749-6632.1999.tb09370.x; Head GA, 1998, J AUTONOM NERV SYST, V72, P163, DOI 10.1016/S0165-1838(98)00101-5; HENNING M, 1971, J PHARM PHARMACOL, V23, P407, DOI 10.1111/j.2042-7158.1971.tb08671.x; Hollborn M, 2006, GRAEF ARCH CLIN EXP, V244, P732, DOI 10.1007/s00417-005-0154-9; Hornig C, 2000, LAB INVEST, V80, P443, DOI 10.1038/labinvest.3780050; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Khan ZP, 1999, ANAESTHESIA, V54, P146, DOI 10.1046/j.1365-2044.1999.00659.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2005, JAMA-J AM MED ASSOC, V293, P77, DOI 10.1001/jama.293.1.77; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; MAGLIONE D, 1993, ONCOGENE, V8, P925; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MORISHITA K, 1995, J BIOL CHEM, V270, P27948, DOI 10.1074/jbc.270.46.27948; Muthig V, 2007, CIRC RES, V101, P682, DOI 10.1161/CIRCRESAHA.107.151563; Raab U, 1999, BIOCHEM J, V339, P579, DOI 10.1042/0264-6021:3390579; Raab U, 1999, FEBS LETT, V459, P249, DOI 10.1016/S0014-5793(99)01252-1; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Roy H, 2006, FEBS LETT, V580, P2879, DOI 10.1016/j.febslet.2006.03.087; Szelenyi J, 2000, ANN NY ACAD SCI, V917, P145; Tordjman R, 2001, BLOOD, V97, P1968, DOI 10.1182/blood.V97.7.1968; VANZWIETEN PA, 1984, AM J MED, V77, P17, DOI 10.1016/S0002-9343(84)80033-9; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; VIGLIETTO G, 1995, ONCOGENE, V11, P1569; Vuorela P, 1997, BIOL REPROD, V56, P489, DOI 10.1095/biolreprod56.2.489; Wakiya K, 1996, J BIOL CHEM, V271, P30823, DOI 10.1074/jbc.271.48.30823	44	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2766	10.1371/journal.pone.0002766	http://dx.doi.org/10.1371/journal.pone.0002766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648513	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000264302900036
J	Sanz-Blasco, S; Valero, RA; Rodriguez-Crespo, I; Villalobos, C; Nunez, L				Sanz-Blasco, Sara; Valero, Ruth A.; Rodriguez-Crespo, Ignacio; Villalobos, Carlos; Nunez, Lucia			Mitochondrial Ca2+ Overload Underlies A beta Oligomers Neurotoxicity Providing an Unexpected Mechanism of Neuroprotection by NSAIDs	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM; CORTICAL-NEURONS; OXIDATIVE STRESS; CALCIUM; ACTIVATION; INHIBITION; APOPTOSIS	Dysregulation of intracellular Ca2+ homeostasis may underlie amyloid beta peptide (A beta) toxicity in Alzheimer's Disease (AD) but the mechanism is unknown. In search for this mechanism we found that A beta(1-42) oligomers, the assembly state correlating best with cognitive decline in AD, but not A beta fibrils, induce a massive entry of Ca2+ in neurons and promote mitochondrial Ca2+ overload as shown by bioluminescence imaging of targeted aequorin in individual neurons. A beta oligomers induce also mitochondrial permeability transition, cytochrome c release, apoptosis and cell death. Mitochondrial depolarization prevents mitochondrial Ca2+ overload, cytochrome c release and cell death. In addition, we found that a series of nonsteroidal anti-inflammatory drugs (NSAIDs) including salicylate, sulindac sulfide, indomethacin, ibuprofen and R-flurbiprofen depolarize mitochondria and inhibit mitochondrial Ca2+ overload, cytochrome c release and cell death induced by A beta oligomers. Our results indicate that i) mitochondrial Ca2+ overload underlies the neurotoxicity induced by A beta oligomers and ii) inhibition of mitochondrial Ca2+ overload provides a novel mechanism of neuroprotection by NSAIDs against A beta oligomers and AD.	[Sanz-Blasco, Sara; Valero, Ruth A.; Villalobos, Carlos; Nunez, Lucia] Univ Valladolid, IBGM, Valladolid, Spain; [Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Fac Ciencias Quimicas, Dept Bioquim Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM); Universidad de Valladolid; Complutense University of Madrid	Sanz-Blasco, S (corresponding author), Univ Valladolid, IBGM, Valladolid, Spain.	carlosv@ibgm.uva.es	nunez, lucia/AAG-8018-2019; Villalobos, Carlos/M-9839-2017; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Villalobos, Carlos/0000-0002-0429-3846; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Nunez, Lucia/0000-0002-9638-5747	Spanish Instituto de Salud Carlos III [PI04/1510, PI07/0766]; Junta de Castilla y Leon [VA022A05]; Ministerio de Educacion y Ciencia [BFU2006-05202]; Consejo Superior de Investigaciones Cientificas (CSIC)	Spanish Instituto de Salud Carlos III(Instituto de Salud Carlos III); Junta de Castilla y Leon(Junta de Castilla y Leon); Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas (CSIC)	This work was supported by public, competitive grants from the spanish Instituto de Salud Carlos III (PI04/1510 and PI07/0766), Junta de Castilla y Leon (VA022A05), Ministerio de Educacion y Ciencia (MEC, BFU2006-05202) and Consejo Superior de Investigaciones Cientificas (CSIC). None of the funding agencies have any role in the design and conduct of the study, collection, analysis or interpretation of the data nor the preparation review or approval of the manuscript.	Abramov AY, 2003, J NEUROSCI, V23, P5088; Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Brocard JB, 2001, J PHYSIOL-LONDON, V531, P793, DOI 10.1111/j.1469-7793.2001.0793h.x; BURDICK D, 1992, J BIOL CHEM, V267, P546; Canevari L, 2004, NEUROCHEM RES, V29, P637, DOI 10.1023/B:NERE.0000014834.06405.af; Canu N, 2003, CEREBELLUM, V2, P270, DOI 10.1080/14734220310004289; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; De Felice FG, 2007, J BIOL CHEM, V282, P11590, DOI 10.1074/jbc.M607483200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Deshpande A, 2006, J NEUROSCI, V26, P6011, DOI 10.1523/JNEUROSCI.1189-06.2006; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Dubinsky JM, 1998, J NEUROSCI RES, V53, P728, DOI 10.1002/(SICI)1097-4547(19980915)53:6<728::AID-JNR10>3.0.CO;2-U; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Geula C, 2003, J COMP NEUROL, V455, P249, DOI 10.1002/cne.10475; Guo Q, 1998, P NATL ACAD SCI USA, V95, P3227, DOI 10.1073/pnas.95.6.3227; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Kawai K, 2001, NEUROPATHOLOGY, V21, P13, DOI 10.1046/j.1440-1789.2001.00362.x; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Mahmud T, 1996, ARTHRITIS RHEUM, V39, P1998, DOI 10.1002/art.1780391208; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Marx J, 2007, SCIENCE, V318, P384, DOI 10.1126/science.318.5849.384; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; MURPHY TH, 1992, J NEUROSCI, V12, P4834; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Norenberg MD, 2007, NEUROCHEM INT, V50, P983, DOI 10.1016/j.neuint.2007.02.008; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Nunez L, 1996, EUR J NEUROSCI, V8, P192, DOI 10.1111/j.1460-9568.1996.tb01180.x; Nunez L, 2007, J PHYSIOL-LONDON, V580, P385, DOI 10.1113/jphysiol.2006.126524; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Petronilli V, 1998, BIOFACTORS, V8, P263, DOI 10.1002/biof.5520080314; Pivovarova NB, 2004, J NEUROSCI, V24, P5611, DOI 10.1523/JNEUROSCI.0531-04.2004; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rogers KL, 2005, EUR J NEUROSCI, V21, P597, DOI 10.1111/j.1460-9568.2005.03871.x; Simakova O, 2006, BIOCHEMISTRY-US, V45, P5907, DOI 10.1021/bi060148g; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Stutzmann GE, 2007, ANN NY ACAD SCI, V1097, P265, DOI 10.1196/annals.1379.025; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; VALERO RA, 2008, CELL CALCIU IN PRESS; Villalobos C, 2002, FASEB J, V16, DOI 10.1096/fj.01-0630com; Villalobos C, 2001, J BIOL CHEM, V276, P40293, DOI 10.1074/jbc.C100465200; Voronina SG, 2004, J BIOL CHEM, V279, P27327, DOI 10.1074/jbc.M311698200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wegiel J, 1999, BRAIN RES, V818, P41, DOI 10.1016/S0006-8993(98)01279-7; Xie L, 2005, J CELL BIOL, V168, P911, DOI 10.1083/jcb.200407079; Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002	60	165	178	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2718	10.1371/journal.pone.0002718	http://dx.doi.org/10.1371/journal.pone.0002718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648507	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900005
J	Dong, WB; Tang, XJ; Yu, YH; Nilsen, R; Kim, R; Griffith, J; Arnold, J; Schuttler, HB				Dong, Wubei; Tang, Xiaojia; Yu, Yihai; Nilsen, Roger; Kim, Rosemary; Griffith, James; Arnold, Jonathan; Schuttler, H. Bernd			Systems Biology of the Clock in Neurospora crassa	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; MICROARRAY ANALYSIS; DEPENDENT REGULATION; SIGNALING PATHWAYS; REGULATORY NETWORK; FILAMENTOUS FUNGUS; OSMOTIC-STRESS; WHITE COLLAR-1; FEEDBACK LOOPS; GENOME	A model-driven discovery process, Computing Life, is used to identify an ensemble of genetic networks that describe the biological clock. A clock mechanism involving the genes white-collar-1 and white-collar-2 (wc-1 and wc-2) that encode a transcriptional activator (as well as a blue-light receptor) and an oscillator frequency (frq) that encodes a cyclin that deactivates the activator is used to guide this discovery process through three cycles of microarray experiments. Central to this discovery process is a new methodology for the rational design of a Maximally Informative Next Experiment (MINE), based on the genetic network ensemble. In each experimentation cycle, the MINE approach is used to select the most informative new experiment in order to mine for clock-controlled genes, the outputs of the clock. As much as 25% of the N. crassa transcriptome appears to be under clock-control. Clock outputs include genes with products in DNA metabolism, ribosome biogenesis in RNA metabolism, cell cycle, protein metabolism, transport, carbon metabolism, isoprenoid (including carotenoid) biosynthesis, development, and varied signaling processes. Genes under the transcription factor complex WCC (= WC-1/WC-2) control were resolved into four classes, circadian only (612 genes), light-responsive only (396), both circadian and light-responsive (328), and neither circadian nor light-responsive (987). In each of three cycles of microarray experiments data support that wc-1 and wc-2 are auto-regulated by WCC. Among 11,000 N. crassa genes a total of 295 genes, including a large fraction of phosphatases/kinases, appear to be under the immediate control of the FRQ oscillator as validated by 4 independent microarray experiments. Ribosomal RNA processing and assembly rather than its transcription appears to be under clock control, suggesting a new mechanism for the post-transcriptional control of clock-controlled genes.	[Dong, Wubei; Arnold, Jonathan] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Tang, Xiaojia; Yu, Yihai; Nilsen, Roger; Kim, Rosemary; Griffith, James; Schuttler, H. Bernd] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Griffith, James] Univ Georgia, Coll Agr & Environm Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Dong, WB (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	arnold@uga.edu	Schuttler, Heinz-Bernd/AFT-0395-2022	Dong, Wubei/0000-0001-8513-8751; arnold, jonathan/0000-0001-5845-1048; Tang, Xiaojia/0000-0003-2457-9953	NSF [DBI-0243574, MCB-0542915, BES-0425762]; Sun Grid [12021957]; University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences	NSF(National Science Foundation (NSF)); Sun Grid; University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences	NSF DBI-0243574, NSF MCB-0542915, NSF BES-0425762, Sun Grid Grant 12021957, The University of Minnesota Supercomputer Center and the University of Georgia College of Agricultural and Environmental Sciences supported this work. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves R, 2000, BIOINFORMATICS, V16, P534, DOI 10.1093/bioinformatics/16.6.534; ARNOLD J, 2004, HDB IND MYCOLOGY, P597; ARNOLD J, 2006, IEEE P 1 INT C COMP, P119; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomfield P., 1976, FOURIER ANAL TIME SE; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Clarke DC, 2006, IEE P SYST BIOL, V153, P412, DOI 10.1049/ip-syb:20050055; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Correa A, 2002, EUKARYOT CELL, V1, P273, DOI 10.1128/EC.1.2.273-280.2002; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dai JL, 2007, BIOMETRICS, V63, P1245, DOI 10.1111/j.1541-0420.2007.00801.x; Davidian M., 1995, NONLINEAR MODELS REP; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Paula RM, 2006, J BIOL RHYTHM, V21, P159, DOI 10.1177/0748730406288338; DHARMANANDA S, 1980, THESIS U CALIFORNIA; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Dong W, 2007, IET SYST BIOL, V1, P257, DOI 10.1049/iet-syb:20060080; Dunlap JC, 2007, ADV GENET, V57, P49, DOI 10.1016/S0065-2660(06)57002-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; GILES NH, 1991, J HERED, V82, P1; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Gutierrez RA, 2002, P NATL ACAD SCI USA, V99, P11513, DOI 10.1073/pnas.152204099; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; Heisenberg W., 1949, PHYS PRINCIPLES QUAN; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Inada M, 2004, P NATL ACAD SCI USA, V101, P434, DOI 10.1073/pnas.0307425100; Jazwinski SM, 2002, ANNU REV MICROBIOL, V56, P769, DOI 10.1146/annurev.micro.56.012302.160830; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Lin Y, 2002, P NATL ACAD SCI USA, V99, P9562, DOI 10.1073/pnas.132269699; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Logan DA, 2007, BIOINFORMATION, V1, P390, DOI 10.6026/97320630001390; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Mannhaupt G, 2003, NUCLEIC ACIDS RES, V31, P1944, DOI 10.1093/nar/gkg293; Masloff S, 2002, FUNGAL GENET BIOL, V36, P107, DOI 10.1016/S1087-1845(02)00010-5; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Muirhead R. J., 1982, ASPECTS MULTIVARIATE; NAKASHIMA H, 1981, PLANT CELL PHYSIOL, V22, P231; Nowrousian M, 2003, GENETICS, V164, P923; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Pregueiro AM, 2006, SCIENCE, V313, P644, DOI 10.1126/science.1121716; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Townsend JP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-54; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Vitalini MW, 2007, P NATL ACAD SCI USA, V104, P18223, DOI 10.1073/pnas.0704900104; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Xiong MM, 2004, GENETICS, V166, P1037, DOI 10.1534/genetics.166.2.1037; Yang YH, 2004, GENE DEV, V18, P255, DOI 10.1101/gad.1152604; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; Youssar L, 2006, FUNGAL GENET BIOL, V43, P752, DOI 10.1016/j.fgb.2006.05.003; YU Y, 2005, THESIS U GEORGIA; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104	95	81	82	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3105	10.1371/journal.pone.0003105	http://dx.doi.org/10.1371/journal.pone.0003105			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769678	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796800010
J	Kawabata, H; Zeki, S				Kawabata, Hideaki; Zeki, Semir			The Neural Correlates of Desire	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; LATERAL OCCIPITAL COMPLEX; VISUAL SEXUAL STIMULI; ORBITOFRONTAL CORTEX; FACIAL ATTRACTIVENESS; HUMAN BRAIN; FUNCTIONAL SPECIALIZATION; AMYGDALA RESPONSE; NUCLEUS-ACCUMBENS; FACE PERCEPTION	In an event-related fMRI study, we scanned eighteen normal human subjects while they viewed three categories of pictures (events, objects and persons) which they classified according to desirability (desirable, indifferent or undesirable). Each category produced activity in a distinct part of the visual brain, thus reflecting its functional specialization. We used conjunction analysis to learn whether there is a brain area which is always active when a desirable picture is viewed, regardless of the category to which it belongs. The conjunction analysis of the contrast desirable. undesirable revealed activity in the superior orbito-frontal cortex. This activity bore a positive linear relationship to the declared level of desirability. The conjunction analysis of desirable. indifferent revealed activity in the mid-cingulate cortex and in the anterior cingulate cortex. In the former, activity was greater for desirable and undesirable stimuli than for stimuli classed as indifferent. Other conjunction analyses produced no significant effects. These results show that categorizing any stimulus according to its desirability activates three different brain areas: the superior orbito-frontal, the mid-cingulate, and the anterior cingulate cortices.	[Kawabata, Hideaki; Zeki, Semir] UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England; [Kawabata, Hideaki] Kagoshima Univ, Dept Psychol, Kagoshima 890, Japan	University of London; University College London; Kagoshima University	Kawabata, H (corresponding author), UCL, Dept Cell & Dev Biol, Wellcome Lab Neurobiol, London, England.	zeki.pa@ucl.ac.uk	Zeki, Semir/AAA-1789-2020		Wellcome Trust, London, UK; Honda Research Institute, Wako, Japan	Wellcome Trust, London, UK(Wellcome Trust); Honda Research Institute, Wako, Japan	The work was supported by the Wellcome Trust, London, UK; and by the Honda Research Institute, Wako, Japan. Funding bodies had no role in design, execution or analysis of the study.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bonson KR, 2002, NEUROPSYCHOPHARMACOL, V26, P376, DOI 10.1016/S0893-133X(01)00371-2; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dackis C, 2005, NAT NEUROSCI, V8, P1431, DOI 10.1038/nn1105-1431; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Elliott R, 2003, J NEUROSCI, V23, P303; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gerlach C, 2002, NEUROPSYCHOLOGIA, V40, P1254, DOI 10.1016/S0028-3932(01)00222-6; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hamann S, 2004, NAT NEUROSCI, V7, P411, DOI 10.1038/nn1208; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; Kampe KKW, 2001, NATURE, V413, P589, DOI 10.1038/35098149; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kawabata H, 2004, J NEUROPHYSIOL, V91, P1699, DOI 10.1152/jn.00696.2003; Kelley AE, 2002, J NEUROSCI, V22, P3306; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lerner Y, 2002, CEREB CORTEX, V12, P163, DOI 10.1093/cercor/12.2.163; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nutt D, 2007, J PSYCHOPHARMACOL, V21, P461, DOI 10.1177/0269881106069938; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Pernet C, 2004, NEUROIMAGE, V22, P1563, DOI 10.1016/j.neuroimage.2004.03.044; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rolls ET, 2007, EUR J NEUROSCI, V26, P1067, DOI 10.1111/j.1460-9568.2007.05724.x; Rolls ET, 2003, CEREB CORTEX, V13, P308, DOI 10.1093/cercor/13.3.308; Rolls ET, 2003, EUR J NEUROSCI, V18, P695, DOI 10.1046/j.1460-9568.2003.02779.x; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smith KS, 2007, J NEUROSCI, V27, P1594, DOI 10.1523/JNEUROSCI.4205-06.2007; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang GJ, 2004, NEUROIMAGE, V21, P1790, DOI 10.1016/j.neuroimage.2003.11.026; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Wiggs CL, 1999, NEUROPSYCHOLOGIA, V37, P103; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Winston JS, 2007, NEUROPSYCHOLOGIA, V45, P195, DOI 10.1016/j.neuropsychologia.2006.05.009; Winston JS, 2003, NEUROIMAGE, V20, P84, DOI 10.1016/S1053-8119(03)00303-3; ZEKI S, 1991, J NEUROSCI, V11, P641; Zeki S, 2003, CEREB CORTEX, V13, P189, DOI 10.1093/cercor/13.2.189; Zeki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002180; ZEKI SM, 1978, NATURE, V274, P423, DOI 10.1038/274423a0	60	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3027	10.1371/journal.pone.0003027	http://dx.doi.org/10.1371/journal.pone.0003027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728753	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796400002
J	Butin-Israeli, V; Uzi, D; Abd-El-Latif, M; Pizov, G; Eden, A; Haviv, YS; Oppenheim, A				Butin-Israeli, Veronika; Uzi, Dotan; Abd-El-Latif, Mahmoud; Pizov, Galina; Eden, Arieh; Haviv, Yosef S.; Oppenheim, Ariella			DNA-Free Recombinant SV40 Capsids Protect Mice from Acute Renal Failure by Inducing Stress Response, Survival Pathway and Apoptotic Arrest	PLOS ONE			English	Article								Viruses induce signaling and host defense during infection. Employing these natural trigger mechanisms to combat organ or tissue failure is hampered by harmful effects of most viruses. Here we demonstrate that SV40 empty capsids (Virus Like Particles-VLPs), with no DNA, induce host Hsp/c70 and Akt-1 survival pathways, key players in cellular survival mechanisms. We postulated that this signaling might protect against organ damage in vivo. Acute kidney injury (AKI) was chosen as target. AKI is critical, prevalent disorder in humans, caused by nephrotoxic agents, sepsis or ischemia, via apoptosis/necrosis of renal tubular cells, with high morbidity and mortality. Systemic administration of VLPs activated Akt-1 and upregulated Hsp/c70 in vivo. Experiments in mercury-induced AKI mouse model demonstrated that apoptosis, oxidative stress and toxic renal failure were significantly attenuated by pretreatment with capsids prior to the mercury insult. Survival rate increased from 12% to >60%, with wide dose response. This study demonstrates that SV40 VLPs, devoid of DNA, may potentially be used as prophylactic agent for AKI. We anticipate that these finding may be projected to a wide range of organ failure, using empty capsids of SV40 as well as other viruses.	[Butin-Israeli, Veronika; Uzi, Dotan; Abd-El-Latif, Mahmoud; Oppenheim, Ariella] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel; [Pizov, Galina] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel; [Eden, Arieh] Carmel Lady Davis Med Ctr, Dept Anesthesiol & Critical Care Med, Haifa, Israel; [Haviv, Yosef S.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Nephrol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Clalit Health Services; Carmel Medical Center; Hebrew University of Jerusalem	Butin-Israeli, V (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91010 Jerusalem, Israel.	Ariella@cc.huji.ac.il	Butin-Israeli, Veronika/AAQ-2391-2020		NIH [R01 CA 100479-01A2]; The Israel Science Foundation [604/07]; NATIONAL CANCER INSTITUTE [R01CA100479] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NIH Grant R01 CA 100479-01A2 and by The Israel Science Foundation Grant No. 604/07.	ACHESON NH, 1981, DNA TUMOR VIRUSES, P125; Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361; Aufricht C, 2005, PEDIATR NEPHROL, V20, P707, DOI 10.1007/s00467-004-1812-6; Bai XC, 2002, J BIOCHEM, V131, P207, DOI 10.1093/oxfordjournals.jbchem.a003089; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BLACK PH, 1964, VIROLOGY, V24, P381, DOI 10.1016/0042-6822(64)90175-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chromy LR, 2006, J VIROL, V80, P5086, DOI 10.1128/JVI.80.10.5086-5091.2006; DAVENPORT RJ, 2002, SCI AGING KNOWL ENV; Dawn-Linsley M, 2005, J NEUROSCI METH, V141, P219, DOI 10.1016/j.jneumeth.2004.06.010; HAVERTY TP, 1988, J CELL BIOL, V107, P1359, DOI 10.1083/jcb.107.4.1359; Heyman Samuel N, 2002, Curr Opin Crit Care, V8, P526, DOI 10.1097/00075198-200212000-00008; Ignatov A, 2006, BRIT J PHARMACOL, V149, P490, DOI 10.1038/sj.bjp.0706909; Jo SK, 2006, J AM SOC NEPHROL, V17, P3082, DOI 10.1681/ASN.2005101077; Kelly KJ, 2005, CONTRIB NEPHROL, V148, P86, DOI 10.1159/000086054; KHANDJIAN EW, 1983, MOL CELL BIOL, V3, P1; Kimchi-Sarfaty C, 2004, CURR PHARM BIOTECHNO, V5, P451, DOI 10.2174/1389201043376670; Kimchi-Sarfaty C, 2004, BIOTECHNIQUES, V37, P270, DOI 10.2144/04372RR04; Kondo R, 1998, GENE THER, V5, P575, DOI 10.1038/sj.gt.3300623; Lu CY, 2007, CURR OPIN NEPHROL HY, V16, P83, DOI 10.1097/MNH.0b013e3280403c4e; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; McCullough P, 2006, CATHETER CARDIO INTE, V67, P335, DOI 10.1002/ccd.20658; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; Meschi M, 2006, CRIT CARE MED, V34, P2060, DOI 10.1097/01.CCM.0000227651.73500.BA; Mukherjee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000765; Nilakantan V, 2007, MOL CELL BIOCHEM, V304, P1, DOI 10.1007/s11010-007-9480-z; Norkin LC, 2002, J VIROL, V76, P5156, DOI 10.1128/JVI.76.10.5156-5166.2002; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Preiss S, 2007, CARDIOVASC RES, V73, P833, DOI 10.1016/j.cardiores.2006.12.019; Riordan M, 2006, NAT CLIN PRACT NEPHR, V2, P149, DOI 10.1038/ncpneph0117; SAINIS I, 1994, FEBS LETT, V355, P282, DOI 10.1016/0014-5793(94)01210-5; Sandalon Z, 1997, VIROLOGY, V237, P414, DOI 10.1006/viro.1997.8796; SANDALON Z, 2001, SV40 PROTOCOLS; Stacchiotti A, 2006, J HISTOCHEM CYTOCHEM, V54, P1149, DOI 10.1369/jhc.6A6932.2006; Strayer DS, 2005, CURR GENE THER, V5, P151, DOI 10.2174/1566523053544281; Tanemura M, 2006, TRANSPLANT P, V38, P3315, DOI 10.1016/j.transproceed.2006.10.082; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Weisbord SD, 2006, J AM SOC NEPHROL, V17, P2871, DOI 10.1681/ASN.2006030301; Zhao H, 2006, MOL NEUROBIOL, V34, P249, DOI 10.1385/MN:34:3:249	43	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2998	10.1371/journal.pone.0002998	http://dx.doi.org/10.1371/journal.pone.0002998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714386	gold, Green Published			2022-12-27	WOS:000264420900023
J	Estrada-Pena, A; Acevedo, P; Ruiz-Fons, F; Gortazar, C; de la Fuente, J				Estrada-Pena, Agustin; Acevedo, Pelayo; Ruiz-Fons, Francisco; Gortazar, Christian; de la Fuente, Jose			Evidence of the Importance of Host Habitat Use in Predicting the Dilution Effect of Wild Boar for Deer Exposure to Anaplasma spp.	PLOS ONE			English	Article							IBERIAN RED DEER; CERVUS-ELAPHUS-HISPANICUS; TICK-BORNE PATHOGENS; SUS-SCROFA; DISEASE PERSISTENCE; LYME-DISEASE; MARGINALE; DENSITY; PHAGOCYTOPHILUM; RICKETTSIALES	Foci of tick-borne pathogens occur at fine spatial scales, and depend upon a complex arrangement of factors involving climate, host abundance and landscape composition. It has been proposed that the presence of hosts that support tick feeding but not pathogen multiplication may dilute the transmission of the pathogen. However, models need to consider the spatial component to adequately explain how hosts, ticks and pathogens are distributed into the landscape. In this study, a novel, lattice-derived, behavior-based, spatially-explicit model was developed to test how changes in the assumed perception of different landscape elements affect the outcome of the connectivity between patches and therefore the dilution effect. The objective of this study was to explain changes in the exposure rate (ER) of red deer to Anaplasma spp. under different configurations of suitable habitat and landscape fragmentation in the presence of variable densities of the potentially diluting host, wild boar. The model showed that the increase in habitat fragmentation had a deep impact on Habitat Sharing Ratio (HSR), a parameter describing the amount of habitat shared by red deer and wild boar, weighted by the probability of the animals to remain together in the same patch (according to movement rules), the density of ticks and the density of animals at a given vegetation patch, and decreased the dilution effect of wild boar on deer Anaplasma ER. The model was validated with data collected on deer, wild boar and tick densities, climate, landscape composition, host vegetation preferences and deer seropositivity to Anaplasma spp. (as a measure of ER) in 10 study sites in Spain. However, although conditions were appropriate for a dilution effect, empirical results did not show a decrease in deer ER in sites with high wild boar densities. The model showed that the HSR was the most effective parameter to explain the absence of the dilution effect. These results suggest that host habitat usage may weaken the predicted dilution effect for tick-borne pathogens and emphasize the importance of the perceptual capabilities of different hosts in different landscapes and habitat fragmentation conditions for predictions of dilution effects.	[Estrada-Pena, Agustin] Fac Vet, Dept Parasitol, Zaragoza, Spain; [Acevedo, Pelayo; Ruiz-Fons, Francisco; Gortazar, Christian; de la Fuente, Jose] Inst Investigac Recursos Cineget IREC, CSIC UCLM JCCM, Ciudad Real, Spain; [Acevedo, Pelayo] Cent Sci Lab, Wildlife Ecol & Management Grp, York, N Yorkshire, England; [de la Fuente, Jose] Oklahoma State Univ, Ctr Vet Hlth Sci, Dept Vet Pathobiol, Stillwater, OK USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Food & Environment Research Agency; Oklahoma State University System; Oklahoma State University - Stillwater	Estrada-Pena, A (corresponding author), Fac Vet, Dept Parasitol, Zaragoza, Spain.	aestrada@unizar.es	Ruiz-Fons, Francisco/K-3161-2014; Acevedo, Pelayo/L-6737-2013; de la Fuente, José/AAU-1197-2020; Gortazar, Christian/E-7918-2012	Ruiz-Fons, Francisco/0000-0002-0820-5292; Acevedo, Pelayo/0000-0002-3509-7696; de la Fuente, José/0000-0001-7383-9649; Gortazar, Christian/0000-0003-0012-4006; Estrada Pena, Agustin/0000-0001-7483-046X	Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha [06036-00 ICS-JCCM]; Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar [MEC AGL2005-07401]; International Cooperation Program of the European Union [510561]; Junta de Comunidades de Castilla-La Mancha, Spain	Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha; Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar; International Cooperation Program of the European Union; Junta de Comunidades de Castilla-La Mancha, Spain(Junta de Comunidades de Castilla-La Mancha)	This research was supported by grants "Epidemiologia de zoonosis transmitidas por garrapatas en Castilla La Mancha" (06036-00 ICS-JCCM), Epidemiologia de las enfermedades compartidas entre ungulados silvestres y ganado en Espana: aproximacion multidisciplinar (MEC AGL2005-07401) and FEDER and was facilitated through the Integrated Consortium on Ticks and Tick-borne Diseases (ICTTD-3), financed by the International Cooperation Program of the European Union, coordination action project No. 510561. PA has a postdoc grant from the Junta de Comunidades de Castilla-La Mancha, Spain. Contributions intended to support the filed works and data collection. Sponsors are public and have no role in any activity.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; CARRANZA J, 1991, APPL ANIM BEHAV SCI, V30, P363, DOI 10.1016/0168-1591(91)90141-J; Corson MS, 2004, ECOL MODEL, V180, P487, DOI 10.1016/j.ecolmodel.2004.04.034; de la Fuente J, 2005, VECTOR-BORNE ZOONOT, V5, P390, DOI 10.1089/vbz.2005.5.390; de la Fuente J, 2004, EUR J WILDLIFE RES, V50, P187, DOI 10.1007/s10344-004-0060-1; de la Fuente J, 2004, VET MICROBIOL, V100, P163, DOI 10.1016/j.vetmic.2004.02.007; de la Fuente J, 2007, VET MICROBIOL, V119, P375, DOI 10.1016/j.vetmic.2006.09.011; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Estrada-Pena A, 2006, ECOL MODEL, V193, P663, DOI 10.1016/j.ecolmodel.2005.09.015; Estrada-Pena A, 2005, LANDSCAPE ECOL, V20, P529, DOI 10.1007/s10980-004-3318-9; FAHRIG L, 1985, ECOLOGY, V66, P1762, DOI 10.2307/2937372; Gilbert L, 2001, J ANIM ECOL, V70, P1053, DOI 10.1046/j.0021-8790.2001.00558.x; Ginsberg HS, 2002, J VECTOR ECOL, V27, P215; Ginsberg HS, 1996, EXP APPL ACAROL, V20, P533, DOI 10.1007/BF00048285; Hulinska D, 2004, APMIS, V112, P239, DOI 10.1111/j.1600-0463.2004.apm11204-0503.x; Kennedy M, 1997, BEHAVIOUR, V134, P905, DOI 10.1163/156853997X00223; KITRON K, 2007, EUROPEAN J WILDLIFE, DOI DOI 10.1007/S10344-007-0157-4; Kitron Uriela, 1994, P198; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kocan KM, 2004, PARASITOLOGY, V129, pS285, DOI 10.1017/S0031182003004700; Massei G, 1997, J ZOOL, V242, P411, DOI 10.1111/j.1469-7998.1997.tb03845.x; MCGARIGAL K, 1995, PNW351 USDA FOR SERV; Ninyerola M, 2005, ATLAS CLIMATICO DIGI; Norman R, 1999, J THEOR BIOL, V200, P111, DOI 10.1006/jtbi.1999.0982; Randolph S.E., 2002, P119; Rosa R, 2003, J THEOR BIOL, V224, P359, DOI 10.1016/S0022-5193(03)00173-5; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; Ruiz-Fons F, 2006, VET PARASITOL, V140, P133, DOI 10.1016/j.vetpar.2006.03.033; Saura S, 2001, PHOTOGRAMM ENG REM S, V67, P1027; SINGER FJ, 1981, J WILDLIFE MANAGE, V45, P343, DOI 10.2307/3807917; THOMAS L, 2006, DISTANCE 5 RELEASE X; Torina A, 2007, ZOONOSES PUBLIC HLTH, V54, P8, DOI 10.1111/j.1863-2378.2007.00989.x; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; VANBUSKIRK J, 1995, ECOL APPL, V5, P1133, DOI 10.2307/2269360; Vicente J, 2007, OECOLOGIA, V152, P655, DOI 10.1007/s00442-007-0690-6; Vuilleumier S, 2006, ECOL MODEL, V190, P159, DOI 10.1016/j.ecolmodel.2005.04.017; Ward AI, 2004, MAMMAL REV, V34, P315, DOI 10.1111/j.1365-2907.2004.00046.x	38	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2999	10.1371/journal.pone.0002999	http://dx.doi.org/10.1371/journal.pone.0002999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714379	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900024
J	Hong, MG; Myers, AJ; Magnusson, PKE; Prince, JA				Hong, Mun-Gwan; Myers, Amanda J.; Magnusson, Patrik K. E.; Prince, Jonathan A.			Transcriptome-Wide Assessment of Human Brain and Lymphocyte Senescence	PLOS ONE			English	Article								Background: Identifying biological pathways that vary across the age spectrum can provide insight into fundamental mechanisms that impact disease and frailty in the elderly. Few methodological approaches offer the means to explore this question on as broad a scale as gene expression profiling. Here, we have evaluated mRNA expression profiles as a function of age in two populations; one consisting of 191 individuals with ages-at-death ranging from 65-100 years and with postmortem brain mRNA measurements of 13,216 genes and a second with 1240 individuals ages 15-94 and lymphocyte mRNA estimates for 18,519 genes. Principal Findings: Among negatively correlated transcripts, an enrichment of mitochondrial genes was evident in both populations, providing a replication of previous studies indicating this as a common signature of aging. Sample differences were prominent, the most significant being a decrease in expression of genes involved in translation in lymphocytes and an increase in genes involved in transcription in brain, suggesting that apart from energy metabolism other basic cell processes are affected by age but in a tissue-specific manner. In assessing genomic architecture, intron/exon sequence length ratios were larger among negatively regulated genes in both samples, suggesting that a decrease in the expression of non-compact genes may also be a general effect of aging. Variance in gene expression itself has been theorized to change with age due to accumulation of somatic mutations and/or increasingly heterogeneous environmental exposures, but we found no evidence for such a trend here. Significance: Results affirm that deteriorating mitochondrial gene expression is a common theme in senescence, but also highlight novel pathways and features of gene architecture that may be important for understanding the molecular consequences of aging.	[Hong, Mun-Gwan; Magnusson, Patrik K. E.; Prince, Jonathan A.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat, Coral Gables, FL 33124 USA	Karolinska Institutet; University of Miami	Hong, MG (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Jonathan.Prince@ki.se	Magnusson, Patrik KE/C-4458-2017; Hide, Winston A/V-2727-2017; Hide, Winston/R-3815-2019; Hide, Winston Hide/C-7217-2009; Myers, Amanda J/B-1796-2010; Hong, Mun-Gwan/J-2839-2013	Magnusson, Patrik KE/0000-0002-7315-7899; Hide, Winston A/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Myers, Amanda J/0000-0002-3100-9396; Hong, Mun-Gwan/0000-0001-8603-8293	The Swedish Medical Research Council; Swedish Alzheimer Foundation (Alzheimerfonden); Johnnie B Byrd Institute; National Institute on Aging (NIA) [AG05146, P50 AG16570, AG05128, P30 AG19610]; National Alzheimer's Coordinating Center (NACC) [U01 AG016976]; NINDS [NS39764]; NIMH [MH60451]; Glaxo Smith Kline; NIH [P50-AG08671, AG05144, P50AG05681, P50 AG05136, P30-AG13846, AG10161]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG016976, P50AG005144, P50AG008671, P50AG005128, P50AG005681, P50AG005146, P30AG010161, P30AG013846, P50AG016570, P30AG019610, P50AG005136] Funding Source: NIH RePORTER	The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Alzheimer Foundation (Alzheimerfonden); Johnnie B Byrd Institute; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Alzheimer's Coordinating Center (NACC); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Glaxo Smith Kline(GlaxoSmithKline); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful for financial support from The Swedish Medical Research Council, the Swedish Alzheimer Foundation (Alzheimerfonden), and from the Johnnie B Byrd Institute. For the brain sample, data and biomaterials were collected from several National Institute on Aging (NIA) and National Alzheimer's Coordinating Center (NACC, grant #U01 AG016976) funded sites. John A. Hardy, PhD, Marcelle Morrison-Bogorad, PhD, Tony Phelps, PhD and Walter Kukull PhD are thanked for helping to co-ordinate this collection. The directors, pathologist and technicians involved include: National Institute on Aging: Ruth Seemann, John Hopkins Alzheimer's Disease Research Center (NIA grant # AG05146): Juan C. Troncoso, MD, Dr. Olga Pletnikova, University of California, Los Angeles (NIA grant # P50 AG16570):Harry Vinters, MD, The Kathleen Price Bryan Brain Bank, Duke University Medical Center (NIA grant #AG05128, NINDS grant # NS39764, NIMH MH60451 also funded by Glaxo Smith Kline): Christine Hulette, MD, Director, John F. Ervin, Stanford University: Dikran Horoupian, MD, Ahmad Salehi, MD, PhD, New York Brain Bank, Taub Institute, Columbia University (NYBB): Jean Paul Vonsattel, MD, Katerina Mancevska, Massachusetts General Hospital: E. Tessa Hedley-Whyte, MD, Karlotta Fitch, University of Michigan (NIH grant P50-AG08671): Dr. Roger Albin, University of Kentucky (NIH #AG05144): William Markesbery, MD, Mayo Clinic, Jacksonville: Dennis W. Dickson, MD, University Southern California: Caroll A. Miller, MD, Washington University, St Louis Alzheimer's Disease Research Center (NIH #P50AG05681): Dan McKeel, MD, John C. Morris, MD, Eugene Johnson, Jr., PhD, Virginia Buckles, PhD, University of Washington, Seattle (NIH #P50 AG05136):Thomas Montine, MD, PhD, University of Pennsylvania School of Medicine, Alzheimer's Disease Research Center: John Q Trojanowski, MD, Virginia M Lee, MD, Vivianna Van Deerlin, MD, Boston University Alzheimer's Disease Research Center (NIH grant P30-AG13846): Ann C. McKee, Sun Health Research Institute, Arizona (NIA #P30 AG19610): Joseph Rogers, PhD, Thomas G. Beach, MD, PhD, Emory University: Bruce H. Wainer, MD, PhD, Marla Gearing, PhD, University of Texas, Southwestern Medical School: Charles L. White, III, M.D., Roger Rosenberg, University of California, Davis: William Ellis, MD, Rush University Medical Center, Rush Alzheimer's Disease Center (NIH #AG10161): David A. Bennett, M.D. Julie A. Schneider, MD, MS, University of Miami/NPF Brain Endowment Bank: Deborah C. Mash, MD, Margaret J Basile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2005, CURR OPIN IMMUNOL, V17, P480, DOI 10.1016/j.coi.2005.07.019; Charmantier A, 2006, P NATL ACAD SCI USA, V103, P6587, DOI 10.1073/pnas.0511123103; Cichowski K, 2008, CELL, V133, P958, DOI 10.1016/j.cell.2008.05.027; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; Curran JE, 2007, HUM MOL GENET, V16, P1504, DOI 10.1093/hmg/ddm101; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; GOLDSTEIN S, 1991, P NATL ACAD SCI USA, V88, P9680, DOI 10.1073/pnas.88.21.9680; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hughes KA, 2002, P NATL ACAD SCI USA, V99, P14286, DOI 10.1073/pnas.222326199; Kluger A, 1997, J GERONTOL B-PSYCHOL, V52, pP28, DOI 10.1093/geronb/52B.1.P28; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MASLIAH E, 1993, NEUROLOGY, V43, P192, DOI 10.1212/WNL.43.1_Part_1.192; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; TERRY RD, 1987, ANN NEUROL, V21, P530, DOI 10.1002/ana.410210603; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; TOLLEFSBOL TO, 1986, EXP GERONTOL, V21, P129, DOI 10.1016/0531-5565(86)90067-7; Tumeh PC, 2007, SEMIN NUCL MED, V37, P69, DOI 10.1053/j.semnuclmed.2006.10.002; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	36	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3024	10.1371/journal.pone.0003024	http://dx.doi.org/10.1371/journal.pone.0003024			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714388	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900046
J	Potzl, J; Botteron, C; Tausch, E; Pedre, X; Mueller, AM; Mannel, DN; Lechner, A				Poetzl, Johann; Botteron, Catherine; Tausch, Eugen; Pedre, Xiomara; Mueller, Andre M.; Maennel, Daniela N.; Lechner, Anja			Tracing Functional Antigen-Specific CCR6(+) Th17 Cells after Vaccination	PLOS ONE			English	Article								Background: The function of T helper cell subsets in vivo depends on their location, and one hallmark of T cell differentiation is the sequential regulation of migration-inducing chemokine receptor expression. CC-chemokine receptor 6 (CCR6) is a trait of tissue-homing effector T cells and has recently been described as a receptor on T helper type 17 (Th17) cells. Th17 cells are associated with autoimmunity and the defence against certain infections. Although, the polarization of Th cells into Th17 cells has been studied extensively in vitro, the development of those cells during the physiological immune response is still elusive. Methodology/Principal Findings: We analysed the development and functionality of Th17 cells in immune-competent mice during an ongoing immune response. In naive and vaccinated animals CCR6(+) Th cells produce IL-17. The robust homeostatic proliferation and the presence of activation markers on CCR6(+) Th cells indicate their activated status. Vaccination induces antigen-specific CCR6(+) Th17 cells that respond to in vitro re-stimulation with cytokine production and proliferation. Furthermore, depletion of CCR6(+) Th cells from donor leukocytes prevents recipients from severe disease in experimental autoimmune encephalomyelitis, a model for multiple sclerosis in mice. Conclusions/Significance: In conclusion, we defined CCR6 as a specific marker for functional antigen-specific Th17 cells during the immune response. Since IL-17 production reaches the highest levels during the immediate early phase of the immune response and the activation of Th17 cells precedes the Th1 cell differentiation we tent to speculate that this particular Th cell subset may represent a first line effector Th cell subpopulation. Interference with the activation of this Th cell subtype provides an interesting strategy to prevent autoimmunity as well as to establish protective immunity against infections.	[Poetzl, Johann; Botteron, Catherine; Tausch, Eugen; Maennel, Daniela N.; Lechner, Anja] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Pedre, Xiomara; Mueller, Andre M.] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Mueller, Andre M.] Multiple Sclerosis Res Ctr New York, New York, NY USA	University of Regensburg; University of Regensburg	Potzl, J (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	anja.lechner@klinik.uni-regensburg.de		Pedreiturria, Xiomara/0000-0002-3024-3826	Deutsche Forschungsgemeinschaft [LE 2435/1-1]; Medical Faculty of the University of Regensburg; Bayerische Forschungsstiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Faculty of the University of Regensburg; Bayerische Forschungsstiftung	This work was supported by a project grant of the Deutsche Forschungsgemeinschaft (LE 2435/1-1 to AL) and an intramural ReForM grant of the Medical Faculty of the University of Regensburg. A scholarship of the Bayerische Forschungsstiftung was granted to JP. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Bauer S, 2001, P NATL ACAD SCI USA, V98, P9237, DOI 10.1073/pnas.161293498; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Betti M, 2006, ANN ONCOL, V17, P235; Bogdan C, 1996, CURR OPIN IMMUNOL, V8, P517, DOI 10.1016/S0952-7915(96)80040-9; Cai GF, 2007, EUR J IMMUNOL, V37, P602, DOI 10.1002/eji.200636787; Chen X, 2007, J IMMUNOL, V178, P6123, DOI 10.4049/jimmunol.178.10.6123; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dorfman JR, 2002, MICROBES INFECT, V4, P547, DOI 10.1016/S1286-4579(02)01571-X; Fitzhugh DJ, 2000, J IMMUNOL, V165, P6677, DOI 10.4049/jimmunol.165.12.6677; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; Homey B, 2000, J IMMUNOL, V164, P6621, DOI 10.4049/jimmunol.164.12.6621; Khader SA, 2005, J IMMUNOL, V175, P788, DOI 10.4049/jimmunol.175.2.788; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; Kim CH, 2001, J CLIN INVEST, V108, P1331, DOI 10.1172/JCI13543; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Laan M, 1999, J IMMUNOL, V162, P2347; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lechner A, 2007, MICROBES INFECT, V9, P291, DOI 10.1016/j.micinf.2006.12.002; Levings AK, 2005, CURR TOP MICROBIOL, V293, P303; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	44	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2951	10.1371/journal.pone.0002951	http://dx.doi.org/10.1371/journal.pone.0002951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698357	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600037
J	Liu, LH; Zhu, SZ; Gong, ZY; Low, BC				Liu, Lihui; Zhu, Shizhen; Gong, Zhiyuan; Low, Boon Chuan			K-ras/PI3K-Akt Signaling Is Essential for Zebrafish Hematopoiesis and Angiogenesis	PLOS ONE			English	Article								The RAS small GTPases orchestrate multiple cellular processes. Studies on knock-out mice showed the essential and sufficient role of K-RAS, but not N-RAS and H-RAS in embryonic development. However, many physiological functions of K-RAS in vivo remain unclear. Using wild-type and fli1:GFP transgenic zebrafish, we showed that K-ras-knockdown resulted in specific hematopoietic and angiogenic defects, including the impaired expression of erythroid-specific gene gata1 and sse3-hemoglobin, reduced blood circulation and disorganized blood vessels. Expression of either K-rasC40 that links to phosphoinositide 3-kinase (PI3K) activation, or Akt2 that acts downstream of PI3K, could rescue both hematopoietic and angiogenic defects in the K-ras knockdown. Consistently, the functional rescue by k-ras mRNA was significantly suppressed by wortmannin, a PI3K-specific inhibitor. Our results provide direct evidence that PI3K-Akt plays a crucial role in mediating K-ras signaling during hematopoiesis and angiogenesis in vivo, thus offering new targets and alternative vertebrate model for studying these processes and their related diseases.	[Liu, Lihui; Zhu, Shizhen; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117548, Singapore; [Zhu, Shizhen; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Mol Biol Lab, Singapore, Singapore	National University of Singapore; National University of Singapore	Liu, LH (corresponding author), Natl Univ Singapore, Dept Biol Sci, Cell Signaling & Dev Biol Lab, Singapore 117548, Singapore.	dbslowbc@nus.edu.sg	Low, Boon Chuan/AAU-7685-2021; Low, Boon Chuan/H-8049-2012; Gong, Zhiyuan/H-8794-2012	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Gong, Zhiyuan/0000-0002-9660-5260	Biomedical Research Council of Singapore	Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Biomedical Research Council of Singapore.	Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Cheng R, 1997, MOL MAR BIOL BIOTECH, V6, P40; Choi K, 1998, DEVELOPMENT, V125, P725; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; HAN M, 1993, NATURE, V363, P133, DOI 10.1038/363133a0; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Khalaf WF, 2005, BLOOD, V105, P3538, DOI 10.1182/blood-2004-05-2021; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Kranenburg O, 2004, BBA-REV CANCER, V1654, P23, DOI 10.1016/j.bbcan.2003.09.004; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LUBBERT M, 1992, ONCOGENE, V7, P263; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARSHA JM, 1998, MOL CELL BIOL, V18, P3718; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Parker J, 1996, SEMIN HEMATOL, V33, P206; Prior IA, 2001, J CELL SCI, V114, P1603; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zhang J, 2005, P NATL ACAD SCI USA, V102, P14605, DOI 10.1073/pnas.0507446102; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	29	35	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2850	10.1371/journal.pone.0002850	http://dx.doi.org/10.1371/journal.pone.0002850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682746	Green Submitted, gold, Green Published			2022-12-27	WOS:000264366600006
J	VanRullen, R; Pascual-Leone, A; Battelli, L				VanRullen, Rufin; Pascual-Leone, Alvaro; Battelli, Lorella			The Continuous Wagon Wheel Illusion and the 'When' Pathway of the Right Parietal Lobe: A Repetitive Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							ILLUSORY MOTION REVERSAL; VISUAL-ATTENTION; RIVALRY; PERCEPTION; NEGLECT	A continuous periodic motion stimulus can sometimes be perceived moving in the wrong direction. These illusory reversals have been taken as evidence that part of the motion perception system samples its inputs as a series of discrete snapshots although other explanations of the phenomenon have been proposed, that rely on the spurious activation of low-level motion detectors in early visual areas. We have hypothesized that the right inferior parietal lobe ('when' pathway) plays a critical role in timing perceptual events relative to one another, and thus we examined the role of the right parietal lobe in the generation of this "continuous Wagon Wheel Illusion'' (c-WWI). Consistent with our hypothesis, we found that the illusion was effectively weakened following disruption of right, but not left, parietal regions by low frequency repetitive transcranial magnetic stimulation (1 Hz, 10 min). These results were independent of whether the motion stimulus was shown in the left or the right visual field. Thus, the c-WWI appears to depend on higher-order attentional mechanisms that are supported by the 'when' pathway of the right parietal lobe.	[VanRullen, Rufin] Univ Toulouse, CerCo, UPS, Toulouse, France; [VanRullen, Rufin] CNRS, Fac Med Rangueil, UMR5549, Toulouse, France; [Pascual-Leone, Alvaro; Battelli, Lorella] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Neurol, Berenson Allen Ctr Noninvasive Brain Stimulat, Boston, MA USA; [Pascual-Leone, Alvaro] Univ Autonoma Barcelona, Inst Guttmann Neurorehab, Badalona, Spain; [Battelli, Lorella] Harvard Univ, Dept Psychol, Vision Sci Lab, Cambridge, MA USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Autonomous University of Barcelona; Harvard University	VanRullen, R (corresponding author), Univ Toulouse, CerCo, UPS, Toulouse, France.	lbattell@bidmc.harvard.edu	Pascual-Leone, Alvaro/G-6566-2011; Pascual-Leone, Alvaro/AAC-5101-2019; VanRullen, Rufin/B-2150-2008	Pascual-Leone, Alvaro/0000-0001-8975-0382; VanRullen, Rufin/0000-0002-3611-7716	Philippe Foundation; Agence Nationale de la Recherche [JCJC06_140102]; Fyssen Foundation; European Science Foundation (EURYI); Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center [NCRR MO1 RR01032]; NEI [EY15960];  [RO1-EY12091];  [R21-EY0116168];  [K24 RR018875]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001032, K24RR018875] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091, F32EY015960] Funding Source: NIH RePORTER	Philippe Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); Fyssen Foundation; European Science Foundation (EURYI)(European Science Foundation (ESF)); Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	R.V. is supported by the Philippe Foundation, the Agence Nationale de la Recherche (project JCJC06_140102), the Fyssen Foundation and the European Science Foundation (EURYI). A.P.L. is supported by RO1-EY12091, R21-EY0116168 and K24 RR018875, and the Harvard-Thorndike General Clinical Research Center at Beth Israel Deaconess Medical Center (NCRR MO1 RR01032). L.B. is supported by NEI EY15960.	Andrews T, 2005, TRENDS COGN SCI, V9, P261, DOI 10.1016/j.tics.2005.04.004; Andrews TJ, 2005, TRENDS COGN SCI, V9, P560, DOI 10.1016/j.tics.2005.10.006; Battelli L, 2003, BRAIN, V126, P2164, DOI 10.1093/brain/awg221; Battelli L, 2001, NEURON, V32, P985, DOI 10.1016/S0896-6273(01)00536-0; BATTELLI L, 2006, ROLE MT PARIETAL LOB; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Bonneh YS, 2004, NEUROREPORT, V15, P473, DOI 10.1097/00001756-200403010-00018; CARMEL D, 2008, CAUSAL ROLE RIGHT PA; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Holcombe AO, 2005, TRENDS COGN SCI, V9, P559, DOI 10.1016/j.tics.2005.10.009; Husain M, 1997, NATURE, V385, P154, DOI 10.1038/385154a0; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kline K, 2004, VISION RES, V44, P2653, DOI 10.1016/j.visres.2004.05.030; Kline KA, 2006, VISION RES, V46, P1158, DOI 10.1016/j.visres.2005.08.021; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; Mottaghy FM, 2002, EUR J NEUROSCI, V16, P1627, DOI 10.1046/j.1460-9568.2002.02209.x; Pakarian P, 2003, PERCEPTION, V32, P1307, DOI 10.1068/p5133; Pascual-Leone A, 1998, J CLIN NEUROPHYSIOL, V15, P333, DOI 10.1097/00004691-199807000-00005; Purves D, 1996, P NATL ACAD SCI USA, V93, P3693, DOI 10.1073/pnas.93.8.3693; Rojas D, 2006, VISION RES, V46, P1155, DOI 10.1016/j.visres.2005.07.023; Schouten J.F., 1967, MODELS PERCEPTION SP, P44; Valero-Cabre A, 2007, EXP BRAIN RES, V176, P603, DOI 10.1007/s00221-006-0639-8; Van Rullen R, 2007, VISION RES, V47, P2143, DOI 10.1016/j.visres.2007.03.019; VanRullen R, 2006, J NEUROSCI, V26, P502, DOI 10.1523/JNEUROSCI.4654-05.2006; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; VanRullen R, 2006, VISION RES, V46, P4091, DOI 10.1016/j.visres.2006.07.030; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Williams ZM, 2003, NAT NEUROSCI, V6, P616, DOI 10.1038/nn1055	32	30	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2911	10.1371/journal.pone.0002911	http://dx.doi.org/10.1371/journal.pone.0002911			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682842	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600067
J	Brenkman, AB; de Keizer, PLJ; van den Broek, NJF; Jochemsen, AG; Burgering, BMT				Brenkman, Arjan B.; de Keizer, Peter L. J.; van den Broek, Niels J. F.; Jochemsen, A. G.; Burgering, Boudewijn M. Th.			Mdm2 Induces Mono-Ubiquitination of FOXO4	PLOS ONE			English	Article								Background: The Forkhead box O (FOXO) class of transcription factors are involved in the regulation of several cellular responses including cell cycle progression and apoptosis. Furthermore, in model organisms FOXOs act as tumor suppressors and affect aging. Previously, we noted that FOXOs and p53 are remarkably similar within their spectrum of regulatory proteins [1]. For example, the de-ubiquitinating enzyme USP7 removes ubiquitin from both FOXO and p53. However, Skp2 has been identified as E3 ligase for FOXO1, whereas Mdm2 is the prime E3 ligase for p53. Principal Findings/Methodology: Here we provide evidence that Mdm2 acts as an E3 ligase for FOXO as well. In vitro incubation of Mdm2 and FOXO results in ATP-dependent (multi) mono-ubiquitination of FOXO similar to p53. Furthermore, in vivo co-expression of Mdm2 and FOXO induces FOXO mono-ubiquitination and consistent with this result, siRNA-mediated depletion of Mdm2 inhibits mono-ubiquitination of FOXO induced by hydrogen peroxide. Regulation of FOXO ubiquitination by Mdm2 is likely to be direct since Mdm2 and FOXO co-immunoprecipitate. In addition, Mdm2-mediated ubiquitination regulates FOXO transcriptional activity. Conclusions/Significance: These data identify Mdm2 as a novel E3 ligase for FOXOs and extend the analogous mode of regulation between FOXO and p53.	[Brenkman, Arjan B.; de Keizer, Peter L. J.; van den Broek, Niels J. F.; Burgering, Boudewijn M. Th.] Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands; [Jochemsen, A. G.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Burgering, Boudewijn M. Th.] Ctr Biomed Genet Univ, Dept Physiol Chem, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Ctr Biomed Genet, Dept Physiol Chem, Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl	de+Keizer, Peter/AAD-5320-2020	de+Keizer, Peter/0000-0002-6948-925X	European Commission Transfog Consortium [LSHC-CT-2004-503438]	European Commission Transfog Consortium(European CommissionEuropean Commission Joint Research Centre)	A.B.B was supported by the European Commission Transfog Consortium (LSHC-CT-2004-503438). The funder only paid for the author's post-doc salary.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Brooks CL, 2004, CELL CYCLE, V3, P436; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; de Graaf P, 2003, J BIOL CHEM, V278, P38315, DOI 10.1074/jbc.M213034200; Di Fiore PP, 2003, NAT REV MOL CELL BIO, V4, P491, DOI 10.1038/nrm1124; ESSERS MA, 2004, EMBO J; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Salmena L, 2007, NAT REV CANCER, V7, P409, DOI 10.1038/nrc2145; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Winkler GS, 2005, METHOD ENZYMOL, V399, P355, DOI 10.1016/S0076-6879(05)99024-1; Wolff S, 2006, EXP GERONTOL, V41, P894, DOI 10.1016/j.exger.2006.06.054; YANG JY, 2008, NAT CELL BIOL	29	94	101	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2819	10.1371/journal.pone.0002819	http://dx.doi.org/10.1371/journal.pone.0002819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665269	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300038
J	Yang, HJ; Takagi, H; Konishi, Y; Ageta, H; Ikegami, K; Yao, I; Sato, S; Hatanaka, K; Inokuchi, K; Seog, DH; Setou, M				Yang, Hyunjeong; Takagi, Hiroshi; Konishi, Yoshiyuki; Ageta, Hiroshi; Ikegami, Koji; Yao, Ikuko; Sato, Showbu; Hatanaka, Ken; Inokuchi, Kaoru; Seog, Dae-Hyun; Setou, Mitsutoshi			Transmembrane and Ubiquitin-Like Domain-Containing Protein 1 (Tmub1/HOPS) Facilitates Surface Expression of GluR2-Containing AMPA Receptors	PLOS ONE			English	Article							ACID TRANSPORTER ATA2; PLASMA-MEMBRANE; DEGRADATION; TRAFFICKING; GLUR2; ENDOCYTOSIS; INTERACTS; ABP/GRIP; REVEALS; KINESIN	Some ubiquitin-like (UBL) domain-containing proteins are known to play roles in receptor trafficking. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) undergo constitutive cycling between the intracellular compartment and the cell surface in the central nervous system. However, the function of UBL domain-containing proteins in the recycling of the AMPARs to the synaptic surface has not yet been reported. Here, we report that the Transmembrane and ubiquitin-like domain-containing 1 (Tmub1) protein, formerly known as the Hepatocyte Odd Protein Shuttling ( HOPS) protein, which is abundantly expressed in the brain and which exists in a synaptosomal membrane fraction, facilitates the recycling of the AMPAR subunit GluR2 to the cell surface. Neurons transfected with Tmub1/HOPS-RNAi plasmids showed a significant reduction in the AMPAR current as compared to their control neurons. Consistently, the synaptic surface expression of GluR2, but not of GluR1, was significantly decreased in the neurons transfected with the Tmub1/HOPS-RNAi and increased in the neurons overexpressing EGFP-Tmub1/HOPS. The altered surface expression of GluR2 was speculated to be due to the altered surface-recycling of the internalized GluR2 in our recycling assay. Eventually, we found that GluR2 and glutamate receptor interacting protein (GRIP) were coimmunoprecipitated by the anti-Tmub1/HOPS antibody from the mouse brain. Taken together, these observations show that the Tmub1/HOPS plays a role in regulating basal synaptic transmission; it contributes to maintain the synaptic surface number of the GluR2-containing AMPARs by facilitating the recycling of GluR2 to the plasma membrane.	[Yang, Hyunjeong] Tokyo Inst Technol, Dept Biol Informat, Kanagawa, Japan; [Yang, Hyunjeong; Takagi, Hiroshi; Konishi, Yoshiyuki; Ageta, Hiroshi; Ikegami, Koji; Yao, Ikuko; Sato, Showbu; Hatanaka, Ken; Inokuchi, Kaoru; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Seog, Dae-Hyun] Inje Univ, Colle Med, Dept Biochem, Pusan, South Korea; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan	Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Inje University; Hamamatsu University School of Medicine	Yang, HJ (corresponding author), Tokyo Inst Technol, Dept Biol Informat, Kanagawa, Japan.	setou@hama-med.ac.jp	Inokuchi, Kaoru/AAI-9693-2020	Inokuchi, Kaoru/0000-0002-5393-3133	Mitsubishi Kagaku Institute of Life Sciences	Mitsubishi Kagaku Institute of Life Sciences	Mitsubishi Kagaku Institute of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Della Fazia MA, 2005, J CELL SCI, V118, P3185, DOI 10.1242/jcs.02452; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Goto E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001490; Hara T, 2005, MOL CELL BIOL, V25, P9292, DOI 10.1128/MCB.25.21.9292-9303.2005; Harms KJ, 2005, J NEUROSCI, V25, P6379, DOI 10.1523/JNEUROSCI.0302-05.2005; Hatanaka K, 2006, BIOCHEM BIOPH RES CO, V350, P610, DOI 10.1016/j.bbrc.2006.09.093; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Hatanaka T, 2006, J BIOL CHEM, V281, P39273, DOI 10.1074/jbc.M604534200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ikegami K, 2008, FEBS LETT, V582, P1129, DOI 10.1016/j.febslet.2008.02.079; Ikegami K, 2007, P NATL ACAD SCI USA, V104, P3213, DOI 10.1073/pnas.0611547104; Ikegami K, 2006, J BIOL CHEM, V281, P30707, DOI 10.1074/jbc.M603984200; Inoue E, 2006, NEURON, V50, P261, DOI 10.1016/j.neuron.2006.03.018; Inoue S, 2000, BIOCHEM BIOPH RES CO, V268, P553, DOI 10.1006/bbrc.2000.2170; Kulangara K, 2007, J BIOL CHEM, V282, P2395, DOI 10.1074/jbc.M606471200; Leask A, 1997, NEUROSCI LETT, V229, P17, DOI 10.1016/S0304-3940(97)00412-6; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Niibori Y, 2007, NEUROSCI RES, V57, P399, DOI 10.1016/j.neures.2006.11.014; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pieroni S, 2008, CELL CYCLE, V7, P1462, DOI 10.4161/cc.7.10.5882; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; SAHARA Y, 1991, NEUROSCI RES, V10, P200, DOI 10.1016/0168-0102(91)90057-6; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Steiner P, 2005, EMBO J, V24, P2873, DOI 10.1038/sj.emboj.7600755; Tanaka K, 1998, MOL CELLS, V8, P503; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	51	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2809	10.1371/journal.pone.0002809	http://dx.doi.org/10.1371/journal.pone.0002809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665261	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300028
J	Gonzalez, D; Grillo, MJ; De Miguel, MJ; Ali, T; Arce-Gorvel, V; Delrue, RM; Conde-Alvarez, R; Munoz, P; Lopez-Goni, I; Iriarte, M; Marin, CM; Weintraub, A; Widmalm, G; Zygmunt, M; Letesson, JJ; Gorvel, JP; Blasco, JM; Moriyon, I				Gonzalez, David; Grillo, Maria-Jesus; De Miguel, Maria-Jesus; Ali, Tara; Arce-Gorvel, Vilma; Delrue, Rose-May; Conde-Alvarez, Raquel; Munoz, Pilar; Lopez-Goni, Ignacio; Iriarte, Maite; Marin, Clara-M.; Weintraub, Andrej; Widmalm, Goeran; Zygmunt, Michel; Letesson, Jean-Jacques; Gorvel, Jean-Pierre; Blasco, Jose-Maria; Moriyon, Ignacio			Brucellosis Vaccines: Assessment of Brucella melitensis Lipopolysaccharide Rough Mutants Defective in Core and O-Polysaccharide Synthesis and Export	PLOS ONE			English	Article								Background: The brucellae are facultative intracellular bacteria that cause brucellosis, one of the major neglected zoonoses. In endemic areas, vaccination is the only effective way to control this disease. Brucella melitensis Rev 1 is a vaccine effective against the brucellosis of sheep and goat caused by B. melitensis, the commonest source of human infection. However, Rev 1 carries a smooth lipopolysaccharide with an O-polysaccharide that elicits antibodies interfering in serodiagnosis, a major problem in eradication campaigns. Because of this, rough Brucella mutants lacking the O-polysaccharide have been proposed as vaccines. Methodology/Principal Findings: To examine the possibilities of rough vaccines, we screened B. melitensis for lipopolysaccharide genes and obtained mutants representing all main rough phenotypes with regard to core oligosaccharide and O-polysaccharide synthesis and export. Using the mouse model, mutants were classified into four attenuation patterns according to their multiplication and persistence in spleens at different doses. In macrophages, mutants belonging to three of these attenuation patterns reached the Brucella characteristic intracellular niche and multiplied intracellularly, suggesting that they could be suitable vaccine candidates. Virulence patterns, intracellular behavior and lipopolysaccharide defects roughly correlated with the degree of protection afforded by the mutants upon intraperitoneal vaccination of mice. However, when vaccination was applied by the subcutaneous route, only two mutants matched the protection obtained with Rev 1 albeit at doses one thousand fold higher than this reference vaccine. These mutants, which were blocked in O-polysaccharide export and accumulated internal O-polysaccharides, stimulated weak anti-smooth lipopolysaccharide antibodies. Conclusions/Significance: The results demonstrate that no rough mutant is equal to Rev 1 in laboratory models and question the notion that rough vaccines are suitable for the control of brucellosis in endemic areas.	[Gonzalez, David; Conde-Alvarez, Raquel; Lopez-Goni, Ignacio; Iriarte, Maite; Moriyon, Ignacio] Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain; [Grillo, Maria-Jesus] CSIC UPNA Gobierno Navarra, Inst Agrobiotecnol, Pamplona, Spain; [De Miguel, Maria-Jesus; Munoz, Pilar; Marin, Clara-M.; Blasco, Jose-Maria] Gobierno Aragon, Sanidad Anim, CITA, Zaragoza, Spain; [Ali, Tara; Widmalm, Goeran] Stockholm Univ, Arrhenius Lab, Stockholm, Sweden; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] Aix Marseille Univ, Fac Sci Luminy, Ctr Immunol Marseille Luminy, Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] INSERM, U631, Marseille, France; [Arce-Gorvel, Vilma; Gorvel, Jean-Pierre] CNRS, UMR6102, Marseille, France; [Delrue, Rose-May; Letesson, Jean-Jacques] Fac Univ Notre Dame Paix FUNDP, URBM, Lab Immunol Microbiol, Namur, Belgium; [Weintraub, Andrej] Karolinska Univ Hosp, Div Clin Bacteriol, Dept Lab Med, Karolinska Inst, Stockholm, Sweden; [Zygmunt, Michel] IASP, Infectiol Anim Sante Publ, INRA, UR1282, Nouzilly, France	University of Navarra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra; Stockholm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University of Namur; Karolinska Institutet; Karolinska University Hospital; INRAE	Gonzalez, D (corresponding author), Univ Navarra, Dept Microbiol & Parasitol, E-31080 Pamplona, Spain.	Imoriyon@unav.es	BLASCO, JOSE M/C-7034-2013; Marin, Clara M/S-5531-2017; Conde-Álvarez, Raquel/K-5854-2014; Moriyon, Ignacio/N-4764-2016; De Miguel, María Jesús/K-5860-2014; López-Goñi, Ignacio/K-2572-2017; Gorvel, Jean-Pierre/O-1332-2018; IRIARTE, MAITE/L-9460-2014; Jean-Jacques, LETESSON/AHB-6921-2022; González, David/L-4474-2014; Muñoz, Pilar M/K-5877-2014; Blasco, Julian/A-5319-2008; Grilló, María-Jesús/F-9621-2011	BLASCO, JOSE M/0000-0002-6112-5312; Marin, Clara M/0000-0002-1974-9025; Conde-Álvarez, Raquel/0000-0003-0046-3577; Moriyon, Ignacio/0000-0002-4288-0195; De Miguel, María Jesús/0000-0002-5037-3687; López-Goñi, Ignacio/0000-0002-3873-8743; Gorvel, Jean-Pierre/0000-0002-2829-9804; IRIARTE, MAITE/0000-0002-6726-8920; González, David/0000-0002-7799-2613; Muñoz, Pilar M/0000-0002-7970-4929; Blasco, Julian/0000-0002-9750-383X; Grilló, María-Jesús/0000-0002-1819-0186; Widmalm, Goran/0000-0001-8303-4481; LETESSON, Jean-Jacques/0000-0002-5838-0224; Arce-Gorvel, Vilma/0000-0003-0090-837X; Zygmunt, Michel/0000-0002-1389-6366; Weintraub, Andrej/0000-0003-3646-247X	European Commission [QLK2-CT-2002-00918]; Ministerio de Ciencia y Tecnologia of Spain [AGL2004-01162/GAN]	European Commission(European CommissionEuropean Commission Joint Research Centre); Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by the European Commission (Research Contract QLK2-CT-2002-00918) and the Ministerio de Ciencia y Tecnologia of Spain (Proyecto AGL2004-01162/GAN).	Adone R, 2005, INFECT IMMUN, V73, P4198, DOI 10.1128/IAI.73.7.4198-4204.2005; Allen CA, 1998, INFECT IMMUN, V66, P1008, DOI 10.1128/IAI.66.3.1008-1016.1998; Aragon V, 1996, J BACTERIOL, V178, P1070, DOI 10.1128/jb.178.4.1070-1079.1996; Ariza J, 1999, REV MED MICROBIOL, V10, P125; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; BOWDEN RA, 1995, INFECT IMMUN, V63, P3945, DOI 10.1128/IAI.63.10.3945-3952.1995; BOWSER DV, 1974, INFECT IMMUN, V9, P772, DOI 10.1128/IAI.9.4.772-774.1974; BRAUN W, 1958, P SOC EXP BIOL MED, V97, P393, DOI 10.3181/00379727-97-23752; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CAFISO D, 1983, METHOD ENZYMOL, V171, P342; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CLOECKAERT A, 1990, INFECT IMMUN, V58, P3980, DOI 10.1128/IAI.58.12.3980-3987.1990; Cloeckaert A, 2004, VACCINE, V22, P2827, DOI 10.1016/j.vaccine.2004.01.001; Conde-Alvarez R, 2006, CELL MICROBIOL, V8, P1322, DOI 10.1111/j.1462-5822.2006.00712.x; Crawford RM, 1996, INFECT IMMUN, V64, P2188, DOI 10.1128/IAI.64.6.2188-2192.1996; de Bagues MPJ, 2004, INFECT IMMUN, V72, P2429, DOI 10.1128/IAI.72.4.2429-2433.2004; Delrue RM, 2004, FEMS MICROBIOL LETT, V231, P1, DOI 10.1016/S0378-1097(03)00963-7; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; DETILLEUX PG, 1990, VET PATHOL, V27, P317, DOI 10.1177/030098589002700503; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Fernandez-Prada CM, 2003, INFECT IMMUN, V71, P2110, DOI 10.1128/IAI.71.4.2110-2119.2003; Fernandez-Prada CM, 2001, INFECT IMMUN, V69, P4407, DOI 10.1128/IAI.69.7.4407-4416.2001; FREEMAN BA, 1961, J INFECT DIS, V108, P333, DOI 10.1093/infdis/108.3.333; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Garin-Bastuji B, 1998, VET RES, V29, P255; GARINBASTUJI B, 1990, J CLIN MICROBIOL, V28, P2169, DOI 10.1128/JCM.28.10.2169-2174.1990; Godfroid F, 2000, RES MICROBIOL, V151, P655, DOI 10.1016/S0923-2508(00)90130-X; Grillo MJ, 2006, VACCINE, V24, P2910, DOI 10.1016/j.vaccine.2005.12.038; Grillo MJ, 2000, BIOLOGICALS, V28, P119, DOI 10.1006/biol.2000.0249; Guzman-Verri C, 2002, P NATL ACAD SCI USA, V99, P12375, DOI 10.1073/pnas.192439399; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Hallez R, 2007, APPL ENVIRON MICROB, V73, P1375, DOI 10.1128/AEM.01873-06; Heinrichs DE, 1998, J BIOL CHEM, V273, P29497, DOI 10.1074/jbc.273.45.29497; Holst O, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P115; Iriarte M., 2004, Brucella: molecular and cellular biology, P159; ITO M, 1993, CARBOHYD RES, V242, P173, DOI 10.1016/0008-6215(93)80032-A; Kahl-McDonagh MM, 2006, INFECT IMMUN, V74, P4048, DOI 10.1128/IAI.01787-05; Kneidinger B, 2003, BIOCHEM J, V371, P989, DOI 10.1042/BJ20030099; KNIREL YA, 1995, EUR J BIOCHEM, V232, P391, DOI 10.1111/j.1432-1033.1995.tb20823.x; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Maudlin I, 2006, CONTROL NEGLECTED ZO; McQuiston JR, 1999, INFECT IMMUN, V67, P3830, DOI 10.1128/IAI.67.8.3830-3835.1999; Monreal D, 2003, INFECT IMMUN, V71, P3261, DOI 10.1128/IAI.71.6.3261-3271.2003; MORENO E, 1984, INFECT IMMUN, V43, P779, DOI 10.1128/IAI.43.3.779-782.1984; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Nicoletti P., 1990, Animal brucellosis., P283; Pei JW, 2004, INFECT IMMUN, V72, P440, DOI 10.1128/IAI.72.1.440-450.2004; PERRY MB, 1990, ADVANCES IN BRUCELLOSIS RESEARCH, P76; Porte F, 2003, INFECT IMMUN, V71, P1481, DOI 10.1128/IAI.71.3.1481-1490.2003; Price NP, 2005, GLYCOBIOLOGY, V15, p29R, DOI 10.1093/glycob/cwi065; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rajashekara G, 2005, CELL MICROBIOL, V7, P1459, DOI 10.1111/j.1462-5822.2005.00570.x; Rittig MG, 2003, J LEUKOCYTE BIOL, V74, P1045, DOI 10.1189/jlb.0103015; ROJAS N, 1994, CLIN DIAGN LAB IMMUN, V1, P206, DOI 10.1128/CDLI.1.2.206-213.1994; ROSENBERG M, 2007, FEMS MICROBIOL LETT, V9, P33; SANGARI F, 1991, MICROB PATHOGENESIS, V11, P443, DOI 10.1016/0882-4010(91)90040-H; SCHURIG GG, 1981, INFECT IMMUN, V34, P1000, DOI 10.1128/IAI.34.3.1000-1007.1981; Schurig GG, 2002, VET MICROBIOL, V90, P479, DOI 10.1016/S0378-1135(02)00255-9; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x; Spink WW, 1956, NATURE BRUCELLOSIS; Ugalde JE, 2000, INFECT IMMUN, V68, P5716, DOI 10.1128/IAI.68.10.5716-5723.2000; Velasco J, 2000, INFECT IMMUN, V68, P3210, DOI 10.1128/IAI.68.6.3210-3218.2000; Vemulapalli R, 2000, INFECT IMMUN, V68, P3927, DOI 10.1128/IAI.68.7.3927-3932.2000; Verger JM, 1988, TECHNIQUES BRUCELLOS; Vizcaino N, 2001, INFECT IMMUN, V69, P6738, DOI 10.1128/IAI.69.11.6738-6748.2001; WILSON JB, 1960, ANN NY ACAD SCI, V88, P1155, DOI 10.1111/j.1749-6632.1960.tb20106.x; Winter AJ, 1996, AM J VET RES, V57, P677; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381	71	102	115	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2760	10.1371/journal.pone.0002760	http://dx.doi.org/10.1371/journal.pone.0002760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648644	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900030
J	Martin, B; Brenneman, R; Becker, KG; Gucek, M; Cole, RN; Maudsley, S				Martin, Bronwen; Brenneman, Randall; Becker, Kevin G.; Gucek, Marjan; Cole, Robert N.; Maudsley, Stuart			iTRAQ Analysis of Complex Proteome Alterations in 3xTgAD Alzheimer's Mice: Understanding the Interface between Physiology and Disease	PLOS ONE			English	Article							DIAZEPAM-BINDING INHIBITOR; NEUROFIBRILLARY TANGLES; SYNAPTIC PATHOLOGY; A-BETA; BRAIN; TAU; DEMENTIA; PLAQUES; NEURODEGENERATION; IMMUNOREACTIVITY	Alzheimer's disease (AD) is characterized by progressive cognitive impairment associated with accumulation of amyloid beta-peptide, synaptic degeneration and the death of neurons in the hippocampus, and temporal, parietal and frontal lobes of the cerebral cortex. Analysis of postmortem brain tissue from AD patients can provide information on molecular alterations present at the end of the disease process, but cannot discriminate between changes that are specifically involved in AD versus those that are simply a consequence of neuronal degeneration. Animal models of AD provide the opportunity to elucidate the molecular changes that occur in brain cells as the disease process is initiated and progresses. To this end, we used the 3xTgAD mouse model of AD to gain insight into the complex alterations in proteins that occur in the hippocampus and cortex in AD. The 3xTgAD mice express mutant presenilin-1, amyloid precursor protein and tau, and exhibit AD-like amyloid and tau pathology in the hippocampus and cortex, and associated cognitive impairment. Using the iTRAQ stable-isotope-based quantitative proteomic technique, we performed an in-depth proteomic analysis of hippocampal and cortical tissue from 16 month old 3xTgAD and non-transgenic control mice. We found that the most important groups of significantly altered proteins included those involved in synaptic plasticity, neurite outgrowth and microtubule dynamics. Our findings have elucidated some of the complex proteome changes that occur in a mouse model of AD, which could potentially illuminate novel therapeutic avenues for the treatment of AD and other neurodegenerative disorders.	[Martin, Bronwen; Brenneman, Randall; Maudsley, Stuart] NIA, Neurosci Lab, Intramural Res Program, Biomed Res Ctr, Baltimore, MD 21224 USA; [Becker, Kevin G.] NIA, Biomed Res Ctr, Intramural Res Program, Res Resources Branch, Baltimore, MD USA; [Gucek, Marjan; Cole, Robert N.] Johns Hopkins Sch Med, Proteom Facil, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Johns Hopkins Medicine	Martin, B (corresponding author), NIA, Neurosci Lab, Intramural Res Program, Biomed Res Ctr, Baltimore, MD 21224 USA.	maudsleyst@grc.nia.nih.gov	Maudsley, Stuart/AAV-9929-2021; Maudsley, Stuart/Q-4782-2019	Maudsley, Stuart/0000-0002-1868-184X; Martin, Bronwen/0000-0002-9185-6925; Becker, Kevin/0000-0002-6794-6656	Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000319, Z01AG000616, ZIAAG000325, Z01AG000325, Z01AG000319, Z01AG000318, ZIAAG000318, ZICAG000616] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Intramural Research Program of the National Institute on Aging.	Alappat SR, 2003, DEV DYNAM, V228, P59, DOI 10.1002/dvdy.10353; Alliegro MC, 2000, EXP CELL RES, V255, P270, DOI 10.1006/excr.1999.4776; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Attems J, 2007, ACTA NEUROPATHOL, V113, P53, DOI 10.1007/s00401-006-0146-9; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bailey JA, 2006, ANN NY ACAD SCI, V1086, P54, DOI 10.1196/annals.1377.001; BARBACCIA ML, 1986, ARCH GEN PSYCHIAT, V43, P1143; Beal MF, 2004, J BIOENERG BIOMEMBR, V36, P381, DOI 10.1023/B:JOBB.0000041772.74810.92; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BRAAK H, 1986, NEUROSCI LETT, V65, P351, DOI 10.1016/0304-3940(86)90288-0; BRAAK H, 1996, ACTA NEUROL SCAND  S, V9, P1107; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Churchill GA, 2001, NAT GENET, V29, P355, DOI 10.1038/ng1201-355; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; Dhanasekaran M, 2005, CURR NEUROVASC RES, V2, P447, DOI 10.2174/156720205774962656; Donowitz M, 2007, J PROTEOME RES, V6, P4068, DOI 10.1021/pr0701761; Edgar PF, 1999, MOL PSYCHIATR, V4, P173, DOI 10.1038/sj.mp.4000463; FERRERO P, 1988, J NEUROL SCI, V87, P327, DOI 10.1016/0022-510X(88)90257-2; Graham RLJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r110; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Guo YR, 2007, MOL CELL PROTEOMICS, V6, P689, DOI 10.1074/mcp.M600398-MCP200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hashimoto M, 2003, NEUROCHEM RES, V28, P1743, DOI 10.1023/A:1026073324672; HYMAN BT, 1994, NEUROBIOL AGING, V15, P353, DOI 10.1016/0197-4580(94)90031-0; Kassie F, 2008, CARCINOGENESIS, V29, P610, DOI 10.1093/carcin/bgn014; Kelly BL, 2007, NEUROSCIENCE, V147, P60, DOI 10.1016/j.neuroscience.2007.03.047; Kendziorski C, 2005, P NATL ACAD SCI USA, V102, P4252, DOI 10.1073/pnas.0500607102; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; LEIFER D, 1993, J NEUROL SCI, V119, P217, DOI 10.1016/0022-510X(93)90137-N; MASLIAH E, 1995, NEUROBIOL AGING, V16, P280, DOI 10.1016/0197-4580(95)00020-F; Masliah E, 2001, J ALZHEIMERS DIS, V3, P121, DOI 10.3233/JAD-2001-3117; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Minger SL, 2001, J NEUROPATH EXP NEUR, V60, P929, DOI 10.1093/jnen/60.10.929; MINOSHIMA S, 1994, LANCET, V344, P895, DOI 10.1016/S0140-6736(94)92871-1; Nagy JI, 1996, BRAIN RES, V717, P173, DOI 10.1016/0006-8993(95)01526-4; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Nelson RL, 2007, EXP NEUROL, V205, P166, DOI 10.1016/j.expneurol.2007.01.037; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SLOVITER RS, 1991, J COMP NEUROL, V308, P381, DOI 10.1002/cne.903080306; Smith SKF, 2000, MOL BRAIN RES, V78, P100, DOI 10.1016/S0169-328X(00)00079-6; Suga K, 2004, BIOCHEM J, V381, P619, DOI 10.1042/BJ20040618; Sugimori K, 2007, PSYCHIAT CLIN NEUROS, V61, P159, DOI 10.1111/j.1440-1819.2007.01631.x; TROJANOWSKI JQ, 1995, NEUROBIOL AGING, V16, P335, DOI 10.1016/0197-4580(94)00176-2; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; WALDVOGEL HJ, 1991, BRAIN RES, V546, P329, DOI 10.1016/0006-8993(91)91497-O; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang EY, 1996, BIOCHEM BIOPH RES CO, V229, P176, DOI 10.1006/bbrc.1996.1776; Zhang SD, 2004, BIOINFORMATICS, V20, P2821, DOI 10.1093/bioinformatics/bth336; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P898	55	94	95	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2750	10.1371/journal.pone.0002750	http://dx.doi.org/10.1371/journal.pone.0002750			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648646	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900021
J	Mastroianni, M; Watanabe, K; White, TB; Zhuang, FL; Vernon, J; Matsuura, M; Wallingford, J; Lambowitz, AM				Mastroianni, Marta; Watanabe, Kazuo; White, Travis B.; Zhuang, Fanglei; Vernon, Jamie; Matsuura, Manabu; Wallingford, John; Lambowitz, Alan M.			Group II Intron-Based Gene Targeting Reactions in Eukaryotes	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; RNA; RECOMBINATION; PROTEIN; ENDONUCLEASE; MANIPULATION; MUTAGENESIS; INTEGRATION; RECOGNITION; DROSOPHILA	Background: Mobile group II introns insert site-specifically into DNA target sites by a mechanism termed retrohoming in which the excised intron RNA reverse splices into a DNA strand and is reverse transcribed by the intron-encoded protein. Retrohoming is mediated by a ribonucleoprotein particle that contains the intron-encoded protein and excised intron RNA, with target specificity determined largely by base pairing of the intron RNA to the DNA target sequence. This feature enabled the development of mobile group II introns into bacterial gene targeting vectors ("targetrons'') with programmable target specificity. Thus far, however, efficient group II intron-based gene targeting reactions have not been demonstrated in eukaryotes. Methodology/Principal Findings: By using a plasmid-based Xenopus laevis oocyte microinjection assay, we show that group II intron RNPs can integrate efficiently into target DNAs in a eukaryotic nucleus, but the reaction is limited by low Mg2+ concentrations. By supplying additional Mg2+, site-specific integration occurs in up to 38% of plasmid target sites. The integration products isolated from X. laevis nuclei are sensitive to restriction enzymes specific for double-stranded DNA, indicating second-strand synthesis via host enzymes. We also show that group II intron RNPs containing either lariat or linear intron RNA can introduce a double-strand break into a plasmid target site, thereby stimulating homologous recombination with a co-transformed DNA fragment at frequencies up to 4.8% of target sites. Chromatinization of the target DNA inhibits both types of targeting reactions, presumably by impeding RNP access. However, by using similar RNP microinjection methods, we show efficient Mg2+-dependent group II intron integration into plasmid target sites in zebrafish (Danio rerio) embryos and into plasmid and chromosomal target sites in Drosophila melanogster embryos, indicating that DNA replication can mitigate effects of chromatinization. Conclusions/Significance: Our results provide an experimental foundation for the development of group II intron-based gene targeting methods for higher organisms.	[Mastroianni, Marta; Watanabe, Kazuo; White, Travis B.; Zhuang, Fanglei; Vernon, Jamie; Matsuura, Manabu; Wallingford, John; Lambowitz, Alan M.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mastroianni, M (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	lambowitz@mail.utexas.edu		White, Travis/0000-0002-0069-5987	NIH [GM037949, HD054349]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104, R01GM037949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM037949 and HD054349.	Aizawa Y, 2003, MOL CELL, V11, P795, DOI 10.1016/S1097-2765(03)00069-8; Anderson WF, 1998, NATURE, V392, P25; Baum C, 2004, MOL THER, V9, P5, DOI 10.1016/j.ymthe.2003.10.013; Beumer K, 2006, GENETICS, V172, P2391, DOI 10.1534/genetics.105.052829; Bibikova M, 2002, GENETICS, V161, P1169; Bojanowski K, 1998, EXP CELL RES, V244, P286, DOI 10.1006/excr.1998.4205; Bunz F, 2002, CURR OPIN ONCOL, V14, P73, DOI 10.1097/00001622-200201000-00013; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Carroll D, 1996, PROG NUCLEIC ACID RE, V54, P101, DOI 10.1016/S0079-6603(08)60361-X; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; CAZENAVE C, 1994, J BIOL CHEM, V269, P25185; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Cui XX, 2004, J MOL BIOL, V340, P211, DOI 10.1016/j.jmb.2004.05.004; Daniels DL, 1996, J MOL BIOL, V256, P31, DOI 10.1006/jmbi.1996.0066; Dickson L, 2004, GENETICS, V168, P77, DOI 10.1534/genetics.104.027003; DION AS, 1967, P NATL ACAD SCI USA, V58, P2367, DOI 10.1073/pnas.58.6.2367; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Eskes R, 2000, MOL CELL BIOL, V20, P8432, DOI 10.1128/MCB.20.22.8432-8446.2000; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; Fedorova O, 2002, METHODS, V28, P323, DOI 10.1016/S1046-2023(02)00239-6; Frazier CL, 2003, APPL ENVIRON MICROB, V69, P1121, DOI 10.1128/AEM.69.2.1121-1128.2003; Granlund M, 2001, J BACTERIOL, V183, P2560, DOI 10.1128/JB.183.8.2560-2569.2001; Gregan J, 2001, MOL GEN GENET, V264, P773, DOI 10.1007/s004380000366; Guo HT, 2000, SCIENCE, V289, P452, DOI 10.1126/science.289.5478.452; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hagedorn M, 1998, BIOL REPROD, V59, P1240, DOI 10.1095/biolreprod59.5.1240; Handwerger KE, 2002, J CELL SCI, V115, P2011; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jones JP, 2005, MOL THER, V11, P687, DOI 10.1016/j.ymthe.2005.01.014; Karberg M, 2001, NAT BIOTECHNOL, V19, P1162, DOI 10.1038/nbt1201-1162; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Marshall E, 2002, SCIENCE, V298, P34, DOI 10.1126/science.298.5591.34; MAZUR P, 1988, CRYOBIOLOGY, V25, P510, DOI 10.1016/0011-2240(88)90305-7; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Minden J, 1999, ADV MOLEC BIOL, P471; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Mohr G, 2000, GENE DEV, V14, P559; MORL M, 1990, CELL, V60, P629, DOI 10.1016/0092-8674(90)90666-3; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Perutka J, 2004, J MOL BIOL, V336, P421, DOI 10.1016/j.jmb.2003.12.009; Podar M, 1998, NATURE, V391, P915, DOI 10.1038/36142; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Rodriguez SA, 2008, APPL ENVIRON MICROB, V74, P2619, DOI 10.1128/AEM.02905-07; Romani AMP, 2002, BIOMETALS, V15, P271, DOI 10.1023/A:1016082900838; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; San Filippo J, 2002, J MOL BIOL, V324, P933, DOI 10.1016/S0022-2836(02)01147-6; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; SEGAL DJ, 1995, P NATL ACAD SCI USA, V92, P806, DOI 10.1073/pnas.92.3.806; Shao L, 2007, CELL RES, V17, P963, DOI 10.1038/cr.2007.91; Singh NN, 2001, J MOL BIOL, V309, P361, DOI 10.1006/jmbi.2001.4658; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; STEINBERG M, 1957, CARNEGIE I WASHINGTO, V56, P347; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Vogel J, 2002, EMBO J, V21, P3794, DOI 10.1093/emboj/cdf359; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; WIESENBERGER G, 1992, J BIOL CHEM, V267, P6963; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Yao J, 2006, RNA, V12, P1271, DOI 10.1261/rna.68706	73	39	69	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3121	10.1371/journal.pone.0003121	http://dx.doi.org/10.1371/journal.pone.0003121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769669	Green Published, Green Submitted, gold			2022-12-27	WOS:000264416600009
J	Zhang, QJ; Li, XL; Wang, D; Huang, XC; Mathis, JM; Duan, WM; Knight, D; Shi, R; Glass, J; Zhang, DQ; Eisenbach, L; Jefferies, WA				Zhang, Qian-Jin; Li, Xiao-Lin; Wang, David; Huang, Xiao-Cong; Mathis, J. Michael; Duan, Wei-Ming; Knight, David; Shi, Runhua; Glass, Jonathan; Zhang, Dong-Qing; Eisenbach, Lea; Jefferies, Wilfred A.			Trogocytosis of MHC-I/Peptide Complexes Derived from Tumors and Infected Cells Enhances Dendritic Cell Cross-Priming and Promotes Adaptive T Cell Responses	PLOS ONE			English	Article								The transporter associated with antigen processing ( TAP) and the major histocompatibility complex class I (MHC-I), two important components of the MHC-I antigen presentation pathway, are often deficient in tumor cells. The restoration of their expression has been shown to restore the antigenicity and immunogenicity of tumor cells. However, it is unclear whether TAP and MHC-I expression in tumor cells can affect the induction phase of the T cell response. To address this issue, we expressed viral antigens in tumors that are either deficient or proficient in TAP and MHC-I expression. The relative efficiency of direct immunization or immunization through cross-presentation in promoting adaptive T cell responses was compared. The results demonstrated that stimulation of animals with TAP and MHC-I proficient tumor cells generated antigen specific T cells with greater killing activities than those of TAP and MHC-I deficient tumor cells. This discrepancy was traced to differences in the ability of dendritic cells (DCs) to access and sample different antigen reservoirs in TAP and MHC-I proficient versus deficient cells and thereby stimulate adaptive immune responses through the process of cross-presentation. In addition, our data suggest that the increased activity of T cells is caused by the enhanced DC uptake and utilization of MHC-I/peptide complexes from the proficient cells as an additional source of processed antigen. Furthermore, we demonstrate that immune-escape and metastasis are promoted in the absence of this DC 'arming' mechanism. Physiologically, this novel form of DC antigen sampling resembles trogocytosis, and acts to enhance T cell priming and increase the efficacy of adaptive immune responses against tumors and infectious pathogens.	[Zhang, Qian-Jin; Li, Xiao-Lin; Wang, David; Huang, Xiao-Cong; Mathis, J. Michael; Duan, Wei-Ming; Knight, David; Shi, Runhua; Glass, Jonathan] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA; [Zhang, Dong-Qing] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China; [Eisenbach, Lea] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Microbiol & Immunol & Zool, Biomed Res Ctr, Michael Smith Lab, Vancouver, BC V5Z 1M9, Canada	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Shanghai Jiao Tong University; Weizmann Institute of Science; University of British Columbia	Zhang, QJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Dept Cellular Biol & Anat,Gene Therapy Program, Shreveport, LA 71105 USA.	qzhang@lsuhsc.edu	; Mathis, J. Michael/J-1379-2018	Eisenbach, Lea R/0000-0002-4816-1968; Mathis, J. Michael/0000-0001-5528-5195	Louisiana Board of Regents; Feist-Weiller Cancer Center; Louisiana State Gene Therapy Program; Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport; National Natural Science Foundation of China; Shanghai Commission of Science and Technology [07JC14033]; Shanghai Leading Academic Discipline Project [T0206]; CIHR; PCRF	Louisiana Board of Regents; Feist-Weiller Cancer Center; Louisiana State Gene Therapy Program; Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); CIHR(Canadian Institutes of Health Research (CIHR)); PCRF	This work was supported by Louisiana Board of Regents, Feist-Weiller Cancer Center, Louisiana State Gene Therapy Program and Department of Cellular Biology & Anatomy at LSU Health Sciences Center-Shreveport. Dr. Dong-Qing Zhang is supported by National Natural Science Foundation of China (No., No.), Shanghai Commission of Science and Technology (No. 07JC14033) and Shanghai Leading Academic Discipline Project (T0206). Dr. Wilfred A. Jefferies is supported by CIHR and PCRF.	Agrawal S, 2004, CELL IMMUNOL, V228, P130, DOI 10.1016/j.cellimm.2004.04.006; Alimonti J, 2000, NAT BIOTECHNOL, V18, P515, DOI 10.1038/75373; Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; BACIK I, 1994, J IMMUNOL, V152, P381; Bullock TNJ, 2003, J IMMUNOL, V170, P1822, DOI 10.4049/jimmunol.170.4.1822; Bullock TNJ, 2000, J IMMUNOL, V164, P2354, DOI 10.4049/jimmunol.164.5.2354; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chiang EY, 2003, J IMMUNOL, V170, P4515, DOI 10.4049/jimmunol.170.9.4515; Dai Jie, 2003, Cancer Immun, V3, P1; Evans M, 2001, J IMMUNOL, V167, P5420, DOI 10.4049/jimmunol.167.9.5420; Gabathuler R, 1998, J CELL BIOL, V140, P17, DOI 10.1083/jcb.140.1.17; GABATHULER R, 1994, J EXP MED, V180, P1415, DOI 10.1084/jem.180.4.1415; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Hoffmann TK, 2006, INT J CANCER, V118, P1984, DOI 10.1002/ijc.21565; HUANG AYC, 1994, SCIENCE, V264, P961, DOI 10.1126/science.7513904; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Hudrisier D, 2002, ELSO GAZ, V9, P1; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; JEFFERIES WA, 1993, J IMMUNOL, V151, P2974; Johnsen AK, 1999, J IMMUNOL, V163, P4224; Kallfelz M, 1999, INT J CANCER, V81, P125, DOI 10.1002/(SICI)1097-0215(19990331)81:1<125::AID-IJC21>3.0.CO;2-2; LEVITSKY HI, 1994, J EXP MED, V179, P1215, DOI 10.1084/jem.179.4.1215; Li ZH, 2002, FRONT BIOSCI-LANDMRK, V7, pD731; LI ZH, 1994, CHINESE CARLIN TYPE, P37; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lou YM, 2005, CANCER RES, V65, P7926, DOI 10.1158/0008-5472.CAN-04-3977; Momburg F, 1998, ADV IMMUNOL, V68, P191, DOI 10.1016/S0065-2776(08)60560-X; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; PLAKSIN D, 1988, P NATL ACAD SCI USA, V85, P4463, DOI 10.1073/pnas.85.12.4463; Ronchetti A, 1999, J IMMUNOL, V163, P130; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Seliger B, 2000, IMMUNOL TODAY, V21, P455, DOI 10.1016/S0167-5699(00)01692-3; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Spiliotis ET, 2000, IMMUNITY, V13, P841, DOI 10.1016/S1074-7613(00)00081-9; Ueda G, 2004, CANCER SCI, V95, P248, DOI 10.1111/j.1349-7006.2004.tb02211.x; Vitalis TZ, 2005, PLOS PATHOG, V1, P289, DOI 10.1371/journal.ppat.0010036; Zhang Q. J., 2007, INT J CANC; Zhang QJ, 2000, J IMMUNOL, V164, P4513, DOI 10.4049/jimmunol.164.9.4513	43	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3097	10.1371/journal.pone.0003097	http://dx.doi.org/10.1371/journal.pone.0003097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769733	gold, Green Submitted, Green Published			2022-12-27	WOS:000264796800004
J	Adekar, SP; Takahashi, T; Jones, RM; Al-Saleem, FH; Ancharski, DM; Root, MJ; Kapadnis, BP; Simpson, LL; Dessain, SK				Adekar, Sharad P.; Takahashi, Tsuyoshi; Jones, R. Mark; Al-Saleem, Fetweh H.; Ancharski, Denise M.; Root, Michael J.; Kapadnis, B. P.; Simpson, Lance L.; Dessain, Scott K.			Neutralization of Botulinum Neurotoxin by a Human Monoclonal Antibody Specific for the Catalytic Light Chain	PLOS ONE			English	Article								Background: Botulinum neurotoxins (BoNT) are a family of category A select bioterror agents and the most potent biological toxins known. Cloned antibody therapeutics hold considerable promise as BoNT therapeutics, but the therapeutic utility of antibodies that bind the BoNT light chain domain (LC), a metalloprotease that functions in the cytosol of cholinergic neurons, has not been thoroughly explored. Methods and Findings: We used an optimized hybridoma method to clone a fully human antibody specific for the LC of serotype A BoNT (BoNT/A). The 4LCA antibody demonstrated potent in vivo neutralization when administered alone and collaborated with an antibody specific for the HC. In Neuro-2a neuroblastoma cells, the 4LCA antibody prevented the cleavage of the BoNT/A proteolytic target, SNAP-25. Unlike an antibody specific for the HC, the 4LCA antibody did not block entry of BoNT/A into cultured cells. Instead, it was taken up into synaptic vesicles along with BoNT/A. The 4LCA antibody also directly inhibited BoNT/A catalytic activity in vitro. Conclusions: An antibody specific for the BoNT/A LC can potently inhibit BoNT/A in vivo and in vitro, using mechanisms not previously associated with BoNT-neutralizing antibodies. Antibodies specific for BoNT LC may be valuable components of an antibody antidote for BoNT exposure.	[Adekar, Sharad P.; Dessain, Scott K.] Lankenau Inst Med Res, Wynnewood, PA USA; [Takahashi, Tsuyoshi; Al-Saleem, Fetweh H.; Ancharski, Denise M.; Simpson, Lance L.] Thomas Jefferson Univ, Div Infect Dis & Environm Med, Philadelphia, PA USA; [Jones, R. Mark; Root, Michael J.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA USA; [Kapadnis, B. P.] Univ Pune, Dept Microbiol, Pune, Maharashtra, India	Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; Jefferson University; Savitribai Phule Pune University	Adekar, SP (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	dessains@mlhs.org	Al-Saleem, Fetweh/AAE-4264-2019		National Institutes of Health [R01-AI065967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health grant R01-AI065967.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, HYBRIDOMA, V27, P11, DOI 10.1089/hyb.2007.0536; [Anonymous], 2004, TXB PEDIAT INFECT DI; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Brunger AT, 2007, PLOS PATHOG, V3, P1191, DOI 10.1371/journal.ppat.0030113; *CAL DEP HLTH SERV, 2003, BOT IMM GLOB INTR HU; CAMPBELL MJ, 1992, MOL IMMUNOL, V29, P193, DOI 10.1016/0161-5890(92)90100-C; Coronella JA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e85; Darling RJ, 2004, ASSAY DRUG DEV TECHN, V2, P647, DOI 10.1089/adt.2004.2.647; Dessain SK, 2004, J IMMUNOL METHODS, V291, P109, DOI 10.1016/j.jim.2004.05.005; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Fischer A, 2007, P NATL ACAD SCI USA, V104, P10447, DOI 10.1073/pnas.0700046104; Keller JE, 1999, FEBS LETT, V456, P137, DOI 10.1016/S0014-5793(99)00948-5; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; Lefranc MP, 2005, NUCLEIC ACIDS RES, V33, pD593, DOI 10.1093/nar/gki065; Levy R, 2007, J MOL BIOL, V365, P196, DOI 10.1016/j.jmb.2006.09.084; Mahrhold S, 2006, FEBS LETT, V580, P2011, DOI 10.1016/j.febslet.2006.02.074; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Razai A, 2005, J MOL BIOL, V351, P158, DOI 10.1016/j.jmb.2005.06.003; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; URASHIMA M, 1995, BLOOD, V85, P1903, DOI 10.1182/blood.V85.7.1903.bloodjournal8571903; Verderio C, 2006, EMBO REP, V7, P995, DOI 10.1038/sj.embor.7400796; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Xie L, 2005, J IMMUNOL METHODS, V304, P1, DOI 10.1016/j.jim.2005.04.009	33	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3023	10.1371/journal.pone.0003023	http://dx.doi.org/10.1371/journal.pone.0003023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714390	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900045
J	Catron, DJ; Noor, MAF				Catron, Daniel J.; Noor, Mohamed A. F.			Gene Expression Disruptions of Organism versus Organ in Drosophila Species Hybrids	PLOS ONE			English	Article								Hybrid dysfunctions, such as sterility, may result in part from disruptions in the regulation of gene expression. Studies of hybrids within the Drosophila simulans clade have reported genes expressed above or below the expression observed in their parent species, and such misexpression is associated with male sterility in multigenerational backcross hybrids. However, these studies often examined whole bodies rather than testes or had limited replication using less-sensitive but global techniques. Here, we use a new RNA isolation technique to re-examine hybrid gene expression disruptions in both testes and whole bodies from single Drosophila males by real-time quantitative RT-PCR. We find two early-spermatogenesis transcripts are underexpressed in hybrid whole-bodies but not in assays of testes alone, while two late-spermatogenesis transcripts seem to be underexpressed in both whole-bodies and testes alone. Although the number of transcripts surveyed is limited, these results provide some support for a previous hypothesis that the spermatogenesis pathway in these sterile hybrids may be disrupted sometime after the expression of the early meiotic arrest genes.	[Catron, Daniel J.; Noor, Mohamed A. F.] Duke Univ, Dept Biol, Durham, NC 27710 USA	Duke University	Catron, DJ (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	NOOR@DUKE.EDU		Noor, Mohamed/0000-0002-5400-4408	National Science Foundation [0509780, 0715484]; National Institutes of Health [GM076051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076051] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by National Science Foundation grants 0509780 and 0715484 and National Institutes of Health grant GM076051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artieri CG, 2007, J MOL EVOL, V65, P697, DOI 10.1007/s00239-007-9048-2; Barbash DA, 2007, J EXP ZOOL PART B, V308B, P74, DOI 10.1002/jez.b.21128; Bertucci Lisa A., 2001, Drosophila Information Service, V84, P166; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Ginsberg SD, 2005, METHODS, V37, P229, DOI 10.1016/j.ymeth.2005.09.003; Haerty W, 2006, MOL BIOL EVOL, V23, P1707, DOI 10.1093/molbev/msl033; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Jiang JQ, 2003, DEVELOPMENT, V130, P563, DOI 10.1242/dev.00246; Johnson NA, 2000, J THEOR BIOL, V205, P527, DOI 10.1006/jtbi.2000.2070; Johnson NA, 2007, GENETICA, V129, P57, DOI 10.1007/s10709-006-0033-2; Lin David M., 2007, V399, P133, DOI 10.1007/978-1-59745-504-6_10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000781; McDermott SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002442; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Michalak P, 2004, J MOL EVOL, V59, P277, DOI 10.1007/s00239-004-2622-y; Michalak P, 2008, GENE, V416, P61, DOI 10.1016/j.gene.2008.03.006; Michalak P, 2008, GENOMICS, V91, P158, DOI 10.1016/j.ygeno.2007.10.013; Moehring AJ, 2007, MOL BIOL EVOL, V24, P137, DOI 10.1093/molbev/msl142; Noor MAF, 2005, GENET RES, V85, P119, DOI 10.1017/S0016672305007500; Ortiz-Barrientos D, 2007, GENETICA, V129, P71, DOI 10.1007/s10709-006-0034-1; PEREZ DE, 1993, GENETICS, V134, P261; Porter AH, 2002, EVOLUTION, V56, P2103; Ranz JM, 2006, TRENDS ECOL EVOL, V21, P29, DOI 10.1016/j.tree.2005.09.002; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Rottscheidt R, 2007, GENETICS, V177, P1553, DOI 10.1534/genetics.107.076190; SCHARTL M, 1995, TRENDS GENET, V11, P185, DOI 10.1016/S0168-9525(00)89041-1; Schartl M, 1999, GENETICS, V153, P1385; White-Cooper H, 2000, DEVELOPMENT, V127, P5463; Wu C. I., 1992, MOL PALEOPOPULATION, P191	33	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3009	10.1371/journal.pone.0003009	http://dx.doi.org/10.1371/journal.pone.0003009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714377	gold, Green Published			2022-12-27	WOS:000264420900034
J	Kostarakos, K; Hartbauer, M; Romer, H				Kostarakos, Konstantinos; Hartbauer, Manfred; Roemer, Heiner			Matched Filters, Mate Choice and the Evolution of Sexually Selected Traits	PLOS ONE			English	Article								Background: Fundamental for understanding the evolution of communication systems is both the variation in a signal and how this affects the behavior of receivers, as well as variation in preference functions of receivers, and how this affects the variability of the signal. However, individual differences in female preference functions and their proximate causation have rarely been studied. Methodology/Principal Findings: Calling songs of male field crickets represent secondary sexual characters and are subject to sexual selection by female choice. Following predictions from the "matched filter hypothesis'' we studied the tuning of an identified interneuron in a field cricket, known for its function in phonotaxis, and correlated this with the preference of the same females in two-choice trials. Females vary in their neuronal frequency tuning, which strongly predicts the preference in a choice situation between two songs differing in carrier frequency. A second "matched filter'' exists in directional hearing, where reliable cues for sound localization occur only in a narrow frequency range. There is a strong correlation between the directional tuning and the behavioural preference in no-choice tests. This second "matched filter'' also varies widely in females, and surprisingly, differs on average by 400 Hz from the neuronal frequency tuning. Conclusions/Significance: Our findings on the mismatch of the two "matched filters'' would suggest that the difference in these two filters appears to be caused by their evolutionary history, and the different trade-offs which exist between sound emission, transmission and detection, as well as directional hearing under specific ecological settings. The mismatched filter situation may ultimately explain the maintenance of considerable variation in the carrier frequency of the male signal despite stabilizing selection.	[Kostarakos, Konstantinos; Hartbauer, Manfred; Roemer, Heiner] Karl Franzens Univ Graz, Graz, Austria	University of Graz	Kostarakos, K (corresponding author), Karl Franzens Univ Graz, Graz, Austria.	heinrich.roemer@uni-graz.at		Kostarakos, Konstantinos/0000-0003-3337-049X	Austrian Science Fund [P17986-B06]	Austrian Science Fund(Austrian Science Fund (FWF))	Research in this project was funded by the Austrian Science Fund (FWF, Project P17986-B06) to HR.	ATKINS G, 1992, J COMP PHYSIOL A, V170, P363; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bentsen CL, 2006, AM NAT, V167, pE102, DOI 10.1086/501376; Brooks R, 2005, EVOLUTION, V59, P871, DOI 10.1111/j.0014-3820.2005.tb01760.x; CAPRANICA RR, 1983, VERTEBRATE NEUROETHO, P701; Dawkins MS, 1996, AM NAT, V148, P937, DOI 10.1086/285964; DIRSH VM, 1975, B BRIT MUS NAT HIST, V10, P349; Ferreira M, 2002, J ZOOL, V257, P163, DOI 10.1017/S0952836902000766; Gerhardt H. Carl, 2001, P73; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gilbert F, 2000, J EXP BIOL, V203, P983; Greenfield MD, 2002, SIGNALLERS RECEIVERS; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hedwig B, 2005, J EXP BIOL, V208, P915, DOI 10.1242/jeb.01452; Hedwig B, 2004, NATURE, V430, P781, DOI 10.1038/nature02787; HILL GE, 1994, BEHAV ECOL, V5, P64, DOI 10.1093/beheco/5.1.64; HILL KG, 1976, NATURE, V262, P390, DOI 10.1038/262390a0; HUBER F, 1984, J COMP PHYSIOL, V155, P725, DOI 10.1007/BF00611589; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; KIRKPATRICK M, 1987, SEXUAL SELECTION TES, P67; MICHELSEN A, 1995, J EXP BIOL, V198, P1817; MICHELSEN A, 1995, NATURE, V375, P639, DOI 10.1038/375639a0; MICHELSEN A, 1998, COMP HEARING INSECTS, P18; NOCKE H, 1972, J COMP PHYSIOL, V80, P141, DOI 10.1007/BF00696487; POLLACK GS, 1986, J COMP PHYSIOL A, V158, P549, DOI 10.1007/BF00603799; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; RYAN MJ, 1993, PHILOS T ROY SOC B, V340, P187, DOI 10.1098/rstb.1993.0057; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; Scheuber H, 2003, P ROY SOC B-BIOL SCI, V270, P1779, DOI 10.1098/rspb.2003.2449; Scheuber H, 2003, ANIM BEHAV, V65, P721, DOI 10.1006/anbe.2003.2083; SCHILDBERGER K, 1988, J COMP PHYSIOL A, V163, P621, DOI 10.1007/BF00603846; SCHILDBERGER K, 1994, FORTS ZOOL, V39, P209; SHAROV AG, 1968, T PALEONTOL I ACAD S, V118, P1; SIMMONS L.W., 1996, P ROY SOC LOND B BIO, V236, P305; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Sun LX, 2000, BEHAV ECOL, V11, P102, DOI 10.1093/beheco/11.1.102; THORSON J, 1982, J COMP PHYSIOL, V146, P361, DOI 10.1007/BF00612706; Verburgt L, 2008, J COMP PHYSIOL A, V194, P79, DOI 10.1007/s00359-007-0292-0; Von Helversen D, 2004, ANIM BEHAV, V68, P131, DOI 10.1016/j.anbehav.2003.10.020; WENDLER G, 1993, J COMP PHYSIOL A, V173, P557, DOI 10.1007/BF00197764; WILCZYNSKI W, 1992, BRAIN BEHAV EVOLUT, V39, P229, DOI 10.1159/000114120; Witte K, 2005, BEHAV ECOL, V16, P571, DOI 10.1093/beheco/ari032	44	42	41	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3005	10.1371/journal.pone.0003005	http://dx.doi.org/10.1371/journal.pone.0003005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714350	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900030
J	Robach, P; Calbet, JAL; Thomsen, JJ; Boushel, R; Mollard, P; Rasmussen, P; Lundby, C				Robach, Paul; Calbet, Jose A. L.; Thomsen, Jonas J.; Boushel, Robert; Mollard, Pascal; Rasmussen, Peter; Lundby, Carsten			The Ergogenic Effect of Recombinant Human Erythropoietin on (V)over dotO(2)max Depends on the Severity of Arterial Hypoxemia	PLOS ONE			English	Article								Treatment with recombinant human erythropoietin (rhEpo) induces a rise in blood oxygen-carrying capacity (CaO2) that unequivocally enhances maximal oxygen uptake ((V)over dotO(2)max) during exercise in normoxia, but not when exercise is carried out in severe acute hypoxia. This implies that there should be a threshold altitude at which (V)over dotO(2)max is less dependent on CaO2. To ascertain which are the mechanisms explaining the interactions between hypoxia, CaO2 and (V)over dotO(2)max we measured systemic and leg O-2 transport and utilization during incremental exercise to exhaustion in normoxia and with different degrees of acute hypoxia in eight rhEpo-treated subjects. Following prolonged rhEpo treatment, the gain in systemic (V)over dotO(2)max observed in normoxia (6-7%) persisted during mild hypoxia (8% at inspired O-2 fraction (FIO2) of 0.173) and was even larger during moderate hypoxia (14-17% at FIO2 = 0.153-0.134). When hypoxia was further augmented to FIO2 = 0.115, there was no rhEpo-induced enhancement of systemic (V)over dotO(2)max or peak leg (V)over dotO(2). The mechanism highlighted by our data is that besides its strong influence on CaO2, rhEpo was found to enhance leg (V)over dotO(2)max in normoxia through a preferential redistribution of cardiac output toward the exercising legs, whereas this advantageous effect disappeared during severe hypoxia, leaving augmented CaO2 alone insufficient for improving peak leg O-2 delivery and (V)over dotO(2). Finally, that (V)over dotO(2)max was largely dependent on CaO2 during moderate hypoxia but became abruptly CaO2-independent by slightly increasing the severity of hypoxia could be an indirect evidence of the appearance of central fatigue.	[Robach, Paul] Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France; [Calbet, Jose A. L.; Thomsen, Jonas J.; Rasmussen, Peter; Lundby, Carsten] Rigshosp, Copenhagen Muscle Res Ctr, Copenhagen, Denmark; [Rasmussen, Peter] Rigshosp, Dept Anaesthesia, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Ed, Las Palmas Gran Canaria, Spain; [Lundby, Carsten] Aarhus Univ, Dept Sport Sci, Aarhus, Denmark; [Boushel, Robert] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Robach, Paul; Mollard, Pascal] Univ Paris 13, Lab Reponses Cellulaires Fonctionnelles Hypoxie, EA 2363, Bobigny, France	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Universidad de Las Palmas de Gran Canaria; Aarhus University; University of Copenhagen; Universite Paris 13	Robach, P (corresponding author), Ecole Natl Ski & Alpinisme, Chamonix Mt Blanc, France.	paul.robach@jeunesse-sports.gouv.fr	Ernst-Rasmussen, Peter Bonde/B-8203-2013; Boushel, Robert/ABD-7840-2021; Calbet, Jose A L/H-6693-2015	Ernst-Rasmussen, Peter Bonde/0000-0003-1761-4562; Calbet, Jose A L/0000-0002-9215-6234; antunez, Ariel/0000-0002-2548-7885	Anti Doping Danmark (Denmark); Kulturministeriet (Denmark); Bundesamt fur Sport (Switzerland); Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain)	Anti Doping Danmark (Denmark); Kulturministeriet (Denmark); Bundesamt fur Sport (Switzerland); Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain)	This study was supported by research fundings from Anti Doping Danmark (Denmark), Kulturministeriet (Denmark) and Bundesamt fur Sport (Switzerland) to C.L. This study was also supported in part by research funding from Gobierno de Canarias (Ayudas para estancias postdoctorales)(Spain) to J.A.L.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/jphysiol.2007.129700; ANDERSEN P, 1985, J PHYSIOL-LONDON, V366, P233, DOI 10.1113/jphysiol.1985.sp015794; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Audran M, 1999, MED SCI SPORT EXER, V31, P639, DOI 10.1097/00005768-199905000-00003; BENDER PR, 1988, J APPL PHYSIOL, V65, P2592, DOI 10.1152/jappl.1988.65.6.2592; Birkeland KI, 2000, MED SCI SPORT EXER, V32, P1238, DOI 10.1097/00005768-200007000-00009; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boushel R, 2001, CIRCULATION, V104, P1785, DOI 10.1161/hc4001.097040; Calbet JAL, 2006, AM J PHYSIOL-REG I, V291, pR447, DOI 10.1152/ajpregu.00746.2005; Calbet JAL, 2004, J PHYSIOL-LONDON, V558, P319, DOI 10.1113/jphysiol.2003.059287; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR304, DOI 10.1152/ajpregu.00156.2002; Calbet JAL, 2002, J PHYSIOL-LONDON, V545, P715, DOI 10.1113/jphysiol.2002.029108; Charloux A, 2000, EUR J APPL PHYSIOL, V82, P313, DOI 10.1007/s004210000226; EKBLOM B, 1991, Scandinavian Journal of Medicine and Science in Sports, V1, P88; Gonzalez-Alonso J, 2003, CIRCULATION, V107, P824, DOI 10.1161/01.CIR.0000049746.29175.3F; Hansen J, 2000, J PHYSIOL-LONDON, V527, P387, DOI 10.1111/j.1469-7793.2000.00387.x; Hansen J, 2000, ACTA PHYSIOL SCAND, V168, P489, DOI 10.1046/j.1365-201x.2000.00701.x; HEIDENREICH S, 1991, KIDNEY INT, V39, P259, DOI 10.1038/ki.1991.31; KANSTRUP IL, 1984, MED SCI SPORT EXER, V16, P256; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lundby C, 2008, J APPL PHYSIOL, V105, P581, DOI 10.1152/japplphysiol.90484.2008; Lundby C, 2006, SCAND J MED SCI SPOR, V16, P35, DOI 10.1111/j.1600-0838.2004.00434.x; Lundby C, 2004, AM J PHYSIOL-REG I, V287, pR1202, DOI 10.1152/ajpregu.00725.2003; Lundby C, 2008, J APPL PHYSIOL, V105, P417, DOI 10.1152/japplphysiol.90529.2008; Lundby C, 2008, J PHYSIOL-LONDON, V586, P123, DOI 10.1113/jphysiol.2007.146035; Lundby C, 2007, J PHYSIOL-LONDON, V578, P309, DOI 10.1113/jphysiol.2006.122689; Mollard P, 2007, EUR J APPL PHYSIOL, V100, P663, DOI 10.1007/s00421-007-0457-0; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Richard R, 2001, EUR J APPL PHYSIOL, V85, P202, DOI 10.1007/s004210100458; ROBERTSON RJ, 1988, J APPL PHYSIOL, V64, P1644, DOI 10.1152/jappl.1988.64.4.1644; ROBERTSON RJ, 1982, J APPL PHYSIOL, V53, P490, DOI 10.1152/jappl.1982.53.2.490; Russell G, 2002, EUR J APPL PHYSIOL, V86, P442, DOI 10.1007/s00421-001-0560-6; Saltin B, 2006, J APPL PHYSIOL, V100, P744, DOI 10.1152/japplphysiol.01395.2005; Schuler B, 2007, SCAND J MED SCI SPOR, V17, P588, DOI 10.1111/j.1600-0838.2006.00611.x; STENBERG J, 1966, J APPL PHYSIOL, V21, P1589, DOI 10.1152/jappl.1966.21.5.1589; Thomsen JJ, 2007, EUR J APPL PHYSIOL, V101, P481, DOI 10.1007/s00421-007-0522-8; VOGEL JA, 1974, J APPL PHYSIOL, V36, P169, DOI 10.1152/jappl.1974.36.2.169; Wagner PD, 2006, J APPL PHYSIOL, V100, P745, DOI 10.1152/japplphysiol.01395a.2005; Wagner PD, 1985, J APPL PHYSIOL, V100, P747; Warburton DER, 1999, SPORTS MED, V27, P241, DOI 10.2165/00007256-199927040-00004; Young AJ, 1996, J APPL PHYSIOL, V81, P252, DOI 10.1152/jappl.1996.81.1.252	41	47	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2996	10.1371/journal.pone.0002996	http://dx.doi.org/10.1371/journal.pone.0002996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714372	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900021
J	Auvert, B; Marseille, E; Korenromp, EL; Lloyd-Smith, J; Sitta, R; Taljaard, D; Pretorius, C; Williams, B; Kahn, JG				Auvert, Bertran; Marseille, Elliot; Korenromp, Eline L.; Lloyd-Smith, James; Sitta, Remi; Taljaard, Dirk; Pretorius, Carel; Williams, Brian; Kahn, James G.			Estimating the Resources Needed and Savings Anticipated from Roll-Out of Adult Male Circumcision in Sub-Saharan Africa	PLOS ONE			English	Article							HIV PREVENTION; TRANSMISSION; INFECTION; RISK; IMPACT; RAKAI; MEN	Background: Trials in Africa indicate that medical adult male circumcision (MAMC) reduces the risk of HIV by 60%. MAMC may avert 2 to 8 million HIV infections over 20 years in sub-Saharan Africa and cost less than treating those who would have been infected. This paper estimates the financial and human resources required to roll out MAMC and the net savings due to reduced infections. Methods: We developed a model which included costing, demography and HIV epidemiology. We used it to investigate 14 countries in sub-Saharan Africa where the prevalence of male circumcision was lower than 80% and HIV prevalence among adults was higher than 5%, in addition to Uganda and the Nyanza province in Kenya. We assumed that the roll-out would take 5 years and lead to an MC prevalence among adult males of 85%. We also assumed that surgery would be done as it was in the trials. We calculated public program cost, number of full-time circumcisers and net costs or savings when adjusting for averted HIV treatments. Costs were in USD, discounted to 2007. 95% percentile intervals (95% PI) were estimated by Monte Carlo simulations. Results: In the first 5 years the number of circumcisers needed was 2 282 (95% PI: 2 018 to 2 959), or 0.24 (95% PI: 0.21 to 0.31) per 10 000 adults. In years 6-10, the number of circumcisers needed fell to 513 (95% PI: 452 to 664). The estimated 5-year cost of rolling out MAMC in the public sector was $919 million (95% PI: 726 to 1 245). The cumulative net cost over the first 10 years was $672 million (95% PI: 437 to 1 021) and over 20 years there were net savings of $2.3 billion (95% PI: 1.4 to 3.4). Conclusion: A rapid roll-out of MAMC in sub-Saharan Africa requires substantial funding and a high number of circumcisers for the first five years. These investments are justified by MAMC's substantial health benefits and the savings accrued by averting future HIV infections. Lower ongoing costs and continued care savings suggest long-term sustainability.	[Auvert, Bertran; Sitta, Remi] Hop Paul Brousse, INSERM, U687, Villejuif, France; [Auvert, Bertran] Univ Versailles, Fac Med, St Maurice, France; [Auvert, Bertran] APHP, Hop Ambroise Pare, Boulogne, France; [Marseille, Elliot; Kahn, James G.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA USA; [Korenromp, Eline L.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands; [Korenromp, Eline L.] Global Fund Fight AIDS, Tuberculosis & Malaria, Geneva, Switzerland; [Lloyd-Smith, James] Penn State Univ, Dept Biol, University Pk, PA USA; [Taljaard, Dirk] Progressus, Johannesburg, South Africa; [Pretorius, Carel] SACEMA, Stellenbosch, South Africa; [Williams, Brian] WHO, STB PME, Geneva, Switzerland	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; World Health Organization	Auvert, B (corresponding author), Hop Paul Brousse, INSERM, U687, Villejuif, France.	bertran.auvert@uvsq.fr	/K-4080-2012; Lloyd-Smith, James/AAG-4463-2021	/0000-0001-7941-502X; Williams, Brian/0000-0002-3174-4876	Agence Nationale de Recherche sur le SIDA [12126]; INSERM (France); South African Centre for Epidemiological Modelling and Analysis (SACEMA); National Institute on Drug Abuse (NIDA) [R01 DA15612]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR)); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); South African Centre for Epidemiological Modelling and Analysis (SACEMA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Agence Nationale de Recherche sur le SIDA (ANRS)-12126 (France), INSERM (France), the South African Centre for Epidemiological Modelling and Analysis (SACEMA) and the National Institute on Drug Abuse (NIDA) R01 DA15612 (USA). The funding agencies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CHOOSING INT COST EF; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bodri M, 2006, ANTIVIR THER, V11, P63; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Dal Poz Mario R, 2006, Hum Resour Health, V4, P21, DOI 10.1186/1478-4491-4-21; *DEP HLTH, NAT HIV SYPH ANT SER, P1; Gold MR, 1996, COST EFFECTIVENESS H; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; HAYES RJ, 1995, J TROP MED HYG, V98, P1; *HUM SCI RES COUNC, N MAND HSRC STUD HIV; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; Lagarde E, 2007, AFR J UROL, V13, P17; Lindegren ML, 1999, JAMA-J AM MED ASSOC, V282, P531, DOI 10.1001/jama.282.6.531; MCINTOSH PA, 1895, MED REC, V47, P381; Peltzer K, 2007, SAHARA J, V4, P658; Pincock S, 2007, LANCET, V370, P1817, DOI 10.1016/S0140-6736(07)61759-0; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Thulasiraj R, 2000, Community Eye Health, V13, P22; Tshehlo R, 2007, COSTING MALE CIRCUMC; *UNAIDS WHO UNICEF, UNIVERSAL ACCESS SCA; *US CENTR INT AG T, 2008, AFR DEV IND 2007; Venkatesh R, 2005, BRIT J OPHTHALMOL, V89, P1079, DOI 10.1136/bjo.2004.063479; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2008, AIDS, V22, P567, DOI 10.1097/QAD.0b013e3282f3f406; WESTERCAMP N, 2006, AIDS BEHAV; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; GLOBAL FUND	29	52	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2679	10.1371/journal.pone.0002679	http://dx.doi.org/10.1371/journal.pone.0002679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682725	Green Published, gold			2022-12-27	WOS:000264366600001
J	Dong, ZF; Han, HL; Cao, J; Zhang, X; Xu, L				Dong, ZhiFang; Han, HuiLi; Cao, Jun; Zhang, Xia; Xu, Lin			Coincident Activity of Converging Pathways Enables Simultaneous Long-Term Potentiation and Long-Term Depression in Hippocampal CA1 Network In Vivo	PLOS ONE			English	Article								Memory is believed to depend on activity-dependent changes in the strength of synapses, e. g. long-term potentiation (LTP) and long-term depression (LTD), which can be determined by the sequence of coincident pre- and postsynaptic activity, respectively. It remains unclear, however, whether and how coincident activity of converging efferent pathways can enable LTP and LTD in the pathways simultaneously. Here, we report that, in pentobarbital-anesthetized rats, stimulation (600 pulses, 5 Hz) to Schaffer preceding to commissural pathway within a 40-ms timing window induced similar magnitudes of LTP in both pathways onto synapses of CA1 neurons, with varied LTP magnitudes after reversal of the stimulation sequence. In contrast, in urethane-anesthetized or freely-moving rats, the stimulation to Schaffer preceding to commissural pathway induced Schaffer LTP and commissural LTD simultaneously within a 40-ms timing window, without affecting synaptic efficacy in the reversed stimulation sequence. Coincident activity of Schaffer pathways confirmed the above findings under pentobarbital and urethane anesthesia. Thus, coincident activity of converging afferent pathways tends to switch the pathways to be LTP only or LTP/LTD depending on the activity states of the hippocampus. This network rule strengthens the view that activity-dependent synaptic plasticity may well contribute to memory process of the hippocampal network with flexibility or stability from one state to another.	[Dong, ZhiFang; Han, HuiLi; Cao, Jun; Xu, Lin] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Peoples R China; [Zhang, Xia] Univ Ottawa, Inst Mental Hlth Res, Ottawa, ON, Canada; [Xu, Lin] Cent S Univ, Second Xiangya Hosp, Mental Hlth Inst, Changsha, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; University of Ottawa; Central South University	Dong, ZF (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Kunming, Peoples R China.	Xia.Zhang@rohcg.on.ca; lxu@vip.163.com	Dong, Zhifang/Q-2467-2019; Xu, Lin/T-5531-2017	Xu, Lin/0000-0002-2710-3507	National Natural Science Foundation; Basic Research Program (973) of Ministry of Science and Technology; Chinese Academy of Sciences; National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA [Independent Investigator Award]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Basic Research Program (973) of Ministry of Science and Technology(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA(NARSAD)	This work was supported by grants from the National Natural Science Foundation, the Basic Research Program (973) of Ministry of Science and Technology and Chinese Academy of Sciences (to L.X. and J.C.). X.Z. is the recipient of Independent Investigator Award from the National Alliance for Research on Schizophrenia and Depression (NARSAD) in the USA.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abraham WC, 2005, TRENDS NEUROSCI, V28, P73, DOI 10.1016/j.tins.2004.12.003; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Cao J, 2004, NEUROSCI RES, V49, P229, DOI 10.1016/j.neures.2004.03.001; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Dong ZF, 2006, HIPPOCAMPUS, V16, P1017, DOI 10.1002/hipo.20234; Dong ZF, 2006, HIPPOCAMPUS, V16, P809, DOI 10.1002/hipo.20216; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; FOX SE, 1986, EXP BRAIN RES, V62, P495; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; KAIBARA T, 1993, J NEUROSCI, V13, P2391, DOI 10.1523/JNEUROSCI.13-06-02391.1993; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; O'Keefe J, 1993, Curr Opin Neurobiol, V3, P917, DOI 10.1016/0959-4388(93)90163-S; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Wei HM, 2002, NEUROSCI LETT, V324, P181, DOI 10.1016/S0304-3940(02)00183-0; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Xu L, 1997, NATURE, V387, P497, DOI 10.1038/387497a0; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204	30	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2848	10.1371/journal.pone.0002848	http://dx.doi.org/10.1371/journal.pone.0002848			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682723	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600004
J	Ofek, G; Revell, CM; Hu, JC; Allison, DD; Grande-Allen, KJ; Athanasiou, KA				Ofek, Gidon; Revell, Christopher M.; Hu, Jerry C.; Allison, David D.; Grande-Allen, K. Jane; Athanasiou, Kyriacos A.			Matrix Development in Self-Assembly of Articular Cartilage	PLOS ONE			English	Article								Background: Articular cartilage is a highly functional tissue which covers the ends of long bones and serves to ensure proper joint movement. A tissue engineering approach that recapitulates the developmental characteristics of articular cartilage can be used to examine the maturation and degeneration of cartilage and produce fully functional neotissue replacements for diseased tissue. Methodology/Principal Findings: This study examined the development of articular cartilage neotissue within a self-assembling process in two phases. In the first phase, articular cartilage constructs were examined at 1, 4, 7, 10, 14, 28, 42, and 56 days immunohistochemically, histologically, and through biochemical analysis for total collagen and glycosaminoglycan (GAG) content. Based on statistical changes in GAG and collagen levels, four time points from the first phase (7, 14, 28, and 56 days) were chosen to carry into the second phase, where the constructs were studied in terms of their mechanical characteristics, relative amounts of collagen types II and VI, and specific GAG types (chondroitin 4-sulfate, chondroitin 6-sulfate, dermatan sulfate, and hyaluronan). Collagen type VI was present in initial abundance and then localized to a pericellular distribution at 4 wks. N-cadherin activity also spiked at early stages of neotissue development, suggesting that self-assembly is mediated through a minimization of free energy. The percentage of collagen type II to total collagen significantly increased over time, while the proportion of collagen type VI to total collagen decreased between 1 and 2 wks. The chondroitin 6-to 4-sulfate ratio decreased steadily during construct maturation. In addition, the compressive properties reached a plateau and tensile characteristics peaked at 4 wks. Conclusions/Significance: The indices of cartilage formation examined in this study suggest that tissue maturation in self-assembled articular cartilage mirrors known developmental processes for native tissue. In terms of tissue engineering, it is suggested that exogenous stimulation may be necessary after 4 wks to further augment the functionality of developing constructs.	[Ofek, Gidon; Revell, Christopher M.; Hu, Jerry C.; Allison, David D.; Grande-Allen, K. Jane; Athanasiou, Kyriacos A.] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University	Athanasiou, KA (corresponding author), Rice Univ, Dept Bioengn, Houston, TX USA.	athanasiou@rice.edu	Grande-Allen, Kathryn/P-4042-2014; Hu, Jerry/E-7385-2013	Grande-Allen, Kathryn/0000-0003-1533-3767; Hu, Jerry/0000-0003-0651-1461	NIH NIAMS [R0l AR053286]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053286] Funding Source: NIH RePORTER	NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH NIAMS R0l AR053286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulos LG, 2005, ACTA BIOMATER, V1, P317, DOI 10.1016/j.actbio.2005.02.001; Alexopoulos LG, 2005, J BIOMECH, V38, P509, DOI 10.1016/j.jbiomech.2004.04.012; Alexopoulos LG, 2003, J BIOMECH ENG-T ASME, V125, P323, DOI 10.1115/1.1579047; Archer CW, 1996, J ANAT, V189, P23; *ARTHR, 2007, DIS CTR OST; Asanbaeva A., 2007, BIOMECH MODEL MECHAN; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; BAYLISS MT, 1978, BIOCHEM J, V176, P683, DOI 10.1042/bj1760683; Bharadwaj AG, 2007, J BIOL CHEM, V282, P20561, DOI 10.1074/jbc.M702964200; Bland YS, 1996, ANAT EMBRYOL, V194, P607; Brown AN, 2000, TISSUE ENG, V6, P297, DOI 10.1089/107632700418029; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; DIMICCO MA, 2007, OSTEOARTHRITIS CARTI; ELDER BD, 2007, J ORTHOP RES; Elder BD, 2008, J ORTHOP RES, V26, P238, DOI 10.1002/jor.20480; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Fraser SA, 2006, TISSUE ENG, V12, P569, DOI 10.1089/ten.2006.12.569; Grande-Allen KJ, 2004, GLYCOBIOLOGY, V14, P621, DOI 10.1093/glycob/cwh076; Grande-Allen KJ, 2003, J AM COLL CARDIOL, V42, P271, DOI 10.1016/S0735-1097(03)00626-0; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; Haider MA, 2006, BIOMECH MODEL MECHAN, V5, P160, DOI 10.1007/s10237-006-0026-1; Hashimoto K, 2006, INFLAMM RES, V55, P72, DOI 10.1007/s00011-005-0012-6; Hayes AJ, 2007, J HISTOCHEM CYTOCHEM, V55, P853, DOI 10.1369/jhc.7A7210.2007; Hing WA, 2002, OSTEOARTHR CARTILAGE, V10, P297, DOI 10.1053/joca.2002.0517; Hu J. C., 2003, HDB HISTOLOGY METHOD; Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; KEMPSON GE, 1976, BIOCHIM BIOPHYS ACTA, V428, P741, DOI 10.1016/0304-4165(76)90205-1; KEMPSON GE, 1982, ANN RHEUM DIS, V41, P508, DOI 10.1136/ard.41.5.508; Knight MM, 1998, BBA-MOL CELL RES, V1405, P67, DOI 10.1016/S0167-4889(98)00102-5; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Lewis S, 1999, ANN RHEUM DIS, V58, P441, DOI 10.1136/ard.58.7.441; Morrison EH, 1996, J ANAT, V189, P9; Mow Van C., 1997, P113; MOW VC, 1989, J BIOMECH, V22, P853, DOI 10.1016/0021-9290(89)90069-9; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; OBERLENDER SA, 1994, CELL ADHES COMMUN, V2, P521, DOI 10.3109/15419069409014216; OBERLENDER SA, 1994, DEVELOPMENT, V120, P177; Oshin AO, 2007, VET COMP ORTHOPAED, V20, P151, DOI 10.1160/VCOT-07-02-0018; Pacifici M, 2000, CONNECT TISSUE RES, V41, P175, DOI 10.3109/03008200009005288; Pavasant P, 1996, MATRIX BIOL, V15, P423, DOI 10.1016/S0945-053X(96)90161-4; Pietila K, 1999, CELLS TISSUES ORGANS, V164, P30, DOI 10.1159/000016640; Platt D, 1998, EQUINE VET J, V30, P43, DOI 10.1111/j.2042-3306.1998.tb04087.x; POOLE CA, 1988, J CELL SCI, V90, P635; POOLE CA, 1992, J CELL SCI, V103, P1101; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Pullig O, 1999, OSTEOARTHR CARTILAGE, V7, P191, DOI 10.1053/joca.1998.0208; QUARTO R, 1993, DEVELOPMENT, V117, P245; ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007; RUOSLAHTI E, 1991, CELL, V64, P867, DOI 10.1016/0092-8674(91)90308-L; SHAPIRO IM, 1991, AM J CLIN NUTR, V54, pS1209, DOI 10.1093/ajcn/54.6.1209s; Shelton JC, 2003, CELLS TISSUES ORGANS, V175, P140, DOI 10.1159/000074630; Sherwin AF, 1999, HISTOCHEM J, V31, P623, DOI 10.1023/A:1003811310619; SORRELL JM, 1989, DEVELOPMENT, V106, P657; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; YOUN I, 2006, OSTEOARTHRITIS CARTI	64	110	115	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2795	10.1371/journal.pone.0002795	http://dx.doi.org/10.1371/journal.pone.0002795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665220	Green Published, gold			2022-12-27	WOS:000264304300014
J	Beer, AL; Heckel, AH; Greenlee, MW				Beer, Anton L.; Heckel, Andreas H.; Greenlee, Mark W.			A Motion Illusion Reveals Mechanisms of Perceptual Stabilization	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL JITTER; PROPRIOCEPTION; LUMINANCE; RESPONSES; STRIATE; OBJECT; SIZE; AREA	Visual illusions are valuable tools for the scientific examination of the mechanisms underlying perception. In the peripheral drift illusion special drift patterns appear to move although they are static. During fixation small involuntary eye movements generate retinal image slips which need to be suppressed for stable perception. Here we show that the peripheral drift illusion reveals the mechanisms of perceptual stabilization associated with these micromovements. In a series of experiments we found that illusory motion was only observed in the peripheral visual field. The strength of illusory motion varied with the degree of micromovements. However, drift patterns presented in the central (but not the peripheral) visual field modulated the strength of illusory peripheral motion. Moreover, although central drift patterns were not perceived as moving, they elicited illusory motion of neutral peripheral patterns. Central drift patterns modulated illusory peripheral motion even when micromovements remained constant. Interestingly, perceptual stabilization was only affected by static drift patterns, but not by real motion signals. Our findings suggest that perceptual instabilities caused by fixational eye movements are corrected by a mechanism that relies on visual rather than extraretinal (proprioceptive or motor) signals, and that drift patterns systematically bias this compensatory mechanism. These mechanisms may be revealed by utilizing static visual patterns that give rise to the peripheral drift illusion, but remain undetected with other patterns. Accordingly, the peripheral drift illusion is of unique value for examining processes of perceptual stabilization.	[Beer, Anton L.; Greenlee, Mark W.] Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany; [Beer, Anton L.; Heckel, Andreas H.; Greenlee, Mark W.] Univ Regensburg, Expt & Clin Neurosci Programme, Regensburg, Germany	University of Regensburg; University of Regensburg	Beer, AL (corresponding author), Univ Regensburg, Inst Psychol, D-8400 Regensburg, Germany.	anton.beer@psychologie.uni-regensburg.de	Greenlee, Mark/M-6414-2018	Greenlee, Mark/0000-0003-2305-9286; Beer, Anton L./0000-0002-0297-6838	Elite Network Bavaria; Bundesministerium fur Bildung und Forschung [01GW0661-3]; European Union [IST 027198]	Elite Network Bavaria; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by the Elite Network Bavaria (ENB), the Bundesministerium fur Bildung und Forschung (BMBF, Project "Visuospatial Cognition", 01GW0661-3), and the European Union (FP6, Project "Decisions in Motion", IST 027198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGEMAN B, 1991, VISION RES, V31, P1903, DOI 10.1016/0042-6989(91)90185-8; Conway BR, 2005, J NEUROSCI, V25, P5651, DOI 10.1523/JNEUROSCI.1084-05.2005; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; Eagleman DM, 2001, NAT REV NEUROSCI, V2, P920, DOI 10.1038/35104092; Engbert R, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P103, DOI 10.1016/B978-044451020-4/50007-4; Faubert J, 1999, PERCEPTION, V28, P617, DOI 10.1068/p2825; FRASER A, 1979, NATURE, V281, P565, DOI 10.1038/281565a0; Galletti C, 2003, NEUROPSYCHOLOGIA, V41, P1717, DOI 10.1016/S0028-3932(03)00174-X; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; GATTASS R, 1981, J COMP NEUROL, V201, P519, DOI 10.1002/cne.902010405; GAUTHIER GM, 1990, SCIENCE, V249, P58, DOI 10.1126/science.2367852; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Greene E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000871; HELMHOLTZ HV, 1866, HDB PHYSL; Horwitz GD, 2003, J NEUROPHYSIOL, V90, P1333, DOI 10.1152/jn.00146.2003; Kitaoka A, 2006, J 3 DIMENSIONAL IMAG, V20, P9; Kitaoka A., 2003, VISION, V15, P261, DOI DOI 10.11247/JSSDJ.58; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Murakami I, 2003, VISION RES, V43, P957, DOI 10.1016/S0042-6989(03)00070-1; Murakami I, 2001, VISION RES, V41, P173, DOI 10.1016/S0042-6989(00)00237-6; Murakami I, 1996, VISION RES, V36, P3629, DOI 10.1016/0042-6989(96)00094-6; Murakami I, 1998, NATURE, V395, P798, DOI 10.1038/27435; Murakami I, 2006, VISION RES, V46, P2421, DOI 10.1016/j.visres.2006.01.030; Naor-Raz G, 2000, PERCEPTION, V29, P325; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; REINHARDTRUTLAND AH, 1988, PSYCHOL BULL, V103, P57, DOI 10.1037/0033-2909.103.1.57; Reppas JB, 2002, NEURON, V35, P961, DOI 10.1016/S0896-6273(02)00823-1; Sasaki Y, 2002, NEURON, V35, P1147, DOI 10.1016/S0896-6273(02)00899-1; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; TANAKA K, 1993, J NEUROPHYSIOL, V69, P128, DOI 10.1152/jn.1993.69.1.128; Tayama T, 2000, PERCEPTION, V29, P761, DOI 10.1068/p3078; Vallines I, 2006, J NEUROSCI, V26, P5965, DOI 10.1523/JNEUROSCI.0817-06.2006; ZUBER BL, 1965, SCIENCE, V150, P1459, DOI 10.1126/science.150.3702.1459	36	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2741	10.1371/journal.pone.0002741	http://dx.doi.org/10.1371/journal.pone.0002741			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648651	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900012
J	Bradnam, KR; Korf, I				Bradnam, Keith R.; Korf, Ian			Longer First Introns Are a General Property of Eukaryotic Gene Structure	PLOS ONE			English	Article								While many properties of eukaryotic gene structure are well characterized, differences in the form and function of introns that occur at different positions within a transcript are less well understood. In particular, the dynamics of intron length variation with respect to intron position has received relatively little attention. This study analyzes all available data on intron lengths in GenBank and finds a significant trend of increased length in first introns throughout a wide range of species. This trend was found to be even stronger when using high-confidence gene annotation data for three model organisms Arabidopsis thaliana, Caenorhabditis elegans, and Drosophila melanogaster) which show that the first intron in the 5' UTR is - on average - significantly longer than all downstream introns within a gene. A partial explanation for increased first intron length in A. thaliana is suggested by the increased frequency of certain motifs that are present in first introns. The phenomenon of longer first introns can potentially be used to improve gene prediction software and also to detect errors in existing gene annotations.	[Bradnam, Keith R.; Korf, Ian] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis	Bradnam, KR (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	krbradnam@ucdavis.edu	Bradnam, Keith/A-5570-2009	Bradnam, Keith/0000-0002-3881-294X	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work funded by NIH grant	Akashi H, 2006, GENETICS, V172, P1711, DOI 10.1534/genetics.105.049676; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Chamary JV, 2004, MOL BIOL EVOL, V21, P1014, DOI 10.1093/molbev/msh087; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Collins L, 2006, MOL BIOL EVOL, V23, P901, DOI 10.1093/molbev/msj084; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Gaffney DJ, 2006, PLOS GENET, V2, P1912, DOI 10.1371/journal.pgen.0020204; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Ho SH, 2001, DEV DYNAM, V221, P422, DOI 10.1002/dvdy.1161; Hong X, 2006, MOL BIOL EVOL, V23, P2392, DOI 10.1093/molbev/msl111; Jeon JS, 2000, PLANT PHYSIOL, V123, P1005, DOI 10.1104/pp.123.3.1005; JONSSON JJ, 1992, NUCLEIC ACIDS RES, V20, P3191, DOI 10.1093/nar/20.12.3191; Kalari Krishna R., 2006, In Silico Biology, V6, P237; Keightley PD, 2003, P NATL ACAD SCI USA, V100, P13402, DOI 10.1073/pnas.2233252100; Kriventseva EV, 1999, J BIOMOL STRUCT DYN, V17, P281, DOI 10.1080/07391102.1999.10508361; Levy S, 2001, BIOINFORMATICS, V17, P871, DOI 10.1093/bioinformatics/17.10.871; Li SW, 2007, BIOCHEM BIOPH RES CO, V360, P586, DOI 10.1016/j.bbrc.2007.06.085; Lin K, 2005, NUCLEIC ACIDS RES, V33, P6522, DOI 10.1093/nar/gki970; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Marais G, 2005, GENETICS, V170, P481, DOI 10.1534/genetics.104.037333; MASCARENHAS D, 1990, PLANT MOL BIOL, V15, P913, DOI 10.1007/BF00039430; Morello L, 2002, PLANT J, V29, P33, DOI 10.1046/j.0960-7412.2001.01192.x; Nielsen H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-256; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Reese MG, 2000, GENOME RES, V10, P529, DOI 10.1101/gr.10.4.529; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rogers A, 2008, NUCLEIC ACIDS RES, V36, pD612, DOI 10.1093/nar/gkm975; Rose AB, 1997, PLANT J, V11, P455, DOI 10.1046/j.1365-313X.1997.11030455.x; Rose AB, 2002, RNA, V8, P1444, DOI 10.1017/S1355838202020551; Rose AB, 2008, PLANT CELL, V20, P543, DOI 10.1105/tpc.107.057190; RUSSELL CB, 1994, NUCLEIC ACIDS RES, V22, P1221, DOI 10.1093/nar/22.7.1221; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; SMITH MW, 1988, J MOL EVOL, V27, P45, DOI 10.1007/BF02099729; SPIETH J, 1993, CELL, V73, P521, DOI 10.1016/0092-8674(93)90139-H; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stenoien HK, 2007, J EVOLUTION BIOL, V20, P1223, DOI 10.1111/j.1420-9101.2007.01301.x; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinogradov AE, 2006, GENOME RES, V16, P347, DOI 10.1101/gr.4318206; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930	46	83	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3093	10.1371/journal.pone.0003093	http://dx.doi.org/10.1371/journal.pone.0003093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769727	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796800003
J	Chrisanthar, R; Knappskog, S; Lokkevik, E; Anker, G; Ostenstad, B; Lundgren, S; Berge, EO; Risberg, T; Mjaaland, I; Maehle, L; Engebretsen, LF; Lillehaug, JR; Lonning, PE				Chrisanthar, Ranjan; Knappskog, Stian; Lokkevik, Erik; Anker, Gun; Ostenstad, Bjorn; Lundgren, Steinar; Berge, Elisabet O.; Risberg, Terje; Mjaaland, Ingvil; Maehle, Lovise; Engebretsen, Lars Fredrik; Lillehaug, Johan Richard; Lonning, Per Eystein			CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer	PLOS ONE			English	Article								Background: Chemoresistance is the main obstacle to cure in most malignant diseases. Anthracyclines are among the main drugs used for breast cancer therapy and in many other malignant conditions. Single parameter analysis or global gene expression profiles have failed to identify mechanisms causing in vivo resistance to anthracyclines. While we previously found TP53 mutations in the L2/L3 domains to be associated with drug resistance, some tumors harboring wild-type TP53 were also therapy resistant. The aim of this study was; 1) To explore alterations in the TP53 gene with respect to resistance to a regular dose epirubicin regimen (90 mg/m(2) every 3 week) in patients with primary, locally advanced breast cancer; 2) Identify critical mechanisms activating p53 in response to DNA damage in breast cancer; 3) Evaluate in vitro function of Chk2 and p14 proteins corresponding to identified mutations in the CHEK2 and p14((ARF)) genes; and 4) Explore potential CHEK2 or p14((ARF)) germline mutations with respect to family cancer incidence. Methods and Findings: Snap-frozen biopsies from 109 patients collected prior to epirubicin (as preoperative therapy were investigated for TP53, CHEK2 and p14((ARF)) mutations by sequencing the coding region and p14((ARF)) promoter methylations. TP53 mutastions were associated with chemoresistance, defined as progressive disease on therapy (p = 0.0358; p = 0.0136 for mutations affecting p53 loop domains L2/L3). Germline CHEK2 mutations (n = 3) were associated with therapy resistance (p = 0.0226). Combined, mutations affecting either CHEK2 or TP53 strongly predicted therapy resistance (p = 0.0101; TP53 mutations restricted to the L2/L3 domains: p = 0.0032). Two patients progressing on therapy harbored the CHEK2 mutation, Arg95Ter, completely abrogating Chk2 protein dimerization and kinase activity. One patient (Epi132) revealed family cancer occurrence resembling families harboring CHEK2 mutations in general, the other patient (epi203) was non-conclusive. No mutation or promoter hypermethylation in p14((ARF)) were detected. Conclusion: This study is the first reporting an association between CHEK2 mutations and therapy resistance in human cancers and to document mutations in two genes acting direct up/down-stream to each other to cause therapy failure, emphasizing the need to investigate functional cascades in future studies.	[Chrisanthar, Ranjan; Knappskog, Stian; Anker, Gun; Lonning, Per Eystein] Univ Bergen, Sect Oncol, Inst Med, Bergen, Norway; [Chrisanthar, Ranjan; Knappskog, Stian; Anker, Gun; Lonning, Per Eystein] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Chrisanthar, Ranjan; Knappskog, Stian; Berge, Elisabet O.; Lillehaug, Johan Richard] Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; [Lokkevik, Erik] Rikshospitalet Univ Hosp, Norwegian Radium Hosp, Dept Oncol, Oslo, Norway; [Ostenstad, Bjorn] Ullevaal Univ Hosp, Dept Oncol, Oslo, Norway; [Lundgren, Steinar] St Olavs Univ Hosp, Dept Oncol, Trondheim, Norway; [Risberg, Terje] Univ Tromso, Inst Clin Med, Univ Hosp N Norway, Dept Oncol, Tromso, Norway; [Mjaaland, Ingvil] Stavanger Univ Hosp, Div Hematol & Oncol, Stavanger, Norway; [Maehle, Lovise] Rikshospitalet Univ Hosp, Dept Med Genet, Oslo, Norway; [Engebretsen, Lars Fredrik] Haukeland Hosp, Ctr Med Genet & Mol Med, Bergen, Norway; [Lundgren, Steinar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, Trondheim, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; National Hospital Norway; University of Oslo; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; Stavanger University Hospital; University of Oslo; National Hospital Norway; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU)	Chrisanthar, R (corresponding author), Univ Bergen, Sect Oncol, Inst Med, Bergen, Norway.	per.lonning@helse-bergen.no		Lonning, Per Eystein/0000-0002-8890-6303; Knappskog, Stian/0000-0002-4153-1655	Norwegian Cancer Society; Rosa sloyfe Breast Cancer Fund Raising; Norwegian Health Region West (HelseVest) [fellowship]; Innovest program of Excellence	Norwegian Cancer Society(Norwegian Cancer Society); Rosa sloyfe Breast Cancer Fund Raising; Norwegian Health Region West (HelseVest); Innovest program of Excellence	This work was supported by grants from the Norwegian Cancer Society, the "Rosa sloyfe" Breast Cancer Fund Raising, the Norwegian Health Region West (HelseVest) and the Innovest program of Excellence. Ranjan Chrisanthar was a recipient of a fellowship from Helse Vest. The Clinical Trial research office is financially supported by the Norwegian Cancer Society. None of the funders had any role with respect to study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alba E, 2004, J CLIN ONCOL, V22, P2587, DOI 10.1200/JCO.2004.08.125; Bartek J, 2001, NAT REV MOL CELL BIO, V2, P877, DOI 10.1038/35103059; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; BERGH J, 1995, NAT MED, V1, P1029, DOI 10.1038/nm1095-1029; Berns EMJJ, 1998, BRIT J CANCER, V77, P1130, DOI 10.1038/bjc.1998.187; Bertheau P, 2007, PLOS MED, V4, P585, DOI 10.1371/journal.pmed.0040090; BORRESEN AL, 1995, GENE CHROMOSOME CANC, V14, P71, DOI 10.1002/gcc.2870140113; Buscemi G, 2004, ONCOGENE, V23, P7691, DOI 10.1038/sj.onc.1207986; Chehab NH, 2000, GENE DEV, V14, P278; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen C, 2005, BIOCHEM BIOPH RES CO, V333, P427, DOI 10.1016/j.bbrc.2005.05.126; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Chipuk JE, 2003, J CLIN IMMUNOL, V23, P355, DOI 10.1023/A:1025365432325; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; CLANTZ SA, 2002, PRIMER BIOSTATISTICS; Early Breast Cancer Trialists' Collaborative G., 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Efeyan A, 2006, NATURE, V443, P159, DOI 10.1038/443159a; ENOCH T, 1995, TRENDS BIOCHEM SCI, V20, P426, DOI 10.1016/S0968-0004(00)89093-3; Evans DG, 2008, J MED GENET, V45, P63, DOI 10.1136/jmg.2007.054700; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Falck J, 2001, ONCOGENE, V20, P5503, DOI 10.1038/sj.onc.1204811; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Geisler S, 2001, CANCER RES, V61, P2505; Gurley KE, 2007, MOL CANCER RES, V5, P1312, DOI 10.1158/1541-7786.MCR-07-0223; HAHN M, 1993, CLIN CHEM, V39, P549; HALAZONETIS TD, 1993, EMBO J, V12, P5057, DOI 10.1002/j.1460-2075.1993.tb06199.x; Hannemann J, 2005, J CLIN ONCOL, V23, P3331, DOI 10.1200/JCO.2005.09.077; HAYWARD JL, 1977, BRIT J CANCER, V35, P292, DOI 10.1038/bjc.1977.42; Hernandez-Boussard T, 1999, HUM MUTAT, V14, P1; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; JONES MH, 1992, GENE CHROMOSOME CANC, V5, P89, DOI 10.1002/gcc.2870050113; Kandioler-Eckersberger D, 2000, CLIN CANCER RES, V6, P50; Khan S, 2004, ONCOGENE, V23, P6040, DOI 10.1038/sj.onc.1207824; Knoop AS, 2005, J CLIN ONCOL, V23, P7483, DOI 10.1200/JCO.2005.11.007; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Lee S, 2003, CURR OPIN GENET DEV, V13, P90, DOI 10.1016/S0959-437X(02)00014-X; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Lonning PE, 2007, ANN ONCOL, V18, P1293, DOI 10.1093/annonc/mdm013; Lonning PE, 2005, NAT CLIN PRACT ONCOL, V2, P26, DOI 10.1038/ncponc0072; Lonning PE, 2004, TRENDS MOL MED, V10, P113, DOI 10.1016/j.molmed.2004.01.005; Lonning PE, 2003, LANCET ONCOL, V4, P177; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Nister M, 2005, ONCOGENE, V24, P3563, DOI 10.1038/sj.onc.1208354; Norberg T, 2001, CANCER RES, V61, P8317; Palmero I, 2002, ONCOGENE, V21, P2939, DOI 10.1038/sj/onc/1205371; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; Pivot X, 1999, INT J ONCOL, V15, P381; Reddy A, 2002, BRIT J CANCER, V86, P756, DOI 10.1038/sj.bjc.6600131; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sekaric P, 2007, ONCOGENE, V26, P6261, DOI 10.1038/sj.onc.1210462; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Skotheim RI, 2001, CANCER GENET CYTOGEN, V127, P64, DOI 10.1016/S0165-4608(00)00433-7; Sorlie T, 2006, MOL CANCER THER, V5, P2914, DOI 10.1158/1535-7163.MCT-06-0126; Speidel D, 2006, ONCOGENE, V25, P940, DOI 10.1038/sj.onc.1209126; Staalesen V, 2004, ONCOGENE, V23, P8535, DOI 10.1038/sj.onc.1207928; Staalesen V, 2006, CLIN CANCER RES, V12, P6000, DOI 10.1158/1078-0432.CCR-05-2822; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Sullivan A, 2002, ONCOGENE, V21, P1316, DOI 10.1038/sj.onc.1205207; Tanner M, 2006, J CLIN ONCOL, V24, P2428, DOI 10.1200/JCO.2005.02.9264; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tsang WP, 2005, INT J CANCER, V114, P331, DOI 10.1002/ijc.20818; Varley JM, 2003, HUM MUTAT, V21, P313, DOI 10.1002/humu.10185; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160; Wu XL, 2001, J BIOL CHEM, V276, P2971, DOI 10.1074/jbc.M009727200	74	68	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3062	10.1371/journal.pone.0003062	http://dx.doi.org/10.1371/journal.pone.0003062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725978	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796300008
J	Lee, H; Leamey, CA; Sawatari, A				Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu			Rapid Reversal of Chondroitin Sulfate Proteoglycan Associated Staining in Subcompartments of Mouse Neostriatum during the Emergence of Behaviour	PLOS ONE			English	Article							STRIATAL PROJECTION NEURONS; PARVALBUMIN-CONTAINING NEURONS; FAST-SPIKING INTERNEURONS; MONKEY CAUDATE NEURONS; PERINEURONAL NETS; EXTRACELLULAR-MATRIX; DOPAMINE NEURONS; BASAL GANGLIA; RAT-BRAIN; GABAERGIC INTERNEURONS	Background: The neostriatum, the mouse homologue of the primate caudate/putamen, is the input nucleus for the basal ganglia, receiving both cortical and dopaminergic input to each of its sub-compartments, the striosomes and matrix. The coordinated activation of corticostriatal pathways is considered vital for motor and cognitive abilities, yet the mechanisms which underlie the generation of these circuits are unknown. The early and specific targeting of striatal subcompartments by both corticostriatal and nigrostriatal terminals suggests activity-independent mechanisms, such as axon guidance cues, may play a role in this process. Candidates include the chondroitin sulfate proteoglycan (CSPG) family of glycoproteins which have roles not only in axon guidance, but also in the maturation and stability of neural circuits where they are expressed in lattice-like perineuronal nets (PNNs). Methodology/Principal Findings: The expression of CSPG-associated structures and PNNs with respect to neostriatal subcompartments has been examined qualitatively and quantitatively using double-labelling for Wisteria floribunda agglutinin (WFA), and the mu-opioid receptor (mu OR), a marker for striosomes, at six postnatal ages in mice. We find that at the earliest ages (postnatal day (P) 4 and P10), WFA-positive clusters overlap preferentially with the striosome compartment. By P14, these clusters disappear. In contrast, PNNs were first seen at P10 and continued to increase in density and spread throughout the caudate/putamen with maturation. Remarkably, the PNNs overlap almost exclusively with the neostriatal matrix. Conclusions/Significance: This is the first description of a reversal in the distribution of CSPG associated structures, as well as the emergence and maintenance of PNNs in specific subcompartments of the neostriatum. These results suggest diverse roles for CSPGs in the formation of functional corticostriatal and nigrostriatal connectivity within the striosome and matrix compartments of the developing caudate/putamen.	[Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; [Lee, Hyunchul; Leamey, Catherine A.; Sawatari, Atomu] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Lee, H (corresponding author), Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia.	atomu@medsci.usyd.edu.au		Leamey, Catherine/0000-0002-3390-4933; Lee, Hyunchul/0000-0002-1427-6521	University of Sydney; NHMRC; Simons Foundation	University of Sydney(University of Sydney); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Simons Foundation	University of Sydney Research and Development Grant (AS), NHMRC Project Grant and Simons Foundation (CAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams I, 2001, NEUROSCIENCE, V108, P285, DOI 10.1016/S0306-4522(01)00419-5; Ajmo JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-14; Alpar A, 2006, BRAIN RES, V1120, P13, DOI 10.1016/j.brainres.2006.08.069; ANDERSON KD, 1990, J COMP NEUROL, V295, P339, DOI 10.1002/cne.902950302; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; Bracci E, 2002, J NEUROPHYSIOL, V87, P2190, DOI 10.1152/jn.00754.2001; BRAUER K, 1993, BRAIN RES, V631, P167, DOI 10.1016/0006-8993(93)91205-7; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; Bruckner G, 1996, BRAIN RES, V720, P84, DOI 10.1016/0006-8993(96)00152-7; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bruckner G, 2000, J COMP NEUROL, V428, P616, DOI 10.1002/1096-9861(20001225)428:4<616::AID-CNE3>3.0.CO;2-K; Bruckner G, 1996, J NEUROCYTOL, V25, P333, DOI 10.1007/BF02284806; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1994, J CHEM NEUROANAT, V8, P11, DOI 10.1016/0891-0618(94)90032-9; Bruckner G, 2003, J CHEM NEUROANAT, V26, P37, DOI 10.1016/S0891-0618(03)00036-X; CABOCHE J, 1991, DEV BRAIN RES, V58, P111, DOI 10.1016/0165-3806(91)90243-C; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Centonze D, 2003, J NEUROSCI, V23, P6245; CHANG HT, 1992, BRAIN RES, V574, P307, DOI 10.1016/0006-8993(92)90830-3; Charvet I, 1998, DEV BRAIN RES, V109, P229, DOI 10.1016/S0165-3806(98)00088-1; Charvet I, 1998, J NEUROSCI RES, V51, P612, DOI 10.1002/(SICI)1097-4547(19980301)51:5<612::AID-JNR8>3.0.CO;2-I; CHESSELET MF, 1983, LIFE SCI, V33, P37, DOI 10.1016/0024-3205(83)90438-1; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; Costa C, 2007, J CHEM NEUROANAT, V33, P111, DOI 10.1016/j.jchemneu.2007.01.006; COWAN RL, 1990, J COMP NEUROL, V302, P197, DOI 10.1002/cne.903020202; Cromwell HC, 2003, J NEUROPHYSIOL, V89, P2823, DOI 10.1152/jn.01014.2002; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; DONOGHUE JP, 1986, BRAIN RES, V365, P397, DOI 10.1016/0006-8993(86)91658-6; EDLEY SM, 1982, BRAIN RES, V249, P184, DOI 10.1016/0006-8993(82)90186-X; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; GATES MA, 1993, J CHEM NEUROANAT, V6, P179, DOI 10.1016/0891-0618(93)90040-B; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1987, J NEUROSCI, V7, P3915; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; GERFEN CR, 1988, BRAIN RES, V460, P161, DOI 10.1016/0006-8993(88)91217-6; GIMENEZAMAYA JM, 1991, J NEUROSCI, V11, P779; GRAYBIEL AM, 1984, P NATL ACAD SCI-BIOL, V81, P7980, DOI 10.1073/pnas.81.24.7980; Grigoriadis N, 1996, PEDIATR NEUROL, V14, P41, DOI 10.1016/0887-8994(95)00225-1; HARTIG W, 1992, NEUROREPORT, V3, P869; Hartig W, 1999, BRAIN RES, V842, P15, DOI 10.1016/S0006-8993(99)01784-9; HATTORI T, 1973, EXP NEUROL, V38, P70, DOI 10.1016/0014-4886(73)90008-3; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hoover JE, 2003, J NEUROPHYSIOL, V89, P1576, DOI 10.1152/jn.01009.2002; INIGUEZ C, 1990, DEV BRAIN RES, V57, P43, DOI 10.1016/0165-3806(90)90183-Y; Jacobs EC, 2007, EUR J NEUROSCI, V25, P17, DOI 10.1111/j.1460-9568.2006.05258.x; Janis LS, 1999, J NEUROSCI, V19, P4962; JIMENEZCASTELLANOS J, 1989, NEUROSCIENCE, V32, P297, DOI 10.1016/0306-4522(89)90080-8; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KIMURA M, 1992, EXP BRAIN RES, V89, P473; KIMURA M, 1993, ADV NEUROL, V60, P62; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kita H, 1996, NEUROSCIENCE, V70, P925, DOI 10.1016/0306-4522(95)00410-6; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; Koppe G, 1997, CELL TISSUE RES, V288, P33, DOI 10.1007/s004410050790; Leamey CA, 2007, PLOS BIOL, V5, P2077, DOI 10.1371/journal.pbio.0050241; Leamey CA, 2008, CEREB CORTEX, V18, P53, DOI 10.1093/cercor/bhm031; Lee IH, 2006, J NEUROPHYSIOL, V95, P2391, DOI 10.1152/jn.01053.2005; Lee IH, 2003, J NEUROPHYSIOL, V89, P2528, DOI 10.1152/jn.01055.2002; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Mace K, 2002, J NEUROSCI RES, V70, P46, DOI 10.1002/jnr.10381; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Matsui F, 1998, BRAIN RES, V790, P45, DOI 10.1016/S0006-8993(98)00009-2; McEwen ML, 1997, DEV PSYCHOBIOL, V30, P313, DOI 10.1002/(SICI)1098-2302(199705)30:4<313::AID-DEV5>3.0.CO;2-R; Miyachi S, 1997, EXP BRAIN RES, V115, P1, DOI 10.1007/PL00005669; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Morishima M, 2006, J NEUROSCI, V26, P4394, DOI 10.1523/JNEUROSCI.0252-06.2006; Murakami T, 1997, ARCH HISTOL CYTOL, V60, P347, DOI 10.1679/aohc.60.347; Murakami T, 1999, ARCH HISTOL CYTOL, V62, P273, DOI 10.1679/aohc.62.273; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Nisenbaum LK, 1998, DEV NEUROSCI-BASEL, V20, P113, DOI 10.1159/000017307; OKANO K, 1987, EXP BRAIN RES, V66, P155; OOHIRA A, 1988, J BIOL CHEM, V263, P10240; OOHIRA A, 1994, NEUROSCI RES, V20, P195, DOI 10.1016/0168-0102(94)90088-4; OOHIRA A, 1994, NEUROSCIENCE, V60, P145, DOI 10.1016/0306-4522(94)90210-0; PARENT A, 1989, NEUROSCI LETT, V96, P140, DOI 10.1016/0304-3940(89)90047-5; Parthasarathy HB, 1997, J NEUROSCI, V17, P2477; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Plotkin JL, 2005, EUR J NEUROSCI, V22, P1097, DOI 10.1111/j.1460-9568.2005.04303.x; Ramanathan S, 2002, J NEUROSCI, V22, P8158; Reimers S, 2007, EUR J NEUROSCI, V25, P2640, DOI 10.1111/j.1460-9568.2007.05514.x; Satoh T, 2003, J NEUROSCI, V23, P9913; Schlosser B, 1999, J COMP NEUROL, V405, P185, DOI 10.1002/(SICI)1096-9861(19990308)405:2<185::AID-CNE4>3.0.CO;2-B; SCHULTZ W, 1993, PROG BRAIN RES, V99, P227; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Sieber BA, 2004, MOL CELL NEUROSCI, V26, P418, DOI 10.1016/j.mcn.2004.03.009; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; SUR M, 1988, J NEUROSCI, V8, P874; TEPPER JM, BRAIN RES REV; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; VANDERKOOY D, 1984, DEV BRAIN RES, V14, P300, DOI 10.1016/0165-3806(84)90318-3; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wang HB, 2007, NEUROSCI LETT, V425, P195, DOI 10.1016/j.neulet.2007.08.033; Wegner F, 2003, EXP NEUROL, V184, P705, DOI 10.1016/S0014-4886(03)00313-3; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; WOOLSEY TA, 1975, J COMP NEUROL, V164, P79, DOI 10.1002/cne.901640107; Wu Y, 2000, NEUROSCI RES, V38, P49, DOI 10.1016/S0168-0102(00)00140-1; YOUNG NM, 1985, CAN J BIOCHEM CELL B, V63, P268, DOI 10.1139/o85-039	115	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3020	10.1371/journal.pone.0003020	http://dx.doi.org/10.1371/journal.pone.0003020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714376	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420900043
J	Martin, KJ; Patrick, DR; Bissell, MJ; Fournier, MV				Martin, Katherine J.; Patrick, Denis R.; Bissell, Mina J.; Fournier, Marcia V.			Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets	PLOS ONE			English	Article								Background: One of the major tenets in breast cancer research is that early detection is vital for patient survival by increasing treatment options. To that end, we have previously used a novel unsupervised approach to identify a set of genes whose expression predicts prognosis of breast cancer patients. The predictive genes were selected in a well-defined three dimensional (3D) cell culture model of non-malignant human mammary epithelial cell morphogenesis as downregulated during breast epithelial cell acinar formation and cell cycle arrest. Here we examine the ability of this gene signature (3D-signature) to predict prognosis in three independent breast cancer microarray datasets having 295, 286, and 118 samples, respectively. Methods and Findings: Our results show that the 3D-signature accurately predicts prognosis in three unrelated patient datasets. At 10 years, the probability of positive outcome was 52, 51, and 47 percent in the group with a poor-prognosis signature and 91, 75, and 71 percent in the group with a good-prognosis signature for the three datasets, respectively (Kaplan-Meier survival analysis, p<0.05). Hazard ratios for poor outcome were 5.5 (95% CI 3.0 to 12.2, p<0.0001), 2.4 (95% CI 1.6 to 3.6, p<0.0001) and 1.9 (95% CI 1.1 to 3.2, p = 0.016) and remained significant for the two larger datasets when corrected for estrogen receptor (ER) status. Hence the 3D-signature accurately predicts breast cancer outcome in both ER-positive and ER-negative tumors, though individual genes differed in their prognostic ability in the two subtypes. Genes that were prognostic in ER+ patients are AURKA, CEP55, RRM2, EPHA2, FGFBP1, and VRK1, while genes prognostic in ER-patients include ACTB, FOXM1 and SERPINE2 (Kaplan-Meier p<0.05). Multivariable Cox regression analysis in the largest dataset showed that the 3D-signature was a strong independent factor in predicting breast cancer outcome. Conclusions: The 3D-signature accurately predicts breast cancer outcome across multiple datasets and holds prognostic value for both ER-positive and ER-negative breast cancer. The signature was selected using a novel biological approach and hence holds promise to represent the key biological processes of breast cancer.	[Martin, Katherine J.] Bioarray Consulting, Belmont, MA USA; [Patrick, Denis R.; Fournier, Marcia V.] GlaxoSmithKline, Oncol Ctr Excellence Drug Discovery, Dept Oncol Biol, Collegeville, PA USA; [Bissell, Mina J.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	GlaxoSmithKline; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Martin, KJ (corresponding author), Bioarray Consulting, Belmont, MA USA.	Marcia.V.Fournier@GSK.com	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355	GlaxoSmithKline; Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy [DE-AC02-05CH11231]; Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division [03-76SF00098]; National Cancer Institute [R01CA064786, U54CA126552, U54CA112970-01]; NATIONAL CANCER INSTITUTE [U54CA126552, U54CA112970, R01CA064786] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy(United States Department of Energy (DOE)); Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GlaxoSmithKline. MJB is supported by grants from the Office of Biological and Environmental Research (OBER) of the U.S. Department of Energy (DE-AC02-05CH11231), a Distinguished Fellow Award; Low Dose Radiation Program and the Office of Health and Environmental Research, Health Effects Division (03-76SF00098); by National Cancer Institute awards R01CA064786, U54CA126552 and U54CA112970-01.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bin Fang W, 2005, ONCOGENE, V24, P7859, DOI 10.1038/sj.onc.1208937; Bissell MJ, 2007, BIOCHEM SOC T, V35, P18, DOI 10.1042/BST0350018; Branca M, 2003, SCIENCE, V300, P238, DOI 10.1126/science.300.5617.238; Brantley-Sieders DM, 2005, FASEB J, V19, P1884, DOI 10.1096/fj.05-4038fje; Carles-Kinch K, 2002, CANCER RES, V62, P2840; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Edgren H, 2006, CANCER CELL, V10, P453, DOI 10.1016/j.ccr.2006.11.007; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Gruvberger SK, 2003, BREAST CANCER RES, V5, P23, DOI 10.1186/bcr548; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lu M, 2003, CANCER RES, V63, P3425; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Martinez-Garay I, 2006, GENOMICS, V87, P243, DOI 10.1016/j.ygeno.2005.11.006; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Teschendorff AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r101; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; 2007, CANC FACTS FIGURES	29	174	184	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2994	10.1371/journal.pone.0002994	http://dx.doi.org/10.1371/journal.pone.0002994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714348	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900020
J	Musgrove, EA; Sergio, CM; Loi, S; Inman, CK; Anderson, LR; Alles, MC; Pinese, M; Caldon, CE; Schutte, J; Gardiner-Garden, M; Ormandy, CJ; McArthur, G; Butt, AJ; Sutherland, RL				Musgrove, Elizabeth A.; Sergio, C. Marcelo; Loi, Sherene; Inman, Claire K.; Anderson, Luke R.; Alles, M. Chehani; Pinese, Mark; Caldon, C. Elizabeth; Schuette, Judith; Gardiner-Garden, Margaret; Ormandy, Christopher J.; McArthur, Grant; Butt, Alison J.; Sutherland, Robert L.			Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer	PLOS ONE			English	Article							DNA-REPLICATION; GROWTH-FACTOR; CYCLIN D1; ANTIESTROGEN RESISTANCE; TRANSCRIPTION FACTOR; ENDOCRINE THERAPY; MCF-7 CELLS; EXPRESSION; RECEPTOR; SURVIVAL	Background: Estrogen is a pivotal regulator of cell proliferation in the normal breast and breast cancer. Endocrine therapies targeting the estrogen receptor are effective in breast cancer, but their success is limited by intrinsic and acquired resistance. Methodology/Principal Findings: With the goal of gaining mechanistic insights into estrogen action and endocrine resistance, we classified estrogen-regulated genes by function, and determined the relationship between functionally-related genesets and the response to tamoxifen in breast cancer patients. Estrogen-responsive genes were identified by transcript profiling of MCF-7 breast cancer cells. Pathway analysis based on functional annotation of these estrogen-regulated genes identified gene signatures with known or predicted roles in cell cycle control, cell growth (i.e. ribosome biogenesis and protein synthesis), cell death/survival signaling and transcriptional regulation. Since inducible expression of c-Myc in antiestrogen-arrested cells can recapitulate many of the effects of estrogen on molecular endpoints related to cell cycle progression, the estrogen-regulated genes that were also targets of c-Myc were identified using cells inducibly expressing c-Myc. Selected genes classified as estrogen and c-Myc targets displayed similar levels of regulation by estrogen and c-Myc and were not estrogen-regulated in the presence of siMyc. Genes regulated by c-Myc accounted for 50% of all acutely estrogen-regulated genes but comprised 85% (110/129 genes) in the cell growth signature. siRNA-mediated inhibition of c-Myc induction impaired estrogen regulation of ribosome biogenesis and protein synthesis, consistent with the prediction that estrogen regulates cell growth principally via c-Myc. The 'cell cycle', 'cell growth' and 'cell death' gene signatures each identified patients with an attenuated response in a cohort of 246 tamoxifen-treated patients. In multivariate analysis the cell death signature was predictive independent of the cell cycle and cell growth signatures. Conclusions/Significance: These functionally-based gene signatures can stratify patients treated with tamoxifen into groups with differing outcome, and potentially identify distinct mechanisms of tamoxifen resistance.	[Musgrove, Elizabeth A.; Sergio, C. Marcelo; Inman, Claire K.; Anderson, Luke R.; Alles, M. Chehani; Pinese, Mark; Caldon, C. Elizabeth; Schuette, Judith; Gardiner-Garden, Margaret; Ormandy, Christopher J.; Butt, Alison J.; Sutherland, Robert L.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Musgrove, Elizabeth A.; Anderson, Luke R.; Alles, M. Chehani; Caldon, C. Elizabeth; Ormandy, Christopher J.; Butt, Alison J.; Sutherland, Robert L.] Univ New S Wales NSW, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Loi, Sherene; McArthur, Grant] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [McArthur, Grant] Univ Melbourne, St Vincents Hosp, Dept Med, Parkville, Vic 3052, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Peter Maccallum Cancer Center; St Vincent's Hospital Melbourne; University of Melbourne	Musgrove, EA (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	e.musgrove@garvan.org.au	Ormandy, Chris/G-4165-2014; Caldon, Liz/C-1559-2009; Sutherland, Robert L/A-8378-2008; Anderson, Luke/D-1780-2012; Loi, Sherene/H-1979-2016	Caldon, Liz/0000-0003-1392-3472; Anderson, Luke/0000-0003-3654-1258; Loi, Sherene/0000-0001-6137-9171; Ormandy, Christopher/0000-0002-2504-7919; Pinese, Mark/0000-0001-5078-6687; Butt, Alison/0000-0002-6216-5105	Association for International Cancer Research; National Health and Medical Research Council of Australia; Cancer Institute NSW; Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer); Cure Cancer Australia; Petre Foundation; RT Hall Trust; National Breast Cancer Foundation	Association for International Cancer Research; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer); Cure Cancer Australia; Petre Foundation; RT Hall Trust; National Breast Cancer Foundation	This research was supported by the Association for International Cancer Research, the National Health and Medical Research Council of Australia, the Cancer Institute NSW, the Australian Cancer Research Foundation (ACRF Unit for the Molecular Genetics of Cancer), Cure Cancer Australia, the Petre Foundation and the RT Hall Trust. EAM and AJB are Cancer Institute NSW Fellows. SL is a National Breast Cancer Foundation Scholar. LRA and CEC are Cancer Institute NSW Scholars. These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Ali S, 2002, NAT REV CANCER, V2, P101, DOI 10.1038/nrc721; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Benjamini Y, 2001, ANN STAT, V29, P1165; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Butt AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1985; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Cheng ASL, 2006, MOL CELL, V21, P393, DOI 10.1016/j.molcel.2005.12.016; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; DALY RJ, 1991, CELL GROWTH DIFFER, V2, P457; Dellapasqua S, 2005, J CLIN ONCOL, V23, P1736, DOI 10.1200/JCO.2005.11.050; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HAMILTON TH, 1968, SCIENCE, V161, P649, DOI 10.1126/science.161.3842.649; Hinsby AM, 2006, MOL CELL, V22, P285, DOI 10.1016/j.molcel.2006.03.012; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; KIRKLAND JL, 1992, ENDOCRINOLOGY, V130, P3223, DOI 10.1210/en.130.6.3223; LEROY F, 1975, NATURE, V258, P259, DOI 10.1038/258259a0; Lobenhofer EK, 2002, MOL ENDOCRINOL, V16, P1215, DOI 10.1210/me.16.6.1215; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Mukherjee S, 2005, J BIOL CHEM, V280, P17617, DOI 10.1074/jbc.M502278200; MUSGROVE EA, 1989, CANCER RES, V49, P2398; Nicholson RI, 2005, J STEROID BIOCHEM, V93, P257, DOI 10.1016/j.jsbmb.2004.12.006; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Prall OWJ, 1998, MOL CELL BIOL, V18, P4499, DOI 10.1128/MCB.18.8.4499; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Pratt MAC, 1998, FEBS LETT, V440, P403, DOI 10.1016/S0014-5793(98)01499-9; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rodrik V, 2005, MOL CELL BIOL, V25, P7917, DOI 10.1128/MCB.25.17.7917-7925.2005; SACEDA M, 1988, MOL ENDOCRINOL, V2, P1157, DOI 10.1210/mend-2-12-1157; Smith IE, 2005, J CLIN ONCOL, V23, P5108, DOI 10.1200/JCO.2005.04.005; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stender JD, 2007, MOL ENDOCRINOL, V21, P2112, DOI 10.1210/me.2006-0474; Strasser-Weippl K, 2005, J CLIN ONCOL, V23, P1751, DOI 10.1200/JCO.2005.11.038; SUTHERLAND RL, 1983, CANCER RES, V43, P3998; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	56	79	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2987	10.1371/journal.pone.0002987	http://dx.doi.org/10.1371/journal.pone.0002987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714337	Green Published, gold			2022-12-27	WOS:000264420900013
J	Krauledat, M; Tangermann, M; Blankertz, B; Muller, KR				Krauledat, Matthias; Tangermann, Michael; Blankertz, Benjamin; Mueller, Klaus-Robert			Towards Zero Training for Brain-Computer Interfacing	PLOS ONE			English	Article								Electroencephalogram (EEG) signals are highly subject-specific and vary considerably even between recording sessions of the same user within the same experimental paradigm. This challenges a stable operation of Brain-Computer Interface (BCI) systems. The classical approach is to train users by neurofeedback to produce fixed stereotypical patterns of brain activity. In the machine learning approach, a widely adapted method for dealing with those variances is to record a so called calibration measurement on the beginning of each session in order to optimize spatial filters and classifiers specifically for each subject and each day. This adaptation of the system to the individual brain signature of each user relieves from the need of extensive user training. In this paper we suggest a new method that overcomes the requirement of these time-consuming calibration recordings for long-term BCI users. The method takes advantage of knowledge collected in previous sessions: By a novel technique, prototypical spatial filters are determined which have better generalization properties compared to single-session filters. In particular, they can be used in follow-up sessions without the need to recalibrate the system. This way the calibration periods can be dramatically shortened or even completely omitted for these 'experienced' BCI users. The feasibility of our novel approach is demonstrated with a series of online BCI experiments. Although performed without any calibration measurement at all, no loss of classification performance was observed.	[Krauledat, Matthias; Tangermann, Michael; Blankertz, Benjamin; Mueller, Klaus-Robert] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany	Technical University of Berlin	Krauledat, M (corresponding author), Berlin Inst Technol, Machine Learning Lab, Berlin, Germany.	kraulem@cs.tu-berlin.de	Muller, Klaus R/C-3196-2013; Tangermann, Michael/ABE-4178-2020; Mueller, Klaus-Robert/Y-3547-2019	Mueller, Klaus-Robert/0000-0002-3861-7685; Blankertz, Benjamin/0000-0002-2437-4846; Tangermann, Michael/0000-0001-6729-0290	Bundesministerium fur Bildung und Forschung (BMBF) [FKZ 01IBE01A, FKZ 16SV2231]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-1]; IST Programme of the European Community, under the PASCAL Network of Excellence [IST-2002-506778]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IST Programme of the European Community, under the PASCAL Network of Excellence(European Commission)	The studies were supported by grants of the Bundesministerium fur Bildung und Forschung (BMBF), FKZ 01IBE01A and FKZ 16SV2231, the Deutsche Forschungsgemeinschaft (DFG), MU 987/3-1, and by the IST Programme of the European Community, under the PASCAL Network of Excellence, IST-2002-506778. This publication only reflects the authors' views.	Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blanco A, 2002, TAPPI J, V1, P14; BLANKERTZ B, 2008, BERLIN BRAIN COMPUTE; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Blankertz B, 2007, LECT NOTES COMPUT SC, V4555, P759; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Blankertz B, 2006, J UNIVERS COMPUT SCI, V12, P581; Blankertz B, 2006, IEEE T NEUR SYS REH, V14, P147, DOI 10.1109/TNSRE.2006.875557; Dornhege G., 2007, BRAIN COMPUTER INTER; Dornhege G., 2006, ADV NEURAL INF PROCE, V18, P315, DOI 10.5555/2976248.2976288; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Duda R.O., 2006, PATTERN CLASSIFICATI; Fukunaga K., 2013, INTRO STAT PATTERN R; Harmeling S, 2006, NEUROCOMPUTING, V69, P1608, DOI 10.1016/j.neucom.2005.05.015; Jasper HH, 1938, ARCH NEURO PSYCHIATR, V39, P96, DOI 10.1001/archneurpsyc.1938.02270010106010; KOLES ZJ, 1991, ELECTROENCEPHALOGR C, V796, P440; KRAULEDAT, 2007, ADV NEURAL INFORM PR, V19, P753; KRAULEDAT M, 2006, P 3 INT BRAIN COMP I, P60; Krauledat M., 2007, BRAIN COMPUTER INTER, P305; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; MEINECKE FC, 2005, INT J IMAGING SYSTEM; Muller KR, 2006, IEEE SIGNAL PROC MAG, V23, P128, DOI 10.1109/MSP.2006.1708426; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Muller KR, 2003, IEEE T NEUR SYS REH, V11, P165, DOI 10.1109/TNSRE.2003.814484; Neuper C, 2001, CLIN NEUROPHYSIOL, V112, P2084, DOI 10.1016/S1388-2457(01)00661-7; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Popescu F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000637; Shenoy P, 2006, J NEURAL ENG, V3, pR13, DOI 10.1088/1741-2560/3/1/R02; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Vidaurre C, 2006, IEEE T BIO-MED ENG, V53, P1214, DOI 10.1109/TBME.2006.873542	31	185	190	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2967	10.1371/journal.pone.0002967	http://dx.doi.org/10.1371/journal.pone.0002967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698427	gold, Green Submitted, Green Published			2022-12-27	WOS:000264412600052
J	Mager, U; Degenhardt, T; Pulkkinen, L; Kolehmainen, M; Tolppanen, AM; Lindstrom, J; Eriksson, JG; Carlberg, C; Tuomilehto, J; Uusitupa, M				Mager, Ursula; Degenhardt, Tatjana; Pulkkinen, Leena; Kolehmainen, Marjukka; Tolppanen, Anna-Maija; Lindstrom, Jaana; Eriksson, Johan G.; Carlberg, Carsten; Tuomilehto, Jaakko; Uusitupa, Matti		Finnish Diabet Prevention Study	Variations in the Ghrelin Receptor Gene Associate with Obesity and Glucose Metabolism in Individuals with Impaired Glucose Tolerance	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HORMONE SECRETAGOGUE RECEPTOR; BODY-MASS INDEX; BINDING PROTEIN; MESSENGER-RNA; LIFE-STYLE; FTO GENE; FAT MASS; TRANSCRIPTION; EXPRESSION	Background: Ghrelin may influence the development of obesity through its role in the control of energy balance, food intake, and regulation of body weight. The effects of ghrelin are mediated via the growth hormone secretagogue receptor (GHSR). Methodology/Principal Findings: We genotyped 7 single nucleotide polymorphisms (SNPs) in the GHSR gene and assessed the association between those SNPs and obesity and type 2 diabetes-related phenotypes from 507 middle-aged overweight persons with impaired glucose tolerance participating in the Finnish Diabetes Prevention Study (DPS). Additionally, we performed in silico screening of the 59-regulatory region of GHSR and evaluated SNPs disrupting putative transcription factor (TF) binding sites in vitro with gelshift assays to determine differences in protein binding between different alleles of SNPs. Rs9819506 in the promoter region of GHSR was associated with body weight (p=0.036); persons with rs9819506-AA genotype having the lowest body weight. Individuals with rs490683-CC genotype displayed highest weight loss in the whole study population (p=0.032). The false discovery rate for these results was,10%. Rs490683 and rs509035 were associated with several measures of glucose and insulin metabolism during the follow-up. Rs490683 may be a functional SNP, since gelshift experiments showed differential protein binding between the alleles, with higher binding to the G-allele. Rs490683-C may disrupt a putative binding site for the TF nuclear factor 1 (NF-1), thus rs4906863-GG genotype where the NF-1 site is intact may lead to a higher GHSR gene expression. Conclusion/Significance: Polymorphisms in the GHSR promoter may modify changes in body weight during long-term lifestyle intervention and affect ghrelin receptor signalling through modulation of GHSR gene expression.	[Mager, Ursula; Pulkkinen, Leena; Kolehmainen, Marjukka; Tolppanen, Anna-Maija; Uusitupa, Matti] Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, FIN-70211 Kuopio, Finland; [Degenhardt, Tatjana; Carlberg, Carsten] Univ Kuopio, Dept Biosci Biochem, FIN-70211 Kuopio, Finland; [Lindstrom, Jaana; Eriksson, Johan G.; Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabetes Unit, Helsinki, Finland; [Carlberg, Carsten] Univ Luxembourg, Life Sci Res Unit, Luxembourg, Luxembourg; [Eriksson, Johan G.; Tuomilehto, Jaakko] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, FIN-00014 Helsinki, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki, Finland	University of Eastern Finland; University of Eastern Finland; Finland National Institute for Health & Welfare; University of Luxembourg; University of Helsinki	Mager, U (corresponding author), Univ Kuopio, Dept Clin Nutr, Food & Hlth Res Ctr, FIN-70211 Kuopio, Finland.	ursula.mager@uku.fi	Carlberg, Carsten/C-9075-2011; Uusitupa, Matti Ilmari Julius/AAX-4929-2020	Carlberg, Carsten/0000-0003-2633-0684; Eriksson, Johan/0000-0002-2516-2060; Griebler, Ursula/0000-0002-9958-3714; Lindstrom, Jaana/0000-0001-9255-020X	Academy of Finland [209445, 40758, 117844, 38387, 46558]; EVO-fund of Kuopio University Hospital [5179, 5198, 5952, 5926]; Ministry of Education of Finland; Finnish Diabetes Foundation; Sigrid Juselius Foundation; Austrian Academy of Sciences; RTN NucSys of the European Union; Finnish Graduate School on Applied Bioscience; Yrjo Jahnsson Foundation	Academy of Finland(Academy of Finland); EVO-fund of Kuopio University Hospital; Ministry of Education of Finland; Finnish Diabetes Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Austrian Academy of Sciences; RTN NucSys of the European Union; Finnish Graduate School on Applied Bioscience; Yrjo Jahnsson Foundation	This work has been financially supported by grants from the Academy of Finland (number 209445 to MK, numbers 40758 and 117844 to MU; numbers 38387 and 46558 to JT), the EVO-fund of Kuopio University Hospital (numbers 5179, 5198, 5952 and 5926 to MU), the Ministry of Education of Finland, the Finnish Diabetes Foundation, Sigrid Juselius Foundation, the Austrian Academy of Sciences, the RTN NucSys of the European Union, the Finnish Graduate School on Applied Bioscience and the Yrjo Jahnsson Foundation.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baessler A, 2005, DIABETES, V54, P259, DOI 10.2337/diabetes.54.1.259; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BORGMEYER U, 1984, NUCLEIC ACIDS RES, V12, P4295, DOI 10.1093/nar/12.10.4295; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Dossus L, 2008, CARCINOGENESIS, V29, P1360, DOI 10.1093/carcin/bgn083; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Fox CS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hattori N, 2001, J CLIN ENDOCR METAB, V86, P4284, DOI 10.1210/jc.86.9.4284; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; JONES KA, 1987, CELL, V48, P79, DOI 10.1016/0092-8674(87)90358-8; Kim MS, 2003, NEUROREPORT, V14, P1317, DOI [10.1097/01.wnr.0000078703.79393.d2, 10.1097/00001756-200307180-00006]; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Vartiainen J, 2004, EUR J ENDOCRINOL, V150, P457, DOI 10.1530/eje.0.1500457; Wang HJ, 2004, J CLIN ENDOCR METAB, V89, P157, DOI 10.1210/jc.2003-031395; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; *WHO, 1985, WHO TECH REP SER, V727, pR1; Willesen MG, 1999, NEUROENDOCRINOLOGY, V70, P306, DOI 10.1159/000054491; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	42	24	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2941	10.1371/journal.pone.0002941	http://dx.doi.org/10.1371/journal.pone.0002941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698404	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600027
J	Krishnamoorthy, S				Krishnamoorthy, Srinivasan			Receptor Tyrosine Kinase (RTK) Mediated Tyrosine Phosphor- Proteome from Drosophila S2 (ErbB1) Cells Reveals Novel Signaling Networks	PLOS ONE			English	Article								Protein phosphorylation mediates many critical cellular responses and is essential for many biological functions during development. About one-third of cellular proteins are phosphorylated, representing the phosphor-proteome, and phosphorylation can alter a protein's function, activity, localization and stability. Tyrosine phosphorylation events mediated by aberrant activation of Receptor Tyrosine Kinase (RTK) pathways have been proven to be involved in the development of several diseases including cancer. To understand the systems biology of RTK activation, we have developed a phosphor-proteome focused on tyrosine phosphorylation events under insulin and EGF signaling pathways using the PhosphoScan (R) technique coupled with high-throughput mass spectrometry analysis. Comparative proteomic analyses of all these tyrosine phosphorylation events revealed that around 70% of these pY events are conserved in human orthologs and paralogs. A careful analysis of published in vivo tyrosine phosphorylation events from literature and patents revealed that around 38% of pY events from Drosophila proteins conserved on 185 human proteins are confirmed in vivo tyrosine phosphorylation events. Hence the data are validated partially based on available reports, and the credibility of the remaining 62% of novel conserved sites that are unpublished so far is very high but requires further follow-up studies. The novel pY events found in this study that are conserved on human proteins could potentially lead to the discovery of drug targets and biomarkers for the detection of various cancers and neurodegenerative diseases.	[Krishnamoorthy, Srinivasan] Harvard Univ, Sch Med, Dept Surg, Pediat Surg Res Labs,Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Krishnamoorthy, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Pediat Surg Res Labs,Massachusetts Gen Hosp, Boston, MA 02115 USA.	ksrini10@gmail.com			NIH [R01 GM-61707, P01-HD-39942, Project2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funding for supplies and chemicals used in this study was from grants from NIH R01 GM-61707 and P01-HD-39942, Project2. The author did not receive any salary for this work.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Chang YC, 2008, J PROTEOME RES, V7, P1055, DOI 10.1021/pr700801p; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Fishman MC, 2005, NATURE, V437, P491, DOI 10.1038/437491a; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haluska F, 2007, SEMIN ONCOL, V34, P546, DOI 10.1053/j.seminoncol.2007.09.011; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mason GF, 2006, DIABETES, V55, P929, DOI 10.2337/diabetes.55.04.06.db05-1325; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Nam NH, 2003, CURR DRUG TARGETS, V4, P159, DOI 10.2174/1389450033346966; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schiller JH, 2008, CANCER INVEST, V26, P81, DOI 10.1080/07357900701511847; Schumacher JA, 2007, J MOL DIAGN, V9, P169, DOI 10.2353/jmoldx.2007.060031; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088	19	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2877	10.1371/journal.pone.0002877	http://dx.doi.org/10.1371/journal.pone.0002877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682802	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600033
J	Zogopoulos, G; Jorgensen, C; Bacani, J; Montpetit, A; Lepage, P; Ferretti, V; Chad, L; Selvarajah, S; Zanke, B; Hudson, TJ; Pawson, T; Gallinger, S				Zogopoulos, George; Jorgensen, Claus; Bacani, Julinor; Montpetit, Alexandre; Lepage, Pierre; Ferretti, Vincent; Chad, Lauren; Selvarajah, Subani; Zanke, Brent; Hudson, Thomas J.; Pawson, Tony; Gallinger, Steven			Germline EPHB2 Receptor Variants in Familial Colorectal Cancer	PLOS ONE			English	Article								Familial clustering of colorectal cancer occurs in 15-20% of cases, however recognized cancer syndromes explain only a small fraction of this disease. Thus, the genetic basis for the majority of hereditary colorectal cancer remains unknown. EPHB2 has recently been implicated as a candidate tumor suppressor gene in colorectal cancer. The aim of this study was to evaluate the contribution of EPHB2 to hereditary colorectal cancer. We screened for germline EPHB2 sequence variants in 116 population-based familial colorectal cancer cases by DNA sequencing. We then estimated the population frequencies and characterized the biological activities of the EPHB2 variants identified. Three novel nonsynonymous missense alterations were detected. Two of these variants (A438T and G787R) result in significant residue changes, while the third leads to a conservative substitution in the carboxy-terminal SAM domain (V945I). The former two variants were found once in the 116 cases, while the V945I variant was present in 2 cases. Genotyping of additional patients with colorectal cancer and control subjects revealed that A438T and G787R represent rare EPHB2 alleles. In vitro functional studies show that the G787R substitution, located in the kinase domain, causes impaired receptor kinase activity and is therefore pathogenic, whereas the A438T variant retains its receptor function and likely represents a neutral polymorphism. Tumor tissue from the G787R variant case manifested loss of heterozygosity, with loss of the wild-type allele, supporting a tumor suppressor role for EPHB2 in rare colorectal cancer cases. Rare germline EPHB2 variants may contribute to a small fraction of hereditary colorectal cancer.	[Zogopoulos, George; Jorgensen, Claus; Bacani, Julinor; Selvarajah, Subani; Pawson, Tony; Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Zogopoulos, George; Gallinger, Steven] Mt Sinai Hosp, Dr Zane Cohen Digestive Dis Clin Res Ctr, Toronto, ON, Canada; [Montpetit, Alexandre; Lepage, Pierre; Ferretti, Vincent; Chad, Lauren] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Zanke, Brent; Hudson, Thomas J.; Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Zanke, Brent; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; McGill University; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Zogopoulos, G (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sgallinger@mtsinai.on.ca	Gallinger, Steven/E-4575-2013; Pawson, Tony J/E-4578-2013	Jorgensen, Claus/0000-0002-7841-943X	National Cancer Institute, National Institutes of Health [CA-96-011]; Colon Cancer Family Registry; Ontario Genomics Institute; Genome Quebec; Ministere du Developpement yconomique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; Society of University Surgeons; National Cancer Institute of Canada [Terry Fox Foundation Research Fellowship]; Burroughs Wellcome Fund [Clinician-Scientist Award in Translational Research]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Colon Cancer Family Registry; Ontario Genomics Institute; Genome Quebec; Ministere du Developpement yconomique et Regional et de la Recherche du Quebec; Ontario Institute for Cancer Research; Society of University Surgeons; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the National Cancer Institute, National Institutes of Health under RFA # CA-96-011 (to SG) and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating institutions or investigators in the Colon CFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the Colon CFR. Cancer Care Ontario, as the host organization to the ARCTIC Genome Project, acknowledges that this Project was partly funded by Genome Canada through the Ontario Genomics Institute, by Genome Quebec, the Ministere du Developpement yconomique et Regional et de la Recherche du Quebec and the Ontario Institute for Cancer Research. GZ is a Scholar of the Society of University Surgeons and a recipient of a Terry Fox Foundation Research Fellowship from the National Cancer Institute of Canada. TJH is a recipient of a Clinician-Scientist Award in Translational Research from the Burroughs Wellcome Fund.	Aasheim HC, 2005, BBA-GEN SUBJECTS, V1723, P1, DOI 10.1016/j.bbagen.2005.01.011; Alazzouzi H, 2005, CANCER RES, V65, P10170, DOI 10.1158/0008-5472.CAN-05-2580; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Cotterchio M, 2000, Chronic Dis Can, V21, P81; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; HENKEMEYER M, 1994, ONCOGENE, V9, P1001; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Kittles RA, 2006, J MED GENET, V43, P507, DOI 10.1136/jmg.2005.035790; Kokko A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-145; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; Oba SM, 2001, CANCER LETT, V164, P97, DOI 10.1016/S0304-3835(00)00716-3; OGUNBIYI OA, 1997, GASTROENTEROLOGY, V113, P76176; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; PRAML C, 1995, ONCOGENE, V11, P1357; Shitoh K, 2001, GENE CHROMOSOME CANC, V30, P32, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1065>3.0.CO;2-I; SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x; Sparks AB, 1998, CANCER RES, V58, P1130; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2	24	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2885	10.1371/journal.pone.0002885	http://dx.doi.org/10.1371/journal.pone.0002885			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682749	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600041
J	Andersson, AF; Lindberg, M; Jakobsson, H; Backhed, F; Nyren, P; Engstrand, L				Andersson, Anders F.; Lindberg, Mathilda; Jakobsson, Hedvig; Backhed, Fredrik; Nyren, Pal; Engstrand, Lars			Comparative Analysis of Human Gut Microbiota by Barcoded Pyrosequencing	PLOS ONE			English	Article								Humans host complex microbial communities believed to contribute to health maintenance and, when in imbalance, to the development of diseases. Determining the microbial composition in patients and healthy controls may thus provide novel therapeutic targets. For this purpose, high-throughput, cost-effective methods for microbiota characterization are needed. We have employed 454-pyrosequencing of a hyper-variable region of the 16S rRNA gene in combination with sample-specific barcode sequences which enables parallel in-depth analysis of hundreds of samples with limited sample processing. In silico modeling demonstrated that the method correctly describes microbial communities down to phylotypes below the genus level. Here we applied the technique to analyze microbial communities in throat, stomach and fecal samples. Our results demonstrate the applicability of barcoded pyrosequencing as a high-throughput method for comparative microbial ecology.	[Andersson, Anders F.; Lindberg, Mathilda; Jakobsson, Hedvig; Engstrand, Lars] Swedish Inst Infect Dis Control, Solna, Sweden; [Andersson, Anders F.] Uppsala Univ, BMC, Dept Ecol & Evolution, Limnol, Uppsala, Sweden; [Lindberg, Mathilda; Jakobsson, Hedvig; Engstrand, Lars] Karolinska Inst, Dept Microbiol, Cell & Tumor Biol, Stockholm, Sweden; [Backhed, Fredrik] Gothenburg Univ, Sahlgrenska Ctr Cardiovasc & Metabol Res, Wallenberg Lab, Gothenburg, Sweden; [Nyren, Pal] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden	Swedish Institute for Infectious Disease Control; Uppsala University; Karolinska Institutet; University of Gothenburg; Royal Institute of Technology	Andersson, AF (corresponding author), Swedish Inst Infect Dis Control, Solna, Sweden.	Lars.Engstrand@smi.ki.se	Backhed, Fredrik/ABE-6613-2020; Andersson, Anders/J-9310-2019; WU, TAKLON/A-2827-2010	Backhed, Fredrik/0000-0002-4871-8818; Andersson, Anders/0000-0002-3627-6899; 	Swedish Medical Research Council; Swedish Research Council; Swedish Cancer Foundation; Carl Tryggers Foundation; Knut and Alice Wallenberg Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Carl Tryggers Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by grants from the Swedish Medical Research Council, The Swedish Research Council, The Swedish Cancer Foundation, Carl Tryggers Foundation, and Knut and Alice Wallenberg Foundation (Metagenomic Sequencing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; CHAO A, 1984, SCAND J STAT, V11, P265; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; HAYEK LC, 1996, SURVEYING NATURAL PO; JAKOBSSON H, 2007, SCAND J INF IN PRESS; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; PACE NR, 1985, ASM NEWS, V51, P4; Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007; Palming J, 2006, BIOCHEM BIOPH RES CO, V343, P43, DOI 10.1016/j.bbrc.2006.02.114; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x; WOSTMANN BS, 1983, LAB ANIM SCI, V33, P46	37	726	771	2	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2836	10.1371/journal.pone.0002836	http://dx.doi.org/10.1371/journal.pone.0002836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665274	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300055
J	Arduini, BL; Gallagher, GR; Henion, PD				Arduini, Brigitte L.; Gallagher, Glen R.; Henion, Paul D.			Zebrafish Endzone Regulates Neural Crest-Derived Chromatophore Differentiation and Morphology	PLOS ONE			English	Article								The development of neural crest-derived pigment cells has been studied extensively as a model for cellular differentiation, disease and environmental adaptation. Neural crest-derived chromatophores in the zebrafish (Danio rerio) consist of three types: melanophores, xanthophores and iridiphores. We have identified the zebrafish mutant endzone (enz), that was isolated in a screen for mutants with neural crest development phenotypes, based on an abnormal melanophore pattern. We have found that although wild-type numbers of chromatophore precursors are generated in the first day of development and migrate normally in enz mutants, the numbers of all three chromatophore cell types that ultimately develop are reduced. Further, differentiated melanophores and xanthophores subsequently lose dendricity, and iridiphores are reduced in size. We demonstrate that enz function is required cell autonomously by melanophores and that the enz locus is located on chromosome 7. In addition, zebrafish enz appears to selectively regulate chromatophore development within the neural crest lineage since all other major derivatives develop normally. Our results suggest that enz is required relatively late in the development of all three embryonic chromatophore types and is normally necessary for terminal differentiation and the maintenance of cell size and morphology. Thus, although developmental regulation of different chromatophore sublineages in zebrafish is in part genetically distinct, enz provides an example of a common regulator of neural crest-derived chromatophore differentiation and morphology.	[Arduini, Brigitte L.; Gallagher, Glen R.; Henion, Paul D.] Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA; [Henion, Paul D.] Ohio State Univ, Dept Neurosci, Columbus, OH USA	Ohio State University; Ohio State University	Arduini, BL (corresponding author), Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA.	henion.1@osu.edu		Gallagher, Glen/0000-0001-6837-9473; Arduini, Brigitte/0000-0002-8587-3518	NIH [GM076505, P30-NS045758]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant GM076505 with additional support from NIH grant P30-NS045758.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; An M, 2002, J COMP NEUROL, V446, P267, DOI 10.1002/cne.10214; Arduini BL, 2004, MECH DEVELOP, V121, P1353, DOI 10.1016/j.mod.2004.06.006; Bagnara JT, 1973, CHROMATOPHORES COLOR; BAGNARA JT, 1998, COMP ANATOMY PHYSL P, P9; BAKER BI, 1986, GEN COMP ENDOCR, V63, P62, DOI 10.1016/0016-6480(86)90182-6; BARBER LD, 1987, GEN COMP ENDOCR, V65, P79, DOI 10.1016/0016-6480(87)90225-5; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bisgrove BW, 1997, J NEUROBIOL, V33, P749; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cornell RA, 2004, MECH DEVELOP, V121, P1365, DOI 10.1016/j.mod.2004.06.005; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; EPPERLEIN HH, 1990, ADV ANAT EMBRYOL CEL, V118, P1; Fukamachi S, 2004, P NATL ACAD SCI USA, V101, P10661, DOI 10.1073/pnas.0401278101; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; GREEN JA, 1991, J ENDOCRINOL, V128, P267, DOI 10.1677/joe.0.1280267; Halaban R, 2000, PIGM CELL RES, V13, P4, DOI 10.1034/j.1600-0749.2000.130103.x; Henion PD, 1996, DEV GENET, V18, P11; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Hogben LT, 1922, P R SOC LOND B-CONTA, V93, P318, DOI 10.1098/rspb.1922.0024; Honore SM, 2003, DEV BIOL, V260, P79, DOI 10.1016/S0012-1606(03)00247-1; Huber WE, 2003, J BIOL CHEM, V278, P45224, DOI 10.1074/jbc.M309036200; Jackson IJ, 1997, HUM MOL GENET, V6, P1613, DOI 10.1093/hmg/6.10.1613; JOHNSON SL, 1995, DEV BIOL, V167, P27, DOI 10.1006/dbio.1995.1004; Kawauchi H, 2004, PEPTIDES, V25, P1577, DOI 10.1016/j.peptides.2004.03.025; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kelsh RN, 2000, DEV BIOL, V225, P277, DOI 10.1006/dbio.2000.9840; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Knapik EW, 1996, DEVELOPMENT, V123, P451; Knight RD, 2003, DEVELOPMENT, V130, P5755, DOI 10.1242/dev.00575; Kumagai T, 1998, EXP ANIM TOKYO, V47, P265, DOI 10.1538/expanim.47.265; Lahav R, 2005, INT J DEV BIOL, V49, P173, DOI 10.1387/ijdb.041951rl; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Le Douarin N, 1999, NEURAL CREST, Vxxiii; Le Guyader S, 2002, PIGM CELL RES, V15, P27; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; LISTER J, 1858, PHILOS T ROY SOC LON, V148, P627; Lister JA, 2002, MICROSC RES TECHNIQ, V58, P435, DOI 10.1002/jemt.10161; Lister JA, 1999, DEVELOPMENT, V126, P3757; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; Nagatsu T, 1999, MOL NEUROBIOL, V19, P79, DOI 10.1007/BF02741379; Nakamura M, 2002, J DERMATOL SCI, V28, P1, DOI 10.1016/S0923-1811(01)00158-X; Nataf V, 1996, P NATL ACAD SCI USA, V93, P9645, DOI 10.1073/pnas.93.18.9645; Nechiporuk A, 1999, GENOME RES, V9, P1231, DOI 10.1101/gr.9.12.1231; NORDLUND JJ, 1998, PIGMENTARY SYSTEM PH, pR24; Odenthal J, 1996, DEVELOPMENT, V123, P391; ODONNELL JM, 1989, DEV GENET, V10, P273, DOI 10.1002/dvg.1020100316; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2003, DEV BIOL, V256, P221, DOI 10.1016/S0012-1606(03)00016-2; Parichy DM, 2003, DEVELOPMENT, V130, P817, DOI 10.1242/dev.00307; Parichy DM, 2000, DEVELOPMENT, V127, P3031; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; Pickart MA, 2004, PIGM CELL RES, V17, P461, DOI 10.1111/j.1600-0749.2004.00189.x; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Quigley IK, 2002, MICROSC RES TECHNIQ, V58, P442, DOI 10.1002/jemt.10162; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; Rawls JF, 2003, GENETICS, V163, P997; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; REAUME AG, 1991, GENETICS, V129, P1099; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; SILVERS W, 1979, COAT COLORS MICE MOD, pR14; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; STEEL KP, 1992, DEVELOPMENT, V115, P1111; STREISINGER G, 1986, GENETICS, V112, P311; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; WOOD JM, 1995, BIOCHEM BIOPH RES CO, V206, P480, DOI 10.1006/bbrc.1995.1068	78	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2845	10.1371/journal.pone.0002845	http://dx.doi.org/10.1371/journal.pone.0002845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665240	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300064
J	Locke, JB; Aziz, RK; Vicknair, MR; Nizet, V; Buchanan, JT				Locke, Jeffrey B.; Aziz, Ramy K.; Vicknair, Mike R.; Nizet, Victor; Buchanan, John T.			Streptococcus iniae M-Like Protein Contributes to Virulence in Fish and Is a Target for Live Attenuated Vaccine Development	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; GROUP-B STREPTOCOCCI; TROUT ONCORHYNCHUS-MYKISS; HYBRID STRIPED BASS; C5A PEPTIDASE; RAINBOW-TROUT; ANTIMICROBIAL PEPTIDE; COMPLEMENT-SYSTEM; AEROMONAS-SALMONICIDA; SURFACE-PROTEINS	Background: Streptococcus iniae is a significant pathogen in finfish aquaculture, though knowledge of virulence determinants is lacking. Through pyrosequencing of the S. iniae genome we have identified two gene homologues to classical surface-anchored streptococcal virulence factors: M-like protein (simA) and C5a peptidase (scpl). Methodology/Principal Findings: S. iniae possesses a Mga-like locus containing simA and a divergently transcribed putative mga-like regulatory gene, mgx. In contrast to the Mga locus of group A Streptococcus (GAS, S. pyogenes), scpl is located distally in the chromosome. Comparative sequence analysis of the Mgx locus revealed only one significant variant, a strain with an insertion frameshift mutation in simA and a deletion mutation in a region downstream of mgx, generating an ORF which may encode a second putative mga-like gene, mgx2. Allelic exchange mutagenesis of simA and scpl was employed to investigate the potential role of these genes in S. iniae virulence. Our hybrid striped bass (HSB) and zebrafish models of infection revealed that M-like protein contributes significantly to S. iniae pathogenesis whereas C5a peptidase-like protein does not. Further, in vitro cell-based analyses indicate that SiMA, like other M family proteins, contributes to cellular adherence and invasion and provides resistance to phagocytic killing. Attenuation in our virulence models was also observed in the S. iniae isolate possessing a natural simA mutation. Vaccination of HSB with the Delta simA mutant provided 100% protection against subsequent challenge with a lethal dose of wild-type (WT) S. iniae after 1,400 degree days, and shows promise as a target for live attenuated vaccine development. Conclusions/Significance: Analysis of M-like protein and C5a peptidase through allelic replacement revealed that M-like protein plays a significant role in S. iniae virulence, and the Mga-like locus, which may regulate expression of this gene, has an unusual arrangement. The M-like protein mutant created in this research holds promise as live-attenuated vaccine.	[Locke, Jeffrey B.; Nizet, Victor; Buchanan, John T.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Locke, Jeffrey B.; Nizet, Victor] Univ Calif San Diego, Scripps Inst Oceanography, Ctr Marine Biotechnol & Biomed, La Jolla, CA USA; [Aziz, Ramy K.] Cairo Univ, Fac Pharm, Dept Microbiol & Immunol, Cairo, Egypt; [Vicknair, Mike R.] Kent SeaTech Corp, San Diego, CA USA; [Nizet, Victor] Univ Califo San Diego, Skaggs Sch Pharm & Pharm Sci, La Jolla, CA USA; [Buchanan, John T.] Aqua Bounty Technol, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; Egyptian Knowledge Bank (EKB); Cairo University; University of California System; University of California San Diego	Locke, JB (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	jtbuchanan@gmail.com	Nizet, Victor/AAF-3190-2019; Aziz, Ramy/B-2918-2009	Nizet, Victor/0000-0003-3847-0422; Aziz, Ramy/0000-0002-4448-7100	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration [NA04OAR4170038]; California Sea Grant College Program [59-A-N]; California State Resources Agency; NIH [5 T32 GM067550]; USDA [2006-35600-16569]; Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER	National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); California Sea Grant College Program; California State Resources Agency; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This publication was supported in part by the National Sea Grant College Program of the U.S. Department of Commerce's National Oceanic and Atmospheric Administration under NOAA Grant #NA04OAR4170038, project #59-A-N, through the California Sea Grant College Program; and in part by the California State Resources Agency. The views expressed herein do not necessarily reflect the views of any of those organizations. Additional funding was provided by the NIH Training Program in Marine Biotechnology grant #5 T32 GM067550. The DNA sequence of S. iniae strain 9117 was supported by USDA grant #2006-35600-16569 at the Baylor College of Medicine Human Genome Sequencing Center (BCM-HGSC).	Agnew W, 2007, VET MICROBIOL, V122, P1, DOI 10.1016/j.vetmic.2007.03.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baiano JCF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-67; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boshra H, 2006, FISH SHELLFISH IMMUN, V20, P239, DOI 10.1016/j.fsi.2005.04.004; Boshra H, 2004, FISH SHELLFISH IMMUN, V17, P293, DOI 10.1016/j.fsi.2004.04.002; Boshra H, 2004, J IMMUNOL, V172, P4381, DOI 10.4049/jimmunol.172.7.4381; Buchanan JT, 2005, INFECT IMMUN, V73, P6935, DOI 10.1128/IAI.73.10.6935-6944.2005; BUCHANAN JT, 2008, VET MICROBI IN PRESS; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chaffin DO, 2000, J BACTERIOL, V182, P4466, DOI 10.1128/JB.182.16.4466-4477.2000; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; CLEARY PP, 1992, INFECT IMMUN, V60, P5219, DOI 10.1128/IAI.60.12.5219-5223.1992; COURTNEY HS, 1992, MICROB PATHOGENESIS, V12, P199, DOI 10.1016/0882-4010(92)90054-R; Dale JB, 2008, ADV EXP MED BIOL, V609, P53, DOI 10.1007/978-0-387-73960-1_5; DALE JB, 1985, J EXP MED, V162, P583, DOI 10.1084/jem.162.2.583; ELLEN RP, 1972, INFECT IMMUN, V5, P826, DOI 10.1128/IAI.5.5.826-830.1972; Eyngor M, 2007, FEMS MICROBIOL LETT, V277, P238, DOI 10.1111/j.1574-6968.2007.00973.x; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Felsenstein J, 1997, SYST BIOL, V46, P101, DOI 10.2307/2413638; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; FISCHETTI VA, 1977, J INFECT DIS, V136, pS222, DOI 10.1093/infdis/136.Supplement.S222; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; Franken C, 2001, MOL MICROBIOL, V41, P925, DOI 10.1046/j.1365-2958.2001.02563.x; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; Fuller JD, 2001, INFECT IMMUN, V69, P1994, DOI 10.1128/IAI.69.4.1994-2000.2001; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Geyer A, 2000, MOL GEN GENET, V262, P965, DOI 10.1007/PL00008665; HEATH DG, 1989, P NATL ACAD SCI USA, V86, P4741, DOI 10.1073/pnas.86.12.4741; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HILL HR, 1988, J IMMUNOL, V141, P3551; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Holland MCH, 2004, J IMMUNOL, V172, P349, DOI 10.4049/jimmunol.172.1.349; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Husmann LK, 1997, INFECT IMMUN, V65, P1422, DOI 10.1128/IAI.65.4.1422-1430.1997; Jadoun J, 1997, ADV EXP MED BIOL, V418, P511; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Karlyshev AV, 2000, BIOTECHNIQUES, V28, P1078, DOI 10.2144/00286bm05; LANCEFIELD RC, 1962, J IMMUNOL, V89, P307; LARSEN SA, 1970, APPL MICROBIOL, V20, P40, DOI 10.1128/AEM.20.1.40-45.1970; Lau SKP, 2003, J CLIN MICROBIOL, V41, P1004, DOI 10.1128/JCM.41.3.1004-1009.2003; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lawrence ML, 1997, INFECT IMMUN, V65, P4642, DOI 10.1128/IAI.65.11.4642-4651.1997; Locke JB, 2007, DIS AQUAT ORGAN, V76, P17, DOI 10.3354/dao076017; Locke JB, 2007, J BACTERIOL, V189, P1279, DOI 10.1128/JB.01175-06; Lowe BA, 2007, INFECT IMMUN, V75, P1255, DOI 10.1128/IAI.01484-06; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marsden MJ, 1996, INFECT IMMUN, V64, P3863, DOI 10.1128/IAI.64.9.3863-3869.1996; Marsden MJ, 1998, VACCINE, V16, P1087, DOI 10.1016/S0264-410X(98)80103-5; MASSELL BF, 1969, J AMER MED ASSOC, V207, P1115, DOI 10.1001/jama.207.6.1115; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Moshynskyy I, 2003, MICROB PATHOGENESIS, V35, P203, DOI 10.1016/S0882-4010(03)00150-5; NAKANO Y, 1995, GENE, V162, P157, DOI 10.1016/0378-1119(95)00320-6; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; NONAKA M, 1981, J IMMUNOL, V126, P1495; Nonaka M, 2000, FISH SHELLFISH IMMUN, V10, P215, DOI 10.1006/fsim.1999.0252; OCONNOR SP, 1987, J INFECT DIS, V156, P495, DOI 10.1093/infdis/156.3.495; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pahlman LI, 2006, J IMMUNOL, V177, P1221, DOI 10.4049/jimmunol.177.2.1221; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Phelps HA, 2005, ZEBRAFISH, V2, P87, DOI 10.1089/zeb.2005.2.87; PHILLIPS GN, 1981, P NATL ACAD SCI-BIOL, V78, P4689, DOI 10.1073/pnas.78.8.4689; PIER GB, 1976, INT J SYST BACTERIOL, V26, P545, DOI 10.1099/00207713-26-4-545; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Purushothaman SS, 2004, INDIAN J MED RES, V119, P44; RELF WA, 1994, GENE, V144, P25, DOI 10.1016/0378-1119(94)90198-8; Russo R, 2006, AQUACULTURE, V256, P105, DOI 10.1016/j.aquaculture.2006.02.046; Salonius K, 2005, DEV BIOLOGICALS, V121, P189; Shimizu C, 2003, IN VITRO CELL DEV-AN, V39, P29; Shoemaker CA, 2001, AM J VET RES, V62, P174, DOI 10.2460/ajvr.2001.62.174; SIMPSON WJ, 1990, J BACTERIOL, V172, P696, DOI 10.1128/jb.172.2.696-700.1990; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; STOLLERMAN GH, 1991, CLIN IMMUNOL IMMUNOP, V61, P131, DOI 10.1016/S0090-1229(05)80019-4; Subramaniam S, 1998, PROTEINS, V32, P1; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THORNTON JC, 1991, MICROB PATHOGENESIS, V11, P85, DOI 10.1016/0882-4010(91)90002-R; Timoney JF, 1997, INFECT IMMUN, V65, P3600, DOI 10.1128/IAI.65.9.3600-3605.1997; Vahling CM, 2006, J BACTERIOL, V188, P863, DOI 10.1128/JB.188.3.863-873.2006; Vasi J, 2000, INFECT IMMUN, V68, P294, DOI 10.1128/IAI.68.1.294-302.2000; Vivas J, 2004, FISH SHELLFISH IMMUN, V16, P193, DOI 10.1016/S1050-4648(03)00078-0; Wang HL, 2002, BIOTECHNIQUES, V33, P26, DOI 10.2144/02331bm02; Weinstein MR, 1997, NEW ENGL J MED, V337, P589, DOI 10.1056/NEJM199708283370902; WEXLER DE, 1985, P NATL ACAD SCI USA, V82, P8144, DOI 10.1073/pnas.82.23.8144; WHITNACK E, 1985, J EXP MED, V162, P1983, DOI 10.1084/jem.162.6.1983; ZABRISKIE JB, 1966, J EXP MED, V124, P661, DOI 10.1084/jem.124.4.661; Zlotkin A, 2003, INFECT IMMUN, V71, P2318, DOI 10.1128/IAI.71.5.2318-2325.2003	101	70	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2824	10.1371/journal.pone.0002824	http://dx.doi.org/10.1371/journal.pone.0002824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665241	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300043
J	Hiss, JA; Resch, E; Schreiner, A; Meissner, M; Starzinski-Powitz, A; Schneider, G				Hiss, Jan A.; Resch, Eduard; Schreiner, Alexander; Meissner, Michael; Starzinski-Powitz, Anna; Schneider, Gisbert			Domain Organization of Long Signal Peptides of Single-Pass Integral Membrane Proteins Reveals Multiple Functional Capacity	PLOS ONE			English	Article								Targeting signals direct proteins to their extra - or intracellular destination such as the plasma membrane or cellular organelles. Here we investigated the structure and function of exceptionally long signal peptides encompassing at least 40 amino acid residues. We discovered a two-domain organization ("NtraC model") in many long signals from vertebrate precursor proteins. Accordingly, long signal peptides may contain an N-terminal domain (N-domain) and a C-terminal domain (C-domain) with different signal or targeting capabilities, separable by a presumably turn-rich transition area (tra). Individual domain functions were probed by cellular targeting experiments with fusion proteins containing parts of the long signal peptide of human membrane protein shrew-1 and secreted alkaline phosphatase as a reporter protein. As predicted, the N-domain of the fusion protein alone was shown to act as a mitochondrial targeting signal, whereas the C-domain alone functions as an export signal. Selective disruption of the transition area in the signal peptide impairs the export efficiency of the reporter protein. Altogether, the results of cellular targeting studies provide a proof-of-principle for our NtraC model and highlight the particular functional importance of the predicted transition area, which critically affects the rate of protein export. In conclusion, the NtraC approach enables the systematic detection and prediction of cryptic targeting signals present in one coherent sequence, and provides a structurally motivated basis for decoding the functional complexity of long protein targeting signals.	[Hiss, Jan A.; Resch, Eduard; Schreiner, Alexander; Meissner, Michael; Starzinski-Powitz, Anna; Schneider, Gisbert] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Proteom, Frankfurt, Germany	Goethe University Frankfurt	Hiss, JA (corresponding author), Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, Ctr Membrane Proteom, Frankfurt, Germany.	g.schneider@modlab.de		Hiss, Jan Alexander/0000-0003-0559-4330; Schneider, Gisbert/0000-0001-6706-1084; Resch, Eduard/0000-0002-7685-6388	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University; Frankfurt am Main; Sonderforschungsbereich 579 [A11.2]; Sonderforschungsbereich 628 [p7]; Deutsche Forschungsgemeinschaft Sta [187/16-1]	Beilstein-Institut zur Forderung der Chemischen Wissenschaften; Centre for Membrane Proteomics at Goethe-University; Frankfurt am Main; Sonderforschungsbereich 579; Sonderforschungsbereich 628; Deutsche Forschungsgemeinschaft Sta	This research was supported by the Beilstein-Institut zur Forderung der Chemischen Wissenschaften, the Centre for Membrane Proteomics at Goethe-University, Frankfurt am Main, the Sonderforschungsbereich 579 ("RNA-Ligand Interactions", project A11.2), the Sonderforschungsbereich 628 ("Functional Membrane Proteomics", project p7), and the Deutsche Forschungsgemeinschaft Sta 187/16-1.	Al-Qahtani A, 1998, BIOCHEM J, V331, P521, DOI 10.1042/bj3310521; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Bharti S, 2004, MOL BIOL CELL, V15, P397, DOI 10.1091/mbc.E03-05-0281; Blobel G, 2000, BIOSCIENCE REP, V20, P303, DOI 10.1023/A:1010318832604; Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, BIOCHEM BIOPH RES CO, V357, P633, DOI 10.1016/j.bbrc.2007.03.162; Dultz E, 2008, J BIOL CHEM, V283, P9966, DOI 10.1074/jbc.M705712200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Feng ZP, 2001, BIOPOLYMERS, V58, P491, DOI 10.1002/1097-0282(20010415)58:5<491::AID-BIP1024>3.0.CO;2-I; Foulquier F, 2002, BIOCHEM J, V362, P491, DOI 10.1042/0264-6021:3620491; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; GRAY L, 1989, J CELL SCI, P45; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; IZARD JW, 1994, MOL MICROBIOL, V13, P765, DOI 10.1111/j.1365-2958.1994.tb00469.x; Jakob V, 2006, MOL BIOL CELL, V17, P3397, DOI 10.1091/mbc.E05-11-1034; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MEISSNER M, 2008, PROTEINS IN PRESS; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ouzzine M, 1999, J BIOL CHEM, V274, P31401, DOI 10.1074/jbc.274.44.31401; RAMANUJAN S, 2006, BIOCH SCI, V31, P563; RESCH E, 2008, TRAFFIC IN PRESS; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Schneider G, 2004, PROTEOMICS, V4, P1571, DOI 10.1002/pmic.200300786; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Szabady RL, 2005, P NATL ACAD SCI USA, V102, P221, DOI 10.1073/pnas.0406055102; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tamura T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-466; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1994, SIGNAL PEPTIDASES; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEIDMANN M, 1984, NATURE, V309, P637, DOI 10.1038/309637a0; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yuan Z, 2004, J COMPUT CHEM, V25, P632, DOI 10.1002/jcc.10411	45	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2767	10.1371/journal.pone.0002767	http://dx.doi.org/10.1371/journal.pone.0002767			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648515	Green Published, Green Submitted, gold			2022-12-27	WOS:000264302900037
J	Tang, JW; Ngai, KLK; Lam, WY; Chan, PKS				Tang, Julian W.; Ngai, Karry L. K.; Lam, Wai Y.; Chan, Paul K. S.			Seasonality of Influenza A(H3N2) Virus: A Hong Kong Perspective (1997-2006)	PLOS ONE			English	Article							A H3N2; EVOLUTION; DYNAMICS; REVEALS; EPIDEMIOLOGY; PATTERNS; MODEL	Background: The underlying basis for the seasonality of influenza A viruses is still uncertain. Phylogenetic studies investigated this phenomenon but have lacked sequences from more subtropical and tropical regions, particularly from Southeast Asia. Methodology/Principal Findings: 281 complete hemagglutinin (HA) and neuraminidase (NA) sequences were obtained from influenza A(H3N2) viruses, collected over 10 years (1997-2006) from Hong Kong. These dated sequences were analyzed with influenza A(H3N2) vaccine strain sequences (Syd/5/97, Mos/10/99, Fuj/411/02, Cal/7/04) and 315 other publicly available dated sequences from elsewhere, worldwide. In addition, the NA sequence alignment was inspected for the presence of any naturally occurring, known, neuraminidase inhibitor (NAI) resistance-associated amino acid mutations (R292K and E119V). Before 2001, the Hong Kong HA and NA sequences clustered more closely with the older vaccine sequences (Syd/5/97, Mos/10/99) than did sequences from elsewhere. After 2001, this trend reversed with significant clusters containing HA and NA sequences from different locations, isolated at different times, suggesting that viral migration may account for much of the influenza A(H3N2) seasonality during this 10-year period. However, at least one example from Hong Kong was found suggesting that in some years, influenza A(H3N2) viruses may persist in the same location, perhaps continuing to circulate, sub-clinically, at low levels between seasons, to re-emerge in the influenza season the following year, relatively unchanged. None of these Hong Kong influenza A(H3N2) NA sequences contained any of the known NAI-resistance associated mutations. Conclusions/Significance: The seasonality of influenza A(H3N2) may be largely due to global migration, with similar viruses appearing in different countries at different times. However, occasionally, some viruses may remain within a single location and continue to circulate within that population, to re-emerge during the next influenza season, with relatively little genetic change. Naturally occurring NAI resistance mutations were absent or, at least, very rare in this population.	[Tang, Julian W.; Ngai, Karry L. K.; Lam, Wai Y.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Stanley Ho Ctr Emerging Infect Dis, Hong Kong Special Adm Region, Shatin, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Tang, JW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China.	jwtang49@hotmail.com	Chan, Paul KS/J-9360-2013; , Julian W Tang/H-2348-2014	Chan, Paul KS/0000-0002-6360-4608; Tang, Julian/0000-0002-4963-1028	Chinese University of Hong Kong [2041215]	Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded in part by a Direct Grant from The Chinese University of Hong Kong to JWT (Project Code: 2041215). The study sponsors had no influence in the study design, data collection, analysis or interpretation, the writing of the paper and the decision to submit this work for publication.	*AM COLL EP, 2000, ETH GUID I; Andreasen V, 2003, J MATH BIOL, V46, P504, DOI 10.1007/s00285-002-0186-2; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Boni MF, 2006, P ROY SOC B-BIOL SCI, V273, P1307, DOI 10.1098/rspb.2006.3466; Boni MF, 2004, THEOR POPUL BIOL, V65, P179, DOI 10.1016/j.tpb.2003.10.002; Casagrandi R, 2006, MATH BIOSCI, V200, P152, DOI 10.1016/j.mbs.2005.12.029; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; HAMMOND GW, 1989, REV INFECT DIS, V11, P494; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Russell KL, 2005, VACCINE, V23, P1981, DOI 10.1016/j.vaccine.2004.10.023; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; SHORTRIDGE KF, 1982, LANCET, V2, P812; Smith DJ, 2006, SCIENCE, V312, P392, DOI 10.1126/science.1122665; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stone L, 2007, NATURE, V446, P533, DOI 10.1038/nature05638; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tippmann HF, 2004, BRIEF BIOINFORM, V5, P82, DOI 10.1093/bib/5.1.82; van Nimwegen E, 2006, SCIENCE, V314, P1884, DOI 10.1126/science.1137300; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121	38	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2768	10.1371/journal.pone.0002768	http://dx.doi.org/10.1371/journal.pone.0002768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648550	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900038
J	Dash, RK; Li, YJ; Kim, J; Beard, DA; Saidel, GM; Cabrera, ME				Dash, Ranjan K.; Li, Yanjun; Kim, Jaeyeon; Beard, Daniel A.; Saidel, Gerald M.; Cabrera, Marco E.			Metabolic Dynamics in Skeletal Muscle during Acute Reduction in Blood Flow and Oxygen Supply to Mitochondria: In-Silico Studies Using a Multi-Scale, Top-Down Integrated Model	PLOS ONE			English	Article							TRICARBOXYLIC-ACID CYCLE; OXIDATIVE-PHOSPHORYLATION; PROLONGED EXERCISE; GLYCOGEN-PHOSPHORYLASE; CIRCULATORY OCCLUSION; COMPUTATIONAL MODEL; ENERGY-METABOLISM; POOL SIZE; LACTATE; GLYCOLYSIS	Control mechanisms of cellular metabolism and energetics in skeletal muscle that may become evident in response to physiological stresses such as reduction in blood flow and oxygen supply to mitochondria can be quantitatively understood using a multi-scale computational model. The analysis of dynamic responses from such a model can provide insights into mechanisms of metabolic regulation that may not be evident from experimental studies. For the purpose, a physiologically-based, multi-scale computational model of skeletal muscle cellular metabolism and energetics was developed to describe dynamic responses of key chemical species and reaction fluxes to muscle ischemia. The model, which incorporates key transport and metabolic processes and subcellular compartmentalization, is based on dynamic mass balances of 30 chemical species in both capillary blood and tissue cells (cytosol and mitochondria) domains. The reaction fluxes in cytosol and mitochondria are expressed in terms of a general phenomenological Michaelis-Menten equation involving the compartmentalized energy controller ratios ATP/ADP and NADH/NAD(+). The unknown transport and reaction parameters in the model are estimated simultaneously by minimizing the differences between available in vivo experimental data on muscle ischemia and corresponding model outputs in coupled with the resting linear flux balance constraints using a robust, nonlinear, constrained-based, reduced gradient optimization algorithm. With the optimal parameter values, the model is able to simulate dynamic responses to reduced blood flow and oxygen supply to mitochondria associated with muscle ischemia of several key metabolite concentrations and metabolic fluxes in the subcellular cytosolic and mitochondrial compartments, some that can be measured and others that can not be measured with the current experimental techniques. The model can be applied to test complex hypotheses involving dynamic regulation of cellular metabolism and energetics in skeletal muscle during physiological stresses such as ischemia, hypoxia, and exercise.	[Dash, Ranjan K.; Li, Yanjun; Kim, Jaeyeon; Saidel, Gerald M.; Cabrera, Marco E.] Case Western Reserve Univ, Ctr Modeling Integrat Metabol Syst, Cleveland, OH USA; [Li, Yanjun; Kim, Jaeyeon; Saidel, Gerald M.; Cabrera, Marco E.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH USA; [Cabrera, Marco E.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH USA; [Dash, Ranjan K.; Cabrera, Marco E.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH USA; [Beard, Daniel A.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI USA; [Beard, Daniel A.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Medical College of Wisconsin; Medical College of Wisconsin	Dash, RK (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	mec6@cwru.edu		Saidel, Gerald/0000-0003-2159-2343	National Aeronautics and Space Administration [NNJ06HD81G]; National Institute of General Medical Sciences of the National Institute of Health [GM-66309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM066309] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); National Institute of General Medical Sciences of the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work presented in this manuscript was supported by grants from the National Aeronautics and Space Administration (NASA Johnson Space Center-NNJ06HD81G) and the National Institute of General Medical Sciences of the National Institute of Health (GM-66309). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; Ainscow EK, 1999, EUR J BIOCHEM, V266, P737, DOI 10.1046/j.1432-1327.1999.00856.x; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE633, DOI 10.1152/ajpendo.00239.2004; Beard DA, 2002, BIOPHYS J, V83, P79, DOI 10.1016/S0006-3495(02)75150-3; BEARD DA, 2008, MICROCIRCULATION, V1; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Blomstrand E, 1999, J PHYSIOL-LONDON, V514, P293, DOI 10.1111/j.1469-7793.1999.293af.x; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Brand MD, 1996, J THEOR BIOL, V182, P351, DOI 10.1006/jtbi.1996.0174; Cabrera ME, 1998, PROG BIOPHYS MOL BIO, V69, P539, DOI 10.1016/S0079-6107(98)00024-8; Cabrera ME, 1998, ANN BIOMED ENG, V26, P1, DOI 10.1114/1.28; Cabrera ME, 1999, AM J PHYSIOL-REG I, V277, pR1522, DOI 10.1152/ajpregu.1999.277.5.R1522; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V345, P167, DOI 10.1113/jphysiol.1983.sp014972; Dash RK, 2008, IEEE T BIO-MED ENG, V55, P1298, DOI 10.1109/TBME.2007.913422; Dash RK, 2007, BIOMED ENG ONLINE, V6, DOI 10.1186/1475-925X-6-14; Dash RK, 2006, ANN BIOMED ENG, V34, P1129, DOI 10.1007/s10439-005-9066-4; Dash RK, 2004, ANN BIOMED ENG, V32, P1676, DOI 10.1007/s10439-004-7821-6; FELL D, 1996, UNDERSTANDING CONTRO; Gibala MJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE235; Gibala MJ, 2002, J PHYSIOL-LONDON, V545, P705, DOI 10.1113/jphysiol.2002.028084; GREEN HJ, 1995, J APPL PHYSIOL, V78, P138, DOI 10.1152/jappl.1995.78.1.138; GUTIERREZ G, 1988, J APPL PHYSIOL, V65, P608, DOI 10.1152/jappl.1988.65.2.608; Howarth KR, 2004, J APPL PHYSIOL, V97, P579, DOI 10.1152/japplphysiol.01344.2003; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; KATZ A, 1988, AM J PHYSIOL, V255, pC140, DOI 10.1152/ajpcell.1988.255.2.C140; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Koonen DPY, 2005, BBA-MOL CELL BIOL L, V1736, P163, DOI 10.1016/j.bbalip.2005.08.018; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Korzeniewski B, 2004, BIOPHYS CHEM, V110, P147, DOI 10.1016/j.bpc.2004.01.011; Kushmerick MJ, 1998, COMP BIOCHEM PHYS B, V120, P109, DOI 10.1016/S0305-0491(98)00026-1; Lai N, 2006, EUR J APPL PHYSIOL, V97, P380, DOI 10.1007/s00421-006-0176-y; LAI N, 2007, ANN BIOMED ENG; Lambeth MJ, 2002, ANN BIOMED ENG, V30, P808, DOI 10.1114/1.1492813; Lasdon L. S., 1978, ACM Transactions on Mathematical Software, V4, P34, DOI 10.1145/355769.355773; Nelson DL, 2000, LEHNINGER PRINCIPLES; Parolin ML, 2000, AM J PHYSIOL-ENDOC M, V278, pE522, DOI 10.1152/ajpendo.2000.278.3.E522; Phillips SM, 1996, AM J PHYSIOL-ENDOC M, V270, pE265, DOI 10.1152/ajpendo.1996.270.2.E265; Putman CT, 1998, AM J PHYSIOL-ENDOC M, V275, pE132, DOI 10.1152/ajpendo.1998.275.1.E132; Radegran G, 1999, J APPL PHYSIOL, V87, P2375, DOI 10.1152/jappl.1999.87.6.2375; RADHAKRISHNAN K, 1993, RP1327 NASA; Ray CA, 1998, J APPL PHYSIOL, V85, P1194, DOI 10.1152/jappl.1998.85.3.1194; SAHLIN K, 1987, BIOCHEM J, V245, P551, DOI 10.1042/bj2450551; SAHLIN K, 1990, AM J PHYSIOL, V259, pC834, DOI 10.1152/ajpcell.1990.259.5.C834; Sahlin K., 2004, PRINCIPLES EXERCISE, P87; Segel IH., 1993, ENZYME KINETICS BEHA; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Timmons JA, 1996, AM J PHYSIOL-ENDOC M, V270, pE400, DOI 10.1152/ajpendo.1996.270.3.E400; TURCOTTE LP, 1992, AM J PHYSIOL, V262, pE791; van Hall G, 2002, J PHYSIOL-LONDON, V543, P1047, DOI 10.1113/jphysiol.2002.023796; Vinnakota K, 2006, BIOPHYS J, V91, P1264, DOI 10.1529/biophysj.105.073296; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Zhou LF, 2005, J PHYSIOL-LONDON, V569, P925, DOI 10.1113/jphysiol.2005.093146; Zhou LF, 2005, AM J PHYSIOL-HEART C, V288, pH2400, DOI 10.1152/ajpheart.01030.2004; Zhou LF, 2006, AM J PHYSIOL-HEART C, V291, pH1036, DOI 10.1152/ajpheart.01382.2005	59	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3168	10.1371/journal.pone.0003168	http://dx.doi.org/10.1371/journal.pone.0003168			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779864	Green Submitted, gold, Green Published			2022-12-27	WOS:000264425100004
J	Hossain, MJ; Hickman, D; Perez, DR				Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.			Evidence of Expanded Host Range and Mammalian-Associated Genetic Changes in a Duck H9N2 Influenza Virus Following Adaptation in Quail and Chickens	PLOS ONE			English	Article							A VIRUSES; HUMAN INFECTION; AVIAN H9N2; HONG-KONG; MOLECULAR CHARACTERIZATION; POULTRY; TRANSMISSION; REPLICATION; EVOLUTION; HEMAGGLUTININ	H9N2 avian influenza viruses continue to circulate worldwide; in Asia, H9N2 viruses have caused disease outbreaks and established lineages in land-based poultry. Some H9N2 strains are considered potentially pandemic because they have infected humans causing mild respiratory disease. In addition, some of these H9N2 strains replicate efficiently in mice without prior adaptation suggesting that H9N2 strains are expanding their host range. In order to understand the molecular basis of the interspecies transmission of H9N2 viruses, we adapted in the laboratory a wildtype duck H9N2 virus, influenza A/duck/Hong Kong/702/79 (WT702) virus, in quail and chickens through serial lung passages. We carried out comparative analysis of the replication and transmission in quail and chickens of WT702 and the viruses obtained after 23 serial passages in quail (QA23) followed by 10 serial passages in chickens (QA23CkA10). Although the WT702 virus can replicate and transmit in quail, it replicates poorly and does not transmit in chickens. In contrast, the QA23CkA10 virus was very efficient at replicating and transmitting in quail and chickens. Nucleotide sequence analysis of the QA23 and QA23CkA10 viruses compared to the WT702 virus indicated several nucleotide substitutions resulting in amino acid changes within the surface and internal proteins. In addition, a 21-amino acid deletion was found in the stalk of the NA protein of the QA23 virus and was maintained without further modification in the QA23CkA10 adapted virus. More importantly, both the QA23 and the QA23CkA10 viruses, unlike the WT702 virus, were able to readily infect mice, produce a large-plaque phenotype, showed faster replication kinetics in tissue culture, and resulted in the quick selection of the K627 amino acid mammalian-associated signature in PB2. These results are in agreement with the notion that adaptation of H9 viruses to land-based birds can lead to strains with expanded host range.	[Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.] Univ Maryland, Dept Vet Med, College Pk, MD USA; [Hossain, Md Jaber; Hickman, Danielle; Perez, Daniel R.] Virginia Maryland Region Coll Vet Med, College Pk, MD USA	University System of Maryland; University of Maryland College Park	Hossain, MJ (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Mol Virol & Vaccines Branch, Atlanta, GA 30333 USA.	dperez1@umd.edu	Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	NIAID-NIH [RO1AI052155, HHSN266200700010C]; USDA-CSREES [2005-05523]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052155] Funding Source: NIH RePORTER	NIAID-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); USDA-CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded in part from the following grants and contracts: NIAID-NIH RO1AI052155, USDA-CSREES 2005-05523, and NIAID-NIH HHSN266200700010C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; BEARE AS, 1991, ARCH VIROL, V119, P37, DOI 10.1007/BF01314321; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Kim JA, 2006, VET MICROBIOL, V118, P169, DOI 10.1016/j.vetmic.2006.07.007; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Lipatov AS, 2003, J VIROL, V77, P3816, DOI 10.1128/JVI.77.6.3816-3823.2003; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Mase M, 2005, VIROLOGY, V339, P101, DOI 10.1016/j.virol.2005.05.010; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; MURPHY BR, 1982, INFECT IMMUN, V37, P1119, DOI 10.1128/IAI.37.3.1119-1126.1982; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Nili H, 2003, AVIAN DIS, V47, P828, DOI 10.1637/0005-2086-47.s3.828; Ninomiya A, 2002, VET MICROBIOL, V88, P107, DOI 10.1016/S0378-1135(02)00105-0; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Perez DR, 2003, AVIAN DIS, V47, P1114, DOI 10.1637/0005-2086-47.s3.1114; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Shortridge K F, 1992, Semin Respir Infect, V7, P11; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Sorrell EM, 2007, AVIAN DIS, V51, P264, DOI 10.1637/7538-032906R.1; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Wan H, 2007, J VIROL, V81, P5181, DOI 10.1128/JVI.02827-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	52	104	111	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3170	10.1371/journal.pone.0003170	http://dx.doi.org/10.1371/journal.pone.0003170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JY	18779858	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425100006
J	Borlido, J; Veltri, G; Jackson, AP; Mills, IG				Borlido, Joana; Veltri, Greg; Jackson, Antony P.; Mills, Ian G.			Clathrin Is Spindle-Associated but Not Essential for Mitosis	PLOS ONE			English	Article								Background: Clathrin is a multimeric protein involved in vesicle coat assembly. Recently clathrin distribution was reported to change during the cell cycle and was found to associate with the mitotic spindle. Here we test whether the recruitment of clathrin to the spindle is indicative of a critical functional contribution to mitosis. Methodology/Principal Findings: Previously a chicken pre-B lymphoma cell line (DKO-R) was developed in which the endogenous clathrin heavy chain alleles were replaced with the human clathrin heavy chain under the control of a tetracycline-regulatable promoter. Receptor-mediated and fluid-phase endocytosis were significantly inhibited in this line following clathrin knockout, and we used this to explore the significance of clathrin heavy chain expression for cell cycle progression. We confirmed using confocal microscopy that clathrin colocalised with tubulin at mitotic spindles. Using a propidium iodide flow cytometric assay we found no statistical difference in the cell cycle distribution of the knockout cells versus the wild-type. Additionally, we showed that the ploidy and the recovery kinetics following cell cycle arrest with nocodazole were unchanged by repressing clathrin heavy chain expression. Conclusions/Significance: We conclude that the association of clathrin with the mitotic spindle and the contribution of clathrin to endocytosis are evolutionarily conserved. However we find that the contribution of clathrin to mitosis is less robust and dependent on cellular context. In other cell-lines silencing RNA has been used by others to knockdown clathrin expression resulting in an increase in the mitotic index of the cells. We show an effect on the G2/M phase population of clathrin knockdown in HEK293 cells but show that repressing clathrin expression in the DKO-R cell-line has no effect on the size of this population. Consequently this work highlights the need for a more detailed molecular understanding of the recruitment and function of clathrin at the spindle, since the localisation but not the impact of clathrin on mitosis appears to be robust in plants, mammalian and chicken B-cells.	[Borlido, Joana; Mills, Ian G.] Li Ka Shing Canc Res Ctr, Urooncol Res Grp, CRUK Cambridge Res Inst, Cambridge, England; [Veltri, Greg] Li Ka Shing Canc Res Ctr, CRUK Cambridge Res Inst, Flow Cytomet Core, Cambridge, England; [Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge, England	CRUK Cambridge Institute; CRUK Cambridge Institute; University of Cambridge	Borlido, J (corresponding author), Li Ka Shing Canc Res Ctr, Urooncol Res Grp, CRUK Cambridge Res Inst, Cambridge, England.	ian.mills@cancer.org.uk	Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083; Jackson, Antony Philip/0000-0002-2895-7387; Sarabando Borlido, Joana/0000-0003-2622-0901	EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship; CRUK; MRC [G0500966] Funding Source: UKRI; Medical Research Council [G0500966] Funding Source: researchfish	EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship(European Commission); CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JB is the recipient of an EU/Marie Curie Cancer Cure Early Stage Research Training (CANCURE) Fellowship. GV and IGM are supported by core CRUK funding.	ACTON SL, 1990, J CELL BIOL, V111, P1419, DOI 10.1083/jcb.111.4.1419; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Boucrot E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001477; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; CROWTHER RA, 1981, J CELL BIOL, V91, P790, DOI 10.1083/jcb.91.3.790; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Hawkins TE, 2002, P NATL ACAD SCI USA, V99, P8054, DOI 10.1073/pnas.132598099; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; KEEN JH, 1979, CELL, V16, P303, DOI 10.1016/0092-8674(79)90007-2; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Pearse B M, 1982, Cold Spring Harb Symp Quant Biol, V46 Pt 2, P703; PYPAERT M, 1991, J CELL BIOL, V114, P1159, DOI 10.1083/jcb.114.6.1159; Radulescu AE, 2007, MOL BIOL CELL, V18, P94, DOI 10.1091/mbc.E06-06-0532; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Tahara H, 2007, PROTOPLASMA, V230, P1, DOI 10.1007/s00709-006-0226-7; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Wettey FR, 2002, SCIENCE, V297, P1521, DOI 10.1126/science.1074222; Wettey Frank R, 2006, Subcell Biochem, V40, P119	25	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3115	10.1371/journal.pone.0003115	http://dx.doi.org/10.1371/journal.pone.0003115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769625	gold, Green Published, Green Submitted			2022-12-27	WOS:000264418300007
J	Hase, K; Takahashi, D; Ebisawa, M; Kawano, S; Itoh, K; Ohno, H				Hase, Koji; Takahashi, Daisuke; Ebisawa, Masashi; Kawano, Sayaka; Itoh, Kikuji; Ohno, Hiroshi			Activation-Induced Cytidine Deaminase Deficiency Causes Organ-Specific Autoimmune Disease	PLOS ONE			English	Article								Activation-induced cytidine deaminase (AID) expressed by germinal center B cells is a central regulator of somatic hypermutation (SHM) and class switch recombination (CSR). Humans with AID mutations develop not only the autosomal recessive form of hyper-IgM syndrome (HIGM2) associated with B cell hyperplasia, but also autoimmune disorders by unknown mechanisms. We report here that AID(-/-) mice spontaneously develop tertiary lymphoid organs (TLOs) in non-lymphoid tissues including the stomach at around 6 months of age. At a later stage, AID(-/-) mice develop a severe gastritis characterized by loss of gastric glands and epithelial hyperplasia. The disease development was not attenuated even under germ-free (GF) conditions. Gastric autoantigen -specific serum IgM was elevated in AID(-/-) mice, and the serum levels correlated with the gastritis pathological score. Adoptive transfer experiments suggest that autoimmune CD4(+) T cells mediate gastritis development as terminal effector cells. These results suggest that abnormal B-cell expansion due to AID deficiency can drive B-cell autoimmunity, and in turn promote TLO formation, which ultimately leads to the propagation of organ-specific autoimmune effector CD4(+) T cells. Thus, AID plays an important role in the containment of autoimmune diseases by negative regulation of autoreactive B cells.	[Hase, Koji; Takahashi, Daisuke; Ebisawa, Masashi; Kawano, Sayaka; Ohno, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Kanagawa, Japan; [Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Kanagawa, Japan; [Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	RIKEN; Yokohama City University; University of Tokyo	Hase, K (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Kanagawa, Japan.	ohno@rcai.riken.jp	Takahashi, Daisuke/C-3799-2019; Ohno, Hiroshi/L-7899-2014	Takahashi, Daisuke/0000-0001-8624-1160; Ohno, Hiroshi/0000-0001-8776-9661; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan [Grants-in-Aid]; Uehara Memorial Foundation; The Japan Science Society [Sasakawa Scientific Research]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); The Japan Science Society	This study was supported in part by Grants-in-Aid for Young Scientists (B) (K H), Scientific Research (B) (HO), and Scientific Research in Priority Areas (HO and KH) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Uehara Memorial Foundation (KH) and the Sasakawa Scientific Research Grant from The Japan Science Society (KH).	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; FUKUMA K, 1988, GASTROENTEROLOGY, V94, P274, DOI 10.1016/0016-5085(88)90413-1; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Itoh K, 2000, J EXP MED, V192, P1151, DOI 10.1084/jem.192.8.1151; Katakai T, 2003, J IMMUNOL, V171, P4359, DOI 10.4049/jimmunol.171.8.4359; Kendall PL, 2007, J IMMUNOL, V178, P5643, DOI 10.4049/jimmunol.178.9.5643; KOJIMA A, 1980, LAB INVEST, V42, P387; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Murakami T, 2007, BLOOD, V110, P1215, DOI 10.1182/blood-2007-01-068387; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Narushima Seiko, 1999, Microbial Ecology in Health and Disease, V11, P55, DOI 10.1080/089106099435934; Nemazee D, 1996, IMMUNOL TODAY, V17, P25, DOI 10.1016/0167-5699(96)80565-2; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Quartier P, 2004, CLIN IMMUNOL, V110, P22, DOI 10.1016/j.clim.2003.10.007; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shi KR, 2001, J IMMUNOL, V166, P650, DOI 10.4049/jimmunol.166.1.650; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; STRICKLAND RG, 1973, AM J DIG DIS, V18, P426, DOI 10.1007/BF01071995; Suzuki K, 2004, P NATL ACAD SCI USA, V101, P1981, DOI 10.1073/pnas.0307317101; Takai T, 1996, NATURE, V379, P346, DOI 10.1038/379346a0; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; WOTHERSPOON AC, 1993, LANCET, V342, P575, DOI 10.1016/0140-6736(93)91409-F; Yan J, 2006, J IMMUNOL, V177, P4481, DOI 10.4049/jimmunol.177.7.4481; Zhang ZX, 2001, ARTHRITIS RHEUM, V44, P2275, DOI 10.1002/1529-0131(200110)44:10<2275::AID-ART390>3.0.CO;2-K	36	48	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3033	10.1371/journal.pone.0003033	http://dx.doi.org/10.1371/journal.pone.0003033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716662	gold, Green Published, Green Submitted			2022-12-27	WOS:000264426800010
J	Kong, QP; Salas, A; Sun, C; Fuku, N; Tanaka, M; Zhong, L; Wang, CY; Yao, YG; Bandelt, HJ				Kong, Qing-Peng; Salas, Antonio; Sun, Chang; Fuku, Noriyuki; Tanaka, Masashi; Zhong, Li; Wang, Cheng-Ye; Yao, Yong-Gang; Bandelt, Hans-Juergen			Distilling Artificial Recombinants from Large Sets of Complete mtDNA Genomes	PLOS ONE			English	Article							MACROHAPLOGROUP-M; DNA-SEQUENCE; MITOCHONDRIAL; PHYLOGENY; LINEAGES; ERRORS; IDENTIFICATION; MUTATION; PHANTOM; SINGLE	Background: Large-scale genome sequencing poses enormous problems to the logistics of laboratory work and data handling. When numerous fragments of different genomes are PCR amplified and sequenced in a laboratory, there is a high immanent risk of sample confusion. For genetic markers, such as mitochondrial DNA ( mtDNA), which are free of natural recombination, single instances of sample mix-up involving different branches of the mtDNA phylogeny would give rise to reticulate patterns and should therefore be detectable. Methodology/Principal Findings: We have developed a strategy for comparing new complete mtDNA genomes, one by one, to a current skeleton of the worldwide mtDNA phylogeny. The mutations distinguishing the reference sequence from a putative recombinant sequence can then be allocated to two or more different branches of this phylogenetic skeleton. Thus, one would search for two ( or three) near-matches in the total mtDNA database that together best explain the variation seen in the recombinants. The evolutionary pathway from the mtDNA tree connecting this pair together with the recombinant then generate a grid-like median network, from which one can read off the exchanged segments. Conclusions: We have applied this procedure to a large collection of complete human mtDNA sequences, where several recombinants could be distilled by our method. All these recombinant sequences were subsequently corrected by de novo experiments - fully concordant with the predictions from our data-analytical approach.	[Kong, Qing-Peng; Sun, Chang; Wang, Cheng-Ye; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Kong, Qing-Peng; Zhong, Li] Yunnan Univ, Laboratory for Conservat & Utilizat Bio Resource, Kunming, Peoples R China; [Salas, Antonio] Univ Santiago Compostela, Fac Med, Inst Med Legal, Unidade Xenet, Galicia, Spain; [Fuku, Noriyuki; Tanaka, Masashi] Tokyo Metropolitan Inst Gerontol, Dept Genom Longevity & Hlth, Tokyo, Japan; [Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mechanisms, Beijing 100864, Peoples R China; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Universidade de Santiago de Compostela; Tokyo Metropolitan Institute of Gerontology; Chinese Academy of Sciences; Kunming Institute of Zoology; University of Hamburg	Kong, QP (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China.	bandelt@math.uni-hamburg.de	Zhong, Li/GZM-4358-2022; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019; Sun, Chang/I-6326-2012; Yao, Yong-Gang/AAH-2303-2021	Zhong, Li/0000-0003-1611-5171; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Yao, Yong-Gang/0000-0002-2955-0693; Fuku, Noriyuki/0000-0001-7792-5835	National Basic Research Program of China [2007CB507405]; Light in Western China" of the Chinese Academy of Sciences	National Basic Research Program of China(National Basic Research Program of China); Light in Western China" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by grants from National Basic Research Program of China (No. 2007CB507405) and "Light in Western China" of the Chinese Academy of Sciences (to Q-PK). Y-GY was supported by the Chinese Academy of Sciences.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P47; Bandelt HJ, 2007, BIOCHEM BIOPH RES CO, V352, P283, DOI 10.1016/j.bbrc.2006.10.131; Bandelt HJ, 2007, MOL PHYLOGENET EVOL, V42, P256, DOI 10.1016/j.ympev.2006.07.013; Bandelt HJ, 2006, NUCL ACID M, V18, P117; Bandelt HJ, 2005, REGNUM VEG, V143, P245; Bandelt HJ, 2006, ANN HUM GENET, V70, P314, DOI 10.1111/j.1469-1809.2005.00234.x; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Bandelt HJ, 2005, J MED GENET, V42, P957, DOI 10.1136/jmg.2005.033589; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 2005, BIOCHEM BIOPH RES CO, V333, P122, DOI 10.1016/j.bbrc.2005.04.055; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2003, ANN HUM GENET, V67, P512, DOI 10.1046/j.1469-1809.2003.00049.x; Bandelt HJ, 2001, INT J LEGAL MED, V115, P64, DOI 10.1007/s004140100228; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Bandelt HJ, 2002, AM J HUM GENET, V71, P1150, DOI 10.1086/344397; Bandelt HJ, 2004, RECHTSMEDIZIN, V14, P251; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Brandstatter A, 2005, ELECTROPHORESIS, V26, P3414, DOI 10.1002/elps.200500307; Brandstatter A, 2003, INT J LEGAL MED, V117, P180, DOI 10.1007/s00414-002-0350-7; Budowle V, 2004, J FORENSIC SCI, V49, P1256; Chinnery PF, 2003, J NEUROL NEUROSUR PS, V74, P1188, DOI 10.1136/jnnp.74.9.1188; Coble MD, 2004, INT J LEGAL MED, V118, P137, DOI 10.1007/s00414-004-0427-6; Elson JL, 2006, TRENDS GENET, V22, P603, DOI 10.1016/j.tig.2006.09.004; Furey TS, 2004, GENOME RES, V14, P2034, DOI 10.1101/gr.2467904; Gajer P, 2004, NUCLEIC ACIDS RES, V32, P562, DOI 10.1093/nar/gkh216; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2004, J HUM GENET, V49, P414, DOI 10.1007/s10038-004-0170-3; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Monson K.L., 2002, FORENSIC SCI COMMUN, V4, P2; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; POLANSKEY D, 2005, FORENSIC SCI COMMUN, V7, P1; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Salas A, 2007, FORENSIC SCI INT, V168, P1, DOI 10.1016/j.forsciint.2006.05.037; Salas A, 2005, PLOS MED, V2, P1158, DOI 10.1371/journal.pmed.0020296; Salas A, 2005, BIOCHEM BIOPH RES CO, V335, P891, DOI 10.1016/j.bbrc.2005.07.161; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tanaka M, 1996, Methods Enzymol, V264, P407, DOI 10.1016/S0076-6879(96)64037-3; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Tsaousis AD, 2005, MOL BIOL EVOL, V22, P925, DOI 10.1093/molbev/msi084; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Yao YG, 2004, FORENSIC SCI INT, V141, P1, DOI 10.1016/j.forsciint.2003.12.004; Yao YG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000681; Young WY, 2006, AM J MED GENET A, V140A, P2188, DOI 10.1002/ajmg.a.31434	55	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3016	10.1371/journal.pone.0003016	http://dx.doi.org/10.1371/journal.pone.0003016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714389	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900040
J	Schutte, M; Elstrodt, F; Bralten, LBC; Nagel, JHA; Duijm, E; Hollestelle, A; Vuerhard, MJ; Wasielewski, M; Peeters, JK; van der Spek, P; Smitt, PAS; French, PJ				Schutte, Mieke; Elstrodt, Fons; Bralten, Linda B. C.; Nagel, Jord H. A.; Duijm, Elza; Hollestelle, Antoinette; Vuerhard, Maartje J.; Wasielewski, Marijke; Peeters, Justine K.; van der Spek, Peter; Smitt, Peter A. Sillevis; French, Pim J.			Exon Expression Arrays as a Tool to Identify New Cancer Genes	PLOS ONE			English	Article								Background: Identification of genes that are causally implicated in oncogenesis is a major goal in cancer research. An estimated 10-20% of cancer-related gene mutations result in skipping of one or more exons in the encoded transcripts. Here we report on a strategy to screen in a global fashion for such exon-skipping events using PAttern based Correlation (PAC). The PAC algorithm has been used previously to identify differentially expressed splice variants between two predefined subgroups. As genetic changes in cancer are sample specific, we tested the ability of PAC to identify aberrantly expressed exons in single samples. Principal Findings: As a proof-of-principle, we tested the PAC strategy on human cancer samples of which the complete coding sequence of eight cancer genes had been screened for mutations. PAC detected all seven exon-skipping mutants among 12 cancer cell lines. PAC also identified exon- skipping mutants in clinical cancer specimens although detection was compromised due to heterogeneous (wild-type) transcript expression. PAC reduced the number of candidate genes/exons for subsequent mutational analysis by two to three orders of magnitude and had a substantial true positive rate. Importantly, of 112 randomly selected outlier exons, sequence analysis identified two novel exon skipping events, two novel base changes and 21 previously reported base changes (SNPs). Conclusions: The ability of PAC to enrich for mutated transcripts and to identify known and novel genetic changes confirms its suitability as a strategy to identify candidate cancer genes.	[Schutte, Mieke; Elstrodt, Fons; Nagel, Jord H. A.; Hollestelle, Antoinette; Wasielewski, Marijke] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands; [Bralten, Linda B. C.; Duijm, Elza; Vuerhard, Maartje J.; Smitt, Peter A. Sillevis; French, Pim J.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Neurol, Rotterdam, Netherlands; [Peeters, Justine K.; van der Spek, Peter] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Bioinformat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Schutte, M (corresponding author), Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, Rotterdam, Netherlands.	a.schutte@erasmusmc.nl; p.french@erasmusmc.nl		French, Pim/0000-0002-0668-9529; Hollestelle, Antoinette/0000-0003-1166-1966	Susan G. Komen Breast Cancer Foundation [BCTR0601309]; Dutch Cancer Society Koningin Wilhelmina Fonds; DDHK [2002-2687]; Erasmus MC Mrace 2005	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); DDHK; Erasmus MC Mrace 2005	This work was supported by the Susan G. Komen Breast Cancer Foundation (BCTR0601309), the Dutch Cancer Society Koningin Wilhelmina Fonds, DDHK 2002-2687 and Erasmus MC Mrace 2005.	BECKER KF, 1994, CANCER RES, V54, P3845; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Frederick L, 2000, NEURO-ONCOLOGY, V2, P159, DOI 10.1093/neuonc/2.3.159; Frederick L, 2000, CANCER RES, V60, P1383; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hahn SA, 1996, SCIENCE, V271, P350, DOI 10.1126/science.271.5247.350; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Nishikawa Ryo, 2004, Brain Tumor Pathol, V21, P53, DOI 10.1007/BF02484510; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Su Gloria H, 2002, Hum Mutat, V19, P81, DOI 10.1002/humu.9002; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van de Wetering M, 2001, CANCER RES, V61, P278; Wasielewski M, 2006, BREAST CANCER RES TR, V99, P97, DOI 10.1007/s10549-006-9186-z	24	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3007	10.1371/journal.pone.0003007	http://dx.doi.org/10.1371/journal.pone.0003007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18688287	gold, Green Published			2022-12-27	WOS:000264420900032
J	Butchar, JP; Cremer, TJ; Clay, CD; Gavrilin, MA; Wewers, MD; Marsh, CB; Schlesinger, LS; Tridandapani, S				Butchar, Jonathan P.; Cremer, Thomas J.; Clay, Corey D.; Gavrilin, Mikhail A.; Wewers, Mark D.; Marsh, Clay B.; Schlesinger, Larry S.; Tridandapani, Susheela			Microarray Analysis of Human Monocytes Infected with Francisella tularensis Identifies New Targets of Host Response Subversion	PLOS ONE			English	Article								Francisella tularensis is a gram-negative facultative bacterium that causes the disease tularemia, even upon exposure to low numbers of bacteria. One critical characteristic of Francisella is its ability to dampen or subvert the host immune response. In order to help understand the mechanisms by which this occurs, we performed Affymetrix microarray analysis on transcripts from blood monocytes infected with the virulent Type A Schu S4 strain. Results showed that expression of several host response genes were reduced such as those associated with interferon signaling, Toll-like receptor signaling, autophagy and phagocytosis. When compared to microarrays from monocytes infected with the less virulent F. tularensis subsp. novicida, we found qualitative differences and also a general pattern of quantitatively reduced pro-inflammatory signaling pathway genes in the Schu S4 strain. Notably, the PI3K/Akt1 pathway appeared specifically down-regulated following Schu S4 infection and a concomitantly lower cytokine response was observed. This study identifies several new factors potentially important in host cell subversion by the virulent Type A F. tularensis that may serve as novel targets for drug discovery.	[Butchar, Jonathan P.; Gavrilin, Mikhail A.; Wewers, Mark D.; Marsh, Clay B.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Div Pulm & Crit Care, Columbus, OH 43210 USA; [Cremer, Thomas J.] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH USA; [Clay, Corey D.; Schlesinger, Larry S.] Ohio State Univ, Ctr Microb Interface Biol, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Div Pulm & Crit Care, Columbus, OH 43210 USA.	jon.butchar@osumc.edu	Wewers, Mark/AAB-6202-2021; Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011	Gavrilin, Mikhail/0000-0003-2003-768X	NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program [1-U54-AI-057153]; NIH [R01 AI059406, P01 CA095426]; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059406, U54AI057153] Funding Source: NIH RePORTER	NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored by the NIH/NIAID Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research (RCE) Program. The authors wish to acknowledge membership within and support from the Region V Great Lakes RCE (NIH award 1-U54-AI-057153). This work was also supported by NIH grants R01 AI059406 and P01 CA095426 to ST.	Andersson H, 2006, GENES IMMUN, V7, P503, DOI 10.1038/sj.gene.6364321; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Andersson H, 2006, J MED MICROBIOL, V55, P1023, DOI 10.1099/jmm.0.46553-0; ANTHONY LSD, 1989, MICROB PATHOGENESIS, V7, P421, DOI 10.1016/0882-4010(89)90022-3; Bosio CM, 2005, J IMMUNOL, V175, P6792, DOI 10.4049/jimmunol.175.10.6792; Butchar JP, 2007, J IMMUNOL, V178, P4445, DOI 10.4049/jimmunol.178.7.4445; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Cole LE, 2006, J IMMUNOL, V176, P6888, DOI 10.4049/jimmunol.176.11.6888; CONLAN J, 2008, MOL IMMUNOL; Dudoit S, 2003, BIOTECHNIQUES, P45; Duenas AI, 2006, INT IMMUNOL, V18, P785, DOI 10.1093/intimm/dxl015; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FORTIER AH, 1992, INFECT IMMUN, V60, P817, DOI 10.1128/IAI.60.3.817-825.1992; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golovliov I, 1996, FEMS IMMUNOL MED MIC, V13, P239, DOI 10.1111/j.1574-695X.1996.tb00244.x; GOLOVLIOV I, 1995, INFECT IMMUN, V63, P534, DOI 10.1128/IAI.63.2.534-538.1995; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; HUNTER S, 1993, EXP HEMATOL, V21, P1492; KARTTUNEN R, 1987, J CLIN MICROBIOL, V25, P1074, DOI 10.1128/JCM.25.6.1074-1078.1987; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; LEIBY DA, 1992, INFECT IMMUN, V60, P84, DOI 10.1128/IAI.60.1.84-89.1992; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; LOFGREN S, 1983, INFECT IMMUN, V39, P715; MALKOVA D, 1986, FOLIA PARASIT, V33, P87; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McLendon MK, 2006, ANNU REV MICROBIOL, V60, P167, DOI 10.1146/annurev.micro.60.080805.142126; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Nimmerjahn F, 2003, EUR J IMMUNOL, V33, P1250, DOI 10.1002/eji.200323730; Parsa KVL, 2006, PLOS PATHOG, V2, P681, DOI 10.1371/journal.ppat.0020071; PROCTOR RA, 1975, INFECT IMMUN, V11, P146, DOI 10.1128/IAI.11.1.146-151.1975; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Santic M, 2007, CELL MICROBIOL, V9, P2314, DOI 10.1111/j.1462-5822.2007.01021.x; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song MM, 1998, J BIOL CHEM, V273, P35056, DOI 10.1074/jbc.273.52.35056; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; SURCEL HM, 1991, INFECT IMMUN, V59, P1948, DOI 10.1128/IAI.59.6.1948-1953.1991; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; WOOLARD M, 2008, INFECT IMMUN; YAMAGATA M, 1994, GENE, V139, P223, DOI 10.1016/0378-1119(94)90760-9; Yang RB, 1998, NATURE, V395, P284, DOI 10.1038/26239; Zhao L, 2006, CHEM-ASIAN J, V1, P203, DOI 10.1002/asia.200600097	55	95	95	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2924	10.1371/journal.pone.0002924	http://dx.doi.org/10.1371/journal.pone.0002924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698339	gold, Green Published, Green Submitted			2022-12-27	WOS:000264412600010
J	Yang, SH; Peng, Q; Francisco, MS; Wang, YJ; Zeng, Q; Yang, CH				Yang, Shihui; Peng, Quan; Francisco, Michael San; Wang, Yongjun; Zeng, Quan; Yang, Ching-Hong			Type III Secretion System Genes of Dickeya dadantii 3937 Are Induced by Plant Phenolic Acids	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; ERWINIA-CHRYSANTHEMI; REGULATORY RNA; SALICYLIC-ACID; IMPROVED GFP; HRP GENES; EXPRESSION; VIRULENCE; HOST; DEFENSE	Background: Dickeya dadantii is a broad-host range phytopathogen. D. dadantii 3937 (Ech3937) possesses a type III secretion system (T3SS), a major virulence factor secretion system in many Gram-negative pathogens of plants and animals. In Ech3937, the T3SS is regulated by two major regulatory pathways, HrpX/HrpY-HrpS-HrpL and GacS/GacA-rsmB-RsmA pathways. Although the plant apoplast environment, low pH, low temperature, and absence of complex nitrogen sources in media have been associated with the induction of T3SS genes of phytobacteria, no specific inducer has yet been identified. Methodology/Principal Findings: In this work, we identified two novel plant phenolic compounds, o-coumaric acid (OCA) and t-cinnamic acid (TCA), that induced the expression of T3SS genes dspE (a T3SS effector), hrpA (a structural protein of the T3SS pilus), and hrpN (a T3SS harpin) in vitro. Assays by qRT-PCR showed higher amounts of mRNA of hrpL (a T3SS alternative sigma factor) and rsmB (an untranslated regulatory RNA), but not hrpS (a sigma(54)- enhancer binding protein) of Ech3937 when these two plant compounds were supplemented into minimal medium (MM). However, promoter activity assays using flow cytometry showed similar promoter activities of hrpN in rsmB mutant Ech148 grown in MM and MM supplemented with these phenolic compounds. Compared with MM alone, only slightly higher promoter activities of hrpL were observed in bacterial cells grown in MM supplemented with OCA/TCA. Conclusion/Significance: The induction of T3SS expression by OCA and TCA is moderated through the rsmB-RsmA pathway. This is the first report of plant phenolic compounds that induce the expression T3SS genes of plant pathogenic bacteria.	[Yang, Shihui; Peng, Quan; Wang, Yongjun; Zeng, Quan; Yang, Ching-Hong] Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI USA; [Francisco, Michael San] Texas Tech Univ, Dept Biol Sci, Lubbock, TX USA	University of Wisconsin System; University of Wisconsin Milwaukee; Texas Tech University System; Texas Tech University	Yang, SH (corresponding author), Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA.	chyang@uwm.edu	Yang, Shihui/AAE-4100-2020; YANG, SHIHUI/A-6526-2008	Yang, Shihui/0000-0002-9394-9148; YANG, SHIHUI/0000-0002-9394-9148; Wang, Yongjun/0000-0002-8488-3423	Research Growth Initiative of the University of Wisconsin-Milwaukee; National Science Foundation [EF-0332163]	Research Growth Initiative of the University of Wisconsin-Milwaukee; National Science Foundation(National Science Foundation (NSF))	This project is supported by grants from a Research Growth Initiative of the University of Wisconsin-Milwaukee and the National Science Foundation (award no. EF-0332163).	Aldon D, 2000, TRENDS MICROBIOL, V8, P489, DOI 10.1016/S0966-842X(00)01859-X; Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Alhenc-Gelas M, 2000, THROMB HAEMOSTASIS, V83, P86; ARLAT M, 1992, MOL PLANT MICROBE IN, V5, P187, DOI 10.1094/MPMI-5-187; Barabote RD, 2003, J BACTERIOL, V185, P5772, DOI 10.1128/JB.185.19.5772-5778.2003; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Bouhenni R, 2005, APPL ENVIRON MICROB, V71, P4935, DOI 10.1128/AEM.71.8.4935-4937.2005; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Chang JH, 2004, CURR OPIN MICROBIOL, V7, P11, DOI 10.1016/j.mib.2003.12.006; Chatterjee A, 2003, MOL PLANT MICROBE IN, V16, P1106, DOI 10.1094/MPMI.2003.16.12.1106; Chatterjee A, 2002, J BACTERIOL, V184, P4089, DOI 10.1128/JB.184.15.4089-4095.2002; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Cui Y, 1999, J BACTERIOL, V181, P6042, DOI 10.1128/JB.181.19.6042-6052.1999; Fagard M, 2007, MOL PLANT MICROBE IN, V20, P794, DOI 10.1094/MPMI-20-7-0794; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Ham JH, 2004, MOL PLANT MICROBE IN, V17, P184, DOI 10.1094/MPMI.2004.17.2.184; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Lopez-Solanilla E, 2001, MOL PLANT MICROBE IN, V14, P386, DOI 10.1094/MPMI.2001.14.3.386; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Miller WG, 1997, GENE, V191, P149, DOI 10.1016/S0378-1119(97)00051-6; Montesano M, 2005, MOL PLANT PATHOL, V6, P541, DOI [10.1111/j.1364-3703.2005.00305.x, 10.1111/J.1364-3703.2005.00305.X]; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Nasser W, 2005, MOL PLANT MICROBE IN, V18, P1205, DOI 10.1094/MPMI-18-1205; Park D, 2006, MOL MICROBIOL, V61, P1397, DOI 10.1111/j.1365-2958.2006.05320.x; Peng Q, 2006, MOL PLANT MICROBE IN, V19, P451, DOI 10.1094/MPMI-19-0451; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ravirala RS, 2007, MOL PLANT MICROBE IN, V20, P313, DOI 10.1094/MPMI-20-3-0313; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; YALPANI N, 1993, PLANT PHYSIOL, V103, P315, DOI 10.1104/pp.103.2.315; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999; Yang SH, 2008, MOL PLANT MICROBE IN, V21, P133, DOI 10.1094/MPMI-21-1-0133; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005	41	60	66	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2973	10.1371/journal.pone.0002973	http://dx.doi.org/10.1371/journal.pone.0002973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698421	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600057
J	Doroghazi, JR; Buckley, DH				Doroghazi, James R.; Buckley, Daniel H.			Evidence from GC-TRFLP that Bacterial Communities in Soil Are Lognormally Distributed	PLOS ONE			English	Article							SPECIES-ABUNDANCE; DIVERSITY; MODEL; DNA	The Species Abundance Distribution (SAD) is a fundamental property of ecological communities and the form and formation of SADs have been examined for a wide range of communities including those of microorganisms. Progress in understanding microbial SADs, however, has been limited by the remarkable diversity and vast size of microbial communities. As a result, few microbial systems have been sampled with sufficient depth to generate reliable estimates of the community SAD. We have used a novel approach to characterize the SAD of bacterial communities by coupling genomic DNA fractionation with analysis of terminal restriction fragment length polymorphisms (GC-TRFLP). Examination of a soil microbial community through GC-TRFLP revealed 731 bacterial operational taxonomic units (OTUs) that followed a lognormal distribution. To recover the same 731 OTUs through analysis of DNA sequence data is estimated to require analysis of 86,264 16S rRNA sequences. The approach is examined and validated through construction and analysis of simulated microbial communities in silico. Additional simulations performed to assess the potential effects of PCR bias show that biased amplification can cause a community whose distribution follows a power-law function to appear lognormally distributed. We also show that TRFLP analysis, in contrast to GC-TRFLP, is not able to effectively distinguish between competing SAD models. Our analysis supports use of the lognormal as the null distribution for studying the SAD of bacterial communities as for plant and animal communities.	[Doroghazi, James R.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Buckley, Daniel H.] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY USA	Cornell University; Cornell University	Doroghazi, JR (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA.	dhb28@cornell.edu	Buckley, Daniel H/B-8089-2008	Buckley, Daniel H/0000-0003-1654-2907	National Science Foundation [MCB-0447586]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation under award number MCB-0447586.	Buckley DH, 2007, APPL ENVIRON MICROB, V73, P3196, DOI 10.1128/AEM.02610-06; Buckley DH, 2007, APPL ENVIRON MICROB, V73, P3189, DOI 10.1128/AEM.02609-06; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Bunge J, 2006, SCIENCE, V313, DOI 10.1126/science.1126593; Cohan FM, 2006, PHILOS T R SOC B, V361, P1985, DOI 10.1098/rstb.2006.1918; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Curtis TP, 2006, PHILOS T R SOC B, V361, P2023, DOI 10.1098/rstb.2006.1921; Dewdney AK, 2000, BIOL BULL-US, V198, P152, DOI 10.2307/1542811; Dunbar J, 2002, APPL ENVIRON MICROB, V68, P3035, DOI 10.1128/AEM.68.6.3035-3045.2002; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Figuerola ELM, 2007, ENVIRON MICROBIOL, V9, P1780, DOI 10.1111/j.1462-2920.2007.01298.x; Frey JC, 2006, J MICROBIOL METH, V67, P9, DOI 10.1016/j.mimet.2006.02.011; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GANS J, 2006, SCIENCE, V313, P918; Gray JS, 2006, J ANIM ECOL, V75, P752, DOI 10.1111/j.1365-2656.2006.01095.x; Holben WE, 2004, APPL ENVIRON MICROB, V70, P2263, DOI 10.1128/AEM.70.4.2263-2270.2004; Hong SH, 2006, P NATL ACAD SCI USA, V103, P117, DOI 10.1073/pnas.0507245102; MACARTHUR R, 1960, AM NAT, V94, P25, DOI 10.1086/282106; Maina GG, 2000, CONSERV BIOL, V14, P1335, DOI 10.1046/j.1523-1739.2000.98510.x; May R.M., 1975, P81; McGill BJ, 2003, NATURE, V422, P881, DOI 10.1038/nature01583; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; Narang R, 2004, MICROB ECOL, V47, P396, DOI 10.1007/s00248-003-1026-7; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; R Development Core Team, 2006, R LANG ENV STAT COMP; Sambrook J., MOL CLONING LAB MANU; Schloss PD, 2006, PLOS COMPUT BIOL, V2, P786, DOI 10.1371/journal.pcbi.0020092; Sloan WT, 2007, MICROB ECOL, V53, P443, DOI 10.1007/s00248-006-9141-x; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Volkov I, 2006, SCIENCE, V313, DOI 10.1126/science.1121225; Woodcock S, 2007, FEMS MICROBIOL ECOL, V62, P171, DOI 10.1111/j.1574-6941.2007.00379.x	34	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2910	10.1371/journal.pone.0002910	http://dx.doi.org/10.1371/journal.pone.0002910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682841	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600066
J	Efroni, S; Carmel, L; Schaefer, CG; Buetow, KH				Efroni, Sol; Carmel, Liran; Schaefer, Carl G.; Buetow, Kenneth H.			Superposition of Transcriptional Behaviors Determines Gene State	PLOS ONE			English	Article								We introduce a novel technique to determine the expression state of a gene from quantitative information measuring its expression. Adopting a productive abstraction from current thinking in molecular biology, we consider two expression states for a gene-Up or Down. We determine this state by using a statistical model that assumes the data behaves as a combination of two biological distributions. Given a cohort of hybridizations, our algorithm predicts, for the single reading, the probability of each gene's being in an Up or a Down state in each hybridization. Using a series of publicly available gene expression data sets, we demonstrate that our algorithm outperforms the prevalent algorithm. We also show that our algorithm can be used in conjunction with expression adjustment techniques to produce a more biologically sound gene-state call. The technique we present here enables a routine update, where the continuously evolving expression level adjustments feed into gene-state calculations. The technique can be applied in almost any multi-sample gene expression experiment, and holds equal promise for protein abundance experiments.	[Efroni, Sol; Schaefer, Carl G.; Buetow, Kenneth H.] NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA; [Carmel, Liran] Natl Ctr Biotechnol Informat, Natl Lib Med, NIH, Bethesda, MD USA; [Buetow, Kenneth H.] NCI, Lab Populat Genet, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Efroni, S (corresponding author), NCI, Ctr Biomed Informat & Informat Technol, NIH, Rockville, MD USA.	buetowk@nih.gov	Efroni, Sol/I-6752-2012	Efroni, Sol/0000-0001-7927-6349	NATIONAL CANCER INSTITUTE [Z01BC011059, ZIABC011059] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BITTNER M, 2006, INT GENOMICS CONSORT; Boes T, 2005, METHOD INFORM MED, V44, P414; BOLSTAD B, 2007, RMAEXPRESS; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Duda R. O., 2001, PATTERN CLASSIFICATI, P654, DOI DOI 10.1007/S00357-007-0015-9; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; HOGG RV, 2005, INTRO MATH STAT, P704; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; IRIZARRY RA, 2007, AFFYCOMP, V2; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; LEE AH, 2007, BIOMETRICS, V63, P10; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Mayrose I, 2005, BIOINFORMATICS, V21, P151, DOI 10.1093/bioinformatics/bti1125; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Regev A, 2002, NATURE, V419, P343, DOI 10.1038/419343a	15	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2901	10.1371/journal.pone.0002901	http://dx.doi.org/10.1371/journal.pone.0002901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682855	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600057
J	Ueda, S; Kawamata, M; Teratani, T; Shimizu, T; Tamai, Y; Ogawa, H; Hayashi, K; Tsuda, H; Ochiya, T				Ueda, Shinobu; Kawamata, Masaki; Teratani, Takumi; Shimizu, Taku; Tamai, Yoshitaka; Ogawa, Hiromasa; Hayashi, Katsuyuki; Tsuda, Hiroyuki; Ochiya, Takahiro			Establishment of Rat Embryonic Stem Cells and Making of Chimera Rats	PLOS ONE			English	Article								The rat is a reference animal model for physiological studies and for the analysis of multigenic human diseases such as hypertension, diabetes, neurological disorders, and cancer. The rats have long been used in extensive chemical carcinogenesis studies. Thus, the rat embryonic stem (rES) cell is an important resource for the study of disease models. Attempts to derive ES cells from various mammals, including the rat, have not succeeded. Here we have established two independent rES cells from Wister rat blastocysts that have undifferentiated characters such as Nanog and Oct3/4 genes expression and they have stage-specific embryonic antigen (SSEA) -1, -3, -4, and TRA-1-81 expression. The cells were successfully cultured in an undifferentiated state and can be possible over 18 passages with maintaining more than 40% of normal karyotype. Their pluripotent potential was confirmed by the differentiation into derivatives of the endoderm, mesoderm, and ectoderm. Most importantly, the rES cells are capable of producing chimera rats. Therefore, we established pluripotent rES cell lines that are widely used to produce genetically modified experimental rats for study of human diseases.	[Ueda, Shinobu; Kawamata, Masaki; Teratani, Takumi; Ochiya, Takahiro] Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Tokyo 104, Japan; [Ueda, Shinobu] Waseda Univ, Comprehensive Res Org, Tokyo, Japan; [Shimizu, Taku; Tamai, Yoshitaka] BANYU, Tsukuba Res Inst, Tsukuba, Ibaraki, Japan; [Ogawa, Hiromasa] CLEA Japan Inc, Tokyo, Japan; [Hayashi, Katsuyuki] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Tsuda, Hiroyuki] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Toxicol, Nagoya, Aichi, Japan	National Cancer Center - Japan; Waseda University; Novartis; DNA Chip Research Inc.; Nagoya City University	Ochiya, T (corresponding author), Natl Canc Ctr, Res Inst, Sect Studies Metastasis, Tokyo 104, Japan.	tochiya@ncc.go.jp	Ochiya, Takahiro/AAH-7585-2019; Ogawa, Hiromasa/AAE-2865-2019	Kawamata, Masaki/0000-0002-2607-9672	Ministry of Health, Labour and Welfare of Japan [Grant-in-Aid]; Ministry of Education, Culture, Sports, Science and Technology [Grant-in-Aid]; Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan; Foundation for Promotion of Cancer Research [Research Resident Fellowships]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan; Foundation for Promotion of Cancer Research	This work is supported by a Grant-in-Aid for the Third-Term Comprehensive 10-Year Strategy for Cancer Control, Health Science Research Grants for Research on the Human Genome and Gene Therapy from the Ministry of Health, Labour and Welfare of Japan, a Grant-in-Aid for Scientific Research on Priority Areas Cancer from the Ministry of Education, Culture, Sports, Science and Technology, and the Program for Promotion of Fundamental Studies in Health Sciences of the Organization for Pharmaceutical Safety and Research of Japan. S.U. and M.K. were awardees of Research Resident Fellowships from the Foundation for Promotion of Cancer Research.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brenin D, 1997, TRANSPLANT P, V29, P1761, DOI 10.1016/S0041-1345(97)00046-8; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; DEFELICI M, 1982, EXP CELL RES, V142, P476, DOI 10.1016/0014-4827(82)90393-7; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FUJIWARA Y, 1994, P NATL ACAD SCI USA, V91, P12258, DOI 10.1073/pnas.91.25.12258; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; IANNACCONE PM, 1994, DEV BIOL, V163, P288, DOI 10.1006/dbio.1994.1146; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; KOMIYA T, 1995, BIOCHEM BIOPH RES CO, V207, P405, DOI 10.1006/bbrc.1995.1202; Liu X, 1997, DEV DYNAM, V209, P85; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Longo L, 1997, TRANSGENIC RES, V6, P321, DOI 10.1023/A:1018418914106; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OUHIBI N, 1995, MOL REPROD DEV, V40, P311, DOI 10.1002/mrd.1080400307; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Stranzinger GF, 1996, INT J EXP PATHOL, V77, P263; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Suzuki H, 1997, EXP ANIM TOKYO, V46, P17, DOI 10.1538/expanim.46.17; Takahama Y, 1998, ONCOGENE, V16, P3189, DOI 10.1038/sj.onc.1201826; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	34	58	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2800	10.1371/journal.pone.0002800	http://dx.doi.org/10.1371/journal.pone.0002800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665239	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300019
J	Zuin, A; Gabrielli, N; Calvo, IA; Garcia-Santamarina, S; Hoe, KL; Kim, DU; Park, HO; Hayles, J; Ayte, J; Hidalgo, E				Zuin, Alice; Gabrielli, Natalia; Calvo, Isabel A.; Garcia-Santamarina, Sarela; Hoe, Kwang-Lae; Kim, Dong Uk; Park, Han-Oh; Hayles, Jacqueline; Ayte, Jose; Hidalgo, Elena			Mitochondrial Dysfunction Increases Oxidative Stress and Decreases Chronological Life Span in Fission Yeast	PLOS ONE			English	Article								Background: Oxidative stress is a probable cause of aging and associated diseases. Reactive oxygen species (ROS) originate mainly from endogenous sources, namely the mitochondria. Methodology/Principal Findings: We analyzed the effect of aerobic metabolism on oxidative damage in Schizosaccharomyces pombe by global mapping of those genes that are required for growth on both respiratory-proficient media and hydrogen-peroxide-containing fermentable media. Out of a collection of approximately 2700 haploid yeast deletion mutants, 51 were sensitive to both conditions and 19 of these were related to mitochondrial function. Twelve deletion mutants lacked components of the electron transport chain. The growth defects of these mutants can be alleviated by the addition of antioxidants, which points to intrinsic oxidative stress as the origin of the phenotypes observed. These respiration-deficient mutants display elevated steady-state levels of ROS, probably due to enhanced electron leakage from their defective transport chains, which compromises the viability of chronologically-aged cells. Conclusion/Significance: Individual mitochondrial dysfunctions have often been described as the cause of diseases or aging, and our global characterization emphasizes the primacy of oxidative stress in the etiology of such processes.	[Zuin, Alice; Gabrielli, Natalia; Calvo, Isabel A.; Garcia-Santamarina, Sarela; Ayte, Jose; Hidalgo, Elena] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain; [Hoe, Kwang-Lae; Kim, Dong Uk] KRIBB, Pombe Deletion Project, Taejon, South Korea; [Park, Han-Oh] Bioneer Corp, Taejon, South Korea; [Hayles, Jacqueline] Canc Res UK, London, England	Pompeu Fabra University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cancer Research UK	Zuin, A (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona, Spain.	elena.hidalgo@upf.edu	Santamarina, Sarela Garcia/AAA-2261-2021; Garcia Santamarina, Sarela/O-4477-2017; Hidalgo, Elena/K-2919-2014; Ayte, Jose/L-5217-2014	Santamarina, Sarela Garcia/0000-0002-0611-7918; Garcia Santamarina, Sarela/0000-0002-0611-7918; Hidalgo, Elena/0000-0002-3768-6785; Ayte, Jose/0000-0002-6354-0536; Calvo Arnedo, Isabel/0000-0001-6619-4571; Hoe, Kwang Lae/0000-0002-3943-4549	Direccion General de Investigacion of Spain [BFU2006-02610]; Spanish program Consolider-Ingenio 2010 [CSD 2007-0020]	Direccion General de Investigacion of Spain(Spanish Government); Spanish program Consolider-Ingenio 2010	This work was supported by Direccion General de Investigacion of Spain Grant BFU2006-02610, and by the Spanish program Consolider-Ingenio 2010 Grant CSD 2007-0020 to E.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfa C, 1993, EXPT FISSION YEAST L; BRYLA J, 1969, BIOCHIM BIOPHYS ACTA, V189, P327; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P1, DOI 10.1007/BF02046695; BULDER CJE, 1964, ANTON VAN LEE J M S, V30, P442, DOI 10.1007/BF02046758; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P157, DOI 10.1099/00221287-44-2-157; deJongGubbels P, 1996, MICROBIOL-UK, V142, P1399, DOI 10.1099/13500872-142-6-1399; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; Giorgio M, 2007, NAT REV MOL CELL BIO, V8, p722A; GONZALEZFLECHA B, 1995, J BIOL CHEM, V270, P13681, DOI 10.1074/jbc.270.23.13681; HESLOT H, 1970, J BACTERIOL, V104, P473, DOI 10.1128/JB.104.1.473-481.1970; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Jara M, 2007, MOL BIOL CELL, V18, P2288, DOI 10.1091/mbc.E06-11-1039; Johnson FB, 1999, CELL, V96, P291, DOI 10.1016/S0092-8674(00)80567-X; Krishnan KJ, 2007, ANN NY ACAD SCI, V1100, P227, DOI 10.1196/annals.1395.024; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; POOLE RK, 1973, BIOCHEM J, V136, P195, DOI 10.1042/bj1360195; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Saiki R, 2003, EUR J BIOCHEM, V270, P4113, DOI 10.1046/j.1432-1033.2003.03804.x; SLATER EC, 1973, BIOCHIM BIOPHYS ACTA, V301, P129, DOI 10.1016/0304-4173(73)90002-5; Suzuki K, 1997, J BIOCHEM, V121, P496; Swerdlow RH, 2007, ANTIOXID REDOX SIGN, V9, P1591, DOI 10.1089/ars.2007.1676; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2005, P NATL ACAD SCI USA, V102, P8875, DOI 10.1073/pnas.0503251102; Zuin A, 2005, J BIOL CHEM, V280, P36708, DOI 10.1074/jbc.M508400200	36	65	67	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2842	10.1371/journal.pone.0002842	http://dx.doi.org/10.1371/journal.pone.0002842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665268	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300061
J	Galliano, MF; Toulza, E; Jonca, N; Gonias, SL; Serre, G; Guerrin, M				Galliano, Marie-Florence; Toulza, Eve; Jonca, Nathalie; Gonias, Steven L.; Serre, Guy; Guerrin, Marina			Binding of alpha 2ML1 to the Low Density Lipoprotein Receptor-Related Protein 1 (LRP1) Reveals a New Role for LRP1 in the Human Epidermis	PLOS ONE			English	Article								Background: The multifunctional receptor LRP1 has been shown to bind and internalize a large number of protein ligands with biological importance such as the pan-protease inhibitor alpha 2-macroglobulin (alpha 2M). We recently identified A2ML1, a new member of the alpha 2M gene family, expressed in epidermis. alpha 2ML1 might contribute to the regulation of desquamation through its inhibitory activity towards proteases of the chymotrypsin family, notably KLK7. The expression of LRP1 in epidermis as well as its ability to internalize alpha 2ML1 was investigated. Methods and Principal Findings: In human epidermis, LRP1 is mainly expressed within the granular layer of the epidermis, which gathers the most differentiated keratinocytes, as shown by immunohistochemistry and immunofluorescence using two different antibodies. By using various experimental approaches, we show that the receptor binding domain of alpha 2ML1 (RBDI) is specifically internalized into the macrophage-like cell line RAW and colocalizes with LRP1 upon internalization. Coimmunoprecipitation assays demonstrate that RBDl binds LRP1 at the cell surface. Addition of RAP, a universal inhibitor of ligand binding to LRP1, prevents RBDl binding at the cell surface as well as internalization into RAW cells. Silencing Lrp1 expression with specific siRNA strongly reduces RBDl internalization. Conclusions and Significance: Keratinocytes of the upper differentiated layers of epidermis express LRP1 as well as alpha 2ML1. Our study also reveals that alpha 2ML1 is a new ligand for LRP1. Our findings are consistent with endocytosis by LRP1 of complexes formed between alpha 2ML1 and proteases. LRP1 may thus control desquamation by regulating the biodisponibility of extracellular proteases.	[Galliano, Marie-Florence; Toulza, Eve; Jonca, Nathalie; Serre, Guy; Guerrin, Marina] CHU PURPAN, UMR UDEAR CNRS UPS 165, Toulouse, France; [Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA USA	CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Diego	Galliano, MF (corresponding author), CHU PURPAN, UMR UDEAR CNRS UPS 165, Toulouse, France.	mweber@udear.cnrs.fr	Jonca, Nathalie/AAX-3870-2020; Toulza, Eve/A-9919-2012	Jonca, Nathalie/0000-0003-3602-0102; Toulza, Eve/0000-0003-2049-2279	Centre National de la Recherche Scientifique; Toulouse III Paul Sabatier University	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Toulouse III Paul Sabatier University	This work was supported in part by grants from the "Centre National de la Recherche Scientifique" and the Toulouse III Paul Sabatier University.	Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arandjelovic S, 2007, J NEUROCHEM, V103, P694, DOI 10.1111/j.1471-4159.2007.04800.x; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Birkenmeier G, 1998, ARCH DERMATOL RES, V290, P561, DOI 10.1007/s004030050352; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Cai ML, 1998, PROTEIN SCI, V7, P2669, DOI 10.1002/pro.5560071221; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; FELDMAN SR, 1992, ACTA DERM-VENEREOL, V72, P331; Galliano MF, 2006, J BIOL CHEM, V281, P5780, DOI 10.1074/jbc.M508017200; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Grey A, 2004, MOL ENDOCRINOL, V18, P2268, DOI 10.1210/me.2003-0456; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Howard GC, 1996, J BIOL CHEM, V271, P14105, DOI 10.1074/jbc.271.24.14105; Huang W, 2000, J BIOL CHEM, V275, P1089, DOI 10.1074/jbc.275.2.1089; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KRISTENSEN T, 1990, FEBS LETT, V276, P151, DOI 10.1016/0014-5793(90)80530-V; LAMARRE J, 1991, LAB INVEST, V65, P3; LAMARRE J, 1993, J CLIN INVEST, V91, P1219, DOI 10.1172/JCI116283; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Rozen S, 2000, Methods Mol Biol, V132, P365; Simon M, 2001, J BIOL CHEM, V276, P20292, DOI 10.1074/jbc.M100201200; SOTTRUPJENSEN L, 1986, FEBS LETT, V205, P20, DOI 10.1016/0014-5793(86)80857-2; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; Verges M, 2004, J BIOL CHEM, V279, P9030, DOI 10.1074/jbc.M312908200; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Wu SM, 1998, J IMMUNOL, V161, P4356	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2729	10.1371/journal.pone.0002729	http://dx.doi.org/10.1371/journal.pone.0002729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648652	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900007
J	Hayman, DTS; Suu-Ire, R; Breed, AC; McEachern, JA; Wang, LF; Wood, JLN; Cunningham, AA				Hayman, David T. S.; Suu-Ire, Richard; Breed, Andrew C.; McEachern, Jennifer A.; Wang, Linfa; Wood, James L. N.; Cunningham, Andrew A.			Evidence of Henipavirus Infection in West African Fruit Bats	PLOS ONE			English	Article							NIPAH VIRUS; ENCEPHALITIS	Henipaviruses are emerging RNA viruses of fruit bat origin that can cause fatal encephalitis in man. Ghanaian fruit bats (megachiroptera) were tested for antibodies to henipaviruses. Using a Luminex multiplexed microsphere assay, antibodies were detected in sera of Eidolon helvum to both Nipah (39%, 95% confidence interval: 27-51%) and Hendra (22%, 95% CI: 11-33%) viruses. Virus neutralization tests further confirmed seropositivity for 30% (7/23) of Luminex positive serum samples. Our results indicate that henipavirus is present within West Africa.	[Hayman, David T. S.; Cunningham, Andrew A.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Hayman, David T. S.; Wood, James L. N.] Univ Cambridge, Cambridge Infect Dis Consortium, Cambridge, England; [Suu-Ire, Richard] Wildlife Div Forestry Commission, Accra, Ghana; [Breed, Andrew C.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia; [Breed, Andrew C.; McEachern, Jennifer A.; Wang, Linfa] Australian Biosecurity Cooperat Res Ctr, Geelong, Vic, Australia; [McEachern, Jennifer A.; Wang, Linfa] Australian Anim Hlth Lab, CSIRO Livestock Industries, Geelong, Vic, Australia	Zoological Society of London; University of Cambridge; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hayman, DTS (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	A.Cunningham@ioz.ac.uk	Breed, Andrew C/A-5682-2011; wang, lin/HHM-2225-2022; wang, lin/GSE-3040-2022; Wood, James/A-1626-2008; Cunningham, Andrew A/E-7536-2010; Barr, Jennifer A/H-9254-2013	Breed, Andrew C/0000-0002-3439-9510; Wood, James/0000-0002-0258-3188; Wang, Lin-Fa/0000-0003-2752-0535; Barr, Jennifer/0000-0001-5266-9142; Hayman, David/0000-0003-0087-3015	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge	Institute of Zoology, Zoological Society of London; Cambridge Infectious Diseases Consortium, University of Cambridge(University of Cambridge)	This work was funded by the Institute of Zoology, Zoological Society of London and the Cambridge Infectious Diseases Consortium, University of Cambridge. Personnel (AAC, JLNW & DTSH) from both funding organisations conceived of, and conducted, the work and wrote the manuscript.	Alvarez Y, 1999, MOL BIOL EVOL, V16, P1061, DOI 10.1093/oxfordjournals.molbev.a026195; ANDERSON R M, 1991; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bossart KN, 2005, J VIROL, V79, P6690, DOI 10.1128/JVI.79.11.6690-6702.2005; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; DEFREES SL, 1988, MAMMAL SPECIES, V312, P1, DOI DOI 10.2307/3504095; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Rosevear D., 1965, BATS W AFRICA; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; THRUSFIELD MT, 1997, VET EPIDEMIOLOGY	17	158	163	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2739	10.1371/journal.pone.0002739	http://dx.doi.org/10.1371/journal.pone.0002739			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648649	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900010
J	Noorlander, CW; Ververs, FFT; Nikkels, PGJ; van Echteld, CJA; Visser, GHA; Smidt, MP				Noorlander, Cornelle W.; Ververs, Frederique F. T.; Nikkels, Peter G. J.; van Echteld, Cees J. A.; Visser, Gerard H. A.; Smidt, Marten P.			Modulation of Serotonin Transporter Function during Fetal Development Causes Dilated Heart Cardiomyopathy and Lifelong Behavioral Abnormalities	PLOS ONE			English	Article								Background: Women are at great risk for mood and anxiety disorders during their childbearing years and may become pregnant while taking antidepressant drugs. In the treatment of depression and anxiety disorders, selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed drugs, while it is largely unknown whether this medication affects the development of the central nervous system of the fetus. The possible effects are the product of placental transfer efficiency, time of administration and dose of the respective SSRI. Methodology/Principal Findings: In order to attain this information we have setup a study in which these parameters were measured and the consequences in terms of physiology and behavior are mapped. The placental transfer of fluoxetine and fluvoxamine, two commonly used SSRIs, was similar between mouse and human, indicating that the fetal exposure of these SSRIs in mice is comparable with the human situation. Fluvoxamine displayed a relatively low placental transfer, while fluoxetine showed a relatively high placental transfer. Using clinical doses of fluoxetine the mortality of the offspring increased dramatically, whereas the mortality was unaffected after fluvoxamine exposure. The majority of the fluoxetine-exposed offspring died postnatally of severe heart failure caused by dilated cardiomyopathy. Molecular analysis of fluoxetine-exposed offspring showed long-term alterations in serotonin transporter levels in the raphe nucleus. Furthermore, prenatal fluoxetine exposure resulted in depressive- and anxiety-related behavior in adult mice. In contrast, fluvoxamine-exposed mice did not show alterations in behavior and serotonin transporter levels. Decreasing the dose of fluoxetine resulted in higher survival rates and less dramatic effects on the long-term behavior in the offspring. Conclusions: These results indicate that prenatal fluoxetine exposure affects fetal development, resulting in cardiomyopathy and a higher vulnerability to affective disorders in a dose-dependent manner.	[Noorlander, Cornelle W.; Smidt, Marten P.] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Ververs, Frederique F. T.] Univ Med Ctr Utrecht, Dept Pharm, Utrecht, Netherlands; [Nikkels, Peter G. J.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [van Echteld, Cees J. A.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Visser, Gerard H. A.] Univ Med Ctr Utrecht, Dept Obstet, Neonatol & Gynaecol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Noorlander, CW (corresponding author), Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.	m.p.smidt-2@umcutrecht.nl		Smidt, Marten/0000-0002-8815-747X	Universtity of Utrecht; Hersenstichting [15F07(2).22]	Universtity of Utrecht; Hersenstichting	"Universtity of Utrecht" HIPO grant (M.P. Smidt), "Hersenstichting" grant (15F07(2).22) (C.W. Noorlander/M.P. Smidt)	ALWAN S, 2007, NEW ENGL J MED, V356, P2732; Bairy KL, 2007, PHARMACOLOGY, V79, P1, DOI 10.1159/000096645; Benmansour S, 1999, J NEUROSCI, V19, P10494; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, OBSTET GYNECOL, V103, P1344; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; CUZZELL JZ, 2006, DERMATOL NURS, V18, P6; GREENE MF, 2007, NEW ENGL J MED, V356, P26; Hendrick V, 2003, AM J OBSTET GYNECOL, V188, P812, DOI 10.1067/mob.2003.172; Hirano K, 2005, BRIT J PHARMACOL, V144, P695, DOI 10.1038/sj.bjp.0706108; Holmes A, 2003, BIOL PSYCHIAT, V54, P953, DOI 10.1016/j.biopsych.2003.09.003; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Kallen B, 2004, BIRTH DEFECTS RES B, V71, P395, DOI 10.1002/bdrb.20025; Laine K, 2003, ARCH GEN PSYCHIAT, V60, P720, DOI 10.1001/archpsyc.60.7.720; Lisboa SFS, 2007, PHARMACOLOGY, V80, P49, DOI 10.1159/000103097; Llewellyn AM, 1997, J CLIN PSYCHIAT, V58, P26; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Mirza NR, 2007, PROG NEURO-PSYCHOPH, V31, P858, DOI 10.1016/j.pnpbp.2007.01.020; MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182; Moses-Kolko EL, 2005, JAMA-J AM MED ASSOC, V293, P2372, DOI 10.1001/jama.293.19.2372; Nebigil CG, 2000, P NATL ACAD SCI USA, V97, P9508, DOI 10.1073/pnas.97.17.9508; Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973; Nonacs R, 2003, PSYCHIAT CLIN N AM, V26, P547, DOI 10.1016/S0193-953X(03)00046-7; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Reefhuis J, 2006, NEW ENGL J MED, V354, P2188; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; van Laake LW, 2007, NAT PROTOC, V2, P2551, DOI 10.1038/nprot.2007.371; Verney C, 2002, ANAT REC, V267, P87, DOI 10.1002/ar.10089; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; Zeskind PS, 2004, PEDIATRICS, V113, P368, DOI 10.1542/peds.113.2.368	35	118	118	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2782	10.1371/journal.pone.0002782	http://dx.doi.org/10.1371/journal.pone.0002782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18716672	Green Submitted, gold, Green Published			2022-12-27	WOS:000264302900052
J	Toupet, K; Compan, V; Crozet, C; Mourton-Gilles, C; Mestre-Frances, N; Ibos, F; Corbeau, P; Verdier, JM; Perrier, V				Toupet, Karine; Compan, Valerie; Crozet, Carole; Mourton-Gilles, Chantal; Mestre-Frances, Nadine; Ibos, Francoise; Corbeau, Pierre; Verdier, Jean-Michel; Perrier, Veronique			Effective Gene Therapy in a Mouse Model of Prion Diseases	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRP GENOTYPE; PENTOSAN POLYSULFATE; BLOOD-TRANSFUSION; SURVIVAL TIMES; SCRAPIE; PROTEIN; SHEEP; REPLICATION; ASSOCIATION	Classical drug therapies against prion diseases have encountered serious difficulties. It has become urgent to develop radically different therapeutic strategies. Previously, we showed that VSV-G pseudotyped FIV derived vectors carrying dominant negative mutants of the PrP gene are efficient to inhibit prion replication in chronically prion-infected cells. Besides, they can transduce neurons and cells of the lymphoreticular system, highlighting their potential use in gene therapy approaches. Here, we used lentiviral gene transfer to deliver PrPQ167R virions possessing anti-prion properties to analyse their efficiency in vivo. Since treatment for prion diseases is initiated belatedly in human patients, we focused on the development of a curative therapeutic protocol targeting the late stage of the disease, either at 35 or 105 days post-infection (d.p.i.) with prions. We observed a prolongation in the lifespan of the treated mice that prompted us to develop a system of cannula implantation into the brain of prion-infected mice. Chronic injections of PrPQ167R virions were done at 80 and 95 d.p.i. After only two injections, survival of the treated mice was extended by 30 days (20%), accompanied by substantial improvement in behaviour. This delay was correlated with: (i) a strong reduction of spongiosis in the ipsilateral side of the brain by comparison with the contralateral side; and (ii) a remarkable decrease in astrocytic gliosis in the whole brain. These results suggest that chronic injections of dominant negative lentiviral vectors into the brain, may be a promising approach for a curative treatment of prion diseases.	[Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] Univ Montpellier 2, Montpellier, France; [Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] Inserm, U710, Montpellier, France; [Toupet, Karine; Mestre-Frances, Nadine; Ibos, Francoise; Verdier, Jean-Michel; Perrier, Veronique] EPHE, Paris, France; [Compan, Valerie] CNRS, Inst Genom Fonctionnelle, UMR 5203, Montpellier, France; [Crozet, Carole] CNRS, Inst Genet Humaine, UPR 1142, Montpellier, France; [Mourton-Gilles, Chantal] CNRS, FRE3009 BioRad, Grabels, France; [Corbeau, Pierre] CNRS, UPR 1142, Lab Lentivirus Transfert Genes, Montpellier, France	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Toupet, K (corresponding author), Univ Montpellier 2, Montpellier, France.	veronique.perrier@univ-montp2.fr	crozet, carole/ABB-5877-2021; Perrier, Veronique/AAK-3594-2020; Mestre-Francés, Nadine/V-6289-2019	Mestre-Francés, Nadine/0000-0002-6856-3067; Crozet, Carole/0000-0002-7292-7046; COMPAN, Valerie/0000-0002-4634-2765; VERDIER, Jean-Michel/0000-0002-7252-1556; perrier, veronique/0000-0002-6570-7504	GIS "Infections a prions" [A62]; Inserm; Biotherapy Prize 2008 from Thermo Fisher Scientific	GIS "Infections a prions"; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Biotherapy Prize 2008 from Thermo Fisher Scientific	GIS "Infections a prions" project number A62 in 2001, Inserm dotation, VP has received the Biotherapy Prize 2008 from Thermo Fisher Scientific.	Aguzzi A, 2001, NAT REV NEUROSCI, V2, P745, DOI 10.1038/35094590; ANDREOLOTTI O, 2004, METHODS TOOLS BIOSCI, P82; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; Baylis M, 2000, P ROY SOC B-BIOL SCI, V267, P2029, DOI 10.1098/rspb.2000.1245; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Crozet C, 2004, J CELL SCI, V117, P5591, DOI 10.1242/jcs.01484; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Farquhar C, 1999, LANCET, V353, P117, DOI 10.1016/S0140-6736(98)05395-1; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; GENOUD N, 2008, AM J PATHOL; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; Haik S, 2004, NEUROLOGY, V63, P2413, DOI 10.1212/01.WNL.0000148596.15681.4D; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; KIM YS, 1987, J GEN VIROL, V68, P695, DOI 10.1099/0022-1317-68-3-695; KITAMOTO T, 1994, PHILOS T R SOC B, V343, P391, DOI 10.1098/rstb.1994.0034; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; LEE CI, 2007, PROTEIN SCI; Lowenstein PR, 2007, CURR GENE THER, V7, P347, DOI 10.2174/156652307782151498; Marella M, 2005, J BIOL CHEM, V280, P1529, DOI 10.1074/jbc.M410966200; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; Perrier V, 2002, P NATL ACAD SCI USA, V99, P13079, DOI 10.1073/pnas.182425299; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Shibuya S, 1998, ANN NEUROL, V43, P826, DOI 10.1002/ana.410430618; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Whittle IR, 2006, ACTA NEUROCHIR, V148, P677, DOI 10.1007/s00701-006-0772-y; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	39	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2773	10.1371/journal.pone.0002773	http://dx.doi.org/10.1371/journal.pone.0002773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648643	Green Published, gold			2022-12-27	WOS:000264302900043
J	Liu, H; Rahman, A; Semino-Mora, C; Doi, SQ; Dubois, A				Liu, Hui; Rahman, Arifur; Semino-Mora, Cristina; Doi, Sonia Q.; Dubois, Andre			Specific and Sensitive Detection of H-pylori in Biological Specimens by Real-Time RT-PCR and In Situ Hybridization	PLOS ONE			English	Article								PCR detection of H. pylori in biological specimens is rendered difficult by the extensive polymorphism of H. pylori genes and the suppressed expression of some genes in many strains. The goal of the present study was to (1) define a domain of the 16S rRNA sequence that is both highly conserved among H. pylori strains and also specific to the species, and (2) to develop and validate specific and sensitive molecular methods for the detection of H. pylori. We used a combination of in silico and molecular approaches to achieve sensitive and specific detection of H. pylori in biologic media. We sequenced two isolates from patients living in different continents and demonstrated that a 546-bp domain of the H. pylori 16S rRNA sequence was conserved in those strains and in published sequences. Within this conserved sequence, we defined a 229-bp domain that is 100% homologous in most H. pylori strains available in GenBank and also is specific for H. pylori. This sub-domain was then used to design (1) a set of high quality RT-PCR primers and probe that encompassed a 76-bp sequence and included at least two mismatches with other Helicobacter sp. 16S rRNA; and (2) in situ hybridization antisense probes. The sensitivity and specificity of the approaches were then demonstrated by using gastric biopsy specimens from patients and rhesus monkeys. This H. pylori-specific region of the 16S rRNA sequence is highly conserved among most H. pylori strains and allows specific detection, identification, and quantification of this bacterium in biological specimens.	[Liu, Hui; Rahman, Arifur; Semino-Mora, Cristina; Doi, Sonia Q.; Dubois, Andre] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Liu, H (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Room A3060, Bethesda, MD 20814 USA.	adubois@usuhs.edu			USUHS [R0-83GM]; NIH [R01-CA082312]; NATIONAL CANCER INSTITUTE [R01CA082312] Funding Source: NIH RePORTER	USUHS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work supported in part by USUHS grant R0-83GM and by NIH Grant R01-CA082312.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P6221, DOI 10.1093/nar/20.23.6221; Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; *APPL CORP, 2001, PRIM EXPR SOFTW V2 0; Aspholm M, 2006, METHOD ENZYMOL, V417, P293, DOI 10.1016/S0076-6879(06)17020-2; Aspholm M, 2006, PLOS PATHOG, V2, P989, DOI 10.1371/journal.ppat.0020110; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Avenaud P, 2000, CANCER, V89, P1431, DOI 10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.3.CO;2-X; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Camorlinga-Ponce M, 2004, J CLIN PATHOL, V57, P822, DOI 10.1136/jcp.2004.017087; Castera L, 2006, WORLD J GASTROENTERO, V12, P7278, DOI 10.3748/wjg.v12.i45.7278; Chong SKF, 1996, J CLIN MICROBIOL, V34, P2728, DOI 10.1128/JCM.34.11.2728-2730.1996; Contreras M, 2007, LETT APPL MICROBIOL, V45, P553, DOI 10.1111/j.1472-765X.2007.02227.x; Doi SQ, 2005, VET MICROBIOL, V108, P133, DOI 10.1016/j.vetmic.2005.04.003; Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000; DRAZEK ES, 1994, J CLIN MICROBIOL, V32, P1799, DOI 10.1128/JCM.32.7.1799-1804.1994; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; ECKLOFF BW, 1994, INT J SYST BACTERIOL, V44, P320, DOI 10.1099/00207713-44-2-320; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Forman D, 2000, BRIT MED J, V320, P1682, DOI 10.1136/bmj.320.7251.1682; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; GENTA RM, 1994, HUM PATHOL, V25, P221, DOI 10.1016/0046-8177(94)90191-0; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Gorkiewicz G, 2003, J CLIN MICROBIOL, V41, P2537, DOI 10.1128/JCM.41.6.2537-2546.2003; GRAY MW, 1984, NUCLEIC ACIDS RES, V12, P5837, DOI 10.1093/nar/12.14.5837; HANDT LK, 1994, INFECT IMMUN, V62, P2367, DOI 10.1128/IAI.62.6.2367-2374.1994; HO SA, 1991, J CLIN MICROBIOL, V29, P2543, DOI 10.1128/JCM.29.11.2543-2549.1991; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; Lan ZD, 1999, TOXICON, V37, P815, DOI 10.1016/S0041-0101(98)00221-9; LIU H, 2006, GASTROENTEROLOGY, V130, pT1608; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Riley LK, 1996, J CLIN MICROBIOL, V34, P942, DOI 10.1128/JCM.34.4.942-946.1996; Semino-Mora C, 2003, J INFECT DIS, V187, P1165, DOI 10.1086/368133; Smith JG, 1996, CLIN DIAGN LAB IMMUN, V3, P66, DOI 10.1128/CDLI.3.1.66-72.1996; Smith SI, 2004, WORLD J GASTROENTERO, V10, P1958; Sturegard E, 2004, ALIMENT PHARM THER, V19, P613, DOI 10.1111/j.1365-2036.2004.01880.x; Suerbaum S, 2002, INT J SYST EVOL MICR, V52, P437, DOI 10.1099/00207713-52-2-437; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4	38	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2689	10.1371/journal.pone.0002689	http://dx.doi.org/10.1371/journal.pone.0002689			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648543	Green Submitted, gold, Green Published			2022-12-27	WOS:000264057200033
J	Sethupathy, P; Giang, H; Plotkin, JB; Hannenhalli, S				Sethupathy, Praveen; Giang, Hoa; Plotkin, Joshua B.; Hannenhalli, Sridhar			Genome-Wide Analysis of Natural Selection on Human Cis-Elements	PLOS ONE			English	Article								Background: It has been speculated that the polymorphisms in the non-coding portion of the human genome underlie much of the phenotypic variability among humans and between humans and other primates. If so, these genomic regions may be undergoing rapid evolutionary change, due in part to natural selection. However, the non-coding region is a heterogeneous mix of functional and non-functional regions. Furthermore, the functional regions are comprised of a variety of different types of elements, each under potentially different selection regimes. Findings and Conclusions: Using the HapMap and Perlegen polymorphism data that map to a stringent set of putative binding sites in human proximal promoters, we apply the Derived Allele Frequency distribution test of neutrality to provide evidence that many human-specific and primate-specific binding sites are likely evolving under positive selection. We also discuss inherent limitations of publicly available human SNP datasets that complicate the inference of selection pressures. Finally, we show that the genes whose proximal binding sites contain high frequency derived alleles are enriched for positive regulation of protein metabolism and developmental processes. Thus our genome-scale investigation provides evidence for positive selection on putative transcription factor binding sites in human proximal promoters.	[Sethupathy, Praveen; Hannenhalli, Sridhar] Univ Penn, Dept Genet, Sch Med, Sch Engn & Appl Sci, Philadelphia, PA USA; [Giang, Hoa; Plotkin, Joshua B.] Univ Penn, Sch Engn & Appl Sci, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar] Univ Penn, Sch Engn & Appl Sci, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Sethupathy, P (corresponding author), Univ Penn, Dept Genet, Sch Med, Sch Engn & Appl Sci, Philadelphia, PA USA.	sridharh@pcbi.upenn.edu	Hu, Ruogu/B-2203-2008; Plotkin, Joshua B/E-6947-2013		NIH [R21GM078203, R01GM085226]; Vietnam Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078203, R01GM085226] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vietnam Education Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	PS was supported by NIH R21GM078203 awarded to SH. SH was supported by NIH grant R01GM085226. HG was supported by Vietnam Education Foundation Fellowship.	BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Bush EC, 2005, PLOS COMPUT BIOL, V1, P593, DOI 10.1371/journal.pcbi.0010073; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Everett L, 2006, BIOINFORMATICS, V22, pE117, DOI 10.1093/bioinformatics/btl260; Fay JC, 2001, GENETICS, V158, P1227; Fay JC, 2000, GENETICS, V155, P1405; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hahn MW, 2007, GENETICA, V129, P7, DOI 10.1007/s10709-006-0029-y; HAYGOOD R, 2007, NAT GENET; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; SAWYER SA, 1992, GENETICS, V132, P1161; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Sethupathy Praveen, 2008, Advances in Bioinformatics, V2008, P257864, DOI 10.1155/2008/257864; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	32	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3137	10.1371/journal.pone.0003137	http://dx.doi.org/10.1371/journal.pone.0003137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781197	Green Published, gold, Green Submitted			2022-12-27	WOS:000264425700003
J	Merchant, H; Zarco, W; Bartolo, R; Prado, L				Merchant, Hugo; Zarco, Wilbert; Bartolo, Ramon; Prado, Luis			The Context of Temporal Processing Is Represented in the Multidimensional Relationships between Timing Tasks	PLOS ONE			English	Article							NEURAL MECHANISMS; TIME; PERCEPTION; INTERVALS; VARIABILITY; COGNITION; PREMOTOR	In the present study we determined the performance interrelations of ten different tasks that involved the processing of temporal intervals in the subsecond range, using multidimensional analyses. Twenty human subjects executed the following explicit timing tasks: interval categorization and discrimination (perceptual tasks), and single and multiple interval tapping (production tasks). In addition, the subjects performed a continuous circle-drawing task that has been considered an implicit timing paradigm, since time is an emergent property of the produced spatial trajectory. All tasks could be also classified as single or multiple interval paradigms. Auditory or visual markers were used to define the intervals. Performance variability, a measure that reflects the temporal and non-temporal processes for each task, was used to construct a dissimilarity matrix that quantifies the distances between pairs of tasks. Hierarchical clustering and multidimensional scaling were carried out on the dissimilarity matrix, and the results showed a prominent segregation of explicit and implicit timing tasks, and a clear grouping between single and multiple interval paradigms. In contrast, other variables such as the marker modality were not as crucial to explain the performance between tasks. Thus, using this methodology we revealed a probable functional arrangement of neural systems engaged during different timing behaviors.	[Merchant, Hugo; Zarco, Wilbert; Bartolo, Ramon; Prado, Luis] UNAM, Inst Neurobiol, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Merchant, H (corresponding author), UNAM, Inst Neurobiol, Queretaro, Mexico.	merchant@inb.unam.mx	Bartolo, Ramon/AAB-6579-2022; Merchant, Hugo/E-8703-2019	Bartolo, Ramon/0000-0003-2165-9747; Merchant, Hugo/0000-0002-3488-9501; Zarco, Wilbert/0000-0002-3599-0476	PAPIIT [IN209305]; FIRCA [TW007224-01A1]; FOGARTY INTERNATIONAL CENTER [R03TW007224] Funding Source: NIH RePORTER	PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); FIRCA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported in part by PAPIIT: IN209305 and FIRCA: TW007224-01A1.	Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GOLDSTONE S, 1959, J EXP PSYCHOL, V57, P243, DOI 10.1037/h0040745; Grondin S, 2001, PERCEPT PSYCHOPHYS, V63, P1214, DOI 10.3758/BF03194535; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Hazeltine E, 1997, TRENDS COGN SCI, V1, P163, DOI 10.1016/S1364-6613(97)01058-9; Hoshi E, 2004, PROG BRAIN RES, V143, P507, DOI 10.1016/S0079-6123(03)43047-1; IVRY RB, 1995, J EXP PSYCHOL HUMAN, V21, P3, DOI 10.1037/0096-1523.21.1.3; Ivry RB, 2002, ANN NY ACAD SCI, V978, P302, DOI 10.1111/j.1749-6632.2002.tb07576.x; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Johnson, 1998, APPL MULTIVARIATE ST; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Merchant H, 2006, J NEUROPHYSIOL, V95, P1, DOI 10.1152/jn.00422.2005; Merchant H, 2003, J NEUROPHYSIOL, V90, P675, DOI 10.1152/jn.00331.2003; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Rammsayer TH, 2004, PSYCHOL RES-PSYCH FO, V69, P115, DOI 10.1007/s00426-003-0164-3; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Robertson SD, 1999, J EXP PSYCHOL HUMAN, V25, P1316, DOI 10.1037/0096-1523.25.5.1316; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; Spencer RMC, 2003, J MOTOR BEHAV, V35, P371, DOI 10.1080/00222890309603157; Spencer RMC, 2003, SCIENCE, V300, P1437, DOI 10.1126/science.1083661; Wearden JH, 1998, Q J EXP PSYCHOL-B, V51, P97; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	34	51	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3169	10.1371/journal.pone.0003169	http://dx.doi.org/10.1371/journal.pone.0003169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422JY	18779860	gold, Green Submitted, Green Published			2022-12-27	WOS:000264425100005
J	Kulkarni, H; Agan, BK; Marconi, VC; O'Connell, RJ; Camargo, JF; He, WJ; Delmar, J; Phelps, KR; Crawford, G; Clark, RA; Dolan, MJ; Ahuja, SK				Kulkarni, Hemant; Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Camargo, Jose F.; He, Weijing; Delmar, Judith; Phelps, Kenneth R.; Crawford, George; Clark, Robert A.; Dolan, Matthew J.; Ahuja, Sunil K.			CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals	PLOS ONE			English	Article								Background: Whether vexing clinical decision-making dilemmas can be partly addressed by recent advances in genomics is unclear. For example, when to initiate highly active antiretroviral therapy ( HAART) during HIV-1 infection remains a clinical dilemma. This decision relies heavily on assessing AIDS risk based on the CD4(+) T cell count and plasma viral load. However, the trajectories of these two laboratory markers are influenced, in part, by polymorphisms in CCR5, the major HIV coreceptor, and the gene copy number of CCL3L1, a potent CCR5 ligand and HIV-suppressive chemokine. Therefore, we determined whether accounting for both genetic and laboratory markers provided an improved means of assessing AIDS risk. Methods and Findings: In a prospective, single-site, ethnically-mixed cohort of 1,132 HIV-positive subjects, we determined the AIDS risk conveyed by the laboratory and genetic markers separately and in combination. Subjects were assigned to a low, moderate or high genetic risk group (GRG) based on variations in CCL3L1 and CCR5. The predictive value of the CCL3L1-CCR5 GRGs, as estimated by likelihood ratios, was equivalent to that of the laboratory markers. GRG status also predicted AIDS development when the laboratory markers conveyed a contrary risk. Additionally, in two separate and large groups of HIV+ subjects from a natural history cohort, the results from additive risk-scoring systems and classification and regression tree (CART) analysis revealed that the laboratory and CCL3L1-CCR5 genetic markers together provided more prognostic information than either marker alone. Furthermore, GRGs independently predicted the time interval from seroconversion to CD4(+) cell count thresholds used to guide HAART initiation. Conclusions: The combination of the laboratory and genetic markers captures a broader spectrum of AIDS risk than either marker alone. By tracking a unique aspect of AIDS risk distinct from that captured by the laboratory parameters, CCL3L1-CCR5 genotypes may have utility in HIV clinical management. These findings illustrate how genomic information might be applied to achieve practical benefits of personalized medicine.	[Kulkarni, Hemant; Camargo, Jose F.; He, Weijing; Crawford, George; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA; [Kulkarni, Hemant; Camargo, Jose F.; He, Weijing; Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Med, San Antonio, TX USA; [Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Delmar, Judith; Dolan, Matthew J.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD USA; [Agan, Brian K.; Marconi, Vincent C.; O'Connell, Robert J.; Delmar, Judith; Dolan, Matthew J.] Wilford Hall United States Air Force Med Ctr, Infect Dis Serv, Lackland AFB, TX USA; [Agan, Brian K.; Dolan, Matthew J.] Wilford Hall United States Air Force Med Ctr, Henry M Jackson Fdn, Lackland AFB, TX USA; [Agan, Brian K.; Marconi, Vincent C.; Delmar, Judith; Dolan, Matthew J.] San Antonio Mil Med Ctr, Ft Sam Houston, TX USA; [Phelps, Kenneth R.] Stratton Veterans Affairs Med Ctr, Albany, NY USA; [Phelps, Kenneth R.] Albany Med Coll, Albany, NY USA; [Ahuja, Sunil K.] Univ Texas, Hlth Sci Ctr, Dept Microbiol & Immunol & Biochem, San Antonio, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Albany Medical College; University of Texas System; University of Texas Health San Antonio	Kulkarni, H (corresponding author), S Texas Vet Hlth Care Syst, Vet Adm Res Ctr AIDS & HIV Infect 1, San Antonio, TX USA.	mdolan@idcrp.org; ahujas@uthscsa.edu	Clark, Robert/Q-6764-2019; Marconi, Vincent/GRJ-4553-2022; Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Kulkarni, Hemant/AEM-5750-2022	Clark, Robert/0000-0002-4892-3619; Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System; MERIT [R37046326]; NIH [AI043279, MH069270]; Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research; Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); HHS/NIH/NIAID/DCR [HU0001-05-2-0011]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046326, R01AI043279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069270] Funding Source: NIH RePORTER	Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System(US Department of Veterans Affairs); MERIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Scientist Award; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS); HHS/NIH/NIAID/DCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Veterans Administration (VA) Center on AIDS and HIV infection of the South Texas Veterans Health Care System, and a MERIT (R37046326) and other awards (AI043279 and MH069270) from the NIH to S.K.A. S.K.A. is a recipient of the Elizabeth Glaser Scientist Award and the Burroughs Wellcome Clinical Scientist Award in Translational Research. Support for the Wilford Hall Medical Center cohort was provided by the Infectious Disease Clinical Research Program (IDCRP) of the Uniformed Services University of the Health Sciences (USUHS), of which the Tri-Service AIDS Clinical Consortium (TACC) is a component. The IDCRP is a Department of Defense tri-service program executed through USUHS and the Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF), in collaboration with HHS/NIH/NIAID/DCR through Interagency Agreement HU0001-05-2-0011. The authors have no commercial or other association that might pose a conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahab SF, 2003, P NATL ACAD SCI USA, V100, P15006, DOI 10.1073/pnas.2035075100; Ahuja SK, 2008, NAT MED, V14, P413, DOI 10.1038/nm1741; Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005; BIRX DL, 1993, J ACQ IMMUN DEF SYND, V6, P1248; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Cohen CJ, 2004, CLIN INFECT DIS, V39, P1705, DOI 10.1086/425934; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; Dolan MJ, 2007, NAT IMMUNOL, V8, P1324, DOI 10.1038/ni1521; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Dybul Mark, 2002, MMWR Recomm Rep, V51, P1; Florence E, 2003, HIV Med, V4, P255, DOI 10.1046/j.1468-1293.2003.00156.x; Friedman RS, 2006, NAT IMMUNOL, V7, P1101, DOI 10.1038/ni1384; Gallagher EJ, 1998, ANN EMERG MED, V31, P391, DOI 10.1016/S0196-0644(98)70352-X; Gervaix A, 2002, J INFECT DIS, V185, P1055, DOI 10.1086/339802; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; GORDIN FM, 1994, J INFECT DIS, V169, P893, DOI 10.1093/infdis/169.4.893; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Hendrickson SL, 2008, JAIDS-J ACQ IMM DEF, V48, P263, DOI 10.1097/QAI.0b013e31816fdc5f; Hladik F, 2005, J VIROL, V79, P11677, DOI 10.1128/JVI.79.18.11677-11684.2005; Holmberg SD, 2004, CLIN INFECT DIS, V39, P1699, DOI 10.1086/425743; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Hunt PW, 2008, CURR OPIN HIV AIDS, V3, P342, DOI 10.1097/COH.0b013e3282fbaa92; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Kalish RS, 1999, J ALLERGY CLIN IMMUN, V103, P192, DOI 10.1016/S0091-6749(99)70489-6; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Kaslow RA, 2005, J INFECT DIS, V191, pS68, DOI 10.1086/425269; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Ketas TJ, 2007, VIROLOGY, V364, P281, DOI 10.1016/j.virol.2007.02.022; KNIKER WT, 1984, ANN ALLERGY, V52, P75; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Lalezari J, 2008, J INFECT DIS, V197, P721, DOI 10.1086/527327; Langdorf M I, 2002, Eur J Emerg Med, V9, P115, DOI 10.1097/00063110-200206000-00003; Lederman MM, 2006, JAMA-J AM MED ASSOC, V296, P815, DOI 10.1001/jama.296.7.815; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; Li L, 2004, STAT MED, V23, P271, DOI 10.1002/sim.1715; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Lillard JW, 2003, BLOOD, V101, P807, DOI 10.1182/blood-2002-07-2305; Lin YL, 2002, P NATL ACAD SCI USA, V99, P15590, DOI 10.1073/pnas.242134499; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maas JJ, 1998, J INFECT DIS, V178, P1024, DOI 10.1086/515655; Mangano A, 2001, J INFECT DIS, V183, P1574, DOI 10.1086/320705; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; Mayer H., 2006, 16 INT AIDS C; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Menten P, 1999, J CLIN INVEST, V104, pR1, DOI 10.1172/JCI7318; Molon B, 2005, NAT IMMUNOL, V6, P465, DOI 10.1038/ni1191; Moore DM, 2005, JAIDS-J ACQ IMM DEF, V40, P288, DOI 10.1097/01.qai.0000182847.38098.d1; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Nakajima T, 2007, IMMUNOGENETICS, V59, P793, DOI 10.1007/s00251-007-0252-4; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; O'Brien TR, 2000, AIDS, V14, P821, DOI 10.1097/00002030-200005050-00008; Pinto LA, 2000, EUR J IMMUNOL, V30, P2048, DOI 10.1002/1521-4141(200007)30:7<2048::AID-IMMU2048>3.0.CO;2-I; Podlekareva D, 2006, J INFECT DIS, V194, P633, DOI 10.1086/506366; Province MA, 2001, ADV GENET, V42, P273, DOI 10.1016/S0065-2660(01)42028-1; Reynes J, 2000, J INFECT DIS, V181, P927, DOI 10.1086/315315; Reynes J, 2001, AIDS, V15, P1627, DOI 10.1097/00002030-200109070-00004; Reyues J, 2003, JAIDS-J ACQ IMM DEF, V34, P114, DOI 10.1097/00126334-200309010-00018; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; SADAM M, 2008, 15 C RETR OPP INF; Salkowitz JR, 2003, CLIN IMMUNOL, V108, P234, DOI 10.1016/S1521-6616(03)00147-5; Shalekoff S, 2008, JAIDS-J ACQ IMM DEF, V48, P245, DOI 10.1097/QAI.0b013e31816fdc77; Silverberg MJ, 2006, AIDS, V20, P1531, DOI 10.1097/01.aids.0000237369.41617.0f; Tarwater PM, 2001, J ACQ IMMUN DEF SYND, V27, P168, DOI 10.1097/00126334-200106010-00012; Taub DD, 1996, J IMMUNOL, V156, P2095; TELENTI A, 2008, CURRENT OPINION HIV, V28, P1; Thomas SM, 2006, AIDS, V20, P1879, DOI 10.1097/01.aids.0000244207.49123.ff; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Valdez H, 1999, JAMA-J AM MED ASSOC, V282, P734, DOI 10.1001/jama.282.8.734; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; Vincent T, 2006, JAIDS-J ACQ IMM DEF, V43, P377, DOI 10.1097/01.qai.0000234088.64655.45; Vlahou Antonia, 2003, Clin Breast Cancer, V4, P203, DOI 10.3816/CBC.2003.n.026; Xin XM, 1999, FEBS LETT, V457, P219, DOI 10.1016/S0014-5793(99)01035-2; Yeni PG, 2004, JAMA-J AM MED ASSOC, V292, P251, DOI 10.1001/jama.292.2.251; Zhang ZQ, 2004, VIROLOGY, V320, P75, DOI 10.1016/j.virol.2003.11.017; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665; Zou WP, 2000, J IMMUNOL, V165, P4388, DOI 10.4049/jimmunol.165.8.4388; AIDS RES HUM RETROVI, V16, P1123; 2005, GUIDELINES USE ANTIR	92	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3165	10.1371/journal.pone.0003165	http://dx.doi.org/10.1371/journal.pone.0003165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776933	gold, Green Published, Green Submitted			2022-12-27	WOS:000264424300009
J	Garcia-Lecea, M; Kondrychyn, I; Fong, SH; Ye, ZR; Korzh, V				Garcia-Lecea, Marta; Kondrychyn, Igor; Fong, Steven H.; Ye, Zhang-Rui; Korzh, Vladimir			In vivo Analysis of Choroid Plexus Morphogenesis in Zebrafish	PLOS ONE			English	Article							ROOF PLATE; ENHANCER TRAP; MIND-BOMB; EXPRESSION; BRAIN; HEDGEHOG; GENE; CELLS; SPECIFICATION; NEUROGENESIS	Background: The choroid plexus (ChP), a component of the blood-brain barrier (BBB), produces the cerebrospinal fluid (CSF) and as a result plays a role in (i) protecting and nurturing the brain as well as (ii) in coordinating neuronal migration during neurodevelopment. Until now ChP development was not analyzed in living vertebrates due to technical problems. Methodology/Principal Findings: We have analyzed the formation of the fourth ventricle ChP of zebrafish in the GFP-tagged enhancer trap transgenic line SqET33-E20 (Gateways) by a combination of in vivo imaging, histology and mutant analysis. This process includes the formation of the tela choroidea (TC), the recruitment of cells from rhombic lips and, finally, the coalescence of TC resulting in formation of ChP. In Notch-deficient mib mutants the first phase of this process is affected with premature GFP expression, deficient cell recruitment into TC and abnormal patterning of ChP. In Hedgehog-deficient smu mutants the second phase of the ChP morphogenesis lacks cell recruitment and TC cells undergo apoptosis. Conclusions/Significance: This study is the first to demonstrate the formation of ChP in vivo revealing a role of Notch and Hedgehog signalling pathways during different developmental phases of this process.	[Garcia-Lecea, Marta; Kondrychyn, Igor; Fong, Steven H.; Ye, Zhang-Rui; Korzh, Vladimir] ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Garcia-Lecea, M (corresponding author), ASTAR, Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore, Singapore.	mgarcia@imcb.a-star.edu.sg; vlad@imcb.a-star.edu.sg	Kondrychyn, Igor/AAC-6237-2022; Kondrychyn, Igor/C-2621-2016; Kondrychyn, Igor/A-9468-2010; Korzh, Vladimir P/H-1596-2011	Kondrychyn, Igor/0000-0002-2268-7291; Kondrychyn, Igor/0000-0002-2268-7291; Korzh, Vladimir P/0000-0002-6580-7986	Agency for Science, Technology and Research (A-STAR) of Singapore	Agency for Science, Technology and Research (A-STAR) of Singapore(Agency for Science Technology & Research (A*STAR))	VK's lab is supported by the Agency for Science, Technology and Research (A-STAR) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1980, J COMP NEUROL, V194, P1, DOI 10.1002/cne.901940102; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Baehr C, 2006, FLUIDS BARRIERS CNS, V3, DOI 10.1186/1743-8454-3-13; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; BILL B, PLOS ONE IN PRESS; Bingham S, 2003, DEV DYNAM, V228, P451, DOI 10.1002/dvdy.10429; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chandrasekhar A, 2004, DEV DYNAM, V229, P143, DOI 10.1002/dvdy.10444; Chen WB, 2001, DEVELOPMENT, V128, P2385; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; Dziegielewska KM, 2001, MICROSC RES TECHNIQ, V52, P5, DOI 10.1002/1097-0029(20010101)52:1<5::AID-JEMT3>3.3.CO;2-A; Estrach S, 2007, J CELL SCI, V120, P2944, DOI 10.1242/jcs.016253; Fong SH, 2005, DEVELOPMENT, V132, P3587, DOI 10.1242/dev.01933; FRANZ T, 1994, ACTA ANAT, V150, P38; Gingras S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000808; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hashimoto Paulo H., 1992, Arteriosclerosis and Thrombosis, V67, P595; HIGUCHI M, 1995, MOL BRAIN RES, V29, P263, DOI 10.1016/0169-328X(94)00257-F; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Irvin DK, 2004, J NEUROSCI RES, V75, P330, DOI 10.1002/jnr.10843; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; JACOBSEN M, 1982, DEV BRAIN RES, V3, P239, DOI 10.1016/0165-3806(82)90024-4; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jiang YJ, 1996, DEVELOPMENT, V123, P205; JOHANSON CE, 2003, NEUROSCIENCE MED, P165; Joly JS, 2007, SEMIN CELL DEV BIOL, V18, P512, DOI 10.1016/j.semcdb.2007.06.001; Ke ZY, 2008, MOL CELL NEUROSCI, V37, P388, DOI 10.1016/j.mcn.2007.10.013; Ke ZY, 2005, DEV DYNAM, V232, P479, DOI 10.1002/dvdy.20242; Korzh V, 1998, DEV DYNAM, V213, P92, DOI 10.1002/(SICI)1097-0177(199809)213:1<92::AID-AJA9>3.0.CO;2-T; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Lam CS, 2003, MOL CELL NEUROSCI, V22, P501, DOI 10.1016/S1044-7431(03)00031-9; LAMETSCHWANDTNER A, 1983, Z MIKROSK ANAT FORSC, V97, P265; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lundberg F, 1999, J NEUROSURG, V90, P101, DOI 10.3171/jns.1999.90.1.0101; Netsky M G, 1970, Neurosci Res (N Y), V3, P131; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pons S, 2001, DEVELOPMENT, V128, P1481; Redzic ZB, 2005, CURR TOP DEV BIOL, V71, P1, DOI 10.1016/S0070-2153(05)71001-2; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STRONG LH, 1956, AM J ANAT, V99, P249, DOI 10.1002/aja.1000990204; STURROCK RR, 1979, J ANAT, V129, P777; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; TSUNEKI K, 1986, J HIRNFORSCH, V27, P441; TURKEVICH N. G., 1963, ARKH ANAT GISTOL I EMBRIOL, V44, P81; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Wang XK, 2003, DEV DYNAM, V227, P587, DOI 10.1002/dvdy.10331; Wechsler-Reya RJ, 2001, TRENDS NEUROSCI, V24, P680, DOI 10.1016/S0166-2236(00)02058-0; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE	54	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3090	10.1371/journal.pone.0003090	http://dx.doi.org/10.1371/journal.pone.0003090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769618	Green Published, Green Submitted, gold			2022-12-27	WOS:000264416600001
J	Paganin, F; Schouler, L; Cuissard, L; Noel, JB; Becquart, JP; Besnard, M; Verdier, L; Rousseau, D; Arvin-Berod, C; Bourdin, A				Paganin, Fabrice; Schouler, Laurent; Cuissard, Laurent; Noel, Jean Baptiste; Becquart, Jean-Philippe; Besnard, Mathieu; Verdier, Laurent; Rousseau, Denis; Arvin-Berod, Claude; Bourdin, Arnaud			Airway and Esophageal Stenting in Patients with Advanced Esophageal Cancer and Pulmonary Involvement	PLOS ONE			English	Article								Background: Most inoperable patients with esophageal-advanced cancer (EGC) have a poor prognosis. Esophageal stenting, as part of a palliative therapy management has dramatically improved the quality of live of EGC patients. Airway stenting is generally proposed in case of esophageal stent complication, with a high failure rate. The study was conducted to assess the efficacy and safety of scheduled and non-scheduled airway stenting in case of indicated esophageal stenting for EGC. Methods and Findings: The study is an observational study conducted in pulmonary and gastroenterology endoscopy units. Consecutive patients with EGC were referred to endoscopy units. We analyzed the outcome of airway stenting in patients with esophageal stent indication admitted in emergency or with a scheduled intervention. Forty-four patients (58 +/-\-8 years of age) with esophageal stenting indication were investigated. Seven patients (group 1) were admitted in emergency due to esophageal stent complication in the airway (4 fistulas, 3 cases with malignant infiltration and compression). Airway stenting failed for 5 patients. Thirty-seven remaining patients had a scheduled stenting procedure (group 2): stent was inserted for 13 patients with tracheal or bronchial malignant infiltration, 12 patients with fistulas, and 12 patients with airway extrinsic compression (preventive indication). Stenting the airway was well tolerated. Life-threatening complications were related to group 1. Overall mean survival was 26+/-10 weeks and was significantly shorter in group 1 (6+/-7.6 weeks) than in group 2 (28+/-11 weeks), p < 0.001). Scheduled double stenting significantly improved symptoms (95% at day 7) with a low complication rate (13%), and achieved a specific cancer treatment (84%) in most cases. Conclusion: Stenting the airway should always be considered in case of esophageal stent indication. A multidisciplinary approach with initial airway evaluation improved prognosis and decreased airways complications related to esophageal stent. Emergency procedures were rarely efficient in our experience.	[Paganin, Fabrice; Arvin-Berod, Claude; Bourdin, Arnaud] GHSR, Serv Pneumol, St Pierre, France; [Schouler, Laurent; Cuissard, Laurent; Becquart, Jean-Philippe] GHSR, Serv Gastroenterol, St Pierre, France; [Noel, Jean Baptiste] GHSR, Serv Radiol, St Pierre, France; [Besnard, Mathieu] GHSR, Serv Chirurg Thorac, St Pierre, France; [Verdier, Laurent; Rousseau, Denis] GHSR, Serv Anesth Reanimat, St Pierre, France	CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion; CHU Reunion	Paganin, F (corresponding author), GHSR, Serv Pneumol, St Pierre, France.	f.paganin@orange.fr						Acunas B, 1996, RADIOLOGY, V199, P648, DOI 10.1148/radiology.199.3.8637981; Alvares JF, 2002, ENDOSCOPY, V34, P592, DOI 10.1055/s-2002-33215; Baron Todd H, 2007, Gastrointest Endosc Clin N Am, V17, P83, DOI 10.1016/j.giec.2007.01.004; Belleguic C, 1999, ENDOSCOPY, V31, P232, DOI 10.1055/s-1999-13674; Bolliger CT, 2006, EUR RESPIR J, V27, P1258, DOI 10.1183/09031936.06.00013906; Chan KPW, 2002, CHEST, V122, P1069, DOI 10.1378/chest.122.3.1069; COLT HG, 1992, GASTROINTEST ENDOSC, V38, P485, DOI 10.1016/S0016-5107(92)70482-9; Conio M, 2007, AM J GASTROENTEROL, V102, P2667, DOI 10.1111/j.1572-0241.2007.01565.x; Dahan L, 2006, GASTROEN CLIN BIOL, V30, P253, DOI 10.1016/S0399-8320(06)73162-1; Dasgupta A, 1998, GASTROINTEST ENDOSC, V47, P532, DOI 10.1016/S0016-5107(98)70258-5; De Olabozal J, 2001, AM J GASTROENTEROL, V96, P2800, DOI 10.1016/S0002-9270(01)02709-5; DEPALMA GD, 1995, AM J GASTROENTEROL, V90, P2140; DO YS, 1993, RADIOLOGY, V187, P673, DOI 10.1148/radiology.187.3.7684529; Freitag L, 1996, CHEST, V110, P1155, DOI 10.1378/chest.110.5.1155; GUDOVSKY LM, 1993, ANN THORAC SURG, V55, P868, DOI 10.1016/0003-4975(93)90108-T; Hasan S, 2004, ENDOSCOPY, V36, P731, DOI 10.1055/s-2004-825668; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Horns MYV, 2004, ENDOSCOPY, V36, P880, DOI 10.1055/s-2004-825855; Lecleire S, 2007, ALIMENT PHARM THER, V25, P955, DOI 10.1111/j.1365-2036.2007.03280.x; Lee SH, 2001, BRIT J RADIOL, V74, P891, DOI 10.1259/bjr.74.886.740891; Morgan RA, 1997, RADIOLOGY, V204, P527, DOI 10.1148/radiology.204.2.9240548; Nomori H, 2000, ANN THORAC SURG, V70, P1803, DOI 10.1016/S0003-4975(00)02042-7; Saxon RR, 1995, J VASC INTERV RADIOL, V6, P747, DOI 10.1016/S1051-0443(95)71180-0; SCHAER J, 1992, GASTROINTEST ENDOSC, V38, P7, DOI 10.1016/S0016-5107(92)70322-8; Shimi S M, 2000, Semin Laparosc Surg, V7, P9; Shin JH, 2004, RADIOLOGY, V232, P252, DOI 10.1148/radiol.2321030733; Sihoe ADL, 2004, SURG ONCOL, V13, P17, DOI 10.1016/j.suronc.2004.01.001; Takamori S, 1996, ANN THORAC SURG, V62, P844, DOI 10.1016/S0003-4975(96)00394-3; TUEBERGEN D, 2008, J GASTROINTEST  0304; UTTS SJ, 1985, GASTROINTEST ENDOSC, V31, P383, DOI 10.1016/S0016-5107(85)72253-5; van den Bongard HJG, 2002, GASTROINTEST ENDOSC, V55, P110, DOI 10.1067/mge.2002.119731; Wang MQ, 2001, J VASC INTERV RADIOL, V12, P465, DOI 10.1016/S1051-0443(07)61886-7; Yamamoto Ryoji, 2002, Jpn J Thorac Cardiovasc Surg, V50, P1	33	21	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3101	10.1371/journal.pone.0003101	http://dx.doi.org/10.1371/journal.pone.0003101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769726	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796800008
J	Paz, GJ; Babikian, T; Asarnow, R; Esposito, K; Erol, HK; Wong, ML; Licinio, J				Paz-Filho, Gilberto J.; Babikian, Talin; Asarnow, Robert; Esposito, Karin; Erol, Halil K.; Wong, Ma-Li; Licinio, Julio			Leptin Replacement Improves Cognitive Development	PLOS ONE			English	Article							INSULIN-RESISTANCE; NEONATAL LEPTIN; ARCUATE NUCLEUS; BODY-WEIGHT; RECEPTOR; OBESITY; DEFICIENCY; BEHAVIOR; FAT; NEUROENDOCRINE	Background: Leptin changes brain structure, neuron excitability and synaptic plasticity. It also regulates the development and function of feeding circuits. However, the effects of leptin on neurocognitive development are unknown. Objective: To evaluate the effect of leptin on neurocognitive development. Methodology: A 5-year-old boy with a nonconservative missense leptin gene mutation (Cys-to-Thr in codon 105) was treated with recombinant methionyl human leptin (r-metHuLeptin) at physiologic replacement doses of 0.03 mg/kg/day. Cognitive development was assessed using the Differential Ability Scales (DAS), a measure of general verbal and nonverbal functioning; and selected subtests from the NEPSY, a measure of neuropsychological functioning in children. Principal Findings: Prior to treatment, the patient was morbidly obese, hypertensive, dyslipidemic, and hyperinsulinemic. Baseline neurocognitive tests revealed slower than expected rates of development (developmental age lower than chronological age) in a majority of the areas assessed. After two years, substantial increases in the rates of development in most neurocognitive domains were apparent, with some skills at or exceeding expectations based on chronological age. We also observed marked weight loss and resolution of hypertension, dyslipidemia and hyperinsulinemia. Conclusions: We concluded that replacement with r-metHuLeptin is associated with weight loss and changes in rates of development in many neurocognitive domains, which lends support to the hypothesis that, in addition to its role in metabolism, leptin may have a cognitive enhancing role in the developing central nervous system.	[Paz-Filho, Gilberto J.; Esposito, Karin; Erol, Halil K.; Wong, Ma-Li; Licinio, Julio] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Pharmacogenom, Miami, FL 33136 USA; [Paz-Filho, Gilberto J.] SEMPR, Curitiba, Parana, Brazil; [Babikian, Talin; Asarnow, Robert] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA	University of Miami; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Paz, GJ (corresponding author), Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Ctr Pharmacogenom, Miami, FL 33136 USA.	jlicinio@med.miami.edu	Paz-Filho, Gilberto J/C-6499-2008; Wong, Ma-Li/D-7903-2011; Wong, Ma-Li/ABD-5525-2020; Esposito, Karin/AAG-6878-2019; Licinio, Julio/L-4244-2013	Wong, Ma-Li/0000-0003-1512-3073; Licinio, Julio/0000-0001-6905-5884; Paz-Filho, Gilberto/0000-0002-5940-4996; Erol, Halil Kutlu/0000-0001-5760-4276	National Institutes of Health [R01DK058851, K24RR016966, R01DK063240, K24RR017365, M01RR000865]; Amgen, Inc; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865, K24RR017365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063240, R01DK058851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen, Inc(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants: R01DK058851, K24RR016966 (to J.L.), R01DK063240, K24RR017365 (to M.-L.W.) and M01RR000865 (to G. Levey), and by a grant from Amgen, Inc. During the course of this study, Amgen, Inc. and Amylin Pharmaceuticals, Inc. provided r-MetHuLeptin. Neither Amgen, Inc., nor Amylin Pharmaceuticals, Inc. contributed to the design, analysis, or writing of this study.	Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Alexe DM, 2006, CLIN MED RES, V4, P326, DOI 10.3121/cmr.4.4.326; Baicy K, 2007, P NATL ACAD SCI USA, V104, P18276, DOI 10.1073/pnas.0706481104; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Ben XM, 2001, CHINESE MED J-PEKING, V114, P636; BEREITER DA, 1979, BRAIN RES, V165, P249, DOI 10.1016/0006-8993(79)90557-2; BEREITER DA, 1980, BRAIN RES, V202, P201, DOI 10.1016/0006-8993(80)90655-1; Bluher Susann, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P458, DOI 10.1097/MED.0b013e3282f1cfdc; Bouret SG, 2007, J NEUROENDOCRINOL, V19, P575, DOI 10.1111/j.1365-2826.2007.01563.x; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Brennan Aoife M, 2007, Curr Diab Rep, V7, P1, DOI 10.1007/s11892-007-0001-y; Butler MG, 1998, AM J MED GENET, V75, P7, DOI 10.1002/(SICI)1096-8628(19980106)75:1<7::AID-AJMG3>3.3.CO;2-B; Ceddia RB, 2005, INT J OBESITY, V29, P1175, DOI 10.1038/sj.ijo.0803025; Chan JL, 2005, LANCET, V366, P74, DOI 10.1016/S0140-6736(05)66830-4; Chan JL, 2003, J CLIN INVEST, V111, P1409, DOI 10.1172/JCI200317490; Cock TA, 2003, LANCET, V362, P1572, DOI 10.1016/S0140-6736(03)14747-2; Durakoglugil M, 2005, J NEUROCHEM, V95, P396, DOI 10.1111/j.1471-4159.2005.03375.x; Ellis KJ, 1997, PEDIATR RES, V42, P484, DOI 10.1203/00006450-199710000-00010; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Garza JC, 2008, J BIOL CHEM, V283, P18238, DOI 10.1074/jbc.M800053200; Gibson WT, 2004, J CLIN ENDOCR METAB, V89, P4821, DOI 10.1210/jc.2004-0376; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Harvey J, 2003, ANN MED, V35, P197, DOI 10.1080/07853890310008251; Harvey J, 2003, NEUROPHARMACOLOGY, V44, P845, DOI 10.1016/S0028-3908(03)00076-5; Harvey J, 2007, CURR OPIN PHARMACOL, V7, P643, DOI 10.1016/j.coph.2007.10.006; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kratzsch J, 2005, J CLIN ENDOCR METAB, V90, P2212, DOI 10.1210/jc.2004-1454; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Licinio J, 2007, INT J OBESITY, V31, P1859, DOI 10.1038/sj.ijo.0803703; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Licinio J, 2007, APPETITE, V49, P594, DOI 10.1016/j.appet.2007.03.228; Mantzoros CS, 2001, J CLIN ENDOCR METAB, V86, P3284, DOI 10.1210/jc.86.7.3284; Matochik JA, 2005, J CLIN ENDOCR METAB, V90, P2851, DOI 10.1210/jc.2004-1979; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Rahilly S, 2007, BIOCHEM SOC T, V35, P33, DOI 10.1042/BST0350033; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Petridou E, 2005, CLIN ENDOCRINOL, V62, P366, DOI 10.1111/j.1365-2265.2005.02225.x; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Proulx K, 2002, ENDOCRINOLOGY, V143, P4683, DOI 10.1210/en.2002-220593; SENA A, 1985, J NEUROL SCI, V68, P233, DOI 10.1016/0022-510X(85)90104-2; Seufert J, 2004, DIABETES, V53, pS152, DOI 10.2337/diabetes.53.2007.S152; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Steppan CM, 1999, BIOCHEM BIOPH RES CO, V256, P600, DOI 10.1006/bbrc.1999.0382; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Udagawa J, 2006, ENDOCRINOLOGY, V147, P647, DOI 10.1210/en.2005-0791; Udagawa J, 2006, BRAIN RES, V1120, P74, DOI 10.1016/j.brainres.2006.08.116; Udagawa J, 2006, NEUROENDOCRINOL LETT, V27, P177; Walker CD, 2007, J NEUROSCI RES, V85, P816, DOI 10.1002/jnr.21173; Williamson DA, 2005, APPETITE, V45, P75, DOI 10.1016/j.appet.2005.01.002; Winocur G, 2005, BEHAV NEUROSCI, V119, P1389, DOI 10.1037/0735-7044.119.5.1389	59	110	112	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3098	10.1371/journal.pone.0003098	http://dx.doi.org/10.1371/journal.pone.0003098			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769731	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796800005
J	Hagni, K; Eng, K; Hepp-Reymond, MC; Holper, L; Keisker, B; Siekierka, E; Kiper, DC				Haegni, Karin; Eng, Kynan; Hepp-Reymond, Marie-Claude; Holper, Lisa; Keisker, Birgit; Siekierka, Ewa; Kiper, Daniel C.			Observing Virtual Arms that You Imagine Are Yours Increases the Galvanic Skin Response to an Unexpected Threat	PLOS ONE			English	Article								Multi-modal visuo-tactile stimulation of the type performed in the rubber hand illusion can induce the brain to temporarily incorporate external objects into the body image. In this study we show that audio-visual stimulation combined with mental imagery more rapidly elicits an elevated physiological response (skin conductance) after an unexpected threat to a virtual limb, compared to audio-visual stimulation alone. Two groups of subjects seated in front of a monitor watched a first-person perspective view of slow movements of two virtual arms intercepting virtual balls rolling towards the viewer. One group was instructed to simply observe the movements of the two virtual arms, while the other group was instructed to observe the virtual arms and imagine that the arms were their own. After 84 seconds the right virtual arm was unexpectedly "stabbed'' by a knife and began "bleeding''. This aversive stimulus caused both groups to show a significant increase in skin conductance. In addition, the observation-with-imagery group showed a significantly higher skin conductance (p<0.05) than the observation-only group over a 2-second period shortly after the aversive stimulus onset. No corresponding change was found in subjects' heart rates. Our results suggest that simple visual input combined with mental imagery may induce the brain to measurably temporarily incorporate external objects into its body image.	[Haegni, Karin; Kiper, Daniel C.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland; [Eng, Kynan; Hepp-Reymond, Marie-Claude; Holper, Lisa] Univ Zurich, ETH, Inst Neuroinformat, CH-8006 Zurich, Switzerland; [Keisker, Birgit] Univ Hosp Zurich, Inst Neuroradiol, Zurich, Switzerland; [Siekierka, Ewa] Univ Hosp Zurich, Dept Neurol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Hagni, K (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport, Zurich, Switzerland.	kynan@ini.phys.ethz.ch		Eng, Kynan/0000-0002-1434-8767; Holper, Lisa/0000-0002-2599-3649	Swiss National Center of Competence in Neural Plasticity and Repair; Gebert Ruf Foundation [GRS-059-05]	Swiss National Center of Competence in Neural Plasticity and Repair; Gebert Ruf Foundation	This work was supported by the Swiss National Center of Competence in Neural Plasticity and Repair, and by the Gebert Ruf Foundation grant GRS-059-05.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Binkofski F, 2000, HUM BRAIN MAPP, V11, P273, DOI 10.1002/1097-0193(200012)11:4<273::AID-HBM40>3.0.CO;2-0; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Critchley HD, 2000, J NEUROSCI, V20, P3033; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Ehrsson HH, 2007, SCIENCE, V317, P1048, DOI 10.1126/science.1142175; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ENG K, 2007, MED BIOL ENG COMPUTI; Eng K, 2007, MED BIOL ENG COMPUT, V45, P901, DOI 10.1007/s11517-007-0239-1; Gangitano M, 2001, NEUROREPORT, V12, P1489, DOI 10.1097/00001756-200105250-00038; Lenggenhager B, 2007, SCIENCE, V317, P1096, DOI 10.1126/science.1143439; Mandryk RL, 2004, PHYSL INDICATORS EVA; Meehan M, 2005, APPL PSYCHOPHYS BIOF, V30, P239, DOI 10.1007/s10484-005-6381-3; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pertaub DP, 2001, STUD HEALTH TECHNOL, V81, P372; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Scherberger H, 2007, J NEUROSCI, V27, P2001, DOI 10.1523/JNEUROSCI.4274-06.2007; SHERMER CD, 2000, ACAD EMERG MED, V7, P530; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; SVEBAK S, 1982, BIOL PSYCHOL, V14, P113, DOI 10.1016/0301-0511(82)90019-9; Sveistrup Heidi, 2004, J Neuroeng Rehabil, V1, P10, DOI 10.1186/1743-0003-1-10	30	32	32	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3082	10.1371/journal.pone.0003082	http://dx.doi.org/10.1371/journal.pone.0003082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769476	Green Published, gold			2022-12-27	WOS:000264796600004
J	Merabet, LB; Hamilton, R; Schlaug, G; Swisher, JD; Kiriakopoulos, ET; Pitskel, NB; Kauffman, T; Pascual-Leone, A				Merabet, Lotfi B.; Hamilton, Roy; Schlaug, Gottfried; Swisher, Jascha D.; Kiriakopoulos, Elaine T.; Pitskel, Naomi B.; Kauffman, Thomas; Pascual-Leone, Alvaro			Rapid and Reversible Recruitment of Early Visual Cortex for Touch	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TACTILE PERCEPTION; MULTISENSORY INTEGRATION; CORTICAL ACTIVITY; OCCIPITAL CORTEX; ADAPTIVE-CHANGES; NEURAL-NETWORKS; BLIND HUMANS; BRAILLE; ACTIVATION	Background: The loss of vision has been associated with enhanced performance in non-visual tasks such as tactile discrimination and sound localization. Current evidence suggests that these functional gains are linked to the recruitment of the occipital visual cortex for non-visual processing, but the neurophysiological mechanisms underlying these crossmodal changes remain uncertain. One possible explanation is that visual deprivation is associated with an unmasking of non-visual input into visual cortex. Methodology/Principal Findings: We investigated the effect of sudden, complete and prolonged visual deprivation (five days) in normally sighted adult individuals while they were immersed in an intensive tactile training program. Following the five-day period, blindfolded subjects performed better on a Braille character discrimination task. In the blindfold group, serial fMRI scans revealed an increase in BOLD signal within the occipital cortex in response to tactile stimulation after five days of complete visual deprivation. This increase in signal was no longer present 24 hours after blindfold removal. Finally, reversible disruption of occipital cortex function on the fifth day ( by repetitive transcranial magnetic stimulation; rTMS) impaired Braille character recognition ability in the blindfold group but not in non-blindfolded controls. This disruptive effect was no longer evident once the blindfold had been removed for 24 hours. Conclusions/Significance: Overall, our findings suggest that sudden and complete visual deprivation in normally sighted individuals can lead to profound, but rapidly reversible, neuroplastic changes by which the occipital cortex becomes engaged in processing of non-visual information. The speed and dynamic nature of the observed changes suggests that normally inhibited or masked functions in the sighted are revealed by visual loss. The unmasking of pre-existing connections and shifts in connectivity represent rapid, early plastic changes, which presumably can lead, if sustained and reinforced, to slower developing, but more permanent structural changes, such as the establishment of new neural connections in the blind.	[Merabet, Lotfi B.; Hamilton, Roy; Schlaug, Gottfried; Swisher, Jascha D.; Kiriakopoulos, Elaine T.; Pitskel, Naomi B.; Kauffman, Thomas; Pascual-Leone, Alvaro] Beth Israel Deaconess Med Ctr, Dept Neurol, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Merabet, LB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Ctr Noninvas Brain Stimulat, Boston, MA 02215 USA.	apleone@bidmc.harvard.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Merabet, Lotfi B./V-2735-2017; merabet, lotfi/AAU-8259-2020; Pascual-Leone, Alvaro/G-6566-2011	Pascual-Leone, Alvaro/0000-0001-8975-0382; Merabet, Lotfi B./0000-0002-8094-9536; merabet, lotfi/0000-0002-8094-9536; 	National Institutes of Health [RO1 EY12091, K24 RR018875, RR 01032]; Milton Foundation; Spanish Organization for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018875, M01RR001032] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milton Foundation; Spanish Organization for the Blind; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported in part by grants from the National Institutes of Health (RO1 EY12091, K24 RR018875), the Milton Foundation, the Spanish Organization for the Blind, and grant RR 01032 from the National Institutes of Health to the GCRC at BIDMC.	Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Burton H, 2004, HUM BRAIN MAPP, V23, P210, DOI 10.1002/hbm.20064; Burton H, 2002, J NEUROPHYSIOL, V88, P3359, DOI 10.1152/jn.00129.2002; Burton H, 2002, J NEUROPHYSIOL, V87, P589, DOI 10.1152/jn.00285.2001; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; Carroll T, 1961, BLINDNESS WHAT IT IS; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; Deibert E, 1999, NEUROLOGY, V52, P1413, DOI 10.1212/WNL.52.7.1413; Falchier A, 2002, J NEUROSCI, V22, P5749; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Goldreich D, 2003, J NEUROSCI, V23, P3439; Goldreich D, 2006, PERCEPT PSYCHOPHYS, V68, P1363, DOI 10.3758/BF03193735; Gougoux F, 2004, NATURE, V430, P309, DOI 10.1038/430309a; Grant AC, 2000, PERCEPT PSYCHOPHYS, V62, P301, DOI 10.3758/BF03205550; Gugino LD, 2001, CLIN NEUROPHYSIOL, V112, P1781, DOI 10.1016/S1388-2457(01)00633-2; Hamilton R, 2000, NEUROREPORT, V11, P237, DOI 10.1097/00001756-200002070-00003; Hamilton RH, 1998, TRENDS COGN SCI, V2, P168, DOI 10.1016/S1364-6613(98)01172-3; HOLLINS M, 1988, PERCEPT PSYCHOPHYS, V43, P380, DOI 10.3758/BF03208809; James TW, 2002, NEUROPSYCHOLOGIA, V40, P1706, DOI 10.1016/S0028-3932(02)00017-9; JOHANSSON RS, 1980, BRAIN RES, V184, P343, DOI 10.1016/0006-8993(80)90803-3; Kadosh RC, 2006, CURR BIOL, V16, pR962, DOI 10.1016/j.cub.2006.10.017; Kauffman T, 2002, NEUROREPORT, V13, P571, DOI 10.1097/00001756-200204160-00007; KUJALA T, 1995, NEUROSCI LETT, V183, P143, DOI 10.1016/0304-3940(94)11135-6; Kupers R, 2007, NEUROLOGY, V68, P691, DOI 10.1212/01.wnl.0000255958.60530.11; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Merabet L, 2004, NEURON, V42, P173, DOI 10.1016/S0896-6273(04)00147-3; Merabet LB, 2004, J NEURO-OPHTHALMOL, V24, P109, DOI 10.1097/00041327-200406000-00003; Merabet LB, 2007, J NEUROPHYSIOL, V97, P1633, DOI 10.1152/jn.00806.2006; Negyessy L, 2006, EUR J NEUROSCI, V23, P1919, DOI 10.1111/j.1460-9568.2006.04678.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pascual-Leone A, 2001, PROG BRAIN RES, V134, P427; Pascual-Leone A, 1999, NEUROPSYCHOLOGIA, V37, P207; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1993, BRAIN, V116, P39, DOI 10.1093/brain/116.1.39; Pietrini P, 2004, P NATL ACAD SCI USA, V101, P5658, DOI 10.1073/pnas.0400707101; Pitskel NB, 2007, NEUROREPORT, V18, P1703, DOI 10.1097/WNR.0b013e3282f0d2c1; Prather SC, 2002, COGNITIVE BRAIN RES, V14, P91, DOI 10.1016/S0926-6410(02)00063-0; Ramos-Estebanez C, 2007, J NEUROSCI, V27, P4178, DOI 10.1523/JNEUROSCI.5468-06.2007; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sadato Norihiro, 2006, Suppl Clin Neurophysiol, V59, P75; SATHIAN K, 1991, PERCEPT PSYCHOPHYS, V50, P237, DOI 10.3758/BF03206747; Sathian K, 1997, NEUROREPORT, V8, P3877, DOI 10.1097/00001756-199712220-00008; Sathian K, 2005, DEV PSYCHOBIOL, V46, P279, DOI 10.1002/dev.20056; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Stevens AA, 2007, J NEUROSCI, V27, P10734, DOI 10.1523/JNEUROSCI.1669-07.2007; Stoesz MR, 2003, INT J PSYCHOPHYSIOL, V50, P41, DOI 10.1016/S0167-8760(03)00123-5; Sur M, 2001, NAT REV NEUROSCI, V2, P251, DOI 10.1038/35067562; Theoret H, 2004, J PHYSIOL-PARIS, V98, P221, DOI 10.1016/j.jphysparis.2004.03.009; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; Wittenberg GF, 2004, EUR J NEUROSCI, V20, P1923, DOI 10.1111/j.1460-9568.2004.03630.x; Zangaladze A, 1999, NATURE, V401, P587, DOI 10.1038/44139; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107	62	178	179	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3046	10.1371/journal.pone.0003046	http://dx.doi.org/10.1371/journal.pone.0003046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728773	Green Published, Green Submitted, gold			2022-12-27	WOS:000264796400004
J	Zhang, Z; Chen, J; Guo, FZ; He, LR; Wu, YZ; Zeng, CQ; Xiao, XY; He, DC				Zhang, Zhao; Chen, Jian; Guo, Fuzheng; He, Liren; Wu, Yizhou; Zeng, Changqing; Xiao, Xueyuan; He, Dacheng			A High-Temporal Resolution Technology for Dynamic Proteomic Analysis Based on S-35 Labeling	PLOS ONE			English	Article								As more and more research efforts have been attracted to dynamic or differential proteomics, a method with high temporal resolution and high throughput is required. In present study, a S-35 in vivo Labeling Analysis for Dynamic Proteomics (SiLAD) was designed and tested by analyzing the dynamic proteome changes in the highly synchronized A549 cells, as well as in the rat liver 2/3 partial hepatectomy surgery. The results validated that SiLAD technique, in combination with 2-Dimensional Electrophoresis, provided a highly sensitivity method to illustrate the non-disturbed endogenous proteins dynamic changes with a good temporal resolution and high signal/noise ratio. A significant number of differential proteins can be discovered or re-categorized by this technique. Another unique feature of SiLAD is its capability of quantifying the rate of protein expression, which reflects the cellular physiological turn points more effectively. Finally, the prescribed SiLAD proteome snapshot pattern could be potentially used as an exclusive symbol for characterizing each stage in well regulated biological processes.	[Zhang, Zhao; Chen, Jian; Guo, Fuzheng; He, Liren; Wu, Yizhou; Zeng, Changqing; Xiao, Xueyuan; He, Dacheng] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Univ Confederated Inst Prote, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, Z (corresponding author), Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat Biol, Univ Confederated Inst Prote, Beijing 100875, Peoples R China.	dhe@bnu.edu.cn	Wang, Limin/O-3724-2015		Major State Basic Research Program of China [2006CB910100]; NSF [90208020]; Natural Science Foundation of Beijing [30671066]; Science Technology Committee of Beijing [Y0204002040111]	Major State Basic Research Program of China(National Basic Research Program of China); NSF(National Science Foundation (NSF)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Science Technology Committee of Beijing	This work was supported by Special Grant of the Major State Basic Research Program of China (No. 2006CB910100), NSF Major Plans Grant (90208020), Natural Science Foundation of Beijing (No. 30671066) and Science Technology Committee of Beijing (No. Y0204002040111).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Dasgupta P, 2004, MOL CELL BIOL, V24, P9527, DOI 10.1128/MCB.24.21.9527-9541.2004; Dengjel J, 2007, NAT BIOTECHNOL, V25, P566, DOI 10.1038/nbt1301; Fatatis A, 1999, FASEB J, V13, P1291, DOI 10.1096/fasebj.13.11.1291; Guo FZ, 2006, PROTEOMICS, V6, P3075, DOI 10.1002/pmic.200500322; Halligan BD, 2004, NUCLEIC ACIDS RES, V32, pW638, DOI 10.1093/nar/gkh356; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu VW, 2001, FASEB J, V15, P1562, DOI 10.1096/fj.01-0102com; Julka Samir, 2005, Briefings in Functional Genomics & Proteomics, V4, P158, DOI 10.1093/bfgp/4.2.158; Lay AJ, 2000, NATURE, V408, P869, DOI 10.1038/35048596; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mazzotti G, 1998, MICROSC RES TECHNIQ, V40, P418, DOI 10.1002/(SICI)1097-0029(19980301)40:5<418::AID-JEMT8>3.0.CO;2-M; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Monteoliva Lucia, 2004, Briefings in Functional Genomics & Proteomics, V3, P220, DOI 10.1093/bfgp/3.3.220; Motiwala T, 2004, P NATL ACAD SCI USA, V101, P13844, DOI 10.1073/pnas.0405451101; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Schubert P, 2006, ANAL BIOANAL CHEM, V386, P482, DOI 10.1007/s00216-006-0609-9; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; VISHWANATHA JK, 1992, J CELL SCI, V101, P25; Yarm FR, 2002, MOL CELL BIOL, V22, P6209, DOI 10.1128/MCB.22.17.6209-6221.2002; Zwijsen RML, 1996, MOL CELL BIOL, V16, P2554	24	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2991	10.1371/journal.pone.0002991	http://dx.doi.org/10.1371/journal.pone.0002991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714357	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900017
J	Chapple, CE; Guigo, R				Chapple, Charles E.; Guigo, Roderic			Relaxation of Selective Constraints Causes Independent Selenoprotein Extinction in Insect Genomes	PLOS ONE			English	Article							SELENOCYSTEINE INSERTION SYSTEM; MULTIPLE SEQUENCE ALIGNMENT; IN-SILICO IDENTIFICATION; DROSOPHILA; ANTIOXIDANT; MITOCHONDRIAL; DISRUPTION; REDUCTASE; DEFENSE; PATTERN	Background: Selenoproteins are a diverse family of proteins notable for the presence of the 21st amino acid, selenocysteine. Until very recently, all metazoan genomes investigated encoded selenoproteins, and these proteins had therefore been believed to be essential for animal life. Challenging this assumption, recent comparative analyses of insect genomes have revealed that some insect genomes appear to have lost selenoprotein genes. Methodology/Principal Findings: In this paper we investigate in detail the fate of selenoproteins, and that of selenoprotein factors, in all available arthropod genomes. We use a variety of in silico comparative genomics approaches to look for known selenoprotein genes and factors involved in selenoprotein biosynthesis. We have found that five insect species have completely lost the ability to encode selenoproteins and that selenoprotein loss in these species, although so far confined to the Endopterygota infraclass, cannot be attributed to a single evolutionary event, but rather to multiple, independent events. Loss of selenoproteins and selenoprotein factors is usually coupled to the deletion of the entire no-longer functional genomic region, rather than to sequence degradation and consequent pseudogenisation. Such dynamics of gene extinction are consistent with the high rate of genome rearrangements observed in Drosophila. We have also found that, while many selenoprotein factors are concomitantly lost with the selenoproteins, others are present and conserved in all investigated genomes, irrespective of whether they code for selenoproteins or not, suggesting that they are involved in additional, non-selenoprotein related functions. Conclusions/Significance: Selenoproteins have been independently lost in several insect species, possibly as a consequence of the relaxation in insects of the selective constraints acting across metazoans to maintain selenoproteins. The dispensability of selenoproteins in insects may be related to the fundamental differences in antioxidant defense between these animals and other metazoans.	[Chapple, Charles E.] Inst Municipal Invest Med, Barcelona, Spain; [Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Chapple, CE (corresponding author), Univ Pompeu Fabra, Ctr Genom Regulat, Catalonia, Spain.	roderic.guigo@crg.es	Guigo, Roderic/D-1303-2010	Guigo, Roderic/0000-0002-5738-4477	Spanish Ministery of Education and Science [pre-doctoral fellowship]; BioSapiens European Network of Excellence	Spanish Ministery of Education and Science(Spanish Government); BioSapiens European Network of Excellence	The work described here is funded by grants from the Spanish Ministery of Education and Science and from the BioSapiens European Network of Excellence to RG. CEC is reciepient of a pre-doctoral fellowship from the Spanish Ministery of Education and Science.	Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; Alsina B, 1999, J CELL SCI, V112, P2875; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bock A., 2006, SELENIUM ITS MOL BIO, V2nd, P9, DOI DOI 10.1007/0-387-33827-6_2; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Cameron Stephen L., 2006, Arthropod Systematics & Phylogeny, V64, P27; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; Castellano S, 2001, EMBO REP, V2, P697, DOI 10.1093/embo-reports/kve151; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Chen P, 2006, CHINESE SCI BULL, V51, P2860, DOI 10.1007/s11434-006-2206-x; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gromer S, 2003, P NATL ACAD SCI USA, V100, P12618, DOI 10.1073/pnas.2134510100; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrell L, 2002, NUCLEIC ACIDS RES, V30, P2011, DOI 10.1093/nar/30.9.2011; Hassanin A, 2006, MOL PHYLOGENET EVOL, V38, P100, DOI 10.1016/j.ympev.2005.09.012; Hirosawa-Takamori M, 2004, EMBO REP, V5, P317, DOI 10.1038/sj.embor.7400097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kwon SY, 2003, MOL CELL BIOL, V23, P8495, DOI 10.1128/MCB.23.23.8495-8504.2003; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Lobanov AV, 2008, PROTEIN SCI, V17, P176, DOI 10.1110/ps.073261508; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu CL, 2006, FEBS LETT, V580, P5189, DOI 10.1016/j.febslet.2006.08.065; Maiorino M, 2007, J MOL BIOL, V365, P1033, DOI 10.1016/j.jmb.2006.10.033; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Missirlis F, 2002, J BIOL CHEM, V277, P11521, DOI 10.1074/jbc.M111692200; Missirlis F, 2001, CURR BIOL, V11, P1272, DOI 10.1016/S0960-9822(01)00393-1; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Morozova N, 2003, GENES CELLS, V8, P963, DOI 10.1046/j.1365-2443.2003.00687.x; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Novoselov SV, 2002, EMBO J, V21, P3681, DOI 10.1093/emboj/cdf372; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Sato M, 2003, BIOINFORMATICS, V19, P1371, DOI 10.1093/bioinformatics/btg183; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; SMALLHOWARD A, 2006, SELENIUM ITS MOL BIO, P81; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Taskov K, 2005, NUCLEIC ACIDS RES, V33, P2227, DOI 10.1093/nar/gki507; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Whiting MF, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P69; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	54	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2968	10.1371/journal.pone.0002968	http://dx.doi.org/10.1371/journal.pone.0002968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698431	Green Published, gold			2022-12-27	WOS:000264412600053
J	Bilican, B; Fiore-Heriche, C; Compston, A; Allen, ND; Chandran, S				Bilican, Bilada; Fiore-Heriche, Christelle; Compston, Alastair; Allen, Nicholas D.; Chandran, Siddharthan			Induction of Olig2(+) Precursors by FGF Involves BMP Signalling Blockade at the Smad Level	PLOS ONE			English	Article								During normal development oligodendrocyte precursors (OPCs) are generated in the ventral spinal cord in response to Sonic hedgehog (Shh) signalling. There is also a second, late wave of oligodendrogenesis in the dorsal spinal cord independent of Shh activity. Two signalling pathways, controlled by bone morphogenetic protein and fibroblast growth factor (FGF), are active players in dorsal spinal cord specification. In particular, BMP signalling from the roof plate has a crucial role in setting up dorsal neural identity and its inhibition is sufficient to generate OPCs both in vitro and in vivo. In contrast, FGF signalling can induce OPC production from dorsal spinal cord cultures in vitro. In this study, we examined the cross-talk between mitogen-activated protein kinase (MAPK) and BMP signalling in embryonic dorsal spinal cord cultures at the SMAD1/5/8 (SMAD1) transcription factor level, the main effectors of BMP activity. We have previously shown that FGF2 treatment of neural precursor cells (NPCs) derived from rat E14 dorsal spinal cord is sufficient to generate OPCs in vitro. Utilising the same system, we now show that FGF prevents BMP-induced nuclear localisation of SMAD1-phosphorylated at the C-terminus (C-term-pSMAD1). This nuclear exclusion of C-term-pSMAD1 is dependent on MAPK activity and correlates with OLIG2 upregulation, the obligate transcription factor for oligodendrogenesis. Furthermore, inhibition of the MAPK pathway abolishes OLIG2 expression. We also show that SMAD4, which acts as a common partner for receptor-regulated Smads including SMAD1, associates with a Smad binding site in the Olig2 promoter and dissociates from it upon differentiation. Taken together, these results suggest that FGF can promote OPC generation from embryonic NPCs by counteracting BMP signalling at the Smad1 transcription factor level and that Smad-containing transcriptional complexes may be involved in direct regulation of the Olig2 promoter.	[Bilican, Bilada; Compston, Alastair; Chandran, Siddharthan] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Fiore-Heriche, Christelle] Univ Cambridge, MRC Res Ctr, Dept Oncol Hutchison, Cambridge, England; [Allen, Nicholas D.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	University of Cambridge; University of Cambridge; Cardiff University	Bilican, B (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	bb337@cam.ac.uk	Messier, Claude/A-2322-2008; allen, nick d/A-4336-2010	Messier, Claude/0000-0002-4791-1763; Allen, Nicholas/0000-0003-4009-186X	Husky Foundation; Medical Research Council (UK); BBSRC	Husky Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the Husky Foundation, Medical Research Council (UK), BBSRC and Sir David Walker. Funding bodies had no input on design and conduct of experiments or interpretation of data.	Attisano L, 2001, GENOME BIOL, V2; Bambakidis Nicholas C, 2004, Spine J, V4, P16, DOI 10.1016/j.spinee.2003.07.004; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; Cai J, 2005, NEURON, V45, P41, DOI 10.1016/j.neuron.2004.12.028; Chandran S, 2003, DEVELOPMENT, V130, P6599, DOI 10.1242/dev.00871; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984; Kuroda H, 2005, GENE DEV, V19, P1022, DOI 10.1101/gad.1306605; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mekki-Dauriac S, 2002, DEVELOPMENT, V129, P5117; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Miller RH, 2004, J NEUROSCI RES, V76, P9, DOI 10.1002/jnr.20047; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Murtaugh LC, 2001, DEV CELL, V1, P411, DOI 10.1016/S1534-5807(01)00039-9; Orentas DM, 1999, DEVELOPMENT, V126, P2419; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Schmiesing JA, 2000, MOL CELL BIOL, V20, P6996, DOI 10.1128/MCB.20.18.6996-7006.2000; Spagnoli FM, 2006, CURR OPIN GENET DEV, V16, P469, DOI 10.1016/j.gde.2006.08.004; Stavridis MP, 2003, BIOCHEM SOC T, V31, P45, DOI 10.1042/bst0310045; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; TSANG M, 2004, SCI STKE, pPE17, DOI DOI 10.1126/STKE.2282004PE17; Vallstedt A, 2005, NEURON, V45, P55, DOI 10.1016/j.neuron.2004.12.026; WARF BC, 1991, J NEUROSCI, V11, P2477; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Woodruff RH, 2001, INT J DEV NEUROSCI, V19, P379, DOI 10.1016/S0736-5748(00)00083-6; Xian HQ, 2005, BIOCHEM BIOPH RES CO, V327, P155, DOI 10.1016/j.bbrc.2004.11.149; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	46	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2863	10.1371/journal.pone.0002863	http://dx.doi.org/10.1371/journal.pone.0002863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682850	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000264366600019
J	Dromer, F; Bernede-Bauduin, C; Guillemot, D; Lortholary, O				Dromer, Francoise; Bernede-Bauduin, Claire; Guillemot, Didier; Lortholary, Olivier		French Cryptococcosis Study Grp	Major Role for Amphotericin B-Flucytosine Combination in Severe Cryptococcosis	PLOS ONE			English	Article								Background: The Infectious Diseases Society of America published in 2000 practical guidelines for the management of cryptococcosis. However, treatment strategies have not been fully validated in the various clinical settings due to exclusion criteria during therapeutic trials. We assessed here the optimal therapeutic strategies for severe cryptococcosis using the observational prospective CryptoA/D study after analyzing routine clinical care of cryptococcosis in university or tertiary care hospitals. Methodology/Principal Findings: Patients were enrolled if at least one culture grew positive with Cryptococcus neoformans. Control of sterilization was warranted 2 weeks (Wk2) and 3 months (Mo3) after antifungal therapy onset. 208 HIV-positive or -negative adult patients were analyzed. Treatment failure (death or mycological failure) at Wk2 and Mo3 was the main outcome measured. Combination of amphotericin B+flucytosine (AMB+5FC) was the best regimen for induction therapy in patients with meningoencephalitis and in all patients with high fungal burden and abnormal neurology. In those patients, treatment failure at Wk2 was 26% in the AMB+5FC group vs. 56% with any other treatments (p<0.001). In patients treated with AMB+5FC, factors independently associated with Wk2 mycological failure were high serum antigen titer (OR [95%CI] = 4.43[1.21-16.23], p = 0.025) and abnormal brain imaging (OR = 3.89[1.23-12.31], p = 0.021) at baseline. Haematological malignancy (OR = 4.02[1.32-12.25], p = 0.015), abnormal neurology at baseline (OR = 2.71[1.10-6.69], p = 0.030) and prescription of 5FC for less than 14 days (OR = 3.30[1.12-9.70], p = 0.030) were independently associated with treatment failure at Mo3. Conclusion/Significance: Our results support the conclusion that induction therapy with AMB+5FC for at least 14 days should be prescribed rather than any other induction treatments in all patients with high fungal burden at baseline regardless of their HIV serostatus and of the presence of proven meningoencephalitis.	[Dromer, Francoise; Lortholary, Olivier] CNRS, URA3012, Ctr Natl Reference Mycol & Antifong, Inst Pasteur, Paris, France; [Bernede-Bauduin, Claire; Guillemot, Didier] INSERM U657, Paris, France; [Bernede-Bauduin, Claire; Guillemot, Didier] Inst Pasteur, Paris, France; [Guillemot, Didier] Univ Versailles Saint Quentin, Fac Med Paris Ile France Ouest, Versailles, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malades, Ctr Infectiol Necker Pasteur, Serv Maladies Infect Trop, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Dromer, F (corresponding author), CNRS, URA3012, Ctr Natl Reference Mycol & Antifong, Inst Pasteur, Paris, France.	dromer@pasteur.fr	Guillemot, Didier/AAN-3051-2020	Guillemot, Didier/0000-0002-8497-1765	Institut Pasteur; Institut de Veille Sanitaire; Ensemble contre le sida-SIDACTION	Institut Pasteur(European Commission); Institut de Veille Sanitaire; Ensemble contre le sida-SIDACTION	The financial contribution of Institut Pasteur (through the "programme de recherche clinique), Institut de Veille Sanitaire (through the National Reference Center for Mycoses and Antifungals) and of Ensemble contre le sida-SIDACTION (through a grant to FD) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 2001, STAT METHODS MED RES; BENNETT JE, 1979, NEW ENGL J MED, V301, P126, DOI 10.1056/NEJM197907193010303; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Brouwer AE, 2005, J INFECT DIS, V192, P681, DOI 10.1086/432073; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Brouwer AE, 2007, ANTIMICROB AGENTS CH, V51, P1038, DOI 10.1128/AAC.01188-06; CHARLIER C, 2008, PLOS ONE IN PRESS; Dannaoui E, 2006, ANTIMICROB AGENTS CH, V50, P2464, DOI 10.1128/AAC.01520-05; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; DROMER F, 1996, CLIN INFECT DIS   S2, V22, P154; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603; HAMILL R, 1999, 39 INT C ANT AG CHEM; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Joly V, 1996, CLIN INFECT DIS, V23, P556, DOI 10.1093/clinids/23.3.556; Jongwutiwes U, 2007, CURR HIV RES, V5, P355, DOI 10.2174/157016207780636551; Larsen RA, 2007, ANTIMICROB AGENTS CH, V51, P343, DOI 10.1128/AAC.00742-06; Larsen RA, 2005, ANTIMICROB AGENTS CH, V49, P952, DOI 10.1128/AAC.49.3.952-958.2005; Larsen RA, 1996, ANTIMICROB AGENTS CH, V40, P2178, DOI 10.1128/AAC.40.9.2178; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Lortholary O, 1999, J ANTIMICROB CHEMOTH, V43, P817, DOI 10.1093/jac/43.6.817; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; McCarthy KM, 2006, AIDS, V20, P2199, DOI 10.1097/QAD.0b013e3280106d6a; Micol R, 2007, JAIDS-J ACQ IMM DEF, V45, P555, DOI 10.1097/QAI.0b013e31811ed32c; Mirza SA, 2003, CLIN INFECT DIS, V36, P789, DOI 10.1086/368091; PAPPAS P, 2007, 46 ANN C ANT AG CHEM; Pappas Peter G., 2001, Curr Infect Dis Rep, V3, P365, DOI 10.1007/s11908-001-0077-5; Pappas PG, 2004, J INFECT DIS, V189, P2185, DOI 10.1086/420829; Perfect JR, 2007, PLOS MED, V4, P232, DOI 10.1371/journal.pmed.0040047; Pitisuttithum P, 2001, J INFECTION, V43, P226, DOI 10.1053/jinf.2001.0916; Robinson PA, 1999, CLIN INFECT DIS, V28, P82, DOI 10.1086/515074; Saag MS, 1999, CLIN INFECT DIS, V28, P291, DOI 10.1086/515110; SAAG MS, 1992, NEW ENGL J MED, V326, P83, DOI 10.1056/NEJM199201093260202; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Schwarz P, 2006, ANTIMICROB AGENTS CH, V50, P113, DOI 10.1128/AAC.50.1.113-120.2006; Schwarz P, 2007, ANTIMICROB AGENTS CH, V51, P383, DOI 10.1128/AAC.00446-06; Sharkey PK, 1996, CLIN INFECT DIS, V22, P315, DOI 10.1093/clinids/22.2.315; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; WHITE M, 1992, J INFECT DIS, V165, P960, DOI 10.1093/infdis/165.5.960	40	81	88	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2870	10.1371/journal.pone.0002870	http://dx.doi.org/10.1371/journal.pone.0002870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682846	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600026
J	Fu, XD; Giretti, MS; Baldacci, C; Garibaldi, S; Flamini, M; Sanchez, AM; Gadducci, A; Genazzani, AR; Simoncini, T				Fu, Xiao-Dong; Giretti, Maria S.; Baldacci, Chiara; Garibaldi, Silvia; Flamini, Marina; Sanchez, Angel Matias; Gadducci, Angiolo; Genazzani, Andrea R.; Simoncini, Tommaso			Extra-Nuclear Signaling of Progesterone Receptor to Breast Cancer Cell Movement and Invasion through the Actin Cytoskeleton	PLOS ONE			English	Article								Progesterone plays a role in breast cancer development and progression but the effects on breast cancer cell movement or invasion have not been fully explored. In this study, we investigate the actions of natural progesterone and of the synthetic progestin medroxyprogesterone acetate (MPA) on actin cytoskeleton remodeling and on breast cancer cell movement and invasion. In particular, we characterize the nongenomic signaling cascades implicated in these actions. T47-D breast cancer cells display enhanced horizontal migration and invasion of three-dimensional matrices in the presence of both progestins. Exposure to the hormones triggers a rapid remodeling of the actin cytoskeleton and the formation of membrane ruffles required for cell movement, which are dependent on the rapid phosphorylation of the actin-regulatory protein moesin. The extra-cellular small GTPase RhoA/Rho-associated kinase (ROCK-2) cascade plays central role in progesterone-and MPA-induced moesin activation, cell migration and invasion. In the presence of progesterone, progesterone receptor A (PRA) interacts with the G protein G alpha(13), while MPA drives PR to interact with tyrosine kinase c-Src and to activate phosphatidylinositol-3 kinase, leading to the activation of RhoA/ROCK-2. In conclusion, our findings manifest that progesterone and MPA promote breast cancer cell movement via rapid actin cytoskeleton remodeling, which are mediated by moesin activation. These events are triggered by RhoA/ROCK-2 cascade through partially differing pathways by the two compounds. These results provide original mechanistic explanations for the effects of progestins on breast cancer progression and highlight potential targets to treat endocrine-sensitive breast cancers.	[Fu, Xiao-Dong; Giretti, Maria S.; Baldacci, Chiara; Garibaldi, Silvia; Flamini, Marina; Sanchez, Angel Matias; Gadducci, Angiolo; Genazzani, Andrea R.; Simoncini, Tommaso] Univ Pisa, MCGEL, Dept Reprod Med & Child Dev, Pisa, Italy; [Fu, Xiao-Dong] Sun Yat sen Univ, Zhongshan Sch Med, Dept Physiol, Guangzhou, Peoples R China	University of Pisa; Sun Yat Sen University	Simoncini, T (corresponding author), Univ Pisa, MCGEL, Dept Reprod Med & Child Dev, Pisa, Italy.	t.simoncini@obgyn.med.unipi.it	Simoncini, Tommaso/AAC-1879-2019; Gadducci, Angiolo/AAC-1332-2019	Simoncini, Tommaso/0000-0002-2971-0079; Gadducci, Angiolo/0000-0002-4404-406X	Italian University and Scientific Research Ministry (MIUR) [2004057090_007]	Italian University and Scientific Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by PRIN grant 2004057090_007 by the Italian University and Scientific Research Ministry (MIUR).	Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Faivre EJ, 2007, MOL CELL BIOL, V27, P466, DOI 10.1128/MCB.01539-06; Fournier A, 2005, INT J CANCER, V114, P448, DOI 10.1002/ijc.20710; Fournier A, 2008, J CLIN ONCOL, V26, P1260, DOI 10.1200/JCO.2007.13.4338; Fu XD, 2007, SEMIN REPROD MED, V25, P178, DOI 10.1055/s-2007-973430; Giretti MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002238; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; Hughes SC, 2007, CURR OPIN CELL BIOL, V19, P51, DOI 10.1016/j.ceb.2006.12.004; Humphreys RC, 1997, J MAMMARY GLAND BIOL, V2, P343, DOI 10.1023/A:1026343212187; Hyder SM, 2001, INT J CANCER, V92, P469, DOI 10.1002/ijc.1236; Kamps AR, 2005, ANN NY ACAD SCI, V1049, P17, DOI 10.1196/annals.1334.003; Karteris E, 2006, MOL ENDOCRINOL, V20, P1519, DOI 10.1210/me.2005-0243; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Kato S, 2005, J CLIN ENDOCR METAB, V90, P1181, DOI 10.1210/jc.2004-0857; Kelly P, 2006, J BIOL CHEM, V281, P26483, DOI 10.1074/jbc.M604376200; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Lee S, 2006, INT J CANCER, V118, P1285, DOI 10.1002/ijc.21481; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Louvet-Vallee S, 2000, BIOL CELL, V92, P305, DOI 10.1016/S0248-4900(00)01078-9; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Machelon V, 1996, J CELL BIOCHEM, V61, P619, DOI 10.1002/(SICI)1097-4644(19960616)61:4<619::AID-JCB16>3.0.CO;2-A; McGowan EM, 2003, J MOL ENDOCRINOL, V31, P241, DOI 10.1677/jme.0.0310241; Mote PA, 2002, BREAST CANCER RES TR, V72, P163, DOI 10.1023/A:1014820500738; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Ross RK, 2000, JNCI-J NATL CANCER I, V92, P328, DOI 10.1093/jnci/92.4.328; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Saitoh M, 2005, ENDOCRINOLOGY, V146, P4917, DOI 10.1210/en.2004-1535; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Simoncini T, 2004, ENDOCRINOLOGY, V145, P5745, DOI 10.1210/en.2004-0510; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Sitruk-Ware R, 2003, ANN ENDOCRINOL-PARIS, V64, P178; Stanczyk FZ, 2003, STEROIDS, V68, P879, DOI 10.1016/j.steroids.2003.08.003; Thomas CP, 2006, AM J PHYSIOL-RENAL, V290, pF306, DOI 10.1152/ajprenal.00062.2005; Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507; Vanzulli SI, 2005, CARCINOGENESIS, V26, P1055, DOI 10.1093/carcin/bgi060; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	51	76	79	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2790	10.1371/journal.pone.0002790	http://dx.doi.org/10.1371/journal.pone.0002790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665217	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300009
J	Jaron, B; Maranghi, E; Leclerc, C; Majlessi, L				Jaron, Barbara; Maranghi, Eddie; Leclerc, Claude; Majlessi, Laleh			Effect of Attenuation of Treg during BCG Immunization on Anti-Mycobacterial Th1 Responses and Protection against Mycobacterium tuberculosis	PLOS ONE			English	Article							REGULATORY T-CELLS; CUTTING EDGE; BOVIS BCG; FUNCTIONAL INACTIVATION; ENHANCE PROTECTION; IMMUNE-RESPONSE; CD4(+)CD25(+); MICE; VACCINATION; INFECTION	Background: The functional equilibrium between natural regulatory T cells (Treg) and effector T cells can affect the issue of numerous infections. In unvaccinated mice, the influence of Treg in the control of primary infection with mycobacteria remains controversial. Methodology: Here, we evaluated the role of Treg during prophylactic vaccination with Mycobacterium bovis BCG (Bacillus Calmette-Guerin) on the induction of T cell responses and on the protective effect against subsequent M. tuberculosis challenge in mice. Principal Findings: We demonstrated that, subsequent to BCG injection, Treg were recruited to the draining lymph nodes and negatively control anti-mycobacterial CD4(+) - but not CD8(+) - T-cell responses. Treatment of BCG-immunized mice with an anti-CD25 mAb (PC61) induced an increase IFN-gamma response against both subdominant and immunodominant regions of the protective immunogen TB10.4. In Treg-attenuated, BCG-immunized mice, which were then infected with M. tuberculosis, the lung mycobacterial load was significantly, albeit moderately, reduced compared to the control mice. Conclusions: Our results provide the first demonstration that attenuation of Treg subset concomitant to BCG vaccination has a positive, yet limited, impact on the protective capacity of this vaccine against infection with M. tuberculosis. Thus, for rational design of improved BCG, it should be considered that, although the action of Treg does not represent the major cause of the limited efficiency of BCG, the impact of this cell population on the subsequent control of M. tuberculosis growth is significant and measurable.	[Jaron, Barbara; Leclerc, Claude; Majlessi, Laleh] Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, Paris, France; [Maranghi, Eddie] Inst Pasteur, Animalerie Centrale, Paris, France; [Jaron, Barbara; Leclerc, Claude; Majlessi, Laleh] Inst Natl Sante & Rech Med, U883, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jaron, B (corresponding author), Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, Paris, France.	lmajless@pasteur.fr			European [HEALTH-F3-2007-201762]	European(European Science Foundation (ESF))	European contract HEALTH-F3-2007-201762	Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189; Brandt L, 2002, INFECT IMMUN, V70, P672, DOI 10.1128/IAI.70.2.672-678.2002; Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Cohen J, 2006, SCIENCE, V313, P1554; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Doherty TM, 2005, VACCINE, V23, P2109, DOI 10.1016/j.vaccine.2005.01.060; Fecci PE, 2006, CLIN CANCER RES, V12, P4294, DOI 10.1158/1078-0432.CCR-06-0053; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; Gordon SV, 1999, MOL MICROBIOL, V32, P643, DOI 10.1046/j.1365-2958.1999.01383.x; Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05; Hill JA, 2007, NAT IMMUNOL, V8, P124, DOI 10.1038/ni0207-124; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994; Kamath AB, 2004, J EXP MED, V200, P1479, DOI 10.1084/jem.20041690; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kursar M, 2002, J EXP MED, V196, P1585, DOI 10.1084/jem.20011347; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; LECLERC C, 1991, J VIROL, V65, P711, DOI 10.1128/JVI.65.2.711-718.1991; Lohr J, 2006, IMMUNOL REV, V212, P149, DOI 10.1111/j.0105-2896.2006.00414.x; Lyadova IV, 2000, J IMMUNOL, V165, P5921, DOI 10.4049/jimmunol.165.10.5921; Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006; Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570; Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003; Majlessi L, 2007, J IMMUNOL, V179, P1825, DOI 10.4049/jimmunol.179.3.1825; Manca C, 1999, J IMMUNOL, V162, P6740; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Preville X, 2005, CANCER RES, V65, P641; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Quinn KM, 2008, EUR J IMMUNOL, V38, P695, DOI 10.1002/eji.200737888; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Stephens LA, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036; Taylor MD, 2005, J IMMUNOL, V174, P4924, DOI 10.4049/jimmunol.174.8.4924; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; WHO, 2007, WHO REP 2007; Zelenay S, 2006, J IMMUNOL, V177, P2036, DOI 10.4049/jimmunol.177.4.2036-a	47	59	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2833	10.1371/journal.pone.0002833	http://dx.doi.org/10.1371/journal.pone.0002833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665224	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300052
J	Johnston, J; Iser, WB; Chow, DK; Goldberg, IG; Wolkow, CA				Johnston, Josiah; Iser, Wendy B.; Chow, David K.; Goldberg, Ilya G.; Wolkow, Catherine A.			Quantitative Image Analysis Reveals Distinct Structural Transitions during Aging in Caenorhabditis elegans Tissues	PLOS ONE			English	Article							GENE-EXPRESSION PROFILE; TRANSCRIPTIONAL PROFILE; MUSCLE STRENGTH; MORTALITY; PROTEINS; PATTERNS; CYCLE; MASS	Aging is associated with functional and structural declines in many body systems, even in the absence of underlying disease. In particular, skeletal muscles experience severe declines during aging, a phenomenon termed sarcopenia. Despite the high incidence and severity of sarcopenia, little is known about contributing factors and development. Many studies focus on functional aspects of aging-related tissue decline, while structural details remain understudied. Traditional approaches for quantifying structural changes have assessed individual markers at discrete intervals. Such approaches are inadequate for the complex changes associated with aging. An alternative is to consider changes in overall morphology rather than in specific markers. We have used this approach to quantitatively track tissue architecture during adulthood and aging in the C. elegans pharynx, the neuromuscular feeding organ. Using pattern recognition to analyze aged-grouped pharynx images, we identified discrete step-wise transitions between distinct morphologies. The morphology state transitions were maintained in mutants with pharynx neurotransmission defects, although the pace of the transitions was altered. Longitudinal measurements of pharynx function identified a predictive relationship between mid-life pharynx morphology and function at later ages. These studies demonstrate for the first time that adult tissues undergo distinct structural transitions reflecting postdevelopmental events. The processes that underlie these architectural changes may contribute to increased disease risk during aging, and may be targets for factors that alter the aging rate. This work further demonstrates that pattern analysis of an image series offers a novel and generally accessible approach for quantifying morphological changes and identifying structural biomarkers.	[Johnston, Josiah; Goldberg, Ilya G.] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Iser, Wendy B.; Chow, David K.; Wolkow, Catherine A.] NIA, Lab Neurosci, Intramural Res Program, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Johnston, J (corresponding author), NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	igg@nih.gov; wolkowca@grc.nia.nih.gov	Goldberg, Ilya/H-5307-2011	Goldberg, Ilya/0000-0001-8514-6110	National Institute on Aging, National Institutes of Health; Ellison Medical Foundation [New Scholar in Aging Award]; NATIONAL INSTITUTE ON AGING [ZICAG000685, ZIAAG000320] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Wolkow and Goldberg labs are funded by the National Institute on Aging as part of the National Institutes of Health Intramural Research Program. This work was also supported by a New Scholar in Aging Award from the Ellison Medical Foundation (C.A.W.).	Bishop C. M, 2006, PATTERN RECOGNITION; BRENNER S, 1974, GENETICS, V77, P71; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Chow DK, 2006, EXP GERONTOL, V41, P252, DOI 10.1016/j.exger.2005.12.004; de Fockert JW, 2001, SCIENCE, V291, P1803, DOI 10.1126/science.1056496; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Garigan D, 2002, GENETICS, V161, P1101; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Helfrich YR, 2007, ARCH DERMATOL, V143, P397, DOI 10.1001/archderm.143.3.397; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; JOHNSON TE, 1987, P NATL ACAD SCI USA, V84, P3777, DOI 10.1073/pnas.84.11.3777; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Locke John, 1690, ESSAY HUMANE UNDERST; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Murphy RF, 2006, NAT BIOTECHNOL, V24, P1223, DOI 10.1038/nbt1006-1223; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Orlov N, 2006, I S BIOMED IMAGING, P1152; ORLOV N, 2007, VISION SYSTEMS SEGME; ORLOV N, 2008, WND CHARM MULTIPURPO; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Rantanen T, 2000, J GERONTOL A-BIOL, V55, pM168, DOI 10.1093/gerona/55.3.M168; Rodwell GEJ, 2004, PLOS BIOL, V2, P2191, DOI 10.1371/journal.pbio.0020427; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Wolkow CA, 2006, EXP GERONTOL, V41, P1001, DOI 10.1016/j.exger.2006.06.033; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115	35	43	48	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2821	10.1371/journal.pone.0002821	http://dx.doi.org/10.1371/journal.pone.0002821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665238	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300040
J	Pacheco, AG; Durovni, B; Cavalcante, SC; Lauria, LM; Moore, RD; Moulton, LH; Chaisson, RE; Golub, JE				Pacheco, Antonio G.; Durovni, Betina; Cavalcante, Solange C.; Lauria, L. M.; Moore, Richard D.; Moulton, Lawrence H.; Chaisson, Richard E.; Golub, Jonathan E.			AIDS-Related Tuberculosis in Rio de Janeiro, Brazil	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; IMPACT; AFRICA; BURDEN; RISK; ERA	Background: We studied the incidence of tuberculosis, AIDS, AIDS deaths and AIDS-TB co-infection at the population level in Rio de Janeiro, Brazil where universal and free access to combination antiretroviral therapy has been available since 1997. Methodology/Principal Findings: This was a retrospective surveillance database match of Rio de Janeiro databases from 1995-2004. Proportions of tuberculosis occurring within 30 days and between 30 days and 1 year after AIDS diagnosis were determined. Generalized additive models fitted with cubic splines with appropriate estimating methods were used to describe rates and proportions over time. Overall, 90,806 tuberculosis cases and 16,891 AIDS cases were reported; 3,125 tuberculosis cases within 1 year of AIDS diagnosis were detected. Tuberculosis notification rates decreased after 1997 from a fitted rate (fR per 100,000) of 166.5 to 138.8 in 2004. AIDS incidence rates increased 26% between 1995 and 1998 (30.7 to 38.7) followed by a 33.3% decrease to 25.8 in 2004. AIDS mortality rates decreased dramatically after antiretroviral therapy was introduced between 1995 (27.5) and 1999 (13.4). The fitted proportion (fP) of patients with tuberculosis diagnosed within one year of AIDS decreased from 1995 (24.4%) to 1998 (15.2%), remaining stable since. Seventy-five percent of tuberculosis diagnoses after an AIDS diagnosis occurred within 30 days of AIDS diagnosis. Conclusions/Significance: Our results suggest that while combination ART should be considered an essential component of the response to the HIV and HIV/tuberculosis epidemics, it may not be sufficient alone to prevent progression from latent TB to active disease among HIV-infected populations. When tuberculosis is diagnosed prior to or at the same time as AIDS and ART has not yet been initiated, then ART is ineffective as a tuberculosis prevention strategy for these patients. Earlier HIV/AIDS diagnosis and ART initiation may reduce TB incidence in HIV/AIDS patients. More specific interventions will be required if HIV-related tuberculosis incidence is to continue to decline.	[Pacheco, Antonio G.] Fiocruz MS, PROCC, ENSP, BR-21045900 Rio De Janeiro, Brazil; [Cavalcante, Solange C.] Fiocruz MS, IPEC, Rio De Janeiro, Brazil; [Durovni, Betina; Cavalcante, Solange C.; Lauria, L. M.] Municipal Hlth Secretariat, Rio De Janeiro, Brazil; [Durovni, Betina] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Ctr Tuberculosis Res, Baltimore, MD 21218 USA; [Moore, Richard D.; Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21218 USA; [Moore, Richard D.; Chaisson, Richard E.; Golub, Jonathan E.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21218 USA; [Moulton, Lawrence H.; Chaisson, Richard E.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21218 USA	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pacheco, AG (corresponding author), Fiocruz MS, PROCC, ENSP, BR-21045900 Rio De Janeiro, Brazil.	jgolub@jhmi.edu	Pacheco, Antonio Guilherme/E-6378-2013	Pacheco, Antonio Guilherme/0000-0003-3095-1774; Moulton, Lawrence/0000-0001-7041-7387	Bill and Melinda Gates Foundation; USAID; NIH [AI066994, AI01637, AI45432, D43 TW05574]; FOGARTY INTERNATIONAL CENTER [D43TW005574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI045432, K24AI001637, K01AI066994] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by the Bill and Melinda Gates Foundation, USAID, and NIH Grants AI066994, AI01637, AI45432 and D43 TW05574. Funders had no role in the design and conduct of the study or in the collection, analysis, or interpretation of the data. The funders had no input in the preparation, review or approval of the manuscript.	Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Brito Ana Maria de, 2005, Braz J Infect Dis, V9, P9, DOI 10.1590/S1413-86702005000100004; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 1999, INT J TUBERC LUNG D, V3, P457; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Girardi E, 2000, AIDS, V14, P1985, DOI 10.1097/00002030-200009080-00015; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Jones JL, 2000, INT J TUBERC LUNG D, V4, P1026; Kritski AL, 2004, J BRAS PNEUMOL S2, pS62; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lutz M., 2006, PROGRAMMING PYTHON; Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012; *MIN SAUD SECR VIG, 2006, REC TER ANT AD AD IN; Miranda A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000826; R Development Core Team, 2006, R LANG ENV STAT COMP; Raviglione M, 2001, INT J TUBERC LUNG D, V5, P213; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Soares Elizabeth Cristina Coelho, 2006, J. bras. pneumol., V32, P444, DOI 10.1590/S1806-37132006000500012; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; World Health Organisation, 2007, WHO CAS DEF HIV SURV	21	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2008	3	9							e3132	10.1371/journal.pone.0003132	http://dx.doi.org/10.1371/journal.pone.0003132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KD	18781195	Green Submitted, Green Published, gold			2022-12-27	WOS:000264425700002
J	Lisewski, AM				Lisewski, Andreas Martin			Random Amino Acid Mutations and Protein Misfolding Lead to Shannon Limit in Sequence-Structure Communication	PLOS ONE			English	Article							ALGORITHMIC COMPLEXITY; INFORMATION-THEORY; DEGRADATION; FOLD	The transmission of genomic information from coding sequence to protein structure during protein synthesis is subject to stochastic errors. To analyze transmission limits in the presence of spurious errors, Shannon's noisy channel theorem is applied to a communication channel between amino acid sequences and their structures established from a large-scale statistical analysis of protein atomic coordinates. While Shannon's theorem confirms that in close to native conformations information is transmitted with limited error probability, additional random errors in sequence (amino acid substitutions) and in structure (structural defects) trigger a decrease in communication capacity toward a Shannon limit at 0.010 bits per amino acid symbol at which communication breaks down. In several controls, simulated error rates above a critical threshold and models of unfolded structures always produce capacities below this limiting value. Thus an essential biological system can be realistically modeled as a digital communication channel that is (a) sensitive to random errors and (b) restricted by a Shannon error limit. This forms a novel basis for predictions consistent with observed rates of defective ribosomal products during protein synthesis, and with the estimated excess of mutual information in protein contact potentials.	[Lisewski, Andreas Martin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lisewski, AM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lisewski@bcm.edu			W. M. Keck Center for Computational and Structural Biology [training fellowship]; National Science Foundation [DBI-0547695]; National Institutes of Health [R01 GM066099]; March of Dimes [FY06-371]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066099] Funding Source: NIH RePORTER	W. M. Keck Center for Computational and Structural Biology; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by a training fellowship from the Gulf Coast Consortia through the W. M. Keck Center for Computational and Structural Biology (AML), as well as through grants from the National Science Foundation (DBI-0547695), National Institutes of Health (R01 GM066099), and March of Dimes (MOD FY06-371).	Adami C, 2004, PHYS LIFE REV, V1, P3, DOI 10.1016/j.plrev.2004.01.002; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ay J, 1998, PROTEINS, V30, P155, DOI 10.1002/(SICI)1097-0134(19980201)30:2<155::AID-PROT5>3.0.CO;2-M; Berezovsky IN, 2001, PROTEIN ENG, V14, P403, DOI 10.1093/protein/14.6.403; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BRILLOUIN L, 1962, SCI INFORM THEORY, pCH10; Cline MS, 2002, PROTEINS, V49, P7, DOI 10.1002/prot.10198; Crooks GE, 2004, PROTEINS, V57, P804, DOI 10.1002/prot.20262; Crooks GE, 2004, BIOINFORMATICS, V20, P1603, DOI 10.1093/bioinformatics/bth132; Dewey TG, 1996, PHYS REV E, V54, pR39, DOI 10.1103/PhysRevE.54.R39; Dewey TG, 1997, PHYS REV E, V56, P4545, DOI 10.1103/PhysRevE.56.4545; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; ELLIS N, 1982, MOL GEN GENET, V188, P169, DOI 10.1007/BF00332670; GALLAGER RG, 1965, IEEE T INFORM THEORY, V11, P3, DOI 10.1109/TIT.1965.1053730; Gupta MK, 2006, IEEE ENG MED BIOL, V25, P46, DOI 10.1109/MEMB.2006.1578663; HERZEL H, 1995, PHYSICA A, V216, P518, DOI 10.1016/0378-4371(95)00104-F; HERZEL H, 1994, CHAOS SOLITON FRACT, V4, P97, DOI 10.1016/0960-0779(94)90020-5; HOBOHM U, 1994, PROTEIN SCI, V3, P522; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Lisewski AM, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl788; Mandelbrot B., 1953, COMMUN THEOR, P486; May EE, 2006, IEEE ENG MED BIOL, V25, P28, DOI 10.1109/MEMB.2006.1578660; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Miller EJ, 2002, P NATL ACAD SCI USA, V99, P10359, DOI 10.1073/pnas.162219099; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ofran Y, 2006, PROTEINS, V64, P275, DOI 10.1002/prot.20964; Orengo C A, 2003, Methods Biochem Anal, V44, P249; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Qian SB, 2006, J BIOL CHEM, V281, P392, DOI 10.1074/jbc.M509126200; Qian Shu-Bing, 2005, V301, P271; Scheibel T, 2006, HANDB EXP PHARM, V172, P199; Schlegel C, 1999, IEEE COMMUN LETT, V3, P205, DOI 10.1109/4234.775255; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shannon C. E., 1949, MATH THEORY COMMUNIC; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Taguchi YH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-404; Thangavel K, 2006, ANN OPER RES, V143, P317, DOI 10.1007/s10479-006-7391-0; Vendruscolo M, 1997, FOLD DES, V2, P295, DOI 10.1016/S1359-0278(97)00041-2; Weiss MS, 2001, TRENDS BIOCHEM SCI, V26, P521, DOI 10.1016/S0968-0004(01)01935-1; Yockey H.P., 2005, INFORM THEORY EVOLUT; YOCKEY HP, 1974, J THEOR BIOL, V46, P369, DOI 10.1016/0022-5193(74)90005-8; YOCKEY HP, 1958, S INF THEOR BIOL GAT; ZHU J, 2005, PROTEINS, V14, P417	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3110	10.1371/journal.pone.0003110	http://dx.doi.org/10.1371/journal.pone.0003110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769673	Green Submitted, Green Published, gold			2022-12-27	WOS:000264416600006
J	Elfakess, R; Dikstein, R				Elfakess, Rofa; Dikstein, Rivka			A Translation Initiation Element Specific to mRNAs with Very Short 5 ' UTR that Also Regulates Transcription	PLOS ONE			English	Article								Transcription is controlled by cis regulatory elements, which if localized downstream to the transcriptional start site (TSS), in the 5'UTR, could influence translation as well. However presently there is little evidence for such composite regulatory elements. We have identified by computational analysis an abundant element located downstream to the TSS up to position +30, which controls both transcription and translation. This element has an invariable ATG sequence, which serves as the translation initiation codon in 64% of the genes bearing it. In these genes the initiating AUG is preceded by an extremely short 5'UTR. We show that translation in vitro and in vivo is initiated exclusively from the AUG of this motif, and that the AUG flanking sequences create a strong translation initiation context. This motif is distinguished from the well-known Kozak in its unique ability to direct efficient and accurate translation initiation from mRNAs with a very short 5'UTR. We therefore named it TISU for Translation Initiator of Short 5'UTR. Interestingly, this translation initiation element is also an essential transcription regulatory element of Yin Yang 1. Our characterization of a common transcription and translation element points to a link between mammalian transcription and translation initiation.	[Elfakess, Rofa; Dikstein, Rivka] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Elfakess, R (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	rivka.dikstein@weizmann.ac.il			Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This work was supported by a grant from the Israel Science Foundation, founded by the Israel Academy of Sciences and Humanities.	Ainbinder E, 2004, MOL CELL BIOL, V24, P2444, DOI 10.1128/MCB.24.6.2444-2454.2004; Ainbinder E, 2002, MOL CELL BIOL, V22, P6354, DOI 10.1128/MCB.22.18.6354-6362.2002; Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Amir-Zilberstein L, 2007, MOL CELL BIOL, V27, P5246, DOI 10.1128/MCB.00586-07; BUSHMEYER S, 1995, J BIOL CHEM, V270, P30213; ELKAN TLB, 1994, FITTING MIXTURE MODE, P28; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Johansson E, 1998, J BIOL CHEM, V273, P29816, DOI 10.1074/jbc.273.45.29816; KOZAK M, 1994, BIOCHIMIE, V76, P815, DOI 10.1016/0300-9084(94)90182-1; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; LEE JS, 1995, NUCLEIC ACIDS RES, V23, P925, DOI 10.1093/nar/23.6.925; LEE YM, 1994, DNA CELL BIOL, V13, P1029, DOI 10.1089/dna.1994.13.1029; Moshonov S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-92; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; RIGGS KJ, 1991, MOL CELL BIOL, V11, P1765, DOI 10.1128/MCB.11.3.1765; SATYAMOORTHY K, 1993, MOL CELL BIOL, V13, P6621, DOI 10.1128/MCB.13.11.6621; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6	21	57	62	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2008	3	8							e3094	10.1371/journal.pone.0003094	http://dx.doi.org/10.1371/journal.pone.0003094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RO	18769482	gold, Green Published, Green Submitted			2022-12-27	WOS:000264796600011
J	Sissoko, D; Moendandze, A; Malvy, D; Giry, C; Ezzedine, K; Solet, JL; Pierre, V				Sissoko, Daouda; Moendandze, Amrat; Malvy, Denis; Giry, Claude; Ezzedine, Khaled; Solet, Jean Louis; Pierre, Vincent			Seroprevalence and Risk Factors of Chikungunya Virus Infection in Mayotte, Indian Ocean, 2005-2006: A Population-Based Survey	PLOS ONE			English	Article								Background: Since 2006, Chikungunya virus (CHIKV) has re-emerged as an important pathogen of global concern. However, individual and household factors associated with the acquisition and the magnitude of clinically silent CHIKV infections remain poorly understood. In this present study, we aimed to investigate the seroprevalence, estimate the proportion of symptomatic illness and identify the risk factors for CHIKV infection in the primo-exposed population of Mayotte. Methods/Principal Findings: We conducted a household-based cross sectional serosurvey in Mayotte in November and December 2006 using complex multistage cluster sampling. To produce the results representative of the island population aged 2 years or older, sample data were adjusted with sample weights. Explanatory and multiple logistic regression analyses were performed to investigate associations between CHIKV infection seropositivity (presence of IgM and/or IgG to CHIKV by enzyme-linked immunoabsorbent assay) and risk factors. A total of 1154 individuals were analyzed. The overall seroprevalence of CHIKV infection was 37.2% (95% CI = 33.9-40.5), 318 (72.3%) of the seropositive participants reported symptoms consistent with a CHIKV infection during the epidemic period. Risk factors for CHIKV seropositivity among adults (aged 15 years and older) were male gender, low socioeconomic index, schooling <= 6 years and living in makeshift housing. Conclusions: Our findings indicate that roughly one out of four CHIKV infections is asymptomatic. Conditions associated with poverty may be considered as critical in CHIKV acquisition. Thus, these conditions should be taken into account in the development of future prevention strategies of CHIKV disease.	[Sissoko, Daouda; Solet, Jean Louis; Pierre, Vincent] Inst Veille Sanitaire Cellule Intterreg Epidemiol, St Denis, Reunion, France; [Moendandze, Amrat] Direct Affaires Sanitaires Sociales Mayotte, Mamoudzou, France; [Malvy, Denis; Ezzedine, Khaled] Ctr Hosp Region Univ, Hop St Andre, Serv Med Interne Maladies Trop, Bordeaux, France; [Malvy, Denis; Ezzedine, Khaled] Univ Bordeaux, Fac Med, Inst Med Trop, Bordeaux, France; [Giry, Claude] Ctr Hosp Mayotte, Lab Biol, Mamoudzou, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Sissoko, D (corresponding author), Inst Veille Sanitaire Cellule Intterreg Epidemiol, St Denis, Reunion, France.	daouda.sissoko@sante.gouv.fr	Ezzedine, Khaled/A-3072-2009; Ezzedine, Khaled/F-2716-2017; Sissoko, Daouda/L-9193-2013; MALVY, Denis/T-7930-2019	Ezzedine, Khaled/0000-0002-5468-4589; Sissoko, Daouda/0000-0002-8890-7170; 	French Health Ministry	French Health Ministry	The study was sponsored by the French Health Ministry. The sponsor of the study had no role in the study design, data collection, analysis, interpretation, or writing of the report. All authors had full access to all data. DS had the final responsibility for the decision to submit for publication.	Beesoon S, 2008, EMERG INFECT DIS, V14, P337, DOI 10.3201/eid1402.071024; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; BRIGHTON SW, 1983, S AFR MED J, V63, P313; Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586; Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013; Chretien JP, 2007, AM J TROP MED HYG, V76, P405, DOI 10.4269/ajtmh.2007.76.405; da Rosa APAT, 2000, EMERG INFECT DIS, V6, P298; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Houweling Tanja AJ, 2003, Int J Equity Health, V2, P8, DOI 10.1186/1475-9276-2-8; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Josseran L, 2006, EMERG INFECT DIS, V12, P1994; Jupp P. G., 1988, The arboviruses: epidemiology and ecology. Volume II., P137; Jupp PG, 1996, S AFR MED J, V86, P35; Klar, 1990, ADEQUACY SAMPLE SIZE; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X; Mackenzie JS, 2001, EMERG INFECT DIS, V7, P497, DOI 10.3201/eid0707.017703; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Mavalankar D, 2007, LANCET INFECT DIS, V7, P306, DOI 10.1016/S1473-3099(07)70091-9; Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637; MYERS RM, 1965, INDIAN J MED RES, V53, P694; OBEYESEKERE I, 1972, BRIT HEART J, V34, P821; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f; Reiskind MH, 2008, AM J TROP MED HYG, V78, P422, DOI 10.4269/ajtmh.2008.78.422; Reiter P, 2003, EMERG INFECT DIS, V9, P86; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Renault P, 2007, AM J TROP MED HYG, V77, P727; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROBINSON M C, 1956, Cent Afr J Med, V2, P394; Romi R, 1999, J AM MOSQUITO CONTR, V15, P425; SALMON CT, 1983, PUBLIC OPIN QUART, V47, P270, DOI 10.1086/268785; Sang RC, 2008, AM J TROP MED HYG, V78, P77; SARKAR JK, 1965, INDIAN J MED RES, V53, P921; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168	46	134	134	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 26	2008	3	8							e3066	10.1371/journal.pone.0003066	http://dx.doi.org/10.1371/journal.pone.0003066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RL	18725980	gold, Green Published, Green Submitted			2022-12-27	WOS:000264796300012
J	Sironen, T; Klingstrom, J; Vaheri, A; Andersson, LC; Lundkvist, A; Plyusnin, A				Sironen, Tarja; Klingstrom, Jonas; Vaheri, Antti; Andersson, Leif C.; Lundkvist, Ake; Plyusnin, Alexander			Pathology of Puumala Hantavirus Infection in Macaques	PLOS ONE			English	Article								Hantaviruses are globally important human pathogens that cause hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Capillary leakage is central to hantaviral diseases, but how it develops, has remained unknown. It has been hypothesized that the pathogenesis of hantavirus infection would be a complex interplay between direct viral effects and immunopathological mechanisms. Both of these were studied in the so far best model of mild hemorrhagic fever with renal syndrome, i.e. cynomolgus macaques infected with wild-type Puumala hantavirus. Viral RNA detected by in situ hybridization and nucleocapsid protein detected by immunohistochemical staining were observed in kidney, spleen and liver tissues. Inflammatory cell infiltrations and tubular damage were found in the kidneys, and these infiltrations contained mainly CD8-type T-cells. Importantly, these results are consistent with those obtained from patients with hantaviral disease, thus showing that the macaque model of hantavirus infection mimics human infection also on the tissue level. Furthermore, both the markers of viral replication and the T-cells appeared to co-localize in the kidneys to the sites of tissue damage, suggesting that these two together might be responsible for the pathogenesis of hantavirus infection.	[Sironen, Tarja; Vaheri, Antti; Plyusnin, Alexander] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Klingstrom, Jonas; Lundkvist, Ake] Karolinska Inst, MTC, Swedish Inst Infect Dis Control, Stockholm, Sweden; [Andersson, Leif C.] Univ Helsinki, Haartman Inst, Dept Pathol, HUSLAB, Helsinki, Finland	University of Helsinki; Karolinska Institutet; Swedish Institute for Infectious Disease Control; University of Helsinki	Sironen, T (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	Tarja.Sironen@helsinki.fi	Vaheri, Antti/AAV-1523-2020	Sironen, Tarja/0000-0002-2344-2755; Klingstrom, Jonas/0000-0001-9076-1441	The Academy of Finland; Helsinki Biomedical Graduate School; Sigrid Juselius Foundation; Finnish Cultural Foundation; Swedish Medical Research Council	The Academy of Finland(Academy of Finland); Helsinki Biomedical Graduate School; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported by grants from The Academy of Finland, Helsinki Biomedical Graduate School, Sigrid Juselius Foundation, Finnish Cultural Foundation, and from the Swedish Medical Research Council. None of these had any role in the study.	Bustamante EA, 1997, CHEST, V112, P1133, DOI 10.1378/chest.112.4.1133; GROEN J, 1995, J INFECT DIS, V172, P38, DOI 10.1093/infdis/172.1.38; Groen J, 1996, CLIN NEPHROL, V46, P379; Hautala T, 2002, CLIN INFECT DIS, V35, P96, DOI 10.1086/340859; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; Hooper JW, 2008, J VIROL, V82, P1332, DOI 10.1128/JVI.01822-07; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Kilpatrick ED, 2004, J IMMUNOL, V172, P3297, DOI 10.4049/jimmunol.172.5.3297; KIM GR, 1985, AM J TROP MED HYG, V34, P388, DOI 10.4269/ajtmh.1985.34.388; Klingstrom J, 2006, J VIROL, V80, P8279, DOI 10.1128/JVI.00742-06; Klingstrom J, 2002, J VIROL, V76, P444, DOI 10.1128/JVI.76.1.444-449.2002; Klingstrom J, 2008, ANTIVIR THER, V13, P125; Linderholm M, 1996, J INFECT DIS, V173, P38, DOI 10.1093/infdis/173.1.38; Lundkvist A, 1997, J VIROL, V71, P9515, DOI 10.1128/JVI.71.12.9515-9523.1997; Makela S, 2004, AM J KIDNEY DIS, V43, P809, DOI 10.1053/j.ajkd.2003.12.044; McElroy AK, 2002, J INFECT DIS, V186, P1706, DOI 10.1086/345768; Milazzo ML, 2002, J INFECT DIS, V186, P1390, DOI 10.1086/344735; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Mustonen J, 1996, KIDNEY INT, V49, P217, DOI 10.1038/ki.1996.29; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Niikura M, 2004, ARCH VIROL, V149, P1279, DOI 10.1007/s00705-004-0306-y; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Plyusnin A, 1997, J CLIN MICROBIOL, V35, P1090, DOI 10.1128/JCM.35.5.1090-1096.1997; Price P, 1999, IMMUNOL REV, V167, P257, DOI 10.1111/j.1600-065X.1999.tb01398.x; Temonen M, 1996, CLIN IMMUNOL IMMUNOP, V78, P47, DOI 10.1006/clin.1996.0007; Terajima M, 2007, IMMUNOL LETT, V113, P117, DOI 10.1016/j.imlet.2007.08.003; Tuuminen T, 2007, J IMMUNOL, V179, P1988, DOI 10.4049/jimmunol.179.3.1988; VAPALAHTI O, 1995, J MED VIROL, V46, P293, DOI 10.1002/jmv.1890460402; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Waeckerle-Men Y, 2007, NEPHROL DIAL TRANSPL, V22, P1527, DOI 10.1093/ndt/gfl818; Wahl-Jensen V, 2007, J VIROL, V81, P7449, DOI 10.1128/JVI.00238-07; YANAGIHARA R, 1988, ARCH VIROL, V101, P125, DOI 10.1007/BF01314657; ZAKI SR, 1995, AM J PATHOL, V146, P552	34	48	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 21	2008	3	8							e3035	10.1371/journal.pone.0003035	http://dx.doi.org/10.1371/journal.pone.0003035			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422KO	18716663	gold, Green Submitted, Green Published			2022-12-27	WOS:000264426800012
J	Morel, E; Fouquet, S; Strup-Perrot, C; Thievend, CP; Petit, C; Loew, D; Faussat, AM; Yvernault, L; Pincon-Raymond, M; Chambaz, J; Rousset, M; Thenet, S; Clair, C				Morel, Etienne; Fouquet, Stephane; Strup-Perrot, Carine; Thievend, Cathy Pichol; Petit, Constance; Loew, Damarys; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline			The Cellular Prion Protein PrPc Is Involved in the Proliferation of Epithelial Cells and in the Distribution of Junction-Associated Proteins	PLOS ONE			English	Article								Background: The physiological function of the ubiquitous cellular prion protein, PrPc, is still under debate. It was essentially studied in nervous system, but poorly investigated in epithelial cells. We previously reported that PrPc is targeted to cell-cell junctions of polarized epithelial cells, where it interacts with c-Src. Methodology/Findings: We show here that, in cultured human enterocytes and in intestine in vivo, the mature PrPc is differentially targeted either to the nucleus in dividing cells or to cell-cell contacts in polarized/differentiated cells. By proteomic analysis, we demonstrate that the junctional PrPc interacts with cytoskeleton-associated proteins, such as gamma-and beta-actin, alpha-spectrin, annexin A2, and with the desmosome-associated proteins desmoglein, plakoglobin and desmoplakin. In addition, co-immunoprecipitation experiments revealed complexes associating PrPc, desmoglein and c-Src in raft domains. Through siRNA strategy, we show that PrPc is necessary to complete the process of epithelial cell proliferation and for the sub-cellular distribution of proteins involved in cell architecture and junctions. Moreover, analysis of the architecture of the intestinal epithelium of PrPc knock-out mice revealed a net decrease in the size of desmosomal junctions and, without change in the amount of BrdU incorporation, a shortening of the length of intestinal villi. Conclusions/Significance: From these results, PrPc could be considered as a new partner involved in the balance between proliferation and polarization/differentiation in epithelial cells.	[Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] Univ Pierre & Marie Curie 6, Ctr Rech Cordeliers, F-75006 Paris, France; [Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] INSERM, U 872, F-75006 Paris, France; [Morel, Etienne; Fouquet, Stephane; Thievend, Cathy Pichol; Petit, Constance; Faussat, Anne-Marie; Yvernault, Lucile; Pincon-Raymond, Martine; Chambaz, Jean; Rousset, Monique; Thenet, Sophie; Clair, Caroline] Univ Paris Descartes Paris 5, UMR S 872, F-75006 Paris, France; [Strup-Perrot, Carine] Inst Gustave Roussy PRI, UPRES EA 27 10, F-94805 Villejuif, France; [Loew, Damarys] Inst Curie, Lab Spectromet Masse Proteom, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Morel, E (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.	caroline.clair@crc.jussieu.fr	MOREL, Etienne L/F-4765-2010; MOREL, Etienne/N-2194-2014; Thenet, Sophie/GQY-5726-2022	MOREL, Etienne L/0000-0001-7340-1313; MOREL, Etienne/0000-0002-4763-4954; Thenet, Sophie/0000-0002-0336-2942; Damarys, Loew/0000-0002-9111-8842	Ministere National de la Recherche et de la Technologie fellowship; F. Aupetit Association; INSERM; Ministere de la recherche	Ministere National de la Recherche et de la Technologie fellowship; F. Aupetit Association; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de la recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	E. Morel was recipient of a Ministere National de la Recherche et de la Technologie fellowship. S. Fouquet was recipient of a grant from F. Aupetit association. This work was supported in part by grants from INSERM (ATC Prion) and from Ministere de la recherche (GIS Prion).	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; Benaud C, 2004, J CELL BIOL, V164, P133, DOI 10.1083/jcb.200307098; BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149; Brockes JP, 1999, CURR OPIN NEUROBIOL, V9, P571, DOI 10.1016/S0959-4388(99)00016-1; Brown DR, 2002, J NEUROSCI RES, V67, P211, DOI 10.1002/jnr.10118; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; CHANTRET I, 1994, J CELL SCI, V107, P213; Crozet C, 2006, MOL CELL NEUROSCI, V32, P315, DOI 10.1016/j.mcn.2006.05.004; Dong CF, 2008, ARCH BIOCHEM BIOPHYS, V470, P83, DOI 10.1016/j.abb.2007.11.007; Dusek RL, 2007, J DERMATOL SCI, V45, P7, DOI 10.1016/j.jdermsci.2006.10.006; FEVRIER B, 2004, P NATL ACAD SCI US; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2001, ADV PROTEIN CHEM, V57, P229; Gu YP, 2003, NEUROBIOL DIS, V12, P133, DOI 10.1016/S0969-9961(02)00014-1; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Hosokawa T, 2008, BIOCHEM BIOPH RES CO, V366, P657, DOI 10.1016/j.bbrc.2007.11.163; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; KALINA M, 1977, J CELL BIOL, V74, P726, DOI 10.1083/jcb.74.3.726; Lechler T, 2007, J CELL BIOL, V176, P147, DOI 10.1083/jcb.200609109; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; Mange A, 2004, J CELL SCI, V117, P2411, DOI 10.1242/jcs.01094; Martins VR, 2001, BRAZ J MED BIOL RES, V34, P585, DOI 10.1590/S0100-879X2001000500005; Meyer RK, 2000, J BIOL CHEM, V275, P38081, DOI 10.1074/jbc.M007114200; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nieznanski K, 2005, BIOCHEM BIOPH RES CO, V334, P403, DOI 10.1016/j.bbrc.2005.06.092; Pammer J, 2000, VIRCHOWS ARCH, V436, P466, DOI 10.1007/s004280050474; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Prusiner SB, 1998, BRAIN PATHOL, V8, P499; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Rouvinski A, 2003, BIOCHEM BIOPH RES CO, V308, P750, DOI 10.1016/S0006-291X(03)01470-0; Rybner C, 2002, J CELL BIOCHEM, V84, P408, DOI 10.1002/jcb.10017; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Shmakov AN, 2000, J PATHOL, V191, P318, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH640>3.0.CO;2-4; Simmen FA, 2007, AM J PHYSIOL-GASTR L, V292, pG1757, DOI 10.1152/ajpgi.00013.2007; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; Sugaya M, 2002, J DERMATOL SCI, V28, P126, DOI 10.1016/S0923-1811(01)00160-8; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; Villagra NT, 2006, NEUROBIOL DIS, V21, P181, DOI 10.1016/j.nbd.2005.07.003; WEISSMANN C, 1994, ANN NY ACAD SCI, V724, P235, DOI 10.1111/j.1749-6632.1994.tb38913.x	48	55	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3000	10.1371/journal.pone.0003000	http://dx.doi.org/10.1371/journal.pone.0003000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714380	Green Published, gold, Green Submitted			2022-12-27	WOS:000264420900025
J	Antons, AK; Wang, R; Kalams, SA; Unutmaz, D				Antons, Amanda K.; Wang, Rui; Kalams, Spyros A.; Unutmaz, Derya			Suppression of HIV-Specific and Allogeneic T Cell Activation by Human Regulatory T Cells Is Dependent on the Strength of Signals	PLOS ONE			English	Article								Regulatory T cells (Tregs) suppress immune responses against both self and non-self antigens. Tregs require activation through the T cell receptor (TCR) and IL-2 to exert their suppressive functions. However, how strength of TCR signals modulate the potency of Treg-mediated suppression of antigen-specific T cell activation remain unclear. We found that both strength of TCR signals and ratios of Tregs to target cells, either through superantigen, allogeneic antigens or HIV-specific peptides, modified the suppressive ability of Tregs. While human Tregs were able to mediate suppression in the presence of only autologous antigen-presenting cells, this was much less efficient as compared to when Tregs were activated by allogeneic dendritic cells. In another physiologically relevant system, we show that the strength of peptide stimulation, high frequency of responder CD8+ T cells or presence of high IL-2 can override the suppression of HIV-specific CD8+ T cells by Tregs. These findings suggest that ratios and TCR activation of human Tregs, are important parameters to overcome robust immune responses to pathogens or allogeneic antigens. Modulating the strength of T cell signals and selective enhancement or depletion of antigen-specific Tregs thus may have implications for designing potent vaccines and regulating immune responses during allogeneic transplantation and chronic infections.	[Antons, Amanda K.; Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA; [Kalams, Spyros A.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Wang, Rui; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY USA	Vanderbilt University; Vanderbilt University; New York University	Antons, AK (corresponding author), Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37212 USA.	Derya.Unutmaz@nyumc.org			National Institutes of Health [R01 AI065303, AI39966]; Vanderbilt-Meharry Center for AIDS Research [P30 AI54999]; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999, R01AI039966, R01AI065303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Meharry Center for AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant R01 AI065303 to DU and R01 grant AI39966, Vanderbilt-Meharry Center for AIDS Research (P30 AI54999), Elizabeth Glaser Pediatric AIDS Foundation to SAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; Aseffa A, 2002, J IMMUNOL, V169, P3232, DOI 10.4049/jimmunol.169.6.3232; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Belkaid Y, 2002, NATURE, V420, P502, DOI 10.1038/nature01152; Bennett CL, 2001, CURR OPIN PEDIATR, V13, P533, DOI 10.1097/00008480-200112000-00007; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cabarrocas J, 2006, P NATL ACAD SCI USA, V103, P8453, DOI 10.1073/pnas.0603086103; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Cohen JL, 2002, J EXP MED, V196, P401, DOI 10.1084/jem.20020090; Coutinho A, 2005, CURR TOP MICROBIOL, V293, P43, DOI 10.1007/3-540-27702-1_3; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Hisaeda H, 2004, NAT MED, V10, P29, DOI 10.1038/nm975; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kursar M, 2004, J IMMUNOL, V172, P3167, DOI 10.4049/jimmunol.172.5.3167; Legrand FA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000102; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Liu YJ, 2006, TRENDS IMMUNOL, V27, P215, DOI 10.1016/j.it.2006.03.004; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Miedema F, 1992, Immunodefic Rev, V3, P173; Miura Y, 2004, BLOOD, V104, P2187, DOI 10.1182/blood-2004-03-1040; Montagnoli C, 2002, J IMMUNOL, V169, P6298, DOI 10.4049/jimmunol.169.11.6298; Motsinger A, 2002, J EXP MED, V195, P869, DOI 10.1084/jem.20011712; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Oswald-Richter K, 2004, EUR J IMMUNOL, V34, P1705, DOI 10.1002/eji.200424892; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sereti I, 2005, J CLIN INVEST, V115, P1839, DOI 10.1172/JCI24307; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sugimoto K, 2003, HEPATOLOGY, V38, P1437, DOI 10.1016/j.hep.2003.09.026; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taams LS, 2001, EUR J IMMUNOL, V31, P1122, DOI 10.1002/1521-4141(200104)31:4<1122::AID-IMMU1122>3.0.CO;2-P; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahata Y, 2004, EXP HEMATOL, V32, P622, DOI 10.1016/j.exphem.2004.03.012; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Thornton AM, 2000, J IMMUNOL, V164, P183, DOI 10.4049/jimmunol.164.1.183; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Wood Kathryn J, 2003, Novartis Found Symp, V252, P177; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	54	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2952	10.1371/journal.pone.0002952	http://dx.doi.org/10.1371/journal.pone.0002952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698349	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600038
J	Dequeant, ML; Ahnert, S; Edelsbrunner, H; Fink, TMA; Glynn, EF; Hattem, G; Kudlicki, A; Mileyko, Y; Morton, J; Mushegian, AR; Pachter, L; Rowicka, M; Shiu, A; Sturmfels, B; Pourquie, O				Dequeant, Mary-Lee; Ahnert, Sebastian; Edelsbrunner, Herbert; Fink, Thomas M. A.; Glynn, Earl F.; Hattem, Gaye; Kudlicki, Andrzej; Mileyko, Yuriy; Morton, Jason; Mushegian, Arcady R.; Pachter, Lior; Rowicka, Maga; Shiu, Anne; Sturmfels, Bernd; Pourquie, Olivier			Comparison of Pattern Detection Methods in Microarray Time Series of the Segmentation Clock	PLOS ONE			English	Article								While genome-wide gene expression data are generated at an increasing rate, the repertoire of approaches for pattern discovery in these data is still limited. Identifying subtle patterns of interest in large amounts of data (tens of thousands of profiles) associated with a certain level of noise remains a challenge. A microarray time series was recently generated to study the transcriptional program of the mouse segmentation clock, a biological oscillator associated with the periodic formation of the segments of the body axis. A method related to Fourier analysis, the Lomb-Scargle periodogram, was used to detect periodic profiles in the dataset, leading to the identification of a novel set of cyclic genes associated with the segmentation clock. Here, we applied to the same microarray time series dataset four distinct mathematical methods to identify significant patterns in gene expression profiles. These methods are called: Phase consistency, Address reduction, Cyclohedron test and Stable persistence, and are based on different conceptual frameworks that are either hypothesis- or data-driven. Some of the methods, unlike Fourier transforms, are not dependent on the assumption of periodicity of the pattern of interest. Remarkably, these methods identified blindly the expression profiles of known cyclic genes as the most significant patterns in the dataset. Many candidate genes predicted by more than one approach appeared to be true positive cyclic genes and will be of particular interest for future research. In addition, these methods predicted novel candidate cyclic genes that were consistent with previous biological knowledge and experimental validation in mouse embryos. Our results demonstrate the utility of these novel pattern detection strategies, notably for detection of periodic profiles, and suggest that combining several distinct mathematical approaches to analyze microarray datasets is a valuable strategy for identifying genes that exhibit novel, interesting transcriptional patterns.	[Dequeant, Mary-Lee; Glynn, Earl F.; Hattem, Gaye; Mushegian, Arcady R.; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO USA; [Ahnert, Sebastian] Cavendish Lab, Cambridge, England; [Edelsbrunner, Herbert; Mileyko, Yuriy] Duke Univ, Dept Comp Sci, Durham, NC USA; [Edelsbrunner, Herbert] Duke Univ, Dept Math, Durham, NC USA; [Edelsbrunner, Herbert] Geomagic, Res Triangle Pk, NC USA; [Fink, Thomas M. A.] INSERM U900, Paris, France; [Fink, Thomas M. A.] Curie Inst, CNRS, UMR 144, Paris, France; [Fink, Thomas M. A.] Paris Tech, Ecole Mines Paris, Fontainebleau, France; [Kudlicki, Andrzej; Rowicka, Maga] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX USA; [Morton, Jason; Pachter, Lior; Shiu, Anne; Sturmfels, Bernd] Univ California, Dept Math, Berkeley, CA USA; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO USA	Stowers Institute for Medical Research; University of Cambridge; Duke University; Duke University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Howard Hughes Medical Institute	Dequeant, ML (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	olp@stowers-institute.org	Kudlicki, Andrzej/C-7612-2012; Pourquié, Olivier/CAJ-5443-2022; Mushegian, Arcady/ABF-5387-2021; Rowicka, Maga/E-2496-2012; Kudlicki, Andrzej/AAG-8537-2019	Pourquié, Olivier/0000-0001-5189-1227; Mushegian, Arcady/0000-0002-6809-9225; Rowicka, Maga/0000-0002-4011-071X; Kudlicki, Andrzej/0000-0001-8158-9600; Pachter, Lior/0000-0002-9164-6231; Hattem, Gaye/0000-0002-2411-3056	DARPA [HR 0011-05-1-0057, HR0011-05-1-0007]; Lucent Technologies Bell Labs [Graduate Research Fellowship]; NIH [GM U54 GM74942]; Association pour la Recherche sur le Cancer (ARC), France; Stowers Institute for Medical Research; Howard Hughes Medical Institute [Investigator]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Lucent Technologies Bell Labs; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer (ARC), France(Fondation ARC pour la Recherche sur le Cancer); Stowers Institute for Medical Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was partially supported by DARPA grant HR 0011-05-1-0057. HE and YM mathematical work was supported by DARPA grant HR0011-05-1-0007. AS research was supported by a Lucent Technologies Bell Labs Graduate Research. Fellowship; AK and MR research was supported by NIH grant GM U54 GM74942; and SA research was supported by Association pour la Recherche sur le Cancer (ARC), France. OP, AM, MLD, EG and GH research was supported by the Stowers Institute for Medical Research. OP is a Howard Hughes Medical Institute Investigator.	Ahnert SE, 2006, BIOINFORMATICS, V22, P1471, DOI 10.1093/bioinformatics/btl121; AHNERT SE, 2006, NEW DISTANCE MEASURE, P1; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Clewley RH, 2008, IEEE T BIO-MED ENG, V55, P430, DOI 10.1109/TBME.2007.903712; COHENSTEINER D, 2007, LIPSCHITZ FUNCTIONS; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Edelsbrunner H, 2002, DISCRETE COMPUT GEOM, V28, P511, DOI 10.1007/s00454-002-2885-2; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Fink TMA, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/38006; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Ishikawa A, 2004, MECH DEVELOP, V121, P1443, DOI 10.1016/j.mod.2004.08.003; Jouve C, 2000, DEVELOPMENT, V127, P1421; Kudlicki A, 2007, BIOINFORMATICS, V23, P1559, DOI 10.1093/bioinformatics/btm126; Latinkic BV, 2003, DEVELOPMENT, V130, P2429, DOI 10.1242/dev.00449; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Lin SM, 2004, BIOINFORMATICS, V20, P3659, DOI 10.1093/bioinformatics/bth404; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; MORTON J, 2006, ARXIVMATHST0605173; Morton J, 2007, STAT APPL GENET MOL, V6; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Schwartz DR, 2003, CANCER RES, V63, P2913; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Suriben R, 2006, DEV DYNAM, V235, P3177, DOI 10.1002/dvdy.20968; Yeung KY, 2001, BIOINFORMATICS, V17, P309, DOI 10.1093/bioinformatics/17.4.309	35	38	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2856	10.1371/journal.pone.0002856	http://dx.doi.org/10.1371/journal.pone.0002856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682743	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000264366600012
J	Liang, J; Song, WJ; Tromp, G; Kolattukudy, PE; Fu, MG				Liang, Jian; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui			Genome-Wide Survey and Expression Profiling of CCCH-Zinc Finger Family Reveals a Functional Module in Macrophage Activation	PLOS ONE			English	Article								Previously, we have identified a novel CCCH zinc finger protein family as negative regulators of macrophage activation. To gain an overall insight into the entire CCCH zinc finger gene family and to evaluate their potential role in macrophage activation, here we performed a genome-wide survey of CCCH zinc finger genes in mouse and human. Totally 58 CCCH zinc finger genes in mouse and 55 in human were identified and most of them have not been reported previously. Phylogenetic analysis revealed that the mouse CCCH family was divided into 6 groups. Meanwhile, we employed quantitative real-time PCR to profile their tissue expression patterns in adult mice. Clustering analysis showed that most of CCCH genes were broadly expressed in all of tissues examined with various levels. Interestingly, several CCCH genes Mbnl3, Zfp36l2, Zfp36, Zc3h12a, Zc3h12d, Zc3h7a and Leng9 were enriched in macrophage-related organs such as thymus, spleen, lung, intestine and adipose. Consistently, a comprehensive assessment of changes in expression of the 58 members of the mouse CCCH family during macrophage activation also revealed that these CCCH zinc finger genes were associated with the activation of bone marrow-derived macrophages by lipopolysaccharide. Taken together, this study not only identified a functional module of CCCH zinc finger genes in the regulation of macrophage activation but also provided the framework for future studies to dissect the function of this emerging gene family.	[Liang, Jian; Song, Wenjun; Tromp, Gail; Kolattukudy, Pappachan E.; Fu, Mingui] Univ Cent Florida, Coll Med, Biomol Sci Ctr, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida	Liang, J (corresponding author), Univ Cent Florida, Coll Med, Biomol Sci Ctr, Orlando, FL 32816 USA.	mfu@mail.ucf.edu	kolattukudy, pappachan e/A-1350-2012; Song, Wenjun/HGB-4891-2022	Song, Wenjun/0000-0002-6355-2983	UCF Starting Package; National Institutes of Health [HL69458]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL069458, R01HL069458] Funding Source: NIH RePORTER	UCF Starting Package; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by UCF Starting Package (to M.F) and National Institutes of Health Grant HL69458 (to P.E.K).	Addepalli B, 2007, NUCLEIC ACIDS RES, V35, P4453, DOI 10.1093/nar/gkm457; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bai CY, 1996, MOL CELL BIOL, V16, P6661; Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Burke B., 2002, MACROPHAGE; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Carrick DM, 2004, ARTHRITIS RES THER, V6, P248, DOI 10.1186/ar1441; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hwang ES, 2002, J IMMUNOL, V169, P248, DOI 10.4049/jimmunol.169.1.248; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Ma J, 2003, CELL MOL LIFE SCI, V60, P2334, DOI 10.1007/s00018-003-3020-0; Mackay JP, 1998, TRENDS BIOCHEM SCI, V23, P1, DOI 10.1016/S0968-0004(97)01168-7; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; NIU J, 2008, J BIOL CHEM IN PRESS; Ramos SBV, 2004, DEVELOPMENT, V131, P4883, DOI 10.1242/dev.01336; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Vicente M, 2007, DIFFERENTIATION, V75, P427, DOI 10.1111/j.1432-0436.2006.00156.x; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang M, 2007, CANCER RES, V67, P93, DOI 10.1158/0008-5472.CAN-06-2723; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; Zhou L, 2006, CIRC RES, V98, P1, DOI DOI 10.1161/01	37	118	124	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2880	10.1371/journal.pone.0002880	http://dx.doi.org/10.1371/journal.pone.0002880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682727	Green Published, gold			2022-12-27	WOS:000264366600036
J	Somorjai, IML; Martinez-Arias, A				Somorjai, Ildiko M. L.; Martinez-Arias, Alfonso			Wingless Signalling Alters the Levels, Subcellular Distribution and Dynamics of Armadillo and E-Cadherin in Third Instar Larval Wing Imaginal Discs	PLOS ONE			English	Article								Background: Armadillo, the Drosophila orthologue of vertebrate beta-catenin, plays a dual role as the key effector of Wingless/Wnt1 signalling, and as a bridge between E-Cadherin and the actin cytoskeleton. In the absence of ligand, Armadillo is phosphorylated and targeted to the proteasome. Upon binding of Wg to its receptors, the "degradation complex'' is inhibited; Armadillo is stabilised and enters the nucleus to transcribe targets. Methodology/Principal Findings: Although the relationship between signalling and adhesion has been extensively studied, few in vivo data exist concerning how the "transcriptional'' and "adhesive'' pools of Armadillo are regulated to orchestrate development. We have therefore addressed how the subcellular distribution of Armadillo and its association with E-Cadherin change in larval wing imaginal discs, under wild type conditions and upon signalling. Using confocal microscopy, we show that Armadillo and E-Cadherin are spatio-temporally regulated during development, and that a punctate species becomes concentrated in a subapical compartment in response to Wingless. In order to further dissect this phenomenon, we overexpressed Armadillo mutants exhibiting different levels of activity and stability, but retaining E-Cadherin binding. Arm(S10) displaces endogenous Armadillo from the AJ and the basolateral membrane, while leaving E-Cadherin relatively undisturbed. Surprisingly, Delta NArm(1-155) caused displacement of both Armadillo and E-Cadherin, results supported by our novel method of quantification. However, only membrane-targeted Myr-Delta NArm(1-155) produced comparable nuclear accumulation of Armadillo and signalling to Arm(S10). These experiments also highlighted a row of cells at the A/P boundary depleted of E-Cadherin at the AJ, but containing actin. Conclusions/Significance: Taken together, our results provide in vivo evidence for a complex non-linear relationship between Armadillo levels, subcellular distribution and Wingless signalling. Moreover, this study highlights the importance of Armadillo in regulating the subcellular distribution of E-Cadherin	[Somorjai, Ildiko M. L.; Martinez-Arias, Alfonso] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge	Somorjai, IML (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	ildiko.somorjai@obs-banyuls.fr; ama11@cus.cam.ac.uk	Martinez Arias, Alfonso/F-1966-2010	Somorjai, Ildiko/0000-0001-5243-6664	Wellcome Trust; NSERC; Commonwealth Trust	Wellcome Trust(Wellcome TrustEuropean Commission); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Commonwealth Trust	This work was funded by the Wellcome Trust. I.S. was a student on the 4-year Wellcome Trust PhD Programme in Developmental Biology, and received additional financial assistance from NSERC and the Commonwealth Trust.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Arias AM, 2003, NAT REV MOL CELL BIO, V4, P321, DOI 10.1038/nrm1078; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Asally M, 2005, EXP CELL RES, V308, P357, DOI 10.1016/j.yexcr.2005.05.011; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Bustos VH, 2006, P NATL ACAD SCI USA, V103, P19725, DOI 10.1073/pnas.0609424104; Castano J, 2002, J BIOL CHEM, V277, P31541, DOI 10.1074/jbc.M204376200; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Cong F, 2004, MOL CELL BIOL, V24, P2000, DOI 10.1128/MCB.24.5.2000-2011.2004; Cox RT, 1999, DEVELOPMENT, V126, P1327; Cox RT, 1999, GENETICS, V153, P319; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; deCelis JF, 1996, DEVELOPMENT, V122, P359; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Gorfinkiel N, 2007, J CELL SCI, V120, P3289, DOI 10.1242/jcs.010850; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Graham TA, 2001, NAT STRUCT BIOL, V8, P1048, DOI 10.1038/nsb718; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Guger KA, 2000, DEV BIOL, V223, P441, DOI 10.1006/dbio.2000.9770; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hagen T, 2004, BIOCHEM J, V379, P471, DOI 10.1042/BJ20031749; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Hayward P, 2006, DEV DYNAM, V235, P2656, DOI 10.1002/dvdy.20902; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Hoffmans R, 2005, CURR BIOL, V15, P1207, DOI 10.1016/j.cub.2005.05.054; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Klein T, 1999, DEVELOPMENT, V126, P913; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Langdon T, 2006, DEV DYNAM, V235, P998, DOI 10.1002/dvdy.20735; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Lawrence N, 2000, INT J DEV BIOL, V44, P749; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Major RJ, 2005, DEVELOPMENT, V132, P3823, DOI 10.1242/dev.01957; Marygold SJ, 2003, MECH DEVELOP, V120, P157, DOI 10.1016/S0925-4773(02)00439-2; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Narasimha M, 2008, J CELL SCI, V121, P747, DOI 10.1242/jcs.019422; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Ohsugi M, 1999, DEV DYNAM, V216, P168, DOI 10.1002/(SICI)1097-0177(199910)216:2<168::AID-DVDY7>3.0.CO;2-R; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Pai LM, 1996, J BIOL CHEM, V271, P32411, DOI 10.1074/jbc.271.50.32411; Pai LM, 1997, DEVELOPMENT, V124, P2255; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; PEIFER M, 1993, J CELL SCI, V105, P993; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; PEIFER M, 1992, J CELL BIOL, V118, P681, DOI 10.1083/jcb.118.3.681; Penman GA, 2005, J CELL SCI, V118, P4741, DOI 10.1242/jcs.02589; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Solanas G, 2004, J BIOL CHEM, V279, P49849, DOI 10.1074/jbc.M408685200; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; SULLIVAN W, 2000, DROSOPHILA PROTOCOLS, P720; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; Townsley FM, 2004, NAT CELL BIOL, V6, P626, DOI 10.1038/ncb1141; Wodarz A, 2006, J CELL SCI, V119, P2425, DOI 10.1242/jcs.02973; Woods DF, 1997, DEV GENET, V20, P111, DOI 10.1002/(SICI)1520-6408(1997)20:2<111::AID-DVG4>3.3.CO;2-O; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	81	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2893	10.1371/journal.pone.0002893	http://dx.doi.org/10.1371/journal.pone.0002893			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682750	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600049
J	Tremblay, K; Lemire, M; Potvin, C; Tremblay, A; Hunninghake, GM; Raby, BA; Hudson, TJ; Perez-Iratxeta, C; Andrade-Navarro, MA; Laprise, C				Tremblay, Karine; Lemire, Mathieu; Potvin, Camille; Tremblay, Alexandre; Hunninghake, Gary M.; Raby, Benjamin A.; Hudson, Thomas J.; Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.; Laprise, Catherine			Genes to Diseases (G2D) Computational Method to Identify Asthma Candidate Genes	PLOS ONE			English	Article								Asthma is a complex trait for which different strategies have been used to identify its environmental and genetic predisposing factors. Here, we describe a novel methodological approach to select candidate genes for asthma genetic association studies. In this regard, the Genes to Diseases (G2D) computational tool has been used in combination with a genome-wide scan performed in a sub-sample of the Saguenay-Lac-St-Jean (SLSJ) asthmatic familial collection (n = 609) to identify candidate genes located in two suggestive loci shown to be linked with asthma (6q26) and atopy (10q26.3), and presenting differential parent-of-origin effects. This approach combined gene selection based on the G2D data mining analysis of the bibliographic and protein public databases, or according to the genes already known to be associated with the same or a similar phenotype. Ten genes (LPA, NOX3, SNX9, VIL2, VIP, ADAM8, DOCK1, FANK1, GPR123 and PTPRE) were selected for a subsequent association study performed in a large SLSJ sample (n = 1167) of individuals tested for asthma and atopy related phenotypes. Single nucleotide polymorphisms (n = 91) within the candidate genes were genotyped and analysed using a family-based association test. The results suggest a protective association to allergic asthma for PTPRE rs7081735 in the SLSJ sample (p = 0.000463; corrected p = 0.0478). This association has not been replicated in the Childhood Asthma Management Program (CAMP) cohort. Sequencing of the regions around rs7081735 revealed additional polymorphisms, but additional genotyping did not yield new associations. These results demonstrate that the G2D tool can be useful in the selection of candidate genes located in chromosomal regions linked to a complex trait.	[Tremblay, Karine; Potvin, Camille] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Tremblay, Karine; Potvin, Camille; Tremblay, Alexandre; Laprise, Catherine] Univ Montreal, Chicoutimi Hosp, Community Genom Ctr, Saguenay, Canada; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hunninghake, Gary M.; Raby, Benjamin A.] Harvard Med Sch, Brigham & Womens Hosp, Channing Lab, Boston, MA USA; [Hudson, Thomas J.] McGill Univ, Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Perez-Iratxeta, Carolina; Andrade-Navarro, Miguel A.] Ottawa Hlth Res Inst, Mol Med, Ottawa, ON, Canada; [Andrade-Navarro, Miguel A.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, Berlin, Germany; [Laprise, Catherine] Univ Quebec, Dept Sci Fondamentales, Saguenay, Canada	Laval University; Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Quebec; University of Quebec Chicoutimi	Tremblay, K (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada.	catherine_laprise@uqac.ca	Andrade, Miguel A/B-6565-2008; Raby, Benjamin/AAK-3866-2021	Andrade, Miguel A/0000-0001-6650-1711; Tremblay, Karine/0000-0002-2774-9738; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research; Respiratory Health Network of the Fonds de la recherche en sante du Quebec; National Heart, Lung and Blood Institute, National Institutes of Health [U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, T32 HL07427]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL083069, U01HL065899, U01HL075419, F32HL083634, R01HL086601, T32HL007427] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Respiratory Health Network of the Fonds de la recherche en sante du Quebec; National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Canadian Institutes of Health Research and the Respiratory Health Network of the Fonds de la recherche en sante du Quebec financially supported this work. The Childhood Asthma Management Program Genetics Ancillary Study is supported by U01 HL075419, U01 HL65899, P01 HL083069, R01 HL 086601, and T32 HL07427 from the National Heart, Lung and Blood Institute, National Institutes of Health.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Begin P, 2007, AM J RESP CRIT CARE, V175, P1109, DOI 10.1164/rccm.200607-1012OC; Blumenthal MN, 2005, CURR OPIN ALLERGY CL, V5, P141, DOI 10.1097/01.all.0000162306.12728.c2; Bouchard G, 1989, Hist Mes, V4, P39, DOI 10.3406/hism.1989.874; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Cookson WOC, 2000, HUM MOL GENET, V9, P2359, DOI 10.1093/hmg/9.16.2359; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; HEYER E, 1995, AM J HUM GENET, V56, P970; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Hoffjan S, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-14; Hoffjan S, 2002, CURR OPIN IMMUNOL, V14, P709, DOI 10.1016/S0952-7915(02)00393-X; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Koh MS, 2007, INT J CLIN PRACT, V61, P1371, DOI 10.1111/j.1742-1241.2007.01426.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Labuda M, 1996, AM J HUM GENET, V59, P633; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lemire M, 2004, AM J HUM GENET, V75, P571, DOI 10.1086/424528; Lemire M, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S159; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li LW, 2000, SEMIN IMMUNOL, V12, P75, DOI 10.1006/smim.2000.0209; Lopez-Bigas N, 2004, NUCLEIC ACIDS RES, V32, P3108, DOI 10.1093/nar/gkh605; Maddox L, 2002, ANNU REV MED, V53, P477, DOI 10.1146/annurev.med.53.082901.103921; Nakamura K, 1996, BIOCHEM BIOPH RES CO, V218, P726, DOI 10.1006/bbrc.1996.0129; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oeth P., 2005, IPLEX ASSAY INCREASE; Perez-Iratxeta C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-45; Perez-Iratxeta C, 2007, NUCLEIC ACIDS RES, V35, pW212, DOI 10.1093/nar/gkm223; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; Reed CE, 2006, J ALLERGY CLIN IMMUN, V118, P543, DOI 10.1016/j.jaci.2006.06.020; Richter A, 1999, AM J HUM GENET, V64, P768, DOI 10.1086/302274; Sandford A, 1996, AM J RESP CRIT CARE, V153, P1749, DOI 10.1164/ajrccm.153.6.8665031; Schumann G, 1998, MOL BRAIN RES, V62, P56, DOI 10.1016/S0169-328X(98)00237-X; Scriver CR, 2001, ANNU REV GENOM HUM G, V2, P69, DOI 10.1146/annurev.genom.2.1.69; Sully V, 2001, BIOCHEM BIOPH RES CO, V286, P184, DOI 10.1006/bbrc.2001.5360; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Tanuma N, 1999, EUR J BIOCHEM, V259, P46, DOI 10.1046/j.1432-1327.1999.00004.x; Tremblay K, 2006, GENES IMMUN, V7, P632, DOI 10.1038/sj.gene.6364340; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2907	10.1371/journal.pone.0002907	http://dx.doi.org/10.1371/journal.pone.0002907			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682798	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000264366600063
J	Vinci, G; Xia, XH; Veitia, RA				Vinci, Giovanna; Xia, Xuhua; Veitia, Reiner A.			Preservation of Genes Involved in Sterol Metabolism in Cholesterol Auxotrophs: Facts and Hypotheses	PLOS ONE			English	Article							LAMIN-B RECEPTOR; CAENORHABDITIS-ELEGANS; BIOSYNTHETIC PROTEIN; ENZYME; RATES; METHYLTRANSFERASE; ORGANIZATION; REQUIREMENT; EVOLUTION; REDUCTASE	Background: It is known that primary sequences of enzymes involved in sterol biosynthesis are well conserved in organisms that produce sterols de novo. However, we provide evidence for a preservation of the corresponding genes in two animals unable to synthesize cholesterol (auxotrophs): Drosophila melanogaster and Caenorhabditis elegans. Principal Findings: We have been able to detect bona fide orthologs of several ERG genes in both organisms using a series of complementary approaches. We have detected strong sequence divergence between the orthologs of the nematode and of the fruitfly; they are also very divergent with respect to the orthologs in organisms able to synthesize sterols de novo (prototrophs). Interestingly, the orthologs in both the nematode and the fruitfly are still under selective pressure. It is possible that these genes, which are not involved in cholesterol synthesis anymore, have been recruited to perform different new functions. We propose a more parsimonious way to explain their accelerated evolution and subsequent stabilization. The products of ERG genes in prototrophs might be involved in several biological roles, in addition to sterol synthesis. In the case of the nematode and the fruitfly, the relevant genes would have lost their ancestral function in cholesterogenesis but would have retained the other function(s), which keep them under pressure. Conclusions: By exploiting microarray data we have noticed a strong expressional correlation between the orthologs of ERG24 and ERG25 in D. melanogaster and genes encoding factors involved in intracellular protein trafficking and folding and with Start1 involved in ecdysteroid synthesis. These potential functional connections are worth being explored not only in Drosophila, but also in Caenorhabditis as well as in sterol prototrophs.	[Vinci, Giovanna; Veitia, Reiner A.] UM 3, Univ Paris 05,CNRS, Dept Genet & Dev,Inst Cochin,U567, INSERM,Fac Med Paris Descartes,UMR 8104, Paris, France; [Xia, Xuhua] Univ Ottawa, Biol Dept, CAREG, Ottawa, ON, Canada; [Veitia, Reiner A.] Univ Denis Diderot Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Ottawa; UDICE-French Research Universities; Universite Paris Cite	Vinci, G (corresponding author), UM 3, Univ Paris 05,CNRS, Dept Genet & Dev,Inst Cochin,U567, INSERM,Fac Med Paris Descartes,UMR 8104, Paris, France.	veitia@cochin.inserm.fr	Xia, Xuhua/E-5264-2010; Vinci, Giovanna/M-1311-2017	Xia, Xuhua/0000-0002-3092-7566; 	INSERM; Paris VII university	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Paris VII university	Supported by the INSERM and Paris VII university.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aspock G, 1999, GENOME RES, V9, P909, DOI 10.1101/gr.9.10.909; Beckstead RB, 2006, CELL, V124, P1137, DOI 10.1016/j.cell.2006.03.001; Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P199, DOI 10.1016/S0303-7207(00)00416-0; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eichler J, 2004, TRENDS BIOCHEM SCI, V29, P221, DOI 10.1016/j.tibs.2004.03.001; Freeman MR, 1999, DEVELOPMENT, V126, P4591; Haines TH, 2001, PROG LIPID RES, V40, P299, DOI 10.1016/S0163-7827(01)00009-1; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Hulsen T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-398; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; LEES ND, 1995, LIPIDS, V30, P221, DOI 10.1007/BF02537824; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Mo C, 2003, BBA-MOL CELL BIOL L, V1633, P68, DOI 10.1016/S1388-1981(03)00088-X; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Mo CQ, 2005, J LIPID RES, V46, P1991, DOI 10.1194/jlr.M500153-JLR200; Mo CQ, 2004, BBA-MOL CELL BIOL L, V1686, P30, DOI 10.1016/j.bbalip.2004.08.001; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Porter JA, 1996, SCIENCE, V274, P255, DOI 10.1126/science.274.5285.255; Quackenbush J, 2003, SCIENCE, V302, P240, DOI 10.1126/science.1090887; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rosenfeld JM, 1998, J BIOL CHEM, V273, P16112, DOI 10.1074/jbc.273.26.16112; Roth GE, 2004, P NATL ACAD SCI USA, V101, P1601, DOI 10.1073/pnas.0308212100; Scheel J, 1999, NAT CELL BIOL, V1, P127, DOI 10.1038/10100; SCHROEDER F, 1995, MOL MEMBR BIOL, V12, P113, DOI 10.3109/09687689509038505; SCHROEDER F, 1991, P SOC EXP BIOL MED, V196, P235; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; SCHULER E, 1994, J BIOL CHEM, V269, P11312; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Silve S, 1998, BBA-LIPID LIPID MET, V1392, P233, DOI 10.1016/S0005-2760(98)00041-1; SOULLAM B, 1993, J CELL BIOL, V120, P1093, DOI 10.1083/jcb.120.5.1093; Tijet N, 2001, GENE, V262, P189, DOI 10.1016/S0378-1119(00)00533-3; Veitia RA, 2001, J GENET, V80, P17, DOI 10.1007/BF02811414; Wagner N, 2004, J CELL SCI, V117, P2015, DOI 10.1242/jcs.01052; Waterham HR, 2003, AM J HUM GENET, V72, P1013, DOI 10.1086/373938; Wendler F, 2006, DEVELOPMENT, V133, P3055, DOI 10.1242/dev.02472; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2001, DATA ANAL MOL BIOL E, P277; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Ye Q, 1998, Subcell Biochem, V31, P587; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	50	40	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2883	10.1371/journal.pone.0002883	http://dx.doi.org/10.1371/journal.pone.0002883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682733	gold, Green Published, Green Submitted			2022-12-27	WOS:000264366600039
J	Reif, KE; Stout, RW; Henry, GC; Foil, LD; Macaluso, KR				Reif, Kathryn E.; Stout, Rhett W.; Henry, Gretchen C.; Foil, Lane D.; Macaluso, Kevin R.			Prevalence and Infection Load Dynamics of Rickettsia felis in Actively Feeding Cat Fleas	PLOS ONE			English	Article							CTENOCEPHALIDES-FELIS; TRANSOVARIAL TRANSMISSION; MOLECULAR-IDENTIFICATION; WOLBACHIA INFECTIONS; MURINE TYPHUS; SIPHONAPTERA; BIOLOGY; ASSOCIATION; HENSELAE; OPOSSUMS	Background: Rickettsia felis is a flea-associated rickettsial pathogen recurrently identified in both colonized and wild-caught cat fleas, Ctenocephalides felis. We hypothesized that within colonized fleas, the intimate relationship between R. felis and C. felis allows for the coordination of rickettsial replication and metabolically active periods during flea bloodmeal acquisition and oogenesis. Methodology/Principal Findings: A quantitative real-time PCR assay was developed to quantify R. felis in actively feeding R. felis-infected fleas. In three separate trials, fleas were allowed to feed on cats, and a mean of 3.9 x 10(6) R. felis 17-kDa gene copies was detected for each flea. A distinct R. felis infection pattern was not observed in fleas during nine consecutive days of bloodfeeding. However, an inverse correlation between the prevalence of R. felis-infection, which ranged from 96% in Trial 1 to 35% in Trial 3, and the R. felis-infection load in individual fleas was identified. Expression of R. felis-infection load as a ratio of R. felis/C. felis genes confirmed that fleas in Trial 3 had significantly greater rickettsial loads than those in Trial 1. Conclusion/Significance: Examining rickettsial infection dynamics in the flea vector will further elucidate the intimate relationship between R. felis and C. felis, and facilitate a more accurate understanding of the ecology and epidemiology of R. felis transmission in nature.	[Reif, Kathryn E.; Stout, Rhett W.; Henry, Gretchen C.; Macaluso, Kevin R.] Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Foil, Lane D.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Macaluso, KR (corresponding author), Louisiana State Univ, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	kmacaluso@vetmed.lsu.edu			Louisiana Board of Regents (LEQSF); National Institutes of Health [P20RR0201595, RR017504-01]; National Institute of Allergy and Infectious Diseases [R21AI70705]; NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR017504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070705] Funding Source: NIH RePORTER	Louisiana Board of Regents (LEQSF); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Louisiana Board of Regents (LEQSF), the National Institutes of Health (NIH; P20RR0201595), and the National Institute of Allergy and Infectious Diseases (R21AI70705). Gretchen Henry was supported by an NIH T35 (RR017504-01) awarded to LSU-SVM.	ADAMS JR, 1990, AM J TROP MED HYG, V43, P400, DOI 10.4269/ajtmh.1990.43.400; AZAD AF, 1992, P NATL ACAD SCI USA, V89, P43, DOI 10.1073/pnas.89.1.43; Azad AF, 1997, EMERG INFECT DIS, V3, P319, DOI 10.3201/eid0303.970308; Bauer O, 2006, AM J TROP MED HYG, V74, P444, DOI 10.4269/ajtmh.2006.74.444; Bitam I, 2006, AM J TROP MED HYG, V74, P532, DOI 10.4269/ajtmh.2006.74.532; Boostrom A, 2002, EMERG INFECT DIS, V8, P549, DOI 10.3201/eid0806.010350; Cheng Q, 2000, MED VET ENTOMOL, V14, P44, DOI 10.1046/j.1365-2915.2000.00202.x; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; DRYDEN MW, 1994, VET PARASITOL, V52, P1, DOI 10.1016/0304-4017(94)90031-0; DRYDEN MW, 1989, VET PARASITOL, V34, P117, DOI 10.1016/0304-4017(89)90171-4; Foil L, 1998, J MED ENTOMOL, V35, P625, DOI 10.1093/jmedent/35.5.625; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Gorham CH, 2003, J PARASITOL, V89, P283, DOI 10.1645/0022-3395(2003)089[0283:WEIFS]2.0.CO;2; Henry KM, 2007, MOL CELL PROBE, V21, P17, DOI 10.1016/j.mcp.2006.06.002; Higgins J. A., 1994, Insect Molecular Biology, V3, P27, DOI 10.1111/j.1365-2583.1994.tb00147.x; Horigane M, 2007, ARCH INSECT BIOCHEM, V64, P186, DOI 10.1002/arch.20170; Jiang J, 2006, EMERG INFECT DIS, V12, P1281, DOI 10.3201/eid1708.060327; Macaluso KR, 2001, VECTOR-BORNE ZOONOT, V1, P45, DOI 10.1089/153036601750137660; Macaluso KR, 2008, VECTOR-BORNE ZOONOT, V8, P391, DOI 10.1089/vbz.2007.0218; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Noden BH, 1998, J MED ENTOMOL, V35, P410, DOI 10.1093/jmedent/35.4.410; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Parola P, 2003, ANN NY ACAD SCI, V990, P173, DOI 10.1111/j.1749-6632.2003.tb07359.x; Pornwiroon W, 2007, ISME J, V1, P394, DOI 10.1038/ismej.2007.38; Pornwiroon W, 2006, APPL ENVIRON MICROB, V72, P5589, DOI 10.1128/AEM.00532-06; Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278; Rolain JM, 2002, ANTIMICROB AGENTS CH, V46, P2747, DOI 10.1128/AAC.46.9.2747-2751.2002; Rust MK, 1997, ANNU REV ENTOMOL, V42, P451, DOI 10.1146/annurev.ento.42.1.451; Schloderer D, 2006, EMERG INFECT DIS, V12, P841, DOI 10.3201/eid1205.051458; SCHRIEFER ME, 1994, J CLIN MICROBIOL, V32, P949, DOI 10.1128/JCM.32.4.949-954.1994; Stevenson HL, 2005, J MED ENTOMOL, V42, P163, DOI 10.1603/0022-2585(2005)042[0163:DORFIA]2.0.CO;2; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wedincamp J, 2000, J VECTOR ECOL, V25, P123; Wedincamp J, 2002, J VECTOR ECOL, V27, P96; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WILLIAMS SG, 1992, J CLIN MICROBIOL, V30, P1758, DOI 10.1128/JCM.30.7.1758-1762.1992; Zanetti AS, 2008, J MED ENTOMOL, V45, P267, DOI 10.1603/0022-2585(2008)45[267:CORIIA]2.0.CO;2; Zavala-Velazquez E, 2002, VECTOR-BORNE ZOONOT, V2, P69, DOI 10.1089/153036602321131869	38	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2805	10.1371/journal.pone.0002805	http://dx.doi.org/10.1371/journal.pone.0002805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665265	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300024
J	Gaspar, M; Gill, MB; Loesing, JB; May, JS; Stevenson, PG				Gaspar, Miguel; Gill, Michael B.; Loesing, Jens-Bernhard; May, Janet S.; Stevenson, Philip G.			Multiple Functions for ORF75c in Murid Herpesvirus-4 Infection	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; PSEUDORABIES VIRUS; COMPLETE SEQUENCE; GENE-EXPRESSION; VIRAL-PROTEINS; GLYCOPROTEIN-M; CELLS; IDENTIFICATION; TRANSCRIPTION; REPLICATION	All gamma-herpesviruses encode at least one homolog of the cellular enzyme formyl-glycineamide-phosphoribosylamidotransferase. Murid herpesvirus-4 (MuHV-4) encodes 3 (ORFs 75a, 75b and 75c), suggesting that at least some copies have acquired new functions. Here we show that the corresponding proteins are all present in virions and localize to infected cell nuclei. Despite these common features, ORFs 75a and 75b did not substitute functionally for a lack of ORF75c, as ORF75c virus knockouts were severely impaired for lytic replication in vitro and for host colonization in vivo. They showed 2 defects: in-coming capsids failed to migrate to the nuclear margin following membrane fusion, and genomes that did reach the nucleus failed to initiate normal gene expression. The latter defect was associated with a failure of in coming virions to disassemble PML bodies. The capsid transport deficit seemed to be functionally more important, since ORF75c(-) MuHV-4 infected both PML+ and PML- cells poorly. The original host enzyme has therefore evolved into a set of distinct and multi-functional viral tegument proteins. One important function is moving incoming capsids to the nuclear margin for viral genome delivery.	[Gaspar, Miguel; Gill, Michael B.; Loesing, Jens-Bernhard; May, Janet S.; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England	University of Cambridge	Gaspar, M (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge CB2 1QP, England.	pgs27@cam.ac.uk	Bosse, Jens Bernhard/D-7336-2011; Stevenson, Philip/F-6651-2011; Stevenson, Philip g/F-9688-2014	Bosse, Jens Bernhard/0000-0001-7252-5541; Stevenson, Philip g/0000-0002-3520-5060	Wellcome Trust Senior Clinical Fellow [GR076956MA]; Medical Research Council [G0400427, G0701185, G9800903]; CR-UK [C19612/A6189]; Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany; Studienstiftung des Deutschen Volkes; MRC [G0701185, G0400427, G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Wellcome Trust Senior Clinical Fellow(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany; Studienstiftung des Deutschen Volkes; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427,G0701185 and G9800903 and by CR-UK grant C19612/A6189. JBL was supported by the Heinrich Hertz-Stiftung fund of the Federal state of North Rhine-Westphalia, Germany and by the Studienstiftung des Deutschen Volkes.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Antinone SE, 2006, J VIROL, V80, P5494, DOI 10.1128/JVI.00026-06; Bechtel JT, 2005, J VIROL, V79, P4952, DOI 10.1128/JVI.79.8.4952-4964.2005; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; Bortz E, 2003, J VIROL, V77, P13425, DOI 10.1128/JVI.77.24.13425-13432.2003; Coleman HM, 2005, J GEN VIROL, V86, P561, DOI 10.1099/vir.0.80565-0; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; Davison AJ, 2005, J VIROL, V79, P12880, DOI 10.1128/JVI.79.20.12880-12892.2005; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; Diefenbach RJ, 2008, REV MED VIROL, V18, P35, DOI 10.1002/rmv.560; DUSH MK, 1985, P NATL ACAD SCI USA, V82, P2731, DOI 10.1073/pnas.82.9.2731; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; EFSTATHIOU S, 1990, J GEN VIROL, V71, P1355, DOI 10.1099/0022-1317-71-6-1355; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Feederle R, 2006, J VIROL, V80, P9435, DOI 10.1128/JVI.00473-06; GARDELLA T, 1984, J VIROL, V50, P248, DOI 10.1128/JVI.50.1.248-254.1984; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Granzow H, 2005, J VIROL, V79, P3200, DOI 10.1128/JVI.79.5.3200-3205.2005; Hair JR, 2007, J GEN VIROL, V88, P1689, DOI 10.1099/vir.0.82548-0; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KWONG AD, 1987, P NATL ACAD SCI USA, V84, P1926, DOI 10.1073/pnas.84.7.1926; Lembo D, 2004, J VIROL, V78, P4278, DOI 10.1128/JVI.78.8.4278-4288.2004; Lyman MG, 2007, J VIROL, V81, P11363, DOI 10.1128/JVI.01281-07; Martinez-Guzman D, 2003, J VIROL, V77, P10488, DOI 10.1128/JVI.77.19.10488-10503.2003; May JS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002131; May JS, 2005, J VIROL, V79, P3459, DOI 10.1128/JVI.79.6.3459-3467.2005; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; OHARE P, 1985, J VIROL, V56, P723, DOI 10.1128/JVI.56.3.723-733.1985; PATTERSON D, 1975, SOMAT CELL GENET, V1, P91, DOI 10.1007/BF01538734; Patterson D, 1999, GENE, V239, P381, DOI 10.1016/S0378-1119(99)00378-9; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Rosa GT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000560; Smith CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001048; Song MJ, 2005, P NATL ACAD SCI USA, V102, P3805, DOI 10.1073/pnas.0404521102; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Zimmermann W, 2001, J VIROL, V75, P1186, DOI 10.1128/JVI.75.3.1186-1194.2001	47	41	41	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2781	10.1371/journal.pone.0002781	http://dx.doi.org/10.1371/journal.pone.0002781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648660	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900051
J	Ioannidis, JPA				Ioannidis, John P. A.			Measuring Co-Authorship and Networking-Adjusted Scientific Impact	PLOS ONE			English	Article							H-INDEX; MULTIPLE AUTHORSHIP; HIRSCH-INDEX; UNIVERSITIES; COAUTHORSHIP; PUBLICATION; DISCLOSURE; PATTERNS; MEDICINE; RANKING	Appraisal of the scientific impact of researchers, teams and institutions with productivity and citation metrics has major repercussions. Funding and promotion of individuals and survival of teams and institutions depend on publications and citations. In this competitive environment, the number of authors per paper is increasing and apparently some co-authors don't satisfy authorship criteria. Listing of individual contributions is still sporadic and also open to manipulation. Metrics are needed to measure the networking intensity for a single scientist or group of scientists accounting for patterns of co-authorship. Here, I define I-1 for a single scientist as the number of authors who appear in at least I-1 papers of the specific scientist. For a group of scientists or institution, In is defined as the number of authors who appear in at least In papers that bear the affiliation of the group or institution. I-1 depends on the number of papers authored N-p. The power exponent R of the relationship between I-1 and N-p categorizes scientists as solitary (R>2.5), nuclear (R = 2.25-2.5), networked (R = 2-2.25), extensively networked (R = 1.75-2) or collaborators (R<1.75). R may be used to adjust for co-authorship networking the citation impact of a scientist. In similarly provides a simple measure of the effective networking size to adjust the citation impact of groups or institutions. Empirical data are provided for single scientists and institutions for the proposed metrics. Cautious adoption of adjustments for co-authorship and networking in scientific appraisals may offer incentives for more accountable co-authorship behaviour in published articles.	[Ioannidis, John P. A.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA USA	University of Ioannina; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ioannidis, John P. A./G-9836-2011					Abt HA, 2007, SCIENTOMETRICS, V73, P281, DOI 10.1007/s11192-007-1807-8; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Batista PD, 2006, SCIENTOMETRICS, V68, P179, DOI 10.1007/s11192-006-0090-4; Drenth JPH, 1998, JAMA-J AM MED ASSOC, V280, P219, DOI 10.1001/jama.280.3.219; Egghe L, 2006, SCIENTOMETRICS, V69, P121, DOI 10.1007/s11192-006-0143-8; Enserink M, 2007, SCIENCE, V317, P1026, DOI 10.1126/science.317.5841.1026; EPSTEIN RJ, 1993, BRIT MED J, V306, P765, DOI 10.1136/bmj.306.6880.765; FETTERS MD, 1995, SOC SCI MED, V41, P375, DOI 10.1016/0277-9536(95)00090-T; Fetters MD, 1997, BRIT MED J, V315, P747; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Hama Y, 2001, CAN ASSOC RADIOL J, V52, P25; Hirsch JE, 2007, P NATL ACAD SCI USA, V104, P19193, DOI 10.1073/pnas.0707962104; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Ilakovac V, 2007, CAN MED ASSOC J, V176, P41; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Ioannidis JP, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-30; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Khan KS, 1999, AM J OBSTET GYNECOL, V181, P503, DOI 10.1016/S0002-9378(99)70585-5; King JT, 2000, NEUROSURGERY, V47, P435, DOI 10.1097/00006123-200008000-00032; Kinney AL, 2007, P NATL ACAD SCI USA, V104, P17943, DOI 10.1073/pnas.0704416104; Kostoff RN, 2006, SCI ENG ETHICS, V12, P543, DOI 10.1007/s11948-006-0052-5; Mainous AG, 2002, FAM MED, V34, P462; Mowatt G, 2002, JAMA-J AM MED ASSOC, V287, P2769, DOI 10.1001/jama.287.21.2769; Papatheodorou SI, 2008, J CLIN EPIDEMIOL, V61, P546, DOI 10.1016/j.jclinepi.2007.07.017; Parker GB, 2007, MED J AUSTRALIA, V187, P650, DOI 10.5694/j.1326-5377.2007.tb01459.x; POWERS RD, 1988, AM J EMERG MED, V6, P647, DOI 10.1016/0735-6757(88)90111-8; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; SHULKIN DJ, 1993, ACAD MED, V68, P688, DOI 10.1097/00001888-199309000-00015; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Tarnow E, 2002, SCI ENG ETHICS, V8, P175, DOI 10.1007/s11948-002-0017-2; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Weeks WB, 2004, SOC SCI MED, V59, P1949, DOI 10.1016/j.socscimed.2004.02.029; Wendl MC, 2007, NATURE, V449, P403, DOI 10.1038/449403b; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013	36	46	46	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2778	10.1371/journal.pone.0002778	http://dx.doi.org/10.1371/journal.pone.0002778			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420PY	18648663	gold, Green Submitted, Green Published			2022-12-27	WOS:000264302900048
J	Otterstatter, MC; Thomson, JD				Otterstatter, Michael C.; Thomson, James D.			Does Pathogen Spillover from Commercially Reared Bumble Bees Threaten Wild Pollinators?	PLOS ONE			English	Article							ANTHER-SMUT INFECTION; HONEY-BEE; BOMBUS-TERRESTRIS; CROP POLLINATION; PARASITIC MITES; WORLDWIDE MIGRATION; APIDAE ACTIVITY; SPATIAL SPREAD; HYMENOPTERA; DISEASE	The conservation of insect pollinators is drawing attention because of reported declines in bee species and the 'ecosystem services' they provide. This issue has been brought to a head by recent devastating losses of honey bees throughout North America (so called, 'Colony Collapse Disorder'); yet, we still have little understanding of the cause(s) of bee declines. Wild bumble bees (Bombus spp.) have also suffered serious declines and circumstantial evidence suggests that pathogen 'spillover' from commercially reared bumble bees, which are used extensively to pollinate greenhouse crops, is a possible cause. We constructed a spatially explicit model of pathogen spillover in bumble bees and, using laboratory experiments and the literature, estimated parameter values for the spillover of Crithidia bombi, a destructive pathogen commonly found in commercial Bombus. We also monitored wild bumble bee populations near greenhouses for evidence of pathogen spillover, and compared the fit of our model to patterns of C. bombi infection observed in the field. Our model predicts that, during the first three months of spillover, transmission from commercial hives would infect up to 20% of wild bumble bees within 2 km of the greenhouse. However, a travelling wave of disease is predicted to form suddenly, infecting up to 35-100% of wild Bombus, and spread away from the greenhouse at a rate of 2 km/wk. In the field, although we did not observe a large epizootic wave of infection, the prevalences of C. bombi near greenhouses were consistent with our model. Indeed, we found that spillover has allowed C. bombi to invade several wild bumble bee species near greenhouses. Given the available evidence, it is likely that pathogen spillover from commercial bees is contributing to the ongoing decline of wild Bombus in North America. Improved management of domestic bees, for example by reducing their parasite loads and their overlap with wild congeners, could diminish or even eliminate pathogen spillover.	[Otterstatter, Michael C.; Thomson, James D.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Otterstatter, MC (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	michael.otterstatter@utoronto.ca		Otterstatter, Michael/0000-0001-5489-014X	Natural Sciences and Engineering Research Council of Canada (NSERC); Ontario Graduate Scholarships (OGS)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarships (OGS)(Ontario Graduate Scholarship)	Funding for this research was provided by grants to the authors by the Natural Sciences and Engineering Research Council of Canada (NSERC) and Ontario Graduate Scholarships (OGS). No funding agencies had any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Altizer SM, 1998, AM MIDL NAT, V139, P147, DOI 10.1674/0003-0031(1998)139[0147:VBATTO]2.0.CO;2; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; BANASZAK J, 1992, AGR ECOSYST ENVIRON, V40, P179, DOI 10.1016/0167-8809(92)90091-O; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Buchmann S, 2005, BEE WORLD, V86, P71, DOI 10.1080/0005772X.2005.11417316; Buchmann SL, 1996, SCIENCES, V36, P22, DOI 10.1002/j.2326-1951.1996.tb03254.x; Burney DA, 2005, TRENDS ECOL EVOL, V20, P395, DOI 10.1016/j.tree.2005.04.022; Colla SR, 2008, BIODIVERS CONSERV, V17, P1379, DOI 10.1007/s10531-008-9340-5; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Diamond J., 2010, RUZHYA MIKROBY STALI; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Dwyer G, 1998, AM NAT, V152, P485, DOI 10.1086/286185; DWYER G, 1994, AM NAT, V143, P533, DOI 10.1086/285619; DWYER G, 1995, ECOLOGY, V76, P1262, DOI 10.2307/1940933; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; ENTWISTLE PF, 1983, J APPL ECOL, V20, P473, DOI 10.2307/2403521; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Forup ML, 2005, ECOL ENTOMOL, V30, P47, DOI 10.1111/j.0307-6946.2005.00660.x; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gegear RJ, 2006, P ROY SOC B-BIOL SCI, V273, P1073, DOI 10.1098/rspb.2005.3423; Ghazoul J, 2005, TRENDS ECOL EVOL, V20, P367, DOI 10.1016/j.tree.2005.04.026; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; Goka K, 2000, JPN J APPL ENTOMOL Z, V44, P47, DOI 10.1303/jjaez.2000.47; Goka K, 2001, MOL ECOL, V10, P2095, DOI 10.1046/j.0962-1083.2001.01323.x; Goka K, 2006, POPUL ECOL, V48, P285, DOI 10.1007/s10144-006-0010-8; GORBUNOV PS, 1987, ZOOL ZH, V66, P1775; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; Inari N, 2005, POPUL ECOL, V47, P77, DOI 10.1007/s10144-004-0205-9; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; KEVAN PG, 1991, P ENTOMOL SOC ONT, V122, P15; KEVAN PG, 1990, BEE WORLD, V71, P119, DOI 10.1080/0005772X.1990.11099048; Kevan PG, 2001, CONSERV ECOL, V5; Kremen C, 2004, ECOL LETT, V7, P1109, DOI 10.1111/j.1461-0248.2004.00662.x; Kremen C, 2002, P NATL ACAD SCI USA, V99, P16812, DOI 10.1073/pnas.262413599; LAVERTY TM, 1988, CAN ENTOMOL, V120, P965, DOI 10.4039/Ent120965-11; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; LIU HJ, 1973, THESIS GUELPH U GUEL, P130; Ludwig JA, 1988, STAT ECOLOGY; MACFARLANE RP, 1974, THESIS GUELPH U GUEL, P210; MacPhee Ross D.E., 1997, P169; McCullagh P, 1989, GEN LINEAR MODELS; Morandin LA, 2001, CAN ENTOMOL, V133, P883, DOI 10.4039/Ent133883-6; Morandin LA, 2001, J ECON ENTOMOL, V94, P462, DOI 10.1603/0022-0493-94.2.462; Murray, 2002, MATH BIOL I INTRO IN; Niwa S, 2004, JPN J APPL ENTOMOL Z, V48, P60, DOI 10.1303/jjaez.2004.60; *NRC COMM STAT POL, 2006, STAT POLL N AM; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Otterstatter MC, 2004, APIDOLOGIE, V35, P351, DOI 10.1051/apido:2004024; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; ROCHE BM, 1995, ECOLOGY, V76, P1863, DOI 10.2307/1940719; Ruiz-Gonzalez MX, 2006, ECOL ENTOMOL, V31, P616, DOI 10.1111/j.1365-2311.2006.00823.x; Sabara HA, 2004, J ECON ENTOMOL, V97, P727, DOI 10.1603/0022-0493(2004)097[0727:IOBVSA]2.0.CO;2; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Samways MJ, 2006, CONSERV BIOL, V20, P245, DOI 10.1111/j.1523-1739.2006.00349.x; Samways MJ, 1996, BIODIVERS CONSERV, V5, P1047, DOI 10.1007/BF00052715; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 1998, APIDOLOGIE, V29, P525, DOI 10.1051/apido:19980605; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Sokal R.R., 2012, BIOMETRY; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; THORP R, 2005, RED LIST POLLINATOR; VANDERSTEEN J, 2006, BIODIVERSITY IMPACT, P105; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Walther-Hellwig K, 2000, J INSECT BEHAV, V13, P239, DOI 10.1023/A:1007740315207; White A, 1999, OIKOS, V85, P487, DOI 10.2307/3546698; White A, 2000, OIKOS, V89, P137, DOI 10.1034/j.1600-0706.2000.890115.x; Whittington R, 2004, J ECON ENTOMOL, V97, P1384, DOI 10.1603/0022-0493-97.4.1384; Whittington R, 2004, CAN J PLANT SCI, V84, P599, DOI 10.4141/P02-192; Whittington R, 2003, J INVERTEBR PATHOL, V84, P54, DOI 10.1016/S0022-2011(03)00123-X; Williams P, 2005, BIOL CONSERV, V122, P33, DOI 10.1016/j.biocon.2004.06.019; Winter K, 2006, IMPORTATION NONNATIV; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775	82	132	136	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2771	10.1371/journal.pone.0002771	http://dx.doi.org/10.1371/journal.pone.0002771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648661	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900041
J	Sommer, WH; Kraft, A; Schmidt, S; Olma, MC; Brandt, SA				Sommer, Wieland H.; Kraft, Antje; Schmidt, Sein; Olma, Manuel C.; Brandt, Stephan A.			Dynamic Spatial Coding within the Dorsal Frontoparietal Network during a Visual Search Task	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SCALE NEURAL-NETWORK; VISUOSPATIAL ATTENTION; TOP-DOWN; CONJUNCTION SEARCH; PARAMETRIC FMRI; HUMAN BRAIN; BOTTOM-UP; VOLUNTARY; NEGLECT	To what extent are the left and right visual hemifields spatially coded in the dorsal frontoparietal attention network? In many experiments with neglect patients, the left hemisphere shows a contralateral hemifield preference, whereas the right hemisphere represents both hemifields. This pattern of spatial coding is often used to explain the right-hemispheric dominance of lesions causing hemispatial neglect. However, pathophysiological mechanisms of hemispatial neglect are controversial because recent experiments on healthy subjects produced conflicting results regarding the spatial coding of visual hemifields. We used an fMRI paradigm that allowed us to distinguish two attentional subprocesses during a visual search task. Either within the left or right hemifield subjects first attended to stationary locations (spatial orienting) and then shifted their attentional focus to search for a target line. Dynamic changes in spatial coding of the left and right hemifields were observed within subregions of the dorsal front-parietal network: During stationary spatial orienting, we found the well-known spatial pattern described above, with a bilateral hemifield representation in the right hemisphere and a contralateral preference in the left hemisphere. However, during search, the right hemisphere had a contralateral preference and the left hemisphere equally represented both hemifields. This finding leads to novel perspectives regarding models of visuospatial attention and hemispatial neglect.	[Sommer, Wieland H.; Kraft, Antje; Schmidt, Sein; Olma, Manuel C.; Brandt, Stephan A.] Berlin Neuroimaging Ctr, Dept Neurol, Berlin, Germany; [Sommer, Wieland H.; Schmidt, Sein; Brandt, Stephan A.] Bernstein Ctr Computat Neurosci, Berlin, Germany; [Sommer, Wieland H.] Ludwig Maximilians Univ Munchen, Univ Hosp Grosshadern, Dept Clin Radiol, Munich, Germany	University of Munich	Sommer, WH (corresponding author), Berlin Neuroimaging Ctr, Dept Neurol, Berlin, Germany.	stephan.brandt@charite.de	Schmidt, Sein/AFR-1244-2022; Schmidt, Sein/AAT-2308-2021		Bernstein Center for Computational Neuroscience Berlin; German Research Foundation [BR 1691/3-2]	Bernstein Center for Computational Neuroscience Berlin; German Research Foundation(German Research Foundation (DFG))	Funding was obtained from the Bernstein Center for Computational Neuroscience Berlin (W.H.S., S.S., C3-CH) and the German Research Foundation (A.K., S.S.; BR 1691/3-2).	Beauchamp MS, 2001, NEUROIMAGE, V14, P310, DOI 10.1006/nimg.2001.0788; Collie A, 2000, J EXP PSYCHOL HUMAN, V26, P1733, DOI 10.1037//0096-1523.26.6.1733; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Danckert JA, 2003, BRADFORD BOOKS, P29; Donner T, 2000, EUR J NEUROSCI, V12, P3407, DOI 10.1046/j.1460-9568.2000.00223.x; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Duncan J, 1999, J EXP PSYCHOL GEN, V128, P450, DOI 10.1037/0096-3445.128.4.450; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; FORSTER DH, 1991, P ROY SOC LOND B BIO, V243, P75; Gainotti G, 1996, NEUROSCI BIOBEHAV R, V20, P617, DOI 10.1016/0149-7634(95)00074-7; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Hagler DJ, 2007, NEUROIMAGE, V35, P1562, DOI 10.1016/j.neuroimage.2007.01.033; Hagler DJ, 2006, NEUROIMAGE, V29, P567, DOI 10.1016/j.neuroimage.2005.08.058; Hahn B, 2006, NEUROIMAGE, V32, P842, DOI 10.1016/j.neuroimage.2006.04.177; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heilman K. M, 1983, LOCALIZATION NEUROPS, P471; Hemond CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000574; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Hung J, 2005, J NEUROSCI, V25, P9602, DOI 10.1523/JNEUROSCI.0879-05.2005; Kastner Sabine, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P483, DOI 10.3758/CABN.4.4.483; Kim YH, 1999, NEUROIMAGE, V9, P269, DOI 10.1006/nimg.1999.0408; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Kraft A, 2005, COGNITIVE BRAIN RES, V24, P19, DOI 10.1016/j.cogbrainres.2004.12.004; Kraft A, 2007, BRAIN RES, V1133, P123, DOI 10.1016/j.brainres.2006.11.043; Macaluso E, 2007, EXP BRAIN RES, V180, P23, DOI 10.1007/s00221-006-0841-8; Macmillan N. A., 2004, DETECTION THEORY USE; Mayer AR, 2004, NEUROIMAGE, V23, P534, DOI 10.1016/j.neuroimage.2004.06.027; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Muller NG, 2003, NEUROIMAGE, V20, P1578, DOI 10.1016/S1053-8119(03)00416-6; Muller NG, 2003, J NEUROSCI, V23, P3561; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Niemeier M, 2005, CEREB CORTEX, V15, P325, DOI 10.1093/cercor/bhh134; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Peelen MV, 2004, NEUROIMAGE, V22, P822, DOI 10.1016/j.neuroimage.2004.01.044; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Talairach I., 1988, COPLANAR STEREOTACTI; TSAL Y, 1988, PERCEPT PSYCHOPHYS, V44, P15, DOI 10.3758/BF03207469; Turatto M, 2000, PERCEPT PSYCHOPHYS, V62, P935, DOI 10.3758/BF03212079; VALLAR G, 1988, CORTEX, V24, P399, DOI 10.1016/S0010-9452(88)80003-0; Vandenberghe R, 2005, BRAIN, V128, P2843, DOI 10.1093/brain/awh522; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; Zenger B, 1997, J EXP PSYCHOL HUMAN, V23, P1783, DOI 10.1037/0096-1523.23.6.1783	58	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2008	3	9							e3167	10.1371/journal.pone.0003167	http://dx.doi.org/10.1371/journal.pone.0003167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	422JY	18779857	Green Published, Green Submitted, gold			2022-12-27	WOS:000264425100003
J	Matsuoka, Y; Takumi, S; Kawahara, T				Matsuoka, Yoshihiro; Takumi, Shigeo; Kawahara, Taihachi			Flowering Time Diversification and Dispersal in Central Eurasian Wild Wheat Aegilops tauschii Coss.: Genealogical and Ecological Framework	PLOS ONE			English	Article								Timing of flowering is a reproductive trait that has significant impact on fitness in plants. In contrast to recent advances in understanding the molecular basis of floral transition, few empirical studies have addressed questions concerning population processes of flowering time diversification within species. We analyzed chloroplast DNA genealogical structure of flowering time variation in central Eurasian wild wheat Aegilops tauschii Coss. using 200 accessions that represent the entire species range. Flowering time measured as days from germination to flowering varied from 144.0 to 190.0 days (average 161.3 days) among accessions in a common garden/greenhouse experiment. Subsequent genealogical and statistical analyses showed that (1) there exist significant longitudinal and latitudinal clines in flowering time at the species level, (2) the early-flowering phenotype evolved in two intraspecific lineages, (3) in Asia, winter temperature was an environmental factor that affected the longitudinal clinal pattern of flowering time variation, and (4) in Transcaucasus-Middle East, some latitudinal factors affected the geographic pattern of flowering time variation. On the basis of palaeoclimatic, biogeographic, and genetic evidence, the northern part of current species' range [which was within the temperate desert vegetation (TDV) zone at the Last Glacial Maximum] is hypothesized to have harbored species refugia. Postglacial southward dispersal from the TDV zone seems to have been driven by lineages that evolved short-flowering time phenotypes through different genetic mechanisms in Transcaucasus-Middle East and Asia.	[Matsuoka, Yoshihiro] Fukui Prefectural Univ, Fukui, Japan; [Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo, Japan; [Kawahara, Taihachi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan	Fukui Prefectural University; Kobe University; Kyoto University	Matsuoka, Y (corresponding author), Fukui Prefectural Univ, Fukui, Japan.	matsuoka@fpu.ac.jp			Ministry of Agriculture, Forestry and Fisheries of Japan [GD2006]; Ministry of Education, Culture, Sports, Science and Technology, Japan [17201045]	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Agriculture, Forestry and Fisheries of Japan (Integrated research project for plant, insect and animal using genome technology, GD2006) to Y.M. and, in part, by a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Basic Research A, No. 17201045) to T.K., S.T., and Y.M.	[Anonymous], 2005, PHYLIP PHYLOGENY INF; Ansari MH, 2007, REV PALAEOBOT PALYNO, V145, P201, DOI 10.1016/j.revpalbo.2006.10.005; BANDELT HJ, 1995, GENETICS, V141, P743; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Franzke A, 2004, MOL ECOL, V13, P2789, DOI 10.1111/j.1365-294X.2004.02272.x; Fu DL, 2005, MOL GENET GENOMICS, V273, P54, DOI 10.1007/s00438-004-1095-4; Hauser TP, 2000, HEREDITAS, V132, P95, DOI 10.1111/j.1601-5223.2000.00095.x; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Ishii T, 2001, THEOR APPL GENET, V103, P896, DOI 10.1007/s001220100715; Kihara H., 1965, RESULTS KYOTO U SCI, P1; Kihara H, 1944, AGR HORTIC, V19, P889; Matsuoka Y, 2005, THEOR APPL GENET, V111, P265, DOI 10.1007/s00122-005-2020-x; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Minch E, 1997, MICROSAT COMPUTER PR; PUGSLEY AT, 1965, NATURE, V207, P108, DOI 10.1038/207108a0; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Rhone B, 2008, MOL ECOL, V17, P930, DOI 10.1111/j.1365-294X.2007.03619.x; Roberts Neil, 1993, P194; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tanaka M., 1991, Wheat Information Service, P33; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Weber E, 1998, AM J BOT, V85, P1110, DOI 10.2307/2446344; Welsh J. R., 1973, Proceedings of the fourth international wheat genetics symposium. Biochemical and physiological genetics., P879; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; ZOHARY D, 1969, EUPHYTICA, V18, P58	36	58	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2008	3	9							e3138	10.1371/journal.pone.0003138	http://dx.doi.org/10.1371/journal.pone.0003138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HU	18769547	Green Published, gold, Green Submitted			2022-12-27	WOS:000264419100006
J	Rajalingam, K; Sharma, M; Lohmann, C; Oswald, M; Thieck, O; Froelich, CJ; Rudel, T				Rajalingam, Krishnaraj; Sharma, Manu; Lohmann, Christine; Oswald, Monique; Thieck, Oliver; Froelich, Christopher J.; Rudel, Thomas			Mcl-1 Is a Key Regulator of Apoptosis Resistance in Chlamydia trachomatis-Infected Cells	PLOS ONE			English	Article								Chlamydia are obligate intracellular bacteria that cause variety of human diseases. Host cells infected with Chlamydia are protected against many different apoptotic stimuli. The induction of apoptosis resistance is thought to be an important immune escape mechanism allowing Chlamydia to replicate inside the host cell. Infection with C. trachomatis activates the Raf/MEK/ERK pathway and the PI3K/AKT pathway. Here we show that inhibition of these two pathways by chemical inhibitors sensitized C. trachomatis infected cells to granzyme B-mediated cell death. Infection leads to the Raf/MEK/ERK-mediated up-regulation and PI3K-dependent stabilization of the anti-apoptotic Bcl-2 family member Mcl-1. Consistently, interfering with Mcl-1 up-regulation sensitized infected cells for apoptosis induced via the TNF receptor, DNA damage, granzyme B and stress. Our data suggest that Mcl-1 up-regulation is primarily required to maintain apoptosis resistance in C. trachomatis-infected cells.	[Rajalingam, Krishnaraj; Sharma, Manu; Lohmann, Christine; Oswald, Monique; Thieck, Oliver; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Froelich, Christopher J.] Evanston Northwestern Res Inst, Evanston, IL USA	Max Planck Society	Rajalingam, K (corresponding author), Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, Emmy Noether Grp DFG, Frankfurt, Germany.	thomas.rudel@biozentrum.uni-wuerzburg.de	Rajalingam, krishnaraj/D-3081-2011; Sharma, Manu/AAF-5854-2019	Sharma, Manu/0000-0003-3120-9854	Sixth Research Framework Program of the European Union, Project RIGHT [LSHB-CT-2004 005276]	Sixth Research Framework Program of the European Union, Project RIGHT	We acknowledge the help of the EURIT team (www.eurit-network.org) with the validation of siRNAs. We thank Dr. Ulrich Steinhoff for excellent advice and valuable discussions, Dr. Sri. Raja for sharing fluorescently labelled GrB and Kathleen Gottschalk for help with generating shMcl-1 stable cell lines. Dr. Sonja Kimmig and Dr. Claudia Sievers are thanked for providing the viral particles and Dr. Volker Brinkmann for measuring the inclusion sizes. This work was supported by funding under the Sixth Research Framework Program of the European Union, Project RIGHT (LSHB-CT-2004 005276) to T.R.	Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Byrne GI, 2004, NAT REV MICROBIOL, V2, P802, DOI 10.1038/nrmicro1007; Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Dean D, 2001, INFECT IMMUN, V69, P2442, DOI 10.1128/IAI.69.4.2442-2447.2001; Dong F, 2005, INFECT IMMUN, V73, P1861, DOI 10.1128/IAI.73.3.1861-1864.2005; Dong F, 2004, INFECT IMMUN, V72, P3863, DOI 10.1128/IAI.72.7.3863-3868.2004; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402; Fischer SF, 2004, INFECT IMMUN, V72, P1107, DOI 10.1128/IAI.72.2.1107-1115.2004; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; GRAYSTON JT, 1992, ANNU REV MED, V43, P317, DOI 10.1146/annurev.med.43.1.317; GRAYSTON JT, 1975, J INFECT DIS, V132, P87, DOI 10.1093/infdis/132.1.87; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Han J, 2005, J BIOL CHEM, V280, P16383, DOI 10.1074/jbc.M411377200; Hess S, 2001, ARTHRITIS RHEUM-US, V44, P2392, DOI 10.1002/1529-0131(200110)44:10<2392::AID-ART404>3.0.CO;2-I; HILBI H, 1997, PARASITOLOGY, V115, P79; MacFarlane M, 2002, J BIOL CHEM, V277, P36611, DOI 10.1074/jbc.M200317200; MAURER F, 1906, HDB VERGLEICHENDEN 1, V3, P1; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Muller A, 2001, INT J MED MICROBIOL, V291, P197, DOI 10.1078/1438-4221-00125; ODAKE S, 1991, BIOCHEMISTRY-US, V30, P2217, DOI 10.1021/bi00222a027; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; Rajalingam K, 2006, PLOS PATHOG, V2, P1013, DOI 10.1371/journal.ppat.0020114; Rajalingam K, 2007, APOPTOSIS, V12, P1503, DOI 10.1007/s10495-007-0067-7; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verbeke Philippe, 2006, PLoS Pathog, V2, pe45, DOI 10.1371/journal.ppat.0020045; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xia MS, 2003, J INFECT DIS, V187, P424, DOI 10.1086/367962; Xiao YM, 2004, INFECT IMMUN, V72, P5470, DOI 10.1128/IAI.72.9.5470-5474.2004; YING S, 2007, MICROBES INFECT; Ying SM, 2005, INFECT IMMUN, V73, P1399, DOI 10.1128/IAI.73.3.1399-1403.2005	41	83	97	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3102	10.1371/journal.pone.0003102	http://dx.doi.org/10.1371/journal.pone.0003102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769617	Green Published, gold, Green Submitted			2022-12-27	WOS:000264416600002
J	Hartmann, K; Bruehl, C; Golovko, T; Draguhn, A				Hartmann, Kristin; Bruehl, Claus; Golovko, Tatyana; Draguhn, Andreas			Fast Homeostatic Plasticity of Inhibition via Activity-Dependent Vesicular Filling	PLOS ONE			English	Article								Synaptic activity in the central nervous system undergoes rapid state-dependent changes, requiring constant adaptation of the homeostasis between excitation and inhibition. The underlying mechanisms are, however, largely unclear. Chronic changes in network activity result in enhanced production of the inhibitory transmitter GABA, indicating that presynaptic GABA content is a variable parameter for homeostatic plasticity. Here we tested whether such changes in inhibitory transmitter content do also occur at the fast time scale required to ensure inhibition-excitation-homeostasis in dynamic cortical networks. We found that intense stimulation of afferent fibers in the CA1 region of mouse hippocampal slices yielded a rapid and lasting increase in quantal size of miniature inhibitory postsynaptic currents. This potentiation was mediated by the uptake of GABA and glutamate into presynaptic endings of inhibitory interneurons (the latter serving as precursor for the synthesis of GABA). Thus, enhanced release of inhibitory and excitatory transmitters from active networks leads to enhanced presynaptic GABA content. Thereby, inhibitory efficacy follows local neuronal activity, constituting a negative feedback loop and providing a mechanism for rapid homeostatic scaling in cortical circuits.	[Hartmann, Kristin; Bruehl, Claus; Golovko, Tatyana; Draguhn, Andreas] Univ Heidelberg, Dept Physiol & Pathophysiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Hartmann, K (corresponding author), Univ Heidelberg, Dept Physiol & Pathophysiol, Heidelberg, Germany.	andreas.draguhn@physiologie.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [SFB488, FoGru577]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft SFB488 and FoGru577	Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Axmacher N, 2004, J NEUROPHYSIOL, V91, P25, DOI 10.1152/jn.00797.2003; Barberis A, 2004, EUR J NEUROSCI, V20, P1803, DOI 10.1111/j.1460-9568.2004.03624.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; BORDEN LA, 1992, J BIOL CHEM, V267, P21098; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chiu CS, 2005, J NEUROSCI, V25, P3234, DOI 10.1523/JNEUROSCI.3364-04.2005; Chiu CS, 2002, J NEUROSCI, V22, P10251; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; DINGLEDINE R, 1985, J PHYSIOL-LONDON, V366, P387, DOI 10.1113/jphysiol.1985.sp015804; DURING MJ, 1995, NATURE, V376, P174, DOI 10.1038/376174a0; EDWARDS FA, 1990, J PHYSIOL-LONDON, V430, P213, DOI 10.1113/jphysiol.1990.sp018289; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Esclapez M, 1999, J COMP NEUROL, V412, P488; Fisher JL, 2004, J PHYSIOL-LONDON, V561, P433, DOI 10.1113/jphysiol.2003.051839; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; Frerking M, 1997, J NEUROPHYSIOL, V78, P1293, DOI 10.1152/jn.1997.78.3.1293; Fricke MN, 2007, J NEUROCHEM, V102, P1895, DOI 10.1111/j.1471-4159.2007.04649.x; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Hajos N, 2000, EUR J NEUROSCI, V12, P810, DOI 10.1046/j.1460-9568.2000.00964.x; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hartmann K, 2004, EUR J PHARMACOL, V497, P139, DOI 10.1016/j.ejphar.2004.06.044; He Y, 2000, J COMP NEUROL, V418, P255; Hsu CC, 2000, J BIOL CHEM, V275, P20822, DOI 10.1074/jbc.M001403200; Iwai Y, 2003, J NEUROSCI, V23, P6695; Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Liang SL, 2006, J NEUROSCI, V26, P8537, DOI 10.1523/JNEUROSCI.0329-06.2006; Masson J, 2006, J NEUROSCI, V26, P4660, DOI 10.1523/JNEUROSCI.4241-05.2006; Mathews GC, 2003, J NEUROSCI, V23, P2040; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mellor JR, 1997, J PHYSIOL-LONDON, V503, P353, DOI 10.1111/j.1469-7793.1997.353bh.x; Melone M, 2004, CEREB CORTEX, V14, P562, DOI 10.1093/cercor/bhh018; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Perrais D, 1999, J NEUROSCI, V19, P578; Rae C, 2003, J NEUROCHEM, V85, P503, DOI 10.1046/j.1471-4159.2003.01713.x; Ribak CE, 1996, J COMP NEUROL, V367, P595, DOI 10.1002/(SICI)1096-9861(19960415)367:4<595::AID-CNE9>3.0.CO;2-#; ROEPSTORFF A, 1992, NEUROSCI LETT, V146, P131, DOI 10.1016/0304-3940(92)90060-K; Schousboe A, 2004, BIOCHEM PHARMACOL, V68, P1557, DOI 10.1016/j.bcp.2004.06.041; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sulzer D, 2000, REV NEUROSCIENCE, V11, P159; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Van der Kloot W, 2002, J PHYSIOL-LONDON, V541, P385, DOI 10.1113/jphysiol.2001.014407	50	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2979	10.1371/journal.pone.0002979	http://dx.doi.org/10.1371/journal.pone.0002979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714334	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900006
J	Bachvaroff, TR; Place, AR				Bachvaroff, Tsvetan R.; Place, Allen R.			From Stop to Start: Tandem Gene Arrangement, Copy Number and Trans-Splicing Sites in the Dinoflagellate Amphidinium carterae	PLOS ONE			English	Article							BINDING-PROTEIN; PLASTID GENOME; FINE-STRUCTURE; ORGANIZATION; DNA; EXPRESSION; PERIDININ; SYMBIODINIUM; DIVERSITY; RUBISCO	Dinoflagellate genomes present unique challenges including large size, modified DNA bases, lack of nucleosomes, and condensed chromosomes. EST sequencing has shown that many genes are found as many slightly different variants implying that many copies are present in the genome. As a preliminary survey of the genome our goal was to obtain genomic sequences for 47 genes from the dinoflagellate Amphidinium carterae. A PCR approach was used to avoid problems with large insert libraries. One primer set was oriented inward to amplify the genomic complement of the cDNA and a second primer set would amplify outward between tandem repeats of the same gene. Each gene was also tested for a spliced leader using cDNA as template. Almost all (14/15) of the highly expressed genes (i.e. those with high representation in the cDNA pool) were shown to be in tandem arrays with short intergenic spacers, and most were trans-spliced. Only two moderately expressed genes were found in tandem arrays. A polyadenylation signal was found in genomic copies containing the sequence AAAAG/C at the exact polyadenylation site and was conserved between species. Four genes were found to have a high intron density (>5 introns) while most either lacked introns, or had only one to three. Actin was selected for deeper sequencing of both genomic and cDNA copies. Two clusters of actin copies were found, separated from each other by many non-coding features such as intron size and sequence. One intron-rich gene was selected for genomic walking using inverse PCR, and was not shown to be in a tandem repeat. The first glimpse of dinoflagellate genome indicates two general categories of genes in dinoflagellates, a highly expressed tandem repeat class and an intron rich less expressed class. This combination of features appears to be unique among eukaryotes.	[Bachvaroff, Tsvetan R.; Place, Allen R.] Univ Maryland, Biotechnol Inst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Bachvaroff, TR (corresponding author), Univ Maryland, Biotechnol Inst, Baltimore, MD USA.	bachvarofft@si.edu	Place, Allen R/F-9267-2013		National Oceanic and Atmospheric Administration Coastal Ocean Program [NA04NOS4780276, NA05NOS4781196, U50/CCU 323376]; Centers for Disease Control and Prevention; Maryland Department of Health and Mental Hygiene; NSF [EF-0626678]	National Oceanic and Atmospheric Administration Coastal Ocean Program(National Oceanic Atmospheric Admin (NOAA) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maryland Department of Health and Mental Hygiene; NSF(National Science Foundation (NSF))	Funded by the National Oceanic and Atmospheric Administration Coastal Ocean Program under award #NA04NOS4780276 (to ARP) and #NA05NOS4781196 and Grant # U50/CCU 323376, Centers for Disease Control and Prevention and the Maryland Department of Health and Mental Hygiene (to ARP) and NSF grant EF-0626678. The sponsors and funders had no role in the design and conduct, or collection, analysis, and interpretation of the data, or preparation, review, or approval of the manuscript.	ANDERSEN RA, 1997, J PHYSL S, V33; Bachvaroff TR, 2006, J MOL EVOL, V62, P42, DOI 10.1007/s00239-004-0365-4; Bachvaroff TR, 2004, PROTIST, V155, P65, DOI 10.1078/1434461000165; Barbrook AC, 2000, MOL GEN GENET, V263, P152, DOI 10.1007/s004380050042; Barbrook AC, 2001, MOL GENET GENOMICS, V266, P632, DOI 10.1007/s004380100582; BJORNLAND T, 1979, J PHYCOL, V15, P457; BUTSCHLI O, 1885, KLASSEN ORDNUNGEN TH, V1, P865; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Chatton E., 1920, Archives de Zoologie Experimentale Paris, V59; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; DODGE JD, 1971, PROTOPLASMA, V73, P145, DOI 10.1007/BF01275591; Doyle J. J., 1987, PHYTOCHEM B, P11; Guillebault D, 2002, J BIOL CHEM, V277, P40881, DOI 10.1074/jbc.M205624200; HAAPALA OK, 1973, NATURE-NEW BIOL, V244, P195, DOI 10.1038/newbio244195a0; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; HARATA M, 1994, P NATL ACAD SCI USA, V91, P8258, DOI 10.1073/pnas.91.17.8258; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; HILLER RG, 1995, FEBS LETT, V363, P175, DOI 10.1016/0014-5793(95)00297-M; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Joubes J, 2000, PLANT MOL BIOL, V43, P735, DOI 10.1023/A:1006446417196; Kubota T, 2006, BIOL PHARM BULL, V29, P1314, DOI 10.1248/bpb.29.1314; LaJeunesse TC, 2005, J PHYCOL, V41, P880, DOI 10.1111/j.0022-3646.2005.04231.x; Le QH, 1997, MOL GEN GENET, V255, P595, DOI 10.1007/s004380050533; LEE DH, 1993, J BIOL CHEM, V268, P8842; Lidie KB, 2005, MAR BIOTECHNOL, V7, P481, DOI 10.1007/s10126-004-4110-6; Lidie KB, 2007, J EUKARYOT MICROBIOL, V54, P427, DOI 10.1111/j.1550-7408.2007.00282.x; Liu LY, 2006, J PHYCOL, V42, P96, DOI 10.1111/j.1529-8817.2006.00165.x; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; MADDISON WP, 2000, MACCLADE VERSION 4; MAXSON R, 1983, ANNU REV GENET, V17, P239, DOI 10.1146/annurev.ge.17.120183.001323; MORSE D, 1995, SCIENCE, V268, P1622, DOI 10.1126/science.7777861; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, BIOCHEMISTRY-US, V40, P15862, DOI 10.1021/bi011651q; Parrow MW, 2004, J PHYCOL, V40, P664, DOI 10.1111/j.1529-8817.2004.03202.x; RAE PMM, 1976, SCIENCE, V194, P1062, DOI 10.1126/science.988637; Reichman JR, 2003, MOL BIOL EVOL, V20, P2143, DOI 10.1093/molbev/msg233; RIZZO PJ, 1972, SCIENCE, V176, P796, DOI 10.1126/science.176.4036.796; Rowan R, 1996, PLANT CELL, V8, P539, DOI 10.1105/tpc.8.3.539; Swofford DL, 2002, PAUP PHYLOGENETIC AN; WILCOX LW, 1985, SCIENCE, V227, P192, DOI 10.1126/science.227.4683.192; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P4201, DOI 10.1093/nar/gkg469; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	45	130	132	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2929	10.1371/journal.pone.0002929	http://dx.doi.org/10.1371/journal.pone.0002929			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698341	gold, Green Submitted, Green Published			2022-12-27	WOS:000264412600015
J	Pyron, RA; Burbrink, FT; Guiher, TJ				Pyron, R. Alexander; Burbrink, Frank T.; Guiher, Timothy J.			Claims of Potential Expansion throughout the U.S. by Invasive Python Species Are Contradicted by Ecological Niche Models	PLOS ONE			English	Article							DISTRIBUTIONS; CLIMATE; GECKOS	Background: Recent reports from the United States Geological Survey (USGS) suggested that invasive Burmese pythons in the Everglades may quickly spread into many parts of the U. S. due to putative climatic suitability. Additionally, projected trends of global warming were predicted to significantly increase suitable habitat and promote range expansion by these snakes. However, the ecological limitations of the Burmese python are not known and the possible effects of global warming on the potential expansion of the species are also unclear. Methodology/Principal Findings: Here we show that a predicted continental expansion is unlikely based on the ecology of the organism and the climate of the U. S. Our ecological niche models, which include variables representing climatic extremes as well as averages, indicate that the only suitable habitat in the U. S. for Burmese pythons presently occurs in southern Florida and in extreme southern Texas. Models based on the current distribution of the snake predict suitable habitat in essentially the only region in which the snakes are found in the U. S. Future climate models based on global warming forecasts actually indicate a significant contraction in suitable habitat for Burmese pythons in the U. S. as well as in their native range. Conclusions/Significance: The Burmese python is strongly limited to the small area of suitable environmental conditions in the United States it currently inhabits due to the ecological niche preferences of the snake. The ability of the Burmese python to expand further into the U. S. is severely limited by ecological constraints. Global warming is predicted to significantly reduce the area of suitable habitat worldwide, underscoring the potential negative effects of climate change for many species.	[Pyron, R. Alexander; Guiher, Timothy J.] CUNY, Grad Sch, Dept Biol, New York, NY 10021 USA; [Pyron, R. Alexander; Burbrink, Frank T.; Guiher, Timothy J.] CUNY, Coll Staten Island, Dept Biol, Staten Isl, NY USA	City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Pyron, RA (corresponding author), CUNY, Grad Sch, Dept Biol, New York, NY 10021 USA.	rpyron@gc.cuny.edu	Pyron, Robert/F-1681-2014	Pyron, Robert/0000-0003-2524-1794				Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Grinnell J., 1917, Auk Cambridge Mass, V34; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; MCDIARMID RW, 1999, SNAKE SPECIES WORLD, P511; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Rodda GH, 2009, BIOL INVASIONS, V11, P241, DOI 10.1007/s10530-008-9228-z; Snow R. W., 2007, BIOL BOAS PYTHONS, P417	12	51	54	2	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2931	10.1371/journal.pone.0002931	http://dx.doi.org/10.1371/journal.pone.0002931			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698351	Green Published, gold			2022-12-27	WOS:000264412600017
J	Steinert, S; Lee, E; Tresset, G; Zhang, DW; Hortsch, R; Wetzel, R; Hebbar, S; Sundram, JR; Kesavapany, S; Boschke, E; Kraut, R				Steinert, Steffen; Lee, Esther; Tresset, Guillaume; Zhang, Dawei; Hortsch, Ralf; Wetzel, Richard; Hebbar, Sarita; Sundram, Jeyapriya Raja; Kesavapany, Sashi; Boschke, Elke; Kraut, Rachel			A Fluorescent Glycolipid-Binding Peptide Probe Traces Cholesterol Dependent Microdomain-Derived Trafficking Pathways	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; CHOLERA-TOXIN; MEMBRANE DOMAINS; CELL-SURFACE; ENDOCYTIC PATHWAY; ENDOGENOUS SEED; MODEL MEMBRANES; GM1 GANGLIOSIDE; BETA-PROTEIN	Background: The uptake and intracellular trafficking of sphingolipids, which self-associate into plasma membrane microdomains, is associated with many pathological conditions, including viral and toxin infection, lipid storage disease, and neurodegenerative disease. However, the means available to label the trafficking pathways of sphingolipids in live cells are extremely limited. In order to address this problem, we have developed an exogenous, non-toxic probe consisting of a 25-amino acid sphingolipid binding domain, the SBD, derived from the amyloid peptide A beta, and conjugated by a neutral linker with an organic fluorophore. The current work presents the characterization of the sphingolipid binding and live cell trafficking of this novel probe, the SBD peptide. SBD was the name given to a motif originally recognized by Fantini et al [1] in a number of glycolipid-associated proteins, and was proposed to interact with sphingolipids in membrane microdomains. Methodology/Principal Findings: In accordance with Fantini's model, optimal SBD binding to membranes depends on the presence of sphingolipids and cholesterol. In synthetic membrane binding assays, SBD interacts preferentially with raft-like lipid mixtures containing sphingomyelin, cholesterol, and complex gangliosides in a pH-dependent manner, but is less glycolipid-specific than Cholera toxin B (CtxB). Using quantitative time-course colocalization in live cells, we show that the uptake and intracellular trafficking route of SBD is unlike that of either the non-raft marker Transferrin or the raft markers CtxB and Flotillin2-GFP. However, SBD traverses an endolysosomal route that partially intersects with raft-associated pathways, with a major portion being diverted at a late time point to rab11-positive recycling endosomes. Trafficking of SBD to acidified compartments is strongly disrupted by cholesterol perturbations, consistent with the regulation of sphingolipid trafficking by cholesterol. Conclusions/Significance: The current work presents the characterization and trafficking behavior of a novel sphingolipid-binding fluorescent probe, the SBD peptide. We show that SBD binding to membranes is dependent on the presence of cholesterol, sphingomyelin, and complex glycolipids. In addition, SBD targeting through the endolysosomal pathway in neurons is highly sensitive to cholesterol perturbations, making it a potentially useful tool for the analysis of sphingolipid trafficking in disease models that involve changes in cholesterol metabolism and storage.	[Steinert, Steffen; Lee, Esther; Tresset, Guillaume; Zhang, Dawei; Hortsch, Ralf; Wetzel, Richard; Hebbar, Sarita; Kraut, Rachel] ASTAR, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Sundram, Jeyapriya Raja; Kesavapany, Sashi] Natl Univ Singapore, Dept Biochem, Neurobiol Programme, Singapore, Singapore; [Wetzel, Richard; Boschke, Elke] Tech Univ Dresden, Inst Lebensmittel Bioverfahrenstech, Dresden, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore; Technische Universitat Dresden	Steinert, S (corresponding author), Tech Univ Stuttgart, Inst Phys 3, Stuttgart, Germany.	rkraut@ibn.a-star.edu.sg	Kraut, Rachel/A-2221-2011	Zhang, Dawei/0000-0001-6613-945X	Institute of Bioengineering and Nanotechnology; Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology(Agency for Science Technology & Research (A*STAR)); Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology and the Singapore Bioimaging Consortium (Biomedical Research Council, Agency for Science, Technology and Research, Singapore).	ANTES P, 1992, CHEM PHYS LIPIDS, V62, P269, DOI 10.1016/0009-3084(92)90064-V; Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; BIEDLER JL, 1978, CANCER RES, V38, P3751; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brown RE, 1998, J CELL SCI, V111, P1; CALORINI L, 1987, LIPIDS, V22, P651, DOI 10.1007/BF02533944; CHENG ZJ, 2006, MOL BIOL CELL; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DELEAU M, 1996, B PSYCHOL, V3, P1; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Fantini J, 1997, J BIOL CHEM, V272, P7245, DOI 10.1074/jbc.272.11.7245; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hao MM, 2004, J BIOL CHEM, V279, P14171, DOI 10.1074/jbc.M309793200; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Hua W, 2006, J CELL BIOL, V172, P1035, DOI 10.1083/jcb.200512012; Hunziker W, 1996, BIOESSAYS, V18, P379, DOI 10.1002/bies.950180508; ICHIKAWA S, 1994, P NATL ACAD SCI USA, V91, P2703, DOI 10.1073/pnas.91.7.2703; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; KOVAL M, 1991, BIOCHIM BIOPHYS ACTA, V1082, P113, DOI 10.1016/0005-2760(91)90184-J; Kuziemko GM, 1996, BIOCHEMISTRY-US, V35, P6375, DOI 10.1021/bi952314i; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; LENCER W, 1995, TARGETING CHOLERA TO; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; MacKenzie CR, 1997, J BIOL CHEM, V272, P5533, DOI 10.1074/jbc.272.9.5533; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marks DL, 2002, TRENDS CELL BIOL, V12, P605, DOI 10.1016/S0962-8924(02)02399-1; Massol RH, 2004, MOL BIOL CELL, V15, P3631, DOI 10.1091/mbc.E04-04-0283; Mattson MP, 2005, NAT CELL BIOL, V7, P1045, DOI 10.1038/ncb1105-1045; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; PELKMANS L, 2001, CAVEOLAR ENDOCYTOSIS, V3, P473; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Puri V, 1999, NAT CELL BIOL, V1, P386, DOI 10.1038/14084; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; SALZMAN NH, 1989, J CELL BIOL, V109, P2097, DOI 10.1083/jcb.109.5.2097; Sandvig K, 2004, INT J MED MICROBIOL, V293, P483, DOI 10.1078/1438-4221-00294; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sharma P, 2002, SEMIN CELL DEV BIOL, V13, P205, DOI 10.1016/S1084-9521(02)00049-6; Shogomori H, 2001, J BIOL CHEM, V276, P9182, DOI 10.1074/jbc.M009414200; Simons K, 2000, TRENDS CELL BIOL, V10, P459, DOI 10.1016/S0962-8924(00)01847-X; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; Soreghan M, 2003, ADV DRUG DELIVER REV, V55, P1515, DOI 10.1016/j.addr.2003.07.007; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Torgersen ML, 2001, J CELL SCI, V114, P3737; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; UI K, 1994, IN VITRO CELL DEV-AN, V30A, P209; Vruchte DT, 2004, J BIOL CHEM, V279, P26167, DOI 10.1074/jbc.M311591200; Wang TY, 2000, BIOPHYS J, V79, P1478, DOI 10.1016/S0006-3495(00)76399-5; WIEGANDT H, 1992, BIOCHIM BIOPHYS ACTA, V1123, P117, DOI 10.1016/0005-2760(92)90101-Z; Wolf AA, 1998, J CELL BIOL, V141, P917, DOI 10.1083/jcb.141.4.917; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441	102	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2933	10.1371/journal.pone.0002933	http://dx.doi.org/10.1371/journal.pone.0002933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18716682	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600019
J	Ban, M; Elson, J; Walton, A; Turnbull, D; Compston, A; Chinnery, P; Sawcer, S				Ban, Maria; Elson, Joanna; Walton, Amie; Turnbull, Douglas; Compston, Alastair; Chinnery, Patrick; Sawcer, Stephen			Investigation of the Role of Mitochondrial DNA in Multiple Sclerosis Susceptibility	PLOS ONE			English	Article								Several lines of evidence suggest that mitochondrial genetic factors may influence susceptibility to multiple sclerosis. To explore this hypothesis further, we re-sequenced the mitochondrial genome (mtDNA) from 159 patients with multiple sclerosis and completed a haplogroup analysis including a further 835 patients and 1,506 controls. A trend towards over-representation of super-haplogroup U was the only evidence for association with mtDNA that we identified in these samples. In a parallel analysis of nuclear encoded mitochondrial genes, we also found a trend towards association with the complex I gene, NDUFS2. These results add to the evidence suggesting that variation in mtDNA and nuclear encoded mitochondrial genes may contribute to disease susceptibility in multiple sclerosis.	[Ban, Maria; Walton, Amie; Compston, Alastair; Sawcer, Stephen] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Elson, Joanna; Turnbull, Douglas; Chinnery, Patrick] Newcastle Univ, Med Sch, Mitochondrial Res Grp, Framlington Place, Newcastle Upon Tyne, Tyne & Wear, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK	Ban, M (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England.	mb531@medschl.cam.ac.uk		/0000-0002-3551-5624; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust [057097]; Medical Research Council [G0700061]; National Institute of Health [NS 049477-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049477] Funding Source: NIH RePORTER; Medical Research Council [G90/63] Funding Source: researchfish; MRC [G90/63, G0700061] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Trust (grant 057097), the Medical Research Council (G0700061) and the National Institute of Health (NS 049477-01A1). The Funders did not play any role in the design and conduct of the study, in the collection, analysis and interpretation of data, and in the preparation, review, or approval of the manuscript.	Andrews HE, 2005, MED HYPOTHESES, V64, P669, DOI 10.1016/j.mehy.2004.09.001; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Chalmers RM, 1996, ANN NEUROL, V40, P239, DOI 10.1002/ana.410400216; CHALMERS RM, 1995, J NEUROL, V242, P332, DOI 10.1007/BF00878877; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; HARDING AE, 1992, BRAIN, V115, P979, DOI 10.1093/brain/115.4.979; Houshmand M, 2005, MULT SCLER J, V11, P728, DOI 10.1191/1352458505ms1228sr; HUSTED CA, 1994, ANN NEUROL, V36, P157, DOI 10.1002/ana.410360207; Kalman B, 1996, J NEUROL SCI, V140, P75, DOI 10.1016/0022-510X(96)00112-8; Kalman B, 1997, Mult Scler, V2, P279; Kalman B, 1995, Mult Scler, V1, P32; Kalman B, 1999, ACTA NEUROL SCAND, V99, P16; Kaminski M, 2007, MOL CELL BIOL, V27, P3625, DOI 10.1128/MCB.02295-06; KELLARWOOD H, 1994, ANN NEUROL, V36, P109, DOI 10.1002/ana.410360121; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; MayrWohlfart U, 1996, ACTA NEUROL SCAND, V94, P167, DOI 10.1111/j.1600-0404.1996.tb07048.x; Mihailova SM, 2007, EUR J NEUROL, V14, P44, DOI 10.1111/j.1468-1331.2006.01541.x; NISHIMURA M, 1995, NEUROLOGY, V45, P1333, DOI 10.1212/WNL.45.7.1333; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Otaegui D, 2004, MULT SCLER J, V10, P532, DOI 10.1191/1352458504ms1069oa; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Qi XP, 2006, J BIOL CHEM, V281, P31950, DOI 10.1074/jbc.M603717200; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Simoni L, 2000, AM J HUM GENET, V66, P262, DOI 10.1086/302706; Taylor RW, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.15.e74; Torroni A, 1996, GENETICS, V144, P1835; Ugalde C, 2004, HUM MOL GENET, V13, P659, DOI 10.1093/hmg/ddh071; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1191/135245898678919456; Vyshkina T, 2005, J NEUROL SCI, V228, P55, DOI 10.1016/j.jns.2004.09.027; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wilichowski E, 1998, NEUROPEDIATRICS, V29, P307, DOI 10.1055/s-2007-973583	35	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2891	10.1371/journal.pone.0002891	http://dx.doi.org/10.1371/journal.pone.0002891			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682780	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600047
J	Bishop, MT; Ritchie, DL; Will, RG; Ironside, JW; Head, MW; Thomson, V; Bruce, M; Manson, JC				Bishop, Matthew T.; Ritchie, Diane L.; Will, Robert G.; Ironside, James W.; Head, Mark W.; Thomson, Val; Bruce, Moira; Manson, Jean C.			No Major Change in vCJD Agent Strain after Secondary Transmission via Blood Transfusion	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; PRION STRAIN; MICE; SCRAPIE; BSE; SUSCEPTIBILITY; INFECTIVITY; PRIMATES	Background: The identification of transmission of variant Creutzfeldt-Jakob disease (vCJD) by blood transfusion has prompted investigation to establish whether there has been any alteration in the vCJD agent following this route of secondary transmission. Any increase in virulence or host adaptation would require a reassessment of the risk analyses relating to the possibility of a significant secondary outbreak of vCJD. Since there are likely to be carriers of the vCJD agent in the general population, there is a potential for further infection by routes such as blood transfusion or contaminated surgical instruments. Methodology: We inoculated both wild-type and transgenic mice with material from the first case of transfusion associated vCJD infection. Principal Findings: The strain transmission properties of blood transfusion associated vCJD infection show remarkable similarities to the strain of vCJD associated with transmission from bovine spongiform encephalopathy (BSE). Conclusions: Although it has been hypothesized that adaptation of the BSE agent through secondary passage in humans may result in a greater risk of onward transmission due to an increased virulence of the agent for humans, our data presented here in two murine models suggest no significant alterations to transmission efficiency of the agent following human-to-human transmission of vCJD.	[Bishop, Matthew T.; Ritchie, Diane L.; Will, Robert G.; Ironside, James W.; Head, Mark W.] Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland; [Thomson, Val; Bruce, Moira; Manson, Jean C.] Univ Edinburgh, Roslin Inst, Neuropathogenesis Div, Edinburgh, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Bishop, MT (corresponding author), Univ Edinburgh, Western Gen Hosp, Natl CJD Surveillance Unit, Edinburgh, Midlothian, Scotland.	Jean.Manson@roslin.ed.ac.uk		Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108; manson, jean/0000-0002-0175-9890	UK Department of Health; Medical Research Council; MRC [G0600953, G0700640, G9721848] Funding Source: UKRI; Medical Research Council [G0700640, G0600953, G9721848] Funding Source: researchfish	UK Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the UK Department of Health and the Medical Research Council. The sponsors had no role in study design, data analysis, or the decision to submit for publication.	Andrews NJ, 2003, LANCET, V361, P751, DOI 10.1016/S0140-6736(03)12632-3; Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Baron T, 2002, TRENDS MOL MED, V8, P495, DOI 10.1016/S1471-4914(02)02416-4; Barron RM, 2005, J GEN VIROL, V86, P859, DOI 10.1099/vir.0.80525-0; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; BRUCE ME, 1991, J GEN VIROL, V72, P595, DOI 10.1099/0022-1317-72-3-595; Bruce ME, 2007, PRIONS IN HUMANS AND ANIMALS, P573; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Cervenakova L, 2003, TRANSFUSION, V43, P1687, DOI 10.1046/j.0041-1132.2003.00586.x; Cooper JK, 2007, VOX SANG, V92, P302, DOI 10.1111/j.1423-0410.2007.00904.x; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; IRONSIDE JW, 2006, BMJ; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Manson JC, 2006, BIOCHEM SOC T, V34, P1155, DOI 10.1042/BST0341155; MCCUTCHEON S, 2007, TRANSMISSION BSE INF; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Taguchi Y, 2003, AM J PATHOL, V163, P2585, DOI 10.1016/S0002-9440(10)63613-9; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zeidler M, 1997, LANCET, V350, P668, DOI 10.1016/S0140-6736(05)63366-1; 2006, CDR WEEKLY, V16	35	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2878	10.1371/journal.pone.0002878	http://dx.doi.org/10.1371/journal.pone.0002878			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682737	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600034
J	Coluccio, AE; Rodriguez, RK; Kernan, MJ; Neiman, AM				Coluccio, Alison E.; Rodriguez, Rachael K.; Kernan, Maurice J.; Neiman, Aaron M.			The Yeast Spore Wall Enables Spores to Survive Passage through the Digestive Tract of Drosophila	PLOS ONE			English	Article								In nature, yeasts are subject to predation by flies of the genus Drosophila. In response to nutritional starvation Saccharomyces cerevisiae differentiates into a dormant cell type, termed a spore, which is resistant to many types of environmental stress. The stress resistance of the spore is due primarily to a spore wall that is more elaborate than the vegetative cell wall. We report here that S. cerevisiae spores survive passage through the gut of Drosophila melanogaster. Constituents of the spore wall that distinguish it from the vegetative cell wall are necessary for this resistance. Ascospores of the distantly related yeast Schizosaccharomyces pombe also display resistance to digestion by D. melanogaster. These results suggest that the primary function of the yeast ascospore is as a cell type specialized for dispersion by insect vectors.	[Coluccio, Alison E.; Rodriguez, Rachael K.; Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Kernan, Maurice J.] SUNY Stony Brook, Ctr Dev Genet, Dept Neurobiol & Behavior, Stony Brook, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Coluccio, AE (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Aaron.Neiman@sunysb.edu		Neiman, Aaron/0000-0002-6600-6996; Kernan, Maurice/0000-0002-1546-6159	NIH [GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM072540 to A. M. N.	Arellano M, 2000, MOL MICROBIOL, V35, P79, DOI 10.1046/j.1365-2958.2000.01678.x; BEGON M, 1986, GENET BIOL DROSOPHIL, P345; BREWER BJ, 1980, P NATL ACAD SCI-BIOL, V77, P5380, DOI 10.1073/pnas.77.9.5380; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1988, J BIOL CHEM, V263, P11569; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; CARLILE MJ, 1994, FUNGI; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; DAWES IW, 1974, MOL GEN GENET, V131, P281, DOI 10.1007/BF00264859; DOW JAT, 1992, J EXP BIOL, V172, P355; EGEL R, 1977, ARCH MICROBIOL, V112, P109, DOI 10.1007/BF00446662; ELGIN SCR, 1980, GENET BIOL DROSOPHIL, P112; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Herman PK, 1997, EMBO J, V16, P6171, DOI 10.1093/emboj/16.20.6171; House H.L., 1974, P63; Howe H.F., 1986, P123; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; KREGERVANRIJ NJW, 1978, ARCH MICROBIOL, V117, P73, DOI 10.1007/BF00689354; KREGERVANRIJ NJW, 1969, YEASTS, P5; Lodder J, 1958, CHEMISTRY BIOLOGY YE, P1; Matsuo Y, 2005, FEBS LETT, V579, P2737, DOI 10.1016/j.febslet.2005.04.008; MILLER MW, 1962, APPL MICROBIOL, V10, P394, DOI 10.1128/AEM.10.5.394-400.1962; MORAIS PB, 1994, ANTON LEEUW INT J G, V66, P313, DOI 10.1007/BF00882766; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; PHAFF H. J., 1956, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V22, P145, DOI 10.1007/BF02538322; Prillinger H, 1997, YEAST, V13, P945, DOI 10.1002/(SICI)1097-0061(199708)13:10<945::AID-YEA150>3.0.CO;2-5; Pulvirenti A, 2002, ANN MICROBIOL, V52, P245; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Rose MD., 1990, METHODS YEAST GENETI; SHIHATA AMEA, 1951, AM NAT, V85, P381, DOI 10.1086/281692; SHIMODA C, 1980, CAN J MICROBIOL, V26, P741, DOI 10.1139/m80-129; Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781; Trail F, 2007, FEMS MICROBIOL LETT, V276, P12, DOI 10.1111/j.1574-6968.2007.00900.x; Wenny DG, 2001, EVOL ECOL RES, V3, P51; XU LZ, 1995, MOL CELL BIOL, V15, P6572	41	120	125	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2873	10.1371/journal.pone.0002873	http://dx.doi.org/10.1371/journal.pone.0002873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682732	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600029
J	Harris, D; DeBolt, S				Harris, Darby; DeBolt, Seth			Relative Crystallinity of Plant Biomass: Studies on Assembly, Adaptation and Acclimation	PLOS ONE			English	Article							CELLULOSE CRYSTALLINITY; WOOD; DIFFRACTION; FLEXURE; CELLS	Plant biomechanical design is central to cell shape, morphogenesis, reproductive performance and protection against environmental and mechanical stress. The cell wall forms the central load bearing support structure for plant design, yet a mechanistic understanding of its synthesis is incomplete. A key tool for studying the structure of cellulose polymorphs has been x-ray diffraction and fourier transform infrared spectroscopy (FTIR). Relative crystallinity index (RCI) is based on the x-ray diffraction characteristics of two signature peaks and we used this technique to probe plant assembly, adaptation and acclimation. Confocal microscopy was used to visualize the dynamics of cellulose synthase in transgenic Arabidopsis plants expressing a homozygous YFP::CESA6. Assembly: RCI values for stems and roots were indistinguishable but leaves had 23.4 and 21.6% lower RCI than stems and roots respectively. Adaptation: over 3-fold variability in RCI was apparent in leaves from 35 plant species spanning Ordovician to Cretaceous periods. Within this study, RCI correlated positively with leaf geometric constraints and with mass per unit area, suggestive of allometry. Acclimation: biomass crystallinity was found to decrease under conditions of thigmomorphogenesis in Arabidopsis. Further, in etiolated pea hypocotyls, RCI values also decreased compared to plants that were grown in light, consistent with alterations in FTIR cellulose fingerprint peaks and live cell imaging experiments revealing rapid orientation of the YFP:: cellulose synthase-6 array in response to light. Herein, results and technical challenges associated with the structure of the cell wall that gives rise to sample crystallinity are presented and examined with respect to adaptation, acclimation and assembly in ecosystem-level processes.	[Harris, Darby; DeBolt, Seth] Univ Kentucky, Dept Hort, Lexington, KY 40546 USA	University of Kentucky	Harris, D (corresponding author), Univ Kentucky, Dept Hort, Lexington, KY 40546 USA.	seth.debolt@uky.edu			University of Kentucky	University of Kentucky	University of Kentucky provided startup funds to the author.	Andersson S, 2000, J WOOD SCI, V46, P343, DOI 10.1007/BF00776394; Andersson S, 2003, J WOOD SCI, V49, P531, DOI 10.1007/s10086-003-0518-x; Andersson S, 2004, TREES-STRUCT FUNCT, V18, P346, DOI 10.1007/s00468-003-0312-9; [Anonymous], 1949, PHYS CHEM CELLULOSE; Brett CT, 2000, INT REV CYTOL, V199, P161, DOI 10.1016/S0074-7696(00)99004-1; Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877; DeBolt S, 2007, PLANT PHYSIOL, V145, P334, DOI 10.1104/pp.107.104703; DeBolt S, 2007, P NATL ACAD SCI USA, V104, P5854, DOI 10.1073/pnas.0700789104; Ennos AR, 1997, TRENDS ECOL EVOL, V12, P108, DOI 10.1016/S0169-5347(96)10066-5; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Graham LE, 2000, P NATL ACAD SCI USA, V97, P4535, DOI 10.1073/pnas.97.9.4535; Hematy K, 2007, CURR BIOL, V17, P922, DOI 10.1016/j.cub.2007.05.018; HONJO G, 1958, NATURE, V181, P326, DOI 10.1038/181326a0; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Liu Y, 2007, ANN BOT-LONDON, V99, P121, DOI 10.1093/aob/mcl230; MANDOLI DF, 1982, P NATL ACAD SCI-BIOL, V79, P2902, DOI 10.1073/pnas.79.9.2902; McCarthy MC, 2007, INT J PLANT SCI, V168, P751, DOI 10.1086/513491; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Newman RH, 2004, HOLZFORSCHUNG, V58, P91, DOI 10.1515/HF.2004.012; Niklas KJ, 2008, AM J BOT, V95, P549, DOI 10.3732/ajb.0800034; Nishiyama Y., 2002, ADV XRAY ANAL, V45, P385; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; PURI VP, 1984, BIOTECHNOL BIOENG, V26, P1219, DOI 10.1002/bit.260261010; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Saren MP, 2001, J STRUCT BIOL, V136, P101, DOI 10.1006/jsbi.2001.4434; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Smith VC, 2003, J EXP BOT, V54, P845, DOI 10.1093/jxb/erg068; Stubicar N, 1998, HOLZFORSCHUNG, V52, P455, DOI 10.1515/hfsg.1998.52.5.455; Swenson NG, 2008, AM J BOT, V95, P516, DOI 10.3732/ajb.95.4.516; TEEAAR R, 1987, POLYM BULL, V17, P231; TELEWSKI FW, 1989, TREE PHYSIOL, V5, P113, DOI 10.1093/treephys/5.1.113; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; VITOUSEK PM, 1995, ECOLOGY, V76, P712, DOI 10.2307/1939338; WEIMER PJ, 1995, BIOTECHNOL BIOENG, V48, P169, DOI 10.1002/bit.260480211; Woodcock DW, 2003, ANN BOT-LONDON, V91, P529, DOI 10.1093/aob/mcg054; Wright IJ, 2007, ANN BOT-LONDON, V99, P1003, DOI 10.1093/aob/mcl066; Wright IJ, 2000, BIOL J LINN SOC, V69, P521, DOI 10.1111/j.1095-8312.2000.tb01222.x; Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689	39	36	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2897	10.1371/journal.pone.0002897	http://dx.doi.org/10.1371/journal.pone.0002897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682826	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600053
J	Wise, RA; Wang, B; You, ZB				Wise, Roy A.; Wang, Bin; You, Zhi-Bing			Cocaine Serves as a Peripheral Interoceptive Conditioned Stimulus for Central Glutamate and Dopamine Release	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; INTRAVENOUS COCAINE; INTRAADMINISTRATION ASSOCIATIONS; EXTRACELLULAR DOPAMINE; TRANSPORTER OCCUPANCY; SODIUM-CHANNELS; ONSET CUES; IN-VIVO; RATS	Intravenous injections of cocaine HCl are habit-forming because, among their many actions, they elevate extracellular dopamine levels in the terminal fields of the mesocorticolimbic dopamine system. This action, thought to be very important for cocaine's strong addiction liability, is believed to have very short latency and is assumed to reflect rapid brain entry and pharmacokinetics of the drug. However, while intravenous cocaine HCl has almost immediate effects on behavior and extracellular dopamine levels, recent evidence suggests that its central pharmacological effects are not evident until 10 or more seconds after IV injection. Thus the immediate effects of a given intravenous cocaine injection on extracellular dopamine concentration and behavior appear to occur before there is sufficient time for cocaine to act centrally as a dopamine uptake inhibitor. To explore the contribution of peripheral effects of cocaine to the early activation of the dopamine system, we used brain microdialysis to measure the effects of cocaine methiodide (MI)-a cocaine analogue that does not cross the blood brain barrier-on glutamate (excitatory) input to the dopamine cells. IP injections of cocaine MI were ineffective in cocaine-naive animals but stimulated ventral tegmental glutamate release in rats previously trained to lever-press for cocaine HCl. This peripherally triggered glutamate input was sufficient to reinstate cocaine-seeking in previously trained animals that had undergone extinction of the habit. These findings offer an explanation for short-latency behavioral responses and immediate dopamine elevations seen following cocaine injections in cocaine-experienced but not cocaine-naive animals.	[Wise, Roy A.; Wang, Bin; You, Zhi-Bing] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wise, RA (corresponding author), NIDA, Behav Neurosci Branch, Intramural Res Program, NIH,Dept Hlth & Human Serv, Baltimore, MD USA.	rwise@intra.nida.nih.gov	Wise, Roy A/A-6465-2012		Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000471, ZIADA000471] Funding Source: NIH RePORTER	Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services	AKIMOTO K, 1989, BRAIN RES, V490, P339, DOI 10.1016/0006-8993(89)90251-5; BLACK J, 1985, BRAIN RES, V359, P113, DOI 10.1016/0006-8993(85)91418-0; BYKOV KM, 1957, CEREBRAL CORRTEX INT; COLPAERT FC, 1976, EUR J PHARMACOL, V40, P195, DOI 10.1016/0014-2999(76)90372-1; CRUMB WJ, 1990, BIOPHYS J, V57, P589, DOI 10.1016/S0006-3495(90)82574-1; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DEWIT H, 1977, CAN J PSYCHOL, V31, P195, DOI 10.1037/h0081662; EIKELBOOM R, 1982, PSYCHOL REV, V89, P507, DOI 10.1037/0033-295X.89.5.507; ETTENBERG A, 1982, PSYCHOPHARMACOLOGY, V78, P204, DOI 10.1007/BF00428151; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; Fowler JS, 1998, SYNAPSE, V28, P111, DOI 10.1002/(SICI)1098-2396(199802)28:2<111::AID-SYN1>3.0.CO;2-E; GERBER GJ, 1975, PHARMACOL BIOCHEM BE, V3, P1055, DOI 10.1016/0091-3057(75)90016-7; GOEDERS NE, 1983, SCIENCE, V221, P773, DOI 10.1126/science.6879176; Hascup KN, 2008, J PHARMACOL EXP THER, V324, P725, DOI 10.1124/jpet.107.131698; HUANG JT, 1974, PHARMACOL BIOCHEM BE, V2, P669, DOI 10.1016/0091-3057(74)90036-7; Ikemoto S, 2004, NEUROPHARMACOLOGY, V47, P190, DOI 10.1016/j.neuropharm.2004.07.012; Kalivas PW, 1998, J NEUROCHEM, V70, P1497; KALIVAS PW, 1993, J NEUROSCI, V13, P276; Kim JA, 1999, J EXP PSYCHOL ANIM B, V25, P491, DOI 10.1037/0097-7403.25.4.491; Kiyatkin EA, 2000, NEUROSCIENCE, V98, P729, DOI 10.1016/S0306-4522(00)00168-8; KNUEPFER MM, 1992, J PHARMACOL EXP THER, V263, P734; Legault M, 1999, SYNAPSE, V31, P241, DOI 10.1002/(SICI)1098-2396(19990315)31:4<241::AID-SYN1>3.0.CO;2-#; Legault M, 2000, J NEUROSCI, V20, P1635; Legault M, 2001, EUR J NEUROSCI, V13, P819, DOI 10.1046/j.0953-816x.2000.01448.x; Mateo Y, 2004, EUR J NEUROSCI, V20, P2838, DOI 10.1111/j.1460-9568.2004.03736.x; PETTIT HO, 1989, PHARMACOL BIOCHEM BE, V34, P899, DOI 10.1016/0091-3057(89)90291-8; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Premkumar LS, 2005, J MEMBRANE BIOL, V204, P129, DOI 10.1007/s00232-005-0755-6; Rahman MA, 2005, ANAL CHEM, V77, P4854, DOI 10.1021/ac050558v; REITH MEA, 1986, J BIOL CHEM, V261, P7300; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; ROBERTS DCS, 1977, PHARMACOL BIOCHEM BE, V6, P615, DOI 10.1016/0091-3057(77)90084-3; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SELLERS EM, 1989, NIDA RES MG, V92, P287; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Siegel S, 1999, ADDICTION, V94, P1113, DOI 10.1046/j.1360-0443.1999.94811132.x; SIEGEL S, 1976, SCIENCE, V193, P323, DOI 10.1126/science.935870; Sokolowska M, 2002, J EXP PSYCHOL ANIM B, V28, P309, DOI 10.1037//0097-7403.28.3.309; Stewart J., 1987, HDB PSYCHOPHARMACOLO, P1; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TELLA SR, 1990, J PHARMACOL EXP THER, V252, P491; Volkow ND, 1997, NATURE, V386, P827, DOI 10.1038/386827a0; Weise-Kelly L, 2001, J EXP PSYCHOL-ANIM B, V27, P125, DOI 10.1037//0097-7403.27.2.125; WISE RA, 1987, PHARMACOL THERAPEUT, V35, P227, DOI 10.1016/0163-7258(87)90108-2; WISE RA, 1995, PSYCHOPHARMACOLOGY, V120, P10, DOI 10.1007/BF02246140; You ZB, 2007, J NEUROSCI, V27, P10546, DOI 10.1523/JNEUROSCI.2967-07.2007; Zhang XF, 2002, J PHARMACOL EXP THER, V301, P1119, DOI 10.1124/jpet.301.3.1119	48	70	71	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2846	10.1371/journal.pone.0002846	http://dx.doi.org/10.1371/journal.pone.0002846			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	421NW	18682722	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600002
J	Xu, JZ; Knutson, MD; Carter, CS; Leeuwenburgh, C				Xu, Jinze; Knutson, Mitchell D.; Carter, Christy S.; Leeuwenburgh, Christiaan			Iron Accumulation with Age, Oxidative Stress and Functional Decline	PLOS ONE			English	Article							SKELETAL-MUSCLE APOPTOSIS; CALORIE RESTRICTION; NONHEME IRON; PHYSICAL PERFORMANCE; DIFFERENT TISSUES; RAT-LIVER; DAMAGE; RNA; PROTEINS; OVERLOAD	Identification of biological mediators in sarcopenia is pertinent to the development of targeted interventions to alleviate this condition. Iron is recognized as a potent pro-oxidant and a catalyst for the formation of reactive oxygen species in biological systems. It is well accepted that iron accumulates with senescence in several organs, but little is known about iron accumulation in muscle and how it may affect muscle function. In addition, it is unclear if interventions which reduced age-related loss of muscle quality, such as calorie restriction, impact iron accumulation. We investigated non-heme iron concentration, oxidative stress to nucleic acids in gastrocnemius muscle and key indices of sarcopenia (muscle mass and grip strength) in male Fischer 344 X Brown Norway rats fed ad libitum (AL) or a calorie restricted diet (60% of ad libitum food intake starting at 4 months of age) at 8, 18, 29 and 37 months of age. Total non-heme iron levels in the gastrocnemius muscle of AL rats increased progressively with age. Between 29 and 37 months of age, the non-heme iron concentration increased by approximately 200% in AL-fed rats. Most importantly, the levels of oxidized RNA in gastrocnemius muscle of AL rats were significantly increased as well. The striking age-associated increase in non-heme iron and oxidized RNA levels and decrease in sarcopenia indices were all attenuated in the calorie restriction (CR) rats. These findings strongly suggest that the age- related iron accumulation in muscle contributes to increased oxidative damage and sarcopenia, and that CR effectively attenuates these negative effects.	[Xu, Jinze; Carter, Christy S.; Leeuwenburgh, Christiaan] Univ Florida, Inst Aging, Dept Aging & Geriatr, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32611 USA; [Knutson, Mitchell D.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL USA; [Carter, Christy S.] Gainesville VA Geriatr Res, Ed & Clin Ctr GRECC, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Xu, JZ (corresponding author), Univ Florida, Inst Aging, Dept Aging & Geriatr, Div Biol Aging Genom & Biomarkers Core, Gainesville, FL 32611 USA.	mknutson@ufl.edu; cleeuwen@aging.ufl.edu	Xu, Jinze/G-7868-2011; Carter, Christy/E-6630-2011	Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994, AG21042]; CSC [AG024526]; National Institutes of Health [DK065064]; University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center NIH [1 P30 AG028740]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK065064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024526, R01AG021042, R01AG017994, P30AG028740] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CSC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Institute on Aging; Claude D. Pepper Older Americans Independence Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to CL from the National Institute on Aging (AG17994 and AG21042) and to CSC (AG024526), a K01 grant (DK065064) to MK from the National Institutes of Health. This work was supported by the University of Florida Institute on Aging and the Claude D. Pepper Older Americans Independence Center NIH Grant # 1 P30 AG028740.	Altun M, 2007, MUSCLE NERVE, V36, P223, DOI 10.1002/mus.20808; BARKER T, 2007, J PHYSL; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Brewer GJ, 2007, EXP BIOL MED, V232, P323; Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Carlini RG, 2006, NEPHROL DIAL TRANSPL, V21, P3055, DOI 10.1093/ndt/gfl341; Carmeli E, 2000, GERONTOLOGY, V46, P249, DOI 10.1159/000022168; Carter CS, 2004, J GERONTOL A-BIOL, V59, P416; Castello L, 2005, FASEB J, V19, P1863, DOI 10.1096/fj.04-2864fje; Childs A, 2001, FREE RADICAL BIO MED, V31, P745, DOI 10.1016/S0891-5849(01)00640-2; Cook CI, 1998, MECH AGEING DEV, V102, P1, DOI 10.1016/S0047-6374(98)00005-0; DEMETRIUMS L, 2004, GERONTOLOGICAL SOC A, V59, pB902; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dunaief JL, 2006, INVEST OPHTH VIS SCI, V47, P4660, DOI 10.1167/iovs.06-0568; Focht SJ, 1997, NEUROSCIENCE, V79, P255, DOI 10.1016/S0306-4522(96)00607-0; Fontana L, 2007, JAMA-J AM MED ASSOC, V297, P986, DOI 10.1001/jama.297.9.986; Galey Jean-Baptiste, 1997, V38, P167; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Hofer T, 2006, BIOL CHEM, V387, P103, DOI 10.1515/BC.2006.014; Hofer T, 2008, EXP GERONTOL, V43, P563, DOI 10.1016/j.exger.2008.02.007; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Kamel HK, 2003, NUTR REV, V61, P157, DOI 10.1301/nr.2003.may.157-167; Killilea DW, 2004, ANN NY ACAD SCI, V1019, P365, DOI 10.1196/annals.1297.063; Kozlov AV, 1996, BIOMETALS, V9, P98, DOI 10.1007/BF00188097; Le Couteur DG, 2008, ANAT REC, V291, P672, DOI 10.1002/ar.20661; Leeuwenburgh C, 1997, ARCH BIOCHEM BIOPHYS, V346, P74, DOI 10.1006/abbi.1997.0297; Leeuwenburgh C, 2001, CURR MED CHEM, V8, P829, DOI 10.2174/0929867013372896; LEEUWENBURGH C, 1994, AM J PHYSIOL, V267, pR439, DOI 10.1152/ajpregu.1994.267.2.R439; Levenson CW, 2004, AGEING RES REV, V3, P251, DOI 10.1016/j.arr.2004.03.001; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Marzani B., 2004, BASIC APPL MYOL, V14, P37; Marzetti E, 2008, AM J PHYSIOL-REG I, V294, pR558, DOI 10.1152/ajpregu.00620.2007; Marzetti E, 2006, EXP GERONTOL, V41, P1234, DOI 10.1016/j.exger.2006.08.011; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Merry BJ, 2000, ANN NY ACAD SCI, V908, P180; Mumby S, 1998, BBA-GEN SUBJECTS, V1380, P102, DOI 10.1016/S0304-4165(97)00124-4; Nakano M, 2003, FREE RADICAL BIO MED, V35, P826, DOI 10.1016/S0891-5849(03)00432-5; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Okunade GW, 1999, BIOSCIENCE REP, V19, P1, DOI 10.1023/A:1020113121995; Polla AS, 2003, AGEING RES REV, V2, P25, DOI 10.1016/S1568-1637(02)00048-X; Powers SK, 2007, J APPL PHYSIOL, V102, P2389, DOI 10.1152/japplphysiol.01202.2006; Powers SK, 2005, AM J PHYSIOL-REG I, V288, pR337, DOI 10.1152/ajpregu.00469.2004; RAO G, 1990, J NUTR, V120, P602, DOI 10.1093/jn/120.6.602; Rao KS, 2003, MOL CELL BIOCHEM, V253, P313, DOI 10.1023/A:1026004208822; Rebouche CJ, 2004, J BIOCHEM BIOPH METH, V58, P239, DOI 10.1016/j.jbbm.2003.11.003; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; Rikans LE, 1997, ARCH BIOCHEM BIOPHYS, V344, P85, DOI 10.1006/abbi.1997.0172; Robach P, 2007, BLOOD, V109, P4724, DOI 10.1182/blood-2006-08-040006; ROBERTS SB, 1995, J GERONTOL A-BIOL, V50, P101; Roth JA, 2003, BIOCHEM PHARMACOL, V66, P1, DOI 10.1016/S0006-2952(03)00145-X; ROTHMAN RJ, 1992, MOL PHARMACOL, V42, P703; SHERTZER HG, 1992, BIOCHEM PHARMACOL, V44, P1367, DOI 10.1016/0006-2952(92)90538-T; Sohal RS, 1999, FREE RADICAL BIO MED, V27, P287, DOI 10.1016/S0891-5849(99)00052-0; Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058; St Pierre TG, 2000, HYPERFINE INTERACT, V126, P75, DOI 10.1023/A:1012636510472; SWERLICK RA, 2004, J INVEST DERMATOL, V122, pR9; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Terman A, 2006, ANTIOXID REDOX SIGN, V8, P197, DOI 10.1089/ars.2006.8.197; Volpi E, 2004, CURR OPIN CLIN NUTR, V7, P405, DOI 10.1097/01.mco.0000134362.76653.b2; Wang ZJ, 1998, INVEST OPHTH VIS SCI, V39, P631; Weindruch R, 1997, NEW ENGL J MED, V337, P986, DOI 10.1056/NEJM199710023371407; Wood JC, 2007, AM J HEMATOL, V82, P1132, DOI 10.1002/ajh.21099; Wood RJ, 2004, AGEING RES REV, V3, P355, DOI 10.1016/j.arr.2004.04.002; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	68	86	90	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2865	10.1371/journal.pone.0002865	http://dx.doi.org/10.1371/journal.pone.0002865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682742	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600021
J	Chen, S; Owens, GC; Edelman, DB				Chen, Sigeng; Owens, Geoffrey C.; Edelman, David B.			Dopamine Inhibits Mitochondrial Motility in Hippocampal Neurons	PLOS ONE			English	Article							SYNTHASE KINASE-3; AXONAL-TRANSPORT; GROWTH-FACTOR; RECEPTORS; EXPRESSION; AKT; D-2; SYNTAPHILIN; SEROTONIN; MOVEMENT	Background: The trafficking of mitochondria within neurons is a highly regulated process. In an earlier study, we found that serotonin (5-HT), acting through the 5-HT1A receptor subtype, promotes axonal transport of mitochondria in cultured hippocampal neurons by increasing Akt activity, and consequently decreasing glycogen synthase kinase (GSK3 beta) activity. This finding suggests a critical role for neuromodulators in the regulation of mitochondrial trafficking in neurons. In the present study, we investigate the effects of a second important neuromodulator, dopamine, on mitochondrial transport in hippocampal neurons. Methodology/Principal Findings: Here, we show that dopamine, like 5-HT, regulates mitochondrial motility in cultured hippocampal neurons through the Akt-GSK3 beta signaling cascade. But, in contrast to the stimulatory effect of 5-HT, administration of exogenous dopamine or bromocriptine, a dopamine 2 receptor (D2R) agonist, caused an inhibition of mitochondrial movement. Moreover, pretreatment with bromocriptine blocked the stimulatory effect of 5-HT on mitochondrial movement. Conversely, in cells pretreated with 5-HT, no further increases in movement were observed after administration of haloperidol, a D2R antagonist. In contrast to the effect of the D2R agonist, addition of SKF38393, a dopamine 1 receptor (D1R) agonist, promoted mitochondrial transport, indicating that the inhibitory effect of dopamine was actually the net summation of opposing influences of the two receptor subtypes. The most pronounced effect of dopamine signals was on mitochondria that were already moving directionally. Western blot analysis revealed that treatment with either a D2R agonist or a D1R antagonist decreased Akt activity, and conversely, treatment with either a D2R antagonist or a D1R agonist increased Akt activity. Conclusions/Significance: Our observations strongly suggest a role for both dopamine and 5-HT in regulating mitochondrial movement, and indicate that the integrated effects of these two neuromodulators may be important in determining the distribution of energy sources in neurons.	[Chen, Sigeng; Owens, Geoffrey C.; Edelman, David B.] Inst Neurosci, San Diego, CA USA		Edelman, DB (corresponding author), Inst Neurosci, San Diego, CA USA.	david_edelman@nsi.edu	Chen, Sigeng/G-1678-2014		Neurosciences Research Foundation	Neurosciences Research Foundation	Work supported by the Neurosciences Research Foundation. The Neurosciences Research Foundation did not have any role in the design and conduct of the study, the collection, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Beal M Flint, 2007, Novartis Found Symp, V287, P183; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Beaulieu JM, 2007, INT J NEUROPSYCHOPH, V10, P3, DOI 10.1017/S1461145706006857; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Ben-Shachar D, 2002, J NEUROCHEM, V83, P1241, DOI 10.1046/j.1471-4159.2002.01263.x; Bozzi Y, 2006, TRENDS NEUROSCI, V29, P167, DOI 10.1016/j.tins.2006.01.002; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; BRENNERLAVIE H, 2007, BIOCH BIOPHYS ACTA; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Curran MA, 2000, MOL THER, V1, P31, DOI 10.1006/mthe.1999.0007; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Frederick RL, 2007, TRAFFIC, V8, P1668, DOI 10.1111/j.1600-0854.2007.00644.x; George Susan R, 2007, ScientificWorldJournal, V7, P58; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Inazu M, 1999, NEUROSCI RES, V34, P235, DOI 10.1016/S0168-0102(99)00053-X; Inazu M, 1999, LIFE SCI, V64, P2239, DOI 10.1016/S0024-3205(99)00175-7; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Lee D, 2000, MOL PSYCHIATR, V5, P332, DOI 10.1038/sj.mp.4000723; Lee H, 2002, IEEE T NANOTECHNOL, V1, P219, DOI 10.1109/TNANO.2002.807376; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Malaiyandi LM, 2005, J NEUROSCI, V25, P9507, DOI 10.1523/JNEUROSCI.0868-05.2005; Millan MJ, 2004, EUR J PHARMACOL, V500, P371, DOI 10.1016/j.ejphar.2004.07.038; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mistry SK, 2002, P NATL ACAD SCI USA, V99, P1621, DOI 10.1073/pnas.022646599; Mookherjee P, 2007, J CELL BIOCHEM, V102, P196, DOI 10.1002/jcb.21287; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tremblay P, 2006, CURR DRUG TARGETS, V7, P149, DOI 10.2174/138945006775515464; Trimmer PA, 2005, ANTIOXID REDOX SIGN, V7, P1101, DOI 10.1089/ars.2005.7.1101; Ward MW, 2000, J NEUROSCI, V20, P7208; Weikop P, 2007, J PSYCHOPHARMACOL, V21, P795, DOI 10.1177/0269881107077347; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; ZHANG X, 2008, P NATL ACAD SCI US	48	61	64	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2804	10.1371/journal.pone.0002804	http://dx.doi.org/10.1371/journal.pone.0002804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665222	gold, Green Published			2022-12-27	WOS:000264304300023
J	Gillet, L; Colaco, S; Stevenson, PG				Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.			The Murid Herpesvirus-4 gL Regulates an Entry-Associated Conformation Change in gH	PLOS ONE			English	Article								The glycoprotein H (gH)/gL heterodimer is crucial for herpesvirus membrane fusion. Yet how it functions is not well understood. The Murid Herpesvirus-4 gH, like that of other herpesviruses, adopts its normal virion conformation by associating with gL. However, gH switched back to a gL-independent conformation after virion endocytosis. This switch coincided with a conformation switch in gB and with capsid release. Virions lacking gL constitutively expressed the downstream form of gH, prematurely switched gB to its down-stream form, and showed premature capsid release with poor infectivity. These data argue that gL plays a key role in regulating a gH and gB functional switch from cell binding to membrane fusion.	[Gillet, Laurent; Colaco, Susanna; Stevenson, Philip G.] Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England	University of Cambridge	Gillet, L (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Cambridge, England.	pgs27@cam.ac.uk	Stevenson, Philip g/F-9688-2014; Stevenson, Philip/F-6651-2011	Stevenson, Philip g/0000-0002-3520-5060; Gillet, Laurent/0000-0002-1047-2525	Fonds National Belge de la Recherche Scientifique; Wellcome Trust [GR076956MA]; Medical Research Council [G0400427, G9800903]; CR-UK [C19612/A6189]; MRC [G0400427] Funding Source: UKRI	Fonds National Belge de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CR-UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	LG is a Postdoctoral Researcher of the Fonds National Belge de la Recherche Scientifique. PGS is a Wellcome Trust Senior Clinical Fellow (GR076956MA). This work was also supported by Medical Research Council grants G0400427 and G9800903 and by CR-UK grant C19612/A6189.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104; Avitabile E, 2007, J VIROL, V81, P11532, DOI 10.1128/JVI.01343-07; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Clement C, 2006, J CELL BIOL, V174, P1009, DOI 10.1083/jcb.200509155; Coleman HM, 2003, J VIROL, V77, P2410, DOI 10.1128/JVI.77.4.2410-2417.2003; De Lima BD, 2004, J VIROL, V78, P5103, DOI 10.1128/JVI.78.10.5103-5112.2004; FITZGERALD D, 1980, CELL, V21, P867, DOI 10.1016/0092-8674(80)90450-X; Galdiero S, 2005, J BIOL CHEM, V280, P28632, DOI 10.1074/jbc.M505196200; Gill MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001808; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2008, J GEN VIROL, V89, P1352, DOI 10.1099/vir.0.83519-0; Gillet L, 2007, EMBO J, V26, P5131, DOI 10.1038/sj.emboj.7601925; Gillet L, 2007, J VIROL, V81, P13082, DOI 10.1128/JVI.01141-07; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2007, J VIROL, V81, P280, DOI 10.1128/JVI.01616-06; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; HUTCHINSON L, 1992, J VIROL, V66, P2240, DOI 10.1128/JVI.66.4.2240-2250.1992; KAYE JF, 1992, J GEN VIROL, V73, P2693, DOI 10.1099/0022-1317-73-10-2693; Klupp BG, 1997, J VIROL, V71, P7687, DOI 10.1128/JVI.71.10.7687-7695.1997; KOZUCH O, 1993, ACTA VIROL, V37, P101; May JS, 2005, TRAFFIC, V6, P780, DOI 10.1111/j.1600-0854.2005.00316.x; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stevenson PG, 2002, MICROBES INFECT, V4, P1177, DOI 10.1016/S1286-4579(02)01643-X; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tibbetts SA, 2003, J VIROL, V77, P7696, DOI 10.1128/JVI.77.13.7696-7701.2003; Turner A, 1998, J VIROL, V72, P873, DOI 10.1128/JVI.72.1.873-875.1998	32	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2811	10.1371/journal.pone.0002811	http://dx.doi.org/10.1371/journal.pone.0002811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665235	Green Submitted, gold, Green Published			2022-12-27	WOS:000264304300030
J	Parienti, JJ; Das-Douglas, M; Massari, V; Guzman, D; Deeks, SG; Verdon, R; Bangsberg, DR				Parienti, Jean-Jacques; Das-Douglas, Moupali; Massari, Veronique; Guzman, David; Deeks, Steven G.; Verdon, Renaud; Bangsberg, David R.			Not All Missed Doses Are the Same: Sustained NNRTI Treatment Interruptions Predict HIV Rebound at Low-to-Moderate Adherence Levels	PLOS ONE			English	Article								Background: While the relationship between average adherence to HIV potent antiretroviral therapy is well defined, the relationship between patterns of adherence within adherence strata has not been investigated. We examined medication event monitoring system (MEMS) defined adherence patterns and their relation to subsequent virologic rebound. Methods and Results: We selected subjects with at least 3-months of previous virologic suppression on a non-nucleoside reverse transcriptase inhibitor (NNRTI)-based regimen from two prospective cohorts in France and North America. We assessed the risk of virologic rebound, defined as HIV RNA of >400 copies/mL according to several MEMS adherence measurements. Seventy two subjects were studied, five of them experienced virologic rebound. Subjects with and without virologic rebound had similar baseline characteristics including treatment durations, regimen (efavirenz vs nevirapine), and dosing schedule. Each 10% increase in average adherence decreased the risk of virologic rebound (OR = 0.56; 95% confidence interval (CI) [0.37, 0.81], P < 0.002). Each additional consecutive day off therapy for the longest treatment interruption (OR = 1.34; 95% CI [1.15, 1.68], P < 0.0001) and each additional treatment interruption for more than 2 days (OR = 1.38; 95% CI [1.13, 1.77], P < 0.002) increased the risk of virologic rebound. In those with low-to-moderate adherence (i.e.,80%), treatment interruption duration (16.2 days versus 6.1 days in the control group, P < 0.02), but not average adherence (53.1% vs 55.9%, respectively, P = 0.65) was significantly associated with virologic rebound. Conclusions: Sustained treatment interruption may pose a greater risk of virologic rebound on NNRTI therapy than the same number of interspersed missed doses at low-to-moderate adherence.	[Parienti, Jean-Jacques; Verdon, Renaud] Cote Nacre Univ Hosp, Clin Res & Biostat Dept, Caen, France; [Parienti, Jean-Jacques; Massari, Veronique] Pierre Marie Curie Univ Paris 6, INSERM U707, UMR S707, Paris, France; [Das-Douglas, Moupali; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA USA; [Guzman, David] Univ Calif San Francisco, Epidemiol & Prevent Intervent Ctr, Div Infect Dis, San Francisco, CA USA	CHU de Caen NORMANDIE; Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco	Parienti, JJ (corresponding author), Cote Nacre Univ Hosp, Clin Res & Biostat Dept, Caen, France.	parienti-jj@chu-caen.fr	Massari, Veronique/E-6151-2017; Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590	Cote de Nacre University Hospital; NIMH [RO-54907]; NIAAA [K-24 015287]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054907] Funding Source: NIH RePORTER	Cote de Nacre University Hospital; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by Cote de Nacre University Hospital and NIMH RO-54907. Dr. Bangsberg received additional support from NIAAA K-24 015287.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Bangsberg DR, 2006, CLIN INFECT DIS, V43, P939, DOI 10.1086/507526; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; DANEL C, 2008, 5 C RETR OPP INF BOS; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2003, J INFECT DIS, V188, P388, DOI 10.1086/376535; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Kuss O, 2002, STAT MED, V21, P3789, DOI 10.1002/sim.1421; Maggiolo F, 2005, CLIN INFECT DIS, V40, P158, DOI 10.1086/426595; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Parienti JJ, 2007, AIDS, V21, P2217, DOI 10.1097/QAD.0b013e3282eff388; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Ribaudo HJ, 2006, CLIN INFECT DIS, V42, P401, DOI 10.1086/499364; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Ruiz L, 2007, AIDS, V21, P169, DOI 10.1097/QAD.0b013e328011033a; Shuter J, 2007, JAIDS-J ACQ IMM DEF, V45, P4, DOI 10.1097/QAI.0b013e318050d8c2	21	154	155	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2783	10.1371/journal.pone.0002783	http://dx.doi.org/10.1371/journal.pone.0002783			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665246	Green Published, gold			2022-12-27	WOS:000264304300002
J	Wiederman, SD; Shoemaker, PA; O'Carroll, DC				Wiederman, Steven D.; Shoemaker, Patrick A.; O'Carroll, David C.			A Model for the Detection of Moving Targets in Visual Clutter Inspired by Insect Physiology	PLOS ONE			English	Article							LARGE MONOPOLAR CELLS; FIRST OPTIC GANGLION; ON-OFF UNITS; MOTION DETECTION; TRANSIENT CELLS; NATURAL IMAGES; NEURONAL BASIS; ORGANIZATION; FLY; SYSTEM	We present a computational model for target discrimination based on intracellular recordings from neurons in the fly visual system. Determining how insects detect and track small moving features, often against cluttered moving backgrounds, is an intriguing challenge, both from a physiological and a computational perspective. Previous research has characterized higher-order neurons within the fly brain, known as 'small target motion detectors' (STMD), that respond robustly to moving features, even when the velocity of the target is matched to the background (i.e. with no relative motion cues). We recorded from intermediate-order neurons in the fly visual system that are well suited as a component along the target detection pathway. This full-wave rectifying, transient cell (RTC) reveals independent adaptation to luminance changes of opposite signs (suggesting separate ON and OFF channels) and fast adaptive temporal mechanisms, similar to other cell types previously described. From this physiological data we have created a numerical model for target discrimination. This model includes nonlinear filtering based on the fly optics, the photoreceptors, the 1(st) order interneurons (Large Monopolar Cells), and the newly derived parameters for the RTC. We show that our RTC-based target detection model is well matched to properties described for the STMDs, such as contrast sensitivity, height tuning and velocity tuning. The model output shows that the spatiotemporal profile of small targets is sufficiently rare within natural scene imagery to allow our highly nonlinear 'matched filter' to successfully detect most targets from the background. Importantly, this model can explain this type of feature discrimination without the need for relative motion cues.	[Wiederman, Steven D.; O'Carroll, David C.] Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia; [Shoemaker, Patrick A.] Tanner Res Inc, Monrovia, CA USA	University of Adelaide	Wiederman, SD (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Discipline Physiol, Adelaide, SA, Australia.	steven.wiederman@adelaide.edu.au	Wiederman, Steven D/G-1556-2012; O'Carroll, David C/C-4320-2008	Wiederman, Steven D/0000-0002-0902-803X; O'Carroll, David C/0000-0002-2352-4320	US Air Force Office of Scientific Research (AFOSR) [FA 9550-04-1-0294, FA 9550-04-1-0283]	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by grants from the US Air Force Office of Scientific Research (AFOSR) FA 9550-04-1-0294, FA 9550-04-1-0283.	ARNETT DW, 1971, SCIENCE, V173, P929, DOI 10.1126/science.173.4000.929; ARNETT DW, 1972, J NEUROPHYSIOL, V35, P429, DOI 10.1152/jn.1972.35.4.429; Barnett PD, 2007, CURR BIOL, V17, P569, DOI 10.1016/j.cub.2007.02.039; Bex PJ, 2002, J OPT SOC AM A, V19, P1096, DOI 10.1364/JOSAA.19.001096; BRINKWORTH RSA, 2007, BIOMIMETIC MOTION DE, P137; BRINKWORTH RSA, 2006, P SPIE, V3; Collett T., 1975, P437; COOMBE PE, 1989, J COMP PHYSIOL A, V166, P23, DOI 10.1007/BF00190206; Douglass JK, 2003, MICROSC RES TECHNIQ, V62, P132, DOI 10.1002/jemt.10367; EGELHAAF M, 1985, BIOL CYBERN, V52, P267, DOI 10.1007/BF00336983; GILBERT C, 1991, J COMP PHYSIOL A, V169, P395, DOI 10.1007/BF00197653; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Higgins CM, 2004, BIOL CYBERN, V91, P417, DOI 10.1007/s00422-004-0518-y; James A. C., 1990, THESIS AUSTR NATL U; JANSONIUS NM, 1993, J COMP PHYSIOL A, V172, P467, DOI 10.1007/BF00213528; JANSONIUS NM, 1991, J COMP PHYSIOL A, V168, P631, DOI 10.1007/BF00224353; JARVILEHTO M, 1970, J COMP PHYSL, V69, P134; JUUSOLA M, 1995, J GEN PHYSIOL, V105, P117, DOI 10.1085/jgp.105.1.117; KELLER A, 2002, THESIS BAYERISCHEN J; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; LAUGHLIN SB, 1993, J COMP PHYSIOL A, V172, P593, DOI 10.1007/BF00213682; Nordstrom K, 2006, PLOS BIOL, V4, P378, DOI 10.1371/journal.pbio.0040054; Nordstrom K, 2006, P ROY SOC B-BIOL SCI, V273, P1211, DOI 10.1098/rspb.2005.3424; OCARROLL D, 1993, NATURE, V362, P541, DOI 10.1038/362541a0; OCARROLL DC, 1992, J COMP PHYSIOL A, V171, P447, DOI 10.1007/BF00194577; OSORIO D, 1987, J COMP PHYSIOL A, V161, P431, DOI 10.1007/BF00603968; OSORIO D, 1991, VISUAL NEUROSCI, V7, P345, DOI 10.1017/S0952523800004831; Rind FC, 1996, J NEUROPHYSIOL, V75, P967, DOI 10.1152/jn.1996.75.3.967; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; ROWELL CHF, 1977, J EXP BIOL, V68, P157; Shoemaker PA, 2005, BIOL CYBERN, V93, P275, DOI 10.1007/s00422-005-0007-y; SRINIVASAN MV, 1990, PROC R SOC SER B-BIO, V240, P279, DOI 10.1098/rspb.1990.0038; SRINIVASAN MV, 1990, J COMP PHYSIOL A, V166, P287, DOI 10.1007/BF00204803; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stavenga DG, 2003, J COMP PHYSIOL A, V189, P1, DOI 10.1007/s00359-002-0370-2; Straw AD, 2006, J EXP BIOL, V209, P4339, DOI 10.1242/jeb.02517; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; van Hateren JH, 2001, VISION RES, V41, P1851, DOI 10.1016/S0042-6989(01)00052-9; VANHATEREN JH, 1992, J COMP PHYSIOL A, V171, P157, DOI 10.1007/BF00188924; WACHENFELD A, 1994, THESIS U KOLN KOLN; WAGNER H, 1986, PHILOS T ROY SOC B, V312, P581, DOI 10.1098/rstb.1986.0019; WEHRHAHN C, 1979, BIOL CYBERN, V32, P239, DOI 10.1007/BF00337647	44	84	85	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2784	10.1371/journal.pone.0002784	http://dx.doi.org/10.1371/journal.pone.0002784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665213	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300003
J	Arque, G; Fotaki, V; Fernandez, D; de Lagran, MM; Arbones, ML; Dierssen, M				Arque, Gloria; Fotaki, Vassiliki; Fernandez, David; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara			Impaired Spatial Learning Strategies and Novel Object Recognition in Mice Haploinsufficient for the Dual Specificity Tyrosine-Regulated Kinase-1A (Dyrk1A)	PLOS ONE			English	Article								Background: Pathogenic aneuploidies involve the concept of dosage-sensitive genes leading to over- and underexpression phenotypes. Monosomy 21 in human leads to mental retardation and skeletal, immune and respiratory function disturbances. Most of the human condition corresponds to partial monosomies suggesting that critical haploinsufficient genes may be responsible for the phenotypes. The DYRK1A gene is localized on the human chromosome 21q22.2 region, and has been proposed to participate in monosomy 21 phenotypes. It encodes a dual-specificity kinase involved in neuronal development and in adult brain physiology, but its possible role as critical haploinsufficient gene in cognitive function has not been explored. Methodology/Principal Findings: We used mice heterozygous for a Dyrk1A targeted mutation (Dyrk1A+/-) to investigate the implication of this gene in the cognitive phenotypes of monosomy 21. Performance of Dyrk1A+/- mice was assayed 1/ in a navigational task using the standard hippocampally related version of the Morris water maze, 2/ in a swimming test designed to reveal potential kinesthetic and stress-related behavioral differences between control and heterozygous mice under two levels of aversiveness (25 degrees C and 17 degrees C) and 3/ in a long-term novel object recognition task, sensitive to hippocampal damage. Dyrk1A+/- mice showed impairment in the development of spatial learning strategies in a hippocampally-dependent memory task, they were impaired in their novel object recognition ability and were more sensitive to aversive conditions in the swimming test than euploid control animals. Conclusions/Significance: The present results are clear examples where removal of a single gene has a profound effect on phenotype and indicate that haploinsufficiency of DYRK1A might contribute to an impairment of cognitive functions and stress coping behavior in human monosomy 21.	[Arque, Gloria; Fotaki, Vassiliki; Fernandez, David; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara] Pompeu Fabra Univ, Genes & Dis Program, Genom Regulat Ctr CRG, Barcelona, Spain; [Arque, Gloria; Martinez de Lagran, Maria; Arbones, Maria L.; Dierssen, Mara] CIBERER, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Arque, G (corresponding author), Pompeu Fabra Univ, Genes & Dis Program, Genom Regulat Ctr CRG, Barcelona, Spain.	mara.dierssen@crg.es	Dierssen, Mara/G-3552-2015; Arbones, Maria/D-4668-2016; Arque, Gloria/AAT-7266-2020; martinez de lagran, maria/L-2027-2015	Dierssen, Mara/0000-0003-0853-6865; Arbones, Maria/0000-0002-6035-0235; Arque, Gloria/0000-0002-8039-3726; martinez de lagran, maria/0000-0002-0836-6491; Fotaki, Vassiliki/0000-0001-9112-3257	Departament d'Educacio i Universitats; Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya"); Instituto de Salud Carlos III" of the Ministry of Health (CIBERER); Spanish Ministry of Education and Science [GEN2003-20651-C06-03, SAF2004-02808, SAF2007-60827]; Areces Foundations [LSHG-CT-2006-037627]; Marato TV3 [LSHG-CT-2006-037627]; AnEUploidy project [LSHG-CT-2006-037627]; EU [LSHG-CT-2006-037627]	Departament d'Educacio i Universitats; Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya")(Generalitat de Catalunya); Instituto de Salud Carlos III" of the Ministry of Health (CIBERER); Spanish Ministry of Education and Science(Spanish Government); Areces Foundations; Marato TV3; AnEUploidy project; EU(European Commission)	The laboratories of MD and MA are supported by the Departament d'Educacio i Universitats and the Departament de Salut of the Catalan Autonomous Government ("Generalitat de Catalunya"); the "Instituto de Salud Carlos III" of the Ministry of Health (CIBERER). This work was supported by grants from the Spanish Ministry of Education and Science (GEN2003-20651-C06-03, SAF2004-02808,SAF2007-60827), the Marato TV3, Jerome Lejeune, and Areces Foundations and the AnEUploidy project (LSHG-CT-2006-037627). DF was supported by the EU (LSHG-CT-2006-037627).	AHN KJ, 2006, NEUROBIOL DIS; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Benavides-Piccione R, 2005, NEUROBIOL DIS, V20, P115, DOI 10.1016/j.nbd.2005.02.004; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; CHETTOUH Z, 1995, AM J HUM GENET, V57, P62; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Dierssen M, 2001, J NEURAL TRANSM-SUPP, P131; Ehling D, 2004, AM J MED GENET A, V131A, P265, DOI 10.1002/ajmg.a.30361; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fernandez F, 2008, BEHAV BRAIN RES, V188, P233, DOI 10.1016/j.bbr.2007.09.015; Fernandez F, 2007, NEUROSCI LETT, V421, P137, DOI 10.1016/j.neulet.2007.04.075; Fotaki V, 2004, BEHAV NEUROSCI, V118, P815, DOI 10.1037/0735-7044.118.4.815; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Galdzicki Z, 2001, BRAIN RES REV, V35, P115, DOI 10.1016/S0926-6410(00)00074-4; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; HURET JL, 1995, CLIN GENET, V48, P140; Kessler RJ, 2004, PSYCHIAT QUART, V75, P99, DOI 10.1023/B:PSAQ.0000007564.35985.55; Kingwell J, 2006, SPACE POLICY, V22, P63, DOI 10.1016/j.spacepol.2005.11.005; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; Li RH, 1997, P NATL ACAD SCI USA, V94, P14506, DOI 10.1073/pnas.94.26.14506; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Martinez-Cue C, 2005, BEHAV BRAIN RES, V163, P174, DOI 10.1016/j.bbr.2005.04.016; Martinez-Cue C, 2002, BEHAV BRAIN RES, V134, P185, DOI 10.1016/S0166-4328(02)00026-8; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1990, EUR J NEUROSCI, V2, P1016, DOI 10.1111/j.1460-9568.1990.tb00014.x; Nadel L, 2003, GENES BRAIN BEHAV, V2, P156, DOI 10.1034/j.1601-183X.2003.00026.x; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pellegrini-Calace M, 2006, BIOINFORMATICS, V22, P775, DOI 10.1093/bioinformatics/btl006; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Rahmani Z, 1998, BIOCHEM BIOPH RES CO, V253, P514, DOI 10.1006/bbrc.1998.9803; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Song WJ, 1996, GENOMICS, V38, P331, DOI 10.1006/geno.1996.0636; Stasko MR, 2004, BEHAV BRAIN RES, V154, P1, DOI 10.1016/j.bbr.2004.01.012; SUTHERLAND RJ, 1988, J NEUROSCI, V8, P1863; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tuschl K, 2007, AM J MED GENET A, V143A, P2065, DOI 10.1002/ajmg.a.31792; WHISHAW IQ, 1995, PHYSIOL BEHAV, V58, P687, DOI 10.1016/0031-9384(95)00110-5; WHISHAW IQ, 1985, BEHAV NEUROSCI, V99, P979, DOI 10.1037/0735-7044.99.5.979; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6; WIENER SI, 1993, J NEUROSCI, V13, P3802; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yao GM, 2006, GENET MED, V8, P1, DOI 10.1097/01.gim.0000195892.60506.3f	55	74	74	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2575	10.1371/journal.pone.0002575	http://dx.doi.org/10.1371/journal.pone.0002575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648535	Green Published, Green Submitted, gold			2022-12-27	WOS:000263288200040
J	Melgari, JM; Pasqualetti, P; Pauri, F; Rossini, PM				Melgari, Jean-Marc; Pasqualetti, Patrizio; Pauri, Flavia; Rossini, Paolo Maria			Muscles in "Concert'': Study of Primary Motor Cortex Upper Limb Functional Topography	PLOS ONE			English	Article								Background: Previous studies with Transcranial Magnetic Stimulation (TMS) have focused on the cortical representation of limited group of muscles. No attempts have been carried out so far to get simultaneous recordings from hand, forearm and arm with TMS in order to disentangle a 'functional' map providing information on the rules orchestrating muscle coupling and overlap. The aim of the present study is to disentangle functional associations between 12 upper limb muscles using two measures: cortical overlapping and cortical covariation of each pair of muscles. Interhemispheric differences and the influence of posture were evaluated as well. Methodology/Principal Findings: TMS mapping studies of 12 muscles belonging to hand, forearm and arm were performed. Findings demonstrate significant differences between the 66 pairs of muscles in terms of cortical overlapping: extremely high for hand-forearm muscles and very low for arm vs hand/forearm muscles. When right and left hemispheres were compared, overlapping between all possible pairs of muscles in the left hemisphere (62.5%) was significantly higher than in the right one (53.5%). The arm/hand posture influenced both measures of cortical association, the effect of Position being significant [p=.021] on overlapping, resulting in 59.5% with prone vs 53.2% with supine hand, but only for pairs of muscles belonging to hand and forearm, while no changes occurred in the overlapping of proximal muscles with those of more distal districts. Conclusions/Significance: Larger overlapping in the left hemisphere could be related to its lifetime higher training of all twelve muscles studied with respect to the right hemisphere, resulting in larger intra-cortical connectivity within primary motor cortex. Altogether, findings with prone hand might be ascribed to mechanisms facilitating coupling of muscles for object grasping and lifting -with more proximal involvement for joint stabilization- compared to supine hand facilitating actions like catching. TMS multiple-muscle mapping studies permit a better understanding of motor control and 'plastic' reorganization of motor system.	[Melgari, Jean-Marc; Rossini, Paolo Maria] Univ Campus Biomed, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo Maria] Fatebenefratelli Hosp, AFaR, Rome, Italy; [Pasqualetti, Patrizio; Rossini, Paolo Maria] IRCCS SAN RAFFAELE, Casa Cura SAN RAFFAELE Cassino, Rome, Italy; [Pauri, Flavia] Univ Roma La Sapienza, ORL, Dept Neurol, Rome, Italy	University Campus Bio-Medico - Rome Italy; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome	Melgari, JM (corresponding author), Univ Campus Biomed, Rome, Italy.	j.melgari@unicampus.it	Rossini, Paolo M./D-4994-2013; Pasqualetti, Patrizio/D-4496-2013	Rossini, Paolo M./0000-0003-2665-534X; Pasqualetti, Patrizio/0000-0001-5560-1979	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	AFaR, Fatebenefratelli Hospital-Isola Tiberina, Roma	ANDERSEN P, 1975, PROC R SOC SER B-BIO, V188, P31, DOI 10.1098/rspb.1975.0002; Arunachalam R, 2005, J NEUROPHYSIOL, V94, P2162, DOI 10.1152/jn.01173.2004; BARKER AT, 1985, LANCET, V1, P1106; BERARDELLI A, 1991, CURR OPIN NEUROL NEU, V4, P770; BERARDELLI A, 1994, EXP BRAIN RES, V98, P501; Bohning DE, 2003, CLIN NEUROPHYSIOL, V114, P2210, DOI 10.1016/S1388-2457(03)00232-3; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cantello R, 2002, J CLIN NEUROPHYSIOL, V19, P272, DOI 10.1097/00004691-200208000-00003; Capaday C, 2004, NEUROSCIENTIST, V10, P207, DOI 10.1177/107385403262109; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Cicinelli P, 2003, STROKE, V34, P2653, DOI 10.1161/01.STR.0000092122.96722.72; Cicinelli P, 2000, NEUROREPORT, V11, P701, DOI 10.1097/00001756-200003200-00010; Cicinelli P, 1997, ELECTROMYOGR MOTOR C, V105, P438, DOI 10.1016/S0924-980X(97)00052-0; Cicinelli P, 1997, MUSCLE NERVE, V20, P535, DOI 10.1002/(SICI)1097-4598(199705)20:5<535::AID-MUS1>3.0.CO;2-A; CICINELLI P, 2005, CEREB CORTEX; COHEN LG, 1990, ELECTROEN CLIN NEURO, V75, P350, DOI 10.1016/0013-4694(90)90113-X; COHEN LG, 1988, NEUROLOGY, V38, P904, DOI 10.1212/WNL.38.6.904; COHEN LG, 1991, ELECTROEN CLIN NEURO, P36; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; DONOGHUE JP, 1992, EXP BRAIN RES, V89, P1; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Foltys H, 2003, CLIN NEUROPHYSIOL, V114, P2404, DOI 10.1016/S1388-2457(03)00263-3; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GOULD HJ, 1986, J COMP NEUROL, V247, P297, DOI 10.1002/cne.902470303; Gregori B, 2005, EXP BRAIN RES, V166, P43, DOI 10.1007/s00221-005-2337-3; Gugino LD, 2001, CLIN NEUROPHYSIOL, V112, P1781, DOI 10.1016/S1388-2457(01)00633-2; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; HUMPHREY DR, 1986, FED PROC, V45, P2687; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; JABRE JF, 2000, CLIN NEUROPHYSIOL, V53, P171; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; Korvenoja A, 1999, HUM BRAIN MAPP, V8, P13, DOI 10.1002/(SICI)1097-0193(1999)8:1<13::AID-HBM2>3.0.CO;2-B; Krings T, 1998, ELECTROMYOGR MOTOR C, V109, P85, DOI 10.1016/S0924-980X(97)00078-7; Krings T, 2001, NEUROSURG REV, V24, P171, DOI 10.1007/s101430100151; KRINGS T, 2001, NEUROL CLIN NEUROPHY, V1, P2; KWAN HC, 1978, J NEUROPHYSIOL, V41, P1120, DOI 10.1152/jn.1978.41.5.1120; LEMON RN, 1987, EXP BRAIN RES, V66, P621, DOI 10.1007/BF00270695; Liepert J, 2004, RESTOR NEUROL NEUROS, V22, P269; Liepert J, 1999, CURR OPIN NEUROL, V12, P709, DOI 10.1097/00019052-199912000-00009; Lotze M, 2003, CLIN NEUROPHYSIOL, V114, P306, DOI 10.1016/S1388-2457(02)00380-2; MERTON PA, 1980, J PHYSIOL-LONDON, V305, pP9; MERTON PA, 1980, NATURE, V285, P227, DOI 10.1038/285227a0; MERTON PA, 1982, LANCET, V2, P597; Mills KR, 1999, EEG CL N SU, P239; Neggers SFW, 2004, NEUROIMAGE, V21, P1805, DOI 10.1016/j.neuroimage.2003.12.006; Nielsen JF, 1996, J CLIN NEUROPHYSIOL, V13, P423, DOI 10.1097/00004691-199609000-00005; Nithi KA, 2000, MUSCLE NERVE, V23, P1542, DOI 10.1002/1097-4598(200010)23:10<1542::AID-MUS10>3.0.CO;2-A; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Pascual-Leone A, 1999, EEG CL N SU, P157; PASCUALLEONE A, 1994, ELECTROEN CLIN NEURO, V93, P42, DOI 10.1016/0168-5597(94)90090-6; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; Rossini Paolo M, 2004, Phys Med Rehabil Clin N Am, V15, P263, DOI 10.1016/S1047-9651(03)00124-4; Rossini PM, 1996, NEUROSCI LETT, V214, P191, DOI 10.1016/0304-3940(96)12940-2; Rossini PM, 2000, BRAIN RES REV, V33, P131, DOI 10.1016/S0169-328X(00)00090-5; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 2004, RESTOR NEUROL NEUROS, V22, P193; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; ROSSINI PM, 1995, BRAIN RES, V676, P314, DOI 10.1016/0006-8993(95)00113-5; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V61, P272, DOI 10.1016/0013-4694(85)91094-6; ROSSINI PM, 1985, ELECTROEN CLIN NEURO, V60, P320, DOI 10.1016/0013-4694(85)90006-9; Rossini PM, 1998, NEUROREPORT, V9, P2141, DOI 10.1097/00001756-199806220-00043; Rossini PM, 1999, CEREB CORTEX, V9, P161, DOI 10.1093/cercor/9.2.161; Rossini PM, 1999, EEG CL N SU, V50, P210; ROTHWELL JC, 1987, NEUROSURGERY, V20, P156; Sanes JN, 1997, ADV NEUROL, V73, P277; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Sanes JN, 2001, NEUROIMAGE, V13, P968, DOI 10.1006/nimg.2000.0733; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; SESSLE BJ, 1982, J PHYSIOL-LONDON, V323, P245, DOI 10.1113/jphysiol.1982.sp014071; STRICK PL, 1982, J NEUROPHYSIOL, V48, P139, DOI 10.1152/jn.1982.48.1.139; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Wassermann EM, 1996, NEUROIMAGE, V3, P1, DOI 10.1006/nimg.1996.0001; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; WILSON SA, 1993, J NEUROL SCI, V118, P134, DOI 10.1016/0022-510X(93)90102-5; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V; Ziemann U, 2001, CLIN NEUROPHYSIOL, V112, P107, DOI 10.1016/S1388-2457(00)00502-2	84	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3069	10.1371/journal.pone.0003069	http://dx.doi.org/10.1371/journal.pone.0003069			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RM	18728785	Green Published, gold, Green Submitted			2022-12-27	WOS:000264796400009
J	Leal, WS; Barbosa, RMR; Xu, W; Ishida, Y; Syed, Z; Latte, N; Chen, AM; Morgan, TI; Cornel, AJ; Furtado, A				Leal, Walter S.; Barbosa, Rosangela M. R.; Xu, Wei; Ishida, Yuko; Syed, Zainulabeuddin; Latte, Nicolas; Chen, Angela M.; Morgan, Tania I.; Cornel, Anthony J.; Furtado, Andre			Reverse and Conventional Chemical Ecology Approaches for the Development of Oviposition Attractants for Culex Mosquitoes	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; YELLOW-FEVER MOSQUITO; LIGAND RELEASE; MOTH PHEROMONE; QUINQUEFASCIATUS; RESPONSES; IDENTIFICATION; DIPTERA; FIELD; PH	Synthetic mosquito oviposition attractants are sorely needed for surveillance and control programs for Culex species, which are major vectors of pathogens causing various human diseases, including filariasis, encephalitis, and West Nile encephalomyelitis. We employed novel and conventional chemical ecology approaches to identify potential attractants, which were demonstrated in field tests to be effective for monitoring populations of Cx. p. quinquefasciatus in human dwellings. Immunohistochemistry studies showed that an odorant-binding protein from this species, CquiOBP1, is expressed in trichoid sensilla on the antennae, including short, sharp-tipped trichoid sensilla type, which house an olfactory receptor neuron sensitive to a previously identified mosquito oviposition pheromone (MOP), 6-acetoxy-5-hexadecanolide. CquiOBP1 exists in monomeric and dimeric forms. Monomeric CquiOBP1 bound MOP in a pH-dependent manner, with a change in secondary structure apparently related to the loss of binding at low pH. The pheromone antipode showed higher affinity than the natural stereoisomer. By using both CquiOBP1 as a molecular target in binding assays and gas chromatography-electroantennographic detection (GC-EAD), we identified nonanal, trimethylamine (TMA), and skatole as test compounds. Extensive field evaluations in Recife, Brazil, a region with high populations of Cx. p. quinquefasciatus, showed that a combination of TMA (0.9 mu g/l) and nonanal (0.15 ng/ml) is equivalent in attraction to the currently used infusion-based lure, and superior in that the offensive smell of infusions was eliminated in the newly developed synthetic mixture.	[Leal, Walter S.; Xu, Wei; Ishida, Yuko; Syed, Zainulabeuddin; Latte, Nicolas; Chen, Angela M.; Morgan, Tania I.] Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA; [Barbosa, Rosangela M. R.; Furtado, Andre] Ctr Pesquisas Ageu Magalhaes Fiocruz, Dept Entomol, Recife, PE, Brazil; [Cornel, Anthony J.] Univ Calif Davis, Dept Entomol, Mosquito Control Res Lab, Davis, CA USA	University of California System; University of California Davis; Fundacao Oswaldo Cruz; University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Barbosa, Rosângela/AAC-3339-2020; Xu, Wei/G-4709-2010; Leal, Walter/ABC-6940-2021; syed, zainulabeuddin/L-4961-2016	Barbosa, Rosângela/0000-0002-1171-598X; syed, zainulabeuddin/0000-0002-6235-7115; Leal, Walter/0000-0002-6800-1240; Latte, Nicolas/0000-0002-3822-315X; Leal Filho, Walter/0000-0002-1241-5225; Xu, Wei/0000-0003-4019-5140	National Institutes of Health [1U01AI05826-01]; Bedoukian Research Inc (BRI)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bedoukian Research Inc (BRI)	This work was supported in part by the National Institutes of Health (1U01AI05826-01) and a research agreement with Bedoukian Research Inc (BRI). BRI provided samples of the mosquito oviposition pheromone, but funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SA, 2004, J VECTOR ECOL, V29, P285; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Barbosa RMR, 2007, MEM I OSWALDO CRUZ, V102, P523, DOI 10.1590/S0074-02762007005000058; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; Braks MAH, 2007, J CHEM ECOL, V33, P567, DOI 10.1007/s10886-006-9223-8; CHRISTIANSEN JA, 2005, P PAP CAL MOSQ CONTR, P89; Clements A. N., 1999, BIOL MOSQUITOES SENS; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; DAWSON GW, 1990, J CHEM ECOL, V16, P1779, DOI 10.1007/BF01020494; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Du YJ, 1999, J MED ENTOMOL, V36, P158, DOI 10.1093/jmedent/36.2.158; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; HWANG YS, 1987, J CHEM ECOL, V13, P245, DOI 10.1007/BF01025885; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Ishida Y, 2002, J CHEM ECOL, V28, P867, DOI 10.1023/A:1015253214273; Ishida Yuko, 2003, Journal of Asia-Pacific Entomology, V6, P45, DOI 10.1016/S1226-8615(08)60166-1; Kline DL, 2007, MED VET ENTOMOL, V21, P323, DOI 10.1111/j.1365-2915.2007.00697.x; KOTSUKI H, 1990, J ORG CHEM, V55, P4417, DOI 10.1021/jo00301a038; LAURENCE BR, 1985, J CHEM ECOL, V11, P643, DOI 10.1007/BF00988573; LAURENCE BR, 1982, J CHEM SOC CHEM COMM, P59, DOI 10.1039/c39820000059; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Mboera LEG, 2000, J CHEM ECOL, V26, P1193, DOI 10.1023/A:1005432010721; McAbee RD, 2008, AM J TROP MED HYG, V78, P303, DOI 10.4269/ajtmh.2008.78.303; MILLAR JG, 1994, J AM MOSQUITO CONTR, V10, P374; Nasci Roger S., 1996, P85; Olagbemiro TO, 2004, J CHEM ECOL, V30, P965, DOI 10.1023/B:JOEC.0000028461.86243.19; Olagbemiro TO, 1999, J AGR FOOD CHEM, V47, P3411, DOI 10.1021/jf990294b; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; REISEN WK, 1987, J AM MOSQUITO CONTR, V3, P601; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Syed Z, 2007, CHEM SENSES, V32, P727, DOI 10.1093/chemse/bjm040; Trexler JD, 2003, J AM MOSQUITO CONTR, V19, P228; Wogulis M, 2006, BIOCHEM BIOPH RES CO, V339, P157, DOI 10.1016/j.bbrc.2005.10.191; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; 2008, CALIFORNIA MOSQUITO	42	114	125	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2008	3	8							e3045	10.1371/journal.pone.0003045	http://dx.doi.org/10.1371/journal.pone.0003045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LH	18725946	Green Published, gold, Green Submitted			2022-12-27	WOS:000264428800010
J	Nicholson, EM; Brunelle, BW; Richt, JA; Kehrli, ME; Greenlee, JJ				Nicholson, Eric M.; Brunelle, Brian W.; Richt, Juergen A.; Kehrli, Marcus E., Jr.; Greenlee, Justin J.			Identification of a Heritable Polymorphism in Bovine PRNP Associated with Genetic Transmissible Spongiform Encephalopathy: Evidence of Heritable BSE	PLOS ONE			English	Article							PRION PROTEIN GENE; TRANSGENIC MICE; PROMOTER REGION; NEURODEGENERATION; DISEASE; CATTLE; INFECTION; VARIANTS; MUTATION; SCRAPIE	Background: Bovine spongiform encephalopathy (BSE) is a transmissible spongiform encephalopathy (TSE) of cattle. Classical BSE is associated with ingestion of BSE-contaminated feedstuffs. H- and L-type BSE, collectively known as atypical BSE, differ from classical BSE by displaying a different disease phenotype and they have not been linked to the consumption of contaminated feed. Interestingly, the 2006 US H- type atypical BSE animal had a polymorphism at codon 211 of the bovine prion gene resulting in a glutamic acid to lysine substitution (E211K). This substitution is analogous a human polymorphism associated with the most prevalent form of heritable TSE in humans, and it is considered to have caused BSE in the 2006 US atypical BSE animal. In order to determine if this amino acid change is a heritable trait in cattle, we sequenced the prion alleles of the only known offspring of this animal, a 2-year-old heifer. Principal Findings: Sequence analysis revealed that both the 2006 US atypical BSE animal and its 2-year-old heifer were heterozygous at bovine prion gene nucleotides 631 through 633 for GAA ( glutamic acid) and AAA ( lysine). Both animals carry the E211K polymorphism, indicating that the allele is heritable and may persist within the cattle population. Conclusions: This is the first evidence that the E211K polymorphism is a germline polymorphism, not a somatic mutation, suggesting BSE may be transmitted genetically in cattle. In the event that E211K proves to result in a genetic form of BSE, this would be the first indication that all 3 etiologic forms of TSEs ( spontaneous, hereditary, and infectious) are present in a non-human species. Atypical BSE arising as both genetic and spontaneous disease, in the context of reports that at least some forms of atypical BSE can convert to classical BSE in mice, suggests a cattle origin for classical BSE.	[Nicholson, Eric M.; Richt, Juergen A.; Kehrli, Marcus E., Jr.; Greenlee, Justin J.] ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Brunelle, Brian W.] ARS, Natl Anim Dis Ctr, Pre Harvest Food Safety & Enter Dis Res Unit, USDA, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Nicholson, EM (corresponding author), ARS, Virus & Prion Dis Livestock Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA.	Eric.Nicholson@ars.usda.gov	Greenlee, Justin/Y-5732-2019; Richt, Juergen/AAL-3632-2020	Greenlee, Justin/0000-0003-2202-3054; Kehrli, Marcus/0000-0003-4850-5211	United States Department of Agriculture, Agriculture Research Service	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the United States Department of Agriculture, Agriculture Research Service.	Arnold ME, 2004, PREV VET MED, V66, P35, DOI 10.1016/j.prevetmed.2004.07.007; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Brunelle BW, 2007, J ANIM SCI, V85, P3142, DOI 10.2527/jas.2007-0208; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2005, FEBS LETT, V579, P6237, DOI 10.1016/j.febslet.2005.09.099; Castilla J, 2004, J NEUROSCI, V24, P2156, DOI 10.1523/JNEUROSCI.3811-03.2004; Clawson ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001830; Cutlip RC, 2001, CAN J VET RES, V65, P131; Geldermann H, 2006, ANIM GENET, V37, P469, DOI 10.1111/j.1365-2052.2006.01519.x; Horwich AL, 1997, CELL, V89, P499, DOI 10.1016/S0092-8674(00)80232-9; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Juling K, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-33; Kashkevich K, 2007, FASEB J, V21, P1547, DOI 10.1096/fj.06-7522com; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Pennington H, 2006, LANCET, V367, P298, DOI 10.1016/S0140-6736(06)68061-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Richt JA, 2007, J VET DIAGN INVEST, V19, P142, DOI 10.1177/104063870701900202; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Sauter-Louis C, 2006, SCHWEIZ ARCH TIERH, V148, P245, DOI 10.1024/0036-7281.148.5.245; Seabury CM, 2004, P NATL ACAD SCI USA, V101, P15142, DOI 10.1073/pnas.0406403101; SPUDICH S, 1995, MOL MED, V1, P607, DOI 10.1007/BF03401601; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; *USDA APHIS, 2006, ALB BSE INV FIN EP R	28	55	59	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2912	10.1371/journal.pone.0002912	http://dx.doi.org/10.1371/journal.pone.0002912			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698343	Green Published, Green Submitted, gold			2022-12-27	WOS:000264412600001
J	O'Brien, CA; Plotkin, LI; Galli, C; Goellner, JJ; Gortazar, AR; Allen, MR; Robling, AG; Bouxsein, M; Schipani, E; Turner, CH; Jilka, RL; Weinstein, RS; Manolagas, SC; Bellido, T				O'Brien, Charles A.; Plotkin, Lilian I.; Galli, Carlo; Goellner, Joseph J.; Gortazar, Arancha R.; Allen, Matthew R.; Robling, Alexander G.; Bouxsein, Mary; Schipani, Ernestina; Turner, Charles H.; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; Bellido, Teresita			Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes	PLOS ONE			English	Article							OSTEOBLAST-DERIVED PTHRP; PARATHYROID-HORMONE; BETA-CATENIN; IN-VIVO; GENE-EXPRESSION; TRABECULAR BONE; PRIMARY HYPERPARATHYROIDISM; DIFFERENTIATED OSTEOBLASTS; OSTEOCLAST DIFFERENTIATION; PTH/PTHRP RECEPTOR	Osteocytes, former osteoblasts buried within bone, are thought to orchestrate skeletal adaptation to mechanical stimuli. However, it remains unknown whether hormones control skeletal homeostasis through actions on osteocytes. Parathyroid hormone (PTH) stimulates bone remodeling and may cause bone loss or bone gain depending on the balance between bone resorption and formation. Herein, we demonstrate that transgenic mice expressing a constitutively active PTH receptor exclusively in osteocytes exhibit increased bone mass and bone remodeling, as well as reduced expression of the osteocyte-derived Wnt antagonist sclerostin, increased Wnt signaling, increased osteoclast and osteoblast number, and decreased osteoblast apoptosis. Deletion of the Wnt co-receptor LDL related receptor 5 (LRP5) attenuates the high bone mass phenotype but not the increase in bone remodeling induced by the transgene. These findings demonstrate that PTH receptor signaling in osteocytes increases bone mass and the rate of bone remodeling through LRP5-dependent and independent mechanisms, respectively.	[O'Brien, Charles A.; Plotkin, Lilian I.; Galli, Carlo; Goellner, Joseph J.; Gortazar, Arancha R.; Jilka, Robert L.; Weinstein, Robert S.; Manolagas, Stavros C.; Bellido, Teresita] Univ Arkansas Med Sci, Div Endocrinol, Ctr Osteoporosis & Metab Bone Dis, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Allen, Matthew R.; Robling, Alexander G.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Bloomington, IN 47405 USA; [Bouxsein, Mary] Beth Israel Deaconess Med Ctr, Harvard Med Sch, Dept Orthoped Surg, Orthoped Biomechan Lab, Boston, MA USA; [Schipani, Ernestina] Massachusetts Gen Hosp, Harvard Med Sch, Endocrine Unit, Boston, MA USA; [Turner, Charles H.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Bloomington, IN 47405 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Indiana University System; Indiana University Bloomington; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Indiana University System; Indiana University Bloomington	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Div Endocrinol, Ctr Osteoporosis & Metab Bone Dis, Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.	caobrien@uams.edu; tbellido@iupui.edu	Allen, Matthew/A-8799-2015; O'Brien, Charles A./AAL-5078-2020; Galli, Carlo/D-4728-2014; Gortazar, Arancha/G-5385-2017; Plotkin, Lilian/H-7188-2019	Allen, Matthew/0000-0002-1174-9004; Galli, Carlo/0000-0001-7476-7181; Gortazar, Arancha/0000-0001-5072-3141; Plotkin, Lilian/0000-0002-9537-4544	National Institutes of Health [R01 DK076007, R01 AR049794, P01 AG13918, S10-RR023710]; Department of Veterans Affairs; University of Arkansas for Medical Sciences Tobacco Settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710, S10RR017868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053237, R01AR049794, R01AR053643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); University of Arkansas for Medical Sciences Tobacco Settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (R01 DK076007, R01 AR049794, P01 AG13918, and S10-RR023710), the Department of Veterans Affairs, and University of Arkansas for Medical Sciences Tobacco Settlement funds.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bonewald LF, 2007, ANN NY ACAD SCI, V1116, P281, DOI 10.1196/annals.1402.018; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2004, MECH DEVELOP, V121, P397, DOI 10.1016/j.mod.2004.02.004; Chen XS, 2005, J BONE MINER RES, V20, P1454, DOI 10.1359/jbmr.2005.20.8.1454; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; FERMOR B, 1995, J BONE MINER RES, V10, P1935; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; JILKA RL, 2007, PRINCIPLES BONE BIOL; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; KE HZ, 2006, J MUSCULOSKEL NEURON, V6, P359; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Kim JS, 2002, CANCER RES, V62, P2744; Kousteni S, 2001, CELL, V104, P719, DOI 10.1016/S0092-8674(01)00268-9; Kousteni S, 2007, MOL CELL BIOL, V27, P1516, DOI 10.1128/MCB.01550-06; Langdahl BL, 1996, BONE, V18, P103, DOI 10.1016/8756-3282(95)00443-2; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu BY, 1998, ENDOCRINOLOGY, V139, P1952, DOI 10.1210/en.139.4.1952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Marotti G, 1996, Ital J Anat Embryol, V101, P25; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; NEUMAN WF, 1975, CALC TISS RES, V18, P263, DOI 10.1007/BF02546245; NIJWEIDE PJ, 2002, PRINCIPLES BONE BIOL, P93; Noble BS, 1997, BONE, V20, P273, DOI 10.1016/S8756-3282(96)00365-1; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Parfitt AM, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P497; PARFITT AM, 1976, METABOLISM, V25, P909, DOI 10.1016/0026-0495(76)90124-4; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Parfitt AM, 1996, J CLIN ENDOCR METAB, V81, P3584, DOI 10.1210/jc.81.10.3584; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; PYRAH LN, 1966, BRIT J SURG, V53, P245, DOI 10.1002/bjs.1800530402; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; RODAN GA, 1981, CALCIFIED TISSUE INT, V33, P349, DOI 10.1007/BF02409454; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tomkinson A, 1997, J CLIN ENDOCR METAB, V82, P3128, DOI 10.1210/jc.82.9.3128; Tomkinson A, 1998, J BONE MINER RES, V13, P1243, DOI 10.1359/jbmr.1998.13.8.1243; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; Weinstein R. S, 2002, DISORDERS BONE MINER, P448; Weinstein RS, 2000, J CLIN ENDOCR METAB, V85, P2907, DOI 10.1210/jc.85.8.2907; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; WYSOLMERSKI JJ, 2001, PARATHYROIDS, P275; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	83	274	284	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2942	10.1371/journal.pone.0002942	http://dx.doi.org/10.1371/journal.pone.0002942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698360	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600028
J	van Sorge, NM; Ebrahimi, CM; McGillivray, SM; Quach, D; Sabet, M; Guiney, DG; Doran, KS				van Sorge, Nina M.; Ebrahimi, Celia M.; McGillivray, Shauna M.; Quach, Darin; Sabet, Mojgan; Guiney, Donald G.; Doran, Kelly S.			Anthrax Toxins Inhibit Neutrophil Signaling Pathways in Brain Endothelium and Contribute to the Pathogenesis of Meningitis	PLOS ONE			English	Article								Background: Anthrax meningitis is the main neurological complication of systemic infection with Bacillus anthracis approaching 100% mortality. The presence of bacilli in brain autopsies indicates that vegetative bacteria are able to breach the blood-brain barrier (BBB). The BBB represents not only a physical barrier but has been shown to play an active role in initiating a specific innate immune response that recruits neutrophils to the site of infection. Currently, the basic pathogenic mechanisms by which B. anthracis penetrates the BBB and causes anthrax meningitis are poorly understood. Methodology/Principal Findings: Using an in vitro BBB model, we show for the first time that B. anthracis efficiently invades human brain microvascular endothelial cells (hBMEC), the single cell layer that comprises the BBB. Furthermore, transcriptional profiling of hBMEC during infection with B. anthracis revealed downregulation of 270 (87%) genes, specifically key neutrophil chemoattractants IL-8, CXCL1 (Gro alpha) and CXCL2 (Gro beta), thereby strongly contrasting hBMEC responses observed with other meningeal pathogens. Further studies using specific anthrax toxin-mutants, quantitative RTPCR, ELISA and in vivo assays indicated that anthrax toxins actively suppress chemokine production and neutrophil recruitment during infection, allowing unrestricted proliferation and dissemination of the bacteria. Finally, mice challenged with B. anthracis Sterne, but not the toxin-deficient strain, developed meningitis. Conclusions/Significance: These results suggest a significant role for anthrax toxins in thwarting the BBB innate defense response promoting penetration of bacteria into the central nervous system. Furthermore, establishment of a mouse model for anthrax meningitis will aid in our understanding of disease pathogenesis and development of more effective treatment strategies.	[van Sorge, Nina M.; McGillivray, Shauna M.; Doran, Kelly S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA USA; [Ebrahimi, Celia M.; Quach, Darin; Doran, Kelly S.] San Diego State Univ, Dept Biol, San Diego, CA USA; [Ebrahimi, Celia M.; Quach, Darin; Doran, Kelly S.] San Diego State Univ, Ctr Microb Sci, San Diego, CA USA; [Sabet, Mojgan; Guiney, Donald G.] Univ Calif San Diego, Dept Med, La Jolla, CA USA	University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; University of California System; University of California San Diego	van Sorge, NM (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA USA.	kdoran@sciences.sdsu.edu	McGillivray, Shauna/AAN-3074-2021; van Sorge, Nina/E-3290-2017	McGillivray, Shauna/0000-0002-8863-1522; van Sorge, Nina/0000-0002-2695-5863; Quach, Darin/0000-0002-3244-5376	NIH [1U01AI077989]; NINDS/NIH [R01NS051247]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant 1U01AI077989 from the NIH to D.G.G. and R01NS051247 from the NINDS/NIH to K.S.D.	ABRAMOVA FA, 1993, P NATL ACAD SCI USA, V90, P2291, DOI 10.1073/pnas.90.6.2291; Batty S, 2006, CELL MICROBIOL, V8, P130, DOI 10.1111/j.1462-5822.2005.00606.x; Betz A L, 1992, NIDA Res Monogr, V120, P54; BETZ AL, 1985, FED PROC, V44, P2614; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Doran KS, 2003, J CLIN INVEST, V112, P736, DOI 10.1172/JCI200317335; Drysdale M, 2007, INFECT IMMUN, V75, P1757, DOI 10.1128/IAI.01712-06; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; During RL, 2005, J INFECT DIS, V192, P837, DOI 10.1086/432516; During RL, 2007, EMBO J, V26, P2240, DOI 10.1038/sj.emboj.7601687; FRITZ DL, 1995, LAB INVEST, V73, P691; GLEISER CA, 1967, FED PROC, V26, P1518; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Heninger S, 2006, INFECT IMMUN, V74, P6067, DOI 10.1128/IAI.00719-06; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Kim KS, 2001, INFECT IMMUN, V69, P5217, DOI 10.1128/IAI.69.9.5217-5222.2001; Lanska DJ, 2002, NEUROLOGY, V59, P327, DOI 10.1212/WNL.59.3.327; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Mayer-Scholl A, 2005, PLOS PATHOG, V1, P179, DOI 10.1371/journal.ppat.0010023; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nizet V, 1997, INFECT IMMUN, V65, P5074, DOI 10.1128/IAI.65.12.5074-5081.1997; PEZARD C, 1991, INFECT IMMUN, V59, P3472, DOI 10.1128/IAI.59.10.3472-3477.1991; Popov SG, 2004, CELL MICROBIOL, V6, P225, DOI 10.1046/j.1462-5822.2003.00358.x; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Sasik R, 2002, BIOINFORMATICS, V18, P1633, DOI 10.1093/bioinformatics/18.12.1633; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; STINS MF, 1994, AM J PATHOL, V145, P1228; Stins MF, 1997, IN VITRO CELL DEV-AN, V33, P243; Storie I, 2003, CYTOM PART B-CLIN CY, V55B, P1, DOI 10.1002/cyto.b.10051; TURNBULL PCB, 1991, VACCINE, V9, P533, DOI 10.1016/0264-410X(91)90237-Z; Unwin RD, 2006, CELL CYCLE, V5, P1587, DOI 10.4161/cc.5.15.3101; WELKOS SL, 1988, MICROB PATHOGENESIS, V4, P53, DOI 10.1016/0882-4010(88)90048-4; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982	39	52	53	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2964	10.1371/journal.pone.0002964	http://dx.doi.org/10.1371/journal.pone.0002964			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698416	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600049
J	Goldar, A; Labit, H; Marheineke, K; Hyrien, O				Goldar, Arach; Labit, Helene; Marheineke, Kathrin; Hyrien, Olivier			A Dynamic Stochastic Model for DNA Replication Initiation in Early Embryos	PLOS ONE			English	Article							XENOPUS EGG EXTRACT; MCM PROTEINS; S-PHASE; YEAST; CHROMATIN; ORIGINS; PHOSPHORYLATION; INCREASES; COMPLEXES; CLUSTERS	Background: Eukaryotic cells seem unable to monitor replication completion during normal S phase, yet must ensure a reliable replication completion time. This is an acute problem in early Xenopus embryos since DNA replication origins are located and activated stochastically, leading to the random completion problem. DNA combing, kinetic modelling and other studies using Xenopus egg extracts have suggested that potential origins are much more abundant than actual initiation events and that the time-dependent rate of initiation, I(t), markedly increases through S phase to ensure the rapid completion of unreplicated gaps and a narrow distribution of completion times. However, the molecular mechanism that underlies this increase has remained obscure. Methodology/Principal Findings: Using both previous and novel DNA combing data we have confirmed that I(t) increases through S phase but have also established that it progressively decreases before the end of S phase. To explore plausible biochemical scenarios that might explain these features, we have performed comparisons between numerical simulations and DNA combing data. Several simple models were tested: i) recycling of a limiting replication fork component from completed replicons; ii) time-dependent increase in origin efficiency; iii) time-dependent increase in availability of an initially limiting factor, e. g. by nuclear import. None of these potential mechanisms could on its own account for the data. We propose a model that combines time-dependent changes in availability of a replication factor and a fork-density dependent affinity of this factor for potential origins. This novel model quantitatively and robustly accounted for the observed changes in initiation rate and fork density. Conclusions/Significance: This work provides a refined temporal profile of replication initiation rates and a robust, dynamic model that quantitatively explains replication origin usage during early embryonic S phase. These results have significant implications for the organisation of replication origins in higher eukaryotes.	[Goldar, Arach] Commissariat Energie Atom, Serv Biol Integrat & Genet Mol, Gif Sur Yvette, France; [Labit, Helene; Marheineke, Kathrin; Hyrien, Olivier] Ecole Normale Superieure, CNRS, UMR 8541, Paris, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Goldar, A (corresponding author), Commissariat Energie Atom, Serv Biol Integrat & Genet Mol, Gif Sur Yvette, France.	arach.goldar@cea.fr; hyrien@biologie.ens.fr	goldar, arach/I-8479-2012; Hyrien, Olivier/R-5108-2017	Hyrien, Olivier/0000-0001-8879-675X; Marheineke, Kathrin/0000-0002-1514-0167	Association pour la Recherche sur le Cancer; Ligue Contre le Cancer (Comite de Paris); Agence Nationale pour la Recherche; Fondation pour la Recherche Medicale; MENESR	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Contre le Cancer (Comite de Paris)(Ligue nationale contre le cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); MENESR	The O.H. lab is supported by the Association pour la Recherche sur le Cancer, the Ligue Contre le Cancer (Comite de Paris), the Agence Nationale pour la Recherche and the Fondation pour la Recherche Medicale. H.L. was supported by fellowships from the MENESR and the ARC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Bechhoefer J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.098105; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Bevington P.R., 1969, DATA REDUCTION ERROR, P336; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; CALLAN HG, 1972, PROC R SOC SER B-BIO, V181, P19, DOI 10.1098/rspb.1972.0039; Czajkowsky DM, 2008, J MOL BIOL, V375, P12, DOI 10.1016/j.jmb.2007.10.046; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Herrick J, 2000, J MOL BIOL, V300, P1133, DOI 10.1006/jmbi.2000.3930; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1992, NUCLEIC ACIDS RES, V20, P1463, DOI 10.1093/nar/20.7.1463; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Jun S, 2004, CELL CYCLE, V3, P223; Jun S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011909; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Lau E, 2006, EMBO REP, V7, P425, DOI 10.1038/sj.embor.7400624; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Legouras I, 2006, YEAST, V23, P951, DOI 10.1002/yea.1416; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Lu ZH, 1998, MOL BIOL CELL, V9, P1163, DOI 10.1091/mbc.9.5.1163; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Patel PK, 2006, MOL BIOL CELL, V17, P308, DOI 10.1091/mbc.E05-07-0657; Rhind N, 2006, NAT CELL BIOL, V8, P1313, DOI 10.1038/ncb1206-1313; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Torres-Rosell J, 2007, SCIENCE, V315, P1411, DOI 10.1126/science.1134025; Torres-Rosell J, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-19; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yao RJ, 2003, P NATL ACAD SCI USA, V100, P6628, DOI 10.1073/pnas.1131932100; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhang HY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.051903	44	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2919	10.1371/journal.pone.0002919	http://dx.doi.org/10.1371/journal.pone.0002919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682801	Green Submitted, Green Published, gold			2022-12-27	WOS:000264366600069
J	Hao, JJ; Daleo, MA; Murphy, CK; Yu, PB; Ho, JN; Hu, JY; Peterson, RT; Hatzopoulos, AK; Hong, CC				Hao, Jijun; Daleo, Marie A.; Murphy, Clare K.; Yu, Paul B.; Ho, Joshua N.; Hu, Jianyong; Peterson, Randall T.; Hatzopoulos, Antonis K.; Hong, Charles C.			Dorsomorphin, a Selective Small Molecule Inhibitor of BMP Signaling, Promotes Cardiomyogenesis in Embryonic Stem Cells	PLOS ONE			English	Article							CARDIAC MESODERM; PROGENITOR CELLS; SMOOTH-MUSCLE; INDUCTION; DIFFERENTIATION; SPECIFICATION; HEART; CARDIOMYOCYTE; FIBROBLASTS; PROTEINS	Background: Pluripotent embryonic stem (ES) cells, which have the capacity to give rise to all tissue types in the body, show great promise as a versatile source of cells for regenerative therapy. However, the basic mechanisms of lineage specification of pluripotent stem cells are largely unknown, and generating sufficient quantities of desired cell types remains a formidable challenge. Small molecules, particularly those that modulate key developmental pathways like the bone morphogenetic protein (BMP) signaling cascade, hold promise as tools to study in vitro lineage specification and to direct differentiation of stem cells toward particular cell types. Methodology/Principal Findings: We describe the use of dorsomorphin, a selective small molecule inhibitor of BMP signaling, to induce myocardial differentiation in mouse ES cells. Cardiac induction is very robust, increasing the yield of spontaneously beating cardiomyocytes by at least 20 fold. Dorsomorphin, unlike the endogenous BMP antagonist Noggin, robustly induces cardiomyogenesis when treatment is limited to the initial 24-hours of ES cell differentiation. Quantitative-PCR analyses of differentiating ES cells indicate that pharmacological inhibition of BMP signaling during the early critical stage promotes the development of the cardiomyocyte lineage, but reduces the differentiation of endothelial, smooth muscle, and hematopoietic cells. Conclusions/Significance: Administration of a selective small molecule BMP inhibitor during the initial stages of ES cell differentiation substantially promotes the differentiation of primitive pluripotent cells toward the cardiomyocytic lineage, apparently at the expense of other mesodermal lineages. Small molecule modulators of developmental pathways like dorsomorphin could become versatile pharmacological tools for stem cell research and regenerative medicine.	[Hao, Jijun; Daleo, Marie A.; Murphy, Clare K.; Ho, Joshua N.; Hu, Jianyong; Hatzopoulos, Antonis K.; Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Hong, Charles C.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN USA; [Yu, Paul B.; Peterson, Randall T.] Harvard Univ, Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA USA; [Hu, Jianyong; Hatzopoulos, Antonis K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Vanderbilt University	Hao, JJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Cardiovasc Med, Nashville, TN 37212 USA.	charles.c.hong@vanderbilt.edu	Yu, Paul B./J-7540-2019; Hong, Charles/C-9989-2010; Hatzopoulos, Antonis/D-2049-2010; Hatzopoulos, Antonis/X-2043-2019	Yu, Paul B./0000-0003-2145-4944; Hatzopoulos, Antonis/0000-0001-5610-0017; Peterson, Randall/0000-0003-0727-3469	NIH [HL081535, HL083958]; GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079943, K08HL081535, R01HL083958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease(GlaxoSmithKline); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants HL081535 (CCH) and HL083958 (AKH), and a grant from the GlaxoSmithKline Research & Education Foundation for Cardiovascular Disease (CCH).	Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Emre N, 2007, CURR OPIN CHEM BIOL, V11, P252, DOI 10.1016/j.cbpa.2007.04.024; Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Koike M, 2007, J BIOSCI BIOENG, V104, P294, DOI 10.1263/jbb.104.294; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Mishra L, 2005, SCIENCE, V310, P68, DOI 10.1126/science.1118389; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olson EN, 2001, SCIENCE, V291, P2327, DOI 10.1126/science.1060063; Palermo J, 1996, CIRC RES, V78, P504, DOI 10.1161/01.RES.78.3.504; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schoenebeck JJ, 2007, DEV CELL, V13, P254, DOI 10.1016/j.devcel.2007.05.012; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu P. B., 2007, NAT CHEM BIOL; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	139	167	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2904	10.1371/journal.pone.0002904	http://dx.doi.org/10.1371/journal.pone.0002904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682835	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600060
J	Gil, M; Menzel, R; De Marco, RJ				Gil, Mariana; Menzel, Randolf; De Marco, Rodrigo J.			Does an Insect's Unconditioned Response to Sucrose Reveal Expectations of Reward?	PLOS ONE			English	Article							APIS-MELLIFERA L.; HONEY-BEE; PROBOSCIS REFLEX; BRAIN; BEHAVIOR; MEMORY; MUSHROOM; NEURONS; PATTERN; BODY	We asked whether and how a sequence of a honeybee's experience with different reward magnitudes changes its subsequent unconditioned proboscis extension response (PER) to sucrose stimulation of the antennae, 24 hours after training, in the absence of reward, and under otherwise similar circumstances. We found that the bees that had experienced an increasing reward schedule extended their probosces earlier and during longer periods in comparison to bees that had experienced either decreasing or constant reward schedules, and that these effects at a later time depend upon the activation of memories formed on the basis of a specific property of the experienced reward, namely, that its magnitude increased over time. An anticipatory response to reward is typically thought of as being rooted in a subject's expectations of reward. Therefore our results make us wonder to what extent a long-term 'anticipatory' adjustment of a honeybee's PER is based upon an expectation of reward. Further experiments will aim to elucidate the neural substrates underlying reward anticipation in harnessed honeybees.	[Gil, Mariana; Menzel, Randolf; De Marco, Rodrigo J.] Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol Neurobiol, D-1000 Berlin, Germany	Free University of Berlin	Gil, M (corresponding author), Free Univ Berlin, Dept Biol Chem Pharm, Inst Biol Neurobiol, D-1000 Berlin, Germany.	mgdm04@yahoo.com.ar; demarco@neurobiologie.fu-berlin.de		De Marco, Rodrigo/0000-0002-2082-4264	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Our study has been supported by funds from the Deutsche Forschungsgemeinschaft.	BICKER G, 1989, NATURE, V337, P33, DOI 10.1038/337033a0; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BRAUN G, 1992, J NEUROPHYSIOL, V67, P588, DOI 10.1152/jn.1992.67.3.588; ERBER E, 1997, J COMP PHYSL, V181, P1432; Gil M, 2007, LEARN MEMORY, V14, P491, DOI 10.1101/lm.618907; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAMMER M, 1994, SOC NEUR ABSTR, V20, P258; Haupt SS, 2007, J COMP PHYSIOL A, V193, P523, DOI 10.1007/s00359-007-0208-z; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; HORI S, 2006, J COMP PHYSIOL A, V192, P1432; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; LOGAN FA, 1960, INCENTIVE; Menzel R, 2001, LEARN MEMORY, V8, P53, DOI 10.1101/lm.38801; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; REHDER V, 1987, J INSECT PHYSIOL, V33, P501, DOI 10.1016/0022-1910(87)90115-6; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Schroeter U, 2007, CELL TISSUE RES, V327, P647, DOI 10.1007/s00441-006-0197-1; Schroter U, 2003, J COMP NEUROL, V465, P168, DOI 10.1002/cne.10843; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; SMITH BH, 1989, ETHOLOGY, V82, P68; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tolman E. C., 1959, PSYCHOL STUDY SCI, P92	28	8	8	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2810	10.1371/journal.pone.0002810	http://dx.doi.org/10.1371/journal.pone.0002810			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665249	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000264304300029
J	Null, B; Liu, CW; Hedehus, M; Conolly, S; Davis, RW				Null, Brian; Liu, Corey W.; Hedehus, Maj; Conolly, Steven; Davis, Ronald W.			High-Resolution, In Vivo Magnetic Resonance Imaging of Drosophila at 18.8 Tesla	PLOS ONE			English	Article								High resolution MRI of live Drosophila was performed at 18.8 Tesla, with a field of view less than 5 mm, and administration of manganese or gadolinium-based contrast agents. This study demonstrates the feasibility of MR methods for imaging the fruit fly Drosophila with an NMR spectrometer, at a resolution relevant for undertaking future studies of the Drosophila brain and other organs. The fruit fly has long been a principal model organism for elucidating biology and disease, but without capabilities like those of MRI. This feasibility marks progress toward the development of new in vivo research approaches in Drosophila without the requirement for light transparency or destructive assays.	[Null, Brian; Davis, Ronald W.] Stanford Genome Technol Ctr, Dept Biochem, Bio X Program, Stanford, CA USA; [Liu, Corey W.] Stanford Magnetic Resonance Lab, Stanford, CA USA; [Hedehus, Maj] Varian Inc, NMR Instruments, Palo Alto, CA USA; [Conolly, Steven] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA USA	Stanford University; University of California System; University of California Berkeley	Null, B (corresponding author), Stanford Genome Technol Ctr, Dept Biochem, Bio X Program, Stanford, CA USA.	zenbonz@gmail.com	Vorobev, Alexander/C-1918-2016; Zhang, Lin/F-6815-2013	Vorobev, Alexander/0000-0002-7324-428X; Zhang, Lin/0000-0002-4394-2685	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	National Science Foundation Major Research Instrumentation Development Grant	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bernstein M.A., 2004, HDB MRI PULSE SEQUEN, DOI 10.1016/B978-012092861-3/50021-2; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Engstrom Y, 2004, TRENDS BIOTECHNOL, V22, P600, DOI 10.1016/j.tibtech.2004.09.002; GANDHI S, 2007, J VISION, V7, P42; Gilad AA, 2007, NAT BIOTECHNOL, V25, P217, DOI 10.1038/nbt1277; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Grant SC, 2000, MAGNET RESON MED, V44, P19, DOI 10.1002/1522-2594(200007)44:1<19::AID-MRM4>3.0.CO;2-F; Haddad D, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.7; Hart AG, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.5; Jasanoff A, 2002, J MAGN RESON, V158, P79, DOI 10.1016/S1090-7807(02)00063-0; Lee SC, 2006, BIOPHYS J, V90, P1797, DOI 10.1529/biophysj.105.073502; Lee SC, 2001, J MAGN RESON, V150, P207, DOI 10.1006/jmre.2001.2319; Lilley Kathryn S., 2003, Briefings in Functional Genomics & Proteomics, V2, P106, DOI 10.1093/bfgp/2.2.106; Manev H, 2003, TRENDS PHARMACOL SCI, V24, P41, DOI 10.1016/S0165-6147(02)00004-4; Mason GF, 2006, NMR BIOMED, V19, P690, DOI 10.1002/nbm.1080; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Raghunand N, 2006, MAGN RESON MED, V55, P1272, DOI 10.1002/mrm.20904; Raghunand Natarajan, 2006, Methods Mol Med, V124, P347; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Ruden DM, 2005, ANNU REV NUTR, V25, P499, DOI 10.1146/annurev.nutr.25.050304.092708; Schoofs Liliane, 2003, Briefings in Functional Genomics & Proteomics, V2, P114, DOI 10.1093/bfgp/2.2.114; Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103; Serber Z, 2005, METHOD ENZYMOL, V394, P17, DOI 10.1016/S0076-6879(05)94002-0; Shen J, 2004, J MAGN RESON, V170, P290, DOI 10.1016/j.jmr.2004.05.022; Taraszka JA, 2005, J PROTEOME RES, V4, P1223, DOI 10.1021/pr050038g; Tyszka JM, 2005, CURR OPIN BIOTECH, V16, P93, DOI 10.1016/j.copbio.2004.11.004; Xun ZY, 2007, J PROTEOME RES, V6, P348, DOI 10.1021/pr060488o	28	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2817	10.1371/journal.pone.0002817	http://dx.doi.org/10.1371/journal.pone.0002817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665264	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300036
J	Lee, EJ; Kim, JM; Lee, MK; Jameson, JL				Lee, Eun Jig; Kim, Jeong Mo; Lee, Mi Kyung; Jameson, J. Larry			Splice Variants of the Forkhead Box Protein AFX Exhibit Dominant Negative Activity and Inhibit AFX alpha-Mediated Tumor Cell Apoptosis	PLOS ONE			English	Article								Background: Loss-of-function in the apoptosis-inducing genes is known to facilitate tumorigenesis. AFX (FOXO4), a member of forkhead transcription factors functions as a tumor suppressor and has 2 isoforms, AFX alpha (505 a.a.) and AFX zeta (450 a.a.). In human cancer cells, we identified an N-terminally deleted form of AFX alpha (alpha 198-505), translated from a downstream start and 2 short N-terminal AFX proteins (90, and 101 a.a.) produced by aberrant splicing. Methods and Findings: We investigated the expression and role of these AFX variants. Cell transduction study revealed that short N-terminal AFX proteins were not stable. Though alpha(198-505) protein expression was detected in the cytoplasm and nucleus, alpha(198-505) expressing cells did not show a nucleocytoplasmic shuttling mediated by PI3 kinase signaling. Whereas, we observed this shuttling in cells expressing either AFX alpha or AFX zeta protein. AFX zeta and alpha(198-505) lost the ability to transactivate BCL6 or suppress cyclin D2 gene expression. These variants did not induce cancer cell death whereas AFX alpha resulted in apoptosis. We found that AFX zeta and alpha(198-505) suppress the AFX alpha stimulation of BCL6 promoter in a dose dependent manner, indicating dominant negative activity. These variants also inhibited AFX alpha induction of apoptosis. Conclusions: Loss of function by aberrant splicing and the dominant negative activity of AFX variants may provide a mechanism for enhanced survival of neoplastic cells.	[Lee, Eun Jig; Kim, Jeong Mo] Yonsei Univ, Coll Med, Seoul, South Korea; [Lee, Eun Jig; Jameson, J. Larry] Northwestern Univ, Feinberg Sch Med, Div Endocrinol, Metabolism, & Mo Med, Chicago, IL USA; [Lee, Mi Kyung] Ilsan Hosp, Natl Hlth Insurance Corp, Koyang, South Korea	Yonsei University; Yonsei University Health System; Northwestern University; Feinberg School of Medicine; NHIS Ilsan Hospital	Lee, EJ (corresponding author), Yonsei Univ, Coll Med, Seoul, South Korea.	ljameson@northwestern.edu		Jameson, James/0000-0001-9538-4059; Lee, Eun Jig/0000-0002-9876-8370	Yonsei University College of Medicine	Yonsei University College of Medicine(General Electric)	CMB-YUHAN Research Grant from Yonsei University College of Medicine (2007-01). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Arden KC, 2004, MOL CELL, V14, P416, DOI 10.1016/S1097-2765(04)00213-8; Barr FG, 2001, ONCOGENE, V20, P5736, DOI 10.1038/sj.onc.1204599; Barthelemy C, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-48; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Ciechomska I, 2003, ONCOGENE, V22, P7617, DOI 10.1038/sj.onc.1207137; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gan LX, 2005, BIOCHEM BIOPH RES CO, V337, P1092, DOI 10.1016/j.bbrc.2005.09.169; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Ishikawa T, 2004, MOL CELL BIOL, V24, P8323, DOI 10.1128/MCB.24.19.8323-8331.2004; Lee EJ, 1999, J CLIN ENDOCR METAB, V84, P786, DOI 10.1210/jc.84.2.786; Lee EJ, 2001, MOL MED, V7, P773, DOI 10.1007/BF03401968; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Matsuzaki H, 2005, J BIOCHEM, V138, P485, DOI 10.1093/jb/mvi146; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Scheidler S, 1996, P NATL ACAD SCI USA, V93, P9805, DOI 10.1073/pnas.93.18.9805; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Smith PJ, 2002, ENDOCRINOLOGY, V143, P146, DOI 10.1210/en.143.1.146; So CW, 2003, BLOOD, V101, P633, DOI 10.1182/blood-2002-06-1785; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Tang TTL, 2002, J BIOL CHEM, V277, P14255, DOI 10.1074/jbc.M110901200; Urbich C, 2005, FASEB J, V19, P974, DOI 10.1096/fj.04-2727fje; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Yang ZY, 2002, J BIOL CHEM, V277, P8068, DOI 10.1074/jbc.M106091200	38	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2743	10.1371/journal.pone.0002743	http://dx.doi.org/10.1371/journal.pone.0002743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648506	Green Submitted, gold, Green Published			2022-12-27	WOS:000264302900014
J	Gupta, PK; Moayeri, M; Crown, D; Fattah, RJ; Leppla, SH				Gupta, Pradeep K.; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Leppla, Stephen H.			Role of N-Terminal Amino Acids in the Potency of Anthrax Lethal Factor	PLOS ONE			English	Article								Anthrax lethal factor (LF) is a Zn+2-dependent metalloprotease that cleaves several MAPK kinases and is responsible for the lethality of anthrax lethal toxin (LT). We observed that a recombinant LF (LF-HMA) which differs from wild type LF (LF-A) by the addition of two residues (His-Met) to the native Ala (A) terminus as a result of cloning manipulations has 3-fold lower potency toward cultured cells and experimental animals. We hypothesized that the "N-end rule'', which relates the half-life of proteins in cells to the identity of their N-terminal residue, might be operative in the case of LF, so that the N-terminal residue of LF would determine the cytosolic stability and thereby the potency of LF. Mutational studies that replaced the native N-terminal residue of LF with known N-end rule stabilizing or destabilizing residues confirmed that the N-terminal residue plays a significant role in determining the potency of LT for cultured cells and experimental animals. The fact that a commercially-available LF preparation (LF-HMA) that is widely used in basic research studies and for evaluation of vaccines and therapeutics is 3-fold less potent than native LF (LF-A) should be considered when comparing published studies and in the design of future experiments.	[Gupta, Pradeep K.; Moayeri, Mahtab; Crown, Devorah; Fattah, Rasem J.; Leppla, Stephen H.] NIAID, Lab Bacterial Dis, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gupta, PK (corresponding author), NIAID, Lab Bacterial Dis, Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Moayeri, Mahtab/0000-0002-4448-8883	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001031, Z01AI001031] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Baillie L, 1998, J APPL MICROBIOL, V84, P741; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Falnes PO, 1998, EMBO J, V17, P615, DOI 10.1093/emboj/17.2.615; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Gupta P, 1998, INFECT IMMUN, V66, P862, DOI 10.1128/IAI.66.2.862-865.1998; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Kim J, 2003, PROTEIN EXPRES PURIF, V30, P293, DOI 10.1016/S1046-5928(03)00132-3; Lacy DB, 2002, J BIOL CHEM, V277, P3006, DOI 10.1074/jbc.M109997200; LEPPLA SH, 1988, METHOD ENZYMOL, V165, P103; LEPPLA SH, 1991, METHOD ENZYMOL, V195, P153; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2007, CELL MICROBIOL, V9, P977, DOI 10.1111/j.1462-5822.2006.00845.x; LONDON E, 1989, BIOCHEM BIOPH RES CO, V160, P333, DOI 10.1016/0006-291X(89)91660-4; Malatynska E, 1998, PHARMACOLOGY, V57, P117, DOI 10.1159/000028232; Meinnel T, 2006, BIOL CHEM, V387, P839, DOI 10.1515/BC.2006.107; Melnyk RA, 2006, J BIOL CHEM, V281, P1630, DOI 10.1074/jbc.M511164200; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Mourez M, 2005, REV PHYSIOL BIOCH P, V152, P135, DOI 10.1007/s10254-004-0028-2; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Pomerantsev AP, 2004, INFECT IMMUN, V72, P5814, DOI 10.1128/IAI.72.10.5814-5823.2004; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Schnupf P, 2007, INFECT IMMUN, V75, P5135, DOI 10.1128/IAI.00164-07; SINGH Y, 1989, J BIOL CHEM, V264, P19103; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Varshavsky A, 1997, GENES CELLS, V2, P13, DOI 10.1046/j.1365-2443.1997.1020301.x; Varughese M, 1998, MOL MED, V4, P87, DOI 10.1007/BF03401732; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Webster JI, 2003, P NATL ACAD SCI USA, V100, P5706, DOI 10.1073/pnas.1036973100; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; WRIGHT GG, 1962, J BACTERIOL, V83, P515, DOI 10.1002/path.1700830225; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101	41	45	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3130	10.1371/journal.pone.0003130	http://dx.doi.org/10.1371/journal.pone.0003130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769623	Green Published, gold, Green Submitted			2022-12-27	WOS:000264418300011
J	Comoy, EE; Casalone, C; Lescoutra-Etchegaray, N; Zanusso, G; Freire, S; Marce, D; Auvre, F; Ruchoux, MM; Ferrari, S; Monaco, S; Sales, N; Caramelli, M; Leboulch, P; Brown, P; Lasmezas, CI; Deslys, JP				Comoy, Emmanuel E.; Casalone, Cristina; Lescoutra-Etchegaray, Nathalie; Zanusso, Gianluigi; Freire, Sophie; Marce, Dominique; Auvre, Frederic; Ruchoux, Marie-Magdeleine; Ferrari, Sergio; Monaco, Salvatore; Sales, Nicole; Caramelli, Maria; Leboulch, Philippe; Brown, Paul; Lasmezas, Corinne I.; Deslys, Jean-Philippe			Atypical BSE (BASE) Transmitted from Asymptomatic Aging Cattle to a Primate	PLOS ONE			English	Article								Background: Human variant Creutzfeldt-Jakob Disease (vCJD) results from foodborne transmission of prions from slaughtered cattle with classical Bovine Spongiform Encephalopathy (cBSE). Atypical forms of BSE, which remain mostly asymptomatic in aging cattle, were recently identified at slaughterhouses throughout Europe and North America, raising a question about human susceptibility to these new prion strains. Methodology/Principal Findings: Brain homogenates from cattle with classical BSE and atypical (BASE) infections were inoculated intracerebrally into cynomolgus monkeys (Macacca fascicularis), a non-human primate model previously demonstrated to be susceptible to the original strain of cBSE. The resulting diseases were compared in terms of clinical signs, histology and biochemistry of the abnormal prion protein (PrPres). The single monkey infected with BASE had a shorter survival, and a different clinical evolution, histopathology, and prion protein (PrPres) pattern than was observed for either classical BSE or vCJD-inoculated animals. Also, the biochemical signature of PrPres in the BASE-inoculated animal was found to have a higher proteinase K sensitivity of the octa-repeat region. We found the same biochemical signature in three of four human patients with sporadic CJD and an MM type 2 PrP genotype who lived in the same country as the infected bovine. Conclusion/Significance: Our results point to a possibly higher degree of pathogenicity of BASE than classical BSE in primates and also raise a question about a possible link to one uncommon subset of cases of apparently sporadic CJD. Thus, despite the waning epidemic of classical BSE, the occurrence of atypical strains should temper the urge to relax measures currently in place to protect public health from accidental contamination by BSE-contaminated products.	[Comoy, Emmanuel E.; Lescoutra-Etchegaray, Nathalie; Freire, Sophie; Marce, Dominique; Auvre, Frederic; Ruchoux, Marie-Magdeleine; Leboulch, Philippe; Brown, Paul; Deslys, Jean-Philippe] CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France; [Casalone, Cristina; Caramelli, Maria] Ist Zooprofilattico Sperimentale Piemonte, Turin, Italy; [Zanusso, Gianluigi; Ferrari, Sergio; Monaco, Salvatore] Policlin GB Rossi, Verona, Italy; [Sales, Nicole; Lasmezas, Corinne I.] Scripps Florida, Jupiter, FL USA; [Leboulch, Philippe] Brigham & Womens Hosp, Harvard Med Sch, Genet Div, Boston, MA USA	CEA; UDICE-French Research Universities; Universite Paris Saclay; IZS Piemonte Liguria e Valle D'aosta; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Comoy, EE (corresponding author), CEA, Inst Emerging Dis & Innovat Therapies, Fontenay Aux Roses, France.	emmanuel.comoy@cea.fr	Ferrari, Sergio/AAE-5649-2019; Casalone, Cristina/J-6763-2018; Zanusso, Gianluigi/K-2823-2018; Monaco, Salvatore/K-4659-2018	Casalone, Cristina/0000-0001-5271-832X; Zanusso, Gianluigi/0000-0001-5199-6264; Monaco, Salvatore/0000-0003-3191-8597; ferrari, sergio/0000-0003-3855-5135	Network of Excellence NeuroPrion	Network of Excellence NeuroPrion	This work has been supported by the Network of Excellence NeuroPrion.	Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; DESLYS JP, 1999, Patent No. 9914242; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Krasnianski A, 2006, ARCH NEUROL-CHICAGO, V63, P876, DOI 10.1001/archneur.63.6.876; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; WILL RG, 1996, LANCET, V347, P925; Williams L, 2007, J GEN VIROL, V88, P688, DOI 10.1099/vir.0.81957-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Yutzy B, 2007, J GEN VIROL, V88, P3469, DOI 10.1099/vir.0.83128-0	26	104	106	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3017	10.1371/journal.pone.0003017	http://dx.doi.org/10.1371/journal.pone.0003017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714385	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900041
J	Thompson, EC; Travers, AA				Thompson, Elizabeth C.; Travers, Andrew A.			A Drosophila Smyd4 Homologue Is a Muscle-Specific Transcriptional Modulator Involved in Development	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; ACUTE-LEUKEMIA; CELL FATES; MELANOGASTER; EXPRESSION; REPRESSION; DOMAIN; MYND; DIVERSIFICATION; IDENTIFICATION	Background: SET and MYND domain (Smyd) proteins are involved in the transcriptional regulation of cellular proliferation and development in vertebrates. However, the in vivo functions and mechanisms by which these proteins act are poorly understood. Methodology/Principal Findings: We have used biochemical and genetic approaches to study the role of a Smyd protein in Drosophila. We identified eleven Drosophila genes that encode Smyd proteins. CG14122 encodes a Smyd4 homologue that we have named dSmyd4. dSmyd4 repressed transcription and recruited class I histone deacetylases (HDACs). A region of dSmyd4 including the MYND domain interacted directly with,150 amino acids at the N-termini of dHDAC1 and dHDAC3. dSmyd4 interacts selectively with Ebi, a component of the dHDAC3/SMRTER co-repressor complex. During embryogenesis dSmyd4 was expressed throughout the mesoderm, with highest levels in the somatic musculature. Muscle-specific RNAi against dSmyd4 resulted in depletion of the protein and lead to severe lethality. Eclosion is the final moulting stage of Drosophila development when adult flies escape from the pupal case. 80% of dSmyd4 knockdown flies were not able to eclose, resulting in late pupal lethality. However, many aspects of eclosion were still able to occur normally, indicating that dSmyd4 is likely to be involved in the development or function of adult muscle. Conclusions/Significance: Repression of transcription by dSmyd4 and the involvement of this protein in development suggests that aspects of Smyd protein function are conserved between vertebrates and invertebrates.	[Thompson, Elizabeth C.; Travers, Andrew A.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Thompson, EC (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ect26@mrc-lmb.cam.ac.uk		Thompson, Elizabeth/0000-0003-3506-0401	MRC [studentship]; MRC [MC_U105184288] Funding Source: UKRI; Medical Research Council [MC_U105184288] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	ECT was supported by an MRC studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Baker PW, 2005, GENETICS, V170, P1747, DOI 10.1534/genetics.105.041749; BATE M, 1991, DEVELOPMENT, V113, P79; BATE M, 1990, DEVELOPMENT, V110, P791; BODMER R, 1993, DEVELOPMENT, V118, P719; Borkowski OMD, 1995, DEVELOPMENT, V121, P4183; BOUR BA, 1995, GENE DEV, V9, P730, DOI 10.1101/gad.9.6.730; BRAND AH, 1993, DEVELOPMENT, V118, P401; BREEN TR, 1993, DEVELOPMENT, V117, P119; Brown MA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-26; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Dworak HA, 2002, BIOESSAYS, V24, P591, DOI 10.1002/bies.10115; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; JONES RS, 1990, GENETICS, V126, P185; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Lutterbach B, 1998, MOL CELL BIOL, V18, P3604, DOI 10.1128/MCB.18.6.3604; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; Qi D, 2008, EMBO J, V27, P898, DOI 10.1038/emboj.2008.26; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Riechmann V, 1997, DEVELOPMENT, V124, P2915; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	35	39	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e3008	10.1371/journal.pone.0003008	http://dx.doi.org/10.1371/journal.pone.0003008			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714374	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900033
J	Deus, HF; Stanislaus, R; Veiga, DF; Behrens, C; Wistuba, II; Minna, JD; Garner, HR; Swisher, SG; Roth, JA; Correa, AM; Broom, B; Coombes, K; Chang, A; Vogel, LH; Almeida, JS				Deus, Helena F.; Stanislaus, Romesh; Veiga, Diogo F.; Behrens, Carmen; Wistuba, Ignacio I.; Minna, John D.; Garner, Harold R.; Swisher, Stephen G.; Roth, Jack A.; Correa, Arlene M.; Broom, Bradley; Coombes, Kevin; Chang, Allen; Vogel, Lynn H.; Almeida, Jonas S.			A Semantic Web Management Model for Integrative Biomedical Informatics	PLOS ONE			English	Article							SOFTWARE; BIOINFORMATICS; TECHNOLOGIES; ONTOLOGIES; SCIENCE; HEALTH; RDF	Background: Data, data everywhere. The diversity and magnitude of the data generated in the Life Sciences defies automated articulation among complementary efforts. The additional need in this field for managing property and access permissions compounds the difficulty very significantly. This is particularly the case when the integration involves multiple domains and disciplines, even more so when it includes clinical and high throughput molecular data. Methodology/Principal Findings: The emergence of Semantic Web technologies brings the promise of meaningful interoperation between data and analysis resources. In this report we identify a core model for biomedical Knowledge Engineering applications and demonstrate how this new technology can be used to weave a management model where multiple intertwined data structures can be hosted and managed by multiple authorities in a distributed management infrastructure. Specifically, the demonstration is performed by linking data sources associated with the Lung Cancer SPORE awarded to The University of Texas MDAnderson Cancer Center at Houston and the Southwestern Medical Center at Dallas. A software prototype, available with open source at www.s3db.org, was developed and its proposed design has been made publicly available as an open source instrument for shared, distributed data management. Conclusions/Significance: The Semantic Web technologies have the potential to addresses the need for distributed and evolvable representations that are critical for systems Biology and translational biomedical research. As this technology is incorporated into application development we can expect that both general purpose productivity software and domain specific software installed on our personal computers will become increasingly integrated with the relevant remote resources. In this scenario, the acquisition of a new dataset should automatically trigger the delegation of its analysis.	[Deus, Helena F.; Stanislaus, Romesh; Veiga, Diogo F.; Broom, Bradley; Coombes, Kevin; Chang, Allen; Vogel, Lynn H.; Almeida, Jonas S.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Deus, Helena F.] Univ Nova Lisboa, Inst Tecnol Quim Biol, Lisbon, Portugal; [Behrens, Carmen; Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Minna, John D.; Garner, Harold R.] Univ Texas Southwestern Med Ctr, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; [Garner, Harold R.] Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; [Garner, Harold R.] Univ Texas Southwestern Med Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX USA; [Garner, Harold R.] Univ Texas Southwestern Med Ctr, Ctr Biomed Invent, Dallas, TX USA; [Garner, Harold R.] Univ Texas Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Swisher, Stephen G.; Roth, Jack A.; Correa, Arlene M.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX USA; [Vogel, Lynn H.] Columbia Univ, Dept Biomed Informat, New York, NY USA	University of Texas System; UTMD Anderson Cancer Center; Universidade Nova de Lisboa; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Columbia University	Deus, HF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA.	jalmeida@mdanderson.org	Veiga, Diogo Troggian/J-9279-2019; Almeida, Jonas/C-9093-2009	Veiga, Diogo Troggian/0000-0002-4018-5375; Almeida, Jonas/0000-0002-7883-7922; Deus, Helena/0000-0003-2995-568X; Coombes, Kevin/0000-0002-7630-2123	National Cancer Institute (NCI) of the US National Institutes of Health (NIH) [P50 CA70907]; National Heart, Lung and Blood Institute (NHLBI) [N01-HV-28181]; Center for Clinical and Translational Sciences [1UL1RR024148]; European Union Commission [LSHM-CT-2003-503413]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028181] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA070907] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Clinical and Translational Sciences; European Union Commission(European Commission); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by the National Heart, Lung and Blood Institute (NHLBI), by the National Cancer Institute (NCI) of the US National Institutes of Health (NIH), and by the Center for Clinical and Translational Sciences under contracts no. N01-HV-28181, P50 CA70907, and 1UL1RR024148, respectively. The authors also acknowledge support by the PREVIS project, contract number LSHM-CT-2003-503413 from the European Union Commission.	AHO JDU, 1979, P 6 ACM SIGACT SIGPL, P110; Almeida JS, 2006, NAT BIOTECHNOL, V24, P1070, DOI 10.1038/nbt0906-1070; Aranguren ME, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-57; Baker T, 2005, LECT NOTES COMPUT SC, V3815, P495; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Blake J, 2004, NAT BIOTECHNOL, V22, P773, DOI 10.1038/nbt0604-773; Blake JA, 2006, J BIOMED INFORM, V39, P314, DOI 10.1016/j.jbi.2006.01.003; BORLAND J, 2007, TECHNOLOGY REV   MAR; Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P2, DOI 10.1111/j.1471-1842.2007.00701.x; Brazhnik O, 2007, J BIOMED INFORM, V40, P252, DOI 10.1016/j.jbi.2006.09.001; Bridges Michael W, 2007, Health Manag Technol, V28, P10; BRIDGES MW, 2007, HLTH MANAG TECHNOL, V28, P10; BRIDGES MW, 2007, HLTH MANAG TECHNOL, V28, P8; Feigenbaum L, 2007, BRIEF BIOINFORM, V8, P195, DOI 10.1093/bib/bbm017; Foster I, 2005, SCIENCE, V308, P814, DOI 10.1126/science.1110411; Gomadam K, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON WEB SERVICES, PROCEEDINGS, P545; Good BM, 2006, BRIEF BIOINFORM, V7, P275, DOI 10.1093/bib/bbl025; Gordon PMK, 2007, BIOINFORMATICS, V23, P1178, DOI 10.1093/bioinformatics/btm060; GREEN H, 2007, BUSINESSWEEK, P28; Hendler J, 2003, SCIENCE, V299, P520, DOI 10.1126/science.1078874; HERMAN RSI, 2007, RESOURCE DESCRIPTION; Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410; ISAAC JPA, 2007, SKOS USE CASES REQUI; KLIMEK J, 2007, J PROTEOME RES; KOMATSOULIS GA, 2007, J BIOMED INFORM; Lam Hugo Y K, 2006, AMIA Annu Symp Proc, P464; Merelli E, 2007, BRIEF BIOINFORM, V8, P45, DOI 10.1093/bib/bbl014; Miller M, 2006, NAT BIOTECHNOL, V24, P22, DOI 10.1038/nbt0106-22; Musser J, 2006, WEB 2 0 PRINCIPLES B; Nadkarni PM, 2007, J AM MED INFORM ASSN, V14, P244, DOI 10.1197/jamia.M2349; Neumann E, 2007, BRIEF BIOINFORM, V8, P141, DOI 10.1093/bib/bbm013; Neumann Eric, 2005, Sci STKE, V2005, ppe22; Orchard Sandra, 2007, Proteomics, V7, P3436, DOI 10.1002/pmic.200700658; Orchard S, 2007, PROTEOMICS, V7, P1006, DOI 10.1002/pmic.200700014; Pedrioli PGA, 2004, NAT BIOTECHNOL, V22, P1459, DOI 10.1038/nbt1031; Post LJG, 2007, BIOINFORMATICS; Robu I, 2006, J MED LIBR ASSOC, V94, P198; Ruttenberg A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S2; Silva Sara, 2003, BMC Med Inform Decis Mak, V3, P9, DOI 10.1186/1472-6947-3-9; Soldatova LN, 2005, NAT BIOTECHNOL, V23, P1095, DOI 10.1038/nbt0905-1095; Stanislaus R, 2005, BIOINFORMATICS, V21, P1754, DOI 10.1093/bioinformatics/bti246; Stoeckert C, 2006, NAT BIOTECHNOL, V24, P21, DOI 10.1038/nbt0106-21a; Wang XS, 2005, NAT BIOTECHNOL, V23, P1099, DOI 10.1038/nbt1139; WASS J, 2006, BIOIT WORLD, V5, P22; Wiley HS, 2004, NAT BIOTECHNOL, V22, P1037, DOI 10.1038/nbt0804-1037; Zhang Songmao, 2006, Pac Symp Biocomput, P200, DOI 10.1142/9789812701626_0019	47	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2946	10.1371/journal.pone.0002946	http://dx.doi.org/10.1371/journal.pone.0002946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698353	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600032
J	Nielsen, BS; Egeblad, M; Rank, F; Askautrud, HA; Pennington, CJ; Pedersen, TX; Christensen, IJ; Edwards, DR; Werb, Z; Lund, LR				Nielsen, Boye S.; Egeblad, Mikala; Rank, Fritz; Askautrud, Hanne A.; Pennington, Caroline J.; Pedersen, Tanja X.; Christensen, Ib J.; Edwards, Dylan R.; Werb, Zena; Lund, Leif R.			Matrix Metalloproteinase 13 Is Induced in Fibroblasts in Polyomavirus Middle T Antigen-Driven Mammary Carcinoma without Influencing Tumor Progression	PLOS ONE			English	Article							HUMAN BREAST CARCINOMAS; STROMAL CELLS; COLLAGENASE-3 EXPRESSION; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR-MATRIX; GELATINASE-A; CANCER; GROWTH; MODEL; PROTEASES	Matrix metalloproteinase (MMP) 13 (collagenase 3) is an extracellular matrix remodeling enzyme that is induced in myofibroblasts during the earliest invasive stages of human breast carcinoma, suggesting that it is involved in tumor progression. During progression of mammary carcinomas in the polyoma virus middle T oncogene mouse model (MMTV-PyMT), Mmp13 mRNA was strongly upregulated concurrently with the transition to invasive and metastatic carcinomas. As in human tumors, Mmp13 mRNA was found in myofibroblasts of invasive grade II and III carcinomas, but not in benign grade I and II mammary intraepithelial neoplasias. To determine if MMP13 plays a role in tumor progression, we crossed MMTV-PyMT mice with Mmp13 deficient mice. The absence of MMP13 did not influence tumor growth, vascularization, progression to more advanced tumor stages, or metastasis to the lungs, and the absence of MMP13 was not compensated for by expression of other MMPs or tissue inhibitor of metalloproteinases. However, an increased fraction of thin collagen fibrils was identified in MMTV-PyMT; Mmp13(-/-) compared to MMTV-PyMT; Mmp13(+/+) tumors, showing that collagen metabolism was altered in the absence of MMP13. We conclude that the expression pattern of Mmp13 mRNA in myofibroblasts of invasive carcinomas in the MMTV-PyMT breast cancer model recapitulates the expression pattern observed in human breast cancer. Our results suggest that MMP13 is a marker of carcinoma-associated myofibroblasts of invasive carcinoma, even though it does not make a major contribution to tumor progression in the MMTV-PyMT breast cancer model.	[Nielsen, Boye S.; Pedersen, Tanja X.; Christensen, Ib J.; Lund, Leif R.] Rigshospitalet, Finsen Lab, Copenhagen, Denmark; [Egeblad, Mikala; Askautrud, Hanne A.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Rank, Fritz] Rigshospitalet, Dept Pathol, Copenhagen, Denmark; [Pennington, Caroline J.; Edwards, Dylan R.] Univ East Anglia, Sch Biol Sci, Norwich, Norfolk, England; [Askautrud, Hanne A.] Ullevaal Univ Hosp, Dept Med Genet, Oslo, Norway; [Askautrud, Hanne A.] Univ Oslo, Fac Med, Oslo, Norway	Rigshospitalet; University of California System; University of California San Francisco; Rigshospitalet; University of East Anglia; University of Oslo; University of Oslo	Nielsen, BS (corresponding author), Exiqon AS, Diagnost Prod Dev, Vedbaek, Denmark.	lund@inet.uni2.dk	Egeblad, Mikala/GNP-0620-2022; Edwards, Dylan R/B-4734-2009	Edwards, Dylan R/0000-0002-3292-2064; Askautrud, Hanne/0000-0002-4404-3622; Egeblad, Mikala/0000-0002-3371-1445; Pedersen, Tanja Xenia/0000-0003-2515-3022	Danish Cancer Society; Meyer Foundation; Danish Medical Research Council; European Commission [LSHC-CT-2003-503297, FP7]; National Cancer Institute [CA057621, CA072006]; Medical Research Council [G0100250] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA057621] Funding Source: NIH RePORTER	Danish Cancer Society(Danish Cancer Society); Meyer Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was financially supported by the Danish Cancer Society, the Meyer Foundation, the Danish Medical Research Council (ME), the European Commission: grant number LSHC-CT-2003-503297 (Cancerdegradome) and FP7 grant (Microenvimet), and by the National Cancer Institute (USA) grants CA057621 and CA072006 (ZW). None of these supporting institutions played any role during the study and manuscript preparation.	Almholt K, 2007, J MAMMARY GLAND BIOL, V12, P83, DOI 10.1007/s10911-007-9040-x; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Cunha GR, 2003, INT J CANCER, V107, P1, DOI 10.1002/ijc.11335; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FERGUSON JE, 1992, CELL TISSUE RES, V268, P167, DOI 10.1007/BF00338066; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; FREIJE JMP, 1994, J BIOL CHEM, V269, P16766; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Green KA, 2006, DEV BIOL, V299, P164, DOI 10.1016/j.ydbio.2006.07.021; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hart R, 2006, J MINIM INVAS GYN, V13, P126, DOI 10.1016/j.jmig.2005.11.015; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Koong AC, 2000, CANCER RES, V60, P883; Kosaki N, 2007, BIOCHEM BIOPH RES CO, V354, P846, DOI 10.1016/j.bbrc.2006.12.234; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LOCHTER A, 1995, SEMIN CANCER BIOL, V6, P165, DOI 10.1006/scbi.1995.0017; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lund LR, 1999, EMBO J, V18, P4645, DOI 10.1093/emboj/18.17.4645; Maglione JE, 2001, CANCER RES, V61, P8298; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; Nielsen BS, 2001, CANCER RES, V61, P7091; Nielsen BS, 2001, LAB INVEST, V81, P1485, DOI 10.1038/labinvest.3780363; Nielsen BS, 2001, AM J PATHOL, V158, P1997, DOI 10.1016/S0002-9440(10)64671-8; Nuttall RK, 2003, MOL CANCER RES, V1, P333; Offersen BV, 2003, AM J PATHOL, V163, P1887, DOI 10.1016/S0002-9440(10)63547-X; Olumi AF, 1999, CANCER RES, V59, P5002; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2007, CANCER BIOL THER, V6, P618, DOI 10.4161/cbt.6.4.4255; Papakonstantinou E, 2003, CYTOKINE, V24, P25, DOI 10.1016/S1043-4666(03)00253-9; Pedersen TX, 2005, CARCINOGENESIS, V26, P1233, DOI 10.1093/carcin/bgi065; Pedersen TX, 2003, ONCOGENE, V22, P3964, DOI 10.1038/sj.onc.1206614; Price JS, 2002, AGING CELL, V1, P57, DOI 10.1046/j.1474-9728.2002.00008.x; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; SZABOVA L, 2007, ONCOGENE; Uria JA, 1997, CANCER RES, V57, P4882; Vajner L, 2006, INT J EXP PATHOL, V87, P383, DOI 10.1111/j.1365-2613.2006.00493.x; Wells JEA, 2003, J NEUROSCI, V23, P10107, DOI 10.1523/jneurosci.23-31-10107.2003; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090	55	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2959	10.1371/journal.pone.0002959	http://dx.doi.org/10.1371/journal.pone.0002959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698413	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000264412600044
J	Kong, A; Calleja, V; Leboucher, P; Harris, A; Parker, PJ; Larijani, B				Kong, Anthony; Calleja, Veronique; Leboucher, Pierre; Harris, Adrian; Parker, Peter J.; Larijani, Banafshe			HER2 Oncogenic Function Escapes EGFR Tyrosine Kinase Inhibitors via Activation of Alternative HER Receptors in Breast Cancer Cells	PLOS ONE			English	Article								Background: The response rate to EGFR tyrosine kinase inhibitors (TKIs) may be poor and unpredictable in cancer patients with EGFR expression itself being an inadequate response indicator. There is limited understanding of the mechanisms underlying this resistance. Furthermore, although TKIs suppress the growth of HER2-overexpressing breast tumor cells, they do not fully inhibit HER2 oncogenic function at physiological doses. Methodology and Principal Findings: Here we have provided a molecular mechanism of how HER2 oncogenic function escapes TKIs' inhibition via alternative HER receptor activation as a result of autocrine ligand release. Using both Forster Resonance Energy Transfer (FRET) which monitors in situ HER receptor phosphorylation as well as classical biochemical analysis, we have shown that the specific tyrosine kinase inhibitors (TKIs) of EGFR, AG1478 and Iressa (Gefitinib) decreased EGFR and HER3 phosphorylation through the inhibition of EGFR/HER3 dimerization. Consequent to this, we demonstrate that cleavage of HER4 and dimerization of HER4/HER2 occur together with reactivation of HER3 via HER2/HER3, leading to persistent HER2 phosphorylation in the now resistant, surviving cells. These drug treatment-induced processes were found to be mediated by the release of ligands including heregulin and betacellulin that activate HER3 and HER4 via HER2. Whereas an anti-betacellulin antibody in combination with Iressa increased the anti-proliferative effect in resistant cells, ligands such as heregulin and betacellulin rendered sensitive SKBR3 cells resistant to Iressa. Conclusions and Significance: These results demonstrate the role of drug-induced autocrine events leading to the activation of alternative HER receptors in maintaining HER2 phosphorylation and in mediating resistance to EGFR tyrosine kinase inhibitors (TKIs) in breast cancer cells, and hence specify treatment opportunities to overcome resistance in patients.	[Kong, Anthony; Calleja, Veronique; Larijani, Banafshe] Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England; [Kong, Anthony; Parker, Peter J.] Canc Res UK, London Res Inst, Lincolns Inn Fields lab, Protein Phosphorylat Lab, London, England; [Harris, Adrian] Univ Oxford, John Radcliffe Hosp, Canc Res UK, Weatherall Inst Mol Med IMM, Oxford, England; [Leboucher, Pierre] Coll France, Lab Physiol Percept Action, Paris, France; [Parker, Peter J.] Guys Hosp, Kings Coll, Scho Med, Div Canc Studies, London, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; University of Oxford; UDICE-French Research Universities; PSL Research University Paris; College de France; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Kong, A (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England.	banafshe.larijani@cancer.org.uk	Larijani, Banafshe/H-3909-2015; Parker, Peter j/D-5192-2013; Harris, Adrian L/ABA-3343-2020	Larijani, Banafshe/0000-0003-4735-1169; Harris, Adrian L/0000-0003-1376-8409; parker, peter/0000-0002-6218-2933; Kong, Anthony/0000-0002-3989-3948	Cancer Research UK Pilot Project	Cancer Research UK Pilot Project	The work was partially funded by a Cancer Research UK Pilot Project grant awarded to AK.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Anderson NG, 2001, INT J CANCER, V94, P774, DOI 10.1002/ijc.1557; Anido J, 2003, CLIN CANCER RES, V9, P1274; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Arteaga CL, 2002, ONCOLOGIST, V7, P31; Baselga J, 2002, ANN ONCOL, V13, P8, DOI 10.1093/annonc/mdf092; Bazley LA, 2005, ENDOCR-RELAT CANCER, V12, pS17, DOI 10.1677/erc.1.01032; Britten CD, 2004, MOL CANCER THER, V3, P1335; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Cheng QC, 2003, J BIOL CHEM, V278, P38421, DOI 10.1074/jbc.M302111200; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; Kong A, 2006, CANCER RES, V66, P2834, DOI 10.1158/0008-5472.CAN-05-2994; Larijani B, 2003, CURR BIOL, V13, P78, DOI 10.1016/S0960-9822(02)01395-7; Loeffler-Ragy J, 2006, EUR J CANCER, V42, P109, DOI 10.1016/j.ejca.2005.08.034; Menendez JA, 2006, J CLIN ONCOL, V24, P3735, DOI 10.1200/JCO.2005.04.3489; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Moasser MM, 2001, CANCER RES, V61, P7184; Moulder SL, 2001, CANCER RES, V61, P8887; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICHOLSON S, 1989, LANCET, V1, P182; Normanno N, 2002, ANN ONCOL, V13, P65, DOI 10.1093/annonc/mdf020; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Polychronis A, 2005, LANCET ONCOL, V6, P383, DOI 10.1016/S1470-2045(05)70176-5; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Strunk KE, 2007, CANCER RES, V67, P6582, DOI 10.1158/0008-5472.CAN-06-4145; Tan M, 1999, CANCER RES, V59, P1620; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Vecchi M, 1997, J CELL BIOL, V139, P995, DOI 10.1083/jcb.139.4.995; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Xu FJ, 1997, CLIN CANCER RES, V3, P1629; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zhou WL, 2000, J BIOL CHEM, V275, P34737, DOI 10.1074/jbc.M003756200	46	58	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2881	10.1371/journal.pone.0002881	http://dx.doi.org/10.1371/journal.pone.0002881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682844	Green Submitted, gold, Green Published			2022-12-27	WOS:000264366600037
J	Hosu, BG; Mullen, SF; Critser, JK; Forgacs, G				Hosu, Basarab G.; Mullen, Steven F.; Critser, John K.; Forgacs, Gabor			Reversible Disassembly of the Actin Cytoskeleton Improves the Survival Rate and Developmental Competence of Cryopreserved Mouse Oocytes	PLOS ONE			English	Article							DISRUPT MICROFILAMENT ORGANIZATION; MAGNETIC TWEEZERS; PLASMA-MEMBRANE; LIVING CELLS; FERTILIZATION; VITRIFICATION; EMBRYOS; LATRUNCULINS; MICROTUBULES; MATURATION	Effective cryopreservation of oocytes is critically needed in many areas of human reproductive medicine and basic science, such as stem cell research. Currently, oocyte cryopreservation has a low success rate. The goal of this study was to understand the mechanisms associated with oocyte cryopreservation through biophysical means using a mouse model. Specifically, we experimentally investigated the biomechanical properties of the ooplasm prior and after cryopreservation as well as the consequences of reversible dismantling of the F-actin network in mouse oocytes prior to freezing. The study was complemented with the evaluation of post-thaw developmental competence of oocytes after in vitro fertilization. Our results show that the freezing-thawing process markedly alters the physiological viscoelastic properties of the actin cytoskeleton. The reversible depolymerization of the F-actin network prior to freezing preserves normal ooplasm viscoelastic properties, results in high post-thaw survival and significantly improves developmental competence. These findings provide new information on the biophysical characteristics of mammalian oocytes, identify a pathophysiological mechanism underlying cryodamage and suggest a novel cryopreservation method.	[Hosu, Basarab G.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA; [Mullen, Steven F.] 21st Century Med, Fontana, CA USA; [Forgacs, Gabor] Univ Missouri, Dept Biol Sci, Columbia, MO USA; [Critser, John K.; Forgacs, Gabor] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA; [Forgacs, Gabor] Univ Missouri, Dept Phys, Columbia, MO USA	Harvard University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Mullen, SF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA USA.	sfm5ff@mizzou.edu			NSF [IBN0083653]; NASA [NAG2-1211]; NIH [RR014821]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR014821] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was partially supported by grants NSF-IBN0083653, NASA-NAG2-1211 (to G.F.) and NIH-RR014821 (to J.K.C.). The granting agencies had no influence on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini D, 2004, ESSENTIAL IVF: BASIC RESEARCH AND CLINICAL APPLICATIONS, P43; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Bernard A, 1996, HUM REPROD UPDATE, V2, P193, DOI 10.1093/humupd/2.3.193; BIGGERS J, 1972, OOGENESIS; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Cobo A, 2001, FERTIL STERIL, V75, P354, DOI 10.1016/S0015-0282(00)01725-8; CRICK FHC, 1950, EXP CELL RES, V1, P37, DOI 10.1016/0014-4827(50)90048-6; de Vries AHB, 2005, BIOPHYS J, V88, P2137, DOI 10.1529/biophysj.104.052035; Dobrinsky JR, 2000, BIOL REPROD, V62, P564, DOI 10.1095/biolreprod62.3.564; Ebner T, 2003, HUM REPROD, V18, P1294, DOI 10.1093/humrep/deg232; Eroglu A, 1998, FERTIL STERIL, V69, P944, DOI 10.1016/S0015-0282(98)00030-2; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Feneberg W, 2001, EUR BIOPHYS J BIOPHY, V30, P284, DOI 10.1007/s002490100135; FUKU E, 1995, MOL REPROD DEV, V40, P177, DOI 10.1002/mrd.1080400206; Fung Y. C., 1993; GALLICANO GI, 1994, MECH DEVELOP, V45, P211; GORBSKY GJ, 1990, P NATL ACAD SCI USA, V87, P6049, DOI 10.1073/pnas.87.16.6049; GRUDZINSKAS JG, 1995, GAMETES OOCYTE, pR13; Guilak F, 2002, BIOPHYS J, V82, P720, DOI 10.1016/S0006-3495(02)75434-9; HIRAMOTO Y, 1969, EXP CELL RES, V56, P201, DOI 10.1016/0014-4827(69)90003-2; Hosu BG, 2003, REV SCI INSTRUM, V74, P4158, DOI 10.1063/1.1599066; Hotamisligil S, 1996, BIOL REPROD, V55, P161, DOI 10.1095/biolreprod55.1.161; Janmey PA, 1998, PHYSIOL REV, V78, P763, DOI 10.1152/physrev.1998.78.3.763; Karlsson JOM, 1996, HUM REPROD, V11, P1296; KAROW AM, 1997, REPROD TISSUE BANKIN, pR18; Larman MG, 2006, REPRODUCTION, V131, P53, DOI 10.1530/rep.1.00878; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lenormand G, 2004, J R SOC INTERFACE, V1, P91, DOI 10.1098/rsif.2004.0010; Mandelbaum J, 1998, HUM REPROD, V13, P161, DOI 10.1093/humrep/13.suppl_3.161; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; Miyake K, 2001, J CELL SCI, V114, P3487; Moller W, 2000, BIOPHYS J, V79, P720, DOI 10.1016/S0006-3495(00)76330-2; Nagy ZP, 2003, FERTIL STERIL, V80, P67, DOI 10.1016/S0015-0282(03)00569-7; Park SE, 2001, FERTIL STERIL, V75, P1177, DOI 10.1016/S0015-0282(01)01809-X; PICKERING SJ, 1991, HUM REPROD, V6, P142, DOI 10.1093/oxfordjournals.humrep.a137248; PICKERING SJ, 1990, FERTIL STERIL, V54, P102; POLLARD TD, 1984, J CELL BIOL, V99, pS33, DOI 10.1083/jcb.99.1.33s; Prather RS, 2003, THERIOGENOLOGY, V59, P115, DOI 10.1016/S0093-691X(02)01263-3; Saunders KM, 1999, BIOL REPROD, V61, P178, DOI 10.1095/biolreprod61.1.178; SCHATTEN G, 1986, EXP CELL RES, V166, P191, DOI 10.1016/0014-4827(86)90519-7; SCHROEDER AC, 1990, J REPROD FERTIL, V89, P43, DOI 10.1530/jrf.0.0890043; Shaw T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098102; SIMERLY C, 1995, GAMETES OOCYTE, P54; SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Summers MC, 2000, HUM REPROD, V15, P1791, DOI 10.1093/humrep/15.8.1791; Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991; Togo T, 1999, J CELL SCI, V112, P719; VALBERG PA, 1985, J CELL BIOL, V101, P130, DOI 10.1083/jcb.101.1.130; VANBLERKOM J, 1989, HUM REPROD, V4, P883, DOI 10.1093/oxfordjournals.humrep.a137006; VINCENT C, 1989, J REPROD FERTIL, V87, P809, DOI 10.1530/jrf.0.0870809; VINCENT C, 1990, MOL REPROD DEV, V26, P227, DOI 10.1002/mrd.1080260306; VINCENT C, 1991, MOL REPROD DEV, V28, P394, DOI 10.1002/mrd.1080280412; Vincent C, 1992, Oxf Rev Reprod Biol, V14, P73; Wilmut I, 1998, REPROD FERT DEVELOP, V10, P639, DOI 10.1071/RD98047; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002	59	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2787	10.1371/journal.pone.0002787	http://dx.doi.org/10.1371/journal.pone.0002787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665248	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300006
J	Kohler, B; Anguissola, S; Concannon, CG; Rehm, M; Kogel, D; Prehn, JHM				Koehler, Barbara; Anguissola, Sergio; Concannon, Caoimhin G.; Rehm, Markus; Koegel, Donat; Prehn, Jochen H. M.			Bid Participates in Genotoxic Drug-Induced Apoptosis of HeLa Cells and Is Essential for Death Receptor Ligands' Apoptotic and Synergistic Effects	PLOS ONE			English	Article								Background: The BH3-only protein Bid is an important component of death receptor-mediated caspase activation. Bid is cleaved by caspase-8 or -10 into t-Bid, which translocates to mitochondria and triggers the release of caspase-activating factors. Bid has also been reported to be cleaved by other proteases. Methodology/Principal Findings: To test the hypothesis that Bid is a central mediator of stress-induced apoptosis, we investigated the effects of a small molecule Bid inhibitor on stress-induced apoptosis, and generated HeLa cells deficient for Bid. Stable knockdown of bid lead to a pronounced resistance to Fas/CD95- and TRAIL-induced caspase activation and apoptosis, and significantly increased clonogenic survival. While Bid-deficient cells were equally sensitive to ER stress-induced apoptosis, they showed moderate, but significantly reduced levels of apoptosis, as well as increased clonogenic survival in response to the genotoxic drugs Etoposide, Oxaliplatin, and Doxorubicin. Similar effects were observed using the Bid inhibitor BI6C9. Interestingly, Bid-deficient cells were dramatically protected from apoptosis when subtoxic concentrations of ER stressors, Etoposide or Oxaliplatin were combined with subtoxic TRAIL concentrations. Conclusions/Significance: Our data demonstrate that Bid is central for death receptor-induced cell death and participates in anti-cancer drug-induced apoptosis in human cervical cancer HeLa cells. They also show that the synergistic effects of TRAIL in combination with either ER stressors or genotoxic anti-cancer drugs are nearly exclusively mediated via an increased activation of Bid-induced apoptosis signalling.	[Koehler, Barbara; Anguissola, Sergio; Concannon, Caoimhin G.; Rehm, Markus; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Anguissola, Sergio; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, RCSI Ctr Human Proteom, Dublin, Ireland; [Koehler, Barbara; Koegel, Donat] Johann Wolfgang Goethe Univ Clin, Ctr Neurol & Neurosurg, Frankfurt, Germany	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kohler, B (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	prehn@rcsi.ie	Prehn, Jochen HM/A-3928-2010; Concannon, Caoimhin/B-2075-2010; Rehm, Markus/C-3398-2012	Prehn, Jochen HM/0000-0003-3479-7794; Rehm, Markus/0000-0001-6149-9261; Kogel, Donat/0000-0003-1209-0210	Science Foundation Ireland [03/RP1/B344]; Higher Education Authority; Health Research Board [RP/2005/206]; Deutsche Forschungsgemeinschaft [PR 338/9-3, PR 338/9-4]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Higher Education Authority; Health Research Board; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by grants from Science Foundation Ireland (03/RP1/B344), the Higher Education Authority (PRTLI Cycle 3, Program of Human Genomics) and Health Research Board (RP/2005/206) to J.H.M.P., and by a grant from the Deutsche Forschungsgemeinschaft (PR 338/9-3 and 9-4) to D.K. and J.H.M.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti JB, 2001, J BIOL CHEM, V276, P6974, DOI 10.1074/jbc.M008444200; Becattini B, 2006, P NATL ACAD SCI USA, V103, P12602, DOI 10.1073/pnas.0603460103; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Clohessy JG, 2006, J BIOL CHEM, V281, P5750, DOI 10.1074/jbc.M505688200; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Coultas L, 2004, MOL CELL BIOL, V24, P1570, DOI 10.1128/MCB.24.4.1570-1581.2004; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Ganten TM, 2005, HEPATOLOGY, V42, P588, DOI 10.1002/hep.20807; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Gao ZH, 2005, J BIOL CHEM, V280, P38271, DOI 10.1074/jbc.M506488200; Gibson SB, 2000, MOL CELL BIOL, V20, P205, DOI 10.1128/MCB.20.1.205-212.2000; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Gross A, 2006, CELL CYCLE, V5, P582, DOI 10.4161/cc.5.6.2575; Hacki J, 2000, ONCOGENE, V19, P2286, DOI 10.1038/sj.onc.1203592; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Hetschko H, 2008, J NEURO-ONCOL, V86, P265, DOI 10.1007/s11060-007-9472-6; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Jimbo A, 2003, EXP CELL RES, V283, P156, DOI 10.1016/S0014-4827(02)00033-2; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kawahara A, 1998, J CELL BIOL, V143, P1353, DOI 10.1083/jcb.143.5.1353; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Konig HG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-7; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li WH, 2007, CANCER RES, V67, P2247, DOI 10.1158/0008-5472.CAN-06-3793; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Mandic A, 2002, MOL CELL BIOL, V22, P3003, DOI 10.1128/MCB.22.9.3003-3013.2002; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Miao J, 2004, INT J ONCOL, V25, P651; Milhas D, 2005, J BIOL CHEM, V280, P19836, DOI 10.1074/jbc.M414358200; Mitsiades CS, 2001, BLOOD, V98, P795, DOI 10.1182/blood.V98.3.795; Nagane M, 2000, CANCER RES, V60, P847; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nawrocki ST, 2007, CANCER RES, V67, P6987, DOI 10.1158/0008-5472.CAN-07-0812; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Oberkovitz G, 2007, CELL DEATH DIFFER, V14, P1628, DOI 10.1038/sj.cdd.4402181; Onuki R, 2002, P NATL ACAD SCI USA, V99, P14716, DOI 10.1073/pnas.232177599; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Reimertz C, 2003, J CELL BIOL, V162, P587, DOI 10.1083/jcb.200305149; Sarig R, 2003, J BIOL CHEM, V278, P10707, DOI 10.1074/jbc.M210296200; Sax JK, 2002, NAT CELL BIOL, V4, P842, DOI 10.1038/ncb866; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Sheikh MS, 1998, CANCER RES, V58, P1593; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; Singh R, 2002, J BIOL CHEM, V277, P37630, DOI 10.1074/jbc.M203648200; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Tafani M, 2002, J BIOL CHEM, V277, P10073, DOI 10.1074/jbc.M111350200; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Wagner KW, 2004, J BIOL CHEM, V279, P35047, DOI 10.1074/jbc.M400708200; Wang XY, 2006, BIOCHEM PHARMACOL, V71, P1540, DOI 10.1016/j.bcp.2006.02.011; Ward MW, 2006, J BIOL CHEM, V281, P5837, DOI 10.1074/jbc.M511562200; Waterhouse NJ, 2005, J BIOL CHEM, V280, P4476, DOI 10.1074/jbc.M410985200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Werner AB, 2004, J BIOL CHEM, V279, P28771, DOI 10.1074/jbc.M400268200; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wlodkowic D, 2007, LEUKEMIA RES, V31, P1687, DOI 10.1016/j.leukres.2007.03.008; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu XX, 2007, CANCER SCI, V98, P1969, DOI 10.1111/j.1349-7006.2007.00632.x; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamaguchi H, 2003, CANCER RES, V63, P1483; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zinkel SS, 2007, CELL, V130, P9, DOI 10.1016/j.cell.2007.06.035; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	81	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2844	10.1371/journal.pone.0002844	http://dx.doi.org/10.1371/journal.pone.0002844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665234	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300063
J	Mereghetti, L; Sitkiewicz, I; Green, NM; Musser, JM				Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.			Remodeling of the Streptococcus agalactiae Transcriptome in Response to Growth Temperature	PLOS ONE			English	Article								Background: To act as a commensal bacterium and a pathogen in humans and animals, Streptococcus agalactiae (group B streptococcus, GBS) must be able to monitor and adapt to different environmental conditions. Temperature variation is a one of the most commonly encountered variables. Methodology/Principal Findings: To understand the extent to which GBS modify gene expression in response to temperatures encountered in the various hosts, we conducted a whole genome transcriptome analysis of organisms grown at 30 degrees C and 40 degrees C. We identified extensive transcriptome remodeling at various stages of growth, especially in the stationary phase (significant transcript changes occurred for 25% of the genes). A large proportion of genes involved in metabolism was up-regulated at 30 degrees C in stationary phase. Conversely, genes up-regulated at 40 degrees C relative to 30 degrees C include those encoding virulence factors such as hemolysins and extracellular secreted proteins with LPXTG motifs. Over-expression of hemolysins was linked to larger zones of hemolysis and enhanced hemolytic activity at 40 degrees C. A key theme identified by our study was that genes involved in purine metabolism and iron acquisition were significantly up-regulated at 40 degrees C. Conclusion/Significance: Growth of GBS in vitro at different temperatures resulted in extensive remodeling of the transcriptome, including genes encoding proven and putative virulence genes. The data provide extensive new leads for molecular pathogenesis research.	[Mereghetti, Laurent; Sitkiewicz, Izabela; Green, Nicole M.; Musser, James M.] Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA; [Mereghetti, Laurent] Ctr Hosp Univ Tours, Fac Med, EA3854, Tours, France	The Methodist Hospital System; The Methodist Hospital - Houston; CHU Tours	Musser, JM (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	jmmusser@tmhs.org	Sitkiewicz, Izabela/G-5058-2011	Sitkiewicz, Izabela/0000-0001-8228-9917				Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Alcantara RB, 2004, INFECT IMMUN, V72, P4911, DOI 10.1128/IAI.72.8.4911-4917.2004; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Berry RJ, 2003, CAN J ANIM SCI, V83, P687, DOI 10.4141/A03-012; Bishop EJ, 2007, EPIDEMIOL INFECT, V135, P1248, DOI 10.1017/S0950268807008515; Clancy A, 2006, MOL MICROBIOL, V59, P707, DOI 10.1111/j.1365-2958.2005.04974.x; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Ferenci T, 2007, ANN NY ACAD SCI, V1113, P105, DOI 10.1196/annals.1391.003; Forquin MP, 2007, INFECT IMMUN, V75, P2063, DOI 10.1128/IAI.01565-06; Gajdos V, 2008, EUR J OBSTET GYN R B, V136, P265, DOI 10.1016/j.ejogrb.2006.10.026; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Gottschalk B, 2006, J BACTERIOL, V188, P5984, DOI 10.1128/JB.00768-05; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; Harris TO, 2003, J CLIN INVEST, V111, P61, DOI 10.1172/JCI200316270; Herbert MA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-31; Herbert MA, 2004, CURR OPIN INFECT DIS, V17, P225, DOI 10.1097/00001432-200406000-00009; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003; MARCHLEWICZ BA, 1981, INFECT IMMUN, V34, P787, DOI 10.1128/IAI.34.3.787-794.1981; Motin VL, 2004, J BACTERIOL, V186, P6298, DOI 10.1128/JB.186.18.6298-6305.2004; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nizet V, 1996, INFECT IMMUN, V64, P3818, DOI 10.1128/IAI.64.9.3818-3826.1996; Oliveira ICM, 2006, CLIN MICROBIOL INFEC, V12, P887, DOI 10.1111/j.1469-0691.2006.01508.x; Pritzlaff CA, 2001, MOL MICROBIOL, V39, P236, DOI 10.1046/j.1365-2958.2001.02211.x; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Samen U, 2007, INFECT IMMUN, V75, P5405, DOI 10.1128/IAI.00717-07; Santi I, 2007, MOL MICROBIOL, V63, P754, DOI 10.1111/j.1365-2958.2006.05555.x; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P939, DOI 10.1097/01.inf.0000239267.42561.06; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Smoot LM, 2001, P NATL ACAD SCI USA, V98, P10416, DOI 10.1073/pnas.191267598; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; Spellerberg B, 1999, J BACTERIOL, V181, P3212, DOI 10.1128/JB.181.10.3212-3219.1999; Stintzi A, 2003, J BACTERIOL, V185, P2009, DOI 10.1128/JB.185.6.2009-2016.2003; Sumby P, 2005, P NATL ACAD SCI USA, V102, P1679, DOI 10.1073/pnas.0406641102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thieringer HA, 1998, BIOESSAYS, V20, P49; Vanberg C, 2007, APPL ENVIRON MICROB, V73, P5501, DOI 10.1128/AEM.00545-07; White-Ziegler CA, 2007, J BACTERIOL, V189, P5429, DOI 10.1128/JB.01929-06; Yildirim AO, 2002, FEMS MICROBIOL LETT, V212, P187, DOI 10.1111/j.1574-6968.2002.tb11265.x	43	39	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2785	10.1371/journal.pone.0002785	http://dx.doi.org/10.1371/journal.pone.0002785			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665215	gold, Green Published, Green Submitted			2022-12-27	WOS:000264304300004
J	Strathdee, SA; Lozada, R; Ojeda, VD; Pollini, RA; Brouwer, KC; Vera, A; Cornelius, W; Nguyen, L; Magis-Rodriguez, C; Patterson, TL; El Cuete, P				Strathdee, Steffanie A.; Lozada, Remedios; Ojeda, Victoria D.; Pollini, Robin A.; Brouwer, Kimberly C.; Vera, Alicia; Cornelius, Wayne; Nguyen, Lucie; Magis-Rodriguez, Carlos; Patterson, Thomas L.; El Cuete, Proyecto			Differential Effects of Migration and Deportation on HIV Infection among Male and Female Injection Drug Users in Tijuana, Mexico	PLOS ONE			English	Article							RISK BEHAVIORS; SEX WORKERS; GENDER-DIFFERENCES; SAN-FRANCISCO; UNITED-STATES; TRANSMISSION; PREVALENCE; PREVENTION; MIGRANTS; DISEASES	HIV prevalence is rising, especially among high risk females in Tijuana, Baja California, a Mexico-US border city situated on major migration and drug trafficking routes. We compared factors associated with HIV infection among male and female injection drug users (IDUs) in Tijuana in an effort to inform HIV prevention and treatment programs. IDUs aged >= 18 years were recruited using respondent-driven sampling and underwent testing for HIV, syphilis and structured interviews. Logistic regression identified correlates of HIV infection, stratified by gender. Among 1056 IDUs, most were Mexican-born but 67% were born outside Tijuana. Reasons for moving to Tijuana included deportation from the US (56% for males, 29% for females), and looking for work/better life (34% for females, 15% for males). HIV prevalence was higher in females versus males (10.2% vs. 3.5%, p = 0.001). Among females (N = 158), factors independently associated with higher HIV prevalence included younger age, lifetime syphilis infection and living in Tijuana for longer durations. Among males (N = 898), factors independently associated with higher HIV prevalence were syphilis titers consistent with active infection, being arrested for having 'track-marks', having larger numbers of recent injection partners and living in Tijuana for shorter durations. An interaction between gender and number of years lived in Tijuana regressed on HIV infection was significant (p = 0.03). Upon further analysis, deportation from the U. S. explained the association between shorter duration lived in Tijuana and HIV infection among males; odds of HIV infection were four-fold higher among male injectors deported from the US, compared to other males, adjusting for all other significant correlates (p = 0.002). Geographic mobility has a profound influence on Tijuana's evolving HIV epidemic, and its impact is significantly modified by gender. Future studies are needed to elucidate the context of mobility and HIV acquisition in this region, and whether US immigration policies adversely affect HIV risk.	[Strathdee, Steffanie A.; Ojeda, Victoria D.; Pollini, Robin A.; Brouwer, Kimberly C.; Vera, Alicia; Nguyen, Lucie; Patterson, Thomas L.; El Cuete, Proyecto] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Lozada, Remedios] Patronado Pro COMUSIDA AC, Tijuana, Mexico; [Cornelius, Wayne] Univ Calif San Diego, Dept Political Sci, La Jolla, CA USA; [Magis-Rodriguez, Carlos] Ctr Nacl Prevencion Control VIH SIDA, Mexico City, DF, Mexico; [Patterson, Thomas L.] Dept Vet Affairs Med Ctr, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Strathdee, SA (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Strathdee, Steffanie A/B-9042-2009	Strathdee, Steffanie/0000-0002-7724-691X; HARVEY-VERA, ALICIA/0000-0002-8708-8169	National Institute on Drug Abuse (NIDA) [R01DA019829, R21DA24381];  [K01DA022923];  [K01DA020354];  [DA09829-S2]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019829, K01DA022923, R37DA019829, K01DA020364, R21DA024381] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); ; ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the National Institute on Drug Abuse (NIDA) (R01DA019829 and R21DA24381). Dr. Pollini is supported by K01DA022923; Dr. Brouwer is supported by K01DA020354 and Dr. Ojeda is supported by DA09829-S2.	Aral SO, 2007, SEX TRANSM INFECT, V83, pI1, DOI 10.1136/sti.2007.027169; Bluthenthal R. N., 1999, International Journal of Drug Policy, V10, P25, DOI 10.1016/S0955-3959(98)00076-0; Borges G, 2007, AM J PUBLIC HEALTH, V97, P1847, DOI 10.2105/AJPH.2006.097915; BROUWER K, J IMMIGRANT IN PRESS; Brouwer KC, 2006, SUBST USE MISUSE, V41, P707, DOI 10.1080/10826080500411478; Brouwer KC, 2006, J URBAN HEALTH, V83, P299, DOI 10.1007/s11524-005-9027-0; Bucardo J, 2005, DRUG ALCOHOL DEPEN, V79, P281, DOI 10.1016/j.drugalcdep.2005.02.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CORNELIUS W, OAXACALIFOR IN PRESS; CORNELIUS W, 2008, 4 GENERATION NORTENO; Cruz MF, 2007, AIDS BEHAV, V11, P253, DOI 10.1007/s10461-006-9148-9; del Rio C, 2002, AIDS, V16, P1445, DOI 10.1097/00002030-200207260-00001; Deren S, 2003, AIDS BEHAV, V7, P405, DOI 10.1023/B:AIBE.0000004732.74061.3f; Deren S, 2003, AM J PUBLIC HEALTH, V93, P812, DOI 10.2105/AJPH.93.5.812; Ehrlich S., 2006, HIV RISK ASSESSMENT; Evans JL, 2003, J URBAN HEALTH, V80, P137, DOI 10.1093/jurban/jtg137; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Franzini Luisa, 2001, Ethnicity and Disease, V11, P496; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1226, DOI 10.1001/archpsyc.61.12.1226; GRUND JPC, 1992, BRIT J ADDICT, V87, P381; Harvey E, 1998, AIDS CARE, V10, P313, DOI 10.1080/713612412; HAWKES SJ, 1993, AIDS CARE, V5, P207, DOI 10.1080/09540129308258601; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hirsch JS, 2007, AM J PUBLIC HEALTH, V97, P986, DOI 10.2105/AJPH.2006.088492; INEGI, 2005, 12 CENS GEN POBL VIV; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lagarde E, 2003, INT J EPIDEMIOL, V32, P744, DOI 10.1093/ije/dyg111; Latkin CA, 2003, INT J STD AIDS, V14, P770, DOI 10.1258/09564620360719831; Magis-Rodriguez C, 2005, J PSYCHOACTIVE DRUGS, V37, P333, DOI 10.1080/02791072.2005.10400528; Magis-Rodriguez C, 2004, JAIDS-J ACQ IMM DEF, V37, pS215, DOI 10.1097/01.qai.0000141252.16099.af; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480; Montgomery SB, 2002, AM J DRUG ALCOHOL AB, V28, P453, DOI 10.1081/ADA-120006736; NUNEZNETO B, 2007, BORDER SECURITY SAN; OJEDA V, AM J PUBL H IN PRESS; Organista KC, 2004, JAIDS-J ACQ IMM DEF, V37, pS227, DOI 10.1097/01.qai.0000141250.08475.91; Parrado EA, 2004, PERSPECT SEX REPRO H, V36, P150, DOI 10.1111/j.1931-2393.2004.tb00016.x; Paschane DM, 2000, SOC SCI MED, V50, P1091, DOI 10.1016/S0277-9536(99)00357-3; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; PHILBIN M, AIDS BEHAV IN PRESS; Pollini RA, 2008, ADDICTION, V103, P101, DOI 10.1111/j.1360-0443.2007.02051.x; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; San Diego Association of Governments (SANDAG), 2007, ALL CROSS CAL PORTS; *SEC USDOH, 2006, YB IMM STAT 2005; *SECR SAL, 2007, CONS NAC PREV CONTR; Soskolne V, 2002, SOC SCI MED, V55, P1297, DOI 10.1016/S0277-9536(01)00282-9; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; STRATHDEE SA, JAMA IN PRESS; STRATHDEE SA, 2005, J URBAN HLTH S4, V82, P58; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, DRUG ALCOHOL DEPEN, V92, P132, DOI 10.1016/j.drugalcdep.2007.07.001; Viani RM, 2006, JAIDS-J ACQ IMM DEF, V41, P87, DOI 10.1097/01.qai.0000174657.71276.9f	54	89	90	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2690	10.1371/journal.pone.0002690	http://dx.doi.org/10.1371/journal.pone.0002690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	420QM	18665250	gold, Green Submitted, Green Published			2022-12-27	WOS:000264304300001
J	Benedetti-Cecchi, L; Bertocci, I; Vaselli, S; Maggi, E; Bulleri, F				Benedetti-Cecchi, Lisandro; Bertocci, Iacopo; Vaselli, Stefano; Maggi, Elena; Bulleri, Fabio			Neutrality and the Response of Rare Species to Environmental Variance	PLOS ONE			English	Article							COMMUNITY STRUCTURE; ABUNDANCE DISTRIBUTIONS; SAMPLING FORMULA; DIVERSITY; NICHE; VARIABILITY; MODEL; INVERTEBRATES; DISTURBANCE; COMPETITION	Neutral models and differential responses of species to environmental heterogeneity offer complementary explanations of species abundance distribution and dynamics. Under what circumstances one model prevails over the other is still a matter of debate. We show that the decay of similarity over time in rocky seashore assemblages of algae and invertebrates sampled over a period of 16 years was consistent with the predictions of a stochastic model of ecological drift at time scales larger than 2 years, but not at time scales between 3 and 24 months when similarity was quantified with an index that reflected changes in abundance of rare species. A field experiment was performed to examine whether assemblages responded neutrally or non-neutrally to changes in temporal variance of disturbance. The experimental results did not reject neutrality, but identified a positive effect of intermediate levels of environmental heterogeneity on the abundance of rare species. This effect translated into a marked decrease in the characteristic time scale of species turnover, highlighting the role of rare species in driving assemblage dynamics in fluctuating environments.	[Benedetti-Cecchi, Lisandro; Bertocci, Iacopo; Maggi, Elena; Bulleri, Fabio] Univ Pisa, Dipartimento Biol, Pisa, Italy; [Vaselli, Stefano] Univ Port, Ctr Interdisciplinar Investigacao Marinha Ambie, Lab Coastal Biodivers, Portalegre, Portugal	University of Pisa; Universidade do Porto	Benedetti-Cecchi, L (corresponding author), Univ Pisa, Dipartimento Biol, Pisa, Italy.	lbenedetti@biologia.unipi.it	Benedetti-Cecchi, Lisandro/J-8225-2019; Bertocci, Iacopo/I-5121-2013; Maggi, Elena/AAR-9910-2021	Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Bertocci, Iacopo/0000-0002-1519-1677; MAGGI, Elena/0000-0001-6934-9380; Bulleri, Fabio/0000-0002-7335-6791	University of Pisa; Italian National Inter-University Consortium for Marine Sciences (CoNISMa); Census of Marine Life Programme NaGISA; MARBEF	University of Pisa; Italian National Inter-University Consortium for Marine Sciences (CoNISMa); Census of Marine Life Programme NaGISA; MARBEF	This study was supported by grants from the University of Pisa, the Italian National Inter-University Consortium for Marine Sciences (CoNISMa,) the Census of Marine Life Programme NaGISA and the MARBEF (Marine Biodiversity and Ecosystem Functioning) Network of Excellence funded in the Community's Sixth Framework Programme.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Alonso D, 2004, ECOL LETT, V7, P901, DOI 10.1111/j.1461-0248.2004.00640.x; Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Alonso D, 2007, TRENDS ECOL EVOL, V22, P232, DOI 10.1016/j.tree.2007.02.011; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; [Anonymous], 1996, ERROR GROWTH EXPT KN, DOI DOI 10.7208/CHICAGO/9780226511993.001.0001; Azaele S, 2006, NATURE, V444, P926, DOI 10.1038/nature05320; Bell G, 2000, AM NAT, V155, P606, DOI 10.1086/303345; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Benedetti-Cecchi L, 2001, MAR ECOL PROG SER, V215, P79, DOI 10.3354/meps215079; Benedetti-Cecchi L, 2007, TRENDS ECOL EVOL, V22, P231, DOI 10.1016/j.tree.2007.02.008; Benton TG, 2001, ECOL LETT, V4, P236, DOI 10.1046/j.1461-0248.2001.00225.x; Bertocci I, 2005, ECOLOGY, V86, P2061, DOI 10.1890/04-1698; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Burnham K. P., 1998, MODEL SELECTION INFE; Cadotte MW, 2007, P ROY SOC B-BIOL SCI, V274, P2739, DOI 10.1098/rspb.2007.0925; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Etienne RS, 2007, ECOL LETT, V10, P608, DOI 10.1111/j.1461-0248.2007.01052.x; Etienne RS, 2005, ECOL LETT, V8, P493, DOI 10.1111/j.1461-0248.2005.00745.x; Etienne RS, 2005, ECOL LETT, V8, P253, DOI 10.1111/j.1461-0248.2004.00717.x; Fargione J, 2003, P NATL ACAD SCI USA, V100, P8916, DOI 10.1073/pnas.1033107100; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Hu XS, 2007, AM NAT, V170, P844, DOI 10.1086/522935; Hubbell Stephen P., 2001, V32, pi; Legendre P., 2012, NUMERICAL ECOLOGY; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; Maurer BA, 1999, UNTANGLING ECOLOGICA; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; McKane AJ, 2004, THEOR POPUL BIOL, V65, P67, DOI 10.1016/j.tpb.2003.08.001; Menconi M, 1999, J EXP MAR BIOL ECOL, V233, P1, DOI 10.1016/S0022-0981(98)00123-3; Pueyo S, 2007, ECOL LETT, V10, P1017, DOI 10.1111/j.1461-0248.2007.01096.x; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rickfeld RE, 2003, OIKOS, V100, P185, DOI 10.1034/j.1600-0706.2003.12018.x; STEELE JH, 1985, NATURE, V313, P355, DOI 10.1038/313355a0; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; UGLAND KI, 1982, OIKOS, V39, P171, DOI 10.2307/3544482; Ulrich W, 2006, OIKOS, V114, P338, DOI 10.1111/j.2006.0030-1299.14773.x; VASSEUR A, 2007, IMPACT ENV VARIABILI; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wootton JT, 1998, AM NAT, V152, P803, DOI 10.1086/286210; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211	62	16	16	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2777	10.1371/journal.pone.0002777	http://dx.doi.org/10.1371/journal.pone.0002777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648545	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900047
J	Meinzer, U; Esmiol-Welterlin, S; Barreau, F; Berrebi, D; Dussaillant, M; Bonacorsi, S; Chareyre, F; Niwa-Kawakita, M; Alberti, C; Sterkers, G; Villard, C; Lesuffleur, T; Peuchmaur, M; Karin, M; Eckmann, L; Giovannini, M; Ollendorff, V; Wolf-Watz, H; Hugot, JP				Meinzer, Ulrich; Esmiol-Welterlin, Sophie; Barreau, Frederick; Berrebi, Dominique; Dussaillant, Monique; Bonacorsi, Stephane; Chareyre, Fabrice; Niwa-Kawakita, Michiko; Alberti, Corinne; Sterkers, Ghislaine; Villard, Claude; Lesuffleur, Thecla; Peuchmaur, Michel; Karin, Michael; Eckmann, Lars; Giovannini, Marco; Ollendorff, Vincent; Wolf-Watz, Hans; Hugot, Jean-Pierre			Nod2 Mediates Susceptibility to Yersinia pseudotuberculosis in Mice	PLOS ONE			English	Article								Nucleotide oligomerisation domain 2 (NOD2) is a component of the innate immunity known to be involved in the homeostasis of Peyer patches (PPs) in mice. However, little is known about its role during gut infection in vivo. Yersinia pseudotuberculosis is an enteropathogen causing gastroenteritis, adenolymphitis and septicaemia which is able to invade its host through PPs. We investigated the role of Nod2 during Y. pseudotuberculosis infection. Death was delayed in Nod2 deleted and Crohn's disease associated Nod2 mutated mice orogastrically inoculated with Y. pseudotuberculosis. In PPs, the local immune response was characterized by a higher KC level and a more intense infiltration by neutrophils and macrophages. The apoptotic and bacterial cell counts were decreased. Finally, Nod2 deleted mice had a lower systemic bacterial dissemination and less damage of the haematopoeitic organs. This resistance phenotype was lost in case of intraperitoneal infection. We concluded that Nod2 contributes to the susceptibility to Y. pseudotuberculosis in mice.	[Meinzer, Ulrich; Barreau, Frederick; Dussaillant, Monique; Lesuffleur, Thecla; Hugot, Jean-Pierre] Univ Paris 07, INSERM, Hop Robert Debre, U843, Paris, France; [Meinzer, Ulrich; Hugot, Jean-Pierre] Hop Robert Debre, Assistance Publ Hop Paris, Serv Gastroenterol Pediat, Paris, France; [Meinzer, Ulrich; Wolf-Watz, Hans] Umea Univ, Dept Mol Biol, Umea, Sweden; [Esmiol-Welterlin, Sophie; Ollendorff, Vincent] Univ Paul Cezanne, UMR CNRS 6263, ISM2 Biosci, Marseille, France; [Esmiol-Welterlin, Sophie; Ollendorff, Vincent] Univ Montpellier II, Differenciation Cellulaire Croissance, INRA, UMR 866, Montpellier, France; [Berrebi, Dominique] Univ Paris 07, Assistance Publ Hop Paris, Hop Robert Debre, Serv Anatom Pathol, Paris, France; [Bonacorsi, Stephane; Peuchmaur, Michel] Univ Paris 07, Assistance Publ Hop Paris, Hop Robert Debre, Serv Microbiol, Paris, France; [Chareyre, Fabrice; Niwa-Kawakita, Michiko] Univ Paris 07, Inst Univ Hematol, INSERM U674, Paris, France; [Alberti, Corinne; Giovannini, Marco] Univ Paris 07, AP HP, Hop Robert Debre, Dept Epidemiol Clin, Paris, France; [Sterkers, Ghislaine] Univ Paris 07, AP HP, Hop Robert Debre, Serv Immunol, Paris, France; [Villard, Claude] UMR911 CRO2 UFR Pharm, Plateau Proteom Timone, Marseille, France; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Expression & Signal Transduct, La Jolla, CA USA; [Eckmann, Lars] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Umea University; UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California San Diego; University of California System; University of California San Diego	Meinzer, U (corresponding author), Univ Paris 07, INSERM, Hop Robert Debre, U843, Paris, France.	jean-pierre.hugot@rdb.aphp.fr	lesuffleur, thecla/AAC-2980-2020; Meinzer, Ulrich/N-4282-2019; Bonacorsi, Stéphane/HGB-3185-2022; Hugot, Jean-Pierre/F-6594-2012; berrebi, dominique/B-1419-2014	Ollendorff, Vincent/0000-0001-9751-2202; Kawakita, Michiko/0000-0002-9450-583X; Hugot, Jean-Pierre/0000-0002-8446-6056; Barreau, Frederick/0000-0002-7150-9619; Villard, claude/0000-0002-6600-0762	INSERM; Region Ile-de-France; Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris; Fondation de la Recherche Medicale; MESR [fellowship]; Swedish Research Council; National Institutes of Health	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Ile-de-France(Region Ile-de-France); Broad Medical Research Program; Association Francois Aupetit; Mairie de Paris(Region Ile-de-France); Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); MESR(Ministry of Research, France); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support for this study came from the INSERM, Region Ile-de-France, the Broad Medical Research Program, the Association Francois Aupetit, the Mairie de Paris, the Fondation de la Recherche Medicale, a MESR french fellowship to SEM, the Swedish Research Council, and the National Institutes of Health.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; ABBOTT M, 1986, J INFECTION, V13, P143, DOI 10.1016/S0163-4453(86)92869-0; Autenrieth IB, 1996, J MED MICROBIOL, V44, P285, DOI 10.1099/00222615-44-4-285; Barreau F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000523; BOLIN I, 1984, INFECT IMMUN, V43, P72; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; Clark MA, 1998, INFECT IMMUN, V66, P1237, DOI 10.1128/IAI.66.3.1237-1243.1998; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Fujimura Y, 1996, GUT, V38, P724, DOI 10.1136/gut.38.5.724; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Handley SA, 2004, INFECT IMMUN, V72, P1645, DOI 10.1128/IAI.72.3.1645-1656.2004; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; HEESEMANN J, 1993, APMIS, V101, P417, DOI 10.1111/j.1699-0463.1993.tb00130.x; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; IBBOTSON JP, 1992, CLIN EXP IMMUNOL, V87, P224, DOI 10.1111/j.1365-2249.1992.tb02979.x; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jackson M, 1999, INFECT IMMUN, V67, P2867, DOI 10.1128/IAI.67.6.2867-2873.1999; Kallinowski F, 1998, HEPATO-GASTROENTEROL, V45, P1552; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Meinzer U, 2005, INFLAMM BOWEL DIS, V11, P639, DOI 10.1097/01.MIB.0000165114.10687.bf; Monack DM, 1998, J EXP MED, V188, P2127, DOI 10.1084/jem.188.11.2127; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Saebo Arve, 2005, Eur J Intern Med, V16, P176, DOI 10.1016/j.ejim.2004.11.008; Stainier Isabelle, 1998, Clin Microbiol Infect, V4, P673, DOI 10.1111/j.1469-0691.1998.tb00650.x; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; VanKruiningen HJ, 1997, J CLIN GASTROENTEROL, V25, P470, DOI 10.1097/00004836-199709000-00017; ZAL T, 1994, J EXP MED, V180, P2089, DOI 10.1084/jem.180.6.2089	35	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2769	10.1371/journal.pone.0002769	http://dx.doi.org/10.1371/journal.pone.0002769			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648508	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900039
J	Wong, CCL; Wong, CM; Ko, FCF; Chan, LK; Ching, YP; Yam, JWP; Ng, IOL				Wong, Carmen Chak-Lui; Wong, Chun-Ming; Ko, Frankie Chi-Fat; Chan, Lo-Kong; Ching, Yick-Pang; Yam, Judy Wai-Ping; Ng, Irene Oi-Lin			Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma	PLOS ONE			English	Article								Aims: Deleted in liver cancer 1 (DLC1), a member of RhoGTPase activating protein (GAP) family, is known to have suppressive activities in tumorigenicity and cancer metastasis. However, the underlying molecular mechanisms of how DLC1 suppresses cell motility have not been fully elucidated. Rho-kinase (ROCK) is an immediate down-stream effector of RhoA in mediating cellular cytoskeletal events and cell motility. In the present study, we aimed to investigate the effects of DLC1 on Rho/ROCK signaling pathway in hepatocellular carcinoma (HCC). Methodology/Principal Findings: We demonstrated that DLC1 negatively regulated ROCK-dependent actomyosin contractility. From immumofluorescence study, we found that ectopic expression of DLC1 abrogated Rho/ROCK-mediated cytoskeletal reorganization including formation of stress fibers and focal adhesions. It also downregulated cortical phosphorylation of myosin light chain 2 (MLC2). These inhibitory events by DLC1 were RhoGAP-dependent, as RhoGAP-deficient mutant of DLC1 (DLC1 K714E) abolished these inhibitory events. In addition, from western study, DLC1 inhibited ROCK-related myosin light chain phosphatase targeting unit 1 (MYPT1) phosphorylation at Threonine 853. By examining cell morphology under microscope, we found that ectopic expression of dominant-active ROCK released cells from DLC1-induced cytoskeletal collapse and cell shrinkage. Conclusion: Our data suggest that DLC1 negatively regulates Rho/ROCK/MLC2. This implicates a ROCK-mediated pathway of DLC1 in suppressing metastasis of HCC cells and enriches our understanding in the molecular mechanisms involved in the progression of hepatocellular carcinoma.	[Wong, Carmen Chak-Lui; Wong, Chun-Ming; Ko, Frankie Chi-Fat; Chan, Lo-Kong; Ching, Yick-Pang; Yam, Judy Wai-Ping; Ng, Irene Oi-Lin] Univ Hong Kong, Dept Pathol, SH Ho Fdn Res Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Wong, CCL (corresponding author), Univ Hong Kong, Dept Pathol, SH Ho Fdn Res Lab, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk	Ko, Frankie Chi Fat/C-4759-2009; WONG, Chun-Ming/A-6739-2009; Kong, Chan Lo/AAI-9300-2020; Yam, Judy Wai Ping/C-4454-2009; Wong, Carmen Chak Lui/C-4660-2009	Ko, Frankie Chi Fat/0000-0002-0393-9668; WONG, Chun-Ming/0000-0002-2497-7858; Kong, Chan Lo/0000-0003-3082-1013; Ng, Irene Oi-lin/0000-0001-7532-2029; Yam, Judy Wai Ping/0000-0002-5637-121X; CHING, Yick Pang/0000-0002-6461-8358; Wong, Carmen Chak Lui/0000-0001-5866-4705	Hong Kong Research Grants Council [HKU 7436/04M]; RGC Collaborative Reseaarch Fund [HKU 1/06C]; Michael and Betty Kadoorie Cancer Genetics Research Program 2004	Hong Kong Research Grants Council(Hong Kong Research Grants Council); RGC Collaborative Reseaarch Fund; Michael and Betty Kadoorie Cancer Genetics Research Program 2004	The study was funded by Hong Kong Research Grants Council (HKU 7436/04M), RGC Collaborative Reseaarch Fund (HKU 1/06C), Michael and Betty Kadoorie Cancer Genetics Research Program 2004. I.O.L. Ng is Loke Yew Professor in Pathology.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ananthakrishnan R, 2007, INT J BIOL SCI, V3, P303; Barberis D, 2005, J CELL SCI, V118, P4689, DOI 10.1242/jcs.02590; Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200; Genda T, 1999, HEPATOLOGY, V30, P1027, DOI 10.1002/hep.510300420; Goodison S, 2005, CANCER RES, V65, P6042, DOI 10.1158/0008-5472.CAN-04-3043; Guan M, 2006, CLIN CANCER RES, V12, P1412, DOI 10.1158/1078-0432.CCR-05-1906; Hagerty L, 2007, J BIOL CHEM, V282, P4884, DOI 10.1074/jbc.M609990200; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; HALL A, 1992, CELL, V69, P389, DOI 10.1016/0092-8674(92)90441-E; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Katoh K, 2001, J CELL BIOL, V153, P569, DOI 10.1083/jcb.153.3.569; Kaverina I, 2002, INT J BIOCHEM CELL B, V34, P746, DOI 10.1016/S1357-2725(01)00171-6; Kawai K, 2004, BIOCHEM SOC T, V32, P1107, DOI 10.1042/BST0321107; Kim TY, 2007, BIOCHEM BIOPH RES CO, V355, P72, DOI 10.1016/j.bbrc.2007.01.121; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakagawa H, 2005, MOL CANCER RES, V3, P425, DOI 10.1158/1541-7786.MCR-05-0002; Ng IOL, 2000, CANCER RES, V60, P6581; Peacock JG, 2007, MOL BIOL CELL, V18, P3860, DOI 10.1091/mbc.E07-01-0075; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Plaumann M, 2003, J CANCER RES CLIN, V129, P349, DOI 10.1007/s00432-003-0440-z; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Song Li-jie, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P428; Sturge J, 2006, J CELL BIOL, V175, P337, DOI 10.1083/jcb.200602125; Syed V, 2005, ONCOGENE, V24, P1774, DOI 10.1038/sj.onc.1207991; Takamura M, 2001, HEPATOLOGY, V33, P577, DOI 10.1053/jhep.2001.22652; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Vicari RM, 2005, J AM COLL CARDIOL, V46, P1803, DOI 10.1016/j.jacc.2005.07.047; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wong CM, 2003, CANCER RES, V63, P7646; Wong CM, 2005, CANCER RES, V65, P8861, DOI 10.1158/0008-5472.CAN-05-1318; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x; Yoshioka K, 1999, CANCER RES, V59, P2004; Yoshioka K, 1998, J BIOL CHEM, V273, P5146, DOI 10.1074/jbc.273.9.5146; Yuan BZ, 1998, CANCER RES, V58, P2196; Yuan BZ, 2003, CANCER GENET CYTOGEN, V140, P113, DOI 10.1016/S0165-4608(02)00674-X; Yuan BZ, 2004, ONCOGENE, V23, P1405, DOI 10.1038/sj.onc.1207291; Yuan BZ, 2003, ONCOGENE, V22, P445, DOI 10.1038/sj.onc.1206064; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	57	50	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2779	10.1371/journal.pone.0002779	http://dx.doi.org/10.1371/journal.pone.0002779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648664	gold, Green Published, Green Submitted			2022-12-27	WOS:000264302900049
J	Rueda, P; Balabanian, K; Lagane, B; Staropoli, I; Chow, K; Levoye, A; Laguri, C; Sadir, R; Delaunay, T; Izquierdo, E; Pablos, JL; Lendinez, E; Caruz, A; Franco, D; Baleux, F; Lortat-Jacob, H; Arenzana-Seisdedos, F				Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Laguri, Cedric; Sadir, Rabia; Delaunay, Thierry; Izquierdo, Elena; Luis Pablos, Jose; Lendinez, Elena; Caruz, Antonio; Franco, Diego; Baleux, Francoise; Lortat-Jacob, Hugues; Arenzana-Seisdedos, Fernando			The CXCL12 gamma Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins	PLOS ONE			English	Article								The CXCL12 gamma chemokine arises by alternative splicing from Cxcl12, an essential gene during development. This protein binds CXCR4 and displays an exceptional degree of conservation (99%) in mammals. CXCL12 gamma is formed by a protein core shared by all CXCL12 isoforms, extended by a highly cationic carboxy-terminal (C-ter) domain that encompass four overlapped BBXB heparan sulfate (HS)-binding motifs. We hypothesize that this unusual domain could critically determine the biological properties of CXCL12 gamma through its interaction to, and regulation by extracellular glycosaminoglycans (GAG) and HS in particular. By both RT-PCR and immunohistochemistry, we mapped the localization of CXCL12 gamma both in mouse and human tissues, where it showed discrete differential expression. As an unprecedented feature among chemokines, the secreted CXCL12 gamma strongly interacted with cell membrane GAG, thus remaining mostly adsorbed on the plasmatic membrane upon secretion. Affinity chromatography and surface plasmon resonance allowed us to determine for CXCL12 gamma one of the higher affinity for HS (K-d = 0.9 nM) ever reported for a protein. This property relies in the presence of four canonical HS-binding sites located at the C-ter domain but requires the collaboration of a HS-binding site located in the core of the protein. Interestingly, and despite reduced agonist potency on CXCR4, the sustained binding of CXCL12 gamma to HS enabled it to promote in vivo intraperitoneal leukocyte accumulation and angiogenesis in matrigel plugs with much higher efficiency than CXCL12 alpha. In good agreement, mutant CXCL12 gamma chemokines selectively devoid of HS-binding capacity failed to promote in vivo significant cell recruitment. We conclude that CXCL12 gamma features unique structural and functional properties among chemokines which rely on the presence of a distinctive C-ter domain. The unsurpassed capacity to bind to HS on the extracellular matrix would make CXCL12 gamma the paradigm of haptotactic proteins, which regulate essential homeostatic functions by promoting directional migration and selective tissue homing of cells.	[Rueda, Patricia; Lendinez, Elena; Caruz, Antonio; Franco, Diego] Univ Jaen, Dept Biol Expt, Jaen, Spain; [Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Arenzana-Seisdedos, Fernando] Inst Pasteur, Viral Pathogenesis lab, Paris, France; [Rueda, Patricia; Balabanian, Karl; Lagane, Bernard; Staropoli, Isabelle; Chow, Ken; Levoye, Angelique; Arenzana-Seisdedos, Fernando] INSERM U819, Paris, France; [Laguri, Cedric; Sadir, Rabia; Lortat-Jacob, Hugues] Inst Structural Biol, Gagophile lab, UMR 5075 CNRS CEA UJF, Grenoble, France; [Delaunay, Thierry] INRA, Villenave Dornon, France; [Izquierdo, Elena; Luis Pablos, Jose] Hosp Octubre 12, Unidad Investigac, Serv Reumatol, Madrid, Spain; [Baleux, Francoise] Inst Pasteur, Unite Chim Organ, Paris, France	Universidad de Jaen; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; INRAE; Hospital Universitario 12 de Octubre; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rueda, P (corresponding author), Univ Jaen, Dept Biol Expt, Jaen, Spain.	farenzan@pasteur.fr	Arenzana-Seisdedos, Fernando/E-5835-2016; Levoye, Angelique/ABC-7892-2021; Izquierdo, Elena/Z-1861-2019; Lagane, Bernard/AAA-2205-2019; Balabanian, Karl/I-2990-2016; Balabanian, Karl/S-6250-2019; Caruz, Antonio/N-5557-2014; Lagane, Bernard/K-8446-2016	Izquierdo, Elena/0000-0002-3355-2798; Lagane, Bernard/0000-0002-3459-7867; Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; Caruz, Antonio/0000-0002-5788-7840; laguri, cedric/0000-0002-5429-6914; Rueda, Patricia/0000-0003-1553-0840; Levoye, Angelique/0000-0002-7125-7327; Franco, Diego/0000-0002-5669-7164	French Agence National pour la Recherche (ANR); Agence National pour la Recherche sur le SIDA (ANRS); Institut National de la Sante et la Recherche Medicale (INSERM); Institut Pasteur; Fondo de Investigaciones Sanitarias [FIS 05/060]; FPDI program sponsored by the Andalucia autonomous government (Spain) [fellowship]; Croucher Foundation (Hong Kong); ANR-Maladies Rares	French Agence National pour la Recherche (ANR)(French National Research Agency (ANR)); Agence National pour la Recherche sur le SIDA (ANRS)(ANRSFrench National Research Agency (ANR)); Institut National de la Sante et la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur(European Commission); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); FPDI program sponsored by the Andalucia autonomous government (Spain); Croucher Foundation (Hong Kong); ANR-Maladies Rares(French National Research Agency (ANR))	This work is supported by grants from the French Agence National pour la Recherche (ANR), the Agence National pour la Recherche sur le SIDA (ANRS) Institut National de la Sante et la Recherche Medicale (INSERM), Institut Pasteur and Fondo de Investigaciones Sanitarias (Spain, FIS 05/060). PR is a fellowship recipient from the FPDI program sponsored by the Andalucia autonomous government (Spain). KC and AL are supported by Croucher Foundation (Hong Kong) and ANR-Maladies Rares, respectively. CL is supported by an ANR postdoctoral grant.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; Ferrara N, 1999, NAT MED, V5, P1359, DOI 10.1038/70928; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Jones KS, 2005, J VIROL, V79, P12692, DOI 10.1128/JVI.79.20.12692-12702.2005; Kantele JM, 2000, J IMMUNOL, V164, P5035, DOI 10.4049/jimmunol.164.10.5035; Klein RS, 2001, DEVELOPMENT, V128, P1971; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Miao Z, 2007, P NATL ACAD SCI USA, V104, P15735, DOI 10.1073/pnas.0610444104; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pablos JL, 2003, J IMMUNOL, V170, P2147, DOI 10.4049/jimmunol.170.4.2147; PASSANITI A, 1992, LAB INVEST, V67, P519; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sadir R, 2004, J BIOL CHEM, V279, P43854, DOI 10.1074/jbc.M405392200; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Sandhoff R, 2005, BBA-MOL CELL BIOL L, V1687, P52, DOI 10.1016/j.bbalip.2004.11.011; Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Soriano SF, 2002, J EXP MED, V196, P311, DOI 10.1084/jem.20012041; Staropoli I, 2000, J BIOL CHEM, V275, P35137, DOI 10.1074/jbc.M003868200; Stumm RK, 2002, J NEUROSCI, V22, P5865; Sweeney EA, 2002, BLOOD, V99, P44, DOI 10.1182/blood.V99.1.44; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Valenzuela-Fernandez A, 2001, J BIOL CHEM, V276, P26550, DOI 10.1074/jbc.M100411200; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; ZIMRIN AB, 1995, BIOCHEM BIOPH RES CO, V213, P630, DOI 10.1006/bbrc.1995.2178; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2008	3	7							e2543	10.1371/journal.pone.0002543	http://dx.doi.org/10.1371/journal.pone.0002543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	406IM	18648536	Green Published, gold			2022-12-27	WOS:000263288200015
J	Peters, JH; Preijers, FW; Woestenenk, R; Hilbrands, LB; Koenen, HJPM; Joosten, I				Peters, Jorieke H.; Preijers, Frank W.; Woestenenk, Rob; Hilbrands, Luuk B.; Koenen, Hans J. P. M.; Joosten, Irma			Clinical Grade Treg: GMP Isolation, Improvement of Purity by CD127(pos) Depletion, Treg Expansion, and Treg Cryopreservation	PLOS ONE			English	Article								Background: Treg based immunotherapy is of great interest to facilitate tolerance in autoimmunity and transplantation. For clinical trials, it is essential to have a clinical grade Treg isolation protocol in accordance with Good Manufacturing Practice (GMP) guidelines. To obtain sufficient Treg for immunotherapy, subsequent ex vivo expansion might be needed. Methodology/Principal Findings: Treg were isolated from leukapheresis products by CliniMACS based GMP isolation strategies, using anti-CD25, anti-CD8 and anti-CD19 coated microbeads. CliniMACS isolation procedures led to 40-60% pure CD4(pos) CD25(high) FoxP3(pos) Treg populations that were anergic and had moderate suppressive activity. Such CliniMACS isolated Treg populations could be expanded with maintenance of suppressive function. Alloantigen stimulated expansion caused an enrichment of alloantigen-specific Treg. Depletion of unwanted CD19(pos) cells during CliniMACS Treg isolation proved necessary to prevent B-cell outgrowth during expansion. CD4(pos) CD127(pos) conventional T cells were the major contaminating cell type in CliniMACS isolated Treg populations. Depletion of CD127(pos) cells improved the purity of CD4(pos) CD25(high) FoxP3(pos) Treg in CliniMACS isolated cell populations to approximately 90%. Expanded CD127(neg) CliniMACS isolated Treg populations showed very potent suppressive capacity and high FoxP3 expression. Furthermore, our data show that cryopreservation of CliniMACS isolated Treg is feasible, but that activation after thawing is necessary to restore suppressive potential. Conclusions/Significance: The feasibility of Treg based therapy is widely accepted, provided that tailor-made clinical grade procedures for isolation and ex vivo cell handling are available. We here provide further support for this approach by showing that a high Treg purity can be reached, and that isolated cells can be cryopreserved and expanded successfully.	[Peters, Jorieke H.; Koenen, Hans J. P. M.; Joosten, Irma] Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands; [Preijers, Frank W.; Woestenenk, Rob] Radboud Univ Nijmegen, Cent Hematol Lab, Nijmegen, Netherlands; [Hilbrands, Luuk B.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Peters, JH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Bloodtransfus & Transplantat Immunol, NL-6525 ED Nijmegen, Netherlands.	I.Joosten@abti.umcn.nl	Hilbrands, Luuk/B-4921-2011; Woestenenk, Rob/C-6119-2016; Koenen, Hans J.P.M./A-2852-2014; Joosten, Irma/N-4418-2013; Preijers, Frank/L-4586-2015	Hilbrands, Luuk/0000-0002-4935-9765; Joosten, Irma/0000-0003-2950-4977; 	Dutch Kidney Foundation [C05-2106]	Dutch Kidney Foundation	This study was supported by a grant of the Dutch Kidney Foundation (C05-2106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bushell A, 2005, J IMMUNOL, V174, P3290, DOI 10.4049/jimmunol.174.6.3290; Curtis RE, 1999, BLOOD, V94, P2208; Earle KE, 2005, CLIN IMMUNOL, V115, P3, DOI 10.1016/j.clim.2005.02.017; Edinger M, 2003, NAT MED, V9, P1144, DOI 10.1038/nm915; Golshayan D, 2006, BLOOD, V6, P1879; Gross TG, 1999, BONE MARROW TRANSPL, V23, P251, DOI 10.1038/sj.bmt.1701554; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Hoffmann P, 2004, BLOOD, V104, P895, DOI 10.1182/blood-2004-01-0086; Joffre O, 2004, BLOOD, V103, P4216, DOI 10.1182/blood-2004-01-0005; Jones SC, 2003, BIOL BLOOD MARROW TR, V9, P243, DOI 10.1053/bbmt.2003.50027; Karakhanova S, 2006, J IMMUNOTHER, V29, P336, DOI 10.1097/01.cji.0000203080.43235.9e; Koenen HJPM, 2005, J IMMUNOL, V174, P7573, DOI 10.4049/jimmunol.174.12.7573; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kreijveld E, 2006, J IMMUNOL METHODS, V314, P103, DOI 10.1016/j.jim.2006.06.001; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002233; Roncarolo MG, 2007, NAT REV IMMUNOL, V7, P585, DOI 10.1038/nri2138; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tarbell KV, 2004, J EXP MED, V199, P1467, DOI 10.1084/jem.20040180; Taylor AL, 2005, CRIT REV ONCOL HEMAT, V56, P155, DOI 10.1016/j.critrevonc.2005.03.015; Trenado A, 2003, J CLIN INVEST, V112, P1688, DOI 10.1172/JCI17702; Wichlan DG, 2006, J IMMUNOL METHODS, V315, P27, DOI 10.1016/j.jim.2006.06.014; Yamazaki S, 2006, P NATL ACAD SCI USA, V103, P2758, DOI 10.1073/pnas.0510606103	28	80	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3161	10.1371/journal.pone.0003161	http://dx.doi.org/10.1371/journal.pone.0003161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776930	gold, Green Published, Green Submitted			2022-12-27	WOS:000264424300006
J	Turville, SG; Aravantinou, M; Miller, T; Kenney, J; Teitelbaum, A; Hu, LY; Chudolij, A; Zydowsky, TM; Piatak, M; Bess, JW; Lifson, JD; Blanchard, J; Gettie, A; Robbiani, M				Turville, Stuart G.; Aravantinou, Meropi; Miller, Todd; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Tom M.; Piatak, Michael, Jr.; Bess, Julian W., Jr.; Lifson, Jeffrey D.; Blanchard, James; Gettie, Agegnehu; Robbiani, Melissa			Efficacy of Carraguard (R)-Based Microbicides In Vivo Despite Variable In Vitro Activity	PLOS ONE			English	Article								Anti-HIV microbicides are being investigated in clinical trials and understanding how promising strategies work, coincident with demonstrating efficacy in vivo, is central to advancing new generation microbicides. We evaluated Carraguard (R) and a new generation Carraguard-based formulation containing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 (PC-817). Since dendritic cells (DCs) are believed to be important in HIV transmission, the formulations were tested for the ability to limit DC-driven infection in vitro versus vaginal infection of macaques with RT-SHIV (SIVmac239 bearing HIV reverse transcriptase). Carraguard showed limited activity against cell-free and mature DC-driven RT-SHIV infections and, surprisingly, low doses of Carraguard enhanced infection. However, nanomolar amounts of MIV-150 overcame enhancement and blocked DC-transmitted infection. In contrast, Carraguard impeded infection of immature DCs coincident with DC maturation. Despite this variable activity in vitro, Carraguard and PC-817 prevented vaginal transmission of RT-SHIV when applied 30 min prior to challenge. PC-817 appeared no more effective than Carraguard in vivo, due to the limited activity of a single dose of MIV-150 and the dominant barrier effect of Carraguard. However, 3 doses of MIV-150 in placebo gel at and around challenge limited vaginal infection, demonstrating the potential activity of a topically applied NNRTI. These data demonstrate discordant observations when comparing in vitro and in vivo efficacy of Carraguard-based microbicides, highlighting the difficulties in testing putative anti-viral strategies in vitro to predict in vivo activity. This work also underscores the potential of Carraguard-based formulations for the delivery of anti-viral drugs to prevent vaginal HIV infection.	[Turville, Stuart G.; Aravantinou, Meropi; Miller, Todd; Kenney, Jessica; Teitelbaum, Aaron; Hu, Lieyu; Chudolij, Anne; Zydowsky, Tom M.; Robbiani, Melissa] Ctr Biomed Res, Populat Council, HIV & AIDS Program, New York, NY USA; [Piatak, Michael, Jr.; Bess, Julian W., Jr.; Lifson, Jeffrey D.] NCI, SAIC Frederick, AIDS & Canc Virus Program, Frederick, MD USA; [Blanchard, James] Tulane Univ Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY USA	Population Council; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Tulane University; Rockefeller University	Turville, SG (corresponding author), Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Virus Res, Sydney, NSW, Australia.	mrobbiani@popcouncil.org		Turville, Stuart/0000-0003-1918-5343	USAID [GPO-A-00-04-00019-00]; NIH [R37 AI040877, AI065412, RR00164]; 2002 Elizabeth Glaser Scientist; NH&MRC of Australia [CJ Martin Fellowship]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065412, R37AI040877] Funding Source: NIH RePORTER	USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2002 Elizabeth Glaser Scientist; NH&MRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the USAID Cooperative Agreement GPO-A-00-04-00019-00, NIH grants R37 AI040877 and AI065412, and the NIH base grant RR00164. MR is a 2002 Elizabeth Glaser Scientist. SGT is supported by a CJ Martin Fellowship of the NH&MRC of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Bakri Y, 2001, J IMMUNOL, V166, P3780, DOI 10.4049/jimmunol.166.6.3780; Balzarini J, 1998, AIDS, V12, P1129, DOI 10.1097/00002030-199810000-00004; Bartolini B, 2003, ANTIVIR RES, V58, P139, DOI 10.1016/S0166-3542(02)00209-7; Bollen LJM, 2008, JAIDS-J ACQ IMM DEF, V47, P253, DOI 10.1097/QAI.0b013e31815d2f12; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Cavrois M, 2006, J VIROL, V80, P1992, DOI 10.1128/JVI.80.4.1992-1999.2006; *CDCP, 2000, JAMA-J AM MED ASSOC, V284, P1376; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Cline AN, 2005, J MED PRIMATOL, V34, P303; CRUBLET E, 2008, J BIOL CHEM; Cummins JE, 2007, ANTIMICROB AGENTS CH, V51, P1770, DOI 10.1128/AAC.01129-06; Dezzutti CS, 2004, ANTIMICROB AGENTS CH, V48, P3834, DOI 10.1128/AAC.48.10.3834-3844.2004; DiClemente RJ, 2004, JAMA-J AM MED ASSOC, V292, P171, DOI 10.1001/jama.292.2.171; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Frank I, 2008, J VIROL, V82, P5329, DOI 10.1128/JVI.01987-07; Frank I, 2003, JAIDS-J ACQ IMM DEF, V34, P7, DOI 10.1097/00126334-200309010-00002; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706; Hu QX, 2004, J EXP MED, V199, P1065, DOI 10.1084/jem.20022212; *I LAB AN RES COMM, 1985, GUID CAR US LAB AN, P1; Izquierdo-Useros N, 2007, J VIROL, V81, P7559, DOI 10.1128/JVI.02572-06; Jagodzinski PP, 1999, VIRAL IMMUNOL, V12, P23, DOI 10.1089/vim.1999.12.23; Kaiser J, 2008, SCIENCE, V320, P30, DOI 10.1126/science.320.5872.30; Kawamura T, 2000, J EXP MED, V192, P1491, DOI 10.1084/jem.192.10.1491; Ketas TJ, 2003, AIDS RES HUM RETROV, V19, P177, DOI 10.1089/088922203763315678; Ketas TJ, 2003, J VIROL, V77, P2762, DOI 10.1128/JVI.77.4.2762-2767.2003; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2004, AIDS RES HUM RETROV, V20, P772, DOI 10.1089/0889222041524661; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Maguire RA, 2001, SEX TRANSM DIS, V28, P259, DOI 10.1097/00007435-200105000-00003; Maguire RA, 1998, SEX TRANSM DIS, V25, P494, DOI 10.1097/00007435-199810000-00010; McDermott AB, 2004, J VIROL, V78, P3140, DOI 10.1128/JVI.78.6.3140-3144.2004; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; MCDONALD D, 2003, ENHANCEMENT HIV INFE; MEYLAN PRA, 1994, ANTIMICROB AGENTS CH, V38, P2910, DOI 10.1128/AAC.38.12.2910; MILLER CJ, 1994, J VIROL, V68, P6391, DOI 10.1128/JVI.68.10.6391-6400.1994; Moulard M, 2000, J VIROL, V74, P1948, DOI 10.1128/JVI.74.4.1948-1960.2000; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; POPE M, 1994, CELL, V78, P389, DOI 10.1016/0092-8674(94)90418-9; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Reece JC, 1998, J EXP MED, V187, P1623, DOI 10.1084/jem.187.10.1623; Richardson BA, 2002, JAMA-J AM MED ASSOC, V287, P1171, DOI 10.1001/jama.287.9.1171; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schmitz JE, 1999, AM J PATHOL, V154, P1923, DOI 10.1016/S0002-9440(10)65450-8; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; SKOLER S, 2008, EFFICACY CARRA UNPUB; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; TRAPP S, 2008, DOUBLE STRANDE UNPUB; Trapp S, 2006, J LEUKOCYTE BIOL, V80, P1076, DOI 10.1189/jlb.0206121; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2005, J VIROL, V79, P13519, DOI 10.1128/JVI.79.21.13519-13527.2005; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Vachot L, 2008, JAIDS-J ACQ IMM DEF, V48, P398, DOI 10.1097/QAI.0b013e3181776bc7; van de Wiigert JHHM, 2007, JAIDS-J ACQ IMM DEF, V46, P538, DOI 10.1097/QAI.0b013e318159d5a8; van de Wijgert JHHM, 2007, AIDS, V21, P2369, DOI 10.1097/QAD.0b013e3282ef83fd; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veazey RS, 2003, J EXP MED, V198, P1551, DOI 10.1084/jem.20031266; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Wang JH, 2007, J VIROL, V81, P8933, DOI 10.1128/JVI.00878-07; West JT, 2002, J VIROL, V76, P3338, DOI 10.1128/JVI.76.7.3338-3349.2002; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zacharopoulos VR, 1997, CLIN DIAGN LAB IMMUN, V4, P465, DOI 10.1128/CDLI.4.4.465-468.1997; ZARETZKY FR, 1995, INFECT IMMUN, V63, P3520, DOI 10.1128/IAI.63.9.3520-3526.1995; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	81	67	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3162	10.1371/journal.pone.0003162	http://dx.doi.org/10.1371/journal.pone.0003162			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776937	gold, Green Published, Green Submitted			2022-12-27	WOS:000264424300007
J	Xu, GL; Karch, C; Li, N; Lin, NW; Fromholt, D; Gonzales, V; Borchelt, DR				Xu, Guilian; Karch, Celeste; Li, Ning; Lin, Nianwei; Fromholt, David; Gonzales, Victoria; Borchelt, David R.			Receptor-Associated Protein (RAP) Plays a Central Role in Modulating A beta Deposition in APP/PS1 Transgenic Mice	PLOS ONE			English	Article								Background: Receptor associated protein ( RAP) functions in the endoplasmic reticulum ( ER) to assist in the maturation of several membrane receptor proteins, including low density lipoprotein receptor-related protein (LRP) and lipoprotein receptor 11 (SorLA/LR11). Previous studies in cell and mouse model systems have demonstrated that these proteins play roles in the metabolism of the amyloid precursor protein (APP), including processes involved in the generation, catabolism and deposition of beta-amyloid (A beta) peptides. Methodology/Principal Findings: Mice transgenic for mutant APPswe and mutant presenilin 1 (PS1dE9) were mated to mice with homozygous deletion of RAP. Unexpectedly, mice that were homozygous null for RAP and transgenic for APPswe/PS1dE9 showed high post-natal mortality, necessitating a shift in focus to examine the levels of amyloid deposition in APPswe/PS1dE9 that were hemizygous null for RAP. Immunoblot analysis confirmed 50% reductions in the levels of RAP with modest reductions in the levels of proteins dependent upon RAP for maturation [ LRP trend towards a 20% reduction; SorLA/LR11 statistically significant 15% reduction (p<0.05)]. Changes in the levels of these proteins in the brains of [APPswe/PS1dE9](+/-)/RAP(+/-) mice correlated with 30-40% increases in amyloid deposition by 9 months of age. Conclusions/Significance: Partial reductions in the ER chaperone RAP enhance amyloid deposition in the APPswe/PS1dE9 model of Alzheimer amyloidosis. Partial reductions in RAP also affect the maturation of LRP and SorLA/LR11, which are each involved in several different aspects of APP processing and Ab catabolism. Together, these findings suggest a central role for RAP in Alzheimer amyloidogenesis.	[Xu, Guilian; Karch, Celeste; Fromholt, David; Borchelt, David R.] Univ Florida, Santa Fe Hlth Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA; [Karch, Celeste; Li, Ning; Lin, Nianwei] Univ Florida, Interdisciplin Grad Program, Gainesville, FL 32611 USA; [Xu, Guilian; Fromholt, David; Gonzales, Victoria; Borchelt, David R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21218 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University	Xu, GL (corresponding author), Univ Florida, Santa Fe Hlth Alzheimers Dis Res Ctr, McKnight Brain Inst, Dept Neurosci, Gainesville, FL 32610 USA.	borchelt@mbi.ufl.edu	Lin, Nianwei/AAD-9805-2019; Lin, Nianwei/I-4919-2012; Lin, Nianwei/I-4653-2013	Lin, Nianwei/0000-0002-0811-8797; Karch, Celeste/0000-0002-6854-5547	Alzheimer's Association [Zenith Award]	Alzheimer's Association(Alzheimer's Association)	We gratefully thank Joachim Herz for sharing the RAP KO mice through Jackson Laboratory and providing us LRP and RAP antibodies. This work was supported by grants from the Alzheimer's Association (Zenith Award [DRB]).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Cam JA, 2005, J BIOL CHEM, V280, P15464, DOI 10.1074/jbc.M500613200; Cam JA, 2004, J BIOL CHEM, V279, P29639, DOI 10.1074/jbc.M313893200; Causevic M, 2003, J NEUROPATH EXP NEUR, V62, P999, DOI 10.1093/jnen/62.10.999; Clatworthy AE, 1997, ARCH NEUROL-CHICAGO, V54, P1289, DOI 10.1001/archneur.1997.00550220087019; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Fallin D, 1997, NEUROSCI LETT, V233, P145, DOI 10.1016/S0304-3940(97)00634-4; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jankowsky JL, 2005, PLOS MED, V2, P1318, DOI 10.1371/journal.pmed.0020355; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lesuisse C, 2001, HUM MOL GENET, V10, P2525, DOI 10.1093/hmg/10.22.2525; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Narita M, 1997, J NEUROCHEM, V69, P1904; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Qiu ZH, 1999, J NEUROCHEM, V73, P1393, DOI 10.1046/j.1471-4159.1999.0731393.x; Rebeck GW, 2001, MOL BRAIN RES, V87, P238, DOI 10.1016/S0169-328X(01)00006-7; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Savonenko AV, 2003, NEUROBIOL DIS, V12, P194, DOI 10.1016/S0969-9961(02)00012-8; Scott WK, 1998, NEUROGENETICS, V1, P179, DOI 10.1007/s100480050026; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Uden E, 2000, MICROSC RES TECHNIQ, V50, P268, DOI 10.1002/1097-0029(20000815)50:4<268::AID-JEMT3>3.0.CO;2-1; Van Uden E, 1999, MOL CELL NEUROSCI, V14, P129, DOI 10.1006/mcne.1999.0772; Van Uden E, 2002, J NEUROSCI, V22, P9298; Veinbergs I, 2001, EXP NEUROL, V170, P15, DOI 10.1006/exnr.2001.7684; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; WavrantDeVrieze F, 1997, NEUROSCI LETT, V227, P68, DOI 10.1016/S0304-3940(97)00304-2; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Willnow TE, 1998, BIOL CHEM, V379, P1025; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Xu GL, 2002, ALZ DIS ASSOC DIS, V16, P191, DOI 10.1097/00002093-200207000-00010; YAMAMOTO T, 1986, NEUROPATH APPL NEURO, V12, P3, DOI 10.1111/j.1365-2990.1986.tb00677.x; Yoon IS, 2005, J BIOL CHEM, V280, P20140, DOI 10.1074/jbc.M413729200; Zerbinatti CV, 2004, P NATL ACAD SCI USA, V101, P1075, DOI 10.1073/pnas.0305803101	45	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2008	3	9							e3159	10.1371/journal.pone.0003159	http://dx.doi.org/10.1371/journal.pone.0003159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422JQ	18776935	Green Published, Green Submitted, gold			2022-12-27	WOS:000264424300004
J	Goz, D; Studholme, K; Lappi, DA; Rollag, MD; Provencio, I; Morin, LP				Goez, Didem; Studholme, Keith; Lappi, Douglas A.; Rollag, Mark D.; Provencio, Ignacio; Morin, Lawrence P.			Targeted Destruction of Photosensitive Retinal Ganglion Cells with a Saporin Conjugate Alters the Effects of Light on Mouse Circadian Rhythms	PLOS ONE			English	Article								Non-image related responses to light, such as the synchronization of circadian rhythms to the day/night cycle, are mediated by classical rod/cone photoreceptors and by a small subset of retinal ganglion cells that are intrinsically photosensitive, expressing the photopigment, melanopsin. This raises the possibility that the melanopsin cells may be serving as a conduit for photic information detected by the rods and/or cones. To test this idea, we developed a specific immunotoxin consisting of an anti-melanopsin antibody conjugated to the ribosome-inactivating protein, saporin. Intravitreal injection of this immunotoxin results in targeted destruction of melanopsin cells. We find that the specific loss of these cells in the adult mouse retina alters the effects of light on circadian rhythms. In particular, the photosensitivity of the circadian system is significantly attenuated. A subset of animals becomes non-responsive to the light/dark cycle, a characteristic previously observed in mice lacking rods, cones, and functional melanopsin cells. Mice lacking melanopsin cells are also unable to show light induced negative masking, a phenomenon known to be mediated by such cells, but both visual cliff and light/dark preference responses are normal. These data suggest that cells containing melanopsin do indeed function as a conduit for rod and/or cone information for certain non-image forming visual responses. Furthermore, we have developed a technique to specifically ablate melanopsin cells in the fully developed adult retina. This approach can be applied to any species subject to the existence of appropriate anti-melanopsin antibodies.	[Goez, Didem; Rollag, Mark D.; Provencio, Ignacio] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Studholme, Keith; Morin, Lawrence P.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Morin, Lawrence P.] SUNY Stony Brook, Med Ctr, Program Neurosci, Stony Brook, NY 11794 USA; [Lappi, Douglas A.] Adv Targeting Syst, San Diego, CA USA	University of Virginia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Goz, D (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	lawrence.morin@stonybrook.edu	Morin, Lawrence P/B-7487-2009	Morin, Lawrence/0000-0002-6580-6545; Provencio, Ignacio/0000-0003-1175-920X; Lappi, Douglas/0000-0003-4239-7387; studholme, keith/0000-0002-0037-514X	NIH [R01 NS22168, R01 NS052112]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052112, R01NS022168] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH grant R01 NS22168 to LPM NIH grant R01 NS052112 to IP The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansuscript.	BALL SL, 2003, INVEST OPHTHALMOLVIS, V44, P7; BAVER SB, 2008, EUR J NEURO IN PRESS; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berger-Sweeney J, 2001, J NEUROSCI, V21, P8164, DOI 10.1523/JNEUROSCI.21-20-08164.2001; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Gunhan E, 2002, J NEUROSCI, V22, P2265, DOI 10.1523/JNEUROSCI.22-06-02265.2002; Hatori M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002451; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Kingston R E, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1013s31; Kline RH, 2008, J NEUROSCI, V28, P904, DOI 10.1523/JNEUROSCI.4452-07.2008; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; LIKHTIK E, 2008, NATURE; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; Martin JL, 2001, J COMP NEUROL, V436, P127; MICHON JJ, 1991, INVEST OPHTH VIS SCI, V32, P280; Molina A, 2008, ANNU REV MED, V59, P237, DOI 10.1146/annurev.med.59.060906.220345; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Morin LP, 2003, J COMP NEUROL, V465, P401, DOI 10.1002/cne.10881; Morin LP, 2002, J BIOL RHYTHM, V17, P217, DOI 10.1177/07430402017003005; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Pappas BA, 1996, DEV BRAIN RES, V96, P52, DOI 10.1016/0165-3806(96)00095-8; Redlin U, 1999, J COMP PHYSIOL A, V184, P439, DOI 10.1007/s003590050343; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; THORPE PE, 1985, J NATL CANCER I, V75, P151; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Whenham N, 2008, CLIN BREAST CANCER, V8, P38, DOI 10.3816/CBC.2008.n.002; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; Wrenn CC, 1999, BRAIN RES, V847, P284, DOI 10.1016/S0006-8993(99)02099-5; YOSHIMURA T, 1994, J BIOL RHYTHM, V9, P51, DOI 10.1177/074873049400900105; ZHANG DQ, 2008, PNAS IN PRESS	39	119	120	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 5	2008	3	9							e3153	10.1371/journal.pone.0003153	http://dx.doi.org/10.1371/journal.pone.0003153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IE	18773079	Green Submitted, Green Published, gold			2022-12-27	WOS:000264420100010
J	Ravetti, MG; Moscato, P				Ravetti, Martin Gomez; Moscato, Pablo			Identification of a 5-Protein Biomarker Molecular Signature for Predicting Alzheimer's Disease	PLOS ONE			English	Article								Background: Alzheimer's disease (AD) is a progressive brain disease with a huge cost to human lives. The impact of the disease is also a growing concern for the governments of developing countries, in particular due to the increasingly high number of elderly citizens at risk. Alzheimer's is the most common form of dementia, a common term for memory loss and other cognitive impairments. There is no current cure for AD, but there are drug and non-drug based approaches for its treatment. In general the drug-treatments are directed at slowing the progression of symptoms. They have proved to be effective in a large group of patients but success is directly correlated with identifying the disease carriers at its early stages. This justifies the need for timely and accurate forms of diagnosis via molecular means. We report here a 5-protein biomarker molecular signature that achieves, on average, a 96% total accuracy in predicting clinical AD. The signature is composed of the abundances of IL-1 alpha, IL-3, EGF, TNF-alpha and G-CSF. Methodology/Principal Findings: Our results are based on a recent molecular dataset that has attracted worldwide attention. Our paper illustrates that improved results can be obtained with the abundance of only five proteins. Our methodology consisted of the application of an integrative data analysis method. This four step process included: a) abundance quantization, b) feature selection, c) literature analysis, d) selection of a classifier algorithm which is independent of the feature selection process. These steps were performed without using any sample of the test datasets. For the first two steps, we used the application of Fayyad and Irani's discretization algorithm for selection and quantization, which in turn creates an instance of the (alpha-beta)-k-Feature Set problem; a numerical solution of this problem led to the selection of only 10 proteins. Conclusions/Significance: the previous study has provided an extremely useful dataset for the identification of AD biomarkers. However, our subsequent analysis also revealed several important facts worth reporting: 1. A 5-protein signature (which is a subset of the 18-protein signature of Ray et al.)has the same overall performance (when using the same classifier). 2. Using more than 20 different classifiers available in the widely-used Weka software package, our 5-protein signature has, on average, a smaller prediction error indicating the independence of the classifier and the robustness of this set of biomarkers (i.e. 96% accuracy when predicting AD against non-demented control). 3. Using very simple classifiers, like Simple Logistic or Logistic Model Trees, we have achieved the following results on 92 samples: 100 percent success to predict Alzheimer's Disease and 92 percent to predict Non Demented Control on the AD dataset.	[Ravetti, Martin Gomez; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia	University of Newcastle	Ravetti, MG (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia.	martin.ravetti@newcastle.edu.au; pablo.moscato@newcastle.edu.au	Ravetti, Martin/K-1108-2012; Abrams, William R/A-5782-2008; MOSCATO, PABLO ALBERTO/G-7668-2013	Ravetti, Martin/0000-0001-7781-0034; Moscato, Pablo/0000-0003-2570-5966				BERRETTA R, 2008, BIOINFORMATICS, V2; Berretta R, 2007, J RES PRACT INF TECH, V39, P287; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; COTTA C, 2004, EVOLUTIONARY SEARCH, P21; COTTA C, 2007, HDB APPROXIMATION AL; Finch CE, 2007, CURR ALZHEIMER RES, V4, P185, DOI 10.2174/156720507780362254; Landwehr N, 2005, MACH LEARN, V59, P161, DOI 10.1007/s10994-005-0466-3; Magaki S, 2007, EXP GERONTOL, V42, P233, DOI 10.1016/j.exger.2006.09.015; MENDES A, 2008, MICROARRAYS IDENTIFY, P131; MOSCATO P, 2005, GENES RELATED ALZHEI, P84; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Witten I. H., 2005, DATA MINING PRACTICA; 2007, ARIADNE GENOMICS, V1	13	80	82	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 3	2008	3	9							e3111	10.1371/journal.pone.0003111	http://dx.doi.org/10.1371/journal.pone.0003111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422HM	18769539	gold, Green Submitted, Green Published			2022-12-27	WOS:000264418300003
J	Essien, K; Hannenhalli, S; Stoeckert, CJ				Essien, Kobby; Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.			Computational Analysis of Constraints on Noncoding Regions, Coding Regions and Gene Expression in Relation to Plasmodium Phenotypic Diversity	PLOS ONE			English	Article							MALARIA PARASITE; REGULATORY MOTIFS; GENOME SEQUENCE; DNA-BINDING; FALCIPARUM; EVOLUTION; LIFE; REVEALS; DISCOVERY; ALIGNMENT	Background: Malaria-causing Plasmodium species exhibit marked differences including host choice and preference for invading particular cell types. The genetic bases of phenotypic differences between parasites can be understood, in part, by investigating constraints on gene expression and genic sequences, both coding and regulatory. Methodology/Principal Findings: We investigated the evolutionary constraints on sequence and expression of parasitic genes by applying comparative genomics approaches to 6 Plasmodium genomes and 2 genome-wide expression studies. We found that the coding regions of Plasmodium transcription factor and sexual development genes are relatively less constrained, as are those of genes encoding CCCH zinc fingers and invasion proteins, which all play important roles in these parasites. Transcription factors and genes with stage-restricted expression have conserved upstream regions and so do several gene classes critical to the parasite's lifestyle, namely, ion transport, invasion, chromatin assembly and CCCH zinc fingers. Additionally, a cross-species comparison of expression patterns revealed that Plasmodium-specific genes exhibit significant expression divergence. Conclusions/Significance: Overall, constraints on Plasmodium's protein coding regions confirm observations from other eukaryotes in that transcription factors are under relatively lower constraint. Proteins relevant to the parasite's unique lifestyle also have lower constraint on their coding regions. Greater conservation between Plasmodium species in terms of promoter motifs suggests tight regulatory control of lifestyle genes. However, an interspecies divergence in expression patterns of these genes suggests that either expression is controlled via genomic or epigenomic features not encoded in the proximal promoter sequence, or alternatively, the combinatorial interactions between motifs confer species-specific expression patterns.	[Essien, Kobby] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Essien, Kobby; Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.] Univ Penn, Ctr Bioinformat, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar; Stoeckert, Christian J., Jr.] Univ Penn, Sch Med, Dept Genet, Philadelphia 19104, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Essien, K (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	stoeckrt@pcbi.upenn.edu	Hide, Winston Hide/C-7217-2009; Hide, Winston/R-3815-2019; Hide, Winston A/V-2727-2017	Hide, Winston Hide/0000-0002-8621-3271; Hide, Winston/0000-0002-8621-3271; Hide, Winston A/0000-0002-8621-3271	National Human Genome Research Institute [T32HG000046, 5R01AI058515-05, 5R21GM078203-02]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM078203] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KE was supported by grants T32HG000046 from the National Human Genome Research Institute and 5R01AI058515-05 (to CJS). SH was supported by 5R21GM078203-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chow CS, 2003, MOL BIOCHEM PARASIT, V129, P199, DOI 10.1016/S0166-6851(03)00101-4; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Farre D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r140; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Iwama H, 2004, P NATL ACAD SCI USA, V101, P17156, DOI 10.1073/pnas.0407670101; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; LANZER M, 1992, NUCLEIC ACIDS RES, V20, P3051, DOI 10.1093/nar/20.12.3051; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Lee S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-168; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; OLDHAM MC, 2006, P NATL ACAD SCI USA; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; *US CDCP, MAL YELL BOOK, pCH4; van Noort V, 2006, TRENDS GENET, V22, P73, DOI 10.1016/j.tig.2005.12.002; Vardhanabhuti S, 2007, NUCLEIC ACIDS RES, V35, P3203, DOI 10.1093/nar/gkm201; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhou YY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001570; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2008	3	9							e3122	10.1371/journal.pone.0003122	http://dx.doi.org/10.1371/journal.pone.0003122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422GW	18769675	gold, Green Published, Green Submitted			2022-12-27	WOS:000264416600010
J	de Smith, AJ; Walters, RG; Coin, LJM; Steinfeld, I; Yakhini, Z; Sladek, R; Froguel, P; Blakemore, AIF				de Smith, Adam J.; Walters, Robin G.; Coin, Lachlan J. M.; Steinfeld, Israel; Yakhini, Zohar; Sladek, Rob; Froguel, Philippe; Blakemore, Alexandra I. F.			Small Deletion Variants Have Stable Breakpoints Commonly Associated with Alu Elements	PLOS ONE			English	Article								Copy number variants (CNVs) contribute significantly to human genomic variation, with over 5000 loci reported, covering more than 18% of the euchromatic human genome. Little is known, however, about the origin and stability of variants of different size and complexity. We investigated the breakpoints of 20 small, common deletions, representing a subset of those originally identified by array CGH, using Agilent microarrays, in 50 healthy French Caucasian subjects. By sequencing PCR products amplified using primers designed to span the deleted regions, we determined the exact size and genomic position of the deletions in all affected samples. For each deletion studied, all individuals carrying the deletion share identical upstream and downstream breakpoints at the sequence level, suggesting that the deletion event occurred just once and later became common in the population. This is supported by linkage disequilibrium (LD) analysis, which has revealed that most of the deletions studied are in moderate to strong LD with surrounding SNPs, and have conserved long-range haplotypes. Analysis of the sequences flanking the deletion breakpoints revealed an enrichment of microhomology at the breakpoint junctions. More significantly, we found an enrichment of Alu repeat elements, the overwhelming majority of which intersected deletion breakpoints at their poly-A tails. We found no enrichment of LINE elements or segmental duplications, in contrast to other reports. Sequence analysis revealed enrichment of a conserved motif in the sequences surrounding the deletion breakpoints, although whether this motif has any mechanistic role in the formation of some deletions has yet to be determined. Considered together with existing information on more complex inherited variant regions, and reports of de novo variants associated with autism, these data support the presence of different subgroups of CNV in the genome which may have originated through different mechanisms.	[de Smith, Adam J.; Walters, Robin G.; Froguel, Philippe; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England; [Coin, Lachlan J. M.] Imperial Coll London, Dept Epidemiol & Publ Hlth, London, England; [Steinfeld, Israel; Yakhini, Zohar] Agilent Lab, Petah Tiqwa, Israel; [Sladek, Rob] McGill Univ, Genome Quebec Innovat Ctr, Dept Human Genet, Montreal, PQ H3A 2T5, Canada; [Sladek, Rob] McGill Univ, Genome Quebec Innovat Ctr, Dept Med, Montreal, PQ H3A 2T5, Canada; [Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS 8090, Lille, France	Imperial College London; Imperial College London; Agilent Technologies; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	de Smith, AJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London, England.	a.blakemore@imperial.ac.uk	Walters, Robin G/E-6069-2010; Blakemore, Alexandra I F/D-2253-2009; Coin, Lachlan/O-4976-2019; Coin, Lachlan JM/A-9001-2014; FROGUEL, Philippe/O-6799-2017; Sladek, Robert/R-2391-2019	Walters, Robin G/0000-0002-9179-0321; Blakemore, Alexandra I F/0000-0003-0661-564X; Coin, Lachlan/0000-0002-4300-455X; Coin, Lachlan JM/0000-0002-4300-455X; FROGUEL, Philippe/0000-0003-2972-0784; Sladek, Robert/0000-0002-2730-1204; Yakhini, Zohar/0000-0002-0420-5412; de Smith, Adam/0000-0003-4880-7543	Hammersmith Hospital Trust; Genome Quebec; MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: researchfish	Hammersmith Hospital Trust; Genome Quebec; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Hammersmith Hospital Trust, and SNP genotyping was funded by Genome Quebec.	Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Callinan PA, 2005, J MOL BIOL, V348, P791, DOI 10.1016/j.jmb.2005.02.043; Chan CY, 2007, NUCLEIC ACIDS RES, V35, P5051, DOI 10.1093/nar/gkm442; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Dewannieux M, 2005, GENOMICS, V86, P378, DOI 10.1016/j.ygeno.2005.05.009; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Han K, 2007, PLOS GENET, V3, P1939, DOI 10.1371/journal.pgen.0030184; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KIM PM, 2007, COPY NUMBER VA UNPUB; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; KRAWCZAK M, 1991, HUM GENET, V86, P425; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Perry GH, 2008, AM J HUM GENET, V82, P685, DOI 10.1016/j.ajhg.2007.12.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rozen S, 2000, Methods Mol Biol, V132, P365; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; SMIT AFA, 1996 2004 REPEATMASK; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; DATABASE GENOMIC VAR	42	42	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2008	3	8							e3104	10.1371/journal.pone.0003104	http://dx.doi.org/10.1371/journal.pone.0003104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	427RQ	18769679	Green Published, gold			2022-12-27	WOS:000264796800009
J	Smith, SA; Tank, DC; Boulanger, LA; Bascom-Slack, CA; Eisenman, K; Kingery, D; Babbs, B; Fenn, K; Greene, JS; Hann, BD; Keehner, J; Kelley-Swift, EG; Kembaiyan, V; Lee, SJ; Li, PY; Light, DY; Lin, EH; Ma, C; Moore, E; Schorn, MA; Vekhter, D; Nunez, PV; Strobel, GA; Donoghue, MJ; Strobel, SA				Smith, Stephen A.; Tank, David C.; Boulanger, Lori-Ann; Bascom-Slack, Carol A.; Eisenman, Kaury; Kingery, David; Babbs, Beatrice; Fenn, Kathleen; Greene, Joshua S.; Hann, Bradley D.; Keehner, Jocelyn; Kelley-Swift, Elizabeth G.; Kembaiyan, Vivek; Lee, Sun Jin; Li, Puyao; Light, David Y.; Lin, Emily H.; Ma, Cong; Moore, Emily; Schorn, Michelle A.; Vekhter, Daniel; Nunez, Percy V.; Strobel, Gart A.; Donoghue, Michael J.; Strobel, Scott A.			Bioactive Endophytes Warrant Intensified Exploration and Conservation	PLOS ONE			English	Article								Background: A key argument in favor of conserving biodiversity is that as yet undiscovered biodiversity will yield products of great use to humans. However, the link between undiscovered biodiversity and useful products is largely conjectural. Here we provide direct evidence from bioassays of endophytes isolated from tropical plants and bioinformatic analyses that novel biology will indeed yield novel chemistry of potential value. Methodology/Principal Findings: We isolated and cultured 135 endophytic fungi and bacteria from plants collected in Peru. nrDNAs were compared to samples deposited in GenBank to ascertain the genetic novelty of cultured specimens. Ten endophytes were found to be as much as 15-30% different than any sequence in GenBank. Phylogenetic trees, using the most similar sequences in GenBank, were constructed for each endophyte to measure phylogenetic distance. Assays were also conducted on each cultured endophyte to record bioactivity, of which 65 were found to be bioactive. Conclusions/Significance: The novelty of our contribution is that we have combined bioinformatic analyses that document the diversity found in environmental samples with culturing and bioassays. These results highlight the hidden hyperdiversity of endophytic fungi and the urgent need to explore and conserve hidden microbial diversity. This study also showcases how undergraduate students can obtain data of great scientific significance.	[Smith, Stephen A.; Tank, David C.; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Boulanger, Lori-Ann; Bascom-Slack, Carol A.; Eisenman, Kaury; Kingery, David; Babbs, Beatrice; Fenn, Kathleen; Greene, Joshua S.; Hann, Bradley D.; Keehner, Jocelyn; Kelley-Swift, Elizabeth G.; Kembaiyan, Vivek; Lee, Sun Jin; Li, Puyao; Light, David Y.; Lin, Emily H.; Ma, Cong; Moore, Emily; Schorn, Michelle A.; Vekhter, Daniel; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Nunez, Percy V.] Univ Nacl San Antonio Abad Cusco, Cuzco, Peru; [Strobel, Gart A.] Montana State Univ, Dept Plant Sci, Bozeman, MT USA	Yale University; Yale University; Universidad Nacional de San Antonio Abad del Cusco; Montana State University System; Montana State University Bozeman	Smith, SA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	stephen.smith@yale.edu	Fenn, Kathleen/L-6371-2019; Smith, Stephen/AAE-8623-2019; schorn, michelle/AAD-6284-2020; Smith, Stephen/B-3451-2010	Smith, Stephen/0000-0003-2035-9531; Fenn, Kathleen/0000-0001-6327-4365	Yale University; Howard Hughes Medical Institute; NSF [OISE-0636212]	Yale University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF))	This program was supported in part by a grant to Yale University, in support of S. Strobel, from the Howard Hughes Medical Institute through the HHMI Professors Program and by NSF grant OISE-0636212. The funding sources had no role in the design or conduct of the study.	Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Bacon C. W., 2000, MICROBIAL ENDOPHYTES, DOI 10.1201/9781482277302; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; HAWKSWORTH DL, 2004, STUD MYCOL, V50, P9; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; SMITH SA, 2008, PHYUTILITY PHYLOINFO; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel SA, 2007, NAT CHEM BIOL, V3, P356, DOI 10.1038/nchembio0707-356; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	14	64	89	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2008	3	8							e3052	10.1371/journal.pone.0003052	http://dx.doi.org/10.1371/journal.pone.0003052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422LJ	18725962	Green Published, Green Submitted, gold			2022-12-27	WOS:000264429000005
J	Work, TM; Aeby, GS; Maragos, JE				Work, Thierry M.; Aeby, Greta S.; Maragos, James E.			Phase Shift from a Coral to a Corallimorph-Dominated Reef Associated with a Shipwreck on Palmyra Atoll	PLOS ONE			English	Article							RHODACTIS-RHODOSTOMA; MASS MORTALITY; IRON; ACROPORA; PHYTOPLANKTON; COMMUNITIES; TENTACLES; OCEAN	Coral reefs can undergo relatively rapid changes in the dominant biota, a phenomenon referred to as phase shift. Various reasons have been proposed to explain this phenomenon including increased human disturbance, pollution, or changes in coral reef biota that serve a major ecological function such as depletion of grazers. However, pinpointing the actual factors potentially responsible can be problematic. Here we show a phase shift from coral to the corallimorpharian Rhodactis howesii associated with a long line vessel that wrecked in 1991 on an isolated atoll (Palmyra) in the central Pacific Ocean. We documented high densities of R. howesii near the ship that progressively decreased with distance from the ship whereas R. howesii were rare to absent in other parts of the atoll. We also confirmed high densities of R. howesii around several buoys recently installed on the atoll in 2001. This is the first time that a phase shift on a coral reef has been unambiguously associated with man-made structures. This association was made, in part, because of the remoteness of Palmyra and its recent history of minimal human habitation or impact. Phase shifts can have long-term negative ramification for coral reefs, and eradication of organisms responsible for phase shifts in marine ecosystems can be difficult, particularly if such organisms cover a large area. The extensive R. howesii invasion and subsequent loss of coral reef habitat at Palmyra also highlights the importance of rapid removal of shipwrecks on corals reefs to mitigate the potential of reef overgrowth by invasives.	[Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA; [Aeby, Greta S.] Univ Hawaii, Hawaii Inst Marine Biol, Honolulu, HI 96822 USA; [Maragos, James E.] US Fish & Wildlife Serv, Pacific Isl Refuges, Honolulu, HI USA	United States Department of the Interior; United States Geological Survey; University of Hawaii System; United States Department of the Interior; US Fish & Wildlife Service	Work, TM (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA.	thierry_work@usgs.gov	Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090	US Geological Survey; Hawaii Institute of Marine Biology (University of Hawaii)	US Geological Survey(United States Geological Survey); Hawaii Institute of Marine Biology (University of Hawaii)	Funding provided by the US Geological Survey and Hawaii Institute of Marine Biology (University of Hawaii).	Anderson LWJ, 2005, BIOL INVASIONS, V7, P1003, DOI 10.1007/s10530-004-3123-z; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; BRAINARD R, 2005, STATE CORAL REEF ECO, P338; Butler A, 1998, SCIENCE, V281, P207, DOI 10.1126/science.281.5374.207; CHADWICK NE, 1991, HYDROBIOLOGIA, V216, P263, DOI 10.1007/BF00026473; CHADWICK NE, 1987, BIOL BULL, V173, P110, DOI 10.2307/1541866; Chadwick-Furman NE, 2000, INVERTEBR BIOL, V119, P351; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; CHISHOLM SW, 1991, LIMNOL OCEANOGR, V36, pU1507; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; ENTSCH B, 1983, MAR BIOL, V73, P17, DOI 10.1007/BF00396281; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Johnson KS, 1997, MAR CHEM, V57, P137, DOI 10.1016/S0304-4203(97)00043-1; Kuguru B, 2007, MAR BIOL, V151, P1287, DOI 10.1007/s00227-006-0589-5; Kuguru BL, 2004, MAR BIOL, V145, P875, DOI 10.1007/s00227-004-1376-9; Langmead O, 1999, MAR BIOL, V134, P479, DOI 10.1007/s002270050564; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Maragos James, 2008, V1, P643, DOI 10.1007/978-1-4020-6847-8_16; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; PETERS EC, 1981, MAR POLLUT BULL, V12, P333, DOI 10.1016/0025-326X(81)90106-5; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Schroeder RE, 2008, B MAR SCI, V82, P345; Tkachenko KS, 2007, MAR BIOL, V151, P185, DOI 10.1007/s00227-006-0467-1; Tortell PD, 1999, FEMS MICROBIOL ECOL, V29, P1; WILLIAMS RB, 1991, HYDROBIOLOGIA, V216, P539, DOI 10.1007/BF00026511; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881	30	65	68	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2989	10.1371/journal.pone.0002989	http://dx.doi.org/10.1371/journal.pone.0002989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714355	Green Published, Green Submitted, gold			2022-12-27	WOS:000264420900015
J	Mullen, GED; Ellis, RD; Miura, K; Malkin, E; Nolan, C; Hay, M; Fay, MP; Saul, A; Zhu, DM; Rausch, K; Moretz, S; Zhou, H; Long, CA; Miller, LH; Treanor, J				Mullen, Gregory E. D.; Ellis, Ruth D.; Miura, Kazutoyo; Malkin, Elissa; Nolan, Caroline; Hay, Mhorag; Fay, Michael P.; Saul, Allan; Zhu, Daming; Rausch, Kelly; Moretz, Samuel; Zhou, Hong; Long, Carole A.; Miller, Louis H.; Treanor, John			Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; CPG-7909; AMA-1; ADJUVANT; MONKEYS; MICE; OLIGODEOXYNUCLEOTIDE; OLIGONUCLEOTIDES; IMMUNIZATION; CANDIDATE	Background: Apical Membrane Antigen 1 (AMA1), a polymorphic merozoite surface protein, is a leading blood-stage malaria vaccine candidate. This is the first reported use in humans of an investigational vaccine, AMA1-C1/Alhydrogel, with the novel adjuvant CPG 7909. Methods: A phase 1 trial was conducted at the University of Rochester with 75 malaria-naive volunteers to assess the safety and immunogenicity of the AMA1-C1/Alhydrogel+CPG 7909 malaria vaccine. Participants were sequentially enrolled and randomized within dose escalating cohorts to receive three vaccinations on days 0, 28 and 56 of either 20 mu g of AMA1-C1/Alhydrogel (R)+564 mu g CPG 7909 (n = 15), 80 mu g of AMA1-C1/Alhydrogel (R) (n = 30), or 80 mu g of AMA1-C1/Alhydrogel+564 mu g CPG 7909 (n = 30). Results: Local and systemic adverse events were significantly more likely to be of higher severity with the addition of CPG 7909. Anti-AMA1 immunoglobulin G (IgG) were detected by enzyme-linked immunosorbent assay (ELISA), and the immune sera of volunteers that received 20 mu g or 80 mu g of AMA1-C1/Alhydrogel+CPG 7909 had up to 14 fold significant increases in anti-AMA1 antibody concentration compared to 80 mg of AMA1-C1/Alhydrogel alone. The addition of CPG 7909 to the AMA1-C1/Alhydrogel vaccine in humans also elicited AMA1 specific immune IgG that significantly and dramatically increased the in vitro growth inhibition of homologous parasites to levels as high as 96% inhibition. Conclusion/Significance: The safety profile of the AMA1-C1/Alhydrogel+CPG 7909 malaria vaccine is acceptable, given the significant increase in immunogenicity observed. Further clinical development is ongoing. Trial Registration: ClinicalTrials.gov NCT00344539	[Mullen, Gregory E. D.; Ellis, Ruth D.; Miura, Kazutoyo; Zhu, Daming; Rausch, Kelly; Miller, Louis H.] NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD USA; [Malkin, Elissa] PATH Malaria Vaccine Initiative, Bethesda, MD USA; [Nolan, Caroline; Hay, Mhorag; Treanor, John] Univ Rochester, Dept Med, Rochester, NY USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Bethesda, MD USA; [Saul, Allan] Novartis Vaccines Inst Global Hlth Srl NVGH, Siena, Italy; [Moretz, Samuel; Zhou, Hong; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mullen, GED (corresponding author), NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD USA.	greg.mullen@kcl.ac.uk; ellisru@niaid.nih.gov	Saul, Allan/ABH-2091-2020; Miura, Kazutoyo/AAY-9751-2020; Saul, Allan J/I-6968-2013; Fay, Michael P/A-2974-2008	Saul, Allan/0000-0003-0665-4091; Miura, Kazutoyo/0000-0003-4455-2432; Saul, Allan J/0000-0003-0665-4091; Fay, Michael P/0000-0002-8643-9625	Extramural and Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; GIA Reference Center is supported by the PATH Malaria Vaccine Initiative, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, Z01AI001056, ZIAAI001056, Z01AI001001, ZIAAI001001, Z01AI001020, ZIAAI001020, Z01AI000241] Funding Source: NIH RePORTER	Extramural and Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GIA Reference Center is supported by the PATH Malaria Vaccine Initiative, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Extramural and Intramural Research Programs of the National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The GIA Reference Center is supported by the PATH Malaria Vaccine Initiative, USA.	Aebig JA, 2007, J IMMUNOL METHODS, V323, P139, DOI 10.1016/j.jim.2007.04.003; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; CAMPBELL G, 1985, J AM STAT ASSOC, V80, P998, DOI 10.2307/2288566; *CLINICALTRIALS GO, 2006, NCT00341250 CLINICAL; COLLINS WE, 1994, AM J TROP MED HYG, V51, P711, DOI 10.4269/ajtmh.1994.51.711; Cooper CL, 2005, AIDS, V19, P1473, DOI 10.1097/01.aids.0000183514.37513.d2; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Dicko A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001045; Dicko A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001563; DUAN S, P NATL ACAD IN PRESS; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Epstein JE, 2007, CURR OPIN MOL THER, V9, P12; Escalante AA, 2001, MOL BIOCHEM PARASIT, V113, P279, DOI 10.1016/S0166-6851(01)00229-8; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Keren DF, 2002, CLIN LAB MED, V22, P447, DOI 10.1016/S0272-2712(01)00012-9; Klinman DM, 2006, EXPERT REV VACCINES, V5, P365, DOI 10.1586/14760584.5.3.365; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Mullen GED, 2006, VACCINE, V24, P2497, DOI 10.1016/j.vaccine.2005.12.034; Mullen GED, 2007, VACCINE, V25, P5343, DOI 10.1016/j.vaccine.2007.05.007; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Polley SD, 2001, GENETICS, V158, P1505; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; REMARQUE EJ, 2008, INFECT IMMUN; SHMERLING RH, 1991, AM J MED, V91, P528, DOI 10.1016/0002-9343(91)90190-9; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Team. RDC, 2007, R LANG ENV STAT COMP; van der Spuy ZM, 2004, BEST PRACT RES CL OB, V18, P755, DOI 10.1016/j.bpobgyn.2004.06.001; *WHO, 2005, WORLD MAL REP	35	96	107	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2940	10.1371/journal.pone.0002940	http://dx.doi.org/10.1371/journal.pone.0002940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698359	Green Submitted, Green Published, gold			2022-12-27	WOS:000264412600026
J	Fuhrman, LE; Shianna, KV; Aballay, A				Fuhrman, Laura E.; Shianna, Kevin V.; Aballay, Alejandro			High-Throughput Isolation and Mapping of C. elegans Mutants Susceptible to Pathogen Infection	PLOS ONE			English	Article								We present a novel strategy that uses high-throughput methods of isolating and mapping C. elegans mutants susceptible to pathogen infection. We show that C. elegans mutants that exhibit an enhanced pathogen accumulation (epa) phenotype can be rapidly identified and isolated using a sorting system that allows automation of the analysis, sorting, and dispensing of C. elegans by measuring fluorescent bacteria inside the animals. Furthermore, we validate the use of Amplifluor (R) as a new single nucleotide polymorphism (SNP) mapping technique in C. elegans. We show that a set of 9 SNPs allows the linkage of C. elegans mutants to a 5-8 megabase sub-chromosomal region.	[Fuhrman, Laura E.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA; [Shianna, Kevin V.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA	Duke University; Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27706 USA.	a.aballay@duke.edu			NIH;  [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM070977, R01GM070977] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH GM070977. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; ALEGADO RA, 2008, CELL MICROBIOL; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Bengra C, 2002, CLIN CHEM, V48, P2131; BRENNER S, 1974, GENETICS, V77, P71; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gravato-Nobre MJ, 2005, CELL MICROBIOL, V7, P741, DOI 10.1111/j.1462-5822.2005.00523.x; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; Meneely PM, 2002, GENETICS, V162, P1169; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Myakishev MV, 2001, GENOME RES, V11, P163, DOI 10.1101/gr.157901; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nairz Knud, 2007, V396, P419; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2882	10.1371/journal.pone.0002882	http://dx.doi.org/10.1371/journal.pone.0002882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682730	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600038
J	Levavasseur, E; Laffont-Proust, I; Morain, E; Faucheux, BA; Privat, N; Peoc'h, K; Sazdovitch, V; Brandel, JP; Hauw, JJ; Haik, S				Levavasseur, Etienne; Laffont-Proust, Isabelle; Morain, Emilie; Faucheux, Baptiste A.; Privat, Nicolas; Peoc'h, Katell; Sazdovitch, Veronique; Brandel, Jean-Philippe; Hauw, Jean-Jacques; Haik, Stephane			Regulating Factors of PrPres Glycosylation in Creutzfeldt-Jakob Disease - Implications for the Dissemination and the Diagnosis of Human Prion Strains	PLOS ONE			English	Article							MOLECULAR-BASIS; BSE AGENT; PROTEIN; HETEROGENEITY; PRPSC; PHENOTYPE; MUTATION; UK	Objective: The glycoprofile of pathological prion protein (PrPres) is widely used as a diagnosis marker in Creutzfeldt-Jakob disease (CJD) and is thought to vary in a strain-specific manner. However, that the same glycoprofile of PrPres always accumulates in the whole brain of one individual has been questioned. We aimed to determine whether and how PrPres glycosylation is regulated in the brain of patients with sporadic and variant Creutzfeldt-Jakob disease. Methods: PrPres glycoprofiles in four brain regions from 134 patients with sporadic or variant CJD were analyzed as a function of the genotype at codon 129 of PRNP and the Western blot type of PrPres. Results: The regional distribution of PrPres glycoforms within one individual was heterogeneous in sporadic but not in variant CJD. PrPres glycoforms ratio significantly correlated with the genotype at codon 129 of the prion protein gene and the Western blot type of PrPres in a region-specific manner. In some cases of sCJD, the glycoprofile of thalamic PrPres was undistinguishable from that observed in variant CJD. Interpretation: Regulations leading to variations of PrPres pattern between brain regions in sCJD patients, involving host genotype and Western blot type of PrPres may contribute to the specific brain targeting of prion strains and have direct implications for the diagnosis of the different forms of CJD.	[Levavasseur, Etienne; Laffont-Proust, Isabelle; Morain, Emilie; Faucheux, Baptiste A.; Privat, Nicolas; Sazdovitch, Veronique; Brandel, Jean-Philippe; Haik, Stephane] INSERM, Avenir Team Human Prion Dis, Paris, France; [Faucheux, Baptiste A.; Sazdovitch, Veronique; Hauw, Jean-Jacques; Haik, Stephane] APHP, R Escourolle Neuropathol Lab, Paris, France; [Hauw, Jean-Jacques; Haik, Stephane] French Natl Ctr Reference Unconvention Transmiss, InVS, Paris, France; [Peoc'h, Katell] Lariboisiere Hosp, Biochem & Mol Biol Dept, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institute of Public Health Surveillance; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Haik, S (corresponding author), INSERM, Avenir Team Human Prion Dis, Paris, France.	haik@chups.jussieu.fr	Haik, Stephane/M-7247-2018; Peoc'h, Katell/V-1604-2017; Peoc'h, Katell/D-5261-2014	Peoc'h, Katell/0000-0002-8203-1243; 	Region Ile-de-France; INVS; Assistance Publique-Hapitaux de Paris	Region Ile-de-France(Region Ile-de-France); INVS; Assistance Publique-Hapitaux de Paris	This work was supported by grants from Region Ile-de-France and INVS. B.A.F. acknowledges funding from the Assistance Publique-Hapitaux de Paris (Delegation a la Recherche Clinique et au Developpement).	Asante EA, 2006, P NATL ACAD SCI USA, V103, P10759, DOI 10.1073/pnas.0604292103; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Chadeau-Hyam M, 2003, STAT METHODS MED RES, V12, P247, DOI 10.1191/0962280203sm330ra; Chasseigneaux S, 2006, NEUROSCI LETT, V408, P165, DOI 10.1016/j.neulet.2006.08.008; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Head MW, 2004, ANN NEUROL, V55, P851, DOI 10.1002/ana.20127; Hill AF, 2006, BRAIN, V129, P676, DOI 10.1093/brain/awl013; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; MONARI L, 1994, P NATL ACAD SCI USA, V91, P2839, DOI 10.1073/pnas.91.7.2839; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1996, ANN NEUROL, V39, P767, DOI 10.1002/ana.410390613; Peoc'h K, 2000, HUM MUTAT, V15; Pocchiari M, 2004, BRAIN, V127, P2348, DOI 10.1093/brain/awh249; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 1999, NEUROLOGY, V53, P2173, DOI 10.1212/WNL.53.9.2173; Somerville RA, 1999, J GEN VIROL, V80, P1865, DOI 10.1099/0022-1317-80-7-1865; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Vorberg I, 2002, J BIOL CHEM, V277, P36775, DOI 10.1074/jbc.M206865200	30	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2786	10.1371/journal.pone.0002786	http://dx.doi.org/10.1371/journal.pone.0002786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665216	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300005
J	Maibach, EW; Chadwick, A; McBride, D; Chuk, M; Ebi, KL; Balbus, J				Maibach, Edward W.; Chadwick, Amy; McBride, Dennis; Chuk, Michelle; Ebi, Kristie L.; Balbus, John			Climate Change and Local Public Health in the United States: Preparedness, Programs and Perceptions of Local Public Health Department Directors	PLOS ONE			English	Article								While climate change is inherently a global problem, its public health impacts will be experienced most acutely at the local and regional level, with some jurisdictions likely to be more burdened than others. The public health infrastructure in the U. S. is organized largely as an interlocking set of public agencies at the federal, state and local level, with lead responsibility for each city or county often residing at the local level. To understand how directors of local public health departments view and are responding to climate change as a public health issue, we conducted a telephone survey with 133 randomly selected local health department directors, representing a 61% response rate. A majority of respondents perceived climate change to be a problem in their jurisdiction, a problem they viewed as likely to become more common or severe over the next 20 years. Only a small minority of respondents, however, had yet made climate change adaptation or prevention a top priority for their health department. This discrepancy between problem recognition and programmatic responses may be due, in part, to several factors: most respondents felt personnel in their health department-and other key stakeholders in their community-had a lack of knowledge about climate change; relatively few respondents felt their own health department, their state health department, or the Centers for Disease Control and Prevention had the necessary expertise to help them create an effective mitigation or adaptation plan for their jurisdiction; and most respondents felt that their health department needed additional funding, staff and staff training to respond effectively to climate change. These data make clear that climate change adaptation and prevention are not currently major activities at most health departments, and that most, if not all, local health departments will require assistance in making this transition. We conclude by making the case that, through their words and actions, local health departments and their staff can and should play a role in alerting members of their community about the prospect of public health impacts from climate change in their jurisdiction.	[Maibach, Edward W.] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Chadwick, Amy] Penn State Univ, State Coll, PA USA; [McBride, Dennis] Milford Dept Hlth, Milford, MA USA; [Chuk, Michelle] Natl Assoc County & City Hlth Officials, Washington, DC USA; [Ebi, Kristie L.] ESS, LLC, Alexandria, VA USA; [Balbus, John] Environm Defense, Washington, DC USA	George Mason University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Maibach, EW (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	emaibach@gmu.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187				[Anonymous], CLIMATE CHANGE HLTH; Bedsworth L., 2008, CLIMATE CHANGE CALIF; BENJAMIN G, 2008, PUBLIC HLTH COMMUNIT; Campbell-Lendrum D, 2007, B WORLD HEALTH ORGAN, V85, P161; CONFALONIERI U, 2007, HUMAN HLTH CLIMATE C, P339; Epstein PR, 2005, NEW ENGL J MED, V353, P1433, DOI 10.1056/NEJMp058079; FRUMKIN H, 2006, CLIMATE CHANGE PUBLI; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; GODLEE F, 2008, BMJ-BRIT MED J, V336, DOI DOI 10.1136/BMJ.39469.569815.47; Haines A, 2006, PUBLIC HEALTH, V120, P585, DOI 10.1016/j.puhe.2006.01.002; Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Leiserowitz A, 2006, CLIMATIC CHANGE, V77, P45, DOI 10.1007/s10584-006-9059-9; Markandya A, 2007, LANCET, V370, P979, DOI 10.1016/S0140-6736(07)61253-7; MARYONDAVIS A, 2008, ITS TIME ACT CLIMATE; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; McMichael AJ, 2007, LANCET, V370, P1253, DOI 10.1016/S0140-6736(07)61256-2; National Research Council, 2007, EV PROGR US CLIM CHA; Patz JA, 2006, ANN TROP MED PARASIT, V100, P535, DOI 10.1179/136485906X97426; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Patz JA, 2007, ECOHEALTH, V4, P397, DOI 10.1007/s10393-007-0141-1; WILKINSON P, 2007, LANCET, DOI DOI 10.1016/S0140-6736(06)61252-5; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9	24	73	75	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2838	10.1371/journal.pone.0002838	http://dx.doi.org/10.1371/journal.pone.0002838			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665266	Green Published, gold			2022-12-27	WOS:000264304300057
J	Mantyla, E; Alessio, GA; Blande, JD; Heijari, J; Holopainen, JK; Laaksonen, T; Piirtola, P; Klemola, T				Mantyla, Elina; Alessio, Giorgio A.; Blande, James D.; Heijari, Juha; Holopainen, Jarmo K.; Laaksonen, Toni; Piirtola, Panu; Klemola, Tero			From Plants to Birds: Higher Avian Predation Rates in Trees Responding to Insect Herbivory	PLOS ONE			English	Article							NATURAL ENEMIES; EMISSION; REFLECTANCE; OLFACTION; VOLATILES; INVOLVEMENT; ATTRACTION; EVOLUTION; RESPONSES; ISOPRENE	Background: An understanding of the evolution of potential signals from plants to the predators of their herbivores may provide exciting examples of co-evolution among multiple trophic levels. Understanding the mechanism behind the attraction of predators to plants is crucial to conclusions about co-evolution. For example, insectivorous birds are attracted to herbivore-damaged trees without seeing the herbivores or the defoliated parts, but it is not known whether birds use cues from herbivore-damaged plants with a specific adaptation of plants for this purpose. Methodology: We examined whether signals from damaged trees attract avian predators in the wild and whether birds could use volatile organic compound (VOC) emissions or net photosynthesis of leaves as cues to detect herbivore-rich trees. We conducted a field experiment with mountain birches (Betula pubescens ssp. czerepanovii), their main herbivore (Epirrita autumnata) and insectivorous birds. Half of the trees had herbivore larvae defoliating trees hidden inside branch bags and half had empty bags as controls. We measured predation rate of birds towards artificial larvae on tree branches, and VOC emissions and net photosynthesis of leaves. Principal Findings and Significance: The predation rate was higher in the herbivore trees than in the control trees. This confirms that birds use cues from trees to locate insect-rich trees in the wild. The herbivore trees had decreased photosynthesis and elevated emissions of many VOCs, which suggests that birds could use either one, or both, as cues. There was, however, large variation in how the VOC emission correlated with predation rate. Emissions of (E)-DMNT [(E)-4,8dimethyl-1,3,7-nonatriene], b-ocimene and linalool were positively correlated with predation rate, while those of highly inducible green leaf volatiles were not. These three VOCs are also involved in the attraction of insect parasitoids and predatory mites to herbivore-damaged plants, which suggests that plants may not have specific adaptations to signal only to birds.	[Mantyla, Elina; Laaksonen, Toni; Klemola, Tero] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Alessio, Giorgio A.; Blande, James D.; Heijari, Juha; Holopainen, Jarmo K.; Piirtola, Panu] Dept Environm Sci, Kuopio, Finland	University of Turku	Mantyla, E (corresponding author), Univ Turku, Sect Ecol, Dept Biol, Turku, Finland.	elkuma@utu.fi	Holopainen, Jarmo K./B-1656-2008; Laaksonen, Toni/B-4241-2014; Klemola, Tero/B-9235-2014; Blande, James/Q-9611-2019; Mäntylä, Elina/B-7777-2008	Holopainen, Jarmo K./0000-0001-5026-3245; Laaksonen, Toni/0000-0001-9035-7131; Klemola, Tero/0000-0002-8510-329X; Mäntylä, Elina/0000-0002-2267-7114; Blande, James/0000-0001-6822-0649	Jenny and Antti Wihuri Foundation; European Commission [MRTN-CT-2003-504720]; Finnish Cultural Foundation; EU LAPBIAT programme; Academy of Finland [111195, 209198, 111543]	Jenny and Antti Wihuri Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); EU LAPBIAT programme; Academy of Finland(Academy of Finland)	The study was financially supported by Jenny and Antti Wihuri Foundation (grant to E.M.), European Commission (ISONET, MRTN-CT-2003-504720, J.K.H and J.D.B), Finnish Cultural Foundation (grant to J.D.B), EU LAPBIAT programme (grant to G.A.) and the Academy of Finland (decision no. 111195 to T.K., 209198 to T.L. and 111543 to J.K.H, J.H. and P.P.).	Amo L, 2008, FUNCT ECOL, V22, P289, DOI 10.1111/j.1365-2435.2007.01361.x; BOEGE K, 2006, OIKOS, V115, P559; Cuthill Innes C., 2006, P3; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M, 2000, ENTOMOL EXP APPL, V97, P237, DOI 10.1023/A:1004111624780; Gershenzon J, 2007, P NATL ACAD SCI USA, V104, P5257, DOI 10.1073/pnas.0700906104; Gotelli NJ, 2013, ECOSIMR 1 00; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; GUENTHER AB, 1993, J GEOPHYS RES-ATMOS, V98, P12609, DOI 10.1029/93JD00527; Gwinner H, 2008, ANIM BEHAV, V75, P971, DOI 10.1016/j.anbehav.2007.08.008; Hagen SB, 2008, P ROY SOC B-BIOL SCI, V275, P1509, DOI 10.1098/rspb.2008.0122; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Haukioja E., 1988, P163; HEINRICH B, 1983, ECOLOGY, V64, P592, DOI 10.2307/1939978; Helmig D, 2006, ATMOS ENVIRON, V40, P4150, DOI 10.1016/j.atmosenv.2006.02.035; Holopainen Jarmo K., 2004, Trends in Plant Science, V9, P529, DOI 10.1016/j.tplants.2004.09.006; Janssen A, 2002, OIKOS, V97, P134, DOI 10.1034/j.1600-0706.2002.970114.x; Jones MP, 2007, J EXOT PET MED, V16, P69, DOI 10.1053/j.jepm.2007.03.012; Joutsensaari J, 2005, ATMOS CHEM PHYS, V5, P1489, DOI 10.5194/acp-5-1489-2005; KALLIO P, 1978, REP KEVO SUBARCTIC, V14, P38; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Louis J, 2005, REMOTE SENS ENVIRON, V96, P37, DOI 10.1016/j.rse.2005.01.013; Mantyla E, 2004, ECOL LETT, V7, P915, DOI 10.1111/j.1461-0248.2004.00653.x; Mantyla E, 2008, BEHAV ECOL, V19, P325, DOI 10.1093/beheco/arm135; MARQUIS RJ, 1994, ECOLOGY, V75, P2007, DOI 10.2307/1941605; Mennerat A, 2005, BEHAV PROCESS, V70, P264, DOI 10.1016/j.beproc.2005.07.005; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Muller MS, 2006, OIKOS, V114, P507, DOI 10.1111/j.2006.0030-1299.14668.x; Niinemets U, 2004, TRENDS PLANT SCI, V9, P180, DOI 10.1016/j.tplants.2004.02.006; Penuelas J, 2004, TRENDS ECOL EVOL, V19, P402, DOI 10.1016/j.tree.2004.06.002; Penuelas J, 2004, NEW PHYTOL, V162, P115, DOI 10.1046/j.1469-8137.2004.01007.x; Petit C, 2002, ECOL LETT, V5, P585, DOI 10.1046/j.1461-0248.2002.00361.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Roper TJ, 1999, ADV STUD BEHAV, V28, P247, DOI 10.1016/S0065-3454(08)60219-3; Rosenstiel TN, 2004, PLANT BIOLOGY, V6, P12, DOI 10.1055/s-2003-44722; Shimoda T, 2005, J CHEM ECOL, V31, P2019, DOI 10.1007/s10886-005-6075-6; Sipura M, 1999, OECOLOGIA, V121, P537, DOI 10.1007/s004420050960; Staudt M, 2007, TREE PHYSIOL, V27, P1433, DOI 10.1093/treephys/27.10.1433; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Van Bael SA, 2008, ECOLOGY, V89, P928, DOI 10.1890/06-1976.1; van der Meijden E, 2000, OIKOS, V89, P202, DOI 10.1034/j.1600-0706.2000.890123.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Vuorinen T, 2007, ARTHROPOD-PLANT INTE, V1, P159, DOI 10.1007/s11829-007-9013-4; Zangerl AR, 2003, BASIC APPL ECOL, V4, P91, DOI 10.1078/1439-1791-00135; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; [No title captured]	52	114	116	2	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2832	10.1371/journal.pone.0002832	http://dx.doi.org/10.1371/journal.pone.0002832			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665271	Green Published, Green Submitted, gold			2022-12-27	WOS:000264304300051
J	Tkacik, G; Gregor, T; Bialek, W				Tkacik, Gasper; Gregor, Thomas; Bialek, William			The Role of Input Noise in Transcriptional Regulation	PLOS ONE			English	Article								Gene expression levels fluctuate even under constant external conditions. Much emphasis has usually been placed on the components of this noise that are due to randomness in transcription and translation. Here we focus on the role of noise associated with the inputs to transcriptional regulation; in particular, we analyze the effects of random arrival times and binding of transcription factors to their target sites along the genome. This contribution to the total noise sets a fundamental physical limit to the reliability of genetic control, and has clear signatures, but we show that these are easily obscured by experimental limitations and even by conventional methods for plotting the variance vs. mean expression level. We argue that simple, universal models of noise dominated by transcription and translation are inconsistent with the embedding of gene expression in a network of regulatory interactions. Analysis of recent experiments on transcriptional control in the early Drosophila embryo shows that these results are quantitatively consistent with the predicted signatures of input noise, and we discuss the experiments needed to test the importance of input noise more generally.	[Tkacik, Gasper; Gregor, Thomas; Bialek, William] Princeton Univ, Lewis Sigler Inst Integrat Genom, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Gregor, Thomas] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ USA; [Bialek, William] Princeton Univ, Princeton Ctr Theoretical Phys, Princeton, NJ USA	Princeton University; Howard Hughes Medical Institute; Princeton University; Princeton University	Tkacik, G (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	gtkacik@princeton.edu	Tkacik, Gasper/C-3510-2011	Gregor, Thomas/0000-0001-9460-139X; Tkacik, Gasper/0000-0002-6699-1455	NSF [PHY-0650617]; NIH [P50 GM071508, R01 GM077599]; Burroughs Wellcome Program in Biological Dynamics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R01GM077599] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Program in Biological Dynamics(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NSF Grant PHY-0650617; NIH grants P50 GM071508, R01 GM077599; Burroughs Wellcome Program in Biological Dynamics	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Barlow H B, 1971, Vision Res, VSuppl 3, P87; BARLOW HB, 1981, PROC R SOC SER B-BIO, V212, P1, DOI 10.1098/rspb.1981.0022; BERG HC, 1977, BIOPHYS J, V20, P193, DOI 10.1016/S0006-3495(77)85544-6; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; BIALEK W, 1987, ANNU REV BIOPHYS BIO, V16, P455; BIALEK W, 2006, ARXIVORGQBIOMN060100; BIALEK W, 2002, PHYS BIOMOLECULES CE, P485; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Burz DS, 1998, EMBO J, V17, P5998, DOI 10.1093/emboj/17.20.5998; CONTI F, 1975, J PHYSIOL-LONDON, V248, P45, DOI 10.1113/jphysiol.1975.sp010962; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; FATT P, 1950, NATURE, V166, P597, DOI 10.1038/166597a0; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; LECAR H, 1971, BIOPHYS J, V11, P1068, DOI 10.1016/S0006-3495(71)86278-1; LECAR H, 1971, BIOPHYS J, V11, P1048, DOI 10.1016/S0006-3495(71)86277-X; Luria SE, 1943, GENETICS, V28, P491; Ma XG, 1996, DEVELOPMENT, V122, P1195; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedone PV, 1996, P NATL ACAD SCI USA, V93, P2822, DOI 10.1073/pnas.93.7.2822; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Ptashne M., 1992, A GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Reinitz J, 2007, NATURE, V448, P420, DOI 10.1038/448420a; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schneidman E, 1998, NEURAL COMPUT, V10, P1679, DOI 10.1162/089976698300017089; SIGWORTH FJ, 1977, NATURE, V270, P265, DOI 10.1038/270265a0; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; STEVENS CF, 1972, BIOPHYS J, V12, P1028, DOI 10.1016/S0006-3495(72)86141-1; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; van Zon JS, 2006, BIOPHYS J, V91, P4350, DOI 10.1529/biophysj.106.086157; VERVEEN AA, 1965, KYBERNETIK, V2, P152; VERVEEN AA, 1968, PR INST ELECTR ELECT, V56, P906, DOI 10.1109/PROC.1968.6443; Walczak AM, 2005, BIOPHYS J, V88, P828, DOI 10.1529/biophysj.104.050666; Winston RL, 1999, BIOCHEMISTRY-US, V38, P5138, DOI 10.1021/bi982856a; Zhao C, 2002, DEVELOPMENT, V129, P1669	43	66	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2774	10.1371/journal.pone.0002774	http://dx.doi.org/10.1371/journal.pone.0002774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648612	Green Published, gold, Green Submitted			2022-12-27	WOS:000264302900044
J	Bentley, RA				Bentley, R. Alexander			Random Drift versus Selection in Academic Vocabulary: An Evolutionary Analysis of Published Keywords	PLOS ONE			English	Article								The evolution of vocabulary in academic publishing is characterized via keyword frequencies recorded in the ISI Web of Science citations database. In four distinct case-studies, evolutionary analysis of keyword frequency change through time is compared to a model of random copying used as the null hypothesis, such that selection may be identified against it. The case studies from the physical sciences indicate greater selection in keyword choice than in the social sciences. Similar evolutionary analyses can be applied to a wide range of phenomena; wherever the popularity of multiple items through time has been recorded, as with web searches, or sales of popular music and books, for example.	[Bentley, R. Alexander] Univ Durham, Dept Anthropol, Durham, England	Durham University	Bentley, RA (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	r.a.bentley@durham.ac.uk	Bentley, R Alexander/GWZ-8982-2022	Bentley, R. Alexander/0000-0001-9086-2197				Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Bentley RA, 2006, ANTIQUITY, V80, P196, DOI 10.1017/S0003598X00093364; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bentley RA, 2003, AM ANTIQUITY, V68, P459, DOI 10.2307/3557104; Bordieu P., 1977, OUTLINE THEORY PRACT; Fryer RG, 2004, Q J ECON, V119, P767, DOI 10.1162/0033553041502180; Gillespie J. H., 2004, POPULATION GENETICS; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Hahn MW., 2003, P R SOC LOND B, V270, pS1, DOI [10.1098/rspb.2002.2234, DOI 10.1098/RSPB.2002.2234]; Hayes B, 2008, AM SCI, V96, P274, DOI 10.1511/2008.73.3822; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; HULL DL, 2001, SCI SELECTION; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ioannidis JPA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000005; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; MESOUDI A, EVOLUTION H IN PRESS; Minnhagen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001690; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Shennan SJ, 2001, AM ANTIQUITY, V66, P577, DOI 10.2307/2694174; Shennan S, 2008, P NATL ACAD SCI USA, V105, P3175, DOI 10.1073/pnas.0800666105; Simkin M.V., 2003, COMPLEX SYSTEMS, V14, P269, DOI DOI 10.1111/J.1740-9713.2006.00202.X; Simkin MV, 2007, J AM SOC INF SCI TEC, V58, P1661, DOI 10.1002/asi.20653; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; WITTEN TA, 1981, PHYS REV LETT, V47, P1400, DOI 10.1103/PhysRevLett.47.1400; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	30	32	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 27	2008	3	8							e3057	10.1371/journal.pone.0003057	http://dx.doi.org/10.1371/journal.pone.0003057			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	427RM	18728786	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000264796400006
J	Rodriguez-Girones, MA; Llandres, AL				Rodriguez-Girones, Miguel A.; Llandres, Ana L.			Resource Competition Triggers the Co-Evolution of Long Tongues and Deep Corolla Tubes	PLOS ONE			English	Article								Background: It is normally thought that deep corolla tubes evolve when a plant's successful reproduction is contingent on having a corolla tube longer than the tongue of the flower's pollinators, and that pollinators evolve ever-longer tongues because individuals with longer tongues can obtain more nectar from flowers. A recent model shows that, in the presence of pollinators with long and short tongues that experience resource competition, coexisting plant species can diverge in corolla-tube depth, because this increases the proportion of pollen grains that lands on co-specific flowers. Methodology/Principal Findings: We have extended the model to study whether resource competition can trigger the co-evolution of tongue length and corolla-tube depth. Starting with two plant and two pollinator species, all of them having the same distribution of tongue length or corolla-tube depth, we show that variability in corolla-tube depth leads to divergence in tongue length, provided that increasing tongue length is not equally costly for both species. Once the two pollinator species differ in tongue length, divergence in corolla-tube depth between the two plant species ensues. Conclusions/Significance: Co-evolution between tongue length and corolla-tube depth is a robust outcome of the model, obtained for a wide range of parameter values, but it requires that tongue elongation is substantially easier for one pollinator species than for the other, that pollinators follow a near-optimal foraging strategy, that pollinators experience competition for resources and that plants experience pollination limitation.	[Rodriguez-Girones, Miguel A.; Llandres, Ana L.] CSIC, Estac Expt Zonas Aridas, Dept Funct & Evolutionary Ecol, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Rodriguez-Girones, MA (corresponding author), CSIC, Estac Expt Zonas Aridas, Dept Funct & Evolutionary Ecol, Almeria, Spain.	rgirones@eeza.csic.es	Rodriguez-Girones, Miguel A/H-1859-2015	Rodriguez-Girones, Miguel A/0000-0002-5619-9819	Spanish Ministry of Science and Technology [CGL2007-63223]; CSIC [I3P-BPD2005]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CSIC	This work was supported by the Spanish Ministry of Science and Technology (project CGL2007-63223 to MARG)and CSIC (studentship I3P-BPD2005 to ALL). Funders played no role in this study.	Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Belt T., 1874, NATURALIST NICARAGUA; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; Darwin C., 1877, VARIOUS CONTRIVANCES; Darwin C. R., 1904, VARIOUS CONTRIVANCES; Heinrich B., 1979, BUMBLEBEE EC; JOHNSON SD, 1995, PLANT SYST EVOL, V195, P169, DOI 10.1007/BF00989293; Johnson SD, 1997, EVOLUTION, V51, P45, DOI 10.1111/j.1558-5646.1997.tb02387.x; Kitching IJ, 2002, ZOOL J LINN SOC-LOND, V135, P471, DOI 10.1046/j.1096-3642.2002.00021.x; LAVERTY TM, 1980, CAN J ZOOL, V58, P1324, DOI 10.1139/z80-184; LAVERTY TM, 1994, ANIM BEHAV, V47, P531, DOI 10.1006/anbe.1994.1077; Lindberg AB, 2001, J TROP ECOL, V17, P323, DOI 10.1017/S0266467401001213; Muchhala N, 2006, NATURE, V444, P701, DOI 10.1038/444701a; NILSSON LA, 1988, NATURE, V334, P147, DOI 10.1038/334147a0; PELEG B, 1992, GAME ECON BEHAV, V4, P232, DOI 10.1016/0899-8256(92)90017-M; Rodriguez-Girones MA, 2007, AM NAT, V170, P455, DOI 10.1086/520121; Rodriguez-Girones MA, 2006, BEHAV ECOL, V17, P905, DOI 10.1093/beheco/arl024; STEVENS SS, 1960, AM SCI, V48, P226; Wasserthal LT, 1997, BOT ACTA, V110, P343, DOI 10.1111/j.1438-8677.1997.tb00650.x; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857	20	22	22	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2008	3	8							e2992	10.1371/journal.pone.0002992	http://dx.doi.org/10.1371/journal.pone.0002992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422IM	18714343	gold, Green Submitted, Green Published			2022-12-27	WOS:000264420900018
J	Boasso, A; Hardy, AW; Anderson, SA; Dolan, MJ; Shearer, GM				Boasso, Adriano; Hardy, Andrew W.; Anderson, Stephanie A.; Dolan, Matthew J.; Shearer, Gene M.			HIV-Induced Type I Interferon and Tryptophan Catabolism Drive T Cell Dysfunction Despite Phenotypic Activation	PLOS ONE			English	Article								Infection by the human immunodeficiency virus (HIV) is characterized by functional impairment and chronic activation of T lymphocytes, the causes of which are largely unexplained. We cultured peripheral blood mononuclear cells (PBMC) from HIV-uninfected donors in the presence or absence of HIV. HIV exposure increased expression of the activation markers CD69 and CD38 on CD4 and CD8 T cells. IFN-alpha/beta, produced by HIV-activated plasmacytoid dendritic cells (pDC), was necessary and sufficient for CD69 and CD38 upregulation, as the HIV-induced effect was inhibited by blockade of IFN-alpha/beta receptor and mimicked by recombinant IFN-alpha/beta. T cells from HIV-exposed PBMC showed reduced proliferation after T cell receptor stimulation, partially prevented by 1-methyl tryptophan, a competitive inhibitor of the immunesuppressive enzyme indoleamine (2,3)-dioxygenase (IDO), expressed by HIV-activated pDC. HIV-induced IDO inhibited CD4 T cell proliferation by cell cycle arrest in G1/S, and prevented CD8 T cell from entering the cell cycle by downmodulating the costimulatory receptor CD28. Finally, the expression of CHOP, a marker of the stress response activated by IDO, was upregulated by HIV in T cells in vitro and is increased in T cells from HIV-infected patients. Our data provide an in vitro model for HIV-induced T cell dysregulation and support the hypothesis that activation of pDC concomitantly contribute to phenotypic T cell activation and inhibition of T cell proliferative capacity during HIV infection.	[Boasso, Adriano; Hardy, Andrew W.; Shearer, Gene M.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Boasso, Adriano] Imperial Coll, Fac Med, Dept Immunol, London, England; [Boasso, Adriano] Westminster Med Sch & Hosp, London, England; [Anderson, Stephanie A.] Henry M Jackson Fdn, Wilford Hall Med Ctr, Infect Dis Clin Res Program IDCRP, Lackland AFB, TX USA; [Dolan, Matthew J.] Henry M Jackson Fdn, San Antonio Mil Med Ctr SAMMC, Infect Dis Clin Res Program IDCRP, Ft Sam Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Imperial College London; Imperial College London; San Antonio Military Medical Center	Boasso, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	a.boasso@imperial.ac.uk		Boasso, Adriano/0000-0001-9673-6319	Intramural research Program of the CCR, NCI; Intramural AIDS Targeted Antiviral Program (IATAP); NATIONAL CANCER INSTITUTE [Z01BC009267, ZIABC009267] Funding Source: NIH RePORTER	Intramural research Program of the CCR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural research Program of the CCR, NCI and by the Intramural AIDS Targeted Antiviral Program (IATAP).	Abe M, 2005, AM J TRANSPLANT, V5, P1808, DOI 10.1111/j.1600-6143.2005.00954.x; Abel K, 2002, J VIROL, V76, P8433, DOI 10.1128/JVI.76.16.8433-8445.2002; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Boasso A, 2005, BLOOD, V105, P1574, DOI 10.1182/blood-2004-06-2089; BOASSO A, 2008, CLIN IMMUNO IN PRESS; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Boasso A, 2007, BLOOD, V109, P3351, DOI 10.1182/blood-2006-07-034785; Boasso A, 2007, CURR DRUG METAB, V8, P217, DOI 10.2174/138920007780362527; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brown KN, 2007, J IMMUNOL, V178, P6958, DOI 10.4049/jimmunol.178.11.6958; Chen LG, 2007, J IMMUNOL, V178, P6634, DOI 10.4049/jimmunol.178.10.6634; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; De Milito A, 2004, CURR HIV RES, V2, P11, DOI 10.2174/1570162043485068; DICKMEISS E, 1990, Tokai Journal of Experimental and Clinical Medicine, V15, P263; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; DOLAN MJ, 1995, J INFECT DIS, V172, P79, DOI 10.1093/infdis/172.1.79; Douek Daniel, 2007, Top HIV Med, V15, P114; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Dyrhol-Riise AM, 1999, AIDS, V13, P2365, DOI 10.1097/00002030-199912030-00008; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Foli A, 2007, J INFECT DIS, V196, P1409, DOI 10.1086/521832; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; Fowke KR, 1997, AIDS, V11, P1013, DOI 10.1097/00002030-199708000-00010; Funderburg N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001915; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; GONG V, 1984, AM J EMERG MED, V2, P336, DOI 10.1016/0735-6757(84)90131-1; Gougeon M L, 1995, Curr Top Microbiol Immunol, V200, P177; GOUGEON ML, 1995, ADV EXP MED BIOL, V374, P121; Gougeon ML, 1997, J IMMUNOL, V158, P2964; Grant RS, 2000, REDOX REP, V5, P105, DOI 10.1179/135100000101535366; Grant RS, 2000, J VIROL, V74, P4110, DOI 10.1128/JVI.74.9.4110-4115.2000; Grundstrom Susanna, 2006, Curr HIV/AIDS Rep, V3, P32, DOI 10.1007/s11904-006-0006-1; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Hosmalin A, 2006, J LEUKOCYTE BIOL, V80, P984, DOI 10.1189/jlb.0306154; Ito T, 2005, SPRINGER SEMIN IMMUN, V26, P221, DOI 10.1007/s00281-004-0180-4; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Martinson JA, 2007, IMMUNOLOGY, V120, P526, DOI 10.1111/j.1365-2567.2007.02530.x; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moanna Abeer, 2005, Curr HIV/AIDS Rep, V2, P16, DOI 10.1007/s11904-996-0004-3; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Paiardini M, 2006, J VIROL, V80, P634, DOI 10.1128/JVI.80.2.634-642.2006; Paiardini M, 2004, IMMUNOL RES, V29, P253, DOI 10.1385/IR:29:1-3:253; Paiardini M, 2001, J VIROL, V75, P10843, DOI 10.1128/JVI.75.22.10843-10855.2001; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pelchen-Matthews A, 1998, EUR J IMMUNOL, V28, P3639, DOI 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pitcher C, 1999, MOL BIOL CELL, V10, P677, DOI 10.1091/mbc.10.3.677; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Silvestri G, 2005, J MED PRIMATOL, V34, P243, DOI 10.1111/j.1600-0684.2005.00122.x; Smith DG, 2001, J NEUROVIROL, V7, P56; Soumelis V, 2001, BLOOD, V98, P906, DOI 10.1182/blood.V98.4.906; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Trimble LA, 2000, BLOOD, V96, P1021, DOI 10.1182/blood.V96.3.1021.015k37_1021_1029; Trimble LA, 2000, J VIROL, V74, P7320, DOI 10.1128/JVI.74.16.7320-7330.2000; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Vigano A, 2000, CHEM IMMUNOL, V75, P207; Woelk CH, 2004, AIDS RES HUM RETROV, V20, P1210, DOI 10.1089/aid.2004.20.1210; ZACK JA, 1995, ADV EXP MED BIOL, V374, P27; Zhang Z, 2005, CELL MOL IMMUNOL, V2, P411	86	97	106	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2961	10.1371/journal.pone.0002961	http://dx.doi.org/10.1371/journal.pone.0002961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698365	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600046
J	Chamberlain, G; Wright, K; Rot, A; Ashton, B; Middleton, J				Chamberlain, Giselle; Wright, Karina; Rot, Antal; Ashton, Brian; Middleton, Jim			Murine Mesenchymal Stem Cells Exhibit a Restricted Repertoire of Functional Chemokine Receptors: Comparison with Human	PLOS ONE			English	Article							MARROW STROMAL CELLS; INFLAMED JOINTS; BONE; EXPRESS; DIFFERENTIATION; RECRUITMENT; ENGRAFTMENT; PHENOTYPE; MIGRATION; EXPOSURE	Mesenchymal stem cells (MSCs) are non-haematopoeitic, stromal cells that are capable of differentiating into mesenchymal tissues such as bone and cartilage. They are rare in bone marrow, but have the ability to expand many-fold in culture, and retain their growth and multi-lineage potential. The properties of MSCs make them ideal candidates for tissue engineering. It has been shown that MSCs, when transplanted systemically, can home to sites of injury, suggesting that MSCs possess migratory capacity; however, mechanisms underlying migration of these cells remain unclear. Chemokine receptors and their ligands play an important role in tissue-specific homing of leukocytes. Here we define the cell surface chemokine receptor repertoire of murine MSCs from bone marrow, with a view to determining their migratory activity. We also define the chemokine receptor repertoire of human MSCs from bone marrow as a comparison. We isolated murine MSCs from the long bones of Balb/c mice by density gradient centrifugation and adherent cell culture. Human MSCs were isolated from the bonemarrow of patients undergoing hip replacement by density gradient centrifugation and adherent cell culture. The expression of chemokine receptors on the surface of MSCs was studied using flow cytometry. Primary murine MSCs expressed CCR6, CCR9, CXCR3 and CXCR6 on a large proportion of cells (73 +/- 11%, 44 +/- 25%, 55 +/- 18% and 96 +/- 2% respectively). Chemotaxis assays were used to verify functionality of these chemokine receptors. We have also demonstrated expression of these receptors on human MSCs, revealing some similarity in chemokine receptor expression between the two species. Consequently, these murine MSCs would be a useful model to further study the role of chemokine receptors in in vivo models of disease and injury, for example in recruitment of MSCs to inflamed tissues for repair or immunosupression.	[Chamberlain, Giselle; Ashton, Brian; Middleton, Jim] Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Wright, Karina] Keele Univ, Med Sch, RJAH Orthopaed Hosp, Oswestry, Shrops, England; [Rot, Antal] Novartis Inst BioMed Res, Vienna, Austria	Keele University; Keele University; Novartis	Chamberlain, G (corresponding author), Keele Univ, Leopold Muller Arthrit Res Ctr, Sch Med, RJAH Orthopaed Hosp, Oswestry, Shrops, England.	jim.middleton@rjah.nhs.uk		Rot, Antal/0000-0002-9730-6166	Keele University (UK); The Biotechnology and Biological Science Research Council (UK); BBSRC [BB/D014905/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014905/1] Funding Source: researchfish	Keele University (UK); The Biotechnology and Biological Science Research Council (UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was from Keele University (UK) and The Biotechnology and Biological Science Research Council (UK).	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Butcher EC, 1999, ADV IMMUNOL, V72, P209, DOI 10.1016/S0065-2776(08)60022-X; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Fox JM, 2007, BRIT J HAEMATOL, V137, P491, DOI 10.1111/j.1365-2141.2007.06610.x; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LOPEZ PA, 2007, STEM CELLS, V25, P1737; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Minguell JJ, 2001, EXP BIOL MED, V226, P507, DOI 10.1177/153537020122600603; Mohan K, 2007, J IMMUNOL, V179, P8463, DOI 10.4049/jimmunol.179.12.8463; Nanki T, 2005, ARTHRITIS RHEUM, V52, P3004, DOI 10.1002/art.21301; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Ringe J, 2007, J CELL BIOCHEM, V101, P135, DOI 10.1002/jcb.21172; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Saruta M, 2007, J IMMUNOL, V178, P3293, DOI 10.4049/jimmunol.178.5.3293; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Von Luttichau I, 2005, STEM CELLS DEV, V14, P329, DOI 10.1089/scd.2005.14.329; WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C	33	96	99	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2934	10.1371/journal.pone.0002934	http://dx.doi.org/10.1371/journal.pone.0002934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698345	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000264412600020
J	Kanerva, A; Lavilla-Alonso, S; Raki, M; Kangasniemi, L; Bauerschmitz, GJ; Takayama, K; Ristimaki, A; Desmond, RA; Hemminki, A				Kanerva, Anna; Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Takayama, Koichi; Ristimaki, Ari; Desmond, Renee A.; Hemminki, Akseli			Systemic Therapy for Cervical Cancer with Potentially Regulatable Oncolytic Adenoviruses	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CONDITIONALLY REPLICATIVE ADENOVIRUS; OVARIAN-CANCER; CYCLOOXYGENASE-2 PROMOTER; ENHANCED INFECTIVITY; GENE-TRANSCRIPTION; FACTOR VEGF; EXPRESSION; VECTOR; CARCINOMA	Clinical trials have confirmed the safety of selectively oncolytic adenoviruses for treatment of advanced cancers. However, increasingly effective viruses could result in more toxicity and therefore it would be useful if replication could be abrogated if necessary. We analyzed viruses containing the cyclooxygenase-2 (Cox-2) or vascular endothelial growth factor (VEGF) promoter for controlling replication. Anti-inflammatory agents can lower Cox-2 protein levels and therefore we hypothesized that also the promoter might be affected. As Cox-2 modulates expression of VEGF, also the VEGF promoter might be controllable. First, we evaluated the effect of anti-inflammatory agents on promoter activity or adenovirus infectivity in vitro. Further, we analyzed the oncolytic potency of the viruses in vitro and in vivo with and without the reagents. Moreover, the effect of on virus replication was analyzed. We found that RGD-4C or Ad5/3 modified fibers improved the oncolytic potency of the viruses in vitro and in vivo. We found that both promoters could be downregulated with dexamethasone, sodium salicylate, or salicylic acid. Oncolytic efficacy correlated with the promoter activity and in vitro virus production could be abrogated with the substances. In vivo, we saw good therapeutic efficacy of the viruses in a model of intravenous therapy of metastatic cervical cancer, but the inhibitory effect of dexamethasone was not strong enough to provide significant differences in a complex in vivo environment. Our results suggest that anti-inflammatory drugs may affect the replication of adenovirus, which might be relevant in case of replication associated side effects.	[Kanerva, Anna; Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Hemminki, Akseli] Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland; [Kanerva, Anna] Helsinki Univ Cent Hosp HUCH, Dept Obstet & Gynecol, Helsinki, Finland; [Lavilla-Alonso, Sergio; Raki, Mari; Kangasniemi, Lotta; Bauerschmitz, Gerd J.; Hemminki, Akseli] Helsinki Univ Cent Hosp HUCH, HUSLAB, Transplantation Lab, Helsinki, Finland; [Bauerschmitz, Gerd J.] Univ Dusseldorf, Dept Obstet & Gynecol, Dusseldorf, Germany; [Takayama, Koichi] Kyushu Univ, Res Inst Dis Chest, Fukuoka, Japan; [Ristimaki, Ari] Univ Helsinki, Genome Scale Biol Program, Helsinki Univ Cent Hosp, HUSLAB, Helsinki, Finland; [Desmond, Renee A.] Univ Alabama Birmingham, Biostat & Bioinformat Unit, Comprehensive Canc Ctr, Birmingham, AL USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Heinrich Heine University Dusseldorf; Kyushu University; University of Helsinki; Helsinki University Central Hospital; University of Alabama System; University of Alabama Birmingham	Kanerva, A (corresponding author), Univ Helsinki, Canc Gene Therapy Grp, Mol Canc Biol Program, Helsinki, Finland.	akseli.hemminki@helsinki.fi		Takayama, Koichi/0000-0002-7723-8960	EU FP6 THERADPOX; APOTHERAPY; HUCH Research Funds (EVO); Sigrid Juselius Foundation; Academy of Finland; Emil Aaltonen Foundation; Finnish Cancer Society; University of Helsinki; Sohlberg Foundation; Instrumentarium Research Fund; Finnish Oncology Association; Helsinki Biomedical Graduate School; Helsinki Graduate School in Biotechnology and Molecular Biology; Finnish Cultural Foundation; Research Foundation of Bayer Schering Pharma; Deutsche Forschungsgemeinschaft/DFG; Biocentrum Helsinki; Finnish Cancer Institute	EU FP6 THERADPOX(European Commission); APOTHERAPY; HUCH Research Funds (EVO); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Cancer Society; University of Helsinki; Sohlberg Foundation; Instrumentarium Research Fund; Finnish Oncology Association; Helsinki Biomedical Graduate School; Helsinki Graduate School in Biotechnology and Molecular Biology; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Research Foundation of Bayer Schering Pharma; Deutsche Forschungsgemeinschaft/DFG(German Research Foundation (DFG)); Biocentrum Helsinki; Finnish Cancer Institute	This work was supported by EU FP6 THERADPOX and APOTHERAPY, HUCH Research Funds (EVO), Sigrid Juselius Foundation, Academy of Finland, Emil Aaltonen Foundation, Finnish Cancer Society, University of Helsinki, Sohlberg Foundation, Instrumentarium Research Fund, Finnish Oncology Association, Helsinki Biomedical Graduate School, Helsinki Graduate School in Biotechnology and Molecular Biology, Finnish Cultural Foundation, Research Foundation of Bayer Schering Pharma, Deutsche Forschungsgemeinschaft/DFG and Biocentrum Helsinki. A.H. is K. Albin Johansson Research Professor of the Finnish Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 2007, MOL THER, V15, P1410, DOI 10.1038/sj.mt.6300206; Barker SD, 2003, J GENE MED, V5, P300, DOI 10.1002/jgm.341; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bauerschmitz GJ, 2004, INT J CANCER, V111, P303, DOI 10.1002/ijc.20217; Benckert C, 2003, CANCER RES, V63, P1083; Binley K, 2003, GENE THER, V10, P540, DOI 10.1038/sj.gt.3301944; BLAIR GE, 1989, VIRUS RES, V14, P339, DOI 10.1016/0168-1702(89)90026-9; Bruning A, 2001, HUM GENE THER, V12, P391, DOI 10.1089/10430340150504019; Cao Y, 2002, J CELL PHYSIOL, V190, P279, DOI 10.1002/jcp.10068; Casado E, 2001, CLIN CANCER RES, V7, P2496; Cheng WF, 1999, OBSTET GYNECOL, V93, P761, DOI 10.1016/S0029-7844(98)00505-5; Chow NH, 1997, HUM PATHOL, V28, P698, DOI 10.1016/S0046-8177(97)90179-9; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Eibl G, 2005, CANCER RES, V65, P982; Fechner H, 2003, GENE THER, V10, P1680, DOI 10.1038/sj.gt.3302051; Ferrandina G, 2002, J CLIN ONCOL, V20, P973, DOI 10.1200/JCO.20.4.973; Fujimoto J, 1999, BRIT J CANCER, V80, P827, DOI 10.1038/sj.bjc.6690428; Gralla RJ, 1999, J CLIN ONCOL, V17, P2971, DOI 10.1200/JCO.1999.17.9.2971; Hemminki A, 2003, CANCER RES, V63, P847; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; Insel PA, 1996, PHARMACOL BASIS THER, P617; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kanerva A, 2004, INT J CANCER, V110, P475, DOI 10.1002/ijc.20129; Kanerva A, 2004, GENE THER, V11, P552, DOI 10.1038/sj.gt.3302181; Kanerva A, 2007, EXPERT OPIN BIOL TH, V7, P1347, DOI 10.1517/14712598.7.9.1347; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kirn D, 2001, NAT MED, V7, P781, DOI 10.1038/89901; Krasnykh V, 2001, J VIROL, V75, P4176, DOI 10.1128/JVI.75.9.4176-4183.2001; Kulkarni S, 2001, CLIN CANCER RES, V7, P429; Lam JT, 2004, J GENE MED, V6, P1333, DOI 10.1002/jgm.635; Loncaster JA, 2000, BRIT J CANCER, V83, P620, DOI 10.1054/bjoc.2000.1319; Manome Y, 1998, HUM GENE THER, V9, P1409, DOI 10.1089/hum.1998.9.10-1409; Moriuchi M, 2001, J VIROL, V75, P192, DOI 10.1128/JVI.75.1.192-198.2001; Nagi P, 2003, J GASTROINTEST SURG, V7, P364, DOI 10.1016/S1091-255X(02)00437-7; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pruzanski W, 1998, BBA-MOL CELL RES, V1403, P47, DOI 10.1016/S0167-4889(98)00029-9; Rajecki M, 2007, MOL CANCER THER, V6, P742, DOI 10.1158/1535-7163.MCT-06-0403; Raki M, 2005, GENE THER, V12, P1198, DOI 10.1038/sj.gt.3302517; Rein DT, 2004, J GENE MED, V6, P1281, DOI 10.1002/jgm.606; Ristimaki A, 1996, BIOCHEM J, V318, P325, DOI 10.1042/bj3180325; Russell WC, 2000, J GEN VIROL, V81, P2573, DOI 10.1099/0022-1317-81-11-2573; Sarkioja M, 2008, J GENE MED, V10, P744, DOI 10.1002/jgm.1193; Small EJ, 2006, MOL THER, V14, P107, DOI 10.1016/j.ymthe.2006.02.011; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Symensma TL, 2003, J VIROL, V77, P12753, DOI 10.1128/JVI.77.23.12753-12763.2003; TORDJMAN C, 1995, BBA-LIPID LIPID MET, V1256, P249, DOI 10.1016/0005-2760(95)00026-9; WALSH D, 1992, CLEV CLIN J MED, V59, P505, DOI 10.3949/ccjm.59.5.505; Wesseling JG, 2001, CANCER GENE THER, V8, P990, DOI 10.1038/sj.cgt.7700403; Xu XM, 1999, P NATL ACAD SCI USA, V96, P5292, DOI 10.1073/pnas.96.9.5292; Yamamoto M, 2003, GASTROENTEROLOGY, V125, P1203, DOI 10.1016/S0016-5085(03)01196-X; Yamamoto M, 2001, MOL THER, V3, P385, DOI 10.1006/mthe.2001.0275; Yu W, 2007, CURR CANCER DRUG TAR, V7, P141, DOI 10.2174/156800907780058817; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	56	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2917	10.1371/journal.pone.0002917	http://dx.doi.org/10.1371/journal.pone.0002917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698374	Green Published, gold, Green Submitted			2022-12-27	WOS:000264412600005
J	Saez, ME; Gonzalez-Sanchez, JL; Ramirez-Lorca, R; Martinez-Larrad, MT; Zabena, C; Gonzalez, A; Moron, FJ; Ruiz, A; Serrano-Rios, M				Saez, Maria E.; Gonzalez-Sanchez, Jose L.; Ramirez-Lorca, Reposo; Martinez-Larrad, Maria T.; Zabena, Carina; Gonzalez, Alejandro; Moron, Francisco J.; Ruiz, Agustin; Serrano-Rios, Manuel			The CAPN10 Gene Is Associated with Insulin Resistance Phenotypes in the Spanish Population	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; HUMAN SKELETAL-MUSCLE; CALPAIN-10 GENE; METABOLIC SYNDROME; HAPLOTYPE STRUCTURE; VARIANTS; GLUCOSE; EXPRESSION; RISK; SUSCEPTIBILITY	Cardiovascular disease is the leading cause of morbidity and mortality in the industrialized world. Familial aggregation of cardiovascular risk factors is a frequent finding, but genetic factors affecting its presentation are still poorly understood. The calpain 10 gene (CAPN10) has been associated with type 2 diabetes (T2DM), a complex metabolic disorder with increased risk of cardiovascular disease. Moreover, the CAPN10 gene has been associated with the presence of metabolic syndrome (MS) in T2DM and in polycystic ovary syndrome (PCOS). In this work, we have analysed whether the polymorphisms UCSNP44, -43, -19 and -63 are related to several cardiovascular risk factors in the context of MS. Molecular analysis of CAPN10 gene was performed in 899 individuals randomly chosen from a cross-sectional population-based epidemiological survey. We have found that CAPN10 gene in our population is mainly associated with two indicators of the presence of insulin resistance: glucose levels two hours after a 75-g oral glucose tolerance test (OGTT) and HOMA values, although cholesterol levels and blood pressure values are also influenced by CAPN10 variants. In addition, the 1221/1121 haplogenotype is under-represented in individuals that fulfil the International Diabetes Federation (IDF) diagnostic criteria for MS. Our results suggest that CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.	[Saez, Maria E.; Ramirez-Lorca, Reposo; Moron, Francisco J.; Ruiz, Agustin] Neocodex, Dept Genom Estruct, Seville, Spain; [Gonzalez-Sanchez, Jose L.; Martinez-Larrad, Maria T.; Zabena, Carina; Serrano-Rios, Manuel] Hosp Clin San Carlos, Dept Med Interna 2, Madrid, Spain; [Gonzalez, Alejandro] Ctr Avanzado Fertilidad CAF, Unidad Reprod Genet Humana, Cadiz, Spain	Hospital Clinico San Carlos	Saez, ME (corresponding author), Neocodex, Dept Genom Estruct, Seville, Spain.	mesaez@neocodex.es	Ramirez-Lorca, Reposo/A-5807-2012; Reposo, Ramirez-Lorca/D-7907-2014; Ruiz, Agustín/L-4469-2019; Morón, Francisco J/A-4852-2012; Ruiz, Agustin/G-5677-2012; Saez, Maria E/C-8093-2012; Serrano Ríos, Manuel/E-4625-2019	Ruiz, Agustín/0000-0003-2633-2495; Serrano Ríos, Manuel/0000-0002-3214-1444; Ramirez Lorca, Reposo/0000-0002-1594-0404; MORON CIVANTO, FRANCISCO J./0000-0002-1961-2723; Saez, Maria/0000-0001-9299-2534	Ministerio de Ciencia y Tecnologia of Spain [FIT-010000-2003-36, FIT-010000-2003-89, FIT-0100002003-70, PTQ2003-0783, PTQ2003-0546, PTQ2003-0549]; Fondo de Investigaciones Sanitarias [FISS 03/1618]; Red de Centros RCMN, Madrid, Spain [C03/08]; CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas)	Ministerio de Ciencia y Tecnologia of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Red de Centros RCMN, Madrid, Spain; CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas)	This work has been partially funded by the Ministerio de Ciencia y Tecnologia of Spain (FIT-010000-2003-36, FIT-010000-2003-89, FIT-0100002003-70, PTQ2003-0783, PTQ2003-0546 and PTQ2003-0549). It has been also supported by grants FISS 03/1618 from Fondo de Investigaciones Sanitarias, a grant from Red de Centros RCMN (C03/08), Madrid, Spain and by CIBERDEM (Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], CIRCULATION, V106, P3143; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Brown AE, 2007, MOL GENET METAB, V91, P318, DOI 10.1016/j.ymgme.2007.05.001; Carlsson E, 2004, J CLIN ENDOCR METAB, V89, P3601, DOI 10.1210/jc.2003-032105; Chen SF, 2007, CHINESE MED J-PEKING, V120, P2218, DOI 10.1097/00029330-200712020-00012; Clark VJ, 2005, HUM GENET, V117, P258, DOI 10.1007/s00439-005-1305-0; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cox NJ, 2004, DIABETES, V53, pS19, DOI 10.2337/diabetes.53.2007.S19; DIAZVILLASENOR A, 2007, BLOOD CELLS MOL 1025; Ehrmann DA, 2002, J CLIN ENDOCR METAB, V87, P1669, DOI 10.1210/jc.87.4.1669; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Fingerlin TE, 2002, DIABETES, V51, P1644, DOI 10.2337/diabetes.51.5.1644; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Genuth S, 2003, DIABETES CARE, V26, P3160; Gonzalez A, 2003, J CLIN ENDOCR METAB, V88, P5529, DOI 10.1210/jc.2003-030322; Gonzalez A, 2002, J CLIN ENDOCR METAB, V87, P3971, DOI 10.1210/jc.87.8.3971; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hong Jing, 2002, Zhonghua Nei Ke Za Zhi, V41, P370; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kang ES, 2006, DIABETES RES CLIN PR, V73, P268, DOI 10.1016/j.diabres.2006.01.011; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; Martinez-Larrad MT, 2005, MED CLIN-BARCELONA, V125, P481; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norton L, 2008, J CLIN ENDOCR METAB, V93, P992, DOI 10.1210/jc.2007-1981; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; PORETSKY L, 1987, ENDOCR REV, V8, P132, DOI 10.1210/edrv-8-2-132; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Shima Y, 2003, CLIN CHIM ACTA, V336, P89, DOI 10.1016/S0009-8981(03)00320-6; Song YQ, 2004, AM J HUM GENET, V74, P208, DOI 10.1086/381400; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Tschritter O, 2003, DIABETES CARE, V26, P1026, DOI 10.2337/diacare.26.4.1026; Tsuchiya T, 2006, MOL GENET METAB, V89, P174, DOI 10.1016/j.ymgme.2006.05.013; Vander Molen J, 2005, AM J HUM GENET, V76, P548, DOI 10.1086/428784; Vollmert C, 2007, AM J PHYSIOL-ENDOC M, V292, pE836, DOI 10.1152/ajpendo.00584.2005; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Wu B, 2005, DIABETES RES CLIN PR, V68, P155, DOI 10.1016/j.diabres.2004.09.015; Xu Qing-song, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P100	46	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2008	3	8							e2953	10.1371/journal.pone.0002953	http://dx.doi.org/10.1371/journal.pone.0002953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	422FK	18698425	gold, Green Published, Green Submitted			2022-12-27	WOS:000264412600039
J	Cook, BL; Ernberg, KE; Chung, HY; Zhang, SG				Cook, Brian L.; Ernberg, Karin E.; Chung, Hyeyoun; Zhang, Shuguang			Study of a Synthetic Human Olfactory Receptor 17-4: Expression and Purification from an Inducible Mammalian Cell Line	PLOS ONE			English	Article								In order to begin to study the structural and functional mechanisms of olfactory receptors, methods for milligram-scale purification are required. Here we demonstrate the production and expression of a synthetically engineered human olfactory receptor hOR17-4 gene in a stable tetracycline-inducible mammalian cell line (HEK293S). The olfactory receptor gene was fabricated from scratch using PCR-based gene-assembly, which facilitated codon optimization and attachment of a 9-residue bovine rhodopsin affinity tag for detection and purification. Induction of adherent cultures with tetracycline together with sodium butyrate led to hOR17-4 expression levels of similar to 30 mu g per 150 mm tissue culture plate. Fos-choline-based detergents proved highly capable of extracting the receptors, and fos-choline-14 (N-tetradecylphosphocholine) was selected for optimal solubilization and subsequent purification. Analysis by SDS-PAGE revealed both monomeric and dimeric receptor forms, as well as higher MW oligomeric species. A two-step purification method of immunoaffinity and size exclusion chromatography was optimized which enabled 0.13 milligrams of hOR17-4 monomer to be obtained at >90% purity. This high purity of hOR17-4 is not only suitable for secondary structural and functional analyses but also for subsequent crystallization trials. Thus, this system demonstrates the feasibility of purifying milligram quantities of the GPCR membrane protein hOR17-4 for fabrication of olfactory receptor-based bionic sensing device.	[Cook, Brian L.; Ernberg, Karin E.; Chung, Hyeyoun; Zhang, Shuguang] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Cook, BL (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752	John Simon Guggenheim Fellowship; NSF-CCR-0122419 MIT Center for Bits & Atoms; MIT-UROP program; ROHM Corporation, Kyoto, Japan	John Simon Guggenheim Fellowship; NSF-CCR-0122419 MIT Center for Bits & Atoms; MIT-UROP program; ROHM Corporation, Kyoto, Japan	SZ gratefully acknowledges a John Simon Guggenheim Fellowship to provide freedom to pursue new frontiers of research of membrane proteins. BC was partly supported from the NSF-CCR-0122419 MIT Center for Bits & Atoms. HC was supported by MIT-UROP program. This work was also supported in part from a generous grant from ROHM Corporation, Kyoto, Japan.	Breer H, 2003, ANAL BIOANAL CHEM, V377, P427, DOI 10.1007/s00216-003-2113-9; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carr PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh160; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Ebrahimi FAW, 1998, CURR BIOL, V8, pR431, DOI 10.1016/S0960-9822(98)70271-4; Farrens DL, 2002, J PEPT RES, V60, P336, DOI 10.1034/j.1399-3011.2002.21066.x; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; GAT U, 1994, EUR J BIOCHEM, V225, P1157, DOI 10.1111/j.1432-1033.1994.1157b.x; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Ivic L, 2002, J NEUROBIOL, V50, P56, DOI 10.1002/neu.10016; Jayadev S, 1999, ENDOCRINOLOGY, V140, P2010, DOI 10.1210/en.140.5.2010; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Katada S, 2004, J NEUROCHEM, V90, P1453, DOI 10.1111/j.1471-4159.2004.02619.x; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; Kiefer H, 1996, BIOCHEMISTRY-US, V35, P16077, DOI 10.1021/bi9612069; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200; Levasseur G, 2003, EUR J BIOCHEM, V270, P2905, DOI 10.1046/j.1432-1033.2003.03672.x; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu AH, 2003, GENOMICS, V81, P443, DOI 10.1016/S0888-7543(03)00022-3; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Lu M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-34; Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Nekrasova E, 1996, EUR J BIOCHEM, V238, P28, DOI 10.1111/j.1432-1033.1996.0028q.x; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Olender T, 2004, GENOMICS, V83, P361, DOI 10.1016/j.ygeno.2003.08.009; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Shimada M, 2002, J BIOL CHEM, V277, P31774, DOI 10.1074/jbc.M204166200; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Takayama H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002314; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhu L, 2004, J BIOL CHEM, V279, P53828, DOI 10.1074/jbc.M408472200	46	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2920	10.1371/journal.pone.0002920	http://dx.doi.org/10.1371/journal.pone.0002920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682799	Green Published, gold			2022-12-27	WOS:000264366600070
J	Dube, S; Qin, J; Ramakrishnan, R				Dube, Simant; Qin, Jian; Ramakrishnan, Ramesh			Mathematical Analysis of Copy Number Variation in a DNA Sample Using Digital PCR on a Nanofluidic Device	PLOS ONE			English	Article							TRANSCRIPTION; GENE	Copy Number Variations (CNVs) of regions of the human genome have been associated with multiple diseases. We present an algorithm which is mathematically sound and computationally efficient to accurately analyze CNV in a DNA sample utilizing a nanofluidic device, known as the digital array. This numerical algorithm is utilized to compute copy number variation and the associated statistical confidence interval and is based on results from probability theory and statistics. We also provide formulas which can be used as close approximations.	[Dube, Simant; Qin, Jian; Ramakrishnan, Ramesh] Fluidigm Corp, San Francisco, CA USA		Dube, S (corresponding author), Fluidigm Corp, San Francisco, CA USA.	simant.dube@fluidigm.com		Dube, Simant/0000-0002-8059-531X	Fludigim Corporation	Fludigim Corporation	The authors are employees of Fludigim Corporation and this work was undertaken at Fluidigm.	BAER M, 1990, NUCLEIC ACIDS RES, V18, P97, DOI 10.1093/nar/18.1.97; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; Fieller EC, 1932, BIOMETRIKA, V24, P428, DOI 10.2307/2331976; FIELLER EC, 1954, J ROY STAT SOC B, V16, P175; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; KAPADIA AS, 2005, MATHEMATICAL STAT AP, P617; Lo YMD, 2007, P NATL ACAD SCI USA, V104, P13116, DOI 10.1073/pnas.0705765104; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P408; PAPOULIS A, 1965, PROBABILITY RANDOM V, P583; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ropers HH, 2007, AM J HUM GENET, V81, P199, DOI 10.1086/520679; SCHEAFFER RL, 1990, INTRO PROBABILITY IT, P363; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sheskin D. J, 2000, HDB PARAMETRIC NONPA, P982; Sindelka R, 2008, NUCLEIC ACIDS RES, V36, P387, DOI 10.1093/nar/gkm1024; Spurgeon SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001662; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; VONLUXBURG U, 2002, TR133 MAX PLANK I BI; VONLUXBURG U, 2007, ARXIV07110198V1; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	22	198	244	6	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2876	10.1371/journal.pone.0002876	http://dx.doi.org/10.1371/journal.pone.0002876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682853	Green Published, Green Submitted, gold			2022-12-27	WOS:000264366600032
J	Morel, AP; Lievre, M; Thomas, C; Hinkal, G; Ansieau, S; Puisieux, A				Morel, Anne-Pierre; Lievre, Marjory; Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain			Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition	PLOS ONE			English	Article								Recently, two novel concepts have emerged in cancer biology: the role of so-called "cancer stem cells'' in tumor initiation, and the involvement of an epithelial-mesenchymal transition (EMT) in the metastatic dissemination of epithelial cancer cells. Using a mammary tumor progression model, we show that cells possessing both stem and tumorigenic characteristics of "cancer stem cells'' can be derived from human mammary epithelial cells following the activation of the Ras-MAPK pathway. The acquisition of these stem and tumorigenic characters is driven by EMT induction.	[Morel, Anne-Pierre; Lievre, Marjory; Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain] Ctr Leon Berard, F-69373 Lyon, France; [Thomas, Clemence; Hinkal, George; Ansieau, Stephane; Puisieux, Alain] Inserm, U590, Lyon, France; [Puisieux, Alain] Univ Lyon, ISPB, Lyon, France	UNICANCER; Centre Leon Berard; Institut National de la Sante et de la Recherche Medicale (Inserm)	Morel, AP (corresponding author), Ctr Leon Berard, F-69373 Lyon, France.	puisieux@lyon.fnclcc.fr	Ansieau, Stephane/I-6195-2016; MOREL, Anne-Pierre/AAN-7072-2021	ANSIEAU, Stephane/0000-0003-0989-2108; PUISIEUX, Alain/0000-0002-9938-3798	Institut National du Cancer; Ligue contre le Cancer; Breast Cancer Research Foundation	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue contre le Cancer(Ligue nationale contre le cancer); Breast Cancer Research Foundation	This work was granted by the Institut National du Cancer, the Ligue contre le Cancer and the Breast Cancer Research Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cobaleda C, 2000, BLOOD, V95, P1007, DOI 10.1182/blood.V95.3.1007.003k35_1007_1013; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Gotzmann J, 2004, MUTAT RES-REV MUTAT, V566, P9, DOI 10.1016/S1383-5742(03)00033-4; HAY JG, 1995, HUM GENE THER, V6, P1487, DOI 10.1089/hum.1995.6.11-1487; Holyoake TL, 2002, LEUKEMIA, V16, P549, DOI 10.1038/sj.leu.2402444; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2007, NEW ENGL J MED, V356, P294, DOI 10.1056/NEJMe068292; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oft M, 1996, GENE DEV, V10, P2462, DOI 10.1101/gad.10.19.2462; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vermeulen L, 2008, CELL DEATH DIFFER; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	40	1195	1244	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 6	2008	3	8							e2888	10.1371/journal.pone.0002888	http://dx.doi.org/10.1371/journal.pone.0002888			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	421NW	18682804	Green Published, gold, Green Submitted			2022-12-27	WOS:000264366600044
J	Ham, TS; Lee, SK; Keasling, JD; Arkin, AP				Ham, Timothy S.; Lee, Sung K.; Keasling, Jay D.; Arkin, Adam P.			Design and Construction of a Double Inversion Recombination Switch for Heritable Sequential Genetic Memory	PLOS ONE			English	Article								Background: Inversion recombination elements present unique opportunities for computing and information encoding in biological systems. They provide distinct binary states that are encoded into the DNA sequence itself, allowing us to overcome limitations posed by other biological memory or logic gate systems. Further, it is in theory possible to create complex sequential logics by careful positioning of recombinase recognition sites in the sequence. Methodology/Principal Findings: In this work, we describe the design and synthesis of an inversion switch using the fim and hin inversion recombination systems to create a heritable sequential memory switch. We have integrated the two inversion systems in an overlapping manner, creating a switch that can have multiple states. The switch is capable of transitioning from state to state in a manner analogous to a finite state machine, while encoding the state information into DNA. This switch does not require protein expression to maintain its state, and "remembers'' its state even upon cell death. We were able to demonstrate transition into three out of the five possible states showing the feasibility of such a switch. Conclusions/Significance: We demonstrate that a heritable memory system that encodes its state into DNA is possible, and that inversion recombination system could be a starting point for more complex memory circuits. Although the circuit did not fully behave as expected, we showed that a multi-state, temporal memory is achievable.	[Ham, Timothy S.; Keasling, Jay D.; Arkin, Adam P.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Lee, Sung K.; Keasling, Jay D.; Arkin, Adam P.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA USA; [Keasling, Jay D.] Univ Calif, Dept Chem Engn, Berkeley, CA USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Ham, TS (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Lee, Sung K/HGC-6832-2022; Keasling, Jay D/J-9162-2012; Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008; Lee, Sung K/E-6525-2010	Keasling, Jay D/0000-0003-4170-6088; Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931; 	National Science Foundation; NIH [5R01-GM63525-03]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063525] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Science Foundation supported Synthetic Biology Engineering Research Center. APA would like to acknowledge NIH grant # 5R01-GM63525-03 for allowing the initiation of this project and the Howard Hughes Medical Institute for partial support during its progress. We authors declare that no competing interests exist.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; ANDERSON JC, 2006, ADDRESSABLE CONJUGAT; ARKIN A, 1994, BIOPHYS J, V67, P560, DOI 10.1016/S0006-3495(94)80516-8; BARRICK D, 1994, NUCLEIC ACIDS RES, V22, P1287, DOI 10.1093/nar/22.7.1287; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Blomfield IC, 1997, MOL MICROBIOL, V23, P705, DOI 10.1046/j.1365-2958.1997.2241615.x; Carrier TA, 1997, BIOTECHNOL PROGR, V13, P699, DOI 10.1021/bp970095h; DAY A, 2007, BACTOBLOOD; Dworkin J, 1997, P NATL ACAD SCI USA, V94, P985, DOI 10.1073/pnas.94.3.985; GALLY DL, 1994, J BACTERIOL, V176, P5665, DOI 10.1128/JB.176.18.5665-5672.1994; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; HAYNES KA, 2008, IET SYNTHETIC BIOL, V1, P44; HJELMFELT A, 1991, P NATL ACAD SCI USA, V88, P10983, DOI 10.1073/pnas.88.24.10983; Isaacs FJ, 2006, NAT BIOTECHNOL, V24, P545, DOI 10.1038/nbt1208; JOHNSON RC, 2002, BACTERIAL SITE SPECI; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; KOMANO T, 1987, NUCLEIC ACIDS RES, V15, P1165, DOI 10.1093/nar/15.3.1165; Lee SK, 2005, J BACTERIOL, V187, P2793, DOI 10.1128/JB.187.8.2793-2800.2005; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; MOSKOWITZ IPG, 1991, GENE DEV, V5, P1635, DOI 10.1101/gad.5.9.1635; OSUNA R, 1995, J BACTERIOL, V177, P2021, DOI 10.1128/jb.177.8.2021-2032.1995; Parker J, 2003, EMBO REP, V4, P7, DOI 10.1038/sj.embor.embor719; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANDMEIER H, 1990, P NATL ACAD SCI USA, V87, P1109, DOI 10.1073/pnas.87.3.1109; VANPUTTE P, 1992, TRENDS GENET, V8, P457; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Wolf DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001700	35	102	107	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2815	10.1371/journal.pone.0002815	http://dx.doi.org/10.1371/journal.pone.0002815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665232	Green Submitted, Green Published, gold			2022-12-27	WOS:000264304300034
J	Ibanez-Ventoso, C; Vora, M; Driscoll, M				Ibanez-Ventoso, Carolina; Vora, Mehul; Driscoll, Monica			Sequence Relationships among C-elegans, D-melanogaster and Human microRNAs Highlight the Extensive Conservation of microRNAs in Biology	PLOS ONE			English	Article							BRAIN-EXPRESSED MICRORNAS; TARGET PREDICTIONS; SMALL RNAS; IDENTIFICATION; GENES; MOUSE; INHIBITION; PATTERNS; TESTIS; ROLES	microRNAs act in a prevalent and conserved post-transcriptional gene regulatory mechanism that impacts development, homeostasis and disease, yet biological functions for the vast majority of miRNAs remain unknown. Given the power of invertebrate genetics to promote rapid evaluation of miRNA function, recently expanded miRNA identifications (miRBase 10.1), and the importance of assessing potential functional redundancies within and between species, we evaluated miRNA sequence relationships by 59 end match and overall homology criteria to compile a snapshot overview of miRNA families within the C. elegans and D. melanogaster genomes that includes their identified human counterparts. This compilation expands literature documentation of both the number of families and the number of family members, within and between nematode and fly models, and highlights sequences conserved between species pairs or among nematodes, flies and humans. Themes that emerge include the substantial potential for functional redundancy of miRNA sequences within species (84/139 C. elegans miRNAs and 70/152 D. melanogaster miRNAs share significant homology with other miRNAs encoded by their respective genomes), and the striking extent to which miRNAs are conserved across species-over half (73/139) C. elegans miRNAs share sequence homology with miRNAs encoded also in both fly and human genomes. This summary analysis of mature miRNA sequence relationships provides a quickly accessible resource that should facilitate functional and evolutionary analyses of miRNAs and miRNA families.	[Ibanez-Ventoso, Carolina; Vora, Mehul; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Ibanez-Ventoso, C (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	driscoll@biology.rutgers.edu	Vora, Mehul/P-4848-2016	Vora, Mehul/0000-0002-1239-6458	NIH [R01 AG024882, R21 AG029376]; NATIONAL INSTITUTE ON AGING [R01AG024882, R21AG029376] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work has been supported by NIH grant R01 AG024882 and R21 AG029376.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Esau CC, 2008, METHODS, V44, P55, DOI 10.1016/j.ymeth.2007.11.001; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esquela-Kerscher A, 2005, DEV DYNAM, V234, P868, DOI 10.1002/dvdy.20572; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; GREY F, 2007, MED MICROBIOL IMMUNO; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hayes GD, 2006, DEVELOPMENT, V133, P4631, DOI 10.1242/dev.02655; HE L, 2004, NAT REV GENET, V5, P522; Huang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-66; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Karali M, 2007, INVEST OPHTH VIS SCI, V48, P509, DOI 10.1167/iovs.06-0866; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lakshmipathy U, 2007, STEM CELLS DEV, V16, P1003, DOI 10.1089/scd.2007.0026; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Novotny GW, 2007, INT J ANDROL, V30, P316, DOI 10.1111/j.1365-2605.2007.00773.x; Orom UA, 2006, GENE, V372, P137, DOI 10.1016/j.gene.2005.12.031; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sandmann T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001265; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tagami Y, 2007, DNA RES, V14, P227, DOI 10.1093/dnares/dsm022; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014; NATL BIORESOURCE PRO; MIRBASE	85	122	137	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2818	10.1371/journal.pone.0002818	http://dx.doi.org/10.1371/journal.pone.0002818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665242	Green Submitted, gold, Green Published			2022-12-27	WOS:000264304300037
J	Kirby, MX; Jones, DS; MacFadden, BJ				Kirby, Michael Xavier; Jones, Douglas S.; MacFadden, Bruce J.			Lower Miocene Stratigraphy along the Panama Canal and Its Bearing on the Central American Peninsula	PLOS ONE			English	Article								Before the formation of the Central American Isthmus, there was a Central American Peninsula. Here we show that southern Central America existed as a peninsula as early as 19 Ma, based on new lithostratigraphic, biostratigraphic and strontium chemostratigraphic analyses of the formations exposed along the Gaillard Cut of the Panama Canal. Land mammals found in the Miocene Cucaracha Formation have similar body sizes to conspecific taxa in North America, indicating that there existed a terrestrial connection with North America that allowed gene flow between populations during this time. How long did this peninsula last? The answer hinges on the outcome of a stratigraphic dispute: To wit, is the terrestrial Cucaracha Formation older or younger than the marine La Boca Formation? Previous stratigraphic studies of the Panama Canal Basin have suggested that the Cucaracha Formation lies stratigraphically between the shallow-marine Culebra Formation and the shallow-to-upper-bathyal La Boca Formation, the latter containing the Emperador Limestone. If the La Boca Formation is younger than the Cucaracha Formation, as many think, then the peninsula was short-lived (1-2 m.y.), having been submerged in part by the transgression represented by the overlying La Boca Formation. On the other hand, our data support the view that the La Boca Formation is older than the Cucaracha Formation. Strontium dating shows that the La Boca Formation is older (23.07 to 20.62 Ma) than both the Culebra (19.83-19.12 Ma) and Cucaracha (Hemingfordian to Barstovian North American Land Mammal Ages; 19-14 Ma) formations. The Emperador Limestone is also older (21.24-20.99 Ma) than the Culebra and Cucaracha formations. What has been called the "La Boca Formation'' (with the Emperador Limestone), is re-interpreted here as being the lower part of the Culebra Formation. Our new data sets demonstrate that the main axis of the volcanic arc in southern Central America more than likely existed as a peninsula connected to northern Central America and North America for much of the Miocene, which has profound implications for our understanding of the tectonic, climatic, oceanographic and biogeographic history related to the formation of the Isthmus of Panama.	[Kirby, Michael Xavier] Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Balboa, Panama; [Jones, Douglas S.; MacFadden, Bruce J.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL USA	Smithsonian Institution; Smithsonian Tropical Research Institute; State University System of Florida; University of Florida	Kirby, MX (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Paleoecol & Archaeol, Balboa, Panama.	mkirby@flmnh.ufl.edu			U.S. National Science Foundation [EAR0642528, OISE0638538]; Smithsonian Institution	U.S. National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution)	Funded by the U.S. National Science Foundation (EAR0642528 and OISE0638538) and the Smithsonian Institution.	Bhattacharya J.P., 1992, FACIES MODELS RESPON, P157; Blacut G, 1969, Contr. Cushman Fdn foramin. Res., V20, P1; Burton KW, 1997, NATURE, V386, P382, DOI 10.1038/386382a0; CASE JE, 1974, GEOL SOC AM BULL, V85, P645, DOI 10.1130/0016-7606(1974)85<645:OCFBOE>2.0.CO;2; Coates A.G., 1999, B AM PALEONTOL, V357, P17; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Coates Anthony G., 1996, P21; Collins L.S., 1995, GEOLOGICAL SOC AM SP, P263, DOI DOI 10.1130/SPE295-P263; Collins L. S., 1999, B AM PALEONTOL, V357, P5; Collins LS, 1996, GEOLOGY, V24, P687, DOI 10.1130/0091-7613(1996)024<0687:TLMPIS>2.3.CO;2; Compton R. R., 1985, GEOLOGY IN THE FIELD, P398; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; EMILIANI C, 1972, PALAEOGEOGR PALAEOCL, V11, P1, DOI 10.1016/0031-0182(72)90034-X; Escalante G., 1990, CARIBBEAN REGION GEO, VH, P201; Gradstein FM, 2004, GEOLOGIC TIME SCALE; GRAHAM A, 1985, ANN MO BOT GARD, V72, P485, DOI 10.2307/2399100; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haug GH, 2001, GEOLOGY, V29, P207, DOI 10.1130/0091-7613(2001)029<0207:ROPUOO>2.0.CO;2; HILL RT, 1898, B MUS COMP ZOOL HARV, V28, P151; HODELL DA, 1994, PALEOCEANOGRAPHY, V9, P405, DOI 10.1029/94PA00292; HODELL DA, 1991, GEOLOGY, V19, P24, DOI 10.1130/0091-7613(1991)019<0024:VITSIC>2.3.CO;2; JACKSON JBC, 1993, SCIENCE, V260, P1624, DOI 10.1126/science.260.5114.1624; Jackson Jeremy B. C., 1996, P234; Johnson KG, 2006, J PALEONTOL, V80, P283, DOI 10.1666/0022-3360(2006)080[0283:TELREM]2.0.CO;2; JONES DS, 1993, FLORIDA GEOLOGICAL S, V37, P15; JONES SM, 1950, GEOL SOC AM BULL, V61, P893, DOI 10.1130/0016-7606(1950)61[893:GOGLAV]2.0.CO;2; KEIGWIN L, 1982, SCIENCE, V217, P350, DOI 10.1126/science.217.4557.350; KEIGWIN LD, 1978, GEOLOGY, V6, P630, DOI 10.1130/0091-7613(1978)6<630:PCOTIO>2.0.CO;2; Kirby MX, 2005, PALAEOGEOGR PALAEOCL, V228, P193, DOI 10.1016/j.palaeo.2005.06.002; LOWRIE A, 1982, MAR GEOL, V45, P261, DOI 10.1016/0025-3227(82)90114-1; MACDONALD DF, 1919, US NATL MUSEUM B, V103, P525; MACDONALD DF, 1913, ISTHMIAN GEOLOGY IST, P564; MacFadden BJ, 2004, OECOLOGIA, V140, P169, DOI 10.1007/s00442-004-1571-x; Macfadden BJ, 2006, J VERTEBR PALEONTOL, V26, P720, DOI 10.1671/0272-4634(2006)26[720:NAMLMF]2.0.CO;2; MALLINSON DJ, 1994, J SEDIMENT RES B, V64, P392; MANN P, 1995, GEOLOGICAL SOC AM SP, V295, pR11; Martin EE, 1999, PALEOCEANOGRAPHY, V14, P74, DOI 10.1029/1998PA900008; McArthur JM, 2001, J GEOL, V109, P155, DOI 10.1086/319243; Miall A D, 1992, FACIES MODELS RESPON, P119; MIALL AD, 1978, FLUVIAL SEDIMENTOLOG, P858; Miller KG, 1991, PALEOCEANOGRAPHY, V6, P33, DOI 10.1029/90PA01941; MILLER KG, 1995, GEOLOGY, V23, P747, DOI 10.1130/0091-7613(1995)023<0747:CMSION>2.3.CO;2; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; OSLICK JS, 1994, PALEOCEANOGRAPHY, V9, P427, DOI 10.1029/94PA00249; PETTIJOHN FJ, 1987, SAND SANDSTONE, P586; PIN C, 1992, ANAL CHIM ACTA, V269, P249, DOI 10.1016/0003-2670(92)85409-Y; Pratt TL, 2003, TECTONOPHYSICS, V368, P211, DOI 10.1016/S0040-1951(03)00159-8; Reineck H.E., 1975, DEPOSITIONAL SEDIMEN, P439; Retallack G.J., 2001, SOILS INTRO PALEOPED, V2nd, DOI [10.1002/9780470698716, DOI 10.1002/9780470698716]; Retallack GJ, 2007, PALAIOS, V22, P667, DOI 10.2110/palo.2006.p06-130r; Savin S. M., 1985, GREAT AM BIOTIC INTE, P303, DOI DOI 10.1007/978-1-4684-9181-4_12; SLAUGHTER B H, 1981, Journal of Vertebrate Paleontology, V1, P111; Tedford Richard H., 2004, P169; TERRY ROBERT A., 1956, OCCAS PAPERS CALIFORNIA ACAD SCI, V23, P1; VANDENBOLD WA, 1972, MICROPALEONTOLOGY, V18, P410, DOI DOI 10.2307/1485049; Vermeij G. J., 1978, BIOGEOGRAPHY ADAPTAT, P332; VERMEIJ GJ, 1986, MALACOLOGIA, V27, P29; Webb S.D., 1985, GREAT AM BIOTIC INTE, P357, DOI DOI 10.1007/978-1-4684-9181-4_14; Weyl P. K., 1968, METEOROL MONOGR, V8, P37; WHITMORE FC, 1965, SCIENCE, V148, P180, DOI 10.1126/science.148.3667.180; WOODRING WP, 1949, AAPG BULL, V33, P223; WOODRING WP, 1965, SCIENCE, V148, P961, DOI 10.1126/science.148.3672.961; WOODRING WP, 1966, P AM PHILOS SOC, V110, P425; WOODRING WP, 1964, US GEOLOGICAL SURV C, V306, P241; WOODRING WP, 1957, US GEOLOGICAL SURV A, V306, P1; Wright David B., 1998, P389	69	129	130	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2791	10.1371/journal.pone.0002791	http://dx.doi.org/10.1371/journal.pone.0002791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665219	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300010
J	Ostermeier, GC; Wiles, MV; Farley, JS; Taft, RA				Ostermeier, G. Charles; Wiles, Michael V.; Farley, Jane S.; Taft, Robert A.			Conserving, Distributing and Managing Genetically Modified Mouse Lines by Sperm Cryopreservation	PLOS ONE			English	Article								Background: Sperm from C57BL/6 mice are difficult to cryopreserve and recover. Yet, the majority of genetically modified (GM) lines are maintained on this genetic background. Methodology/Principal Findings: Reported here is the development of an easily implemented method that consistently yields fertilization rates of 70 +/- 5% with this strain. This six-fold increase is achieved by collecting sperm from the vas deferens and epididymis into a cryoprotective medium of 18% raffinose (w/v), 3% skim milk (w/v) and 477 mu M monothioglycerol. The sperm suspension is loaded into 0.25 mL French straws and cooled at 37 +/- 1 degrees C/min before being plunged and then stored in LN2. Subsequent to storage, the sperm are warmed at 2,232 +/- 162 degrees C/min and incubated in in vitro fertilization media for an hour prior to the addition of oocyte cumulus masses from superovulated females. Sperm from 735 GM mouse lines on 12 common genetic backgrounds including C57BL/6J, BALB/cJ, 129S1/SvImJ, FVB/NJ and NOD/ShiLtJ were cryopreserved and recovered. C57BL/6J and BALB/cByJ fertilization rates, using frozen sperm, were slightly reduced compared to rates involving fresh sperm; fertilization rates using fresh or frozen sperm were equivalent in all other lines. Developmental capacity of embryos produced using cryopreserved sperm was equivalent, or superior to, cryopreserved IVF-derived embryos. Conclusions/Significance: Combined, these results demonstrate the broad applicability of our approach as an economical and efficient option for archiving and distributing mice.	[Ostermeier, G. Charles; Farley, Jane S.; Taft, Robert A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Ostermeier, G. Charles; Wiles, Michael V.] Jackson Lab, Technol Eval & Dev, Bar Harbor, ME USA	Jackson Laboratory; Jackson Laboratory	Taft, RA (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	rob.taft@jax.org	Ostermeier, G. Charles/Y-1172-2019	Ostermeier, G. Charles/0000-0002-3951-512X; wiles, michael/0000-0002-3620-8386; Taft, Robert/0000-0002-3634-3342	Ellison Medical Foundation; NIH [RR01262]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001262] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded in part by: The Ellison Medical Foundation; NIH grant RR01262; and Howard Hughes Medical Institute.	ALVAREZ JG, 1984, BIOL REPROD, V30, P833, DOI 10.1095/biolreprod30.4.833; Amann RP, 2005, THERIOGENOLOGY, V63, P698, DOI 10.1016/j.theriogenology.2004.04.010; Bailey JL, 2000, J ANDROL, V21, P1; Bath ML, 2003, BIOL REPROD, V68, P19, DOI 10.1095/biolreprod.102.007344; Byers SL, 2006, THERIOGENOLOGY, V65, P1716, DOI 10.1016/j.theriogenology.2005.09.016; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Clark J.D., 1996, GUIDE CARE USE LAB A; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Critser J K, 2000, ILAR J, V41, P197; DELAMIRANDE E, 1995, FREE RADICAL BIO MED, V18, P487, DOI 10.1016/0891-5849(94)00169-K; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Ecroyd HW, 2003, BIOL REPROD, V69, P347, DOI 10.1095/biolreprod.102.012716; Fuller SJ, 1997, MOL REPROD DEV, V46, P318, DOI 10.1002/(SICI)1098-2795(199703)46:3&lt;318::AID-MRD10&gt;3.0.CO;2-V; GIANFORTONI JG, 1985, GAMETE RES, V11, P59, DOI 10.1002/mrd.1120110107; GLENISTER PH, 1999, MOUSE GENETICS TRANS; Jiang MX, 2005, MOL REPROD DEV, V72, P129, DOI 10.1002/mrd.20328; Kaneko T, 2006, THERIOGENOLOGY, V66, P1098, DOI 10.1016/j.theriogenology.2006.02.049; Kito S, 2005, ZYGOTE, V13, P145, DOI 10.1017/S0967199405003205; Koshimoto C, 2002, BIOL REPROD, V66, P1477, DOI 10.1095/biolreprod66.5.1477; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; Mammoto A, 1996, BIOL REPROD, V55, P1063, DOI 10.1095/biolreprod55.5.1063; NAGY A, 2003, MANIPULATING MOUSE E, P175; NAKAGATA N, 1993, EXP ANIM TOKYO, V42, P317, DOI 10.1538/expanim1978.42.3_317; Songsasen N, 1997, CRYOBIOLOGY, V35, P255, DOI 10.1006/cryo.1997.2047; Stacy R, 2006, CRYOBIOLOGY, V52, P99, DOI 10.1016/j.cryobiol.2005.10.006; Szczygiel MA, 2002, BIOL REPROD, V67, P287, DOI 10.1095/biolreprod67.1.287; Sztein JM, 2000, BIOL REPROD, V63, P1774, DOI 10.1095/biolreprod63.6.1774; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; WOLF DP, 1976, J REPROD FERTIL, V48, P213, DOI 10.1530/jrf.0.0480213; Yildiz C, 2007, REPRODUCTION, V133, P585, DOI 10.1530/REP-06-0256	32	77	78	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 30	2008	3	7							e2792	10.1371/journal.pone.0002792	http://dx.doi.org/10.1371/journal.pone.0002792			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420QM	18665210	Green Published, gold, Green Submitted			2022-12-27	WOS:000264304300011
J	Lopardo, T; Lo Iacono, N; Marinari, B; Giustizieri, ML; Cyr, DG; Merlo, G; Crosti, F; Costanzo, A; Guerrini, L				Lopardo, Teresa; Lo Iacono, Nadia; Marinari, Barbara; Giustizieri, Maria L.; Cyr, Daniel G.; Merlo, Giorgio; Crosti, Francesca; Costanzo, Antonio; Guerrini, Luisa			Claudin-1 Is a p63 Target Gene with a Crucial Role in Epithelial Development	PLOS ONE			English	Article								The epidermis of the skin is a self-renewing, stratified epithelium that functions as the interface between the human body and the outer environment, and acts as a barrier to water loss. Components of intercellular junctions, such as Claudins, are critical to maintain tissue integrity and water retention. p63 is a transcription factor essential for proliferation of stem cells and for stratification in epithelia, mutated in human hereditary syndromes characterized by ectodermal dysplasia. Both p63 and Claudin-1 null mice die within few hours from birth due to dehydration from severe skin abnormalities. These observations suggested the possibility that these two genes might be linked in one regulatory pathway with p63 possibly regulating Claudin-1 expression. Here we show that silencing of Delta Np63 in primary mouse keratinocytes results in a marked down-regulation of Claudin-1 expression (-80%). Delta Np63 alpha binds in vivo to the Claudin-1 promoter and activates both the endogenous Claudin-1 gene and a reporter vector containing a -1.4 Kb promoter fragment of the Claudin-1 gene. Accordingly, Claudin-1 expression was absent in the skin of E15.5 p63 null mice and natural p63 mutant proteins, specifically those found in Ankyloblepharon-Ectodermal dysplasia-Clefting (AEC) patients, were indeed altered in their capacity to regulate Claudin-1 transcription. This correlates with deficient Claudin-1 expression in the epidermis of an AEC patient carrying the 1537T p63 mutation. Notably, AEC patients display skin fragility similar to what observed in the epidermis of Claudin-1 and p63 null mice. These findings reinforce the hypothesis that these two genes might be linked in a common regulatory pathway and that Claudin-1 may is an important p63 target gene involved in the pathogenesis of ectodermal dysplasias.	[Lopardo, Teresa; Lo Iacono, Nadia; Guerrini, Luisa] Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy; [Marinari, Barbara; Giustizieri, Maria L.; Costanzo, Antonio] Univ Roma Tor Vergata, Dept Dermatol, Rome, Italy; [Cyr, Daniel G.] INRS, Inst Armand Frappier, Laval, PQ, Canada; [Merlo, Giorgio] Univ Turin, Mol Biotech Ctr, Dulbecco Telethon Lab, Turin, Italy; [Crosti, Francesca] Med Genet Lab AO San Gerardo, Monza, Italy	University of Milan; University of Rome Tor Vergata; University of Quebec; Institut national de la recherche scientifique (INRS); University of Turin	Lopardo, T (corresponding author), Univ Milan, Dept Biomol Sci & Biotechnol, Milan, Italy.	luisa.guerrini@unimi.it	Costanzo, Antonio/D-3896-2012; Costanzo, Antonio/GZG-2433-2022; Cyr, Daniel/AIC-9460-2022	Costanzo, Antonio/0000-0001-9697-2557; 	Telethon [GGP05056]; AIRC; PRIN (MIUR)	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); PRIN (MIUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by a grant from Telethon (GGP05056) to L.G., by AIRC grant to A.C. and by a PRIN (MIUR) grant to L.G. and A.C.	Alexandre MD, 2005, J CELL SCI, V118, P2683, DOI 10.1242/jcs.02406; ANDERSON JM, 1988, J CELL BIOL, V106, P1141, DOI 10.1083/jcb.106.4.1141; Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; Barbieri CE, 2006, EXP CELL RES, V312, P695, DOI 10.1016/j.yexcr.2005.11.028; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Dufresne J, 2007, BIOL REPROD, V76, P825, DOI 10.1095/biolreprod.106.057430; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Ghioni P, 2002, MOL CELL BIOL, V22, P8659, DOI 10.1128/MCB.22.24.8659-8668.2002; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Kostera MI, 2004, J DERMATOL SCI, V34, P3, DOI 10.1016/j.jdermsci.2003.10.003; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Levi G, 2006, MECH DEVELOP, V123, P3, DOI 10.1016/j.mod.2005.10.007; Lo Iacono M, 2006, CELL CYCLE, V5, P78; Lo Iacono N, 2008, DEVELOPMENT, V135, P1377, DOI 10.1242/dev.011759; MARINARI B, 2008, J INVES DER IN PRESS; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nishi H, 2001, J BIOL CHEM, V276, P41717, DOI 10.1074/jbc.M101241200; QIAO F, 2005, SCI STKE, V31, pRE7; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; STEVENSON BR, 1988, J CELL BIOL, V107, P2401, DOI 10.1083/jcb.107.6.2401; Testoni B, 2006, NUCLEIC ACIDS RES, V34, P928, DOI 10.1093/nar/gkj477; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita S, 2000, J CELL BIOL, V149, P13, DOI 10.1083/jcb.149.1.13; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; van Bokhoven H, 2002, TRENDS MOL MED, V8, P133, DOI 10.1016/S1471-4914(01)02260-2; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; VANDERHOOFT SL, 1993, PEDIATR DERMATOL, V10, P334, DOI 10.1111/j.1525-1470.1993.tb00394.x; Wessagowit V, 2000, CLIN EXP DERMATOL, V25, P441, DOI 10.1046/j.1365-2230.2000.00683.x; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu ASL, 2003, J BIOL CHEM, V278, P17350, DOI 10.1074/jbc.M213286200	39	65	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2008	3	7							e2715	10.1371/journal.pone.0002715	http://dx.doi.org/10.1371/journal.pone.0002715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	420PY	18648642	Green Submitted, Green Published, gold			2022-12-27	WOS:000264302900002
J	Victoria, B; Ahmed, A; Zuerner, RL; Ahmed, N; Bulach, DM; Quinteiro, J; Hartskeerl, RA				Victoria, Berta; Ahmed, Ahmed; Zuerner, Richard L.; Ahmed, Niyaz; Bulach, Dieter M.; Quinteiro, Javier; Hartskeerl, Rudy A.			Conservation of the S10-spc-alpha Locus within Otherwise Highly Plastic Genomes Provides Phylogenetic Insight into the Genus Leptospira	PLOS ONE			English	Article							FAMILY LEPTOSPIRACEAE; RIBOSOMAL-RNA; DNA; INTERROGANS; SEROVARS; EVOLUTION; NOV.; DIFFERENTIATION; BORGPETERSENII; IDENTIFICATION	S10-spc-alpha is a 17.5 kb cluster of 32 genes encoding ribosomal proteins. This locus has an unusual composition and organization in Leptospira interrogans. We demonstrate the highly conserved nature of this region among diverse Leptospira and show its utility as a phylogenetically informative region. Comparative analyses were performed by PCR using primer sets covering the whole locus. Correctly sized fragments were obtained by PCR from all L. interrogans strains tested for each primer set indicating that this locus is well conserved in this species. Few differences were detected in amplification profiles between different pathogenic species, indicating that the S10-spc-alpha locus is conserved among pathogenic Leptospira. In contrast, PCR analysis of this locus using DNA from saprophytic Leptospira species and species with an intermediate pathogenic capacity generated varied results. Sequence alignment of the S10-spc-alpha locus from two pathogenic species, L. interrogans and L. borgpetersenii, with the corresponding locus from the saprophyte L. biflexa serovar Patoc showed that genetic organization of this locus is well conserved within Leptospira. Multilocus sequence typing (MLST) of four conserved regions resulted in the construction of well-defined phylogenetic trees that help resolve questions about the interrelationships of pathogenic Leptospira. Based on the results of secY sequence analysis, we found that reliable species identification of pathogenic Leptospira is possible by comparative analysis of a 245 bp region commonly used as a target for diagnostic PCR for leptospirosis. Comparative analysis of Leptospira strains revealed that strain H6 previously classified as L. inadai actually belongs to the pathogenic species L. interrogans and that L. meyeri strain ICF phylogenetically co-localized with the pathogenic clusters. These findings demonstrate that the S10-spc-alpha locus is highly conserved throughout the genus and may be more useful in comparing evolution of the genus than loci studied previously.	[Victoria, Berta; Quinteiro, Javier] Univ Santiago Compostela, Fac Biol, Dept Biochem & Mol Biol, Galicia, Spain; [Ahmed, Ahmed; Hartskeerl, Rudy A.] Royal Trop Inst KIT, Dept Biomed Res, Natl Collaborating Cre Reference Res Leptospirosis, WHO FAO OIE, Amsterdam, Netherlands; [Zuerner, Richard L.] USDA, Agr Res Serv, Natl Anim Dis Ctr, Bacterial Dis Livestock Res Unit, Ames, IA USA; [Ahmed, Niyaz] Ctr DNA Fingerprinting & Diagnost, Pathogen Evolut Lab, Hyderabad, Andhra Pradesh, India; [Bulach, Dieter M.] Monash Univ, Dept Microbiol, Australian Res Council, Ctr Excellence Structural & Funct Microbial Genom, Clayton, Vic, Australia	Universidade de Santiago de Compostela; Food & Agriculture Organization of the United Nations (FAO); United States Department of Agriculture (USDA); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Monash University	Victoria, B (corresponding author), Univ Santiago Compostela, Fac Biol, Dept Biochem & Mol Biol, Galicia, Spain.	r.hartskeerl@kit.nl	Bulach, Dieter M/D-5793-2011; Quinteiro, Javier/C-4410-2011; Ahmed, Niyaz/D-2589-2010; Zuerner, Richard/AAG-7645-2021	Bulach, Dieter M/0000-0001-9823-6078; Quinteiro, Javier/0000-0002-8683-9522; Ahmed, Niyaz/0000-0001-6425-7583; 				Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARIL C, 1992, J BACTERIOL, V174, P7566, DOI 10.1128/JB.174.23.7566-7571.1992; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; do Oliveira MAA, 2003, J MED MICROBIOL, V52, P127, DOI 10.1099/jmm.0.04923-0; ELBARADI TTAL, 1987, J MOL BIOL, V195, P909, DOI 10.1016/0022-2836(87)90494-3; ELLINGHAUSEN HC, 1965, AM J VET RES, V26, P45; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GOURSE RL, 1981, P NATL ACAD SCI-BIOL, V78, P2722, DOI 10.1073/pnas.78.5.2722; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; HILLIS DM, 1992, J HERED, V83, P189, DOI 10.1093/oxfordjournals.jhered.a111190; JOHNSON RC, 1967, J BACTERIOL, V94, P27, DOI 10.1128/JB.94.1.27-31.1967; Kositanont U, 2007, DIAGN MICR INFEC DIS, V57, P117, DOI 10.1016/j.diagmicrobio.2006.07.014; Letocart M, 1999, INT J SYST BACTERIOL, V49, P231, DOI 10.1099/00207713-49-1-231; Letocart M, 1997, J CLIN MICROBIOL, V35, P248, DOI 10.1128/JCM.35.1.248-253.1997; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; MANIATIS T, 1983, MOL CLONING LAB MANU; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; PASTER BJ, 1991, J BACTERIOL, V173, P6101, DOI 10.1128/JB.173.19.6101-6109.1991; Perolat P, 1998, INT J SYST BACTERIOL, V48, P851, DOI 10.1099/00207713-48-3-851; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Priya CG, 2007, J POSTGRAD MED, V53, P236; RAMADASS P, 1992, INT J SYST BACTERIOL, V42, P215, DOI 10.1099/00207713-42-2-215; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Rossetti CA, 2005, VET MICROBIOL, V107, P241, DOI 10.1016/j.vetmic.2005.01.015; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Slack AT, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-95; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VALVEREDE MAD, 2008, INFECTION G IN PRESS; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407; ZUERNER RL, 1993, J BACTERIOL, V175, P5445, DOI 10.1128/JB.175.17.5445-5451.1993; Zuerner RL, 2000, FEMS MICROBIOL LETT, V182, P303, DOI 10.1016/S0378-1097(99)00598-4	42	84	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2008	3	7							e2752	10.1371/journal.pone.0002752	http://dx.doi.org/10.1371/journal.pone.0002752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	417DX	18648538	Green Published, Green Submitted, gold			2022-12-27	WOS:000264057200074
